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This year, 2,985 abstracts (original contributions) were
submitted for evaluation. Each was graded by eight rec-
ognized authorities in a special area of interest. Ac-
ceptance for presentation was based on the relative grade
ranking in each of the 26 categories.
Ample meeting space combined with the introduction
of poster sessions permitted the 1986 Annual Scientific
Session Program Committee to accept 999 abstracts, ap-
proximately 33.5% of the number submitted. This rep-
resents the largest number of abstracts accepted at any
Annual Scientific Session of the American College of
Monday, March 10, 1986
10:30AM-12:00NOON, Room #264/265/266
Intraoperative Echocardiography
ULTRASONIC INTRAOPERATIVE EVALUATION OF CORONARY LESIONS
David McPherson, MD, Steve Collins, PhD, Michelle Hunt,
BS, Loren Hiratzka, MD, Melvin Marcus, MD, FACC, Richard
Kerber, MD, FACC, U. of Iowa, Iowa City, IA
Quantitative angiographic evaluation of coronary lesions
assumes circular lumen geometry, which may not be true.
Intraoperative high frequency epicardial echocardiography
(HFE) allows in-vivo evaluation of coronary lesions not
previously possible. We utilized HFE in 26 patients (31
lesions) undergoing CABG. Lesion shapes based on con-
tours of the arterial lumen and wall circumference were
quantified. The variability of atherosclerotic involve-
ment was measured using the ratio of maximum (max) to
minimum (min) arterial wall thickness (WT), and the % of
wall circumference that had normal WT (~0.7 mm in preVi-
ous studies). Residual coronary lumen shape was evaluat-
ed by measuring max/min lumen diameter (LD); shape was
classified as circular (ratio ~ 1.5:1); oval (>1.5:1) or
complex. The location of the residual lumen within the
vessel was considered eccentric if the lumen center was
displaced from the vessel center by > 1 lumen radius.
Results: Max/min WT was 3.1±0.3 M±SEK (range 1.3-7.5).
16731 lesions had ratios> 2.0, indicating varying degrees
of wall involvement within individual lesions. Portions
of the wall were normal in 16/31 lesions; the %normal
circumference ranged from 9-85%. Max/min LD was 1.5±0.1
M±SEK (range 1.1 to 2.9). The shape of the residual coro-
nary lumen was noncircular in 16 lesions: 13 oval, 3
complex. Seven residual coronary lumens were eccentrica~
ly placed within the vessels.
Conclusions: These data provide the first quantitative
in-vivo measurements of cross-sectional coronary lesion
morphology. In-vivo coronary lesions often have variable
WT and noncircular lumens which are eccentrically
placed. In these lesions,angiographic techniques for
evaluating stenosis severity are likely to be inaccurate.
Cardiology. Many excellent contributions were received
for this year's competition, and we appreciate your sup-
port and interest.
Robert A. O'Rourke, MD, FACC
Chairman, 1986 Annual Scientific Session
Program Committee
Michael H. Crawford, MD, FACC
Co-Chairman, 1986 Annual Scientific Session
Program Committee
TRANS-ESOPHAGEAL REAL TIME DOPPLER FLOW IMAGING:
A NEW METHOD FOR INTRAOPERATIVE CARDIAC
EVALUATION. Martin E. Goldman MD FACC, Daniel Thys MD,
Samuel Ritter MD, Zaharia Hillel MD PHD, Joel Kaplan MD, Mt.
Sinai Medical Center, NY, NY
Intraoperative detection and quantification of valvular
regurgitation or intracardiac shunt flow is difficult and
inaccurate by current methods: hemodynamics and palpation.
Therefore, we describe for the first time the application of
intraoperative transesophageal real time Doppler flow imaging
(Aloka and Irex) with a 5 MHz phased transducer mounted on a
modified gastroscope. The machine superimposes a wide sector
color-coded Doppler flow over a real time 2-D echocardiographic
image. The tube length is 100 em long, with 32 imaging elements
spaced 0.18 mm apart, with an axial resolution of Imm, and has
a 900 image sector and 1200 anterior-posterior flexibility.
Patients with valvular regurgitation, stenosis or intracardiac
shunts were evaluated. In each patient the probe was easily
passed into the esophagous, positioned behind the left atrium,
and quiCkly demonstrated the abnormal flow in several views: 4
chamber, long or short axis. The presence and severity of
abnormal flow was easily recognizable and estimated based on
the total area of abnormal colored flow compared to the size of
the entire chamber (i.e., the LA in mitral regurgitation) and
correlated well with catheterization findings. Also, changes in
the regurgitant or shunt flow due to variations in anesthetic
agents and arrhythmias were clearly visible on line in the
operating room.
Thus, transesophageal real-time Doppler flow imaging is
superior to present methods for detection of abnormal blood flow
in the operating room because it is rapid, reproducible and allows
detection of beat to beat changes in flow patterns. Real time
Doppler flow can evaluate the presence and severity of abnormal
cardiac flow both before and immediately following a surgical
procedure to detect its adequacy in the operating suite,
potentially reducing surgical morbidity and mortality.
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THE INTRAOPERATIVE DETECTION OF MYOCARDIAL INFARCTION BY
TRANS ESOPHAGEAL ECHOCARDIOGRAPHY
Bruce Shivel~, M.D., Thomas Watters, M.D., David Benefiel,
'I'I';1J;'I MiehAr C8lililan, M.D., Elias H. Botvinick, M.D.,
F.A.C.C., Nelson B. Schiller, M.D., F.A.C.C., University of
California, San Francisco, CA
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We assessed the value of transesophageal echocardiography (2D-
TEE) for detection of intraoperative myocardial infarction (MI)
in 57 patients (pts) undergoing coronary bypass surgery.
During the first 24 hrs postop all pts had ~2 EXG s and ~l O<MB
and irifarct-avid imaging with Technetium 99m-Imidodiphosphonate
(lOP) 3-7 days pos top. Wall motion on serial intraop 2D-TEE
recordings was scored in each of 4 quadrants of the LV short
axis view. Final scores required
agreement by 2 of 3 observers blinded to
other test resul ts. 2D-TEE was 1$ for
MI if a normal region became hypo- or
akinetic or if a hypOkinetic region
became akinetic. 2D-TEE was E) for MI
if regional wall motion showed transient
or no change. Pts wi th any' 2 of 3
tests (t\ (EKG, CKHB, or IDP) were
considered <l> for MI. 6 pts with the
fi rs t (}) CKHB > 24 hrs pos top were
excludea. Table 1 shows that for
detection of MI 2D-TEE had a sensitivi ty
of .46, specificity of .95, <!l
predictive value of .75 and 0
predictive value of .84. If pts with
baseline severe diffuse hypokinesis are
excluded, the number of false (=) 's
decreases from 7 to 4. Table 2 Shows
relative a~eement of &KG and 2D-TEE
wi th MI ( IDP and <I> CKMB). The
frequency 0 agreement of 2D-TEE with
HI is > EXG with MI. Table 3 shows
high agreement of lOP and 2D-TEE wi th
MI (EEl EXG and 1+\ O<MB). 2D-TEE shows
promise for immediate postop detection
of HI in this high risk group when &KG
is the only other available test. The
sensitivi ty of 2D-TEE is higher in pts
wi thou t severe ly decreased baseline
sys tolie func tion.
COLOR DOPPLER FLOW MAPPING FOR INTRAOPERATIVE ASSESSMENT
OF VALVULOPLASTY AND REPAIR OF CONGENITAL HEART DISEASE.
Gerald Maurer. MD. FACC; Lawrence Czer, MD, FACC; Michele
De Robertis, RN; Aurelio Chaux, MD, FACC; Robert Kass,
MD, FACC; Myles Lee, MD, FACC, Jack Matloff, MD, FACC.
Cedars-Sinai Medical Center, Los Angeles, CA
To study the usefulness of intraoperative (OP) Doppler
color flow mapping (CFM) as an early predictor for the
success of cardiac surgical repair procedures, and to
compare the grading of valvular regurgitation to angio-
graphy and closed chest CFM, we performed OP CFM in 35
pts. The transducer was placed directly on the epicardium
before and immediately after cardiopulmonary bypass; in
addition, closed chest pre- and post-operative CFM was
done. Seven valvuloplasty procedures were studied: 2 for
ischemic mitral regurgitation (MR), 2 tricuspid annulo-
plasties, 2 cleft mitral valve repairs and 1 cleft tri-
cuspid valve repair. OP CFM showed that in 6 of the 7,
regurgitation decreased from severe (3 or 4+) to none or
trace. One mitral valve was found to be insufficient (3+)
at the residual cleft. Postoperative CFM and physical
examination confirmed these findings early (pre-dis-
charge) as well as in subsequent follow up. The adequacy
of shunt closure of secundum (4) and primum ASD (2), VSD
(2), patent foramen ovale (2) and the atrial redirection
of flow in Mustard procedure for d-transposition (1) were
clearly confirmed. In 15 pts with St. Jude valve replace-
ments (7 mitral,S aortic, 3 double) mild prosthetic
valve regurgitation and 3 separate antegrade flow jets
were demonstrated. Seven control pts with CABG and no
valve surgery were also studied. In all groups, severity
of MR and aortic regurgitation by OP CFM corresponded
well to angiography and closed chest CFM.
CONCLUSION: OP CFM appears to be a powerful intraopera-
tive predictor of the outcome of valvuloplasty and
congenital repair procedures and may thus prevent the
need for later reoperation.
INTRA-OPERATIVE ECHOCARDIOGRAPHIC EVALUATION OF THE TEX-
TURE OF THE ISCHEMIC MYOCARDIUM.
K. Chandrasekaran, M.D., J. F. Greenleaf, Ph.D., K. H.
Kim, M.D., B. S. Robinson, Ph.D., W. D. Edwards, M.D.,
F.A.C.C., J. B. Seward, M.D., F.A.C.C., and A. J. Tajik,
M.D., F.A.C.C., Mayo Clinic, Rochester, MN
The effect of variable periods of reversible ischemia
(Is) on 2D echo (2DE) texture (Tx) of the myocardium
(M) was evaluated from 2DE obtained intra-operatively
in 9 dogs using a high-frequency (Hf) 12 MHz ultrasonic
scanner to determine whether it can identify Is Mfrom
normal. 2DE of anterior (Aw) and posterolateral (Pw)
walls of left ventricle were obtained in the control
state (C), and at 5, IS, and 30 mins (') of Is produced
by ligation of left anterior descending coronary artery.
8-bit gray level values for backscatter amplitude (Bs)
were obtained from digitized video images. Aw thickness
(t) decreased during systole (S) and diastole (D) at 5'
of Is compared to C. No further changes occurred at 15'
and 30' of Is. t in mm at C were 5=6.8+2.2 and D=4.4+1.2
and at 5' of Is, S=3+0.5 and D=2.4+0.6: 2DE of Aw sub-
jected to Is, revealed increased brlghtness compared to C
and normally perfused Pw. Mean gray level values (x~SD)
of Bs from Aw and Pw were:
# Aw(S) Aw(D) # Pw(S) Pw(D)
C 9 40.3+37.7 72.6+47.6 8 38.3+25.1 66.6+39.0
5' 7 66.1+46.0* 67.4+33.9t 6 28.0+11.2 52.5+34.5
IS' 8 97.5+51.4* 88.6+54.2t 7 39.6~23.3 69.3~38.9
30' 8 101.5+45.6* 95.7+40.1t 7 40.3+23.6 74.4+43.4
(P*<O.OOOl, tP<0.05 compared to C)
We conclude: Hf 2DE revealed abnormal Tx of Is Mwhich
could be confidently differentiated from normal M. Gray
level values significantly increased in Is Mas early as
5', thereby providing a potential means of reliably re-
cognizing Is Mintra-operatively.
THE CONTINUOUS WAVE DOPPLER ESOPHAGEAL PROBE: A NEW
METHOD FOR MEASUREMENT OF CARDIAC OUTPUT DURING SURGERY
Anil Kumar, MD, S Minagoe, MD, D Thangathurai, MD, M
Mikhail, MD, D Novia, MD, J Viljoen, MD, PAN Chandra-
ratna, MD, FACC, SH Rahimtoola, MD, FACC. LAC-USC Medical
Center, Los Angeles, CA
In 14 patients (pts) with cardiopulmonary disease
cardiac output (CO) was measured during surgery with a
new continuous wave doppler (CWO) transducer positioned
in the esophagus. The ultrasound beam interrogates
descending aortic flow at 45°. The transducer was
connected to a modified Ultracom Cardiac Output Monitor
and blood flow velocity in descending aorta (DAV) was
measured. Doppler cardiac output (DCO) was determined by
the relationship DCO=K.DAV, where K is a derived constant
based on ascending aortic diameter and a simultaneous
measurement of blood flow velocity in ascending aorta
from a suprasternal probe and the DAV. CO was also
measured by thermodilution technique (TDCO). TDCO and DCO
measurements (n=246 in 14 pts) temporally close were
averaged & arranged into epochs (n=84). Mean TDCO was
5.90~3.27 (~SD) l/min & mean DCO was 6.21~4.0/min for the
whole group (r=.76; SEE=I.76 l/min). Trends in TDCO were
reliably paralleled by DCO except at very high CO values.
Adequate Doppler signal was unobtainable in 1 pt:
frequent transducer repositioning was needed in another.
No untoward effects were noted. Reproducibility studies
in 8 other pts showed good interobserver (mean difference
.41~.36 l/min) and intraobserver (mean difference
.64~.52 l/min) reproducibility. DCa measurement by CWD
esophageal probe is a noninvasive method for measuring co
during surgery in high risk pts with cardiopulmonary
disease.
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10:30AM-12:00NOON, Room #260/261
Clinical Cardiac Pacing
DISCRIMINANT P WAVE SENSING ABOLISHES ENDLESS LOOP TACHY-
CARDIA
Peter T. Klementowicz, M.D., Seymour Furman, M.D., F.A.C.C.
Montefiore Medical Center, Bronx, New York
Adequate atrial sensing depends upon several features of
the atrial signal: amplitude, slew rate and frequency con-
tent. With the introduction of dual chamber pacemakers
which have multiple atrial amplitude sensing values, selec-
tive P wave sensing is possible. Antegrade atrial signals
can be sensed while smaller retrograde signals are ignored.
To demonstrate the clinical utility of selective P wave
sensing we studied 5 consecutive pts who had 1) retrograde
conduction 2) antegrade atrial signals which were at least
1.4 times larger than their corresponding retrograde atrial
signals and 3) dual chamber pulse generators which are cap-
able of discriminating this difference in atrial amplitude.
Each pt was programmed to the DDD mode and the postventri-
cular atrial refractory interval was at least 100 ms short-
er than the individual's minimal retrograde conduction
time. Two atrial sensitivity settings were evaluated in
each pt: a high setting to ensure sensing of both antegrade
and retrograde P waves and a lower setting to allow sensing
of antegrade P waves only. Ambulatory Holter monitoring de-
monstrated that with a high sensitivity setting each pt
sustained endless loop tachycardia (mean # of episodes 41,
range 6 to 143) and that a low atrial sensitivity setting
eliminated the tachycardia. With the lower atrial sensitiv-
ity setting, there was only sporadic atrial undersensing
(1.5 episodes for each 1000 P waves). Conclusions: This
study demonstrates that atrial signals having different am-
plitudes can be selectively sensed. Also, dual chamber pul-
se generators with mulitple atrial amplitude sensitivity
values can discriminate antegrade from retrograde P waves,
ensure antegrade sensing, reject retrograde P waves and
eliminate endless loop tachycardia.
THE LATE EFFECTS OF STEROID-ELUTING LEADS
Gerald C. Timmis, M.D., F.A.C.C., Victor Parsonnet, M.D.,
F.A.C.C., Seymour Gordon, M.D., F.A.C.C., Douglas C.
Westveer, M.D., F.A.C.C. and James R. Stewart, M.D.,
F.A.C.C., William Beaumont Hospital, Royal Oak, Michigan
and Beth Israel Medical Center, Newark, New Jersey.
Previous reports have compared the performance of steroid-
eluting leads (S-lead; Medtronic 4003) to that of conven-
tional leads. This study contrasts chronic thresholds
resulting from elution of dexamethasone-sodium phoshate
to those of identically configured control leads with
platimum-coated porous titanium electrodes but no steroid
(C-lead; 10176). Twenty of 28 patients with the S-Lead and
6 of 14 with the C-Lead were followed for 18 months to
determine whether prevention of early threshold peaking and
subsequent lowering of thresholds is sustained by the
S-Lead. Serial pulse width (PW) thresholds at one quarter
generator output (1.35 V) were measured each week (wk) x 6
and every three months (mo) thereafter, using a Medtronic
5907C programmer-receiver. A plot of serial thresholds (ms)
• is depicted. While no threshold peaking
,_~:,' ~ I I J,~ ~~~~r::~ew;~~s~~~~~:lt;a~~w~~ ~~r~~holdSmonths (p=.023, ANOVA) with the S-Lead
(.15+.05) than the C-Lead (.27+.004). No
exit-block was seen with S- or-C-Leads.
This suggests that early steriod-suppress-
ion of inflammation and/or fibrosis
'-..-.,..--.--,---.- chronically increases effective current
.... density and/or lowers pacing impedance.
CONCLUSIONS: Chronic thresholds with S-Leads are consis-
tently lower than those of C-Leads. To improve generator
longevity current drain can be programmed to its lowest
level with S-Leads which are also ideal for managing high
threshold problems.
THE EFFECTS OF NUCLEAR MAGNETIC RESONANCE (NMR) ON
IMPLANTABLE PULSE GENERATORS
David L. Hayes, M.D., F.A.C.C., David R. Holmes, Jr.,
M.D., F.A.C.C., Joel E. Gray, Ph.D., Joseph G. Fetter*,
George C. Aram*, Peter Tarjan, M.D.**, Lisa Prechter**,
Mayo Clinic, Rochester, MN; * Medtronic, Inc.,
Minneapolis, MN; and ** Cordis Corporation, Miami, FL.
Whether all patients with permanent pacemakers should be
restricted from NMR studies has not been established.
This study assessed the effects of an NMR imager
operating at 1500 gauss and 6.4 megahertz on 5 single and
9 dual-chamber pacemakers from 5 manufacturers in the
VVI, AAI, DDD and VDD modes. Pacemakers were implanted
and connected to leads in an anesthetized dog placed in
the NMR radio frequency field which was pulsed at 200,
300, and 1000 pulse/minute rate with a maximum power of
1000 watts. The dog was connected to ECG telemetry and
femoral intra-arterial pressure monitoring. All pace-
maker reed switches closed producing asynchronous pacing
as they were brought into the static magnetic field.
Four single and 4 dual-chamber pacemakers paced the heart
at the radio frequency pulse period resulting in rates to
300/min and concomitant fall in intra-arterial pressure.
Phantom programming was not observed. Two pacemakers did
display transient complete inhibition following a period
of radio frequency exposure.
Summary: The mechanism of this rapid pacing at the
radio frequency pulse period is not completely understood.
Although it appears that patients with implanted pulse
generators not affected during our tests may undergo NMR
scans of comparable field strengths, other pulse genera-
tors and NMR units of greater field strengths must be
evaluated before any comprehensive recommendation can be
made.
PHYSIQIroIC PACING BASED ON BEAT-'IO-BEAT MEAStJREMENr OF
RIGIfl' VENTRICUIlIR dP/dt MAX: INITIAL FEASIBILITY
S'IUDIES IN MAN.
Arjun Sharma, M.D., F.A.C.C., Richard Sutton, M.D.,
F.A.C.C., Tan Bennett, Ph.D., George Klein, M.D.,
F.A.C.C., Kenneth Anderson, Robert Beck, London,
canada1 London, England1 and Minneapolis.
Recent studies in a canine model of heart block
indicate that pacing rates controlled by right
ventricular (RVl dP/dt max may closely awroximate the
rate response to atrial synchronous pacing (VAT). we
examined the feasibility of using this new modality to
provide physiologic pacing in man. Four patients (age
31-84) with C01lplete heart block were studied. A
permanent ventricular endocardial pacing lead
(Medtronic 6220) which incorp:>rates a dynamic pressure
sensor was implanted with a WI pacemaker (Medtronic
2451). RV pressure was non-invasively monitored by
telemetry at times between 3 and 18 months post
implant. The patients underwent treadmill exercise
testing and postural changes during WI pacing at rate
70. This data was used to determine the relationship
between dP/dt max and pacing rate. Patients underwent
repeat treadmill testing with the IN pressure wave form
COOIpUter processed on a beat-to-beat basis. '!he
computer emitted pulses at a variable rate
proportionate to RV dP/dt max, and the amplified pulses
were used to drive the pacemaker in the triggered mode.
In this mode of pacing increases in rate were observed
with increased exercise levels (f:1 HR+29.3+5.4 bpn at
peak exercise). Rate increased with actiVe postural
change (+ 12 bpn) and passive tilt (+ 11.3 bpn). we
conclude that physiologic pacing based on RV dP/dt max
is a feasible alternative to present modalities.
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With I (n- 54) 1.8 3.7 1.8 7.3
Prior II (n-126) 1.5 5.5 5.5 12.5
HI III (n- 73) 2.7 8.2 10.9 21.8
SW abnormality was responsible for placing 7/11 no prior
HI pts with events and 4/6 prior HI pts with events into
Group III. Conclusion: 1) different patterns of PD and SW
by Q-Tl are predictive of I-year coronary events in pa-
tients with and without prior MI and 2) quantification of
SW adds to the prognostic abilility of PO alone.
Monday, March 10, 1986
10:30AM-12:00NOON, Room #360/361
Thallium 201: I. Quantitative Methods and
Dipyridamole Studies
PROGNOSIS IN CORONARY ARTEllY DISEASE: ASSESSMENT BY QUAN-
TITATIVE STRESS-REDISTRIBUTION 11-201 MYOCARDIAL SCINTI-
GRAPHY. Jamshid Maddahi, MD, FACC; Joshua Gurewitz, CNMT;
Timothy Bateman, MD, FACC; Howard Stani10ff, MD, FACC; Is-
hac Cohen, PhD; Daniel Berman, MD, FACC. Cedars-Sinai Med-
ical Center, Los Angeles, CA
Total
3.3
9.8
19.6
I (n-481)
II (n-232)
III (n- 56)
We have previously shown with quantitative stress-redis-
tribution Tl-20l studies (Q-Tl) that the presence of per-
fusion defect (PO) and/or slow washout (SW) in the distri-
bution of left-main (1M) and/or all three coronary arter-
ies (TVD) identifies high-risk angiographic CAD. Thus, we
assessed whether different patterns of PO and SW could
predict subsequent coronary events in 1022 patients who
underwent stress-redistribution Q-Tl imaging from July
1980 to July 1982. Of 86 pts suffering a coronary event at
1 year followup, 13 had cardiac deaths, 27 nonfatal myo-
cardial infarctions (MI), and 46 worsening of symptoms re-
quiring late bypass surgery (LCABG) (>60 days after Q-Tl).
In the 769 without and 253 with prior MI, the prognostic
significance of 3 Q-Tl patterns were assessed: I) normal,
II) abnormal but Without, and III) with PO and/or SW in
TVD or 1M distribution. Event rates (%):
Death HI LCABG
0.2 0.8 2.3
2.1 1.7 6.0
3.6 7.1 8.9
No
Prior
HI
The need for a cardiac pacemaker responsive to metabolic
demand is well accepted, but the methods to monitor metabolic
demand have been deficient. A new method is described which
uses intravascular impedance (lImp) changes to monitor respira-
tory (Resp) rate and tidal volume. A potential advantage of this
method is that a permanent pacing system would require only
minor modifications of standard pacing leads.
Employing standard multipolar catheters nine patients had
unipolar and bipolar lImp measurements using multiple sites [SVC,
pectoral skin (SK), and endocardial and free-floating RA and RV
sites] as the stimUlating and sensing electrodes. The current
source was a 1 mAmp, 33 IJsec, 90 Hz signal. The amplitudes of
both the Resp and stroke volume (SV) components of the lImp
were measured. The ratio of maximal forced ventilation (MFV) to
normal breathing (nasal thermistor) was used as an index of
sensitivity; the ratio of the Resp to the SV components was used
as an index of specificity.
lImp changes reflecting Resp rate, tidal volume and SV were
accurately determined in all patients. The average lImp during
normal Resp and during MFV for all configurations studied were
0.37 ± 0.34 and 1.23 ± 1.07 ohms, respectively. The SV component
varied from 0.2 to 0.35 ohms depending upon electrode sites. The
best combination of sensitivity and specificity was obtained by
stimulating from the free-floating RV and SK sites and sensing
from the free-floating RA and SK sites. This produced sensitivity
and specificity ratios of 6 and 13, respectively.
Thus, Resp rate and tidal volume measurements using lImp
with multipolar catheters in the SVC and cardiac chambers are
technically feasible and may provide a new method suitable for
use as a rate controller for cardiac pacing.
RESpmATION RELATED INTRAVASCULAR IMPEDANCE
CHANGES AS A RATE CONTROLLER FOR CARDIAC
PACING. Tony Simmons MD, James Maloney MD, Freddy Abi-
Samra MD, Harry Valenta PhD, Tibor Napholtz, PhD, Lon Castle
MD, Victor Morant, MD. Cleveland Clinic Fndn., Cleveland, OH
BIPOLAR PACING THRESHOLDS BETWEEN A SINGLE MYOCARDIAL
ELECTRODE AND EPICARDIAL PATCH ELECTRODE ARE SUPERIOR TO
THOSE BETWEEN TWO MYOCARDIAL ELECTRODES.
Paul J. Troup. H.D., F.A.C.C., Jule N. Wetherbee, H.D.,
Peter D. Chapman, M.D., Gordon N. Olinger, M.D.,
Medical College of Wisconsin, Milwaukee, Wi.
To determine the feasibility of pacing from 1 of the
shocking leads of the automatic implantable cardioverter
defibrillator (AICD), we compared pacing data between 2
Intec Model 1-511 myocardial screw-in electrodes (MSEs)
and those between 1 of the MSEs and a ventricular [13.5
om2 (11 patients) or 27 cm2 (32 patients)] patch
shocking electrode placed over the anterior or
posterolateral left ventricle in 113 patients undergoing
AICD lead system implants. The pacing threshold data
were as follows:
·SILENT" EXERTIONAL ISCHEMIA IN PATIENTS VITH HIGH-RISK
CORONARY ARTEllY DISEASE. Steven Reisman, MO; Jamshid
Maddahi, MD, FACC; Alan Rozanski, MO; Daniel Berman, MD,
FACC. VA Medical Center, Long Beach, and Cedars-Sinai
Hedical Center, Los Angeles, CA
In light of recent reports suggesting a high frequency of
asymptomatic ("silent") ischemia in patients with coronary
artery disease (CAD), increasing attention is being focus-
ed on the clinical importance of chest pain symptomatology
in patients with "high-risk" CAD, defined as left-main
and/or triple-vessel CAD. Since the results of testing in-
fluence clinical decisions in this group, we analyzed the
relationship between the presence or absence of exertional
angina during treadmill testing and the extent and severi-
ty of exercise-induced ischemia, by evaluating 55 consecu-
tive patients (pts) with Tl-201 exercise-induced ischemia
(>1 reversible segment) and left-main and/or triple-vessel
stenosis (>50%). Three-view Tl-201 scintigrams were divi-
ded into 15 segments. Severity of exercise-induced ischem-
ia was represented by a Tl-201 ischemic severity score
(ISS) and extent of ischemia by Ureversible Tl-201 seg-
ments. Exertional angina during treadmill testing was
present in 34 pts (62%) (GpI) and absent in 21 pts (38%)
(GpII).
ISS # R Segs Ex Dur HR Max STt
GpI 7-:1+4."6 4.2+2. 5 ~ 134.7+22.9 2':O+i'":5
GpII 6.7+4.0 4.0+2.0 7.9~3.3 137.4+18.4 2.4+1.1
R segs-reversible -segments; Ex-exercise; Our-duration
(minutes); HR-peak heart rate; Max STt- maximum ST depres-
sion (mm). No significant differences were noted between
the two groups. We conclude that in pts with high-risk CAD
and Tl-201 ischemia, silent exertional ischemia is common
and does not indicate a less ischemic group. Thus, the
presence or-absence of angina during treadmill testing may
not be reliable for guiding medical or surgical interven-
tion in this patient group.
MSE to Patch
1.06j:O.77 volts'
3.32±3.0 mA
383±131 ohms'
13.05±5.8 mV
~
1.90±1.2 volts
3.30±2.4 mA
640±150 ohms
12.113±5.8 mV
Voltage Threshold
Current Threshold
Resistance
Electrogram Amplitude
• = p <0.01.
There was no significant voltage threshold difference
between the 13.5 cm2 and 27 cm2 patch employed as the
pacing anode. We conclude that voltage threshold and
resistance are significantly reduced by pacing between a
myocardial lead and patch electrode without compromising
eleotrogram amplitude when compared with pacing between
2 MSEs. A greater safety margin for ventricular capture
may be provided in patients with future generation AICDs
employing the patch electrode for pacing.
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QUANTITATIVE SUBTRACTION THALLIUM-201 IMAGING TO
ASSESS THE EFFECTS OF ACUTE REPERFUSION IN
MYOCARDIAL INFARCTION
Robert C. Bourse, M.D.; Russell C. Reeves, MD, FACC; William
J. Rogers, MD, FACC; Patrick L. Whitlow, MD, FACC; Joseph
R. Logic, MD; Michael V. Yester, Ph.D; Gerald M. Pohost, MD,
FACC. University of Alabama, Birmingham, Alabama.
We applied a new computerized subtraction program to
myocardial Tl-201 images obtained prior to and immediately
after intracoronary streptokinase and/or coronary angioplasty in
16 male patients with acute myocardial infarction (age=49.1!8).
Reperfusion by either method was demonstrated in 13 of 16
patients 5.7+1.3 hr after onset of pain. Prior to intervention
early images-eEl were obtained 10 min after 1 mCi of T1-201 IV,
in the anterior and 450LAO views. After intervention, "mask"
images were obtained, an additional 2 mCi given, and repeat
images were obtained. The subtraction program aligns the mask
and repeat images in each view and produces a "subtracted"
image (S) representing Tl-201 distribution after the 2 mCi dose.
Delayed images (D) were obtained 2 hr later. A gated
radionuclide angiogram was then performed and repeated 7 days
post MI. All thallium images were quantitatively analyzed
resulting in an index of thallium activity for each of IS segments
in each view normalized to the segment with the most activity in
E. The Tl-201 activity in segments with decreased activity in E
«60% of the maximum activity) were compared to these same
segments in Sand 0 and the differences summed to obtain a
value comparing images in each patient. Patients with
improvement in global ejection fraction> 5 units had increased
Tl-201 activity in S compared to E (S-E = 9.2+4), significantly
higher than patients with no significant change in ejection
fraction (5-E = 2.7+6; p<.05). No significant difference was found
in D-E activity between groups. We conclude that quantitative
subtraction Tl-201 imaging may permit early prediction of
myocardial salvage (as evidenced by improvement in myocardial
function) with acute reperfusion in myocardial infarction.
DIPYRIIlAHOLE 'l'BALLIUM IMAGING UNMASKS EVIDENCE OF
ISCHEMIA IN PATIENTS WITH NORMAL BUT SUBMAXIHAL
EXERCISE 'l'BALLIUH TEST
DAVid Z. Ygupg, H.D,. Timothy E. Guiney. H.D•• F.A.C.C••
George Pelko. B.A•• Kenneth A. HcKulick. H.D•• H. William
Strausl. H.D•• F.A.C.C•• Robert D. Okada. H.D•• F.A.C.C••
Charlel A. Boucher. H.D•• F,A.C.C•• Maslachuletts Generll
Holpital. Boston. MA
False negative exercise thallium seaus occur wheu the
level of exercise wal lubmaximal and the perfusion
abnormality was not _asked. To study the incidence of
this probl_. we evaluated the ability of non-exercise
stresl thallium imaging following intravenous dipyridamole
to detect ilchemia in patientl with DOrmal but submaximal
exercile thallium telts. In a prospective study of 385
consecutive exercise thallium tests. 72 (19%) were judged
to be DOrmal submaximal tests after meeting the following
criteria: (1) maximum heart rate achieved <85% of the
heart rate predicted based on age and/or shortened
treadmill time and (2) absence of angina. diagnostic
ST-Iegment depression and thallium redistribution.
Twenty-one patientl conlented to return for dipyridamole
thallium bRaging within a mean period of 18 dayl. Six
(291) of these demonstrated thallium redistribution with
dipyridamole thallium imaging that was not present during
exercise thallium imaging. Hean age (57 vs 53 years).
maximum heart rate achieved (135 vs 134 bpm). treadmill
time (5.5 vS 7.2 min) and hiltory of previous myocardial
infarction (2 vs 5) were limilar (P=NS) in thOle with and
without redistribution.
We conclude (1) normal lubmaximal exercise thallium telts
occur comaonly in an active nuclear cardiology laboratory
and (2) dipyridamole thallium imaging _aske evidence of
ilchemia in more than 25 percent of such cases.
QUANTITATIVE ASSESSllENT OF DIPYRIDAMOLE THALLIUH-201 PLA-
NAR SCINTIGRAMS: COMPARISON OF DIPXRIDAKOLE-SPECIFlC TO
STRESS NORMAL LIHITS. George T O'Byrne, MB; Daniel Berman,
MD, FACC; Kenneth Van Train, BS; John Friedman, MD; David
Ramsdale, BA; Alan Rozanski, MD; Jamshid Maddahi, MD,
FACC. Cedars-Sinai Medical Center, Los Angeles, CA
Since visual interpretation of dipyridamole (dipy) thalli-
um-201 (Tl) is subjective, we developed an objective
technique for identification of initial defects or slow
washout abnormalities from dipy Tl studies and evaluated
34 patients (pts) (19 catheterized CAD pts and 12 with a
<1% likelihood of CAD). Following 0.56 mg/kg dipy and
hand-grip exercise, Tl and subsequently aminophylline were
injected intravenously. Three-view, IG-minute images were
obtained at 5 minutes and 4 hours after dipy. Following
interpolative background subtraction and 9-point smooth-
ing, initial distribution and %washout circumferential
profiles in each pt were compared with the lower limit of
normal (nl) derived from the low-likelihood dipy pts. For
comparison, CPs were also compared to previously developed
stress and washout nl limits from low-likelihogd pts hav-
ing stress Tl. Abnormality was defined by ~2 18 arcs fal-
ling below nl limits. Results:
CAD LAD LCX RCA TOTAL VESSELS
Sens & (Spec) 89% 76% 46% ill 73%
c Dipy Nl Limits (62%) (78%) (78%) (73%)
INABILITY OF PLANAR THALLIUM SCINTIGRAPHY TO PREDICT 50%
DECREASE IN CORONARY VASODILATOR RESERVE.
Charlotte L.Talman, R.N •• M.S.N., Philip E. Aylward,
M.D •• Carl W. White, M.D., F.A.C.C., Robert F. Wilson,
M.D., Peter T. Kirchner, M.D., Karim Rezai, M.D., Melvin
L. Marcus, M.D., F.A.C.C., University of Iowa, Iowa City,
Iowa
Previous validation studies of thallium scintigraphy (TS)
have relied almost entirely on percent stenosis (%S)
measurements from coronary angiograms. To validate TS
with a more sophisticated gold standard, we assessed
coronary vasodilator reserve (CVDR) in individual vessels
with a unique coronary Doppler catheter before and after
intracoronary Papaverine. In 18 normals, CVDR assessed
by measuring peak-to-resting flow velocity was 5.1±0.6
(range 3.7-8.2). We measured CVDR in 13 stenosed vessels
of patients with primarily single-vessel disease (3 LAD;
5 LCx; 3RCA; 2 double vessel) and normal left ventricular
function. %S varied from 20% to 95%. Within 14 days of
the physiologic study. TS was performed utilizing
intravenous dipyridamole. TS planar images were
interpreted by 3 experienced readers who were blinded to
any clinical data. As expected, in the study group (N-6)
with normal CVDR (4.68±.30, mean±SEM) all scintigrams
were normal. Surprisingly, in the 7 with low CVDR
(2.47±.22) no TS defects were detectable. In a previous
study in patients with multivessel coronary disease
(N-51) planar dipyridamole TS had a sensitivity of 80%.
These preliminary data suggest that planar TS with
dipyridamole cannot reliably detect coronary obstructive
lesions associated with a 50% decline in CVDR. Studies
in additional patients will be needed to determine the
decline in CVDR that can be detected with TS.
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DIFFERENCES BETWEEN TRUE AND FALSE LINKING IN PATIENTS
WITH ACCESSORY PATHWAYS
Agustin Castellanos,M.D.,F.A.C.C., Bolivar Portillo,M.D.,
Liaqat Zaman, M.D., Richard M. Luceri, M.D. ,and Robert J.
Myerburg, M.D.,F.A.C.C., University of Miami, Miami, FL.
Lehman et al presented a variety of examples where the
unifying theme reflected that each impulse entering a
macroreentry circuit was functionally linked to the se-
quelae of the previous impulse in a way capable of pro-
ducing repetitive functional block. To evaluate linking
(L), that is, the mechanisms of perpetuation of function-
al anterograde(A) block in an accessory pathway(AP),elec-
trophysiologic studies were performed in 12 patients(pts)
with manifest Wolff-Parkinson-White syndrome who had: a)
bidirectionally-conducting AP with fusion QRS complexes
during sinus rhythm and narrow ventricular beats during
reciprocating tachycardia(RT); and b) 1:1 AV conduction
at similar cycle lengths through the normal pathway, as
well as via the AP. In 11/12 pts, L was maintained by
interference when atrial stimulation(AS) was started
during sinus rhythm because each new A impulse was block-
ed (within the AP) by the refractoriness produced by the
retrograde(R) concealed penetration of the previous im-
pulse and every R impulse was blocked by the refractori-
ness engendered by the concealed A impulse. The latter
also prevented initiation of RT upon the cessation of AS.
On the other hand, when AS was initiated during RT, L was
sustained by collision within the AP and was followed by
resumption of the RT upon stopping AS{entrainment).Final-
ly, when 1:1 conduction took place via the AP, the level
(within the normal pathway) at which this "reversed" L
occurred could not be determined. To summarize: 1) both
L and "reversed" L are maintained by interference, but
when collision is the sustaining cause, the phenomenon
is not true L, but a separate mechanism, namely
entrainment.
lished in Ref 1 &2, the 12 lead ECG rarely predicted the
exact location of the AP.
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Accessory A-V Connections
esu s were no a ected >y QRS width « or > 120 msec).
AP No uerta wave Ref 1 Uelta wave Ref 2
Loc Pt C BP WP tl; BP WP
Left 18 3 +Vl ,:V6 Q-QS I, VE 1 +VI-V4, .:11 ,III ,F
Lat. +QRSII I -V6 +/-V6 -V6.-+-VS
Lett 13 0 +Vl -+V~ 0 +VI-V4 :l~,~~~,FPost. +QRS VI -~ III +VS
l +VI-V4, +V6
Post. 9 0 -11,111, +V2-V6 1 -II III
Para- -F,+I rSVI ,RsV~ ~ -II. II 1,1 +1,L,V4-6
Septa +V2 +/-Vl
RIght 3 0 Q,Q:>llll' -VI 0 +1,L,V4_6 -II ,III ,F
Post. -QRSIIIV +V3,+/-+V +/-V2
RIght 4 u -ljRSll IV: .:!:.Yl 0 +I,L,V4_6 -+11 ,UIFLat. +1 +7-V2
Total 4/ 3, 47 2/47
In conclusIon: In thIS group of pts. uSIng criteria estab-
THE VALUE OF THE RESTING 12 LEAD ECG FOR LOCALIZING THE
SITE OF PREEXCITATION IN PATIENTS WITH WOLFF-PARKINSON-
WHITE SYNDROME: DISCREPANCY WITH PREVIOUS OBSERVATIONS.
Lemery R, Hammill SC, Holmes DR, Mankin HT, Danielson GK,
Gersh BJ, Wood DL, Osborn MJ, Mayo Clinic, Rochester, MN.
Criteria for localizing an accessory pathway{AP) have been
established using the 12 lead ECG (World Health Organiza-
tion criteria, Ref 1) and using maximal preexcitation dur-
ing atrial pacing (Duke criteria, Ref 2). To determine the
usefuln~ss of both sets of criteria,we reviewed 47 pts who
had a sln~le antegrade conducting AP at the time of surgi-
cal ablatIon. The delta wave was analyzed on the resting
ECG comparing with Ref 1 &2: exact concordance (EC) best
predictors (BP) and worst predictors (WP) of AP location.
R lt t ff b
PATTERNS OF RETROGRADE HIS PURKINJE SYSTEM BLOCK
INITIATING ORTHODROMIC TACHYCARDIA WITH VENTRICULAR PACING
IN THE ~LFF PARKINSON WHITE SYNDROME. Patrick Tchou, MD,
Mohammad Jazayeri, MD, Issam AI-Bitar, MD, Rehan Mahmud,
MD, FACC, Stepben Denker, MD, FACC, Michael H. Lehmann,
MD, FACC and Masood Akhtar, MD, FACC, Univ. of WI ML
Sinai Ked Center, Milwaukee, WI
Using a specially designed pacing protocol, the manner in
which the orthodromic tachycardia (OT) induction is
acbieved during constant cycle length incremental ventri-
cular pacing (VP) was systematically studied in 16
patients with WOlff Parkinson White syndrome (WPW). A
train of VP (5252) was initiated after a programmable
interval (5152) follOWing a controlled atrial drive
(5151)' The number of beats in the S2 train was
progressively increased from l-S beats and the retrograde
response of His Purkinje system (HPS), accessory pathways
(AP) and the AV node was separately analyzed for each beat
of the 52 train. Results: In all patients a retrograde
bloc kin the HPS appeared essent ial to init iate the OT.
However, three distinct patterns of HPS block preceded the
QT induction. In 11/16 the block of second or the third
beat (retrograde Wenckebach HPS) initiated QT. When OT
induction was delayed beyond the third beat of S2 train
two other patterns preceded the OT onset. In 2/16 a 2:1
retrograde block occurred in the HPS and AP until the 4th
beat which conducted via the AP only, and started the OT.
Remaining three cases demonstrated a Linking phenomenon in
the BPS for extended period of time beyond the third beat.
During Linking an anterograde migration in the site of
block preceded the initiation of QT. These data illustrate
that the onset of QT with VP involves complex electro-
physiologic mechanisms and emphasize the inportance of a
beat l:¥ beat analysis for establishing the precise
mechanism of OT initiation during VP in the WPW syndrome.
TACHYCARDIAS ffiIGINATING IN ACCESSffiY PATHIJIAY NETWlJlKS I'III'IICKING ATRIAL
FLUTTER AND FISRIllATION
WJackman, I'D, J YelJlg lai Wah, I'l3 ChS, K Friday. I'ID. FACC,A Khan, I'ID,
1'1 Sakurai, I'ID, R Lazzara. I'ID. FACC, University of Oklahana and VA _ical
Center, Oklahoma City, [J(
We have shown that accessory AV pathways(AP) may fUlCtion as a mesh-
work of branching fibers, with some branc~es not electrically connected
to the atrilJll, ventricle or both. These isolated netll/Orks could theoreti-
cally support reentry. In 3 pts, a rapid, irregular tachycardia was
associated with nearly continuous electrical activation in the AP appara-
tus. Changes in the timing of key AP potentials were followed by similar
changes in the timing of atrial activation. Slock within the pattern
of continuous activation was followed by termination of the tachycardia.
In pt 1 with a concealed left paraseptal AP and pt 2 with an overt left
anterior AP, AP potentials were recorded along the coronary sirus for
distances of 6 mm and 20 mm, respectively, using closely spaced orthogo-
nal electrodes and low recording gain. AP tachycardia was induced by
programmed atrial stimulation. Retrograde atrial activation produced
discrete P waves simulating atrial flutter in pt 1. Rapid, irregular
preexcited QRS complexes masked P waves and mimicked atrial fibrillation
in pt 2. l'Iean tachycardia cycle length (Cl) in pt 1 was 180 msec with
110 msec continuous AP activity through the 80 msec isoelectric period
between P waves. In pt 2, mean tachycardia Cl was lBS msec. Continuous
electrical activity was present near the ventricular insertion of the
AP while the atrial insertion of the AP and local atrilJll were activated
in the same sequence as during ventricular pacing. In pt 3 with an overt
right anterior AP, nunerous interrelated AP potentials were recorded
over a IS mm segnent of the tricuspid anulus from 2 mm spaced bipolar
electrodes on an octapolar catheter positioned against the tricuspid
anulus, parallel to the His bundle catheter. AP tachycardia was induced
by rapid ventricular pacing during oral encainide therapy and had mean
CL 31 D msec with 165 msec continuous AP activit y spanning the 125 msec
isoelectric interval betWeen P waves. Pacing the AP produced identical
p waves. We conclude. Sustained reentry can occur within AP netll/Orks
mimicking atrial flutter and fibrillation, and may aCCOlJlt for the unusu-
ally high incidence of these arrhythmias in WPW pts.
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INTRAOPERATIVE USE OF SOCK AND PLAQUE ELECTRODES IN
PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME.
Humberto Vidai11et Jr., MD, James E. Lowe, MD, FACC,
Lawrence D. German, MD, FACC, Peng-Sheng Chen, MD,
G. Stephen Greer, MD, Wi 11 i am M. Smith, PhD, Seth J.
Worley, MD, Raymond E. Ideker, MD, PhD, Duke University
Medical Center, Durham, NC
Intraoperative mapping with a hand-held probe electrode
requires a sustained rhythm lasting 5-10 minutes.
To overcome this limitation, we studied 16 WPW patients
using a computerized system that maps from 60 electrodes
simultaneously. A sock, with 6 rows of electrodes from
base to apex, is placed over the ventricles. The time
from placing the sock to analyzing the base row of
electrodes is 5 minutes. A plaque with 2.5mm
interelectrode spacing is then placed over the early
site at the AV groove for detailed mapping. During
plaque recording, the rest of the sock recordings are
analyzed and a complete epicardial map is drawn in
an additional 8 minutes. This technique rapidly detects
early activation at the AV groove as do other computer
systems using only a band of electrodes at the AV groove.
The addition of complete epicardial mapping is important,
because in 2 patients with septal pathways, the site
of ventricular breakthrough was below the strip recorded
by the AV band. Complete epicardial maps allowed us
to study rapidly changing or short-lived electrical
events including isolated premature impulses, initiation
and termination of reciprocating tachycardia (RT) by
pacing, entrainment and changing degrees of fusion
by pacing during RT, and the ventricular response during
the onset, maintenance and termination of atrial
fi bri 11 ati on. Thi s techni que offers speci fi c advantages
over the hand-held probe or computer systems with only
an AV band of electrodes.
EFFECTS OF ELECTRODE CATHETER SHOCKS DELIVERED NEAR THE
TRICUSPID ANNULUS IN DOGS
Michael A. Ruder, M.D., Jesse C. Davis, M.D., Michael
Eldar, M.D., Melvin M. Scheinman, M.D., FACC, University
of California, San Francisco, CA.
In order to assess the feasibility of using electrical
discharges to interrupt right free wall accessory path-
ways, a series of shocks (S) were delivered from a per-
cutaneously inserted electrode catheter positioned
fluoroscopically at a number of sites around the tricus-
pid annulus (TA) to a chest wall patch (anode) in dogs.
S were 50J (6 sites), 100J (2), 200J (5) or 400J (3).
Endocardial electrograms (atrial(A) and ventricular (V»,
right ventriculograms and pressures were recorded before
and after S. Transient atroventricular block and unsus-
tained ventricular tachycardia were frequent; 1 dog had
ventricular fibrillation but none died. Ten days later,
no evidence of tricuspid regurgitation or right heart de-
compensation was found. On gross examination, evidence
of transmural damage was found with S of greater than
200J but there were no perforations. Endocardial Zesion
area correlat~d with energy delivered, from 62 mm for
50J to 221 mm for 400J. When the ratio of the A to V
electrogram amplitude was 1.0 to 1.5, the lesion extend-
ed to the TA ; when less than 1.0, the center of the le-
sion was below the TA. Mild coronary artery adventitial
inflammation was seen at 2 sites (200J and 400J) and
medial inflammation in 1 (400J). We conclude that this
catheter technique yields reproducible damage of the
atrial wall adjacent to the TA in such a distribution
that it may prove suitable for interrupting right free
wall accessory pathways in humans.
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The Mitral Valve: Structural Features in Health and
Disease
PHENOTYPIC HETEROGEllEITY IN MITRAL VALVE PROLAPSE:
RELATION OF MITRAL VALVE ABNOIlMALITIES TO BODY WEIGHT AND
BLOOD PRESSUlE
Riccardo Pini. M.D •• Barbara Greppi. M.D •• Richard B.
DeverOUI. M.D.. FACC. Jay A. Erlebacher. M.D •• Mariaue C.
Spitzer. Randi Kramer-Fol. M.S •• W. Ted Brown. M.D ••
Ph.D. Cornell Medical Center. New York. New York
To relate anatomic and functional mitral valve (MV) ab-
normalitiea to other phenotypic featurea of MV prolapae
(MVP) we analyzed computerized 2-dt-enaional echo MV
images frame-by-frame through 1 cardiac cycle in 30
patients (pta) with MVP and 23 age & aex matched
controla. Poaterior mitral leaflet length (PML). mitral
anular diameter and the % change in anular diameter from
early to late ayatole (%oanulua) were meaaured. and
time-motion echoea reconatructed to detect motion of
pointa equally apaced along the leafleta versua intra-
cardiac reference framea. 14/30 MVP pta exhibited
syatolic MV billowing into the left atrium (type 1 MVP)
and 16 did not (type 2 MVP). Time-motion reconatruction
showed typical M-mode MVP independent of overall heart
motion in 8/16 pts with type 2 MVP on the aingle cycle
analyzed. Measuremente in MVP pta and controle:
Cgptrgla HiE=l Hil:1
PML (cm/M l ) 0.8110.11 0.97~0.17** 0.88:0.19
Auulus (cm/Ml ) 1.52:0.23 1.68!O.24* 1.60±O.36
%4Auulua 19t13 22~12 38±13***
Weight/height (cm!kg) 0.41±0.08 0.40±0.05 0.34~.03**
Systolic BP (mm Hg) 129.*20 l26±18 l16±13*
Significance va controla: *p<0.05. **p<0.005. ***p<0.001
!hua. quantitative 2-D echo reveals 2 patterna of MVP.
both aasociated with typical M-aode and auacultatory
featurea. type 1 with fixed mitral leaflet and anular
enlargement and leaflet billowing. type 2 with dynamic
systolic expausion of the mitral anulua in pts with a
phenotype with low body weight and blood presaure.
IN VIVO VALIDATION OF A NON PLANAR MITRAL ANNULAR SHAPE:
IMPLICATIONS FOR THE DIAGNOSIS OF MITRAL VALVE PROLAPSE
Robert A Levine, MD, FACC, Maroo 0 Triulzi, MD, Pamela
Harrigan, -xr:tliiirE:'1reyiiiiiii7 MD, FACC, Massaohusetts General
Hospital, Boston, MA
By cross-seotional eohooardiography (2DE), the mitral
leaflets (MLs) appear to be displaoed above the mitral
annulus (MA) in the apioal four-chamber (A4C) view in a
surprisingly high peroent of normals, but bear a normal
relation to the HA in orthogonal views. This discrepanoy
can be explained in 2 ways: 1) the HA is planar and true
leaflet displaoement ooours in only 1 view; or 2) the HA
is nonplanar, as suggested by animal studies, and lies on
a hyperbolio paraboloid. The seoond theory prediots that
the MLs will lie below the apparent MA plane in views
interseoting the most superior points of the HA, and above
it in views through the lowest points. To address this
question we studied 16 patients (pts) age 13-79 ~eleoted
for apioal image quality. Exoluded were pts with oaloified
MA, LV dysfunotion, and rheumatio or infeotive mitral
disease. Serial LV apioal 2DE views were obtained at 300
rotational intervals. The HA was defined as the ML hinge
points and its 3~imensional systolio oonfiguration was
reoonstruoted based on the rotational geometry. RESULTS:
Vertioal distanoe of MA points from the transduoer along
the rotational axis was plotted against angle of rotation.
In all 16 pts, this ourve was bimodal with maxima near the
aorta and posterior LV wall and minima medially and
laterally. The differenoe between the most apioal and
basal points was .6-1. 90m (mean 1.3>' CONCLUSION: The HA
is nonplanar in the pts stUdied, lying along a hyperbolio
paraboloid. The apparent disorepanoy in HL-MA relation in
apioal views oan be attributed to MA oonfiguration without
aotual ML displaoement above the most superior MA poilts.
~fIiidings ohallengettie" assumption of a planar M and
the diagnosis of prolapse in many otherwise normal people.
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EMIT Total (n=15)
R-IV Total (n=20)
FMV Free Margin(n=8)
mv Free Margin (n=9)
FlDPPY MITRAL VALVES: ABNOR-lAL MOCHANICAL PROPERTIFS-
BASIS FOR ELOOGATIOO AND RUPlURE OF ClJ)RDAE TFlIDINEAE.
Girraj Bansal, M.D.,Ph.D., Peter B. Baker, M.D., Charles
F. Wooley, M.D., F.A.C.C., Jarres Kilman, M.D.,F.A.C.C.,
Harisios Boudoulas, M.D., F.A.C.C., Albert J. Kolibash,
M.D., F.A.C.C., Ohio State University, Columbus, Ohio.
Abnonnal elongation and rupture of chordae tendineae (cr)
are camr:m firxiings in patients with severely flOW}'
mitral valves (EMIT). To uOOerstand the rrechani.sm of these
chordal abnonnalities, we tested the hypothesis that cr
fran EMIT have different rrechani.cal properties than cr
fran nonnal mitral valves (R-IV). Fifteen cr fran 5 EMIT
(surgery) and 20 cr fran 6 R-IV (autopsy) were tested in an
uniaxial tension node in an Instron machine. load vs elon-
gation curves were obtained for each cr until fracture.
cr of similar di.arreter were used in both EMIT and NMV to
deteImine fracture stress and fracture strain. Fracture
stress (fracture load/original cross-sectional area) and
fracture strain (total elongation/original cr length)
were calculated for each cr. Data are shown (nean + ISO).
Fracture S~ss8 Fracture Strain
(dynes/an ) 10 (%)
2.96+1.96 27.3t6.5
5.62tl.60 p<O.Ol 27.6tll.9
1.83!O.51 p<O.Ol 26.9±4.3
5.13tl.26 24.6tlO.9
cr fran EMIT had lower nean fracture stress than cr fran
mv. cr attached to the free margins of the EMIT leaflets
had the lowest fracture stress when ernpll"ed to any other
cr (P<0.05). Fracture strain in cr fran EMIT was not
statistically different ernpll"ed to cr fran NMIT. Thus,
the grossly abnonnal fracture stress may be contributing
to the rupture of cr in patients with FMV.
PEPTIDERGIC INNERVATION IN HUMAN MITRAL VALVE:
ALTERATIONS IN MITRAL STENOSIS AND PROLAPSE.
Jose M. Brum, M.D., Lester E. Wold, M.D., William D.
Edwards, M.D., Vay L. W. Go, M.D., Alfred A. Bove, M.D.,
Ph.D., F.A.C.C., Mayo Clinic, Rochester, MH.
The human mitral valve has been considered to be devoid
of sensory innervation. If present, a sensory function
of the mitral valve could contribute to local regulation
of myocardial function. Recently nerve structures have
been described in human heart valves. Substance P (SP),
a neuro peptide related with sensory nerve activity, is
present in human heart nerves. To determine if SP exists
in human mitral valves, cadaver valves (n-6) were
collected in.a period of 4 to 16 hours postmortem (PM).
Pathoanatomic examination excluded cardiac diseases.
Mitral valve samples (n-ll) were also collected from
patients referred for valve replacement surgery for
mitral stenosis (MS), mitral valve prolapse (MVP) , and
papillary muscle rupture (PR). Radioimmunoassay tech-
nique determined concentration (ng/g) of SP-like immu-
noreactivity (SP-LI). SP-LI was present in all samples
(0.27+0.08) of the PM group. In the MS group 4 of 8
valves showed SP-LI (0.56+0.11). MVP patients had no
SP-LI in the valves. The-highest SP-LI was found in a
patient with PR (1.40 ng/g). The presence of SP-LI in PM
normal valves contrasts with the absence of SP-LI in 4 of
8 MS and MVP patients. The results suggest that altera-
tion of mitral valve peptidergic sensory innervation
occurs in mitral valve disease.
SURGICAL PATHOLOGY OF THE MITRAL VALVE: STUDY OF 628
CASES.
Lyle J. Olson, M.D., Ramiah Subramanian, M.D., William
D. Edwards, M.D., FACC. Mayo Clinic and Mayo
Foundation, Rochester, Minnesota.
To determine whether the causes of mitral disease
have changed appreciably in the past 2 decades, we
reviewed grossly the mitral valves from 628 patients who
had undergone mitral valve replacement at our institu-
tion during 1965, 1970, 1975, or 1980. Postinflammatory
(including rheumatic) disease accounted for 78% of 628
cases and for 99% of 416 with mitral stenosis with (263)
or without (151) regurgitation; 2 valves were congeni-
tally stenotic. Among 212 patients with clinically pure
mitral regurgitation, floppy valves accounted for 37%,
postinflammatory 34%, ischemic disease 10%, infective
endocarditis 7%, cardiomyopathy 3%, chordal rupture 3%,
congenital anomaly 2%, and chronic aortic regurgitation
1%; the cause was indeterminate in 2%. The relative
incidence of clinically pure mitral regurgitation due to
a floppy valve increased during each of the 4 years of
the study, accounting for 17% of 29 cases in 1965 and
57% of 49 cases requiring mitral valve replacement in
1980. In postinflammatory cases, there were more fema-
les (71%) but with floppy valves there were more males
(73%). At our institution, postinflammatory disease was
the most common cause for excision of mitral valves in
each of the 4 years of the study; its relative incidence
has not changed appreciably since 1965. Our findings
suggest that (i) the incidence of chronic rheumatic
disease has not yet begun to diminish or (ii) many epi-
sodes of acute rheumatic fever may be subclinical or
(iii) some forms of nonrheumatic mitral valve disease
may produce gross alterations indistinguishable from
chronic rheumatic valvulitis.
FUNCTIONAL PATHOLOGY OF MITRAL REGURGITATION IN ACTIVE
RHEUMATIC CARDITIS - SURGICAL AND ECHOCARDIOGRAPHIC
OBSERVATIONS.
Richard Marcus MB, Pinhas Sareli MD, Manuel Antunes MD,
Manuel Magalhaes MD, Theo Meyer MB, Thomas Grieve MO,
John Barlow MD. Dept. Cardiology, Baragwanath Hospital
& Dept. Histopathology, S. African Institute for
Medical Research and University of the Witwatersrand,
Johannesburg, South Africa.
Active rheumatic carditis (ARC) was confirmed at opera-
tion in 61 black pts subjected to correction of severe
mitral regurgitation (MR). Mitral valve replacement was
performed in 34 pts and mitral valvuloplasty in 27. His-
tological corroboration of the diagnosis was available
in 48 pts. In 13 pts, all of whom underwent valvuloplasty,
insufficient tissue was submitted for histological assess-
ment. Sixteen pts also required aortic valve replacement.
There were 40 females and 21 males with a mean age of 13+
4 (SO) yrs. All pts presented in NYHA Class III (36 pts)-
or Class IV. Mean cardiothoracic ratio was 66+7 (SO) %.
Severity of MR was confirmed by the following-intra-
operative pressures (mmHg): mean LA=26+9 (SO) with a V
wave = 49+18 (SO); LV end diastolic = 16+6 (SO). Pre-
operative-2-D and M-mode echo demonstrat~d marked pro-
lapse of the anterior mitral leaflet (AML) in 57 pts.
At operation AML prolapse was confirmed in all 57. Of
these 57, mitral anular dilatation was found in 54 (95%),
chordal elongation in 50 (88%) and chordal rupture in 4
(17%). Of the total 61 pts, some fibrosis and retraction
of mitral leaflet tissue was noted in 8. We conclude
that AML prolpase is the most consistent valvular abnor-
mality in severe MR caused by active rheumatic valvu-
litis. It results from chordal elongation which is
almost invariably accompanied by anular dilatation.
Chordal rupture was rare in this study.
JACC Vol 7. No 2
February 1986' 9A
ABSTRACTS 9A
Monday, March 10, 1986
10:30AM-12:00NOON, Room #157
Cardiac Transplantation
DEVELOPMENT OF CORONARY ATHEROSCLEROSIS IN THE
TRANSPLANTED HEART IMMUNOSUPPRESSED WITH CYCLOSPORINE AND
PREDNISONE
Barry F. Uretsky, MD
a
FACC; Srinivas Murali, MD; Ann Lee,
MsN; P. Sudhakar Red y, MD, FACC; Bartley P. Griffith,
MD; Robert L. Hardesty, MD; Alfredo Trento, MD; Henry T.
Bahnson, MD University of Pittsburgh, PA.
Coronary atherosclerosis (CA) is a late sequelae post-
cardiac transplantation (TX) in patients (pts) treated
with azathioprine and prednisone (pred) but the preva-
lence of CA and associated factors have not been evalu-
ated in pts post-TX on cyclosporine (Cy) and pred immuno-
suppression. In this group of pts we found by coronary
arteriography CA in 19% (11/57 pts) at 1 year; 17% (4/24
pts) at 2 years, and 45% (5/11 pts) at 3 years. Of the 8
pts studied more than once, 6 (75%) developed CA after
the first year. Recurrent (2 or more) major rejection
episodes diagnosed by endomyocardial biopsy were associ-
ated with a higher prevalence of CA (47% vs 9.5% without
recurrent rejection, p<O.05 at 1 year, 43% vs 6% at 2
years p<O.05). Use of antiplatelet agents [aspirin (A)
and persantine (P)] was associated with a lower preva-
lence of CA (11.5% CA on A/P vs 26% CA not on A/P at 1
year; 12.5% CA on A/P vs 25% CA without A/P at 2 years)
but these trends did not reach statistical significance.
A pre-TX history of CA was not a predisposing factor for
post-TX CA. Of 6 pts who died within 1 year after coron-
ary arteriography, 5 had no CA by coronary arteriography
but had CA at autopsy.
These data demonstrate that CA develops in post-TX pts
treated with Cy and pred and is probably underestimated
by coronary arteriography. CA appears to be related to
recurrent rejection and may be ameliorated by anti-
platelet agents.
HYPERLIPIDEMIA AND HYPERTENSION FOLLOWING HEART
TRANSPLANTATION: POTENTIAL CAUSES OF CORONARY
ATHEROSCLEROSIS? Diane M. Becker, Sc.D., Maria
Markakis, B.S., Michael Sension,B.S., Susan Vitalis,
B.S., Kenneth Baughman, M.D., F.A.C.C., Thomas A.
Pearson, M.D, Ph.D. Johns Hopkins Medical Institutions,
BaIt imore, MD.
Coronary atherosclerosis remains a significant cause of
heart transplant (HtTr) failure, yet factors responsible
for this have been poorly documented. To study the
potential contribution of known coronary risk factors,
we examined blood pressure, serum lipids, exercise,
smoking and diet in 27 patients from 3 to 24 months
following HtTr. Post transplant, no patients smoked, 67%
had a regular aerobic exercise regimen, and 70% followed
a low salt, prudent diet. Although only one patient had
hypertension prior to HtTr and all patients were on
antihypertensive pharmacotherapy post transplant, 84%
had blood pressure 140/90 by 3 months post HtTr. Most
striking was a progressive rise in mean total serum
cholesterol from a pre HtTr level of 171 mg.% +/- 36
mg.% to mean levels of 239 mg.%, 263 mg.%, and 302 mg.%
at 3~ 6, 9 months respectively post HtTr, with no
furtner rise of levels thereafter. Cholesterol levels
pre HtTr and 3 months post HtTr did not correlate well
with later levels, while 6 month levels predicted levels
at 9, 12, 18, and 24 months post HtTr (p=.Ol). In
patients 6 months post HtTr, triglyceride levels (x=156
mg.% +/- 94 mg.%) and HDL cholesterol levels (x=52 mg.%
+/- 16 mg.%), were within normal limits but LDL
cholesterol (x=142 mg.% +/- 46 mg.%) and apoprotein B
levels (x=121 mg.% +/- 38 mg.%) were markedly elevated.
LDL cholesterol level correlated with time since HtTr
(p=.02) but not with predisone dose, diet or exercise.
Screening of blood pressure and serum lipids 6 months
post HtTr will identify a high prevalence of
hypertension and Type II hyperlipoproteinemia, which may
be amenable to treatment. Identification and reduction
of these two known risk factors may be beneficial in
reducing the risk of late coronary atherosclerosis in
HtTr.
PATIENTS DENIED CARDIAC TRANSPLANTATION FOR NON-MEDICAL
CR ITER IA: A CX>NTROL GROUP. L Worner Stevenson. MoD..
Michael B. Fowler,M.D., John S. Schroeder,MoD.,F.A.C.C.,
Kathleen A. Dracup,R.N., Suzanne Ii. CI ark,R.N., Victoria
Fon~ UCLA and Stanford Medical Centers, Los Angeles
and Stanford, Ca II forn Ia.
Cardiac transplantation (Ctxl has not been tested
agaInst present medIcal therapy In a control led trial. To
determine the benefit of Ctx we defined as a control
group 36 patients (ptsl evaluated since 1981 who were
found medically eligible but were denied Ctx on other
criteria. For 32 pts, hemodynamics and outcomes could be
obtained and compared to those of pts undergoing Ct~
Criteria for rejection were psychological status In 15
pts, financial status In 8, patient Indecision In 5, and
body size In ~ Control pts were actually less
compromised than pts receiving Ctx, but there were no
significant differences In clinical class (contr21 ~4
vs. 3.8 Ctxl, cardiac Index (1.9 vs. 1.7 L/mln/m l,
pul monary wedge pressure (26 vs. 27 mmHgl, or right
atrial pressure (12 vs. 12 mmHgl.
Four pts underwent Ctx elsewher~ For the remaining 28
control pts, 24 of whom received vasodilators, actuarIal
survival at 3 mos. was 40~ compared to 8~ after Ctx, at
6 mos. 21 ~ vs. 86~, 1 yr. 13~ vs. 84~, and at 3 yrs. 7~
vs.72%. 2 of 3 control pts surviving 3 yrs. had
Initially decided against transplantation. 14/25 deaths
In the control group were sudden, the remainder related
to hemodynamic deterioration.
100~survlval
50r
: Ctx
__________:::============~~~~COntrol
1 yr. 3 yrs.
Most pts rejected on non-medical criteria die within 3
mos. although occasional long-term survival does occu~
Ctx offers significant Improvement In survival when
compared to current medical therap~
THE DEVELOPMENT OF TRICUSPID REGURGITATION AFTER
ORTHOTOPIC CARDIAC TRANSPLANT
Marc K. Lewen DO, Robert J. Bryg MD, Leslie W. Miller MD,
George A. Williams MD FACC, Arthur J. Labovitz MD FACC,
St. Louis University School of Medicine, St. Louis, NO
In order to assess the incidence and etiology of
tricuspid regurgitation (TR) after orthotopic cardiac
transplantation, the files of 18 surviving transplant
patients (range 1-37 months, mean 14.5 months) were
reviewed. Patients ranged in age from 10-56 years with 8
having idiopathic congestive cardiomyopathy, 7 ischemic
cardiomyopathy, 2 valvular heart disease and 1 congenital
heart disease. Serial echocardiography and Doppler
evaluation of all valves, hemodynamics, grade of
rejection, and the cold storage time of the transplanted
heart were analyzed. TR was demonstrated by Doppler in
16/18 patients, 9 with moderate to severe (mod/sev) TR and
7 with mild TR. Of the 9 patients with mod/sev TR, 4 had
PA systolic pressure of 60 mmHg or greater prior to
transplantation while only 1 patient with mild TR had a
preop PA systolic pressure of 60 mmHg. Of the patients
with mod/sev TR, 8/9 had right ventricular volume overload
(RVVO) pattern by echocardiography while only 2/7 with
mild TR had RVVO. Two patients with significant TR had
torn tricuspid chordae. TR developed within the first
month after transplantation in most patients. There was
no relationShip between the development or severity of TR
with age, cold storage time, grade of rejection or post
transplant hemodynamics. Although 16/18 had TR, no
patients required treatment for right heart failure after
one month. In conclusion: 1) TR occurs in most patients
after orthotopic cardiac transplantation. 2) Severe
pulmonary hypertension prior to transplantation
predisposed the recipient to the development of mod/sev
TR. 3) Despite the echocardiographic findings of RVVO,
TR is well tolerated post transplantation.
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SYSTOLIC AND DIASTOLIC VENTRICULAR FUNCTION AT REST AND
DURING EXERCISE IN HEART-TRANSPLANT PATIENTS.
Mario S. Verani, M.D., F.A.C.C., James B. Young, M.D.,
F.A.C.C., Avanlndra Jaln, M.D., Sameh Tadros, M.D., H.
David Short, M.D., George P. Noon, M.D., F.A.C.C.,
Robert Roberts, M.D., F.A.C.C., Michael E. DeBakey,
M.D., F.A.C.C. The Methodist Hospital, Baylor College of
Medicine, Houston, TX.
Little is known about the functional adaptations of the
transplanted heart. Accordingly, we assessed the systo-
lic and diastolic ventricular performance after cardiac
transplantation (T) in 13 patients, aged 17-56 (median
42 years), using radionuclide angiography before, early
post-T (median 4 days) and late post-T (median 114
days). All patients had myocardial biopsy just prior to
the studies. Supine bicycle exercise was performed in
10 patients undergoing late studies. In all early and
late post-T studies, the right atrium appeared dilated
and akinetic although all patients were in sinus rhythm.
The LV ejection fraction (EF) improved from 19 ± 10%
(mean ± SO) pre-T to 61 ± 6% early post-T (p < .001).
The LV peak diastolic filling rate (PDFR) was normal
(3.6 ± 1.0 EDV/sec) early post-I. These variables re-
mained normal at the late study. The RV-EF was also nor-
mal in the early (44 ± 4%) and late studies (47 ± 7%).
Patients exercised for 420 ± 149 seconds and increased
the LV-EF from 56 ± 4 to 62 ± 10% (p < .05) and RV-EF
from 47 to 54% (p < .03). Eight of 10 patients in-
creased the LV-EF normally (by ~ 5%). Similarly, exer-
cise PDFR increased, from 2.9 ± .4 to 3.6 ± 1.0 EDV/sec
(ns). The only patient with a fall in exercise LV-EF
had class 2 rejection by biopsy. The other patients had
either normal biopsy (n = 5) or minimal rejection (n =
3). Thus, despite abnormal atrial function, rest and
exercise systolic and diastolic ventricular function are
usually preserved late after cardiac transplantation.
ELECTRICAL PULSE TRAINS TO ACTIVATE LATISSIMUS nOFsI
MUSCLE CHRONICALLY FOR POTENTIAL CARDIAC AUGMENTATION
John D. Mannion, M.D., Michael A. Acker, M.D., Aida S.
Khalafalla, Ph.D., Stanley Salmons, Ph.D., Larry W.
Stephenson, M.D., F.A.C.C., Hospital of the University of
Pennsylvania, Philadelphia
Patients with hypoplastic or failing ventricles could be
helped by auxiliary ventricles (AV) constructed from
fatigue-resistant skeletal muscle. We have already made
canine latissimus dorsi muscle (LDM) more fatigue resis-
tant by continuous low-frequency electrical stimulation
for 6 weeks. Recently we constructed AVs from electrical-
ly conditioned LDMs. They were connected to the circula-
tion and generated significant pressure and flow for 4
hours. Unconditioned AVs fatigued « 4 mins). The
chronic effects on the LDM of electrical pulse trains of
the type needed to accuate an AV are, however, unknown.
The LDMs of 3 groups of 3 dogs each were therefore stimu-
lated with a 45 Hz burst pattern (100 ms on; 400 ms off)
or continuous patterns at 2 and 10 Hz. At the end of 6
wks all 9 stimulated LDMs had acquired a uniformly Type
I fatigue-resistant histochemical profile which was
found in only 45 + 7.6% of contralateral control muscles.
Histologic architecture was preserved. In stimulated
LDMs the content of slow myosin increased and fast de-
creased. All stimulated muscles fatigued significantly
more slowly than controls (P < 0.05). Thus. burst
patterns suitable for chronic actuation of AVs are not
only well tolerated by the LDMs but are as effective as
2 and 10 Hz conditioning frequencies in producing
improved fatigue resistance.
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Considerations in Measuring Cardiac Function
A METHOD OF ESTIMATING LEFT VENTRICULAR PRELOAD
IN THE PRESENCE OF POSITIVE AIRWAY PRESSURE IN
MAN.
Roy V. Ditchey, M.D., FACC, JoAnn Lindenfeld, M.D., FACC,
Jose Pacheco, M.D., FACC, and Karen Dawson, RN, University
of Colorado Health Sciences Center, Denver, CO
Positive airway pressure (PAP) causes similar increments in
intrapericardial and intracavitary right ventricular end-
diastolic pressures in dogs. For this reason, and because right
ventricular pressure constitutes part of the effective "external"
pressure acting on the left ventricle via the interventricular
septum, subtraction of the effects of PAP on right heart filling
pressures accurately corrects left ventricular filling pressures
for the effects of PAP on intrathoracic pressure in this model.
To determine whether these concepts can be applied clinically,
we measured cardiac output (CO) and pUlmonary wedge and
central venous pressures with and without 15 cmH20 of
continuous PAP under 3 filling conditions in 5 patients. The
relationship between wedge pressure and cardiac output was
shifted to the right by PAP in each case (i.e., wedge pressure
:: ::;"" was higher for any CO). However,
~ co""".... when wedge pressures measured in
the presence of PAP were
corrected by subtracting the
effects of PAP on central venous
pressure, the wedge-CO
relationship was shifted back
toward control in each case, with
overlap of mean control and
corrected wedge pressures at
matched cardiac outputs. We
conclude that the increment in
central venous pressure can be
L..,-----:,';:""'.---- used to correct wedge pressures
,... ", for the effects of PAP in man.
VARIABILITY OF RIGHT HEART OXYGEN SATURATIONS IN ADULTS
WITH AND WITHOUT LEFT-TO-RIGHT INTRACARDIAC SHUNTING.
L. David Hill is, MD, FACC, Brian G. Firth, MD, D Phil,
FACC, and Michael-o. Winniford. MD, U of Texas Health
Science Center, Dallas, TX.
The oximetric detection of intracardiac left-to-right
shunting requires knowledge of the variability of oxygen
measurements in the right heart chambers of patients
without shunting. Previous studies have examined this
variability in a relatively small number of subjects
without shunting and have based their limits of accepta-
bility on multiple measurements of oxygen content or
saturation in each right heart chamber. It is the prac-
tice in many catheterization laboratories and intensive
care units to measure the oxygen saturation of single
blood specimens from the superior vena cava (SVC), right
atrium (RA), and pulmonary artery (PA) during right heart
catheterization, but no previous study has assessed the
variabil ity of such single measurements in adults with
and without intracardiac left-to-right shunting. We
measured the oxygen saturations of SVC, RA, and PA single
blood samples in 961 adults [492 men, 469 women, aged
50 ± 13 (mean ± SO) years]. In the 912 without intracar-
diac shunting, the differences in oxygen saturation
between SVC and RA, RA and PA, and SVC and PA were 3.3 ±
2.6%, 2.1 ± 1.9%, and 3.5 ± 2.7%, respectively, so that
the normal limits of variability (mean ± 2SDs) for these
oxygen saturation differences were 8.5%, 5.9%, and 8.9%,
respectively. Of the 49 patients with intracardiac shunt-
ing, these limits of variability correctly identified 44
(90%), and the 5 with shunting whose saturation differ-
ences were below these limits had small shunts (Qp/Qs
ratios ~ 1.9). Thus, an assessment of oxygen saturations
from single blood specimens from SVC, RA, and PA offers
excellent sensitivity, specificity, and predictive accu-
racy in identifying patients with and without shunting.
lACC Vol 7, No 2
February 1986 11 A
ABSTRACfS llA
Diastolic PN Late Early Flow
Earl~ Late Ear~~ Decel. Time
A PULSED DOPPLER EXlfOCARDIOORAPHIC S'lU>Y a TlWEMImAL
FLClf IN PATIENl'S WITH DILM'ID <::Am>ICJ«CBTBY
Katsu Takena!ta, 11), Ali Dabestani, 11), Julius MGardin,
MO, FACe, Alice Allfie, sandra Clark, walter L Henry, 11),
FACe. thiversity of california, Irvine, california.
DoWler echocardiography has proven useful in evaluating
LV diastolic functiCl1 by assessing early diastolic
filling. Although patients with dilated cardiauyopathy
(DCM) are known to have abnormal LV diastolic eatpliance
and relaxatiCl1, early diastolic LV filling has been
reported to be normal. To further evaluate this awarent
discrepancy, we measured peak flow veloci.ty (PFV) in
early and late diastole (in QlV'sec), ratio of late-to-
early diastolic PFV, and deoeleratiQ\ time of early
filling flow (in msec) fran Dowler mitral flow
recordings in 21 DCM patients with mitral regurgitatiCl1
(Ma), 6 DCM patients without Ma and 19 age-matched normal
subjects. Results (Dean) were as follows:
INFLUENCE OF PRELOAD AND AFTERLOAD ON POST-EXTRASYSTOLIC
POTENTIATION IN NORMAL SUBJECTS AND PATIENTS WITH VALVULAR
HEART DISEASE
Thomas Wisenbaugh, M.D., Anthony DeMaria, M.D., Veterans
Administration and University of Kentucky Medical Centers,
Lexington, KY
The role of altered preload and afterload in post-
extrasystolic potentiation(PESP) of LV performance is
uncertain. Simultaneous cineangiography and micromanometry
were therefore performed for control and PESP beats in 20
pts: 10 normals(NL) and 10 with severe valvular disease
(VHD): 4 with aortic regurgitation, 3 with aortic
stenosis, 3 with mitral regurgitation. Measures of LV
performance were: eje2tion fraction(EF), end systolic(ES)volume index (VI,cc/M ),_tnd mean normalized systolic
ejection rate (MNSER,sec ). LV pre- and afterload were
measured as ~nd diastolic (ED) VI and mean systolic stress
(MSS,kdyn/cm ), respectively: (mean + STD, *p .05 vs C)
NL -VHD
Control PESP Control PESP
EF 0.66+0.04 0.75+0.05* 0.59+0.090.70+0.09*
MNSER 2.33~0.73 2.89~0.99* 1.77~0.36 2.33~0.51*
ESVI 24~7 19~7 58~34 45~29*
EDVI 69~19 74~19* 137~56 141~55
MSS 153+54 140+49 175~44 170~40
A smaller increase in-EDVI with PESP in VHD-(3%) than NL
(8%) was associated with a reduced index of LV compliance
(dV/VdP at ED=.020 mmHg-l vs .062 for NL, p 0.01). Thus,
although utilization of preload reserve contributed to
PESP in NL, favorable changes in length and load did not
account for substantial PESP of ventricular performance
with hemodynamic overload imposed by VHD. These data
indicate that augmented inotropic state is the major
determinant of PESP in man.
PREDICTORS OF POSTOPERATIVE LEFT VENTRICULAR DYSFUNCTION
FOLLOWING OPERATION FOR CHRONIC MITRAL REGURGITATION.
G.J. Kontos, Jr., M.D., A.A. Bove, M.D., F.A.C.C., H.V.
Schaff, M.D., F.A.C.C., N.H. Lazarow, M.D., and B.J.
Gersh, M.B., Ch.B., D.Phil., F.A.C.C., Mayo Clinic,
Rochester, MN 55905.
To determine whether preoperative indices of LV per-
formance predict postoperative low CO, we studied 17
patients undergoing valve replacement or repair for
chronic mitral regurgitation. Preoperative systolic LV
performance was quantitated with pressure volume analysis
from ventriculograms, and patients were divided into
Group I, 9 patients with no postoperative low CO, and
Group II, 8 patients with postoperative low CO requirin9
inotropic support. Ten patients without overt heart
disease were controls.
Abbreviations: EJF=ejection fraction; EVDI=end-diastolic
volume index (ml/m2); LVMI=left ventricular mass index
(gm/m2); M/V=ratio of LVMI to EDVI; ESWS/ESVI=ratio of
end-systolic wall stress to end-systolic volume index.
*p<0.05 vs I; tp<0.05 vs control
Results indicate that patients with low CO following
correction of mitral regurgitation have inadequate com-
pensatory LV hypertrophy. Neither extent of LV dilata-
tion nor indices of LV systolic function identified
patients with postoperative low CO, but indices of LV
mass and M/V ratio may be useful predictors.
I
II
Control
EJF
61±8
63±11
67±8
EDVI
142±72t
111±19t
63±14
LVMI
140±65t
90±25*
68+17
M/V
1.04±O.43
0.82±0.22t
1.11+0.32
ESWS/ESVI
3.8±2.3
3.4±1.2t
5.5+2.5
NONINVASIVE MEASUREMENT OF PEAK AORTIC BLOOD
ACCELERATION WITH CONTINUOUS WAVE DOPPLER FOR
THE ASSESSMENT OF LEFT VENTR ICULAR PERFORMANCE
IN PATIENTS.
Hani N. Sabbah. B.S., Fareed Khaja, M.D.,
F.A.C.C., James F. Brymer, M.D., F.A.C.C.,
Thomas M. McFarland, M.D., David E. Albert,
M.D., and Paul D. Stein, M.D., F.A.C.C.
Henry Ford Hospital, Detroit, Michigan
Peak aortic blood acceleration (peak dV/dtl has
been recognised as a sensitive index of global
left ventricular performance. In the present
study peak dV/dt was assessed noninvasively in
pat ient s us i ng a cont i nuous wave Dopp Ier ve I0-
city meter (ExerDop8). Peak instantaneous
aortic velocity (V) and peak dV/dt were measured
by placing the ultrasonic transducer at the
suprasterna I notch. Measurements were made in
36 patients undergoing diagnostic cardiac cathe-
terization. Peak V and peak dV/dt were measured
just prior to left ventriculography. At least
14 consecutive sinus beats were averaged in each
patient. Left ventricular ejection fraction
(EFl, calculated from ventriculograms obtained
in the right anterior oblique projection, ranged
from 20 to 87%. Peak dV/dt, measured
noninvasively, showed a good I inear correlation
with EF, (r = 0.90) and a somewhat better power
fit, r '" 0.93. Peak V had a less close linear
correlation with EF (r = 0.77). These results
indicate that peak dV/dt, measured with
continuous wave Doppler, relates closely to EF
and, therefore, can be used as a noninvasive
indicator of global LV performance.
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Scientific Session.
THE VASOCONSTRICTIVE RESPONSE FOLLOWING ARTERIAL
ANGIOPLASTY IN PIGS: EVIDENCE FOR VASOCONSTRICTION
RESULTING FROM RATHER THAN CAUSING PLATELET-DEPOSITION.
J.Y.T. Lam, M.D., J.B. Chesebro, M.D., F.A.C.C.
L. Badimon, Ph.D., and V. Fuster, M.D., F.A.C.C., Mayo
Clinic, Rochester, MN 55905.
Whether vasoconstriction (VC) causes or results from
platelet deposition (PD) on the arterial wall is u~lear.
Agents such as Prostacyclin (PGI2) and Thromboxane A2
(TxA2) or .their antagonists which affect platelet func-
tion and vascular tone in vitro may assist in defining
the in vivo relationship between VC and PD. We examined
this-relationship in normal pigs that were sacrificed
immediately after angioplasty of the carotid arteries (5
inflations to 6 ATM, 30 seconds each, 1 minute apart):
24 control pigs and 17 pigs treated with intravenous PGI2
50 (50 ng/kg/min, n-8), or SQ 29,548, a selective TxA2
antagonist (0.1 mg/kg bolus then 5 pg/kg/min, n-9). PD
was quantitated using the lllIn-labeled PD of the dilated
segment (x 106/cm2). The degree of VC (average % diame-
ter narrowing proximal and distal to the dilated segment)
was measured from angiographic films taken before and
after angioplasty. PGIZ 50 and SQ 29,548 decreased VC to
18 ± 3% (p<.04) and to 15 ± 3% (p<.03) respectively vs
control (31 ± 3%), without affecting PD (52.6 ± 17.3 and
21.3 ± 4.3 respectively vs 34.5 ± 9.2 for control, P-NS).
VC was directly related to PD in controls (r-0.77,
p<.OOl), and PGI2 proportionately decreased VC for any
given PD, whereas SQ 29,548 decreased VC independent of
PD. Since VC correlated directly with PD in controls and
since TxAZ receptor blockade and PGI2 infusion decrease
VC without decreasing PD, VC appears to be the result
rather than the cause of PD. PGIZ/TxA2 balance appear
more important for vasomotor tone control, rather than
the regulation of PD in vivo, when the thrombogenic
stimulus from severe arterial wall injury is great.
FATTY ACID ACCUMDLATION IS A MARKER OF MYOCYTE
VIABILITY IN ISCHEKIC-REPERFUSED MYOCARDIUM
D. Doualas Miller. M.D•• John B. Gill. M.D•• Martha
Barlai-Kovach. B.A•• Mark A. Nedelman. B.A•• H. Thomas
Aretz. M.D•• David R. Elmaleh, Ph.D•• Charles A.
Boucher. M.D•• F.A.C.C•• H. W1lliam Strauss. M.D••
F.A.C.C. Massachusetts General Hospital. Boston. MA
To examine the relationship of fatty acid uVtake (FAU)
to viability to i,chemic-repe~fus~d myocard1um. 10 dogs
had a 15 min (n=5) or 60 min (n=5) left anterior
descending coronary occlusion with a 3 hr reperfusion.
Microsphere myocafClit blood flow (MBF) 1[as measured
during Occlus1on Sr and aft~r release (Sc). 1-125 FA
analog waf given 10 Ci I.V.) with Sc at 3 hr of re-
perfusion. pairet ultrasonic crystals ass~sse6 regional
left ventr1cular LV) systolic shortening (%SS). MYocyte
ulttastructure was determ1ned ~ electron mi~ro,copy
(EM) of 3 hI reperfusion biopsi,s as normal (++).
reversibly (+) or ir~everaiply (-) injured. Ischemic LV
segments 1MBF <0.5ml/min/~) were classified a, ,taining
tr1phlnyltetrazoligp chloride positive IT.T.C.(+):
n=169J or T.T.C. (-) [n=37J for comp.rison of FAU. MBF.
3 hr %SS and EM to normal segments (J = p<0.05):
l.L.Bli. IIIll=§I ..wL. FAUIMBF-Sc 3hr%SS .!!!.
Normal .8Ot..3 .24t..06 .35±.•09]] 35±. 61) ++
TTC(+) .24o.t..2 .26t..04] .38t..lO] 8±.22] +
ITC(-) .2Ot..2 .19±..09 .3Ot..16 It. 7
Ischemic regions became dyskinetic during occlusion (%S8
= -11t.4). Infarcted [T~T.C.(-)/~M(-)] legments remained
akinetic. while viable LT.T.C.(+)/EH{+)J zones recovered
partial systolic fUDc~ion at 3 hr of re~rfusion.
Segmental FAU and FAU/MBF-Sc were significantly
increased (by 37 snd 27%. respectively) in T.T~C.(+)
ischemic segments over that in infarcted segments.
FAU/MBF-Sc was also 9% greater than DOrmal 1n viable
ischemic myocardium. A 60 min occlusion-3 hr
reperfusion model adapted for in vivo single photon
em18sion comfuted tomography (SPECT) showed a similar
llXCeBS of 1- <13 FA analog acttvity over flow
(thallium-20l) in the ischemic border zone of 4/4 canine
myocardial infarct s.
We conclude that FA analog accumulation noninvasively
identifies ischemieally stUDned but viable myocardium
that may be salvaged by sustained reperfusion.
PHOTOSENSITIZATION OF EXPERIMENTAL ATHEROMAS BY
PORPHYRINS, Marc E. Pollock, M.D., John Eugene, M.D.,
F.A.C.C., Marie Hammer-Wilson, M.S. and Michael W. Berns,
Ph.D., VAMC, Long Beach and University of CA, Irvine.
Arteriosclerotic arteries have been shown to fluoresce
when treated with Hematoporphyrin Derivative (HPD). If
porphyrins are localized in the atheromatous plaque,
these plaques should be sensitized to appropriate wave-
length laser radiation. We studied the incorporation,
distribution and photosensitizing properties of a par-
tially purified form of HPD (Photofrin II) in normal and
arteriosclerotic rabbit aortas. A thoracoabdominal ex-
ploration was performed in 15 rabbits. Group I contained
normal rabbits, Group II contained normal rabbits given
5 mg/kg Photofrin II pre-op, Group III contained arterio-
sclerotic rabbits and Group IV contained arteriosclerotic
rabbits given 5 mg/kg Photofrin II 48 hours pre-op. Mul-
tiple aortic biopsies for frozen section were taken from
all rabbits. In addition, open laser endarterectomy
(with an argon ion laser) was performed on Group III and
Group IV rabbits. Frozen sections were studied by Digi-
tal Video Fluorescence Microscopy to determine the dis-
tribution of Photofrin II within the layers of the aortic
wall. The fluorescence of the intima of Group IV rabbits
was found to be significantly (p<.OI) higher than the
fluorescence of the intima, internal elastic lamina,
media or adventitia of the other groups as well as sig-
nificantly (p<.Ol) greater than the fluorescence of the
internal elastic lamina, media or adventitia of Group IV
rabbits. When open laser endarterectomy was performed,
Group III rabbits required 103±14 J/cm2 and Group IV rab-
bits required 33±3 J/cm2 (p<.OI). We conclude that por-
phyrins are selectively localized within the intima of
arteriosclerotic arteries. This localization sensitizes
atheromas to argon ion laser light and facilitates laser
endarterectomy.
EFFECTS OF RYANODINE AND CAFFEINE ON CONTRACTILITY, MEM-
BRANE VOLTAGE AND CA EXCHANGE IN CULTURED CHICK EMBRYO
VENTRICULAR CELLS.
Carl A.F. Rasmussen, Jr., M.D., PhD., John L. Sutko, PhD.
and William H. Barry, M.D., F.A.C.C•. Brigham and Women's
Hospital Boston, MA. '
To investigate the mechanisms of action of ryanodine and
caffeine, and the role of the sarcoplasmic reticulum (SR)
in excitation-contraction (E-C) coupling; we correlated
changes in mechanical and electrical activity caused by
these agents with alterations in 45Ca fluxes and cell Ca
contents in chick embryo ventricular cell monolayer cul-
tures. Ryanodine (10-10 to 10-5M) irreversibly decreased
contraction amplitude by 10 to 70% in a concentration de-
pendent manner with minimal effects on electrical activi-
ty. Ryanodine (10-6M) caused a decrease in rapid 45Ca
uptake, no change in total exchangeable Ca content and no
change in rapid 45Ca efflux relative to control measure-
ments. These results suggest that ryanodine decreases
the release of Ca2+ from the SR without depleting the SR
of Ca2+. Caffeine (1 to 20mM) caused a transient (less
than 10sec) increase in contraction amplitude (5 to 12%
greater than control), followed by a sustained (maximal
after more than 15sec) decrease in contraction amplitude
(9 to 76% less than control) and a decrease in diastolic
membrane voltage (10 mV). Caffeine caused a decrease in
rapid 45Ca uptake, a decrease in total exchangeable Ca
content and an increase in rapid 45Ca efflux. These re-
sults suggest that caffeine produces a decrease in SR
Ca2+ uptake, and/or an increase in SR Ca2+ release that
eventually depletes the SR of Ca2+ to account for its bi-
phasic inotropic effects. Our data in cultured chick em-
bryo ventricular cells support an important role for the
SR in E-C coupling, and indicate that SR Ca2+ is part of
the rapidly exchanging Ca2+ compartment noted in 45Ca
flux studies.
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DIFFERENTIAL CONTROL OF HEART RATE AND SYMPATHETIC
NERVE ACTIVITY DURING DYNAMIC EXERCISE IN HUMANS.
Ronald G. Victor, M.D. CV Center & VA Med Center,
University of Iowa, Iowa City, IA.
This study tested the concept that central command
(CC) and muscle chemoreflexes (MCR) trigger mass sympa-
thetic discharge at the onset of dynamic exercise in
humans. In 19 healthy subjects, I measured heart rate
(HR) and muscle sympathetic nerve activity (MSNA) with
microelectrodes in the peroneal nerve during 2 min of
rhythmic handgrip (RHG) at 10-SO% max with and without
arrested forearm circulation. During nonischemic RHG,
MSNA did not increase even at SO% max but HR rose by
+ll±S bpm (x±SE, p<O.OS). In contrast, during forearm
ischemia RHG at only 30% max increased MSNA by 77±lS%
(p<O.OS). This suggests that, during small muscle exer-
cise, CC increases HR but MCR must be engaged to trig-
ger increases in MSNA. To study exercise of larger
muscles, I measured responses during 2-arm cycling (2
min bouts) at 0-60 watts (W) in 6 subjects. During
cycling at 0-20W, HR rose rapidly (bHR=+22±3 bpm at
20W, p<O.OS) but MSNA did not change. However, during
heavier exercise, MSNA increased (p<O.OS) by 69±16% at
40W and by 121±24% at 60W. Even at these high work
loads, MSNA rose only after the first 30 sec of exer-
cise when HR had already increased by >2S bpm. Thus,
although HR increases promptly at the onset of even
mild large muscle exercise, activation of MSNA occurs
more slowly and at a much higher threshold workload.
In conclusion, these findings challenge the concept
of mass sympathetic discharge at the onset of exercise
and indicate striking differences in the control of HR
and MSNA during rhythmic contraction of both small and
large muscle groups. 1 suggest that these differences
relate to highly differential effects of CC and MCR on
heart rate and muscle sympathetic outflow.
BEt£FlCIAL EFFECTS OF SlPEROXlDE D1SMUTASE OR
ALl.OPURINOL AfTER CANlt£ MYOCARDIAL ISCl-EMIA
AN) REPERFUSION. S. Werns, M.D., M. Shea, M.D., K.
Gallagher, Ph.D., S. Phon, Ph.D., M.D., B. Pitt, M.D.,
F .A.C.C., and B. Lucchesi, Ph.D., M.D., The University of
Michigan Medical School, Ann Arbor,Michigan 48109
Reperfusion injury of ischemic myocardium may be due
to oxygen radicals generated by xanthine oxidase or
neutrophils. Therefore, in an occlusion-reperfusion model of
myocardial ischemia, we evaluated treatment with: superoxide
dismutase (SOD) (5 mg/kg over 2 hours starting 15 minutes pre-
occlusion via the left atrium) or allopurinol (A) (25 mg/kg 18
hours pre-occlusion and 50 mg/kg 15 minutes pre-occlusion via
peripheral vein). Anesthetized dags 02-17 kg) underwent a left
circumflex coronary artery occlusion for 90 minutes. Animals
were sacrificed after either 6 h of reperfusion to measure
infarct size (n=10) or 6 weeks of reperfusion to measure scar
thickness and collagen concentration (n=15). Infarct size as a
percentage of the area at risk was: controls 41±3 t, A 2Ot6 tt,
and SOD 18±2 tt. The differences are not due to differences in
rate-pressure product, an index of myocardial oxygen
demand. Neither drug improved collateral blood flow as
measured with radioactive microspheres. The ratios of scar to
normal LV thickness were: controls .89+.03 and SOD .91+.03
(p > .05). The scar collagen concentrations were: cont~ols
2.9t.5 and SOD 3.5±.4 (p> .05). Thus, both SOD and A salvaged
myocardial tissue, and SOD did not alter scar thickness or
collagen concentration. Therefore, scavengers of oxygen
radicals may prevent reperfusion injury of ischemic
myocardium without deleterious effects on infarct healing.
t All data expressed as x±SEM
tt P < 0.05 vs control
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Pediatric Doppler Echocardiography
EVALUATION OF FETAL CARDIAC HEMODYNAMICS BY COLOR DOPPLER
Dev Maulik, M.D., Navin C. Nanda, M.D., F.A.C.C., Ming
C. Hsiung, M.D., James P. Youngblood, M.D.,
University of Alabama, Birmingnam, Alabama
Color Doppler (CD) studies were performed in 17 pregnant
subjects. CD allowed ready identification of fetal
heart through detection of dynamic flow patterns. Visual
recognition of flow patterns which filled the whole of
vessel lumen facilitated not only alignment of Doppler
cursor parallel to flow but also reproducible measure-
ment of internal diameters of PA (imaged in aortic short
axis view) and ascending aorta (imaged in apical S
chamber view) for reliable estimations of RV and LV
stroke volumes (SV, ml) in 8/17 (48%) fetuses.
Fetal age
(weeks) 22 2S 32 34 34 36 38 39
RVSV (ml) 0.4 1.S 3.1 2.1 4.8 3.6 3.9 3.9
LVSV (ml) 0.2 0.8 1.7 1.1 2.5 1.7 2.1 1.9
Ratio 2.0 1.9 1.8 1.9 1.9 2.0 1.8 2.0
Inferior vena caval flow, always turbulent (mosaic
color), was seen to split into two components-70%
directed into RA and RV, 30% along eustachian valve
through foramen ovale and its valve into LA. lbperior
vena cava flow was laminar. Considerable flow was also
seen entering descending aorta from PA through ductus
arteriosus. CD permits, for the first time, real time
composite characterization of fetal intracardiac flow
patterns and should thus be superior to conventional
Doppler in assessing normal and abnormal hemodynamics.
PULSIlD DOPPLER DIAGROBIS OF ATRlOVBIITRICULAR
VALVE IMSUPPIClEltCY 1M UTERO
James C. Huhta, MD, FACC, Daniel J. Murphy, MD, Robert J.
Carpenter, MD. Sections of Cardiology and OB/GYN, Dept. of
Pediatrics, Baylor College of Medicine/Texas Children's Hasp.,
Houston, Texas.
Atrioventricular valve insufficiency (AVVl) has been suggested
as a sign of fetal distress in utero. Pulsed 2D-directed Doppler
echocardiography was utilize<fTcir the detection of AVVI in 50
fetuses ranging in gestational age from 16-39 weeks. AVVI was
diagnosed when a systolic velocity >1 meter per second was
detected in either atrium and had the typical holosystolic
appearance which identified it as AVVI and not ventricular
outlet velocity. AVVI was present In 8/50 (lU,) fetuses and
confirmed after birth in 5/5. Of 30 fetuses at risk for congenital
heart disease but found to have normal anatomy, 1 had AVVI
(H\). Of 11 fetuses with dysrhythmia, 3/3 with complete heart
block (l normal and 2 with atrioventricular canal) had
intermittent AVVI, while 7 with premature atrial contractions
and 2 with atrial tachycardia had none. Of 9 fetuses with
abnormal cardiac findings, 5 had AVVI (cardiomyopathy-I,
cerebral arteriovenous malformation-I, Ebstein's with pUlmonary
atresia-I, and Rh disease-2). Two patients with a normal heart
and hydrops had no AVVI.
Cancllllions: (1) AVVI occurs in utero and may be diagnosed
by pulsed Doppler echocardiography:-(2) AVVI may be present
in normals, with fetal dysrhythmia, or with congenital or
acquired cardiac dysfunction. It is not present in all forms of
nonimmune hydrops fetalis and cannot be interpreted as a
specific sign of fetal distress.
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REAL-TIME DOPPLER COLOR FLOW MAPPING FOR ASSESSMENT OF
PATCH AND BAFFLE LEARS AFTER SURGERY FOR CONGENITAL HEART
DEFECTS. Kyung J. Chung, M.D., F.A.C.C., Frederick S.
Sherman, M.D., David J. Sahn, M.D., F.A.C.C., Sandra
Hagen-Ansert, R.D.M.S., Richard E. Swensson, M.D.,
F.A.C.C., Lilliam M. Valdes-Cruz, M.D., F.A.C.C., Univ of
Calif, San Diego, CA.
Two-dimensional color flow mapping was performed on 18
patients (PTS) beginning 36 hours after closure of vent-
ricular septal defects (VSD) or intraatrial baffling
procedures for transposition of the great arteries (TGA).
Six PTS had simple VSD, 5 were studied after tetralogy of
Fallot repair, 2 after repair of atrioventricular septal
defect and 5 after a Senning or Mustard procedure. Of 7
VSD patch leaks detected, 4 were posteriorly and super-
iorly located and adjacent to tricuspid valve tissue
under the septal leaflet. Three posterior leaks disap-
peared by the second postoperative week and were not
detectable by Doppler flow mapping or by auscultation at
a 4 - 6 month folloWllp examination. The last one remains
detectable by Doppler and by auscultation. Two PTS had
VSD patch leaks at the superior, anterior edge, adjacent
to the aortic valve and one had a residual leak adjacent
to the pulmonary valve after closure of a supracristal
VSD. In these latter 3 PTS, the shunt remained detect-
able beyond 6 months and it has been surgically verified
in 2. Of the 5 TGA PTS, 3 had baffle leaks localized at
the superior rightward edge of the baffle at the superior
vena caval-right atrial junction. Left-to-right shunts
detected in this area persisted for 1 yr and were con-
firmed by catheterization in 2 PTS 1 yr. postop. We
conclude that color flow mapping is extremely sensitive
for localizing patch and baffle leaks after surgery for
congenital heart disease and that the position of a leak
may have prognostic significance.
OBSTRUC'11011 TO PULMOIIARY YElIOUS RBTUIllI II(
CBlLDRElI IfITB COIfGBIOTAL HEART DlSBASB-DBTBC'11011
BY DOPPLBR
G. Wesley Vick, III. MD. PhD. Achi Ludomirsky. MD. W. Robert
Morrow, MD, James C. Huhta, MD. FACC, Daniel J. Murphy
MD, Mary J. H. Morriss, MD. FACC. Section of Cardiology,
Dept. of Pediatrics. Baylor College of Medicine/Texas Children's
Hospital, Houston. Texas.
Obstruction to pUlmonary venous return (OPVR) occurs in a
number of congenital cardiovascular abnormalities and hemo-
dynamic assessment by cardiac catheterization (cath) may be
difficult. A noninvasive method for detection and quantitation
of OPVR would be useful clinically. Using 20 directed pUlsed
and continuous wave Doppler we examined. prior to cath. 28
patients thought clinically to have possible OPVR. Primary
diagnoses included transposition of the great arteries status
post venous baffle repair-9. total anomalous PVR-8 (2 Post
surgical repair). cor triatriatum-7 (4 post surgical repair). and
congenital mitral stenosis-4 (1 post surgical repair). Severe
OPVR was predicted if Doppler examination measured a diastolic
flow velocity >2 m/sec at any level of the left atrial or left
ventricular inflow.
At cath 9/28 patients had severe OPVR (gradient ~16 mmHg)
and all were correctly detected by Doppler (no false negatives).
The site of pulmonary venous obstruction was localized accu-
rately by 2D/Doppler in all. Mild OPVR correlated with a
biphasic or continuous flow velocity pattern with peak velocities
<2 m/s.
CaDelUlioDs: (1) 2D/Doppler accurately detects severe pUlmonary
venous obstruction in children with congenital heart disease.
(2) This technique should be useful in the selection of patients
for cath-particularly when pulmonary venous obstruction is
suspected postoperatively•
POST OPERATIVE OBSTRUCTION OF PULMONARY VENOUS RETURN:
DETECTION WITH PULSED DOPPLER ECHOCARDIOGRAPHY.
J. Geoffrey Stevenson, M.D .• F.A.C.C., James W. French,
M.D., F.A.C.C .• Isamu Kawabori, M.D .• Stanley J. Stamm,
M.D., Dale C. Hall, M.D., Edward A. Rittenhouse, M.D.,
Peter B. Mansfield, M.D. Children's Orthopedic Hospital
and University of Washington, Seattle, Wa.
The diagnosis of post operative pulmonary venous obstruc-
tion (ObPVR) after repair of anomalous pulmonary venous
return (TAPVR) or transposition (TCA) can be difficult
clinically but early detection is important for effective
care of these patients.
To evaluate whether Doppler echocardiography is useful in
detection of ObPVR, we measured peak blood flow veloci-
ties (maxV) at the anastomotic site of TAPVR repair in 4
patients, and throughout the pulmonary venous atrium in
12 patients with Mustard repair of TCA. Exams were done
1 month to 10 years post-op. In the TAPVR group, 2 were
obstructed (wedge m=23&25mmHg), and had high maxV(2.2&3.6
M/sec). Two without obstruction had significantly lower
wedge pressures (m.15&12mmHg), and maxV(1.1&1.2M/sec).
With TGA, 5 were obstructed (wedge 24-37, m=29.8mmHg),and
had pulmonary venous atrial velocities which were signi-
ficantly higher (maxV 2-2.8, m2.3M/sec) than those in the
7 without obstruction (maxV 0.9-1.3, mI.lM/sec). Distinc-
tive features of Doppler flow in obstruction were high
peak velocity (about twice normal), and turbulence, eith-
er in diastole or throughout the cardiac cycle. Timing
of flow depended upon post-obstructive atrial capacity.
With obstruction near the AV valve, small post-obstruc-
tion chamber, flow was largely limited to diastole. Dop-
pler echocardiography appears sensitive and very useful
in detection of post operative ObPVR.
DETECTION OF CORONARY FLOW BY PULSED DOPPLER AND COLOR
DOPPLER FLOW MAPPING AND ITS DIFFERENTIATION FROM PULMO-
NARY INSUFFICIENCY. Franco Recusani, M.D., Lilliam M.
Valdes-Cruz, M.D., F.A.C.C., Nancy Dalton, R.D.M.S.,
David J. Sahn, M.D., F.A.C.C., Brian Hoit, M.D •• Univof
Calif, San Diego, CA.
Pulmonary insuffiency(PI) by Doppler has been reported in
as many as 90% of normal subjects. We interrogated the RV
outflow tract (RVOT) area with color flow Doppler (CD)
(Aloka 880) and pulsed wave Doppler (PD) (Irex Exemplar)
in 3 open chest dogs, in 24 normal volunteers, in 13
patients (PTS) with proven PI and in 25 PTS without PI
undergoing left and right heart catheterization. In the
dogs, diastolic flow towards the transducer (TX) in the
RVOT area was seen by CD and the timing and duration of
flow was confirmed by spectral and MQ displays. Saline
injections (INJ) through an AO root catheter enhanced the
signal while PA INJ's did not enhance either the systolic
or diastolic signals. In the normals, diastolic flow in
the RVOT area was detected by CD and PD in 22/24; it was
holo or end diastolic lasting 60-17Omsec into systole
after the onset of the QRS; maximal velocity· 95-150
em/sec. In the 13 PTS with proven PI, the RVOT diastolic
flow was shorter, earlier, and differed in time-velocity
sequence from the flow detected in controls. In the cath-
eterized PTS without PI. RVOT area diastolic flow identi-
cal to controls was detected by PD in 20/25 and AO root
echo-contrast INJ enhanced the diastolic signals for 2-3
cardiac cycles in all. PA INJ did not augment the sig-
nals. We conclude that the majority of normal persons
have diastolic flow signals in the RVOT area which prob-
ably represent flow from one of the branches of a coro-
nary artery sampled as an error of azimuthal (planar)
resolution. This flow must be distinguished from PI and
sometimes from a patent ductus arteriosus, especially in
patients evaluated for surgery without catheterization.
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PREDICTION OF THE PRESENCE AND LOCATION OF CORONARY
ARTERY DISEASE BY DIGITAL EXERCISE ECHOCARDIOGRAPHY
Charles G. Vasey, M.D., William F. Armstrong, M.D.,
F.A.C.C., Thomas Ryan, M.D., Paul L. McHenry, M.D.,
F.A.C.C., Harvey Feigenbaum, M.D., F.A.C.C.; Indiana
University School of Medicine, Krannert Institute of
Cardiology, Indianapolis, Indiana
Cineangiograms and digital exercise echocardiograms (EE)
were compared in 88 patients (pts) with presumed coronary
artery disease (CAD) to define the ability of EE wall mo-
tion abnormalities (WMA) to predict the presence and lo-
cation of specific coronary artery lesions. Supine two-
dimensional echocardiograms were performed in parasternal
and apical views immediately before and after treadmill
exercise and were digitized in a continuous loop, quad
screen format. Comparable rest and exercise views were
displayed side by side. CAD was defined as a > SOX dia-
meter narrowing. Anterior WMA (anterior wall,-apex or
anterior septum) were present either at rest or with ex-
ercise in 45 pts, 42 of whom had left anterior descending
or diagonal CAD. Posterior WMA (inferior, posterior or
lateral walls) were present in 48 pts, 45 of whom had
circumflex or right CAD. Left anterior descending CAD
was present in 16 of 17 pts with exercise-induced
anterior WMA. Circumflex or right CAD was present in all
15 pts with new posterior WMA. Predictive
Sensitivity Specificity Accuracy Value
Any Anterior WMA 84 92 88 93
Any Posterior WMA 87 92 89 94
New Anterior WMA 67 97 83 94
New Posterior WMA 68 100 87 100
False-negative EE occurred most frequently in pts whose
exercise heart rates were less than 100. EE were
considered technically difficult but interpretable in
7 pts. We conclude that digital EE can accurately
predict the presence and location of CAD.
OOPPLER AORTIC FLOW VELOCITIES DURING EXERCISE;
RELATION TO EVIDENCE OF MYOCARDIAL ISCHEMIA BY
THALLIUM PERFUSION SCINTIGRAPHY
Michael R. Harrison, MD, Mikel D. Smith, MD, Bruce J. Friedman,
MD, FACC, Oi Ling Kwan, Anthony N, DeMaria, MD, FACC,
University of Kentucky and VAMC, Lexington, KY
Doppler(OOP) detection of abnormal blood flow velocity produced by
exercise-induced myocardial ischemia(lSC) might provide a simple
non-invasive technique to assess the presence or prognosis of coronary
artery disease. However, few data are available regarding changes in
blood flow velocity(VEL) measured by OOP during exercise induced
ISC. Thus, we measured VEL in the ascending aorta by continuous
wave OOP positioned in suprasternal notch in 6 controls (CON) and 40
patients(pts) undergoing exercise thallium scintigraphy (TH), Studies
were performed in the standing position prior to and immediately after
maximal treadmill exercise. TH was interpreted in the standard fashion
and was normal in 17 pts, revealed only infarction (lNF) in 6, and
manifested a reversible defect indicative ofISC in 17. Coronary
angiography was concordant with TIl in 24 of 25 pts in whom it was
performed. OOP measurements were obtained from the outer border of
the spectral record, and included peak VEL and flow VEL integral(FVI)
from onset to termination of flow. Results: (mean, p=non-significant
for all) CON NL INF ISC
Peak VEL (% increase) 59.5 57.1 40.2 38,8
FVI (% increase) 48.0 33.9 35.4 27.5
Flow VEL measurements varied widely in each group, Although VEL
showed the greatest increase during exercise in control and normal, 11
of 17 pts with ISC showed comparable increase. Peak VEL post-
exercise was decreased in 2117 pts with ISC by TH, and 1117 normals.
FYI after exercise was reduced in 3/17 pts with ISC and 4/17 normals.
Thus, although the increase in VEL by OOP with exercise is slightly
less in pts with INF or ISC, variability of response limits the applica-
ion of this method in individual pts. The response of aortic flow VEL
to exercise does not enable the identification of myocardial ischemia.
SUPRASTERNAL EXERCISE DOPPLER (EXERDOP): FEASIBILITY AND
RESULTS IN NORMALS AND PATIENTS WITH SUSPECTED CORONARY
DISEASE. Ih2mA4 ~ ~~, Robert M. Rothbart MD,
Vincent J. Patrone MD, Jane C. Moore MEd, Denny D. Watson
PhD, Robert S. Gibson MD. Unlv. of VA, Charlottesville, VA
Animal studies with Doppler have shown that blood flow
velocity(V) and acceleration(A) rise progressively during
simulated exercise. With induced ischemia, these values
decrease. To evaluate the clinical utility of Exerdop(E)
in humans, 76 normaIs(NL) had E during graded treadmill
exercise (GIT). E was performed at rest, 2 min into each
Bruce stage and immediately post-GIT. Group (G) I included
35 NLs (20-40 yrs) and GIl comprised 41 NLs (40-70 yrs).
Technically adequate E studies were obtained in all 76
subjects through 4 stages of Bruce GIT and proved highly
reprodugible based 00 3GXT8 with E io 30 GI sub1egts.
20-40 years (0=35) 40-70 years (0=41)
A (dV/dt) Velocity A (dV/dt) Velocity
25.9.:1:. 7.0 0.74.:1:..12 Rest 15.3.:1:. 4.77 0.60.:1:..17
33.3.:1:.12.8 1.17.:1:..23 1 30.7.:1:.10.5'7 1.00.:1:..20
41.0.:1:.15.5 1.33.:1:..28 2 42.3.:1:.14.67 1.14.:1:..22
50.5~0.3 1.44.:1:..26 3 50.1.:1:.14.36 1.27.:1:..26
58.7~3.0 1.54.:1:..27 4 54.4.:1:.17.45 1.27.:1:..26
64.~19.1 1.48.:1:..30 Post 61.5.:1:.16.34 1.52.:1:..29
Compared to GI, GIl had lower rest V and A values (p=
0.0001) and lower V at all GTX stages(p~.01). E was per-
formed on 11 additional pts who underwent exercise Tl-201
for suspected CAD. All 8 pts with normal Tl-201 had a pro-
gressive t in exercise V, despite 5 false positive ECGs; 3
pts with exercise-ischemia by Tl-201 had ~ exercise V
(p=.012). Thus: 1)E is a technically feasible adjunct to
routine GXT; 2)01der NL individuals have lower rest A and
V values, and reduced V during exercise; and 3)decreased V
during exercise appears to distinguish true vs false posi-
tive GIr.
DIPYRIDIlMlE-OO DIIB6IIJW. mIX'.AIIlllXJlA: A 'D!Sl' F(Jl IE'l!rn'OO
'I1WtiIl!Nf lSHJI[C awu:s IN U!Fl' VI!N1R1DI.AR -.v.L JOl'][ff
Alberto Marj::rlato ~f), Sergio Chierchia ro, Gillian ~th BSc, Grahan
Davies m:l', FillWO Crea ro, Attillo r.tlseri ro FN:r., RociJey Fosle
ro. Cardiovascular \hit, Rl*l, Itmrersmith & St Mary's H:Jspitals,
L<:r1<bl, L1<.
ExerclSe edxx:ardi~ has re<XJl?I1ized lirnitatias dJe to lII)V8llE!I'lt
artifacts. To overcare this problan we used 00 <:lilraBiroal.
~ (alE) dur~ dlpyridarole (D) adtunistratioo as a
rreans far det.ect~ trmsient ischemic regiooal 1tBll nptioo
alnorrralities (R'IMA) ill angina pectoris. 23 patients with effort;
, angina and pcsitive exercise tests, ..ro had teclnical1y satisfactory
alE were sUrlied. All had angiograrhically siglifica1t COI'QlaI'Y artery
dlsease, 8 with 3 and 15 with 2 vessels involved. alE was recorded in
parasternal~ alUS V1.€!'WS of the left ventricle ciIr~ OCl1trol, D
mfLEioo (0.6 rrgIkg 1.V. over 4 minutes) and reeervery. Reg:\.crlal wall
rrot100 was a:npared d.Iring infLEioo to OCl1trol and reeervery by 00
blmded oOOervers in CQ1S€I1SUS. D:indJced l&fNl. in 11 patients (0
pcs1tive) after 163 2: 92 seccnls (range 66 - 33) seccnls). EOO dlanges
and pam (9 patients) alwa,ys occurred later (3:)1.2 + 98.9 and 3!Xl.2 +
88.9 seccnls after D respectJ.vely) . The locallzatiOO of l&fNl. was well
correlated with the angiograrhic severi"t;y of COI'QlaI'Y lesiCl1S.' In 10
patients (D negative), no!&,MA, EOO dmges or pain were ctserved
cilring D. In 2 patients the results were C<XlSidered eq..ti.vocal dJe to
extensive qyskinesia in the OCl1trol alE. In 0 pcsitive, angina at rest
was rrore caTII01 (10 patients VB 5 patients 1'=£).055) and COI'QlaI'Y
disease rrore severe than ill D negat1ve. FUrtherm::>re, 0 pcsitive sh:o<,led
a la..er COI'QlaI'Y reserve during exercise than 0 negative (time to 1nln
Sf depressicn 172 + 170 and 472 + 179 seccnls respectively, p (0.05).
In ccnclLEicn: 1) D-3lE is an-effective altemative to exercise alE
far the det.ecticn of R'IMA ill patients with severe COI'QlaI'Y disease. 2)
The test rre,y have value in precise~c localisaticn of Em
changes and rre,y allcm the identJ.ficaticn of the :i.sdlmd.a-related vessel
ill patients with 2 or 3 vessel disease.
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DIPYRIDAMOLE-ECHOCARDIOGRAPHY TEST IN PATIENTS WITH
EXERCISE - INDUCED ST SEGMENT ELEVATION,
Eugenlo Ple~no MD, Miehele M~Slnl MD, Aless~ndro
Dlst~nte MD, F~blO L~tt~nzl MD, Antonlo L'Abb~te MD FACC,
C,N.R,. Cllnle~l PhYSIOlogy InstItute, Unlverslty of
PIS~, ITALY,
AIM of this study w~s to test the hypothesis th~t
dlpyrld~mole (DIP) eould offer ~ elue to the ~ssessment
of the underlying eoron~ry ~n~tomy (~nd. posslbly. of the
p~thogenetie meehanism) In patlents (pts) wlth effort
indueed ST elev~tlon, Seventeen eonseeutive pts wlth
exereise Indueed ST segment elevation, in the absenee of
prevlous Inf~retion and b~sal left ventrieular asynergy,
performed DIP- test (l.V, DIP. 0.56 mg/Kg In 4 min,
during 12 lead ECG and 2-D eehoeardlographle monitorlng).
In 9 pts, DIP Indueed ST segment elevatlon, in the same
le~ds whleh showed ST elevatlon on effort, A reverslble
asynergy (oeeurrlng In the reglon eorrespondlng to the
ECG leads wlth dlagnostle ehanges) eould always be
doeumented by eehoeardiogr~phy, In 2 pts, DIP indueed a
reverslble ~synergy In the presenee of ST depresslon, In
all these 11 pts, angiography Invariably showed a severe
(}90X) organle stenosis in the eoronary artery feedlng
the transiently impaired reglon after DIP; 7 pts had
single, 4 had double vessel dlsease, In the remaining 6
pts (all of WhOM with elther spontaneous or ergonovine
induced ST elev~tion), DIP dld not Induce elther ST
elev~tion or depresslon or reglonal asynergy, eoronary
anglography showed absent 13 pts) or slgnlfleant (3 pts)
eoron~ry ~rtery dlse~se, It IS eoneluded that DIP May
Induee tr~nsmur~l IseheMla, as deteeted by the
electrleal hallmark of ST elev~tlon, reproduclng effort
- induced ST elevation, In these eases, a severe organic
stenosis IS alw~ys present in the eoronary artery
feedIng the tr~nsiently asynergie myoeardl~l reglon.
DOPPLER MONmItED HEMODYNAMIC RESPONSE AND EARLY ISCHEMIA
IN ElERCISE STRESS TESTING PREDICTS TRIPLE VESSEL DISEASE.
IIDiU' Mehta. ISc.. David BenneU. F.R.C.P.• teith Da"tias. M.D..
David Wud. F.A.C.C.. lad David ....aerin'. I.Sc.. St. Gaor,e's BospitIJ
Medical School. London. b,laDd.
Apositive ECG eDrcile stress test"ith • poor hellUldynlolDic respoue
hu been IISOciated "ith • hi,h I year IIlOrtaJity in JIOIt-infaretion
pU.ients. We have lIlOaitored nDa-innsively. the hemodyalolDie
respoase to eurcise in 51 patieats"ith • positive eDrcile stress test
(Bruce protocol) 3 "eats JIOIt-infarction. by meuurin, the
muimum acclleration of escendiA, lOttie bJood usiA, Doppler
uJtnsound. Muimum acceleration yu Dbtllilled at rest lad peat
eurcise. ladu"""u. percentale chlA,e (I AlIA). The time to
Daset of ST se,ment depression (STDns) (>lmm depression 80 lDIllCS
after j-point) YU also noted. AU pU.ieats subsequlntJy hid eDroaary
IAliD,raphy lad Ylre eate,Drized into th_ "ith )701 stenosis ill 1.
2 Dr 3 coronary v...ls. The results are preseated u mIlA values
tSEM. StaUstical si,nificuces are related to 3vessel diJeue.
VnseJJ DiwIed li lAMA p SIw
1 16 28.7 t6.7 ~O.ot 5.3 to.5
2 9 32.1 t8.5 {O.OI 3.1 to.5
3 27 12.3 t2.0 1.8 to.2
A poor Doppler response YU defined u • ~.31 increase in
muimum acceleration (the malA .ISD of the value for 3 vessel
diseue patients); similarly. poor STons YU der18ed u <3 minutes.
Usiaa .these criteria the sensitivities lad specificities of these
variables in identityin, 3vessel dill.. "ere ascertllilled.
.l.6MA SIw Comb,jn,ed
Sensitivity 891 931 891
Specificity 601 601 761
Thus. • combination of an attenuated Dolllller monitored
hemodynamic response and early ischemia durin, nercise is hi,hly
predictive of trillle vessel diJe.-. The Doppler technique may thus
be • useful adjunct to routine eDrcile stress testiA, in identityin,
hiah mortaJity rilt patients in the seWaC of myocardia.! infarction.
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THROMBOLYTIC TREATMENT OF ACUTE MYOCARDIAL INFARCTION WITH
RECOMBINANT - TISSUE TYPE PLASMINOGEN ACTIVATOR: CORONARY
STATE AFTER 4 WEEKS
W.G. Schmidt M.D., R. v. Euen M.D•• R. Uebl. M.D.• S. Eifert M.D.• W. Rutsch
M.D.•, M. Schartl M.D.•• H. Schmutzler M.D.•, R. Erbel M.D.••• J. Meyer M.D.··
(on behalf of the European Cooperative Study Group for Recomblnent Ti_-Type
Plasminogen Activator rt-PA).
Dept. of Int. Medicine I, RWTH, Aachen; Dept. of Cardiology. Klinlkum Charlott8n·
burg. F_ Univenity, Berlin ••; Dept. of Int. Medicine II, Uniftrslty of Malnz ••.
91 patients (pts.1 with acute myocardial Infarction (AMI) of I.. than 8 h of duration
were randomly _Igned to treatment with intnMnou. Straptoklll8l8 (SK) or rt-PA
as part of the randomised trial of intravenous recombinant ti....·type plasminogen
activator versus intraVenous SK in AMI. 46 pts went allocated to rt-PA tnta_t
(group PI, 48 pts (group S) rae:eived SK. AftBr traatment the Infarct ntlated coronary
_I W81 patent in 37/45 ptl. (82 %1 of group P and 'D/48 pts. (58 %1 of group S.
In 7 ea-. of ulllllcceuful thrombolysi. the v_I could be racanalized mechanically.
PTCA of the residual stenosis _ performed In 17 _ After succassful raperfu·
.ion. all pts. rae:eived 25.000 Uof heparin per day up to the control examination.
3 - 4 _k. later, a _d alllliogram could be obtained in 48 pts' 3/48 .......
went raoccluded (2/29 in group P and 1/18 in group SI. Reocclullon occur8CI in 1/14
ea-. with an initial residual coronary stenOli. of ~ 90 %of diameter, and in 2/28
ca•• with 50-90 %. In only 8 pts. 112.5 %), the mldual obItftlction _ leu than
50 %, all having patent arteries in the control angio.
In 33 c_ without PTCA the degr. of coronary artery narrowillll could be a..-I
quantitetivaly both immediately after raperfulion and 3-4 waekllater on; there _
a dIe_ from 74 ±14 %to 58:!: 17 %of diameter (p <: 0.06; group P: 74 ±17 to
58 ±21 %. n· 18. group S: 74:!: 9 to 571: 12 %, n· 17). However, in 'D/33 pts' (82
%1 the residual stenosis remained to be ). 50 ".
Thu., a patent infarct ntlated artery i. -.n mO/'l often after treetment with rt-PA •
compared to SK. The Incidance of reocclu.ion and the I'lIlII'8IIlon of stenOiI. ant
.imilar in group S and P. Despite a .lgnificant decraaIe the rasiclual .-I. usually
ntmalnl to be mont than 50 " of diameter within a follow-up periocl of 4 _Ill. Thl.
should be considered concerning further treetment of pts. with special ragard to
PTCA and bypBasurgery.
EFFECT OF INTRAVENOUS THROMBOLYTIC THERAPY ON LV
FUNCTION - REPORT FROM THE NHLBI THROMBOLYSIS
IN MYOCARDIAL INFARCTION!TIMI) TRIAL
Florence H. Sheehan, H,D., for the TIHI
InvestIgators, NHLBI, Bethesda, H.D,
TIHI Phase I rando.ized 290 patients(pts) <7h after acute
ayocardial infarction(HI) to recoabinant tissue
plasainogen activator(rTPA) or streptoklnase(SK). Change
(~) In EF and hypokinesis in the HI region(HYPO) aeasured
by the centerline aethod were deterained in 153
patients(pts) who had analyzable pre-treataent (pre-tr)
and pre-discharge (pre-dc) contrast ventriculograas.
Although pts with reperfusion(R) were aore likely to have
pre-dc cath, iaproveaent in EF was inSIgnificant in both
treataent groups (paIred t for Ll pre-tr to pre-de:
'pC001, Ip(05)
rTPA: ~EF=0.8+7.0 (N=82), ~HYPO=0.4~0.8,(N=75)'
SX: ~EF=I.4~8.1 (N=71), ~HYPO=0.4~0.8,(N=65)*
In eo.blned SX and rTPA pts with known R status, HYPO and
EF laproved in pts with total occlusion (occ) and R (Group
A), HYPO iaproved in pts with subtotal occ (Group B).
Neither l.proved in pts with per.anent occ (Group C), late
R occurring between catha (Group D), or rethroabosis
(Group E):
Group/N A/49 B/25 C/29 D/29 E/IO
~EF 2.5~6.91 2.9~8.8 -1.0~6.6 0.7~8.6 0.5~7.5
~HYPO 0.4~0.7' 0.8~0.9' 0.1~0.7 0.3~O.8 0.0~0.5
In Group A, EF iaproved in pta with R <4h after HI
(~EF=4.3~7.21 (N=22) va 1.0~6.3 (N=27,p=NS for R later
than 4h).
Thus throabolytic therapy with SX and TPA results In
significant iaproveaent in regional wall aotion in the
infarct site. However significant i.proveaent In EF was
seen only in patients who achieved sustained reperfusion.
The increase in EF was greatest in the subset who were
reperfused withIn 4 hrs after HI.
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HAZARDS OF USING POST THROMBOLYTIC ST SEGMENT EVOLUTION
AS A REPERFUSION MARKER. OBSERVATIONS FROM THE TIMI TRIAL
George B. Bren, MD; Alan G. Wasserman, MD, FACC; Allan M.
Ross, MD, FACC; for the TIMI Investigators, Washington, DC
HEPARIN INDUCES CORONARY REPERFUSION IN VERY EARLY
MYOCARDIAL INFARCTION.
Gail O. Berman, M.D., Nelson M. Wolf, M.D., F.A.C.C.,
Jay A. Shechter, M.D., Ted D. Friehling, M.D., Steven
LaPorte, M.D., F.A.C.C., Jerome Brody, M.D.,and Steven
G. Meister, M.D., F.A.C.C., The Medical College of
Pennsylvania, Philadelphia, Pennsylvania.
Heparin is not a thrombolytic drug, but interferes with
components of the coagulation cascade to inhibit fibrin
generation. If given early, it might prevent maturation
of an obstructive intracoronary platelet aggregate to a
stable fibrin thrombus. On this rationale, we gave a
7500-10000 unit bolus of intravenous Heparin (IVH) to 15
hospitalized patients who were seen during the first one
hour of acute myocardial infarction (MI). All had
ongoing ischemic chest pain and new ST segment eleva-
tions > 2 mm in at least 2 contiguous leads, unrespon-
sive to sublingual or intravenous nitrates or both.
Relief of pain and abrupt return of ST segments to (10)
or toward (1) baseline occurred within 20 minutes in 11
patients (73%). Of these, none developed new pathologic
Q waves. Two had no creatine phosphokinase (CPK) eleva-
tions greater than 150% of laboratory normal and 9 had
early peaking CPK curves consistent with coronary reper-
fusion. Eight of these 11 had coronary angiography
within 72 hours after IVH showing patency of the
infarct-related vessel in all. No bleeding complica-
tions occurred in patients receiving IVH alone. Thus
IVH appears to induce reperfusion when administered
during the first 1 hour of acute MI and may be a safe,
effective substitute for thrombolytic drugs in that
situation.
6ST>.3mV
33%
76%
SENS
SPEC
Conclusion:
rel iabl e for
patients.
Decisions regarding secondary strategies to preserve re-
perfused artery patency after IV lytic therapy for MI
would be served by a reliable marker of lysis. As the
use of ST segment elevation (STt) evolution for this
purpose has been controversial we interrogated ECG data
on 273 MI pts in the NHLBI Phase I Thrombolysis in Myo-
cardial Infarction Trial (TIM!). Infarct lead STt was
centrally digitized on admission (Adm) and 2 hours after
IV Streptokinase or rTPA (2hp). Time from pain onset to
treatment was 4.8h. We compared groups with initially
completely obstructed arteries with subsequent sub-
stantial reperfusion (REPER), no reperfusion (NOREP) and
those with initially incomplete obstruction (INCOMP).
REPER NOREP INCOMP
Adm STt .38mV±.22 .38mV±.27 .32mV±.17
2hpSTt .13mV±.11+p<.002+ .19mV±.18 +p<.OOOl+ .09mV±.10
Although there is less STt at 2hp in REPERF vs NOREP
patients, the absolute difference is only .06 mY. Simi-
lar findings were seen when pts were stratified by in-
farct location and with analysis restricted to those
treated ~4 hours. We also evaluated sensitivity (SENS)
and specificity (SPEC) of STt magnitude at 2hp and mag-
nitude of decline in STt (6ST) from adm to 2hp for identi-
fying vessel patency post treatment.
STt<.2mV at 2h STt<.lmV at 2h 6ST>.2mV
- 78% 55% 55%
40% 64% 58%
ST segment evolution is not clinically
distinguishing reperfused from non-reperfused
THE TIME INTERVAL FROM INITIATION OF IV STREPTOKINASE TO
REPERFUSION IS DIRECTLY RELATED TO THE RESIDUAL FIBRINOG-
EN LEVEL AND IS SHORTENED BY PRETREATMENT WITH HEPARIN.
Allan S. Lew MD, Bojan Cercek MD, Pierre Laramee MD,
Hanoch Hod MD, P.K. Shah MD, FACC and William Ganz MD,
CSc, FACC. Cedars-Sinai Medical Center, Los Angeles CA.
In 64 Pts with acute myocardial infarction of ~3 hr dur-
ation, the residual serum fibrinogen following 750,000 U
IV streptokinase (SK) correlated directly (rz O.58,p<.001)
with the time interval from initiation of treatment to
reperfusion (REP). Reperfusion was achieved in 35±21 min
in all 41 Pts with a fibrinogen of ~50 mg% (23±11 mg% at
74±44 min post-SK). In contrast, of the 23 pts with a
fibrinogen of >50 mg% (108±64 mg% at 89±54 min post-SK),
REP was not achieved in 4 Pts and was delayed for 67±39
min in the remaining 19 pts (p<O.OOI vs Pts with FIB of
~50 mg%). All 5 Pts with a fibrinogen of >90 mg% in whom
the pretreatment anti-SK antibody titer was measured had
very high titers suggesting that in these Pts, the high
fibrino~en and the delay or failure of reperfusion were
due to lnactivation of a significant portion of the SK
dose by anti-SK antibodies. Pretreatment with 40 U/Kg IV
heparin significantly shortened SK-REP in the 17 Pts with
fibrinogen of ~50 mg%, but not in the 9 Pts with a resid-
ual fibrinogen of >50 mg% (Table). Symptom duration and
IV-SK infusion rate were comparable in all 4 groups.
FIBRINOGEN ~ 50 mg% FIBRINOGEN > 50 mg%
*p<O.OI. Heparin No Heparin ~ No Heparin
n=17 n=24 n=9 n=10
SK-REP (min): 24±9* 42±23* 70±45 65±34
Our data suggest that: 1) Reperfusion following IV-SK is
delayed or may not occur when the residual fibrinogen is
high, probably due to substantial inactivation of the SK
by preexisting antibodies. 2) In patients in whom IV-SK
markedly depletes fibrinogen, pretreatment with heparin
significantly shortens the time interval to reperfusion.
WHICH PATIENTS BENEFIT MOST OF THROMBOLYSIS IN ACUTE
MYOCARDIAL INFARCTION ?
Frank Velllleer, M.D., Maarten L. Simoons, M.D., F.A.C.C.,
Patrick W. Serruys, M.D., Arnoud van der Laarse, Ph.D.,
Wim Hellllens, Ph.D., Frits BUr, M.D., Jan Res, M.D.,
Chris de Zwaan, M.D., Jacobus Lubsen, Ph.D.
The Netherlands Interuniversity CaIdiology Institute.
To study the effect of thrombolysis (T) 533 pts were
randomly allocated to conventional treatment (C, 264 pts)
or int raco rona ry st reptokinase (Ie SK, 152 pts) or IC SK
preceded by 500.000 U SK intravenously(IV+IC SK, 117 pts).
Baseline characteristics were similar in both groups,
including the sum of ST elevations at admission (SST) and
duration of symptoms before hospital admission.
T was associated with a 30% smaller infarct size as
estimated from total myocaIdial HBDH release (p < 0.0001).
Limitation of infarct size was greater in pts admitted
within 2 hrs (41%) than in pts arriving after 2-4 hrs
(18%); in pts with SST ~2mm (35%) than SST <12 mm (30%);
in pts treated with IV + IC SK (39%) than with IC SK only
(27%). Mean left ventricular ejection fraction (LVEF)
before discharge was 5% higher in T compared to C (49% and
44%, p < 0.001). Differences in LVEF were greater in pts
with SST ~2mm (6%) than in pts with SST <12 mm (4%) and
in pts arriving within 2 hrs (7%) than in pts arriving
after 2-4 hrs (3%). In the subgroup of 68 patients with
STT < 12 mm and arriving after 2-4 hrs no differences were
found in infarct size and LVEF between e and T.
Multivariate analysis confirmed that the interval between
onset of symptoms and hospital admission, and SST were
independently related to the limitation of infarct size
and the improvement of LVEF by thrombolysis.
Early thrombolysis by IC + IV SK limits infarct size and
improves left ventricular function, particularly in pts
with extensive myocardial ischemia (SST ~12 mm) and in pts
hospitalized within 2 hrs after onset of symptoms.
18A ABSTRACTS lAce Vol. 7, No 2
February 1986. 18A
Monday, March 10, 1986
4:00PM-5:30PM, Room #264/265/266
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EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION (MI):
REDUCTION OF INFARCT SIZE, PRESERVATION OF LEFT
VENTRICULAR FUNCTION AND IMPROVED SURVIVAL.
Maarten L. Simoons, M.D., F.A.C.C., Patrick W. Serruys,
M.D., Marcel v/d Brand, M.D., Frits Blir, M.D., Chris de
Zwaan, M.D., Jan Res, M.D., Freek W.A. Verheugt, M.D.,
X. Hanno Krauss, M.D., Willem J. Remme, M.D., Frank
Venneer, M.D., Jacobus Lubsen, Ph.D.
The Netherlands Interuniversity Cardiology Institute.
A randomized trial compa ring ea rly (less than 4 hou rs
after symptoms of myocardial infarction) thrombolysis (T)
by intracoronary (ic) or intravenous (iv) followed by ic
streptokinase with conventional therapy (C) was completed
in March 1985. 533 patients (pts) with MI were randomized,
264 C and 269 T. All baseline data were similar. 35 pts
allocated to T did not accept the intervention. At the end
of the procedure the infarct related artery was patent in
198 pts (85%) and remained occluded in 36 pts allocated to
T. Median time until recanalisation was 200 minutes.
In hospital course was more favorsble after T : cardia-
genic shock 24 C, 13 T (p-0.08), ventricular fibrillation
61 C, 38 T (p-O.Ol), pericarditis 46 C, 19 T (p-0.0004),
although bleeding was more frequent (53 T, 7 C, p-O.OOOl).
Infarct size estimated from serial enzyme release was 30%
lower after T. Global left ventricular function measured
by radionuclide angiography before discharge was better
after T than in C (48+15% vs 44+15%, p-0.003). Mortality
was lower after T, both-at 28 days (16 T, 31 C) and at one
year median follow up (42 C, 23 T, p-O.Ol) although
reinfarction occurred more frequent after T (16 C, 36 T.
p-O.004), in particular in patients with inferior MI.
Early thrombolysis does lead to substantial limitation of
infa rct size. prese rvation of left vent ricula r function
and improved survival. Since reinfarction occurs more fre-
quently after thrombolysis further studies should address
measures to prevent this complication.
PRESERVATION OF MYOCARDIAL FUNCTION IN THE INFARCT ZONE.
FINAL REPORT OF THE DUTCH MULTICENTER RANDOMIZED TRIAL ON
INTRACORONARY THROMBOLYSIS.
Patrick WSerruys, MD, Maarten L Simoons, MD, FACC,
Haryanto Suryapranata, MD, Frank Vermeer, MD, William
Wijns, MD, Marcel vd Brand, MD, Frits Bar, MD, Chris de
Zwaan, MD, X Hanno Krauss, MD, William J Remme, MD, Jan
Res, MD, Freek WA Verheugt, MD, Ronald van Domburg, MS,
Jacobus Lubsen, MD, Paul G Hugenholtz, MD, FACC.
The Netherlands Interuniversity Cardiology Institute.
Between June 1981 and March 1985, 533 pts with AMI were
enrolled within 4 hours of onset of symptoms in a
randomized trial of intracoronary thrombolysis (TR, n=269
pts) with streptokinase versus conventional treatment
(CT, n=264 pts). Median time between onset of symptoms
and recanalization was 200 min and the infarct related
patency was 85%. LV angiography was available prior to
discharge in 332 pts (174 CT, group I, 158 TR gr II). In
gr II a subset of 46 pts (gr III) were recanalized within
180 min. The regional contribution of the infarct zones
(CREF-IZ %) to the global ejection fraction (EF %) were
assessed in 4 LV regions: AB,IB=antero. infero basal; AA,
IA=antero, infero apical. Results as mean ± SD
EF CREF AB CREF AA CREF IB CREF IA
I 47:t14 12.2±4.1 4.4±3.1 10.8±4.7 6.9±4.1
II 53±13* 14.0±3.6" 5.6±3.4" 12.6±4.3" 9.5±3.3*
III 57±11* 14.4±3.9' 6.0±3.7° 13. 6±4. 3" 10.9±3.3*
p < .02 ' P < .01 " P < .005 * p < .0001 versus gr 1,
Analysis following the intention-to-treat principle (gr I
and II) demonstrates that TR reduces the loss of
functional myocardium in anterior as well as in inferior
MI. This beneficial effect is particularly evident when
recanalization is achieved within 3 hours (Group III).
all 1 :!. 11 4 .t 9* 2 .t 13 4 + 12'
anterior I'll 1 .t 9 5 + 9* 3 :!. 10 6-:!. 13°
inferior I'll 1 .t 13 3 ;: 9° 1 :!. 14 2 .t 11
first I'll 1 :!. 12 4 .t 9* 2 :!. 13 3 .t 12°
previous I'll -1 :!:. 7 4 :!:. 9 o :!:. 10 5 :!:. 13
Recurrent I'll within 3 months occurred in 8 C pts (5 ant I'll, 3
inf I'll, i'llVEF -7 and -14~ resp) and in 17 SK pts (4 ant I'll, 13
inf I'll, i'lLVEF 5 and -1~ resp).
Thus, persistent improvement of LVEF by SK is seen in particular
in first and anterior I'll, Improvement of LVEF by SK in inferior
I'll is partly abolished by the higher incidence of recurrent I'll.
PERSISTENT II'PROVEJlENT OF LEFT VENTRICl1.AR FUNCTION IN A
RANDOMIZED CONTROLLED TRIAL OF RECANALIZATION I FINAL REPORT
Jan C.J. Res, 1'1.0" F.W.A. Verheugt, 1'1.0" E.E. van der Wall,
1'1.0., I'I.J. van Eenige, I'I.S.E.E., M.L. Simoons. M.D., F.A.C.C..
C. de Zwaan, 1'1.0., S. Braat, 1'1.0.. W.J. R""""', 1'1.0.. r.
Vermeer, 1'1.0" Interuniversity Cardiology Institute, The
Netherlands
SEQUENTIAL INTRAVENOUS THROMBOLYSIS AND CORONARY
ANGIOPLASTY VS. DIRECT PTCA THERAPY FOR ACUTE MYO-
CARDIAL INFARCTION.
EJ Topol, MO, WW O'Neill. MD, P Lai, MD, A Fung, MD,
PDV Bourdl11on, MD, J Walton, MO. ER Bates, MD,
E Kline. BSN, RN, B Pitt, MD, FACC. University of
Michigan Medical center, Ann Arbor, MI.
The opt ima1 approach to ach i eve myocard iali nfarct
(MI) vessel recanal ization remains undefined. We
compared sequential therapy (5) of intravenous thrombo-
1ys i s (streptok inase 1. 5 mi 11 U) and emergency PTCA
in 31 patients vs. direct (D) PTCA in 29. The 2 groups
were simi 1ar with respect to demograph i c parameters,
infarct location, and time from onset of chest pain to
PTCA. All patients received IV heparin, aspirin +
dipyridamole for 1 wk. Infarct vessel patency was
defined as rapid flow and clearance of contrast (TIMI
Grade 3); bleeding as requiring transfusion, or
resulting in significant morbidity. Follow-up cardiac
catheterization at 1 week post-MI was obtained in 49/60
pat ients. A repeat LV gram was used to determine the
change (Day 7 to Day 0) in ejection fraction (AEF).
S (N=31i 0 (N$29i P
Initial Patency 16 61 4 13 :002
Post-PTCA Patency 27/28 96% 24/29 83% .09
1 Week Patency 25/26 96% 20/23 86% NS
Bleeding 7 22% 9 31% NS
AEF (x+SO) t8.1+10 17.7+7 NS
We conclude: (1) Similar results were-obtained with
sequential vs. direct PTCA therapy with respect to
global LV function, and 1 wk follow-up infarct vessel
status; (2) the comparable incidence of significant
bleeding episodes in the 2 groups suggests that
invasive punctures, heparin and antiplatelet agents are
more important than fibrinolytic therapy in causing
hemorrhage.
day 1-3 ...3 months
C (n=11S) SK (n=139)
day 1-3 ... 2 weeks
C (n$115) SK (n=161)
'p <0.001
mean:!. SO
* p <0.0001
To assess the effect of recanalization on left ventricular
ejection fraction (lVEF) radionuclide angiography was performed
in 533 patients (pts) with acute myocardial infarction (I'll)
enrolled in a randomized controlled trial comparing conventional
treatment (C, 264 pts) with intracoronary streptokinase (SK, 269
pts). Pretreatment with intravenous SK was done in 117 pts. In
416 pts first I'll was diagnosed, 117 had previous I'll. lVEF waS
measured at day 1-3, at 2 weeks and at 3 months after I'll. Within
3 months 34 C and 18 SK pts died. Paired data (I\LVEF) were
obtained I
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LONG TERM FOLLOW-UP OF PATIENTS RECEIVING INTRACORONARY
STREPTOKINASE COMPARED WITH RANDOMLY ASSIGNED CONTROLS.
David H. Schaer, MD, Roy H. Leiboff, MD, FACC, Alan G.
Wasserman, MD, FACC, Lisa W. Martin, MD, P. Jacob
Varghese, MD, FACC, Richard J. Katz, MD, FACC, George B.
Bren, MD, Teresa Bren, RN, Molly Magee, RN, and Allan M.
Ross, MD, FACC, George Washington Univ, Washington, DC
We collected long term follow-up data (27 ± 14 months)
on 100% of a cohort of 83 consecutive acute infarct
(AMI) pts either treated with intracoronary streptokinase
or randomly assigned to a control group also undergoing
immediate coronary angiography. Time from AMI symptoms
onset to treatment was <5h. Outcome analysis was by
infarct artery patency (PAT) n=42 or occlusion (OCC) n=
41, 90 min after start of angiography. Tabulated are
mortality (all but one death[*] known or suspected to be
cardiac) and recurrent ischemic events (angina or rein-
farct), in hospital, after discharge but within 1 year
("1st yr"), and beyond 1 yr (>1 year).
All Cause Mortality Recurrent Ischemia
Patent Occluded p Patent Occluded p
In Hosp 0 pts 2 pts ns 20 pts 3 pts <.001
1st Year 4 pts 4 pts ns 11 pts 7 pts <.02
>1 Year 2 pts 2*pts ns 2 pts 7 pts ns
Total 6 pts 8 pts ns 33 pts 17 pts <.05
Mean discharge ejection fractions in PAT and OCC groups
were identical (45%±14 vs 45%±15, respectively) but was
lower in those who died during follow-up (38%±14) than
for survivors (47±14, p<.05). PTCA or CABG was more often
required in PAT pts, 17/42 (40%), than in OCC pts 8/41
(20%), p<.05. Conclusions: .1) Early and long term sur-
vival was unaffected by infarct artery patency; 2) Early
recurrent ischemic events were common when the infarct
artery was reperfused, often necessitating mechanical in-
tervention.
STATE OF THE INFARCT RELATED CORONARY ARTERY IMMEDIATELY
AND 3 DAYS AFTER SUCCESSFUL INTRACORONARY THROMBOLYSIS WITH
STREPTOKINASE.
Rainer Uebis M.D., Rainer von Essen M.D., Wolfgang G. Schmidt M.D., Rolf Dorr
M.D., Andreas Franke, Heinz Lambertz M.D.
Dept. of Internal Medicine I, RWTH, Aachen, West Germany.
In 365 (79 %, group 1) out of 461 patients (pts) with acute myocardial infarction,
the fint angio revealed a complete thrombotic obstruction; 96 pts (21 %, group 2)
had a high degree of stenosis of the infarct related coronary artery. The remaining
stenosis immediately after successful intracoronary lic.l thrombolysis with Strepto·
kinase (SKI was assessed quantitatively in 140 consecutive pts (n ~ 106 out of group
1, n = 34 out of group 2) using at least 2 angiogrephic projections. A 2nd angio was
obtained 3 days later before removing the introducer sheet. The influence of total
time of occlusion and of the anatomy of the lesion !initially complete or incomplete
obstruction, length, excentricity) on the development of the residual stenosis was
analysed; within the observation period, no mechanical intervention IPTCA, bypass
surgery) took place. 2 - 6 mg of nitroglycerin I hand 25.000 - 35.000 U of heparin
I 24 hs were administered continously
!TIME AFTER GROUP 1 GROUP 2
LYSIS DIAMETER I CROSS SECT. DIAMETER I CROSS SECT.
Immediately 70.7± 9.5 I90.4 ±. 6.1 69.7 ±. 7.2 I 90.2'±' 5.0 ]~rd day 65.8 + 13.7 86.3 !. 10.6 65.8 ±14.1 86.3 + 12.4 •
I ns , • p<O.oool
In only 8 pts, the improvement exceeded 20 % of diameter, whereas the degree
of stenosis remained unchanged ( < 10 %variation) in 111 cases, or even increased
in 5 pts. Excentric stenoses decreased with an average of -6.8 ± 11.3 %, concentric
with ·3.5 ± 8.1 % of diametar (nsl. Lesions < 5 mm of length showed an improve-
mentof -a.0±. 7.1 %, > 5 and ~ 10 mm of-:4.6±9.9%, and >10 mm of -3,6±.
10.2 % (ns). There was no correlation to total time of occlusion.
Thus, despite a slight but significant reduction, the residual stenosis 3 days after
successful thrombolysis is still of hemodynamic importance in the majorIty of pts.
The amount of increase or decrease of narrowing cannot be predicted from the
anatomy of the leSion, and selected pts should be referred to PTCA or bypass surgery
as soon as pOSSIble.
Monday, March 10, 1986
2:00PM-3:30PM, Room #260/261
Angioplasty: Indications and Results
RESTENOSIS AND LATE CARDIAC EVENTS AFTER SUCCESSFUL
CORONARY ANGIOPLASTY IN ELDERLY· PATIENTS.
Pierre Abi-Mansour, M.D., Gary Roubin, M.B., Ph.D.,
Clane Rice, R.N., Clayton Bredlau, M.D., John Douglas,
M.D., Spencer King, M.D., Andreas Gruentzig, M.D.,
F.A.C.C. Emory University SChool of Medicine, Atlanta,
Georgia.
PTCA can be performed in patients (pts) older than
65 years with low morbidity and IIIOrtal1ty but the late
outcome and restenosis rate in these pts is unknown. To
determine the influence of PTCA on survival and cardiac
event rate, we prospectively followed 131 consecutive
pts older than 65 years (age-69,;t3 years, meallj;SD) who
had successful PTCA at Bnory University between 1/1/81
and 12/31/82. 72% were male and 28% female. The inci-
dence of multivessel disease was 17%, pcevious myocar-
dial infarction (MI) 23% and prior bypass surgery
(CABG)8%. The majority of pts (56%) had unstable angina
pectoris. Repeat coronary angiography was llYailable in
101 pts (77%) at a mean time of 8;1;.7 months. Of these,
37 (36%) had restenosis(RS). 11 of 37 were maintained
on medical therapy, 5 had CABG, and 21 had repeat PTCA.
Repeat PTCA was successful in 20/21 pts (95%) but 5 of
these subsequently required CABG because of RS or
disease progression at another site. 2 additional pts
who did not have RS had PTCA for disease progression at
a different site. At late mean follow-up of 30+10
months (range 12-52 11IO.), 2 pts died from noncardTac
causes (malignancy), there were no cardiac deaths and
no MI and 115/131 pts (88%) were asymptomatic or
improved without undergoing CABG.
Conclusion: In elderly pts the restenosis rate after
PTCA is similar to that reported in younger pts. Suc-
cessful PTCA offer s older patients extended effective
therapy with excellent short term surviVal and a low
riSK of subsequent cardiac events.
CORONARY ANG IOPLASTY OF THE "aJLPR IT LES ION": AN
ALTERNATIVE APPROACH IN THE MANAGEMENT OF UNSTABLE ANGINA
WITH M.JLTIV ESSEL 0ISEASE.
Daniel WQhlgelernter. MD, FACC; Henry,," Highman, PAl
Michael Cleman, MD. Yale University, New Haven, CT.
We SQught to test the hYPQthesls that PTCA Qf the
angina-producing vessel or "culprit leslQn" can be
effective therapy fQr selected pt~ with unstable angina
WA) and multi vessel cQrQnary artery disease (MVD). The
Immediate and late fQI IQw-up results were analyzed In 20
pts. with MVD and UA refractory tQ medical therapy whQ
underwent PTeA limited to the presumed angina-producing
vessel. MVD was defined as L70% stenosis In two Qr more
major coronary arterle~ The culprit lesion was
Identified by anglographlc mQrpholQglc features and
localizing reversible Ischemic ST changes on ECG obtained
during eplsQdes of angina Anglographlc characteristics
used to Identify the culprit lesion Included: a) the
presence of Intracoronary thrombus; I.e., visualization
of a fll ling defect Qutf Ined by contrast medium adjacent
to a high-grade stenosis - 6 pt~; b) Irregular, ragged
margins of the area of stenQsls, suggestive of plaque
fIssurIng - 6 pt~; c) sub-total obstructlQn In one
vessel with no other stenQsls greater than 70% - B pt~
All pt~ had successful and uncomplicated PTCA (92% .± 6%
- stenosis pre-PTCA, 11% ± 15% residual stenQsls) with
Immediate resolutlQn of U,," Follow-up after PTCA ranged
from 8-19 months (mean - 11 months), and 1B of 20 pt~
(90%) remaIn asymptQmatlc, with nQ angina or Ischemic EOG
changes Qn maxi mal treadm III test Ing. One pt with
recurrent angIna had restenQsls of the dilated lesion
documented by angiography. The other pt with angina post-
PTCA had no evidence of restenQsI~ We cQnclude that
sIngle-vessel PTCA Qf the "culprit lesion" shQuld be
considered a therapeutic option for selected pt~ with UA
and MVo.
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RECURRENT STENOSIS AFTER CORONARY ANGIOPLASTY.
Jay Hollman, M.D., F.A.C.C., Kathy Galan, R.N., Irving
Franco, M.D., Conrad Simpfendorfer, M.D., Kathy Fatica,
B.S., and Gerald Beck, Ph.D. Cleveland Clinic Founda-
tion, Cleveland, OH.
Recurrent stenosis (RS) after successful percutane-
ous trans luminal coronary angioplasty (PTCA) remains a
major problem with this method of revascularization.
This study analyzed factors present at time of initial
PTCA for their importance in RS. This study involved
angiographic follow-up only; 634 segments in 536
patients. RS, defined as a recurrent stenosis at any
site, was more common in multivessel PTCA (67.9%) than
in single vessel single lesion Cl-v, L) PTCA (37.8%).
Multi-lesion PTCA performed in 1 vessel (37.7%) had no
higher recurrence than I-V, L PTCA (37.8%).
Analysis of 446 patients with I-V, L PTCA showed
diabetic (49.2% vs 36%) more likely to recur. No other
risk factor correlated with recurrence. Patients with
more severe disease (higher CHC) and lesion >90% also
were more likely to recur. Patients left with a
residual stenosis >40% were more likely to recur.
Right coronary stenoses (22.1%) recurred less fre-
quently than left anterior descending (45.2%) or
circumflex (42.9%). The presence of int imal tear at
PTCA site immediately after PTCA is associated with a
lower recurrence rate (29.7% vs 40.4%).
PTCA is associated with a higher recurrence rate in
diabetics, pts with severe disease, and left coronary
artery lesion. Intimal tearing is desirable and may
lower recurrence rate. Recurrence in multivessel PTCA
is higher than I-vessel, one lesion PTCA and appears to
be cumulative.
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN PATIENTS
WITH PRIOR MYOCARDIAL INFARCTION. Michael Savage, M.D.,
John P. Dervan, M.D., Andrew Zalewski, M.D., Sonya Slysh,
M.D. ,James Hopkins, M.D., Sheldon Goldberg, M.D., F.A.C.C.
Thomas Jefferson University Hospital, Philadelphia, PA
Patients undergoing percutaneous transluminal coronary
angioplasty (PTCA) who have had a prior transmural
myocardial infarction (MI) in the distribution of another
coronary artery are properly considered a high-risk group
because of potential severe LV dysfunction if an acute
ischemic complication occurs. Accordingly. to evaluate
the safety and efficacy of PTCA in this setting, 225
consecutive patients undergoing PTCA were divided into:
19 patients (Group I) who had a prior MI remote from the
artery undergoing PTCA, and 206 patients (Group II) with
no remote MI. All patients in Group I had pathologic
Q-waves on ECG and/or segmental akinesis on ventriculo-
graphy, PTCA outcome for Groups I and II were as follows:
Group Pre-PTCA Post-PTCA Gradient Primary
Stenosis(%) Stenosis(%) (mmHg) Success(%)
I 91+6 29+18 7+5 90%
II 94+5 39+27 11+6 84%
p ~ ri ~ ~
Mean severity of stenosis and translesional gradient
post-PTCA were similar in both groups. Furthermore.
primary success (i,e" residual stenosis ~50%) was
comparable in the two groups, There was no difference in
frequency of acute ischemic complications requiring
emergency coronary bypass surgery (Group 1-2 patients.
Group 11-10 patients; NS). Importantly, there were no
deaths in either group. We concludp: (1) PTCA is a
suitable therapeutic procedure in selected patients with
underlying LV dysfunction due to prior MI remote from the
site of angioplasty, (2) with immediate operating room
standby, PTCA can be performed successfully in such
patients with low morbidity and mortality.
FACTORS PREDICTING RECURRENCE IN PATIENTS WHO
HAVE HAD ANGIOPLASTY (PTCA) OF TOTALLY OCCLUDED
VESSELS D~vid A. Clark, M.D., F.A.C.C.,
~Jark P. Hcxmun, H.D., i"'G"ryc-:-Murphy, RN, M.S.,
Jodi Fishman-Rosen, R~, N.S. Richard E. Shaw,
Ph.D., Simon H. Stertzer, !·1.D., F.A.C.C.,
Richard K. rlyler, !·1.D., F.A.C.C., S3n
Francisco Heart InstItute, Daly City, CA
In our series of 1bU patients with totally
occluded coronary arteries without evolving
infarction, 124 patients had successful PTCA
with a reduction of percent diameter stenosis
(PDS) from 100% before to a mean (m) of 26% and
range (r) of 8 to 63% after PTCA and change of
pressure gradient (P) from m=50 mmHg (r=30-o0)
before to m=& mmHg (r=O-20) after PTCA. 97 of
these 124 patients have been followed for at
least 6 months. Of these 97, 45 have had repeat
angiography. 20 had p<:tent vessels, 10% of whom
were symptomatic (false positive). 25 demon-
strated partial or total recurrence, 28~ of
whom were asymptomatic (false negative). Age,
sex, diabetes, rest/nocturnDl angina, duration
of occlusion, PDS and P pre- and post-PTCA
balloon inflation pressure (BIP) and number of
inflations (I) were evaluated to assess predic-
tors of recurrence. Logistic regression an-
alyses demonstrated that recurrence was more
likely to occur in: 1) patients with lesions
requiring more I (p<.05)j and 2) lesions re-
quirIng higher BIP (p<.05). In summary, clini-
cal symptoms (anglna) ;nay not be a reliable
index of recurrence, but lesions requiring more
I and higher BIP may be more likely to recur
following PTCA of recent total occlusions.
PERaJTANEOOS TRANSLUMINAL CORONARY AHmHIBl'I FtR
EARLY POSTINFARCTION ONS'l'ABLE A!l>INA, RFSlL'l'S AM>
F(U,(Jf-(JP•
Sidney O. Gottlieb M.D., Kenneth P. Brin M.D., Ph.D.,
F.A.C.C., Gary D. Walford M.D., Mark Mct;aughey M.D.,
Mary Beth Riegel R.N., and Jeffrey A. Brinker M.D.,
F.A.C.C. The Johns Hopkins Medical Institutions,
Baltimore, MD.
Unstable angina (UAI occurring in the early post-
infarction (post-MIl period is associated with an
increased incidence of unfavorable cardiac events
despite aggressive medical therapy. We examined the
results of coronary angioplasty (CAl in 47 consecutive
patients (ptsl with post-MI UA, who were referred
for CA 12.9 ± 7 days following MI (14 transnural,
1M, and 33 non-'lM). CA was performed on 55 arteries
with a mean stenosis of 95 ± 8%. These included 46
infarct-related arteries, and 9 non-infarct arteries.
Double vessel CA was performed in 8 pts. Successful
CA was achieved in 43 pts (91%), with a mean residual
stenosis of 33 ± 28%. There was no operative mortality,
and follow-up for a mean of 7.5 months revealed 1
cardiac death, 2 myocardial infarctions, and 3 had
surgical revascu1arization. Repeat CA was required
in 6 pts from 2-105 days after initial CA, and was
successful in 5 pts (83%). Of the 40 pts who had
a successful PTCA and were discharged from the hospital
without an unfavorable outcome, 31 (78%) remain angina-
free over the average follow up period of 7.5 months.
The presence of either clot or coronary artery dissection
were not predictive of subsequent unfavorable outcomes.
Thus CA offers a low-risk efficacious therapeutic
option for selected pts with early post-MI unstable
angina.
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The Results of Angioplasty
FRENCH PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
(PTCA) REGISTRY: FOUR YEARS EXPERIENCE.
Michel E. Bertrand, M.D., Jean Marco, M.D., Fran90is
Cherrier, M.D., R. Schmitt, M.D., Ph. Gaspard, M.D., J.
Puel, M.D., B. Valeix, M.D., M. Bory, M.D., H. Crochet,
M.D., H. Geschwind, M.D., R. Berland, M.D., J. Mache-
court, M.D., J.P. Foucault, J.P. Bassand, Cl. Bourdon-
nec, A. QU1ret, F. Jault.
Data collected on 3198 patients (pts) undergoing PTCA in
17 French institutions during the past 4 years have been
analyzed regarding the effectiveness and mid term re-
sults of PTCA. The patients were subd1v1ded in two
groups : Group A (n = 2385) w1th single vessel disease.
Group B (n = 813) w1th multiple vessel disease
Group A Group B
Crossed stenosis 88% 88%
Primary success 73% 78%
Death 0.9% 2.2%
Myocardial 1nfarction 5.2% 5.8%
Emergency CABG 4.1% 4.5%
Negative ex. test post PTCA 85% 74%
The patients were restudied 7.7 months and 5 months la-
ter respectively 1n Group A and Group B.
At the time of re1nvestigation 71% in group A and 65% 1n
group B were free of symptoms. Exerc1se test was negat1-
ve in 75% and 65% respectively. Restenosis, def1ned as a
loss of at least 50% of the initial gain was observed in
31% (group A) and 34% (group B). Thus, success rate was
similar in both the 2 groups but the risk of morta11ty
was higher 1n the group with mult1ple vessel disease
(group B)
LATE RECURRENCE OF ANGINA FOLLOWING CORONARY ANGIOPLASTY:
THE ROLE OF NEW ATHEROSCLEROTIC DISEASE.
Edward W. Robert, M.D., F.A.C.C., William B. Ricks, M.D.,
F.A.C.C., Ronald M. Rossen, M.D., F.A.C.C.,
Michael R. Nagel, M.D., F.A.C.C., Stephen E. Green, M.D.,
F.A.C.C., Ada Koransky, M.D., and Terry Thomas, R.N., Good
Samaritan Hospital, San Jose, California.
To study the etiology of the late recurrence of angina
after coronary angioplasty (PTCA), we retrospectively
analyzed a cohort of 25 patients (pts) who developed evi-
dence for myocardial ischemia and underwent repeat cor-
onary arteriography following a post-PTCA symptom-free
interval of more than 6 mos (LR). Results were compared
with a group of 47 pts (53 initially successful proce-
dures) who developed recurrent ischemia within 6 mos of
PTCA (ER). Indications for angiography in the LR vS ER
groups were asymptomatic positive treadmill (4~ vs l7~),
atypical chest pain (12$ vs 4~), recurrent stable angina
(44~ vS 49~), unstable angina (24~ vS 23~), and acute
myocardial infarction (16~ vs 4~). In the LR group, re-
currence at the dilation site occurred in 7 (28~) vs 39
(74~) in the ER group (p<O.OOl). New atherosclerosis
occurred in 10 (40~) of the LR group vs 3 (6~) of the ER
group (p<O.OOl). In the LR group, 2 of 7 pts with re-
currence had thrombus rather than atherosclerotic re-
stenosis and 1 restenosis accompanied a more critical new
stenosis. Of the 10 pts with new disease, 7 demonstrated
progression in a non-dilated vessel and 2 in the proximal
portion of the dilated vessel. Within LR, atherosclerotic
restenosis occurred earlier (mean 11.0 mos) than new ath-
erosclerotic disease (mean 18.0 mos) (p<O.OS). We con-
clude that restenosis is unusual more than 6 mos after
PTCA and that late (>6 mos) recurrence of myocardial is-
chemia is more commonly associated with new atheroscler-
otic disease.
DISEASE PROGRESSION AFTER CORONARY ANGIOPLASTY (PTCA):
RELATION TO VESSEL INSTRUMENTATION
Kevin Nugent, B.S. , Gary lbubin, M.B., Ph.D., Stephen
Ellis, M.D., Andreas Gruentzig, M.D., F.A.C.C. &Dory
University SChool of Medicine, Atlanta, Georgia
To determine if disease pcogression is accelerated
by vessel instrumentation during PTCA, we studied pce-
PTCA and follow-up arteriograms in 86 patients (ptS)
with 90 dilation sites who had repeat angiography at
least 12 months (mean 21+7 months) after PTCA. Luminal
diameter stenoses in dirited and non-dilated segments
of all diseased vessels were measured using digital
calipers. Restenosis (RS) was defined as a >50'
diameter stenosis at the dilation site. Intraobserver
variability demonstrated a mean difference of 4.1 per-
centage points (range 0-131 in 71 randomly selected
lesions. Disease progression was thus defined as an
increase in diameter stenosis of >15 percentage points
in any non-dilated vessel segment:-
Restenosis was p:esent in 24 of 86 (28'1 patients.
Disease progession occurred with similar frequency in
patients with restenosis and continued success: 15/24
(62') vs 40/62 (64'1. Disease progression also occurred
with similar frequency in dilated and non-dilated ves-
sels. Progression was observed in 36 of 422 (8.7%1 non-
dilated segments of dilated vessels and in 64 of 864
(7.4') of segments in the non-dilated vessels (p-NSI.
We conclude that: 11 instrumentation during PTCA
does not accelerate disease pcogression in the dilated
vessel, and 2) late restenosis after PTCA is not
related to progression of native disease.
LATE RESULTS OF MULTIPLE LESION CORONARY ANCIO-
PLASTY IN AN ACED POPULATION.
ceoffre~ O. Hartzler, M.D., FACC, Barry D. Rutherford,
M.D., ACC, David R. McConahay, M.D., FACC,
Warren L. Johnson, Jr., M.D., FACC, Bob Ligon, M.S.,
and Martha Calki ns, R. N., Mid America Heart Institute,
St. Luke's Hospital, Kansas City, Missouri.
The long-term results of multiple lesion PTCA in elderly
patients have not yet been characterized. Of our first 500
consecutive multiple lesion PTCA procedures between
August 1980 and July 1983, 72 were performed in patients
70 years of age or older. There were liS males and 27
females with ages ranging 70-82 yrs, mean age 71i yrs.
From 2-7 stenoses were dilated (total 206 lesions, 2.86/pt)
with 89% primary success. Complications included myocard-
ial infarction - 2 pts (2.8%) and urgent bypass surgery -
3 pts (Ii. 2%). There were Ii procedure-related deaths for
a mortality of 5.6%. Of 66 pts available for follow up at 1.6-
1i.2 yrs (m =2.3 yrs). there were 3 Mis (Ii. 5%). 6 CABCs
(9%), and 8 deaths (12%). Eight pts (12%) underwent re-
peat PTCA at 2-12 mos (m = 8 mos) for isolated restenosis
in 3 pts, restenosis and new lesions in Ii pts, and new
lesions in 1 pt. At followup, 91% of patients reported symp-
tomatic improvement since PTCA.
Conclusion: Multilesion PTCA in the aged population is
associated with increased procedural risk. The annual
post-procedure incidence of myocardial infarction and
cross-over to CABC is low. The increased mortality at
followup in this early series of elderly patients mandates
continued evaluation and caution in the application of angio-
plasty to this subgroup.
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RESTENOSIS AFTER MULTI-LESION AND MULTI VESSEL CORONARY
ANGIOPLASTY (PTCA).
We conclude that the risk of restenosis is strongly
related to the number of dilatation sites if ML-PTCA is
performed in one vessel. PTCA of multiple discrete
lesions in different vessels is not associated with an
increased risk of restenosis.
To determine the relative incidence of lesion resteno-
sis in patients undergoing multi-lesion (ML) and multi-
vessel (MV) PTCA, we examined the late outcome in 411
patients (pts) who underwent ML or MV PTCA from October
1980 through January 1985. Multi-lesion pts (n-282) had
2 or more lesions dilated at different sites in the
same coronary artery and multivessel pts (n"129) had 2
or more discrete lesions dilated in different coronary
arteries. The time of arteriographic restudy, ML 7.2+5
months vs MV 7.3+5 months (mean+SD) and restudy rate ML
181/282 (64%) vS-MV 86/129 (67%) were similar. Clinical
characteristics: Females, ML 19% vs MV 12%; Age, ML
55+10 years vs MV 54+10 yrs, Duration of symptoms <2
months, ML 28% vs MV 33% and initial results - Diameter
stenosis post-PTCA, ML 23+11% vs MV 25+11% and gradient
post PTCA, ML 13+7111ftHg vsMV 12+6111ftHg were also compar-
able. Restenosis rate per patient was 90/181 (50%) in
multilesion pts vS 30/86(35%) in multivessel pts (p<
0.05) and restenosis rate per lesion was 118/372 (32%)
in multilesion pts and 37/189 (20%) in multivessel pts
(p<0.005) •
Gary Raubin, M.B., Ph.D., Douglas Redd,
Leimgruber, M.D., Pierre Abi-Mansour,
Tate, Andreas Gruentzig, M.D., F.A.C.C.
sity SChool of Medicine, Atlanta, GA.
M.S., Pierre
M. D. , Johnny
Emory univer-
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Thallium 201: II. Quantitative Studies and SPECT
QUANTITATIVE ANALYSIS OF n-201 MYOCARDIAL SINGLE-PHOTON
IlIfISSION COMPUTERIZED ROTATIONAL TOKOGRAPHY: DEVELOl'IIENT,
VALIDATION, AND PROSPECTIVE APPLICATION OF AN OPTIMIZED
COMPUTERIZED NlTROD. Jamshid Maddahi, MD, FACCj Kenneth
Van Train, BSj Christopher Wong, CNMTj Florence Prigent,
MDj Joshua Gurewitz, CNMTj John Friedman, MDj Daniel Ber-
man, MD, FACC. Cedars-Sinai Med Ctr, Los Angeles, CA
To assess the ability of quantitative analysis of stress-
redistribution Tl-201 rotational tomography to detect and
localize coronary artery disease (CAD), we studied 84 male
patients, 41 normals (nls) (34 with <5% calculated likeli-
hood of CAD and 7 with nl coronary arteries) and 43 with
angiographic CAD (~50% stenosis). All pts underwent'
stress-redistribution rotational tomography using 3 mCi of
Tl-201, obtaining 30-32 projections (30 seconds each) over
1800 • After low-pass filtering, images were reconstructed
into short- and vertical long-axis tomograms. For each to-
mogram, a maximum-count circumferential profile was gener-
ated, normalized to its maximum count and plotted onto a
2-dimensional polar coordinate map representing the entire
myocardial distribution of Tl-201. In a random pilot popu-
lation of 15 low-likelihood nls and 15 CAD patients, nl
limits for initial Tl-201 distribution were developed as
well as criteria for abnormality and a topographic scheme
for automatic assignment of the various myocardial regions
to coronary arteries. Subsequently, the developed criteria
were applied prospectively to the remaining 54 pts (26 nls
and 28 CAD's). Results:
Overall LAD LCX RCA
Sensitivity 23/28-.82 18~.72 18!2i=.86 21/26=.81
Specificity 22/26-.84 22/29-.76 24/33-.76 24/28-.86
Conclusion: The described optimized acquisition, proces-
sing, and automatic interpretation approach to stress myo-
cardial Tl-201 rotational tomograms appears to be accurate
for overall detection of CAD and identification of disease
in individual coronary arteries.
IDENTIFICATION AND CHARACTERIZATION OF CAUSES FOR
RECURRENT ANGINAL SYMPTOMS FOLLOWING SUCCESSFUL
CORONARY ANGIOPLASTY: THE RESUL TS OF A FOLLOW-UP
ANGIOGRAPHIC ANAL YSIS John Joelson, M.n., Albert S. Most,
M.n.,FACC, Steven Reinert, MS, David O. Williams, M.n., FACC,
RI Hospital, Brown University, Providence, Rhode Island
The angiographic and clinical characteristics of 77 consecutive
patients (PTS) who underwent follow-up coronary cineangiography
for the assessment of recurrent chest pain following successful
coronary angioplasty (CA) were reviewed to determine I) the re-
sponsible mechanism for recurrent anginal symptoms, and 2)
whether the mechanism could be correctly identified by certain
clinical characteristics short of angiography. Based on angio-
graphic findings, PTS were classified as having restenosis (RE:
n=1I3), development of new, significant coronary disease (NEW:
n= 15), incomplete revascularization OR: n=6) or no coronary
disease (NL: n=13). Groups did not differ in terms of age, gender,
number of dilations performed, peak inflation pressure or in the
pre or post CA stenosis or gradient. Multivessel coronary disease
was more common among those with NE W or IR (P <.0 I). The
elapsed time from CA to onset of recurrent symptoms was the
most powerful predictor of angiographic outcome.
Elapsed Time (months) RE NEW IR NL
< I I 0 11"6"
:> I < 6 110 2 2 II
-; 6 - 2 13 0 3
P < 0.001
Thus, PTS who experience recurrent chest pain following
successful CA have variable angiographic findings. Restenosis is
the most common observation. The time elapsed from CA to the
onset of chest pain is of value in predicting angiographic findings.
Hence, PTS who develop symptoms within one month usually
demonstrate IR or NL. RE is the most common explanation for
chest pain occurring within 1-6 months. Pain occurring after 6
months is usually due to development of new, significant CAD.
QUANTITATIVE IDrATICNAL 1lWLIUM-201 'IOoK:GRAPHY FOR
IDENTIFYIN3 AND LOCALIZING CORJNARY ARTERY DISEASE
(CAD): BULLSEYE POIAR MAP. ~ne DePasquale, M.D.
FACC, Pqatha Nody, M.D. FACC, ~n DePuey, M.D. FAa::,
Ernest Garcia, Ph.D., George pilcher, M.D., Clayton
Bredlau, M.D., Gary Roubin, MB, Ph.D., RJbert Eisner,
Ph.D., Anita Q:lber, Andreas Gruentzig, M.D. FACe,
Harvey Berger, M.D. FACC, Elrory University, Atlanta GA
1b determine the accuracy of tanographic thallium-20l
(Tl) imaging in localizing CAD, exercise (ex) studies
were quantified using maximal count cirCl.l1lferential
profiles in 291 patients (pts). Polar coordinate maps
were constructed as a series of concentric profiles
with the apex at the center and displayed as a
functional image. l'bnnal (nl ) 1 imits were established
using 36 pts with low probability of CAD «5%). 45 of
the pts were used in a pilot study to determine the
best criteria for identification and localization of
perfusion defects; contiguous defects > 2.5 SO fran
mean nl were considered significant. 'Ihese criteria
were applied prospectively to the remaining 210 pts
(179 pts with> 50% diameter stenosis (00) and 31 with
< 50% 00). 86/179 pts hcrl multivessel CAD. 00 was
quantified by digital calipers. 278/630 vessels were
abnl. The sensitivity and specificity of Tl for CAD
detection were 94% and 91%, respectively. The positive
(pos) and negative (neg) predictive values (PV) were:
LAD(n=96) LCX(n=78) RCA(n=104) LCX & RCA
Pos PV 80% 89% 87% 92%
Neg PV 82% 82% 89% 82%
In 25 vessels with subcritical lesions (45-49% 00), 84%
were abnl in the appropriate vascular bed. Thus,
quantitative analysis of rotational Tl tomographic
ima;JElS is a highly accurate technique for determining
the location and severity of CAD.
JACC Vol 7. No 2
February 1986 23A
ABSTRACTS 23A
FACTORS CONTRIBUTING TO ABNORMAL QUANTITATIVE TL-201
SCINTIGRAMS IN PATIENTS WITH ANGIOGRAPHICALLY NORMAL
CORONARY ARTERIES: AN UPDATE.~ .Ii...1J.ll.x. 1m, James
Ryan MD, Denny D. Watson PhD, Robert S. Gibson MD, Joseph
A. Gascho MD, FACC, George A. Beller MD, FACC. University
of Virginia Medical Center, Charlottesville, Virginia
Blinded quantitative readings of exercise thallium (Tl-
201) scintigrams (ExTl) from 380 pts who underwent both
coronary angiography (angio) and ExTl between 3/78 and
9/81 were performed by 2 observers. Overall sensitivity
for detecting pts with stenosis 2.50J (CAD) was 87J
(252/290). Of the 90 patients with normal angio, 32 (36J)
were interpreted as abnormal by uptake or washout crite-
ria, or both. We reviewed the scans retrospectively to
identify potential causes for these "false positives". Of
these 32 pts, 3 had definite prior MI with segmental
akinesis or dyskinesis, 2 had cardiomyopathy and 3 had 25-
50J stenoses. Of the remaining 24 pts, isolated washout
abnormality (n=6), upper septal thinning (n=4), upper
posterolateral thinning (n=2), breast attenuation (n=2),
and apical thinning (n=1) resulted in the abnormal read-
ings. No explanation was apparent in the remaining 9 pts.
Isolated washout abnormalities (IWA) without numerically
signifioant defects lead to the correct identifioation of
only 2/290(1J) pts with CAD and thus would not affect our
overall sensitivity if IWA was eliminated. Thus, the
majority of pts (23/32) with normal coronary arteries and
abnormal quantitative Tl-201 scintigrams have either
structural heart disease, subcritical stenoses, IWA or
recognizable image artifacts. Improved speoificity, with-
out loss of sensitivity, would be achieved if IWA alone
was not considered abnormal. Referral bias may be impor-
tant in these pts who were nonrandomly referred for angio
on the basis of symptoms or abnormal noninvasive test
results.
SEVERELY DEPRESSED LEFT VENTRICULAR FUNCTION: ROLE OF
REST-REDISTRIBUTION THALLIUM-201 IMAGING TO PREDICT
IIIlROVEMENT AFTER CORONARY BYPASS.
TM Bateman, MO, FACC; RJ Gray, MO, FACC; LSC Czer, MO,
FACC; MJ Raymond, 8SN; CM Conklin, BSN; J Maddahi, MO; Y
Charuzi, MO, FACC; ME Lee, MO; JM Mat1off, MO, FACC; OS
Berman, MO, FACC. Cedars-Sinai Med Ctr, Los Angeles, CA.
Because prognosis after coronary artery bypass graft
(CABG) surgery is strongly predicted by the post-CABG left
ventricular ejection fraction (LVEF), the likelihood of
improvement in LVEF should be an important factor in the
selection of pts with very low LVEF for CABG. We hypo-
thesized that rest-redistribution thallium-201 (Tl), by
detection of regions with resting myocardial ischemia,
could identify these pts. We measured pre- and post-CABG
LVEF by radionuclide ventriculography (RNV) in 10 pts (8
male; age 60+12 yrs) with prior myocardial infarction,
unstable angTna, and severely reduced pre-CABG LVEF (all <
30, mean 23+7%). RNV was performed <3 wks pre-CABG and
within 3 months post-CABG. All pts underwent 3 view rest-
redistribution T1 within 3 weeks pre-CABG. Six pts demon-
strated fixed T1 defects only, and pre- and post-CABG
LVEF was unchanged (24+8% pre vs. 27+7% post; p=NS). Four
pts had from 1-4 myocardial segments-with reversible rest-
ing T1 defects; LVEF improved in these pts from 22+5% to
32+5% (p<0.05). In all pts with reversible defects, LVEF
rose by at least 8 EF points, while this rise occurred in
only 1/6 with only fixed defects. Regional wall motion im-
proved post-CABG in the vascular territories with revers-
ible T1 defects, accounting for improvements in LVEF.
Conclusion: In pts with poor LVEF, the presence of revers-
sible resting T1 defects can identify those most likely to
have improved left ventricular function post-CABG.
IMPORTANCE OF THE SITE AND TECHNIQUE OF INTRAVENOUS
THALLIUM INJECTION DURING EXERCISE.
Rami Gal, ILD., Imran Niazi, M.D. and Steven C. Port,
M.D., F.A.C.C. University of Wisconsin, Mount Sinai
Medical Center, Milwaukee, WI.
Neither the site nor the technique of intravenous
thallium (Tl) injection during exercise has been
emphasized as inportant. We prospectively analyzed the
effects of randomly vatting the site (anteCUbital or more
peripheral vein) and technique (with or without a 15cc
saline flush) in 51 patients during routine testing. Both
the usual mfocardial views and a view of the arm injected
were acquired post-exercise (PEx) and 3 hrs later (3Hr).
Arm uptake of Tl (ArmTl) was not seen after medial
anteCUbital injections except in 1 case injected via a 24
hr old indwelling catheter. ArmTl was seen in 19/37 (51%)
of peripheral inject ions, more cOllUllOnly in t he left arm
(53%) than the right (32%). A saline flush did not reduce
ArmTl after peripheral inject10ns. No clinical variables
correlated with ArmTl. A subgroup with ArmTl and no PEx
perfusion defects had 32% fewer PEx (p=O.00009) and 17%
fewer 3Hr (p=.08) net mfocardial cts/pixel. In addition,
mf0card ial thallium washout was signif icant ly slower in
those with ArmTl compared to those without ArmTl
(p=O.009). We conclude that the site of Tl injection
during exercise is of substantial clinical importance.
Injections distal to the antecubital veins often result
in substant ial ArmTl which can seriously compromise
mf0cardial statistics.
REGIONAL VARIABILITY IN THE MYOCARDIAL CLEARANCE OF TL-
201 AND ITS IMPORTANCE IN DETERMINING THE PRESENCE OF
CORONARY ARTERY DISEASE. S. Kaul, MD, FACC, R.D. Okada,
MD, FACC, G.M. Pohost, MD, FACC, C.B. Boucher, MD, FACC.
Massachusetts General Hospital, Boston, MA
There are several limitations in using absolute myocar-
dial clearance (CL) of Tl-201 (Tl) for the detection of
coronary artery disease (CAD). Noncardiac factors such as
peak exercise heart rate and blood level of Tl can affect
the absolute CL of Tl. However, as all myocardial seg-
ments (S) in a heart are exposed to the same noncardiac
factors, a relative difference in CL of Tl between S
could reflect the presence of CAD. Accordingly we an-
alyzed CL in 370 patients: Group I (n=45) had <1J possi-
bility of CADj Group II (n=44) had normal coronary art-
eriesj Group III (n=281) had CAD. Although mean CL in 15
myocardial S in 3 views in Group I was 3.4±.0.7 hrs, the
variability between the slowest and fastest clearing S in
the same heart was as much as 98J. This variability was
systematic: 781 of slowest clearing S were basal while
53J of fastest clearing S were apical (p<O.01l. When
Group II and III patients were compared, based on Group I
values, the absolute CL of Tl had a sensitivity and
specificity of 92J and 16J respectively. However, when CL
in a S was considered abnormal only if it was 98J slower
than in the fastest clearing S in the same heart, sensi-
tivity and specificity changed to 69J and 86J respective-
ly (p<0.01). When the latter values were prOVided for
logistic regression analysis, following the inclusion of
an initial defect, the model chose CL at par with redis-
tribution and lung:heart ratiO for the detection of CAD.
In conclusion: 1) there is significant regional vari-
ability in the myocardial CL of Tl even in normal sub-
jeots; and 2) when CL is considered abnormal after com-
paring with the fastest clearing S in the myocardium, its
diagnostic utility significantly improves.
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Radionuclide Cineangiography: Evaluation of
Ventricular Function
IS nIDlE ABN:RlAL CXJllRACl'II.E RFSERVE IN HYl'ERIm)IVE PATmlrS wrm
lEFT VENIRIaJLAR IIYI'EXmlPIIY? Julio F.'l\lbau,M.D•• Jadwi8a Sz1.acld.c,
M.D., ShImJn BrllJll,M.D., Steven HeiIlerSOi1.N.T., Carol Vo1JJJer, R.N.,
Barry M. Massie, M.D., FA£X:, VAK: alii tm', San Francisco, Q\
Several reports have suggested a1m:>I:ml1 eKerCise (EX) IeSpCIlSe in
SCIIE patients (PIS) with hypertension (Jml) alii Wt ventricular
hypertrophy (LVII). 'Therefore, we exaained the resprose to supine
bicycle eKerCise in 13 IlO11III1s (NL<;) alii 40 HlN PIS~ blood pool
scintigraphy. All HlN PIS loJet'e studied after ale IDlth off therapy.
Additionally, significant carooary disease was ruled out by DUlt:lpl.e
a:n-:inII'asive tests in all aJbjects. 'lWenty-three HlN PIS had
evideoce of LVII by ~aphy. as est:lmated by the:lr Wt
ventrlcular DIlSS :lrxlex (>100 g/m). Caltractile reserve was assessed
by the ratio of peak systolic pressure (PSP) to eoi-systolic vo1l.lle
:lrxlex (ESV), alii the chan8e in EF fron teSt to exerdse (AEF). seven
HIN-LVII PIS had a1m:>I:ml1 rest or fa (sbnl AEF).
NI.') HlN HlN/LVH sbnl fa
EF R (%) 67±8 62±7 67±67 55±10*#°
EF FX (%) 82±6 73±7 75±8 59±6 *i/o
PSP/FSV R(mdlg/ml/~) 3.0±1.2 3.8±1.6 4.2±1.7 3.3±1.0
PSP/FSV Ex(mdlg/ml! ) 8.5±3.0 7.3±4.0 6.5±2.5 3.8±0.8*
PSP FX (1IIIilg) 197±22 209±16 201±20 226±10*i1
MAX l>lJm(L(W}~min) H:ll±l00 853±200 600+..220* 670+..200*#
ESV FX (ml/m') 14±4 18±9 18±7 29±4*11°
* P < .01 VB NL; # p < .05 VB HlN; °p<.05 VB HlN/LVH
All PIS E!lCeIcised to a s:lm11ar ~rate product. PSP/FSV at
rest was rot different lIIIlllg all groJpS but iIx:reased less with FX in
HIN-LVH PIS alii oo1y insignificantly in those with, abI:xn:me,l fa.
Fnd-systolic wall stress (G) at teSt in (1cr' dyn/m') was
significantly higher in abn1 fa PIS 83±H <:aqllII'eIi to HIN-LVH 64±6,
HlN 55±14 alii NI.') 54±15 (all p<.Ol), predic~ the reduction in
contractile reserve alii exerdse to1.erallce.
NONINVASIVE IDENTIFICATION OF HIGH-RISK CORONARY ARTERY
DISEASE
Raymond J. Gibbons, M.D., F.A.C.C., Ian P. Clements, M.D.,
F.A.C.C., Andre C. Lapeyre III, M.D .• Manuel L.
Brown, M.D., and Alan R. Zinsmeister, Ph.D., Mayo Clinic
and Foundation, Rochester, Minnesota.
The purpose of this study was to noninvasively predict
left main and/or 3-vessel coronary artery disease
(LM3VCAD) in a group of 681 patients who underwent both
exercise radionuclide angiography (RNA) and coronary
angiography. When important clinical, ECG, and RNA vari-
ables were considered, logistic regression analysis iden-
tified 7 variables as independently predictive of LM3VCAD:
Variable (in order of importance) Q
Magnitude of ST depression <.0001
Exercise ejection fraction <.0001
Exercise heart rate-blood pressure product <.0001
Sex .0001
Exercise end-systolic volume index .001
Exercise/rest systolic pressure to
end-systolic volume ratio .01
METS of exercise .02
Employing these variables, the patients were separated
into low-, intermediate, and high-risk groups on the basis
of their predicted probability (PRED PROB) of LM3VCAD:
Actual
G~oup N PRED PROB LM3VCAD (n) LM3VCAD %
Low rlsk 216 <.2 20 9%
Intermediate risk 300 .2-.5 78 26%
High risk 165 >.5 117 71%
In conclusion, (1) when both the exercise ECG and RNA are
considered, the risk of LM3VCAD can be estimated noninva-
sively. (2) In this study, the high-risk group, composed
of less than one-quarter of the total group, contained
more than one-half of all the patients with LM3VCAD.
patients lIlI!Inllged in accordance with the guidelines had a
lower incidence of (]IF (4.2%) than those who were not
(lS.S%, P-0.02). ()Uy mild (]IF was seen in patients
managed by the guidelines. In oontrast, of 44 patients
with (]IF not managed by the guidelines, a majority had
moderate to severe (]IF. 1hJs, in patients monitored with
serial RNA during D therapy, adherence to these guide-
lines reduces the incidence and severity of (]IF.
AIJIEROCE ro RADI<HX:LIDE MlllOCARDIOGRAPHIC GOIDELINE'S
RmOCES THE ItaDOCE AR) SEVERITY OF a:mESTIVE HEARl'
FAILURE IN HIGI RIg{ PATIENl'S: THE YALE IXlKOHJBICIN
CARDIarotICI'lY STUDY. 3lIla1d G. SChwartz. MD. Jonathan
Alexander, MD FNX, William B. ~enzie, MD, Philip T.
Sager, MD, John setaro, MD, Peter E. SChwartz, MD, Frans
J. 'lb. *<:kers, MD FNX, Harvey J. Berger, MD FN:r., and
Barry L. Zaret, Me FNX:. Yale university, New Haven, cr.
'l\) assess the efficacy of our guidelines of serial
resting radionuclide angiocardiography (RNA) to prevent
coogestive heart failure «]IF) dIe to doxorubicin (D), we
eatpared guideline adherence to the incidence and
severity of (]IF in high risk patients. we reoomnend
serial RNA prior to initiating D, after 25<r300 ng.tm2,
after 40<r450 ng/m2, and prior to subsequent doses.
Termination of D is reconmended if the left ventricular
ejection fraction (LVEF) declines fran a normal baseline
Q,SO%) by 210% (LVEF units) to .iSO%. With abnormal
baseline LVfF, RNA prior to each dose is reconmended with
disoontinuation of D when LVEF falls ~O%, or to .i30%.
IMPROVED LEFT VENTRICULAR FUNCTION AT REST AFTER CORONARY
ARTERY BYPASS: EVIDENCE FOR SUBCLINICAL ISCHEMIA UNDER
RESTING CONDITIONS.
Vasken Dilsizian, MD, Robert O. Bonow, MD, FACC, Charles
L. McIntoBh, MD. FACC, Michael Jones. MD. Richard O.
Cannon, MD. FACC. Stephen L. Bacharach. PhD. Michael V.
Green. MS and Steven M. Larson. MD. NHLBI. Bethesda. Md.
Successful coronary artery bypass surgery (CABG) improves
exercise induced left ventricular (LV) dysfunction in pts
with coronary artery disease (CAD). but the potential ef-
fect of improving LV function at rest remains controver-
sial. To assess the influence of CABG on LV funotion at
rest. we studied 31 CAD pts without previous infarction
before and 6 mos after CABG by radionuclide angiography
after all cardiac medicines were withdrawn. No pt had
angina at rest. In 27 pts with patent bypass grath.
CABG significantly increased LV ejection fraotion (EF)
during exercise (47+111 preop to 63+91 postop. p<.OOl).
indioating reduction in reversible LV ischemia. Moreover.
LVEF at rest increased (55+9 to 60+81. p<.OOl). With 20 of
27 pts manifesting an increase compared to preoperative
values: 12 of these 20 pts had apparently normal LV func-
tion at rest (EF and regional wall motion) before CABG.
LV regional EF was computed by diViding the LV region of
interest into 20 sectors. Regional analysis indioated
that improved EF at rest after CABG oocurred in those re-
gions developing ischemia during exercise before CABG. In
4 pts with occluded grafts. EF at rest was unchanged by
CABG globally (61+8 to 60+101. p:NS) and regionally. Thus.
LV global and regIonal function at rest improved after
successful CABG. even in pts with apparently normal LV
function before CABG. These data support the ooncept that
many CAD pts have subolinioal LV ischemia under resting
conditions which is reversible after interventions that
restore coronary flow.
grrrmJNE'S FQILCMED
(tHS, 17%)
(]IF 2 (l00% mild (]IF)
K> (]IF 46
GOWIN. NJ1' IDWMP
(~234, S3%)
44 (43% mild CBF,
57% mod/severe CBF)
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EAALY AND LATE EFFECTS OF RIGHT VENTRIQJLAA INFARCTION
ON RIGHT VENTRICULAR SYSTOLIC FUNCTION AT REST AND
EXERCI SE
~.J.... Dell' Ital la, M.D....E.ACC, Richard S. Simmons, MD,
Betty Hey I, Ral ph BI umhardt, MD, Jack Lancaster, Ph.D.,
John C. Lasher. MD, Michael H. Crawford. MD. FACC,
Robert A. O'Rourke, MD, FACC. The University of Texas
Hea Ith scr ence Center, San AntonIo, Tx.
It Is well appreciated that RV ejectIon fraction (EFl
Improves after RV myocardial fnfarctlon (MI), but the
response of the RV to exercise (ex) after RVMI Is
unknown. Twenty-one survIvors of RVMI had J2QI:b. hemo-
dynamic (both RA pressure (P) ~10mmHg and RA:pulmonary
artery wedge P ratio ~0.8) and radlonucllde anglographlc
(RNA) (both RVEF <0.40 and akl nesl s or dyskl nesl s)
crlterla of RVMI. In the 6 month follow-up perIod mean
resting RVEF Increased from 0.28±'0.07[SD] to 0.43±.0.08,
p<O.Ol In 14 pts restudl ed. To assess latent RV dys-
function and RV functional reserve, respiratory gas
exchange and RNA were performed during rapId (1 mIn
stagel, upright bIcycle ex 1 to 3 yrs after RVMI In 6
pts who had a mean RVEF of 0.28±.0.5 at acute MI. At the
time of ex, all 6 pts had an FEVj>85% predIcted, stable
angIna off beta-blockfng drugs, and a mean LVEF of
0.56±'0.15 (range 0.35 to 0.76l. AnaerobIc threshol d (ATl
was determIned by a n~n~lnear Increase (t) In the
vvntllatory equivalent (VE/V02l and a nonl fnear t In the
VCXJ2• No pt had a low AT on ex. To assure that maxImal
ex was achieved, all pts exercised 1 min after AT, then
for 2 min whIle peak LV and RVEF were acquIred. RVEF
t In all pts from 0.48±'0.09 to 0.55±,0.05 (p<0.05l while
LVEF t from 0.56±'0.15 to 0.62±.0.l2 (p=NSl at peak ex.
We conclude that pts survivIng hemodynmamlcally
Important RVMI have no Impairment of functional capacIty
or RV reserve as long as LVEF Is not severely depressed
and angina Is not a limiting factor.
CONTINUOUS MEASUREHENTS OF LEFT VENTRICULAR FUNCTION
IN NODIALS AND PATIENTS WITH CORONARY ARTERY DISEASE
Bal,r, T..,ki. M.D., Tsunehiro Yasuda, M.D., Richard R.
Moore. B.S., John B. Gill, M.D., Charles A. Boucher, M.D.,
F.A.C.C•• Berman Gold, M.D., F.A.C.C. B. William Strauss,
M.D., F.A.C.C•• William T. Tyberg, M.S., Marcia N. Suzuk1,
Ph.D•• Arata Suzuki. Ph.D•• Massachusetts General
Hospital, Boston. MA and Capintec Inc., Ramsey, NJ
We have developed a device (VEST) for the beat-to-beat
measurement of left ventr1cular (LV) function in
ambulatory subjects. To evaluate its clinical
applicability, V5 of the ECG and LV function were
monitored by the VEST in 5 normals and 5 patients with
coronary artery disease (CAD). Following radionuclide
ventriculography using the gamma camera, the VEST
detectors were affixed over the region of LV. The subject
wore the VEST for 2 hours, while performing ordinary
activities, such as sitting, walking and exercising.
Nuclear and ECG data were recorded on a portable recorder.
From the Beat-to-beat LV volume curve, ejection fraction
(EF) was calculated. The standard deviation of serial 15
second average EF at rest was less than 3%. The
correlation of EF calculated by the VEST and gamma camera
was 0.94 at rest and 0.82 during repeated stepwise bicycle
exercise. During walking, EF increased by 8-14% in
normals, while no significant increase was observed in 2
of the CAD patients. Three ischemic episodes with T wave
change were recorded by the VEST. In each episode, EF
decreased by 9-12% 60 to 75 seconds before chest pain and
increased by 12% within 30 seconds of nitroglycerin.
During an episode of ST wave pseudonormalization, EF did
not change. During an episode of transient atrial
fibrillation, EF decreased by 12%.
We conclude that the VEST is a powerful means for
ambulatory monitoring of LV function and ECG
simultaneously.
Monday, March 10, 1986
2:00PM-3:30PM, Room #366/367
Alpha and Beta Adrenergic Blocking Drugs
BETA BLOCKER EFFECTS ON CENTRAL NERVOUS SYSTEM. A
CONTROLLED COMPARATIVE STUDY.
John B. Kostis, M.D., F.A.C.C., Raymond C. Rosen, Ph.D.,
UMDNJ-Rutgers Medical School, New Brunswick, New Jersey
Although there are many reports of central nervous
system (CNS) effects of beta blockers, controlled compar-
ative studies with objective measures are not available.
In a 16-week double-blind, randomized, placebo-
controlled study, atenolol (lOOmg QD), metoprolol (10Omg
BID), pindolol (lOmg BID), propranolol (8Omg BID) and
placebo were given to 30 subjects for one week followed
by a two week washout period. Objective measures of
sleep, sexual function and psychomotor performance were
obtained.
Proprsnolol, metoprolol and pindolol adversely
affected sleep (time asleep from 388.5±4.2 min to
375.4±6.1 p<0.05, number of REM periods 3.78±.16 to
2.67±.15, p <0.001, total REM activity 79.7±6.2 to
58.3!4.91, p<O.OOl, number of awakenings per night 3.9±.5
to 6.3±.7, p<0.005, nightmares per week 0.0 to 0.21±.09)
while atenolol did not appreciably affect these variables.
Pindolol and metoprolol decreased time at maximum
penile tumecense (from 21.26±l.88 min to 19.9h2.l8 and
17.64±1.87 respectively) as opposed to atenolol (to
27.22±3.08, p<0.05).
Coding vigilance score was depressed by pindolol from
53.5!3.4 to 48.6±3.1, p 0.05 but not affected by metopro-
101 (54.9±3.1) or atenolol (5l.5±3.6). Propranolol
effects were generally intermediate between atenolol and
pindolol.
Ancillary properties of beta blockers modulate CNS
effects: these effects are more pronounced in lipophilic
beta blockers and less evident with hydrophilicity. In
addition, intrinsic sympathomimetic activity may
specifically disrupt REM sleep.
LIPID SOLUBILITY DETERMINES THE RELATIVE CNS EFFECTS OF
BETA-BLOCKING AGENTS.
Robert L. Engler, MD, Jul ia Conant, MD, Al Maisel, MD.,
David Janowsky, MD, Martin LeWinter, MD. VA Medical
Center and University of California San Diego, Departments
of Medicine and Psychiatry, San Diego, CA. 92037
The most commonly encountered side effects of B-adrenergic
blocking drugs (BBS) are central nervous system (CNS) in
origin. Lipophilic BBS concentrate in the CNS and might
result in more CNS side effects than hydrophil ic BB agents
at equal peripheral blocking doses. However, controlled
clinical trials have not been made in patients. Accord-
ingly we tested Atenolol (A) (hydrophi 1ic) and Propranolol
(p) (lipophilic) in equiblocking doses (peak exercise
heart rate reduction) against placebo control (C) using a
6 phase (2 weeks/phase) double blinded crossover design
in 17 hypertensive patients. P was given in low (PL, 40
mg bid) and high (PH, 80 mg bid) doses, and A in L (50 mg)
and H (100 mg) doses in one of two randomized sequences:
C-AL-AH-C-PL-PH, or C-PL-PH-C-AL-AH. At the end of each
phase the following were obtained: exercise test, Wechsler
Memory Scale (WEM) , Profile of Mood States (POMS),
Activation/Inhibition Scale (A/I), NIMH behavior rating
scale (NIMHB) Beck Depression Inventory and Purdue
grooved pegboard test. Of 23 variables examined by
repeated measures ANOVA, 5 demonstrated a significant
difference between P and A (p(.05): A/I, NIMHB, NIMH index
of anergy and depression, POMS tension-anxiety, and POMS
depression-dejection. Four variables demonstrated trends
(P(. 15): WEM, POMS vigor, POMS anger-hostility, and POMS
confusion-bewilderment. In all instances the effect of P
was "negative" compared to A indicating a lower sense of
wellbeing or poorer short term memory. We conclude that
lipophilic properties of BBS contribute to unfavorable
CNS side effects in a cl inically relevent fashion.
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DIFFFERENTIAL EFFECT OF BETA-BLOCKADE ON THE INNERVATED
AND DENERVATED HUMAN HEART DURING EXERCISE AND EXOGENOUS
CATECHOLA~I~E STIMULATION
S. Y~su£ ',~. Th~odoroPoulosl, ~. Dhalla l , C.J.
Mathlas , J. Wlttes3 and M. Yacoub Har~field Hospital l ,St. Mary's Hospital , England and NHLBI Bethesda.
We studied 8 patients with heterotopic cardiac
transplantation to evaluate if beta-blockade (BB) has a
differential effect on the innervated(IH) or denervated
heart(DH) and whether this effect varies during exogenous
or endogenous catecholamine(C) stimulation. Heart Rate
(HR) increases during incrempntal isoprenaline
infusions(I) and during maximal dynamic exercise on a
Bruce Protocol were used to measure responses to
exogenous and endogenous C respectively. These studies
were repeated ~efore and after propranolol (O.lmg/kg iv).
Before BB, durlng I the DH was more responsive than the
IH (+2.27±.34 beats/mining of I v +1.59±.26; p(O.Ol) but
during peak exercise, the DH and the IH achieved
identical HR (147±3 v 149±4 beats/min). Following BB, HR
increases to I were similarly attenuated in the DH and
the IH, although the DH continued to be more
sensitive.(+O.72±.13 +.34±.06) In contrast, during
exercise the HR increases were attenuated more in the DH
(65±8%) than the IH. (45±9%,p(O.Ol)
Conclusions: The DH is more sensitive to exogenous C
than is the IH, probably reflecting an increased density
or affinity of beta-receptors. This upregulation appears
to be sufficient to increase the HR of the DH to that of
the IH during peak exercise. BB attenuates the DH and IH
similarly during exogenous C stimulation, but has a more
marked effect on the DH during exercise C reflecting the
ease by which the IH, with a dual source of sympathetic
stimulation, overcomes BB.
HEMODYNAMIC AND ENOOCRIOOWGICAL EFFEcrs OF A NEW
SELEcrIVE arBLOCKING AGENT, TERAZOSIN, IN PATIENTS WITH
ESSENTIAL HYPERTENSION: RESULTS OF WNG-TERM TREATMENT
Fumihiro Tomoda,M.D., Masanobu Takata ,M.D. , Akira Hirai,
M.D., Kiyoshi Ikeda,M.D., Kotaro Yasumoto,M.D., Masato
Mikawa,M.D., Koshiro Yoshida,M.D., Shigetake Sasayama,
M.D. ,FACC
Toyama Medical & Pharmac. University, Toyama , Japan
Terazosin HCl (Ter) is a newly developedaradrenoceptor
antagonist with a longer plasma half life than prazosin.
Fifteen patients with essential hypertension were
treated with Ter (1-4 mg/day) for twelve months.
To assess the mechanism of antihypertensive effect of
Ter, the hemodynamic and endocrinological responses to
Ter were determined before, three and twelve months
after the administration of Ter. Blood pressure reduced
significantly within two weeks after Ter and its effect
was sustained throughout twelve months. Heart rate was
slightly increased during the treatment with Ter.
The hemodynamic studies revealed that total peripheral
resistance is significantly decreased and cardiac output
(dye dilution) is slightly increased, indicating that
antihypertensive effect of Ter is mainly mediated by its
vasodilation. Blood volume (l~IHSA) and plasma volume
were not changed after Ter. Plasma renin activity was
not changed after Ter, but plasma aldosterone was
decreased in response to Ter. Plasma noradrenaline was
increased on the third month, but it was returned to the
baseline value before Ter on the twelfth month. Thus,
terazosin monotherapy lowered blood pressure throughout
one year without drug tolerance including volume
expansion and/or accentuation of renin-angiotensin-
aldosterone system or sympathetic function.
COMPARISON OF LABETALOL TO PROPRANOLOL IN PATIENTS WITH
BOTH ANGINA PECTORIS AND HYPERTENSION: A DOUBLE-BLIND
STUDY.
William Frishman, M.D., F.A.C.C., Shlomo Charlap, M.D.,
Bruce Kimmel, M.D., Larry Laifer, M.D., Marcia Poland,
B.A., William Shapiro, M.D., F.A.C.C., Albert Einstein
Medical School, Bronx, N.Y.
In a randomized, placebo(pl)-controlled, parallel design
trial, the efficacy and safety of labetalol (L), an al-S-
adrenergic blocker with direct vasodilatory activity, was
compared to that of propranolol (p) in 16 patients with
stable angina, an abnormal exercise test, and high BP
(standing diastolic BP >90mmHg and <115mmHg). Patients
received pI for 4 wks, then either L (lOO-800mg BID) or P
(40-420mg BID) titrated over 4 wks to achieve both angina
and BP control, followed by a 4 mos double-blind mainten-
ance phase. Rest and exercise HR and BP, angina frequen-
cy, nitroglycerin consumption, and treadmill exercise time
(Bruce) were assessed. Angina attacks/wk were reduced
from pI, and exercise tolerance increased comparably with
both L and P (all p<o.Ol). Nitroglycerin needs were re-
duced. Standing BP was reduced by both drugs from pI
baseline (157.3+23.2/103.1+12.3 to 130.0+15.8/83.0+6.5
with L; l44.0±.16.3/96.0:!::5.9 to l29.l±.23.0/87.0+6.0-with P,
both p<O.05). The increment in BP with exercise observed
with pI was blunted by both P and L. Compared to pI, both
P and L reduced resting HR (p<o.03); exercise HR was lower
with P than with L (p<O.05). The anti-anginal and BP low-
ering effects were sustained for 4 mos by both P and L
with minimal side effects observed with either drug. Thus,
P and L appear to be equally effective and safe in
patients with both angina and high BP, and by their
actions, relieve angina, improve exercise tolerance, and
reduce elevated BP.
INTRINSIC SYMPATHOMIMETIC ACTIVITY (ISA) BLUNTS EFFECT OF
BETA BLOCKADE ON RENIN AT REST BUT NOT DURING EXERCISE
John B. Kostis, M.D., F.A.C.C., Michael Ruddy, M.D.,
Robert G. Warner, M.D., Grace Bialy, M.D., Susan D.
Krieger, R.N., and Nora Cosgrove, R.N., UHDNJ-Rutgers
Medical School, New Brunswick, NJ
In a randomized double-blind crossover study pindolol
(PIN l2.78±7.9mg BID) and propranolol (PRO lOO±62mg BID)
were given to 21 hyperten- sives. Resting heart rates
were more depressed (p<O.0002) by PRO (from 74±11 to
58±lO p<O.OOOl) than PIN (to 69±9 p:O.05) while exercise
heart rates were equally affected.
Similarly, plasma renin activity (PRA) was suppressed
more (p<O.02) by propranolol(from 2.8±1.9 ng/ml.h to
1.2±0.4 p<O.002) than pindolol (to 2.0±1.4 p<0.12) at
rest but not with exercise.
Serum potassium was increased by propranolol and pindolol
both at rest (from 4.1±O.4 mEq/L to 4.4±0.4, pa O.007 for
PRO and to 4.4±O.5, p-O.05 for PIN) and with exercise
(from 4.3±O.3 to 4.8±0.6, pa O.003 for PRO and to 4.7±O.5,
pa O.002 for PIN). Both drugs were equally effective
(p<O.OOl)in lowering systolic and diastolic pressure at
rest and exercise.
Conclusions: Beta-1 ISA of pindolol counter-balances the
effect of beta blockade on heart rate and renin activity
at rest but not during exercise. However, the different
effect of beta blockade at rest and exercise is not
apparent in regards to blood pressure and serum potassium
(mediated by beta-2 receptors).
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Treatment of Angina
INDUCTION OF NITRATE TOLERANCE IN HUMAN HEART
FAILURE BY CONTINUOUS INTRAVENOUS INFUSION OF
NITROGLYCERIN AND REVERSAL OF TOLERANCE BY
N-ACETYLCYSTEINE, A SULFHYDRYL DONOR. Milton Packer
MD, FACC, Wai KJng Lee MD, Paul Kessler MD, Norma Medina
RN, Madeline Yushak RN. Mt. Sinai Sch of Med, New York, NY
To determine if continuous exposure to nitroglycerin (NTG)
induces drug tolerance in man (as it does in vitro), 21 pts with
heart failure (CHF) were given NTG intravenously (IV) for 48 hrs.
Stroke volume index (SV1, ml/beat/m2), mean arterial (MAP), LV
filling (LVFP) & mean right atrial pressures (MRAP, mm Hg), and
systemic vascular resistance (SVR, d-s-c) were measured before
(Pre), after 2 hrs of 3.2-6.4 mg/min IV-NTG (NTG-2h), after 48
hrs of continuous IV-NTG at same dose (NTG-48h), & 2 hrs after
NTG withdrawal (NTG-W). * = p<.05 vs Pre; t =~5.05, 2h vs 48h
SVI MAp LVFP M AP sVR
Pre-NTG 25.6 80.3 26.8 16.3 1572
NTG-2h 30.0*} t 70.5*} t 17.1 *} t 11.2*} t 1217*} t
NTG-48h 28.0* 80.2 24.3* 14.0* 1367*
NTG-W 25.3 82.7 26.6 15.6 1578
Tolerance to NTG's initial effects developed within 48 hrs, as
variables returned towards pre-NTG values; only 8/21 pts shawed
any + in LVFP or SVR after NTG-W. Tolerance was not related
to changes in weight or plasma renin activity. Before IV-NTG,
all pts responded to oral isosorbide dinitrate (ISDN, 40 mg), but
none did so after tolerance was induced to IV-NTG. ISDN
response returned within 18-24 h (but not within 2-h) of NTG-W.
In 8 pts who developed tolerance to IV-NTG, the addition of N-
acetylcysteine (NAC, 200 mg/kg orally) to IV-NTG produced + in
SVI and -I- in LVFP, MAP, MRAP and SVR (all p<.05), thereby
restoring NTG's initial effects. Yet, NAC produced no hemodyn-
amic effects in 7 pts who had not developed tolerance to NTG.
In conclusion, in mast pts with CHF, continuous NTG therapy
produces the rapid development of organic nitrate tolerance and
cross-tolerance, which may result (in port) from the depletion of
critical sulfhydryl groups at hypothetical nitrate receptor sites.
EARIX TOLERANCE TO HEMODYNAMIC EFFECTS OF SUSTAINED
NITRATE THERAPY WITH HIGH-DOSE TRANSDERMAL NITROGLYCERIN
IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE.
Arie Roth, MD, Daniel Kulick, MD, Lee Freidenberger, RN,
Robert Hong, MD, Shahbudin H Rahimtoola, MD, FACC, Uri
Elkayam, MD, FACC. LAC-USC Medical Center, Los Angeles,CA
Sustained therapy with transdermal nitroglycerin (TNTG)
has been shown to result in early development of toler-
ance in patients(pts) with angina pectoris. In order to
establish whether same phenomenon exists in heart failure
(CHF) , we compared the temporal hemodynamic effect of the
1st & the 2nd dose of TNTG 120mg given q 24hr in 11 pts
who had >20% reduction in pulmonary artery wedge pressure
(PAW). 1st dose TNTG resulted in significant reduction in
right atrial pressure (RA), pulmonary artery pressure(PA)
& PAW lasting 24hrs: (C=control,*p<.OS vs C)
C 2hrs 4hrs 8hrs 12hrs 16hrs 20hrs 24hr
RA 10±4 7±4* 6±4* 6±3* 7±4* 8±4* 8±4* 7±4*
PA 38±7 28±7* 27±7* 26±7* 28±7* 32±S* 31±7* 31±6*
PAW 26±6 17±6* 16±6* IS±6* 18±6* 19±4* 20±S* 19±7*
However, a comparison between hemodynamic measurement
after 2-6hrs after 1st & 2nd TNTG dose showed:
1st dose 2nd dose
2hr 4hr 6hr 2hr 4hr 6hr
RA 7±4 6±4 6±3 9±S* 8±S** 9±6***
PA 28±7 27±7 27±6 32±8* 32±7** 33±10***
PAW 17±7 16±6 16±7 22±7* 21±8** 19±8***
* p<O.OS vs 2 hr, ** p<O.OS vs 4hr, *** p<O.OS vs 6hr
The effect of the 2nd dose TNTG was significantly at-
tenuated when compared to the effect of the 1st dose.
Conclusions: In responders the 1st dose of 120mg TNTG
leads to significant & continuous reduction in RA, PAW
& PA; however, the 2nd dose given 24hr later is signifi-
cantly less effective. These findings suggest early tol-
erance to hemodynamic effects of TNTG in patients with
CHF.
CUTANEOUS NITROGLYCERIN PATCHES: EFFECT ON CORONARY
ARTERIAL DIAMETER.
Abel E. Moreyra, M.D., F.A.C.C., George J. Saviano,
M.D., F.A.C.C., John J. Burns, M.D., F.A.C.C., Joseph
Lauricella, M.D., John B. Kostis, M.D., F.A.C.C.,
UMDNJ-Rutgers Medical School, New Brunswick, NJ.
The use of cutaneous nitroglycerin (NTG) patches has
raised great interest and also controversy. We studied
the coronary dilator and systemic responses to graded
doses of NTG in 25 patients undergoing diagnostic
coronary arteriography (CA) after discontinuation of all
coronary vasodilators for 48 hours. Fifteen patients
received a 51 lIIg NTG patch 2 to 12 hours before CA
(treatment group) and 10 patients did not (control
group) • High resolution coronary angiograms, using 5"
image intensification, were examined in a "blind"
fashion before and after administration of cumulative
doses of intracoronary (IC) NTG (50 to 11350 g). An
electronic caliper was used to measure coronary arterial
diameter of proximal left anterior descending artery
(LAD) and circumflex artery (Cx) segments. Results:
LAD DIAMETER INCREASE % Cx DIAMETER INCREASE %
+-- IC NTG_ 4---IC NTG_
5011 10011 200 Ii 5011& 10011& 200llg
Control 19±4 21±4 28±8 19±9 25±8 21±6
NTG Patch 10±4 12±3 15±7 3±4 7±4 7±4
p<0.04 p<0.015 p<0.03 p<0.05 p<0.015 p<0.04
At a cUDlUlative doae of 350 IIg NTG uan blood pressure
decreased 9±5 mm Hg in the control group and 11±6 in the
trestment group (NS). Heart rate increased 4±9 beats/min
in the control group snd 5±7 in the treatunt group
(NS). Thus, cutaneous NTG patches cause a blunted coro-
nary dilstor response to IC NTG, whereas the systemic
response is maintained. The data suggest a marked
activation of coronary NTG receptors although selective
tolerance to IC nitroglycerin cannot be excluded.
FAILURE OF COMBINATION ANTIANGlNAL THERAPY WITH DILTIAZEM
AND NITROGLYCERIN: ARE TWO DRUGS BETTER THAN ONE?
Jonathan Abrams, M.D., F.A.C.C., and David Hoekenga,
M.D., F.A.C.C., Albuquerque, New Mexico
Diltiazem (DZ) and nitroglycerin (NTG) are vasodilators
with differing cellular mechanisms of action. Although
both have proven antianginal efficacy, it has not been
shown that the use of a calcium channel blocker and a ni-
trate is better than either single drug alone. We com-
pared the effects of DZ only to DZ with oral NTG in an-
gina patients in a double-blind placebo-controlled trial.
12 subjects with angina pectoris and coronary atheroscle-
rosis were treated with oral DZ, DZ + NTG, or placebo
(PLAC) during 3 randomly assigned treatment periods of 2-
3 weeks each. Patients were on no other antianginal
therapy. After 2 baseline treadmill tests (EXT) to in-
sure reproducible EXT response, patients were randomized
to DZ 240 mg/d; DZ/240 mg plus oral NTG to maximal toler-
ance, mean dose 72 mg/d (rsnge 26-78 mg); or placebo.
EXT were performed 2.5 hours after dosing. Results:
TIME TO ANGINA OR FATIGUE (sec)
Therapy Angina Total EXT To 1 mm
Onset Duration ST"
PLAC/PLAC 349 469 311
DZ/PLAC 4l3t 538t 409t
DZ/NTG 425t 535t 4l6t
t p < 0.05 DZ/PLAC vs DZ/NTG • NS
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ADDITIVE EFFECTS OF NITRATES AND CALCIUM ANTAGONISTS
Jean M. Lablanche, M.D., Regis Beuscart, M.D.,
Gilles Traisnel, M.D., Jean Louis Fourrler, M.D.,
Mlchel E. Bertrand, M.D., F.A.C.C. - Hopltal Cardiologi-
que - Lille - France
Nitrates and calcium antagonists may have additive ef-
fects wlth respect to their different cellular mecha-
nisms. Therefore, we designed the following protocol in
12 patients (pts) with variant angina. All had ergome-
trine provoked coronary spasm during coronary arterio-
graphy. Within a period of 3 days, they received either
20 mg of 5 ISMN, (5 isosorbide mononitrate) or nifedipi-
ne (10 mg) and finally a combination of the 2 drugs. An
ergometrine test with incremental doses (0.05, 0.10,
0.20, 0.40 mg) was performed at the same hour of each
phase and 60 minutes after the drug administration. No
pt had a positive test (T+) before the 0.2 mg injection.
T(-) T(+)0.4mg T(-)0.2mg
5 ISMN 3 4 5
Nifedipine 6 4 2
Nif + 5ISMN 10 2 0
By comparison with 5ISMN, nifedipine was superior in 6
pts but inferior in 2 (NS). The combination of nifedipi-
ne and 5 ISMN was superior to nifedipine alone in all
the 6 patients with a positive test (p = 0.03) and supe-
rior to 5 ISMN in all except one (p = 0.01). These re-
sults support the hypothesis that nifedipine and nitra-
tes may have additive effects and their combination is
superior to one of these drugs alone in the prevention
of coronary arterial spasm.
Monday, March 10, 1986
2:00PM-3:30PM, Room #364/365
Pathophysiology of Mitral Valve Disease
INCREASED PLATELET RELEASE PRODUCTS AND AGGREGATION IN
SYMPTOMATIC IIITRAL VALVE PROLAPSE (IIVP)
Andre Pasternac, II.D., F.A.C.C •• Jean-Gilles Latour,
Pb.D., simon touz, I.D., Claudette Gauthier, Ph.D.,
Robert petitclerc
1
II.D., Jacques de Chaaplain, II.D.,
Ph.D., Bruno Vel as, II.D. and Claude Goulet, II.D' l'.A.C.C., 1I0ntreal Heart Institute and University or
1I0ntreal, IIontreal, Canada
Ten sJlllptomatic patients with documented mitral valve
prolapse (II and 2D-ECHO) and a stable hyperadrenerlic
state underwent platelet studies. There were 7 females
and 3 males, mean ale was 53.21:2.7 years. Values ob-
tained previously in ten normal subjects (sex-matched)
were used as reference. Plasma catecholamines were mea-
sured by the technique of Peuler and Johnson in the su-
pine (S) position and 10 minutes after assuminl a
standinl (ST) position. The Platelet-alfrelate ratio
(AGR), platelet factor 4 (PFA), P-th~oabol obulin (BTG),
throaboxane B2 (TxB2) and Fibrlnopeptide (FPA) were
measured. Platelet allrelation to various concentra-
tions (0.23 to 0.91 PI/ml) of ADP epinephrine and
collalen, and to thrombin (0.137, 0.182 U/ml) was test-
ed on PiP. Plasma norepinephrine and epinephrine were
silnificantly elevated in the S (323±29 PI/ml vs
control 201±10 PI/ml, p<.OOl) as well as in the ST po-
sition (747±79 vs 411±20 PI/ml, p<.OOl). 'ree epinephrine
and dopamine were normal in Sand ST positions
BTG PF4 TxB2 AGR
pts (x±SBII) 36.6±5.2 16.3±5.6 456±48 .72±.04
Controls 21.3±1.8 2.3±0.7 386±26 .95±.03
P value <0.01 <0.02 <NS <0.001
The ratio of llatelet atlrelates in blood and the lev-
els of BTG an PF. were ncreased in all patients as
compared to controls (p<O.Oll. Ex vivo platelet al-
Irelation was increased by more than 45~ (p<0.05)
above control values to ADP, collalen and throabin but
was found normal to epinephrine in most patients. One
patient presented spontaneous platelet allrelation.
We conclude that in addition to platelet hlperaurela-
bility which appear related to tne increased hlperad-
renerlic state, platelet activation is taUnl place in
patients with IIVP and mal reflect the increased throm-
boembolic risk in these patients.
Conclusions:
1.Ex-lnduced Ischemia In pats with Insufficient nitrate-response can
be Significantly Improved by VERA as well as by PROP.
2, Since VERA and PROP were equally effective, the reduction of con-
tractility seems to be the prevailing mechanism for a successive antl-
Ischemic therapy In this special subset of pats.
3, Pats with Insufficient nitrate-response usually need a triple therapy
for optimal anti-Ischemic treatment. This can be achieved even without
a significant deterioration of EF during ex.
PROBLEMS OF ANTI-ISCHEMIC DRUG THERAPY IN PATIENTS WITH
INSUFFICIENT NITRATE-RESPONSE.
Sigmund Silber, M.D., Astrid Vogler, M.D. and Karl Theisen, M.D.
University of Munich, Zlemssenstr.l, West-Germany.
The oral administration of Isosorblde-dlnltrate (ISDN) usually leads
to a remarkable Improvement of exerclse(ex)-Induced Ischemia. There
are, however, patients who do not benefit from nitrate therapy,although
preload reduction could also be demonstrated In this grouP of pats.
To assess, whether this special grOuP of pats Improves after a further
Increase of myocardial blood~suPPly with a calcium-antagonist or from
a reduction of contractility with beta-blockade we performed a rando-
mized, double-blind and cross over study In 26 consecutive pats with
no (n=19) or minor (n=7) response to orally given 80mg ISDN. 3x12Omg
Verapamll(VERA)as well as 2xBOmg propranolol(PROP) were additionally
administered for 3 weeks each, followed by another 3 weeks of a
single-blind triple therapy. Ex-tests were performed 2 hrs after the
morning-Ingestions respectively. Pats with standard criteria for CAD
were InclUded only If the ST-segment during ex was~ 1mm and left-
ventricular ejection fraction (EF) at rest was~ 35%, as determined
by radlonucllde-ventrlculography. Results: (mean ! one SO)
ST (mm)
EF-ex(%)
CONTROL:
2.6+1.1
53"!11
ISDN:
2.1+1.2
59"!14
ISDN+VERA:
0.9+0.9
59"!1O
ISDN+PROP: TRIPLE:
0.9+0.7 li:'2+o.4
60"!10 56"!10
Ia ANTIGENS ON VALVULAR TISSUE FROM PATIENTS WITH ACTIVE
RHEUMATIC CARDITIS.
Richard Marcus MB, Bradley Amoils, Ahmed Wadee PhD,
Danny Ninin MB, Peter King MB, Pinhas Sarell MD, Theo
Meyer MB, Solomon Levin MB, Arthur Habson MB. Dept. of
Cardiology, Baragwanath Hospital & Dept. of Immunology
and Anatomical Pathology, South African Institute for
Medical Research & University of Witwatersrand,
Johannesburg, South Africa.
Class II major histocompatibl1ity complex (MHC) antigens
play an important role in actlvating and directing the
immune response. If this system is triggered to respond
to the host's own tlssue, ego valvular fibroblasts, des-
tructive immune phenomena may occur. Acute rheumatic
fever with cardltis and hemodynamlcally severe valvular
insufficiency was dlagnosed 1n 12 black pts, according
to the modi fled Jones criteria. There were 7 males and 5
females with a mean age of 12 yrs (range 9-16). All were
in NYHA Class III (8 pts) or IV, and underwent mltral
(9 pts) or double valve surgery. The presence of active
valvulitls was confirmed macroscopically at operation
and histologically on subsequent llght mlcroscopy.
Valvular tlssue was examined for the presence of Ia
antigens employing both fluorescent and peroxidase
stainlng technlques. Surface Ia antigen expression was
demonstrated on flbroblasts within the heart valves of
all pts, using the Ortho-mune OKIa monoclonal antibody.
ThlS was confirmed with anti-Ia New England Nuclear
antibody. Control heart valve tissue from pts dying with
other cardiac pathologies or following trauma showed no
evidence of autoimmune activity. The aberrant expression
of the Ia antigen (MHC Class II) on heart valve fibro-
blasts during active rheumatic carditis may have an
important role in the development of this disease.
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ImJAUKE lID !EVERIlY <F Mr1H\L Rn.IGL'lJIlmN IN 'lIE Mrm\L VI\UIE
l'KIAH:E S'lNlOf:: A IX:HUR~ SlUJ{ <F III HmENIS
Ian1is P. Pcnidi.s, M.D., FKX::, Midlae1.1tiilli.st:a", RMl,
Jctn R:sB, HP1', GaEy S. Mintz, M.D., FKX::
HitrerBn Ulivet"Si.ty, Rli.l.aielthia, If\
'lb defire tre exa:t~ crD seuerlty cf mitral
tep.gitatim (MR) in plI:is'ts (J;ts) with mitral WI1ve~ (MJP),
~ ed'<x:mrlicgr;py (edD) w:s p![fil:nIrl in III aJl!lEntive
~ (22 1IB'1, 58 WJIB'1), cged ~16 yeam, W'D hD MIP d:i.al}"aB:3 I¥
t:w:>-dimnliala (:.Il) ed'o. (f'tte III ~, 16 (:om) 'IBl!~
crD 11 (14%) hD a ra:nal. P¥d<B1. aranimtim (I'D clidt <r 1lLI1IIr).
'1lE M1n:xi! edD w:s l'BJIltive ti::r MVP in 11 (14%) ~ crD Eq.Ji.VCCB1. <r
rm-di.a:.Jatic in 19 (24%)~. Q1:.D-«tD,~ cf 1m crb!ria
mitral1e1.lflet w:s eIIidert in 45 (56%) ~, WJe tnn 1eIlflets 'IBl!
irwlvei in l5~. Mitral mpgitatim w:s 8Ia1I.BtId~ tre
pJl.sED IIOOe~ crD w:s cp:rtifie:ll¥ 1m~ ted'rIiq.2 as
IId.ninBl <r mild \lhn a~ rsp:gi.ta1t jet w:s J:IlO::I:dED jtEt
~ 1m mitral valve inID tre left ct:riun (rA), crD as JIllierabe <r
BeIIel."e \lhn 1m jet w:s~ \P to mid- <r distal IA. Mitral
t8}JI:lJitat.ial w:s fi::l.rD in 55 cf III (69%) ~ crD it w:s minim!iI. <r
mi.ld in ~ ('B%) crD mDerate <r BeIIel."e in 8 (1~)~. In:J) d. 1m
55 (36%) ~ with !oR I¥ D::{:pl.a", a systolic IlllI:IIlr w:s rtt~ crD
all d. thEm hD mild~ left ctri.al. crD left V8t:rio.Ilic sUe Q'1
M1n:xi! edD 'IBl! si9Ufiantly SlEl1le: in~ with mUd <r I'D !oR as
a:npr:e1 to 1m 8~ with JIllierabe <r BeIIel."e~ All theBe 8~~
IIB'1 (6 Ole[' Sl yeam) crD they lB.B1l.y p:llEll:ttai with dyEplla crD a
~ numr, 1m MIP w:s~ I¥ M1n:xi! crD irwlvei
tnn 1eIlflets 1¥:.D-«tD. 'l\O d. 1m 8~ D:q.linD mitral valve
repl.a;B'rsL In tre~~, tre~ d. MIP I¥ M1n:xi!
(1lilcsystDlic <r late systD1.ic) crD 1m n.J1t:J:!r d. mitral 1eIlflets
irwlvei I¥ :.D-«tD (cm:ricr a'lly <r tnn) 'IBl! rtt p:e:ti.<:.tive d. tre
JiI."ESI'!lE <r~ d.~
In an::hsim: 1) !oR as alIiIeS3Erl I¥ D::{:pl.a" is amm in~ with
MIP, bi is lB.B1l.y mUd crD I1l¥ rtt te 8'B'X'iate1 with en a.dib1e
1lUI:I1lr. 2) In or series, ~Eian:!oRw:s r:a:e (1~) crD lB.B1l.y
<XX1.n"Erl in IIB'1 with MJP, W'D 'IBl! Ole[' Sl year:s ald.
EARLY DIASTOLIC FILLING DYNAMICS DURING EXPERIMENTAL
MITRAL REGURGITATION IN THE CONSCIOUS DOG
Kazuhiro Katayama, M.D., Tsukasa Tajimi, M.D., Brian
Guth, ph.n., Thomas F. Widmann, M.D., Jong Dae Lee, M.D.,
Rainald Seitelberger, M.D., Mark Miller, B.S.E.E. and
Kirk L. Peterson, M.D., F.A.C.C.
University of California, San Diego, California
To study the diastolic mechanisms of left ventricular
adaptation to acute volume overload in mitral regurgita-
tion (MR), 5 dogs were instrumented with a micromanometer
(LV pressure) and sonomicrometers (wall thickness, long
and short axes). LV volume, circumferential wall stress
and eccentricity of LV chamber (derived from the values
of long and short axes) were calculated throughout dias-
tole. Measurements were made at control(C) and up to 4
weeks after creation of MR. Heart rate, peak systolic wall
stress and peak(+)dP/dt showed no significant changes. At
4 weeks after MR end-diastolic volume increased (C-79±4,
MR-119±9 ml, p<O.OOl). Peak filling rate (C-385±50, MR-902
±172 ml/sec, p<0.002) and filling fraction during first
40% of diastolic time (FF40) (C=5l±l, MR-76±5%, p<O.OOl)
increased with no significant change of diastolic time
intervals. Over the period of adaptation to the volume
overload, FF40 correlated with end-diastolic volume (r=
0.52, p<0.02) and total stroke volume (r-0.80, p<O.OOl).
Eccentricity at end-systole decreased (C-0.8l±0.02, MR-
0.79±0.03, p<0.05) and reduction of this ratio during
first 40% of diastolic time was greater in MR than in C
(C-0.05±0.01, MR=0.11±0.02, p<0.005). We conclude that the
LV accommodates the need for increased diastolic volume
during acute MR by increasing proportionately the filling
and spherical deformation during the first 40% of dias-
tole.
MITRAL VALVE ProIAPSE-SUDDEN DEATH w:rm I.(H; TEH1 SURVIVAL
Harisios Boudoulas. M.D"F .A.C.C.. Stephen F. SChaal,
F.A.C.C., Jdln M. Stang, M.D., F.A.C.C., Maty E. Fontana,
M.D., F.A.C.e., Albert J. Kolibash, M.D., F.A.e.e.,
Charles F. Wooley, M.D., F.A.C.C., Ohio State University,
Colllll1l:xJ.s, Ohio.
Sudden death occurring in patients (pts) with mitral valve
prolpase (MIIP) has been reported, the natural course of
MVP pts who survived cardiopuhronary resuscitation (CPR)
has not. Of 9 pts (7 faoale and 2 male, age 22-66, mean
33) with MIIP and sudden death, 7 out-of-hospital, 2 in-
oospital) ventricular fibrillation was doc:Immted in 8 and
CPR was successful in 7. Prior to sudden death 8 pts had
palpitations, 3 syncope and 1 no synptans. Click- IlIlIJlllr
was present in 7 and click only in 2. In the 7 survivors
cardiac catheterization showed MI7P am noIIMl ooronary
arteries in all: echocardiogram showed MIIP in all. One pt
had prolonged electrical systole (ar). Elect:roIilYsiologic
studies in 7 pts showed nonsustai.ned ventricular
tachycardia «10 beats) in 2, mild sinus node and
atrioventricular node disease in 2, intra-His block in 1
am no abnonnalities in 2. '!he 7 CPR survivors (still
alive) are followed fran 1 to 15 years (mean 5.2) 1 durinJ
the follow-up period 2 pts had palpitations, 1 ortOO-
static hypotension and near sync:qJe, 1 palpitations plus
dyspnea and 3 no synptans. 'Dlree pts were treated with
~blockinJ drugs, 2 with l3-blockinJ drugs plus class I
antiarrhythmics, 1 with a pacemaker plus antiarrhyt:l1ni.cs,
and 1 with valve replacement, pacemaker and antiarrhyth-
mics. '1be present study confinns previous reports that a
subset of MIIP pts with long history of palpitations-
arrhyt:lWni.as and syncope may be prone to sudden death. In
addition this study defines the natural course of MVP-
sudden death pts after successful CPR. '1be long tem
prognosis in this group of pts appears better than that
of other causes of sudden cardiac death.
LACK OF ASSOCIATION OF CARDIAC SYMPTOMS WITH MITRAL
VALVE PROLAPSE IN SIXTH GRADE SCHOOLCHILDREN.
Cynthia L. Arfken, Ph.D. , Anthony S. Lachman, M.D.,
F.A.C.C., Peter Schulman. M,D" F.A.C.C., Grover C.M.
Farrish, M.D., Diane S. Slowik, and Kargaret J.
McLaren, M.D., Yale University, New Haven and
University of Connecticut, Farmington.
Prior studies linking chest pain and other cardiac
symptoms to mitral valve prolapse may be biased by
methods of recruitment in that the presence of disease
calls attention to symptoms. To avoid this potential
bias, 591 non-care-seeking children, ages 9-14, 31 with
auscultatory mitral valve prolapse, which at that time
was unknown to them, completed a structured
questionnaire wherein potential cardiac symptoms were
elicited. Chest pain or discomfort anytime in life was
reported in 62% of children without mitral prolapse and
in 42% of those with this condition (P<.05). Fatigue,
palpitations, dizziness and fainting were more common
in the non-prolapse group (NS). Only dyspnea on running
up one flight of stairs was slightly more common in the
children with prolapse (NS). Overall, 26% of the
non-prolapse group and 45% of the prolapse group
reported no symptoms (P<.05). Among children reporting
symptoms, those with mitral prolapse reported no more
symptoms than those without: 1.6 vs. 1.5, (NS).
Findings did not differ between genders. Thus, cardiac
symptoms were more common in adolescents without mitral
valve prolapse than in those with this condition when
symptoms were elicited when subjects were unaware of
their condition. These results fail to support the
contention that chest pain and other cardiac symptoms
are more common in persons with mitral valve prolapse.
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Echo Doppler Methods for Assessment of Valvular
Heart Disease
DOPPLER OVERESTIMATION OF SYSTOLIC AORTIC VALVE GRADIENT
IN PATIENTS WITH AORTIC REGURGITATION.
Shale Gordon,MD,Dan Lavery,MD,Karol Calvo,CCVT,Sanjeev
Saksena,MD,FACc. Newark Beth Israel Med Ctr, Newark, NJ.
Aortic transvalvular pressure gradients have been esti-
mated using Doppler ultrasound in pts with aortic steno-
sis. We compared the accuracy of calculation of aortic
transvalvular pressure gradients (AP) obtained using con-
tinuous wave Doppler (CWD) ultrasound velocities with
measurements obtained from direct pressure recordings in
pts with severe aortic regurgitation (AR).
CWD studies were performed within 24 hrs of cardiac
catheterization on 14 pts with severe (3-4+) AR &absent
to moderate aortic stenosis. CWD measurements of the
aortic valvular flow peak velocity allowed calculation of
the transvaivular2AP by using the modified Bernoulliequation (AP - 4V).
RESULTS: Mean heart rate was comparable for CWD and pres-
sure recordings (p>.2). Direct pressure recordings using
a fluid-filled catheter showed peak to peak aortic AP
ranging from 0 to 35 mm Hg. Mean 6p was 30 ± 16 mm Hg by
CWD and 13 ± 12 mm Hg by direct pressure recordings
(p<.OOI). Comparison with CWO 6p showed overestimation
of 6P by CWD ranging from 1 to 49mm Hg (mean 17), r-.72,
SEE-S.4 mm Hg.
We conclude that CWD cannot reliably predict systolic
aortic pressure gradients when severe AR is present.
DIAGOSIS AND QUANTIFICATION CF AORTIC RErnJRGITATION wrrn
PULSED OOPPLER ECfIX;ARDlOORAPHY IN CCMBINED VALVULAR
DISEASE.
H.Dittmann M.D., K.-R.Karsch M.D., L.Selpel M.D.;
Medical Department III, University of Tuebingen, FRG.
To test the ability of pulsed doppler echocardiography
(PDE) in detection and quantification of aortic regurgi-
tation (AR),64 consecutive patients (14-74 years) with
aortic and mitral valve disease were examined clinically
arxl by echocardiography before cardiac catheterization.
The severity of AR was determined angiographically (I-IV)
and canpared to the extent of the regurgitant jet in the
left ventrl cle measured by PDE.
In 15 of 64 patients (2 mitral stenosis,5 lIIIJ.tral insuffi-
ciencies,3 combined mitral lesions,4 aortic stenosis,1
canbined aortic and mitral lesion) neither angiography
nor PDE shCMed AR (specificity 100%). Apart fran 3 pa-
tients with pool' echo quality PDE correctly detected AR
in 46 of 49 patients (sensitivity 94~).Sensitivityof
the clinical examination was 61~ and m-mode sensitivity
57~.The PDE degree of AR correlated strongly with angio-
graphy (r:: 0.91).In 4 of 5 patients with severe aortic
stenosis the AR I was slightly overestimated.Differen-
tiation between AR III and IV by PDE was not possible.
Hi tral valve disease did not affect quantification of AR
(n=34 patients).
Conclusion: Pulsed doppler echocardiography is superior to
auscultation and echocardiography in detecting aortic re-
gurgitation in the presence of mitral valve disease and
is reliable in estimating the degree of aortic regurgita-
tion.ln patients with severe aortic stenosis AR I is
slightly overestimated by PDE.
NORMAL LEFT VENTRIa.JLlIR IDICCARDICGRAMS IN PATIENTS WITH
AORITC STEOOSIS
Mark Lipton, M.D., Janes Slater, M.D., Paul Kraner, M.D.,
William SChwartz, M.D., H<Mard Winer, M.D., F.A.C.C.,
Itzhak Kronzon, M.D., F .A.C.C., Ephraim Glassman, M.D.,
F.A.C.C. New York University Medical Center, New York, NY
Patients with significant aortic stenosis occasionally
dem:mstrate nonnal LV wall thickness on echocardiography
(echo). In order to assess the inplication of a nonnal
LV echo in aortic stenosis, the herrodynamic, echo and
clinical data of 78 patients who ~nt cardiac cath-
eterization and were found to have aortic stenosis without
other significant valvular disease were analyzed. 17/78
(21%) of these patients had normal LV wall thickness and
end-diastolic internal dinension. LV wall notion scores
and coronary scores were derived by analysis of the anqio-
grams.
oonnal LV echo abnonnal LV echo
Mean Gradient 59.9t9.6(SEM) 56.2t3.2 NS
Aortic Valve Area 0.82tO.15 0.76tO.04 NS
LV Systolic Pressure 202t6 200t4 NS
LVEDP l8.8tl.7 2l.8tl.0 NS
cardiac Index 3.07tO.9l 2.82±0.07 NS
Coronary SCOre 3.47±0.90 4.07tO.52 NS
Wall Motion SCOre 2.50tl.49 4.20tO.9l NS
Age 65.2t2.3 70.0tl.26 NS
'!here were no significant intergroup differences in synp-
tcrns or in the prevelance of ECG evidence of LV hyper-
trophy. we conclude that patients with clinically inpor-
tant aortic stenosis frequently (21%) do not present with
LV hypertrophy or dilatation on echo. Furtherrrore, the
oonnal LV echo patients do oot differ fran the aboomal
LV echo patients in their syrrptans or cardiac catheteri-
zation data.
INACCURACY OF PULSED DOPPLER TECHNIQUE IN ESTIMATING MEAN
PULMONARY ARTERY AND PULMONARY WEDGE PRESSURE IN AN
UNSELECTED PATIENT POPULATION.
Michele Nanna,MD, Shoalin Lin,MD, Charles McKay,MD,FACC,
Michael Trigleth, MD, Satish Choudry, MD, Shahbudin H
Rahimtoola,MD,FACC, PAN Chandraratna,MD,FACC. LAC-USC
Medical Center, Los Angeles, CA.
To assess the accuracy of pulsed Doppler (D) technique in
measuring mean PA pressure(PAP) & PA wedge pressure(PWP)&
their changes after intervention in an unselected patient
population,we obtained simultaneous D & fluid-filled
catheter(C) measurements(meas) in 34 consecutive patients
(pts) during routine cardiac catheterization. 26 pts had
technically satisfactory studies. A 1st set of meas was
obtained before performing an LV angiogram & a 2nd soon
after injection of contrast dye. Pressure & D meas were
independently analyzed by 2 blinded observers. Mean
D PAP & PWP were derived from acceleration time(AT) &
calculated using previously published regression
equations: PAP=-.45xAT+79, PWP= 57-.39xAT. Mean PAP meas
by C ranged from 13 to 46mmHg, mean 25.9t7.7(m±SD) & mean
PWP ranged from 6 to 45mmHg (mean IS.6±7.7). When
measured by C, the intervention effectively changed mean
PAP & PWP by 22%, p<.05,& 22%, p<.05, respectively;
however, D failed to detect such changes(3%,p>.05 &
-20%,p>.05, respectively). Analysis of PAP values before
& after intervention showed a poor correlation between C
& D (R=.4S, SEE =6.62,& P<.OOI). Similar poor correlation
was found when PWP was analyzed(R=.49,SEE=6.1,p<.OOI). In
detecting mean PAP values of >22mmHg,D had a sensitivity
of 64%,specificity of 2S.5%,accuracy of 60%. In detecting
mean PWP values >12mmHg,D had a sensitivity of 94%, a
specificity of 50%, accuracy of 77%. We conclude: 1) In
an unselected patient population,D meas of mean PAP & PWP
are inaccurate; 2) mean PAP & PWP meas by D are unreli-
able in detecting hemodynamic changes after intervention.
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LEFT ATRIAL SPONTANEOUS ECHO CONTRAST IN MITRAL VALVE
DISEASE - AN INDICATOR OF INCREASED THROMBEMBOLIC RISK
Werner G. Daniel, M.D., Ulrich Nellessen, M.D., Barbara
Nonnast-Daniel, M.D., Pjotr Bednarski, M.D., Paul R.
Lichtlen, M.D., F.A.C.C.
Hannover Medical School, Hannover, West Germany
Left ventricular (LV) spontaneous echo contrast (SEC) is
a well-known phenomenon ~n patients (pts) with seriously
impaired LV function. In the left atrium (LA), however,
SEC is only occasionally noted. We studied 38 pts with
mitral stenosis (MS; group I) and 31 pts after mitral
valve replacement (MVR; group II) using conventional
transthoracic (C) and transesophageal (TE) 2D-echocardio-
graphy (ECHO). Twenty-nine group I pts and 25 group II
pts had atrial fibrillation (AF).
Results: SEC was not seen on any C-ECHO but could clearly
be identified by TE-ECHO in 27 group I pts (71 %) (22
with AF) and 15 group II pts (48 %) (all with AF). pts
with SEC had larger LA diameters than those w~thout
(group I: 61.4 ~ 27.0 rom vs 50.3 ~ 11.0 rom; group II:
70.3 + 15.0 rom vs 50.8 + 16.0 rom; p (0.001). Fourteen of
the 42 pts with SEC had-history of arterial embolism
(EMB) and 6 had LA thrombi (TH) proven by surgery and/or
ECHO; 18 SEC-pts (43 %) had EMB and/or TH. In contrast,
only 1 of the 27 pts without SEC (4 %) had EMB, and no
pt had TH (p ( 0.005) .
Conclusion: LA-SEC in pts with MS both before and after
MVR can easily be detected by TE-ECHO; SEC is in particu-
lar found in pts with large LA and may be considered an
indicator of an increased thrombembolic r~sk requiring
consequent anticoagulant therapy.
~TIVE DEX::ISlOO MAKII«; IN 'DUaJSPID VALVE
SURGERY BY 2-D 1DfO. Martin E. Golclnan, M.D. , F.A.C.C. ,
Bruce P. Mindich, M.D., F.A.C.C., 'lheresa Glarino,
R.N., Valentin FUster, M.D., F.A.C.C.. Mt. Sinai
Ii:>spital & St. !Alke's-~lt Ii:>spital center, NY, NY.
8eooOOary tricuspid (T) regurgitation (R) is due
to TN dilatatioo in response to PA hypertension fran
left sided heart (IH) disease. While om may partially
resolve following repair of the IH lesion, significant
residual TR may increase postoperative JOOrbidity. To
quantify the severity of TR and to detennine if T
repair was necessary, 2-D contrast echo (2DCE) was
perfonned in 50 patients (pts) intraqleratively. In
pts with TR, injection of DSW into the TN generated
echogenic contrast with systolic reflux of contrast
into the RA, scored as 0 to 4+. Systolic PA pressure
(1lIIIHg), 2DCE pre and post IH procedure and baseline T
annulus ('IVA) dilnension (1IIIl) were also measured. Pts
were divided by severity of intraqJerative 2DCE om:
0-2+ om and 3-4+ TR. (* = p<0.0001,** =p<0.01)
TR n Pre-PA Post-PA 'IVA
0-2+ 36 31 + 13 27 + 10 26+ 3
3-4+ 14 44 +13* 35 +8** 38 + 4*
'IVA oorrelated better with -TR severity (r=0.75,
p<0.0001), than pre-PA (r=.48,p<0.02). All 14 pts
with 'IVA > 30 IIIIl had 3-4+ om. !nIX>rtantly, the 9/14
pts with-initial 3-4+ TR with severe persistent TR
post IH qJeration, who required T repair oo';tid be
identified only by 2DCE, 00t not by hemxlynanucs nor
palpation. 'lherefore, large 'IVA may indicate chronic
TN dilatation and dysfunction which may renain despite
a reduction in PA pressure. IntraqJerative 2DCE can
identify those pts ('IVA ~30 & 3-4+ om) who will have
residual 3-4+ TR and may have significant benefit fran
'IV repair.
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FIFTEEN HUNDRED CORONARY REOPERATIONS: RESULTS AND
DETERMINANTS OF EARLY AND LATE SURVIVAL
Bruce W. Lytle, MD, FACC, Floyd D. Loop, MD, FACC, Delos
M. Cosgrove, MD, FACC, Paul C. Taylor, MD, Marlene
Goorm&stic, MPH, Carl C, Gill, MD, FACC, Leonard A.R,
Golding, MD, FACC, Robert W. Stewart, MD,
The Cleveland Clinic Foundation, Cleveland, Ohio
Fifteen hundred consecutive patients undergoing a first
reoperation for coronary revascularization were reviewed
to determine early and late results and predictors of
survival, To examine trends, patients were subdivided into
cohorts based on the year of operation: Group A (1967-78,
436 patients), Group B (1979-81, 439 patients), and Group
C (1982-84, 62S patients). Overall operative mortality was
3.31 (SO deaths); 4,61, 2,31 and 3.21 for Groups A, B and
C, respectively. Comparison of cohorts showed that Group C
had increased numbers of women and patients with triple-
vessel disease, left main stenosis (~SOI), abnormal left
ventriCUlar function, age ~70 yrs, ,and graft failure as a
surgical indication (all p <0.001). The mean interval
between operations increased from SO mos. for Group A to
84 mos, for Group C. At reoperation, Group C patients
received more grafts, more mammary artery grafts and had a
higher prevalence of complete revascularization (all p
<0.001), Univariate and multivariate analyses identified
left main stenosis (p<O,OOOl), Class III or IV symptoms
(p=0.0002), advanced age (p=0.0004), Group A (p=O.OOS) and
diabetes (p=O.OS) as predictors of increased in-hospital
mortality. Abnormal left ventricular function (LVF) was
associated with increased risk for Group A (p=O.OS) but
not for Group B or C. Follow-up (mean interval 68 mos.,
range 14-171 mos.) of the first 1000 patients (excluding
30 who died in hospital) documented S-yr. survival of 901.
Multivariate testing identified advanced age (p<O.OOOl),
abnormal LVF (p=O.OOS) and triple-vessel disease (p=0.03)
as predictors of decreased late survival.
CORONARY ARTERY BYPASS GRAFT SURGERY FOR THE THIRD TIME
OR MORE. THE RESULTS OF 90 CONSECUTIVE OPERATIONS.
Jerold Brenowitz, M.D., Gerald Dorros, M.D., F.A.C.C.,
Lynne Schley, R.N., W. Dudley Johnson, M.D., F.A.C.C.,
St. Mary's Hospital, Milwaukee, WI.
During the last 11 years, 87 patients (PTS) underwent 90
consecutive coronary artery bypass graft (CABG) surgeries
performed for the third time or more. Clinical character-
istics showed that 67 PTS (77%) were men, the mean age
was 54 years (range: 28-72). Eighty PTS (89%) had triple
vessel disease. 51 PTS (57%) had a prior myocardial in-
farction, and 32 PTS (36%) had a left ventricular ejec-
tion fraction ~ 50%. All PTS had angina preoperatively
with 88/90 PTS~CASES) (98%) having Class III-IV angina.
Eighty PTS had 2, 9 PTS had 3, and 1 PT had 4 prior sur-
geries. Direct myocardial revascularization was performed
in all PTS with a mean of 3.2 grafts (range: 1-6) placed.
Additional procedures included Vineberg implants on 4 PTS
(4%), left ventricular aneurysmectomy on 4 PTS (4%), and
coronary artery endarterectomy on 32 PTS (36%). Complica-
tions encountered included 8 hospital deaths (9%) and 4
nonfatal perioperative myocardial infarctions (4%). At
hospital discharge, 76/79 surviving PTS (96%) were symp-
tomatically improved. Followup data (excluding 5 foreign
PTS) for a period of 4-132 months (mean: 34 months) is
available on 74/75 PTS (98%). Clinical evaluation showed
33 PTS (48%) were asymptomatic; the remaining 36 PTS
(52%) were symptomatic: 36 PTS (52%) with angina (25.
Class II; 10, Class III; 1, Class IV). There were 5 late
deaths occurring between 1 and 90 months. Three PTS
underwent repeat CABG surgery at 7. 54 and 55 months
postoperatively. These data demonstrate that repeat CABG
can be accomplished in severely symptomatic PTS (regard-
less of the number of prior surgical procedures) with
gratifying operative success and long-term clinical
results.
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COMPARISON OF INTERNAL MAMMARY ARTERY AND SAPHENOUS VEIN
GRAFTS USING STRESS THALLIUM SCINTIGRAPHY.
Richard A. Berger, M.D., F.A.C.C., Bruce Boros, M.D.,
Robert Blews, M.D., David L. Galbut, M.D., and Jerry
Stolzenberg, M.D., Miami Heart Institute, Miami Beach,
FL 33140.
Several studies have documented superior long term pat-
ency of the internal mammary artery (IMA) compared to the
saphenous vein (SV) as a conduit in coronary surgery. To
determine adequacy of flow, we performed stress thallium
scintigraphy in 130 patients 4-6 weeks following coronary
reconstruction. There were 143 IMA and 237 SV grafts.
A standard or modified Bruce protocol was used.Patients
were exercised to 80% of predicted heart rate or until
limiting factors occurred. Thallium scintigrams were re-
viewed by 2 independent radiologists. Ischemia was demon-
strated by perfusion deficits at peak stress which were
absent in the 2-hour delayed film. Defined areas were an-
terior septal, lateral, and postero-inferior.
Ischemia was documented in 18.2% (26/143) of areas sup-
plied by IMA grafts, compared to 7.6% (18/237) of regions
revascularized by SV conduits. This was statistically
significant (P=0.05).Anterior wall ischemia was noted in
22% (21/96) of IMA compared to 5% (1/20) of SV grafts.
Although this was not statistically significant, a defi-
nite trend is suggested.
This study suggests that ischemia demonstrated by
stress thallium scintigraphy in the early post-operative
period is more common with the IMA than the SV graft.
This may reflect graft occlusion or inadequate flow in a
patent graft during exercise.
A PROSPECTIVE EVALUATION OF POSTOPERATIVE FLOW
RESERVE IN INTERNAL MAMMARY ARTERY BYPASS GRAFTS.
Alan M. Johnson, M.D., Denny D. Watson, Ph.D., Robert S.
Gibson, M.D., F.A.C.C., and Irving L. Kron, M.D., F.A.C.C.
Univ. of Virginia Med. Ctr., Charlottesville, Virginia.
The internal mammary artery (IMA) has been advocated for
use in bypass grafting due to its superior long term
patency when compared to saphenous vein. Concern exists
that flow through the IMA may be inadequate during periods
of peak myocardial demand. To investigate this, 24 con-
secutive patients with a mean proximal LAD stenosis of
87.5% were selected for coronary bypass using the IMA.
Within 8 weeks of surgery, all underwent evaluation with
exercise Thallium-20l (TL-20l) scintigraphy. A mean maxi-
mum predicte~ !:eart rate of 101% and rate pressure product
of 29.9 X 10 were achieved at a mean workload of 8.1
METS. TL-20l activity, expressed as a ratio of antero-
septal activity to posterolateral wall activity (or in-
ferior wall activity if the pos~rdateral wall was deemed
abnormal) was 0.97 ~ 0.15. A second group of 25 patients
determined to be normal by either normal ventriculography
and coronary angiography (16) or by a normal history,
physical exam, graded exercise treadmill test, and myo-
cardial distribution of TL-20l (9), was similarly eval-
uated. This group reached a mean maximum predicted heart
rate of 85.3% and a mean rate pressure product of 23.7 X
103, at a mean workload of 9.6 METS. The mean septal to
posterolateral wall TL-20l activity ratio for these normal
patients was 1.0 + 0.15. No significant difference in
relative post-exercise anteroseptal TL-201 activity be-
tween normal patients and IMA bypass recipients can be
demonstrated. The internal mammary artery provides
adequate coronary flow at peak myocardial demand.
CAN THE HIGH RISK UNSTABLE ANGINA PATIENT BE IDENTIFIED?
VA Cooperative Study #28. Prepared by G.V.R.K. Sharma,
M.D., R. Deupree, Ph.D., H. Olson, M.D., N. Shadoff, M.D.,
S:-Scott, M.D., R. Luchi, M.D., S.F. Khuri, M.D., A.F.
Parisi, M.D. West Roxbury VAKC, Harvard Medical School,
Boston and the Coordinating Center, West Haven, CT.
To identify the high-risk patients (pts) with unstable
angina (UA) and evaluate their response to treatment, 468
pts were randomized to medical therapy (M), or coronary
bypass surgery (S) in a multicenter, prospective study.
Pts with left main coronary disease were excluded. Based
on clinical presentation pts were stratified into Type I
or Type II: those with accelerated exertional angina (IA);
rest angina complicating exertional angina (IB); severe,
recent onset angina (IC); prolonged (>15') rest angina
with STf or Tf on EKG (II). The strata were identical when
clinical (age, sex, risk factor) and angiographic profiles
(number of vessels involved, left ventricular function
(LVF» were compared. Mortality rates at 2 yrs:
Type Mortality
REOPERATION FOR CORONARY ARTERY DISEASE.
Robert J. Hall, M.D'
f5
F.A.C.C., MacArthur A. Elayda, M.D.,
Albert G. Gray, Ph.D, enton A. Cooley, M.D., F.A.C.C., Clayton
Foundation for Research-St. Luke's Episcopal Hospital, and Texas
Heart Institute, Houston, Texas.
To determine the operative mortality and long term results in pts
undergoing coronary ortery bypass reoperation (CABR) for recur-
rent angina pectoris, we reviewed the results of our institutions'
15 yrs experience. There were 1607 pts who underwent CABR
from 1970-84. Of these, 958 had their initial CAB (CAB!) and
CABR in our institution; 649 had their CABI elsewhere. Only the
results of 958 pts are included in this study. Three angiographic
indication groups were identified; I) graft failure (GF), 17%; 2)
progression of coronary atherosclerosis (PCA), 34%; and 3) combi-
nation of GF and PCA, 49%. Grafts per pt increased from 1.9 per
pt at CABI to 2.7 at CABR. Bypasses performed were single in
117 (12.2%); double, 345 (36.0%); triple, 365 (38.1 %); quadruple
or more in 131 (13.7%). Early mortality (EM) was 9.2% (88/958).
This was higher compared to the 2.8% (860/30,464) of the total
institutions experience on pts undergoing CAB alone for the same
time period. Major causes of EM were cardiac in origin in 80%
and non-eardiac in 20%. EM for men was 8.7% (74/847) and 12.6%
(14/111) in women. EM according to age, except for men in the
5th decade and women in the 6th decade, increased progressively
with age. 57% of pts had history of MI before CABI while 145 had
MI prior to CABR. At follow-up, angina was relieved or improved
in 75%. Actuarial survival revealed a 5 yr survival (YS) of 80%
or an average annual attrition rate of 4% and a 10 YS of 58% or
an annual attrition of 4.2%. These survival rates are low com-
pared to the 5 and 10 YS of 90% and 73% noted in our total
institution CAB pts. These data reveoled that CABR has a higher
EM compared to those pts undergoing CAB for the first time, and
good long term symptomatic relief and long term survival can be
achieved by CABR in pts who have recurrent angina after CABI
despite the higher risks involved at CABR.
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Coronary Artery Surgery-II
IMPRJI1ED SURVIVAL WITH~ BYPASS SU1lGERY IN PA-
TIl!N1'S WITH SEVERE CI:lR:NAR! ARl.'ERY DISEASE: A MPllOIBD
CASE CXJlrR:)L STtDY IN PATIl!N1'S WITH POl'IiNl'IALLY cea-
ABIE DISEASE ~_ if~, !Ill William S wein-
traub, MO, ~I.J.ayQTlUeIn, rIl, FAa:l Ricky M
SChneider, - !Il, FAa:l Paul A seelaus, BSl Grant vs
Parr, MO, FNXI Gerald LellD1e, MO, FAa:l Jai B
JlI:/arwal, !Il, FAa:l and Richard H He1fant, !Il, FAa:.
Wd-AUantic Heart and Vascular Institute,
Presbyterian- Univ of Pa Medical center, Phila, Pa.
Recent studies suggest that patients with 3 vessel
coronary artery disease (CAD) and abooIIDa1 LV f\n::tion
have better survival rates with bypass surgery 0CIll-
pared to medical therapy alone. By exc1udin,} cross-
overs between groups, case control studies may give
very accurate survival estimates. To be valid, tDliev-
er, selection biases IlIJSt be taken into i!alOUI1t.
'1'tlus, a matd1ed case control mettrJd was used to oom-
pare survival patterns in medically and surgically
treated patients with CAD duri!)3 the 1980's. Patients
with both stable and unstable CAD were entered into a
OCI\tlUterized data base and followed for up to 5 years.
F1tlII this data base, 52 medical patients with P'ten-
tially operable CAD and 45 surgical patients were
matched fur significant 3 vessel disease and abmIlllll1
LV function. '!be medical and surgical greJUPS had \l)
siqnificant differeooes with regard to 21 selected
variables inc1udin,} age (64+8 vs. 63+10), chest pain
type, synptxns and signs of "Oonqestivi" heart failure,
use of cardiac medications, ejection fraction (36+8%
vs. 37+9%), seqnental wall score, a CAD score evaluie-
;~ leSion site and severity or OOIlDrbid diseases such
as hypertension, diabetes, chronic lung disease or
peri~ral vascular disease. 'J.b)se ~tients undergoin:]
coronary~ grafti!)3 had a consIderably improved 4
year survIval CXlIl{)i!red to the medical group (88% vs.
54% and p=.03). In cxxx:1usion, this study used an ef-
fective case control metOOd to suggest that coronary
surgery iDproves progoosis substantially in t:roee pa-
tients with severe CAD and LV dysfunction.
D~ OF SURVIVAL AND ANGINA REOJRRENCE AFl'ER
MYOCARDIAL REVASCULARIZATIOO FOR COOGESTIVE HEARl'
FAIUJRE WITH ANGINA
Richard J. Shemin MD FJ\CC, Anne C. O'Neil BA, Verdi J.
Disesa MD, Lawrence H. Cohn MD FACe, John J. Collins,
Jr. MD FJ\CC, Brigham and waren's Hospital, Boston, MA
The long term benefit of coronary artery bypass
surgery (C'ABG) was studied in 308 patients operated
upon for predaninant congestive heart failure (CHF)
with angina, fran the registry of 3,669 patients
undergoing C'ABG fran 1970-83. 26 clinical, angio-
graphic and operative variables were analyzed as pre-
dictors of survival and recurrent angina using a Cox
multivariate mXlel. Operative mortality was 13% (5%
elective, 44% emergency) • Multivariate predictors for
operative death were operative circumstances, need for
an intra-aortic balloon, ejection fraction (EF), sex,
nl.1lltler of vessels bypassed and left ventricular hyper-
trophy. '!be 5 and 8 year (y) survival of operative
survivors was 68% and 53%. Multivariate predictors for
late survival were EF, nl.1lltler of diseased vessels and
postop CHF. 'lhree vessel disease and EF<40 had a 5 & 8
y survival of 59% and 40% vs. 79% and 66% in patients
with ~40. Multivariate predictors for angina re-
currence were number of diseased vessels, sex and
age. The probability of bein,} free fran angina was 71%
(2 y), 57% (5 y), and 45% (8 y). At a mean postop
interval of 4.5 y, 66% of patients were free of CHF.
Although elective C'ABG has a higher operative mortal-
ity risk in patients with CHF, long term angina relief
is similar to that for patients without CHF. Irrprove-
ment in CHF was maintained for up to 5 y in more than
half of these patients.
tween PMI-VSD and hospital death was: 4,4, and 17 days in
Killip I-II; 30 days in Killip III-IV; and <2 days for
18 of 23 pts in shock. Five-year cumulative survival in
30-day survivors was 100% in group I, 54% in group 3 and
33% in group 4.
In conclusion: 1) in pts with shock following PMI-VSD,
only those operated within 48 hrs survived, 2) the poten-
tial for deterioration as seen in the medically treated
pts, plus the excellent surgical results in group 1 pts,
warrant early repair for all pts with PMI-VSD.
surcl1 ca repan u~ on surVlVa are sown e ow.
SurVlVa I at 1 month
GROUP if Kllll class
pts. I-II III-IV Shock
surger~
1. <4 h 11 2/2 1/1 4/8
2. 48h-14days 6 - 1/1 0/5
3. >14days 26 13/15 8/9 0/2
Total Surgery U 157I7 1000l ms
4. Medical Rx 33 3/6 3/4 0/23
Total All Pts 16 111123 13/1:J 4/38
Among medically-treated pts (Group 4), lnterval be-
PROGNOSIS OF VENTRICULAR SEPTAL DEFECT FOLLOWING ACUTE
MYOCARDIAL INFARCTION. Lemery R MD, Smith HC MD FACC,
Gersh BJ MD FACC, Giuliani ER MD FACC, Schaff HV MD FACC,
Mayo Clinic, Rochester, MN.
Short-term (one month) and long-term survival were
determined in 76 patients (pts) with postmyocardial
infarction ventricular septal defects (PMI-VSD). Mean
age of 44 men and 32 women was 66 years. MI was anterior
in 40 pts and inferior in 36 pts. A history of previous
MI was present in 14% and of hypertension in 43%. One
month survival was 67% (29 of 43) among pts undergoing
surgical repair and 18% (6 of 33) among pts treated medi-
cally. Influence of hemodynamic status and timing of
. 1· . 1 h b 1Years of surgery 1969-73 1974-78 1979-83
Patients 505 1892 2463
Male sex (% ) 85 81 78
Mean age (years) 54 58 61
Hypertension (%) 24 31 48
Acute infarction (% ) <1 1 7
Abnormal wall motion (% ) 38 40 44
Mean number of grafts 1.8 2.3 2.7
Operative mortality (% ) 4.2 1.7 1.6
Follow-up (pt-centuries) 45 122 60
To determine the relationship between
survival and the time-frame of operation, our
coronary bypass surgery patients were divided
into 3 five-year cohorts:
CONTINUED IMPROVEMENT IN LATE SURVIVAL AFTER
CORONARY BYPASS SURGERY DURING 3 CONSECUTIVE
FIVE-YEAR PERIODS
A. Starr, M.D., F.A.C.C., G. L. Grunkemeier,
Ph.D. and S. H. Rahimtoola, M.B., F.A.C.C.
St. Vincent Hospital and Medical Center, Oregon
Health Sciences University, Portland, Oregon
Observed 5-year survival was 85% for the
first cohort and 89% for both of the last 2
cohorts. Relative 5-year survival, computed to
improve intergroup comparability by adjusting
for the changing age and sex distributions,
increased greatly from the first (92%) to the
second (100%) and slightly for the third
(102%). Thus, despite worsening patient risk
profiles, more extensive surgical procedures
and the use of coronary angioplasty for earlier
lesions, late survival following coronary
bypass surgery continues to improve.
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CLINICAL IMPLICATIONS OF LATE STENOSES IN SAPHENOUS VEIN
TO CORONARY BYPASS GRAFTS
Bruce W. Lytle, MD, FACC, Delos M. Cosgrove, MD, FACC,
Kirk Easley, MS, Norman Ratliff, MD, Floyd D. Loop, MD,
FACC The Cleveland Clinic Foundation, Cleveland, Ohio
From data concerning 501 patients who underwent serial
coronary arteriography, first within 5 yrs. of operation
for coronary bypass grafting (Study I) and again, more
than 5 yrs. after operation (Study II), 80 patients were
identified who had a stenotic (not totally occluded)
saphenous vein graft (SVG) at Study II and who did not
undergo immediate reoperation. In these 80 patients, a
total of 144 SVG were surveyed at Study II, of which 34
were angiographically normal, 17 were totallY occlUded
and 93 were stenotic; 56 had stenoses of <50~ and 37 had
stenoses of >50~. Repeat angiography (Study III for 36
patients at a mean interval of 40 mos. after Study II)
showed that of 42 stenotic grafts, 16 (38~) were totally
occlUded, 9 had progression of the stenosis, and 17 (40~)
remained at the same level of stenosis. Clinical follow-
up at a mean interval of 76 mos. after Study II(range
18-153 mos.) documented that 21 patients had died (mean
interval after Study II 36 mos.), 17 myocardial
infarctions had occurred (mean interval 37 mos.) and 22
patients had eventually undergone reoperation (mean
interval 49 mos.).Five-year event-free survival was 45~.
Thirty-two patients with stenotic SVG to the left
anterior descending (LAD) had 5-yr. event-free survival
of 32~ compared with 54~ for the rest of the group
(p=0.04). Multivariate testing confirmed the adverse
influence of a stenotic LAD graft on event-free survival,
whereas left ventriCUlar function and degree of vein
graft stenosis were not influential. Late SVG stenoses
are associated with a high rate of angiographic
progression and are predictors of future clinical events.
Patients with stenoses in SVG to the LAD are at
particularly high risk for clinical events.
THB ROLB OF BARLY GRAFT CHAJlGBS ATTRIBUTBD TO INTIMAL
FIBROUS HYPBRPLASIA IN LATB AORTOCORONARY SAPHENOUS
VEIN GRAFT CLOSURB
Simon Kouz, K.D., .!=L!l!u~c.!.ie~n!!........:c",am":""p""e,:"ai.!:!u""-:-,Ko.=.D~,=,,,---:F~....A~.C=.:.C....... ,
Jacques Lesperance, K.D., and Kartial G. Bourassa,
M.D., F.A.C.C., Montreal Heart Institute, Quebec,
Canada.
Graft modifications noted at one year were related to
late graft closure in a series of 144 patients who had
control angiographic examinations wi thin one month of
surgery, near one year, and between 2 and 14 years
(mean of S±5 years). Of the 224 patent grafts at one
year, 71 had no significant narrowing (3Z') and 153 had
lumen reduction varying from 20 to S~ when compared to
the earlier angiogram. The narrowing was diffuse in
lOS, focal in 16 or both in 29 and were attributed to
intimal fibrous hyperplasia. Graft closure after the
first year was observed in 47 of the 224 grafts (21~).
Grafts without narrowing had only 6 late occlusions
(S.5~) as compared to 41 for grafts showing lumen
reduction (27~) p<O.Ol. In 71 grafts having no
diffuse nor focal narrowings ~2~ closure rate was
S.5~, 23.6~ in Sl grafts having either diffuse or focal
20-35~ narrowings, and 33~ in 72 grafts having similar
narrowings >35~ (p<O.Ol). It is suspected that grafts
with slight to absent lumen reduction also have intimal
fibrosis which is not apparent on serial angiosrams.
Closure rate was hisher in grafts having significant
lumen reduction between 1 and 7.5 years as well as
between 7.5 and 14 years: 17.4~ versus 0 (all 31 srafts
without lumen reduction remained patent), and 34.5~
versus 15~ (p<0.05). These observations suggest that
minimizing early graft changes compatible with intimal
fibrous hyperplasia may retard late sraft closure.
Monday, March 10, 1986
2:00PM-3:30PM, Room #267
Effect of Loading Conditions on the Left Ventricle
NONINVASIVE ASSESSMENT OF THE LEFT VENTRICLE AS A
PULSATILE PUMP: EFFECTS OF INOTROPIC AND AFTERLOAD
CHALLENGES ON VENTRICULAR POWER
Kenneth M, Sorow, M,D" Alex Neumann, SanJeev G, Shroff, Ph,D,
Dina Janzen, The University of Chicago, Chicago, IL
Traditional indices of systemic arterial load IncludIng SVR
describe the heart as a non-pulsatile pump, This may lead to
underestimation of total LV load and energetics. Total LV power
(TP) incorporates both AO pressure (Pr) and flow variables and
therefore can be used as an Index of performance of the coupled
LV-arterIal system, TP can be divided Into: (1) steady power (SP)
which maintains forward blood flow and (2) oscIllatory power (OP)
which Is lost In pulsations of the arterial system, Although both
SP and OP affect LV energetics, only SP results In effective flow,
The efficiency of the LV-arterial coupling can be assessed as
OP/TP, Efficiency rises as this ratio decreases, We have recently
developed a noninvasive method of measuring LV power, AO blood
velocity (by continuous wave Doppler) and tim e-corrected
calibrated carotid pulse tracings were simultaneously recorded In
5 normal subjects, AO root size was measured by 20 echo and
blood flow calculated, Mean AoPr, CO, SVR, TP, SP, and OP were
determined, Data were acquired at baseline, during methoxamine
(M), dobutamlne (D), and M+D Infusions, Percent change from
baseline were (*p<,05i+P<.01):
AoPr CO SVR TP SP OP OP/TP
o -1- 17* ':IT 2'3* 18 46+ +1S*
M 33+ 5 28* 31* 40* -2 -24*
D+M 25+ 14* 11 40+ 43+ 33* -6
TP increased with all Interventions. Dobutamlne Increased CO,
OP, and OP/TP, Methoxamine Increased AoPr, SVR, and SP while
decreasing OP/TP, D+M resulted In the combination of these
effects with no change In OP/TP,
Thus, (1) TP Increased with afterload and inotropic challenges,
(2) dobutamlne wasted energy In the form of OP thus decreasing
efficiency, (3) the traditional Indices of arterial load Incompletely
assess LV performance as a pulsatile pump,
RELATION OF VARIOUS MEASURES OF END-SYSTOLE TO LEFT
VENTRICULAR MAXIMUM TIME-VARYING ELASTANCE IN MAlI.
Mark R. Starling, M.D., F.A.C,C" Richard A. Walsh, M.D.,
F.A.C.C., Louis J. Dell'Italia, M.D., John C. Lasher,
M.D., and Jack L. Lancaster, Ph.D., Univ. of TX Health
Science Center, San Antonio, TX
The rel ati on of vari ous end-systol ic pressure (P I-vol ume
(V) measures to left ventricular maximum time- varying
elastance (Emax) and extrapolated volume (Vo) at zero P in
man are unknown. Thus, 10 patients (7 no I'lna1 and 3 with
aortic regurgitation) without coronary artery disease were
studied with simultaneous high-fidelity P and biplane
cineangiographic (CINE) V with atrial pacing during
control (C), methoxamine (M) and nitroprusside (N)
infusion conditions. There was no significant difference
in mean heart rate or (+ )dP /dtmax between C. M and N.
Emax was defined as the maximum 1inear relation between
instantaneous P vs V points at comparable times during C,
M and N using frame-by-frame analysis. The slopes, m,
(IlIIIHg/ml, r=0.84-l.DD) and V values (ml) for the
end-systolic P-V relations Jlefined as the maximum
relationship of P vs V (maxPV), (-)dP/dtmax P vs V (-dP/
dtPV), P vs V at minimum V (minPV) and central aortic di-
crotic notch (Aodi) P vs V (AodiPV) compared to Emax are:
E.ax .aXPY (-)dP/dtPV .inPV + AodiPY +
m 5 61+1.74 3.67+1.32+ 2.80+1.38* 3.69+1.14 2.56+1.31
r (~s [max) 0:-90 0:-57 0:-92+ 0:-11
V 29+22 7+21+ 15+18 7+22 -2+34*o - - - -
*p<0.05 or +p<O.OI vs Emax
We conclude that (1) the slopes of the end-systol ic P-V
relations for these measures of end-systole underestimate
Emax. (2) the best correlations with Emax are seen for the
maxPV and minPV relations and (3) all Vo valuesunderestimate that at Emax.
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IS THERE A FUNDAMENTAL DIFFERENCE IN THE HYPERTROPHY
RESPONSE WHEN PRESSURE OVERLOAD IS PRESENT FROM BIRTH
RATHER THAN ACQUIRED LATER IN LIFE?
Michael E. Assey, M.D.,F.A.C.C. , James F. Spann, Jr.,
M.D., F.A.C.C., Paul C. Gillette, M.D., F.A.C.C.,
Blase A. Carabello, M.D., F.A.C.C., Medical University
of South Carolina, Charleston, S.C.
Severe childhood aortic stenosis (AS) is associated
w1th "excessive" hypertrophy with resultant low wall
stress and high pump performance, while in the adult
these parameters are usually normal. We wondered
if this reflected a fundamental difference in the
hypertrophy (H) response to a pressure overload (P)
present from birth rather than one acquired later in
life. If a fundamental difference exists, one would
expect the childhood pattern to persist with advancing
age. To test this hypothesis, we examined ventricular
mechanics in 8 children of varying ages (4-19 yrs)
with severe AS and in 5 normal
children. When compared with
normal, AS had significantly
reduced wall stress (63±10 vs ~••
122±25, P <.01) and increased :
ejection fraction (.77±.04 vs 150 •
h3±.03, P <.05). There was no ~ •
direct statistical relationship ~
between age and wall stress.
There was a significant inverse
correlation (r=.60, p<.Ol) be-
tween pressure and wall stress,
regardless of age (Fig. 1).
These data support the hypothesis that there may be
a fundamental d1fference in the hypertrophy response
when the pressure overload is present from birth rather
than acquired later in life.
(P/V)max= 1.31x(ADNP/ESV)+0.08. (s.e.e.=0.21)
ACCURATE ESTIMATES OF MAXIMUM LV PRESSURE-VOLUME RATIO
CAN BE OBTAINED FROM PERIPHERAL DICROTIC NOTCH PRESSURE
AND END SYSTOLIC VOLUME
The maximum value of the ratio of left ventricular (LV)
pressure to volume, (P/V)max, useful In assessing the LV
contractile state, Is sometimes estimated by diViding
perIpheral arterial dicrotic notch pressure (ADNP) by ena
systolic volume (ESV) obtained from nuclear angiography
or echocardlography. In order to determine the accuracy
of such estimates, we compared sImultaneously measured
values of (ADNP/ESV) and (P/V)max In 27 patIents (wIth
normal valvular function) during the first 24 hours
following coronary artery bypass graft surgery. LV
volumes were assessed by computer-aided analysis of
radiographic Images of minute tantalum Intramyocardial
markers Inserted at operation, so as to ouline The LV In
the 30 degree RAO proJection. LV and peripheral arterial
pressures were measured by mlcromanometer-tlpped
catheters. LV pressure-volume diagrams were generated for
a total of 208 three-beat sequences under different
loading and InotropIc conditIons. Linear regression
analysis showed that values of (P/V)max and (ADNP/ESV)
correlated highly (r=0.96). The regression equatIon was
We conclude that a useful estimate of (P/V)max can be
obtained In patients without valvular lesions using the
ratio of peripheral arterial dIcrotIc notch pressure and
end systolic volume.
George T. Dayghters. M.S., Carol W. Mead, B.S., Edwin
L. Alderman, M.D., F.A.C.C., Geraldine C. Derby, R.N.,
Anne Schwarzkopf, B.S., D. Craig Miller, M.D., F.A.C.C.
Palo Alto Medical Foundation, Palo Alto, CA
SYSTEMIC VASCULAR RESISTANCE: AN UNRELIABLE INDEX OF LEFT
VENTRICULAR AFTERLOAD
Kenneth M. Borow, M.D., Roberto Lang, M.D., Alex Neumann,
Dina janzen, Dianne Altman, The Univ of Chicago, Chicago, IL
System ic Yascualr resistance (SVR) is a frequently used clinical
Index of LV afterload. However, SVR reflects peripheral
arteriolar tone rather than ventricular fiber force. In contrast, LV
end-systolic (ES) wall stress (0) has been shown to accurately
measure LV fiber load. It has been previously assumed that
changes In afterload would result in comparable changes In SVR
and 0ES' To study this question, 8 dogs were Instrumented with
central AO microtlp and PA catheters. LV wall thlckness(WT) and
dlmenslons(D) were measured from 20- targeted m-mode echo.
AO m ean(m), RA and LVES pressures, and cardiac output were
recorded. SVR and 0ES were determined under control (C)
conditions and during 5 IC/kg/mln of dobutamlne(DB) and 0.1
IC/kg/mln of norepinephrine(NE). There were no dlfferences( ll) in
COB and C NE data. Load Independent ES Indices of contractility
showed DB and NE to be equally potent positive inotropes.
%ll(DB) p-Value %ll(NE) p-Value
AO mean BP +20 <.05 +35 <.001
CO +39 <.001 +11 <.05
ES Pressure +22 <.01 +34 <.01
ES Dimension -18 <.001 -12 <.01
ES Thickness +18 <.001 +15 <.001
SVR -13 <.01 +24 <.001
0ES -25 <.01 -8 0.12
For both drugs, ES dimension decreased and ES wall thickness
increased counter-balancing the Increase In ES pressure. Thus, ES
wall stress fell. In contrast, SVR Increased significantly with NE
and decreased with DB.
Thus, (1) Discordant changes In LV afterload (I.e. ES wall
stress) and SVR occur. [2] SVR is an unreliable Index of afterload
reflecting peripheral arteriolar tone rather than LV systolic wall
force. (3) At the Infusion rates used in this study, DB and NE have
similar positive Inotropic effects.
LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTION DURING
THE GRADUAL DEVELOPMENT OF PRESSURE OVERLOAD HYPERTROPHY.
Peter K Hoshino, MD, Michael R Zlle, MD, Alvin S
Blaustein, MD, William H Gaasch, MD FACC. Tufts Univ and
VA Medical Center, Boston KA
To characterize the relation between LV systolic func-
tion and diastolic stiffness during the gradual develop-
ment of pressure overload hypertrophy (POR), echo and cath
data were obtained during the year follOWing the applica-
tion of aortic bands in 13 puppies. Development of LV
pump failure (F) in 6 was manifest by decreased endocard-
ial fractional shortening ~FSe,%) and increased end diast-
olic (ed) pressure (P) (26-6 mm Hg) at 12 mo; 7 remained
compens~ted (C) ~t 12 mo (normal FSe & edP). Systolic+
P(F:2~3-32,C:236-24mm Hg;p-NS) and LV/body wt (F:9.8-0.9,
C:8.3-0.5 gm/kg; p-NS) were Similar in the two groups.
Midwall systolic stress (KWo,gm/cm2), shortening (FSe,%)
and an index of ed chamber stiffness (CSed,mmHg/cm) were
derived from dimension (~,mm), wall thickness (T,mm) and
P (mmHg). Data are mean - SEM. *-p(0.05{F vs C),
#=p(0.05(12 vs 6 mo), c=p(0.05(vs normal).
COMPENSATED FAILURE
NO~L 6+mo 12+mo 6+mo 12+mo
Ded 38;1 33;2 37;3 36;2 41;1
Ted 7.2;1 9.7-1C 12.3;1,c 11.8;.4C 13.0;.6~
FSe 39-1 39!4 42-3 36-4 29-2*e
MWo 256++-25 323!42 254!25 318!34 371!46*e
CSed 2.0-0.3 3.7!0.3e 3.3!0.6 4.5!0.9~ 6.4!1.5c.
After an early (6 mo) tendency to increase, both MWo
and CSed fell in C but continued to increase in F. Thus,
the inability to adapt to pressure overload is manifest by
an increased MWo and decreased FSe (afterload excess) that
clOSely correlates with a rise in diastolic chamber stiff-
ness (independent of changes in Ded, T and mass). This may
indicate a change in myocardial properties that affects
both systolic function and intrinsic muscle stiffness.
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Developmental Cardiovascular Studies
AGE-RELATED EFFECTS OF CHRONIC HYPOXIA ON CARDIAC ELECTRO-
PHYSIOLOGICAL FUNCTION. Michael L. Epstein,M.D.,F.A.C.C.,
Stephen P. Baker,Ph.D.,Philip Posner,Ph.D., University of
Flordia, Gainesville, Florida.
We have previously reported, in a 12 week old rabbit
model, changes in cardiac electrophysiological (EP) func-
tion induced by chronic hypoxia. To determine "'ether
these changes are secondary to the duration of hypoxia, we
examined the effect of chronic hypoxia on EP function in
younger animals raised in an hypoxic environment.
Eight week old rabbits raised either in normoxia (N) or
hypoxia (M) were anesthetized and mechanically ventilated.
An intracardiac electrode catheter was used to record the
atrial and ventricular electrogram along with a surface
ECG. Pacing was performed using a pair of teflon-coated
stainless steel wires sutured directly to the RA. The
pacing protocol included rapid atrial pacing as well as
introduction of progressively premature stimuli into a
paced rhythm. Data are presented in milliseconds and are
compared as mean + standard error of the mean. Signifi-
cance was set at P<O.OS.
Unlike the differences found between N and H animals at
12 weeks of age, no significant differences were found in
the control cycle length (CL), corrected pacemaker re-
covery time (CPRT), atrial effective or functional refrac-
tory periods (AERP,AFRP), or atrioventricular nodal (AVN)
ERP in the 8 week old animals.
CL CPRT AERP AVNERP
N 82 + 11.6 119 + 2.2 95 + .4 22 + 7.9
H 42 + 30.1 115 + 6.0 88 +7.0 103 + 6.1 132 + 7.0
Chronic hypoxia did result in a-significant dif erence in
the AVN FRP at this age (N-lSS + 3.4 vs. H-172 + 6.0).
These data indicate that, in this model, the diuration of
chronic hypoxia is an important factor in causing changes
in cardiac EP function.
DEVELOPMENTAL CHANGES IN DOSE AND PLASMA CONCENTRATION OF
LIDOCAINE AND QUINIDINE. Yoshiyuki Morikawa, M.D., Allan
Hordof, M.D., F.A.C.C., Tove Rosen, M.D., Michael Rosen,
M.D., F.A.C.C., Columbia University, New York.
We previously have shown that in intact dogs lidocaine (L)
induces greater use-dependent block of intraventricular
conduction in the young than the adult, whereas for quini-
dine (Q), block is equivalent. Here, we report that devel-
opmental differences in drug metabolism also contribute to
the age-related changes in effects on conduction. We
studied 6 adult and 6 10-week old dogs anesthetized with
pentobarbital. L was given as IV injections of 3, 6, and 9
mg/kg, followed respectively by infusions of 6, 12, and 18
ug/kg/hr. Q was given as an infusion of 20 mg/kg/hr. The
range of total plasma L concentrations [L] = 2.2 - 19.3
ug/ml. Free [L] were measured using a millipore system,
and the ratio free/total plasma [L] was determined. The
regression line for the adults (slope=.63, r=.96) > the
young (slope=.30, r=.77) (p<.005). This suggests greater
protein binding of L in the young and greater availability
of free L at any total plasma [L] in the adult. In con-
trast, there was no age-related difference in the plasma
free/total [Q] over a plasma [Q) range of 2-16 ug/ml. We
also related the total plasma concentration of drug to the
dose given. For each of the three L dosage schedules, the
adult plasma [L] > young [L]. In contrast, there was no
difference in the plasma [Q] in adult and young. In sum,
the ratio of dose to plasma concentration, and the parti-
tion of total/free plasma [L] favors higher free drug
levels in the adult. This could explain the greater effect
of L on conduction in the adult heart. The ratios for Q
are equivalent at both ages, consistent with an equivalent
effect of Q on conduction. Hence, differences in Land Q
metabolism help explain the developmental differences
seen in the effects of both drugs on conduction.
ELECTROPHYSIOLOGIC AND HEMODYNAMIC EFFECTS OF BETHANIDINE
SULFATE ON THE IMMATURE MAMMALIAN HEART
Anne Fournier MD, Ming-Lon Young MD, Adrienne Stolfi,
Henry Gelband MD, Arthur S. Pickoff MD, University of
Miami, Miami, Florida.
Bethanidine sulfate (B), a type I I I antiarrhythmic agent
has proven antifibrillatory effects. B actions on tissue
other than the ventricle or on the immature heart are
unknown. Utilizing standard intracardiac recording and
stimulation techniques, the cumulative electrophysiologic
and hemodynamic effects of B (2.5, 5, 10 and 15 mg/kg IV)
were studied in 10 canine neonates (age: 5-14 days).
Heart rate (HR) increased significantly after the 1st
dose (mean (m): 165 to 188, p<O.OOI) and remained elevated
after doses2 and 3. The msystolic blood pressure (BP)
increased from 54 to 88 mmHg after the 1st dose (p<O.OOI)
and remained elevated after all doses. PA, AH. HV. PR
intervals andsinus node function did not change. A
significant increase was observed in the atrial effective
(AERP) and functional (AFRP) refractory periods (RP)
following eachdose. The total increase in mAERP was
from 66 to 154 msec. while the mAFRP increased from 108
to 190 msec, p<O.OOI. B enhanced atrioventricular nodal
(AVN) function as evidenced by Wenckebach periodicity
occuring at a lower cycle length and AVN RP becoming
atrial limited. The RP of the ventricle did not change.
In summary. in the neonatal canine heart. B enhances AVN
conduction, increases HR and BP which may be due to
catecholamine release. Most importantly, like other type
III agents, B results in a significant prolongation of
atrial refractoriness, and thus may be useful agent in
treating atrial arrhythmias in the neonate.
FUNCTIONAL AND STRUCTURAL CHANGES IN EMBRYONIC MYOCARDIUM
IN A MODEL OF CHRONIC ALCOHOLISM
Roger N. Ruckman, M.D., F.A.C.C., Susan A. O'Brien, B.A.,
Donna J. Messersmith, B.S., and Dennis E. Morse, Ph.D.,
Department of Cardiology, Children's Hospital National
Medical Center, Washington, D.C.
To investigate functional and ultrastructural changes
resulting from chronic exposure to ethanol, chick embryos
were injected with one of seven graded doses of ethanol
or saline (shams) just prior to incubation, and at 24,
48, 72, and 96 hours post incubation. Cinephotoanalysis
was performed on Day 3 at 71 and 73 hours (H-H Stage 19)
and on Day 4 at 95 and 97 hours (H-H Stage 22) post incu-
bation. Heart rate (HR) and shortening fraction (SF) were
measured from the films. Additional embryos sacrificed at
corresponding times were analyzed by electron microscopy.
On Day 3, embryos injected with ethanol doses L0375
ml showed a significant increase in HR as compared to
shams (p <. .05). There was an overall increase in mortal-
ity over time, with the largest increases among those em-
bryos injected with ~ .05 ml ethanol. Among survivors on
Day 4, HR showed a plateau with no statistically signifi-
cant change with increasing dose. In contrast on Day 3,
SF, an index of cardiac contractility, decreased with in-
creasing dose. On Day 4, however, SF increased with dose
as compared to shams. Electron micrographs demonstrated
swelling of mitochondria and margination of nuclear chro-
matin with increasing dose. However, at all but the
highest dose, myofibrils were preserved, which may account
for the ability of the embryonic heart to maintain or
improve SF.
These data suggest that on Day 3 the embryo's de-
fense against chronic ethanol injury is to increase HR to
maintain cardiac output while later in development, on Day
4, survival of the embryo depends on its ability to in-
crease cardiac contractility.
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A REVERSIBLE PULMONARY ARTERY BAND.
AP Rocchini, MD, SR Gundry, MD, RH Beekman, MD, FACC,
KP Gallagher, PhD, OM Behrendt, MD, .FACC, RC Dysko, MD,
K Rosen, MD. C.S. Mott Hosp., Univ. of MiChigan, Ann Arbor
Pulmonary artery banding (PAB) has become an infrequently
used surgical technique; however, if a PAB were developed
that could be relieved without the need for open heart surgery,
we believed that PAB would be used more frequently in the
management of infants with congenital heart disease (CHO).
We placed such a PAB in seven I-week old mongrel puppies
by using 4 loops of an absorbable suture material (either PDS
or Vlcryl). One dog died at 2 months due to right ventricular
(RV) failure. The remaining dogs underwent cardiac
catheterization and pulmonary balloon angioplasty at 6 months
of age. After measuring PA, RV and aortic pressures (P) and
performing a RV angiogram, balloon angloplasty of the PAB
site was performed in the 5 puppies with significant PA
stenosis. A 20 mm balloon angioplasty catheter (Medi-Tech)
was used in all dogs. Balloon angloplasty decreased RVP from
101+44 to 42+8 mmHg p<.05, PA to RV systolic gradient from
59+31 to 7+5-mmHg p<.05, and increased the size of the PAB
site from 10+3 to 18+1 mm p<.05. All dogs were recatheterized
2 months pOst balloon angioplasty and then sacrificed. At
follow-up catheterization RVP was 51~:.5 mmHg, PA to RV
gradient was 7+5 mmHg and PAB site angiographlcally measured
18+2 mm. At -postmortem examination, there was no evidence
of-either the band material or PA damage, and the ratio of
PAB site to aorta was .88+.05. Although these studies are
preliminary, they do suggest that a reversible PAB can be
performed. We believe that such a PAB will be used In the
future to treat children with CHO.
Monday, March 10, 1986
2:00PM-3:30PM, Room #268
Electrical Stimulation and Arrhythmias-Basic
Studies
THE THERMAL RESPONSE OF VENTRICULAR ENDOCARDIUM TO LASER
AND ELECTRICAL ABLATION AND THE DISPARATE EFFECTS OF
DIFFERENT SUPERFUSION MEDIA.
Benjamin I. Lee, M.D., F.A.C.C.; Aldo Notargiacomo, B.S.;
Ross D. Fletcher, M.D., F.A.C.C.; E. Rene Rodriguez, M.D.;
Victor J. Ferrans, M.D.; Yi-Wang Chen, M.D. VA and
Georgetown Medical Centers, and N.H.L.B.I., Washington,
D.C. and Bethesda, Md.
Transcatheter delivered laser and electrical energy pro-
duces discrete ablation of ventricular endocardium (EN)
and may be used to destroy arrhythmogenic foci. To charac-
terize the thermal response (TR) of EN to laser discharge
(LD) and electrical shock (ES), and determine the effect of
different superfusing media on TR and extent of tissue
injury, 57 Nd:YAG LD of 40J and 14 cathodal ES of 200J
each were delivered to EN superfused with either whole
blood (WE) or normal saline (NS). Tissue temperatures were
measured 2mm from the point of contact of the laser fiber
or electrode tip to EN. LD produced greater peak tissue
temperature elevations in WE (30.ltl.9°C) than in NS (14.7
±1.aOC) (p<.OOI) and slower tissue cooling. Resulting EN
lesions were larger in WE than in NS (diameter: 3.25tO.22mm
vs 1.4±a.lmm; p<.OOI). Tissue temperatures also rose after
ES, however, the magnitude of the increase was smaller than
that after LD (p<.OOI). Unlike LD, peak tissue temperatures
and rates of tissue cooling after ES were similar despite
superfusion with WB or NS (15t4.7°CvsI4.8t3.1°C; p=NS).
In conclusion: 1) Thermal mechanisms play an important
role in laser and ES-induced tissue injury, however the
degree of thermal injury is greater with laser than with
ES ablation. 2) The composition of the surrounding fluid
medium influences the thermal effects of LD to a greater
extent than those of ES.
In addition, early afterdepolar1zations, at times
leading to the propagation of extrasystoles, were
cOlllllOn1y seen.
Conclusions: 1) Abnormalities in impulse conduction
and refractoriness as well as afterdepolarizations are
present in a large border zone around the ablation
site following high energy ablation. 2) These
abnormal electrophys10log1c propert1es may provide an
appropriate substrate for arrhythmias.
lBIIOIlUL IIIPULSE COIIlUCTIOII AID IIITI&TIOII AlE PIESEIT
II 1 L1IIGE BORDER ZOIIE AFTER HIGH EIIEIIGY ABUTIOII
Joseph !h Levine, M.D., Joseph F. Spear, Ph.D.,
F.A.C.C., Harlan F. Weisman, M.D., Charles Prood,
H.S., Alan A. Kadish, H.D., Cees de Langen, Ph.D.,E.
Neil Hoore, Ph.D, D.V.M., F.A.C.C., University of
Pennsyl vania, Philadelphia, PA.
Arrhythmias may develop following high energy ablation
in animals and man. To deter.ine the possible
mechanisms of this proarrhythm1c effect, 13 epicardial
t1ssues underwent ablation 1n vitro w1th 5-40 joules
via a 1mm diameter cathode and i.pulse conduction and
action potential characterist1cs were studied.
Results: Abnormalities in conduction velocity (CV)
and action potential duration (APD) were noted in a
border zone greater than 10mm x 10.m around the
ablation site. Heterogeneity of APD also developed
(coefficient of variation (cov) =SD/mean).
ECHO DOPPLER COLOR FLOW MAPPING STUDIES FOR ELUCIDATION
OF CARDIOVASCULAR ANATOMY AND PHYSIOLOGY IN THE H1lHAN
FETUS. David J. Sahn, M.D., F.A.C.C., Sandra Hagen-
Ansert, R.D.M.S., Univ of Calif, San Diego, CA.
We have performed fetal color flow mapping Doppler exam-
inations on 15 pregnant women between 16 and 28 weeks
gestation, all referred for fetal echo because of a major
congenital heart malformation in a previous child. All
fetuses underwent an anatomical cardiac evaluation with a
5KHz, 128 element dynamically focused large aperature
scanner (Acuson) and then had Doppler flow mapping and
spectral Doppler performed using a 3.5KHz flow mapping
scanner (Irex-Aloka). Especially using low gains to opti-
mize lateral and elevational resolution for the flow sig-
nals, unique observations were possible with this new
modality of imaging. In 13 fetuses, the phasic patterns
of flow and real-time flow diameter of the flow across
the foramen ovale from the right to the left atrium could
be recorded. The diameter of the foramen flow was 76f13
(SD)% of the aortic diameter and the peak diastolic
velocity was 41f12 cm/sec. The flow diameters of the
pulmonary artery and the aorta could also be determined
in 14 and 13 fetuses, respectively and in 9, the entire
aortic arch and flow within it was imaged. In 11 fetu-
ses, the "ductal arch" (PA to PDA to descending aorta)
was imaged. Ductal flow diameter was 85fll % of the
aortic root inner diameter. In one fetus referred for a
family history of ventricular septal defect (VSD), a 3mm
large mid muscular VSD was imaged anatomically and on the
flow image, a low velocity early systolic left ventricu-
lar to right ventricular shunt was imaged across it. Our
study prOVides, for the first time, normal data for fora-
men ovale and ductal flow in fetuses. Color flow mapping
Doppler while not yet optimized for fetal cardiac imaging
appears to allow new aspects of the fetal cardiovascular
physiology to be defined noninvasively.
CV (HIS)
control 0.40+0.17
post-shock 0.18+0.14
p<0.001
APD (msec)
193.1+211.7
147.3+31.8
p<0.001
APD-COV (J)
4.0+2.5
18.2+11.0
p<0.001
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RECOVERY OF ACTION POTENTIAL AND CONDUCTION AFTER
FULGURATION OF SHEEP PURKINJE AND VENTRICULAR MYOCARDIAL
FIBERS WITH LOW-ENERGY SHOCKS.
Gilles Lascault, MD, Gerald Nassif, MD, Frederic
Fillette, MD, Yves Grosgogeat, MD, FACC.
CHU Pitie-Salpetriere, Paris, France.
The effects of fulguration or catheter-ablation on
the electrophysiological properties of the conduction
system and myocardium have to be further elucidated. In
this study, we examined the recovery of the electrophys-
iological properties of sheep Purkinje and ventricular
myocardial fibers after resistive shocks (RS) of 2.6
Joules.
After these RS, the resting potential (RP) of cells
located 5 millimeters away from the shock zone was
greatly depressed to - 30 to - 50 mY. Return to normal RP
was progressive and followed an exponential kinetics.
Recovery of conduction was always observed at these shock
energies. Whenever conduction resumed the distal action
potential (DAP) always exhibited a two-component wave-
form. The first component was characteristic of a prepo-
tential which suggested an electrotonic type of response.
Later on, the DAP returned to a normal pattern with rapid
but progressive disappearance of the prepotential.
In conclusion : 1) low-energy RS induce significant
but reversible electrophysiological effects, 2) recovery
of RP is an exponential phenomenon, 3) conduction blocks
secondary to low-energy RS may result from the creation
of an inexcitable segment of tissue allowing an electro-
tonically-mediated conduction before full recovery of
conduction.
A DECLINE IN THE VENTRICULAR FIBRILLATION
THRESHOLD FOLLOWING SUCCESSIVE PREMATURE
EXTRASTIMULI: A MECHANISM FOR INDUCED
"ART IFACTUAL" TACHYARRHYTHMIAS?
Eli S. Gang, MO, FACC, Hrayr Karagueuzian, PhD,
Malte Meesmann, MD, Avile McCullen, William J.
Mandel, MD, FACC, Thomas Peter,MD, FACC,
Cedars-Sinai Medical Center, Los Angeles, CA.
It has been suggested that in some patients
the induction of ventricular fibrillation (VF)
with 3 or more programmed premature
extrastimuli reflects the intensity of the
stimulation protocol rather than an inherent
ventricular vulnerability. In order to test
whether the ventricular fibrillation threshold
(VFT) is progressively lowered during
programmed stimulation using an increasing
number of extrastimuli, we measured the VFT
during standard programmed stimulation (at
twice pacing threshold current) in 9 normal,
anesthetized, closed-chest dogs. The VFT was
measured 3 times in each dog: (a) the
fibrillating test pulse was placed following a
train of 8 paced (SI) beats (VFT-S2), (b)
following a single extrastimulus (VFT-S3), and
(c) after 2 extrastimuli (VFT-S4). Results:
VFT-S3 was 32% lower than VFT-S2 (16±7 rnA vs.
24±10 mA, p<0.005). Furthermore, VFT-S4 was
49% lower than VFt-S2 and significantly lower
than VFT-S3 (12±8 rnA vs. 16±7 rnA, p<0.05).
We conclude that during programmed
stimulation of the heart, the VFT is
progressively lowered by the addition of
multiple extrastimuli. This may account for
the induction of non-clinical VF, particularly
in patients with an already reduced VFT.
MODULATION OF SINUS NODE FUNCTION: ROLES OF HISTA-
MINE IN CARDIAC TRANSPLANT PATIENTS
Andrew E. Epstein, M.D., F.A.C.C., David C. McGiffin, M.D.,
James K. Kirklin, M.D., F.A.C.C., Basil I. Hirschowitz, M.D.,
Albert L. Waldo, M.D. F.A.C.C., UAB, Birmingham, Al
Both the native-innervated (ISN) and transplanted-denervated
(DSN) sinus nodes function after human cardiac transplantation,
providing an opportunity to study SN function simultaneously in
the presence and absence of autonomic innervation. Using
epicardial wire electrodes placed on the native RA cuff and the
donor RA, the responses to histamine (H, 25 mcg/kg/hr IV),
diphenhydramine (0, an HI blocker, 50-75 mg IV) and cimetidine
(C, an H2 blocker, 4 mg/kg IV) were studied in 8 patients to
determine the presence and role of HI and H2 receptors in the
SN. The ISN and DSN responded with similar percent changes in
cycle length (Cl) to H, D, C, and D+C together:
H D C D+C *e<0.05
ISN -16.9%* 0.0% 9.1% 3.6%
DSN -15.5%* 2.2% 3.8% 2.9%
C had both positive and negative chronotropic effects on the ISN
in different patients but had either none or a negative chronotro-
pic effect on the DSN. H had a positive chronotropic effect on
both the ISN (Cl -7.6%, p=0.002) and DSN (Cl -6.4%, p=0.005)
in the presence of C. However, compared to the baseline
response to H, C significantly blunted the response to H only for
the DSN. In the presence of 0, H did not significantly speed
either the DSN (Cl -10.8%, p=0.53) or the DSN (Cl -2.7%,
p=0.50). Conclusions: 1) C and D individually or together do not
significantly slow the sinus rate in either the ISN or DSN; 2) the
altered responses of the DSN to H in the presence of C or 0
demonstrates that both HI and H2 receptors modulate human SN
function; 3) contrary to prior suggestions, there clearly is an HI
receptor in the human SN, and; 4) the denervated transplanted
heart is a unique model to study SN function in the absence of
confounding autonomic nervous system influences.
B1IDOCAIDIAL CATllBTU ABLATIO. or YBliTlIClJLAIl IIDSCLB
IIDVa. AUlltTllMW: UDTJ.Y. ABKOIlMAL AUTOMATICITY.
AID ftIGGBUD ACTIVITY.
Richard Friedman, MD, Jeffrey P. Moak, MD, Arthur Garson,
Jr., MD, FACe, Texas Children's Hospital, Houston, Texas.
Endocardial catheter ablation (ECA) has been advocated
for elimination of medically refractory ventricular
tachyarrhythmias. Previous studies in dogs have
demonstrated the occurrence of ventricular tachycardia
(VT)t or VT and sudden death in the post-ablative period
(PAP). The purpose of our study was to assess the
immediate clinical and electrophysiologic (EP) effects of
various doses of DC electrical shocks (S) applied to the
RV apex (RVA) of puppies (p). Eight beagle P, 2.5-10 mo.
(median 8.5) and 3-1lkg, (median 9.5) were given S
delivered through the distal pole of a uscr tripolar
catheter Which served as the cathode. Each P received 1
S. Delivered energies were: 400J (3), 200J (4), 100J
(l). Six P had 24h of cont inuous ECG assessment before
and after ECA; 2P died after ECA: from ventricular
perforat ion 0) and low cardiac output 0), All 8P
developed VT immediately after ECA and of the 6 Who
lived, all had sustained VT in the 24h PAP. Cellular
action potential (AP) characteristics of ablated muscle
were studied 24h post-ECA. Results of each ablated P
were compared to values obtained from a matched area in
the RVA of 4 normals. Maximum diastolic potent ial was
less negative (p<0.03) maximum upstroke velocity
(V max) was lower- (p<0.05) and AP duration at 50%
repolarization (APD50) was longer (p<0.003 in 5/6, p=0.07
in 1/6) in ablated muscle. There were also islands of
cells with normal AP characteristics in ablated regions.
Evidence of reentry (REE) (2P), abnormal automaticity
(AA) (3P), and triggered activity (TA) (3P) were seen in
cells in ablated regions. We conclude: 0) ECA causes
arrhythmias in the immediate PAP due to REE, AA, or TA.
(2) ECA does not create a homogenous area of destruction
and may leave previously normal or abnormal cells in a
viable state.
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Fibrillation & Defibrillation-Animal Studies
CRITICAL MYOCARDIAL MASS FOR SPONTANEOUS DEFIBRILLATION:
EFFECT OF ACUTE ISCHEMIA AND REPERFUSION.
Alexandros C. Kralios, M.D., F.A.C.C. and Fany A. Kralios,
M.D., VAMC and Univ of Utah Medical Center Salt Lake
City, Utah.
To determine the critical mass (CM) of canine ven-
tricular myocardium able to defibrillate spontaneously
(SDF), chloralose anesthetized mongrel dogs 23-27 Kg
were placed on right or total cardiopulmonary bypass.
With mean systemic arterial pressure maintained at 8QmmHg,
electrophysiologically isolated, spontaneously beating
peninsulas with preserved vasculature were surgically
created. After fibrillation (VF) was induced in the
peninsula with 50Hz trains of 2ms stimuli, the edges
of the tissue were gradually trimmed until SDF occurred.
Repetitive inductions of VF lasting at least for 5 sec.
and followed consistantly by SDF within 30 sec. were
considered as criterion of CM. Subsequently the regional
artery of the peninsula was occluded for 3 min. periods
and VF inductions were attempted every 30 sec. throughout
the occlusion and reperfusion period. Results indicate
(1) CM was 21.9 ~ 2.5g (n=g) for RV and 23.6 ~ 2.6 g (n=4)
for LV peninsulas (2) Ischemia did not affect signifi-
cantly the latency of SDF (control 18.2 + 1.4 sec. vs.
ischemia 22.8 ~ 1.5 sec.) (3) Reperfusion delayed SDF
for up to 305 sec. (mean latency 200.3 + 40.5 sec, p< 0.05
sec). We conclude that for normally perfused myocardium
the CM is larger than anticipated, and is similar for
either ventricle although variable among animals. The
SDF is not affected by ischemia but is prolonged during
reperfusion. These findings suggest that the homogenous
perfusion of either control or ischemia favors SDF.
Sufficient disparity of perfusion and presumably
electrophysiologic properties necessary for sustained VF
develop only during reperfusion.
MECHANISMS OF FAILURE OF DEFIBRILLATION
Nitaro Shibata, MD, Peng-Sheng Chen, MD, Ellen G Dixon, MS,
Patrick Wolf, BS, Ned D. Danieley, MS, William M Smith, PhD, and
Raymond E Ideker, MD,PhD. Duke Univ Med. Ctr , Durham, NC
To see how shocks fail to halt ventricular fibrillation (VF), 41 shocks
were given in 7 open-chest dogs during electrically induced VF, whIle
epicardial recordings were made simultaneously from 56 electrodes
evenly spaced over both ventricles Unsuccessful shocks (0.01 to 5 J)
were given via electrodes on the LV apex and RA, an electrode
configuratIOn shown to create an uneven shock field with much
higher potential gradients (PGs) m the apical half (APEX) than m
the basal half (BASE) of the ventricles. Early sites, defined as an
electrode activatIOn time surrounded by later electrode activation
times, were identified in maps of the immediate postshock period.
Shock energy Mean No. of Mean time (ms) from shock
groups (J) early sites to activation at earliest site
APEX BASE APEX BASE
A: 0.01-0.05 1.9 3.8* 21 14*
B: 0.1-0.5 0.8 3.4* 39 19*
C: 1.0-5 0.0 3.1* 37
*= p<0.05 with number to left
Early sites activatmg :S 25 ms postshock suggest failure to halt VF.
We have shown with mtramural recordmgs that early sites activatmg
> 25 ms postshock indicate that VF is halted and is then relllltlated
by an activation front arising de novo at that site Most PGs at
both the BASE and APEX for Group A shocks and at the BASE for
Group B shocks were too weak to halt VF Higher PGs at the APEX
for Group B shocks and at the BASE for Group C shocks halted VF
in that region but then reillltiated It Still higher PGs at the APEX
for Group C shocks halted VF without remltlatmg It m that regIOn
Thus, PGs generated by defibrillation shocks have at least 3 different
effects (1) Low PGs fail to halt VF, (2) Higher PGs halt but then
remltlate VF; (3) Still higher PGs halt VF without remltlatmg It
Successful defibrillation reqUires a shock strong enough to achieve
this third condition throughout the ventricles
QUANTITATED DEPLETION AND REPLETION OF BODY POTASSIUM
AND VENTRICULAR FIBRILLATION
Brian McGovern, M.B., Nicolaos E. Madias, M.D., Jeremy N.
Ruskin, M.D., F.A.C.C., Vincent J. Canzanello, M.D.,
John T. Harrington, M.D., Hasan Garan, M.D. Massachusetts
General Hospital, Boston, MA +
The influence of isolated body potassium (K ) depletion
on vulnerability to electrically-induced ventricular arr-
hythmias is unknown. We have performed metabolic balance
studies in 11 female, mongrel dogs(10-15kg) during which
strict control of diet and collection of urine for elec-
trolyte measurements were undertaken. After a control
period, dogs were subjected to dietar¥ ~ depletion and
thiazide diuretic treatment. After K depletion, dogs un-
derwent comprehensive electrophysiologic studies (EPS) in-
cluding programmed cardiac stimulation (PCS) using 1,2,
and 3 ventricular premature stimuli in sinus rhythm and 1
and 2 premature stimuli in ventricular pacing. The ven-
tricular fibrillation threshold (VFT) was also determined
in each animal. Percutaneous catheter technique with
methohexital general anesthesia was used. Following these
studies, ~ repletion was performed by dietary ~ supple-
mentation until K+ balance was demonstrated. Results: Mean
body K+ depletion achieved was 63.3 + 4.1 mEq. The serum
~ levels during control, K+depletion and K+repletion
phases were 3.7 + 0.05, 2.7 + 0.04 and 4.1 + 0.05 mEq/l
respectively (p<-O.OOI) , with no major differences in
other measured electrolytes. Ventricular fibrilla~ion
(VF) was provoked during EPS in 8/11 dogs during K de-
pletion but in only 1 dog following ~ repletion(p<0.007).
The mean VFT during K+ deple~ion was 33.9±19.2 rnA, and
rose to 51.5+16.9 rnA after K repletion (p<0.003). We con-
clude that isolated, severe K+ depletion significantly in-
creases susceptibility to PCS-induced VF and reduces VFT
markedly in this canine model.
DETERMINANTS OF VENTRICULAR FIBRILLATION IN A COMPUTER
MODEL OF THE ENTIRE LEFT VENTRICLE.
William M. Decam~li6 M.D. and Charles D. Swerdlow, M.D.,
F.A.C.C., stanto d niversity, Stanford, CA
We modelled conduction globally in a left ventricle
treated topologically as a spherical surface of cells.
This differs from all previous computer models which
cannot simUlate arrhfthm1as globally because they treat
only bounded myocard1al regions. OUr model's parameters
are ventricular diameter (D), mean absolute refractory
period (ARP), ARP standard deviation (SDARP), relative
refractory period (RRP), and maximum conduction speed
(cSmax )' ARP is distributed randomly; depolarized eellsconauet to all nearest cells not 1n their ARP. CS
varies linearly in the RRP from Which mean CS (cSm) is
derived. We studied the effect of 2 extrastimuli at the
end of the ARP after an initial stimulus. Integrations
were performed for all 256 combinations of these
parameter values: D 4, 5, 6, and 7 cmi ARP 175 t 200,225, and 250 ms; SDARP 25 and 50 ms' RRI' 25 and ,0 ms'
cSmax 0.4 ,0.6, 0.8, and 1.0 m/s. integrations stoppedafter reentrant excitation lasted 15 s or electrical
quiescence occurred. The product (F) of 2 dimensionless
terms correlated with sustained reentrant excitation:
F = [D/(ARP x CSm)] x (SDARP/ARP)
The first term in F represents macroscopic conditions
for reentry and the second normalized dispersion of
refractoriness. Integration results are shown below:
Fxl03 <10 10-15 15-20 20-25 25-30 30-40 >40
Integrations (n) 'J'r -00~ ----;ro- --rr- --,.r IU
Tachycardia «!» 0 4 22 20 0 0 0
Fibrillation. 0 0 0 20 100 100 100
For a normal ventricle, we assumed D=5, .ARP=200
lCSm=0.5 SDARP=25, resulting in F=6.2xl0-j. Alventricles with F<12xl0-j recovered. Sustained,
organized depolarizations (tachycardia) occurred at
intermediate values of F. Higher values produced
sustained, chaotic activation (fibrillation). In this
global model, vulnerability to sustained reentrant
excitation depends on F, a relationshi~ among variables,
rather than on the value of any specif1c variable. This
observation may provide insight into the substrate for
ventricular arrhythmias in diffuse myocardial disease.
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ESTIMATION OF CARDIAC SURFACE ACTIVATION SEQUENCE
FROM BODY SURFACE POTENTIAL MAPS
Haruki Kojima, M.D., Mary Jo Burgess, M.D., Robert L.
Lux, Ph.D., J.A. Abildskov, M.D., FACC
University of Utah, Salt Lake City
Activation sequences on the ventricular surface were
estimated from selected body surface (BS) electrocar-
diograms in 7 pentobarbital anesthetized dogs. Up to
50 activation sequences were induced in each dog by
stimulating singly and in time-phased combinations from 2
right and 1 left ventriCUlar pacing catheters. 192 lead
body surface maps were recorded for each sequence. The
chests were then opened, a 75 electrode array placed on
the heart and cardiac surface (CS) maps recorded for the
same activation sequences. Activation times for both
cardiac and body surface waveforms were taken as the times
of minimum QRS derivatives referenced to the time of a
ventricUlar stimulus. For each dog, the covariance matrix
relating cardiac and body surface times was calculated. A
subset of BS sites was selected in the order of importance
for estimating CS activation times. A linear as to CS
estimation transformation was then derived from the
covariance. Using jackknifing (of each sequence) CS times
at 50 CS sites were estimated from times at 3 to 13 BS
sites. Correlation between measured and estimated CS
times was .95±.025 over all dogs with a range of
[.903-.975]. RMS estimation error over all dogs was
7.5±4.4ms. Measured and estimated isochrone maps of CS
activation times were consistently very similar. These
results support the hypothesis that cardiac surface
activation sequence may be sufficiently well estimated
from the body surface that non-invasive characterization
of cardiac activation sequence is possible.
THE MECHANISM FOR "ENTRAINMENT" AND TERMINATION OF
REENTRANT VENTRICULAR TACHYCARDIA BY OVERDRIVE PACING.
Nabil El-Sherif, M.D., F.A.C.C., William B. Gough, Ph.D.,
Mark Restivo, M.S., SUNY, Downstate and VA Medical
Centers, Brooklyn, N.Y.
We studied epicardial activation patterns by a multiplex-
er in 4 dogs post-infarction. In each dog, a reproducible
sustained monomorphic reentrant tachycardia was induced
in the ischemic epicardial layer. The reentrant circuit
had a figure 8 configuration with two circulating wave-
fronts around two arcs of functional conduction block
that coalesced into a slow common reentrant wavefront
(CRWF). Overdrive pacing was applied in trains of 2 to
12 beats at different sites around the reentrant circuit.
Overdrive pacing at cycle lengths (CL), 10 to 30 msec
shorter that the tachycardia CL could perpetuate reentrant
excitation. The paced wavefront arrived earlier at the
entrance side of the CRWF but conducted slower in this
zone. This was consistantly accompanied by modification
of the conduction pattern of the CRWF. In other words,
there was a change in the reentrant pathway. However,
the exit pattern of the CRWF did not change. Following
termination of the paced train, reentrant excitation con-
tinued and the first post-overdrive CL was shorter than
the tachycardia CL. This was due to faster conduction at
the zone that showed the slowest conduction during the
paced train. When the length of the paced train was kept
constant, pacing at shorter CL could terminate reentry.
This occurred when the paced wavefront arrived at a
strategic zone at the entrance side of the CRWF before
refractoriness expired resulting in conduction block. The
study shows that perpetuation of reentry at shorter CL by
overdrive pacing (so called, entrainment) is associated
with subtle but definite changes in the reentrant pathway.
The use of the word "entrainment" to describe this
phenomenon may not be appropriate.
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PROSPECTIVE STUDY OF THE RELATIONSHIP BETWEEN SEX STEROID
HORMONES AND CORONARY HEART DISEASE
Lewis H. Kuller, M.D., Dr.P.H., James P. Gutai, M.D.,
Jane A. Cauley, Dr.P.H., Wanju S. Dai, M.D., Dr.P.H.
University of Pittsburgh, Pittsburgh, Pennsylvania.
The relationship between sex hormone levels and subsequent
risk of heart attack was studied in a historical cohort
study among 163 individuals in the MRFIT Trial who
subsequently had a heart attack and 163 controls. Blood
samples were collected at baseline prior to randomization.
The mean testosterone levels was 789 ng/dl for cases and
771 ng/dl for controls. Androstenedione in 185 ng/dl
cases, and 182 ng/dl for controls, estradiol 26.6 pg/dl
for cases, 25.9 pg/dl for controls, and estrone 70.6 pg/dl
for cases and 72 pg/dl for controls. None of these
differences were statistically significant. There were
also no differences in ratio of testosterone to estrogens.
The testosterone levels were directly correlated with
HOLe, LDLc and inversely with obesity. There was a
strong relationship between androstenedione levels and
cigarette smoking. Data on sex hormone binding globulin
will also be presented. The results to date do not
support previous case-control studies of a relationship
between sex hormone levels and risk of heart attack
among men.
CIRCADIAN VARIATION IN THE FREQUENCY OF ONSET OF STROKE
Thomas Robertson, M.D., John Marler, M.D., James Muller,
M.D., Thomas Price, M.D., Gordon Lan, Ph.D., Jay Mohr,
M.D., Dan Hier, M.D., Philip Wolf, M.D., LouiS Caplan,
M.D., Selma Kunitz, Ph.D., and the Stroke Data Bank
Investigators. National Institutes of Health~Bethesda,MD
Determi nati on that acute vascul ar events are more
likely to start at a particular time of day could
facilitate identification of the triggering mechanism(s).
A recent study demonstrated greater frequency in
late-morning for myocardial infarction. Variation in the
onset of stroke by time of day is not established.
Using consecutive cases in the Stroke Data Bank (an
ongoing multicenter study initiated by the National
Institute of Neurological and Communicative Disorders and
Stroke), the frequency distribution of the time at which
neurologic symptoms were first noted was analyzed for all
1,054 cases with confirmed stroke (see graph--upper line)
and for the 692 who did not have neurological symptoms on
awakening (lower line). As shown, frequency was low in
early morning and high in late morning. Also,
in-hospital progression of neurological deficit was more
frequent in late morning. These rhythms were observed
primarily in ischemic stroke, and this may reflect
variation in thrombotic tendency. Conclusion: Stroke
appears more likely t develop in the late morning.
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CARDIAC FAILURE AND SUDDEN DEATH: THE FRAMINGHAM STUDY
William B. Kannel, M.D., F.A.C.C., Ralph B. D'Agostino,
Ph.D., and L. Adrienne Cupples, Ph.D., Boston University
Medical Center, Boston, Massachusetts
During 30 years of follow-up cardiac failure (CF) inci-
dence doubled with each decade of age with a male
predominance produced by higher coronary heart disease
(CHD) rates. Most CF was associated with hypertension
or CHD. Among 232 men and 229 women who developed CF,
sudden death (SD) occurred at 9 times the general
population rate, age-adjusted. In those who also had
CHD there was a further doubling of risk.
The major predisposing factors for CF included hyper-
tension, obesity, glucose intolerance, heavy smoking,
cardiac enlargement, ECG abnormality and atrial fibrilla-
tion. These were also risk factors for SD. These
shared modifiable risk factors and cardiac impairments
did not entirely account for the markedly increased
risk of SD in CF. This suggests that either the damaged
myocardium or treatment needed to control the CF may be
at fault.
PSYCHOSOCIAL PROFILE OF PATIENTS FOLLOWING l;QRONARY
ARTERY BYPASS GRAFT SURGERY (CABGS) -.
Robin W. Roberts, Ph.D., David W. Coombs, Ph.D., Patrick
Whitlow, M.D., F.A.C.C., John B. Wayne, M.B.A., Edgar D.
Charles, Ph.D., Ken Bynum, Paula Stanton, Dwayne Crist,
Claudina Cabrera. University of Alabama at Birmingham,
Birmingham, Alabama.
Seventy-eight patients who received CABGS during 1984-
85 were interviewed during the hospitalization in which
CABGS was performed and at 3 mo., 6 mo., and 12 mo. post-
discharge to determine their psychosocial status and the
interaction of psychosocial status and clinical outcomes.
Outcome measures include: measures of health status,
utilization of medical services, and measures of psycho-
social status (depression, social support, health locus
of control, stress, and personality type).
At baseline 59% of the patients were depressed and 42%
remained depressed at follow-up. Depressed patients were
more likely to believe that they were powerless to con-
trol their own health and that physicians had more influ-
ence over their health situation than themselves.
Patients who were depressed had longer lengths of stay,
higher relative risk of subsequent cardiac events, lower
perceived health status, and were less likely to return to
work. Patients who reported a large network of social
support were less likely to be depressed, had higher
perceived health status, and were more likely to return
to work. Preliminary analyses indicate that levels of
social support and work status independently and together
affect depression. Data suggest psychosocial status
influences recovery following CABGS. Identification and
counseling of patients with poor psychosocial profiles
may facilitate recovery.
PHYSICAL ACTIVITY, PHYSICAL FITNESS AND CORONARY HEART
DISEASE : INCIDENCE DATA IN THE BELGIAN PHYSICAL FITNESS
STUDY.
John C. Sobolski, M.D., Marcel D. Kornitzer, M.D. Ph.D.,
Guy G. De Backer, M.D. Ph.D., Michele M. Dramaix, M.S.,
S~rge G. Degre, M.D. Ph.D., Henri F. Denolin, M.D. Ph.D.
Medical Cardiology Service - Cliniques Universitaires de
Bruxelles - Hopital Erasme - Belgique.
To study the effects of physical activity [Ph.A.) on and
off the job and of physical fitness [Ph.F.) on incidence
of coronary heart disease [CHD). 2363 Belgian male wor-
kers 40-55 years old, entered a 5 years prospective study.
Data were collected on established risk indicators and on
Ph.A. Ph.F. was derived from a submaximal bicycle exer-
cise test and expressed as the intrapolated PWC 150 or
PWC 15D/kg, i.e. the work load at heart rate 15D/min
(per kg of body weight). There were 31 new fatal or non-
fatal myocardial infarctions. No significant correlation
was demonstrated between quartiles of Ph.A. on and off
the job and incidence of CHD. However, the relative risk
is almost 2/1 when comparing SUbjects without to subjects
with heavy leisure-time activity [2.1 versus 1.21 N.S.).
The incidence of CHD in quartiles of PWC 150 shows a non
Significant trend (Q1 : 2.181 Q4: 0.751 N.S.). A similar
analysis with PWC 15D/kg showed a significant trend
(Q1: 1.511 Q2: 2.33; Q3: 1.681 Q4: 0.341 P = 0.05).
The mean PWC 15D/kg in CHD 1.1 subjects is significantly
lower at baseline compared to CHD I-I subjects (1.34 ver-
sus 1.491 P < 0.03). In a discriminant stepwise analysis
with 9 factors, HDl-cholesterol. smoking and PWC 150/kg
discriminate significantly between subjects who will de-
velop CHD and those who remain CHD free. We conclude that
in this study, PWC 15D/kg. but not Ph.A .• is an indepen-
dent inverse risk indicator of new CHD events.
LIPID PROFILES AND CORONARY RISK DESIGNATION. IMPACT OF
INCONGRUOUS REFERENCE RANGES, VARIABLE LIPID PROFILES,
SEX, AND AGE.
Arlyce F. Vumeas, M.D., BruCl M. McManus. M.D., Ph.D.,
(FACC), Univers1ty of Nebraska Medical Center, 01lIaha, NE
Illterpretation of laboratory lipid values In the context
of coronary heart dieease riek xwulnB obscured by
wldely variable practices for lipid profile reporting.
Of 121 academic cl1D1cal laboratories (eLI) surveyed in
tile United States and Canada, the baBiI of lipid value
lI1terpretation b highly dependent upon choice of
nference populations, age and sex of IUbjects lampled,
and lipid parameters utilized for cardiovascular risk
specification. Of the 121 CLI, 37 utilized publilhed
nportl from a Ipecified louree, 17 utilized "local"
people, 15 utiUzed "healthy" people, 13 a textbook, 12
a pUblished report of unknown source, 10 a manufacturer
insert, 9 unapeeified patienta, and 4 used their own
oplnion. Of 105 clinical laboratoriel, 36 (34%) did not
.pecify age or~x as a determinant in reference ranges,
wllile 36 (34%) ,pecified age only, and 33 (32%)
specified both age and sex. Of 41 CLs specifying a
cardiovascular risk level for blood lipids, 20 utilized
total blood cholesterol (THC), 14 utilizing high denaity
Upoproteln cholesterol (IIDL), ana 15 a TBC/IIDL ratio.
Of CLa utilizing TBC for specification of cardiovascular
risk, the cutoff varied from 200 to 330 mg/dl. All but
one CL reported a IIDL risk of equal to or less than 50
mg/dl and most specified a cardiovascular risk associa-
ted with THC/IIDt ratio of greater than 5. Regional dif-
ferences were present in the 8 geographical areas of
continent. The specific lipid value at whiCh cardiovas-
cular risk is specified are ulconsistent an<! misleading,
and desperately need a UIliform approach to amendment.
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THE CONCENTRATION OF CHOLESTEROL IN SERUM LIPOPROTEINS IN
ZEN MONKS
Toru Kita, M.D., Masayuki Yokode, M.D., Masato Kita,
M.S., Kazuhiro Fujii, M.S. and Chuichi Kawai, M.D.,
F.A.C.C., Kyoto University, Kyoto, Japan.
The mean levels of total cholesterol, LDL-cholesterol,
apoprotein B and total triglyceride were 29.8, .31.0, 34.2
and 40.2% lower in Zen monks compared to that in control
Japanese males. On the other hand, there was no signifi-
cant change in the level of HDL-cholesterol in both
groups. In this paper, we will discuss these lipid data
in association with dietary components.
The functional role of the various serum lipoproteins in
the pathogenesis of atherosclerosis has become better
understood in recent years. It is important to define
the environmental factors, especially dietary factors,
influencing specific lipoproteins. The concentrations of
total, low density lipoprotein (LDL) and high density
lipoprotein (HDL)-cholesterol, total triglyceride and
apoproteins have been examined in Zen monks whose intake
of animal products is almost negligible for 2 to 8 years,
and in age-matched (24 to 35 years) control Japanese
males who eat western style food. The mean levels of
total cholesterol, LDL-cholesterol, apoprotein Band
total triglyceride were shown in Table.
Zen Monks(n=10) Control Males(n=19)
189.7 ± 17.3
109.1 ± 18•.3
61.4 ± 13.6
94.7 ± 21.2
72.4 ± .30 •.3
*p<O.01 **NS
135.1 ± 15.2*
75.3 ± 12.4*
55.0 ± 14.1**
62.3 ± 11.0*
43.3 ± 13.5*
Mean ± SD
Total Cholesterol
LDL-cholesterol
HDL-cholesterol
Apoprotein B
Triglyceride
HIGH DENSITY LIPOPROTEIN CHOLESTEROL: PROGNOSIS AFTER
MYOCARDIAL INFARCTION.
Uri Goldbourt, Ph.D., Lori Mandelzweig, M.P.H. and
Henry N. Neufeld, M.D., F.A.C.C., Epidemiology Section and
Heart Institute, Sheba Med Center, Tel Hashomer, Israel.
In persons without overt clinical coronary heart disease
(CHD) , reduced levels of high density lipoprotein
cholesterol (HDLC) are a known predictor of a first
myocardial infarction (MI), and of death from CHD. In
contrast, little is known about the role of HDLC in the
prognosis of patients with CHD. We therefore examined, in
130 men with electrocardiographic evidence of myocardial
infarction (MI), the relationship of HDLC to prognosis.
Approximately 60% (77 men) died between 1963 and 1978, in
the bottom HDLC quartile ( <30mg/dl). Quartile analysis
was also performed for HDLC as a percent of total cholest-
erol (PHDL), known as a better predictor of CHD incidence.
Mortality was as high as 81% in the bottom quartile
(PHDL - 13%), with a relative mortality risk of 1.71 for
subjects in the bottom quartile compared to those in the
top quartile (PHDL - 19%). Initial mean PHDL in patients
surviving 15 years was significantly higher than in those
dying during that time (17.8 vs. 16.2%, p <.05). Multi-
variate analysis, using the Cox proportional hazards
model, indicated an association near conventional statisti-
cal significance between HDLC and long-term mortality,
(p = .069). The results are comparable with those reported
by the Coronary Drug Project Study. Further investigations
of larger cohorts of MI survivors are needed, before firm
conclusions about the role of HDLe and the potential for
the use of HDLC affecting drugs or life-style changes can
be drawn.
SUPERVISED PHYSICAL EXERCISE AND DIETARY FAT RESTRICTION
IN PATIENTS WITH SYMPTOMATIC CORONARY ARTERY DISEASE:
REDUCTION OF STRESS INDUCED MYOCARDIAL ISCHEMIA
G.Schuler MD, G.Schlierf MD, J.Gorich MD, A.Dinsenbacher
MD, F.Schwarz MD, HC.Mehmel MD, J.Manthey MD, W.Kubler MD,
FACC; Medizinische Universitatsklinik Heidelberg, Germany
The purpose of this study was to assess the effect of low
fat diet ( (20% fat) and daily, supervised training on
serum lipoproteins, on physical work capacity (PWC),and on
the severity of exercise induced myocardial ischemia (EMI)
in patients with symptomatic coronary artery disease (CAD).
EMI was assessed by Tl-201 scintigraphy and expressed in
degrees of LV circumference; maximal myocardial oxygen con-
sumption was estimated from rate-pressure-products (RPP)
during symptom limited exercise. 16 patients were studied
before and following 12 months of treatment. Results were
compared to 16 patients matched for age and severity of
CAD (Gensini score) receiving 'usual care' (CONTROL).
TRAINING CONTROL
Before 12 months Before 12 months
CHOL (mg%) 233±38 19h27 * 239151 243±65
TG (mg%) 186±.76 130±68 * 179±1l4 171±55
PWC (Watt) 152±49 189±52 * 135±24 130±35
RPP xlOOO 26 i5 30 ±4 * 23 16 18 ±4 *
EMI ( 6) 52 ±.39 21 122 * 47 124 48 ±33
CHOL:Cho1esterol, TG:Triglycerides, * p(0.05 (before vs.
12 months)
CONCLUSIONS: Restriction of dietary fat consumption and
supervised physical exercise for 12 months resulted in
significant reduction of serum lipoproteins; stress in-
duced myocardial ischemia was significantly diminished
despite increased physical work capacity and maximal myo-
cardial oxygen consumption, indicating improvement of myo-
cardial perfusion. In the control group maximal myocardial
oxygen consumption decreased, probably as a result of pro-
gression of CAD.
PREVALENCE OF MITRAL VALVE PROLAPSE IN NON-CARE-SEEKING
ADOLESCENTS.
Anthony S. Lachman. M.D•• F.A.C.C., Peter Schulman,
M.D., F.A.C.C., Cynthia L. Arfken, Ph.D., Grover C.M.
Farrish, M.D., Diane S. Slowik, and Margaret J.
McLaren, M.D., University of Connecticut, Farmington,
and Yale University, New Haven.
In prevalence studies of mitral valve prolapse,
selection . bi~s in subject recruitment can limit
accuracy when care-seeking patients are included in the
study population. To determine the prevalence of mitral
valve prolapse virtually free of selection bias, 813
non-care-seeking, demographically heterogeneous sixth
grade children from entire school classes, ages 9-14,
mean, 11.5 years, were examined in four positions by
one or two cardiologists. Mitral valve prolapse,
diagnosed when two independent cardiologists concurred
on the presence of a mid-systolic click or late
systolic murmur, was found in 34 (4.18%), and suspected
by a single cardiologist in an additional 32 (3.95%).
Cardiologists were unaware of any previous auscultatory
findings, the echocardiographic findings or the medical
history. Agreement on the diagnosis of prolapse ranged
from 78% to 100% mDong the four pairs of eXmDining
physicians. Mitral valve prolapse was found in 25 of
406 girls and 9 of 400 boys (6.16% vs. 2.25%, P<.05).
Gender data were missing in 7. Functional murmurs were
present in 12 children with mitral valve prolapse and
in 539 without (35.3% v. 69.2%, P<.05), but the
proportion with third sounds did not differ between the
groups. Thus, even mDong non-care-seeking adolescents
where selection bias is minimal, the prevalence of
mitral valve prolapse is high. Girls have nearly three
times greater prevalence than boys. Functional murmurs
were found less frequently when MVP was present.
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Atrial function, reflected in the radionuclide time-
activity curve as augmented LVEDV, therefore appears to
distinguish physiologic from pathologic left ventricular
hypertrophy and left atrial enlargement.
TPR
<1200
2153±689
1885%777
Zc
<100
240±109
172%67*
PWV(m/sec)
<7
1l.l±1.8
9.5%1.4*
AOP (mmHg)
60-100
l26±16
116±15*
*p<0.05 versus control.AOPamean aortic pressu:~.
TPR=total peripheral resistance, dyn. sec. em •
Normal Range
Control-HTN
NTG-HTN
Ten of the 16 WL had used steroids at some time during
their training and use of steroids inversely correlated
significantly with indices of diastolic filling (with
Ei/Ai, r--O.65). We conclude that WL have increased LVMI
due to both increased EDV and increased wall thickness but
no evidence for ASH or abnormalities of systolic or
diastolic function.
WL 1.89 114+29 2.4+.7 2.1 60 89+19
CONTROLS 1.64 87+15 2.8+.3 2.2 63 72+30
p NS <0.02 NS- NS NS NS
LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTION AND
HYPERTROPHY IN WEIGHTLIFTERS
Anthony Pearson, MD, Michael Schiff, MD, Arthur Labovitz,
MD, FACC, Denise Windhorst, George A. Williams, MD, FACC,
St. Louis University School of Medicine, St. Louis, MO
Concentric LV hypertrophy (LVH) and asymmetric septal
hypertrophy (ASH) have both been described in
weight lifters (WL) but diastolic filling, which is
abnormal in pathologically hypertrophied ventricles, has
not been investigated in such subjects. Accordingly, we
performed Doppler and 2 dimensional echocardiography (2DE)
on 16 competitive WL and 10 age-matched male controls.
Peak (PFR) and mean (MFR) filling rates were determined in
cc/sec as the product of the cross-sectional area of the
mitral annulus and the peak early and mean diastolic
velocities respectively. The flow velocity integrals of
the early (Ei) and atrial (Ai) diastolic filling phases
were also measured. LV end-diastolic volume EDV and
ejection fraction (EF) were measured from the 2DE. WL had
significantly higher LV mass, body surface area (BSA) and
LV mass corrected for BSA (LVMI, g/M2). This was due to
both increased septum (VS) plus posterior wall (pw)
thickness and increased EDV. The ratio of VS to PW in WL
was 1.0. There was no significant difference between WL
and controls in PFR/MFR, Ei/Ai or PFR.
VS+PW(cm) LVMI Ei/Ai PFR/MFR LVEF EDVI(cc/M2)
CONCLUSIONS: High pulse wave velocity and characterstic
impedance both suggest a stiff aortic conduit in
hypertension. Thus, both steady load (TPR) and pUlsatile
load (Zc) are abnormally high. Reduction in distending
pressure by vasodilatation with NTG produces a variable
decrease in stiffness. This suggests the reversibility
of abnormalities in aortic function during therapy in
some patients.
Functionally stiff large arteries may complicate systemic
hypertension (HTN) by accentuating systolic hypertension
and increasing vascular load • Altered stiffness could
be due to the high distending pressure from elevated
arteriolar resistance or due to degenerative wall
changes. In 5 hypertensive pts we quantitated arterial
stiffness by measurements of pulse wave velocity (PWV)
from ascending to descendi~5aorta and characteristic
impedance (Zc, dyn. sec. em ) by averaging impedance
moduli between 4-12Hz. High fidelity pressure and
velocity sensors (Millar) were used at the time of
catheterization. Reduction of distending pressure was
achieved with nitroglycerine (NTG,.3mg,sl)
QUANTITATION OF AORTIC STIFFNESS IN SYSTEMIC HYPERTENSION
John D. Carroll, M.D., Sanjeev Shroff, Ph.D., Patty W.
Arand, BSE, James Rossen M.D., Ted Feldman, M.D.
University of Chicago, Chicago, Illinois.
H
\. (\ r
\) VA
Left atrial function in physiologic and pathologic cardiac
hypertrophy was evaluated by comparing the relative LA
contribution (LAC) to left ventricular end-diastolic
volume (LVEDV) in 12 athletes (A), 12 hypertensives (H),
and 12 normal subjects (N). LAC was measured from
high-resolution, double-gated radionuclide time-activity
curves as a percent of LVEDV. Of note, LAC was found to
increase with age in a separate group of 45 normals
(R-.48,p<.00l) •
CROUP LVMI(g/m2) LAI(cm/m2) LAC(%LVEDV)
N 83±.12 1.5±.0.2 6±.5
A 123 ±. 31 2.0 ±. 0.2 5 ±. 5
H 130 ±. 40 1.8 ±. 0.2 13 ±. 4
Both A and H had significantly increased echocardiographic
LV mass index (LVMI). Left atrial dimension index (LAI)
was also increased in A and H compared to N (both
p<.OOl). LAC was similar in A and N but was significantly
higher in age-matched H vs N (p<.Ol). Although LAI was
greater in A than H (p<.05), LAC waa greater in H than in
A (p<.OOl).
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WHAT IS THE SIGNIFICANCE OF CHEYNE-STO<ES
RESPIRATlON IN SEVERE CHRONIC HEART FAILURE?
HEMODYNAMIC AND CLINICAL CORRELATES IN 167
PATIENTS. Stephen S. Gottlieb MD, Paul Kessler MD, Wai H.Jng
Lee MD, Norma Medina RN, Madeline Yushak RN, Milton Packer
MD, FACe. Mount Sinai School of Medicine, New York, NY
Cheyne-Stokes respiration (CSR) occurs commonly in states of
depressed central nervous system (CNS) function, but its
prevalence and pathogenesis in patients (pts) with heart failure
(CHF) remains unknown. To determine this, we correlated the
occurrence of CSR with simultaneous~performed hemodynamic
and clinical measurements in 167 CH pts, none of whom had
CNS disorders or received CNS depressants. Cardiac index (CI,
l!min!m2), LV stroke work index (SWI, g_m!m2 ), mean arterial
pressure (MAP, mm Hg), LV filling pressure (LVFP, mm Hg),
systemic vascular resistance (SVR, d-s-c), LV ejection fraction
(EF), blood urea nitrogen (BUN, mg!d(), serum creatinine (Cr,
mg!dl) and serum sodium concentrations (Na, meq/l), and CSR
occurrence were assessed grior t2vasodilators in all pts.CSR was present (+CSR in 9 of 167 CHF pts (55%), each of
whom had periods of apnea ranging in duration from 5 to 60 sec.
CI SWI MAp LVFP SVR EF BUN Cr No
+CSR 1.6 15 83 25 2138 17 40 1.9 136
-CSR 1.9* 19* 85 25 1930 17 47 2.1 135
Pts with CSR had a significantly lower cl and swi (* = p<O.OI)
than pts without CSR, but the 2 groups were similar with respect
to other hemodynamic variables. Pts with and without CSR did
not differ in age (65 vs 63 yrs), BUN, Cr or No. CSR distin-
guished pts with a CI < 1.7 l!min!m2 better than EF, BUN or Cr.
In 12 CHF pts with CSR, the administration of a single dose of
hydralazine abolished CSR within 3 hr, and this occurred simult-
aneous with t in CI and SWI without changes in LVFP or EF.
In conclusion, CSR occurs in the majority of pts with~
CHF, identifies pts with on extremely reduced CI better than
other clinical and noninvasive measures of LV function, and can
be abolished by vasodilator drugs that t CI.
ATRIAL FUNCTION IN PHYSIOLOGIC AND PATROLOGIC
VENTRICULAR HYPERTROPHY
Vivienne-Elizabeth Smith. M.D., Orysia Tresznewsky, M.D.,
William B. White, M.D., Mozafarredin K. Karimeddini. M.D ••
Christopher B. Granger, M.D., Arthur L. Riba, M.D.,
F.A.C.C., Arnold M. Katz, M.D., F.A.C.C., University of
Connecticut, Farmington, CT
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Rest 2.1tO.2 10t2 40±S .3St.07
Milrinone 2.6tO.l** 9t2 33±S* ~20t8* ~9t6 .43±.08*
Neither drug significantly altered heart rate.
Conclusions: 1) In congestive heart failure, both milri-
none and dobutarnine significantly improve RV systolic
performance. 2) For doses used, neither drug substan-
tially alters RV preload, as reflected by RA pressure and
RVED volume. 3) For doses achieving similar increases
in CO, milrinone effects a greater decrease in RV after-
load than dobutamine, as reflected by PAES pressure.
4) Similar improvement in RV systolic function with dif-
ferential effect on afterload suggests greater RV ino-
tropic effect of dobutarnine vs. milrinone.
.32t.04*
~17t6* ~8tS .40t.04*
RVES RVED RVEF
volume (% change)
Rest 2.1±0.3 9t2 37t3
Dobutamine 2.6tO.3* 9t2 3St4
MILRINONE AND DOBUTAMINE EFFECTS ON RIGHT VENTRICULAR
PRELOAD, AFTERLOAD, AND SYSTOLIC PERFORMANCE IN CONGESTIVE
HEART FAILURE.
Eric J. Eichhorn, M.D., Marvin A. Konstam, M.D., F.A.C.C.,
David S. Weiland, M.D., David J. Roberts, M.D., Tami T.
Martin, R.N., Nicholas B. Stransky, Deeb N. Salem, M.D.,
F.A.C.C., Tufts-New England Medical Center, Boston, MA
To assess the effects of dobutarnine and milrinone on the
RV, 14 patients with severe congestive heart failure
underwent simultaneous radionuclide-hemodynarnic study.
Patients were randomized to receive intravenous milrinone
(SO meg/kg bolus then O.S meg/kg/min) or dobutamine (2.S
-IS mcg/kg/min) to achieve equal increases in CO. Drug-
induced (steady state) changes in RA pressure, PA end-
systolic (ES) pressure, RVES volume, RV end-diastolic (ED)
volume, and RV ejection fraction (EF) were recorded (mean
±SE; *p<O.OS; **p<O.OOS vs rest):
CI RA PAES
(l/min/m2 ) pressure (nun Hg)
PREDICTORS OF EARLY DEATH IN YOUNG TRANSPLANTABLE
DILATED CARDIOMYOPATHY
P. A. Daly, M.D., C. Viquerat, M.D., C. Simonston,M.D.,
G. Modin, Ph.D., K. Chatterjee, M.B., F.R.C.P.,
F.A.C.C., University of California, San Francisco, Ca.
The selection of candidates for transplant surgery
remains a difficult clinical decision. To assess predic-
tors of early mortality (6 months) in relatively young
patients (PTS), 67 PTS under age 60 were studied. All
PTS had severe dilated cardiomyopathy and were referred
for worsening symptoms (NYHA Class III - 18 PTS·, Class IV
- 49 PTS). There were 34/67 PTS with ischemic heart
disease and nonglycoside inotropes were used in 52/67
PTS. Overall mortality was 34/67 (50%) at 6 months. The
following characteristics were assessed: sex, age, func-
tional class on admission, functional class on discharge
and improvement in functional class, etiology, duration
of congestive heart failure, use of antiarrhythmics, pre-
therapy resting hemodynamics, and arterial norepinephrine
(ART NE). Cox step-wise regression identified only ART
NE (p < .04) and pulmonary capillary wedge pressure (p
<.02) as significant correlates of survival. Despite the
significant correlation, predictive value remains poor.
Arterial NE of >500 pg/ml yielded a 67% mortality group
and a PCWP of >25 mmHg yielded a 55% mortality group.
Similarly, no combination of variables identified a very
high or low risk group. The presence of coronary artery
disease did not increase risk. We conclude: 1) commonly
utilized clinical and hemodynamic variables are of
limited predictive value in selection of candidates for
cardiac transplantation, 2) other metabolic or morpholo-
gic criteria should be sought.
Baseline
Arnrinone
REGIONAL VENTRICULAR FUNCTION WITH CINE CT
Andrew J. Feiring, M.D. , John A. Rumberger, Ph.D., M.D.,
Steve M. Collins, Ph.D., David J. Skorton, M.D.,
F.A.C.C., Michael P. Noel, B.S., Steven J. Reiter, M.D.,
William Stanford, M.D., F.A.C.C. and Melvin L. Marcus,
M.D., F.A.C.C., Univ. of Iowa and CV Ctr, Iowa City, Iowa
Employing changes in segmental endocardial contraction
(SEC) and segmental wall thickening (SWT) to evaluate
regional left ventricular (LV) function requires defini-
tion of normal values. Cine CT provides high temporal
and spatial resolution which should facilitate evaluation
of LV-SEC/LV-SWT. In 11 normal subjects short axis cine-
tomograms were obtained at the high, mid, and low papil-
lary muscle (PM) level during contrast infusion (mean
arterial pressure, 93±10 mmHg; average heart rate,
72±11/min, global LV ejection fraction, 69±7%). At each
level the end-diastolic/systolic frames were identified
and the epicardial (EP) and endocardial (EN) contours
traced. Using both EP and EN centroids contours were
divided by computer into 12, 30° radial segments. SEC
was calculated from both EP and EN centroids. From each
radial segment % LV-SWT was calculated by 3 methods:
myocardial radial segment length (SWTl), shortest dis-
tance from EP to EN (SWT2) and from EN to EP (SWT3).
Results for mid PM level: *p<.05 for standard deviation
SEC-EN vs SEC-EP.
Method SEC-EN% SEC-EP% SWTl% SWT2% SWT3%
Mean±SD 7l±8* 72±19 l22±204 97±55 105±65
Results were similar at other levels and unchanged by
excluding segments containing PM. Due to complex three-
dimensional myocardial motion during contraction as well
as other technical factors, practical considerations (nar-
row normal range, ease of analysis) strongly support the
use of SEC-EN as opposed to SWT (broad range, difficult
analysis) to define regional LV function in patients
using cine-CT.
REDUCTION IN FUNCTIONAL MITRAL REGURGITATION BY AMRINONE
AND MILRINONE IN SEVERE LEFT VENTRICULAR FAILURE
David S. Weiland, M.D., Marvin A. Konstam, M.D., F.A.C.C.,
David J. Roberts, M.D., Steven R. Cohen, M.D., Deeb N.
Salem, M.D., F.A.C.C., Tufts-New England Medical Center,
Boston, MA
The degree to which functional mitral regurgitation is
reduced during amrinone or milrinone therapy in patients
with severe LV failure is unknown. In 16 patients without
primary valvular disease and with severe LV failure {mean
ejection fraction 0.16±O.02 (SE)}, we examined the effect
of intravenous milrinone (SO ~g/kg) or amrinone (3 mg/kg)
on thermodilution CO, and simultaneous radionuclide LV
output (0). Regurgitant output (RO) was calculated as
LVO-CO. At rest regurgitant fraction (RF=RO/LVO) was
<0.20 in 8 patients (group I) and >0.30 in 8 patients
(group II; mean 0.49tO.OS). Following milrinone or amri-
none infusion cardiac output increased 32t9% in sroup I
and SO±7% in group II. Group II regurgitant output and/or
regurgitant fraction decreased. Group II (meantSE):
CO+ LVO+ RO+ RF
l.StO.2 2.8±0.6 l.1±0.1 0.46±O.07
2.3±0.3** 3.2±0.8 0.9±0.3 0.27±0.08*
Baseline 1.8tO.S 4.0±0.7 2.3tO.9 0.SStO.08
Milrinone 2.S±0.S* 4.0±0.7 1.6tO.8* 0.33tO.17
+1/min/m2 ; *p<O.OS; **p<O.OOS vs. baseline. Mean frac-
tional contribution of reduced RO to the increase in CO
induced by amrinone or milrinone was SStI4%. Conclusions:
1) Approximately SO% of patients with severe LV failure
have significant functional mitral regurgitation. 2) Bi-
pyridine (amrinone and milrinone) therapy reduces func-
tional mitral regurgitation, and this effect often con-
tributes substantially to the increase in forward cardiac
output in patients with severe congestive heart failure.
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TIlE IDK1' CF amrre lEI'A IifX](A]E CN IiFI' VENIRIClJlAR Rm'ICN: lAQ(
CF INFliJEI'l:E CF !SA IN amrre srAlll MaNA I'EITCRIS.
Robin J. ~rt:OCote,M.R.e.p., Michael B.D. COO<e, FhD.,
Iavid Pe11antyne, M.D.
The Victoria Wirnary, Glasgow, G42 9lY, Scotland.
Beta blockers llBy ~anise left ventricular functioo. Beta blockers
possessing intrinsic S)'IlIIBtlx:miJretic activity (!SA) might protect LV
cootractility. We therefore carried oot a stu:ly CCID(&ing the chrooic
effects of Proprarolol am Pindolol 00 llBle ratients with stable angina
pectoris. LV functioo was assessed by serial radionuclide ventriculo-
graIitY (RNV), at intervals of 2,6,12,26 am 52 ..eeks follOOng CCJIIlBl:e-
nmt of beta blockade. 'l\.mty-one ratients Ia"e allocated to treatnmt
with Proprarolol am 19 to treatnmt with Pindolol. RNV was perfonred
at rest am during cold pressor test (CPT) am during sustaired
iro1Etric haOOgrip test (SOC). Ibth drugs improved synqltalB of angina
pectoris by at least me divisioo of the NYHA classificatioo. Resting
hemt rate (HR) was significantly redoced by Proprarolol wren canrared
to basal values (p < 0.01 after 6 ..eeks) as was systolic (p < 0.01)
am diastolic (p < 0.05) blood pressure. Although there was no
significant change in resting HR at any t:iJre during treatnmt with
Pindolol, both systolic am diastolic IF fell throoghoot the stu:ly
(p < 0.05 at 6 ..eeks). Ibth CPT am SOC caused increases in HR am IF
in both groops throoghoot the stu:ly (p < 0.01). DJring these inter-
ventioos, the attenuatioo of heart rate was greater with Proprarolol
wren canrared to Pindolol (p < 0.001 at 52..eeks). At rest, Ell was
similar in both groops. DJring Proprarolol treatnmt this rooe
seljUf!1tially fran 4g'/" to 55% at 26..eeks (p < 0.01). ~ change in the
resting Ell occurred in thooe taking Pindolol. ~ increases in the
Ell respoose to SOC am CPT occurred in the Proprarolol groop am in the
Pindolol groop (p = NS). In thooe with sul:rxJrllBl LVEF « :az) resting
Ell improved significantly throoghoot treatnmt with Proprarolol rising
fran a basal value of 3J to 51% at 26 ..eeks (p < 0.001) rot not
Pindolol. Thus LV functioo is improved by Proprarolol in chrooic stable
angina pectoris. There is no apjBrent advantage of !SA in this respect.
THE HAEMODYNAMIC EFFECTS OF QUINAPRIL, A NON-SULPHYDRYL
A.C.E.-INHIBITOR, IN PATIENTS WITH CARDIAC FAILURE
P Holt, MD, J Najm, BSc, LMS, E Sowton, MD, FRCP, FACC
Guy's Hospital, London, England
We studied the effects of Quinapril(CI-906) a new non-
sulphydryl A.C.E.-inhibitor in 10 patients with cardiac
failure, NYHA class 3-4 (9M and 1F aged 43-70 yrs).
Seven had ischaemic heart disease, 2 had congestive
cardiomyopathy, and 1 had corrected transposition. All
patients gave informed consent. A Swan-Ganz thermodilu-
tion catheter was inserted and the right atrial (RA),
pulmonary artery (PA) and pulmonary artery wedge (PAW)
pressures, plus cardiac output (CO) measured. Following
Quinapril 5 mgs orally pressure measurements, CO, heart
rate and BP were measured at 15 mins intervals for 3-4
hrs. Nine patients then continued into the chronic study
receiving Quinapril 5 mgs tds (1 pt withdrew). Non-
invasive investigations continued monthly. Results from
the acute study showed maximum effects 1-2 hrs after drug
administration. Mean BP fell from 93-83 mmHg, mean PAW
fell from 30 to 14 mmHg while mean CO rose from 3.5 to
4.4 l/min. Mean systemic vascular resistance (SVR) fell
from 2010 to 1300 dynes. Effects on BP, CO and SVR con-
tinued 4 hrs; PAW values returned to the pre-treatment
values at 4 hrs. In the chronic study, 6 of 9 patients
have done well with improvement in effort tolerance
(follow-up 2-5 months). Drug therapy was discontinued ln
3 patients, 1 with a pronounced diuresis after 48 hrs
therapy, who became dehydrated, 1 who had a further myo-
cardial infarction and 1 who developed significant hypo-
tension. Thus although considerable haemodynamic improve-
ment occurred in all patients acutely, hypotenslon may
develop during chronic therapy and great care must be
exercised with additional diuretic treatment.
AUJTE J-lEM)[)'{NPMIC AND ANTIISCHEMIC EFFECIS OF INffiAVEN:XJS DILTIAZEM IN
MJIN.
Willan J Ratm€, MD, Diederlk van Hoc:>genI"u.\Yze, MD, D1Ck m.wssen, MD.
ZUlderzlekenhuis, Dept.of CarclJ.ology, Rotterdan, The Netherlands.
The relatloo betwee1 the antllschanlc prqJerties of mtravenous (iv)
Dlltiazan (D) m hurans and Its acute corcnary and systanic haroc\VnaTUc
effects IS i.nC'aIpletely mderstood. In 15 patlents (pts) with corcnary
artery dlsease 2 identlcal pacmg stress tests were carried out 3J min
before (pI) and immediately after (P2) lV D (l:x>lus of 0.4 rrw'kg!mm ,
followed by 0.4 rrw'kg!1O min). No mtoward effects ClC'C'Ur'l"ed during and
after tha infusion. During D infusion a sustained redtrtion m LV
systolic pressure (LVSP ,13%), mean aortlC pressure (13%) and systemic
resistance (SVR,31.%) ocrurred with a a;'% :incTease in cardiac incIe><. In
contrast, changes in corcnary sinus flow (C3F, l.I1C'reElSe 21%), corcnary
reslstance (CVR, decrease a;'%) and CS 02 content (:incTease <l::J%), were
slnrtlasting, only found during tha l:x>lus mfUSlon (values p<: 0.05 vs
control). HR, contractillty indices, LV enddiastolic pressure (LVEIP),
stroke v.ori< incIe>< and l1\Yocardial 02 C'01SUTption (MII02) did not change.
During pacmg HR were elevated with 10 beats/2 min mtil angina, block
or a rraximal HR of lID beats/min. A11:h:>ugh rraximal HR were similar
during l:x>th stress tests and contractility improved during pacing after
D, tha ta1sion time incIe>< was si@1ificantly 1CMer during P2 due to a 17%
decrease in LVSP, ..rom resulted in a si@1ificmt redtrtion in MII02
(17%) a'ld C3F (12i6) , as well as in pac~i.ndtred ischemia. The
redtrtion of l1\Yocardial ischemia was indicated prillBrily by
nomalization of lactate extractioo (LE) during rraximal pacing HR (LE:
- 22+9,7% (P1) vs 6+5,3% (P2)) and by a si@1ificmt redtrtion m L
prodlrtion 15~ after pacing (LE: -50t12i6 (P1) vs -6+-7,8% (P2)).
M:lre::>ver , ST segnent depression was less ciUring pacing (O~23+0,02 mV(Pl)
vs O,l3:!9,O1 mV (P2) a'ld LVEIP post;..pacing redtrect (2Bt3 rmHg-(Pl) vs
13.!.2 rmHg (P2), 'IA1ereas angina, present in all pts during P1, was ab3Ent
m 7, less in 6 and similar in 2 pts after D. 'Ih..s,in hunans, higtl 00ses
of D ind!.re sustained redtrtions in SVR, eq.Jivalent but slnrtlasting
changes m CVR and improve purpfU'X'tioo Wltroutc~ in HR am
contracitlity. Dhas aotiischemic prqJerties due to sustained peri!XJeral
vasodi1atloo resulting in deC'reased IT(YOC'8l''dial 02 derarrl and C'01SUTpti01.
DOES DIGOXIN IMPROVE EXERCISE CAPACITY IN CHRONIC
CONGESTIVE HEART FAILURE?
Jerome L. Fleg, M.D., F.A.C.C., Jeanette G. Wright,
Sheldon H. Gottlieb, M.D. and Edward G. Lakatta, M.D.,
Gerontology Research Center, National Institute on Aging,
Francis Scott Key Medical Center, Baltimore, MD.
The ability of cardiac glycosides to improve exercise
tolerance in patients with congestive heart failure
(CHF) is highly controversial. Twelve ambulatory patients
ages 46-70 years (x D 57.8) with chronic stable CHF,
systolic left ventricular dysfunction (ejection fraction -
33 ~ 12) and sinus rhythm performed maximal treadmill
exercise after four weeks of digoxin or placebo adminis-
tered in a randomized crossover protocol. Serum digoxin
level averaged 1.4 ~ 0.3 ng/m1 during the digoxin phase.
Exercise duration (min.), peak oxygen consumption (V02'
ml/kg/min), maximal heart rate (MHR, beats/min), oxygen
(02) pulse (peak V02 f MHR) , minute ventilation (Vent,
liters/min) and ventilatory equivalent (Vent Equiv, Vent f
total body V02) are shown below. There was no significant
difference between digoxin and placebo in any parameter by
paired t test.
Digoxin Placebo Difference
Duration 7.9 + 2.3 7.7+2.6 0.2 + 1.0
Peak V02 19.3 .. 4.6 18.7" 5.4 0.6 .. 4.2
MHR 141 .. 19 143 .. 23 -2 .. 12
02 pulse 10.5 + 2.0 9.7 + 2.6 0.8 + 1.7
Vent 40.5 .. 11.8 41. 5 .. 12.4 -1.0 ~ 9.5
Vent Equiv 29.2 ~ 4.6 31.1+6.1 -1.9 ~ 5.6
Therefore, in ambulatory patients with stable chronic
CHF, systolic left ventricular dysfunction and sinus
rhythm, digoxin has no discernible beneficial effect on
aerobic exercise performance.
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SUBCOSTAL TWO-DIMENSIONAL ECHOCARDIOGRAPHIC
IDENTIFICATION OF ANOMALOUS ATTACHMENT OF
SEPTUM PRIMUM IN PATIENTS WITH LEFT ATRIO-
VENTRICULAR VALVE UNDERDEVELOPMENT
Alvin J. Chin, M.D., Paul M. Weinberg, M.D., F.A.C.C., J.
Gregg Helton, M.D., Beth Aglira, C.C.P.T., Gerald Barber,
M.D., John D. Murphy, M.D., The Children's Hospital of
Philadelphia, Philadelphia, PA,
A new type of atrial septal defect (ASD) has been described
in association with hypoplastic left heart syndrome - the
septum primum (flap valve of foramen ovale) attaches directly
to the postero-superior LA wall, far to the left of the septum
secundum. We examined 43 infants with left atrioventricular
valve (LAVV) hypoplasia or atresia using subcostal 2-
dimensional echocardiography (long axial oblique atrial views)
to determine the incidence of such "malalignment-type" ASD's.
Twelve of 26 (46%) with normally related great arteries, 9/13
(69%) with double-outlet right ventricle, and 2/4 (50%) with
TGA, single LV, and subaortic outlet chamber had
malalignment-type ASD's, which were usually restrictive in
size.
We conclude that leftward malalignment of the superior
attachments of septum primum occurs frequently in patients
with LAVV underdevelopment, regardless of the type of
conotruncus. Complications associated with ASD enlargement
such as perforation of the LA wall during attempted balloon or
blade atrial septotomy are understandable in the setting of
septum primum malalignment. Because of the anomalous
attachments of the septum primum, the atrial septal
configuration would tend to guide a catheter straight toward
the postero-superior LA wall rather than toward the body of the
~A. Recognition of this atrial septal anomaly is especially
Important when performing atrial septectomy as part of the
Norwood procedure for hypoplastic left heart syndrome.
CYSTIC MEDIONECROSIS IN COARCTATION OF THE AORTA: A POTEN-
TIAL FACTOR CONTRIBUTING TO ADVERSE CONSEQUENCES OBSERVED
FOLLOWING PERCUTANEOUS BALLOON ANGIOPLASTY OF COARCTATION
SITES.
Jeffrey M. Isner, M.D., F.A.C.C., Roberta F. Donaldson,
H.S., Ina Bhan, M.D., Tufts-New England Medical Center,
Boston, MA.
Percutaneous balloon angioplasty applied to sites of aor-
tic coarctation (C) has generally resulted in improved
luminal patency, but has been complicated by an unaccept-
able incidence of adverse consequences, including anuerysm
formation at or near the site of attempted dilatation. We
have recently observed that cystic medionecrosis (CMN) is
a predictabl~ histologic consequence of iatrogenic aortic
C in a dog model of aortic C. To determine if CMN might
similarly be observed in humans with C, we reviewed the
histologic sections prepared from resected portions of
aorta in all patients in whom such specimens had been
preserved following attempted surgical repair of aortic C
(14) and in one patient with non-repaired aortic C studied
at necropsy. A total of 1 to 7 sections from the surgical
specimens and 24 sections from the necropsy specimen were
stained with Verhoeff's elastic tissue stain and alcian
blue, and evaluated according to a scale of 0 to 4+ for
depletion and disarray of elastic tissue; and pseudocyst
formation accompanied by increased glycosaminoglycans
ground substance. If both findings were present and graded
as ~ 2+, then the histologic diagnosis of CMN was con-
sidered to be satisfied. Results: CMN was observed in each
of the 14 resected surgical specimens and in the necropsy
specimen as well. In the latter, CMN was present at the
C site and extended 3 cm. proximal and 2 cm. distal to the
C site. Conclusion: these findings suggest that CMN of the
aorta is a consistent histologic feature of C of the
aorta. This finding may explain not only the high fre-
quency of adverse results observed following attempted
angioplasty of aortic C, but also the known association
of aortic dissection and aortic C.
BALLOON DILATATION ANGlOPLASTY FOR COARCTATION
OF THE AORTA IN INFANTS.
Victoria L. Evans, M.D., Michael R. Nihill,M.D., F.A.C.C. and
Saad Al Yousef, M.D., The Lillie Frank Abercrombie Section
of Pediatric Cardiology, Baylor College of Medicine, Texas
Children's Hospital, Houston, Texas.
Operation for aortic coarctation in (CoA) infancy may be a
lifesaving procedure but it still carries a high mortality and is
frequently followed by recurrence of stenosis. This recurrence
of stenosis is more common when the surgical procedure is
performed in the first 3 months of life. Balloon dilation
angioplasty (BOA) was successfully performed in 10 patients
ages 11 to 30 days (median 14 days) with CoA; PDA was present
in 8, a small VSD in 3, ASD in I, and subvalve AS in 1. Each
patient presented in severe congestive heart failure. The balloon
diameter ranged from 3.5 to 5.0mm on a 4.2 to 5 French shaft.
Selection of balloon diameter was based on angiographic
measurements of the aortic isthmus at the base of the subclavian
artery. The dilatation was performed 3-4 times at 6-8
atmospheres (90-120 pisi). The pre-dilation systolic pressure
gradient (t. P) was 25 to 88, (mean 54)mmHg) and post dilatation
t. P was 0 to 30, (mean 7)mmHg). No serious intraprocedural
complications occurred. The CoA was not totally relieved with
a persisting waist in most patients, but allowed these infants
to clinically improve and grow to an age at which surgical
repair may be performed at a much lower morbidity and mortality
risk. With follow-up of 2 to 9 months, 5 patients had recurrence
of CoA clinically and 2 required surgery 4 and 7 months later.
One patient had CoA repair and pUlmonary artery banding for
unrelieved CHF 2 days post BOA. BOA is a safe, effective,
palliative, nonsurgical alternative for the treatment of discrete
coarctation in infants. Refinements in small balloon design
might improve the long term results of BOA in infants.
HAZARIroS BY-PRlnlCTS OF USER IRRADIATIOO - A Q1ALlTATIVE AND
~TATIVE S1UDY
Ciora Ben-Shachar, M.D., Michael L. Spector, M.D., Dermis E. Morse,
Ph.D.. Merril E. Adarr5, Ph. D., Mark C. Sivakoff, M.D., Thanas A.
Rierrenschneider, M.D., Case Western Reserve University, Cleveland,
and Dept. of Anat~ Medical College of Clno.
Laser Irradiation (ALl) of cardiac tissues in blood ....,diun can create
hazardous products such as tissue debris, throobus, gas and tenper-
ature changes. The purpose of this study was to quantitate the
<m>lD1t of these hazardous by-products. Fresh sel!JlEnts of porcine
vascular walls and myocardiun were irradiated in-vitro with contin-
uous ALl in sodiun phosphate buffer. The <m>lD1t of tissue loss and
debris formation was ....,asured and analyzed with Scanning Electron
Microscopy. Artificial circulation utilizing centrifugal purp (Bio-
Medicus 52OD) ALI irradiation chanber and downstrean tenperature probe
chanber were constructed and heparinized blood was circulated @ 2L/rmn.
ALl irradiation with 400 mic fiber at 6 1/2 watts and 400 mic hot-tip
for 10 min. each were perforIred. Tenperature changes at lasing
site and downstrean chanber, and throobus and gas formation were
Ireasured. Vascular walls and myocardial debris fOrIred at a rate of 227
and 61.5 ng respectively per 1,(xx) ng tissue lased, showing charred
frSl!JlEnted tissue segJ!Ents on SEM with sizes ranging up to 3 nm,
Fra!!J!Ents of cell wall, and intracellular neri:>ranes were also identi-
fled. 23.5 and 15.5 ml of gas were fOrIred by both fiberoptic and hot
tip irradiation respectively. Tenperature elevations were be~en 1
and 3.90 c in las1ng chanber and 1 and 2°C in downstream chanber. l5x5
and 6x4 nm charred throobi fOrIred at catheter tip respectively regard-
less of anticoagulant used. Fiber tip ....,lted during irrad1ation
exposure and its length was shortened significantly. In conclusion:
very significant <m>lD1ts of gas, tissue debris and charred throoDi were
fOrIred during continuous lasing process to the extent that nndi-
fications 1n laser technique and applicatlon 'llIst be developed before
laser therapy can be applied in clinical settings.
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EXERCISE HEMODYNAMICS AFTER A FONTAN
PROCEDURE
Gerald Barber, M.D., Thomas DiSessa, M.D., F.A.C.C., John
Child, M.D., F.A.C.C., Joseph Perloff, M.D., F.A.C.C., Barbara
George, M.D., F.A.C.C., Roberta Williams, M.D., F.A.C.C.,
Hillel Laks, M.D., F.A.C.C. University of California at Los
Angeles, Los Angeles, CA
To assess exercise hemodynamics after a Fontan procedure,
8 patients (2 tricuspid atresia, 6 single ventricle) underwent
cardiac catheterization 16 mo. (mean) postoperatively. Supine
bicycle ergometry was performed in 6; all 8 underwent atrial
pacing. CI, PA 02 saturation, mean PA pressure, and systemic
blood pressure were measured at baseline, during pacing, and, in
6 patients, at peak exercise.
Peak pacing heart rate (158 BPM, mean) was significantly
(P<0.05) greater than peak exercise heart rate (132 BPM1
mean). Exercise CI increased 96% (p 0.01) from 2.4 L/min/m L
(mean, rest) to 4.7 L/min/m2 (peak exercise). Pacing CI
decreased 12% (P<O.OI) from 2.4 Llmin/m2 (rest) to 2.1
L/min/m2 (paced). Rest PA 02 saturation (68%) decreased
significantly (P<O.OI) at peak exercise (33%) but not during
pacing (64%). Exercise mean PA pressure (21 torr) increased by
50% (rest=!4 torr) compared to 14% increase with pacing (16
torr). With exercise, mean systemic blood pressure increased
16% from 86 torr (mean, resting) to 100 torr (mean, peak
exercise). Mean systemic blood pressure was unchanged by
pacing (72 torr mean, rest; 75 torr mean, peak exercise).
Patients after Fontan procedure undergoing supine bicycle
ergometry during cardic catheterization display an inordinate
increase in their PA pressure and decrease in mixed venous 02
saturation relative to the increase in CI and workload. That
atrial pacing did not reveal increased CI relative to PA pressure
increase suggests that CI in these patients is more sensitive to
increased venous return from exercise than heart rate.
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POTDTIAL souaCBB OP ERROR III DETEIlIIDIA'I1011 OP
DOPPLER CARDIAC OUTPUT III PEDIATRIC PA'IIDTS
W. Robert Morrow, MD, Daniel J. Murphy Jr., MD, Larry S.
Jefferson, MD, James C. HUhta, MD, FACC, E. O'Brian Smith,
Ph.D., David J. Fisher, MD, FACC. Lillie Frank Abercrombie
Section of Cardiology, Dept. of Pediatrics, Baylor College of
Medicine and Texas Children's Hospital, Houston, Texas.
To assess potential errors in the estimation of cardiac output
in children by continuous wave Doppler we examined the effect
of variations in site of measurement of aortic dimension and
changes in hemodynamic variables on the correlation of
continuous wave cardiac output (CW-CO) with simultaneous
thermodilution cardiac output (TD-CO). Aortic diameter was
determined in systole from two-dimensional long axis echocar-
diograms at the aortic valve anulus, ascending aorta 2 cm above
the sinuses of Valsalva, and aortic root at the sinuses of
Valsalva. We performed 27 CW-CO measurements of aortic
flow velocity in 12 pediatric intensive care patients (age 7 mos-
16 yrs; weight 7-80 kg). Twenty-two serial studies were
performed in 7 patients. All were receiving inotropic or afterl08d
reducing agents.
Results: The range of TD-CO was 1.1-6.3 I/min. CW-CO and
stroke volume were linearly related to TD-CO and stroke volume
(r-0.94, TD=1.02CW + 0.84, SD=0.45 l/min, p<O.OO1). CalCUlation
of CW-CO from aortic valve anulus diameters gave the best
correlation (r=0.94). In serial studies variations in systemic
vascular resistance (694-4972 U'm2'cm-5) and in heart rate (103-
190) did not affect the strength of the correlations. CW-CO
and TD-CO correlated well on serial examination of individual
patients. We conclude that CW Doppler reliably estimates
cardiac output and stroke volume in infants and children even
in the presence of variations in systemic vascular resistance
and heart rate. The use of aortic valve diameter to calculate
CW-CO gave the best correlation with the smallest error.
IN VIVO EVALUATION OF THE CONTINUITY EQUATION FOR ESTIMA-
TION OF MITRAL VALVE ORIFICE AREA Stanley J. Goldberg,
MD, FACC, University of Arizona, Tucson, AZ
The continuity equation equates the product of mean
velocity multiplied by flow path area for two or more
areas of the circulation under the conditions of constant
flow. Measurement of mitral valve orifice area (MYA) re-
mains a time-consuming method. The purpose of this inves-
tigation was to determine the relationship of (MYA) mea-
sured by the elliptical method (EM) and estimated by the
continuity equation as based on Doppler or Fick AO flow
and mitral mean velocity. The population consisted of 34
individuals (17 normals and 17 patients with various
forms of cardiac diseaes, none of whom had AO or mitral
regurgitation or shunts that would affect AO and mitral
flow differently). AO velocities and vessel dimension
were measured from the suprasternal notch with an off-
axis transducer; CO was computed as the product of vessel
area and mean velocity. The mitral annulus was imaged in
short axis and MYA was computed according to the pub-
lished elliptical method. Maximal mitral spatial veloci-
ty, without angle correction, was measured from the api-
cal view. Mitral mean velocity and AO Doppler flow were
used in the conti~uity equation to compute MYA. Mean MYA
by EM was 4.82 c, (2.2 SD) and by the continuity equa-
tion was 4.96 cm {2.5 SD){p~ns~. The correlation of the
two had a value of +.94 (.72 cm SEE). For the 8 patients
who had Fick2flows at catheterization the cor2elation was+.95 (.35 cm SEE) and MYA means were 3.42 em (1.4 SD)
as derived from Fick flows and 3.17 (1.5 SD) for areas
derived by the continuity equation (p~ ns). These results
demonstrate in vivo that the continuity equation accur-
ately estimates MYA under the conditions of absence of AO
and mitral regurgitation, absence of shunts which would
affect mitral and AO flow differently, and availability
of mitral velocity and AO flow.
CORRELATES OF RESTING AND MAXIMAL EXERCISE SYSTOLIC
BLOOD PRESSURE LEVELS AFTER REPAIR OF COARCTATION
OF THE AORTA.
Stephen R. Daniels, M.D., Frederick W. James, M.D., F.A.C.C.,
Samuel Kaplan, M.D., F.A.C.C., Univ of Cincinnati, Cincinnati, OH.
It has been demonstrated that repair of coarctation of the aorta
may not prevent the subsequent development of elevated systemic
blood pressure and the associated premature morbidity and mor-
tality. We investigated the correlates of resting (RSBP) and
maximal exercise (EXSBP) systolic blood pressure in 42 patients
who had graded exercise tests (ET) after correction of coarctation
of the aorta. The age at surgery was 105.9 ± 48.4 months (mean ±
SO). The age at exercise test was 161.9 ± 53.0 months. Multiple
regression was used in the analysis. The regression model which
best explained the variance of each dependent variable and
included regression coefficients which were significantly different
from a (p < .05) was selected. The independent variables
Investigated included height (HT), weight, body surface area, age
at surgery, age at ET, interval between surgery and ET, highest
systolic blood pressure measured prior to surgery (POSBP), gra-
dient across the coarctation measured at preoperative cardiac
catheterization and the residual gradient (RESG) measured at
cardiac catheterization in those patients where residual coarcta-
tion was suspected clinically. The same combination of independ-
ent variables provided the best regression model for both RSBP
and EXSBP. The models2were RSBP = 27.25 + 44.36 x HT + 0.19 xPOSBP + 0.47 x RESG (r =0.45) an2 EXSBP =87.8 + 126.84 x HT
+ 0.53 x POSBP + 1.31 x RESG (r = .71). None of the other
independent variables, including age at surgery, added significant
explanatory ability to either model. We conclude that increased
preoperative systolic blood pressure and postoperative residual
gradient are important correlates of elevated postoperative RSBP
and EXSBP. Corrective surgery for coarctation may be deferred
in asymptomatic children, as long as blood pressure remains
normal, until an age when repair is less likely to result in
recurrent coarctation.
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1HE RELATIOOHP BElWEEN t.ff<X:AmIAL DYSFLtCTlOO NfJ am¥\RY N.EURYs-tS
IN~I DISEASE. Julian M. Stewart, t1J PIi), Paul K. hOOlf, M.D.
Paul Burleson SA, MicnaeIl1.~--rtZ,"m~ MOOical Colleg:!,
Valhalla, Neti York.
LV dysfurrtien (LVD) occurs in cnildren with KCltIasaki Disease (KD)
WIth ooronary arBJrysrT6 (CA) and f1By awear in pts. without CA as \\ell.
In order to ronimasively detect LVD early in KD \\e <i!velqJed CaTPuter-
ized M-rrcx:Ie echocardiograp'lic rretro:ts to assess systolic and diastolic
p'lase indices nol1lBlized for heart rate and ventricular size and a:m-
pared pts. with and without CA.
32 patients \\ere studied, 10 with KD and 22 a~fIBtdled centrols with-
wt heart disease. KD was diagnse<l by the pres~ of at least 6
clasSiC criteria. eart:rols \\ere divicl:!d into 10 fffirile pts. and 12
afebnle. All KD pts. had at least ere eero in the acute p'lase and a
seanJ durirg CCl'lYales~ (1-6 nooths later). KD agas l1ll1Jld fran 18
nos. to 8 yrs. and \\ere divicl:!d into 2~s based en thep~
(-\fA)(N=5) or ab~ (-CA)(N=5) of CA. Peak rate of LV shortenirg
(PRS) and peak rate of LV relaxatien (PRR) \\ere eatPuted fran standard
M-rrcx:Ie ecro and nol1lBlized for R-R interval and LV size. Percent LV
shortenirg (%5) was also calculated. For centrols, results did not
d:pem en the pres~ of fever. All but ere KD patient (-\fA and in
OIert heart failure) had %5 not statistically different fran ccntrols.
/Jcute PRR was si!J]ificantly less than centrol (p .a5) for lx>th (-\fA)
and (-CA) ~s. (-\fA) pts. had greater re<1.ctien in acute PRR than
(-CA) pts. Durirg CCl'lYales~ PRR ta::are nDI1lBl for all (-CA) pts.
but rerJBined I()/ for (-\fA) pts. (p .a5). Acute and CCl'lYalescent PRS
for (-CA) \\ere not si!J]ificantly different fran centrol but acute PRS
was si!J]ificantly decreased in (-\fA)(p .a5). Durirg foil()/-4) PRS
increased to nDI1lBl in all (-\fA) pts.
These data slJ!P!St: 1) systolic and diastolic p'lase indices are ab-
nol1lBl in KD pts. with CA inJ at foil()/-4) diastolic relaxatien rerJBins
inpaired. 2) Diastolic p'lase abnol1lBlities fIBY be present acutely in
KD pts. without CA but disawear at foll()/-4). 3) Pts. with KD have
LVD even without CA but the duratim of LVD is increased in the
p~ofCA.
CONDUCTION SYSTEM IN CASES OF SUDDEN DEATH IN CONGENITAL
HEART DISEASE MANY YEARS AFTER SURGICAL CORRECTION
Saroja Bharati, M.D., F.A.C.C. & Maurice Lev, M.D. ,F.A.C.C.
Deborah Heart & Lung Center, Browns Mills, New Jersey
The conduction system (CS) and the entire heart were ex-
amined histologically in four patients with congenital
heart disease (CHO) Who had surgery many years before they
died suddenly. All were asymptomatic, in sinus rhythm and
living normally. Case I, a 23 year old male had a Hancock
prosthesis from RV to the pulmonary trunk, for tetralogy
of Fallot with pulmonary atresia at the age of 17. Case 2,
a 20 month old male child had a Senning for transposition
at the age of 8 months. Case 3, a 30 year old female had
an ostium primum repaired at the age of 13. The fourth
case, a 9 year old boy had a Hancock prosthesis from the
RV to the pulmonaries for double outlet LV at the age of 5.
All hearts were enlarged with fibroelastosis. CS revealed
in case I, fibrosis and fatty infiltration (FI) of the
approaches to the SA, AV nodes, edema of the atrial septum,
AV node and AV bundle (AVB) with mononuclear cells, a left
sided AVB, dissolution of parts of the AVB and LBB, marked
fibrosis of RBB, fibrosis of the LV and RV. Case 2 revealed
chronic myocarditis,mostly the infundibulum of RV and the
AV node,and a left sided AV~. Case 3, showed FI, fibrosis
of the approaches to the SA and AV nodes, atrial septum,
AVB, and fibrosis of the bundle branches and the right side
of the septum. Case 4, revealed inflammatory changes in the
approaches to the SA node, in the atrial septum, AV node,
AVB and the right side of the septum. The penetrating AVB
revealed loop formation. The branching AVB was left sided.
In summary, our study reveals that fibrotic scar areas and
chronic inflammatory cell infiltrates in the CS and the
surrounding myocardium are seen after surgery. This may be
associated with myocarditis. These pathologic findings may
form an anatomic substrate for arrhythmogenicity and
sudden death in some cases.
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HEART DISEASE IN BASIC TRAINEES WITH CHEST PAIN
Weslex Covitz, M.D., F.A.C.C., Albert C. Ioblnar, M.D.,
casimlr Eubig, Ph.D., Etheridge J. Lovett, M.D., Jams
Christiansen, M.D., MEdical College of Georgia, Algusta.
Basic trainees who sought medical attention for chest pain
were systematically evaluated to detect heart disease and
identify risk factors. The 218 subjects enrolled were
drawn from a potential population of 14,000 trainees
(1.6%). They were equally divided by sex and race. Their
mean age was 21 ~ 3.8 years. The evaluation c~nsis~ed of
a brief screening exam (phase I), a comprehenslve hlstory
and physical (phase II) and echocardiography and exercise
radionuclide ventriculography (phase III). Phase I exams
were sufficient to exclude heart disease in 114 trainees
(52%). An additional 54 subjects (25%) were returned to
duty after phase II. Of the 50 soldiers who entered
phase III 20 were found to have cardiovascular disease
(9% of total group). The most common noncardiac causes
of chest pain were musculoskeletal 104 (48%) and respi-
ratory 27 (12%). Angina was an infrequent complaint 8/218
(4%) but 3/8 had significant heart disease. The most
frequent reasons for referral to phase III were exercise
induced syncope (20/50), suspected mitral valve prolapse
(10/50), and heart murmur (9/50). Mitral valve prolapse
was confirmed in 15/20 trainees with heart disease. Of
those with prolapse, 7 had exercise induced syncope, one
had exercise induced ventricular arrhythmia, and one had
a hypertensive response to exercise. The 5 subjects with-
out prolapse had exercise induced hypertension(2), 2°
heart block with inadequate heart rate response to exer-
cise, exercise syncope with subendocardial ischemia, and
exercise syncope with abnormal take off of the left coro-
nary. Angina, symptomatic mitral valve prolapse, and
exercise induced syncope were important predictors of
heart disease in basic trainees with chest pain.
PLASMA NOREPINEPHRINE AS AN INDICA TOR OF CON-
GESTIVE HEART FAILURE IN INFANTS AND CHILDREN.
Robert D. Ross M.D., Stephen R. Daniels, M.D., David C.
SChwartz, M.D., ~.A.C.C., David Hannon, M.D., Samuel Kaplan,
M.D., F.A.C.C., Children's Hospital Medical Center and Univer-
sity of Cincinnati, Cincinnati, OH "
Plasma norepinephrine (PNE) is usually elevated In adults WIth
congestive heart failure (CHF) and reflects increased s~~thetic
nervous system output. This finding has not been tested In Infants
and children who, unlike adults, frequently have a large left to
right shunt from a congenital defect as the cause of the CHF. We
studied 70 patients (mean age 4.0 years, range I month-14.5 years)
with a variety of cardiac diagnoses, including 19 with significant
left to right shunts, who were undergoing routine cardiac cath-
eterization (cath). On admission, patients were graded for CHF
according to the following modified NYHA classification: I~No
symptoms; II=Slight limitation of acti~it~ (d.yspne~ on exertIon,
diaphoresis with feeds); III=Marked h"'!ltatlon WIth prolonged
feeding times (in infants) or failure to thrIve, moderate to marked
tachypnea and diaphoresis with activity; IV=Symptomatic at rest.
They were routinely sedated for cath and the PNE sample was
withdrawn from the femoral venous sheath after the patient was
either fully asleep, awake but quiet, or when the HR and BP were
at their baseline. Pulmonic to systemic blood flow (Qp/Qs) was
determined by the Fick method. Results (*= P< 0.01):
TABLE A PNE (mean± LSD) TABLE B PNE(mean±ISD)
NYHA IIPT (mI) Q 7Qs IIPT mI)
• _ • >* <. • ± 4. *
II 18 553.6±361.0>* ~1.8 19 689.7±450.4
III/IV 8 1034.0±373.6
We conclude that children WIth CHF .have elevated PNE and
these levels increase in proportion to the degre~ o~ ~ailure ('!'able
A). Patients with large left to right shunts had slgnlflc~ntly higher
PNE levels than those without or with small left to rIght shunts
(Table B). PNE may be a useful indicator of the presence and
severity of CHF in children.
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AV lODE lURCnOIl III THE IKIIATUU IlAKIlALIAII HUn
~ McCormack, M.D" Henry Gelband, M.D.,
F.A.C.C" Hui Xu, M,D., Adrienne Stolfi, Arthur S,
Pickoff, M.D., F.A.C.C, University of Miami, Miami,
FL.
Previous studies have suggested that the functional
refractory period (FRP) of the neonatal AV node
(AVN) is equal to or shorter than the FRP of the
ventricle (V), providing little or no protection to
the V against rapid atrial rates and allowing
closely cour,led atrial beats to fall within the
"vulnerable' period of the V. We evaluated AVN
function in 16 neonatal puppies (5-15 days)
utilizing intracardiac His bundle recording and
stimu lation techniques. Though the effective re-
fractory periods of the AVN and V were not different
(l4l;!:,18 msec, AVN; l40;!:,14 msec, V), the AVN-FRP in
the neonate was significantly longer than that of
the V (l78;!:,17 msec, AVN; l63;!:,14 msec, V, I' < 0.000.
During atrial extrastimulation, atrioventricular
conduction delay was confined to the AVN (Type I
response) in 15/16 neonates, while combined nodal
and infranodal delay (Type II) was observed in 1/16.
In none of the neonates were increases of more than
20 msec observed in A2H2 or HlH2 with any 10 msec
decrease of AlA2. As another measure of AVN
function, the paced HR resulting in AVN Wenckebach
was determined and compared to the resting HR in the
neonates and in a group of adults (nElO). The HR at
which Wenckebach occurred in the neonates was 322;!:,34
and in the adults 276+59. When divided by the
resting HR for each group, comparable ratios were
obtained for the neonates and adults O.8;!:,0.3,
neonates; 2.l;!:,0.3, adUlts). V arrhythmias were
never induced in the neonate during atria 1 pacing.
We conclude that, contrary to previous reports, the
neonatal AVN-FRP is longer than the V-FRP. Further-
more, the degree of protection offered by the
neonatal AVN to the V against rapid atrial rates is
comparable to that observed in the adult.
SHUNT SIZE AND LONG-TERM PATENCY IN SURGICALLY CREATED
VENTRICULAR SEPTAL DEFECTS IN LABORATORY RATS
Eva B. Griepp, M.D., Eugene A, Grossi, M.D., Stephen B.
CoLVln, M.D.
New York University Medical Center, New York, N,Y.
Although pulmonary vascular disease due to
congenital heart defects has long been recognized as an
important problem, little is understood of the mecha~isms
by which it develops because of the paucity of an1mal
models which permit systematic study. In order ~o
investigate the patho~enesis of Eisenmenger Syndrome 1n
an inbred animal sU1table for long-term stud1es, we have
developed a technique for producing a VSD in the
laboratory rat which consistently results in large
pulmonary/systemic flows (Qp/Qs) for as long as 20 weeKs
postoperatively.
This technique is described as follows. Adult rats
are anesthetized
i
a right thoracotomy performed, and a
purse-string paced 1n the RV wall of the beating heart,
By means of a specially constructed device, a 5 mm
polyethylene gronunet wHh an internal diameter of 1.1 mm
and a flange at one end is inserted through the RV wa 11
and ventricular septum. When the dev1ce is withdrawn,
the grommet remains lodged in the septum. Of the
operative survivoors, less than 20% succumb after the
fust 24 hrs.
To assess shunt patency, 28 rats have been
electivel:( sacrificed. Fifteen (54%) had large
left-to-nght (L-R) shunts (Qp/Qs > 2); 1 had a Qp/Qs <
2; the remainder had no shunt. In those wi th shunts,
Qp/Qs (mean + SEM) by oximetry was 4.8+.5 overall: 4,6 at
1-2 wks (9 racs) , 4.9 at 6-9 wks (5), and 5.4 at 20 wks
(2), Because streaming may result in an overestimation
of pulmonary flow by oximetry, Qp/Qs was also determined
in 8 rats by counting activ1ty in the lungs following
injection of radioactive microspheres into the left
atrium. Average microsphere Qp/Qs was 2.3 + .3 overall:
2.7 at 1 wk (3 rats), 2.1 at 6 wks (3), and 2~2 at 20 wks
(2).
These data indicate that it is fossible to create a
VSD in the rat with shunts consistent y of a magnitude
which are clinically significant. The laboratory rat
may, therefore, prove a useful model for the study of
Eisenmenger Syndrome as well as other sequelae of chronic
L-R shunts.
UNEXPLAINED SYNCOPE IN CHILDREN: COST-EFFECTIVE WORKUP?
Douglas S. Moodie, M.D., F.A.C.C., Matthew Passalacqua,
B.A., Richard Sterba, M.D., F.A.C.C., A. David Rothner,
M.D., Gerald Erenberg, M.D., Robert P. Cruse. D.O.
Clevelsnd Clinic Foundation, Cleveland, OH
The cost-effectiveness of the diagnostic workup of
syncope in children has not been evaluated. We studied
73 pediatric patients (pts) with documented syncope.
There were 34 males and 39 females who ranged in age
from 2 1/2 to 20 yrs (mean age 14 yrs) at presentation.
The following table lists neurologic and cardiologic
tests performed and how many of these tests were normal.
Test # Performed Normal
Neurologic consultation 65 64
Electroencephalogram 64 63
CAT scan 37 36
Cardiac consultation 46 44
EKG 68 64
X-ray 43 43
Echo 43 39
Stress test 21 21
Holter 43 43
EPS 7 6
of the 73 pts, only 3 (4%) had serious abnormalities
which could account for their syncope. The total cost
for the diagnostic tests in these 73 pts was $75,494.
Six diagnostic tests were performed per pt. Twenty-nine
pts were also hospitalized giving an average cost for
the total workup in the 73 pts of $2.973 per pt.
Follow-up ranged from 2 wks to 7 yrs (mean 2 yrs) on 50
pts (69%). Only 9 pts still experienced syncope and in
7 the syncope was less. The need for a more goal
directed and cost-effective approach to pediatric pts
with syncope of unknown origin is neccesary, although at
follow-up most pts' syncope had disappeared or was
less.
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LATE BLECTROPRYSIOLOGIC IllIlCTS or UPEB.IMINTAL
aIGBT 'lIITRICULOTOMY
Jeffre~ P. Moak, MD, Arthur Garaon, Jr., M.D., F.A.C.C.,
Lexas n1Idten's HOspital Houston, Texaa.
Right ventriculotomy (Ven} , required for the repair of
congenital heart defecta t haa been implicated as asubstrate for ventriCUlar arrhythmias (VA) and
conduction disturbances (CD) follow1ng cardiac aurgery.
RVCD have important late implications. In the presence
of central CRBB, the development of atheroaclerotic LBBB
would cauae complete AVB, Our purpose was to study the
electrophysiologic (EP) effects of Yen performed early
in life. Six beagle puppiea underwent Yen at 8 weeks of
age; halter and clinical EP study at 14 mo., followed by
m1croelectrode study (ME). The RV preparat10n consiated
of the RV se~tum and attached free wall. During
superfusion w1th Tyrode's solution and pacing the
proximal RBB at 500 msec, 200-250 ME impalementa of the
endocardial surface were made. six beagle puppiea, with
all except Ven, were the control group (C). Impalements
were grouped into 5 regions: outflow septum (OS),
inflow septum (IS!J outflow free wall (OFW), 1nflow free
wall (IFW) , and Yen region (VR). We found: 1) No
spontaneoua or ind~ced VA or CD were detected in vivo in
the Yen or C. 2) In the C, regional differences in
action potential (AP) characterist1cs were observed. AP
amplitude was> in the FW. OFW-119 +/- 2 va OS-113 +/-
~mv, P<.Ol; IFW-1l8 +/- 3 vs IS-l08 +/- 3mv, P<.Ol.
V max was > in the FW. OFW-527 +/- 29 va OS-39l
+/- 38 V/sec P<,Ol; IFW-SOO +/- 32 vs IS-262 +/- 31
V/aec, P<.Ol. APD 100 was> in the FW, OFW-220 +/- 18
vs OS-202 +/- 15 msec, P<.Ol; IFW-223 +/- 28 vs IS-200
+/- 15 msec, p<.Ol. Similar differences were observed
in the Yen. 3) No cellular activity could be recorded
from 51% of impalementa within the Ven scar, yet NS
differencea in AP characteriatics were observed for
those cells successfully impaled surrounding the Yen.
4) Within the Yen scar, delay and conduction block in
local areas (0,5-l,0mm) were oDserved. S) Despite these
abnormalities, there was no delay' of regional activation
of the VR or OFW. In conclusion no spontaneous or
inducible clinical VA occurred if Ven healed at low RV
pressure. Yen had no effect on AP characteriatics. No
RBB occurred with isolated Yen in the OFW. Our results
suggest "peripheral" RBB that develops following VSD
repair may be more "central" in origin.
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CARDIAC ARRHYTHMIA AS A MECHANISM OF SYNCOPE IN CHILDREN
WITH NORMAL HEARTS.
Karen S. Kuehl, M.D., F.A.C.C., P. Jacob Varghese, M.D.,
F.A.C.C., Lowell W. Perry, M.D., F.A.C.C., Stephen R.
Shapiro, M.D., F.A.C.C., and Lewis P. Scott, III, M.D.,
F.A.C.C., Children's Hospital National Medical Center and
George Washington University Medical Center, Washington,
DC.
Fourteen children ages 4-19 years (mean 13.6 yrs) pre-
sented with recurrent syncope. A complete physical exam-
ination and cardiac catheterization in all patients show-
ed a structurally normal heart. At the time of referral
5/16 were treated for seizures despite normal electro-
encephalogram. All patients underwent 24-hour ambulatory
electrocardiogram, exercise testing, and invasive elec-
trophysiologic study. Cardiac arrhythmia was identified
as a cause of syncope in all, atrio-ventricular (A-V)
block in 6/14, ventricular tachycardia (V.T.) in 4/14,
sinus node dysfunction in 2/14 and supraventricular dys-
rhythmia in 2/14. Syncope occurred with exercise in 5
patients; 4 of these had exercise induced ventricular
tachycardia and 1 had A-V block with exercise. Out of 6
patients with A-V block only 2 required pacing. Of 4
patients with V.T. effective drugs included beta blocking
drugs in all in combination with dilantin or Procainamide
in 3/4. These patients have been followed for a period
of 3-45 months with a mean follow-up of 22 months. Dur-
ing this follow-up period syncope recurred in 3 patients;
2/3 recurrences occurred when drug levels were subthera-
peutic. Conclusions: These studies demonstrate that
cardiac arrhythmia is not an uncommon cause of recurrent
syncope in children with structually normal hearts and
that appropriate antiarrhythmic drugs or pacing prevent
recurrent syncope effectively.
roES RESPCNSE 'ID I.V. JlMIO~ Nr ~PHYSI0UX3IC
S'IUDY PREDIcr CLINICAL RESPCNSE 'ID ORAL 'IHERAPY IN
CHILDREN wrrn SVl'? Ashok V. ~ta, MD, FJIlX:: G.R. sanchez,
MD, S. Brickley, OCPI': A. 0 Riordan, MD: R. ramer, MD.
St. Christopher's Hosp. for Children, Phila., PA.
Correlation between response to LV. amiodarone (AM) at
electrophysiologic study (EPS) and oral AM therapy in
children with supraventricular tachycardia (svr) is not
reported. The reported long-tenn side effects are
variable. We treated with AM 12 children, age 8 1lD-21 yrs
(median 10 yrs) with svr refractory to oonventiooal
therapy.
Of 10 pts who were given LV. AM (5 ng/kg) at EPS over 5
minutes, 2 with W-P-W syndrane and 1 intraatrial svr had
inducible svr at 30 6< 45 min but oone had svr at 60 min
and all were oootrolled 00 oral AM: 1 with intraatrial and
1 fast-slow type svr had persistent svr at 3121 6< 60 min and
on oral AM: 3 with ectopic atrial svr had suwression of
svr at 45-60 min post-AM and on oral AM: 2 had persistent
atrial fibrillation and oral AM \\'as oot started. N::lne had
any side effects with LV. AM therapy. en oral AM trial
only, 1 ectopic svr \\'as well oootrolled and 1 WFW syOOrane
had recurrence on a large dose.
Nine pts were maintained on AM for 3 to 413 (median 18)
rronths. During follow-up, OCIlq?licatioos were: 1 reversible
hypothyroidism after discootinuing AM, 1 chemical
hypothyroidism and mild hypertension, 1 sudden death, 2
transient pruritic skin rash, 1 transient personality
change, and 3 CDrneal opacities.
We ex>nclude that 1) for svr in children, EPS 45-60 min
post I.V. amiodarone is helpful in predicting the clinical
response to oral AM (8/8 pts) 2) LV. and oral AM is
useful in suwressing ectopic atrial svr (4/4 pts), and 3)
AM is associated with significant side effects.
ELECTROPHYSIOLOGIC ASSESSMENT OF SINUS NODE DYSFUNCTION
IN POSTOP PEDIATRIC PATIENTS UTILIZING COMBINED AUTONOMIC
BLOCKADE
Barry Marcus, M.D., Paul C. Gillette, M.D., FACC,
Richard T. Smith, M.D., Jeffrey P. Moak, M.D., Alex
Zinner, Arthur Garson, Jr. M.D., FACC; Baylor College of
Medicine and Texas Children's Hospital, Houston, Texas.
Sinus node dysfunction (SND) is a recognized
problem following surgery for certain congenital heart
defects. To distinguish disordered autonomic regulation
from intrinaic sinus node disease, 7 postop (PO) pts
with SND (5 Mustard, 1 Tetralogy of Fallot (Tet), 1
Fontan) underwent electrophysiology study (EPS) of SN
function at rest and during combined autonomic blockade
(CAB) utilizing propranolol (0.2 mg/kg IV) and atropine
(0.04 mg/kg IV). During CAB, intrinsic heart rate
(IHR), intrinsic corrected sinus node recovery time
(INT-CNSRT) and intrinsic sinoatrial conduction time
(INT-SACT) were measured. These results were compared
with age-matched controls from our lab. Normal (nz 7,
mean age 9 yrs) IHRa128 ± 24, INT-CSNRT=135 ± 40 msec,
INT-SACT=86 ± 19 msec.
Among pts PO Mustard (nz 5, mean age 13 yrs, mean
yrs PO 11), 5/5 had abnormal rest EPS, all had prolonged
INT-SACT, but 3/5 had normal IHR. The pt PO Tet (age 20
yrs, PO 14 yrs) had mildly abnormal rest and intrinSic
SN EPS. The pt PO Fontan (age 16 yrs, PO 1.5 yrs) had
sinus rhythm at rest but left atrial rhythm during CAB.
Conclusions: Different aspects of SND may be expressed
during resting EPS vs EPS utilizing CAB suggesting that
the clinical manifestations of SND can vary with the
prevailing state of autonomic tone. It is possible that
some of the SND seen in postop pts may be on the basis
of disordered autonomic regulation in concert with
intrinsic dysfunction.
ELECTROPHYSIOLOGIC CHARACTERISTICS OF YOUNG PATIENTS WITH
ACCESSORY PATHWAYS AND SuPRAVENTRICULAR TACHYCARDIA.
Barbara Deal, M.D.; Daniel Scagliotti, M.D.; Darrell
Prechel, B.S.; Jose Gallastegui, M.D., FACC; and Robert
Hariman, M.D., FACC; University of Illinois, Chicago,
Illinois.
To evaluate the characteristics of arrhytl:mias in young
pts. with accessory pathways, we performed electrophysio-
logic studies (EPS) in 17 pts. without structural heart
disease presenting with recurrent symptomatic supraven-
tricular tachycardia (SVT) involving accessory pathways.
The mean age of the pts. was 16.7 yrs. (range 6-21 yrs.).
Tachycardias identified at EPS were orthodromic SVT (15
pts.), antidromic SVT (5 pts.), and atrial fibrillation
(AF) (6 pts.). All pts. with AF also had either ortho-
dromic SVT (4 pts.) or both orthodromic and antidromic
SVT (2 pts.). During chronic drug stUdies, a mean of
3.5 drugs/pt. were tested. Drugs successful in prevent-
ing induction of sustained SVT were identified in 10/11
pts. without AF. In contrast, induction of AF and SVT
could be prevented in only 2/6 pts. with AF. Antegrade
refractory periods of the accessory pathway (range 220_
400 msec.) did not correlate with either age or the pres-
ence of AF. During a mean follow-up period of 3.4 yrs.,
chronic anti-arrhythmic therapy based on EPS has been
successful in preventing sustained SVT in 10/13 pts.; 4
pts. with AF underwent surgery. We conclude that in
young pts. with accessory pathways and SVT: (1) EPS
successfully identifies effective drug therapy in the
majority of pts. without AF; (2) AF is not uncommon in
this age group, and is frequently associated with recip-
rocating SVT, suggesting that the accessory pathway and
reciprocating SVT may be implicated in the generation of
AF; and (3) surgery is frequently necessary in young pts.
with AF.
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CATHETER ABLATION OF ECTOPIC ATRIAL OR JUNCTIONAL TACHY-
CARDIA FOCI
J~sse C. Davis, M.D., Melvin M. Scheinman, M.D., F.A.C.C.,
Mlchael A. Ruder, M.D., and Jerry C. Griffin, M.D.,
F.A.C.C., University of California, San Francisco, CA.
Five patients (pts) (ages 17-42 yrs) with incessant or
persistent atrial or junctional tachycardia resistant to
drug therapy for 14±7 yrs underwent programmed electrical
stimulation, endocardial mapping and attempted catheter
ablation of arrhythmic foci. One had cardiomyopathy, 2
develop~d ta:hycardia following cardiac surgery and 2 had
no cardlac d1sease. The tachycardia cycle length was
390±72 msec and was irre9ular in 3 of 5 pts. Transient
slowing of tachycardia occurred in 2 following overdrive
pacing but neither overdrive nor premature atrial or ven-
tricular stimulation provoked or terminated the tachy-
cardia. Tachycardia originated in: the right atrial ap-
pendage (RAA) in one, the posterior septum (PS) in 2, the
atrioventricular junction (AVJ) in 2. One or more direct-
current shocks were delivered from an electrode closest to
the earliest area of endocardial activation to a patch on
th~ chest wall. The mean energy used and the peak CPK MB
U~ltS were 490±175J, 37±29 U/L, respectively. Two pts
wlth AVJ tachycardia required chronic cardiac pacing.
After a follow-up of 7±6 mos, surgical amputation of the
RAA was necessary because of recurrent atrial tachycardia
in one, one pt with PS tachycardia developed atrial flut-
ter and required quinidine, while the others remain free
of tac~ycardia without drug therapy. In all pts, the
mechanlsm of tachycardia appeared to be due to enhanced
automaticity. Catheter ablation of right atrial foci is
particularly attractive since AV conduction is preserved.
Arrhythmia control is possible in those with incessant AVJ
tachycardia but sacrifice of atrioventricular conduction
is required.
IN VITRO ANALYSIS OF EMBOLIC POTENTIAL OF LASER IRRADIA-
TION OF CALCIFIED CARDIOVASCULAR TISSUES.
Jeffrey M. Isner, M.D., F.A.C.C., Roberta F. Donaldson,
B.S., R1chard H. Clarke, Ph.D., Tufts-New England Medical
Center, Boston, MA.
The embolic potential of calcified cardiovascular tissues
s~bjected to laser (L) irradiation has important implica-
t10ns for the extent to which L irradiation can be applied
indiscriminately to all varieties of atherosclerotic pla-
que. A series of in vitro experiments was therefore de-
signed to evaluate this issue, utilizing 5-mm. segments of
heavily calcified human coronary arteries (CAs) obtained
fresh at the time of necropsy, in which the lumina were
totally or sub-totally occluded by atherosclerotic plaque
(n=24); and heavily calcified aortic valve (AV) leaflets
(n=13) excised at AV replacement. L irradiation was de-
livered in the continuous mode from an argon laser (484-
514 nm) to tissue samples immersed in saline within a
quartz cell. Radiographs were used to document the extent
of calcific deposits pre-and post-L irradiation. Power was
varied between 4 and 14 watts; exposure was protracted
(10-15 min) in order to maximize embolic potential. Post-L-
irradiated solution was examined by gross inspection; by
radiographic analysis of graded filtrates; and by micro-
scopic examination of spun sediments of graded filtrate.
Results: in each case, the pre-and post-L radiographs doc-
umented at least partial ablation of calcified lesion; ab-
lation was typically more complete for calcified CA seg-
ments than for calcified AV leaflets. In no case, however,
did gross inspection, radiographic, or microscopic analy-
sis of graded filtrates disclose evidence of particulate,
including calcified, particulate material. Conclusion:
these experiments indicate that vaporization of calcified
cardiovascular lesions induced by L irradiation proceeds
from solid to gas phase without generation of prrticulate
debris, suggesting that in vivo L ablation of such lesions
is unlikely to be complicated by distal particulate embo-
lization.
ANALYSIS OF VAPOR-PHASE PHOTOPRODUCTS RELEASED DURING
EXCIMER LASER PHOTOABLATION OF CARDIOVASCULAR TISSUES.
Richard H. Clarke, Ph.D., Jeffrey M. Isner, M.D., F.A.C.C.,
Tufts-New England Medical Center, Boston, MA
Analysis of photoproducts generated during continuous wave
(CW) laser irradiation of cardiovascular tissues has dis-
closed vapor-phase products indicative of a thermal mech-
anism of laser photoablation; corresponding histologic ex-
amination of the irradiated tissues has disclosed signs of
thermal injury. Excimer laser (ExL) irradiation typically
results in no pathologic evidence of thermal injury; photo-
products liberated during ExL irradiation, however, have
not been previously described. Accordingly, gas chromato-
graphic (GC) analysis was performed of vapor-phase photo-
products released during ExL irradiation of atherosclerotic
coronary segments and myocardium in air (n=14), and blood
(n=8). In air, the principal ExL wavelengths (193, 248,~
351 nm) were delivered to tissue samples through the wall
of a quartz cell, using 10 to 100 mJ/pulse. Gas-phase
photoproducts were collected by withdrawing 1-5 cc gas
samples into a syringe through a rubber septum at the top
of the cell. In blood, 351 nm was delivered via an optical
fiber to the sample placed in the cell under a 3-cm column
of blood, using 14 mJ/pulse; the fiber tip was positioned
1-2 mm above the tissue surface. In air, dominant photo-
products identified in order of elution from the GC column
were: methane, acetylene, ethylene, ethane; propyne, allene,
propylene, and propane; and butene. When a fiberoptic was
used to deliver 351 nm ExL emission, a similar GC spectral
distribution was noted. These photoproducts are indisting-
uishable from those previously identified during CW laser
experiments. These results suggest that the mechanism by
which ExL effects photoablation is not essentially differ-
ent from the mechanism involved in CW laser irradiation,
despite the observed differences in light microscopic find-
ings.
A NEW BALLOON CATHETER AND PRESSURE GENERATING
DEVICE FOR R - WAVE - TRIGGERED CORONARY DILATA-
TION WITH DIASTOLIC FLOW MAINTENANCE.
Adolf Kuhl, M.D., Paul R. Lichtlen, M.D., F.A.C.C.
and Otto Anna, Ph.D., Medical School Hannover,
Federal Republic of Germany.
A new dilatation system is developed allowing
systolic inflation and diastolic deflation of the
ballo?n. A~dit~onall~, during dilatation coronary
flow 1S ma1nta1ned w1thout external perfusion.
The dynamic data of the catheter measured by pie-
zoelectric pressure transducer are: pressure
generator pulse rise time = 2 ms; peak pressure =
16 atm.; balloon inflation time = 40 ms' deflation
time = 60 ms; pressur~ drop = 2 atm.; bu;st pressure
= 12 atm.; balloon dlameter = 3.0 mm at 8 atm .. The
frequency response permits transmission of 20 Hz;
resonan:e frequency is 9 Hz (al ternating pressure).
We stud1ed 8 dogs (thoracotomy, magnetic flow-
meter LAD/RCX, angiography) to prove cohtinuous
flow during dilatation. When the inflation time
of the balloon is up to 80% of the RR - interval
flow decreases only to about 50% of the prior
~xistin~ flow level (balloon deflated). Trigger-
1ng dur1ng systole reveals no significant de-
crease of flow. The transfer function of the dy-
namic dilatation system enables alternating of
the balloon diameter induced by defined pressure
step~. Additionally, sinus wave shaped pressure
prof1les of up to 40 Hz can be superimposed to
the basic inflation tone. From these data it is
concluded that this new dilatation procedure
may become better controlled, more effective
and.sa~er in treatment of various types of ste-
nOS1S 1n coronary artery disease.
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ELEC'mOFHYSIOLOOIC OJARAC'lERISTICS CF CEN'lENARIANS:
EVAIIJATICN BY RFSl'IN; AW AMBUIA'ltm ECG
Peter Callaham. M.D" Terry Kinzel, M.D., Chien S. Kuo,
M.D., David wekstein, Ph.D., Anthooy DeMaria, M.D.,
F.A.C.C., University of Kentucky, wington, KY
Uncertainty cootinues regarding the incidence and
nature of electrophysiologic disturbances associated
with aging. '!berefore, we performed resting (20 pta)
and anbulatory (AM) (10 pts) ECG in 20 individuals
doannented to be 100 years of age or greater. Chly 6 of
the subjects had arrt synptorns or signs coopatible with
heart disease or hypertensioo (mild in all), however, 8
were taking digitalis and 9 diuretics. A normal rest ECG
was obtained in ooly 4 subjects. Heart rate ranged fran
56-86 and 29-114 beat/min by rest and AM ECG
respectively. '!be PR interval was L 200 nsec in 12/18
subjects (mean 210). left ventricular hypertrophy, left
anterior herniblock, right bundle branch block and left
bundle branch block were found in 3/20, 7/20, 1/20 and
4/20 respectively. '!be (Jr interval corrected for heart
rate was prolooged in 15/18. Two subjects manifested
atrial fibrillatiCll. Of the individuals cootinuously
mooitored, supraventricular tachycardia manifested as
runs of 3 or more beats was present in 8/10 and isolated
premature atrial beats were present in 10/10. During AM
9/10 had isolated premature ventricular cooplexes, 6/10
had ventricular couplets, and 3/10 had ventricular
tachycardia. Tl1Js, ECG is typically abnormal in
centenarians even in the absence of overt heart disease.
Significant abnormalities of cardiac rhytlln and
cooductioo awear to aocarpany, but not to prohibit,
advanced age.
PROGNOSIS OF PATIENTS WITH THE KARFAN SYNDROME DIAGNOSED
AFTER AGE 32.
Kwan-Leung Chan, M.D., John A. Callahan, M.D., F.A.C.C.,
Hymie Gordon, M.D., James B. Seward, M.D., F.A.C.C. and A.
Jamil Tajik, M.D., F.A.C.C., Mayo Clinic, Rochester, MN.
Most patients with the Marfan syndrome (MS) die of
cardiovascular (CV) complications; the mean age at death
is said to be 32 years. We have identified 28 patients
(15 males, 13 females) in whom MS was first diagnosed
after age 32 (mean age, 46; range, 32-72) and have
evaluated their CV system. Each had at least 2 of the 4
major diagnostic criteria for MS--family history, long-
limbed habitus, dislocated lenses, and aortic disease. At
the initial diagnosis, only 8 patients were referred for
cardiac symptoms, but 23 had signs of CV disease.
Twenty-seven patients (96%) were followed for a mean of 70
months (range, 1-239). Nine died (7 from CV disease and 2
from cancer). Eleven patients had a total of 15
operations; 4 had 2 operations each. Ten operations were
for ascending aortic aneurysms; 5 were for aortic
dissection--3 in ascending aorta and 2 in previously
operated aortas. Only 1 patient required mitral valve
replacement for mitral insufficiency. A total of 14
patients (52%) had CV events during the follow-up. These
occurred in 11 of 15 patients with and in only 2 of 10
without clinical evidence of aortic insufficiency. Among
13 patients with echocardiographic dilated aortas, 7 had
CV events; none of 4 patients with normal aortas had CV
events. Thus, patients first diagnosed to have MS after
age 32 are rare. They are susceptible to a very high
incidence of CV complications, especially when aortic
involvement is present. Significant mitral insufficiency
is uncounnon.
Monday, March 10, 1986
Poster Displayed: 2:00PM-5:00PM
Author Present: 4:00PM-5:00PM
Hall D, Georgia World Congress Center
Pharmacology-Basic
CISIUII-IIDUCID L&!l-COIJPLID, TlIlJGDID lC'fI0il P01'IIIITDLS
D PUIID.JB PIBIIS
Bela Szabo. M.D., Raed Sweidan, H.D., Benjamin J. Soher-
lag, Ph.D., F.A.C.C., and Ralph Lazzara, H.D., F.A.C.C.
University of Oklahoma Health Soienoes Center and Veterans
Administration Hedioal Center, Oklahoma City, OK
Cs induoes early afterdepolarizations (,BAD) and multiform
ventrioular taohyarrhythm1as in dogs resembling "Torsades
de Pointes". Beoause hypokalemia and bradyoardia often
predispose Torsades de Pointes, we superfused ventrioular
tissues from 35 guinea pigs wi th low-K (2.0 111M) Tyrode
solution, and stimulated at 0.2 Hz. Mu:imum diastolio
potentials hyperpolarized to -96+2mV as measured by
standard mioroeleotrode teohniques. Cs <3.6mH) did not
induoe EADs in hyperpolarized oe11s at low Ko' buttriggered (-T) aotion potentials ('APs) ooourred after
intervals "ef 50-200 mseo of stable diastolio potential
with no interposed EADs. Stimulated APs were followed by
one or more TAPs in whioh the rapid upstrokes appeared
without slow depolarizing prepotentials. TAPs were
assooiated with a progressively prolonged plateaus and
were reversibly supressed by inoreasing the stimulus
frequenoy and shortening of the plateau. Both tast and
slow ohannel integrity were neoessary for TAPs, beoause
low oonoentrations of inhibitors ot either ohannel
('1"1'1:2x10-8H; 0-600:1x10-6M) seleotively eliminated TAPs.
Automatioity as a meohanism for TAPs is unlikely, beoause
Cs inhibits paoemaker ourrents. Exploration throUghout
the small preparation failed to show phase 4 depolariza-
tion. Reentry oould be ruled out beoause late TAPs
ooourred in small Purkinje strands even when oonduotion
was prevented by field stimulation. Cs-induoed EADs have
been related to inhibition of repolarizing ourrenta,how-
ever, the meohanism of late TAPs remains to be eluoidated.
FACILITATED ABSORPTION OF INTRAMUSCULAR (i ,m.) HUMAN rt-PA
WITH METHYLAMINE -- A REMARKABLY NON-TOXIC AGENT
Keith A. A, Fox, M.B" Ch.B., Alice K. Robison, Ph.D.,
RiChard U. Rodriguez, Larry E. Fields, M.D., Stanley J.
Sarnoff, M.D., F,A.C.C., and Burton E. Sobel, M.D,
F.A.C.C., Washington University, St. Louis, MO
We previously induced coronary thrombolysis with i .m.
rt-PA with absorption facilitated by hydroxylamine (HA)
in the injectate and electrical field stimulation (EFS),
However, HA can induce significant methemoglobinemia, and
transient hypotension and tachycardia. To obviate such
potential effects, in this study we characterized
factors contributing to enhancement of absorption of rt-PA
and the potential utility and toxicity of analogs of HA in
64 rabbits. Absorption was measured after i,m, injections
of 2 to 3 mg of concentrated t-PA (50 mg/ml) in solutions
with HA (2.6 to 175 mg, n = 17), in hypertonic media with-
out HA (0.63 M NaCl, n = 2), with vasodilators (.01 M
adenosine or .09 Mhydralazine, n =4), with analogs of HA
including several primary amines (n = 36), or with
t-PA alone (n = 5). One agent, methylamine, was particu-
larly salutary. Methylamine HCl (0.63 M) plus EFS elicited
blood levels of rt-PA within 5 min after i.m. injection of
rt-PA, with functional and immunologic activity similar to
that achieved with HA (129 vs 137 ng/ml/mg rt-PA). How-
ever, in contrast to the case with HA, neither methemoglo-
binemia nor hemodynamic derangements occurred, oxygen
saturation remained unchanged, and only modest local
inflammation and interstitial hemorrhage were evident
microscopically in the injection site after 48 hr. Vaso-
dilators, hypertonic media, reduced amounts of HA, or
rt-PA alone led to much lower blood levels of rt-PA (14,
65, 46, and 4 ng/ml/mg rt-PA respectively). Thus, enhance-
ment of absorption with methylamine leads to effective
blood levels of rt-PA after i.m. injection without toxic
effects potentially associated with hydroxylamine.
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COMPARATIVE EFFECTS OF NITROGLYCERIN AND DILTIAZEM ON
REGRESSED, NEWLY DEVELOPED CORONARY COLLATERALS IN
CONSCIOUS DOGS.
Masatoshi Fujita
f
M.D., Daniel P. McKown, Michael D.
MCKown and Dean rank' in, Dalton Research Center, Univ.
of Missouri, Columbia.
We evaluated acute effects of nitroglycerin (NTG) and
diltiazem (DTZ) on collateral blood flow (CBF) and
regional myocardial function in collateral zone during 2
min coronary occlusions (CO). Studies were conducted in
8 awake unsedated dogs instrumented for measurement of
left circumflex coronary artery (LCCA) flow, segment
lengths in areas perfused by LCCA and left anterior
descending artery (LAD). Pneumatic occluders were placed
around each vessel. Brief, repeated LCCA CO induced
collaterals sufficient for resting metabolic demands in
the region supplied by the LCCA. One week following
cessation of repeated LCCA CO, 2 min LCCA (4 dogs) or LAD
(4 dogs) CO with and without drug pretreatment were
performed on separate days. CBF from the LCCA to the
occlUded LAD area was measured as the stepwise decrease
in LCCA flow upon release of LAD CO. During control CO,
ischemic segment shortening (%AL) deteriorated to 33±9
(SEM)% of preocclusion resting values. Following release
of LCCA CO, blood flow debt repayment (BFDR) was l66±53%.
CBF during LAD CO was 20±5% of resting LCCA flow. These
responses were not altered by DTZ (50 ~g/kg, iv), but NTG
(5 ~g/kg, iv) improved %AL (58±14%, p<.05) associated
with decrease in BFDR (74±26%, p<.05) and increase in CBF
(30±8%, p<.05). Thus, NTG produced greater effects than
DTZ in increasing CBF and regional myocardial function in
the collateral dependent zone when effects of each ~rug
on systemic circulation were minimized by pretreatment
with small doses.
ENHANCED SALVAGE OF REPERFUSED MYOCARDIUM BY DILTIAZEM
ADMINISTERED PRIOR TO CORONARY THROMBOLYSIS.
Robert M. Knabb, Ph.D., Thomas L. Rosamond, M.D.,
Burton E. Sobel, M.D., F.A.C.C., Keith A. A. Fox,
M.B., Ch.B .. and Steven R. Bergmann, M.D., Ph.D ..
Washington University, St. lOU1S, MO.
To determine whether salvage of ischemic myocardium sub-
jected to reperfusion after coronary thrombolysis can be
enhanced significantly with calcium antagonists, coronary
thrombi were induced in 27 dogs with an i.e. copper coil.
Ten control dogs had persistent occlusion. Lysis was
induced in 17 others with i.e. streptokinase (SK) 2 hr
after occlusion. In 9 dogs 9iven SK, diltiazem (15
~g/kg/min) was infused i .v. for 24 hr beginning 30 min
before SK. Regional myocardial blood flow was quantified
with microspheres during occlusion, 1 hr after thrombo-
lysis, and 24 hr later. During occlusion flow averaged
0.10 ± .07 ml/min/9 (mean ± S.D.) and did not differ
among the three groups. Myocardi a1 metabo 1i sm was
assessed antemortum by carbon-ll palmitate positron tomo-
graphy. Infarct size 24 hr after occlusion was quantified
by assay of myocardi a1 CK content and dep 1et ion.
Although di ltiazem did not enhance perfusion after
thrombolysis (1.09 ± .48 without and 1.06 ± .51 with
diltiazem), it enhanced salvage of myocardium. Thus,
infarct size (percent of left ventricle) was greatest in
controls (28 ± lIS), was diminished by thrombolysis alone
(17 ± lOS, p < .05), and was markedly reduced by thrombo-
lysis coupled with diltiazem (9 ± 7S) (p < .05 vs reper-
fusion alone). Increased llC-palmitate uptake in pre-
viously ischemic zones (56S compared with 40S of normal
after reperfusion alone) was consistent with the results
of myocardial CK analysis. Thus, diltiazem enhances
myocardial salvage induced by coronary thrombolysis.
DEMONSTRATION OF IMPAIRED CHOLINERGIC VASODILATION IN
THE ATHEROSCLEROTIC RABBIT IN VIVO
Claus Bossaller, M.D., Hideo Yamamoto, M.D., Philip D.
Henry, M.D., F.A.c.c. Baylor College of Medicine,
Houston, TX
Endothel ium-dependent chol inergic relaxation in vitro
is impaired in large arteries from patients or animals
with atherosclerosis. To assess the significance of
this impairment, we compared vasodilator effects of
acetylcholine (Ach) and nitroprusside (Np), an endo-
thelium-independent agent, in control rabbits (C;n=9)
and in rabbits fed a 1% cholesterol diet for 10 weeks
(A;n=6). After 10 weeks, plasma cholesterol in C and A
averaged 58±6 and 2,100±110 mg/dl (P<O.OI). The hind-
limb of the rabbits was perfused during pento-barbital
anesthesia via an extracorporeal loop at a constant
flow of 5 ml/min, which produced femoral arterial per-
fusion pressures of 71±3 (SE) and 74±2 mm Hg in A and C
(p>O.5). Effects of Ach and Np bolus injections on
hindlimb vascular resistance were determined, and dose-
response curves for the two agents were constructed.
Relative potencies were assessed by calculating ratios
(R) of peak vasodilator responses for the two agents.
The R for 0.2mg Ach/5.0 mg Np averaged 1.46±0.18 for
C, and 0.75±0.18 for A (p<.OI). The R for 2.0mg
Ach/50.0 mg Np averaged 0.96±0.08 for C and 0.56±0.11
for A (p<O.OI). Thus, rabbits with hypercholesterol-
emia exhibited a significantly depressed endothelium-
dependent cholinergic relaxation compared to relaxation
evoked by nitroprusside. Since total vascular resis-
tance is determined predominantly by arteri oles, the
results suggest that hypercholesterolemia may affect
endothelium-dependent relaxation at the level of the re-
sistance vasculature.
PREDOMINANCE OF SMALL VESSELS IN CORONARY CONSTRICTION
DUE TO LEUKOTRIENE D •
Francisco RM Laurind~, M.D., David Ezra, M.D.,
John Czaja, Giora Feuerstein, M.D., and
Robert E Goldstein, M.D., F.A.C.C., USUHS,
Bethesda, MD.
Leukotrienes (LT) are white cell products with powerful
capacity to constrict coronary arteries (CA). Marked
LT-induced contraction of isolated CA has led to the
hypothesis that LT contribute to spasm in epicardial
CA. However, the relative LT effects on small and
large CA have not been demonstrated in vivo. We
infused LTD4, 2 mcg/min, into left anterIOr descending(LAD) CA of 6 open-chest pigs instrumented with LAD
flowmeter and catheters in aorta (AO), left ventricle
(LV) and proximal and distal LAD. Initially, LAD flow
decreased from 43±3 to 13±2 ml/min (SE). Simulta-
neously measured pressure gradient from AO to distal
LAD was unchanged from baseline, while small vessel
flow resistance (distal LAD-LV diastolic pressure
difference/LAD flow) increased from 1.4±0.2 to 4.6±0.6
mmHgxmin/ml (p<O.OOI). Thus, distal CA constriction
was responsible for flow decrement induced by LTD4•With continuing LTD4 infusion, LAD flow "escaped" to32±4 ml/min; pesk reactive hyperemic flow remained
blunted (62±8 ml/min vs. basal-lSl±22, p<O.OI). Large
CA resistance was only minimally increased (0.11±0.3 to
0.13±0.3 mmHgxmin/ml, p-O.063). Hence, continued
exposure to LTD4 can induce persistent decrement in CAflow reserve, mainly as a result of sustained small
vessel constriction.
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CORONARY VASODILATOR EFFECT OF VASOACTIVE INTESTINAL
POLYPEPTIDE IN MAN.
Ib2.mu. c.... Smitherman 1m...~ Sami I. Said MD, Guenter
J. Krejs, MD, Gregory J. Dehmer MD, FACC. VA Medical
Centers, and the University of TX and OK University
Health Science Centers, Dallas, TX and Oklahoma City, OK.
Vasoactive intestinal polypeptide (VIP), a probable
neurotransmitter, is widely distributed in neurons,
including those in heart and near coronary arteries. To
investigate for a physiologic role of VIP in regulation
of the coronary circulation in man, we studied vaso-
dilation induced by VIP during intravenous infusion in 8
unanesthetized men (2 with and 6 without coronary
stenoses) during diagnostic cardiac catheterization.
VIP levels rose from 4l!7 to l61!ss pg/ml (x!SD)
during infusion of 100 pmol/kg/h. Mean femoral artery
pressure '4-ecreased 11% (106:!:19 to 94:!:19, p=.04), and
heart rate increased 13% (70:!:11 to 79!IO, p<.OOI). Mean
pulmonary capillary wedge, right atrial, and pulmonary
arterial preS9ures did not chan~e. Cardiac output in-
creased 21% (6.07!L64 to 7.37-1.78 l/min p=.002). Coro-
nary blood flow rose 30% (139:!:74 to 18l:!:77 ml/min,
p=.002). The 33% decrease in coronary vascular resis-
tance (VR) during infusion (0.87 t .4s to 0.sst.20
mmHg/ml/min., p=.Ol1) was greater than (p<.02s) the 20%
decrease in pulmonary VR (104:!:64 to 83:!:46 dyne sec cm-s ,
p=.022), but not significantll (p<.2) different than the
29% fall in systemic VR (1387-543 to 986:!:298 dyne sec
em-5, p<.02). However, the decrease in coronary VR ex-
ceeded that of systemic VR in 6 of 8 patients. We con-
clude that: (1) VIP is a potent coronary vasodilator in
man; (2) the coronary vascular bed appears to be more
responsive than other vascular beds; and (3) these data
are consistent with a poasible physiological role for
VIP in the regulation of coronary blood flow.
ENHANCED' SALVAGE OF REPERFUSEO, ISCHEMIC MYOCARDIUM BY
a-ADRENERGIC BLOCKADE. Kath~n A. Yamada, Ph.D., Jeffrey
Eo Saffitz, M.D., Ph.D., Bur on Eo Sobel, M.D., F.A.C.C.
and Peter B. Corr, Ph.D., Washington University, St.
Louis, MO.
We have previously shown that reperfusion of ischemic
myocardium is accompanied by augmented a-adrenergic re-
sponsivity and a reversible increase of aI-adrenergic
receptor density. Furthermore, aI-blockade immediately
prior to reperfusion prevents intracellular calcium ac-
cumulation in jeopardized tissue. To determine whether
a-blockade decreases irreversible injury as well, we
studied chloralose anesthetized cats with or without phen-
tolamine (l mg/kg) or HEAT (.4 mg/kg) Lv. In cats
subjected to proximal LAD corona~ occlusion for 3 hr fol-
lowed by 4 hr of reperfusion, the ratio of infarct area
(determined by TTC staining) to risk region (determined
with 99mTc-labeled microspheres immediately prior to
reperfusion) was reduced by 29% (p<.02) by a-blockade 2
min before reperfusion (0.46 ± .04, n=71 compared with
values in non-treated controls (0.65 ± .04, n=7). To
determine whether this difference reflected net salvage or
merely delay of necrosis, CK depletion was assayed at nec-
ropsy in myocardium from 17 additional animals. Following
3 hr of ischemia and 48 hr of reperfusion, the difference
in infarct size was not significant (30 ± 7% in 9 treated
cats compared with 38 ± 6% in 8 controls). However, a-
blockade after less prolonged ischemia of 1 hr followed by
reperfusion for 48 hr salvaged an additional 31% of jeop-
ardized myocardium (infarct size = 22 ± 8%, n=6 compared
with 32 ± 8%, n=6 with reperfusion without blockade).
Thus, a-adrenergic blockade markedly enhances salvage of
myocardium subjected to ischemia for 1 hr followed by re-
perfusion for 48 hr, suggesting that this intervention may
be helpful clinically in the setting of thrombolysis.
CARDIAC GROWTH AND VENTRICULAR FUNCTION AFTER
IMPLANTATION OF A GROWTH HORMONE SECRETING TUMOR: A NEW
MODEL OF CARDIAC HYPERTROPHY
Stanley A. Rubin. M.p., FACC, Tom Nusbickel, Todd
Sherman, M.D., David Mickle, and Shlomo Melmed, M.D.
Cedars-Sinai Medical Center, Los Angeles, CA.
To test the hypothesis that hypertrophy alters
cardiac function, growth hormone secreting tumor cells
(GH-3) or control media (C) was injected into 16 mature
Wi star-Furth rats. Eight weeks after implantation, when
body weight had increased an average of 47%, ventricular
function was measured under anesthesia and analyzed by
digital computer, and cardiac morphology was measured
after sacrifice. Blood levels of growth hormone were
3854±2929 nglml in GH-3 rats and 176±261 nglml in C rats
(p<O.OI). Right and left ventricular weight increased an
average of 41% and 36% respectively in GH-3 rats compared
to C rats. When compared to C rats, GH-3 rats htd
significant!~ decreased heart rate (2S0±73 min- vs
219±39 min ,p<O.05), systolic, diastolic and mean
arterial pressures (mean: 7S.0±23.9 mmHg vs 51.S±7.5
mmHg, p<O.OO~ but no difference in LV end diastolic
pressure (1.7±2.7 mmHg vs 3.7 + 3.5 mmHg, P=N.~). GH-3
rats showed decreased indices of cardiac contractility
(dp/dt) and relaxation (-dp/dt) compared to C; in
response to graded doses of isoproterenol, these indices
increased less in GH-3 than in C. We conclude that
cardiac growth occurs in mature rats in response to GH
excess and that cardiac performance and receptor respon-
siveness is decreased. This new model of cardiac growth
offers excellent opportunities to study the physiology,
morphology and biochemistry of hypertrophy.
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MECHANISM OF DECREASED ISCHEMIA BY BETA-
BLOCKADE DURING EXERCISE; DELETERIOUS EFFECT
WITHOUT DRUG-INDUCED BRADYCARDIA.
Brian D.Guth, PhD, Rainald Seitelberger,M.D., Jong-Dae
Lee,M.D., Kazuhiro Katayama,M.D., Mark Miller, John
Ross,Jr., M.D.,FACC, University of California, San Diego, La
Jolla, CA.
Beta-blockade has been shown to improve regional myocardial
bloodflow (RMBF) and regional function during exercise-
induced ischemia in conscious dogs. The role of reduced heart
rate (HR) in this response was studied in 7 dogs chronically
instrumented with an ameroid constrictor on the left
circumflex coronary artery. RMBF (microspheres) and systolic
wall thickening (%WT, sonomicrometry) were first measured
during a control run in which HR increased from 107:!:. 13 (SO)
to 190:!:. 14 beats per min, ischemic zone %WT decreased from
28.8 + 10.6 to 12•.5 + 7.9% and subendocardial RMBF fell from
1.04 -+ 10 to 0.66- + 27 ml/min/~. An identical run was
repeated after atenoiOl (O.3-I.Omglkg,po), but during the run,
atrial pacing was used to increase heart rate from 162 + 11 to
192 + 16 beats/min., the same level achieved in the control
run. -Regional function initially improved in the atenolol run
compared to control running, but with pacing it deteriorated
below that of the control run (%WT=6.8:!:. 6.4, p<.O.5 compared
to control run); RMBF decreased to 0.47 :!:. .22 (p <,0.5).
These findings indicate that in the absence of drug-induced
bradycardia negative inotropic effects and lowered blood
pressure due to beta-blockade unfavorably influence regional
flow and function; they further suggest that bradycardic drugs
without negative inotropic properties should have even more
favorable effects than beta blockade. It is concluded that the
beneficial effect of beta-blockade on exercise-induced
ischemia is due entirely to slowed heart rate, since with heart
rate controlled a deleterious effect is produced.
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SENSITIZATION OF REPERFUSED MYOCARDIUM TO SUBSEQUENT DE-
CLINES IN CORONARY BLOOD FLOW. Erwin Schroder MD. Donald
Laughlin MSEE, Robert Kieso MS, Michelle Hunt BS, Birgit
Grimlund, Richard Kerber MD, FACC, Uof la, Iowa City, Ia
In open-chest dogs, regional myocardial systolic thick-
ening recovers within 30-60 mins of reperfusion after a 5
min episode of severe ischemia. We hypothesized that
such reperfused myocardium is sensitized to subsequent de-
clines in coronary blood flow, and that this would become
evident by more pronounced regional contraction abnormali-
ties at equivalent flow reductions 30 mins after complete
coronary occlusion (CCO) vs. before CCO. We studied 9
open-chest dogs with stable heart rate (pacing), control-
led arterial pressure and autonomic blockade. An external
shunt was placed between the carotid artery and LAD coro-
nary artery; an ultrasonic flowmeter allowed reproducible
flow reductions. Myocardial perfusion (P) was measured by
radiolabeled microspheres and normalized to the nonis-
chemic wall. Regional systolic wall thickening (WTh) was
measured by a new miniaturized M-mode echo (5 MHz) probe
fixed to the epicardium by suction. Regional P and WTh
were measured at rest and during two different levels of
stable flow reduction (shunt constriction) before (con-
trol) and 30 mins after 5 min CCO (n=5). In a separate
group of dogs (n=4) no intervening CCO was done. Results
(*=p<.02, 30 mins vs. control) (mean values) (P=% of oppo-
site nonischemic wall):
Rest Flow Reduction 1 Flow Reduction 2
Group % Control 30' Control 30' Control 30'
No CCO P -8-6- 83 -6-0- 54 -4-6- 38
(n=4) WTh 46 38 25 21 -4 0
5' CCO P 85 86 74 72 54 50
(n=5) WTh 43 37 31 21 3 -8*
Conclusion: Reperfused myocardium is sensitized to sub-
sequent coronary flow reductions; equivalent declines in
P produce more severe regional contraction abnormalities
after a brief coronary occlusion.
IN VIVO ANGIOSCOPIC DEJ«lNSTRATION OF THROMBUS AS A CAUSE
OF CYCLIC FLOW VARIATION IN STENOSED CANINE CORONARY
ARTERY.
Kiyoshi Inoue, M.D., F.A.C.C. and Keiichi Kuwaki, M.D.
Cardiovascular Disease Center, Tokyo Metropolitan Police
Hospital, Tokyo, Japan.
An episodic, spontaneous decrease interrupted by restora-
tions of' coronary blood f'low is known to occur in an exp-
erimental setting of' a stenosed canine coronary artery
with endothelial damage at the site of narrowing.
In this preparation we studied mechanism responsible f'or
this phenomena. Transluminal coronary angioscopy of' an
antegrade approach using ultrathin f'lexible high resolut-
ion f'iberoptic catheter as well as selective coronary
angiography were applied f'or this purpose. Intimal abra-
sion by a biopsy brush and external ligation of' the prox-
imal site under angioscopic vision were done in the lef't
circumf'lex coronary artery in anesthetized open chest
canine preparation. In seven these preparations charact-
erised by cyclic blood f'low and pressure variation in
association with electrocardiographic ST elevation, angi-
oscopic images of' the stenosed area of the inner wall
were monitared on the video display terminal. Spongy th-
rombus obliterated the stenosed segment and angiographic-
ally total obstruction when the flow decreased, and per-
f'orated thrombus as well as angiographically subtotal
obstruction when the flow restored were clearly visualized.
Postmortem study conf'irmed that thrombus initially produ-
ced over the area of intimal damage gradually distended
distally and proximally and obliterated the lumen. This
data support the previous studies in posturating the imp-
ortant role of' acute, dynamic platelets aggregation and
thrombus for cyclic flow variation in these experimental
setting as well as Prinzmetal angina in the clinical
situation.
SYMPATHETIC CORONARY VASOCONSTRICTION DURING ACUTE RIGHT
VENTRICULAR PRESSURE OVERLOAD.
Xue-Zheng Dai, M.D., Jeffrey S. Schwartz, M.D., F.A.C.C.,
Robert J. Bache, M.D., F.A.C.C.
It has been suggested that right ventricular (RV) failure
during acute pressure overload results from ischemia when
coronary blood flow cannot increase adequately to meet
increased RV metabolic needs. This study was performed to
determine whether maximum coronary vasodilation is present
when RV failure occurs. RV myocardial blood flow (MBF)
was measured with micro spheres during acute pulmonary
artery constriction (PAC) with a chronically implanted
hydraulic occluder to produce RV failure, as indicated by
an increase in RV end-diastolic pressure to greater than
15 mm Hg, in 8 unanesthetized dogs. MBF increased from
1.24±0.2l during control conditions to 2.55±0.33 ml/min/g
during PAO. This value was far less than the maximum MBF
of 4.35±0.8l ml/min/g during coronary vasodilation with
adenosine (1. 0 mg/kg/min) during control conditions.
However, infusion of adenosine during PAO did not signi-
ficantly increase MBF. When alpha-adrenergic blockade was
produced with prazosin (0.5 mg/kg Lv.), adenosine
increased MBF during PAO to 4.30±O.54 ml/min/g, not sig-
nificantly different from adenosine during control condi-
tions. These data indicate that MBF was not maximal when
RV failure occurred, and that adrenergic coronary vaso-
constriction limited the increase in MBF during acute
right ventricular pressure overload.
DOPPLER BLOOD FLOW VELOCITY CHANGES AS A SENSITIVE
INDEX OF THE SEVERITY OF CORONARY STENOSIS.
Randall G. Wilson, MDj Louis A. Sordahl, PhD, FACCj
Karen Rex, MSj and Claude It. Benedict, MD, PhD, FACe.
Univeristy of Texas Medical Branch, Galveston, TX.
Assessment of the functional severity of a corona-
ry stenosis (CS) in coronary artery disease is com-
plex. Presently available techniques are inadequate to
predict the severity of a stenosis <75% in cross
sectional area (CSA). Changes in coronary blood flow
velocity (V) inmediately distal to an evolving thromb-
us have been used as an index of thrombus progression
and appeared to predict the severity of CS. The circu-
mflex coronary artery (LCX) of open-chested dogs was
instrumented with a micrometer controlled hydraUlic
occluder and Doppler flow probes placed proximal and
just distal to the occluder. The proximal Doppler
measured coronary blood flow (CBF). Mi liar pressure
catheters were placed in the aorta and the 1st distal
LCX branch to measure pressure drop (PO) across the
stenosis. Occluder inflation mimicked an el iptical
eccentric stenosis and the reduction in CSA was deter-
mined by coronary casts. The resul ts were:
Decrease in CSA(%) 21.4+1.8 50.5+4.8 73.5+7.7
Increase in V(%)t 111+6* 150+8* 199+13*
CBF (ml/min) 31+7 31+7 31+7
PO (rmiIg) 4+2 5+3 5+2
Hyperemic - -
Response (%)t 94+11 85+12 75+17
t baseline = 100%j values are mean +1 S.D.
* p< 0.01 when canpared to respectiV""e control values.
thus, distal velocity changes are a sensitive index of
early CS unlike other hemodynanic paraneters. This may
be of value in the intraoperative evaluation of the
physiological significance of angiographical Iy demon-
strated stenosis at coronary bypass surgery.
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L70 Slope Flow
(mm) (mmHg7mm)(ml/min/gm)
10.1 35 1.1
10.1 42 1.6*
12.0* 32 1.3
11.2* 38 2.2*
PAPAVERINE INDUCED INCREASED FLOW ENHANCES PERFORHANCE OF
REGIONAL POST-ISCHEMIC MYOCARDIUM
~~g~~ l.'t.~l.l.~' Thomas Aversano, M.D, Lewis Becker,
Persistent regional dysfunction following brief coronary
occlusions is improved by dipyridamole which potentiates
adenosine and increases coronary blood flow. To confirm
that coronary flow, and not a unique adenosine effect, ia
the critical factor, we undertook this study using
papaverine, a smooth muscle relaxer and phosphodiesterase
inhibi tor wi th no known ac tion on adenos ine. Six open-
ches t dogs were ins trumen ted wi th an LV pressure
transducer and rairs of sonomicrometer crystals in the
risk and contro regions. After baseline measurements!
papaverine Img/min IV was infused for 10 min. Repeated)
min occlusions of the LAD were performed wi th 10 min
reflow x12 with a final 90 min recovery period.
Papaverine was then reinfused Img/min IV xlO min. Flow
was assessed by microspheres at baseline, end of recovery
and during papaverine Infusions. Function was determined
by systoHc shortening and the end-systolic pressure-
leng tb rela tionship (ESPLR). The linear ESPLR, defined
by a slope and an intercept (the calculated length at an
LV pressure of 70mHg, L70) was obtained as LV pressure
rose during brief occlusions of the aorta. Below are
mean data from the risk region.
Shortening
(%)
Baseline 18.6
Papaverine 21.9*
Recovery/Post Ischemia 6.7*
Papaverine/Post Rec 13.6*
*P<.05 compared to value above.
Before ischemia papaverine increased shortening,
associa ted wi th a 107. decrease in mean blood pressure,
but did not affect the load-independent ESPLR. With
repeated occlusions risk region systolic shortening was
reduced despi te normal levels of flow, and the ESPLR
shU ted to the right reflec ting decreased performance.
Following papaverine flow increased 707.! shortening
increased and the ESPLR shU ted to the leI t indica ting
improved performance compared to recovery.
Conclusion: The results indicate that dysfunction in
post-ischemic myocardium can be improved by increasing
flows to supernormal levels, independent of the mechanism
of vasodilatation.
MYOCARDIAL ISCHEMIA ATTENUATES CORONARY CONSTRICTION
DUE TO A THROHBOXANE A ANALOG.
Francisco RM Laurindo,~.D., David Ezra, M.D.,
John Czaja, Giora Feuerstein, M.D., and
Robert E Goldstein, M.D., F.A.C.C., USUHS, Bethesda,HO.
Thromboxane A2 (TXA2) is synthesized during acute myo-cardial ischemia and has been thought to exert adverse
coronary constrictor effects. However, consequences of
TIA2 exposure to regionally ischemic in~ heartshave not been explored. We infused U-46619, [(SZ,9a,
lla ,13E,15S)-11,9-(Epoxymethsno)prosta-S, 13-dien-l-oic
acid) a stable TIA
2
analog, into left anterior descend-
ing coronary artery (CA) of 14 open-chest pigs, as 1,3
and 10 mcg boluses, each dose before and during 10 min
myocardial ischemia caused by a proximal subtotal CA
stenosis (snare). Coronary flow (CBF, flowmeter),
aortic pressure, regional contraction and distal CA
pressure (n-6) were monitored. CBF(ml/min, meantSE):
Imcg(n-S) 3mcg(n-7) lOmcg(n-10)
BASELINE- 64t8 63t6 SSt4
CONTROL U-46619 _ 40tI0** 38t3* 2StZ*
ISCHEMIA BASELINE- ZOt3* Z4t4* Zlt3*
U-466I9 - ZOt3 Z4t4 ZOt3
*p<0.01 or **p<O.OS vs. control baseline (ANOVA)
Baseline pressure differences from aorta to distal CA
(control - 0 t 0 and ischemia • 46 t 6 mmHg) were not
modified by U-46619. Thus, constriction of small
coronary vessels due to TXAZ is remarkably attenuatedor abolished during ischemia. Our results suggest that
small vessel constriction caused by substances released
by ischemia is not a likely complication of large-
vessel CA occlusion.
CORONARY VASCULAR PROSTACYCLIN SYNTHESIS IS INHI-
BITED WHEN CYCLIC FLOW VARIAnONS ARE ABOLISHED
WITH ASPIRIN IN NARROWED CANINE CORONARY ARTERIES.
Juliet H. Ashton, Ph.D., William B. Campbell, Ph.D., James M.
Schmitz, M.D., Anne Taylor, M.D., Suresh Raheja, M.D., L.M.
Buja, M.D., F.A.C.C., James T. Willerson, M.D., F.A.C.C., Univ.
of TX Hlth Sci Ctr, Dallas.
Previously, we reported that 1.1-4.6 mg/kg aspirin (ASA)
eliminated cyclic flow variations (CFVs) in a canine model of
coronary artery (CA) stenosis in 75% of dogs. A high dose of
ASA (35 mg/kg) was no more effective than lower doses in
abolishing CFVs. In this study, we determined whether the lower
doses of ASA inhibit both platelet thromboxane A2 (TxA2) and
vascular prostacyclin (PGl2) synthesis while also abolishing
CFVs. CFVs, characterized by repetitive cycles of declining CA
blood flow interrupted by spontaneous increases in flow were
established, and then abolished with ASA (1.1-9.2 mg/kg) in
stenosed left anterior descending CA (LAD STEN) in 6 dogs.
CFVs were also established in a separate group of 6 dogs
(NoASA) for 1 hour. LAD STEN and normal circumflex (CIRC)
vessel segments were incubated at 220 C with vehicle alone (V) or
arachidonic acid (AA). TxB2 and 6-keto-PGFla' inactive
metabolites of TxAZ and PGI2, were measured by RIA in the
incubation media. Values below are expressed as mean + SEM,
pg/mg tissue. *p<O.05 significantly different from V in the same
treatment group.
CIRC LAD STEN
6-K-PGF1a TxB2 6-K-PGF1a
AA NoASA ASA NoASA ASA NoASA ASA
V 76+9 56+22 38+6 7+4 81+8 58+12
1O-6M 201;19* 4Z+7 12Z~8* 19+9 117.!i1* 61~14
1O-5M 350+30* 54+5 142+Z7* 49+5* 125+1Z* 53+8
Thus, PGI2 synthesis is inhibited and TxAZ synthesis 1s markedly
impaired by relatively low ASA concentrations that also
eliminate CFVs, suggesting that TxAZ is an important mediator
of CFVs in this experimental model.
MARKED DECREASE IN BLOOD FLOW AND INCREASE IN VASCULAR
RESISTANCE DURING AND FOLLOWING COMPLEMENT ACTIVATED
PLASMA INFUSION
Lyle J. Swenson, M.D., George A. Pante1y, M.D.,
J: David Bristow, M.D., University of New Mexico,
Albuquerque, New Mexico and Oregon Health Sciences
University, Portland, Oregon
To investigate the acute effects of complement activation
on blood flow, we infused zymosan activated plasma (ZAP)
into the femoral artery of the isolated hind limb of 22
swine. Femoral artery blood flow (Q) decreased abruptly,
was lowest at 1 minute of the infusion, then gradually
returned towards control despite continued infusion.
There was no significant change in femoral artery
pressure (P) or femoral vein pressure, although systemic
effects, as indicated by slightly lower aortic pressure,
were observed at 1 minute. These changes were not pre-
vented by alpha blockade (n=2) or selective granulocyto-
penia produced by cyclophosphamide (n=7), but were
slightly attenuated by prior aspirin administration
(n=3). No changes occurred during control infusion of
heat decomp1emented zymosan activated plasma (hd-ZAP).
Control 1 min S min 10 min
P mm Hg 106*6 92*10 111*S 107*6
Qmlmin 82*22 17*6* 29*9* 42*10*
Mean*SE *p<.Ol ZAP vs. hd-ZAP
Following ZAP infusion, increased vascular resistance
persisted as measured by slope of the PQ relationship
during adenosine induced maximal vasodilation (S.9*1.3
ml/min/mmHg vs. 7.6 t 1.2 ml/min/mmHg control, p<.OS).
This effect was not altered by alpha-adrenergic block-
ade, granulocytopenia, or prior aspirin administration.
Complement activated plasma infusion has marked acute
effects on vascular resistance and blood flow. These
effects appear to be mediated by activated complement
components at the microvascular level.
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DELAYED RECOVERY OF REGIONAL DIASTOLIC FUNCTION FOLLOWING
REVERSIBLE ISCHEMIA IN CONSCIOUS DOGS. Martin L.
Char1at, M.D., Padraig G. O'Neill, M.D., Craig J.
Hartley, Ph.D., Robert Roberts, M.D., FACC, Roberto
Bolli, M.D., Baylor College of Medicine, Houston, Tx.
Although recovery of systolic function following rever-
sible myocardial ischemia is known to be delayed
("stunned" myocardium), the pattern of recovery of dias-
tolic function is unknown. Thus, 8 conscious, unsedated
dogs instrumented with epicardial Doppler probes to mea-
sure myocardial thickening underwent a IS-min occlusion
of the anterior descending coronary artery followed by 7
days of reperfusion. No dog exhibited infarction (histol-
ogy). Regional diastolic function was measured by: 1)
mean rate to half end-diastolic thinning (RHEDT) and 2)
late diastol ic thinning fraction (TF). These two para-
meters reflect LV relaxation at 1/2 and 2/3 of diastole,
respectively. Regional systolic function was measured by
systo1 ic thickening fraction (STF). Following reperfu-
sian, the percent changes from preocc1usion baseline were
as follows: (mean±SE) (+p<O.OS, *p<O.OI vs baseline)
2h 4h 1 da~ 2 da~ 7 da,~
Monday, March 10, 1986
Poster Displayed: 2:00PM-5:00PM
Author Present: 3:00PM-4:00PM
Hall D, Georgia World Congress Center
Coronary Artery Disease-Basic
THE EFFECT OF PROSTAGLANDINS PGEl AND PGE2 ON CHOLESTEROL
EFFLUX FROM HUMAN MONOCYTE-DERIVED MACROPHAGES.
Randee C. Goldstein, MS, Alan C. Wilson, PhD, and Peter
T. !Cuo, MD, FACC, IJ¥DNJ-Rutgers Medical School, New
Brunswick, NJ.
Cholesterol accumulation by monocyte-derived macrophages
(MDM) in the arteri4\l intima is the hallmark of early
atherosclerosis. Recent work indicates increased cellular
metabolism of lipoprotein cholesterol in the presence of
interferon. Other workers report that prostaglandin PGE2
synthesis is also stimulated in interferon-treated MDM.
This study was aimed at assessing the effect of PGEl and
iGE2 ~ MDM cholesterol metabolism. Human ~M were loaded
with H-labelled cholesteryl linoleate (H-CL) fOIJ 24h
with cationized low density lipoprotein containing H-CL
(2000 cpm/nmol) as the sole core component. After 24h the
mass content of CL was 78 nmol{mg cell protein. The
lipid-laden cells were then incubated for 24 h in medium
with high density lipoprotein to promote cholesterol
efflux, alone as control, or with PGEl fr PGE2. Cholest-
erol efflux, measured by the amount of H-CL recovered in
the medium, increased by 42% and 60% over control in the
presence of PGEl and PGE2 respectively. Cholesterol ester
hydrolysis w!.s increased two-fold
3
measrured by the
decrease in H-CL and increase in H-free cholesterol,
and cholesterol esterification by acylCoA-cholesterol:-
acyltransferase w's increased three-fold by both PGEl and
PGE2. Total cell H-cholesterol content was decreased 10%
in control cells, and fell by 16% and 36% when incubated
with PGEl and PGE2 respectively. We conclude that prosta-
glandins PGEl and PGE2 actively modulate cholesterol
metabolism in MDM, increasing both turnover and efflux of
cholesterol.
COD LIVER OIL SUPPLEMENTATION INHIBITS CORONARY ATHERO-
SCLEROSIS IN SWINE - Bonnie H. Weiner, MD, FACC, IS
Ockene,MD,FACC, PH Levine,MD, M Fisher,MD, H Cuenoud,MD,
AS Daoud,MD, J Jarmolych,MD, BF Johnson,MD, M Johnson,BS,
J Hoogasian, MA. UMasa Medical School, Worcester, MA
To determine whether cod liver oil (CLO) supplementation
in a swine model of coronary atherosclerosis inhibits
atherogenesis, 6 animals received 30 ml of CLO/day in
addition to a high cholesterol, high fat (HCHF) diet and
were compared to 11 animals who received the HCHF diet
alone. All animals underwent balloon abrasion of the LAD
after 3 wks on their respective diets. Plasma lipid,
platelet fatty acid, serum thromboxane B2,and 6-keto-PGF~
values were determined at baseline, 3 wks, 4mos and 8 mos.
At 8 mos all animals were sacrificed by perfusion fixation
and the coronary arteries subjected to morphometric anal-
ysis. CLO had no effect on plasma lipid levels. Platelet
arachidonate fell from 24.5±2.5 to 11.8±1.1' (p<.02) in
the CLO group and was unchanged in the controls. Platelet
eicosapentaenoic acid was only detected in the CLO group
and was 8.0±.8' at 8 mos. Thromboxane B2 fell from
l4974.4±12295 to 534.3±358.4 and 6-keto-PGF~ from 270.l±
192.6 to 5l.2±15.9 pg/O.l ml (p<.05 for both) in the CLO
group; they were unchanged from baseline in the controls.
Morphometric analysis of 407 segments from the control
group and 172 from the CLO group demonstrated:
'diseased 'L20' stenosis 'segments with CA++
control 87.5 60.4 43.7
CLO 68.0 7.6 3.4
p<.OOl p<.OOl p<.OOl
CLO supplementation inhibits the development of coronary
atherosclerosis in this model. This may be mediated by
changes in platelet fatty acids and prostaglandins, but
not by plasma lipids. The data are consistent with the
observed reduction in cardiovaSCUlar mortality in
populations with a diet rich in marine oils.
STIMULATION OF CHOLESTERYL ESTER SYNTHESIS IN MACROPHAGES
BY VLDL FROM THE WHHL RABBIT, A MODEL FOR FAMILIAL
HYPERCHOLESTEROLEMIA
Toru Kita, M.D., Masayuki Yokode, M.D. and Chuichi Kawai
M.D., Kyoto University, Kyoto, Japan.
We have previously demonstrated that atherosclerotic
plaques of WHHL rabbit are filled with foam cells. To
study the mechanism of the formation of foam cells in
vitro, we incubated macrophage with lipoproteins from
WHHL rabbit. This WHHL rabbit, an animal model of human
familial hypercholesterolemia, has severe hypercholes-
terolemia, cutaneous xanthomas and fulminant athero-
sclerosis including coronary atherosclerosis because of
the deficiency of LDL receptor. When incubated with
mouse peritoneal macrophages, the VL~t from WHHL rabbit
(WHHL-VLDL) stimulated cholesteryl [ Cloleate synthesis
124-fold more than did VLDL from the normal Japanese
White rabbit (control-VLDL). The enhancement in choles-
teryl ester synthesis and accumulation of WHHL-VLDL was
due to the presence of a high affinity binding receptor
site on the macrophage cell surface that mediated the
uptake and lysosomal degradation of WHHL-VLDL. Competi-
tion studies indicated that the receptor for WHHL-VLDL
was different from that previously described for low
density lipoprotein (LDL) or human acetylated low density
lipoprotein (acetyl-LDL), but that there was cross com-
petition withtJ-VLDL. These results suggest that macro-
phages possess a high affinity receptor that recognizes
the cholesterol-rich VLDL present in the plasma of the
WHHL rabbit and that the receptor which mediates inges-
tion of WHHL-VLDL leads to cholesteryl ester deposition
within macrophages. Thus the uptake of the cholesterol-
rich VLDL from the WHHL rabbit by macrophages in vivo may
play a significant role in the pathogenesis of athero-
sclerosis in the WHHL rabbit.
58A ABSTRACTS lACC Vol 7. No 2
February 1986 58A
SUPPRESSION OF ATHEROGENESIS IN CHOLESTEROL-FED RABBIT
WITH A LOW-DOSED CALCIUM ANTAGONIST (PN 200 110)
Jubran B. Habib, M.D., Claus Bossaller, ~.D., Philip D.
Henry, M.D.
Previous studies on anti-atherogenic effects of calcium
antagonists have yielded in part conflicting results.
In these experiments, drug doses administered were 10
to 100 times higher than those used clinically, and the
possibility that the effects were related to reductions
in arterial pressure was not excluded. To determine
whether the anti-atherogenic action of calcium antagon-
ists is related to arterial hypotension, we have fed
rabbits a 1% cholesterol diet and randomly assigned
them to placebo (P;n=14 rabbits) or dru~ treatment with
the new calcium antagonist PN 200 110 (PN; n=14). The
drug was given orally, 0.3mg/kg/day, which corresponds
to a low dose in man. Diurnal arterial pressure pro-
files in the conscious state at 2-week intervals re-
vealed no significant differences (P>.l) between P and
PN. After 10 weeks before killing the rabbits, plasma
cholesterol, phospholipids and triglycerides did not
differ between groups, mean values (in mg/dl) averaging
2140±116, 792±49 and 122±15 for P, and 2012±115, 683±43
and 103±16 for PN. In P rabbits aortic lesions stain-
able with Sudan IV covered 52±5% of the intimal surface
area and the aortic cholesterol concentration was 72±6
mg/g protein. Corresponding values for aortas from PN
were significantly lower and averaged 36±5% (p<.03) and
52±3 mg/g protein (p<.03). Thus, low-dosed PN 200 110
exerted no hypolipidemic or hypotensive effects. Des-
pite marked elevations in plasma cholesterol the drug
suppressed structura1 and bi ochemi ca1 changes of
atherosclerosis.
VERAPAMIL AND DIET HALT PROGRESSION OF ATHEROSCLEROSIS IN
CHOLESTEROL FED RABBITS
R. Sievers, B.S., T. Rashid, M.D., J. Garrett, M.D.,
S. Blumlein, M.D., F.A.C.C., W. Parmley, M.D., F.A.C.C.,
University of California, San Francisco, Ca.
We previously showed that verapamil (V) suppresses aortic
atherosclerosis (ATH) in cholesterol (C) fed rabbits. To
evaluate the effects of oral V and normal (N) diet on
regression, we studied groups of 5-8 rabbits each for 24
weeks (WK). All groups had a C diet for the first 12 WK.
Group I was then sacrificed and had 38% aortic plaque:
GROUP DIET DRUG %AORTIC VERAPAMIL
(WK 1-121 (Wk 1-121 Plaque Level( ng/ml>
13-24) 13-24)
I CI -I 38 + 24(SD)
II c/c -1- 80:;: 8
III C/N -1- 78 :;: 22
IV c/c V!V 54 :;: 10 54 + 59
V c/c -Iv 70 :;: 23 32 :;: 24
VI C/N -Iv 46 :;: 24 41 :;: 35
During WK 13-24, Group II (C diet) and Group III (N diet)
had similar aortic plaque (80 and 78%). Group IV was
treated with V for 24 WK and had less ATH (54%) than
Group II (80%). In Group V, treatment with V during WK
13-24 did not significantly reduce Ath (70%) compared to
Group II (80%). In Group VI, N diet and V during WK
13-24 significantly reduced ATH (46%),compared to Group
II (80%), and Group III (78%), (p<.05). We conclude that
combined V and N diet can halt the progression of ATH
after a 12 WK C diet in rabbits.
VASCULAR RESPONSIVENESS IN PORCINE CORONARY ARTERIES IS
ALTERED BY AN ATHEROGENIC DIET
Rose Marie Robertson, M.D., F.A.C.C., Maria Victoria
Tantengco, M.D. Charles R. Prince, M.D., Thomas B. Gore,
M.D., James B. Atkinson, Renu Virmani, M.D., Jack N.
Wells, Ph.D., Vanderbilt University., Nashville, TN.
To evaluate the effect of hypercholesterolemia on
vascular responsiveness, we characterized the
concentration-response (CR) relationship to adrenergic
and cell-derived agonists in epicardial coronary arteries
from Pittman-Moore minature swine on control and
atherogenic diets.Coronary arterial rings 2-3 mm wide
were equilibratedoat 1 gm tension in Kr~bs-Ringer­
bicarbonate at 37 C, gassed with 95% 0 -5% CO2 at pH7.4. No atheroscle!~sis_~as seen histologically. Cumula-
tive CR curves (10 -10 M) were performed and results
expressed as percent of the maximum response to KCI.
Mean ED50 (~M) ± SEMAgonist Control Hypercholesterol P value
(na 5) (na 9)
Epinephrine (EPI) 3.4 ± 1.6 2.7 ± 0.8 0.341
Isoproterenol (ISO) 0.1 ± 0.02 3.3 ± 1.1 0.039
Histamine (HIST) 9.4 ± 1.0 7.2 ± 0.9 0.003
Serotonin (5HT) 1.0 ± 0.3 1.0 ± 0.3 0.979
Although there was no significant difference in ED50
for EPI or 5HT, maximum contraction was significantly
increased for both EPI (pa O.003) and 5HT (p-0.002). There
was no dose response relationship between cholesterol
level and reactivity for EPI, HIS, or SER, in that rings
from animals with more severe hypercholesterolemia
(234-474 mg%) were similar to those from control animals;
the greatest difference was seen in animals with moderate
hypercholesterolemia (131-215 mg%). Thus, although
hypercholesterolemia shifts coronary reactivity towards a
more easily vasoconstricted state, other factors than
plasma cholesterol per se appear to be operative.
DISADVANTAGES OF ARGON LASERS FOR ANGIOPLASTY.
Martin B. Leon, MD, FACC, David J. Underhill, MD, Paul D.
smith, PhD, William C. Roberts, MD, FACC, Richard E.
Clark, MD, FACC, Stephen E. Epstein, MD, FACC and
Robert F. Bonner, PhD, NHLBI, Bethesda, Md.
An evaluation of Argon laser (Ar) interactions with human
cadaver coronary arteries (n=9, target sites = 124) pro-
Vides evidence for serious limitations which may compro-
mise the safety and efficacy of Ar angioplasty. Using con-
tinuous Ar through fibers (100-600um) with varying lasing
parameters (.65-6w for 1-60s, fiber-target distance=0-4mm,
media=a1r, saline, and blood) we found: (1) Explosive Tis-
sue Ablation. Infrared surface thermography and histology
indicate that initial crater formation is an inefficient,
single large-step process resulting from explosive vapori-
zat~on of tissue water after surface temperature exceeds
100 C with liberation of gaseous and partiCUlate by-pro-
ducts. (2) Marked Thermal Diffusion. Intense crater char-
ring was surrounded by a broad transmural histologic zone
of injury (zoi); from quantitative ocular micrometry. zoi
surface area averaged >8x crater surface area. Histologic
thermal injury occurred at intimal and adventitial temper-
atures above 45 0 C and required only 4J of the energy
necessary to initiate tissue ablation. (3) Variable Ther-
mal and Ablative Effects. Lasing efficiency and thermal
diffusion varied with power density, lasing media. plaque
composition and especially fiber-target distance. Best Ar
ablative effects were achieved by advancing the fiber to
maintain tissue contact thereby reducing thermal diffu-
sion; however, the direction, magnitude, and rate of
atheroma ablation were difficult to control predisposing
to vessel wall perforation. Hence, Ar angioplasty is non-
selective for plaque, imprecise, associated with severe
thermal injury, and results in variable ablative effects
which may restrict future clinical applications.
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PERSISTENCE OF ANAEROBIC GLUCOSE UTILIZATION IN REPER-
FUSED MYOCARDIUM.
M. Schwaiger, R. Neese, W. Wijns, J. Wisneski, M.
Grover-McKay, M.E. Phelps, H.R. Schelbert, and E. Gertz,
UCLA School of Medicine, Los Angeles, and UCSF School of
Medicine, San Francisco, California.
Positron emission tomography (PET) demonstrates in-
creased F-18 deoxyglucose (FOG) uptake in reperfused
myocardium consistent with enhanced glucose utiliza-
tion. To determine the metabolic ~ate of glucose
(glue), [6_14C) labeled glucose and [1 C) lactate were
infused in 4 of 7 dogs in which PET demonstrated in-
creased FOG uptake in the segment that was reperfused
for 24 hrs after a 3 hr balloon occlusion of the left
anterior descending (LAD). Blood samples were withdrawn
simultaneously from left atrium, LAD vein and coronary
sinus (CS) for determining chemical and labeled glucose,
CO2 and lactate concentrations. Compared to the entire
heart (CS sample) extraction of glucose in the reper-
fused myocardium (LAD vein) was 63% higher and averaged
0.35 ± 0.15 \lDlol/ml. 81 ± 5% of glucose entered gly-
colysis, of which 36 ± 11% was oxidized and 64 ± 11%
released as lactate. The fraction of glucose oxidized
was inversely related to plasma free fatty acid levels
(r~-O .86). Thus, increased FOG uptake in reperfused
myocardium reflects increased glucose utilization in
surviving tissue. Oxidation of glucose likely occurs in
cells which still respond to normal regulatory
mechanisms (Le., FFA levels), as compared to injured
cells which metabolize glucose largely anaerobically.
Therefore, the increased FDG uptake seen on PET reflects
primarily anaerobic glycolysis which persists for
prolonged time periods after reperfusion.
Tuesday, March 11, 1986
8:30AM-I0:00AM, Room #313/314
Critical Evaluation of Doppler Echocardiography
COLOR FLOW MAPPING DOPPLER UNDERESTIMATES JET WIDTH WHEN
COMPARED TO LASER DOPPLER ANEMOMETRY IN AN IN VITRO MODEL
OF ADULT AORTIC STENOSIS. David J. Sahn,M.D:: F.A:C.C.,
Tadashi Tamura, C.Ph., M.S., Lilliam Valdes-Cruz, M.D.,
F.A.C.C. Ren Woo, Hsing-Wen Sung, Ajit Yoganathan,Ph.D.,
Univ of Calif, San Diego, CA.
In this study we evaluated color flow mapping Doppler
(CD) in an in vitro model of aortic stenosis with inter-
rogation frOO ~arch" (transducer to valve distance 8
em). We measured jet width at peak systole by CD map-
ping, 25mm from the valve ring where measurements by
laser Doppler anemometry(LDA) were made. For 20 indivi-
dual gradients (GRAD) (15-105 mmHg) through stenotiC
(O.5-2.8cm2 ) bioprosthetic valves, results showed consis-
tent underestimation by CD compared to LDA jet width
(r=O.42) with the greatest degree of underestimation in
mild stenoses with low velocities. When CD was compared
to LDA jet widths for moderate and severe stenosis only
(GRAD >45mmHg)(N-13), a correlation of r-0.90 was ob-
tained but still with slight underestimation of jet width
by CD. For the 20 GRAD, jet width by LDA was narrower in
the more stenotic valves. As an alternate approach, the
length of formation of the acceleration jet proximal to
the stenotic valves at peak ejection was imaged by CD and
correlated well to actual gradients (r-0.88) suggesting
that in more severe stenosis, acceleration begins at a
longer distance proximal to the valve. Our results
suggest that low velocity cutoffs and signal-to-noise
problems in the CD method at interrogation distances
similar to those required in adult aortic stenosis from
suprasternal or high right parasternal views may substan-
tially limit the accuracy of direct noninvasive jet width
measurement. Alternative methods such as measuring the
distance at which acceleration begins in the outflow
tract proximal to the valve,assessed from apical views
may prove important in adult aortic stenosis.
COMPUTER ANALYSIS OF COLOR DOPPLER IMAGES FOR
QUANTITATIVE ASSESSMENT OF FLOW JETS IN A PHANTOM MODEL
Ann Bolger, MD, Neal Eigler, MD, J Martin Pfaff, BS,
Gerald Maurer, MD, FACC. Cedars-Sinai Medical Center,
Los Angeles, CA
Visual inspection of Doppler Color Flow Mapping (CFM)
images allows only subjective assesment of cardiac flow
patterns. To determine if automatic digital processing
of CFM data could quantify volume (V) and kinetic energy
(KE) transfer in flow jets, we interfaced a CFM machine
with a image processing computer and acquired on-line
images at 10 frames/sec. Forty-six power injections of a
cornstarch solution (volumes 2-20 ml, flow rates 2-20
ml/s) were performed via 3 different orifice areas (OA)
into a submerged phantom chamber. Each pixel represents
a volume due to ultrasonic beam thickness; therefore jet
V of each frame was calculated as the sum of pixels
displaying velocity. Jet V was integrated over the
duration of injection and compared to known injection V.
Jet KE was estimated by quantitative CFM as th~ sum of
(number of pixels x colorimetric pixel velocity) and was
compared to the~redicted KE [1/2 x injectate mass x
(flow rate/OA)]. CFM integrated jet Vwas reproducible
for paired injections (r=0.99), correlated with injection
V (r-0.96, SEE=l.B ml), but was specific for OA. Jet KE
estimated by CFM was also reproducible (r-o.99~, and
correlated with predicted KE (re O.96, SEE=2.1x10 ergs)
up to 20x103 ergs and then plateaued due to aliasing.
CFM measurement of KE was independent of OA. Conclusion:
Quantitative computer analysis of CFM appears capable of
accurate and reproducible calculation of jet kinetic
energy as well as estimation of injection volume for a
given orifice. This technique may ultimately allow for
quantification of CFM jets in the setting of valvular
regurgitation and intracardiac shunts.
IN VITRO STUDIES OF THE ACCURACY OF VELOCITY DETERMINA-
TION AND SPATIAL RESOLUTION OF A COLOR FLOW MAPPING
DOPPLER SYSTEM. Tadashi Tamura, C.Ph, M.S., Lilliam M.
Valdes-Cruz, M.D., F.A.C.C., David J. Sahn, M.D.,
F.A.C.C., Univ of Calif, San Diego, CA.
We tested a commercially available color flow mapping
Doppler system (CD) [Irex Aloka 880, 3.5 MHz transducer
(TX») to image the steady flow of a suspension of corn-
starch (1%) in water, flowing at known velocities through
a series of tygon tubings (internal diameter (ID)e1.6 to
4.8 mm) and latex rubber tubings (ID - 7.9 to 15.9 mm) in
a water tank. Flow through the tubes was imaged at 2-12cm
and 18cm distances from the TX using the near and the far
focus settings of the instrument. First, the color flow
diameters were compared to the known ID of the tubings
oriented at a 30°_ 60° flow angle to the direction of
interrogation to test lateral resolution. At <6 em from
the TX, the CD diameter obtained with the near and far
focus settings correlated equally well with the actual ID
(r=0.99, SEE -0.23mm; and r-0.99, SEE-0.17mm, respec-
tively). Axial resolution was likewise excellent in this
depth range, but results were gain dependent. At >6cm
distance, CD measurements with the near focus overesti-
mated the ID (up to 7 times the ID); the far focus also
overestimated the ID but to a lesser degree (up to 1.8
times the ID of the 2.4mm tube). The lowest flow velo-
city color encoded by the instrument at 0° angle to flow
was 3 cm/sec (133Hz) either towards or away from the TX.
At a flow velocity of 50cm/sec, 6 cm distance from the TX
and mid gain settings, flow through the 1.6mm tube barely
color coded while flow through 2.4mm, 3.2mm and 4.8mm
tubes was easily imaged. These results have direct impli-
cations in clinical studies for imaging small septal
defects or when measuring CD flow diameters of vessels or
valves for volume flow calculations.
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A COMPARISON OF OOPPLER-ECHOCARDIOGRAPHIC METHODS FOR
CALCULATING TRANS-MITRAL BLOOD FLOW IN A CANINE MODEL
Kathryn J Ascah, MD, William J Stewart, MD, Marco 0
Triulzi, MD, Linda-n Gillam, MD, FACC, Arthur E Weyman,
MD, FACC, Massachusetts General Hospital, Boston, MA
Accurate measurement of the valvular cross-sectional area
is an important factor in the Doppler-2D-echocardiographic
calculation of intracardiac blood flow. To compensate for
the variation in mitral valvular cross-sectional area
during diastole, several different methods for calculating
the diastolic mitral valve area (MVA) have been described.
To evaluate the relative accuracy of these methods for
obtaining the effective MVA used in deriving Doppler
mitral blood flow, we compared mitral blood 'flow
calculated using 7 methods of measuring MVA, with known
trans-mitral flow in a canine model. Mitral flow ranged
from .44 - 4.6 l/min. MVA was computed from the maximal
and mid-diastolic antero-posterior (AP) and 4-chamber (4C)
annular dimensions assuming circular and elliptical
configurations. Mitral blood flow was also calculated
using the mean-to-max ratio method described by Fisher.
RESULTS:
METHOD n SLOPE INTERCEPT r SEE
4Cmaximal circle 33 1.18 .64 .84 .69
4Cmid circle 34 1.4 .13 .78 .95
APmaximal circle 50 .86 .37 .81 .57
APmid circle 50 .93 .13 .81 .61
Ellipse maximal 30 1.06 .33 .84 .62
Ellipse mid 30 1.15 .16 .83 .69
FISHER 55 .89 .24 .88 .46
CONCLUSION: All methods yielded satisfactory results.
Methods employing the AP dimensions underestimated floW,
whereas those using the 4C overestimated flow. The
ellipti~al methods result in slopes most closely
approximating unity.
DOPPLER ECHOCARDIOGRAPHIC EVALUATION OF LEFT VENTRICULAR
SYSTOLIC PERFORMANCE - COMPARISON WITH DP/DT AND MINUTE
WORK UNDER VARYING CONDITIONS.
Kenneth Wallmeyer. M,D., Terrence Cogswell, M.D., L.
Samuel Wann, M.D., F.A.C.C., Kiran Sagar, M.D.,
F.A.C.C., Andrea Purnell, B.S., Donna Peterson, B.S., H.
Sidney Klopfenstein, M.D., Ph.D., Medical College of
Wisconsin, Milwaukee, Wi.
To investigate the ability of Doppler echocardiography
of ascending aortic blood flow to assess left
ventricular performance, seven open-chest dogs were
studied under varying conditions of preload, afterload,
and inotropy. Different loading conditions were
achieved using occluders around the venae cavae and the
descending a~rta; changes in inotropic state were
induced by dobutamine infusion (5 meg/kg/min 1. V.) and
propranolol administration (1-2 mg/kg 1. V.) • LV
anterior wall segment length (sonClll1icrometer crystals)
was used as an index of preload, and mean aortic blood
pressure (catheter tip transducer) as an index of
afterload. Phasic ascending aortic blood flow
(electromagnetic flow probe) and LV pressure (high
fidelity transducer) allowed measurement of maximum
aortic flow (elmax), peak acceleration of flow (dQ/dt),
minute work, and dp/dt. A continuous wave Doppler
transducer applied to the aortic arch was used to
measure peak aortic blood flow velocity and mean
acceleration. Data from all hemodynamic states were
pooled and analyzed by the least squares method of
linear regression. Peak velocity correlated closely with
minute work index (r = .78; p<.001) and Qm~ (r = 0.71;
p<.oon and less well with dP/dt (r = 0.63; p< .oon.
Mean acceleration of aortic blood velocity was most
closely correlated with peak dP/dt and dQ/dt (r = 0.83
and 0.70, respectively, p<.001), and less well with
minute work (r = .49, p<.005). In conclusion, Doppler
measurements of peak aortic blood flow velocity and mean
acceleration offer an effective means to assess acute
changes in LV performance under conditions of widely
varying preload, afterload, and contraotility.
ASSESSMENT OF LEFT VENTRICULAR-SYSTEMIC ARTERIAL
COUPLII\G: A NEW APPLICATlO'l OF DOPPLER ECI-()CARDI<X;RAPHY
Alex Neumann, Kenneth M. Borow, MD, Sajeev G. Shroff, PhD,
Dina Janzen, Dianne Altman, Univ of Chicago, Chicago, IL
Doppler echocardiography has allowed noninvasive assessment
of LV and AO flow In humans. Recently, calibrated carotid pulse
tracings (CPT) have been shown to accurately measure
instantaneous LV ejection pressure and wave morphology. The
combination of simultaneously recorded AO flow (from
suprasternal Doppler) and pressure (from CPT corrected for pulse
transmission time) allows assessment of Instantaneous LV and
systemic arterial hemodynamics. This is particularly Important
since traditional indices (such as SVR) use mean pressure (Pm) and
flow and thus describe the heart as a non-pulsatile pump. This
type of assessment may lead to underestimation of LV energetics.
Total LV power (TP) Incorporates Instantaneous AO pressure and
flow and therefore can be used as an index of performance of the
coupled LV-arterial system. TP is more sensitive to changes in
hemodynamic conditions than either pressure or flow considered
alone. TP can be divided Into: (1) steady power (SP) which
maintains forward blood flow and (2) oscillatory power (OP) which
Is lost in pulsations of the arterial system. Only SP results in
effective flow. The efficiency of the LV-arterial coupling can be
assessed as OP/TP.
Using the Integral of AO pressure and flow, Pm, cardiac output
(CO; L/mln), SVR (dyne-sec-cm-5), TP, SP, and OP (mW) were
calculated In 16 normal subjects (age: 38z15 years). AO root size
was measured by 20 echo and blood flow calculated. Heart rate
was 68 Z 10 bpm.
Pm ~ SVR TP SP OP OP/TP
Mean 96 6.1 1290 1580 1260 280 .17
SO 9 1.0 200 320 380 80 .03
These data establish normal values for LV power using this
technique. If only SVR were determined, OP would be neglected.
However, OP accounted for 17% of TP. ThUS, a detailed
noninvasive assessment of the LV-arterial coupling is now possible.
Tuesday, March 11, 1986
10:30AM-12:00NOON, Room #313/314
Doppler Echocardiography for Mitral Valve Disease
DOPPLER DOOKEIS CF MITRAL REX;(JffiITAT!(I;I: REFINIro 'mE
CRlTERlA
TzErYu Dang. K>l John A. Mallery, MD~ Julius H. Gardin,
MD, FAO::.~ Alice Allfie~ sandy Clark~ Walter L. Henry,
MD, FAcx:.. University of California, Irvine, CA
Despite the sensitivity of pllsed DoWler
echocardiography (echo) in detecting mitral regurgitatim
(MR), recent reports have suggested a high-incidence of
false-positive stlXlies for MR in normal subjects. To
devise IOOre specific criteria for MR, p,tlsed DoWler and
left ventriculography were coopared in 86 patients
undergoing clinically indicated cardiac catheterizatim.
In additim, 20 normals were stooied by Dowler.
Twenty-seven of 86 patients (31%) and 4 of 20 normals
(20%) had systolic turbulence in the left atrilDD by
Dowler echo. Ten of these 27 patients had MR by
angiography: all 10 dema1strated hol06ystolic turbulence
in the left atrilDD, maRJed in both the apical four- and
two-chantJer views, with peak jet flow velocity (pFV) >lSO
cnv'sec. Of the 17 of 27 patients with no MR by
angiography, only 2 patients fulfilled all above Dowler
criteria and were falsely identified as having MR. l\malg
the 20 normals, 4 dema1strated systolic (3 had
hol06ystolic) turbulence in the left atrilDD, but PFV in
all was less than ISO cnv'sec. sensitivity and
specificity of the OOlbinatim of DoWler PEV >lSO cnv'sec
plus holosystolic turbulence in both apical views for
detecting MR (coopared with angiography) were 83% and
100%, respectively. we conclude that systolic turbulence
can be detected in the left atrilDD in many normals and
patients without angiographic evidence of mitral
regurgitatim. However, hol06ystolic turbulence recorded
in both apical views with peak flow velocity >lSO cnv'sec
identifies patients with mitral regurgitatim by
angiography.
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EXERCISE DOPPLER ECHOCARDIOGRAPHY IN PATIENTS WITH
ISOLATED MITRAL STENOSIS: CLINICAL FEASIBILITY.
Eugenio Moro, M.D., Folkert J. ten Cate, M.D. and Jos
Roelandt, M.D., F.A.C.C., Thoraxcenter - Erasmus
University Rotterdam, The Netherlands.
DOPPLER MITRAL PRESSURE HALF-TIME IS liQI. AN INDEPENDENT
PREDICTOR OF MITRAL VALVE AREA.
Kiran B. Sagar. M.D •• F.A.C.C., and L. Samuel Wann,
M.D., F.A.C.C., Medioal College of Wisoonsin and
Zablooki VA Medioal Center, Milwaukee, Wi.
MVF m/sec
DFP m/sec
MG mmH~
MVA em
HR b/min
SV m/min
CO l/min
Exercise
110.1:t. 7.5 bpm·
l8.3:t. 7.2 mm Hg.
184.0~9.0 msec••
1.2;t. 0.3 om2..
Mitral valve area oan be estimated from the mitral
Doppler velooi ty flow profile using the pressure
half-time and an empiric oonstant. This constant does
not take into account differenoes in cycle length or
transvalvar gradient and flow. To determine the
influenoe of these variables on the pressure half-time
method, we performed pulsed Doppler eohoes at rest and
during symptom-limited supine bioycle exercise in 10
patients with mitral stenosis. The mean gradient
across the mitral valve was determined from the flow
velooity integral and the mitral valve area
calculated as MVA = _--'2....2.11.0 _
pressure balf-time
B.W.
74.5:t.14.4 bpm
9.4:t. 4.6 mm Hg
225 .2;t.62.0 mseo
1.0:t. 0.3 om2
Heart Rate
Mean Mitral Gradient
Pressure Half-Time
Mitral Valve Area
(mea~D)
• P<.OOl Rest vs Exercise
•• P<.005 Rest vs Exeroise
We conclude: 1) mitral valve area by the pressure
half-time method varies with changes in heart rate,
transvalvar gradient and flow, 2) since anatomic valve
area does not change, the pressure half-time method
probably underestimates true valve area at higher heart
rates and flows, 3) caution is adVised in using the
pressure half-time method to estimate valve area in
patients with rapid heart rates and increased
transvalvar flow.
Doppler is a non-invasive and reproducible tool which
provides relevant information about the dynamic responses
to Ex in pts with MS which occur early during Ex and can
substitute for cath in most patients.
Exercise (Ex) raises heart rate (HR) and cardiac output
(CO) and is helpful in the determination of dynamic mitral
gradient (MG) in patients (pts) with mitral stenosis (MS)
but has important practical limitations during cardiac
catheterization (cath). The feasibility of combined two
dimensional (2D) and continuous wave Doppler (CWD) echo-
cardiography (E) during Ex was tested in 7 pts (mean age
33 years, 5 male and 2 female) with pure MS and sinus
rhythm. Baseline 2D and CWD-E were performed, CWD was
repeated after 1 minute of supine bicycle Ex at work-
loads of 25 and 50 Watts (W). Mitral valve area (MVA) as
determined in short axis parasternal view, was considered
fixed. From the velocity tracings these parameters were
derived: mean flow velocity (MFV) , mean MG, diastolic
filling period (DFP). Stroke volume (SV) was calculated
as DPFxMVAxMFV and CO is the product of SVxHR. Results
are given as mean ~/standard deviation: lfp ( 0.05.
Baseline 25 W 50 W
1.4 + 0.1 1.9 + 0.2* 1.9 + 0.2*
508 +70 340 +45* 355 +48~
9 + 3 16 + 8* 16 + 9*
1.4 +0.4 - - *
65 + 6 89 ±. 9* 90 ±. 7
82 + 4 76 + 8 79 ±. 7 *
5.3 ~ 0.6 6.5 ~ 0.5* 6.7 ±. 0.5
EFFECT OF AORTIC REGURGITATION ON THE DOPPLER-DERIVED
MITRAL PRESSURE HALF-TIME.
Kwan-Leung Chan, M.D. and A. Jamil Tajik, M.D., F.A.C.C.,
Mayo Clinic, Rochester, MM.
Mitral stenosis can be difficult to diagnose in the
presence of aortic regurgitation. Doppler-derived mitral
pressure half-time (MBT) has been useful in quantitating
the severity of mitral stenosis and estimating the mitral
orifice area. MHT has been reported to be independent of
mitral regurgitation and heart rate. To determine the
effect of significant aortic regurgitation on MHT, 17
patients (12 males,S females; mean age, 47 yr; range,
15-79) with nonstenotic mitral valve were prospectively
evaluated by continuous-wave (CW) , pulsed-wave (PW) , and
color flow Doppler studies. Significant aortic
regurgitation, defined by the regurgitant stream tracking
to or beyond the papillary muscle on color flow imaging,
was present in each case. The regurgitant jet was
directed to the anterior mitral leaflet in 14 patients and
toward the ventricular septum in 3 patients. In 9 of the
14, but none of the 3, ew Doppler signal was inadequate
for calculation of MHT because of contamination by the
aortic regurgitation signal. PW study yielded good mitral
inflow signal in each case. The mean MHT by PW was 66 ms
(range, 43-100). In the 8 patients who had both CW and PW
measurements, MHT was similar by both techniques (68 ms vs
67 ms) but the early diastolic flow velocity was higher
with CW (1.10 m/s) than with PW (0.72 m/s) (p < 0.05).
Thus, Doppler-derived MHT does not appear to-be affected
by significant aortic regurgitation. Both CW and PW can
be used to derive MHT, but PW is preferable when the
aortic regurgitant jet is directed toward the anterior
mitral leaflet because signal contamination by aortic
regurgitation can be avoided.
QUANTIFICATION OF MITRAL STENOSIS: A COMPARATIVE STUDY OF
TVO-DIMENSIONAL AND DOPPLER ECHOCARDIOGRAPHY AND INTRACAR-
DIAC HEMODYNAMICS. Melvin A. Gonzalez M.D., John
S. Child, M.D., F.A.C.e:-;--and 1anfni-Kr1"votapTcn, M.D.,
F.A.C.C. UCLA School of Medicine, Los Angeles, CA
Forty-three pts with mitral stenosis (MS) were studied
using 2-D and Doppler echo to assess the relationships
between cath-derived pressure gradient half-time (P~),
Gorlin formula mitral valve area (MVA) , and 2-D echo MVA
as compared to MVAs determined from Doppler velocity
half-times (t~s). A reliable line drawing method for
measuring t~s in the presence of non-linear initial
Doppler velocity profiles was determined to be a line
using the mid-diastolic Doppler profile. The success rate
of each method in quantitation of MS was assessed. MVA
was quantifiable in 91% of pts using 2-D or Doppler, and
in 99% if both ~echniques were used. MVAs from 2-D and
Doppler (HVA(cm )=220/t~ (msec» were compared to MVAs
calculated from Gorlin formula and cath-derived P~s in 27
pts. Doppler t~s and hemodynamic P~s had an inverse ex-
ponential relationship to Gorlin formula MVAs (r=-0.81 and
-0.89, ~espectively); 220 msec approximated a valve area
of 1 em. In the absence of mitral regurgitation both 2-D
and Doppler accurately predicted Gorlin formula MVAs
(r=0.73 and 0.95, respectively). Doppler and 2-D MVAs
were strongly correlated (r=0.89). In the lresence of mi-
tral regurgitation, 2-D MVAs correlated wea ly with Gorlin
formula MVAs (r=0.38) but a strong relationship (r=0.90)
persisted between Doppler and Gorlin formula MVAs.
Thus, 2-D echo provides an accurate anatomic orifice
area whereas Doppler provides additionar-rnIOimation re-
garding physiologic significance of any given MVA. The 2
techniques are accurate and complementary in quantifica-
tion of MS. To achieve these results, it was important to
establish an accurate and reproducible Doppler velocity
line drawing method which does not use early non-linear
portions of the curves.
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DISS 8 :recurrence def. @ without localized intimallasion
The recurrence rate according to definition @ (25.9 %) stetistically was not diffe-
rent in comparison to def. ® (24.8 %1 rasp. def. CD (19.2 %).
Conclusions: In pts with very short steno.s (group A) the frequency of recurrence
attar successful PTCA is lignificantly lower al comparad to group B. An additionel
increase of the initial length (group. C + D) dosl not result in a further increase of
the recurrence rate. In addition, recurrence tendl to be less frequent if PTCA caused
a localized intimel lesion. However, the number of pts il limited and further confir-
mation of theM date il needed.
RECURRENCE RATE AFTER PTCA IN RELATIONSHIP TO THE INITIAL
LENGTH OF CORONARY ARTERY NARROWING
Rainer Uebis M.D., Rainer von Euen M.D., Jiirgen vom Dahl M.D., Hermann J.
Schmitz M.D., Katja Seiger, Sven Effert M.D.
Dept. of Internal Medicine I, RWTH, Aachen, West Germany.
In 100 con.cutive patients (pts) with one-veuel di.ase undergoing elective percu-
taneous transluminal coronary angioplasty (PTCA), the intial length of the lesion
U.e. the MCtion with at least 50 %narrowing of the intial veuel diameter' _ calcu-
lated and comparad to the recurrence rata. A control angiogram attar 5.9 ±. 2.1
months could be obtained in 89 cases. 3 definitions of recurrence were comparad;
CD :long term gain of diameter~20 %;®: loa of initial gain ~ 50 %;@: ®or
increase in diameter stenosis ? 30 % in comparison to narrowing immediately attar
PTCA. In addition, the frequency of e localized intimel lesion - not exceeding the
length of the infleted balloon - in correlation to the recurrence rate was ..alysed.
Results·
LENGTH OF RATE OF RECURRENCE DISS.
GROUP STENOSIS I MM DEF@ G 8
n % n n
A 22 <2 ~~ 1 0 1B 24 2-2.9 33.3 • 6 2 4
C 24 3-3.9 33.3 7 4 3
0 19 ~4 31.6 5 0 5
L~ 99 26.9 19 6 13
.: p 0.05 ; DISS ~: recurrence def. ® and localized intimal lesion
CHARACTERIZATION OF MITRAL STENOSIS VELOCITY JET BY
COMBINED COLOR FLOW IMAGING AND GUIDED CONTINUOUS-WAVE
DOPPLER.
Bijoy K. Khandheria, M.D., A. Jamil Tajik, M.D., F.A.C.C.,
Guy S. Reeder, M.D., F.A.C.C., Mark J. Callahan, M.D.,
Rick A. Nishimura, M.D., F.A.C.C., Fletcher A. Miller,
M.D., F.A.C.C. and James B. Seward, M.D., F.A.C.C., Mayo
Clinic, Rochester, MN.
Color flow imaging (CFI), a new Doppler technology, per-
mits real-time visualization of intracardiac blood flow.
Mitral stenosis jet velocity profiles were defined in 42
patients (35 females, 7 males; mean age 58 yr, range 26-83
yr; mean body surface area 1.65 m2, range 1.44-2.27 m2).
All had satisfactory CFI. Frequency aliasing resulting in
color reversal--producing a central blue zone surrounded
by shades of red/yellow (candle flame appearance)--was
noted in all patients. Variable jet configurations were
identified: central and directed apically in 18/42 (43%);
central and directed laterally (scimitar shape) in 18/42
(43%): and unusual shape in 6 (14%) (mushroom-like in 2,
bifid in 2, posterior in I, and medial in 1). The jet
configuration allowed visualization of maximum velocity
vectors, permitting guided continuous-wave Doppler (CWO)
examination. Diastolic half-times ranged from 90 to 280
msec. On the basis of composite analysis, stenosis was
mild in 16, moderate in 20, and severe in 6. Associated
mitral regurgitation was detected in 21/42 (50%) and
tricuspid regurgitation, in 22/42 (52%). Conclusion: 1.
A mitral stenosis jet was visualized and characterized in
all patients--central in 86% and eccentric in 14%. 2.
Visually guided CWO enabled confident evaluation and
quantitation of Doppler severity of the stenotic valve.
3. CFI promises noninvasive visualization of jet
direction and configuration and directs spectral Doppler
assessment. CFI with guided CWO provides more compre-
hensive information about mitral stenosis.
Grp I
n=22 (%) 0 1(5) 1(5) 3(14) 2(9)
Grp II
N=33 (%) 0 1(3) 0 2(6) 5(15)
In conclusion: (a) Early PTCA for severe angina post
MI was effective and safe with an 80% overall success
rate and a 2% mortality. (b) Survival after successful
PTCA was excellent with no deaths during follow up.
However, in this same group, there were 2 recurrent MIs
and 13 pts (24%) had either severe angina or required
repeat revascu1arization (CAB/PTCA).
Repeat
PTCACABDeath
THE RESULTS OF PERCUTANEOUS TRANSLUMINAL CORONARY
ANGIOPLASTY (PTCA) IN POST INFARCTION ANGINA PECTORIS.
Geoffrey W. Holt, M.B., B.S., Bernard J. Gersh, M.B.,
Ch.B., FACC, David R. Holmes, Jr., M.D., FACe, Ronald E.
V1ietstra, M.B., B.S., FACC, Guy S. Reeder, M.D., FACC,
John F. Bresnahan, M.D., FACe, Hugh C. Smith, M.D.,
FACC. Mayo Clinic, Rochester, MN.
Between May 1980 and Jan. 1985, 69 patients (pts)
underwent PTCA for severe angina within 30 days (mean
12.6) of myocardial infarction (MI). All 69 pts met WHO
criteria for MI. There were 32 pts with Q wave Mis (Grp
I) and 37 pts with non Q wave MIs (Grp II); mean age was
57 years for both groups. PTCA was successful in 80% (55
pts). In Grp I, PTCA was successful in 69% (22 pts); of
the 10 pts who failed PTCA, 5 had emergency coronary
artery bypass (CAB) and 3 elective CAB. In Grp II, PTCA
was successful in 89% (33 pts); of the 4 pts who failed,
3 had emergency CAB (1 death) and 1 elective CAB. 25% (17
pts) of the total group had angioplasty of an occluded
artery which was successful in 7 of 12 Grp 1 pts (58%)
and 5 of 5 Grp II pts (100%).
Tabulated are the late results of the pts successfully
dilated (mean follow up 21 months).
Recurrent Class 111-
Ml IV Angina
Tuesday, March 11, 1986
8:30AM-I0:00AM, Room #260/261
Outcomes Following Angioplasty
LATE ANGIOGRAPHIC OUTCOME FOLLOWING SUCCESSFUL MULTIPLE
LESION PTCA
Michel Vandormael, M.D., Ubeydu11ah Deligonul, M.D.,
All Medhlrad, M.D., Michael Harper, M.D., F.A.C.C.,
Bernard Chaitman, M.D.,F.A.C.C. St. Louis University
School of Medicine, St. Louis, Missouri.
There are few late angiographic follow-up data in
patients (pts) undergoing multilesion-multivessel (ML-
MV) PTCA. Prior to December 1984, 171 consecutive pts
underwent ML-MV PTCA at St. Louis University. PTCA was
clinically successful (functional improvement and no
in-hospital complications) in 158 pts (92%). Of 437
attempted lesions, 385 (88%) were successfully dilated
(>30% reduction diameter and residual lesion <50%) with
balloon inflation times and inflation pressures ranging
from 30-90 sec and 6-10 atm. Aspirin, dipyridamole and
nifedipine were continued for 6 mo. Among the 158 pts
with a clinical success, 86(54%) underwent coronary
angiography an average of 6.4+3.7 months (mo) after
PTCA. The restenosis (R) rate (aiameter increase >50%)
of the 200 lesions dilated in the 86 pts was 34%. -
Among the 47 pts studied because of recurrence of
angina, 74% had R, an average of 5.7 (range 1-20) mo
after the procedure. The R occurred at more than one
dilation site in 40% (14/35) of the pts. Among the 12
symptomatic pts without R, 3 developed a new stenosis
>50% in an area other than the dilation site: 9 had no
aisease progression; 18 pts underwent repeat PTCA and 7
pts had CABG. Among the 39 asymptomatic pts studied
electively 7.4 (range 2-22) mo after PTCA, 11(28%) pts
had R. The R occurred at more than one dilation site
in 18% (2/11) of the pts. Three asymptomatic pts with
R had a repeat PTCA and the remainder received medical
therapy. Thus, the initial success of mu1tilesion/
multivesse1 PTCA is not compromised by an unacceptable
restenosis rate/lesion in the year following the
procedure. In pts with recurrent symptoms, the
predominant cause is restenosis as opposed to disease
progression. Restenosis frequently occurs (46%) at
more than 1 dilation site.
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INCIDENCE OF EARLY RESTENOSIS AFTER SUCCESSFUL PERCUTA-
NEOUS TRANSLUMINAL CORONARY ~IOPLASTY (PTCA)
Stephen Powelson, M.D., Gary Ibubin, M.B., Ph.D, Ball
Whitworth, M.D., Andreas Gruentzig, M.D., F.A.C.C.
Emory university SChool of Medicine, Atlanta, Georgia
To define the incidence of restenosis early after PTCA,
we prospectively performed arteriography 2 days after
PTCA on 50 patients wi th successful dilatation of 70
lesions. Diameter stenoses (OS), measured wi th elec-
tronic calipers, were (mean+SD): IlS pee PTCA: 68+16\,
OS post: 29+13\, and OS at-restudy: 33+14\. Presence
or absence of intimal disruption (intratuminal defect
or extraluminal contrast extravasation) was noted.
Early recurrent stenosis (ERS) was defined as loss of
50\ of initial OS gain, vs continued success (CS).
Early restenosis occurred in 7 of 70 lesions (10\).
For lesions wi th ERS compared to lesions with CS, OS
pre and OS post PTCA were similar but OS at restudy was
higher: ERS vs CS, OS pre: 67+23\ vs 69+17\ (p-NS), OS
post: 21+12\ vs 30+12\ (p-NS);-OS at restudy: 50+16\ vs
31+12(P<O.05). Imm;diately after dilatation, 25 lesions
(36\) had intimal disr uption. The incidence of such
disruption in lesions with ERS was 5/7 (71\) and in
lesions with CS was 20/63 (32\) (P<0.1).
We conclude that early restenosis occurs in 10\ of
lesions after PTCA before discharge. Intimal disruption
occurs commonly after PTCA and is more frequent in
lesions with early restenosis. Long-term follow-up will
clarify whether such changes persist or improve.
CLINICAL AND MORPHOLOGIC FACTORS IN PREDICTION
OF RESTENOSIS AFTER MULTIPLE VESSEL ANGIOPLASTY
Richard E. Shaw, Ph.D., Richard K. Hyler, I·I.D.
F.A.C.C., JodI Fishman-Rosen, R.N., M.S., Mary
C. Murphy, R.N., M.S., Simon H. Stertzer, N.D.,
F.A.C.C., Eric J. Topol, M.D., San Francisco
Heart Institute, Daly City, CA
In patients undergoing angioplasty (PTCA) in
multiple coronary vessels, we tested the hypo-
thesis that clinical factors are more likely to
predict restenosis in patients in whom all
lesions recur (ALR) and that morphologic f~c­
tors are more predictive of restenosis in pa-
tients in whom only some lesions recur (SLR).
Angiographic followup was obtained in 97 pa-
tients who underwent successful multiple vessel
PTCA. The clinical factors evsluated were: sex,
8ge, smoking, rest/nocturnal angina, anginnl
clas:;, angina duration (AD), cholesterol,
hypertension and diabetes. The morphologic
factors assesseo were: percen~ diameter steno-
sis (PU3) and pressure gradients prc- and post-
PTCA, and balloon inflation pressure (BIP).
Uni variate ond multi variate logistic I'egression
showed that compared to patients in whom all
lesions were patent: 1) the ALR group \,as more
likely to have diabetes (pC05), higher levels
of cholesterol (pC01), were current smokers
(pC01), and hod shorter AD (pC05); and 2) the
SLR group was nore likely to have higher PD3
pre-PTCA (p<.05), required higher BIP (p<.OS),
and had shorter AD (p <.05) . Thus ,it appears
that clinical and morphologic factors moy be
related to different patterns of restenosi:; In
patients undergoing multiple vessel PTCA.
ANGIOGRAPHIC PATTERNS OF RESTENOSIS AFTER CORONARY
ANGIOPLASTY OF MULTIPLE VESSELS.
Germano DiSciascio, M.D., Michael J. Cowley, M.D.,
F.A.C.C., George W. Vetrovec, M.D., F.A.C.C. ,Timothy C.
Wolfgang, M.D., Medical College of Virginia, Richmond,
Virginia.
Restenosis (RES) after PTCA is not infrequent but the
angiographic patterns of recurrence after PTCA of
multiple vessels (MV) have not been characterized. In
order to assess this, angiograms were reviewed in 38
patients (pts) who developed clinical recurrence (CR)
after PTCA of MV. CR was defined as return of symptoms
after successful PTCA and RES of one or more lesions
(loss of >50% of initial angiographic improvement). PTCA
was successful in 97 lesions in these 38 pts (2.6/pt); 2
lesions were dilated in 22 pts, 3 lesions in 12 pts, 4
lesions in 3 pts, 5 lesions in 1 pt. Mean lesion severity
was 85.3 ~ 10% pre-PTCA and 42 ~ 13% post-PTCA. In these
pts with CR, RES occurred in 58 of 97 lesions (60%).
Twenty pts (53%) had RES of a single lesion (11 pts with
1 of 2 lesions, 8 pts with 1 of 3 lesions, 1 pt with 1 of
5 lesions); 18 pts (47%) had RES of multiple lesions (11
pts with 2 of 2 lesions, 3 pts with 2 of 3 lesions, 2 pts
with 2 of 4, 1 pt with 3 of 3, 1 pt with 3 of 4 lesions).
Only 12 of 38 pts (31%) had RES of all lesions. Mean %
improvement with PTCA was 43.4 ~ 14% for all lesions and
was not significantly different for lesions with and
without RES. However, mean % stenosis post-PTCA was
significantly higher for lesions with RES (46.2 ~ 13%)
than without RES (35.8 ~ 12%), p<O.OOI. No other
predictors of RES of indiVidual lesions were identified.
Thus, the majority of pts with CR after PTCA of MV do
not have multiple RES, and higher residual post-PTCA
narrowing appears to predict lesion RES in pts with CR
after PTCA of multiple vessels.
Tuesday, March 11, 1986
10:30AM-12:00NOON, Room #260/261
Technological Aspects of Coronary Angioplasty
A NEW R - WAVE - TRIGGERED CORONARY ANGIOPLASTY
CATHETER SYSTEM ALLOWS PROLONGED DILATATION TIME
WITH PHYSIOLOGICAL PERFUSION DURING DILATATION.
Adolf Kuh1, M.D., Gerd-H. Rei1, M.D. and Paul R.
Llchtlen, M.D., F.A.C.C., Medical School Hannover,
Federal Republic of Germany.
We developed a new modified GRUNTZIG coronary
angiop1asty catheter system which allows very f~t
inflation (40 ms) and deflation (60 ms) of the
balloon. This enables R - wave - triggered infla-
tion only during systole and a part of diastole
and continues coronary perfusion, if deflation
time is long enough. We studied 8 dogs (thoraco-
tomy, magnetic flowmeter LAD or RCX, coronary an-
giography) by varying occlusion time from 150ms
up to 80% RR - interval (flow zero). Maximum di-
latation time was 5 minutes. Coronary mean flow
(25! 15 mll did not change significantly dur-
ing inflation up to 30% RR - interval (systolic
duration), and decreased only up to 50% if the
inflation time was approximately 80% of the RR-
i nterva 1. Coronary peak flow increased from 52
+ 32 ml (balloon deflated) to 110 + 50 ml (occlu-
sion time 50% of RR - intervall. -
During 5 minutes of triggered dilatation within
occlusion times lower than 80% of RR - interval
we saw no ischaemic ECG changes and no reactive
hyperaemia, a proof of sufficient coronary perfu-
sion. This new coronary angiop1asty catheter sys-
tem allows physiological perfusion during the en-
tire procedure and thereby a marked prolongation
(10 minutes tested) of dilatation. It is the hope
that in this way the technique becomes safer, i.e.
less arterial injury occurs and ischaemia is re-
duced during procedure.
64A ABSTRACTS JACC Vol 7. No.2
February 1986 64A
QUANTITATIVE ASSESSMENT OF LESION DILATATION DURING
CORONARY ANGIOPLASTY IN MAN.
Linda L. Derner, M.D., Ph.D., Avanindra Jain, M.D., Craig
J. Hartley, Ph.D., Albert E. Raizner, M.D., F.A.C.C.,
John M. Lewis, M.D., F.A.C.C., and Robert Roberts, M.D.,
F.A.C.C., Baylor College of Medicine, Houston, TX.
To assess the mechanism and quantify the extent of
dilatation during coronary angioplasty, we instrumented
the inflation syringe to measure the pressure (p) and
volume (V) within the balloon. P was plotted vs V during
i nfl ati on on an X-Y storage osci 11 oscope before ·i nserti on
(control) to determine balloon properties, and during
each inflation in 39 patients. Compared to control, P
began to rise at lower V within the lesion until the
lesion no longer impeded the balloon and above that pres-
sure the curve superimposed on control. With subsequent
inflations (2-4) the curves met at progressively lower
pressures until they superimposed over the enti re pres-
sure range suggesting complete dilatation of the lesion.
In 32 patients, 7 of whom had calcified lesions, the
curves were smooth and the first inflation intercepted
control at 5 ATM (range 3 to 8). In 7 patients, none of
whom had calcified lesions, an abrupt drop in P was noted
during inflation suggestive of cracking. Six of these
patients had angiographic evidence of dissection compared
to 1 in the other group. We conclude that ba 11 oon P-V
measurements demonstrate the minimum pressure and the
number of inflations required to dilate the lesion and
can be used to detect "cracking"
associated with dissection. 10
Thus, monitoring of dilatationATfl
by th is method shou 1d reduce 5
the number of unnecessary in-
flations, lower the maximum
pressure applied, and help to O~~---~
anticipate complications.
AUTOMATED QUANTITATIVE ANALYSIS OF STENOSES DURING PTCA
Richard W. Smalling, M.D., Ph.D., FACC, Richard L.
Kirkeeide, Ph.D., Linda Parsel, Akira Nishikawa, M.D.,
Robert D. Ekas, Ph.D., and K. Lance Gould, M.D.
University of Texas Medical School at Houston, Houston,
Texas.
Quantitative analysis of 18 stenoses subjected to
percutaneous coronary angioplasty (PTCA) were performed
with orthogonal angiography utilizing densitometry and
border detection with an automated computer program.
The program determined normal vessel as well as stenosis
diameter and cross sectional area, % diameter and area
reduction, calculated coronary flow reserve and
transstenotic pressure gradient. Transstenotic pressure
gradients (DP) were measured pre and post PTCA. Stenosis
severity (SS) was estimated by two experienced
angiographers. There was no correlation between the
measured value of SS (64 ± 15%) and the estimated SS (85
± 8.8%) pre PTCA or post PCA, (43 ± 13 vs. 33 ± 7%).
There was no correlation between % improvement in minimum
coronary diameter (D) and % improvement in measured DP.
There was a poor correlation between improvement in
minimum stenosis D and improvement in calculated coronary
flow reserve (CFR) (R = .42). CFR did increase
significantly from 2.5 ± 1.3 to 4.10 ± .4 (P<.005) post
PTCA. There was a substantial decrease in normal vessel D
adjacent to the stenosis (3.26 ± .64 to 2.98 ± .59 mm, P
< .025) post PTCA which may adversely affect estimates of
PTCA success using geometrical techniques. Since
stenoses with CFR > 3.5 are not physiologically
significant, CFR may be a more useful end point for PTCA
than simple geometric appearance (% diameter reduction)
or transstenotic pressure gradient.
SYNCHRONIZED CORONARY SINUS RETROPERFUSION (SCSR)DURING
LAD ANGIOPLASTY - Bonnie H. Weiner, MO, FACC, Joel M.
Gore, MO, Kathy M. Sloan, BSN, Joseph R. Benotti, MO,
FACC, John MJ. Gaca, MO, Okike N. Okike, MO, Thomas J.
VanderSalm, MO, Steven P. Ball, RN, Jeanne Corrao, BSN,
Joseph S. Alpert, MO, FACC, James E. Dalen, MO, FACC.
UMass Medical School, Worcester, MA
To determine the benefit of SCSR during acute anterior
ischemia, 3 patients (pts) undergoing elective LAD PTCA
were evaluated. Following 2 initial balloon inflations,
SCSR was instituted by inserting 8F catheters into the
femoral artery and coronary sinus (CS). Oxygenated
blood is withdrawn from the femoral artery and is
infused in an ECG synchronized manner during diastole
through the CS catheter. This catheter consists of an
autoinflatable balloon allowing temporary CS occlusion
and an end hole for blood delivery. After 15 minutes of
SCSR, 2 additional inflations were performed. SCSR was
then discontinued and further inflations performed as
necessary. During all inflations, right heart
pressures, transtenotic gradient, chest pain, and 12
lead ECG were recorded. With SCSR the time to the onset
of chest pain increased from 28.3±20.9 sec to 99.7±s8.0
sees. (p<.Os). Compared to no SCSR, the time necessary
for the development of comparable degrees of ST
elevation increased from 60 sec to 137.3±31.s sec
(p<.Os). During balloon occlusions, there were no
differences in the transtenotic gradient or right heart
pressures before, during or after SCSR. Conclusion:
SCSR is effective in delaying the development of chest
pain and ECG changes during LAD PTCA. This may allow
for a safer approach to more complicated disease.
Moreover, with the aid of SCSR, it may be possible to
study the role of longer balloon inflations in
decreasing the incidence of restenosis.
ASPIRIN AND DIPYRIDAMOLE PRETREATMENT IN THE PREVENTION
OF ACUTE THROMBUS FORMATION DURING CORONARY ANGIOPLASTY.
Elliot Barnathan, MD, Warren K. Laskey, MD, FACC, J.
Patrick Kleaveland, MD, FACC, Wililam G. Kussmaul, MD,
John W. Hirshfeld, Jr., MD, FACC, Univer~llty of
Pennsylvania, Philadelphla, PA,
To assess the efficacy of pretreatment wlth aspirin (ASA)
and/or dipyridamole (DP) in the prevention of acute coro-
nary thrombus formation during coronary angioplasty
(PTCA), we reviewed fllms, blinded to treatment group,
and hospital records of 300 consecutive initially
successful PTCA's. Films before PTCA, immediately and 30
min after the last balloon inflation were assessed for
the presence of any thrombus. Thirty-seven patients who
received streptokinase or had 100% stenosls or thrombus
on pre-PTCA fllms were excluded. Group A received no ASA
or DP while Groups B, C, and D received therapy either
preadmlssion, or withln 24 hrs of PTCA, or both. Group
D' (subgroup 0 f Group D) rece i ved ASA and DP both
preadm iss ion and within 24 hrs of the PTCA. The results
listed below lndicate those PTCA's in which a definite
thrombus was visible on either the immediate or 30 min
post-PTCA films. Fourteen of 39 post-PTCA thrombi were
consldered to be clinlcally slgnificant (100% occlusion,
requirlng streptoklnase, or emergency coronary artery
bypass graftlng).
# With Clinlcally
Group Any Thrombus ~ Si~nificant ~
A (control) 22/101 (21.8%) 12 101 (11.9%)
B (DP alone) 4/20 (20.0%) NS 0/20 (0%) NS
C (ASA alone) 4/32 (12.5%) NS 1/32 (3.1%) NS
D (ASA/DP) 9/110 (8.2%) .01 1/110 (0.9%) .002
D'(max ASA/DP) 0/32 (0%) .009 0/32 (0%) .09
Thus, antiplatelet therapy with ASA and DP prior to PTCA
decreases the incidence and clinlcal significance of
acute coronary thrombus formation.
JACC Vol 7, No 2
February 1986 65A
ABSTRACTS 65A
PULSED LASER ANGIOPLASTY: DESIGN CRITERIA FOR CLINICAL
APPLICATION. Frank Litvack. M.D., Warren Grundfest, M.D.,
Tsvi Goldenberg, Ph.D., Todd Sherman,M.D., Stuart
McDermid, Ph.D., James Margitan, Ph.D., Tom Pacala,
Ph.D., James Laudenslager, Ph.D., James Forrester, M.D.,
FACC, Cedars-Sinai Medical Center and Jet Propulsion
Laboratory, Los Angeles and Pasadena, CA.
Pulsed laser angioplasty requires the delivered
energy to be sufficient to ablate calcified plaque, yet
not destroy the transmitting fiberoptic. We defined the
energy reqUirements for tissue ablation through air by
irradiating 727 segments of human cadaver aorta with a Q
switched Nd:YAG (532,355 and 266 nm) and a magnetically
switched excimer laser ~308 nm). Energy density (ED) was
varied from 9-120 mJ/mm . Ablation threshold (AT) was
defined as minimum energy required to create a 1 mm
crater with 2,000 pulses.
~s: ~ Hz AT vs. calcified plague
532 nm 7 nsec -yo 70 mJ/mm~ no
355 nm 7 nsec 10 15 mJ/mm2 Yes266 nm 10 nsec 10 <9mJ/mm2 Yes308 nm 40,150 nsec 10,30 5 mJ/mm Yes
As ED increased, the number of pulses required to
perforate (PP) a segment decreased asymptotically to a
minimum required number (min PP). The energy level
between AT and min PP, therefore, define the cutting
range for each laser. Fiberoptics were destroyed by 10
nsec pulses at AT energies but 150 nsec excimer energy
sufficient to ablate densely calcified plaque was
transmitted through a 0.6 mm o.d., 6 meter long fiber.
Conclusions: 1. AT for plaque is an order of magnitude
lower in the ultraviolet than in the visible. 2. Pulsed
laser ablation via fiberoptics requires low AT and long
pulses and as such the magnetically switched excimer is
the best available pulsed power source for laser
angioplasty.
INTRAVENOUS STREPTOKINASE (STK) IN RURAL COMMUNITY HOSPI-
TALS WITH SUBSEQUENT TRANSFER FOR TERTIARY CARE: SAFETY
AND EFFICACY OF A STRATIFIED APPROACH TO ACUTE MYOCARDIAL
INFARCTION (AMI). Douglas G. Wysham, MD, Douglas R.
Salmon, MD, Wayne N. Leimbach, MD, Dave A. Buchanan, MD,
Robert F. Wilson, MD, J. Michael Kioschos, MD, Maryl R.
Johnson, MD, FACC, Philip E. Aylward, MD, Peter T.
Kirchner, MD, Melvin L. Marcus, MD, FACC, Carl W. White,
MD, FACC. CV Center, University of Iowa, Iowa City, IA.
To maximize benefits from thrombolytic therapy in AMI,
treatment must be begun early, and care continued where
sophisticated diagnostic and interventional facilities are
available. To determine if IV STK given in small rural
hospitals followed by transfer for tertiary care was safe
and could decrease the time to STK treatment, we pro-
spectively studied 31 consecutive patients (pts.) with
AMI. Nineteen received IV STK locally and were trans-
ferred by helicopter using flight nurses trained in de-
fibrillation. Twelve pts. were similarly transferred and
IV STK was begun in our ER. Mean time from pain to IV STK
was 3±.2 hr. (vs. 5.3±.5 using IC STK in our previous
study: AJC 54:705,1984) p<.05. Importantly no compli-
cations occurred in transfer. On arrival patients were
stratified for further therapy based on an isotope ejec-
tion fraction (EF); acute angio~raphy was performed only
in pts. with imrr,ediate EF <50% (18/31). Antegrade flow
was present in 11/18 (61%). Further IC STK reperfused
3/6 totally occluded arteries, but no angiographic im-
provement in flow was seen in those subtotally stenosed.
Final patency was 14/18 (78%). CONCLUSIONS: In a rural
setting, IV STK significantly decreases time to treatment
when compared to IC STK. Immediate transfer after IV
administration of STK can be accomplished safely and sub-
sequent sophisticated care is not precluded. Additional
IC STK, however, adds only modestly to the efficacy of
thrombolysis.
Tuesday, March 11, 1986
8:30AM-I0:00AM, Room #360-361
Thrombolysis III
I/e conclude that 1f thrombolytic therapy 1S delayed
greater that two hours after the onset of pain in
anterior Mil slgnificant dal'lage has occured. Conversely,
early IVSK (less than two hours) is assoc1ated with
preservation of myocardial function.
pm:St:HVATION OF Hm'FICULAE rrmCTIO!! InT!! V":J:Y t:ARLY
INTRAVEJrOUS O''l'REP'rOKINAS1: TP,:HAPY III ACUT': ANTFRIOR
r"YOCAPDIAL INFARCTION.
:'!ervyn ~;. Gotsnan, I:.D., F.R.C.P., F.A.C.C. " David G.
!"ine, :-I.D., Sir,1a \ielber, F.Sc., Dan ~apoznikov, Ph.D.,
Chaim Lotan, K.D., G1deon Koren, M.D., Yonathan Fasin,
I'.ll., Avraham T. \;eiss, r.lJ., Pavid Applebaum, M.D.
Hadassah University Hospital, Jerusalem, Israel.
The effect of myocardial salvaf,e after 1ntravenous
thrombolysis in acute myocardial lnfarchon (Al,'l) is
still beinl?, debated. \/e examined the importance of time
to adm1nistrat1on of intravenous streptok1nase (IVSK) on
cardiac function. ~e administered 750,000 units of IVSK
to 2lj consecutive patients with anterior Mil wi th1n four
hours of the onset of chest pain, who had no eV1dence of
previous A~I. Inf.rct size 1n each pat1ent was assessed
six days after AI'll uS1ng coronary anrciop,raphy to
calculate p,lobal ejection fractiion (GBF) and anterior
regional e,iection fraction (HEFA), and ECG to calculate
an infarct score (SCOH). All 10 pahents receivin~ IVSK
more than two hours after onset of pain had sil7,nificantly
abnormal GCF, m:FA, and SCOR, compared to only about one-
third of the 19 patients receivinp it in less than two
hours.
Analysis of follow-up data to assess the risk of recur-
rent angina or reinfarction ("ischemic double jeopardy")
in patients receiving thrombolytic therapy is confounded
by events potentially secondary to disease in a non-
infarct artery. We therefore determined the prevalence
of recurrent ischemic events over a 12 month follow-up in
all 40 single vessel disease infarct patients managed
within larger thrombolytic trials. All pts had angiog-
raphy <5 hrs from symptom onset. Outcome analysis was
based upon infarct artery patency (PAT), either sponta-
neous or with pharmacologically induced reperfusion (19
pts), or occlusion (OCC) (21 pts) 90 minutes after the
start of angiography. One year mortality was low in both
groups, 1/19 (5%) PAT; 2/21 (9.5%) OCC. There was no
significant difference in resting ejection fraction of
the OCC or PAT groups (49%±10 vs 47%±13). Recurrent
angina during the follow-up year occurred in 10/19 (53%)
of PAT pts but only 1/21 (5%) in the OCC group, p<.Ol.
Recurrent infarction was seen in 3/19 (16%) in the PAT
group and 1/21 (5%) in the OCC group (p=ns). Combining
both endpoints, angina or reinfarct, recurrent ischemia
occurred in 13/19 PAT pts (68%) and 2/21 OCC pts (10%),
p<.OOl. Conclusion: Examination of this cohort confirms
that single vessel infarct patients are at low risk for
further ischemic events unless they have successful re-
perfusion. Further therapeutic strategies (i.e. PTCA)
must be developed to reduce the risk of "ischemic double
jeopardy" in such patients.
PREVALENCE OF RECURRENT ISCHEMIA FOLLOWING THROMBOLYTIC
THERAPY IN A COHORT OF SINGLE VESSEL DISEASE PATIENTS.
David H. Schaer, MD, Alan G. Wasserman, MD, FACC, Roy H.
Leiboff, MD, FACC, Lisa Martin, MD, Richard J. Katz, MD,
FACC, George B. Bren, MD, P. Jacob Varghese, MD, FACC,
Allan M. Ross, MD, FACC, George Washington University,
Washington, DC.
P Value
0":""601
0.0001
0.0001
to IVSK
2-4 hrs.
0/10
0/10
0/10
11 ime
<2 hrs.
GEF >55;---r27i9
REFA >55:, 14/1 L,
SCOR <e 13/17
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INTRAVENOUS UROKINASE IN ACUTE MYOCARDIAL INFARCTION:
ACUTE AND LATE EFFECTS ON LEFT VENTRICULAR THROMBUS
FORMATION
Peter Kremer, Wolfgang Aschenberg, Joachim Schofer,
Detlef G. Mathey. Dept. of Cardiology, University
Hospital Eppendorf, Hamburg, West Germany
Desp~te the similar prevalence of aneurysm formation in
both groups the incidence of LVT was significantly lower
in U pts at follow-up. We conclude that i.v. thrombolysis
with urokinase in acute MI results in a significant re-
duction of LV thrombus formation as compared to conven-
tional treatment.
To determine whether intravenous urokinase in acute
myocardial infarction (MI)reduces the acute and late
ventricular thrombus (LVT) formation we performed two-
dimensional echo at 3-4 weeks and 6 mondths after MI in
patients (pts) allocated to i.v. urokinase (U,n=96) or
conventional treatment (C,n=74). In U pts coronary paten-
cy was achieved in 60% one hour after a bolus injection
of 2 x 106 units urokinase. There were no differences
concerning infarct locat~on or anticoagulant thera~
after MI in both groups. Echoes were blindly interpreted
for LVT and aneurysm (A) formation by two observers.
6 months after MI
C U
9 % 2 %*
16 % 18 %
after MI
U
1 %*
17 %
3-4 weeks
C
11%
16 %
*p < 0.01 (C vs.U)
LV thrombus
LV aneurysm
THE SERUM LEVEL OF D DIMER, A DEGRADATION PRODUCT OF
CROSSLINKED FIBRIN, IS ELEVATED FOLLOWING INTRAVENOUS
STREPTOKINASE BUT NOT FOLLOWING CONVENTIONAL MANAGEMENT
IN ACUTE MYOCARDIAL INFARCTION.
Allan S. Lew MO, Linda Berberian MT, ASCP, Bojan Cercek
MD, Pierre Laramee MD, Stephen Lee MD, Hanoch Hod MD,
P.K. Shah MD, FACC and William Ganz MD, CSc, FACC.
Cedars-Sinai Medical Center, Los Angeles CA.°dimer, a degradation product of crosslinked fibrin, is
generated by fibrinolysis but not by fibrinogenolysis and
can be reliably detected by specific monoclonal antibody
techniques. We studied the effect of high-dose IV strep-
tokinase (SK) in acute myocardial infarction on the serum
level of °dimer. Twenty patients with acute transmural
myocardial infarction of less than 3 hours duration were
studied using a semi-quantitative monoclonal antibody
latex agglutination assay. No patient had an elevated °
dimer on admission. Fourteen patients received IV-SK and
6 patients were treated conventionally. Of the 14 IV-SK
patients, an elevated serum level of °dimer was detected
within 1 hour of streptokinase administration in 12 Pts
and within 4 hours in the remaining 2 patients. Elevated
odimer persisted for more than 10 hrs in all 13 patients
in whom reperfusion was achieved but in the one patient
without reperfusion, elevated D dimer was only briefly
detectable for a 2 hour period following streptokinase.
In contrast, no Ddimer was detected during the first 24
hours in any of the 6 conventionally treated patients in-
cluding 2 patients manifesting the clinical syndrome of
'spontaneous reperfusion'.
Our data suggest that: 1) Coronary thrombolysis by IV
streptokinase generates the crosslinked-fibrin degradat-
ion product, D dimer but 2) No detectable spontaneous
fibrinolysis occurs in conventionally treated patients
with acute myocardial infarction, including patients with
the clinical syndrome of 'spontaneous reperfusion'.
ACUTE NON-Q WAVE INFARCTION ASSOCIATED WITH EARLY ST SEG-
MERT ELEVATION: EVIDERCE OF SPOHTAHEOOS REPERFOSIOH AND
IMPLICATIONS FOR THROMBOLYTIC TRIALS.~ klillU lm,
George A. Beller MD, FACC, Mihai Georghiade MD, FACC,
Thomas W. Nygaard MD, FACC, Denny D. Watson PhD, Robert S.
Gibson MD. Univ. of Virginia, Charlottesville, Virginia
Of 241 consecutive patients (pts) with MB-CK confirmed
acute uncomplicated MI, 162 (67S) had L1mm ST segment t on
the admission ECG. None received thrombolytic therapy or
acute angioplasty. Predischarge angiography, radionuclide
ventriculography and exercise Tl-201 scintigraphy were
performed 10.:t3d post-MI. Based on serial ECGs (days 1,2,3
and 10), all 162 infarcts were classified as Q ([QMI),
n=120[74S) or non-Q wave ([NQMI),n=42[26S). These 2
groups were similar wi th respect to the extent and dis-
tribution of angiographic CAD and time from onset of
symptoms to admission (4.5 vs 4.9hrs,p=NS). Al though QMI
pts exhibited greater STt, the amount observed in the NQMI
group was appreciable: STt per lead (2.3 vs 1.7 mm,p<.01),
I leads with STtL1mm (3.7 vs 2.8,p<.01l, and ESTt (9.3 vs
5.4 mm,p<.Oll. When compared to QMI, the NQMI pts had
shorter time to peak CK (21.8 vs 14.9 hrs,p<.Oll and a
higher infarct vessel patency rate (24S vs 57S,p<.01l as
well as lower peak CK values based on 4 hr sampling (1331
vs 662, p<.01), higher LVEF (45 vs 52S,p<.01) despite a
greater prevalence of prior HI (9 vs 29S,p<.01), fewer LV
segments with akinesis (2.2 vs 1.1,p<.01l and fewer per-
sistent Tl-201 defects (2.1 vs 1.3,p<.01). ThUS, the path-
ogenesis of NQHI in some pts may involve spontaneous
reperfusion characterized by early peaking CK and a high
prevalence of patent infarct vessels which results in
better LV function and regional perfusion. These results
may have implications in the design of thrombolytic trials
since 26S of pts with early STt evolved NQHI with a late
infarct vessel patency rate approaching that seen in pts
treated with thrombolytic agents.
Tuesday, March 11, 1986
10:30AM-12:00NOON, Room #360/361
Myocardial Infarction-Clinical: Prognosis
CLINICAL IKPORTANCE OF EARLY ISCHEMIA AFTER ACUTE
MYOCARDIAL INFARCTION (AMI)
Pierre Theroux. M.D. F.A.C.C., Xavier Bosch, M.D. Guy
B. PelletIer, M.D. F.A.C.C, David D. Waters, M.D,
F.A.C.C., Simon (ouz, M.D., Denis Roy. M.D, Montreal
Heart Institute, Montreal, Canada
Early isch_ia defined as angina with transient ST-T
changes during hospitalization, 24 hours or more after
an AMI was observed in 79 (17.6~) of a consecutive se-
ries of 449 pts surviving an AMI and catheterized a
mean of IO±3 days after admission. Clinical factors
significantly associated with ischemia were: no. of
risk factors (1.6±.7 vs 1.4±.7/pt. p=.OI). duration
of heart disease (38±SO vs 24±46 mo.. p=.02),
previous angina (S3 vs 31~ of pts. p<.OOOS) or MI (34
vs 2~, p<.OI), a non Q-wave AMI (S2 vs 3~.
p<.OOI) and lower feak CK value <l280±1l21 vs
1818±IS81 lUlL. p<.OO). Age, sex. site of HI were
not significant. The angiographic correlates were no.
of ~7~ stenosed vessels (2.1±.8 vs 1.7±.8/pt,
p<.OOOI), no. of diseased coronary segments (2.8±1.4 vs
2.1±1.2, p<.OOOI), left anterior descendin& coronary
involvement (77~ vs 6~ of pts, ~=.Ol), Frlesinger score
(10±2.8 vs 8±2.8, p<.OOOI), Genslni score (S8±32 vs
41±29 , p<.OOOI). no. of normal contractile segments
jeopardized by coronary stenosis (l.9±1.3 vs l.3±1.l/pt,
p<.0002). and fewer collateral vessels (S4 vs 64~ of pts,
p=.04). The ~ stenosis of the infarct-related vessel,
the ejection fraction and the contractile score of the
infarct area were the same. stepwise logistic re&res-
sion retained 3 independent predictors of early lSch-
emia: no. of diseased vessels, presence of non Q wave
AMI and history of rrevious angina.
During hospitaliza ion, 22 of 79 pts with ischemia
(2S') experienced HI extension vs 9 of 370 others
(2.4~ p<.OOOI). During a mean follow-up of 14±S
mo. (2 to 28), the cumulative ~ survival was 83~ in pts
with early isch_ia and 91~ in those without (p=.OI);
survival without MI was 67~ vs 8~ ([<.001) and sur-
vival without cardiac events (death, H l unstable angi-
na, bypass surgery) 3~ vs 6S~ (p<.OOOOll.
Thus early ischemia after AMI is a frequent finding as-
sociated with more severe coronar! artery disease and
identifies a high risk group for M extension in-hospi-
tal and cardiac events during follow-up.
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PREDICTION OF lATE SUSTAINED VENTRICULAR
TACHYARRHYTHMIAS AFTER MYOCARDIAL INFARCTION
Hasen Kiat MB, DavId RIchards MD, DavId Ross MB, FACC,
John Uther MD. Westmead HospItal, NSW AustralIa.
568 clinically well patIents (pts) aged 28-76 years
underwent right ventricular programmed electrIcal
stlmulation wIth a standardIsed protocol 6-28 days after
acute myocardIal infarctIon (AMI). SustaIned (~ 10 sec)
ventrIcular tachycardIa (VT) was InduCIble In 97 (17%)
pts. pts WIth and WIthout inducible VT were SImIlar In
terms of age, coronary anatomy, left ventrIcular
ejectIon fractIon, results of ambulatory ECG monItorIng
and exerCIse testing. All pts were followed for 12
months. Spontaneous ventrIcular tachyarrhythmias
(wItnessed Instantaneous death, documented sustaIned VT
or ventricular fibrillation (VF)) occurred durIng follow
up In 21 of 97 (22%) pts with Inducible VT and 10 of
471(2%) pts without inducible VT (P(0.0005). Spontaneous
ventricular tachyarrythmias durIng follow up In the pts
WIth IndUCIble VT were associated WIth anterior
infarction (71% vs 31%, p<0.001), longer cycle length
of induced VT (250 ± 60 vs 210 ± 32 msec, p< 0.001), and
VT Induction WIth a single extrastimulus (14% vs 1%,
P <0.0n.
We conclude: 1. Inducible VT follOWIng AMI was a strong
predictor of sustained ventrIcular tachyarrhythmias In
the fIrst year after AMI. 2. Non-electrophysioiogic
variables dId not predict ventricular tachyarrhythmias.
3. The power of predictIon by programmed stImulatIon of
late sustaIned ventricular tachyarrhythmias may be
increased by consideration of the site of lnfarctIon,
ease of VT Induction and cycle length of lnduced VT.
lIMITATION OF INFARCT SIZE AND REDUCTION OF LATE
VENTRICULAR ARRYTHMIAS WITH EARLY ADMINISTERED TIMOLOL IN
ACUTE MYOCARDIAL INFARCTION: A ONE-MONTH FOLLOW UP STUDY.
Fernando Rogue, MD for the TIARA Group Investigators,
Clfnica Olivos, Haipu 1660, 1638 Buenos Aires, Argentina.
Results of. experimental and clinical studies suggest
that the early administration of. the beta~blocker timolol
(T) limits infarct size. However, this action has not
been demonstrated using CKMB, a specific marker of ische-
mic damage, and the effect of,early T on late ventricular
arrythmias (lVA) has not been clearly established.
To provide such information, 13 clinical centers rando-
mized 200 patients (pts) out of, 2094 consecutively
screened within 6 hr of,onset of,chest pain of.at least 30
min duration. The 102 pts in the placebo group (P) were
comparable at baseline to the 98 pts given T. Patients
initially received 5.5 mg T iv, followed by oral T (10 mg
bid) for 28 days. Infarct size was determined by serial
analysis of, serum CKMB while LVAs were studied by Holter
monitoring (HM) on days 7, 14, 21 and 28. Results were
analyzed according to the intention to treat approach. In
comparison with P, T reduced significantly the cumulative
release of, CKMB (137.6 lU/l vs 106.0 lU/l; p < 0.01) and
the peak serum activity of. the enzyme (98.6 IU/l vs 76.3
lUll; p < 0.01). The 552 HM of, 162 pts, showed that
ventricular tachycardias occurred in 7 pts of,the T group
and in 16 pts in the P group (p < 0.05). The severity of
ventricular arrythmias, when scored according to Lown, was
lower in the T group; a difference that was significant on
day 14 (p < 0.01). Ten pts in the T group and 18 recei vi ng
P developed left ventricular failure (p > 0.05). Three
patients died in the T group and 7 in the P group.
In conclusion, the beta-blocker timolol given iv within
6 hr of,the onset of. infarction and then orally for 28
days, reduces infarct size as measured by CKMB as well as
the incidence and severity of. late ventricular arrythmias.
OVERVIEW OF MORTALITY RESULTS FROM ALL RANDOMIZED
CONTROLLED TRIALS OF EARLY IV BETA-BLOCKADE AFTER
MYOCARDIAL INFARCTION
ISIS Collaborative Group, Radcliffe Infirmary, Oxford,
England (Chairman P.Sleight, D.M., F.R.C.P.,
Statistician R.Peto, M.A., M.SC., Co-ordinator
R.Collins, M.B. B.S., M.Sc.)
Analys~s for mortality during days 0-7 in all randomized
trials of early IV beta-blockade following myocardial
infarction. The number of deaths Observed in the
treatment group of a particular trial minus the number
Expected in that same trial if treatment had no effect
on mortality (O-E) is tabulated:
TRIALS O-E VARIANCE % REDUCTION
(in treated OF (O-E) IN MORTALITY
patients) (:. SE)
25 small trials -0.1 55.9 o + 12
(238 deaths/5531)
"MIAMI" trial -6.6 41. 7 14 + 14
(172 deaths/5778)
"ISIS" trial -25.9 161.0 15 + 7
(672 deaths/16048)
All IV trials -32.6 256.6 12 + 6
These results suggest that treatment of about 150
patients with early intravenous beta-blocker, followed
by one week of oral treatment, would on average save
about one life.
MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION IN THE MULTI-
CENTER POST INFARCTION PROGRAM. Frank I. Marcus, M.D.,
F.A.C.C., Leonard Cobb, M.D., F.A.C.C., Jesse Edwards,
M.D., F.A.C.C., Lewis Kul1er, M.D., F.A.C.C., Ruth
Serokman and the Multi-Center Post Infarction Research
Group; University of Arizona, Tucson.
We enrolled 867 patients (pts) in a prospective study to
determine prognostic factors in pts surviving the coronary
care unit phase of acute myocardial infarction (MI).
During a mean of 22 months of follow-up, 101 pts died. The
circumstances of death were carefully examined in order to
define the cause, mechanisms, time of occurrence in
relation to mechanism and presence of ischemia in the
terminal event. A classification proposed by Hinkle and
Thaler was used to define the mechanism of cardiac death
and the presence of ischemia. Results: 77 deaths were due
to cardiac causes; of these 75% were arrhythmic. Neither
the frequency of an ejection fraction 40% at discharge
nor the presence of VEDs 10/hr or pairs or runs were
different in pts who dieo-of myocardial failure versus
those who died an arrhythmic death. The time between the
onset of new symptoms and death occurred in less than 1 hr
in 23 pts who had an arrhythmic death and 1 pt who had a
circulatory death. However, when death occurred more than
1 hr after onset of new symptoms, 50% had an arrhythmic
mechanism. Ischemia preceded the terminal event in 66% of
38 pts with a witnessed arrhythmic death and in 63% of 18
pts whose witnessed death was due to myocardial failure.
Conclusion: This stu~ emphasizes the high incidence of
ischemla preceding the terminal event. This finding may
influence strategies to decrease mortality after an MI.
The definition of sudden death as occurring within 1 hr of
onset of symptoms was specific for an arrhythmic death but
the definition of sudden death as within 24 hrs was not
useful in defining the mechanism of death.
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PROPHYLACTIC THERAPY WITH OILTIAZEM PREVENTS EARLY
REINFARCTION: A MULTICENTERED RANDOMIZED DOUBLE-BLIND
TRIAL IN PATIENTS RECOVERING FROM NON-Q-WAVE INFARCTION.
R Roberts, MD, FACC, RS Gibson, MD, WE Boden, MD, FACC,
PTheroux, MD, FAtt, HD Strauss, MD, FACC, CM Pratt, MD,
FACC, M Gheorghiade, MD, FACC, RJ Capone, MD, FACC,
MH Crawford, MD, FACC, RC Schlant MD, FACC, RE Kleiger,
MD, FACC, MB Perryman, PhD, and the DRS Group.
Patients (pts) recovering from non-Q-wave infarction
are recognized to be prone to repetitive episodes of
reinfarction, resulting in a long-term prognosis similar
to Q-wave infarction despite their benign course acutely.
A randomi zed doub1e-b1i nd study of 576 pts wi th non-Q-
wave infarction was performed, 287 receiving diltiazem
(D) and 289 placebo (P), involving 9 universities, 7 in
the U.S. and 2 in Canada. Pts were randomized 24-72 hours
after onset of infarction, manifested by appropriate
symptoms without Q-waves and confirmed by elevated plasma
MBCK. Diltiazem, 360 mg/day, or P was given for up to 14
days. The primary endpoint wa~ reinfarction, defined as a
secondary elevation in plasma MBCK. MBCK was analyzed by
a central core lab as were the ECGs and the study over-
seen by an independent pol icy b6ard. Mean duration of
therapy (l0.5 days) was identical for P and 0, as were
baseline characteristics, including previous MI, age, and
sex. Beta-blockade usage was similar being 51% in 0 and
56% in P. Due to adverse drug effects, 14 pts (4.8%)
withdrew from 0 and 3 pts (1~) from P. The 14-day mortal-
ity (99% follow-up) was similar with 9 deaths in P and 11
in D. Reinfarction occurred in 41 pts, 26 in P and 15 in
0, which is a difference of 42% (p<.04). Withdrawal for
angina occurrec in 11 pts receiving 0 and 21 receiving P,
a difference of 48% (p<.04). These results indicate
diltiazem was well tolerated, safe, and effective in both
the prevention of early recurrent infarction and angina
occurring in patients after non-Q-wave infarction.
Tuesday, March 11, 1986
8:30AM-I0:00AM, Room #366/367
Treatment of Pulmonary Embolism, Pulmonary
Hypertension and Cor Pulmonale
EFFICACY AND SAFETY OF TISSUE PLASMINOGEN ACTIVATOR IN
THE TREATMENT OF ACUTE PULMONARY EMBOLISM.
S. Z. Goldhaber, M.D., F.A.C.C., D. E. Vaughan, M.D.,
J. E. Markis, M.D., A. P. Selwyn, M.D., F.A.C.C.,
M. Meyerovitz, M.D., D. L. Dawley, M.D., D. S. Kim,
M.D., J. Loscalzo, M.D., Ph.D., F.A.C.C., A. Sasahara,
M.D., J. Benotti, M.D., F.A.C.C., E. B. Grossbard,
M.D., E. Braunwald, M.D., F.A.C.C., Harvard Medical
School and Cooperating Institutions, Boston, MA.
Current management of pulmonary embolism (PE) relies on
heparin (for secondary prevention) and rarely utilizes
lytic therapy for primary dissolution of clot, due to
fear of major bleeding complications. Therefore, we
assessed the efficacy and safety of a new lytic agent,
recombinant human tissue-type plasminogen activator
(rt-PA) in the treatment of PE. Patients were excluded
if they had symptoms of PE more than 5 days, active
bleeding, or if they had been operated upon within the
prior week. After establishing the diagnosis of
PE angiographically in 7 patients (4 postoperative and
3 medical), we administered rt-PA by continuous
intravenous infusion (50 mg over 2 hours) and repeated
the angiograms immediately thereafter. Each set of
angiograms was reviewed by at least 3 investigators.
In 5 patients, significant clot lysis occurred at 2
hours. Of the 2 remaining patients, 1 received an
additional 40 mg of rt-PA over 4 hours and demonstrated
marked clot lysis at repeat angiogram immediately
thereafter. The other patient showed improvement on
lung scan 4 hours after the 2-hour rt-PA infusion.
Although minor skin oozing from venipuncture and
arterial blood gas sites was common, no patient
experienced major bleeding. Thus, in this initial pilot
study among carefully selected patients, rt-PA appeared
to be efficacious and safe in the rapid lysis of PE.
C 24 90 80 56 12 1617 1218 14
NIF 24 102* 63* 46* 17* 923* 807* 10*
C 23 90 83 57 13 1815 1261 13
DTZ 27*t 84*t 76*t 49* 13t 1452*t 1035*t 14t
DTZ produced modest t in PVR and SVR which resulted in small
t in PA and BP and t in SVI. Although NIF produced greater t in
PVR and SVR than did DZ (both p<.05), SVI failed to t with NIF,
and thus, BP t markedly followed by a reflex t in HR (both
p<.05 vs DTZ). This response could be explained by a negative
inotropic effect exerted by NIF on the already compromised RV,
since NIF caused a decline in RV performance (RW t and RA t),
whereas DTZ did not (p <.05 vs NIF). Three pts deteriorated
clinically after NIF (severe dyspnea and hypotension), 2 of whom
needed pressors for> 6 hrs; such events were not seen after DTZ.
In conclusion, despite greater t in PVR, NIF exacerbates pre-
existing RV dysfunction in pts with PPH more than does DTZ.
NIFEDIPINE IN COR PULMONALE: HEMODYNAMIC PROFILE, ADVERSE
EFFECTS AND LACK OF SUSTAINED HEMODYNAMIC IMPROVEMENT.
Sakti Mookherjee, M.D.,F.A.C.C.,Kumar Ashutosh, M.D.,
Milton Dunsky, M.D.,Norma Hill, RN, Harold Smulyan, M.D.,
F.A.C.C., Suman Vardan, M.D., Robert Warner, M.D.
V.A. and Upstate Medical Centers, Syracuse, NY.
In 12 patients (pts) with Cor pulmonale (CP), resting
hemodynamics were monitored pre and for 2 hours (hrs) post
20 mg sublingual nifedipine (N) and then q6 hrs for 24 hrs
on N 20 mg orally. At 2 hrs the pulmonary vascular
resistance (PVR) fell from 310+50 (SEM) to 236+36 (p<0.02)
and the systemic vascular resistance (SVR) fell from
1645+139 to 1175+85 dyne sec/cm5 (p<O.OOI), while the
mean-arterial pressure (MAP) fell from 97+5 to 83+4 mmHg
(p<0.005). Cardiac output (CO-Fick) rose-from 4.7+0.5 to
5.4+0.5 L/min (p<0.005), but mean pulmonary arterisl
(MPAP), PA wedge and right atrisl pressures did not
change. At 24 hrs MPAP fell from 31+3 to 25+2 mmHg
(p<0.05) and PVR rose to 276+51 dyne-sec/cm~ albeit
lower than control PVR (p<0.05), while CO returned to
baseline. The fall in PVR was unrelated to control Pa02
which fell from 60+3 to 55+2 torr (p<0.05). MAP fell
further at 24 hrs to 76+3 mmHg (p<O.OI) and SVR to 1163+99
dyne sec/cm5• Right (RV) and left (LV) ventricular -
stroke work, radionuclide RV and LV ejection fractions
(EF) and spirometry (SP) remained unchanged. Of 7 pts
agreeing to participate in a repeat study after 6 weeks on
same therapy, 3 were withdrawn for diarrhea, profound
orthostasis and intractable edema respectively, and 1 was
non-compliant. Three pts restudied after 6 weeks were
subjectively unimproved and their initially reduced
hemodynamic variables including MPAP and PVR returned to
baseline. RVEF, LVEF and SP were unchanged, and mean
PaOz remained low, 51 torr. Thus, N lowers MPAP and PVR
in CP acutely, but has untoward side effects in many pts
and is of doubtful benefit at the end of 6 weeks.
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DILTIAZEM VS. DIGOXIN FOR HEART RATE CONTROL IN'PATIENTS
WITH CHRONIC ATRIAL FIBRILLATION.
Arie Roth, MD, Earl Harrison, MD, FACC, Gladys Mitani,
PharmD, Lee Freidenberger, RN, Shahbudin H Rahimtoola,
MD, FACC, Uri Elkayam, MD, FACC. LAC-USC Medical Center,
Los Angeles, CA
Diltiazem delays atrioventricular conduction & can be
effective for heart rate(HR)control in patients(pts)with
atrial fibrillation(AF). We compared the effects of digo-
xin(Dig)(serum concentration 1.4!0.3ng/ml) & diltiazem
240mg/day(DT240)& 360mg/day(DT360)alone & in combination
on heart rate(HR)response in 12pts with chronic AF. HR
was measured at rest,supine(Sup)& upright (Up) ,during sub-
maximal(S Max)& maximal(Max)exercise(Ex)& 2 minutes post
Ex(2min P Ex). HR(beat/min)was as follows: *p(0.05 vs Dig
Sup Up S Max Ex Max Ex 2min P Ex
Dig 86 101 154 170 116
Dig+DT240 69* 79* 114* 132* 90*
Dig+DT360 65* 70* 103* 121* 85*
DT240 88 107 140* 154* 113
DT360 79 86* 118* 136* 100*
DT360 alone was more effective than Dig at rest & Ex but
resulted in complications in 75% of the pts necessitating
reduction of dose to 240mg/day with resolution of side
effects in most pts. DT240 was more effective than Dig
during Ex but not at rest. Addition of DT to Dig resulted
in enhancement of HR control at rest & Ex, the difference
between Dig + DT240 & Dig + DT360 however was not stat-
istically significant. 9 pts were maintained on Dig +
DT240 for 15-40 days & showed persistent effects. CONCLU-
SIONS: DT 360mg alone is more effective than Dig for HR
control in pts with AF, but associated with high inci-
dence of side effects. The addition of DT 240 to Dig is
safe & results in significant improvement of HR control
at rest & during Ex in pts with chronic AF.
HEMODYNAMIC EFFECTS OF SIMULTANEOUS DOPAMINE AND DIGOXIN
FOLLOWING CORONARY ARTERY BYPASS
W.Konertz,M.D.,C.Maier,M.D"H.H.Sievers,M.D.,A.Bernhard,MD
Dept. of Cardiovascular Surqery and Dept. of Anesthesiolo-
qy, University Kie1, Hospitalstr. 40, 0-2300 Kie1 1, 'RG
Sometimes impaired left ventricular performance occurs
after coronary revascularization and vasodilators as well
as inotropic aqents have to be used.The aim of this study
was to evaluate the effect of simultaneous administration
of dopamine and diqoxin on left ventricular function in
the early postpump period. Investiqations were performed
in 8 open chest patients 30 to 100 min. after disconti-
nuation of cardiopulmonary bypass. Neasurements included
left atrial pressure (LAP), mean aortic pressure (MAP),
heart rate (HR) and cardiac output (CO) with the thermal
dilution technique. From these parameters cardiac index
(CI), stroke volume index (SVI), systemic vascular resi-
stance (SVR) and the double product (DP) were calculated.
Results are summarized in the table below. LAP was kept
constant during all measurements.
before diqoxin after diqoxin
vase line 4 8 base 1ine 4 8
/uq/kq/m in Dopam ine /uq/kq/m inDopam ine
HR 104 106 119" 94 98';-~ 100"'>!
MAP 80 86.... 9~ 84 90" 91'"
SVI 33,4 47,'· 45,2" 37,1 41,2 49, zit
DP 11749 '2922 16252 11998 13030" 1425~*
.. p< 0,05 from base 1ine **p<0,05 before/after diooxin
Simultaneous administration of dopamine and diqoxin showed
an increase of SVI and a siqnificant lower increase of DP
as compared with dopamine alone. It is concluded that in
postoperative coronary patients the chronotropic effects
of dopamine can be amel iorated with diqoxin, which mioht
have imoact on myocardial oxy~en consumption.
USE OF THE END-SYSTOLIC PRESSURE-DIMENSION RELATIONSHIP
TO ASSESS INOTROPIC RESPONSE OF DIGOXIN IN NORMAL MAN.
Thomas L. Shook, M.D., Martin St. John Sutton, M.D.,
F.A.C.C., Joshua Wynne, M.D., F.A.C.C. and Thomas W.
Smith, M.D., F.A.C.C. Brigham & Women's Hospital,
Harvard Medical School, Boston, MA.
The inotropic dose-response curve of chronically
administered digoxin in normal humans is not known. The
end-systolic pressure (ESP)-end-systolic dimension (ESD)
relationship is a sensitive load-independent index of
left ventricular contractility, and can be assessed
using echocardiography, cuff blood pressure, and cali-
brated carotid pulse tracings. We used this methodology
to assess the effect of digoxin on LV contractility in 9
normal volunteers to whom oral digoxin was administered
for at least 8 days in both low-dose (LD) and high-dose
(HD) regimens. Mean serum digoxin (D) levels were 0.9 !
0.1 ng/ml at LD and 2.0 ! 0.4 ng/ml at HD. ESP was
gradually elevated by 30 to 50 mm Hg from baseline using
IV methoxamine and ESD continuously measured. The
bradycardic effect was blocked with IV atropine. The
ESP-ESD regression line was determined by the least-
squares method. The slope, ESD at ESP - 100 mm Hg
(ESP100) and at ESP-ISO mm Hg (ESP150) were compared in
control, low and high digoxin levels.
slope!SD E ESP100!SD ESP150±SD
Control 98!23 .90 3.5l!.19 4.05!.26
(D) 0.9 ng/ml 100±26 .84 3.40!.16 3.93±.15
(D) 2.0 ng/ml 114!35 .90 3.45!.23 3.93!.29
The slope of the ESP-ESD relationship and the end-
systolic dimension at 2 common end-systolic pressures
did not change significantly at either level of serum
digoxin. We conclude that the inotropic effect of
chronically administered digoxin over the usual
therapeutic serum digoxin range is sufficiently small as
not to be demonstrable using this method.
Tuesday, March 11, 1986
10:30AM-12:00NOON, Room #366/367
Treatment of Congestive Heart Failure
ATRIAL PRESSITRE AND SECRETION OF ATRIAL NATRIURETIC
FACTOR INTO THE HUMAN CENTRAL CIRCULATION
Richard J. Rodeheffer, M.D., Issei Tanaka, M.D.,
Teruaki Imada, Ph.D., Alan S. Hollister, M.D., Ph.D,
David Robertson, M.D., Tadashi Inagami, M.D., Vanderbilt
University, Nashville, Tennessee.
Atrial natriuretic factor (ANF), a peptide found in
mammalian cardiac atria, has natriuretic and vasodilatory
properties which may be important in the regulation of
intravascular volume. In order to study factors related
to its release in human subjects we measured pressures
and plasma ANF concentrations in the central circulation
of 34 patients with a variety of cardiovascular
disorders. Plasma ANF concentration incressed from the
vena cava to the right atrium (63±20 pg/ml to 135±39
pg/ml, p-.OOl) and from the vena cava to the aorta
63±20 pg/ml to 148 ± 31 pg/ml, p-.001). Mean right atrisl
pressure was postively correlated with ANF concentration
in the pulmonary artery (r-.S8, p-.OOl), and mean
pulmonary capillary wedge pressure was positively
correlated with ANF concentration in the aorta
(r-.64, p-.OOl). In a subset of patients in whom ANF
concentrations were measured at two different levels of
atrial pressure, increased atrial pressure was
accompanied by increased ANF concentration. ANF levels
measured in fresh myocardium from a patient undergoing
cardiac trsnsplantation showed tissue concentrations in
the stria SOO-fold higher than tissue concentrations in
the ventricles. These data document that ANF is found in
human atrial myocardium and suggest that ANF is released
in response to increased atrial pressure. Such s
secretory release mechanism is consistent with the
hypothesis that ANF plays a role in the regulation of
circulatory volume.
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'" Two by two comparisons for all 4 values; t compared
with all 4 other sites.
The systemic arterial concentration of IR-ANF in 1
normal subjects during cardiac catheterization was
94±31 pg/mI. We conclude: 1. Higher IR-ANF concentra-
tions in our ratients could be related to the stress of
cardiac cathe erization and to jlremedication (diazepam,
10 III p.o.); 2. However. the fact that Ii-ANF concen-
trations were 2 to 6 times higher in the coronary sinus
than in all other sites remains unexplained. Although a
contribution from the ventricles cannot be ruled out,
this difference is probably due to release of the fac-
tor from the atria into the existing atrial veins and
into the coronary sinus.
VERY HIGH CONCENTRATIONS OF llOOJNOREACTIVE ATRIAL
NATRIURETIC FACTOR (IR-ANF) IN THE IIUKAN CORONARY SINUS
Raoul Bonan. M.D .• F.A.C.C .• Simon KOUZ'lt M.D .• Gilbert
Gosselin. M.D .• Martial G. Bourassa. .D .• F.A.C.C .•
Jolanta Gutkowska, Ph.D .• Jacques Genest, M.D., and
Marc Cantin, M.D., Ph.D., Montreal Heart Institute and
Clinical Research Institute of Montreal. Quebec. Canada
Blood samples were collected for plasma IR-ANF determi-
nations at different cardiovascular sites during rou-
tine cardiac catheterization in 10 patients: 5 with
valvular heart disease, 2 with congenital heart dis-
ease, 2 with coronary artery disease and 1 with atypi-
cal chest pain and normal coronary anatomy. A recently
developed direct radio-immunoassay for human plasma was
used to measure IR-ANF (Biochem. Biophys. Res. Comm.
1985; 128: 1350-1357). The plasma concentrations for
these 10 patients were (mean±S.D.):
Femoral vein
Right atrium
Right ventricle =
Systemic artery =
Coronary sinus =
Ii-ANF
pg/ml
91.64± 53.90}96.51± 39.64
l28.19± 66.59
ll4.09± 51.20
45l.48±282.10
p value
NS'"
<0.005t
COMPARATIVE EFFECTS OF TWO CONVERTING-ENZYME
INHIBITORS ON RENAL FUNCTION IN PATIENTS WITH
SEVERE CHRONIC HEART FAlLURE: A PROSPECTIVE
RANDOMIZED CLINICAL TRIAL. Milton Packer MD, FACC,
Wai Hung Lee MD, Norma Medina RN, Madeline Yushak RN.
Mount Sinai School of Medicine, New York, NY
By causing efferent postglomerular arteriolar vasoconstriction
angiotensin II (All) preserves glomerular filtration in patients
(pts) in heart failure (CHF)j hence, suppression of All synthesis
by converting-enzyme inhibition (CEI) is frequently accompanied
by worsening azotemia. To determine if short-octing and long-
acting CEls differ in their effects on renal function, we
randomized 42 pts with CHF to either captopril (CPT, 50 mg
TID, n=21) or enalapril (ENL, 20 mg BID, n=21) for 1-3 months,
during which time diuretics were unaltered and no K supplements
were given. Mean arterial pressure (MAP, mm Hg), weight (wt,
kg), plasma renin activity (PRA, ng/ml/hd, serum creatinine
(SCr, mg/dO & serum patassium concentrations (K, meq/l) and
creatinine clearance (CCr, ml/min) were measured before (pre)
and after CEI. * = p<.05 (pre vs drug); t = p<.05 (CPT vs ENL)
MAp Wt PRA SCr CCr K
Pre 84.4 66.4 3.6 1.4 49.2 4.3
CPT 67.2* 65.1 * 34.5* I.5 55.2 4.3
Pre 81.0 65.7 8.4 1.3 54.0 4.1
ENL 66.7* 66.2 14.7*t 1.7* 44.I*t 4.6*t
Despite similar peak oj. in MAp, ENL (but not Cpn produced + in
SCr and oj. CCr, possibly because its hypotensive effects were
more prolonged. Persistent oj. in MAP and CCr likely limited the
natriuretic and enhanced the antikaliuretic actions of ENLj
hence, wt did not oj., and K +. In contrast, CPT oj. wt (thereby
eliciting a greater reactive + in PRA) and did not +K.
In conclusion, ENL is more likely than CPT to cause renal
insufficiency in CHF pts, probably because of its more prolonged
hypotensive effects and its more prolonged antagonism of the
beneficial postglomerular actions of All. Hence, short-octing
CEls may be safer than long-octing CEls in CHF pts.
DISCREPANCY BETWEEN FIRST DOSE ACE INHIBITION AT REST
AND SUBSEQUENT ACE INHIBITION DURING EXERCISE IN HEART
FAILURE.
Philip C. Kirlin. M.D .• F.A.C.C •• Carolyn Koestner. R.N .•
Park W. Willis. III. M.D •• F.A.C.C .• Cardiology Section,
Michigan State University. East Lansing.
At rest (R). low initial dose ACE inhibition (ACEI) ap-
pears to completely block converting enzyme in heart
failure (CHF). without additional blockade during chronic
ACEI at higher doses. In NYHA Class 2-3(n=8) or 4(n=1)
patients. we studied first dose ACEI at supine R for lh
after low dose captopril (12.5 mg) or lisinopril (5 mg).
as well as 4-8 wks later at higher doses (captopril 25-
50 mg. lisinopril 10-15 mg). Plasma renin activity (PRA)
and plasma aldosterone (aldo) were also assessed during
upright treadmill exercise (E) after 4 wks at each dose.
E duration increased 16% with low dose and 22% with high-
er dose ACEI. At R. initial low dose and later higher
doses produced almost identical reductions in plasma
aldo and blood pressure. indicating similar ACEI. PRA
changes were also insignificantly different between low
and higher doses at R. However. during later E at the
same work load as before ACEI. low dose and higher doses
produced differing levels of ACEI. Low doses caused in-
significant elevations of PRA compared to pre ACEI peak
E (13.1±4 vs 1.4±2 ng/ml/h. p >.16) and insignificant re-
ductions of plasma aIda (308±43 vs 381±94 pg/ml. p>.48).
However. at the same E level higher dose ACEI increased
PRA (to 20.4±1.3 ng/ml/h. p<.Ol) and plasma aIda was lower
(190±28 pg/ml. p<.08) than pre ACEI. Thus. first dose
ACEI at rest may not reflect later ACEI during E. High
doses may be necessary to produce full ACEI during E in
CHF. The more complete ACE blockade may be a factor in
improved E tolerance during higher dose chronic ACEI.
HEMODYNAMIC EFFECTS OF SELECTIVE DOPAMINE-1 RECEPTOR
STIMULATION: COMPARISON OF INTRAVENOUS FENOLDOPAM AND
NITROPRUSSIDE IN HEART FAILURE PATIENTS.
Carlos A. Leon, M.D., A. Addison Taylor, M.D., Connie
Klngry, R.N., James Norton, M.S., Craig M. Pratt, M.D.,
F.A.C.C., Robert Roberts, M.D., F.A.C.C., James B. Young,
M.D., F.A.C.C., Baylor College of Medicine, Houston TX.
Dopamine-1 receptors (DAtR) mediate hemodynamic effects
(HE) which may be benefic'al in pts with congestive heart
failure(CHF). There is at present a paucity of data on
DA R stimulation in pts with CHF. Using intravenous
feAoldopam(FEN) (a selective DA1R agonist), we evaluated
in a crossover, randomly assign~d study the HE of FEN and
compared them to nitroprusside(NP) in 13 pts with CHF
NYHA III-IV (range EF 11-30%). Infusion of both drugs was
given until optimal HE were obtained. This same dose was
then continued for a 6 hr period. Below are HE at base-
line(B), 1 hr, and 2 hr, for NP and FEN (*p<.Ol compared
to B): (Mean±SEM)
FEN-B FEN-1h FEN-2h NP-B NP-1h NP-2h
HR 98±5 99±3 102±3 92±5 89±4 89±5
MBP 88±3 73±2* 76±2* 88±3 70±2* 70±2*
MPAP 41±3 38±3 37±4 41±3 31±2* 31±3*
PCW 26±3 26±3 25±3 27±3 19±2* 19±2*
RAP 16±2 17±2 16±2 15±2 11±1* 11±1*
CI 1.8±.2 2.9±.3* 3.0±.4* 1.9±.1 3.0±.3* 3.0±.3*
SVR 1778±147 959±102* 1006±127* 1725±123 915±83* 904±99*
PVR 393±59 203±29* 190±27* 358±53 191±27* 200±41*
SVI 20±3 30±4* 32±4* 21±3 33±3* 34±3*
We have demonstrated, for the first time, that selective
DA1R stimulation with IV FEN causes a significant reduc-
tion in SVR and BP with concomitant increase in CI and
SVI which is not associated with preload diminution. The
effects persisted during the 6-h period and there was no
significant difference in the magnitude of systemic
vasodilation between FEN and NP.
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ACUTE HEMODYNAMIC RESPONSES TO ORAL FENOLDOPAM,
A DOPAMINE RECEPTOR AGONIST, IN CHRONIC CONG,ES-
TIVE HEART FAILURE.
Bruoe C. Wilson, M.D., Gary S. Franois, M.D.,
F.A.C.C., Susan M. Ziesobe, R.N., and Janet A.
Nelson, R.N., VAMC and University of Minnesota,
Minneapolis, Minnesota.
Fenoldopam mesylate is a seleotive dopamine
(DA 1 ) reoeptor agonist wbiob bas been demon-
strated to enhanoe renal blood flow and sodium
exoretion. In order to evaluate the aoute
hemodynamic effects of this drug in chronic oon-
gestive heart failure (CHF), we studied 8 male
patients (pts) between the ages of 54 and 69
(mean, 61.9 years) with olass II or III ohronio
CHF. Following an oral dose of 100 mg fenoldo-
pam, hemodynamio and regional blood flow
measurements were made over 4 hours. Cardiao
index increased f~om 2.?5±0.18 (±S.E.M.) to
2.83±0.22 L/min/m (p<.Ol) and systemic vasoular
resistanoe degreased from 1496±74 to 1083±383
dynes sec om- (p<.Ol). There was a trend for
mean arterial pressure to decrease (90±2 to 80±3
mmHg, p=.06) and for left ventricular filling
pressure to decrease (2S±S to 21±4 mmHg, p=.06).
Heart rate was statistically unchanged. Penal
blood flow index was deoreased aoutely (34 to 30
units, p<.OS) and after 4 days of treatment (33
to 24, p<.OS). Tbere were no ohanges in hepatio
or forearm blood flow indexes acutely or after 4
days of treatment. Sodium excretion was un-
changed. In conolusion, oral fenoldopam acutely
improves oardiac index in pts with CHF, but this
improvement is not aooompanied by aoute enhance-
ment of regional blood flow or sodium exoretion.
Tuesday, March 11, 1986
8:30AM-I0:00AM, Room #364/365
Ventricular Arrhythmias: Electrophysiologic Testing I
ELECTROPHYSIOLOGIC STUDIES IN PATIENTS WITH NONSUSTAINED
VENTRICULAR TACHYCARDIA AND CORONARY DISEASE: RELATION OF
VENTRICULAR ANEURYSM TO INDUCIBLE TACHYCARDIA AND PROGNO-
SIS. Richard C. Klein, M.D., F.A.C.C., Charles Machell,
M.D., VA Medical Center, Albuquerque, N.M.
To assess the role of electrophysiologic studies (EPS) in
patients Cpt) with nonsustained ventricular tachycardia
(NSVT) and coronary artery disease (CAD) 22 pt with NSVT
( 5 beats) on Holter monitoring and cath-documented CAD
underwent EPS. Prior myocardial infarction was present in
14 pt and discrete left ventricular aneurysm (LVAn) was
present in 11 pt. EPS included single, double and triple
premature stimulation at 3 drivecycles and 2 ventricular
sites. Sustained VT ( 15 seconds) was induced in 9/11 pt
with LVAn and 2/11 without LVAn (p 0.01). All VT were uni-
form in morphology; VT cycle length was 301±96 msec. EPS
defined effective (no inducible VT) therapy in 3/9 pt
with LVAn and 1/2 pt without LVAn. During followup (2-32
months) 5/11 with inducible VT and 1/11 without inducible
VT had sustained VT or sudden cardiac death (p 0.05). 4/5
pt with EPS-induced VT and VT during followup had LVAn.
1 pt without inducible VT but VT during followup also had
LVAn. Subsequent VT/VF was not related to characteristics
of induced VT. Of the 5 pt with EPS-induced VT and VT
during followup, effective therapy could not be defined
by EPS testing in 4. In pt with CAD and NSVT the presence
of LVAn defines a subgroup with a high incidence of in-
dUCible VT at EPS. This group of pt is at high risk for
sustained VT' or sudden death and require aggressive anti-
arrhythmic therapy.
NONSUSTAINED VENTRICULAR TACHYCARDIA: UTILITY OF ELECTRO-
PHYSIOLOGIC STUDY TO GUIDE THERAPY
Alfred E. Buxton, M.D., FACC, Francis E. Marchlinski,
M.D., FACC, JOhn O. Doherty, M.D., Mark E. Josephson,
M.D., FACC University of Pennsylvania, Philadelphia, PA
We performed programmed stimulation in 56 consecutive
patients (pts) with coronary artery disease and nonsus-
tained ventricular tachycardia (VT-NS). Sustained (S) VT
was induced in 24 pts who had a mean ejection fraction
of 38%, vs 46% in pts without inducible VT-S (p:NS). In
Group I (42 pts) therapy was guided by results of pro-
grammed stimulation: pts were given antiarrhythmic
therapy only if VT-S was induced, or if spontaneous VT-NS
caused symptoms: 22 pts received pharmacologic therapy,
and 20 were not treated. In Group II (14 pts) treatment
was not based on programmed stimulation: 11 received
empiric therapy, and 3 no therapy. VT-S was induced in 17
Group I pts vs 8 Group II pts (p:NS). The ejection
fraction in Group I was 42% vs 39% in Group II (p:NS).
After a mean follow-up of 28 months, 8 pts died suddenly.
Sudden death occurred in 6 of 24 pts with inducible VT-S
vs 2 of 32 pts without inducible VT-S (p:.055). Sudden
death occurred in 2 Group I pts vs 6 Group II pts
(p:.002). Sudden death occurred in 0/20 untreated and
2/22 treated Group I pts, vs 2/3 untreated and 4/11
treated Group II pts (p:.002). The ejection fraction of
pts with sudden death was 37% vs 43% in pts without
sudden death (p=NS). We conclude that among pts with
spontaneous VT-NS and coronary artery disease: 1) anti-
arrhythmic therapy guided by programmed stimulation is
superior to empiric antiarrhythmic therapy in prevention
of sudden death, 2) pts who do not have inducible VT-S
have a low probability of sudden death and do not require
antiarrhythmic therapy if the VT-NS is asymptomatic.
OUTCOME IN NON-SUSTAINED VENTRICULAR TACHYCARDIA:
RELATION TO CLINICAL FACTORS, SPONTANEOUS AND INDUCED
VENTRICULAR ARRHYTHMIAS. William P. Batsford, M.D. ,
Linette Sudbrink, R.N., Stephen 1. Stark, M.D., Craig A.
McPherson, M.D., Eleanor E. Kennedy, M.D., Lynda E.
Rosenfeld, M.D. Yale University, New Haven, CT.
To identify potential prognostic factors we analyzed
clinical features, characteristics of spontaneous
arrhythmias and results of electrophysiology studies
(EPS) in 81 patients with nonsustained ventricular
tachycardia (VT). Coronary artery disease(CAD) was
present in 26 pts, congestive cardiomyopathy{CM) in 25
pts, miscellaneous diagnosis(MISC) in 14 pts and no
known structural heart disease(NKSHD) in 16 pts.
Average fo110wup was 17 months(range 1-52).
At EPS sustained VT was induced in 17/81{2l%);
nonsustained VT in 36/81{45%); 28/81(34%) were
nonducib1e{ < 5 nonstimulated ventricular beats with
ventricular pacing and 3 programmed extrastimu1i).
Sudden cardiac death or recurrent symptomatic VT
occurred in 9/53 pts with inducible VT and 0/28 pts
wi thout inducible VT{p < .02). Prognosis was the same in
pts with inducible nonsustained VT or sustained VT{5/36
vs 4/17, p-NS).
Clinical features (disease state, neurological
symptoms, LVEF) and characteristics of spontaneous VT
(cycle length, duration, morphology, and regularity)
were not significant prognostic factors. No pts with
NKSHD died although 1 had recurrent symptomatic VT.
Therefore: 1)C1inica1 features and characteristics of
spontaneous VT do not identify high risk patients.
2)The presence of inducible nonsustained VT or sustained
VT at EPS identified those pts likely to have sudden
cardiac death or recurrent VT. 3)EPS is a useful
prognostic test in pts with clinical nonsustained VT.
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PROSPECTIVE COMPARISION OF RIGHT AND LEFT VENTRICULAR
STIMULATION IN THE INDUCTION OF VENTRICULAR TACHYCARDIA.
Huan~-Ta Lin, MD, David E Mann, MD, FACC, Jerry CLuck,
MO, ACC, Sharon AMagro, PAC, Valerie Sakun, PAC,
Christopher R C Wyndham, MD, FACC. Baylor College of
Medicine, Houston, TX.
To assess the relative efficacy of right (RV) and left
ventricular (LV) stimulation to induce (ind) ventricular
tachycardia (VT), we used a tandem protocol rotating thru
3 sites (RV apex, RV septum, LV apex) with 1-4 extrastim-
uli (ES) at drive cycle length 500 msec and burst pacing.
Spontaneous (spont) arrhythmia in the 38 patients (pts)
was sustained monomorphic VT (SMVT) in 32 (29 recorded in
12-lead ECG), and sudden death in 6 pts. SMVT was induced
in 28 pts from: RV LV Both Total Not
on~y only RV+LV Ind Ind
All induced SMVT -r ~"""IS" !1J
VT similar to spont VT 5 3 9 17 12
For each ES and burst, cumulative yield of all SMVT from
LV stimulation was less than that from RV, as follows:
N 1 ES 2 ES 3 ES 4 ES Burst
RV 30g -g- iT "'"'24 2b --zr-
LV 38 5 13 19 22 23
Induction of VT similar to spont VT followed the same
trend. Of pts wi th VT induced from both LV and RV, the
number of ES needed was: greater in LV LV=RV RV>LV
All induced SMVT 8 ~ --u--
VT similar to spont VT 3 6 0
Analysis of RV apex data alone still showed superior
efficacy over LV stimulation for induction of SMVT, and
comparable efficacy for VT similar to spont VT.
Conclusion: In this prospective study, failure to induce
SMvT 1n the RV would have necessitated LV stimulation in
only 1 of 28 pts. For each ES, the yield from RV is
greater than from LV. Induction of SMVT from the RV usu-
ally requires fewer or the same number of extrastimuli.
EFFECT OF EXERCISE ON THE INDUCTION OF VENTRICULAR
ARRHlTIlUAS BY PROGRIMHED VENTRICULAR STIMULATION
Gregory S Thomas. H.D.,H.P.H., Hichael JE Davis,
I1.B.,B.S., Gregory D. Curfman, N.D., G Hilliam Dec,
H.D., Charles A Boucher, H.D., F.A.C.C., William R
Slater, H.D., Brian HcGovern, I1.B., Hasan (li).,'an, H.D.,
Jeremy N Ruskin, H.D., F.A.C.C., Ilassachusetts General
Hospital, Boston HA.
To assess whether the result of programmed ventricular
stimulation (PVS) is affected by exercise, PVS was
performed before, during, and immediately following
exercise in a select group of 8 patients (pts). All pts
had previous myocardial infarction; 4 had stable angina.
Seven of the 8 pts had spontaneous ventricular
tachycardia (VT), 1 had ventricular fibrillation. Seven
pts were taking an antiarrhythmic drug at the time of
the study. At the RV apex, 1 - 2 extrastimuli were
introduced during ventricular pacing at rest, during
supine symptom-limited bicycle exercise, and during the
first 5 minutes of recovery from exercise. The maximum
workload was 31 + 22 watts (mean + SD). Exercise-
induced ischemia was documented at this workload in 6
pts by the occurrence of either angina or a thallium-201
perfusion defect with redistribution. The result of PVS
during exercise and recovery was the sa.0 ~s at rest in
6 pts (.L.. 2, sustained VT was induced under all
conditions, While, in 4, sustained VT could not be
induced under any conditions). However, in 2 pts
sustained Vl' \-las not induced at rest but was induced
durinc exercise (1 pt) or during recovery (1 pt). Both
of these pts had exercise-induced ischemia. These
preliminary data demonstrate that PVS during exercise is
feasible and indicate that PVS may produce different
results at rest, during exercise or during recovery.
SPONTANEOUS VENTRICULAR ARRHYTHMIA ON AMBULATORY ELECTRO-
CARDIOGRAPHIC RECORDINGS FAIL TO PREDICT WHICH PATIENTS
HAVE INDUCIBLE VENTRICULAR TACHYCARDIA DURING ELECTRO-
PHYSIOLOGIC TESTING.
Craig MPratt, MD, FACC, Beth Thornton, RN, Sharon Magro
PAC, Robert Roberts, MO, FACC, Christopher R C Wyndham,
MD, FACC, Baylor College of Medicine, Houston, TX.
A recent trial claimed that inducible(I) ventricular
tachycardia(VT) during electrophysiologic testing(EPS)
can be predicted by using ambulatory electrocardiographic
recordings(AECG). To investigate this possibility, we
selected 80 patients (pts) age 58±13 (65~,15~) admitted
for: spontaneous sustained(S) VT (N=54), cardiac arrest
(n=4), ventricular fibrillation (n=l1), syncope(n=l1).
EPS produced ISVT in 53 pts (defined as VT>120/minute for
>30 seconds +/01' requiring intervention); 27 pts did not
have ISVT during EPS despite utilizing an identical EPS
protocol with up to 4 extrastimuli and two right ventric-
ular (RV) stimulation sites(RV apex and RV septum). AECG
recordings were performed off antiarrhythmic therapy an
average of 2.5 days from the baseline EPS study. For the
53 pts with ISVT, AECG (mean-22 hI'S) showed 248±52 prema-
ture ventricular complexes (PVC)/hour(hr), 1.2±.3 coup-
lets (C)/hr, and 15±6 runs VT/day. as compared to 164±51
PVC/hI', 1.0±.4C/hr and 3±1.3 runs VT, respectively in the
27 pts without ISVT by EPS(all p=ns). PVC distribution on
AECG in the groups with and without ISVT on EPS:
EPS 0-9 PVC/hI' 10-29 PVC/hI' >30 PVC/hI'
ISVT[n=53) 25% 15% 60%
NO ISVT(n=27) 41% 11% 48%
Tuesday, March 11, 1986
10:30AM-12:00NOON, Room #364/365
Defibrillation
VALUE OF FIELD EXPERIENCE IN IMPROVING A!JTOMATIC
EXTERNAL DEFIBRILLATORS. W. Douglas Weaver, MD, FACC,
Deborah Hill, BA, Carol Fahrenbruch, MSPH, Michael
Copass, MD, Alfred Hallstrom, PhD, Carl Morgan, MSEE,
Leonard A. Cobb, MD, FACC. University of Washington,
Seattle, WA.
An automatic external defibrillator was used by first
responding fire fighters prior to arrival of paramedics
to initially treat 359 patients discovered in cardiac
arrest. The device(Dl) was recently modified(D2) in an
attempt to improve the rhythm detector for the last 61
(17%) patients. One hundred fifteen (81%) of 142
patients discovered in ventricular fibrillation(VF) were
shocked one or more times; 92 (77%) of 119 were shocked
with Dl vs 23 (100%) of 23 using the D2, P <.001. Dl
correctly identified low amplitude VF of <200uV in 11
(17%) of 64 analyses and coarse VF in 139-(63%) of 221
analyses. D2 more often correctly identified both fine
and coarse VF; 9 (90%) of 10 and 32 (86%) of 37 correct
analyses respectively; p <.001 and p-.003. No
inappropriate shocks were delivered with either Dl or
D2. Twenty-six (22%) of patients shocked had regained
spontaneous circulation before paramedic arrival; 76
(53%) of 142 VF patients were admitted to hospital and
38 (27%) were discharged alive. D2 was able to deliver
the first shock sooner (1.4 vs 1.9 min, p<.Ol) and
delivered more shocks per patient (1.7 vs 1.3, p<.05)
than did D1.
We conclude that automatic external defibrillators
can be used by minimally trained first responding
emergency rescuers and permit early resuscitation of a
portion of patients prior to arrival of paramedics.
Extensive field experience with such devices is
mandatory in order to optimize the detector and further
shorten the delays until defibrillation.
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EFFICACY AND SAFETY OF TRANS VENOUS CARD lOVERS ION OF RAPID
VENTRICULAR TACHYCARDIA USING TWO ENERGY WAVEFORMS:
A PROSPECTIVE RANDOMIZED STUDY.
Stephen T Rothbart.MD,FACC, Sanjeev Saksena,MD,FACC,
Demetris Pantopoulos,ME,Ricardo Calvo,MD. Newark Beth
Israel Med Ctr, Newark, NJ.
Transvenous cardioversion(TC)has limited efficacy in
very rapid ventricular tachycardia(VT)&frequently results
inVT acceleration(A),We examined the efficacy&safety of 2
different energy waveform tilts in9pts with rapid VT & or-
ganic heart disease. Using a Medtronic6880catheter posi-
tioned at theRV apex,VT episodes(E)with cycle lengths(CL)
<36Oms induced during electrophysiologic(EP)studies were
treated with an incremental shock protocol of 1.0,2.5,5.0,
&lO.OJ using 2 waveform tilts(27%&82%)at each energy level
in a random fashion.
RESULTS: 27% TILT 82% TILT p(27%vs82%)
Total Hshocks: 22 23 >.2
Mean shock energy(J): 2.0 2.3 >.2
HVTE attempted: 16 15 >.2
HVTE cardioverted: 4 6 >.2
Mean cardioversion energy(J): 1.4 3 >.2
VT acceleration: 2 2 >.2
The meanVTCL for successful termination was295ms at27%
tilt&275ms at82%tilt(p>.2),SuccessfulVT termination was
only achieved inVTCL>210ms.Using either waveform,100f17
(59%)VTE withCL>21Owere terminated.
CONCLUSIONS:l)RapidVT can be successfully terminated in
selected cases withTC;2)VT<CL 210preclude the use of this
technique;3)Comparable efficacy rates are obtained with
27%&82%tilt waveforms in very rapidVT;4)VT acceleration
duringTC with both waveforms requires availability of
transthoracic cardioversion whenever this technique is
employed.
POST-DEFIBRILLATION BRADYCARDIA FOLLOWING IMPLANTAB~E DE-
FIBRILLATOR DISCHARGE.
Edward V. Platia, MD, FACC, Enrico P. Veltri, MD,
Lawrence S.C. Griffith, MD, FACC, Philip R. Reid, MD,
FACC, Thomas Guarnieri, MD, FACC, Levi Watkins, Jr., MD,
Morton M. Mower, MD, FACC, M. Mirowski, MD, FACC, The
Johns Hopkins Medical Institutions and Sinai Hospital,
Baltimore, MD; and Washington Hospital Center, Washington,
DC.
We examined the incidence and nature of post-defibril-
lation bradycardias immediately following automatic im-
plantable cardioverter-defibrillator (AICD) discharge,
Our patient (pt) population consisted of III pts, whose
mean age was 58 yr (range 19-77 yr). Sustained ventricu-
lar tachyarrhythmias were induced post-implant to test
the AICD. Six pts had previously had a permanent VVI
pacemaker implanted.
The AICD discharged 17,2 + 6.1sec (mean + SD) after the
initiation of the induced tachyarrhythmia, At time of
AICD discharge (mean energy 27 + 3,2 joule) VT was present
in 37 pts and VF in 74 pts, FOllowing AICD discharge the
first spontaneous beat occurred after 1.4 + .7sec: the
rhythm was sinus in 38, junctional in 68 pts, and atrial
fibrillation in 5 pts. In 2 pts the temporary pacemaker
was turned on after asystole lasted over 4 sec, and a
permanent VVI pacemaker subsequently implanted, The dur-
ation of the post-discharge pause was the same for VT
(1.2sec) and VF (1.5sec) (p=NS). In pts with implanted
pacemakers, pacing initiated the post-discharge rhythm.
During followup (21 + 9 mo) there was no clinical evidence
of prolonged post-discharge asystole in those pts with
documented AICD discharges.
We conclude that significant post-discharge asystole is
rare in pts with AICDs. Nonetheless, the integrity of
the escape mechanism should be assessed in each pt prior
to hospital discharge.
MECHANISM OF EFFICACY OF TRANSVENOUS CARDIOVERSION OF
VENTRICULAR TACHYARRHYTHMIAS AS DETERMINED BY CARDIAC
MAPPING IN MAN,Sanjeev Saksena,MD,FACC,Stephen T Roth-
bart,MD,FACC,Ricardo Calvo,RD,Demetris Pantopoulos,ME,
Syed M Hussain,MD,FACC. Newark Beth Israel Med Ctr,
Newark, NJ
Transvenous cardioversion(TC)is effective in terminating
ventricular tachycardia(VT)&fibrillation(VF),but the elec-
trophysiologic(EP)mechanisms in man have not been directly
studied,We analyzed theEP effects ofTC shocks(0,03-25J)in
10pts with CAD & VT/VF during preoperative&intraoperative
cardiac mapping using a multi-electrode plaque array with
simultaneousRV&LV electrogram recordings.Synchronous(SYN)
&asynchronous(AS)TC shocks were delivered at the RV apex
using a Medtronic 6880 lead in sinus rhythm, VT & VF,
RESULTS:AS TC shocks of 0,03J in sinus rhythm produced im-
~ local RV depolarization&subsequently conducted to
distant RV & LV sites after 30t080ms.Shocks of 0,05toO,5J
produced immediate depolarization of larger RV&LV regions
with shocks >0.5J producing immediate depolarization of
distantLV sites.SYN successfulTC shocks duringVT produced
either:l)immediateVT termination due to conduction block;
or2)repetitiveV responses(RVR)beforeVT termination,Immedi-
ateVT termination occurred despite prior depolarization of
site of VT origin(SO).RVR's due toTC shocks showed alter-
ation in l)VT rate at theSO&2)the pattern ofRV&LV activa-
tion.AS high energy(>lOJ)termination ofVF showed instan-
taneous depolarization of both RV & LV,
CONCLUSIONS:l)TC shocks produce conduction block in human
ventricle & its extent is dependent on shock energy;2)VT
termination with TC shocks at very low energies is due to
either direct conduction block in an adjoiningSO or indi-
rectly by a paced depolarization penetrating a distant SO;
3)HigherTC energies(>0,5J)alter conduction at a distantSO
directly resulting in VT instability or termination & in
RV & LV.
SUB11IRESHOLD INTRACARDIAC CARDIOVERSION SHORTENS VENTRICULAR
TACHYCARDIA CYCLE LENGTH AND IS A PREDICTOR OF CARDIOVERSION
11IRESHOLD,
Rahul Mehra, PhD, Eric N, Prystowsky, MD, FACC, William M,
Miles, MD, James J, Heger, MIl, FACC, Scott R, Spielman, MIl,
FACC, Douglas P, Zipes, MIl, FACC, Krannert Institute of
Cardiology, Indianapolis, IN,
We analyzed the cycle length (CL) of the first beat (FB)
following synchronized subthreshold Cardioversion (C) in 37
patients with 47 morphologically distinct ventricular
tachycardias (VTCL:407 + 87 msec) to determine the relationship
between the duration of reset (VTCL minus FBCL) and the
amplitude of the C stimulus as well as the ability of the reset
to predict C threshold, C shoCks up to 5 joules ( ( 450 volts)
were delivered through the Medtronic 6880 endocardial lead,
Among the 172 unsuccessful C episodes, the FBCL was shorter
than VTC in 116 (67%); equal to VTCL in 53 (31%) and longer
than VTCL in 3 (2%), In 43 VTs where multiple unsuccessful C
attempts were made, there was a positive correlation between
the duration of the reset and the C voltage (r = .37; p(.Ol)
and between the reset and delivered energy (r=.21; p(.05), In
26 VTs where the threshold of successful C was ),15 joules, the
maxillllm reset measured at (,15 joules was found to be a
significant predictor of whether the threshold of C would be
less than 1 joule, (Logistic Regression Analysis, p=.012),
The greater the reset at (,15 joules, the higher was the
probability that the C threshold was less than 1 joule.
Conclusions: 1) C shocks that do not terminate VT frequently
shorten the FBCL, 2) The duration of the reset increases with
increasing voltage or energy output of the C, 3) Greater reset
measured at low energy subthreshold shocks predicts a greater
likelihood that the C threshold will be less than 1 joule.
These findings are consistant with reentry as the mechanism of
VT and may be used to screen responders for successful
Cardioversion.
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SEQUENTIAL PULSE DEFIBRILLATION USING A
CATHETER AND SKIN ELECTRODE
Michael J. Kallok, PhD, Douglas L. Jones, PhD, George J.
Klein,MD, FACC, Medtronic, Inc., Minneapolis, MN
Sequential pulse defibrillation (SPD), in which a pulse is
delivered from the SVC to RV apex (RVA) , followed 1 msec
later by a second pulse delivered from a left heart (LH)
electrode to RVA, has been shown to reduce defibrillation
threshold (OFT) by 50% or more compared to single pulse
catheter defibrillation. We have previously described the
use of an epicardial patch, coronary sinus catheter, and
subcutaneous plate (SUBCU) as the LH electrode with
similar OFT's obtained with each system. The objective of
this study was to compare OFT obtained with a SUBCU
electrode to those obtained with each of three skin
electrodes (48 cm2, 109 cm2, 172 cm2 surface area,
respectively). Seven halothane anesthetized dogs had a
defibrillation catheter (Medtronic 6880) introduced into
the right' ventricle and a SUBCU electrode (33 cm2)
implanted over the left 4th intercostal space. OFT was
determined by SPD shocks delivered after electrical
induction of VF. The SUBCU electrode was removed and OFT
was then measured using each of the 3 skin electrodes.
OFT's for the SUBCU and 3 skin electrodes were 10.2 + 4.7,
10.0 + 4.5, 11.2 + 3.7, 9.7 + 3.4 joules (mean :; SO),
respeCtively. Analysis o~ variance indicated no
significant difference in OFT among the four LH electrodes
tested (p >.10). We conclude that low energy sequential
pulse defibrillation can be accomplished with an
intracardiac catheter and skin electrode. This may
provide a means for preimplant testing of an implantable
defibrillator that utilizes SPD, and may provide a low
energy alternative to transthoracic defibrillation.
Tuesday, March 11, 1986
10:30AM-12:00NOON, Room #157
Clinical Studies in Pediatric Cardiology
LIFE-THREATENING DIGOXIN TOXICITY IN CHILDREN: TREATMENT
WITH DIGOXIN SPECIFIC FAD FRAGMENTS.
Thomaa Wenger MD, Vincent Butler MD, Edgar Haber MD,
FACC, Thomas Smith MD, FACC, Burroughs Wellcome Co.,
RTP, NC
Twenty pediatric cases of life-threatening digOXin
toxicity have been treated with digoxin specific antibody
fragments (Fab). The age range was 1 day to 4 years.
Nine children became toxic from accidental ingestion.
These patients ingested amounts ranging from 2.25 to
11 mg of digoxin (n=8), had serum concentrations from
6.2 to >100 nglml (n=9) and required Fab doses of 28 to
1,000 mg (n=9). Eleven patients developed severe toxi-
city during therapy for underlying heart disease. Their
calculated boay stores of digoxin ranged from 48 to 833 ~g
of digoxin (n=lO); serum concentrations ranged from 5.2
to 18 nglml (n"9) and Fab doses ranged from 5 to 160 mg
(n"ll). Three cases were due to medication errors.
Nineteen of 20 children responded favorably to Fab.
Reversal of toxicity was rapid, with improvement often
seen within 10 min of Fab administration. Three patients
required resuscitation lasting more than 1 hour for
arrhythmias not responsive to any other therapy, but
which reversed with Fab therapy. Nine patients had renal
inSUfficiency (serum creatinine range 1.3 to 3.1 mg/dl).
Fab requirements were the same as those with normal renal
function and there was no recurrence of toxicity later.
No adverse reactions to Fab were identified other
than hypokalemia, presumably caused by reversing inhi-
bition of the Na+,K+ pump.
Our experience suggests that pediatric ingestions of
greater than 4 mg of digoxin are likely to be life-
threatening, that medication errors constitute an impor-
tant cause of life-threatening digoxin intoxications,
and that treatment with Fab fragments is effective and
appears to be rapid and safe.
RELATIONSHIP OF THE STILL'S MURMUR, SMALL AORTIC DIAMETER
AND HIGH AORTIC VELOCITY Stanley J. Goldberg, MD, FACC,
Marcy L. Schwartz, Hugh D. Allen, MD, FACC, Gerald R.
Marx, MD, FACC, Neil Wilson, MD, University of Arizona,
Tucson, AZ
The etiology of the innocent Still's murmur (SM) re-
mains obscure. To evaluate possible etiologies, we stud-
ied 70 normal subjects; 29 had SM and 41 were random con-
trols who had no murmur (-MUR). Pulsed Doppler and 20
echo were used to determine the magnitude of ascending
(A) and descending (D) aortic (AO) and main pulmonary ar-
tery velocities, maximal spectral widths of all velocity
tracings, AAO diameter, and the percent of each group
with tricuspid regurgitation and left ventricular bands.
Although SM was concentrated in the first decade of life,
it was also found in the second. The most important find-
ing by discriminant analysis was that AAO diameter rela-
tive to body surface area was significantly smaller for
the SM group (21.9 mm) than for the -MUR group (28.6 mm)
(p<.OOI) when other factors were controlled. As a conse-
quence of smaller AO diameter, and since indexed cardiac
output was equal in the 2 groups, mean peak AAO and DAO
velocities were significantly higher in the SM group (118
cm/s and 133 cm/s, respectively) than in the -MUR group
(AAO=107 and DAO=104 cm/s) (p<.OOI and p<.OI respective-
ly). No velocity gradients were found to suggest stenosis
in either group. No significant differences (p>.05) were
found when comparing SM and -MUR groups with respect to
mean peak pulmonary artery velocity, AAO and ,DAD and pul-
monary spectral widths (markers of turbulence). The pre-
sence of tricuspid regurgitation and ventricular bands
was equal in both groups. The important and previously
unreported findings of this study were demonstration in
SM subjects of 1) significantly smaller aortas, 2) higher
aortic velocities, and 3) equal cardiac outputs as com-
pared to controls.
CHROMOSOME ABERRATIONS SECONDARY TO DIAGNOSTIC CARDIAC CA-
THETERIZATION
Anthony A. Raviele, M.D.; David A. Shafer, Ph.D.; LorieA.
Click, R.N.,M.N.; Virginia G. Dunbar, B.S.; Cardiology
Section, Pediatrics Department, Emory University School
of Medicine, Atlanta, Georgia
Twenty-eight (28) patients, aged 1 day to 11.1 years
(mean=4.1 yr) were studied for chromosome changes induced
by diagnostic cardiac catheterization (cath). There were
fourteen (14) boys and fourteen (14) girls. Eleven (11)
were cyanotic and seventeen (17) were acyanotic. A se-
quence of four (I-ml) samples of blood from each patient
were obtained and analyzed for damage: at the beginning
of the cath (1), after fluoroscopy and before cineangio-
graphy (cine) (2), after cine (3), and the following
morning (4). After 2-3 days in culture, double-blind
chromosome analysis was performed on the average of 100
metaphases for each of the four samples. The chromosome
abnormalities seen were acentrics, dicentrics, and rings.
Radiation dose was calculated for each segment of the
procedure. A nonparanetric statistical analysis of the
dose of radiation received and the amount of change seen
was performed. The mean rate of occurrence of aberrations
increased with the sequence number (p=O.OOI). The great-
est change was noted after cine as compared to before
(p=O.OOI). The number of previous caths, patients' clin-
ical condition, and other demographic factors were not
found to correlate with the frequency of aberrations. It
is concluded that chromosome abnormalities are observed
in pediatric patients exposed to diagnostic radiation.
The long-term implications of this finding remain unknown.
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CAN CARDIAC OUTPUT AND EXERCISE FACTOR BE MEASURED BY
DOPPLER ECHOCARDIOGRAPHY DURING SUPINE BICYCLE ERGOMETRY?
Gerald R. Marx, MD, FACC, Richard W. Hicks, MS, Scott M.
Kinzer, MS, Hugh D. Allen, MD, FACC, Stanley J. Goldberg,
MD, FACC, Jack Wilmore, Ph.D., University of Arizona,
Tucson, AZ
To determine if cardiac output (CO) could be measured
by Doppler echo (DE) during exercise, we measured CO at
rest and during supine bicycle ergometry in 19 boys, mean
age 13±0.6 years. Ten subjects underwent two separate
testing periods 3 months apart, and 9 were tested once,
for a total of 29 studies. Pulsed Doppler velocities and
aortic diameter measurements for calculation of CO were
obtained at rest from the suprasternal notch with an
imaging off-axis transducer. Velocities were then mea-
sured with a nonimaging, 90· off-axis 2.25 MHz transducer
during exercise. Oxygen consumption was measured at rest
and exercise which allowed for calculation of exercise
factor (EF), the change in CO divided by the change in
oxygen consumption. Mean nonindexed CO (L/min) increased
from 5.6±1.0 (mean±SD) to 9.3±1.5 L/min at a predeter-
mined 50% maximal exercise level. Simultaneously measured
oxygen consumption (ml/min) increased from mean 210±40 to
895±211. The relationship of CO and oxygen consumption
had a correlation of r-.92. Mean exercise factor for the
group was 5.4t1.4, similar to previously invasively mea-
sured values.
We conclude that Doppler echocardiography measures
cardiac output during supine exercise. When combined with
simultaneously measured oxygen consumption, exercise fac-
tor can be computed. This new noninvasive methodology
should have significant clinical and research potential.
LEFT VENTRICULAR WALL STRESS AND CONTRACTILE FUNCTION
AFTER RASTELLI REPAIR OF TRANSPOSITION OF THE GREAT
ARTERIES.
Thomas P Graham Jr MD FACC. Rodney C G Frankl1n MRCP,
R1chard K H Wyse PhD, Vanda Gooch SSc,
John E Deanf1eld MRCP.
The Hosp1tal for Slck Ch1ldren, Great Ormond Street,
London, UnIted Kingdom.
Abnormal RV funct10n follow1ng 1ntraatr1al repa1r of
transpos1t1on of the great arter1es (TGA) 1S an estab-
11shed f1nd1ng. However, LV funct10n after Rastel11
repair of TGA, where the left ventr1cle 1S the system1c
pump1ng chamber, has not been evaluated. LV wall stress
and contractIle functIon were determIned by echocardlo-
graphy 1n 11 patients stud1ed 0.7 to 13.8 yrs (mean 5.6)
following RastellI repair of TGA wIth ventrIcular septal
defect and left ventr1cular outflow tract obstruct1on.
Age at operat1on ranged from 4.6 to 11.3 yrs (mean 7.4).
Data were compared w1th 24 normals of slm1lar age and
heart rate. LV end-d1astol1c d1menS1on and volume were
slgn1f1cantly 1ncreased above normal, averag1ng ~34 ± 8%
of normal d1menS1on (p< 0.004) and 104 =13 cc/M
(p<O.OO7) rispectlvely. In add1tlon LV wall masZ was215 1 40 g/M versus a normal value of 72 ± 6 g/M
(p<0.004). Mer1d1onal and c1rcumferent1al end-systol1c
and peak SYStOl1C stress values were not slgn1f1cantly
d1fferent between normal and Rastell1 patients.
Est1mates of LV SYStOl1C funct10n 1nclud1ng shorten1ng
fract1on, rate-corrected c1rcumferential f1ber shorten1ng
velocity (VCFc) and eJect10n fract10n were
slgn1f1cantly depressed when compared to normal values.
VCFc evaluated as a funct10n of end-systol1C stress
demonstrated abnormal contractile funct10n in 8/11 (73%)
of patIents. Thus LV funct10n 1S abnormal 1n pat1ents
follow1ng Rastel11 repa1r of complex TGA and LV
d1latat1on and wall hypertrophy persist.
CORONARY ARTERY ABNORMALITIES IN PULMONARY
ATRESIA WITH INTACT VENTRICULAR SEPTUM
J. Kasznica. P. Ursell. W. Gersony. W. Blanc.
Columbia University. New York. NY
Abnormalities of the coronary circulation have been reported
in cases of pulmonary atresia with intact ventricular septum
(PA-IVS). however the origin of this problem has been only
speculative. In PA-IVS. intramyocardial sinusoids (IS) in
the right ventricle (RV). which may persist from fetal life,
have been noted to communicate with the coronary circula-
tion. To evaluate the significance of IS in PA-IVS. we
studied 17 autopsy heart specimens (2 fetuses. 13 neonates.
2 infants) with PA-IVS and: a) analyzed the distribution
and gross and microscopic pathology of the coronary ar-
teries. b) inspected the RV wall for macroscopic (severely
dilated) IS and c) measured RV volumes. The RV volume
of 9 complete hearts was measured by silicone cast and vol-
ume displacement and compared with age- and body weight-
matched normal controls. In comparison with these 9, the
remaining 8 hearts were visually graded as to RV size.
The 17 cases included 13 with small RV (volume <50% of
control) and 4 with normal RV size. None of the hearts
with normal size RV showed either IS or coronary artery
abnormalities. Four of 13 with small RV (including one
fetus of 23 weeks) had both IS and coronary abnormalities;
each of the 4 showed absent coronary os/atrophic coronary
artery (fibrous cord). One of 13 with small RV had tor-
tuous and sclerotic coronaries but no IS. We conclude:
1) 38% of PA-IVS with small RV have major abnormalities of
the coronary arteries, 2) severely dilated IS are present in
80% of PA-IVS cases with coronary abnormalities. 3) coro-
nary abnormalities may be present in fetuses with PA-IVS
as early as 23 weeks of gestation.
Tuesday, March 11, 1986
8:30AM-I0:00AM, Room #267
Circulatory Regulation
ALPHA-ATRIAL NATRIUREmC F1\CIOR IN ClIRDIOVASCUIAR
DISEASE. R.M. ArEmit, M.D., A.L. Gerbes, M.D., D. Ritter,
M.A•• E. Stangl, Ph.D., P. Bach, M.D., J. Zahringer, M.D.
University of Munich, Munich, West Germany.
Recently isolated atrial peptides possess natriuretic
arrl vascular SIlOOth muscle relaxant properties. '!bey are
secreted upon volume arrl/or pressure loading. Thus, they
may play a role in the m:xiulatioo of cardiOlTasCUlar func-
tion. We recently deItonstrated the occurrence of alEt!a-
ANF, the 28 amioo acid residue portion of pre-pro-ANF in
human plasma. The present investigation characterized ANF
in the circulation of patients with cardiOlTasCUlar di-
sease. Plasma fran oonrotensive controls arrl patients
with arterial hypertension or congestive heart failure,
respectively, was extracted by adsorption to resin col-
unns. ANF plasma levels were measured in lyotilllised col-
unn eluates by a sensitive arrl specific RIA. ANF plasma
levels in patients with congestive heart failure or ar-
terial hypertension ...ere considerably higher than those
in ooIlllOtensive controls: 277 + 125 or 62.2 + 19.7, res-
pectively, versus 8.7 + 1.0 fmOl/ml. ANF-iJIlniiooreacti-
vity in plasma extractS of oonrotensive controls consis-
too exclusively of the authentic 28 CIllioo acid peptide,
whereas plasma extracts of hypertensive patients yielded
an additional higher molecular ...eight fOIIII on high per-
fOIIllance gel peIlleation chrana~. QJnclusions: (1) A
specific RIA in conjunction with a OOITel extraction pro-
cedure allCMS for the rapid and reliable detennination of
ANF plasma levels. (2) Hypertensive patients or patients
with congestive heart failure display a, respectively, 7-
or 32-fold increase in ANF plasma levels as cxmpared to
control subjects. (3) In OOd1tion to the authentic alP1a-
ANF, a 13000 dalton precursor is present in the plasma
of hypertensive patients.
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PLASMA ATRIAL NATRIURETIC FACTOR (ANF) IS ELEVATED IN
PATIENTS WITH HEART FAILURE:
JorTe Cheirif M.D., Claus Bossaller M.D., Addison A.
fay or M.D., Carolyn Williams B.S., Robert Roberts
M.D., F.A.C.C. and Philip D. Henry M.D., F.A.C.C.
Baylor College of Medicine, Houston, TX.
*values are means ±SE in pg/ml
Reverse-phase HPLC fractionation of plasma from CHF and
C patients showed a single dominant immunoreactive peak
that corresponded to the peak of exogenous human a ANF.
Thus, ANF varies little with respect to posture and
time, and heart failure with edema is associated with a
substantial elevation in circulating ANF, an appro-
priate response to volume expansion.
Since atrial myocardium of animals with heart failure
may be depleted of ANF and exogenous ANF evokes a
diuresis in animals with cardiogenic edema, we
postulated that patients with heart failure and edema
may be deficient in ANF. Fourteen normotensive patients
with myocardial disease and edema (CHF; ejection
fraction <0.35) and 9 age-matched controls (C) were
studied. ANF was measured by radioimmunoassay
(Peninsula) in peripheral venous blood collected in the
recumbent and standing positions at 8:00 a.m. and 5:00
p.m.:
recumbent a.m.
CHF(n=14) 644±41*
C (n=9) 353±28
p-value <.0001
standing a.m.
605±47
326±42
<.0005
recumbent p.m.
624±43
332±15
<0.0001
rARDIOVASCULAR EFFECTS OF BlrARBONATE IN PATIENTS WITH HYPOXIA AND
rARDIAC DECOMPENSATION. Roberl 6ersjn M0 , K8Ilu Ch8tterjee,
M.D, ,F.A.C.C. and Allen I. Arieff, M.D., V.A.M81. ctr. & Univ. of C8lifornia, san
Francisco, C8
SOOlum blcarb0n8te hils been used In the ther8PY of cardllK: arrest for over
50 yrs. The llSSUmption is thGt its lIdministrDtion will corrlK:t aciOOsis and
thereby improve cardilK: performance. However, the actual cardiovascular
effects of N8HC03 In hypoxic pat1ents h8ve not been well evaluat8l, In previous
studies from our laboratory in hypoxic 00gs (SCience 227:754-56, 1985),
N8HC03 infusion resu1t81 in decrements of cardilK: output (CO) llIld meen
arterial pressure (MAP) with decrements In peripheral oxygen utilization.
We therefore elect81 to stlD( the cardiovascular effects of N8HC03 Infusion in
patients with hypoxia (pa.02=62 mmHQ) llIld COIlllllSt1ve he8rt fallure (NY
HelIrt Assoc. Class III or IV) who had ejection fraction<401. Patients
participat1ng In this stlD( were underlJling elective ri~t he8rt catheterization
llIld pllK:ement of acoronary sinus catheter for other rtlllSOl'lS, To control for N8
80d volume stDtus, pat1ents receiv8l either N8HC03 or NaCI, 2.5 mEq/kglhr
llIld meesurements mllle at 15 min intervals for 1 hr of infusion 80d 1 hr of
recovery. Meesurements were mllle in blood of pH, pC02, 02 content,
bicarbonate & lectate, and of MAP, CO, /leert rate, fill1ng pressures &
coronary sinus now (CSF) , 80d utll128t1on & extrlK:tlon of both oxYlIeD &
lactate by the myocardium. In the initllll 30 min of infusion, there were no
signlfiC8llt ch8nges in CO, MAP, CSF or myocardial oxygen use. However,
myocardial lactate extraction was 501 less with N8HC03 thlln with NaCI
(p<.O I). During the lest 30 min of infusion, the CO, CSF 80d myocardial
extrlK:tion of oxYlIeD & llK:tDte were signiflC8lltly less by 12-501 with
N8HC03 th8n with NaCI (p<.O 1).
These dela suggest that in hypoxic patients with cardiac decompensation
rllallvlng N8HC03: a) blcarbOn8te decrtlllS8S myocardIal oxygen ut1l1zation,
cardiac output lIIld coronary sinus now, resulting in decrllllSlld ability to
extract lactDte; b) there lljlpears to be increased 8Il8erObic mel8bol1sm in the
helIrt as a result of blcarbon8te; c) the routine use of blcarbon8te In such
patients may require re-evaluation
THE EFFECTS OF HEART TRANSPLANTATION ON MAXIMAL FOREARM
BLOOD FLOW.
Lawrence I. Sinoway, M.D., John R. Minotti, M.D., Dwight
Davis, M.D., John L. Pennock, M.D., F.A.C.C., Timothy I.
Musch, Ph.D., and Robert Zelis, M.D., F.A.C.C.
Cardiology, PA State University, Hershey, PA
The effects of heart transplantation on maximal forearm
blood flow in patients (n=6) with decompensated congestive
heart failure (CHF) was studied to define the relationship
between the central and peripheral components in this dis-
ease. Forearm blood flow (FBF) (ml/min·lOOml) was meas-
ured with a strain-gauge plethysmograph (venous occlusion
technique). In addition to basal FBF, the blood flow re-
sponse after release of 5 minutes of arterial occlusion,
the peak reactive hyperemic blood flow (RHBF) response,
was measured as an index of maximal vasodilator capacity.
Minimal resistance (R) and maximal conductance (C) were
derived from the RHBF and mean BP. Each subject was stud-
ied pretransplant, prior to hospital discharge (average
16 days post-transplant) and again as an outpatient
(average of 63 days). We noted the following results:
Basal FBF RHBF R C
Pretransplant 1. 2 21. 0 4--:9 .26
Predischarge 1.5 22.0 4.5 .22
Outpatient 2.2* 39.l*t 2.9*t .42*t
*p<.05 vs pretransplant; tp<.05 vs predischarge
These results indicate that: (1) Despite a dramatic, vir-
tually immediate, enhancement of cardiac function, peri-
pheral indices of vasculature function remain impaired for
an extended time post-transplantation. This suggests that
the peripheral component is a distinct separable entity of
the congestive state, (2) Delayed substantial increases in
peripheral flow occur after discharge. Whether this delay
represents a reduction in immunosuppressive medication, an
improvement in local metabolic function, or a training
effect remains to be elucidated.
VT
68*
3.4
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35.7
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HEMX>YN..',',IIC RECOVERY DURII\G VENTRICULAR TAOlYCARDIA: ROLE
OF a AND B ADRENERGIC RECEPTOR ACTIVATION
Ted Feldman M.D., Kenneth R Gray M.D., John 0 Carroll M.D.
The University of Chicago, Chicago Illinois
VT is hemodynamically tolerated differently by Individual
patients, possibly due to variations in autonomic nervous system
adjustment. In 13 chloralose anesthetized dogs, VT was simulated
by RV pacing (cycle length=250ms). LV function was assessed
during sinus rhythm and 20 sec after initiation of VT before and
after a-blockade with terazocin (n=7; 0.3mg/kg) and !!-blockade
with propranolol (n=6; 2mg/kg). Micromanometers measured peak
LVP, minimum diastolic LVP (Pm in) and max +dP/dt. LV end-
diastolic dimension (EDD) was measured with endocardial piezo
crystals. Sinus interval, an index of autonomic tone, was
determined im mediately after termination of VT.
. CONTROL B-BLoa<ADE
NSR VT 20s NSR VT
Ti4"94 120 78*
3.9 4.2 6.6 10.2*
2108 2344 1502 1233*
37.7 36.2 39.3 38.6
511 333* 456 419
*=p<O.OS vs sinus rhythm
Under control conditions, Immediately after onset of VT there
was severe hypotension. By 20 sec after onset of VT LVP
recovered to sinus values and +dP/dt exceeded sinus values,
despite decreased EDD and LV asynchrony. After !!-blockade LVP
recovery during VT was blunted, Pmin rose, and max +dP/dt failed
to recover. With a-blockade VT produced a sustained fall in LVP,
yet cardiac sympathetic stimulation preserved Pmin, +dP/dt
recovered, and sinus rate accelerated post VT.
CONCLUSIONS: Hemodynamic recovery during VT requires both
a vasoconstriction and aaugmented contraction/relaxation. These
functional responses may be clinically relevant since adrenergic
down-regulation and agents with a or !!-blockIng effects are
com mon in patients susceptible to VT and sudden death.
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ABNORMAL RIGHT HEART HEMODYNAMICS AT REST AND DURING
SUPINE EXERCISE: A COMMON FINDING FOLLOWING ORTHOTOPIC
CARDIAC TRANSPlANTATION
Peter W Pllygfelder MD F.Neil McKenzie, MD, William J. Kostuk ,MD,
FACC, University HospRal, London, Ontario, Canada.
In order to characterize right heart hemodynamics, 21 orthotopic cardiac
transplant (TPI recipients have been studied 0.5-51 mo (mean 16.1 mol
after surgery. Following routine endomyocardial biopsy, right heart
pressures and thermodilution cardiac outputs were obtained with a flow
directed catheter at rest (supine) and during symptom limited graded
supine exercise. In addition, the effect of slow deep inspiration on right
atrial (RA) pressures and wave forms was determined at rest, wRh passive
leg raising (volume loading), and following exercise.
During exercise, stnKing elevations of right atrial (RA), pulmonary artery
(PAl and pulmonary wedge (PW) pressures were seen:
CO mean RAP mean PWP mean PAP PVR
(Vrnk!l (rmt!gl (rmt!gl (rmt!gl (dyne-cm-s-6t
Rest 5.S±'4 6.1±0.5 13.3±0.9 21.4±1.2 112±11
Peak 11.S±O.4· 16.9±1.1' 27.&1:1.3' 38.1±1.9" 73±110
Post S.3±O.4' S.O±O.S" 17.5±1.2" 29.00.0' 127±14
means given ±SEM; '1><.001 vs rest, 0\)<.01 vs rest
During exercise mean RAP doubled in 20 patients. Similarly, mean PWP
doubled in 11 patients. A highly significant rise in mean PAP was seen
despite a reduction in calculated pulmonary vascular resistance.
An abnormal (Kussmaul) inspiratory response of the mean right atrial
pressure was seen in 6 patients at rest, in 11 wRh passive leg raising and in
12 following exercise. In these individuals, a characteristic prominent "Y.
wave with a markedly exaggerated .y. descent was observed with
inspiration. In 6 patients wRh a normal RA wave form during inspiration while
supine with legs down, an abnormal response developed with volume
loading. In contrast, the right ventricular (RV) diastolic pressure decreased
on inspiration in all patients when measured post exercise. Although an
abnormal inspiratory pressure response was most common in studies less
than 1 yr post TP, up to 50% of patients studied beyond 1 yr were also
abnormal.
Mhough the cause of these common abnormal observations post TP is
unknown, pericardial constraint, possibly localized to the atria is suggested.
Spl (n mol/min/m2)
1. 954
4.851*
Cl (1/min/m2)
1. 435
1. 007*
NOREPINEPHRINE KINETICS IN PATIENTS WITH CONGESTIVE HEART
FAILURE.
Dwight Davis, M.D., Janet Robison, John Minotti, M.D.,
Francis Day, M.D., Lawrence I. Sinoway, M.D., Timothy I.
Musch, Ph.D., and Robert Zelis, M.D., F.A.C.C., Cardiolog~
PA State University, Hershey, Pennsylvania
Excessive sympathetic nervous system (SNS) activity plays
an important role in both adaptive and pathophysiological
mechanisms of congestive heart failure. Most investi-
gators have relied on plasma norepinephrine (NE) levels to
assess SNS activity. The steady state plasma level of
norepinephrine, however, is the result of two processes,
spillover (Spl) of norepinephrine into the plasma after
release from sympathetic nerve terminals, and clearance
(CI) of norepinephrine from the circulation. We evaluated
supine norepinephrine levels and norepinephrine kinetics
in 8 normal volunteers and 4 patients with CHF utilizing a
90 minute [3H]-1-norepinephrine infusion to achieve a
steady state plateau concentration. Norepinephrine clear-
ance was calculated from the infusion rate and 3H- NE
concentration (alumina extraction) at steady rate and
norepinephrine spillover was determined from the infusion
rate and norepinephrine plasma concentration (radioenzy-
mat ic techn ique) .
NE (pg/ml)
NL 214.8
CHF 794.6*
(*p<.05)
In patients with CHF, clearance was decreased by 29% and
spillover was increased by 248% compared to normal sub-
jects. Thus, previously reported elevations in norepine-
phrine levels of patients with CHF is due to altered
kinetics involving both an increase in spillover and a
decrease in clearance.
Tuesday, March 11, 1986
10:30AM-12:00NOON, Room #267
Clinical Evaluation of Complex Problems
RaATIVE VIlUE OF BEDSIDE MANEUVERS IN lHE EVIlUATION OF
PATIENTS WllH SYSTQ.IC MJRMJRS.
Nicholas .J...Um.bs4 .MD, Louis J. Del I'ltalla. MD, FACC,
Michael H. Crawford, MD, FACC and Robert A.. O'Rourke,
MD, FACC, Unlv of Tx Health Sci Ctr, San Antonio, Tx.
The relative value of bedside maneuvers In the
differential diagnosis of systolic murmurs has not been
systematically assessed by non-biased auscultators.
Thus, we evaluated Inspiration, Val salva maneuver, rapid
s1'endlng fran 1'be sque1'1'lng posl1'lon, hendgrlp exercise,
and amyl nl1'rlte Inhalation In 45 patients wl1'b murmurs
due to documented: aortic stenosis (AS,n=10), hyper-
trophic cardiomyopathy (HCM,7), mitral regurgitation
(MR,15), ventricular septal defect (VSD,5), and rlght-
sided murmurs (RSM,S). Increases (1') or decreases (~) In
murmur Intensity were evaluated by two cardiologists In
adjacent areas using electronic stethophones, so that
1'be patl ent and 1'be maneuver s were unknow n. The percent
(%l of systolic murmurs that changed as expected were:
MANEUyER BSM ~ HeM .Ma ~
Inspiration 1'100% ~ 7~ ~ 80% ~67% ~7~
Valsalva ~ 71% ~10~ l' 6~ ~93% ~9~
Standing ~ 2~ ~ 7~ 1'100% UO% ~50%
Handgrlp l' 12% ~ 3~ ~10~ 1'67% 1'70%
limy I NI tr I te l' 50% l' 56% 1'1 00% ~77% ~90%
Conclusions; It Is clear that Inspiration best separates
right-sided from left-sided murmurs. The response to
Val salva and standing usually correctly Identifies the
murmur of hypertrophic cardlanyopathy. The murmurs of
mitral regurgitation and ventricular septal defect have
parall el responses to aII maneuver s but can be dl fferen-
tlated from the murmur of aortic stenosis by opposite
responses to handgrlp and amyl nitrite. Thus, the origin
of most systolic murmurs can most accurately be deter-
mined when the auscultatory responses to systematically
applied bedside maneuvers are analyzed In canblnatlon.
KINETICS OF LEUKOCYTE DEPOSITION DURING CANINE CARDIAC
TRANSPLANT REJECTION STUDIED WITH INDIUM-Ill-LEUKOCYTE
SCANNING.
Marvin A. Konstam, M.D., F.A.C.C., Karen Ramberg, M.S.,
Raymond Connolly, Ph.D., Douglas D. Payne, M.D., Boaz
Avitall, M.D., Jeffrey M. Isner, M.D., F.A.C.C., David S.
Weiland, M.D., Barbara A. Brockway, Deeb N. Salem, M.D.,
F.A.C.C., Tufts-New England Medical Center, Boston, MA
At present, direct histologic examination is the only
reliable means for detecting cardiac transplant (Tx) re-
jection in humans or in animal models. Using gamma camera
imaging of indium (In)-lil-oxine-labeled leukocytes, we
studied the in-vivo kinetics of leukocyte deposition in
comparison with histologic evidence of rejection (0 to 3+;
Billingham criteria) in 4 dogs receiving heterotopic Tx
without immunosupression. Leukocyte deposition was quan-
tified as percent of injected activity and as the ratio
of Tx to native (N) heart activity(Tx/N). Beginning 4
days post Tx a progressive increase in leukocyte deposi-
tion was observed. Percent injected In (mean±SE):
Native Tx Tx/N
4 days post Tx: 1.1±0.4 1.0±0.2 I.O±0.2} p<0.05
7 days post Tx: 0.8±0.4 1.9±0.9 2.3±O.1
In all dogs, Tx/N was ~1.25 on day 4 but >2 by day 7.
A 30% increase above initial Tx leukocyte activity cor-
responded to the presence of 2+ rejection based on
histologic criteria.
Conclusions: Beginning 4 days following canine cardiac
Tx (without immunosupression) progressive leukocyte
deposition occurs as detected by In-leukocyte scanning
and correlates with histologic rejection. In-leukocyte
scanning is a valuable tool for studying kinetics of
leukocyte deposition and Tx rejection in animal models
and, potentially, in man.
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NONINVASIVE CHARACTERIZATION OF THE PATHOLOGIC CHANGES IN
PRIMARY PULMONARY HYPERTENSION. Stuart Rich MD, FACC,
Giuseppe G. Pietra MD, Kim Hart RN, Karen Kieras RN, Bruce
H. Brundage MD, FACC. University of Illinois, Chicago IL.
Primary pulmonary hypertension(PPH) has been attributed
to 3 different pathologic etiologies: plexogenic arterio-
pathy{PLEXO), microthrornboernboli(THROMBO), and veno-occlu-
sive disease{VENO}. We evaluated the chest x-ray(CXR) and
pattern of peripheral blood distribution on perfusion lung
scan in 30 pts who fulfilled the NIH registry criteria for
PPH and categorized the lung fields on CXR as normal (28)
or increased bronchovascular markings (2) and the blood
flow on lung scan as normal (19) or diffuse non-segmental
patchy abnormalities {II}. These were correlated with
pathologic specimens from 11 pts obtained from open lung
biopsy (4) or autopsy(7) which were graded based on the
vascular changes and presence of microthrornbi with the
pathologist blinded from the results of the CXR and lung
scan. The findings were:
CXR LUNG SCAN
normal inc. markings normal patchy
PLEXO 5 0 5 0
THROMBO 4 0 1 3
VENO 0 2 0 2
Each group was significantly different from the other
(P(O.OS, Fishers exact test). We conclude that by charact-
erizing the vascular markings on CXR and pattern of per-
fusion lung scans in pts with PPH one may be able to dif-
ferentiate those '1ith PLEXO, THROMBO, or VENO changes on
pathology. The patchy defects noted on the lung scan in
some pts appears to reflect vascular occlusion. Based on
these data, PLEXO is the most common histologic type (63%),
with THROMBO intermediate (30%) and VENO the least common
(7%) in our experience. These findings may have important
implications regarding the selection of vasodilators or
anticoagulants as therapy for pts with PPH.
THE EFFECT OF HIGH DOSE CYCLOPHOSPHAMIDE AND TOTAL BODY
IRRADIATION ON LEFT VENTRICULAR FUNCTION IN ADULT LEUKEMIC
PATIENTS UNDERGOING ALLOGENEIC BONE MARROW TRANSPLANTATION
Ernesto B. Baello, M.D., David W. Ferguson, M.D., Mark
D. Ensberg, M.D., John W. Kugler, M.D., Roger D. Gingrich,
M.D., Ph.D., James O. Armitage, M.D., Lynell W. Klassen,
M.D., Richard E. Kerber, M.D., F.A.C.C., Melvin L. Marcus,
M.D., F.A.C.C., Peter T. Kirchner, M.D., David J. Skorton,
M.D., F.A.C.C. University of Iowa, Iowa City, IA
Protocols used to prepare leukemic patients for bone
marrow transplantation have the potential for cardiac tox-
icity due to the administration of high-dose cyclophospha-
mide and total body irradiation. We have reported one
regimen, combining cytarabine, cyclophosphamide (90 mg/kg)
and total body irradiation (900 rads), which is relatively
effective in the treatment of leukemia. To assess cardiac
effects of this protocol, we performed serial echocardio-
graphy and radionuclide ventriculography in 17 leukemic
patients (ages 18-45, mean 31, 12 males) undergoing allo-
geneic bone marrow transplantation. RESULTS: One and
six days after cyclophosphamide, no significant change
in echocardiographic left ventricular fractional shorten-
ing or increase in left ventricular diastolic dimension
was seen. At an average of 77 days (range 28-358) after
transplant, radionuclide ventriculography revealed no sig-
nificant change in resting ejection fraction in the group
as a whole (58 ± 6.8% [SO] vs. 56 ± 8.0%, p=NS). In four
patients, resting ejection fraction fell into the abnormal
range (from mean ejection fraction of 56% to 44%, lowest =
41%). Ten patients also had exercise radionuclide ventri-
culography and all had normal responses (>5% increase with
exercise) pre- and post-transplant.
We conclude that this effective bone marrow transplanta-
tion regimen has little short-term cardiac toxicity in
the majority of patients.
DOPPLER ECHOCARDIOGRAPHIC EVALUATION OF CARPENTIER
MITRAL VALVULOPLASTY
John Kenny, MD, Lawrence Cohn, MD, FACC, Richard Shemin,
MD, FACC, John J. Collins, MD, FACC, Maureen Plappert,
Martin St. John Sutton, MD, FACC, Cardiovascular
Division, Brigham & Women's Hospital, Boston, MA.
Doppler echocardiographic (DE) studies were performed in
16 patients (10 males) aged 33 to 77 (mean 58) to
evaluate the results of Carpentier Ring mitral
valvuloplasty (CV). At pre-op cardiac catheterization
15 patients had severe mitral regurgitation (MR) and 1
had mitral stenosis and regurgitation. Mitral valve
disease was due to myxomatous degeneration in 7 pts,
ischemic heart disease in 5, rheumatic heart disease in
2, dilated cardiomyopathy in 1 and calcified mitral
valve annulus in 1. Early post-operative DE studies
were performed with the sample volume in the left atrium
to map out regurgitant flow, and in the left ventricle
to record mitral diastolic flow. MR was classified as
Grade I if the MR jet extended only into the first ~ of
the left atrium, Grade II if the jet extended into the
second ~, Grade III if the jet extended into the third ~
and Grade IV if it was detected throughout the left
atrium. We assessed LV inflow obstruction as pressure
half time, mitral valve area and mitral valve gradient
derived from Doppler mitral diastolic flow. Following
CV 9 patients had no MR, 5 had Grade 1 MR and 2 had
Grade II MR. Peak diastolic mitral valve gradient was
7.5 ± 3.0 rnmHg, mean diastolic gradient was 3.0 ±
1.2 rnmHg and pressure half-time was 83±22 msec givin~ a
calculated mitral valve orifice area of 2.9 ± 0.9 em •
We conclude 1) that CV reduces MR without obstructing LV
inflow. 2) DE is an excellent method of evaluating the
results of CV. 3) DE is of value in the longitudinal
follow-up of individual patients.
Tuesday, March 11, 1986
8:30AM-I0:00AM, Room #268
Factors Influencing Myocardial Metabolic Function
EXERCISE TRAINING INFLUENCES CARDIAC ISOMYOSIN COMPOSITION
IN NORMAL AND DIABETIC RODENTS. Gregory Curfman, M.D.,
John Fallon, M.D" Pamela Tupper, B.A., William Skornik,
M.S., Glen Spaulding, D.V.M., Ban-An Khaw, Ph.D., Edgar
Haber, M.D. Massachusetts General Hospital, Boston, MA.
Although endurance-exercise training (ET) influences car-
diac contractile state, the molecular mechanisms involved
are not well understood. We therefore studied the effect
of ET on cardiac isomyosin (CIM) composition in 24 normal
rats, 24 diabetic rats (streptozotocin 60 mg/kg), and 12
normal hamsters. Half of each group underwent ET by
forced swimming for 2 months (rats), or by voluntary run-
ning for 1 or 2 years (hamsters), while the other half
were sedentary (SED). V3 CIM was quantified in LV and RV
extracts using anti-V3 monoclonal antibody as a probe in
conj unction with an ELISA procedure.
The results are summarized in tabular form:
%V3(LV) %V3(RV)
SED ET SED ET
Normal Rats 26+/-7 11+/-7* 29+/-13 20+/-7*
Diabetic Rats 82+/-15# 47+/-26* 87+/-10 42+/-9*
Hamsters (1 yr) 67+/-7 39+/-4* 49+/-2 20+/-2*
Hamsters (2 yr) 95+/-6 81+/-4* 60+/-4 41+/-3*
(*p<O.OOI vs. SED; Hp<O.OOI vs. normal SED)
The data show that both forced and voluntary ET signifi-
cantly reduced the V3 CIM content of the LV and RV in nor-
mal rodents. This effect was attenuated in 2 yr-old ham-
sters, because spontaneous running declined with advancing
age. We confirmed that diabetes results in a large in-
crease in V3 CIM content. However, the diabetes-induced
CIM switch was prevented and reversed by ET, partly owing
to improved glucose intolerance in trained diabetic rats
(mean fasting glucose: SED 554 mg%, ET 320 mg%, p<O.OI).
Exercise-induced switches in CIM composition in normal
and diabetic rodents represent a molecular adaptation of
the contractile apparatus to the exercise-trained state.
JACC Vol. 7. No.2
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These results correlate with mechanical changes in
papillary muscle from these same hearts. In rabbit, as in
rat, changes in cardiac contractility correlate with
changes in myosin isoenzyme composition and are reversible
with insulin.
When 3-4 month 0 rabbits received insulin for 3-4 months,
the results were:
C 0 Treated 0
Ca2+-activated .48 .34+° .45
myosin ATPase
Actin activated .126 .105+ .116
myosin ATPase
%V3 isoenzyme 78 95+° 79
(+p<.05 vs C; °p<'05 vs treated D).
EFFECT OF ATP PRECURSOR ADMINISTRATION ON POST-ISCHEMIC
FUNCTION AND METABOLISM IN ISOLATED RABBIT HEARTS.
~u,ep~ tb~osio M.D., William E. Jacobus l Ph.D. and"lB. ec er, t!:.D., F.A.C.C., Johns Hophns Medical
Institutions, Baltimore, MD.
Loss of lurine nucleotides during early reflow is
considere to be a causative factor for the prolone;ed
depression of myocardial ATP content and card1.ac
function seen after reversible ischemic injury in
"stunned" hearts. Supplementation with ATP precursors
would therefore seem to be a logical approach to
accelerate functional and metabolic recovery of post-
ischemic hearts. In this study we employed a model of
ischemia and reperfusion in the isolatea rabbit heart
in which !JlYocardial levels of ATP were cont inuously
monitored by 31-Phosphorus-NMR spectroscopy. Isovolumic
developed pressure (DP) was also simultaneously assessed
by means of a balloon inserted into the left ventricle.
After equilibration, the hearts were subjected to 20 min
of total global ischemia at room temperature and
reperfused for 2 hrs with perfusate containing either
adenosine (ADO) 100 pM (n=6J, or 5-fIIlinQimidazole-4-
carboxamide riboside \AICAR) 100 pM tn-6J, a direct
precursor of purine nucleot;ides; 6 {ldditional hearts
received normal perfusate tcontrolsJ. Ten min NMR
spectra were acquired during baseline and throughout
ischemia and reperfusion. During reperfusion DP reached
80-85% of baseline in control hearts' myocardial ATP
levels, which were reduced to 74.6+4.4~ of baseline by
the end of ischemia.! did not recover, actually decreas-
ing by an average ot -12.5%/2 hr. ADO treatment did not
induce any difference in function, DP being 78-82% of
baseline; in all hearts, however b ATP synthesis wassignificantly accelerljoted by A 0 treatment, by an
average of +13 .4%/2 hr tp < O.uOS vs controls). AICAR-
treated hearts did not show any difference from controls
in either function or ATP levels, possibly as a conse-
quence of the reported inhibition of adenylosuccinate
lyase, a key enzyme in the purine salvage pathway, by
this drug. These data indicate that in this experimen-
tal model, administration of ADO after ischemia si~nifi­
cantly increases myocardial levels of ATP w1.thout
improving post-ischemic function. Al though ATP level s
ana funct1.on are both depressed in the I!ost-ischemic
heart, there is an apparent dissociat1.on between
function and !JlYocardial ATP content, and the two may
therefore not be directly related.
95+7390+7793+807582
Ca2+-activated
myosin ATPase
%V3 isoenzyme
EFFECTS OF DIABETES ON CARDIAC CONTRACTILE PROTEINS IN THE
RABBIT.
Pia S. Pollack, M.D., Ashwani Malhotra, Ph.D., Fred S.
Fein, M.D., F.A.C.C., James Scheuer, M.D., F.A.C.C.
Montefiore Medical Center/Albert Einstein College of
Medicine, Bronx, New York
In diabetic (D) rats, cardiac myosin ATPase activity
decreases and a shift from the previous dominant VI
isoenzyme to V3 occurs, correlating with depressed
contractility. Rabbit myocardium is mostly V3, but small
isoenzyme shifts might be responsible for some of the
cardiac contractile abnormalities in the 0 rabbit. Male
rabbits were made diabetic with 140-150 mg/kg of alloxan.
Myosin ATPase activity ijJ mole Pi/mg/min) and isoenzyme
distribution in controls (C) and D were (Na 6-8):
~ 1 Month 3 Month 6 Month
CD CDC 0 C 0
.36 .40 .36 .28+ .43 .33+ .46 .28+
HISTAMINE EFFECT ON CONTRACTION FREQUENCY, Na INFLUX AND
CYCLIC AMP IN CULTURED HEART CELLS ARE MEDIATED THROUGH
H RECEPTORS.C~arles l!. Lui, M.D .. and David McCall, M.D., Ph.D.,
F.A.C.C., Univ of TX Health Sci Ctr, San Antonio, TX.
Histamine (H) has been shown to have both positive
inotropic and chronotropic effects. To evaluate the
chronotropic effects, spontaneously contracting
monolayers ~f cul~red rat myocardial cells were treated
with H, 10- M-10- M. This resulted in a dose-dependent
increase in contraction frequency reaching a maximum in
10-5 M. Contraction frequency increased to (mean .:!:.SEM)
129;t3.5%, 19l.:!:.7.a%, 177.:!:.2.82% 4and 180.:!:.3.7% of control in
10- M, 10- M, 10-5 M and 10- M, respectively (for each
'1=10, p<O.OOl). The effect was time-dependent taking 30
min to develop fully. Changes in contraction frequency
were accompanied by parallel increases in the verapamil
(V)-sensitive Na influx. V-sensitive Na influx (p-
mole/cm 2/sec) increased from a control of 10.45+1.44
(mean .:!:.SEM) to 24.34.:!.2641 and 32.57.:!.2.35 at 10 and 30min treatment with 10- MH ('1=5, p<O.OOl). These data
fit the previously described relationship between V-
sensitive Na influx ~nd contraction frequency.
Cimttidine (cimet) (10- M) but not diphenhydramine (D)
(10- M), abol i shed both the rate and Na i nfl ux response
to H. Subsequent studies showed a dose- and time-
dependent elevation of cAMP with H treatment. Cell cAMP
(control=5.25 p-mole/m~ proteiw incre~ed by 30%, 457%,
94% and 224% in 10- M, 10- M, 10- M and 10- M H
respectively, the changes between 10-7 M and 10- 5 M
closely paralleling the changes in beating rate and Na
influx. H effect on CAMP was competitively inhibited by
cimet. The results suggest H increases beating rate by
increasing V-sensitive Na infl ux and that the effects
are mediated by H2 receptors coupled to adenyl ate
cyclase.
IMPAIRED FATTY ACID METABOLISM AS A SIGN OF MILD
REGIONAL ISCHEMIA IN CANINE MYOCARDIUM.
Markus Schwaiger, M.D., Michael C. Fishbein, M.D.,
F.A.C.C., William Wijns, M.D., Mark Block, M.S., Herbert
Hansen, B.S., Carl Selin, M.S., Michael E. Phelps,
Ph.D., Heinrich R. Schelbert, M.D., F.A.C.C., UCLA
School of Medicine, Los Angeles, California.
Positron emission tomography in dogs previously
demonstrated abnormal C-ll palmitate kinetics in the
center of ischemia but also, to a lesser degree, in
myocardium with only mildy reduced blood flow. To study
this finding in the same experimental model,
electronmicroscopic (EM) examination was performed in 11
closed chest dogs af ter a 3 hr balloon occlusion of the
left anterior descending artery. The affected vascular
territory was defined by dye injection. Necrosis was
determined by TTC and regional blood flow (MBF) by
microspheres. Tissue samples for EM were taken from the
center and border of the ischemic segment and from
normal myocardium. In the center, MBF was 14.2 ± 16.7
ml/min/lOO g with classic signs of necrosis on EM. In
the border, EM revealed normal glycogen and
mitochondria. The only abnormality (8 of 11 dogs) were
lipid droplets adjacent to mitochondria. MBF in this
area averaged 51.4 ± 18.4 ml/min/lOO g, which is only
38% lower than in normal myocardium (82.5 ± 18.5
ml/min/lOO g) which was free of lipid droplets. Thus,
consistent with the abnormal C-ll palmitate kinetics,
the deposition of lipid droplets on electron microscopy
indicates impaired fatty acid metabolism while the
preserved glycogen stores suggest compensatory metabolic
adaptation in states of mildly reduced myocardial blood
flow.
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Fewer AAR than BAR were present in light vesicles, and
changes in AAR distribution in these fractions appeared
not to explain agonist or ischemia-induced alterations in
sarcolemmal receptors. Thus the traffic of AAR in
myocardium is apparently different than that of BAR.
RECEPTOR TRAFFIC IN THE MYOCARDIUM: COMPARISON OF a- AND
B-ADRENERGIC RECEPTORS
Alan S. Maisel, Harvey J. Motulsky, Paul A. Insel.
OCSD and VAMC, Ja Jolla, CA
We previously demonstrated that myocardial ischemia
causes an externalization of beta-adrenergic receptors
(BAR) from intracellular light vesicles to the surface
plasma membrane. As alpha-adrenergic receptors (AAR) have
been shown to increase in cardiac membrances after
ischemia, we tested for AAR internalization and external-
ization in response to agonists and ischemia. In one
group of guinea pigs we gave epinephrine (0.25 mg/kg sq)
and sacrificed animals at 45 min; another group underwent
left anterior descending coronary artery ligation for
1 h. We used differential centrifugation of left
ventricular tissue to prepare a sarcolemmal membrane and
light vesicle fraction. AAR and BAR number were
quantitated by binding of [125I]ICYP and [3H]prazosin,
respectively.
QUANTIFICATION OF MYOCARDIAL CREATINE KINASE SUB FORMS IN
BIOPSIES FROM PATIENTS UNDERGOING CARDIAC TRANSPLANTA-
TION. Carlos A. Leon, M.D., James B. Young, M.D., FACC,
Peter R. Puleo, M.D., Michael D. Schneider, M.D.,
Mary Anne Bresser, M.S., Robert Roberts, M.D., FACC, M.
Benjamin Perryman, Ph.D., Baylor College of Medicine,
Houston, Tx.
Three subforms of MM creatine kinase (CK) exist in the
blood, MM-3 the tissue form and MM-2 and MM-l occurring
as a result of proteolysis by plasma carboxypeptidase-N
which removes the C-terminal lysine. Preliminary studies
suggest detection of the newly released tissue form
(MM-3) provides for earlier diagnosis of infarction. More
recently, we have shown rapid release of MM-3 has poten-
tial value as a noninvasive marker to assess reperfusion
during thrombolytic therapy. These studies imply a single
tissue MMCK subform in the myocardium and inability of
the myocardium to convert MM-3 to the other subforms
which is yet to be validated in man. Protease degradation
limits the validity of postmortem myocardial CK subform
analysis. Thus, the present study was performed on biop-
sies from patients undergoing cardiac transplantation.
Biopsies were analyzed for tctal CK and CK subforms. A
total of 184 biopsies were obtained from either RV, LV,
or septum which were endocardial for donor hearts (n=140)
and transmural for recipients (n=44). Samples were
obtained in liquid nitrogen, homogenized, and analyzed
for MMCK subforms on agarose gel electrophoresis. MMCK
activity ran~ed from 2.38-3.3 x 104 IU/mg of protein and
the subform was consistently the tissue subform, namely
MM-3, with no trace of MM-2 or MM-l. These results
indicate myocardial C~ is solely MM-3 dnd conversion to
/oIM-2 or MM-I occurs post-release in the blood. Thus, an
increased level of MM-3 in the circulation reflects
release from tissue and early rapid release in the
setting of infarction is likely to reflect reperfusion.
B-receptors
membranes vesicles
(fmol/mg)
Control 90 80
epinephrine 54 130
Ischemia 135 45
a-receptors
membranes vesicles
(fmol/mg)
86 24
55 26
142 22.
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CANINE CARDIAC aI-ADRENERGIC RECEPTOR CHARACTERIZATION
AND AGONIST-STIMULATED PHOSPHORYLATION OF THE ISOLATED
aI-ADRENERGIC RECEPTOR.
Jeong H. 1m, Ph.D., Hazel R. Bowdon, B.A., Steve W.
Puckett, ph.D. and W.T. Woods, Jr., Ph.D. Departments
of Pharmacology, and Physiology and Biophysics, U.A.B.,
Birmingham, Alabama.
To characterize aI-adrenergic receptors, membrane pro-
teins solubilized from canine ventricular myocytes were
fractionated by chromatography on ion exchange and
Sepharose CL-6B columns, successively. The fraction-
ated samples were photoaffinity labeled with 15-
(4'-azidobenzyl)-1-125I-carazolol (125I-ABC). Alterna-
tively, the ion exchange fractionated samples were
labeled with 125I-ABC, and then chromatographed on a
Sepharose CL-6B column. Three aI-adrenergic receptor
complexes with Mr of >600K, 440K and 110K were
obtained. Upon SOS-PAGE, the complexes were dissociat-
ed into 66K-Da and' 58K-Oa subunits. To test ll-
agonist-stimulated phosphorylation, the purified lll-
receptor was incubated in the absence and presence of
D,L-, D-, and L-isoproterenol (ISO) for 30 min, then
exposed to (y_32p)-ATP. Analysis by SOS-PAGE of the
incubation mixtures showed that D,L- and L-ISO
stimulated the receptor phosphorylation, but D-ISO had
no effect. This result suggests that agonist-
stimulated Ill-receptor phosphorylation may be directly
related to physiological function of Ill-receptors. Mn++
was required for the phosphorylation. The phosphoryla-
tion was stimulated by cAMP, inhibited by a tyrosine
modifying agent tetranitromethane and by Pi. but GTP
had no effect. The results of the phosphorylation
experiments suggest that the agonist-stimulated 111-
receptor phosphorylation may be the initial reaction
for the desensitization of the receptor.
a-I ADRENERGIC RECEPTOR REGULATION OF ATRIOPEPTIN RELEASE
FROM THE RAT HEART. Mark G. Currie, Ph.D. and Walter H.
Newman, Ph.D., Dept. of Pharmacology, Medical University
of South Carolina, Charleston, S.C.
Recent studies have shown that the atria are the source
of a bioactive peptide, atriopeptin (AP) , that may be a
major regulator of the renal and cardiovascular systems.
Our goal in the present study was to determine whether
the release of immunoreactive AP (iAP) from the isolated
perfused rat heart was influenced by adrenergic receptor
stimulation. The data show that the infusion of epineph-
rine and norepinephrine stimulated the release of iAP in-
to the coronary effluent. The !I-agonist isoproterenol
and the a-2 agonist BHT-920 lacked effects on iAP release.
However, the a-I agonist phenylephrine produced a dose-
dependent release of iAP. In the presence of phentol-
amine this release was competitively inhibited with a 28X
shift in the ED
50
(1.2 x 10-8 M vs. 3.4 X 10-s M).
Basal Treated fold
iAP iAP increase
pcg/ml pcg/ml
Control 320±60 340±60 1.1
Epinephrine (lXlO·8M) 220±40 580±80* 2.6
Norepinephrine (IXlO-8M) l80±40 540±100* 3.0
Isoproterenol (lXlO- 8M) 280±40 320±40 1.1
BHT-920 (lxlO-8M) 200±40 220±30 1.1
Phenylephrine (SXIO- 7M) 280±40 420±IIO 1.5
PheDylephrine (5XIO- 8M) 280±40 555±I80* 2.0
PheDylephrine (5XIO- SM) 280±40 940±200* 3.4
Mean values ± S.E. * P < 0.05 vs basal
We cODclude that AP release is stimulated by a-I receptor
activation. This finding suggests an involvement of the
sympathetic nervous system in the physiologic regulation
of AP secretion.
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Changes in AP duration are therefore unrelated to an
increase in steady-state aiNa in the presence of A.
Prolongation of phase 2 of the AP .ay result in transient
increases in aiNa. During Na-K pu.p inhibition by ACS,
this could au~ent aiCa, resulting in greater inotropy.
AMILORIDE POTENTIATES THE POSITIVE INOTROPIC EFFECT OF
ACETYLSTROPHANTHIDIN IN CANINE CARDIAC PURKINJE FIBERS.
Kathleen K. Brown, D.V.M., Anne C. Marchese, M.D.,
Augustus Grant, M.D.,Ph.D., and Harold Strauss, M.D.
Duke University Medical Center, Durha., N.C.
The concurrent use of a.iloride (A) and digitalis
glycosides i.proves cardiac function unrelated to the K
sparing effect. To evaluate the possibility that a
greater rise in both intracellular sodiu. activity (aiNa)
and peak iso.etric tension (T) are produced by
acetylstrophanthidin (ACS) in the presence of A, aiNa, T,
and action potential (AP) characteristics were .easured.
Potentiation of ACS inotropy was seen by .easuring T in
sti.ulated (1 Hz) fibers repeatedly exposed to .1~M ACS
both before (Tl) and after (T2) 2 hr exposure to 10~M A.
In fibers treated with ACS+A, T2/Tl was, on average, 1.72
contrasted with 1.13 in fibers repeatedly exposed to
glycoside alone. No significant change in T was produced
by A alone. AP duration was increased 32%t2.l by A. aiNa
.easure.ents are su..arized below: (.eantSEM, .x, n=6).
Control
aiNa 8.45t1.3
/laiNa/ MOO%T
ACS A
10.87tl.6 7.94tO.9
1. 28tO.2
ACS+A
10.86t 1.0
0.93tO.l
ALPHA 1 AND ALPHA 2 RECEPTOR STIMULATION IN
CONSCIOUS DOGS INCREASE CORONARY RESISTANCE
BUT NOT MYOCARDIAL FUNCTION.
Rainald Seitelberger,M.D., Brian D. Guth,Ph.D., Jong-Dae
Lee,M.D., Kazuhiro Katayama,M.D., Gerd Heusch,M.D. and
John Ross,Jr.,M.D.,FACC, UC San Diego, La Jolla, California.
There is little information on the role of coronary alpha 1 and
alpha 2 receptors in the conscious state, and some studies
suggest that alpha 1 stimulation causes a positive inotropic
effect. Accordingly, dogs were chronically instrumented with
an intracoronary (IC) catheter for drug infusion and a flow
probe on the circumflex coronary artery (CX).
Sonomicrometers were implanted to assess regional systolic
wall thickening (96WT). After beta blockade with propranolol
(Img/kg, iv.), CX end-diastolic resistance (EDCR) was used to
assess the response to various alpha agonists. Alpha 1 agonists
(methoxamine, M, 2011 g/kg. and phenylephrine, P, 611 g/kg,
given IC) increased EDCR an average of 23.696 (p< 0.01, n=9).
This increase was blocked by 0.04mg/kg of the selective alpha
1 blocker prazosin (+.5.796, NS, n=6). The mixed agonist
norepinephrine (NE, 0•.511 g/kg) increased EDCR by 24.396
(p< 0.0.5, n=9). The selective alpha 2 blocker idazoxan
(O.O.5mg/kg) antagonized this effect almost entirely (+6.996,
NS, n=6), whereas no change was observed after prazosin
(+28.296, p< 0.0.5, n=6). Without beta blockade the alpha 1
agonist M did not affect 96WTH, whereas P increased 96WTH
(21.2 ~ 4.0 vs 27.1 ~ .5.4, p< 0.01, n=6). This effect was
eliminated by beta blockade. The selective alpha 2 agonist
BHT 920 (611 g/kg) had no effect on 96WTH.
Therefore, in conscious dogs (1) alpha 1 and alpha 2 receptors
are equipotent in increasing coronary resistance, (2) the
increase in coronary resistance due to NE is mainly mediated
by alpha 2 receptors, and (3) alpha 1 and alpha 2 receptors do
not alter myocardial function.
EFFECTS OF HYPOXIA ON BETA AND ALPHA ADRENERGIC RECEPTOR
DENSITY IN ISOLATED MAMMALIAN CARDIAC MYOCYTES
Ryuichi Matsuo, M.D., Junichi Hayashi, M.D., Hideharu
Manabe, M.D., Yoshio Watanabe, M.D., F.A.C.C.,
Cardiovascular Institute, Fujita Gakuen Health
University, Toyoake, Aichi, Japan.
To precisely determine the kinetics of adrenergic
receptors, we studied the effects of hypoxia on beta and
alpha adrenergic receptor density(ARD) in cardiac cells.
Myocytes were isolated from adult rat hearts, and were
incubated under standard culture conditions. The binding
of high specificity, high specific activity radio-
ligands, [125-I)-pindolol(IPIN) and [125-I)-HEAT(IHEAT),
was used to quantitate beta and alpha adrenergic
receptors, respectively. Equilibrium was reached with a
20-minute period of binding assay. Specific binding
defined by bound IPIN (or IHEAT) displaceable by
propranolol (or prazosin) averaged 86±7%(or 65±7%) at low
IPIN(or lHEAT) concentrations, was saturable, reversible
and stereospecific. Cardiac myocytes were divided into
two groups, being cultured in 50%O~-5%CO~-45%Nl, and the
other in 10%0~-5%C01-85%N2. After 1 hour incubation,
beta ARD was increased in myocytes under 10%02 (1163±104
xl03 receptors(R)/cell) as compared to that under 50%02
(9l2±83 xl0 3 R/cell)(p<0.05, n~6), without significant
changes in their affinity (1053±750 vs 875±470 pM).
Alpha ARD under 10%0~ (204±23 xlO~R/cell) was higher
than that under 50%0~ (162±20 xl03R/cell) (p<0.05, n~6),
again with no changes in their affinity. Similar results
were also seen after 3 hour incubation. Conclusions:
l)ARD in living myocytes was increased in hypoxia.
2)Beta and alpha receptors had similar kinetics and did
not show reciprocal changes in hypoxia. 3)IPIN and lHEAT
are useful tools for investigating receptor kinetics in
mammalian adult myocytes under experimental conditions
such as hypoxia and/or ischemia in vitro.
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ANTI-FIBRILLATORY ACTIVITY OF ACUTE AMIODARONE
ADMINISTRATION: AN EFFECT INDEPENDENT OF CLASS III
ANTI-ARRHYTHMIC ACTIVITY?
Roger A. Marinchak, M.D., Kathleen M. O'Connor, M.S.,
Ted D. Friehling, M.D., Peter R. Kowey,. M.D., F.A.C.C.,
Medical College of Pennsylvania, Philadelphia, Pa,
Administered acutely, amiodarone exhibits anti-adrenergic
activity which may protect against ventricular
fibrillation (VF). We compared RV and LV VF thresholds
with results of programmed extrastimulation (PES) before
(Tl), 30-45 (TZ) and 90-100 (T3) minutes following
amiodarone, 5 mg/kg acutely, then 0.42 mg/kg/hr IV in 9
cats Z weeks after proximal left anterior coronary artery
occlusion and in 6 sham operated cats. Mean heart rate
decreased significantly in both groups without significant
change in arterial blood pressure after amiodarone. Mean
VF thresholds rose significantly at TZ and T3 for the
infarcted but not sham animals. Five of 9 (56%) of the
infarcted cats had PES-induced VT before amiodarone. Of
these, 4 (44%) and Z (2Z%) had inducible VT at T2 and
T3 (pNS). For these 5 cats, VF thresholds were (RV/LV,
mean~SE, mAl: Tl (11.6 ~ 4.9/ 15.Z~3.4); TZ
(50.6~16.6/50.4~15.6); T3 (47.5~23.9/45.3~22.1);
(p=0.03, Tl vs T2' ANOVA). No PES-induced VT occurred
in sham cats. Mean effective refractory periods increased
significantly after amiodarone in infarcted and sham cats
without significant change in dispersion of
refractoriness. Amiodarone's acute anti-fibrillatory
effect is temporally discordant with prevention of VT
induction and may be'related to rapid onset of potent
anti-adrenergic activity in addition to Class III anti-
arrhythmic properties.
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EFFECT OF INTRAVENOUS DESETHYLAMIODARONE IN DOGS
WITH MYOCARDIAL INFARCTION AND INDUCIBLE
VENTRICULAR ARRHYTHMIAS.
Hoshiar Abdollah MB, F. James Brennan MD FACC,
and James F. Brien PhD. Departments of Medicine
and Pharmacology, Queen's University, Kingston
Canada.
To determine if desethylamiodarone (DA), the
major circulatory metabolite of amiodarone, has
antiarrhythmic activity, we administered DA
intravenously to 4 dogs with reproducibly-induc-
ible ventricular tachycardia or fibrillation (VT/
VF) one week after the production of myocardial
infarction by a 2-hour balloon occlusion of the
left anterior descending artery. DA was admin-
istered as a 5 mg/kg bolus followed by a 2-hour
infusion of 8 mg/kg/hr. Electrophysiologic test-
ing was repeated at 30 min intervals during DA
infusion, and plasma CDA] was measured simult-
aneously using an HPLC assay. [DA~ in healthy
and infarcted myocardium was measured at the end
of the infusion. DA ameliorated the arrhythmias
in all 4 dogs: in 2 VT/VF was not inducible and
in the other 2 inducible VF was converted to in-
ducible, stable, well-tolerated VT after 60-120
min of DA infusion. [DAJ in plasma, healthy, and
infarcted myocardium at the end of the infusion
were 0.66~ 0.34 pg/ml, 57.2 "1:30.48, and l1.89:t
5.58 pg/g, respectively. These preliminary data
suggest that DA 1) has antiarrhythmic activity,
2) accumulates rapidly in the myocardium, and 3)
is preferentially distributed into healthy as
opposed to infarcted myocardium.
ORAL LOADING WITH AMIODARONE INCREASES VENTRICULAR
DEFIBRILLATION THRESHOLD WITH IMPLANTED ELECTRODES IN DOGS
Lawrence H. Frame, M.D., F.A.C.C., Ned Hoffman, B.A.,
Steve A. Kolenik, III, B.A., Jeffrey H. Sheldon, B.S.,
University of Pennsylvania, Philadelphia, PA
We studied the effect of oral and IV amiodarone(AMIO) on
ventricular defibrillation threshold(DFT) because of
reports of patients taking AMIO that are refractory to
cardioversion (CV) with the Automatic Implantable Defi-
brillator(AID). CV was performed using an apical LV patch
electrode and RA spring electrode in closed chest pento-
barbitol anesthetized(30 mg/kg) dogs weighing 20-25 Kg.
DFT was measured every 15 min over 3 h by giving incre-
mental shocks (3,5,10,15,20,25,30,35 and 40 joule) start-
ing 20 sec after the onset of ventricular fibrillation
until CV was achieved. We studied the effect of oral AMID
by comparing a control group to two treatment groups that
received 200 mg(9.5~0.1 mg/Kg) or 400 mg(18.4+1.3 mg/Kg)
po per day for 9 days (six dogs in each group;. The table
shows group means (+SE) for the average OFT for each dog
(1st line) and the nighest DFT for each dog (2nd line).
Ortrol 11oII0 200 ng !Xl ad 11oII0 4lD ng !Xl ad
t-tDlIFT (Joules) 810.8 15.61-2.2 18.01-1.3
Ifujlest 1FT (Joules) 12.5+1.2 19.1+2.2 31.7+2.3
Oral AMIO significantly raised DfT in a dose dependent
manner (analysis of variance for significance and Tukey's
method to compare groups, p<.05). In 5 other dogs the OFT
during a 1 h control period (10.2+0.2J) was not different
from the OFT within 2 h after givIng IV AMIO(5mg/Kg) (10.8
+0.5J).
- We conclude that in normal dogs 1) oral loading with
therapeutic doses of AMIO raises DFT in a dose dependent
manner but 2) this effect is not seen within 2 h after IV
AMIO. This lends support to the evidence for AMIO-induced
resistance to cardioversion in patients with an AID.
EFFECT OF INTRAVENOUS AMIODARONE ON VENTRICULAR
FIBRILLATION DURING OUT-OF-HOSPITAL CARDIAC ARREST
Michael Ken1lch. M.D., Klaus-Peter Kunze, M.D., Walter Bleifeld, M.D., F.A.C.C.,
Dept. of Cadiology, University Hospital Eppendorf, Hamburg, West Germany
In 1981-1982 35 patients (pts) with out-of-hospital cardiac arrest due to ventricular
fibrillation (VFI were unresponsive to standard drug therapy and 3 or more DC
countershocks. As a result of further therapy 8 of these 35 pts were successfully re-
suscitated with subsequent lKlmission to hospital. Because of this low success rate we
in_igated the effect of intravenous (i.v.1 amiodarone on VF unresponsive to repe-
titive DC countershocks and standard drug therapy. In 1983 - 1984 we studied pts
with out-of-hospital cardiac arrest due to monitored VF. After standard resuscitation
induding application of i.v. sodium bicarbonate (1 mg/kg bw), initial DC counter-
shock, i.v. lidocaine at a dose of 100 mg and 2 further ineffective DC countershocks,
in the study group an amiodarone bolus of 300 mg was injected and DC counter-
shock w. repeated (group A, n=10). In the control group (group B, n = 10) pts were
treated with additional lidocaine (100 mg) and repetition of DC countershock. In
group A a stable cardiac rhythm was established in 5 of 10 pts. Three pts, 2 with VF,
1 with asystole, required further therapy before haemodynamic stabilisation was
achieved. Of 10 pO in group A, 8 were sucoassfuly resuscitated and lKlmitted to
hospital. In group B initial control was obtained in 2 pO. After identical additional
therapy 3 of 10 pts were admitted to hospital in group B (p .:::::: .05). Mean number
of DC countershocks was 4.60 ( ±. 1.071 in group A and 6.70 ( ±2.41) in group B
(p .: .051. There were no significant differences in age, sex, response time of rescue
and mobile energency care units and history of previous cardiac arrest between the
2 groups. In pO with out-of·hospital cardiac arrest due to VF, unresponsive to re-
peated DC countershocks and i.v. lidocaine, i.v. amiodarone appears to be an
effective antiarrhythmic agent.
FREQUENCY AND DIRECTION-DEPENDENT EFFECTS OF
SINGLE AND COMBINATION ANTIARRHYTHMIC DRUGS ON
CONDUCTION VELOCITY IN VIVO. Harry A. Kopelman, MD,
Ashok K. Baja), MD, John P. Wikswo, Jr., PhD, luc M.
Hondeghem, MD, PhD, Raymond L. Woosley, MD, PhD, Dan M.
Roden, MD, FACC, Vanderbilt University, Nashville, TN.
Factors influencing ventricular conduction velocity (CV) include
fiber orientation and the fast inward sodium current (iNa)'
Mexdetine (M) and quinidine (Q) depress iNa in a cycle length
(CLl-dependent manner, with In vitro time constants for recovery
(1i-) from CL-dependent iNa depression of 0.5-1 sec (M) and 4-8
sec (Q). The effects of MO .8.:!:0.4 ~/mil and Q(4.5.:!:1.7~/mil and
M+Q, a clinically effective drug combinatIOn (M: 2.0.:!:0.4; Q:
4.5.:!:1.3 ,.lAg/mil, on CV were therefore evaluated in 24 open chest
dogs. The AV node was ablated to allow measurements over a
WIde range of CL. An electrode array consisting of a central co-
axial stimulating pair and close bipolar pairs 3 and 6 mm away In
multiple orientations was sewn to the left ventricular epIcardIUm.
In each experiment, CV (m/sec; X:t5D) was determined from
interbipole conduction times in both a rapidly and slowly
propagating orientation and compared to basehne (BL): *p<0.05
CV-RapidlY propagating CV-Slowly propagating
n Cl300 msec 1000 msec 300 msec 1000 msec
Bl 24 .50.:!:.12 .47.:!:.ll .23.!..08 .22.:!:.04
M 13 .43.!..10* .48.!..10 .21.:!:.09* •23.:!:.06
Q 11 .38.!..07* .38.:!:.07* .17.:!:.05* .17.:!:.04*
M+Q 9 .30.:!:.08* .38.:!:.05* .17.:!:.04* •I8.:!:.0 3*
In the presence of drug(s), stimulation at short CL was interrupted
for varying periods and recovery of CV evaluated. For M, '7""r was
206.:!:83 msec and for M+Q 359.:!:90. For Q alone, recovery was
incomplete. Conclusions: 0) Over this range of CL, depression of
CV by M was Cl-dependent; (2) M+Q produced additional
depression of CV over that of Q at shorter Cl, but similar effects
to Q at longer Cl; (3) Depression of CV by drugs was orientation-
independent; (4) 'rr for M was shorter than in vitro recovery of
INa, and recovery with M+Q was slower than with M.
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MCIDPHASIC ACTION RJrENI'lALS OORING AlRIAL FUTITt:R:
EFFOC'IS or' PHARMAQ)[OOICAL INI'ERVENrIONS.
Kuei-Meng Wu, Ph.D., samuel M. Ross, I:l.E.E., and I:lrian
F. Hoffman, M.D., F.A.C.C. Departnent of Phannacology,
Columbia University, New York, NY 10032
Modification of Franz I electrode was developed to
record IOClnophasic action potentials (MAP) during per-
sistent atrial flutter in anesthetized dogs. The tachy-
cardia resulted fran circus IOClvanent in the atrial
tissues above the tricuspid ring. MAP were recorded
fran epicardium or endocardium during sinus rhyttm,
paced atrial rhythms and flutter. The recording elec-
trode was a 1 rrm diameter Ag-AgCl pellet anchored in
the tip of a bell-shaped plaque or a malleable catheter.
The indifferent Ag-AgCl electrode was situated in a
recess 3-5 RID away fran the recording electrode. Effec-
tive refractory period (ERP) was measured by suprathres-
hold stimuli applied at intervals of 8-10 cycles during
paced rhythms at cycle lengths (CL) of 400-500 msec.
Wlen canpared to records during sinus or paced rhythms
MAP recorded during flutter at CL of 150-160 msec
showed incanplete repolarization and a reduced rate of
nse. Acetylcholine (ACh, lU-lOO ug/kg) shortened MAP
by up to 30%, increased take-off potential, decreased
CL by 14% and converted flutter into flbrillatlOn.
Under 400 CL pacing, clofilium (0.5 ng/kg) increased
MAP and ERP by 38% and 56%. During flutter, clofilium
prolonged MAP by 34% am CL by 22% before the flutter
was tenninated. It is therefore concluded, with the
aid of MAP analysis, that circus IOClvanent occuring 1n
partially repolarized tissue around an anatan1cal bar-
rier could be (1) accelerated by agents reducing action
potential duration (APD) (ACh), (2) slowed and tenninated
by agents increasing APD (clofilium).
VOLTAGE AND FREQUENCY DEPENDENT DEPRESSION OF MAXIMUM
UPSTROKE VELOCITY BY FLECAINIDE ACETATE IN OVINE CARDIAC
PURKINJE FIBERS
Gregory A. Kidwell, M.D. and James Coromilas, M.D.,
F.A.C.C. Columbia University, New York, N.Y.
Depression of maximum upstroke velocity (Vmax) by Type I
antiarrhythmic drugs is modulated by both transmembrane
voltage and frequency of stimulation. We studied the
mechanism of Vmax depression by flecainide acetate (FA)
in ovine cardiac Purkinje fibers using a double mi-
croelectrode voltage clamp technique. FA (SuM) shifted
the steady state Vmax - membrane voltage relationship by
5.6 ±2 mV in the hyperpolarizing direction. Affinity of
FA for inactivated Na channels was studied by applying a
depolariZing conditioning pulse (Vc) of varying duration
and magnitude ending 200 msec before a test Vmax. Fol-
lowing long Vc, test Vmax was reduced by up to 30% in
control and by up to 60% in the presence of FA. The
slow inactivation process observed in the absence of
drug was a bi-exponential process with time constants of
3.5 ± 0.9 sec and >90 sec. In the presence of FA a
third phase of inactivation block was apparent with a
time constant (19.8 + 5 sec) intermediate to the two ob-
served in control. Short Vc «1 sec) produced minimal
depression of Vmax consistent with both minimal binding
of FA during the action potential (AP) upstroke and the
long time constant for inactivation block. During AP
trains, frequency dependent depression of Vmax was ob-
served at all frequencies> 0.2 Hz. The time constant
for depression of Vmax during trains was long (12.8 +3
sec at 2 Hz) and recovery of Vmax from steady state
depression was markedly prolonged (time constant of 29.5
+8 sec). We conclude that the slow kinetics for both
Inactivation block and recovery from block results in
depression of Vmax at all physiologic heart rates and
may account for the marked slowing of conduction and
proarrhythmic effects observed clinically with FA.
MECHANISMS UNDERLYING QUINIDINE-INOOCED INHIBITIOO OF
THE SWW INWARD aJRRFNI' IN THE RABBIT ATRIIOVENI'RIaJIAR
NODE
Masao Nishimura, M.D., Yoshizumi Habuchi, M.D., Akihiko
Miyakawa., M.D. and Yoshio Watanabe, M.D., F.A.C.C.
Fujita Gakuen University, Toyoake, Aichi, Japan
Electrophysiologic mechanisms by which quinidine sulfate
inhibits the slow inward current (is) were studied in
the small preparations (0.2xO.2xO.1 mm) of the rabbit
atrioventricular node. Voltage clamp studies using
double microelectrode techniques revealed that the thre-
shold concentration of quinidine to suppress the is was
1 lJg/ml. At a therapeutic concentration of 5 lJg/ml, the
drug decreased the i~ from -44.0 to -30.7 nA and in-
creased its inactivahon time constant from 12.8 to 16.8
msec on depolarization from -40 to -10 mV (P<0.01, n=6).
The steady-state inactivation curve for this current was
shifted to more negative potentials by 2.8 mV (P<0.05,
n=6). The fully activated is recorded at +10 mV mea-
sured -56.3 nA in control, and was decreased to -49.7 nA
by quinidine. After a few minutes of clamping the
membrane potential at -40 mV, quinidine exerted a tonic
blocking action by decreasing the is from -41.7 to -31.7
nA. In the absence of quinidine, a positive current
"staircase" of is was observed on sequential applica-
tion of 10 depolarizing pulses of 2,000 msec. With 200
msec pulses, quinidine minimally reduced the is from
-31.7 to -30.3 nA, whereas with 2,000 msec pulses, it
progressively reduced the i from -30.0 to -23.2 nA,
suggesting a use-dependent b~ockage of is. It is con-
cluded that 1) quinidine exerts a potent blocking action
on is by reducing its fully activated current and shif-
ting the inactivation kinetics towards hyperpolarization
and 2) the drug molecules bind to the is channel not
only in the resting but also in the inactivated state.
AMIODARONE: PREDICTORS OF CLINICAL RESPONSE IN REFRACTORY
ATRIAL FLUTTER AND ATRIAL FIBRILLATION.
.John M. Passmore.M.D. ,Robert 1. Rinkenberger,M.D. ,Ruth A.
Giebel, R.N.,Hing K. Jeang,M.D., Anne H. Dougherty, M.D.,
FACC, and Gerald V. Naccarelli,M.D., FACC. University of
Texas Medical School at Houston, Houston,Texas.
The purpose of this study was to identify clinical
response indicators for amiodarone(Amio) in the therapy
of 40 patients(pts) with refractory atrial flutter(AFl)
and atrial fibrillation(AFib) (21 chronic,19 paroxysmal).
Initial Amio dosage was 800mg daily, tapered to 200-40Omg
daily. Underlying heart disease was ischemic in 16 pts,
dilated cardiomyopathy in 12 pts, valvular in 6 pts, and
idiopathic in 6 pts. Complete responders (CR) (28 Pts,70%)
reverted to sinus rpythm with abolition of symptoms for
at least 3 consecutive mos. before checkup at 6-9 mos.;
partial responders(PR) (6 pts,15%) had a major reduction
in symptoms and/or 90% reduction in frequency of AFI or
AFib;and non-responders(NR) (6 pts,15%) had minimal or no
response. DC cardioversion was necessary in 5/13(38%) of
the CR with chronic AFib,whereas medical reversion alone
was effective in 8/13(62%) of this group. In 3/19(16%)
pts with paroxysmal AFib or AFl,incessant AFI occurred
after initiation of Amio and required cardioversion. Long
term response to Amio was not predicted by age, duration
of symptoms, dosage, height of F wave, ejection fraction,
QTc, side effects, response of concomitant ventricular
arrhythmias, etiology,or chronic vs. paroxysmal rhythm.
However,left atrial(LA) size by M-mode echocardiography
was greater(P<.OOI) in the NR(5:4f.5cm) compared to the
CR(~f.6cm) or the PR(4:0f.7 cm). 100% of pts with
LA<4.6cm were CR or PR, whereas only 50% of pts with LA >
4.6 Cm responded. We conclude: (1)Amio is highly effective
(85% CR or PR) in controlling refractory AFib and
AFl, and (2)LA dimension ~ 4.6cm predicts efficacy.
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EFFECT OF FLECAINIDE ACETATE ON VENTRICULAR
TACHYCARDIA INDUCTION AND VENTRICULAR
FIBRILLATION PREVENTION IN A CONSCIOUS CANINE
MODEL OF SUDDEN DEATH.
William Kou, M.D., Steven Nelson, M.D., Joseph Lynch, Ph.D.,
Lorenzo DiCarlo, M.D., Daniel G. Montgomery, B.S. and Benedict
Lucchesi, Ph.D., M.D., University of Michigan Medical Center,
Ann Arbor, MI.
The efficacy of flecainide acetate (FA) in preventing post-
infarction ventricular tachycardia (VT) induction and ischemic
ventricular fibrillation was evaluated in a conscious canine model
of sudden death. An anterior wall myocardial infarction (Mil was
created by 2-hour acclusion followed by reperfusion of the left
anteriar descending coronary artery of 15 dogs. All dogs had VT
reproducibly inducible 5± I doys after MI by programmed
ventricular stimulation using a maximum of 3 extrastimuli. A
loading dose of intravenous FA, 2 mg/kg over 20 min, was
administered to 7 dogs (group A) and normal saline to 8 dogs
(group B). VT remained inducible in 7/7 group A and 7/8 group B
dogs. In both groups, there was no significant change of VT cycle
length (J60±8 ms vs. 172±12 ms in group A, 189±1O ms vs. 195±12
ms in group B) or in ventricular refractoriness (I47±6 ms vs.
147±5 ms in group A, 169±8 ms vs. I59± II ms in group B). With
mai ntenance intravenous FA, I mg/kg/hr for 4 hrs, to group A and
normal saline to group B, ischemic ventricular fibrillation,
resulting in sudden death, occurred in 6/7 dogs in group A and 8/8
dogs in group B. The mean time to sudden death was 218±/09 min
in group A and 396±86 min in group B. There was no significant
difference between MI size in group A (26±3% of left ventricle
mass) and group B (22±3% of left ventricle mass).
Thus, during the early recovery period after MI, FA does not
prevent VT induction by programmed ventricular stimulation nor
occurrence of ischemic ventricular fibrillation in a conscious
canine model of sudden death.
TIll\LLIlf4 KINETIC3 IN RFPEWUSFD INFAOCTS:
DIFFERENl'IAL EFFECl' CF RESIIlJAL S'l'EN)SIS.
AndrEii'M. GruWald. M.D.. F.A.C.C., Joseph Wiesel,
Bruce R:>bin, IIbnty M. Bodenheiner, M.D., F.A.C.C.
LoRJ Island Jewish Medical center, New Hyde Park, New
York.
Thallium (Tl) scans are camronly used to assess
myocardial salvage following reperfusion (REP) of an
occluded arteJ¥ to a jeopudized rEgion. To examine Tl
kinetics in reperfused infarct 2Dnes, a balloon
occlu~r (00) on the circlJl1flex artery in 6 cbgs was
inflated for 3-4 hours and then deflated. After 3
weeks' rECovery the cbgs u~IWent serial Tl sams
during isoprotemol (ISP) and a l>eek later during
pemantine (PER) infusion. Following intrarenous
adninistration of Tl, anesthetized dogs t.ere imaged in
the IAO projection for 3 hours without Jrovement. 'Ihree
l>eeks later 5 of the dogs un~nent .serial Tl scans
following intrccoronary infusion (IC) to assess
intrinsic washout. After 1 hour of serial images in
the IAO projection, the occlu~r was inflatEd (I) arr3
serial images t.ere again olXained. Dogs t.ere
sa:rificed and infarction confirned at autopsy. Tl
uptcke in the REP infarct zone was 85 ±6% of that seen
in the normal septl.lll. 'lhe %washout: *p=NS *'*p=.005
.lSF* ~ ~ IC-'1'l-WI**
REP infart Z 14±8 18±6 32:1-16 18±12
It)[llal septum 15±lO 17±12 31±17 28±lO
ThIs (1) Tl uptake in REP infarct 2Xll1es is rEduced by
only 15%; (2) where rryocardium is perfusoo by widely
I8tent arteries Tl washout cannot differentiate tetl>een
infarct and nornal zones; (3) roou(]!d Tl washout in REP
zones suggests rontinued hypoperfusion of the
jeo{Brdized rEgion.
Therefore, in reversibly injured myocardium, lactate production is
rapidly replaced by extraction during reperfusion. In contrast, by
the end of 4 hr of coronary occlusion, net lactate production has
already been replaced by extraction. Reperfusion of this
irreversibly injured, infarcted tissue paradoxically leads to
renewed lactate production. This suggests that reperfusion of
areas of infarcted myocardium can unveil or induce further
ischemia as indexed by lactate production.
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PARADOXICAL LACTATE PRODUCTION DURING
REPERFUSION OF ISCHEMIC MYOCARDIUM.
Edward N. Dean, M.D., Thomas M. Annesley, M.D., Thomas R.
Underwood, David A. Canvasser, D.V.M., John M. Nicklas, M.D.
University of Michigan, Ann Arbor, Michigan.
Lactate is extracted by normal myocytes and produced when cells
become ischemic. To determine the effects of reperfusion on
reversibly and irreversibly injured post-ischemic myocardium,
regional lactate metabolism was measured in open-chest
anesthetized dogs. Percent net lactate extraction was
determined between the carotid artery and great cardiac vein
before, at the end of either a 15 minute (n=8) or 4 hour (n=5) left
anterior descending coronary artery occlusi on, and at 30 and 120
minutes post-reperfusion. Results (mean ±SE):
PERCENT LACTATE EXTRACTION
Baseline Occlusion 30" Post
15 min ~ -44 ± 39+ 3O"t8
4 hr 37 ± 13 22 ± 14 -73 ± 11+
+ difference from baseline, p < 0.05
120" Post
36 ± 6
-18 ± 16+
LATENT MYOCARDIAL DYSFUNCTION AFTER BRIEF CORONARY OCCLU-
SION. Erwin Schroder MD, Robert Kieso MS, Michelle Hunt
BS, Marie Schroder MD, Donald Laughlin MSEE, Birgit
Grimlund, Richard Kerber MD, FACC, U of la, Iowa city, Ia
After brief (5 mins) periods of coronary artery occlu-
sion followed by reperfusion, myocardium appears to re-
cover fully within 1 hour. Our hypothesis was that such
myocardium has prolonged latent dysfunction which would
become evident when the reperfused myocardium was chal-
lenged by a second coronary occlusion. This hypothesis is
clinically relevant because multiple ischemic episodes
often occur over short time periods. We studied 16 open-
chest dogs with controlled heart rate and arterial pres-
sure. Regional myocardial function was assessed by mea-
suring systolic wall thickening (WTh) every 5 secs; WTh
was displayed continuously by a new 5 Mz miniaturized echo
transducer, fixed to the epicardium by suction. All dogs
underwent an initial challenge (Challenge 1) of 30 secs of
coronary occlusion (CO). Thereafter the control group (n=
5) underwent no intervention during the next 90 mins,
while the study group (n=ll) underwent 5 mins CO and 90
mins reperfusion. All dogs were rechallenged by 30 secs
CO after 30 mins (Challenge 2) and 90 mins reperfusion.
Results at 30 mins of reperfusion (*=p<.05 Challenge 2 vs.
Challenge 1) (WTh expressed as mean):
Time (Seconds) During Challenpe Coronary Occlusion
Group ~ _5_"_ ~ ~ ~
Challenge # -! -1 -! -1 -! -1 -! -1 -!-1
Control WTh(%) 61 54 36 45 3 9 -6 -14 -8-8
5' CO WTh(%) 56 55 54 17* 17 -9* 3 -11* -9 -15
These changes persisted during a third challenge at 90
mins of reperfusion. Conclusion: After coronary occlusion
(5 mins) and up to 90 mins of reperfusion, apparently
normal systolic thickening deteriorates more quickly in
response to a challenge coronary occlusion. This suggests
the presence of prolonged latent myocardial dysfunction.
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DOES LEFT VENTRICULAR RUPTURE THRESHOLD AFTER MYOCARDIAL
INFARCTION IN THE DOG MEASURE ADEQUACY OF HEALING?
Bodh I. Jugdutt, M.B.,F.A.C.C. Univ of Alberta,Edmonton.
The mechanical resistance of the infarcted LV to rupture,
or rupture threshold (RT), might be a measure of adequacy
of healing after acute myocardial infarction. The temporal
changes in infarct hydroxyproline (OHP;spectrophotometry;
mg/Kg), LV topography (computerassisted analysis of papil-
lary short-axis two-dimensional echocardiographic images
obtained pre-sacrifice) and RT (balloon technique) were
measured in 50 dogs with left anterior descending coronary
artery occlusion: 17 controls (10 no infarcts and 7 dying
< 1 hour postocclusion); 40 infarcts from dogs killed bet-
ween 2 and 42 days. Another 15 dogs were given low dose
nitroglycerin (NG) or ibuprofen (IBU; 6.25 mg/Kg/hr) for 6
hours after occlusion and parameters measured at 7 days:
10 infarcts,S NG, 5 IBU. The thinning ratio (TR, infarct/
normal wall thickness) and expansion index (EI, infarct/
non-infarct segment length) were computed. Results were:
Grou~ n RT~mmHg) OHP!m,/Kg) TR EI
METABOLIC BASIS FOR HETEROGENOUS NORADRENALINE RELEASE
DURING MYOCARDIAL ISCHAEMIA.
Anthony M. Dart, B.M., D.Phil., Rudolph A. Riemersma, Ph.
~ and Albert Sch~mig, M.D. Cardiovascular Research Unit,
University of Edinburgh, U.K.
Denervation studies have shown that non-reflex (i.e.
local) release of noradrenaline (NA) is important for the
production of ventricular fibrillation during myocardial
ischaemia and studies with stop flow ischaemia showed that
local NA release, detected during reperfusion, can be
inhibited by agents which normally block neuronal NA
uptake (eg desipramine, DMI). The metabolic prerequisites
for this release have now been studied in two further
models of the isolated perfused rat heart. Global low
flow (5%) ischaemia with normoxic perfusate does not lead
to increased (vs control) overflow during 40min ischaemia
(n=7). However following 60min substrate-free preperfus-
ion 5% ischaemia produces an enhanced overflow with NA
concentrations (at 25min ischaemia) of 51.4±7.4 in a con-
trol (n=8) and 21.8±1.8pmol/ml in a DMI treated group
(n=8). In a second model anoxic perfusion (p02~lmmHW was
used at normal flow rate without added substrate (n=6),
without substrate but with DMI (n=6) or with llmM glucose
(n=6). NA concentrations in pre-anoxic samples were <0.5
pmol/ml. In the anoxic no substrate series NA concentrat-
ions were 7.3±0.7 (2Omin), 15.1±1.5 (3Omin) and 15.5±0.5
pmol/ml (4Omin) whereas in the DMI group respective val-
ues were 2.5±0.3, 3.1±0.2, and 5.3±0.9. llmM glucose
suppressed NA overflow at all times. The results support
the concept that NA efflux occurs using the same carrier
as normally permits neuronal NA uptake. The metabolic
conditions required suggest that in vivo such release
would be limited to areas of severe flow reduction pro-
ducing markedly heterogenous NA stimulation - a potent-
ially potent arrhythmic insult.
ARE REGIONS OF DELAYED ACTIVATION DURING A BASIC RHYTHM
THE RESPONSIBLE ARRHYTHMOGENIC SUBSTRATE FOR REENTRY?
Mark Restivo, M.S., Raphael Henkin, M.S., William
Craelius, Ph.D., William B. Gough, Ph.D., Nabil
EI-Sherif, M.D., F.A.C.C., SUNY Downstate and VAMC,
Brooklyn, N.Y.
Late potentials (LP) as detected by body surface signal
averaging (SA) techniques may indicate susceptibility to
reentrant ventricular rhythms (RVR). Using a computer-
ized multiplexer system and a high resolution SA system,
we compared the activation times (AT) at 62 epicardial
sites with LP in 3 orthogonal SA leads. The SA ECGs were
recorded at a gain of 35000 at filter settings of 80 to
300Hz for 100-300 beats. Noise levels were on the order
of .5 microvolts or less. RVRs were induced by
programmed stimulation in canine hearts 3-5 days post
infarction and appeared as two circulating wavefronts
traveling around an arc of functional conduction block.
Only those hearts where the final common reentrant
pathway (FCRP) was identified in a thin surviving
epicardial layer were examined. In 7 of 9 experiments,
SA during basic rhythm (BR), sinus or 51-51 pacing:
400-500 msec, detected LP which corresponded temporally
with the region of latest epicardial AT. Subsequent SA
of RVR initiation revealed that sites of LP during a BR
were not always responsible for LP detected in the
52-V I interval. Examination of activation maps for thesebeats confirmed that the region responsible for LP
during BR were not part of the FCRP during reentry.
Regions of marked delay or 2:1 conduction during the BR
usually blocked during S2 and did not participate in the
reentrant process. In conclusion, late potentials
detected during a basic rhythm may be associated with
reentrant arrhythmias. However, the region responsible
for delayed activation during basic beats may not always
participate in the reentrant pathway.
DBPIESSIOI OP LEPT BUGLE lU'ft11&UCIft 1P'lBI COKOllUt
1ITIII OCCLUSIc. AID IIlPBIIPUSZa..
Eugene Patterson. Ph,D .. Benjamin J. Scherlag. Ph.D••
FACC. and Ralph Lazzara. M.D •• FACC. University of
Oklahoma Health Sciences Center and VA Medical Center.
Oklahoma City. OK.
His-Purkinje automaticity was assessed in the normal
canine heart and at 1. 3. and 7 days after temporary
anterior descending coronary artery occlusion (CAD).
Automaticity was evaluated 111 UISl (vagus nerve stimula-
tion) and 111 xllJ:g (superfused His-Purkinje system) (see
table). Under control conditions. the idioventricular
rhythm (IVR) originated most commonly in the proximal
left bundle (PLB). One. 3. and 7 days after CAO (30
min). the site of IVR formation had shifted to the right
DIm COII'1'IOL DAY 1 DAY 3 DAY 7
IVR (bpm) 45%2 30%3· 45%3 56%3
PLB origin 73J OJ" OJ·· OJ·
·p<0.05 (N=15) (N=13) (N=14) (N=3)
DUDP COII1'IIOL DAY 1 DAY 3 DAY 1
PLB (bpm) 40%3 1%2·· 20%8·· 21%9
10-6M Epi 146%18 10%6" 52%9·· 54%9·
PLB origin 75J OJ· 33J OJ
··p<0.01 (N=8) (N=9) (N=6) (N=3)
bundle and His-bundle. On day 1. right bundle automati-
city was also depressed. A decreased response to epine-
phrine was observed in the PLB as late as 7 days post-
CAO. Neither the rate (39%4 bpm) nor the site (57J PLB;
N=7) of the IVR was depressed 24 hr after 15 min of CAO.
Necrosis in the anterior wall (1.5%0.8 gm) was present
after 30 min, but not 15 min of CAO. The PLB function may
be impaired by toxic substances released from the distant-
ly injured myocardium.
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EFFECTS OF ISaID1IA AND REPtIDUSIOO: A <n1PARISOO OF ISOLATill JlUFFER
AND BLOOD PERFUSED IlfARTS.
Takashi SerizalJU, H.D. and Carl S. Apstein, M.D., F.A.C.C. Boston
City Hospital. am Boston lJIdversity School of Medicine, Boston, MA
Most studies usins isolated hearts have utilized Krebs buffer as
coronary perfusate. lJa.lever, receut lJOrl< has suggested that oxygen
free radicals, generated fran leucocytes, and seron canplernent, may
contrilxJte to ischemic-reperfusion injury. To study this issue, \Je
C<Jlll8red t.'le effecy; of IS mia c~lete global ischania am 60 min
reperfusion at 37 C in isolated isovollJllic (bailon-in-LV) rabbit
hearts paced at UJO/min and perfused llith either Krebs-tlenseleit
IxJffer (KHB) (~) or fresh uoole rabbit blood (BIll) (n=lS). Coronary
perfusion pressure lIaS held constant at 80Imflg during pre-and
post-ischemia in both groups. l3LD perfusion resulted in a physiologic
perfusion rate of 1.5-+{).7ml/min/~ carq>ared to 10.S+{).8ml/mim/~ (P(
0.01) llith KHB. Pre-Tscber;dc performance 1J1lS c~ble in the 2
groups; developed pressure/lll' lJaS 9D-:-3/11+lllr.i-lg vs 96+fi/lOtlnlli1g for
l3LD vs KHB. The llLD group had greater tsch6:dc-reperfuston injury than
the KHB group. At end-ischemia both groups llere asystolic, but the l3LD
group had rore severe contracture (LVEIP=4%miIg) than the KHB group
(LVEIP=15+5Imilg, P<.001). After 60 min of reperfusion, cleveloped
pressure lIaS 66+fi% of pre-ischemia KHB, IxJt only 44+S% in the l3LD
group (P':O.OS). -Contracture at em-reperfusion lJllS greB'ter in the llLD
group: LVEDP=37~ vs 18+4rn;tfg, 1'(O.OS), for BIll vs !<lIB. H~er, the
wet/dry weight ratio was greater in the KHB vs BIll group ( 7.3tO.2 vs
S.O+{).l, P(O.OOl), and perfusion duriIlil reperfusion was not rectuced
relative to pre-ischeraia ~lith BIll, IxJt decreased by 23% (1'(0.01) llith
KHB. Conclusion: Ischemic-reperfusion injury, manifested by a greater
loss of contractile flJIK:tion and greater contracture, \Jas llorse in the
BIll group than in the ~m group, despite rore edema and an irerease in
coronary resistance post-ischemia in the latter. Studies uith
IxJffer-perfused hearts nay underestimate the degree of damage caused
by an episode of ischemia all:! reperfusion in vivo, because the IxJffer
perfusate lacks elements llhich contrilxJte significantly to
ischernic-reperfusion injury.
POST-INFARCTION ANEURYSM FORHATION: EFFECT OF EARLY AND
LATE INCREASES IN STRESS. Carolyn M. Connelly, Ph.D.,
Robert J. McLaughlin, Ph.D., W. Mark Vogel, Ph.D., William
N. Grice, Carl S. Apstein, M.D., FACC. Boston University
School of Medicine, Boston, MA
Post-myocardial infarction (MI) aneurysm formation is a
complication which greatly increases morbidity and mortal-
ity; however, the basic factors which cause aneursym for-
mation have not been defined. We assessed the effect of
post-MI scar maturity on a scar's ability to withstand an
imposed load (stress) without undergoing an irreversible
increase in length (strain), since such a length increase
represents the initial step in aneurysm formation.
Post-MI aneurysm formation was studied in 20 rabbits
using excised strips of acutely infarcted (24 hrs) or
healing (3-4 wks) post-MI scar tissue. Strips were repeti-
tively stretched for 1 hr at 4Hz between peak (systolic)
and resting (diastolic) stresses of 2 and 0.2g/mm2, simu-
lating LV pressures of 80/8mmHg. During a 2nd hr, these
stresses were maintained (controls, C) or afterload was
increased (fAL) to a peak stress of 6g/mm2 (240mmHg).
During a 3rd hr all strips were returned to initial con-
ditions. Results are expressed as % increase in strip
length (1) at peak "systolic" stress relative to the strip
length at 1 hr (Lo); (L-Lo)/Lo x 100 ~ SEM.)
Acute Infarct 3-4 Week Scar
C(n-S) fAL(n-S) C(n=S) 'AL(n=S)
2nd hr 0.2+0.1 4.2+1.2* O.S+O.l 4.7+0.7*
3rd hr 0.3+0.1 3.S+1.3* 0.8+0.2 3.9+0.6*
*p (O.OS for tAi vs C.
Conclusion: ~ for 60 min caused a comparable length
increase (2nd hr) in acute infarct and 3-4 wk scars, which
did not reverse with strip unloading (3rd hr). fAL may
predispose to aneurysm formation both early and late after
an MI.
100
'"
"~
"I:}
"I..
73±18(4)+
RAA(+)PHTNRAA(-)PHTN
5l±4 (4)
49±2 (4)
hypertension; *p<O.OS vs
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ISOENZYME DISTRIBUTION IN OVERLOADED HUMAN ATRIAL TISSUE:
Peter Buttrick, M.D., Ashwani Malhotra, Ph.D., Lucille
McDermott, Lillian Lam, and Richard Brodman, M.D.
Division of Cardiology, Montefiore Hospital, Albert
Einstein College of Medicine, Bronx NY.
Distinct myosin isoenzymes have been identified in mam-
malian hearts and reflect the imposed load and the con-
tractile state of the cardiac muscle. In rats, systolic
overload shifts the normal VI predominant isoenzyme pat-
tern to V3• In human ventricular tissue,V3 predominates
and analogous isoenzyme shifts have been difficult to
identify. Human atrial tissue has equimolar VI and V3' We
studied the isoenzyme distribution in pressure and volume
overloaded human atrial appendages (LAA, RAA) obtained at
the time of valve replacement. (MS, mitral stenosis; MR,
mitral regurgitation). Isoenzyme distribution was deter-
mined in crude myosin extracts by nondenaturing pyrophos-
phate gel electrophoresis.
~3 Age LAA
Control 49±13(3) 4S±7(3)
MS 54±18(9) 76±1l(8):+
MR 5l±13(S) 69±16(5) +
(Mean ± SD; (n); PHTN, pulmonary
Control, +p<O.OS vs RAA(-)PHTN,)
No clear relationship could be established between the
severity of the valvular disease and the isoenzyme shift,
although all patients had long-standing symptomatic
disease. In one patient with acute MR 2° to papillary
muscle rupture, no increase in V3 was seen in LAA. These
data show that human atrial tissue can increase %V3 in
response to chronic pressure and/or volume overload and
imply that the tissue has the capacity to alter its
genetic expression in response to a pathologic load.
DELINEATION OF THE CHARACTER AND OXIDATIVE LIMITS OF
MYOCARDIAL PERI-ISCHEMIC BORDERZONE.
Glenn Whitman, M.D., John Haselgrove, Ph.D., and Alden
Harken, M.D.,F.A.C.C., Univ of Colorado, Denver, CO
Although the peri-ischemic borderzone (BZ) is narrow, it
probably provides the substrates of slow conduction and
refractoriness essential for re-entrant arrhythmias. The
purposes of this study were: 1) to determine the distance
between perfused and ischemic myocardium using a marker
dye, hematoporphyrin (HTP) and 2) to characterize the
tissue oxidative levels within this peri-ischemic BZ. A
coronary artery in the ventricular free wall was ligated
in rabbit heart perfused with oxygenated HTP on a modi-
fied Langendorff apparatus. Hearts were then freeze-
clamped to preserve the spatial integrity of the per-
fused/ischemic BZ and perfusion assessed by fluorescence
photography (HTP >600 nm) and ischemia by scanning tissue
fluoremetry (NADH 430-S10 nm).The HTP siagal changes
gradually from high
to low and the NADH
signal from low to
high over.....SOO
microns. We conclude:
1) flow across the
BZ of an experimental
infarct has two
states, "high" and
"norma1" va. "low" I I
and insuffic ient to DI,'e....- a ..
sustain cell viability, 2) this BZ can be delineated by
marker dye fluorescence photography and scanning micro-
fluoremetry, 3) the BZ transition occurs over < SOO
microns, 4) within the BZ are intermediate tissue oxida-
tive levels that may predispose to the slow conduction
and refractoriness necessary for re-entrant arrhythmias.
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LYMPHOCYTE BETA-ADRENERGIC-RECEPTOR DENSITY AND PLASMA
CATECHOLAMINES IN ACUTE MYOCARDIAL INFARCTION.
Babeth Rabinowitz, M.D., F.A.C.C., Moshe Herskowitz,
Ph.D., Ella Elazar, M.Sc., Hanoch Hod, M.D. and
Henry N. Neufeld, M.D., F.A.C.C., Heart Institute,
Sheba Medical Center, Tel Hashomer and Sackler School
of Medicine, Tel Aviv University, Israel.
Although significant changes in plasma catecholamines (CA)
have been previously demonstrated in acute myocardial
infarction (AMI) by us and others, little is known about
the beta-adrenergic receptor density (jB-density) during
the course of AMI. Fifteen patients with definite AMI,
who did not receive therapy with beta agonists or anta-
gonists, were studied. Lymphocyte ft -density in fmol/mg.
protein was measured during the 1st, 2nd and 7th day
after onset of AMI, along with plasma CA. Mean ± SEM of
~-density, CA, heart rate (HR) and blood pressure (BP)
are the following:
Days ,i/density CA HR BP
1st 75.2tlO 599+70 108t9 100±14
2nd 20.1+ 8 407!68 10ot7 98± 9
7th 18.5! 8 312t35 72t4 90± 9
Fifteen noncardiac patients (controls) had }9density 31±8.
The patients with anterior MI had more }9-receptors than
those with inferior MI. ~-density was not increased in
3 patients who received streptokinase.
The physiopathologic significance of the above findings in
relation to the clinical course and the therapeutic inter-
ventions is currently investigated.
The results demonstrate, therefore a high !-density in the
first 24 hours of AMI, which could be partially correlated
with CA levels and the hemodynamic parameters of HR and AP.
The !-density measured in lymphocytes may thus serve as a
slmple marker of sympathetic activity in patients with AMI.
MYOCARDIAL "BIOCHEMISTRY" IN CLOSED CHEST ANIMALS.
M. QAbakk@n, L. Ligeti, M. Sohnall, L. Bolinger, H.
Subramanian, J. Leigh, and B. Chance,
Biochemistry/Biophysics, University of Pennsylvania,
Philadelphia, PA 19104.
Cardiac anatomy can be evaluated with a number of
imaging modalities, including Magnetic Resonance
Imaging. However, in vivo study of cardiac metabolism
related to mechanical function is more difficult and
not done routinely. HethOd~ to study high energy
phosphate metabolism using l p NMR in closed chest dogs
were developed. External surface coils were Place~lover
surgically prepared "cardiac windows" in~. P
NMR spectra were obtained (6-8 minute scans with SIN =
5:1) during control, hypoxic (P 02= 20 Torr), and
hypertensive (methoxamine infusIon to pressures of
300/200 mm Hg) conditions and after successful
resuscitation from cardiac arrest. The relationship
between Pi/PCr (measure of phosphorylation potential)
and cardiac "work" (Heart rate x Blood pressure) was
used as a measure of metabolic state of the heart.
Pi/PCr ratios increased with all interventions:
control = 0.54; !!n!2!i! = 1.42; hypertension = 1.5;
~rest = 1.5. The increase in Pi/PCr was
associated Wit~ increa~d "work" in the hypertensive
state, '1.5Xl0~2.8xl0 ) while hypoxia(1.2Xl0~1.8xl04) and post arrest (1.3xl04~
1.5xl04) were associated with variable work load.
This indicates that the more extreme work load of the
hypertensive state induces maximal velocity (Vmax )
of phosphorylation (ATP synthesis). The velocity of
phosphorylation is far from V in hypoxia. In the
post arrest state, there is a~rent dissociation of
work and Pi/PCr, indicating a loss in metabolic control.
opvt
136+9
240723
224747
139711
11277
SMSpv
221+34
233720
235721
232732
210~34
SMSm om*
C 248+32 191+18
AT 241718 250730
PE 263717 255737
CA 246731 175~18
NP 216731 122+7
V 13+2; V = 11+2.om - opv -
* F (4,20) = 5.39; P< 0.005; F(4,20) = 5.64, P'< 0.005
m = max. om = 0 at SMSm; PV at (P/V)max.
We conclude 1. SMS is independent of stress, hence may
be useful for detecting changes in myocardial contracti-
lity. 2. ESPVR is curvilinear, therefore Emax is not
constant. 3. V is always positive and may have clinical
value in an es£imation of the theoretical maximum ejec-
tion fraction at zero afterload.
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SYSTOLIC MYOCARDIAL STIFFNESS: A NEW CONCEPT IN THE DEVE-
LOPMENT OF THE END SYSTOLIC PRESSURE VOLUME RELATION.
Israel Mirsky, Ph.D., F.A.C.C., Tsukasa Tajimi, M.D., and
Kirk L. Peterson, M.D., F.A.C.C., Brigham and Women's
Hospital, Boston, MA.
The end systolic pressure-volume relation (ESPVR) and
zero stress volume (V ) are derived on the basis of the
new concept of systol~c myocardial stiffness (SMS). Five
dogs were instrumented with micromanometers and sonomi-
crometers (LV long and short axes and wall thickness)
for volume (V) and stress (0) calculations. SMS = KVdo/dV
(K, a geometric factor) was computed from peak 0 to near
end ejection in control (C), angiotensin II (AT), phe-
nylephrine (PE), caval occlusion (CA) and nitroprussi-
de states at constant heart rate. Integration of the SMS
equation yielded the ESPVR: 0 =GP = (SMS/K) log (V/~Q)
where G =a + 6V, V = V exp (-KG /SMS ) and subscrIpt
c denotes control s£ate ~alues at ~nd s~stole.
In order to assess the effect of acute diabetic ketosis on
the heart we studied cardiac function and metabolism in
spontaneously diabetic BB/W rats and compared data to
non-diabetic litter mates. Plasma metabolite levels were
as follows (*p <0.01):
ALTERED ENERGY METABOLISM IN HEARTS FROM SPONTANEOUSLY
DIABETIC BB/W RATS.
Heinrich Taegtmeyer, M.D.,D.Phil,F.A.C.C., Raymond R.
Russell III, B.Sc., Angela L. Silvestain, B.Sc.,
University of Texas Medical School, Houston, Texas.
3-Hydroxy- Aceto-
Glucose butyrate acetate
Non-diabetic (NzIO) 10.1 0.28 0.07
Diabetic (Nz32) 23.3* 3.85* 0.95*
Hearts were freeze-clamped in situ for analysis of
metabolites and enzyme activities. Tissue contents of
2-oxoglutarate (1.14 vs. 0.27), glutamate (20.6 vs. 14.2),
lactate (8.47 vs. 2.79) and pyruvate (1.87 vs. 0.49), were
increased in diabetic vs. control hearts (all values
~mol/g dry, p<0.05). Activities of 2-oxoglutarate
dehydrogenase and lactate dehydrogenase were the same in
both groups. Activities of acetoacetyl-CoA thiolase
(339 vs. 18, p<O.OOl) and of 3-hydroxybutyrate
dehydrogenase (114 vs. 52, p<0.05) were higher, while
activities of phosphorylase (27 vs. 57, p<0.05) and
hexokinase (37 vs. 98, p<0.05) were lower in diabetic than
in control hearts (values: ~mol/min/g wet). When hearts
were perfused as working hearts, intrinsic left
ventricular function, measured by constructing
Frank-Starling curves, was the same in both groups. The
data indicate metabolic adaptation favoring the oxidation
of ketone bodies, inhibition of pyruvate oxidation and a
possible impairment of the 2-oxoglutarate dehydrogenase
reaction in hearts from diabetic animals.
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MEASURES OF REGIONAL FUNCTION IN VENTRICLES
WITH HETEROGENEOUS CONTRACTILE STATE.
Th0r.as Av~rsan~ M.D., W. Lowell Maughan M.D., Lewis
C. ecker.D. FCC. Johns Hopkins University,
Baltimore, MD
This study tested the hypothesis that the end-systolic
pressure-thickness relat10n (ESPTR) is a better me4sure
of regional function than percent wall thickening l%AT)
in the ventricle with regional differences in inotropic
state. Six dogs were instrumented with an LV pressure
transducer 4nd sonomicrometer cr.Ystals in the left anterior
descending lLAD) and circumflex lLC) regions for measurement
of wall thickness (WT). The ESPTR, a~fined by a slope,
Ees) and thickness-axis intercept lTO)..! was obtained
dur1ng caval occlusion. To calculate %A'L, end-systolic
thickness (EST) was def\ned as WI occuring 20 msec prior
to peak negative LV dPtdt. For the ESPTR, end-systole
'fas defined as occuring when the slope of the ESPTR
lEes) was maximal. Measurements were made before (C)
and during intracoronary infusion of dobutamine (D)
into the LC. The LAD-region ESPTR and %AT showed no
change with LC D infusion. Below are LC-region data:
EDT EST %AT Ees TO
(mm) (mm) (mmHg/mm) (mm)
C 11.6 12.9 10.8 -55 14.9
D 12.~* 14.1* 11.9 -183* 15.6
(* = P~.05 vs control; EDT=end-diastolic WI)
The LC-region ESPTR shifted rightward with D, indicating
positive 1notrO\>y, while the standard dimension change
measure, %AT, failed to detect any effect of D on regional
LC function. LC-region %o\T fuled to "hange in p'art
because preload decreased (~ncreas~d EDT). In. addi.ti!ln,
LC D infusion produced reg10nal d1fferences 1n t1m1ng
of end-systole and thus altered the relation between
LV dP/dt and regional end-systole. As a result, EST
in the LC region was measured at a time later than actual
local end-systole. Using the ESPTR, end-systole occured
137 msec after onset-systole in the LC region and 180
msec after onset-systole 1n the LAD region, while end-systole
for th~ ventricle as a whole (20 msec before peak negative
LV dPtdt) occured 190 msec after onset-systole. By
measuring EST at this later time, %AT is underestimated
and fails to increase with D. We conclude that the
ESPTR is a better measure of regional function than
%6 T, since it is load-independent and does not use a
global parameter to time reg10nal end-systole.
THE RATE OF MYOCARDIAL \ULUME LOADING AND REGIONAL
END-SYSTOLIC HYSTERESIS IN INTACT HEARTS.
William P. Miller, M.D., F.A.C.C., Stephen H. Nellis,
Ph.D., and A. James Liedtke, M.D., F.A.C.C. Section of
Cardiology, University of Wisconsin, Madison, WI.
We have previously shown that systolic LVP-segment length
relationships in intact hearts show hysteresis. To deter-
mine the effect of the rate of myocardial stretch on the
magnitude of this hysteresis, 8 paced, extracorporeally
perfused pig hearts were treated with IV propranolol (1 mg
/kg) and atropine (0.1 mg/kg). Simultaneous LVP, myo-
cardial wall thickness (Th) and two perpendicular segment
lengths (SLL, SLC) were measured in consecutive, variably
loaded beats obtained by the LV injection of blood at
fixed rates (R). Randomized trials of infusions at Rl
(56±2 ml/sec) vs R2 (2H2 ml/sec, P < 0.001) resulted in
nearly identical maximal changes in peak LVP (116±4 to
147±4 vs 118±4 to 152±4 mm Hg), LVEDP (7.6±0.5 to 12.2±1.4
vs 7.1±0.4 to 11.2±0.9 mm Hg), Th (l3.7±1.4 to 12.5±1.4 vs
13.9±1.3 to l2.4±1.2 mm), SLL (15.6±1.3 to l6.4±1.4 vs
15.4±1.2 to l6.4±1.4 mm), SLC (11.3±0.7 to 11.9±0.7 vs
lI.l±0.7 to 11.9±0.8 mm). These similar changes however,
occurred over 2-3 beats at Rl vs 5-7 beats at R2 (P <
0.001). Using end- shortening to approximate end-systole
(ES), ESLVP-length relationships obtained at the same time
from the R wave in each cardiac cycle showed hysteresis.
The area of the hysteresis loops increased 97% in ESLVP-Th
(P < 0.025), 89% in ESLVP-SLL (P < 0.01), and 68% in
ESLVP-SLC (P < 0.05), being significantly greater at the
slower rates of loading (R2). These data show that the
myocardium of the intact ventricle has a beat-to-beat
memory that is dependent on the rate of myocardial stretch
and this may represent length dependent activation in the
intact heart.
MEOiANISM CF VENl.'RIaJIAR WALL mrrrn ASYNCHR:NY IN HY-
l'OKINETIC MYOCARDIAL SEnoIENl'S.
Makoto Akaishi, M.D., William S. Weintraub, M.D.,
~.-;-paur Sie1:aus, Ricky M. SChneider, M.D.,
F.A.C.C., Lloyd W. Klein, M.D., F.A.C.C., Jai B.
Aqarwal, M.D., F.A.C.C., Richard H. Helfant, M.D.,
F.A.C.C., Mid-AUantic Heart & Vase Institute,
Presbyterian-u of PA Med Ctr, Philadelphia, PA.
The early systolic bulge and early diastolic soorten-
i~ noted 1n hypokinetic segments (Hypo) despite re-
ta1ned total systolic soortening was analyzed in
chronically instrunented dogs with digitized sommi.-
cranetric data. Using a IIDdeI in which cardiac con-
traction was viewed as time-varying elastance (Elas),
instantaneous tension (T) related to at length
(L) by the exponential relation: T--expl ). Twas
independently obtained by instantaneous inte nal diam-
eter and pressure. c( is a time-vaging elastic c0n-
stant, calculated every I msec. In diastasis, c( and ~
were unchanged (SO of c(=l% of mean). c( was then plot-
ted against time over the cardiac cycle. During c0n-
trol, c( increased fran end-diastole reaching maximum
(45+5% increase) at enci-systole with constant 13. To
Ilr:ldel Hvpo induced by coronary occlusion t:hI:! time
course of c( was the same as pre-ooclusion, but the
value was lower at each point in time. L over time
was derived fran the aboIre equation using measured T
creating a typical asynchronous J1Dtion (Async) curve
seen in Hypo. Ioad variation changed L J1Dtion, but
with constant time sequence of q. Elas approximated
by a linear equation cannot explain this Async.
Derived L correlated with measured L in Hypo (r=.97).
Conclusion: The Async of ischemic JUi'OCClrdilDll is not
due to an asynchronous active state but due to de-
creased contractility and the elastic property of
ischemic JUi'OCClrdilDll. Exponential awroximation of
changil¥J Elas describes regional funct10n better than
a linear JlDdeI.
RIGHT VENTRICULAR DYSFUNCTION AFTER REVERSAL OF SEVERE
PRESSURE OVERLOAD IN THE CAT
Thomas Wisenbaugh, M.D., Dale Paley, George Yu, William
N. O'Connor, M.D., University of Kentucky and VA Medical
Centers, Lexington, Kentucky
Removal of pressure overload(PO) before the onset of
congestive failure(CHF) reverses hypertrophy and
contractile dysfunction in the cat right ventricle(RV).
However, the reversibility of hypertrophy and dysfunc-
tion long after removal of a PO severe enough to cause CHF
has not been studied. We therefore measured RV mass(M) and
function in 6 cats 8-10 months after relief of severe PO
produced by pulmonary artery banding for 2 months. RVP
(72+19 rnrnHg) returned to normal (21+3 vs 26+4 for control)
aft;r band removal. Stroke(S) work(W), indexed(I) for RVM
was determined from electro-magnetic flow and mean
systolic P at 8 rom filling P.
(mean+STD, *p 0.05 vs C)
Body M(kg) RVM(g) RV:LVM SWI
C 4.29 2.06 .23 40.6
(n=6) +054 +037 +003 13.9
PO 4.00 3.71* -.40* 13.1*
(n=6) +.96 +.93 +.07 +3.8
Reversal 4.64 2.98* -.39* 11.4*
(n=5) +1.55 +.46 +.06 +5.3
RV mass re;ained susbstantially elevated and stroke work
per gram of RV remained significantly depressed 8-10
months after pressure overload was completely reversed.
Thus, as previously observed in patients treated sur-
gically for valve disease, ventricular hypertrophy and
pump dysfunction may persist long after reversal of a
severe pressure overload.
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TBl! IN0'11l0PIC AGENT AJlRINONE DOES NOT INCRllASE
IIYOCARDIAL INFAllcr SIZE
Colin A. Caapb.ll. Ph.D., 10.hua WyDDe, M.D., F.A.C.C.,
Prabodh Mehta, M.D., aud Robert A. ~lon.r, ••D., Ph.D.,
F.A.C.C., Wayne Stat. Univer.ity School of Medicin. and
Barper Bo.pital, Detroit, Michilan
It i. often nec•••ary to admini.ter inotropic alent. to
patients with acute 1IJ0cardial infarctions who have
heart failur., but there is often conc.m that luch
al.nt. can .xtend the infarct. Previoul .tudie••howed
that aarinone increase I epicardial S-T selm.nt eleva-
tion and intr&IIJocardial pC02 durinl brief periodl of1IJ0cardial ilchellia; however, whether ..rinone aotually
increase I anatollic infarct .he is UIlkno1fD. Anesthe-
tized dOl' were lubjected to 3 houri of coronary artery
occludon and 3 houra of reperfudon. At 30 minutes
post coronary artery occlulion, dOl' were randomized to
receive either saline (n=9) or allrinone (n=9; lal-1l:l
bolul followed by 6ml-1l:l~r) for 3 hour.. Area.t risk
(All), determin.d usinl 1I0nastral dy., was 19.7±2.6~ in
control dOli and 20.2:1:1." in amrinone-treated dOls
(p=NS). Area of n.croli. (AN), allelled by tetrazolium
stain and expre••ed •• ~ All, w•• 60.6%6.1~ in control
and 54.6:5.~ in amrinone Iroup (p=NS). Preocclu.ion,
LVEDP wa. 11:1 amRl and increal.d after coronary artery
occlulion, but b.fore therapy, to 20%3 ..ul in controls
and to 17:1 maRl in amrinon.-treat.d dOl" Admini.tra-
tion of laline had no .ffect on hellodynamic parameter••
Bowever, ..rinone increaled dP~t from 1589%97 to
2077:111 maRl~1 (p<O.OOI) and heart rate from 139:7 to
166%9 bpa (p<O.Ol), but decreased LVEDP from 17:1:1 to
12±2 ..us (p<O.OI) and 'Yltolic prel.ure froa 121%8 to
100%4 maRl (p(0.025). ThuI, ..rinone did not increale
anatomic infarct .he, pOlsibly due to its diverlent
effects on the determinant. of lIJocardial OXyg'n d.mand.
NORMAL VENTRICULAR DIASTOLIC FILLING IN EARLY LEFT VEN-
TRICULAR HYPERTROPHY IN THE HYPERTENSIVE RABBIT: AN ECHO-
CARDIOGRAPHIC STUDY.
Jonathan Plehn, M.D., William Grice, Mary Huntington, and
Carl S. Apstein, M.D., FACC. Boston University School of
Medicine and Boston City Hospital, Boston, MA
The natural history of changes in diastolic function
during the development of left ventricular hype~trophy
(LVH) are not defined. We serially performed 2-D gU1ded M-
mode echocardiography under light sedation over 6 months in
hypertensive rabbits (one clip, one kidney Goldblatt mod-
el). Systolic BP was 50% greater in the hypertensives (n=7)
vs controls (C,n=7): 167+12 vs 109+9mmHg, peO.Ol. Blinded
echo measurements of LV mass correlated closely with the
weight of the excised LV; r=0.97 for LV wt. vs M-mode LV
cross-section area and r=0.94 for LV wt. vs M-mode "cubed"
LV mass formula. We chose an LVH group (n=5) where all
hearts had a 50% greater LV mass than the mean C value (6.8
+0.4 vs 4.5+0.1 gm, p< 0.001, LV/BW: 2.1 ::0.2 vs 1.4::1
gm/kg, peO.005) and, at similar heart rates, compared LV
filling indices: max. posterior wall thinning rate, max.
normalized LV filling rate, time to max LV filling rate.
These indices were the same in the LVH and C groups (57+15
vs 52+5 mm/sec, 7.0+1.7 vs 7.4::0.4 dD/dt/D, and 60::2-vs
60+4 ;sec for LVH vs-C respectively). Left atrial weight
wa~ increased by 53% in the LVH group.
These results show that serial echocardiographic de-
termination of LV mass is feasible in the rabbit; this
technique should facilitate studies of LVH progression and
regression.
Despite a 50% increase in LV mass in our hypertensive
group, LV fiUing indices were undiminished relative to
controls, suggesting that LV filling was maintained by
"compensatory" left atrial hypertrophy and increased a-
trial transport function.
3.7!1.2
3.2tO.9
CVR
5.m.7
6.5t2.3
NEUROHUMORAL RESPONSES TO PROLONGED CARDIOPULMONARY BARO-
RECEPTOR UNLOADING IN HUMANS. Pramod K. Mohanty, MD, FA-
CC, Marc D. Thames, MD, FACC, James R. Sowers, MD, Car-
olyn McNamara, RN, Frances Beck, MS, Med. Coll. of VA,
V.A. MedIcal Ctr., Richmond, VA.
The responses to lower levels (-10 and -20mmHg) of LBNP
were smaller but had a slmllar time course. Our data
suggest that durl ng the fl rst 10 ml nutes of LBNP refl ex
forearm vasoconstrIctIon IS mediated solely by enhanced
sympathet i c act i VI ty. Renl n-angi otens I n system may con-
tn bute to the vasoconstri ctor responses resu 1t i ng on 1y
from more prolonged LBNP. These data should be taken In-
to conSIderatIon In the deSIgn of future InvestIgations
of the neurohumoral responses to LBNP.
20 mln
49±12*
2l9±43
4.4±0.6*
88±3
67±5
51±9*
278±20*
2.9±0.3
90±5
69±5
LBNP -4OnrnHg
10 mIn3 min
53±11*
325t15*
1. 9±0. 1
87±3
71±4
BaselIne
179±15
2.0±0.4
87±2
69t2
£::, FVR (Unlts)
NE (pg/ml)
PRA (ng/ml/hr)
MAP (mmHg)
HR (beats/mIn)
Most studIes of the reflex responses to cardiopulmonary
baroreceptor unloadIng WIth lower body negatIve pressure
(LBNP) have assessed responses durIng the fIrst few mIn-
utes of LBNP. It IS unknown If these early changes are
representatIve of the steady state. Thus, we determIned
the responses of forearm vascular resIstance (FVR) and
plasma norepi nephn ne (NE) and ren In (PRA) to prolonged
(20 mInutes) LBNP In 9 normal subjects. FVR, NE and PRA
were measured at basel Ine and after 3, 10 and 20 mi ns of
LBNP (-10. -20 and -40 mmHg). The responses to LBNP of
-40mmHg are summarIZed In the table (*p<0.05 vs. con-
tro1).
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CARDIAC HYPERTROPHY AND DIASTOLIC HYPOXIC CONTRACTURE.
Beverly H. Lorell, M.D., F.A.C.C., Laura F. Wexler, M.D.,
Shin Momomura, M.D., Ellen S. Weinberg, Carl S. Apstein,
M.D., F.A.C.C. Harvard and Boston University, Boston, MA.
A rise in left ventricular (LV) diastolic pressure occurs
during angina in humans with LV hypertrophy (LVH); it is
not known if the diastolic response to hypoxia or
ischemia differs if LVH is present. We compared the
effects of hypoxia in isovolumic (balloon-in-LV) hearts
from DOC-salt hypertensive rats (LVH, n=12) with controls
(C, n-13). LV/body wt differed (3.l9t.36 vs 1.89t19,
p<.05). Hearts were buffer-perfused at constant flow
(CF) such that CF was similar in both groups (17.6t3.6 vs
20.2t5.0 [ml/minl/g LV). LV systolic pressure (LVSP, mm
Hg), LVEDP (mm Hg), LV relaxation rate (T, ms), extent of
relaxation (PB,mm Hg), A-V lactate (mM/L) and coronary
resistance (units.g LV) were measured at baseline (B) and
at 3 min of hypoxia, (*p<.05,LVH vs C).
B LVSP LVEDP T P A-V LACT
LVH l70t18* 1l!1.5 20±14 3.0~4.9 .16t.15
C 103t17 10tl.0 28t7 3.6t2.7 .14t.10
Hypoxia
LVH 66t6* 37t5.3* 44.9 33t6.7* -.72t.23
C 38t6 22t5.0 4ltlO 22t4.7 -.73t.16
Thus, there was a greater rise in LVEDP with a more
impaired extent of LV relaxation in LVH vs C in response
to hypoxia.
Conclusion: Hypoxic diastolic contracture is exacerbated
with LVH and could increase susceptibility to pulmonary
congestion in patients with LVH during hypoxia or
ischemia.
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In the open chest animals, additional simultaneous pres-
sure measurements in the pulmonary artery, left atrium,
and left ventricle demonstrated similar ventilatory
variations in the PA, LA, and LV pressures.
We conclude that most baseline ventilatory variation
in blood pressure is abolished in an open-chest, open-
pericardium preparation. However, PEEP still augments
ventilatory variation in arterial pressure, even in the
open-chest, open-pericardium state. This phenomenon is
not due to direct mechanical effects of positive pressure
ventilation on the left ventricle, but may originate from
direct effects on pulmonary arterial compliance and
pulmonary venous return to the left ventricle.
REGULATION OF VENOUS TONE IN THYROTOXIC CALVES
Rich.rd G. G.y. "D. Chri.topher Appleton, "D, Rich.rd W.
Lee, "D, G.ry V. ".rtin, "D, ".rcey Ol.jo., BS, Eug.ne
"orkin, "D, St.v.n Golda.n, "D, FACC. Tucson VA"C .nd
Univ.r.ity of Arizon., Tuc.on, AZ
H.aodynaaic p.r...ter., sean circul.tory filling pr••-
sur. ("CFP) .nd blood volu.. (BV) w.re ....ur.d in 10
c.lves before .nd after 14 d.ily I" injection. of L-thy-
roxin. (200 ug/kg). In conecious calves, thyrotoxico.is
incr••••d (p<.05) he.rt r.te (HR) by 70%, left ventricu-
l.r (LV) sy.tolic pr.ssure (SP) by 22%, c.rdi.c output
(CO) by 120% .nd LV dP/dt by 56%. Th. "CFP, ..asured in
.n.sthetized c.lve., during .sy.tole induced by injec-
tion of .c.tylcholine (150 ag) into the pulaon.ry .rt-
ery, incr••sed in thyrotoxicosis froa 8.3~0.7 to 11.8~
0.9 aa Hg (p<.OI). "CFP-BV curves were constructed to
deteraine venous coapli.nce (neg.tive reciproc.l of the
slop. I and unstressed v.scul.r voluae or V. (voluae in-
tercept). Venous coapliance decre.sed (p<.02) froa 2.1~
0.2 in euthyroid to 1.3~0.1 al/aa Hg/kg in thyrotOXic
c.lves. BV .nd V. incre.sed (p<.02) in thyrotOXicosis.
When euthyroid were coap.r.d to thyrotoxic calves, both
in the presence of g.nglionic blockade (triaethaphan 2
ag/kg/ain, N=5) or .utonoaic block.de (.tropine .4 ag/kg
.nd propranolol .2 ag/kg in euthyroid .nd .4 ag/kg in
thyrotoxic calves, N=51 there were significant (p<.051
increases in HR froa 91~8 to 136~7 and 90~2 to 149~8
beats/ain, LV SP froa 88~8 to 120~4 .nd 120~4 to 148~10
aa Kg, LV dP/dt froa 1297~117 to 2215~252 .nd 1930~221
to 3063~504 aa Kg/s.c, CO froa 91~5 to 176~12 and 108~6
to 234~8 al/ain/kg and "CFP froa 7.0~0.6 to 9.4~0.6 .nd
7.4~1.1 to 10.5~0.3 aa Kg, respectively. Thyrotoxicosis
altered LV function and incre.sed "CFP due to decre.sed
venous coapliance and incre.sed V.. These changes are
not abolished by ganglionic or autonoaic block.de and
a.y represent direct .ctions of thyroid horaone.
*p(0.005
** p( 0.0018±25±22±1
PEEP (cm)
Aortic pressure
variation (mmHg±SD)
EFFECTS OF POSITIVE END-EXPIRATORY PRESSURE ON VENTILA-
TORY VARIATIONS IN ARTERIAL PRESSURE IN OPEN-CHEST PIGS.
James J. Ferguson, MD, Peter Sahagian, BA, Jeanne Y. Wei,
MD, FACC. Harvard-Thorndike Laboratory, Beth Israel
Hospital, Boston, Massachusetts
Among the profound hemodynamic effects of positive
end-expiratory pressure (PEEP) is an augmentation of
ventilatory variations in arterial pressure. To deter-
mine whether this phenomenon is due to direct mechanical
effects of PEEP on the left ventricle, we performed
experiments in 9 thiamylal anesthetized pigs. Ascending
aortic pressure (micromanometer) was measured before and
after a midline thoracotomy and opening the pericardium,
with 0, 5, and 10 cm. of PEEP. In all cases, opening the
chest and pericardium almost completely abolished base-
line ventilatory variations in aortic pressure. However,
with increasing amounts of PEEP, more distinct ventila-
tory variations in aortic pressure re-emerged.
-** I~ ~~*--o 5 10
INFLUENCE OF LEFT ATRIAL PRESSURE AND OTHER FACTORS ON
EVALUATION OF DIASTOLIC FUNCTION FROM EARLY FILLING RATE
Jay S, Meisner, M,S .. Yoshio Ishida, M,D" Robert W,M,
Frater, M.D" F,A,C,C" and Edward L, Yellin, Ph,D,
Albert Einstein College of Medicine, The Bronx, New York
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EFFICACY OF INTRAVENOUS AMIODARONE FOR REFRAC-
TORY VENTRICULAR TACHYCARDIA. Richard C, Klein,
MD, FACC, Charles Machell, MD, VA Medical
Center, Albuquerque, NM
Antiarrhythmic efficacy of intravenous (IV) Ami-
odarone (Amio) was assessed in 2 patients (pt)
with recurrent nonsustained (VT-NS) and 12 pt
with sustained ventricular tachycardia (VT-S),
VT had been refractory to at least 3 prior anti-
arrhythmics in all pt; 10 pt had required 1-16
DC cardioversions, Amio dosing was 5 mg/kg bolus
followed by 10-15 mg/kg/24 hr infusion for 24-48
hours. VT-S was completely suppressed by Amio
alone in 8/12 pt; 1 pt required addition of pro-
cainamide. 2 pt developed refractory VT/EM dis-
sociation after 6 hrs; 1 pt had refractory VT-S
after 36 hr. VT-NS was suppressed >90% in 2 pt
within 30 minutes, Amio blood levels (mcg/ml)
after initial bolus were:
Time(min) 5 15 30 60
Amio 8.9±1.5 6.3±2.9 2.l±1.2 1.0±0.1
Blood pressure was 118/69 prior to Amio, 110/66
after bolus (p(0,05), and 117/68 one hour after
bolus (NS), Pulmonary wedge (PW) and cardiac
output (CO) did not change except in 2 pt with
ventricular dysfunction who required inotropic
and balloon pump support for decreased CO due to
Amio, PR, QRS, QTc intervals did not change,
During follow-up oral Amio has maintained ar-
rhythmia suppression in 6/9 pt, IV Amio as used
in this dosing protocol is effective for acute
therapy of refractory VT but can potentially in-
duce severe heart failure, Long-term Amio re-
sponse is not predicted by acute response con-
sistent with different electrophysiologic
mechanisms of IV and oral Amio.
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Peak rapid filling rate (PRFR) is commonly used in patient
studies as a noninvasive index of diastolic function
because it reflects the time-constant of LV relaxation
(T), However, the precise relationship between PRFR and T
is unclear, Filling is also determined by other factors
(e,g" LAP at mitral valve opening (PCO), LA and LV
compliances, and mitral orifice area) whose individual
influences are difficult to quantify, To study the
problem, a computer model of LV filling dynamics was
developed using data from the chronically instrumented,
conscious dog, We varied T and PCO and determined PRFR
for given LA and LV compliances and mitral orifice areas,
The results showed that PRFR is profoundly influenced by
PCO as we 11 as T - for examp Ie, a change in PCO from 6 to
8 mmHg at a PRFR of 60 mIls would change the predicted T
from 30 to 60 ms (see Figure), Thus, one must consider an
index of LAP (e.g" pulmonary capi llary wedge pressure)
1.0 before ascribing a
low PRFR to slow
LV relaxation,
Decreased LA or LV
comp 1 iance, or
mitra 1 orifice
area would also
tend to over-
estimate T (under-
estimate relaxa-
tion rate) from
PRFR measurement
alone,
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THE AMIODARONE-WARFARIN INTERACTION: INCIDENCE, TIME
COURSE AND CLINICAL SIGNIFICANCE.
Nicholas Kerin, M.D., F.A.C.C., Roger Blevins, Pharm.D.,
Lary Goldman, M.D., Kathy Faitel, B.S.N., Melvyn
Rubenfire, M.D., F.A.C.C., Sinai Hospital of Detroit, and
Wayne State University, Detroit, Michigan.
The amiodarone-warfarin interaction was examined in 9
patients with atrial fibrillation. Selection criteria
included patients on stable doses of warfarin with at
least 2 consecutive prothrombin times obtained within
2 weeks of amiodarone administration. Amiodarone was
initiated in all patients with 5mg/kg infusion followed
by 600-800mg/day orally for 10 days then 200-40Omg/day
maintenance. The prothrombin times were repeated at
I, 2, 4 weeks and 2 months after the start of amiodarone.
A clinically significant change in prothrombin time was
defined as a > 15% increase within 2 months of amiodarone
therapy. Seven patients (78%) had a mean 63% increase in
prothrombin time (range 33-108%) which occurred during the
1st week in 5 (71%) and during the 2nd and 3rd week in
1 patient each. Among these patients the mean baseline
prothrombin time was 18.6!3.5sec and the warfarin dose
was 5.0!2.7mg/day. After 2 months the mean prothrombin
time had returned to 20.5!4.6sec and required less
warfarin in all cases (3.3!2.0mg/day, p<.005). We
conclude that while the mechanism is unclear the amio-
darone-warfarin interaction (1) is frequently seen (78%),
(2) usually occurs during the 1st week, (3) is not
observed after 3 weeks, and (4) results in a clinically
significant reduction in warfarin requirement.
AMIODARONE FOR DRUG RESISTANT ATRIAL FIBRILLATION
Joseph ~ Abbott, M.D., F.A.C.C., Mary Jane Sauve, R.N.,
D.N.S., Patricia Malone, R.N., M.S., Michael Eldar,
M.D., Nelson Schiller, M.D., F.A.C.C., John M. Herre,
M.D., F.A.C.C., Melvin M. Scheinman, M.D., F.A.C.C.,
University of California, San Francisco, CA.
Amiodarone (A) was instituted for treatment in 26
patients (pts) with hemodynamically unstable paroxysms
of atrial fibrillation (AF) resistant to conventional
therapies. Pts were followed over a mean of 20 months
(range 5 to 55 months). Periodic 24-hour HoI tera were
used to titrate A dose for control of arrhythmia.
Median A dose was 200 mg (range, 200 mg week days to
1200 mg per day). Eighteen achieved constant sinus
rhythm [ejection fraction (EF) 60 + 8, LA diameter 3.9
+ .5cml while 6 had adequate rate -control during AF (EF
50 +10 LA 4.5 + 1 cm). Two pts failed to achieve sinus
rhythm or ra tecon trol (EF 55 + 8, LA + 3.7 + .5cm) Two
pts had permanent pacemakers inserted for known
atrioventricular (1) or sinus node (1) dysfunction prior
to initiation of A dosing. No pts had adverse response
to A during initial 2 weeks of loading. Fifteen pts
remain on therapy; 2 died unrelated to A. Of 26 pts, 9
(35%) had side effects (7/26, 27%) or lack of control
(2/26, 8%) resul ting in A being discontinued; 6 pta had
subsequent His bundle abla tion. La te toxic! ty included
visual disturbances (3), pulmonary fibrosis (2), ataxia
(1), neuropathy (1) and hyperthyroidism (1).
Conclusions: In drug resistant AF, A proved effective
for most (24/26-92%), but was associated with a high
cumulative incidence of toxicity despite low maintenance
doses. Response to (A) could not be predicted from LV
EF or LA diameter. If sinus or AV nodal dysfunction is
absent, hospitalization during (A) loading may be
unnecessary.
EFFECTS OF AMIODARONE THERAPY ON ACUTE POST-OPERATIVE
PERIOD OF CARDIAC SURGICAL PATIENTS
M. Tuczu, M.D., J.D. Maloney, M.D., F.A.C.C., F. Sangani,
M.D., K. Hocevar, R.N., L. Golding, M.D., N. Star, M.D.,
V. Morant, M.D., and L. Castle, M.D., F.A.C.C.
Cleveland Clinic Foundation, Cleveland, Ohio
Uncertainty exists regarding possible adverse effects
of Amiodarone (A) in patients (pts) undergoing cardiac
surgery (5). We compared the acute postoperative course
of 20 consecutive pts on chronic A therapy for ventricuhr
tachycardia (VT) (group I), with 20 consecutive pts who
were placed on A one or more months following similar 5
(group 2). A daily dosage averaging 400 mg was admini-
stered (mean of 61 days) prior to S. Factors analyzed in-
cluded preoperative (demographics, A dose and duration,
ventricular function), intraoperative (duration of bypass
and cross-clamp), postoperative (cardiac index, systemic
vascular resistance, respiratory complications, periods
of intubation, lCU days, early post-op mortality.
Preoperatively severity of LV dysfunction was the only
difference identifiable between group 1 &2 (16 vs 12,
statistically insignificant (51) other than VT and A.
Postoperatively group 1 more frequently had low cardiac
index (3 vs 0 (51», low systemic vascular resistance (3
vs 1 (51», respiratory complications requiring prolonged
intubation (4 vs 1 (51», early postoperative death (2 vs
o (51», & day in ICU (mean 4 vs 2.2 days, statistically
significant). Duration of bypass &cross clamp were
similar in groups 1 and 2.
Conclusion: 1) There was a significant increase inICU
days mainly due to adult respiratory distress syndrome.
Although lung toxicity was not suspected preoperatively,
subclinical pulmonary toxicity of A may be the underlying
cause of respiratory problem in these pts. 2) A prospec-
tive study to better define the trend of adverse influ-
ence of A on surgical pts appears indicated.
LONG-TERM EFFICACY OF AMIODARONE THERAPY IN REFRACTORY
SUSTAINED VENTRICULAR TACHYCARDIA:THE ROLE OF ELECTRO-
PHYSIOLOGIC STUDIES AND AMBULATORY MONITORING.
D LaverY,MD,S Saksena,MD,FACC,S Gordon,MD,ST Rothbart,MD,
FACC,MJ Barr,RN.Newark Beth Israel Med Ctr, Newark, NJ.
We examined the value of chronic electrophysiologic stu-
dies(EPS)&followup 24hr Holter(H)monitoring in long-term
management of pts with refractory sustained ventricular
tachycardia(VT)treated with amiodarone(AM).52pts,mean age
65yrs,mean LV ejection fraction(EF)3l!13%,underwent con-
trolEPS.AM(mean dose 737mg/day)was given for 4t06wks.EPS
was repeated&H performed.Results of H were classified ac-
cording to complexity of ventricular ectopic activity
(VEA). Mean followup was l5!11 months.
RESULTS:LVEF & serum AM levels did not predict VT recur-
rence(Recur)on AM.All pts had spontaneous & inducible sus-
tained VT in the drug-free state.After chronic AM therapy,
the results of EPS & H were:
EPS HOLTER
Induciblevr-No InducibleVT ComplexVEA~VEA NoVEA
38 pts 14 pts 13 pts 17 pts 22 pts
VT Recur: 11(29%) Q(O%) 7(54%) 2(12%) 2(9%)
p value: L..<0.03...,J L.<0.001.::::=J '
3pts with inducible nonsustained VT on AM had symptomatic
VT Recur after dose reduction. The sensitivity of EPS vs H
monitoring for VT Recur on AM was 100% & 64%, & specifici-
ty was 39% & 85% respectively,VT Recur was most frequent
in pts with inducible VT &complex VEA on H(incidence-58%;
sensitivity-64%;specificity-8l%) ,Combined EPS & H criteria
improved EPS specificity but reduced sensitivity,
We conclude:l)EPS after chronic AM Rx in pts with sus-
tained VT is highly sensitive for clinical VT Recur;2)Ab-
olition of complex or all VEA during H monitoring on AM
does not fully predict VT suppression;3)Additional anti-
arrhythmic therapy should be considered for pts with
inducible VT on AM.
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AMI~ ALTERS SUPEROXIDE DISMlJI'ASE ACI'IVITY IN HUMl\N
RED BID:lD CELIS.
P. TiJoothy Pollak, M.D., FRCFC, Arjun D. Sharma, M.D.,
F.A.C.C., Rolando F. DelMaestro, M.D. FRCSC, S. George
Carruthers, M.D., FRCPC, University Hospital, London.
Pathology of amiodarone pulmonary fibrosis suggests free
radical induced damage. Interference by amiodarone with
inactivation of free radical would be consistent with
intracellular lipid inclusion bodies seen in patients
(pt) on amiodarone. we examined superoxide diSIIIUtase
activity (SODa) in erythrocytes (ROC) of 13 pt prior to
and 1, 2 and 3 months (mo) after receiving amiodarone.
Changes in SODa post amiodarone therapy formed a bimodal
distribution with 2 statistically different populations
based on predrug SOOa (p < 0.001). Eight pt with a mean
predrug SODa of 443.8+107.0 had an increase in SODa to
142.6%+34.6% of baseline at 1 to 2 mo and 120%+23.8% of
baseline at 3 mo (p <0.05). Five pt with a predrug SODa
of 677.8+76.0 ng/mg-hemoglobin had a decrease to
70.9%:!:.22.5% at 1 mo and to 65.6%+17% at 3 mo (p < 0.05) •
Thus there are differences in pt responses of SODa to
amiodarone. Since drugs can both inhibit and induce the
same enzyme (eg. Ethanol) the net SODa measured may
include inhibition of SODa in old ROC and/or induction
of SODa in new ROC. This may be the first indication
that amiodarone interferes with the protection of cells
from free radicals. A potential relationship between
SODa responses and amiodarone pUlmonary fibrosis may
permit identification of patients at risk for toxicity
by measur ing SODa in ROC.
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ACUTE ELECTROPHYSIOLOGIC EFFECTS AND CLINICAL
LONG TERM EFFICACY OF FLECAINIDE IN PATIENTS
WITH SUPRAVENTRICULAR TACHYCARDIAS
Per I,Hoff,M,D, ,8ertil eie,M.D,and Ole-Jergen
Ohm, M,D, ,F,A,C,C,Medical Dept.University of
8ergen,Norway
The antiarrhythm1c efficacy of Flecainide
acetate (FA) was evaluated during acute electro-
physiologic study (EPS) and long-term treatment
in 20 patients (pts);7 males,13 females,mean age
41i21 years,with paroxysmal supraventr1cular
taChycardias (PSVT). 8 pts had dual 1ntranodal
pathways whereas 12 had accessory extranodal
pathways. EPS was done before (B in table)
an~ after intravenous FA (in table) 2mg/kg body
we1ght (bw) over 15 m1n. ,followed by a mainte-
nance dose of 1.6mg/kg bw over 60 minutes, After
EPS pts were treated with oral FA for 1+3 month&
FA terminated PSVT by blocking retrograde fast
pathway ~fter injection of 0,9iO.5 mg/kg bw
Re1nduct10n of PSVT was prevented in 16 pts,
Effects of FA on the Wenkebach point (WB) and
effective refractory periods (ERP) of atrio-
ventriCUlar (AV) and ventriculoatrial (VA)
fast pathways (FP) are shown in the table:
AV conduction VA conduction
FP ERP WB FP ERP WB
ms beats/min ms beats/min
8 FA B FA B FA B FA
Mean: 360 348 221 198 300 385 195 145
SO: i76 +65 i37 i29 +50 +57 +38 +22
p-value: NS <0,05 <0,05- <0.05-
Long term oral treatment with FA 200-400 mg per
day suppressed P~VT ~n 17 pts. and 400 mg was
part1ally effect1ve 1n 3 pts, Blurred vision was
noted in 4 pts and in 1 pt FA was discontinued.
FA 1S well tolerated.It is effective in the
acute and long-term treatment of PSVT, This
effect is mainly obtained by blocking the retro-
grade FP,
BENEFICIAL EFFECTS OF INTRAVENOUS FLECAINIDE IN
PAROXYSMAL SUPRAVENTRICULAR TACHYARRHYTHMIAS
Pierre Lacombe, M.D., Samuel Levy, M.D.,
F.A.C.C., Marc Metge, M.D., Roland Cointe, M.D.,
Bernard Valeix, M.D., Raymond Gerard, M.D.,
F.A.C.C., University of Marseille, School of
Medicine, Marseille, France
Previous studies on flecainide, a new class I
antiarrhythmic agent, have dealt with its effect
on ventricular arrhythmias. We evaluated the
effect of intravenous (IV) flecainide (1.5mg/kg
over 10 minutes) on paroxysmal supraventricular
tachyarrhythmias with a ventricular rate (VR)
>120 beats/min,in 23 patients (pts) 10 min after
failure of an IV injection of a placebo (isoto-
nic glucose). A good result, i.e. conversion to
sinus rhythm (SR) or slowing of VR <100 be-
ats/min within 10 min was obtained in 14 (61%).
Seven out of 7 pts (100%) with reciprocating
tachycardia found to be related to reentry wi-
thin the atrioventricular node in 3 and to cir-
cus movement tachycardia involving an accessory
pathway in 4, were converted to SR. Seven out of
16 pts (44%) with atrial flutter or fibrillation
had a good result, including conversion to SR in
6 and slowing of VR in 1. IV flecainide was well
tolerated in 20 pts. Side effects included mode-
rate hypotension (lpt) and transient intraven-
tricular conduction defects (2pts). This study
suggests that IV flecainide is very effective
for reciprocating tachycardia termination and
moderately useful for the management of atrial
flutter and fibrillation.
PVC's/hour qTc
243 0.413
19* 0.457*
21* 0.426
rT3 nrnol/l
0.41
0.89*
0.56
T3 nmol/l
1.70
1.29*
3.31*
EFFECT OF TRIIODOTHYRONINE SUBSTITUTION DURING AMIO-
DARONE TREATMENT FOR ARRHYTHMIAS.
R. Polikar, J.J. GOy, J. SChlapfer, Th. Lemarchand-
B6raut, A. Burger, P. Magnenat, P. Nicod. Department of
Medicine, Lausanne, SWitzerland
Whether there is a link between the antiarrhythmic
efficacy of amiodarone (A) and its blocking effect on
the peripheral conversion of tetraiodothyronine (T4) to
triiodothyronine (T3) is unknown. TO further assess
this, we studied 7 patients (aged 32 to 62) with
multiple premature ventricular contractions (PVC's) but
no underlying heart disease. Each patient underwent a
48 hour Holter monitoring, an electrocardiogram and
thyroid function tests including T4, T3 and reverse T3
(rT3) under no treatment (control), after 1 month of A
and after a second month of A with increasing doses of
T3 (up to 75 ~g/day) •
T4 nmol/l
Control 98
A 105
A + T3 53*
• P < 0.05
Treatment with A resulted in a decrease in T3, an
increase in rT3, a marked diminution in PVC frequency
and a prolongation of the corrected qT interval (qTc).
During treatment with A + T3, T3 increased, T4 and rT3
decreased; PVC frequency remained low despite a shorten-
ing of the qTe to values not different from control.
Thus: 1) T3 substitution does not abolish the antiar-
rhythmic efficacy of A, despite a Shortening of the
corrected qT interval. 2) There does not seem to be a
link between the antiarrhythmic efficacy of A and its
metabolic effect on the peripheral metabolism of T4.
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INTRAVENOUS PIRMENOL IN CONVERSION OF
PAROXYSMAL ATRIAL FIBRILLATION
Lauri K.Toivonen, M.D., Markku S.Nieminen, M.D.,
Vesa Manninen, M.D. and M.Heikki Frick, M.D.,
University Central Hospital, Helsinki, Finland
Antifibrillatory effect on the atria of a new
Class I antiarrhythmic agent, pirmenol, was
examined in patients having atrial fibrillation
of recent onset «48 h) and no history of sinus
nodal disease and-taking no antiarrhythmic drugs
other than beta-blockers or digoxin. After a
baseline period of 30 min a 50 mg injection of
pirmenol or placebo was given double-blind in 2
min, and repeated 10 min later if fibrillation
continued. Sinus rhythm was restored in 12 out
of 20 patients (60%) in the pirmenol group
within 2-16 min and in 3 out of 20 patients
(15%) in the placebo goup within 1 hour (p<.Ol).
A dose of 50 mg was effective in 7 and a total
dose of 100 mg in 5 patients. In nonconverters
the mean heart rate increased from 94 to 113
beats/min (p<O.Ol). A nodal rhythm at a rate of
60/min appeared for 15 s in 1 patient. Sinus
arrests or atrioventricular conduction blocks
did not develop. Systolic blood pressure was
not changed in nonresponders or in the whole
pirmenol group. The mean pirmenol plasma level
was 1.3 :to.5 (SO) mg/l 5 min after the first and
2.1 :to.8 mg/l after the second bolus. These
data indicate that pirmenol has antifibrillatory
effect in the atria and suggest that pirmenol
can be used intravenously in conversion of
atrial fibrillation of recent onset in patients
without sinus nodal disorder.
ANTIARRYTHMIC PROPERTIES OF D-SOTOLOL IN PATIENTS WITH
VENTRICULAR TACHYCARDIA DETERMINED BY PROGRAMMED
ELECTRICAL STIMULATION.
Joseph Schwartz, M.D., Jonathan Wynn, M.D., Sharon Maza,
M.D., Barbara Laux, M.D., Deborah Keefe, M.D., Denn1s
Miura, M.D., John Somberg, M.D. Albert Einstein College
of Medicine, Bronx, New York.
The antiarrythmic properties of D-sotolol were studied in
20 patients with cardiac arrest or symptomatic ventricular
tachycardia (VT). Programmed electrical stimulation (PES)
studies were performed in 14 males and 6 females, mean age
67±8 years and mean eject10n fraction of 37%±5%. PES
studies employed a 6 beat pacing train, cycle length of
500 msec with the introduction of 1 to 3 premature stimuli
at twice diastolic threshold at the r1ght ventricular apex
or outflow tract. All patients had inducible VT by PES
while off all antiarrhythmic therapy. D-sotolol was given
as a 2 mg/kg dose diluted in 50 cc of D5W administered
over 15 minutes. D-sotolol did not signif1cantly change
the PR, QRS or QTc intervals from baseline values.
D-sotolol did significantly lower the heart rate (73 to 65
bpm) as well as prolong the ERP of the first extra
stimulus (238 to 276 msec) p<0.05. D-sotolol did not
significantly prolong the AH or HV conduction. D-sotolol
prevented VT induction in 10 pat1ents at PES, while the
other 10 patients had VT provoked. All 20 patients were
studied on proca1namide and only 3 were protected, 2 on
both drugs. Seven of the 10 patients protected by
d-sotolol at PES were discharged on oral d-sotolol, dose
range of 200 to 400 mg twice daily. One pat1ent died at
month post discharged due to acute MI and 1 patient had a
cardiac arrest, resuscitated and placed on amiodarone.
The remaining 5 patients are alive and well after 5±3
months. D-sotolol appears to be an effect1ve
antiarrhythmic in selected patients and is well tolerated.
AMlOOARONE - FLECAINIDE INTERACTION
Patrick Shea, MD, Kenneth Schechtman, PhD, Roop Lal, MD,
Sung Soon Kim, MD, FACC, Rodolphe Ruffy, MD, FACC.
The Jewish Hospital at washington University, St Louis,
Missouri.
Adverse effects resulting from undesirably high plasma
levels of F were effectively prevented by prophylactic
reduction in F dosage. Conclusions: As with several other
drugs, A interacts with F, and the concommitant use of
these agents dictates a reduction in F dosage of about
1/3 .
Amiodarone{A) is commonly combined with Qther
cardioactive drugs and is known to interact with most of
them. A possible interaction between A and flecainide(F)
was examined in 8 patients (mean age=58) with
life-threatening ventricular(V) arrhythmias(n=7) or
atrial flutter and V preexci tation(n=l). In each patierlt
steady-state oral F preceded A, and F doses were reduced
prophylactically when A was begun. Since plds,fta
pharmacokinetics of F are nearly linear with multiple
oral dosage regimens, steady-state trough flecainide
plasma levels(ng/ml) were adjusted for the highest
steady-state daily dose of oral F(mg) given before and
during A treatment and compared. Adjusted plasma level
was defined as: F plasma levell F daily dose. The results
were:
DURING A I!
695+220 0.96
22,>±113 <0.03
3.4±Q.9 <0.01
BEFORE A
690±173
32~103
2.3±Q.8
I. F plasma level(mean±SD)
II. F daily dose(mean±SD)
III. Adjusted plasma level (1/11)
SUPPRESSION OF VENTRICULAR ARRHYTHMIAS BY RECAINAM, A PO-
TENT NEW ANTIARRHYTHMIC.
Maria I. Anastasiou-Nana, M.D., Jeffrey L. Anderson, M.D.,
F.X.C.C., Edward M. Halllpton, Phann.D., John N. Nanas,
M.D., Barbara M. Heath, R.N., University of Utah, LOS Hos-
pital, Salt Lake City, Utah
Recainam (R), a newly synthesized compound displaying po-
tent cl ass I antiarrhythmic activity, was tested in 10
hospitalfzed patients (pts) with frequent (>30/h) prema-
ture ventricular complexes (PVCs). Pt mean age was 57 yr
(21-74); 7/10 were male; 5 had ischemic heart disease, 3
cardiomyopathy, and 2 valvular heart disease. R was given
as a 3.0 mg/kg/40 min loading infusion followed by a 0.9
mg/kg/h maintenance infusion for 23 hand 20 min. Ar-
rhythmia response was assessed both acutely (comparing 1 h
post-drug loading with 2 h before) and chronically (23 h
of mai ntenance wi th 48 h before). Repeti tive beats were
suppressed by a median of lOOt both acutely (p<O.OO6) and
during chronic infusion (from 80.9/h to O/h, p<0.003).
The median frequency of total PVCs decreased acutely by
99.6t (from 392.5/h to 1.5/h, p<0.OO5) and chronically by
99.7t (from 435/h to 1.3/h, p<O.OOl). More than 90t sup-
pression of repetitive beats occurred in all 10 pts (lOOt)
and of total arrhythmias in 9 pts (90t) during the mainte-
nance period. Electrocardiographic PR and QRS intervals
increased by 20t (p<O.OOl) and 25t (p<0.003), respective-
ly, during therapy. However, JTc interval, an index of
repolarfzation tille, decreased by 13t (p<O.OOll. Plasma
recainam concentrations averaged 5.2:1:0.9 I!g/ml after load-
ing and reached a steady state of 3.0:1:0.5 I!g/ml during
maintenance therapy. No adverse symptoms occurred. In
summary, recainam is a promising, highly efficacious, and
well-tolerated agent when administered intravenously for
acute and maintenance suppression of complex ventricular
arrhythmias and deserves further evaluation.
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Conclusion: Despite the symptomet ic improvement, HZN does not
improve the long term survival in pts. with oc.M.
CI
2,6
2,45
Symptoms to
Death
79 months
81 months
N,S,
Mortality
at 19M
11/22(501)
9/20(451)
N,S.
NYH AClass
Worsening at 9M
6/22(271)
1/20(51)
N,S,
No, Pts.
Group I 14
Group II 15
LOi'l3-TE~ HYDRALAZII\E TIiERAPY IN DILATED CARDI~YOPATIiY: EFFECT
ON SURVIVAL.
Mazhar U. Sheikh, M,D" F.A,C,C .. Ambnsh K. GUlpta, M,D.. Fane
RobInson. M.D•• Robert J. Mills, M.D., F.A.C.C•• Kenneth Dais, M.D••
Nayab Ali, M,D.. F,A.C,C.. Won R, Lee, M,D.. F,A.C.C., Georgetown
Cardiology Sectlon, D,C, General Hospital, Washington. D,C,
Effect of vasoclilator therapy on long term survivel in patIents with
dilated cardiomyopathy «()(}.1) is unknown, In this study 42 pts, with
()(}.1 were followed for an average of 68 months (M) (10-240 M), 22 pts,
received digoxin and diuretics (Group 1); and 20 pts. received above
therapy and hydralazine (HZN) in the dose of 100-300 mg/day for a
period of 19M (9-36M) (Group II), Two Groups were comparable as
noted below:
B. p. Mi t ral NYH AClass
No. Pts. ~ Alcohol ~ Regurgitation III or IV
Group I 22 39.5 19 126/83 9 15
Group II 20 40,2 16 121/85 8 15
Hemodynamic data In 29 pts. prior to HZN is summarized as follows;
Heart RAP PA LVFP
Rate ~ ~ ~
90 9 29.9 22.1
B8 10,4 31,1 23,4
Result:
NYH AClass
ImprOVed at 9M
Group I 0/22(01)
Group II 4/20(201)
P, Valve 0/05
Cardiac a-adrenergic responsiveness is routinely
decreased in patients with heart failure (HF) but the
underlying mechanisms are unknown. We examined the
possibility that serum factor(s) interfere with
a-receptor function in 32 patients with cardiac disease
(18 with idiopathic cardiomyopathy and 15 with ischemic
or valvular disease); 12 normals served as controls.
Cardiac dysfunction in the patients was indicated by
elevated pulmonary wedge pressure (34±6 mmHg), low car-
diac index (2.2±0.2 L/mn) and high plasma norepi-
nephrine NE (542±90 pg/ml). [3HjDihydroalprenolol
binding to isolated cardiac myocytes was determined in
vitro in the presence of serum from either controls or
HF patients (1:10 to 1:400 dilution). At 1:100 dilu-
tion, sera from 15 of 18 cardiomyopathic patients were
positive (26±4% inhibition of binding) compared to 7 of
the 15 nonmyopathic patients (27±3% inhibition). In
contrast, none of the healthy controls was positive.
There was no correlation between extent of binding inhi-
bition and plasma NE levels. Preincubation of the posi-
tive sera witb antihuman y-globulin prevented binding
inhibition. These results indicate that a substantial
percentage of HF patients have unidentified serum fac-
tors (1 antibodies) which interact with the a-receptor
binding site and may, explain the decline in
a-adrenergic responsiveness.
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INHIBITION BY SERUM OF [3HjDIHYDROALPRENOLOL BINDING TO
CARDIAC a-RECEPTORS IN PATIENTS WITH HEART FAILURE
Irvin F. Goldenberg, M.D. and Constantinos J. Limas,
M.D.
University of Minnesota, Minneapolis, Minnesota
THE DIRECT RELATION BETWEEN MYOCARDIAL BETA RECEPTOR DOWN
REGULATION, EXERCISE INTOLERANCE, AND LEFT VENTRICULAR
DYSFUNCTION IN DILATED CARDIOMYOPATHY,
Richard S. Engelmeier, M.D., John B. O'Connell, M.D., FACC,
Margaret R. Eisinger, M.D" Maria Rosa Costanzo-Nordin,
M.D., Patrick J. Scanlon, M.D., FACC, Loyola University
Medical Center, Maywood, Illinois.
Beta adrenergic receptor density (BRD) is reduced in fail-
ing hearts explanted at transplantation. The relation of
BRD to exercise capacity (METS), radionuclide left ven-
tricular ejection fraction (EF), cardiac index (CI), and
pulmonary capillary wedge (PCW) in lesser degrees of heart
failure from dilated cardiomyopathy (DC) is explored by
this study. Fourteen DC patients in NYHA functional class
II to IV had an EF of 19.8±14%, exercise capacity of 6.8±
3.8 HETS, CI of 2.4±,9 L/Min/M2, and PCW of 23±11.4 mmHg
at RV endomyocardial biopsy. BRD was measured by incubat-
ing membrane preparations from 42,6±7,5mg of myocardium,
with 7 dilutions of 1125 cyanopindolol in the presence or
absence of 1 uM propranolol yielding 70% specific binding.
BRD averaged 19,1±9.5 femtomole/mg with a KD of 30±21 pic-
omoles. The relation of BRD vs METS, EF, CI and PCW was
analyzed by linear regression analysis as shown:
PARAMETER METS EF CI PCW
R Value :rr- ~ ~ -.60
P Value .0010 .0036 .007 ,02
Conclusion: Myocardial BRD is directly proportional to
exercise capacity and EF, and inversely proportional to
PCW in DC.
THE "GIANT HEART": SIGNIFICANCE OF EXTREME
INCREASE IN LEFT VENTRICULAR MASS IN HYPERTROPHIC
CARDIOMYOPATHY
Eric K. Louie, M.D., F.A.C.C., BarryJ. Maron, M.D., F.A.C.C.,
NHLBI, Bethesda,Md.
Hypertrophic cardiomyopathy(HCM) is characterized by LV
hypertrophywithout dilatation. It is believed that greater
magnitudesof LV mass may adversely affect prognosis. To
studythis, clinicaland morphologicfeatures in 34 patients(pts)
with HCM and particularlymarked LVH were analyzed. Each
pt had massive septal thickeningof 35-52mm; 31 (90%) also had
marked free wall thickening. Despite similar morphology,
clinical features exhibited a broad spectrum. Less than one-
tht,rd of the pts (10) had basal LV outflowobstruction(average
gradient 63mmHg); the majority (24 or 71%) showing no
evidence for significantimpedance to LV ejection. Although,
ECG's of most pts (76%) showed Lva pattern, QRS voltages
were not greatly increased (S in VI, 27 ± 15mm; R in V6,
21 ± 9mm), and QR~ voltages were normal in 8 pts. Clinical
course in 30 pts aged 14-50 years (mean 27) followed 1 year
(mean 6) was variable. Dyspnea or fatigue and presyncopewere
the most commonsymptomsoccurringin 67% and 60% of pts
respectively. In addition, chestpain occurredin 57% of pts and
syncope in 17%. No pt died, but 9 (30%) deteriorated,including
2 ,Who spontaneouslydeveloped completeheart blockand 1 who
experienced ventricular fibrillation from which he was
resuscitated. Most pts (21 or 70%) remained Wlchanged or
improved. Hence, pts with HCM and "giant heart" show the
most massive LV wall thickeningof any cardiac disease. While
this strikingmorphologyintuitively suggestsa Wltque clinical
expression, pts demonstrated a variety of clinical
manifestatior13 and a natural history that did not reflect
Wliformlypoor prognosis.
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PERICARDIOCENTESIS GUIDED BY TWO-DIMENSIONAL
CONTRAST ECHOCARDIOGRAPHY: A NEW FOOLPROOF
TECHNIQUE. Martin Goldman MD FACC, Jorge Camunus MD,
Jane Farhi MD, louis Teichholz MD FAcc, Bruce P. Mindich MD
FACC, Mt. Sinai and St. Luke's-Roosevelt Hospitals, NY, NY
Pericardiocentesis is a potentially dangerous procedure which
can be safely performed under two-dimensional
echocardiographic (2DE) guidance. However, the needle tip
cannot always be visualized in the ultrasound plane or an ideal
ultrasound window cannot be found. Therefore, we hove
developed a method in which 2DE can be performed from any
location to guide the pericardiocentesis. 2DE imaging is done
through any convenient window while a anesthetic or saline filled
syringe and long needle are inserted (preferably suxyphoid or if
necessary precordially), continuously aspirating and injecting
while advancing. Immediately upon entering the pericardial sac,
the injected fluid creates echogenic microbubbles (contrast)
confirming the needle location and the remaining fluid can be
drained immediately or a catheter can be inserted.
Contrast pericardiocentesis has been performed in 10 patients
with pericardial effusions of different sizes with potential
technical problems ranging from tense ascites, pericardial
tumors, postoperative period, pericardial adhesions and pleural
effusions. The technique has been 100% successful without any
complications. In all patients the contrast was immediately
visible even when the needle itself was not seen. A potential
limitation of this method is the identification of loculated
pericardial effusions in which the injectate is not seen from the
attempted imaging window. This problem is remedied by
alligning the transducer along the needle path.
Therefore, pericardiocentesis performed under contrast
echocardiography guidance, described here for the first time, is
a safe, rapid technique which should simplify complicated
pericardiocentesis and reduce the morbidity of the procedure.
ADRENERGIC INFLUENCES ON RENAL AND CORONARY ARTERY BLOOD
FLOII DURING CARDIAC TAMPONADE IN THE CONSCIOUS DOG.
Gregory A. Bernath. M.D •• Terrence L. Cogswell. M.D ••
Donna Peterson. B.S•• Dennis Janzer. M.S.B.E•• H. Sidney
Klopfenstein. M.D •• Ph.D•• Medical College of Wisconsin
and Zablocki VA Medical Center. Milwaukee. Wi.
We examined the role that adrenergic mechanisms play in
controlling renal and coronary blood flow during
progressive cardiac tamponade (CT). Six chronically
instrumented, unanesthetized. conscious dogs were
studied. Cardiac output (electromagnetic flowprobe),
intrapericardial pressure. aortic and right atrial blood
pressures, and renal (RABQ) and ooronary (CABQ) artery
blood flows were recorded (Doppler flowprobes).
Forty-five episodes of CT were induced by
intrapericardial pressure saline infusion during control
(no blockade). alpha blockade (phenoxybenzamine), or
beta blockade (propranolol) from baseline (empty
pericardium) to decompensation (decline in blood
pressure to 70S of baseline).
Blood Flow (I of BaHlipe) at DecODlpeputiop
~ AlPha Blookade Beta Blockade
CO 3~.82 1 58.14 1 47.85 1
RABQ 74.15 I 89.9 99.23 I
~ 34.76 1 94.5 56.85 1
I = p < .05 compared to others in column.
1 = P < .05 compared to its baseline flow.
Thus RABQ is much better preseryed than CO. independent
of adrenergic mechanisms. Furthermore. coronary artery
blood flow in the absence of alpha adrenergic blockade
decreases to approximately the same degree as cardiac
output, suggesting that adjustments in CABQ during CT
are primarily dependent on alpha adrenergic mechanisms.
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LIMITED VASODILATOR RESERVE AFTER ERGONOVINE IN PATIENTS
WITH DILATED CARDIOMYOPATHY AND CHEST PAIN.
Richard O. Cannon. MD, FACC. Martin B. Leon. MD. FACC,
DoUglas R. Rosing. MD. FACC. Sebastian Pallieri. MD
and Stephen E. Epstein. MD. FACC. HHLBI. Bethesda. Md.
Many dilated cardiOllYopatby (DCM) pts oomplain of anginal-
type pain despite angiographioally nor-al coronary arte-
ries (CA). To examine whether abno~ities of coronary
blood flow exist in DCM, 20 pta with DCM (average EF=2lJ)
and normal CA. 8 of whom bad frequent chest pain (AP), un-
derwent lIeasurelient of great cardiac vein flow (OCV-F,
ml/llin) and 0 at rest and during pacing to heart rate
(HR) 150. Left ventricular eD4-diastolic pressure (LVEDP)
was lIeasured at rest and post-paoing. During pacing alone,
5 AP pts had chest pain. assooiated With alightly lower
GCV-F than the 15 pts Without pain (122+32 vs 153+32. NS).
A repeat pacing study was perfor-ed after ergonovIne (E)
0.15mg iv. Data=_D+SD. BP=aean blOOd pressure. CR=coro-
nary resistance (BP/GCV-F). (A-V)02=arterial - GCV O2,Rest HR BP GCV-F CR (A-V)02 LVEDP
No AP(12) 96+11 85+13 97+22 .95+.32 ~O 21+9
AP(8) 87+1~ 96+10 89+33 1.23+.~7 12.~+2.2 14+7
Pacing after-E - - - - -
No AP 150 95~16 163~38 .61~.1~ 12.3~2.5 29+5
AP 150 104+9 115+301 .97+.2611 12.9+2.1+ 24i5
I=P<0.025. II=p<0.005 vs NO-AP;+=<0.025 vs respeotive rest
measurements. All 8 AP pts experienoed ohest pain during
pacing after E despite no signifioant ohange in EKG or CA
luminal diameter by angiography; no chest pain was experi-
enced by the No AP group. "Jooardial ischemia in the AP
pts was suggested by Widening of (A-V)02 differenoe.
Thus. pts with DCM and chest pain may have dynamic limit-
ation in coronary flow reserve, deaonstrable after a vaso-
constrictor stimulus. Whether this oontributes to sYliptoms
or to 1IIY0oardial damage in DCM remains to be determined.
MYOCARDIAL PERFUSION ABNORMALITIES IN PATIENTS WITH
HYPERTROPHIC CARDIOMYOPATHY AND NORMAL CORONARY ARTERIES.
Patrick T. 0' Gara. MD. Robert O. Bonow. MD. FACC. BarbaraA. Damske, RN. Barry J. Maron. MD. FACC. Paolo Spirito.
MD. Stephen L. Baoharaoh, PhD, Miohael B. Green. MS.
Steven M. Larson, MD' and Stephen E. Epstein. MD, FACC,
HHLBI, Bethesda. Md.
Chest pain is a prominent symptom among pts with hyper-
trophic cardiomyopathy (HCM) even in the absence of large
vessel coronary artery disease (CAD). Evidence indioates
that this pain, as well as lIaDf features of the natural
history of HCM. derives from an ischemic origin. We used
Thallium-201 (Tl-20l) single photon emission computed to-
mography and planar scintigraphy to evaluate 1IIY0oardial
perfusion in 18 pts With HCM immediately after syllptom-
limited treadmill exercise and at rest after a 3 br delay.
None had associated CAD. but 12 pts had a history of angi-
na. Resting LV ejection fraction (EF) ranged from 0.30 to
0.99 (lieaIl=0.58+0.27). Reversible regional perfusion de-
fects were identified in 9 of the 18 pts: 7/9 had a his-
tory of chest pain. although exeroise-induced chest pain
did not predict reversible abnorllalities. Irreversible
perfusion defects occurred in 6 of the 18 pts: 5/6 had
resting LVEF <0.47. In 3 of these 5 pts serial echocar-
diographic data were available and demonstrated progres-
sive LV wall thinning andlor cavity dilatation over 3-11
yearsj the other 2 had large apical aneuryllllls with corres-
ponding Tl-201 defects. Thus. 1) reversible regional per-
fusion defects, suggestive of ischemia, and 2) fixed de-
fects, suggestive of 1IIY0cardial scar and associated with
reduoed LVEF, frequently occur in HCM pts. These results
suggest that 1IIY0cardial ischemia not only contributes to
symptoms in HCM, but may also result in fibrosis and
trRnAlllnra.l AnAr. Anti t.h .....hv ton T.V t'tv.Pun"t.-Inn_ ;n Co Cluk_
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VALUE AND LIMITATIONS OF ECHOCARDIOGRAPHY IN DETERMINING
THE CAUSE OF CONGESTIVE CARDIOMYOPATHY.
Cees A. Visser, M.D., Jacques J. Koolen, M.D., George K.
David, M.D., Wybren Jaarsma, M.D., Arend J. Dunning, M.D.,
F.A.C.C., Department of Cardiology, Academic Medical
Center, Amsterdam, The Netherlands.
REVERSIBLE LEFT VENTRICULAR DIASTOLIC ASYNCHRONY AND
RIDIONAL VARIATION IN MAGNITUDE OF EARLY DIASTOLIC
FILLING IN HYPERTROPHIC CARDIOMYOPATHY.
Robert O. Bonow, MD. FACC, Dino F. Vitale, MD, Stephen L.
Bacharach, PhD, Terri M. Frederick, RH. Barry J. Maron,
MD, FACC and Michael V. Green, MS, NHLBI. Bethesda. Md.
Left ventricular (LV) relaxation and diastolic filling are
impaired in many pts with hypertrophic cardiomyopathy
(HCM). To investigate the influence of regional hetero-
geneity on these global abnormalities, we studied 48 HCM
pts by radionuclide angiography at rest. All were in sinus
rhythm with a diastasis interval evident in each LV time
activity curve. LV regional function was assessed by sub-
dividing the LV region of interest into 20 sectors from
which regional time actiVity curves were derived. Region-
al variation in timing between minimum volume and peak
filling rate (6TPFR) was used as a measure of diastolic
asynchrony, and the inter-sector difference in percent
contribution of rapid filling to end-diastolic volume
(EDV) was used to measure regional variation in the mag-
nitude of rapid LV filling (6RFP). Pts with HCM had great-
er 6TPFR (35+24 vs 12+6 ma, p<.OOl) and greater 6RFP (17+8
vs 8+3 I, p<~OOl) than 30 normal subjects. indicating -
asynchronous and heterogeneous diastolic function. Studies
were repeated in all pts after 1-2 wks of oral verapamil,
which decreased both 6TPFR (to 21+16 ma, p<.OOl) and 6RFP
(to 13+71, p<.02). These regional changes were related to
improved global diastolic filling: rapid filling increased
in both rate (3.3+1.1 to 4.4+1.1 EDV/sec, p<.OOl) and mag-
nitude (69+15 to 85+15 1 of LV stroke volume, p<.OOl).
Thus, more-Uniform regional diastolic performance after
verapamil was associated with enhanced global LV filling.
These findings indicate that asynchronous and nonuniform
regional diastolic function may contribute importantly to
the severity of impaired LV diastolic filling in HCM.
To differentiate ischemic from idiopathic congestive car-
diomyopathy (CCMP) 56 patients (pts), all with cineangio-
graphic LV ejection fraction of ~31%, were studied by two
dimensional echocardiography. Coronary artery disease was
present in 30 pts. Wall motion was evaluated in 8 RV and
13 LV segments, each graded on a 6 point scale from -1
(hyperkinesis) to +4 (aneurysmal). Wall motion score (WMS)
of RV and LV was the sum of the scores for each segment.
idiopathic CCMP (n=26) ischemic CCMP (n=30)
17.1±3.8 (12-26) n.s. 18.1±3.4 (12-24)
6.5±2.0 (3-10) * 3.7±1.5 ( 1- 7)
2.9±1.0 (1.4-5.5) * 5.8±2.4 (2.8-12)
LV-WMS
RV-WMS
LV/RV WMS
* - p<O.OI
Coronary artery disease was absent in 16/17 pts with a LV/
RV WMS ratio of <3.0 and present in 19/21 with a ratio of
>4.3. Segmental hyperkinesis of LV was only seen in ische-
mic CCMP (8/3 = 27%). LV aneurysm (well demarcated bulge
in LV contour during both diastole and systole) was seen
in 12 pts of whom 9 (75%) had ischemic CCMP. All 10/26
(38%) idiopathic CCMP pts with left bundle branch block
had an early systolic downward septal dip on M-Mode, where-
as this was consistently absent in the 13/30 (43%) ische-
mic pts. Thus: 1) A LV to RV WMS ratio of <3.0 and >4.3 is
highly associated with an idiopathic respectively ischemic
CCMP; 2) LV segmental hyperkinesis is only seen in ische-
mic CCMP; 3) LV aneurysm is highly associated with ische-
mic CCMP; 4) Early systolic downward septal dip on M-mode
is only seen in pts with left bundle branch block and
idiopathic CCMP.
SUPERIORITY OF CARDIAC DIMENSIONAL CHANGES COM-
PARED TO STANDARD HEMOOYNAMIC INDICES FOR THE
DETECTION OF HUMAN ALLOGRAFT REJECTION
David E. Hansen, M.D., George T. Daughters, M.S., Edwin L.
Alderman, M.D., F.A.C.C., Neil B. Ingels, Ph.D., Edward B.
Stinson, M.D., F.A.C.C., D. Craig Miller, M.D., F.A.C.C., John
C. Baldwin, M.D., Philip E. Oyer, M.D., Ph.D., F.A.C.C.,
Geraldine C. Derby, R.N., Stanford University, Stanford, CA.
Although hemodynamic abnormalities have been well
described in human allograft rejection, their measurement by
non-invasive techniques has not proved sufficient for early
detection, necessitating serial myocardial biopsies. We com-
pared hemodynamic and ejection phase indices with precise
measurements of cardiac dimensions provided by computer-
aided analysis of fluoroscopy of 9 intramyocardial markers
implanted in the anterior, inferior, and lateral LV walls and
aortic valve margins. Measurements of the velocity of circum-
ferential fiber shortening (VCF), end-diastolic volume (ED V),
and end-systolic volume (ESV) were obtained. Hemodynamic
measurements, fluoroscopic marker recordings, and RV myo-
cardial biopsies were carried out prospectively in 7 heart
transplant recipients, starting 6 days postoperatively.
Nine episodes of acute allograft rejection with myocyte
necrosis occurred. Comparision of pre-rejection measurements
with those obtained during rejection showed no significant
change in heart rate, cardiac output, pulmonary capillary wedge
pressure, mean arterial pressure, isovolumetric relaxation time
(by echo), ejection fraction, or VCF. However, EDV increased
significantly from 168!.39 to 200!.50 ml (p <.002) and ESV
increased from 108+37 to 131+48 (p<.0071. We conclude that
precise measurements of alterations in dimension may more
readily detect early rejection than standard hemodynamic
indices.
SYMPATHETIC NERVOUS SYSTEM ACTIVITY IS RELATED TO LEFT
VENTRICULAR DIASTOLIC FILLING IN DIABETES MELLITUS.
Joel K. Kahn, M.D., Benjamin Zola, M.D., Jack E. Juni,
M.D., Aaron I. Vinik, M.D. University of Michigan, Ann
Arbor, Michigan.
The etiology of impaired left ventricular diastolic
filling in patients with diabetes mellitus is unknown.
We measured indices of diastolic filling by analysis of
high temporal resolution radionuclide time-activity
curves in 28 normotensive long-term diabetics without
evidence of ischemic heart disease by clinical and stress
thallium scintigraphic exams. Six (21%) diabetics had
abnormal diastolic filling and differed from diabetics
with normal filling only in their greater severity of
cardiac autonomic neuropathy (CAN) measured by non-
invasive maneuvers (p<.05) and lower norepinephrine
levels in the supine (13l.l±24.7 vs. 356.2±58.4 pg/ml,
p<.Ol) and the upright (224.9±47.8 vs. 673.3±122.3 pg/ml,
p<.005) positions. The diabetics with CAN (n=15) had
depressed diastolic filling compared to their non-neuro-
pathic counterparts measured as time to peak filling rate
(154.2±12.0 vs. l19.l±10.6 msec,p<.05) and time to peak
filling rate normalized to the cardiac cycle length (24.3
±2.2 vs. l6.2±1.5 %,p<.Ol). Of the various tests of
autonomic nervous activity, the fall in systolic blood
pressure with standing, a reflex arc involving mainly
sympathetic pathways, correlated strongest with impaired
diastolic filling (p<.OOl). Age, duration of diabetes,
and the degree of microvascular complications did not
correlate with any of the indices of diastolic filling.
Thus, in patients with diabetes mellitus alterations in
sympathetic nervous system activity are important
correlates of altered left ventricular diastolic filling.
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SUPERIOR SENSITIVITY OF THE VOLTAGE-MASS RELATIONSHIP FOR
THE NONINVASIVE DIAGNOSIS OF CARDIAC AMYLOIDOSIS.
Michael Simons MD, Jeffrey Isner MD, FACC, Natesa Pandian
MD, Marvln Konstam MD, FACC. Tufts-New England Medical
Center, Boston, Massachusetts.
Previous studies have indicated that cardiac amyloido-
sis (A) results in a relatively unique combination of ECG
and echocardiographic (E) findings: diminished QRS volt-
age (calculated as the sum of V1R+V5R) associated with in-
creased cardiac mass (calculated as LV cross-sectional
area using 2DE). The present study was designed to evalu-
ate the sensitivity of this relationship in comparison
with 2 other previously described noninvasive findings in
cardiac A: a "sparkl ing" (S) appearance of the myocardium
on 2DE; and myocardial uptake of technetium-99m-pyrophos-
phate (TcPYP). In 13 pts (Group n, the diagnosis of car-
diac A was established by endomyocardial biopsy, necropsy
and/or restrictive/constrictive physiology associated with
extra-cardiac tissue biopsy-proven A. In Group I, sensiti-
vity of 2DE-S was 44%; sensitivity of TcPYP was 50%. In 7
additional pts (Group II), the clinical diagnosis of car-
diac A was made on the basis of cardiac symptomatology as-
sociated with extra-cardiac tissue-proven A. In Group II,
sensitivity of 2DE-S was 40%; sensitivity of TxPYP was
42%. In contrast, the plot of the voltage-mass relation-
ship for Group I (mean voltage/mass ratlo ~ O.77±0.37;
range ~ 0.1 to 1.55) and Group II (mean voltage/mass ra-
tio ~ 0.85±0.29 (range ~ 0.45 to 1.21) pts clearly separa-
ted them from normal controls with on1y one exception
(sensitivity ~ 92%), a pt with long-standing systemic
hypertension. Evaluation of specificity was not possible
in this study due to absence of necropsy, biopsy, or hemo-
dynamic "gold standard" in pts with systemic A but no ap-
parent cardiac A. Conclusion: the sensitivity of the vol-
tage/mass relationship derived from combined analysis of
ECG and 2DE is superior to 2DE-S and TcPYP for the non-
invasive diagnosis of cardiac A.
ATRIAL FAILURE IN CARDIAC AMYLOIDOSIS.
Jonathan F. Plehn, M.D., Martha Skinner, M.D., Alan S.
Cohen, M.~ and Car~ Apstein, M.D., F.A.C.C. Boston
City Hospital and Boston University School of Meclicine,
Boston, MA.
Cliaical congestive heart failure clue to impaired LV
filling (diastolic failure) with normal or near-normal
systolic function is cornmon in patients Ilith an increased
LV mass due to amyloid infiltration or myocardial
hypertrophy. We hypothesized that these two conditions
might differ in regard to the atrial contribution to LV
filling.
We compared the Doppler trans-mitral flow pa t terns
in 4 patients with biopsy-proven primary systemic
amyloidosis and cardiac amyloid iafil tratiou to 4
patients ui th myocard 1.al hypertrophy (LVII) due to
hypertension or primary hypertrophic cardiomyopathy. The
patients were matched for similar LV mass as ~ssessed by
LV cross-Sfc tional area (anyloicl: 28. 9.:!:.4. 2cr,1 VB. LVH:
29.3+6.3cm ).
-The amyloid patients had a marked reduction of
atrial function compared to the LVH group as assessed by
peak atrial trans-mitrial flow velocity (A) relative to
peak early diastolic trans-mitral velocity (E); the A/E
ratios were, LVH: 1.57+0.31; Amyloicl: 0.50+0.17,
(mean+SEM, n=4/group, P{.025). -
Conclusion: Atrial failure is an important
component of the diastolic failure observed in cardiac
amyloidosis and may be characteristic of this condition.
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Electrophysiology-Basic
THE CARDIAC POTENTIAL FIELD CREATED
BY CHEST WALL DEFmRILLATION
ELECTRODES IN DOGS
Peng-Sheng Chen. M,D., Patrick Wolf, B.S.E.E., Frank J.
Claydon, M.S., Ellen G. Dixon, M.S., Nitaro Shibata, M.D.,
William M. Smith, Ph.D., and Raymond E. Ideker, M.D.,
Ph.D. Duke University Medical Center, Durham, North
Carolina
Although transthoracic ventricular defibrillation (DF) has
been used clinically for many years, there has been no direct
measurement of the cardiac potential field created by chest
wall electrodes. Accordingly, in 5 dogs with the chest
opened through a median sternotomy, 60 epicardial and 36
anterior RV intramural plunge electrodes were applied to the
heart. The halves of the sternum were then reapproximated,
and saline-soaked gauze was interpositioned to fill the gap.
Unipolar potentials ~ere recorded while 5 volt shocks were
given through 78 cm electrodes applied to the right and left
chest wall at the midaxillary lines. Potential gradients
tangential to the epicardium and along the plunges were cal-
culated. The voltage drop from the right to the left margins
of the heart was only 6±4% of the total voltage applied.
The potential gradient tangential to the epicardium varied
widely over the surface of the ventricles. The mean ratio of
the highest to the lowest tangential epicardial gradient was
36.9±27.1. The ratio of the endocardial-epicardial gradient
along the plunge to the tangential epicardial gradient near
the insertion of the plunge was 2.6±5.2. Thus for right and
left chest wall DFs, most of the applied voltage is dissipated
outside the heart, and the tangential epicardial potential gra-
dient is uneven. These results indicate the tremendous
inefficiency of DF with chest wall electrodes and raise the
possibility that much better locations and sizes of DF elec-
trodes can be found by measuring the potential field.
INFLUENCE OF PATHWAY LOCALIZATION ON EFFECTIVE REFRACTORY
PERIODS OF ACCESSORY ATRIOVENTRICULAR PATHWAYS
Michael KentlCh. M.D., Klau..Peter Kunze, M.D., Kart·Heinz Kuck, M.D., Waltw
Bleifeld, MD., F.A.C.C., Dept. of Cardiology, Uniwnity Hospital Eppendorf,
Hamburg, West Germany
In 44 patients (ptsl (14 women, 30 men: meen age 39 yean) with an 8CC8IIlIry AV
pathway (AP) undergoing standard e1ectrophysiologie study the re!lotio..~
the effective refractory periods (ERPs) of myocardial tissue and ERP of the AP were
studied .nd the dependence of the ERP of AP on AP location WW8 analyzed. We
detwmined ERPs of RA, LA via coronary sinul, and RV with the e_imutus
technique, of AP in anterograde (ant) direction during decremental atrial peeing at
the lite of atrial AP insertion, and of AP In retrograde (ratl direction during de-
eremental RV pacing. If ERP of AP was shorter than ERP of the stimulated myo-
cardial tissue (MT) ERP of AP wa. estimated to be 10 msee lea than ERP of MT.
Ant ERP of AP did not differ from rat ERP of AP in right sided API. In left sided
APs ant and rat ERP of AP wal not different from ERP of LA. In right sided, APs,
ant ERP of AP differed lignificandy from ERP of RA (282 ±,46 msvi 224 ±.43 ms,
p <::. .011 and from ERP of RV (217 ± 10 ms, P <.01). No significant difference
was found between ret ERP of AP and ERP of RA and RV. There were no linear
correlation. between ant ERP of right..ided APs and ERP of RA (r· .53), and ant
ERP of lefHided APs and ERP of LA (r =.421. Multiveriate analysis of ERP de·
pending on AP localization showed significant differen_~ ant ERPs of right
septaily located and left latereily located APs (311 ±.48 mlvs248 ±24 ms; p..: .051,
but no differences in ERPs of right laterel (255 ±. 10 mal, left posterior septal (289 ±
34 ml) and left posterior free wail (251 .± 27 msl APs. Moreo_, there wal a linear
decrease of ant ERPfrom right septal to left I_al API. - Conclusio..: 1. Ant and
ret ERP of AP do not correlate with ERP of myocardial tissue. 2. Ant ERP of AP
decreases lignificandy from right septal to left lateral API. A significant linear
deereese of ant ERP of AP wa. shown from right septal to left I_al AP.
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SUBEPICARDIAL OBIGIII or SPOIITADOUS ECTOPIC BElTS II TIIB
IIIFARCTBD DOG BBABT.
Eugene Patterson. Ph.D., Benjamin J. Scherlag, Ph.D.,
FACC, and Ralph Lazzara, M.D., FACC. Univ of Oklahoma
Health Sciences Center and VAMC, Oklahoma City, OK.
Endocardial (ENDO) and epicardial (EPI) recordings were
used to determine the earliest activation site for
spontaneous ventricular beats, 24 hr after coronary artery
ligation. In 13 experiments, premature ventricular beats
(PVEs) and slow ventricular tachycardia with a left bundle
branch block morphology and a 6 -wave in the anterior EKG
leads were observed. EPI activation overlying the central
infarct zone preceded ENDO activation by 20-80 msec.
Early EPI activation was simultaneous with the 6-wave of
the EKG. In any indiVidual experiment, EPI activation was
coupled to the previous beat by a constant, fixed inter-
val. In no experiment was epicardial or endocardial
electrical activity recorded during this interval. The
mean coupling was prolonged by lidocaine from 385±24 to
409±45 msec (p<O.o1), and was decreased by epinephrine
(364±7 msec) and 0-600 (324±32 msec) (p<0.05). Histologic
examination of the EPI site revealed surviving tissue
sparsely connected to surrounding myocardium by narrow
tissue «1 mm) bands through infarcted tissue. Lidocaine
pledgets or intracoronary latex were used to ablate
spontaneous PVBs of EPI origin without altering ENDO
PVEs. The observations suggest an EPI origin for some
PVEs after infarotion. The PVEs may result from electro-
tonio exoitation of EPI tissue from the isohemioally-
injured zone with slow active oonduotion from the site of
origin to the remaining ventrioular tissue.
ELECTROPHYSIOLOGIC EFFECTS OF HIGH K+ AND RAPID
STIMULATION ON AUTOMATICITY OF THE RABBIT SINOATRIAL
NODE.
Masao Nishimura, M.D., Yoshizumi Habuchi, M.D., Shuichi
Hiromasa, M.D., Akihiko Miyakawa, M.D. and Yoshio
Wa tanabe, M.D., F.A.C.C.
Fujita Gakuen University, Toyoake, Aichi, Japan.
Electrophysiologic mechanisms underlying the suppression
of automaticity by high K+ and after rapid stimulation
were studied using small rabbit sinoatrial (SA) nodal
preparations (0.2 x 0.2 x 0.1 mm). When extracellular
K+ concentration was increased from 4 to 8 mM, the
spontaneous firing frequency was decreased from 226 to
186/min, accompanied by reductions in the maximal dias-
tolic potential from -72 to -62 mY, take-off potential
from -48 to -38 mV and rate of diastolic depolarization
from 94 to 71 mY/sec (P<O.Ol, n=6). SA nodal recovery
time after stimulation at 375/min for 30 sec was 230
msec during control, and was prolonged to 512 msec at 8
mM K+ (P<O.Ol, n=5). Voltage clamp experiments revealed
that 8 mM K+ did not affect the slow inward current, but
decreased the outward K+ current (iK,) tail from 30 to 26
nA and increased the hyperpolarizatl.On-activated inward
current from 9 to 12 nA (P<O.Ol, n=5). Deactivation
time constant of the iJ< tail was increased from 135 to
160 msec at -60 mV and J.ts steady-state activation curve
was shifted to more negative potentials by 4 mV by high
K+. After 10 rapid depolarizing pulses at a rate of
375/min, the deactivation time constant of the i K tail
was increased to 210 msec in 4 mM K+ and to 240 msec in
8 mM K+ (P<O.Ol, n=5). These results suggest that high
K+ and rapid stimulation suppress the SA nodal automa-
ticity by inhibiting the deactivating process of the i K
tail. Possible extracellular K+ accumulation by the
rapid stimulation was also suggested.
The incidence of ventricular fibrillation did not corre-
late with MI size (21+6% in Early and 22+7% in Late). Is-
chemia-related ventricular fibrillation was invariably
preceded by reduction of myocardial flow to at least 15%
of control in a critical mass of myocardium regardless of
the coronary vessel occluded and did not occur when flow
reduction was less severe. Thus, spontaneous ventricular
fibrillation in the setting of ischemia following MI is a
blood flow-related phenomenon. The differences in the in-
cidence of ventricular fibrillation between early and late
LAD occlusion, and between late LAD and late LCxM occlu-
sion are associated with the differences in the severity
of reduction in myocardial perfusion.
CORRELATES OF VENTRICULAR FIBRILLATION DURING MYOCARDIAL
ISCHEMIA SUPERIMPOSED ON EARLY AND LATE MYOCARDIAL INFARC-
TION IN A CANINE MODEL
Hasan Garan, M.D. , Jeremy N. Ruskin, M.D., F.A.C.C.
Massachusetts General Hospital, Boston, MA
Thirty dogs underwent apical myocardial infarction (MI)
created by the ligation of the mid left anterior descend-
ing coronary (LAD) artery and all visible collaterals.
Acute, reversible myocardial ischemia was superimposed one
day after MI (Early) in IS dogs and 2 weeks after MI(Late)
in the other 15. Reversible ischemia was created by al-
ternate 10-minute occlusions of proximal LAD or proximal
first left circumflex marginal artery (LCxM). Each occlu-
sion was repeated to test the reproducibility of the arr-
hythmias. Myocardial blood flow before and 2 minutes
after the onset of ischemia was measured by microsphere
technique in 6 Early and 6 Late dogs. The incidence of re-
producible, ischemia-related ventricular fibrillation is
shown:
EFFECT OF TRANSMURAL VERSUS NONTRANSMURAL MYOCARDIAL
INFARCTION ON INDUCIBILITY OF VENTRICULAR ARRHYTHMIAS
DURING STELLATE STIMULATION
John M. Herre, M.D., F.A.C.C., Yuh-Lin Lin, M.D., A. Scott
Mllls, M.D., Lewls Wetsteln, M.D., F.A.C.C., and Marc D.
Thames, M.D., F.A.C.C., Medical College of Virginia,
Richmond, VA.
Transmural myocardial infarction (MI) interrupts sympa-
thetic nerves and denervates viable muscle distal to MI.
In order to determine the importance of this denervation,
we measured ventricular effective refractory period (VERP)
and ease of inducibility of ventricular tachycardia (VT)
or fibrillation (VF) by programmed stimulation from the
right ventricle (RV) and left ventricle (LV) in 16 dogs
before and during left stellate stimulation (LSS). Trans-
mural MI was produced in 6 dogs by latex injection into
the left anterior descending (LAD). Nontransmural MI was
produced in 6 dogs by LAD ligation. Dogs were studied
~14 days after MI. Four dogs with no MI served as con-
trols. Denervation of LV distal to transmural MI was
demonstrated by absence of fall in VERP with LSS.
Results: 6 VERP with LSS Increased Ease of
(msec, mean±SEM) Inducibility with LSS
RV LV RV LV
Control -Tb±4 -15±4 074 ~
Transmural MI -11±2 - Itl 6/6 3/6
Nontransmural MI -12±3 -11±4 1/6 0/6
We conclude that 1) in normal hearts and in hearts with
chronic nontransmural MI, LSS produces balanced changes
in VERP and no increased inducibility and 2) in hearts
with partial denervation produced by transmural MI, LSS
produces unbalanced changes in VERP and increased ease of
inducibility of VT or VF.
Early (l day)
Late (2 weeks)
LAD occlusion
8/1511/15 f p<O. 02
LCxM occlusion
6/15}NS
9/15
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The response to baseline PVS was reproducible following
the reversal of ischemia in 14/15 animals. PVS-induced
SUSVT, in the absence of ischemia, correl?ted with MI size
by logistic regression analysis. Ischemia-induced VF, how-
ever, correlated not with MI size, but with the total size
of the myocardium with critically reduced «15% control)
blood flow during the ischemic episodes. Thus in this model
of late myocardial infarction SUSVT does not appear to be
an acute ischemia-related arrhythmia. The incidence and
the underlying substrates of PVS-induced and acute ischem-
ia-induced ventricular arrhythmias may be different.
MYOCARDIAL ISCHEMIA SUPERIMPOSED ON LATE MYOCARDIAL IN-
FARCTION: A CANINE MODEL OF ISCHEMIA-RELATED VENTRICULAR
ARRHYTHMIAS
Hasan Garan, M.D., Jeremy N. Ruskin, M.D., F.A.C.C.,
Massachusetts General Hospital, Boston, MA
Post-myocardial infarction ventricular arrhythmias asso-
ciated with superimposed myocardial ischemia or induced by
programmed ventricular stimulation (PVS) were investigated
in 15 dogs, two weeks following the ligation of the left
anterior descending coronary artery (LAD). All animals
underwent PVS from RV and LV, before and after episodes of
acute, reversible myocardial ischemia created by 10-minute
occlusions of the proximal first circumflex marginal art-
ery superimposed on 2-week old anteroapical infarction.
Myocardial blood flow, before and 2 minutes after the on-
set of ischemia, was measured by microsphere technique in
6 animals. The incidence of sustained ventricular tachy-
cardia (SUSVT) and ventricular fibrillation (VF) are sho~
Ischemia-induced PVS-induced
SUSVT
VF
0/15
9/15
5/15
8/15
VERAPAMIL-INDUCED SUSTAINED VENTRICULAR TACHYCARDIA IN
ISOLATED, PERFUSED RABBIT HEARTS. A UNIQUE EXPERIMENTAL
MODEL FOR IDIOPATHIC VENTRICULAR TACHYCARDIA.
Yoshio Watanabe, MD, FACC, Hiroko Uchida, MD, Cardiovascu-
lar Institute, Fujita Gakuen University, Toyoake, Japan
Inducibility and characteristics of sustained paroxysmal
ventricular tachycardia (SPVT) were studied in 12 isolated
perfused rabbit hearts. Induction of SPVT was attempted
by rapld electrical stimulation (5 msec square pulses at
20-25 Hz for 2-5 sec) applied at RV outflow tract or LV
apex. SPVT was not induced under normal perfusing condi-
tions, whereas SPVT was produced in all 12 hearts after
verapamil (0.5-1 mg/L) was added to the perfusate. Epi-
cardial activation was mapped with either a roving elect-
rode or 18 close bipolar surface electrodes. QRS patterns
durlng the SPVT either remained stable for a prolonged
period or showed occasional transition to different mor-
phologies, but never showed torsade de pointes configura-
tion. The rate of SPVT ranged from 460 to 800/min. Ex-
cluding 5 hearts in which observations were discontinued
after >60min, the SPVT lasted from 24 to 268 min (mean 120
min). The earliest epicardial activation site was located
in LV in 5, RV in 5 and near the anterior interventricular
groove in 2. Excitation appeared to spread radially from
these sites in II, whereas a large circus movement was su-
ggested in one. OVerdrive pacing for 15-30 beats in 6
hearts captured the ventricles but failed to terminate
SPVT. Addition of disopyramide (5 mg/L) resulted in ter-
mination of SPVT in 3 out of 7, whereas washout of verapa-
mil terminated it in 4 out of 5 hearts. In one heart, ex-
ploration of LV cavity with a roving electrode abruptly
terminated SPVT. Although neither abnormal automaticity
nor micro-reentries can readily explain its mechanism,
this arrhythmia serves as a unique experimental model for
the so-called idiopathic ventricular tachycardia. Possi-
ble clinical implications of these findings are stressed.
CYCLIC AMP PROLONGS \]I' INI'ERVAL BY AN ACTION ANI'AGONISED
BY ADErmINE IN THE RAT HEARl'.
Wilhelm F. Lubbe, MD, FACe, Andrew Gilchrist, B.Sc. and
Robyn Holland, Department of Medicine, University of
Auckland and Green Lane Hospital, Auckland, New Zealand.
In the isolated rat heart adenosine opposes cyclic AMP
induced lowering of the ventncular fibrillatwn
threshold and antagonises spontaneous arrhythmias after
coronary artery ligation. The influence of dibutyryl
cyclic AMP (DBcAMP) on \]I' interval was assessed by
rreasurement of QT/RR ratio on lOOmn/sec recordings of ECG
in Langendorff perfused rat hearts. DBcAMP, :rnfused at
5.01.1T01/min (290-3l0ll/lDl/rnl) increased heart rate fran
270±7 to 3l0±l4bpn; despite this, \]I'/RR increased frem
O.39±O.09 to O.65±0.4 (p<O.OOl). Adenosine, 501.1TOl/l :rn
perfusate during DBcAMP infusion, reduced \]I'/RR to
0.52±O.3 (p<O.OOl). Analogs of adenos:rne were used to
determine its site of action. 2-Chloroadenos:rne, which
is not transported into the cell, did not reduce \]I'/RR
when slowing of heart rate was prevented. In contrast,
exythro-9-(2-hydroxy-3-nonyl) adenine (EHNA), lOl.1TOl/l,
which inhibits adenosine deaminase and increases tissue
adenosine levels threefold, reduced \]I'/RR to O.24±O.2
(p<O.OOl) without alteration in heart rate. ~-phenyl­
isopropyladenosine (PIA) and 5'-N-ethylcarboxanido-
adenosine (NECA), agonists for extracellular R sites, did
not alter \]I'/RR when reduction of heart rate was
prevented by ventricular pacing.
Cyclic AMP and adenosine have opposite effects on
vulnerability to fibrillation and on \]I' interval in the
rat heart; the potent actlon whereby EHNA shortens \]I'
interval and lack of effect of analogs acting at
extracellular sites favor an intracellular site of action
(P site). These observations suggest that cyclic AMP and
adenosine are determinants of the \]I' interval.
CATHETER MEDIATED ELECTRICAL ABLATION: THE RELATION
BETWEEN CURRENT AND PULSE WIDTH ON VOLTAGE BREAKDOWN AND
SHOCK-WAVE GENERATION. Gust H Bardy,MD,FACC, Fernando
Coltorti,MD, Michael Rackson,BSEE, Karl Hanson,BSEE, H
Leon Greene,MD,FACC, Tom D Ivey,MD. Univ WA, Seattle, WA.
A limitation of catheter mediated electrical ablation
of cardiac tissue is shock-wave induced barotrauma.
Electrically, shock-wave formation is characterized by a
breakdown in the voltage waveform.
Our purpose was to study how current amplitUde and
pulse width{PW) relate to voltage breakdown at the time
of shock-wave generation using constant current,
rectangular pulses delivered from a high-voltage,
variable waveform modulator with a wide dynamic range
and bandwidth. A 6Fr 16mm2 surface area Cu electrode
immersed in bovine blood was the cathode and an 8.5cm
disc electrode was the anode. Waveforms were monitored
oscilloscopically and delivered energy was determined by
integrating the voltage and current waveforms. For any
given current, voltage breakdown and shock-wave
generation occurred at substantially different PW's. The
PW recorded is the maximum duration possible for a
particular current before voltage breakdown occurs.
Voltage and energy prior to breakdown are shown below.
current(Amps) 2 4 6 8 10 12 14 16
Pw(psec) 2500 780 320 180 140 96 72 62
Voltage (Volts) 160 320 470 650 760 930 1130 1200
Energy{Joules) 0.8 1.0 0.9 0.9 1.1 1.1 1.1 1.2
Conclusions: A ·strength-duration· curve can be con-
structed which defines the limits of PW for any given
current in order to avoid voltage breakdown associated
with shock-wave generation. The total energy deliverable
in a single pulse without incurring this phenomenon is
relatively small. Very short duration, high amplitude
pulses allow for higher voltages and energies before
shock-wave generation occurs.
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GALLOP.IIIIL (1III!II01t-YBIW'JIIIL) IlDUCIS T1IGGIUD AC'1'IVI1'I
D ClIDI1C CBLLS
Bela Szabo. M. D.. Ph.D.. Raed Sweidan, M. D., Benjamin
J. Soherlag, Ph.D., F.A.C.C., and Ralph Lazzara, M.D.,
F.A.C.C. University of Oklahoma Health Soienoes Center
and VA Medioal Center, Oklahoma City, OK.
It has been observed that intravenous verapamil may elioit
transient, multiform ventrioular taohyoardia in patients,
by an unknown meohanism. To test for the possible
arrhythmogenio effeots of verapamil, guinea pig ventriou-
lar fibers were studied 19 !i1£g and stimulated "at a oyole
length of 500 maeo. Tissues were superfused with a 5.6mMr Tyrodes solution for 1 br and with 2.0-mM r for an
additional 2-3 brs. Aotion potentials (AP) were reoorded
by standard teohniques. In 2.0-mM r maximum diastolio
potentials (MOP) of Purkinje fibers hyperpolarized from
-81±1 mV to -94±2 mV and remained stable. Gallopamil (G)
(1 \l M) oaused an inorease in early repolarization, but
terminal repolarization was delayed leading to early
afterdepolarizations ('EAD) and also triggered APs 4 min
after G. Triggered APs were ooupled to stimulated APs by
an average of 170 maeo and showed the same MOP (-94 mV),
Vm x (430 Vis) and overshoot (+40 mV). Some of the
trfggered APs were followed by EADs. Both triggered APs
and EADs disappeared in 25 min after G was given. We
oonolude that G-induoed triggered APs and EADs at low
[rlo may be the oounterpart of the polymorphous arrhy-
thmias seen in patients, after verapamil. The delay of
terminal repolarization may indioate a reduotion in
repolarizing K-ourrent. G, a known inhibitor of slow
inward ourrent deoreases Ca++ influx during the plateau of
the AP, and secondarily may lead to partial inaotivation
of repolarizing ourrents and generation of EADs and
triggered APs.
INHIBITION IN ISOLATED HUMAN MYOCARDIUM
John R. Windle. M.D •• Douglas P. Zipes, M.D., F.A.C.C.,
Eric N. Prystowsky, M.D., F.A.C.C., Robert F. Gilmour,
Jr., Ph.D., F.A.C.C. Krannert Institute of Cardiology,
Indiana University School of Medicine, Indianapolis, IN
Previous studies demonstrated that a stimulus (S )
delivered within the ventricular effective refra8tory
period (ERP) inhibited a subsequent suprathreshold
intensity stimulus (S2) from producing a propagated
response (inhibition). The purpose of this study was to
demonstrate inhibition in human ventricular trabeculae
(n-lO) obtained at heart transplantation and to determine
the effects of S current intensity, S pulse duration,
SIS interval, a&d hyperkalemia on profongation of action
pot~ntial duration and change in ERP (6ERP) produced by
S. Action potentials were recorded at sites near «2mm)
a&d remote (1-2cm) from a bipolar stimulating electrode
during superfusion with normal or hyperkalemic (KCL - 8 -
l2mM) Tyrode. The ERP was the longest S S2 interval that
failed to produce a propagated action potential. S was
delivered within the ERP and the 6ERP determined. c
Results: 1) S increased action potential duration and
ERP by producfng local responses, 2) 6ERP increased with
increasing S current intensity (S-lOmA), pulse duration
(lO-3Oms), o~ SIS interval (130-2S0ms) 3) hyperkalemia
enhanced the incr~ase in 6ERP by S , 4) during
hyperkalemia S delivered to the nEfar recording site
prevented S2 d~livered to the remote site from producing
a propagatea response. Thus, S increased ERP by
producing nonpropagated local r~sponses; this effect was
enhanced by hyperkalemia. S -induced local responses in
vivo might produce conductio& block and cause or preve;t
reentrant excitation.
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Doppler Echocardiographic Assessments of Aortic
Valve Disease
ASSESSMEN1' CF THE SEVERITY CF AamC~CN BY
PULSED IlClPPLER 1IBIXJ4INAL AamC FLai PAT'lERN
Katsu Takenaka. til, Ali Dabestani, til, Julius MGardin,
MD, FAlX, Daniel Russell, Sandra Clark, Alice Allfie,
walter L Henry, til, FAlX.
tniversity of California, Irvine, California
DoWler echocardiography is a useful noninvasive method
for detecting aortic regurgitatioo (AR). However,
DoWler methods for quantificatioo of AR either involve
relatively time-calswDing prooed1res or are affected by
associated valvular diseases such as aortic or mitral
stenosis. To determine if the presence of retrograde
holo-diastolic flow in the abdaninal aorta (ABO Ao) can
be used to assess the severity of AR, we examined flow in
ABO Ao by p.11sed IJoRller echocardiography in 15 normal
subjects, 10 patients without AR and 31 patients with AR
coofirmed by aortography. In 31 patients with AR, 12 had
mitral regurgitatioo, 11 had mitral stenosis, 8 had
aortic stenosis, 5 had mitral prosthetic valves and 5 had
aortic prosthetic valves. No retrograde diastolic flow
w~ found in ABO Ao of 15 normal subjects and 10 patients
Wlthout AR. Twenty of 21 patients with 1+ or 2+ AR
independently determined by injectioo of iodinated
cootrast into the aortic root did not have retrograde
holo-diastolic flow in ABO Ao while all of 10 patients
with 3+ or 4+ AR had retrograde holo-diastolic flow in
ABO Ao. In ooe patient with 1+ AR and a left-to-right
shunt through a patent cl1etUll arteriosus, retrograde
holo-diastolic flow was detected in ABO Ao.
In cooclusioo, the finding of holo-diastolic retrograde
flow in abdaninal aorta is useful in distinguishing
patients with severe AR fran those with mild or absent
AR. Moreover, the method is easy to perform and a);peaIs
to be independent of the presence of other cardiac
diseases except patent ductus arteriosus with significant
left-to-right shunt.
DIRECTION AND WIDTH OF AORTIC REGURGITANT JETS: ASSESSMENT
BY DOPPLER COLOR FLOW MAPPING.
Alan S. Pearlman, M.D' AF.A.~.C.; Catherine M. Otto~ M.D.;Carolyn L. Janko, R.n..5.; obyn P. Reamer, R.C.P.I.
University of Washington, Seattle, WA
. To study the direction and width of aortic regurgitant
J~ts, we evaluated 14 patients (pts) with aortic regurgita-
~10n (AR) by Doppler color flow mapping (using an IREX 880
lnstrument). Pt ages ranged from 50-80 {mean 62) years, with
8 men and 6 women. AR etiologies: calcific=6; rheumatic=5;
degenerative, congenital, root disease=l each. We measured
AR direction in both long-axis and 4-chamber planes, with
reference to the direction of the left ventricular outflow
tract (LVOT). Jets directed < ± 200 from the LVOT center-
1ine in both planes were considered "parallel"; jets with
greater angulation to the LVOT were considered "oblique".
Jet width, measured lcm below the aortic valve, was normal-
ized for diastolic LVOT diameter at this level and classi-
fied as broad (filling >70% of the LVOT), moderate (35-70%
of the LVOT), or narrow (<35% of the LVOT).
In all pts, discrete diastolic AR jets were visualized in
the LVOT. Of 11 pts with 1-2+ AR, jet width was narrow in
6, moderate in 4, and broad in only 1. Of the 3 pts with
3-4+ AR, jets were broad (n=2) or moderate (n=l); no pt with
significant AR had a narrow jet. Jets were parallel to the
LVOT in 8 pts (2 with significant AR), and oblique in 6
(only 1 with significant AR).
We conclude that diastolic jets of AR show substantial
v~riability, in both width and direction, from pt to pt.
Slnce broad jets generally denoted significant AR while
narrow jets were never severe, the width of an AR jet may
be a clue to severity. Finally, the oblique orientation and
narrow profile of many jets may make it difficult to record
their velocity accurately throughout diastole; this mayex-
plain why LV filling pressure cannot be measured success-
fully from AR velocity in some pts.
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COMBINED COLOR DOPPLER AND CONTINUOUS WAVE DOPPLER IN THE
EVALUATION OF AORTIC STENOSIS
Frederick Helmcke, M.D., Gilbert J. Perry, M.D., Navin C.
Nanda, M.D., F.A.C.C., University of Alabama, Birmingham,
AL
We compared peak to peak and mean catheterization (cath)
gradients with peak instantaneous and mean continuous
wave Doppler (CW) gradients (using the Bernoulli
equation) in 2 groups of patients: Group A-12 patients
in whom the stenotic jet (SJ) was visualized by color
Doppler (CD); Group B-24 patients evaluated by CW alone
(SJ not visualized by CD in 12 patients, CD not per-
formed in 12 patients). CW correlated better with
angiography when the SJ could be seen by CD reflecting
optimal alignment of the CW beam with the direction of
the SJ, which was often eccentric.
The CD width of the SJ at its orlgln (from R parasternal
and/or suprasternal view in 10 patients, L parasternal
long axis view in 2 patients) prOVided an independent
estimate of the severity of aortic stenosis; 4/4 patients
with SJ width <.8cm had a mean cath gradient >50mm, while
8/8 patients with SJ width>.8cm had a mean cath gradient
<50mm. We conclude: 1) CD facilitates optimal alignment
of the CW beam with the SJ resulting in improved
correlation with cath gradients; 2) CD allows the
measurement of the width of the SJ, which independently
confirms the severity of aortic stenosis; 3) CD is
limited by the fact that the SJ was visualized in only
12/24 (507.) patients.
Group A
Group B
CW instantaneous
vs cath peak-peak
r=.91, p<.OOl
r=.76, p<.OOl
CW mean vs
cath mean
r=.93, p<.OOl
r=.86, p<.OOl
DO ASYMPTOMATIC PATIENTS WITH AORTIC STENOSIS REQUIRE
VALVE REPLACEMENT SURGERY? Ih2JD.U. A.. Kli.lX. 1m, Mark L.
Smucker MD, FACC, Robert M. Rothbart MD, Robert S. Gibson
MD. University of Virginia, Charlottesville, Virginia
With the advent of continuous-wave Doppler(CWD), more
pts with asymptomatic (ASx) aortic stenosis (AS) are now
being identified. Since natural history data are scant and
retrospective, we prospectively followed 90 consecutive
pts(age 67±.17) with CWD250mmHg(range 50-134) for 1-39 mos.
Previous work by our group in 72 additional symptomatic
(Sx) AS pts(age 65±.8) verified the accuracy of CWD vs oath
(r=.92,p<.0001l. All 90 pts were followed until death or
valve replacement(AVR) and serial CWD was performed. At
entry, 51 were ASx and 39 were Sx. The groups were similar
with regard to: CWD gradient(68±.19vs68±.17); murmur grade
(3.2vs3.1l; U2 or carotid upstroke(61vs66S);LVH(86vs92J);
and subsequent AVR(10vs15S). Sx pts were older(63vs72yrs,p
=.01), had lower LVEF(63vs53,p<.001), had more ECG strain
(48vs76S,p=.01l and tLA size (63vs84S,p=.02). When all en-
try 2D echos were computer analyzed, Sx pts had greater
end-diastolic(ED) wall thickness(28vs24mm,p<.001), ED myo-
cardial area(60vs49 cm2,p=.001) and derived LV mass(522vs
404g,p=.002). At 15±.8 mos follow-up, 16 ASx pts(31S) be-
came Sx and 18 Sx pts(46S) progressed. Follow-up CWD de-
monstrated higher gradients in the initially ASx
pta who became Sx vs those who remained ASx(ACWD:23±.5vs2±.3
mmHg,p=.OOll. Only 1 ASx pt(2J) suffered cardiac death;
this was nonsudden, after CHF onset. There were 14 cardiac
deaths in the Sx group (36S,p<.001); 5 were sudden(p=.Ol).
Thus, in contrast to Sx pts, ASx pts with significant AS
by CWD and clinical criteria: l)have a good prognosis at
15mos and are at minimal risk for cardiac death; 2)serial
CWD may help identify ASx pts who are prone to symptoms;
3)ASx pts are less likely to exhibit ECG strain and have
lower LV mass which may be related to their more favorable
outcome; and 4)AVR can be deferred until symptoms develop.
ACCURATE NONINVASIVE ASSESSMENT OF AORTIC REGURGITATION
UTILIZING A DOPPLER HALFTIME INDEX
Steve M. Teague, MD, James A. Heinsimer, MD, Jerome
L. Anderson, MD, Edwin G. Olson, MD, and Udho Thadani,
MD, FACe, University of Oklahoma Health Sciences Center
and VA Hospitals, Oklahoma City and Durham, NC.
DHT correlated with AVgrad (corr coef .91) and Angio
(.83), but not with left ventricular end diastolic
pressure (-.59), pulse pressure (-.35), or ejection
fraction (.32). DHT seperated all but 3+ and 4+ Angio
grades (*p<.003), and identified 6 of 6 patients Wl th
severe regurgitation requlring urgent valve replace-
ment (DHT <.15). Doppler aortic regurgitation veloclty
halftime has clinical utility and estimates hemodynam1c
and angiographlc severity.
We utilized continuous wave Doppler ultrasound
to quantltate aortlc regurgitation utilizing a velocity
halftime method analogous to the Doppler approach
to mitral stenosis. Sixty four pat1ents with chronic
aortic regurgitation underwent catheterization to
determine angiographic grade (Angio) and aortlc valve
diastolic pressure halftime (AVgrad). Six patlents
with acute, severe regurgitation underwent valve re-
placement on the basls of clinical and echocardlo-
graphlc findings alone. Doppler halftime (DHT) was
the time reqUired for the high velocity subvalvular
diastolic proflle to decay by 30%. DHT and AVgrad
(means ± std. dev.) are compared to Angio grades:
COLOR DOPPLER ASSESSMENT OF AORTIC INSUFFICIENCY IN TWO
ORTHOGONAL PLANES
Gilbert J. Perry, M.D., Frederick Helmcke, M.D., Navin C.
Nanda, M.D., F.A.C.C., University of Alabama, Birmingham.
1/ PTS
Long Axis
JW/LVOW
4/5
1/5
4/4
6/6
10/10
1/ PTS
>607.
< 37.
57-
4-257.
26-607.
Angiograms
Grade IV-V
1-247. 6/7
25-497. 1/7
1-247. 2/7
25-497. 5/7
50-677. 5/6
687. 1/6
537. 1/11
>677. 10/11
We conclude that J size relative to LVO size just beneath
the aortic valve correlates well with AA grade. Short
axis JA/LVOA correlates better with AA than long axis
JWI LVOW, probably because the short axis view visualizes
the jet in 2 dimensions; however short axis JA/LVOA was
available in only 25/31 PTS (817.).
Grade I
Grade III
Grade II
We previously showed that regurgitant jet (J) width
(W)/LV outflow tract width (JW/LVOW) measured by color
Doppler in the parasternal long axis view correlates with
aortic angiography (AA), while length and long axis area
do not. In an attempt to improve accuracy, we compared
long axis JW/LVOW with J area (A)/LVO area (LVOA) in the
parasternal short axis view, both measured by computer-
ized planimetry immediately beneath the aortic valve. J
was seen in long axis in 31/31 and in short axis in
25/31 patients (PTS). Long axis JW/LVOW correctly pre-
dicted AA grade in 26/31 PTS (847.); 5/31 (167.) were
misclassified by 1 grade (table). Short axis JA/LVOA
correctly predicted AA in 24/25 PTS (967.); 1/25 (47.) was
incorrectly classified by 1 grade.
Short Axis
JA/LVOA
11
4+
.18+.08
.19+.07
12
3+
.26+.07*
. 28±:.06*
24
2+
.46+.09*
.48±:. 10*
23
1+
.64+.14*
.61+.13*
~umber
Angio
DHT
AVgrad
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Nuclear Cardiology: New Imaging Strategies
CARDIAC IMAGING lIND MYOCARDIAL KINETICS OF TECHNETIUM-
TERTIARY BlJI'YL-ISOOITRILE OORING DIPYRIDAMJLE INIXJCED
HYPEREMIA Robert asada, Steven Williams, Charles Boucher,
Kenneth McKusick, I:bnna Dragotakes, Jean Garneau. saint
Francis of Tulsa Medical Research Foundation, Mass. Gen.
Hosp. and New Engl. Nucl., Tulsa OK and Boston MA.
TechnetiLlll....tertiary butyl.... isonitrile (Tc-TBI) has been
shown in our laboratory to produce gamna camera images of
excellent quality in resting dog models of coronary
stenosis. However, Tc-TBI will JOOSt likely be used in con-
junction with exercise or dipyridamole vasodilation. Ac-
cordingly, 14 dogs had partial occlusion of the left an-
terior descending coronary artery (LAD) such that reactive
hyperElllia was partially to canpletely attenuated. Dipyrid-
amole was then infused IV over 4 minutes creating hyper....
EIlIic flows in the left circumflex (LCX) coronary systElll. 5
mCi of Tc-TBI was then aaninistered IV. LAD and LCX zone
regionaly myocardial Tc-TBI activities were continuously
monitored using miniature implantable radiation detectors
and gamna camera imaging over 4 hours. The electrocardio-
gram, blood pressure, distal coronary artery pressure,
sonanicrcmeter determined regional myocardial wall thick-
ness, and cardiac output were also monitored. Microsphere
determined regional myocardial blood flows demonstrated an
LAD/LCX flow ratio of .45 +/- .25 (SO) during dipyrida-
role. Despite this difference in flow, Tc clearance rates
were minimal and equal in the LAD and LCX zones (4 hr.
fractional clearance = .16 +/- .12 for LAD and .17 +/- .11
for LCX, p=ns). G<mna camera images were of excellent
quality and demonstrated the LAD defect in all dogs. In
conclusion: 1) Tc-TBI injected during dipyridamole induced
hyperElllia produces excellent gamna canera images. 2) There
is minimal washout and no redistribution into the initial
defect over time, and thus image quali ty is stable over
time. 3) These findings and the 140 keV gamna make Tc-TBI
a pranising new cardiac perfusion imaging agent.
1-123 PHENYLPENTADECANOIC ACID: ALTERATIONS IN
MYOCAROIAL DISTRIBUTION FOLLOWING EXERCISE IN
CONCENTRIC LEFT VENTRICULAR HYPERTROPHY.
Christopher L. Wolfe, M.D., James R. Corbett, M.D., Padamakar
V. Kulkarni, Ph.D., Patrick L. Kennedy, M.D., Donald E. Jansen,
M.D., and James T. Willerson, M.O., F.A.C.C., Univ of Texas
Health Sci Ctr, Dallas, TX.
Regional alterations in myocardial substrate uptake and/or
utilization have been demonstrated in hypertensive rats. To
determine if alterations in left ventricular (LV) fatty acid uptake
and/or utilization might be present in patients (pts) with LV
concentric hypertrophy (LVH), we compared rest and exercise
1-123 phenylpentadecanoic acid (IPPA) myocardial scintigraphy
in 10 hypertensive pts and 15 normal (NL) volunteers. All LVH
pts had normal coronary arteries by angiography and concentric
LVH by 2-D echocardiography. Quantitative segf!lental analysis
demonstrated heterogeneous LV IPPA activity in LVH pts
compared to NLS following exercise (23 ±8% vs 13 ±5%
difference in mean maximal segmental activity at 4 minutes,
p<O.Ol). Exercise thallium-20l (Tl-201) scintigraphy was normal
in 6 of the 7 LVH pts tested. In LVH pts there was a
significantly greater variation in mean maximal segmental
activity of IPPA as compared to Tl-20l (25±5% vs 16±6%,
p=O.013). The LV distribution of IPPA at rest was similar in LVH
patients and NLS. IPPA washout rates in LVH pts were uniform
and similar to NLS at rest and following exercise. We conclude
that: (1) compared to NLS, pts with LVH demonstrated hetero-
geneous myocardial IPPA activity following exercise but not at
rest; (2) LV washout of IPPA was uniform in LVH pts and similar
to NLS; (3) the distribution of IPPA following exercise in LVH
pts is more heterogeneous than that of Tl-201; (4) pts with LVH
may have altered myocardial uptake and/or utilization of fatty
acids following exercise.
NON-IMAGING NUCLEAR PROBE MEASUREMENT OF LEFT
VENTRICULAR VOLUME DURING RAPIDLY CHANGING LOADING
CONDITIONS: VALIDATION USING SONOMICROMETER-DETERMINED
VOLUMES IN CONSCIOUS OOGS. Peter F. Lord, D.V.M.,
Forrester A. Lee, M.D., Michael Simons, M.D., Wallace
Byrd, Harvey J. Berger, M.D., F.A.C.C., Barry L. Zaret,
M.D., F.A.C.C. Yale School of Medicine, New Haven, CT.
The nuclear probe is used frequently to assess LV
function during changing hemodynamic conditions. Few
data are available concerning the accuracy of this
technique under loading conditions which grossly alter
LV volume and geometry.
Studies were performed on four conscious dogs
instrumented with ultrasonic crystal pairs surgically
implanted along short and long axes of the LV. Nuclear
probe measures of end diastolic (ED), end systolic (ES)
volume, stroke volume (SV) and EF were compared to
sonomicrometer data in 73 matched gated (4-15) beats
digitized at 100 Hz. LV volume was changed rapidly by
occlusion of the vena cava, pulmonary artery, and/or
aorta with or without concurrent infusion of
isoproteronol, propranolol, nitroprusside, or atropine.
Probe volumes were calibrated against sonomicrometer
volumes by setting background counts to a fixed fraction
of ED counts at the beginning of each study. Background
was subsequently adjusted only for decay. Heart rate
varied from 41-207 bpm, EDV from 16-143 ml, and ESV from
7-111 mI. Excellent correlations were obtained between
sonomicrometer and probe data:
EDV ESV SV EF
slope 0.84 0.84 0.81 0.96
r 0.97 0.98 0.81 0.81
Thus, the nuclear probe can accurately track
rapidly changing LV performance under varying loading
conditions which alter LV volume and geometry.
NONINVASIVE IMAGING OF CARDIAC ALLOGRAFT REJECTION USING
INDIUM-Ill MONOCLONAL ANTIHYOSIN.
Linda J. Addonizio, M.D., Robert E. Michler, M.D., Charles
Marboe, M.D., Peter E. Esser, PhD, Lynne L. Johnson, M.D.,
F.A.C.C., David W. Seldin, M.D., Eric A. Rose, M.D.,
Welton M. Gersony, M.D., F.A.C.C., Paul J. Cannon, M.D.,
F.A.C.C., Columbia University, New York, NY.
The acute rejection of cardiac allografts is currently
diagnosed by the presence of myocyte necrosis on
endomyocardial biopsy. Indium-Ill labeled monoclonal
antimyosin Fab (In-lllmAH) binds to disrupted myocytes and
has been used to image myocardial infarction. To test
whether allograft rejection can also be detected and
quantified scintigraphically, 6 dogs that had undergone
intrathoracic heterotopic cardiac allograft
transplantation were injected with In-lllmAH while in
various stages of acute rejection. Planar and single
photon emission tomographic (SPECT) images were obtained
24 hours later. Four dogs had allografts older than 8
months and had been on chronic immunosuppression; 2 dogs
had allografts less than 2 weeks and were not
immunosuppressed. Ratios of activity (CR) comparing
heterotopic to native hearts were calculated from both
SPECT images and in vitro scans of excised and sectioned
hearts, then rejection was scored histopathologically.
In-lllmAH uptake was not visible in planar or SPECT images
of native hearts. Faint diffuse uptake was apparent in
cardiac allografts on chronic immunosuppression and
intense radioactivity was present in hearts with ECG
evidence of rejection. The heterotopic to native heart CR
in the excised hearts with rejection correlated well with
both CR in SPECT images (r-O.93, range 1.7-7.7, mean
4.7±2.9) and histopathological rejection score (r-O.97).
We conclude that imaging with In-lllmAH provides a
noninvasive method to detect the presence, location,and
severity of cardiac allograft rejection.
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MEASUREMENT OF PERCENTAGE MYOCARDIUM INFARCTED USING
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, THALLIUM-20l
AND INDIUM-Ill MONOCLONAL ANTIMYOSIN FAB
Andrew M. Keller, M.D., Lynne L. Johnson, M.D., F.A.C.C.,
Kenneth S. Lerrick, M.D., Jonathan N. Zimmerman, M.D.,
James Coromilas, M.D., F.A.C.C., David W. Seldin, M.D.,
Peter E. Esser, PhD, Paul J. Cannon, M.D., F.A.C.C.,
Columbia University, New York.
Infarct size (IS) expressed as percentage myocardium
infarcted (PMI) is clinically more useful than IS
expressed as absolute mass. We tested the hypothesis that
PMI can be measured non-invasively in vivo using single
photon emission computed tomography (SPECT) dual isotope
imaging in a dog model. Nine dogs were subjected to
balloon catheter coronary artery OCClusion followed by
injection with Indium-Ill monoclonal antimyosin Fab
(In-Ill roAM). After Indium imaging 24 hours later,
Thallium-20l (Tl-20l) was injected and the animals
reimaged. Animals were then sacrificed, their hearts
excised, weighed, and true IS measured using triphenyl
tetrazolium chloride. IS in grams was estimated from
normalized reconstructed Indium SPECT images, and
non-infarcted myocardium (NIM) in grams was estimated from
obliquely reconstructed Thallium SPECT images. A 75%
threshold iso-contour boundary was used for edge
detection. Estimated PMI was calculated by dividing
estimated IS by the sum of both estimated IS plus
estimated NIM. True PMI was calculated by dividing true IS
by true myocardial weight. Linear regression analysis
yielded the following relationship: Estimated PHI - 1.04 X
True PHI + 5.4 percent (r - 0.84, p<.Ol, standard error of
the estimate - 9.6 percent). True PMI ranged from 9.7 to
46.2 percent (mean 22.9 + 13.2 standard deviations). We
conclude that dual isotope SPECT with In-Ill roAM and
Tl-20l can accurately estimate PMI.
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Signal Averaging and Other New Techniques for
Arrhythmia Analysis
ABNORMALITIES IN THE SIGNAL AVERAGED ELECTROCARDIOGRAM IN
PATIENTS WITH VENTRICULAR TACHYCARDIA AND LEfT BUNDLE
BRANCH BLOCK
K. Elizabeth Kindwall, MD, Roxellen Auletto, RN, Rita
falcone, MS, Michael B. Simson, MD, fACC, Univ. of PA,
Phila., PA
Low amplitude, high frequency signals late in the QRS
complex correlate with the presence of ventricular tachy-
cardia (VT) in patients after myocardial infarction (MI).
Patients with left bundle branch block (LBBB) had been ex-
cluded from prior studies. We examined a population of 37
patients with LBBB using signal averaging and 25 Hz high
pass bidirectional filtering. Twenty-four had inducible
sustained VT, and thirteen had no ventricular arrhythmia.
Twenty-four had prior MI; the others had nonischemic,
dilated cardiomyopathy.
Results: QRS Amplitude (pV) Last 40 msec
Duration (msec) of filtered QRS
LBBB VT 177+26 20.9+10.4
LBBB No VT 160+18 39.6+19.6
The high frequency content in the early and midportions
of the QRS were similar in VT and no VT groups. The QRS
duration was longer in the VT group (p<.05). The LBB8-VT
group had a lower amplitude in the last 40 maec of the
filtered QRS than the LBBS-no VT group (p<.OO1). A value
of <30 pV in the late QRS complex predicted VT in the LBBB
patients with a sensitivity of 79', a specificity of 61~,
and a positive predictive accuracy of 7~. Among pstients
with MI, those with VT had a lower amplitude in the last
40 meec of the filtered QRS than those without VT
(22.2+11 vs 37.5+18.5 pV, p<.05). VT patients without
MI also had a lower amplitude in the lsst 40 msec of the
QRS (17.4+71.0 vs 46.0+19.9 pV, p<.on. We conclude:
Patients with L8BB snd-VT hsve characteristic abnormali-
ties in high frequency content late in the QRS which dis-
tingu1sh them from LBBB patients without VT.
We conclude: 1) for pts with inferior infarction and
spontaneous VT-NS, the signal-averaged ECG provides a
sensitive tool for prediction of inducible VT-S. 2) In
pts with VT-NS after anterior infarction, the signal-
averaged ECG is not helpful in predicting inducibility of
VT-C;.
THE SIGNAL-AVERAGED ECG PREDICTS RESULTS OF PROGRAMMED
STIMULATION IN PATIENTS WITH NONSUSTAINED VENTRICULAR
TACHYCARDIA AFTER INFERIOR INFARCTION Alfred E. Buxton,
M.D., FACC, Michael 8. Simson, M.D., FACC, Rlta A.
Falco~e, M.S., Francis E. Marchlinski, M.D., FACC, Mark
t. Josephson, M.D., FACC Univ of PA, Philadelphia, PA
We performed programmed stimulation and signal-averaged
ECGs in 36 consecutive patients (pts) with nonsustained
ventricular tachycardia (VT-NS) following inferior (27)
or anterior (9) myocardial infarction. Sustained (S) VT
was induced in 19 pts. pts with inferior infarction and
inducible VT-S had longer filtered (>25 Hz) QRS (132+19
vs 110+14 ms, p<.OI), and lower voltage in the last ~O ms
of the-filtered QRS (16+9 vs 29+14 ~V, p<.OI), than pts
without inducible VT-S.-Pts with anterior infarction and
inducible VT-S had shorter filtered QRS than pts without
inducible VT-S (95+10 vs 115+10 ms,p<.02), but no
significant difference in the amplitude of the last 40 ms
of the QRS (73+4 vs 34+35 ~V,p=NS). We defined an
abnormal signaT-averageil ECG as filtered QRS duration
>110 ms and amplitude of <25 ~V in the last 40 ms of
the filtered QRS. Applying these criteria to identify pts
with inferior infarction having indUCible VT-S results
in:
CAN IN VIVO QUANTITATIVE PLATELET SCINTIGRAPHY PREDICT IN
VITRO PLATELET DEPOSITION WITHIN INTRAARTERIAL THROMBI:
VALIDATION OF SINGLE AND DUAL RADIOISOTOPIC TECHNIQUES.
Jules Y. T. Lam, M.D., James H. Chesebro, M.D., F.A.C.C.,
Mrinal K. Dewanjee, Ph.D., Juan J. Badimon, Ph.D., and
Valentin Fuster, M.D., F.A.C.C., Mayo Clinic, Rochester,
HN.
lllIn-labeled platelet (0.3-0.5 mCi) scintigraphy alone
or in combination with 99mTc-labeled red blood cell (2
mCi) subtraction scintigraphy appears promising for de-
tecting platelet-thrombus formation, but the reliability
of their quantitative indices is uncertain. We have thus
validated the single and simultaneous dual isotope scin-
tigraphic technique for quantitating platelet deposition
within the thrombus formed during angioplasty (5 infla-
tions to 6 ATM, 30 seconds each, 1 min apart) of the
common carotid arteries in 12 normal pigs. The
lllIn-excess ratio (IE), an in vivo quantitative index of
platelet deposition (PD) derived from dual isotope scin-
tigraphy, as well as two reported indices derived from
sintle isotope scintigrayhy , the thrombus to blood ratio
of IIIn (TBR) and the 1 lIn counts/IOO pixel/pCi of
IllIn injected (CPP) were correlated with the absolute PO
(platelets x 106/cm2) determined in vitro. There was a
strong exponential correlation between IE and in vitro PO
(r-0.8I, p<O.OOI) and a fair correlation between both the
TBR or CPP and in vitro PO (r-0.63 p<0.03, and r-0.64
p<0.02, respectively). The standard error of the esti-
mate was 1.8, 2.2, and 2.2 platelets x 106/cm2 for IE,
CPP, and TBR respectively. Thus, both single and dual
scintigraphic techniques can be used to reliably quan-
titate the in vivo acute platelet-thrombus formation
following angioplasty, but since the correlation and
standard error of the estimate appears to be better by
dual isotope scintigraphy, it may be more reliable when
tested simultaneously in a larger population.
Abnormal
Sensitivity
Specificity
Predictive Value
QRS duration
1.00
.58
.75
Late potential
.80
.33
.60
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SIGNAL AVERAGIN:; CF HIGf GAIN IDLTER EKG REXXlRDIN:;S -
VALIDl\TION CF A NEW TEOiNIQUE FOR rerncrION CF
AFl'ER-rorENI'IALS.
George J. Kelen, M.D., RaIilael Henkin, M.S., Mark
Restivo, M.S., Robert H. zeiler, Ph.D., E'mard B. Caref,
B.S., Nabil El-Sherif, M.D., F.A.C.C., SUNY, D:Jwnstate
and VA Medical Centers, Brooklyn, New York.
Signal averaging techniques have been widely usErl to
dem::lOstrate low amplitude after-p.::>tentials in the Sf
segIlEnt as well as HIS l::undle activity on a surface EKG.
To our knowledge, there has been no previous report of
averaging successfully performed on 24 h::>ur Holter
tapes. A separate belt-worn IlDdule ¥as designed to
pre-amplify (gain XlOO) and filter (40-200Hz) the
surface EKG signal presentErl to one channel of a
conventional two ctlannel Holter reoorder. D.lring
playback at l:x>th real time and 120X real time, the
signals were pissErl to a custan designed trigger circuit
driving the same 12 bit signal averager we use for
real-time recordings and averages accumulatErl over 100
to 800 beats. In six pitients with after-potentials and
six with easily visible HIS activity on convential
real-time signal-averaging, the averagErl signals derived
fran Halter tapes oorrelatErl closely in timing,
awearance and mise level. This new technique awears
to have several advantages:- 1) Clean low noise signals
for exteOOed periods TNhilst the pitients is asleep.
2) Multiple p:ltients can be tapErl simultaneously on
separate recorders and the averaging cbne at a later
time. 3) The time requirErl to accumulate averages of
large nwnbers of beats is greatly reducOO by rapid
playback of the tape. It rE!llBins to be seen TNhether
after-potentials deIIonstratErl on Holter recordings
differ in clinical significance fran th::>se detectErl on
conventional raOOan recordings.
LOY JmX)UENCY REQUIREMENTS g REPRODUCTION (F ISCBEIIIC ST
SEGMENT ABfQUWJTIES DURING ACTIVITY IN MAN.
Gte. A. Iaperi. MD. Charles R.....bert. MD PhD.ead Carl J. Pepia••
MD. FAce. VAMC lAd Uaiversity of Florida. Ge.iJlesville.
Evaluatioa of patients "iLb silent or syaptoaatic ayocardial
itchemia often iavo....es aabulaCory elearocardioaraPhic (B:G)
_aitorinl. AlLboup aeveraJ iaV..ulllors have ...... Lbe need
for FM _Aiton wiLb Icnr frequeacy respoa :ateadial to DC (0 81)
tor relilllie reproduC11oa or ischealc ST a& abIloraaliUes....
to support Lbne reccoaendations are lactinl. The objective of Lbe
p....a& iav..ulation was to deteraiae "heUler elleaded Icnr
frequency respoa.. is a.... fOl'repl'OCluc&ioa of itchealc ST
....n& abnoraalilies. Bipolar ECG recordiols "ere JUde froa ,
aea "iLb coronary artery cIiIeue before. dunal.ead after ered
bicycle eurcile usi.ol a hip fidelity ias&naeatation aaJllifier lAd
FM cape recorder. All patieats hed itchealc ST......&
abnormalllies durinl eurcile "Jlile 3 patieJlts ezpericnced ealiaa
&ad Ul. reaaiaia. 2 reaaiaed asyapeoaaUc Lbroupout Lbe &ea.
UUI a J'Idiz 2 f..Fouriel' U'lAsfora alloriUla (m) lAd a variable
_plial raCe iato a 102. place iaput ..-ray.m spectra were
calcuJa&ed "iLb 10" frequency coatent ellendial to eiLber 0.20. 0.91.
or 1.95 81 for boLb restiIll lAd eureile ECGs. Froa Lbne spectra ECG
tncials "ere resynLbeslzecl usi.ol Lbe iaverse m lAd coapued to
Lbe oriliaal recorde. Visual ia....ctioa of Lbe oriliaalead
resynLbeslzecl ECG tnciap revealeclno obvious differences "Jlel.her
Jow frequency content eDeaded to 0.20. 0.98. or 1.95 Hz. Nuaerical
coajllrilons"ettude by calculatilll Lbe coefficieat or
deteraiaatiOIl ~) betweea Lbe oriliaallAd resyaLbesiled ECG's. p,2
(aelA!,SD) for Lbne coajllrilons was 0.9lJ8!,0.0lI1. In coaclusion Lb.
amplitude respon. characteristics ofECG recordiol equi,....t does
aot require IA eDenclecl Jow frequeacy reale such u Ula& fouad ia
FM S)'ItetDI to accuraCely reproduce itchemic ST.....at
abnonuJitJes iaduced by activity ia aaa.
DO LATE POTENTIALS PREDICT SUSTAINED VENTRICULAR
TACHYCARDIA INDEPENDENT OF LEFT VENTRIaJLAR FUNCTION IN
PATIENTS WITH CORONARY ARTERY DISEASE?
Thomas A. Buckingham, MD, Sanjay Ghosh, PhD, Robert M.
Redd, MD, Bernard R. Chaitman, MD, FACC, Linda Stevens,
RN, Harold L. Kennedy, MD, FACC, St. Louis University
Medical School, St. Louis, MO
A stepwise multiple logistic regression model was used
to analyze the relation of LP variables, age, left
ventricular score, number of disease vessels (>70%
stenosis), and presence of left ventricular aneurysm.
DLAS was shown as the only significant variable which
correlated with sustained VI. These results indicate that
late potentials correlate with sustained VI independent of
left ventricular function or extent of coronary artery
disease.
To determine if late potentials (LP) correlate with
sustained ventricular tachycardia (VI) independent of left
ventricular function, we performed cardiac catheterization
and signal averaged ECG recordings on 48 patients with
coronary artery disease (10 with documented sustained VI
and 38 without). Three criteria for LPs were used;
duration of filtered QRS > 120ms (DQ), duration of low
amplitude signal> 40ms (DLAS), and amplitude of the last
40ms of the QRS >20 uv (AL40). The diagnostic accurscy of
the three LP criteria in indicating patients with
sustained VI was:
NS
.006
.03
P VALUE
67%
80%
72%
ACCURACY
76%
86%
86%
SPECIFICITYSENSITIVITY
22%
58%
44%
chi-square)
DQ
DLAS
AL40
*(by
ACCURACY OF DETECTION OF MYOCARDIAL ISCHEMIA
BY AMPLITUDE-MODULATED AND FREQUENCY-
MODULATED HOLTER TECHNIQUES.
Thomas L. Shook. MD, C. William Balke, MD, Peter W.
Kotilainen, Andrew P. Selwyn, MD, FACC, Peter H. Stone,
MD, FACC. grigham and Women's Hospital, Harvard Medical
School, Boston, MA
Use of amplitude-modulated (AM) ambulatory ECG (AECG)
to detect myocardial ischemia has been limited by concern that
inadequate lOW-frequency response or phase shift may cause
inaccurate or artifactual ST segment recordings. To determine
the acccuracy of AM and frequency-modulated (FM) AECG
systems, we recorded the signal from the same set of two
bipolar chest 'Ieads simultaneously by standard ECG, and AM
and FM AECG recorders in 14 patients during treadmill exer-
cise (ETT) and by simultaneous AM and FM recorders in 9
patients during ambulatory outpatient activities (16 sessions).
From the ETT recordings, ST deviation, R- and S-wave
amplitude, and RR-interval were measured in 543 ECG com-
plexes. The AM system accurately reproduced ST segments as
recorded by standard ECG (range 5.0 mm ST depression to 2.0
mm ST elevation) when measured at the J-point (r=.91, p <
.00ll, and .08 seconds after the J-point (r=.95, p < .00ll. FM
recording was equally accurate when compared with the stan-
dard ECG (r=.89, .95 respectively, p < .00ll. Accuracy of the
AM and FM systems was independent of RR-interval, R- or S-
wave amplitude.
From the ambulatory sessions, the AM technique accurately
recorded the number of episodes of ST deviation-as recorded by
the FM technique (n=24 episodes), as well as the maximum
depth of ST deviation (range 0 to 3 mm ST depression, r=.90).
Both AM and FM AECGs accurately reproduce ST-segment
deviation associated with ischemia. With appropriate modern
devices, theoretical concerns about AM AECG do not appear
justified.
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Variables Affecting Revascularization
PTCA OF DISTAL CORONARY STENOSIS VIA PATENT INTERNAL
MAMMARY ARTERY GRAFTS - IMPROVED RECENT EXPERIENCE.
Lee V. Giorgi, M.D.; Geoffrey O. Hartzler, M.D., F.A.C.C.;
David R. McConahay, M.D., F.A.C.C.; Barry D. Rutherford,
M.D., F.A.C.C.; Warren L. Johnson, M.D., F.A.C.C.
Mid-America Heart Institute, St. Luke's Hospital, Kansas
City, Missouri.
Because of technical factors, PTCA of lesions distal
to lMA graft anastomosis has been limited. Of a total
experience of 4000 PTCA procedures, coronary angioplasty
through patent lMA grafts was attempted on 14 lesions in
13 pts. All pts. were male, aged 38-74 (m=S6 yrs) , with
interval from CABG to PTCA of 4 mos to 11 yrs (m=4.0 yrs).
Thirteen lesions were dilated through a left lMA graft
and one through a right lMA. Three procedures were single
lesion dilatations and 10 were multiple lesion. In 9 pts.
the lMA was cannulated with a "heat-reshaped" standard
Judkins-style right coronary guide catheter over an ex-
change wire. In the other 5, a specially-designed "LIMA"
guide was used. A standard, fixed-wire, non-steerable,
balloon catheter was used in the first 3 pts. (from 6/82-
5/83). For the subsequent 11 lesions a flexible,steerabl~
low-profile balloon was employed.
Two of the first three procedures were failures with
one complicated by lMA dissection and hematoma formation
requiring urgent CABG, but without myocardial infarction.
The subsequent 11 cases were successful (after 5/83) with-
out complications.
Of successfully dilated patients, 11 were asymptomatic
or had improved functional class at follow-up of 1-30 mos
(m=9.4 mos). One had recurrence of angina resulting from
restenosis of a previously-dilated, non-grafted interme-
diate branch.
We conclude that recent technical advances in PTCA
instrumentation have allowed successful and safe angio-
plasty of distal coronary stenoses via patent lMA grafts.
VARIABLES AFFECTING SUCCESS RATES IN ANGIOPLASTY
(PTCA) OF TOTAL OCCLUSIONS. Barry Cohen, MD, Craig
Monsen, MD, William Schwartz, MD, FACC, Robert Perdoncin,
MD, Susan Hosat, MS, Peter Rentrop, MD, FACC. The Mount
Sinai Medical Center, New York, NY 10029.
A panel of 2 angiographers, independent of the angioplasty
team, analyzed success rates in PTCA procedures involving total
occlusions. These lesions were cotegorized according to the TIMI
(Thrombolysis in Myocardial Inforction Trial) classification (T).
T(O) is complete obstruction, T(I) is an obstruction with minimal
antegrade flow incompletely filling the distal vessel. The
population consisted of 69 pts (S9 males); mean age was S8. There
were 39 nO) and 30 T(I) patients. T(O) success rate was 47% in
the first 19 pts, SI% in the subsequent 20 pts (ns). T(I) success
rate was 47% in the first 15 cases, 93% in the subsequent IS cases
(p < 0.00. T(I) had a significantly higher success rate than T(O)
during the second half of the experience (p < 0.000. Funnel-
shaped lesions had higher success rates in both groups (68% of 41
pts) than broad-based lesions (43% of 28 pts) (p < 0.05). Lesions of
less than 12 weeks estimated duration had higher success rates in
both groups (64% of 36 pts) than older lesions (29% of 14 pts)
(p < 0.05). Dissection occurred in 5 T(O) and I I T( 0 pts (p=0.06).
One dissection in each group was associated with ischemia
requiring CABG. Acute reocclusion occurred in 4 nO) pts and I
T(I) pt; it was successfully treated with repeat TCA in each case.
There was one asymptomatic side branch occlusion in each group.
Conclusions: T(I) lesions can be dilated by an experienced
operator with a >90% success rate; success rates are significantly
lower in T(O) lesions. Funnel-shape and occlusion of < 12 weeks
are associated with higher success rates in both groups. There is
a trend towards higher dissection rates in T( I) lesions and higher
reocclusion rates in T(O) lesions.
ARTERIAL BLOOD INFUSION FOR MYOCARDIAL PROTECTION
DURING PTCA
Adam D. Timmis, MD, Jonathan C. P. Crlck, D Phll,
Brian Griffin, MB, Edgar Sowton, MD, FACC.
Guy's Hospltal, London, England
Much of the potential risk of PTCA relates to severe
myocardial ischaemia during balloon inflation. We have
investigated the protective effect of infusing arterial
blood through the angioplasty catheter into the distal
coronary artery during 60 second dilatations. ECG and
echocardiographic indices of regional ischaemia were
monltored during dllatations wlth and without blood
infusion. The effect of lnfusing Hartmans solution was
also evaluated to control for washout effects. Ten
patients were studied. Dllatations without blood pro-
duced chest pain after 22.7 ~ 10.2 seconds (SD) in 7
patlents and signs of regional ischaemia in every case:
echocardiographic dyskinesia occurred within 16.0 ~ 3.2
seconds and ST segment elevation (1.9 ~ 1.3 mm) within
18.4 ~ 6.6 seconds. Blood infusion (45.6 ~ 13.4 ml/min)
dramatically reduced manifestations of ischaemla: only
one patient experienced pain and dyskinesla after 45 and
49 seconds, respectively, though ST segment elevatlon was
observed in 3 cases after 29.3 ~ 5.1 seconds. The peak
ST change, however, was only 0.8 ~ 0.3 mm. In 2 patients
severe chest pain and ST segment elevation were reversed
by infusing blood. Importantly, infusion of Hartmans
solution was unhelpful indicating that delivery of oxygen
and not washout of metabolites was responsible for the
beneficial effects of blood infuslon. These data suggest
that the development of PTCA catheter systems which
permlt blood infusion into the distal coronary artery
will improve the safety of the teChnique. Moreover, by
allowlng more prolonged periods of balloon inflation a
higher success rate can be expected.
ST-ELEVATION AS A MARKER OF PRESENCE, EXTENT AND
LOCATION OF WALL MOTION ABNORMALItiES DURING
CORONARY ANGIOPLASTY. Marc Cohen MD FACC, Steven
J. Sharpf, BA, K. Peter Rentrop, Mo, FACe, Mount Sinai Med
Ctr, New York, N.Y.
Patients (pts) with coronary artery disease undergoing
transluminal coronary angioplasty (TCA) are at risk for sudden
coronary occlusion and subsequent left ventricular dysfunction.
This study assesses the usefulness of different ECG parameters
as markers of presence, extent and location of new wall motion
abnormalities seen during angioplasty balloon inflation (INF). We
prospectively studied 20 pts with isolated LAD(n= II) or
RCA(n=9) disease and a normal baseline LV-gram. Using X-ray
transparent electrodes, a simultaneous 12-lead ECG was
recorded prior to passing the TCA balloon, and another at 30
seconds into the 4th INF cycle. Using a second arterial catheter,
an LV-gram was obtained at 40 seconds into the 4th INF. The
extent of wall motion abnormalities was described as the % of
LV perimeter showing asynergy (Asyn). During INF, 16 of the 20
pts developed new ASYN ranging from 5%-40%. 14/16 pts
developed ST elevation (STt) while only 10/16 had ST depression
(SH). Two pts with RCA lesions and new ASYN=5%, had neither
STt nor SH. ST+ in V2 was the most sensitive marker foranterior wall ASYN. SH In L-1I1 was the most sensitive marker
for inferior wall ASYN. In pts with LAD TCA, %Asyn correlated
with total number of leads (NOL) with SH, 2.5mV, r=.73,
magnitude (Mag) of SH in V, (r=.73), and ~SH in all 12 leads
(r=.62). In pts with RCA TC,Il;", %Asyn correlated with NOL with
STt, r=.77, Mag of SHin L-1I1 (r=.78), and~SHin all 12 leads
(r=.74). %Asyn did not correlate with the presence or absence of
reciprocal ST +. Conclusion: Acute ST + parallels the
development of new asynergy during TCA. The association
between ST + and the extent of asynergy may be useful in
predicting the impact of sudden coronary dissection and
occlusion on ventricular function.
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MULTIVARIATE ANALYSIS OF CLINICAL, ANGIOGRAPHIC AND
EXERCISE TL-201 VARIABLES FOR THE PREDICTION OF RECURRENT
ANGINA AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLAS-
TY (PTCA).~~ Stuckey ~, George A. Beller MD,
FACC, Robert S. Gibson MD, Denny D. Watson PhD, Christine
L. Tedesco RN, Thomas W. Nygaard MD, FACC, Lawrence R.
Burwell MD, FACC. Univ. of Virginia, Charlottesville, VA
We sought to prospectively identity which variables were
significant predictors of recurrent angina (RA) after
PTCA. Of 62 consecutive post-PTCA pts undergoing quantita-
tive exercise Tl-201 scintigraphy (Ex-Tl) at an average of
2 wks post-PTCA, 53 were asymptoma tic prior to ExTl. Of
these, 20( 38" developed RA during follow-up; 14 had re-
peat cath showing restenosis in 11(79') and distal or side
branch stenoses in 3(21'). There was no difference between
persistently asymptomatic and RA groups with respect to ,
stenosis after dilatation (21±16 vs 24±22'), post-PTCA
gradient (16±10 vs 14±-8 mmHg) or remote stenoses. Sensi-
tivity, specificity and predictive accuracy of Tl-201
redistribution (Rd) for subsequent RA were 40', 91' and
72', respectively. For exercise ST~ values were 35',73'
and 58'. By stepwise discriminant function analysis of 22
variables, Tl Rd (F=11.49; p=.0017), any ExTl abnormality
(F=10.57; p=.0025) and left circumflex disease (F=5.12;
p=.03) were the only significant univariate predictors of
RA. Age, female gender, presence of distal stenoses,
treadmill time, METs achieved, rate-pressure product and
exercise ST~ were not identified as significant. When Tl-
201 Rd was included in the model, no further variables
were shown to be predictive. Thus, despite a rather low
sensitivity, Tl-201 Rd, on early post-PTCA exercise
testing was the only significant independent predictor of
subsequent recurrent angina during the 1st year of follow-
up. Angiographic and other exercise test variables were
not predictive.
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Drugs and Coronary Artery Disease
IS THE ANCILLARY PROPERTY OF ALPHA 1 BLOCKADE OF LABETALOL
IMPORTANT?
Xavier E. Prida. M.D., Robert L. Feldman, M.D., F.A.C.C.,
James A. Hill, M.D., F.A.C.C., Carl J. Pepine, M.D.,
F.A.C.C. University of Florida, Gainesville, FL
Beta adrenergic blockers are available with various
ancillary properties. Advantages of the ancillary property
of alphal-adrenergic blockade were assessed by comparing
coronary and systemic effects of Labetalol (L, 0.5 mg/kg
IV) and Propranolol (P, 0.1 mg/kg IV) at rest and during
supine exercise before and after either P (12 patients)
or L (12 patients). At the external work load which
evoked angina before beta blockade, both beta blockers
usually prevented recurrence of exercise evoked angina
(P 8 of 12, L 8 of 12). No adverse effects occurred with
either P or L.
PERCENT CHANGE FROM BEFORE TO AFTER DRUG
At rest, L consistently decreased AoP and SVR, was more
likely to preserve coronary flow and produced less
bradycardia than P. The relationship between CO and
LVEDP was improved at rest and during exercise by L but
not by P.
ThUS, the combination of alpha1 blockade and nonselect-
ive beta blockade (i.e. L) offers potential hemodynamic
advantages as compared to nonselective beta blockade alone
(i.e. P).
EFFECT OF HUMAN CORONARY OCCLUSION ON THROMBOXANE A2 AND
LEUKOTRIENE C4 RELEASE
Jawahar L. Mehta, M.D., F.A.C.C., Robert L. Feldman, M.D.,
F.A.C.C., Robert G. Macdonald, M.D., Gordon Letts, Ph.D.,
University of Florida, Gainesville, FL., and Merck-Frost,
Dorval, Canada.
Release of coronary spasmogens and thrombogenic stimuli
such as thromboxane A2(TxA2) and leukotriene C4(LTC4) dur-
ing PTCA may contribute to acute coronary occlusion or
during follow-up to restenosis. To determine potential
contribution of TxA2 and LTC4, we measured pulmonary
artery(PA) and great cardiac vein(GCV) TxB2 (stable meta-
bolite of TxA2) and LTC4 (both by specific radioimmuno-
assay) in 5 patients undergoing LAD PTCA. Paired plasma
samples were collected before, during and 30 sec after
balloon occlusion. Patients were pretreated only with
aspirin.
During balloon inflation each patient had angina and ST
shifts and GCV flow values decreased an average of 39% at
the site adjacent to GCV blood sampling. PA plasma TxB2
remained unchanged (I, SO pg/ml) but GCV plasma TxB2 levels
increased from (50 pg/ml prior to balloon inflation to
132+44 pg/ml (mean + SD, P {.05) during balloon occlusion
and-to 174+52 pg/ml-during reperfusion. LTC4 levels in GCV
plasma were in the normal range (0.60±O.20 ng/ml;peripher-
al enous plasma from normal subjects 1.0+0.1 ng/ml) and
were unchanged during balloon occlusion (0.75+0.26 ng/ml)
or during reperfusion (0.58+0.20 ng/ml). PA plasma LTC4
levels were also unaffected-by LAD occlusion.
In conclusion, LTC4 levels (PA and GCV) in CAD patients
are similar to values in clinically healthy subjects, and
do not change during acute coronary occlusion or reper-
fusion. In contrast, even in aspirin-treated patients,
coronary venous TxB2 levels increase during coronary
occlusion. Vascular TxA2 release occurs during PTCA.
5 (2.9')*
8 (4.7t)
4 (2.U)
36 (20.9') **
5 (2.9')*
7 (4. It)
Repeat CABG
(n-172)
PTCA
.i!!:.illl.
o
2 (1.4')
o
5 (3.5')
o
bleeding
Death
Q-wave HI
Stroke
Arrhythmias
Infection
Reexploration for
Emergency CABG 2 (1.U)
* p<0.05, ** p<O.OOl
Conclusion: In selected pts with post-CABG progression
of native vessel disease or graft stenosis, Pl'CA may
offer a safer alternative to repeat bypass surgery if
the coronary anatomy is suitable.
CC»IPARISON OF COMPLICATIONS IN PATIENTS WITH PRIOR
CORONARY BYPASS GRAFT SURGERY UNDERGOING All;IOPLASTY OR
REPEAT BYPASS SURGERY
Pierre Abi-Mansour, 11), Gary Gershony, MD, Gary Roubin,
MB, P1iD, Bills Jones, MD, Andreas Grusntzig, MD, FACC.
Emory University School of Medicine, Atlanta, Georgia.
We retrospectively analyZed the in-hospital complica-
tions in 316 consecutive patients (pts) who had initial
coronary bypass graft surgery (CABG) at Emory Hospital
and later required additional myocardial revasculariza-
tion. Between January 1980 and August 1985, Pl'CA was
performed in 144 pts with suitable anatomy and repeat
CABG in 172 pts. In 69 pts (48'), PrCA was performed on
stenosed grafts.
The PTCA and repeat CABG pts had caaparable clinical
profiles: mean age (56 years), men (81'), diabetes (22'
vs 23'), hypertension (45' vs 39'), heart failure (11'
vs 12'), unstable angina (44' vs 49'). The repeat CABG
patients had higher incidence of multivessel disease
(88' vs 78'), and complex coronary anatomy including
high risk graft stenoses not suitable for dilatation.
The incidence of procedure related caaplications in the
2 groups are tabulated below:
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Thus, an increased incidence of ICT clearing was observed
in patients who received heparin. These findings support
use of therapeutic heparinization in UIS patients.
EFFECT OF HEPARIN ON INTRACORONARY THROMBI IN UNSTABLE
ISCHEMIC SYNDROMES.
Daniel Hartman,B.A., Nelson M. Wolf,M.D.,F.A.C.C., Jay A.
Shechter, M.D., Alexis B. Sokil,M.D., Gaetano Capone,
M.D., Steven G. Meister, M.D.,F.A.C.C .. Medical College
of Pennsylvania, Philadelphia, Pennsylvania.
ICT
Disappeared
5
o
Occluded
2
7
Heparin pts.
Controls
Intracoronary thrombi (ICT) are common in patients with
unstable ischemic syndromes (UIS), i.e., unstable angina
and non Q wave myocardial infarction (MI). Heparin has
been reported to reduce the incidence of progression to
transmural MI in such patients. To determine whether
heparin promotes lysis of ICT, we reviewed angiograms of
14 UIS patients who received a course of heparin prior
to a second angiogram and 13 non-randomized control UIS
patients who did not receive heparin. All had ICT on
initial angiograms. Second angiograms were usually
performed for angioplasty. The interval between first
and second angiograms was 22.6+5.1 days for heparin
patients and 18.1+5.0 days for-controls (paNS), Angio-
grams were examined by two blinded observers or a third
in case of disagreement. Patients were considered
improved if ICT disappeared or were reduced in size and
unimproved if ICT were unchanged or became larger or if
the associated stenosis progressed to total occlusion.
Ten of 14 heparin patients improved in contrast to 0 of
14 controls (p<O.OOOl), as detailed below:
ICT ICT
Larger No II Smaller
025
2 4 0
DISPARATE EFFECTS OF NICARDIPINE ON EXERCISE AND PACING
INDUCED ISCHEMIA
Charles R. Lambert. M.D" Ph.D, James A. Hill, M.D.,
FACC, and Carl J. Pepine, M.D., FACC, University of
Florida, Gainesville, FL
To further define the anti-ischemic effects of nicar-
dipine, a new dihydropyridine calcium antagonist,
systemic and coronary hemodynamics were investigated in
17 coronary artery disease patients (pts). Heart rate
(HR),systolic pressure (SP), coronary sinus flow (CSF),
and myocardial oxygen consumption (MVOZ) were measured
before and during pacing or exercise induced angina.
Studies were repeated during nicardipine (Z mg bolus
followed by continuous IV infusion titrated to reduce
SP 10 mmHg). A similar decline in SP was achieved in
pts undergoing both forms of stress. Exercise-induced
angina, however, which occurred in each pt before
nicardipine, was prevented in 8 of 10 pts at the same
level of exercise stress after nicardipine. During
exercise, nicardipine reduced the rise in SP (-9.4%,
P (0.05) and permitted increased exercise before angina
associated with increases in CSF (ZO%, p <: 0.05), HR
(14%) and MVOZ (10%). Angina was not prevented by
nicardipine during pacing stress to the same HR,
despite a reduction in SP (-9.7%) and MVOZ (-17%, both
p <0.05) • These data suggest that nicardipine has very
complex coronary and systemic hemodynamic effects. With
exercise, nicardipine induces systemic and coronary
vasodilation which reduces SP and decreases 0z demand,
thus delaying angina and allowing higher CSF. However,
during pacing, nicardipine induces vasodilation which
reduces SP similarly but does not prevent angina. This
suggests that nicardipine influences other factors
important in exercise-induced angina, but not
operative in pacing induced angina.
CAN INTRACORONARY THROMBOLYSIS PREVENT FREE WALL RUPTURE
OF ACUTE MYOCARDIAL INFARCTION?
Masakiyo Nobuyoshi, M.D., F.A.C.C., Hideyuki Nosaka, M.D.,
Hitoshi Yasumoto, M.D., Kokura Memorial Hospital,
Kitakyushu, 802, Japan
To evaluate the influence of intracoronary thrombolysis
on the incidence of ventricular free wall rupture compli-
cating acute myocardial infarction (AMI), 490 patients
(pts) were analyzed; Group A pts (nz 300) underwent intra-
coronary thrombolysis, and Group B pts (n=190) did not.
Free wall rupture occurred in 11 of Group A pts (11/300 z
3.3% : 9/156 with anterior AMI and Z/144 with inferior
AMI), and 13 of Group B pts (13/190 z 6.2% : 9/119 with
anterior AMI and 4/71 with inferior AMI). The mean
interval from the onset of ischemic pain to the rupture
event was 14 ± 11 hours (mean ± SD) for Group A, and
79 ± 63 hours for Group B pts (p <0.05). The 156 pts
of Group A with anterior AMI on whom coronary angiography
was available, were subdivided into 2 subsets according
to the presence or absence of collaterals. No rupture
was observed in pts (nz 37) with evidence of collaterals.
Out of 114 pts with no collaterals, intracoronary throm-
bolysis was successful in restoring sufficient antegrade
flow in 46 pts, and unsuccessful in the remaining 68 pts.
Free wall rupture occurred in 8/68 (11.8%) pts with no
restoration of flow, and in only 1/46 (2.2%) pts with
successful intracoronary thrombolysis (p< 0.1).
Thus, a) successful intracoronary thrombolysis decreases
the incidence of free wall rupture in AMI, but b) free
wall rupture, if it does occur, occurs significantly
earlier in pts subjected to intracoronary thrombolysis.
CORONARY MORPHOLOGY FOLLOWING STREPTOKINASE IN
MYOCARDIAL INFARCTION AND UNSTABLE ANGINA. A
CLUE TO PATHOGENESIS. John A. Ambrose MD,FACC, Craig
Monsen MD, Stephen Winters MD, Rohit Arora MD, K. Peter
Rentrop MD, FACC, Deborah Rudin BS, Susan Maratea BS, Jacob
Haft MD, FACC, Richard Gorlin MD, FACC, Valentin Fuster
MD, FACC. Mt. Sinai Hospital, NY, NY.
We have shown that eccentric stenoses with overhanging
edges and/or irregular borders (E2) are seen in 2/3's of patientswith either unstable angina or infarction (AMI) and < 100%
occluded ischemia related vessels but rarely in stable angina.
Plaque disruption and thrombus seen pathologically in AMI may
explain this morphology. To further study E2, 37 patients withAMI or unstable angina received intra-coronary streptokinase
(SK). Gr.1 had 17 with AMI and 100% occluded vessels
recanalized with SK. Gr.1I had 10 with AMI and < 100% infarct
vessels pre SK, All were studied acutely « 12 hrs. after AMI) and
17 in Gr.1 and 6 of 10 in Gr.1I were restudied chronically 0-10
wks.) Gr.1I1 had 10 with unstable angina and < 100% occluded
ischemia vessels pre SK and 6 of 10 were restudied.
ACUTE CHRONIC
Gr(numberl rrm- lIe 10) III( 10) 1(17) 11(6) 111(6)
< 100% ~.2 (post SK) 10 7 8 I 4 3
< 100% NOn-E2 7 3 2 4 2 2100% Stenosis 0 0 0 6 0 I
< 50% Stenosis 0 0 0 6 0 0
Following SK, 10 of 17 lesions >50 < 100% in Gr.1 were E
versus 15 of 20 in combined Gr.1I and III (p=ns). No lesion in Gf.
II or III changed morphology acutely with SK. Chronically, I of
17 remained E, in Gr. I versus 7 of 12 in Gr.1I and III (p < .01).
This change was independent of SK dose and heparinization.
Thus, thrombus superimposed on plaque rupture may explain the
changing morphology in AMI and recanalized 100% vessels.
Plaque disruption with or without a minor thrombus may account
for the more stable morphology in initially < 100% occluded
ischemia related vessels in AMI or unstable angina.
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Clinical Effects of Local Anesthetic Antiarrhythmic
Drugs
S'l'EREOSELECl'IVE PHABMAroKINm'!CS AND PHAlMl\COOYNMITCS OF
DISOPYRllMIDE IN MAN.
John J. Lima, Phann D, Harisios Boudoulas, M.D.,;F.A.C.C.
Ohio State University University, Col\lllll:xls, Ohio.
Adverse effects on left ventricular (LV) function of
disopyramide could be minimized by exploiting the
stereoselective properties of the drug. To test this
thesis in 5 healthy males, we raroanly infused 100 JTg of
S(+) and R(-) disopyramide intravenously over 20 minutes
on tw::> occasions separated by one week. Heart rate,
corrected electrical systole (Ql'I), pre-ejection period
(PEPI), LV ejection tine (LVETI), PEP/LVF:r and plasma
concentrations (PC) were reasured before, during and for 5
hours post infusion. The serum protein bWing of S (+)
disopyramide was higher than that of the R(-) enantiarer
at similar unbound concentrations. The unbound clearance
of S (+) disopyramide was higher and its half-life shorter
as eatp:lred to the R(-) enantiarer (604 ml/min vs 401
ml/min and 3.67 vs 4.62 hours respectively). The unbound
renal clearance of S(+) and R(-) disopyramide averaged 338
and 182 ml/min respectively. Maximal changes (~) are
sharln. *p<0.05 between S(+) and R(-).
~arI M'EPI ~LVF:rI 6PEP/LVF:r
S(+) 56+4* 22+5* 2+2* .06±.02*
R(-) 9t2 40±7 -26±5 •17±3
Responses were fitted to the Hill equation; differences in
response were not due to differences in unbound plasma
concentration. Different effect on arI, PEPI, LVF:rI and
PEP/LVF:r by S (+) and R(-) enantianers of disopyramide
suggest different electrotnysiologic effect (arI) and
different effect on LV performance (PEPI, LVETI, PEP/
LVF:r). Thus the phannaookinetics and pharmacodynamics of
S(+) and R(-) of disopyramide are stereoselective.
IMPACf OF VENTRICULAR DYSFUNCfION 00 RESULTS OF
FLECAINIDE THERAPY FOR VENTRICULAR TACHYCARDIA
AIl~~lQ ~ D~faQla ... MaD..., Sheila Senior, R.N.,
Joel Morganroth, M.D., F.A.C.C., Scott R.
Spielman, M.D., F.A.C.C., Allan M. Greenspan,
M.D., F.A.C.C., Leonard N. Horowi tz, M.D.,
F.A.C.C., Likoff Cardiovascular Institute,
Philadelphia, PA.
To evaluate the clinical impact of flecainide's
(FLEC) negative inotropic potential, we studied
87 patients (pts) with sustained (43 pts) and
nonsustained (44 pts) ventricular tachycardia
(VT). All'pts had baseline radionuclide left
ventricular ejection fraction (EF) measured off
antiarrhythmic drugs and heart failure (CHF)
optimally managed before FLEC. FLEC was orally
titrated from 100 mg bid in 50 mg increments at
4 day intervals in hospital. The mean dose was
150 mg bid and mean plasma level was 720 ng/ml.
Before FLEC, compensated CHF (CHF-old) was
present in 26 pts (8 pts with EF>30, 18 pts with
EF~30). On FLEC, 0/49 pts wi th EF>30 had new or
worsened CHF. New or worsened CHF occurred in
8/38 pts with EF~30, 7 with CHF-old and 1
without CHF-old. During FLEC, 6/8 pts with
Class III CHF (all had EF~30) had worsening of
CHF and 4 died. Clinical efficacy and tolerance
of FLEC at 6 mos of therapy was 57% (28/49) in
pts wi th EF>30 and 21% (8/38) in pts wi th EH30
(p<0.05). We conclude that: 1) CHF can occur
during FLEe therapy particularly in pts with
CHF-old and EF~30 and may particularly limit
therapy in pts with severe CHF; 2) clinical
efficacy and tolerance of FLEC is significantly
lower in pts with EF~30.
COMBINATION OF PROCAINAMIDE AND ATRIAL PACING
FOR SUCCESSFUL CONVERSION OF ATRIAL FLUTTER TO
SINUS RHYTHM
Brian Olshansky, M.D., Ken Okumura, M.n. Richard W.
Henthorn, M.D., F.A.e.e., Andrew E. Epstein, M.D., F.A.e.c.,
Vance J. Plumb, M.D., F.A.e.e., Albert L. Waldo, M.D., F.A.e.e.,
University of Alabama at Birmingham, Birmingham, Alabama.
Rapid atrial pacing is a useful technique to terminate atrial
flutter. However, in many patients, interruption of atrial flutter
by this method results in atrial fibrillation. We studied 9
patients who had atrial flutter with a mean cycle length of
2113!:30 ms in whom rapid atrial pacing was performed during
atrial flutter from I site (high RA) in 2 patients, 2 sites (high
RA, coronary sinus) in 3 patients, and 3 sites (high RA, coronary
sinus, low RA) in II patients. Pacing for at least 15 sec was
initiated at a cycle length 10 ms less than the atrial flutter cycle
length from each site. After termination of rapid atrial pacing,
if atrial flutter persisted, rapid atrial pacing was repeated,
decreasing the cycle length in steps until reaching a cycle length
of 160 ms. If atrial flutter continued, then a second, and, if
necessary, a third site was paced. In all patients, atrial flutter
was initially entrained by rapid atrial pacing. Then rapid atrial
pacing at faster rates resulted in conversion to sinus rhythm in 2
patients, sustained atrial fibrillation in 1 pt, and transient atrial
fibrillation with resumption of atrial flutter in the other 6
patients. Intravenous procainamide was given to these later 6
patients 0000 mg to II patients and 500 mg to 2 patients)
increasing their mean atrial flutter cycle length from 250±28 to
311i±113 ms. Then, using the same rapid atrial pacing protocol,
high RA pacing at an average cycle length of 235±65 ms
interrupted atrial flutter, successfully converting the rhythm to
sinus in all patients without induction of atrial fibrillation. Thus,
intravenous procainamide augments the efficacy of rapid atrial
pacing used to convert stable atrial flutter to sinus rhythm in
patients.
eOMBINAnON OF LOW DOSE QUINIDINE AND ToeAINIDE IN
THE TREATMENT OF VENTRICULAR ARRHYTHMIAS IN MAN.
Jean To Barbey, MD, Katherine A. Thompson, MD, Debra S. Echt,
MD, FACC, Raymond L. Woosley, MD, PhD, Dan M. Roden, MD,
FACe. Vanderbilt University, Nashville, TN.
Selected antiarrhythmic combinations are beneficial in the
treatment of patients with ventricular arrhythmias (VA). We
evaluated tocainide (T) and quinidine (Q) singly and in combination
In III patients (age 601:.9 years), all with chronic VA (5081:.627
VEDs/hr X±SD), and 12/111 with runs of nonsustained ventricular
tachycardia (vT) 0-1712/211 hrs). After 2 days of placebo (PL),
therapy was administered in II consecutive 3 day phases: T 1200
mg/day; followed by titration to 1800 or 600 mg/day based on
arrhythmia control and side effects; addition of Q gluconate 9n
mg/day to the titrated dose of T; Q alone. Three patients could
not complete the study because of intolerable side effects (2 Q, I
T). VA were considered suppressed if reduced in frequency by
)70% and VT reduced by )90%.
PL T600 Tl200 Tl800 .Q B:..Q
VA Suppression 0fT1 013 37TT"3T8 3TI I 67TI
Side Effects 0/11 0/3 3/11 3/8 1/11 2/11
QTc (msecl 111191:.112 II 29!.2 II 1196.:!:37* 1179+311*
* Different from PL and Tl200 (p<.05, 2 way ANOVA)
Two patients were discharged on single therapy (IQ, IT), six on
T+Q and three on T+dose-adjusted Q. Of the nine discharged on
T+Q combinations, two later required reduction of T dosage due
to side effects. (Follow-up = 7.:!:3 months.)
Conclusions: QUinidine and tocainide were comparably
effective agents although dose related side effects were more
frequent with tocainide. Adding quinidine to tocainide decreased
toxici ty and enhanced tocainide's efficacy. While the two drugs
exerted additive antiarrhythmic actions, they produced
antagonistic effects on repolarization. This suggests that the
combination may be clinically useful and exerts pharmacologic
actions unlike those of either single agent.
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COMBINED MEXILETINE/CLASS lA TREATMENT OF REFRACTORY VEN-
TRICULAR ARRHYTHMIAS - LONG-TERM RESULTS.
Brian McGovern, M.B., Eric N. Whitford, M.B., Mark H.
Schoenfeld, M.D., Hasan Garan, M.D., Mary McElroy, Jeremy
N. Ruskin, M.D., F.A.C.C. Massachusetts General Hospital,
Boston, Massachusetts
It has been demonstrated that a combination of mexiletine
(M) and a class lA antiarrhythmic drug (AAD) may suppress
ventricular tachycardia during serial electrophysiologic
studies in approximately 30% of patients (pts) with ventri-
cular tachycardia refractory to Class lA AAD and Malone.
The long-term efficacy and tolerance to such a regimen is
unknown however. We evaluated combination AAD therapy in
106 pts. Twenty-nine pts had prior cardiac arrest, 46 pts
had spontaneous sustained ventricular tachycardia and 31
pts had symptomatic nonsustained ventricular tachycardia or
syncope. The mean ejection fraction was 32+15%. Ventri-
cular tachycardia was induced by programmed-cardiac stimu-
lation (PCS) in all pts in the absence of AAD. Spontaneous
or PCS-induced ventricular tachycardia occurred in all pts
during treatment with Class lA AAD and with M alone. Com-
bination of lA AAD and M suppressed ventricular tachycardia
in 32/106 pts (30%). Sixty-five pts were discharged on com-
bination AAD and followed from 1-6 years. Fourteen/65 pts
(22%) have suffered recurrent ventricular tachycardia or
died suddenly. Actuarial freedom from recurrent ventricu-
lar tachycardia is 86% at 1 year, and 72% at 5 years. In 11
of 65 pts (17%) one or both drugs had to be discontinued
because of adverse effects. We conclude that in patients
with inducible ventricular tachycardia refractory to Class
lA AAD and M alone, a combination of lA AAD plus M, l)sup-
presses ventricular tachycardia in 30% of pts 2) provides
effective long-term prophylaxis against recurrent ventri-
cular tachycardia, and 3) is limited by intolerable side
effects from either drug in 17% of pts.
Tuesday, March 11, 1986
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Amiodarone
EFFECTS OF AMIODARONE ON SYMPATHETIC AND PARASYMPATHETIC
CONTROL OF HEART RATE IN MAN.
James J. Heger, MD, FACC, Michael Moran, MS, Eric N.
Prystowsky, MD, FACC. Krannert Institute of Cardiology,
Indiana Univ. Sch. of Medicine, Indianapolis, IN.
Amiodarone (AM) slows sinus heart rate (HR) in man and
produces noncompetitive adrenergic inhibition experimen-
tally. Since the autonomic actions of AM may influence its
antiarrhythmic efficacy, we examined the effect of AM on
sympathetic and parasympathetic control of HR in 7 men,
aged 45 to 65 yrs, treated with AM for control of ventric-
ular (5) or supraventricular (2) tachycardia. Five patients
(pts) had ischemic heart disease and 2 pts had no apparent
disease: all were normotensive, euthyroid and received no
other drugs. Autonomic testing was performed at control
(C) and after 1 week of AM, 1600 mg/day. Parameters meas-
ured were: isoproterenol dose by iv bolus required to in-
crease HR 25/min (CD25) in 7 pts, HR response to 0.15 mg/
kg iv propranolol (P) and 0.03 mg/kg iv atropine (A) in 6
pts, and carotid baroreflex increase in sinus cycle length
(SCL) due to neck collar suction (NCS) of -60 mmHg for 600
msec applied at 40 msec increments through the cardiac
cycle in 5 pts. CD25 increased from 2.68+2.39 at C to 8.90
±10.93 following AM (p<.05). From C to AM the HR at rest,
63±7 to 58±4, following P, 57±7 to 51±3, and after P an:! A,
75±7 to 61±7, were all significantly lower (p<.OI). The HR
decrease after P was similar at C, 7+3 and after AM, 7+2,
as was the increase in HR after A, 18+10 and 10+5, respec-
tively. Changes in CD25 did not correlate with response to
P or P and A. In 2 of 5 pts AM attenuated the maximal SCL
increase produced by NCS by 40 and 50 msec each while 3pts
had ~20 msec change. We conclude that amiodarone signifi-
cantly inhibits the chronotropic response to beta-adrener-
gic stimulation and decreases intrinsic HR, but minimally
alters resting vagal and adrenergic effects on HR or re-
flex vagal slowing of HR.
ELECTROPHYSIOLOGIC PREDICTORS OF LONG TERM OUTCOME WITH
AMIODARONE FOR REFRACTORY VENTRICULAR TACHYCARDIA.
Charles I.Haffajee,MB,MRCP,FACC, Robert L.Gold,MD,
Yoshizumi Yazaki,MD,Kathy Sloan,RN,Joseph S.A1pert,MD,
FACC. Univ.Mass.Medical Center,Worcester,MA.
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Fifty-six patients(pts) with symptomatic and inducible
ventricular tachycardia(VT) refractory to conventional
antiarrhythmic agents had programmed ventricular stimula-
tion(PVS) before and after >4 weeks of high dose oral
amiodarone.A1l 56 pts were maintained on oral amiodarone
(mean 360mg/day) during a mean followup of 22.5 months
(Range 2-45 months).
Results:VT was suppressed in 9 of 56 pts(16%)on amio-
darone(Group A).Of the 47 pts whose VT remained inducible
on amiodarone, 23 pts(51%)had > 25% slowing of VT rate or
conversion to nonsustained VT during PVS(Group B)whereas
the remaining 24 pts(Group C) had no change in VT rate or
had VT exacerbation during PVS.The outcome of all 56pts
during followup is shown below:
# of pts Pts with
VT recurrence
Group A 9 0
Group B 23 3
Group C 24 13
Statistical analysis reveals that Group C
icantly from Group A and Group B(p(.05).
Conclusions:l)VT remains inducible on amiodarone in
most pts(84%) with refractory symptomatic VT.2)VT sup-
pression by amiodarone during PVS results in good long
term prognosis.3)Pts whose VT remains inducible on
amiodarone appear to form 2 groups;those with VT slowing
or conversion to nonsustained VT generally do well
whereas those in whom the VT rate is unchanged or
exacerbated have a poor prognosis.
EFFICACY OF INTRAVENOUS PROPAFENONE IN PATIENTS WITH
W-P-W-SYNDROME
Paul L. Ludmer, M.D., Elliott M. Antman, M.D., FACC,
Peter L. Friedman, M.D., Ph.D. Brigham and Women's
Hospital, Harvard Medical School, Boston, MA.
Intravenous (I.V.) propafenone (P) was studied in 11
patients (pts) with W-P-W syndrome in a double-blind
placebo-controlled trial. Atrial (A), ventricular (V)
and accessory pathway (AP) effective and functional
refractory periods (ERP, FRP in ms.) were measured in
all pts before P. Control characteristics during
circus-movement tachycardia (CMT) and peak V rate (VR)
during atrial flutter or fibrillation (AF) were de-
termined. All parameters were measured again after
placebo and after P 2 mg/kg. Placebo had no effect on
A, Vor AP ERP or FRP, and never caused termination of
CMT or slowed the VR durin9 AF. P lengthened A-ERP
(220±20 to 275±20), A-FRP (278±18 to 315±11), V-ERP
(240±10 to 262±9), antegrade AP-ERP (298±35 to 525±82)
and retrograde AP-ERP (255±28 to 496±66) (p<.05). P
promptly terminated CMT in 10/11 pts due to retrograde
block in the AP in 8/10 and antegrade block in the A-V
node in 2 pts. After P, sustained CMT was not inducible
in 10/11 pts. After P, peak VR during AF was much
slower (231 beats/min to 145 beats/min p< .05). Peak VR
never increased. In 6 pts P caused spontaneous termina-
tion of AF.
We conclude: I.V. P is a safe, rapidly acting agent
that effectively terminates CMT and slows VR during AF
in pts with W-P-W syndrome.
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AMIODARONE PLASMA CONCENTRATIONS: RELATIONSHIP TO ELECTRO-
PHYSIOLOGIC EFFECTS, EFFICACY AND TOXICITY. .tl.uk J...
Greenberg MD., Bruoe B. Lerman MD, Traoey Cook, James R.
Shipe PhD, John P. DiMaroo MD, PhD, FACC. University of
Virginia Medioal Center, Charlottesville, Virginia.
The value of monitoring amiodarone plasma oonoentrations
is unolear. Forty consecutive patients with coronary
disease and sustained ventricular taohyarrhythmias (VT)
underwent eleotrophysiologio studies 29±15 days after
initiation of therapy. There was no correlation (r<0.5)
between amiodarone (1.39±1.16 J18/ml) and desethylamioda-
rone levels (0.84±o.27 Ilg/ml) and ohanges in sinus cyole
length, QTo, ventrioular effeotive refraotory period, AH
and HV intervals, and VT cycle length. Neither higher drug
levels nor more pronounoed electrophysiologic effeots
identified the 9 patients whose arrhythmias were no longer
inducible by programmed stimulation. The relationships
between amiodarone plasma oonoentrations and toxicity and
efficacy were propseotively assessed in a cohort of 113
patients treated with amiodarone (354±105 mg/day) for 9 ±8
months. Excluding patients with common but minor side
effeots (e.g., oorneal deposits and photosensitivity), 50
patients (44" had adverse effeots. Asymptomatic liver
enzyme elevations and subclinioal hypothyroidism were the
adverse effects most frequently seen. Neither amiodarone
(1.77±.1.03 J18/ml) nor desethylamioadrone plasma conoentra-
tions (1.38±0.55 Ilg/ml) during ohronio therapy were re-
lated to any adverse effeots exoept elevated liver en-
zymes. Amiodarone plasma concentrations and dosage also
did not differ between effeotively (81%) and ineffectively
(19" treated patients.
We conclude that moni toring amiodarone and desethyl-
amiodarone levels is not helpful for assessing eleotro-
physiologio effeots or antiarrhythmio effioaoy and is of
limited value in predioting clinically signifioant
toxioity.
FAvawn.E ~IS OF AMI~ 'IBEATED PATllNl'S WITH
NCIUNIXX:IBLE vmmuaJLAR 'l'Jl.OM:ARDIA
Marilyn D. E:zrL M.D., mad N. Murabit, M.D., Jerry L.
Jones, Pablo Denes, M.D., F.A.C.C., Rush-Presbyterian-St.
Luke I s Medical Center, Chicago, IL.
The utility of prograJ'llled ventricular stimulation
(PVS) in patients (pts) with sustainErl ventricular
tachycardia (VT) treatErl with amicxlarone (Am) is
contrOlTersial. Forty-seven patients (nean age 61), 14
with sudden death (SOl and 33 with VT, \Ere studied by
PVS during control and 2 weeks after oral Am (1400 ng.
loading qd. x 7 d., then 400-600 ng. qd. for 7 d.). They
were classifiErl clinically by NYHA class and ejection
fraction (nean 32.2%). Electrophysiologic paraneters
(EP) analyzErl included sinus nerle function, AV ncxlal
function, AR, HIT, ventricular refractory perierl (VRP),
mode of induction of VT <INa), VT cycle ler¥Jth (CL),
change in VRP, change in IND, change in VT-<L. Follow-up
was 1-40 lID. (rean 12.7 lID.). Fourteen of the 47 pts
(30%) had recurrent VT (nean 9.2 lID.), and 9 (19%) had SO
(nean 11.5 lID.). D.lring the post-Am PVS, 37 pts remainErl
inducible (79%) and 10 \Ere noninducible (21%).
Seventeen of the 37 inducible pts diErl (46%); 8 fran SO,
7 fran other cardiac causes, and 2 fran noncardiac
causes. Thirteen of the 37 (35%) had recurrent VT. Q1e
of 10 noninducible pts (10%) diErl suddenly and 1 (10%)
had recurrent vr. By Prcbable Hazards Multiple
Ra:Jression Analysis, there \Ere no clinical or EP
variables of statistical significance in prErliction of
outcane. Ibwever, 8 of 10 noninducible pts are alive
witoout recurrent VT or SO. ~ concll.rle that
noninducibility porterxls the IlDSt favorable prognosis in
VT pts treatErl with Am.
COMBINED EffECTS Of AMIODARONE AND PROCAINAMIDE IN
PATIENTS WITH VENTRICULAR TACHYCARDIA
francis E. Marchllnski, MD, fACC, Alfred E. Buxton, MD,
fACC, Belinda flores, MSN, Darlene Pembrook-Rogers, Mark
E. Josephson, MD, FACC, Univ. of PA, Phila., PA
Most ventricular tachycardia (VT) remains inducible
after amiodarone (A) or procainamide (P). To evaluate the
combined effects of A and P, 30 patients with VT underwent
programmed stimulation in the control state, after P-15
mg/kg with level 9.0+28 Ilg/ml, on day 14+3 of A alone,
1400 mg/day x 7 days-then 400 mg/day and-after A with P-15
mg/kg wlth level 7.7+2.7 Ilg/ml. All VT was inducible af-
ter A alone and P alone. Results expressed as a change (6)
from control study: mean+SD; 6 VT MORPHOLOGY=different or
additional vr morphology-
CET(%)2
57*
76
63
78
23*
70
63
sudden death
57* 66*
88 19
83 26
1 clinical arrhythmia or
death or toxicity
(102 pt)
( 47 pt)
( 55 pt)
( 94 pt)
( 21 pt)
(128 pt)
(149 pt)All pt
* p < 0,05
2 no recurrence,
EF ~ 30
EF > 30
CHF-on
NO CHF-on
CHF-old
NO CHF-old
EFFICACY AND TOLERANCE OF AMIODARONE: SPECIAL REFERENCE
TO CONGESTIVE HEART FAILURE
Angelo A.V. DePaola, M.D., Patricia M. Brady, R.N., Allan
M. Greenspan, M.D., F.A.C.C., Scott R. Spielman, M.D.,
F.A.C.C., Joel Morganroth, M.D., F.A.C.C., Leonard N.
Horowitz, M.D., F.A.C.C., Likoff Cardiovascular
Institute, Philadelphia, PA
We conclude: 1) severe ventricular dysfunction can limit
AMIO therapy; 2) the occurrence of CHF during AMIO
therapy can importantly decrease the CET of this drug.
To evaluate the clinical efficacy and tolerance (CET) of
Amiodarone (AMID) in patients (pt) with ventricular
arrhythmias and severe ventricular dysfunction we eval-
uated 149 pt with sustained (130 pt) and nonsustained
(19 pt) ventricular tachycardia, with regard to radio-
nuclide left ventricular ejection fraction (EF), pre-
sence of congestive heart failure (CHF) , before (CHF-
old) or during therapy (CHF-on) (either worsening of CHF-
old or new onset of CHF). AMIO loading (1000 mg X 7 da,
800 mg X 7 da, 600 mg X 3 months) was followed by
maintenance doses of 200 - 600 mg/da; mean plasma level
of 1,7 meg/mI. Results after 1 year:
SURVIVAL(%) RECURRENCE(%) 1
80 30
91 17
78 25
87 26
A with P
+37+16t
+107+45t
15
A
+21+17
+56+25
15
P
6RV REfRACTORINESS(ms)* +24+12
6VT CYCLE LENGTH (ms)* +65+25
6VT MORPHOLOGY 16
t p<.01 compared to P alone or A alone
* RV refractoriness compared at same rate and VT
cycle length compared only if VT had same morphology
Patients with a 6 in VT morphology after P had a 6 in mor-
phology after A (13/16 patients, p<.01) and after A with P
(11/16 patients, p<.05). The sum of the effect of A alone
plus P alone on VT cycle length correlated with (r=.86, p
<.01) 6 in VT cycle length after A w1th P. The 6 in VT cy-
cle length was not related to the 6 in refraetonness for
A, P, or A with P (-:2>r<.1). A with P prevented VT induc-
hon in 1 patient. We conclude: 1) a 6 in induced VT mor-
phology after A, P, and A with P is common and occurs in
the same patients; 2) the 61n VT cycle length after A with
P can be predicted by summing the 6in cycle length after A
alone and P alone and is not directly related to measur-
able effects on refractoriness; and 3) A with P does not
prevent VT induction if VT induced on A alone and Palone.
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Hypertensive Heart Disease
THE RELATIONSHIP OF BLOOD PRESSURE AND BODY SIZE TO ECHO-
CARDIOGRAPHIC MEASURES IN CHILDREN: BOGALUSA HEART STUDY.
Gregory L. Burke, M.D., Walter S. Culpepper, M.D.,
F.A.C.C., Larry S. Webber, Ph.D., Yu K. Chiang, Ph.D.,
Rene A. Arcilla, M.D., F.A.C.C. and Gerald S. Berenson,
M.D., F.A.C.C. National Research and Demonstration Ctr.--
Arteriosclerosis, LSUMC, New Orleans, Louisiana.
Studies in children show that essential hypertension
clearly begins early in life. Echocardiographic observa-
tions suggest a relatively early response of the heart to
hypertension. M-mode echocardiograms were obtained on 651
children, 7-22 years of age, from a total pediatric commu-
nity. All participants' diastolic blood pressure rank re-
mained in the same height-race-sex specific decile during
two consecutive Bogalusa school surveys. Standard echo-
cardiographic measures of heart size increased with age,
blood pressure and body size in these growing children.
Body surface area and ponderosity (weight/height 3 ) were
found by multiple regression analyses to be the most ap-
propriate covariates for use in adjustment of echocardio-
graphic measurements for body size and age. Males of both
races demonstrated significantly higher left ventricular
(LV) mass, LV wall thickness and LV chamber size. No con-
sistent racial differences in adjusted LV size were noted.
A significant positive correlation was present between
systolic blood pressure and LV wall thickness in systole
(r=0.42, p <0.001), which remains even after adjustment
for body size (r=0.21, p <0.001). Measures of LV wall
thickness increased throughout the entire blood pressure
distribution. Adjusted LV wall stress was significantly
related to both systolic and diastolic blood pressure
levels (r=0.37, p<O.OOl; r=0.27, p<O.OOl, respectively).
These data demonstrate the heart as an early target organ
to respond during the early natural history of hyperten-
sive disease.
CATECHOLAMINE-INDUCED HYPOKALEMIA AND CARDIAC ARRHYTHMIAS
Vasilios Papademetriou, M.D. ,Aldo Notargiacomo, Ross D.
Fletcher, MJD., FACC, Edward D. Freis, M.D., FACC, VA and
Georgetown University Medical Centers, Washington, D.C.
Catecholamines can cause a shift of potassium (K)
intracellularly, but the arrhythmogenic significance of
this change is not known. In this study programmed
stimulation (PS) was performed in 8 Mongrel dogs at
baseline, and after infusion of epinephrine (EP) 0.1 (A)
0.45 (8) 1.5 (e) or 3.8 Ilg/kg/min (D). Plasma K (PK) was
measured prior to each PS. Following induction of
ventricular fibrillation (VF) PK was corrected by infusion
of KCI 0.5 mEq/min for 10 minutes while EP infusion
continued. The same protocol was repeated following
hydrochlorothiazide (H) 100 mg dail y for 2 weeks. Cha nges
in PK were as follows:
EP (ug/kg/min) 0.1 0.45 1.5 3.8
PK Prior to H 3.4(8) 2.7(8) 2.3(4) 2.4(2) 2.1(2)*
(mEq/t) +0.4 +0.3 +0.2 +0.1
PK after H -3.4(8) -2.6(8) -2.0(4) -2.2(2) 2.0(1)*
(mEq/l) +0.4 +0.3 +0.3 +0.1
*In ( ) number of dogs. P<O.Ol for all values of PK
compared to baseline. Prior to H VF was induced in 2
dogs at baseline, 2 with dose A of EP 2 with 8 and 1
with C. One dog was not inducible. Following H therapy VF
was induced in 2 dogs at baseline 3 with dose A, 2 with 8
and 1 with C. At the time of VF prior to H, PK averaged
2.4+0.3 mEq/L. KCI infusion increased PK to 3.6+0.3 mEq
(P<'li.OO1). Of the 7 dogs with VF 6 were still inducible.
After H therapy at the time of VF PK averaged 2.3+0.4. KCI
increased PK to 3.5=.0.5 mEq/L. Of the 8 dogs with
inducible VF 7 were still inducible. In conclusion 1) EP
infusion caused marked hypokalemia in normal dog; 2) H in
the doses used did not affect PK significantly; 3)
Ti trated doses of EP infuslon increased myocardial
vulnerability which was not affected by PK correction.
DOES HYPERTENSIVE HYPERTROPHY CAUSE MYOCARDIAL ELECTRICAL
INSTA8ILlTY •
David~, Mary Ann Sarda, Joseph M. Capasso, Ph.D.,
Herman~nbaum, Sharon Williams and John C. Somberg,
M.D. Albert Einstein College of Medicine, New York.
Myocardial hypertrophy is often associated with a higher
incidence of sudden death. To characterize the increased
vulnerability ventricular hypertrophy may afford we
studied the incidence of arrhythmias following coronary
artery occlusion in 11 rats with hypertensive
hypertrophy. These results were contrasted to the
findings in 14 rats without heart enlargement.
Myocardial hypertrophy was produced by constriction of
the left renal artery with a silver clip. Hypertension
developed in these clipped animals within 2 to 3 weeks
and remained at this level until time of study (10 weeks
later). Animals were anesthetized with pentobarbital (60
mg/kg) and respired on room air. A thoracoto~ was
performed and the left anterior descending coronary
artery occluded while electrocardiogram was continuously
monitored and recorded. No significant difference was
noted in death and incidence of VT following myocardial
infarction in either control or hypertrophied groups.
However, the duration of ventricular tachycardia was
significantly prolonged in the hypertrophied group as
well as the incidence of VF (91% vs 50%) (p < 0.05). The
number of VF events (8 + 3 vs 2 + 0.8) and the duration
(51 + 12 vs 30 + 16 minT were greater in the hypertensive
animil s. These results reveal that a si gnificantly
higher incidence of VF in the hypertrophied group may
represent a greater electrical instability associated
with hypertrophy. This electrical instability may be the
explanation for the higher incidence of sudden death in
the hypertensive hypertrophied population.
THE RIGHT VENTRICLE (RV) IS THICKER IN HYPERTENSIVE
PATIENTS,~ITH LEFT VENTRICULAR HYPERTROPHY (LVH).
Boris Nunez, M.D. , Franz H. Messerli, M.D., F.A.C.C.,
Celso Amodeo, M.D., Guiellermo Garavaglia, M.D., Roland
Schmieder, M.D., and Edward D. Frohlich, M.D., F.A.C.C.,
Ochsner Clinic and Alton Ochsner Med. Fdn., New Orleans.
To assess RV changes in patients with essential hyper-
tension (EH) electrocardiographic and M-mode
echocardiographic criteria were used. 24 patients with
uncomplicated essential hypertension were divided into
two groups, those without LVH and those with LVH, and
compared with 14 normotensive sub jects (NT). Right and
left ventricular dimensions and left atrial emptying
index (LAEI) were (mean + 1 SD):
NT Without LVH With LVH
(n=14) (n=14) (n=10)
MAP 96+7 116+6 115+8
RVWT(d) 3.8+. 84mm 4. 2+. 57mm 7.3+1.8mm.
RVWT(s) 8.6+1.2mm 9.2+1.4. 13.3+3mm.
LAEI .77+3.9 .40+1.2 .44+3.8.
LVM 82+20gr/m2 92+24gr/m2 100+35gr/m2
LVPW(d) 8.8+1mm 8.8+1mm 12.2+1mm
ST(d) 9.5+.9mm 9.6+9mm 17.5+.1mm
MAP=mean arterial pressure; LVM=LV mass; LVPW=LV
posterior wall thickness; ST=septum; d=diastolic;
s=systolic. Right ventricular wall thickness (RVWT)
increased in patients with LVH when compared to those
without LVH and normotensive subjects (p < 0.01). LAEI
was already diminished in patients without LVH as
compared with the normals (p< 0.01). We oonolude that
RV wall changes are assooiated with those of the left
side and reflect a struotural adaptation to increased
afterload and/or other factors stimulating myooardial
hypertrophy. The decrease in LA!I represent early
diastolic functional ohanges assooiated with impaired
ventricular compliance in the early prooess of LVH.
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DIFFERENCES IN GLOBAL AND REGIONAL LEFT VENTRICULAR
PERFORMANCE IN HYPERTENSION AND AORTIC STENOSIS WITH
NORMAL CORONARY ARTERIES
Charles K. Francis, M.D. F.A.C.C., Allan V.N. Goodyer,
M.D. F.A.C.C., Robert Higgins, M.D., Michael Remetz,
M.D., Yale University School of Medicine, New Haven, CT
Alterations in left ventricular performance which occur
with pressure overload due to hypertension (HTN) may
differ from changes associated with aortic stenosis. In
31 patients (pts) with normal coronary arteries, 17 with
essential HTN and 14 with aortic stenosis (AS), regional
wall motion (RWM) was assessed from contrast left
ventriculography and compared to 25 normals (N), using a
computerized technique in which RWM (mean percentage
chord shortening) was calculated for 6 ventricular
regions: anterobasal (AB), anteromedial (AM),
anteroapical (AA), inferoapical (IA), inferomedial (1M),
and inferobasal (IB). Global ejection fraction was
above normal in HTN (77%, p < .02) but normal in AS
(72%). RWM in HTN was significantly increased in the AM
region (72 vs 58 (N». In AS, RWM was significantly
decreased in the IA (31 vs 41 (N» and 1M (28 vs 36 (N»
regions. These data indicate that pressure overload is
associated with abnormalities in RWM in the absence of
coronary artery disease. The pattern of these
abnormalities in RWM may vary with the etiology of the
increased pressure load, HTN demonstrating generalized
hyperkinesis, greatest in the anteromedial region and AS
showing hypokinesis in the inferoapical and inferomedial
regions. These observations are important when
evaluating RWM in pts with left ventricular pressure
overload associated with other cardiac diseases.
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Clinical Hypertension
EPINEPHRINE FACILITATES NEUROGENIC VASOCONSTRICTION IN
NORMAL AND BORDERLINE HYPERTENSIVE SUBJECTS.
John S. Floras, MD, Philip E. Aylward, MD, Ronald G. Vic-
tor, MD, Allyn L. Mark, MD, FACC, and Francois M. Abboud,
MD, FACC, Cardiovascular Center, University of Iowa, Iowa
City.
Epinephrine (EPI) augments neurogenic vasoconstriction
most likely by facilitating the release of norepinephrine
(NE) from sympathetic nerves both when blood levels are
increased and as a co-transmitter released from adrenergic
nerves when blood levels are baseline. To test the
hypothesis that this effect of EPI on pre-junctional beta
receptors is exaggerated in borderline hypertensives (BHT)
we contrasted vasoconstrictor responses to a reflex stimu-
lus (lower body negative pressure, LBNP) and to intra-
arterial NE (18 ng/min) in age-matched subjects before,
during and 30 min after infusion of EPI (50 ng/min) into a
brachial artery. Forearm blood flow was measured simulta-
neously in both arms. The ratio of forearm vasoconstric-
tor responses (FVR) to LBNP/FVR to NE was used as an index
of neurogenic vasoconstriction in these 3 periods.
Results: Ratio of FVR LBNP/FVR NE (infused arm)
Normal (n-8) BRT (n-7)
Before EPI 1.5 0.8
During EPI 5.1 4.1
After EPI 5.3 2.0
The increased ratio of FVR to LBNP/FVR to NE from control
both during and 30 min after infused EPI suggests that BPI
facilitated neural NE release both directly and as a co-
transmitter. Increases in this ratio from control during
and after EPI did not differ significantly in the 2
groups. The results indicate that 1) EPI acts directly
and as a cotransmitter to facilitate neurogenic vasocon-
striction in humans and 2) this effect does not appear to
be augmented in borderline hypertensive subjects.
PULMONARY VASCULAR HYPERSENSITIVITY TO ENDOGENOUS AND
EXOGENOUS CATECHOLAMINES IN HYPERTENSION.
Maur1zio D. Guazzi, M.D., Cesare Fiorentini, M.D., Paolo
Moruzzi, M.D., Mauro Pepi, M.D., Gloria Tamborini, M.D.
Institute of Cardiology, C.N,R., University of Milan,Italy
Elevated pulmonary pressure and resistance in m1!d un-
complicated hypertension suggests that a common mechanism
may produce vasoconstriction in the greater and lesser
circulations. This study was carried out in 16 such pa-
tients and in 9 healthy subjects to compare the vascular
reactivity to release of endogenous catecholamines elic-
ited by mental arithmetic (MAJ and cold pressor test (CPT)
and the dose-response relationship to exogenous (i,v.) epi-
nephrine (Ep) and norepinephr1ne (NEp). MA and CPT were
associated with a predominant rise of Ep and NEp, respec-
tively. Changes were significantly greater in hyperten-
sives (Ep during MA +62 pg.ml; NEp during CPT +65 pg.ml)
than 1n normotensives (Ep during MA +10; NEp during CPT
+11). During these stimuli pulmonary arteriolar resistance
in normotensives was reduced by 13 % and augmented by 7 %
of baseline, respectively; whereas in hypertens1ves it was
raised by 31 and 70 %. In normotensivesthe dose (ug)-re
sponse ( dynes) relationships to Ep and NEp were, respec-
tively: 1:-4, 2:-5, 3:-8, 4:-10 and 2:+3, 4:+6, 6:+7, 8:
+9. These relationships in hypertensives were: 1=+19, 2=
+44, 3=+59, 4=+77 and 2=+39, 4=+45, 6=+76, 8=+104. Group
differences were statistically highly significant. Cardiac
output was raised by Ep and slightly reduced by NEp, both
endogenous and exogenous. In each of these circumstances
pressure in the pulmonary artery was sign1ficantly aug-
mented in hypertensives and not in normotensives.
These findings document that in hypertension both cate-
cholamines, from either source, have a pressor and vaso-
constrictor effect in the lesser circulat10n as a conse-
quence of vascular overreactivity. The oppgsite direction
of changes in resistance between normotens~ves and hyper-
tensives produced by Ep, suggests that a vasoconstrictor
vascular oversensitivity becomes active in the pulmonary
circuit with the development of systemic hypertension.
AI
(%)
35±10
32±7*
33±5
30±5*
NFF1/3
(%/sec)
37±10
43±9*
42±7*
44±10*
IMPROVEMENT OF DIASTOLIC FILLING FOLLOWING HYPERTROPHY
REVERSAL. Julio F. Tubau, M.D., Jadwiga Szlachcic, M.D.,
Barry M. Massie, M.D., FACC, Steven Henderson, CNT, Carol
Vollmer, R.N.; VA Medical Center and UCSF, San Francisco,
California
Diastolic filling (DF) abnormalities are cOlJllllon in
hypertensive (HTN) patients (PTS). Blood pressure (BP)
control for up to 3 months in unselected HTN PTS has
inconclusively affected DF. Therefore, we prospectively
studied 18 HTN PTS with echocardiographic (ECHO) evidence
of left ventricular hypertrophy using list mode
radionuclide angiography (RN). PTS received either
propranolol or labetalol with diuretic added if necessary
to achieve BP control (diastolic BP < 90 mmHg). ECHO
left ventricular mass (LVM) and RN studles were performed
after 4 weeks off therapy at baseline (B), and after 3, 6
and 12 months of BP control. RN studies were analyzed
for ejection fraction (EF), end diastolic volume (V),
peak filling rate (PFR), normalized first 1/3 filling
fraction (NFFI/3) and atrial index (AI).LV mass was
significantly reduced by treatment from 280±37 to 257±39,
249±29 and 251±30 gm and supine BP from 168±14/101±5 to
139±21/84±6, 139±20/83±6 and 134±20/81±9 mmHg at 3,6 and
12 months respectively (all p <.01 vs B).
HR EF V PFR
(bpm) (%) (ml) (ml/sec)
65±10 65±7 122±17 2.5310.4
60±7* 69±5* 128±17 2.89±O.5*
60±7* 70±7* 120±22 2.80±0.5*
58±9* 69±10* 128±22 2.78±O.5*
*p<'Ol
Thus, following hypertrophy reversal DF improved by 3
months and was maintained for the remainder of the
followup. However, the improvement was modest and DF did
not achieve normal values, suggesting a nonreversible
component of DF abnormalities in HTN.
B
3m
6m
12m
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Ct/Ca = 0.515 x F / (0.195 x F +).,) r=0.85. (p<O.OOl)
(.)., = decay constant)
Blood pressure was l13±J7/76±J8 at control. increased to
l33±J6/89+~1 and l32~4/76±J8 during stenosis and
occlusion (p<O.OOl). The Rb-82 estimated flow was 2.810.6
ml/min/g at control. 1.2~0.8 ml/min/g during stenosis and
0.8~O.9 ml/min/g during occlusion. In addition. the
contralateral kidney demonstrated flow reduction to mean
82% and 86% of the control values during stenosis and
occlusion. respectively.
This data suggests that PET with Rb-82 permits repetitive
quantitative assessment of renal perfusion noninvasively
in acute renovascular hypertension.
SERIAL ASSES~MENT OF RENAL PERFUSION IN EXPERIMENTAL
RENOVASCULAR HYPERTENSION BY POSITRON TOMOGRAPHY WITH
RB-82
Nagara T,m.ki. M.D., Carlos A. Rabito. M.D•• Ph.D••
Nathaniel M. Alpert. Ph.D•• Michito Kanke. M.D•• Tsunehiro
Yasuda. M.D•• H. William Strauss. M.D •• F.A.C.C••
Massachusetts General Hospital. Boston. MA
Renal perfusion was measured with positron tomography
(PET) and a continuous infusion of the ultra-short
half-life (75 sec) rubidium-82 (Rb-82) in experimental
renovascular hypertension. Renal blood flow calculated
from PET was compared to that determined by left atrial
injection of microspheres. Renal perfusion images and
microsphere injections were recorded in each 6 dogs at
control. during renal artery stenosis and its occlusion.
Renal concentrations of Rb-82 (Ct) were determined by PET
and arterial activity (Ca) measured by well counting of
blood samples. Ct/Ca was correlated with renal blood flow
(F) measured by microsphere injected at each point.
according to steady state compartment model.
P
<05
<001
NS
NS
NS
liS
Thus, "responders" and "non-
responders" showed llttle
dlfference in mean 24 hr or
dayt iwe systollc or dlastolic
BP, and 4/8 (50%) "non-respon-
ders" nad a 24 hr DBP ~ 80 mw
Hg. These data suggest that
clinlc BP alone provldes an
incomplete view of drug
response and is an imperfect
gUlde to dose tltration in
hypertenslve patlents.
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LlilITATI01~S OF STA1~DARD CLINICAL TRIAL DESIG1~ IN
ASSESSmG ANTIHYPERTENSIVE DRUG RESPOIJSE. AJ.an.JJ
Gradman. 110, FACC, i1icnelle H Ger.,Jaw, as, Patti A
Pan\San, as, \Iest Haven VAHC and Yale Univ, New Haven, CT.
We recently evaluated a new antihypertenslve agent
using both clinic and 24 hr. nonlnvaSlve ambulatory BP
monltoring (ICR) to assess therapeutlc efflcacy. Four-
teen nJale pts (wean age 59) were adwltted to the study on
tile basis of a cllnic supine diastollc BP (SDBP) dunng
placebo of 95-115 mn Hg and then received either blinded
placebo or one of three doses of an experlmental agent.
For dosage adjustment, pts were classed "responders" if
tne clinic SDBP was ~ 90 mm Hg. A co.npanson of cllmc
and 24 hr ABPs in "responders" (n=9) and "non-responders"
(n=8) was performed (n=17 dosage trials in 14 pts):
"Non-Res00nders" "Responders"
157 ± 15 139 ± 19
97 ± 7 86 ± 4
130 + 14 128 ± 11
81 ± 7 79 ± 4
133 ± 14 137 ± 12
83 ± 7 85 ± 6
Normal range. NA 219 :t56 pglmI I 2 SO
A 44±28 !IlIlmi mean va uej;
NEH 7.77 r 2.53 284 t 85 221 t 87
p= .006 .001 .03
PEB 10.27 t 3.23 213 t 40 166 t 50
In summary, our data sbt:M an elevated RBC Na content
with reduced Na pump# (and activity) in PEB v NEB. These
results support the hypothesisthat in ER upregulationof
RBC Na pumps develops in response to increased levels of
a humoral (Na+K) ATPase inhibitor.
RED BrooD CELL (Na+K)ltI'pase IN NEWLY DIAGNOSED AND
PREVICXJSI:f TREATED ESSENTIAL HYPERTENSION
Richard Ringel, lID FACC, John Hamlyn, PhD, Gerard Pinkas,
Bruce Hamilton, lID Univ. of Maryland, Baltimore.
In the presence of (Na+K)ltI'Pase(Na pump) inhibitors,
(eg. digoxin or hypokalemia) the hematopoeticsystem can
increase the number of Na pumps/RBC, thereby -escaping-
inhibition.Elevated levels of an endogenousNa pump
inhibitorhave been found in essential hypertension(ER).
If this inhibitoris a natriuretichormone, levels should
decrease after blood pressure (BP) is lowered by diuretic
therapy, allowingROCs with fewer pumps to be formed.
When therapy is discontinued,hypertensionrecurs and
levels of circulatinginhibitorrise. RBC Na content
should then rise until new RBCs with more pumps can again
be produced.
Therefore, ROC Na content, Na pump #/cell and
activitywere measured in black males with newly
diagnosed EH (NEB,n=27) and with previouslytreated EH
(PER,n=21). Hypertensionin PEB SUbjects was controlled
with diureticst additional therapy in the preceding 6
mas but medicationswere discontinued2-6 wks prior to
study. SUbjects were ~ 30 yrs and had mean BP ~ 108mmHg.
Na content was measured by atomic absorption,Na pump #
by 3H-ouabain binding and pump activityby colorimetric
methods. Data for the two groups included:
RBC Na Content Na Pump// Na pump Activity
(mmole/l RBC) (#/RBC) (umolePi/mg protein/hr)
CLONIDINE SUPRESSION TEST IN THE DIAGNOSIS AND POSTOPERATIVE
CONTROL OF PHEOCHROMOCYTOMA
JoIchim SChofltr, M.D•• Andree T_. M.A., M.D., Dept. of Cenliology. University
Hotp"-I Eppendorf, HlImbulll, Welt Germany
In 8 petiell1l (pta) with erterial hypertelllion pheochromocytoma wei IUIJl8Cted
becIuI8 of I'(mplDl1II and abnormally el_ed urine end p1_ eateehoIaminll.
From ell pta bIoocI Wllllmp!ed in the lUpine potition before, no, and 180 minutu
after 300 ug cloinidine (CI orally. Nor8drenaline (NAI end edrenaline (A) WII
In 6 pta, in whom NA WII outIide the upper normal limit before C, it became nor·
mal after C. In ell 6 pta the abdominal computed tomography (CT) WII normal. In
the 7th pt with hilhly eleveted p111111ll1 catecholaminal, not IUppreaible by C, CT re-
vealed a left aided edrllla! gland tumor. The diagnoail of pheochromocytoma WII
confirmed at IUJ'VlIfY. In the 8th pt an extramedullary tumor could be identified by
CT. Intraoperatively, a malignant pheochromocytoma _ found with __ lo-
cated in the peritoneum and liver,which were milled by CT. Postoperatively, the
C IUppreaaion __ repeated in both pta with pheochromocytoma. W.....I plu-
ma catecholaminu dropped to normal after C in the pt with a pheochromocytoma
located in the edranel gland, thil WII not the _ in the other pt in whom mati-
..... perlilted after operation. - Conclulion: 1) C lupprealion _ il a uaeful aid
in the dlagnoail of pheochromocytoma, llpecially in pta with _ial hyperteMion
and elevated urine and plalma c:ateeholamine co_ion. 21 The C IUppreaaion
tilt _1111 to be lUitable toa_ the efficacy of tumor _ion.
determined uaing a r jdioenzymetjc methOl • IReaulta: before 120 min 180 min
after clenidine
("""mil NA A NA A NA A
1 362 30 251 108 211 89
2 479 11 70 75 131 11
3 340 41 119 71 201 39
4 715 92 442 65 353 51
5 363 41 110 12 97 12
6 423 100 109 25 164 23
7 preoperatively 3916 1975 4292 2158 3770 1821
postoperatively 439 47 238 9 196 17
8 preoperatively 12239 34 12866 39 11183 18
_-.livelv 4220 66 3372 24 2290 18
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Valve Surgery: Hemodynamic Predictors and
Outcomes
LOW WALL STRESS AND EJECTION FRACTION DO NOT PRECLUDE
VALVE REPLACEMENT IN AORTIC STENOSIS WITH HEART FAILURE.
H.u.k.l... SmuQker • .HD...~, David S. Kni tter, BS, Charles
L. Carman, ME, Thomas D. Stuckey, MD, Donald L. Tyson,
BSN, Thomas W. Nygaard, MD, FACC, Irving L. Kron, MD,
FACC, Robert M. Mentzer, MD, Robert S. Gibson, MD.
University of Virginia, Charlottesville, Virginia.
Aortic valve replacement in patients with aortic
stenosis is sometimes withheld due to severe left ven-
tricular (LV) failure and previous findings that low
ejection fraction and low transvalvular gradient in the
face of low afterloading wall stress implies poor surgi-
cal outcome. Mean LV stress and ejection fraction at oath
in 30 patients with severe aortic stenosis undergoing
aortic valve replacement in 1983-4 are plotted below
(X=dead, O=improved) along with previous authors' regres-
sion line for patients with good surgical outcome in the
1970's. Our patients with poor surgical outcome could not
be separated from those with good outoome on the basis of
wall stress and ejeotion fraction. In faot, most of our
patients survived operation and improved dramatioally
despite falling well below 0.7
previous authors' regres-
sion line. There were no 5
deaths in patients without ';j 0
ooronary disease. Our ~.
findings might be at- ~
tributed to better ourrent c
teohniques of myocardial ~O.
preservation. Aortic valve t
replaoement is indicated ~
in patients with aortic ~
stenosis despite severe 0.1~:--==±-~,-:=:*-:-~=~~
ventrioular failure. 150.0 250.0 350.0 450.0
LV Stress, kdyne/cm2
PREOPERATIVE NONINVASIVE F~ SYSTOLIC STRESS/END SYSTOLIC
VOLUME RATIO IN MITRAL REGURGITATION: PREDICTOR OF
POSTOPERATIVE SYMPTOMS.
Jessica Furer, M.D., David Pazer, B.S., Nathaniel Niles,
M.D., Clare Hochreiter. M.D •• Paul Kligfield. M.D ••
F.A.C.C •• Richard Devereux, M.D., F.A.C.C •• Jeffrey S.
Borer. M.D., F.A.C.C •• Cornell Medical Center, New York.
The ratio of LV end systolic stress to end systolic
volume(ESS/ESV) has been proposed as a load independent
contractility index in mitral regurgitation(MR) which
might be useful in defining the timing of mitral valve
replacement(MVR). When determined invasively. preop
ESS/ESV has correlated well with post MVR course and
function. but predictive power of non-invasive ESS/ESV
measurement has not been assessed. Therefore. we
obtained preop echocardiographic LV dimensions and
simultaneous sphygmomanometric blood pressure for ESS/ESV
determination in 15 pts undergoing MVR for isolated
severe MR, and compared results to symptoms(Sx) and LV
function determined by radionuclide cineangiography(RNCA)
ejection fractions(EF) at av 11.9 mos postop. Nine of 11
patients with ESS/ESV>l.l had no or minimal Sx postop
(NYHA functional class[FC] 1 or 2), while 4/4 pts with
ESS/ESV<l.l had persistent FC~3 Sx (p<.025). Predictive
accuracy(PA) of ESS/ESV for such postop Sx was 87%. No
other preop variable, including RNCA LVEF and RVEF (rest
and exercise[ex], echo LV dimensions, and treadmill ex
duration predicted postop Sx, regardless of cutpoint
chosen. In addition. pts with preop ESS/ESV <1.1 trended
to lower postop LVEFre t (37% vs 45%.NS) and ex (38% vs46.5%.NS) and less ex ~olerance (6t2 min vs 8t3 min,NS)
than pts with preop ESS/ESV>l.l. Noninvasive
echocardiographic ESS/ESV ratio may be of value in
defining optimal timing of MVR in pts with MR.
FAILURE OF HEMODYNAMIC-ANGIOGRAPHIC MEASURES TO PREDICT
OUTCOME IN REGURGITANT VALVULAR HEART DISEASE.
Marc C. Cohen, M.D., William G. Kussmaul, M.D., Joseph P.
Kleaveland, M.D., F.A.C.C., John W. Hirshfeld, Jr., M.D.,
F.A.C.C., Warren K. Laskey, M.D., F.A.C.C., University of
Pennsylvania, Philadelphia, PA.
The peak LV systolic pressure: end-systolic volume ratio
(P/V), an approximation of the end-systolic pressure-
volume relationship, has been reported to be a sensitive
index of LV disease. We determined P/V at cardiac
catheterization in 36 patients (27 operated upon) with
chronic mitral regurgitation and 30 patients (16 operated
upon) with chronic aortic regurgitation to assess the
relationship between P/V and survival, overall outcome
(no need for surgery or post-operative improvement versus
poor operative outcome), and post-operative improvement.
In addition, the following variables were evaluated to
determine if they were associated with survival, overall
outcome, and post-operative improvement: pulmonary wedge
pressure, LV end-diastolic pressure, CO, ejection
fraction, end-systolic volume, and end-systolic volume
index. P/V was not associated with survival, overall
outcome, or post-operative improvement in either aortic
or mitral regurgitation. In aortic regurgitation,
ejection fraction was the only variable associated with
survival (60%±8.5 vs. 40%±12.9, p=.002), overall outcome
(6D%±8.6 vs. 43%±14, p=.OOl), and post-operative improve-
ment (55%±5 vs. 44%±15.7, p=.05). We conclude: l)P/V is
not associated with survival, overal1 outcome, or
post-operative improvement in patients with aortic or
mitral regurgitation; 2)In aortic regurgitation, ejection
fraction is associated with all 3 endpoints.
VALUE OF THE REGURGITANT VOLUME TO END-DIASTOLIC VOLUME
RATIO IN THE EVALUATION OF PATIENTS WITH AORTIC
REGURGITATION
Patriok T. O'Gara, MD, Robert O. Bonow, MD, FACC, Gale G.
White, RH, Barry J. Maron, MD, FACC, Steven L. Baoharaoh,
PhD and Miohael V. Green, MS, NHLBI, Bethesda, Md.
Preoperative LV systolic function is an important determi-
nant of survival and funotional results following aortio
valve replaoement (AVR) for ohronio aortic regurgitation
(AR). However, many pts with pre-op LV dysfunction mani-
fest improved LV funotion after AVR and have an exoellent
prognosis. To test the hypothesis that the magnitude of
regurgitant volume (RV) relative to end-diastolic volume
(EDV) may prediot the post-op outoome in suoh pts with AR,
we used radionuolide angiography to study 59 pts (ages 19-
72, mean 44): 22 pts with normal pre-op LV ejection frao-
tion (EF) and 37 pts with subnormal pre-op LVEF. In pts
with normal LVEF, the HV/EDV ratio was signifioantly re-
lated~he pre-op LV diastolio dimension (DD) index (r=
.70, p<.OOl) and prediotive of the ohange in DD that 00-
ourred after AVR (r=.70, p<.OOl). In pts with subnormal
LVEF, no suoh oorrelations were found, presumably beoause
LV dilatation in some pts exoeeds that which is appropri-
ate for the regurgitant volume alone and, therefore, re-
fl_ots irreversible dysfunotion. However, among pts with
subnormal pre-op LVEF, the pre-op RV/EDV ratio did distin-
guish between groups at high and at low risk of death and/
or post-op heart failure (CHF). Of those 16 pts with an
RV/EDV ratio >0.25, there was only 1 death and no post-op
CHF, Whereas among the 21 pts With an RV/EDV ratio iO.25,
7 pts died and 3 had post-op CHF (p<.Ol). Thus, the RV/EDV
ratio is not prediotive of the ohange in LV size following
AVR in pts with subnormal pre-op LVEF, but may provide ad-
ditional prognostio information regarding survival and
clinioal outoome in this group.
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EFFECTS OF SEVERITY AND TYPE OF OVERLOAD ON MYOCARDIAL
BLOOD FLOW RESERVE IN EXPERIMENTAL AORTIC VALVE DISEASE.
Alfred A. Bove. M.D., F.A.C.C., Qian Sufan, M.D •• Jose M.
Brum. M.D •• Mayo Clinic. Rochester. Minnesota.
In this study we hypothesized that myocardial blood flow
reserve (BFR) is reduced in proportion to the degree of
hypertrophy in aortic stenosis (AS) and in aortic insuf-
ficiency (AI). We created pure valvular AS in 6 dogs, AI
with mild stenosis in 5 dogs, and sham operated 7 dogs
(S). BFR was measured with radioactive microspheres at
rest. during intracoronary adenosine (ADO) infusion (1
mg/min), and with pacing induced tachycardia. Left
ventricular (LV) performance was determined by computer
analyzed. 30/sec biplane ventriculograms. A systolic
aortic valve gradient was present in AS (57+27 mmHg) and
AI (34+10). In AI total LV output was 2.2 times forward
cardiac output. End diastolic volume was increased
(p<.Os) in AI (96+21 ml) compared to AS (73+8) and sham
(61+9). and LV mass was highest (p<.Os) in AI (7.2+.4
g/kg) compared to AS (6.4+.9) and sham (4.8+.5). LV
mechanical work output (W) was highest (p<.Os) in AI
(170+34 Joules/min) compared to AS (66+10) and sham
(57+14), and LV mass was correlated with W (R = .516.
p<.Os). BFR expressed as peak/resting flow comparing ADO
flow with control was inversly correlated with LV mass (R
= .638, p<.02) across a spectrum of severity of AS and
AI, and fits a curvilinear function which assumes no
vasogenesis with hypertrophy. We conclude: 1) LV mass
is proportional to LV power requirements in both AS and
AI; 2) increasing mass produces a loss of BFR; and 3)
reduced BFR follows a relationship which indicates that
vasogenesis does not occur in the adult heart subject to
hypertrophy from aortic valve disease.
CORRELATION OF PHYSICAL FINDINGS IN AORTIC INSUFFICIENCY
WITH HEMODYNAMIC SEVERITY. MO Cheitlin. MO, FACC; JD
Bristow, MO, FACC; B Massie, MO, FACC; B Greenberg, MD,
FACC; D Thomas, PhD, G Krishnamurthy MO; D Loge, BS, N
Topic. RN; D Siemienczuk, RN; J Newlands. BA; University
of California. San Francisco.
85 patients (pts) (35 UCSF. 47 Oregon Health Sciences
University) with varying degrees of aortic insufficiency
(AI) had physical findings (PF) correlated with objective
measures of hemodynamic severity (HS) determined by
radioisotope blood pool studies of LV end diastolic vol-
ume index (EDVI). end systolic volume index (ESVI),
regurgitant fraction (RF), and total LV stroke volume
(SV).
~S~i~gn~i~f~iTc~an~c~e~o~f~C~o~r~r~e~la~t~i~o~n~(p~v~a~lu~e~) NS=not significant
Physical Findings EDVI ESVI SV RF
Systolic BP ~ ~ NS NS
Diastolic (D) BP .0004 NS .0001 .0008
Pulse pressure .04 NS NS NS
Duration Diastolic Murmur (DM) .002 .04 .002 NS
Grade DM .0005 NS .00001 NS
Summary Peripheral Signs of AI .0009 .02 .002 NS
Absent Present 2.!£.
Austin-Flint M EDVI 137.0*43.1 165.6%48.0 .007
(vol. = cc LVSV 91.1%37.4 109.8%28.1 .005
% 1 S.D.) RF (%) 58.5%48.01 67.9%14.0 .005
!l RF (%) 56.4%12.7 70.5%9.1 .001
Quinke's EF (%) 63.5%8.1 67.7%9.3 .04
Duroziez' M* EDVI 107.1%22.6 147.5%36.6 .0001
Water Hammer Pulse NS correlations *UCSF only, N=38
There were marked differences in incidence of several
PF in pts from UCSF and OHSU, i.e.. S3 in UCSF pts in
13/38 and OHSU in 1/46, and Duroziez' M in 18/36 UCSF and
4/46 OHSU pts. The most helpful PF correlating with HS
are D BP, duration and grade of DM, presence of Austin-
Flint M. S3' and overall summary of PF of AI.
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PREDIC'I10N OF INFARCT SIZE FROM CARDIAC MYOSIN
IJGHT CHAINS SERUM LEVELS.
Peter P. Liu. MoD.. Tsuneblro YlIIIUda, MoD.. F.A.C.C.. H.
William Str8usII, MoD.. F.A.C.C.. Herman Gold, MoD.. F.A.C.C..
Edgar Haber, M.D., F.A.C.C., Ban-An Kha., Ph.D.
Massachusetts General Hospital, Boston, MA.
The soluble light chains fraction (LC) of cardiac myosin can
be detected in serum after myocardial infarction (MIl using a
radioimmunoassay (RIA) technique. It has been shown to be an
early and sensitive marker of myocardial necrosis. To
determine the potential relationship between the amount of LC
release to infarction size (IS), we obtained serial serum samples
from 18 aaute MI patients at 6 hourly intervals for up to 6
days, and quantitated the LC levels with liquid-phase RIA.
The area under the LC concentration-time aurve was also
integrated from time 0 to eaah of 24, 72 and 120 hrs following
admission. To determine infarct size, patients were injeated
intravenously with T<l-99m labelled antimyosin Fab antibody, and
the volume of uptake from the reconstructed single photon
emission tomographia slices was converted to gram-equiValent of
infarct tissue. Linear regression analysis was performed between
both the LC level (ng/ml) and LC area integral (ng/ml-hr) with
infarct size (gm) at different time intervals, and the correlation
coefficients (R) are as follows:
Time after admission .ll...ht aJ1t. 11....bt ill...Ill:
LC aoncentration(ng/ml)* 31±33 45±30 58±38 48±30
R (LC vs IS) 0.88** 0.71 0.71
R (LC integral vs IS) 0.83 0.79 0.83
**multiple regression identified a single 24hr LC level to
correlate the best with IS (y=.86x+1l; p<.OOI). * mean±SD
Conclusion: Myosin light chains are released early after MI
and usually persist for more than 6 days in the serum. A single
level taken at 24 hrs correlates well with myocardial Infarction
size. Therefore RIA of serum LC may be used to predict the
size of myocardial necrosis from a single 24 hr sample.
PROMPT DETECTION OF ACUTE MYOCARDIAL INFARCTION BY
ANALYSIS OF CK ISOFORMS IN THE FIRST AVAILABLE BLOOD
SAMPLE.
Allan S. Jaffe, M.D., F.A.C.C., Ann Grace, and Burton E.
Sobel, M.D., F.A.C.C., Washington University, St. Louis,
MO.
Acute myocardial infarction often can not be detected as
promptly as desired with conventional plasma isoenzyme
and enzyme assays because most molecular markers of
myocardial injury are liberated slowly. However, we have
preViously detected infarction within 1 hr after coronary
occlusion in dogs by exploiting the rapid post-
translational modification of the myocardial MM CK (MMA)
isoform that gives rise to different isoforms of MM CK
(MMB and MMC) in plasma. To determine whether infarction
can be detected promptly in patients as well, we assayed
MM CK isoforms with an immunoblot procedure in the first
available plasma samples from 12 patients with chest pain
suggestive of infarction and 14 normal controls. In each
control subject and patient MB and total CK values were
well within the normal range in the same samples as those
used for isoform analysis. Total and MB CK values were
virtually identical in patients compared with controls
(92 ± 30 [SO] lUll and 94 ± 33; 5.2 ± 2 and 5.0 ± 3).
However, the fraction of MM CK attributable to the MMA
compared with the MMC isoform in plasma was markedly
different. For controls it averaged 1.3 ± .66 and did not
exceed 2.4. In contrast, even though total and MB CK
values were normal, corresponding ratios of MMA/MMC in
the first available sample from patients with evolving
infarction averaged 16. The ratio exceeded 2.6 (mean + 2
SO in controls) in 75'. Thus, assay of MM CK isoenzymes
in the first available blood sample permits early
detection of myocardial infarction well before MB CK and
total CK values exceed the normal range.
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DECREASED SERUM LEVELS OF PGI2 STABILIZING FACTOR AND
PGI2 SYNTHESIS STIMULATING FACTOR IN ACtITE MYOCARDIAL
INFARCTION
T.Aoyama, MD, Y.Yui, MD, Y.Takatsu, MD, R.Hattori, MD,
T.Susawa, MD, N. Ikeda , MD, K.Sakaguchi, MD, M.Takahashi,
MD, C.Kawai, MD, FACC, Kyoto University, Kyoto, Japan.
Human serum is known to contain two important factors
which regulate PGI2 metabolism. This study was aimed to
investigate the possible role of these factors in the
pathogenesis of acute myocardial infarction(AMI). The
one factor stimulates PGI2 synthesis in blood vessel. The
aortic ring(2 rom length) of rat was incubated for one
hour with 200 ~l serum. The activity of this stimulating
factor(SF) was expressed as 6-keto-PGFla nglmg wet weight
of the ring/hour. The other is stabilizing factor(STF)
that binds to PGI2• After incubation with [3H]PGI2 at
22°C for 3 minutes, one ml of serum was mounted on
Sephadex G-25 column. A part of the activity of [3H] was
found at the voiding fraction corresponding to PGI2-STF
complex. The percentage of this activity for total ac-
tivity was obtained and defined as the activity of STF.
The activities of the two factors were determined in 7
patients with AMI 2.S±0.8(I) and 8OtI7(II) hours after
the onset of chest pain, and compared with those obtained
from 7 normal volunteers. Values are mean±SD.
SF STF
Volunteer 117±48}'" 72±5.5}..,
AMI (I) 15±15* * 52±6.9,. *
AMI (II) 68±20~ ..... 63±5.5~ .....
*p<0.05:Multiple comparison test was used for statistics.
In the very early phase of AMI the serum levels of SF and
STF were significantly reduced, which may be related to
the thrombus formation in the coronary artery in AMI.
THE PROGNOSTIC IMPLICATIONS OF ELEVATED FIBRIN SPECIFIC
CROSS LINKED PRODUCTS AFTER INFARCTION - A MARKER OF
INTENSE ENDOGENOUS THROMBOSIS AND THROMBOLYSIS.
Paul R. Eisenberg, M.D., Burton E. Sobel, M.D., F.A.C.C.,
Laurence Sherman, M.D., Julio Perez, M.D., and
Allan S. Jaffe, M.D., F.A.C.C., Washington University,
St. Louis, MO.
We have previously documented thrombosis in vivo early
after the onset of infarction by assay of fibrino-
peptide A (FPA) in plasma. Assuming that intense and
persistent thrombosis predisposing to complicated
infarcts would be reflected by concomitant endogenous
thrombolysis and hence production of cross linked
fibrin degradation products (D-dimers), in the present
study we assayed plasma D-dimer with an ELISA proce-
dure. Plasma samples were obtained within 10 hr of the
onset of pain in 65 patients with acute transmural
infarction in whom mural thrombi had been excluded
echocardiographically. As anticipated, FPA was
elevated in 92% (33.5 ± 8.5 [SE] nglml, upper limit of
normal: 2.0 ng/ml). D-dimer was normal « 200 ng/ml)
in 55% (138 ± 8 ng/ml) , modestly elevated « 400 ng/ml)
in 17 %averaging 261 ± 16 nglml, and markedly elevated
in 28% (2618 ± 838 ng/ml). Marked elevations of
D-dimer portended severe congestive heart failure,
ventricular fibrillation, or ventricular tachycardia
within the first few hours. Thus, among the 18
patients with marked elevations, 10 (56%) had major
complications of infarction. In contrast, among
patients without marked elevations, such complications
were rare (11%). These results indicate that early
elevation of D-dimer indicative of ongoing, intense
thrombosis and compensatory thrombolysis in vivo
presage extensive and clinically complicated infarc-
tion.
INCREASED PLATELET AGGREGABILITY AFTER ARISING FROM
SLEEP
Geoffrey H. Tofler. MBBS, Charles A. Czeisler PhD, MD,
ACP, John Rutherford MB, FACC, Gordon H. Williams
MD, James E. Muller MD, FACC Brigham and Women's
Hospital, Harvard Medical School, Boston, MA
The frequency of onset of myocardial infarction
(MI) has a marked circadian variation; the frequency of
onset is low during sleep but rises sharply on awakening
reaching a peak at 9 a.m. Since MI results from
thrombus formation, we studied platelet aggregability
during the transition from sleep to wakefulness and
activity.
Seven normal male subjects were studied. Plasma
norepinephrine (NE) and epinephrine (Ept), the mean
concentration (conc) of ADP and Epi required to induce
biphasic platelet aggregation in vitro, and the percent
aggregation at threshold concentration (agg) were
determined in two blood samples drawn prior to arising
(6:30 and 8:00 a.m.) at which mean NE was 120 ~ 29 pg/ml
and Epi was 25 ~ 3 pg/ml and in two samples drawn after
waking and arising to normal activity (9:30 and 11:00
a.m.)at which mean NE was 310 ~ 28 pg/ml and Epi was 57
~ 6 pglml. Mean values and standard error before and
after arising were: (* p < 0.05)
ADP (~) Epi (~M) ADP
agg.conc. agg.conc. %agg.
Prior to
arising 2.8 ~0.2 1.6 ~0.3 24 ~14 12 ~17
After
arising 2.2 ~0.2* 0.8 ~0.3 43 ~14* 37 ~17*
Thus, platelet aggregability is significantly
increased after arising. Further study of this phenome-
non could perhaps clarify the mechanism by which
anti-platelet agents prevent MI and facilitate develop-
ment of new interventions to prevent arterial thrombosis.
ALTERED PLATELET ALPHA2-ADRENOCEPTOR IN
ACUTE MYOCARDIAL INFARCTION AND ITS
RELATION TO PLASMA CATECHOLAMINE LEVELS
K. Sakaguchi, R. Hattori, Y. Yui, Y. Takatsu,
T. Susawa, N. Ikeda, S. Tamaki, H. Nonogi,
C. Kawai. F.A.C.C.
Kyoto University, Kyoto, Japan.
To evaluate the down-regulation mechanism of
platelet alpha2-adrenoceptor in acute
myocardial infarction(AMI), we studied the
changes of the receptor and its relation to
plasma epinephrine(E) and norepinephrine(N)
levels. Alpha2-adrenoceptor gf platelet
membrane was studied using [ H]-yohimbine and E
& N were analyzed by high-performance liquid
chromatography. The number of alpha2-
adrenoceptor(Bmax), the dissociation constant
(Kd), and E & N were compared between 6.6±3,3
hours after the onset of AMI and one month
later in 11 patients with AMI; Bmax increased
significantly from 96.5±50.5 to 157.0±65.7
fmoleslmg protein(p<0.01). However, Kd did not
change significantly(4.33±1.40 vs 4.37±1.22 nM)
E & N, 51±25 & 946±739 pg/ml were normalized to
16±9 & 206±114pg/ml, respectively(p<0.05 for
both).
Although the down-regulation mechanism of
platelet alpha2-adrenoceptor is still
controversial, the above results suggest that
the down-regulation mechanism may exist
between the number of platelet alpha2-adreno-
ceptor and plasma catecholamine levels in AMI.
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BLADE AID BALLOOII ATRIAL SEPTOBTOKY APTER
TRAISSEPTAL ATRIAL PUlIICTORB
G. Wesley Vick, III, MD, PhD, Charles E. Mullins, MD, FACC,
Michael R. Nihill, MD, FACC, J. Timothy Bricker, MD. Section
of Cardiology, Department of Pediatrics, Baylor College of
Medicine and Texas Clfildren's Hospital, Houston, Texas.
Blade and balloon atrial septostomy (BBAS) has usually been
performed by pUlling the blade catheter through a preexisting
atrial opening. We have expanded this technique and now, in
selected cases, place the blade catheter across the interatrial
septum through a sheath introduced after atrial transseptal
puncture. Fourty-one of 88 BBAS procedures performed by us
have employed this method. Primary diagnoses included
transposition (Group I, n=16), left atrioventricular valve atresia
or severe stenosis, (Group II, n=12), double outlet right ventricle
with restrictive ventricular septal defect (Group III, n=2)
tricuspid and/or pulmonary atresia (Group IV, n=6), and
pulmonary vascular obstructive disease (Group V, n=5). Ages
ranged from 1 day to 21 yrs (mean = 2.8 yrs) and weights from
3.5 to 65 kgs (mean 12.8 kg). Eighteen pts had an intact atrial
septum prior to the procedure (7, Group I; 4, Group II; 2, Group
III; 5, Group V). In 23 pts, a restrictive natural ASD was present
initially and a second defect was created alongside it with the
blade. Adequate enlargement of the natural ASD was not possible
in these cases either because of unusual location, or because
of blade slippage. There were two deaths, both in critically ill
infants. Clinical improvement, sometimes dramatic, occurred in
36 pts. Improvement in groups IV and V was characterized by
an increase in systemic perfusion and decrease in right-sided
congestion. Improvement in groups II and III was associated with
a decrease in pulmonary congestion (mean left atrial to right
atrial gradient drop was from 17 to 4 mm Hg). Improved pts in
Group I showed substantial increases in oxygen saturation (mean
femoral arterial saturation increased from 62% to 73%). Thus
the technique of transseptal puncture substantially extends the
applicability and efficacy of BBAS.
PATHOLOGIC SEQUELAE OF BALLOON DILATION ANGIOPLASTY FOR
UNOPERATED COARCTATION OF THE AORTA IN CHILDREN.
William J. Marvin, MD, FACC, Larry T. Mahoney, MD, FACC,
Earl F. Rose, MD, University of Iowa, Iowa City, Iowa.
Vascular injury following balloon dilation angioplasty
(BOA) has been described in coronary, pulmonary, and
peripheral systemic arteries. After entry in an
institutionally reviewed prospective protocol, eleven
asymptomatic children (4-6 yrs) underwent BOA to treat
unoperated coarctation (CA) of the aorta. Follow-up
angiography revealed aortic aneurysms (AN) 7-14 mos.
after BOA in six of these eleven patients. We report the
pathologic findings in these six patients after surgery.
The adventitia was intact in all specimens. A single
AN was found on either the greater or lesser aortic
curvature in 5; one specimen had 2 AN. The AN ranged in
size from 20-50% of the total aortic circumference. All
former CA sites were torn linearly, but linear tears were
also present proximally (2) and distally (4) to the CA in
normal aortic media. No dissections or mural thrombi
were associated with either the AN or the linear tears.
Microscopically, each AN wall was markedly attenuated
with almost a complete absence of vascular muscle and a
variable loss of elastic lamella. In two specimens,
occlusive neofibroelastic proliferation developed in
juxtaposition to a linear tear, and distal to the former
CA. Preexistant CA tissue and secondary intimal fibrosis
were identified and distinct from this neofibroelastic
prol iferation.
Despite the early safety and efficacy of BOA in
relieving hypertension and CA obstruction, the
persistence of aortic tears and the development of both
AN and obstructive neofibroelastic proliferation may
compromise the eventual success compared to CA surgery.
Whether these lesions will appear later in other patients
is unknown and continual reevaluation is indicated.
BALLOON DILATATION iN INFANTS AND CHILDREN WITH
VALV AR AORTIC STENOSIS.
M Choy, MD, RH Beekman, MD, FACC, DC CrOWley, MD, AP
Rocchml, MD. C.S. Mott Children's HOSPital, University of
Michigan, Ann Arbor
We evaluated the efficacy of balloon dilatation (BD) m 1 mfant
and 4 children With valvar aortic stenosIs (AS) ages 7 months
to 14 years. The mfant had Critical AS and was m severe
congestive failure, and 2 of the 4 children had a prevIOus
aortic valvotomy. All patients were heparinized prIOr to
anglOplasty. The aortic valve gradient was determmed USing
Simultaneous LV and AO pressure measurements. The peak
systolic ejection gradient (PSFn) across the aortic valve, LV
and AO cmeanglograms and cardl8c Indexes (Cn were obtained
before and after the BD. The BD was performed In each
patient USing a balloon dl8meter (7 to 18 mm) that was 1 to
3 mm smaller than the aortic annulus d18meter. LV pressure
decreased from 178+9 to 150+8 mmHg (p<.05) (mean+SEM) and
PSFn decreased from 77:!:.14 to 37:!:.5 mmHg (p<.05). -Although
there were no Significant changes In HR (96+10 to 99+10) or
CI (3.3+ .3 to 3.3+.3 l/mm/m2), In the Infant With CritiCal AS
the Cllncreased Trom 2.4 to 3.3 and mixed venous saturatIOn
mcreased from 52 to 65%. There were no complications during
the procedures. Moderate AI was present m 2 patients
follOWing BD: one had mild AI prIOr to BD, and one (our first
patient) underwent BD With a balloon size only 1 mm smaller
than the annulus d18meter. These data indicate that BD IS a
safe and effective means of treating valvar AS, even m Infants
and post operative patients. In addition, a balloon 2-3 mm
smaller than AO annulus size should be used to mmlmlze the
development of AL
BALLOON DILATION ANGIOPLASTY OF POSTOPERATIVE AORTIC
OBSTRUCTIONS. J Phillip Saul MD, John F Keane MD, KennethE
Fellows MD, James E Lock MD FACC. Department of Cardiology,
Children's Hospital, Boston MA
Eighteen patients(3months-22years) with significant post-
operative aortic obstructions (gradient> 20nun1lg) underwent
balloon dilation angioplasty(BDA). Aortic obstructions fol-
lowed subclavian flap repair (SCF) for coarctation (n=6),
end-to-end(E-E) anastomoses for coarctation (n=5) , patch
angioplasty(PA) for coarctation (n=2) , E-E anastomoses for
interrupted aortic arch(IAA, n=4} and PA for hypoplastic
left heart (n=l) • One pt with E-E anastomoses for IAA had 3
sites of aortic narrowing postop, including 1 at the aortic
bypass cannulation site; thus a total of 20 obstructions
were dilated. Balloon sizes were chosen to be 2.5-3.0 times
the diameter of the narrowing: in 4 patients the first bal-
loon was too small, and a larger balloon (up to 4 times the
diameter of the narrowing) was needed.
BOA was successful (>50%decrease in gradient) in 18 of
20 obstructions and 16 of 18 patients: 6/6 postop SCF, 4/5
postop E-E for coarctation, 2/2 postop PA for coarctation,
5/6 postop anastomosis obstruetions (4 pts) for IAA, and
1/1 postop PA for hypoplastic left heart. Aortic obstruc-
tions increased in diameter post-BOA from 3.8± 2.3 rom to
6.9± 3.6 rom (p< O.Ol). Gradients across the obstruction
decreased from 4l±14mmHg to lH8mmHg (p< 0.01). In the
child with multiple postop IAA obstructions, the total
aortic gradient fell from l70mmHg to 35mmHg. Complications
were few; post-BOA pulse loss was successfully treated with
heparin/streptokinase. Followup (2-l2mos) shows sustained
relief in 8/9. Late angiography(n=4) revealed no aneurysms.
Previous reports have indicated that aortic obstructions
following SCF or E-E anastomosis for coarctation can be re-
lieved in most cases with BOA; these data further indicate
that BOA provides significant gradient and anatomic im-
provement in most forms of postop aortic obstructions.
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BALLOON VALVULOPLASTY FOR VALVAR PULMONARY STENOSIS USING
OVERSIZED BALLOONS. Wolfgang Radtke MD, John F Keane MD,
Kenneth E Fellows MD, Peter Lang MD, James E Lock MD FACC.
Department of Cardiology, Children's Hospital, Boston MA.
The optimum balloon size for safe and effective dilation
of valvar pulmonary stenosis(PS) is unknown. Although ani-
mal studies showed that the use of balloon diameters 20-50%
larger than the valve annulus is safe, its safety and effi-
cacy in children with PS has not been evaluated.
In lB pts (6day-19yrs) with typical valvar PS, percutan-
eous balloon valvuloplasty(BV) was attempted using balloon
diameters 0-65% (m=36%)larger than the angiographically de-
termined annulus size(corrected for X-ray magnification) .
A twin balloon technique was employed in 3 pts; in those,
the cross sectional area of the oval enveloping the two bal-
loons was calculated; the diameter of a circle with an area
equal to this oval was taken as the effective dilating di-
ameter. Two pts had had previous surgical valvotomies; two
others had had previous BV at other institutions.
Significant reduction of transvalvar gradient (33-100%,
m=72%) occurred in each patient. The mean pre-BY gradient
of 64rnrnHg (2S-l20rnrnHg) was reduced to l7rnrnHg (0-3OrnrnHg).
The calculated valve areas increased by an average of lBO%.
No significant pulmonary regurgitation was noted, and no
complications occurred.
Two groups (Kan et al. and Rocchini et al.) have pre-
viously reported series of BV in PS giving actual balloon
diameters (designed to be at or near annulus size). In
those reports, mean patient age (4.B yrs) was similar to
ours (5.0 yrs); the average balloon size in those series
(13.6rnm) was smaller than our average balloon size(lB.Ornrn).
Despite similar predilation gradients, the gradient reduc-
tion using larger balloons was somewhar greater(72 vs SB%)~
These data suggest that BV in PS with balloons 30-40%
larger than the annulus is safe, and may result in improved
gradient reduction.
BALI.a:l'1 DIIATATlOO OF SHUNl'-RElATED PUIM:NARY ARl'ERY
Sl'ENOS&S AFl'ER 'l'E'l'RAL(X;Y OF mILO!' REPAIR: FARLY AND SEDR!'
TEIlM RESU11I'S. Guillerno R. sanChez, MD, A.V. Mehta, MD,
S.E. Brickley, OCPl', !oF.S. Black, MD;-St. Christopher's
fbspital for Orildren and TEmple U. SChcxll of Medicine,
Phila., PA.
Pulrronary artery steooses (PAS) in pta with 'IOF
<lCI1plicate the long tenn course and may oot be surgically
correctable. We att.erlpted balloon dilatation (ED) of 8 PAS
[5 in RPA (4 at Waterston, 1 at BT): 3 in proximal IPA (1
atlrear Gortex shunt)] in 5 pts after 'IOF repair. Balloon
diameter was 2-5x RPA and 2-3x IPA steooses diameter.
Inflation pressure was 59-lin (RPA) and 66-B8 (IPA) psi.
BD result was assessed by pressure and cardiac ootput
measurement, angiografhy, and radionuclide study. BD of
LPA produced inprovement in 1 pt (RV pre: 160, post: 105
1ITllH:J: sustained over 6 ItO) but oot in 2 pts (despite
increase in IPA size fran 6 to H'l mo in 1 pt sip Gortex).
BD of RPA in 1 pt sip Waterston (pt A) increased RPA size
fran 4 to 14 mo but produced little inprovement in
pulrronary flow pattern or RV pressure, related
harcdynamically to the size of the non-stenotic proximal
RPA, in 2 pts (sip Waterston) produced 00 inprovement in
RV pressure despite small increase in RPA size, and in 2
pts (sip Waterston, sip BT) failed to obliterate the waist
(at inflation pressures of 103 and 66 psi). No early
<lCI1plications occurred. Follow-up catheterization in pt A
shows restenosis at previous site (RPA 8 mo) 5 ItO after BD
and in a second patient (sip Waterston) shows perfusion
deficits in the right lung 6 ItO after angioplasty.
We conclude: 1. RPA steoosis at previoos shunt is often
poorly <lCI1pliant, 2. increase in PA size after BD is oot
always accxxtparlied by ~ved RV pressure (and thus may
not be clinically significant) and may regress, 3) follow
up studies after apparently su=essful BD of PAS are
necessary.
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QT INTERVAL AND THE SUDDEN INFANT DEATH SYNDROME.
A PROSPECTIVE STUDY.
Alessandro Segantini,M.D., Tiziana Varisco,M.D., Emanuela
Monza,M.D., Valeria Songa ,M.D., Massimo Montemerlo,M.D.,
Patrizia Salice,M.D., Gianluigi Poggio,M.D., Dario Rosti,
M.D., Peter J.Schwartz,M.D.,F.A.C.C.
Istituto Clin. Med. IV, Universit~ di Milano, Italy
In 1976 we proposed that part of the Sudden Infant
Death Syndrome (SIDS) may be due to ventricular fibrilla-
tion triggered by increased sympathetic activity. De-
creased cardiac electrical stability would be enhanced by
a transient developmental imbalance in cardiac sympathetic
innervation. Prolongation of the QT interval is one of the
markers of such an imbalance. Over 9500 non-consecutive
newborns entered a prospective study started in 1977 and
had an ECG taken on 4th day of life. One year survival
data are now available for 6000 infants. There have been
6 SIDS and 4 non SIDS deaths. From our data base, QTc va-
lues> 433 msec exceed the mean by more than 2 standard
deviations (397+18, x+1SD) and are considered prolonged.
non SIDS (n=4) - Qrc: 363,400,401,406
SIDS (n=6) - QTc: 440,440,451,460,480,563
Given the number of newborns with a QTc>433, our data sug-
gest that the risk for SIDS, associated with a prolonged
QT is approximately 40/1000 live births. Although more
data on SIDS victims are still necessary, even a conser-
vative analysis indicates that at least some of the future
SIDS victims can be expected to have a prolonged QT inter-
val. This may allow early identification of some infants
at high risk for SIDS.
THE PElIMA1IBNT FORM OF JUNCTIONAL RECIPROCATING
TACHYCAllDIA: Ii. CAUSE FOR CHRONIC SUPRAVENTB.ICULAIl.
TACBYCAllDIA IN CHILDREN.
Richard T. Smith, Jr., MD Kim D. Armstrong, RN, Janette
Strasburger, MD, Jeffrey 2. Moak, MD, Arthur Garson, Jr.,
MD, FACC.
Chronic "incessant" supraventricular tachycardia (SVT)
has most frequent 1y been considered to oe due to an
atrial ectopic focus (AET). We report 22 cases of
chronic reentrant SVT due to the permanent form of
j unct ional reciprocat ing tachycardia (PJRT).
Differentiation of PJRT from AET is possible by their
characteristics and imRortant because treatment differs.
PJRT criteria were: . 1} "Incessant" SVT present greater
than 10% of a 24 hour period, 2) Visible P waves during
SVT, negative in the inferior leads, 3) Normal or near
normal PR interval during SVT 4) Lack of "warm-up" at
SVT onset, 5) E1ectrophysio{ogic study supporting a
reentrant mechanism. Mean age at diagnosis was 3.9 yrs
(range-fetal to 16 yrs). SVT rate on initial ECG ranged
from 125 to 230 with a mean of 167. In each pt marked
SVT rate variation occurred throughout a 24 hr period; 34
to 125 bpm (Max. minus Min. rate). Myocardial
dysfunction (MD) was documented in 11/22 (50%). To
detect differences between pts with MD and without, we
compared the 2 groups. There was a tendency toward MD
with higher rates, greater daily frequency and longer
duration since diagnosis. The groups significantly d1f-
fered when the 3 factors were combined. The pts received
an average of 3.8 drugs; a traditional drug was effective
in only 1/22 (verapamil). The investigational agent.
encain1de, completely suppressed SVT in 5/9 pts ana
improved control in the other 4. Catheter ablation
improved SV! in 4 pts, however 3 required permanent
pacing and 3 rece ived adjunct ive medicat ion. SV! was
successfully treated surgically in 4/4 pts; 2 had
dissection of the poster1or septum and developed AV
block. The most recent 2 pts had cryoablation of the
posterior septum and are cured of SVT with normal AV
conduction. We conclude: 1}"PJRT" is a common cause of
chronic incessant SV! and should be suspected in pts with
re1at ive1y slow SVT with negat ive P waves in 1eaCls 2, 3
and aVF 2) Differentiation of pts who will develop MD is
difficult and dictates close follow-up, 3) Treatment of
SV! is usually not effective with traditional medical
management, 4) Encainide is frequently effective in
suppressing SVT, 5) Cryoablation of the posterior septum
has been curative without producing complete AV block.
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SUPRAVENTRICULAR TACHYCARDIA DUE TO MULTIPLE ATRIAL
ECTOPIC FOCI: A RELATIVELY COMMON PROBLEM. Arthur
GarsonRoJr •• MD, FACC, Richard T. Smith, Jr.,~effrey
Moak, ,David A. Ott, MD, Paul C. Gillette, MD, FACC,
Victoria L. Evans, MD, and Pat M. Duncan, RN. Lillie
Frank Abercrombie Section of Cardiology, Texas Children's
Hospital, Houston, Texas.
Atrial ectopic focus (AET) is a common mechanism for
chronic "incessant" SVT in children. The majority of pts
require treatment because of symptoms or tachycardia-
induced cardiomyopathy. Management with traditional drugs
fails to restore sinus rhythm and surgery has been thought
to be curative. We have had 32 pts with AET; 18 had
attempted surgical treatment; all 18 had a single abnormal
P-wave axis before surgery, had mapping in the EP lab, and
were thought to have a single focus. However, in 9/18
(50~) after surgical removal of this focus, additional
foci became apparent. In 6/9, the next focus appeared
during surgery; between 3-15 additional foci were
identified and surgically treated. This resulted in cure
in 4/6 but 2/6 deapite almost total atrial disconnection,
continued to have AET. The other 3 pts with multiple foci
had AET recur with a different P-wave axis from 1 wk-2 mo
postop. These have not had reop. Since the overall success
rate for multiple foci (MF) (4/9) was so different from
single foci (SF) (9/9), we compared MF and SF to try to
predict MF. MF had: the same incidence of cardiomyopathy
(78~), faster maximum atrial rate on Holter (89~ of MF
>160/min vs 43~ of Sf, P<.05), faster minimum atrial rate
on Holter (89~ of MF >70/min vs O~ Sf, P<.05), and
different preop ECG (O~ Mf had left atrial P-waves vs 44%
of Sf, P<.025). In conclusion: 1. Approximately half the
pts with AET had Mf. 2. Surgical treatment of Mf is less
successful than Sf. 3. Mf are unlikely with LA P-waves
and slower atrial rates. We speculate that AET may have
different etiologies: MF may be due to extensive atrial
disease such as that found in primary cardiomyopathy or
after myocarditis, whereas Sf may be a developmental
aberration.
ENCAINIDE: A SPECIfIC DRUG fOR PERMANENT JUNCTIONAL RECI-
PROCATING TACHYCARDIA (PJRT) IN CHILDREN. Janette
Strasburger, MD, Richard T. Smith, Jr., MD, Jeffrey P.
Moak, MD, Pat McVey, RN., Arthur Garson, Jr" MD. Lilly
frank Abercrombie Section of Cardiology, Texas Children's
Hospital, Houston, Texas.
The permanent form of junctional reciprocating tachycardia
(PJRT) is responsible for half of the cases of incessant,
chronic supraventricular tachycardia (SVT) in childhood.
It has alao been called "atypical AV node reentry" or
"fast-slow" SVT and is thought to be due to a slowly con-
ducting type of bypass tract that forma the retrograde
limb of SVT. PJRT is resistant to all conventional anti-
arrhythmic drugs. Encainide (E) slows conduction in both
the AV node and bypass tracts in adults with SVT. Because
of these properties, we gave oral E to 9 children, ages 12
months to 19 years (median 4 years) with PJRT refractory
to 1-4 previous medications. PJRT was present 10-100% of
day with heart rates of 187-274/min. four of 9 had secon-
dary cardiomyopathy. Effective E doses ranged from 60 to
120 mg/m2/day given OlD. E caused prolongation of 22%
in PR, 21~ in RP, 34% in ORS, and 10~ in corrected OT in-
tervals. Eighty percent of SVT episodes terminated in the
retrograde direction. In 1-6 months follow-up, E was ef-
fective in 7/9: E alone eliminated 9~ of incessant SVT
episodes in 5/9 patients (pts). E efficacy increased when
combined with verapamil or propranolol in 2/9; the other 2
had inadequate response to combined therapy. No pts ex-
perienced symptoms from the drug. One pt had a ventri-
cular tachycardia episode on 99 mg/m2/day related to ORS
aberrancy. Left ventricular shortening fractions improved
in all 4 pts with cardiomyopathy from a mean of 26 to 38%.
Encainide is a very effective drug in PJRT, a previously
untreatable form of SVT. Cardiomyopathy resolved in chil-
dren when encainide effectively controlled PJRT.
ELECTRICAL ABLATION OF ATRIAL MUSCLE: EARLY
AND LATE ELECTROPHYSIOLOGIC OBSERVATIONS IN
CANINE ATRIA
Jeffrey P. Moak, MD, Richard A. Friedman, MD, Gt"egory
Clark, Arthur Garson Jt"., MD, FACC, Texas Childt"en's
Hospital, Houston, Texas.
Control of ectopic RA focus tachycat"dia or t"eciprocating
AV tachycardia has been attempted with the electt"ode
catheter ablative technique (ECA). This procedure has
had vat"iable effectiveness. Our purpose was to assess
the electt"ophysiologic effects of ECA on atrial tissue,
one of the determinants of ablation efficacy. Eight
beagle puppies (p) undet"went RA ECA using an enet"gy dose
between 100-200 joules. Twenty-four hrs after ECA, the
RA ft"om 4P was studied by standard microelectrode
techniques (ME) (group I). Four P had a clinical EPS
prior to and 11 wks after ECA. These 4p were then
studied by ME (group II). The ce11ulat" atrial action
potential chat"acteristics in the ECA bordet" zone of
Group I was: MDP- 76 +/- 2 vs 60 +/- 4* JDV; V
max- 168 +/- 24 vs 68 +/- 31* V/sec; APD 90- 147 +/- 12
vs 149 +/- 28 msec in normal cells (NC) and ablated
cells (AC), t"espectively. (*-p<.05). A central zone of
"dead cells" (DC) was observed in the ECA region.
Periphet"al to this centt"al zone were islands of DC
surrounded by NC. No spontaneous automatic rhythms wet"e
observed and no trigget"ed activity was elicited in group
1. In gt"oup II, clinical EPS showed inducible NS Atr
Fib in 4/4P. Prior to ECA, 1/4 P had inducible NS Atr
FIt. ME study showed MDP- 76 +/- 1 vs 73 +/- 2* JDV;
V max was 164 +/- 20 vs 134 +/- 27* V/sec; APD
90- 140 +/- 8 vs 134 +/- 21 in NC and AC, respectively.
Conduction block into the central ECA region occurt"ed in
all 4P; 2/4P had inducible atrial echoes in vitro. In
conclusion, ECA can nect"ose small at"eas of atrial
muscle. Clinical failures of ECA may be secondary to
NC within the ECA region. ECA may produce a substrate
responsible for late t"eentrant atrial art"hythmias.
AUTOMATIC ECTOPIC ATRIAL TACHYCARDIA IN CHILDREN: IS
ABLATION NEEDED?: Ashok V. Mehta, MD, FACC; L. Ewing, MD;
E. Sacks, MD, FACC; A. Balian, MD; G.R. Sanchez, MD; St.
Christopher's Hospital for Children & Temple Univ. School
of Medicine, Phila., PA.
Automatic ectopic atrial tachycardia (AAT) is uncommon,
and considered generally resistant to medical therapy;
surgical or catheter ablation has been recommended. We
followed 8 AAT patients (pts) with the following features:
3 males,S females; age at onset: intrapartum-15 yrs (me-
dian 2 yrs); no family history of SVT; no structural heart
disease; LV dysfunction clinically in 3 pts and by echo-
cardiogram in 5/7 pts; rate 220 to 280/min in 7 pts; "p"
axis during SVT 0 to +90· in 6 pts and 0 to -90· in 2 pts.
The diagnosis was confirmed by EP study in 6 pts.
Digoxin (D) alone did not initially suppress tachycardia
in 7/7 pts but improved LV function. Class lA agents (IV
procainamide 2 pts, oral quinidine 3 pts) worsened the AAT
in 4/5 pts. D+propranolol suppressed AAT in 2/5 pts (both
newborn) and propranolol alone in 1 pt. One pt had unsuc-
cessful surgical ablation of the ectopic focus and another
had unsuccessful transcatheter electrical ablation (25
joules). Three pts had a successful trial of IVamiodarone
during EP study. Four pts, who were maintained on oral
amiodarone, had good control of AAT (52 pt-months). During
follow-up of 10 months to 7.5 yrs (median 2 yrs), 3 pts
were free of AAT without medications, 3 pts were well con-
trolled on medication (2 pts amiodarone, 1 pt D), 1 pt on
amiodarone, who had unsuccessful surgical ablation and
permanent VVI pacemaker, died suddenly, and 1 pt was lost
to follow-up.
We conclude that 1) Digoxin+propranolol or amiodarone (IV
and oral) is helpful in suppressing AAT, 2) Class lA
agents are contraindicated in AAT 3) AAT may resolve spon-
taneously during follow-up (3/7 pta) and surgical or cath-
eter ablation may not be warranted.
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Myocarditis: Biopsy
INTEROBSERVER VAR1ABlLlTY IN THE PATHOLOGIC
DIAGNOSIS OF ENOOMYOCARDlALBIOPSlES
JeffreyG. Shanes, M.D., F.A.C.C., Jalal Ghali, M.D., Margaret
E. Billingham,M.D., F.A.C.C., VictorJ. Ferrans, M.D., Ph.D.,
John J. Fenoglio, M.D., F.A.C.C., William E. Edwards, M.D.,
F.A.C.C., Cheng C. Tsai, M.D., JeffreyE. Saffitz, M.D., Ph.D.,
Jeffrey Isner, M.D., F.A.C.C., Jose Manaligod, M.D., Ph.D.
George T. KondOS, M.D., RamiahSubramanian,M.D., University
ofminoisHospital,Chicago,minois.
Controversy exists over the value of endomyocardial
biopsy(EMB)in evaluatingpatients(pts)with dilated cardiomyo-
pathy(DCM) particularlyIn regards to detecting myocarditis
and the value of EMB in assessing prognosis. Interobserver
variability,If high, could explainconflictingreports. To assess
for this, we submitted biopsyspecimensfrom 16 pts with DCM
to 7 cardiac pathologists(ABCDEFG). The same slides were
independentlyreviewed by each and assessed for fibrosis(F),
hypertrophy(H),nuclear changes(NC), on a 0 to 3+ scale, mean
lymphocyte count per HPF (LC) and myocarditis(M). The
percentincidenceof significant(~2+) F,H,NC,LC > 5 celis/HPF
and diagnosedmyocarditisor borderlinemyocarditis(BM) was:
ABC 0 E F G
F(%) 25 25 13 43 38 6 25
H (%) 69 44 31 19 13 88 88
NC(%) 69 38 43 31 69 75 43
LC(%) 19 13 0 13 31 0 0
M (%) 0 25 0 13 38 0 6
BM(%) 6 18 0 13 6 6 0
One or more pathologistsdiagnosed either myocarditis or
borderlinemyocarditisin 11 of the 16 pts. Of these 11 pts, 4
pathologistsagreed in 1 pt, 3 in 2 pts, and 2 pathologistsagreed
in 3 pts.
We conclude that interobservervariability is high in inter-
preting biopsy specimens from pts with DCM. This study
supports that quantitativeand standardizedmethodsare needed
to increasediagnosticconsistency.
RARITY OF MYOCARDITIS ON ENDOMYOCARDIAL BIOPSY IN
PATIENTS WITH NEW ONSET IDIOPATHIC CONGESTIVE HEART
FAILURE. A HISTOLOGIC AND ULTRASTRUCTURAL,
IMMUNOHISTOCHEMICAL AND VIRAL SEROLOGIC ANALYSIS OF
72 PATIENTS
Bruce f. Wall er, M. D. F.A.C.C .• John D. Slack, M.D.,
F.A.C.C., James C. Dillon, M.D., F.A.C.C., Michael J.
Mirro, M.D. F.A.C.C., Kevin Kelly, M.D. F.A.C.C.,
Russel P. Valentine, M.D. F.A.C.C., Moo Noo Yum,
M.D., Morris L.V. French, Ph.D. Indiana University
Medical Center, Indianapolis.
Marked diagnostic variability (3 to 63~) exists in
the evaluation of endomyocardial biopsies (EMB) in
clinical settings in which acute myocarditis is
suspected. We performed a comprehensive laboratory
analysis of EMB and blood serum from 72 patients
(pts) (aged 17-64 years, mean 41;54 males) with onset
of congestive heart failure 2 to 24 weeks (mean 63
days) before EMB each pts was clinically suspected of
haVing myocarditis. We assessed 360 EMB from right
(43 pts, 215 EMB or left (29 pts, 145 EMB)
ventricular walls with light and electron microscopy,
immunohistochemical tissue markers, and viral
cultures. In addition, neutralization or complement
fixation titers for 22 viruses were analyzed on blood
serum. Histologic results were: possible
myocarditis = I (2~) pt, no myocarditIs = 71 (98~)
pts. Electron microscopy dId not alter the
histologic diagnoses. All samples for vIral culture
were negative and all serologIc serum testing was
nondiagnostic for recent viral infections. Thus, we
found an extremely low frequency (2~) of myocarditis
on EBM (2~) in a population of pts clinically
suspected of myocarditis. Multiple laboratory
studies beyond lIght mIcroscopy did not alter the
frequency of myocarditis diagnoses.
HETEROGENOUS ADRENERGIC RESPONSE OF THE MYOCARDIUM TO
CONGESTIVE FAILURE.
Gordon L. Pierpont, M.D., Ph.D., F.A.C.C., Gary S.
Francis, M.D., F.A.C.C., Eugene G. DeMaster, Ph.D., Maria
T. Olivari, M.D., W. Steves Ring, M.D. and Jay N. Cohn,
M.D., F.A.C.C., VA Medical Center and University of
Minnesota, Minneapolis, Minnesota.
The adrenergic nervous system is likely important in the
pathophysiology of congestive heart failure (CHF). Pre-
vious studies have suggested that normaly high concen-
trations of myocardial norepinephrine are depleted in CHF
because of high adrenergic tone. We tested the general
applicability of this theory by examining left ventricu-
lar catecholamines (multiple biopsies) and plasma norepi-
nephrine (NE) in 28 patients (pts) with severe CHF under-
going cardiac transplantation. Plasma NE was elevated in
all (ave. 828.:529 Jl g/ml) , but cardiac NE was quite
variable, ranging from 79 to 2,127 ng/gm (ave. 491+402).
Cardiac dopamine (DA) also varied considerably (r;nge 0
to 713, ave. 154.:164 ng/ gm). Cardiac epinephrine was
consistent ly low or undetectable. Fourteen pts had the
classic pattern of low cardiac NE and elevated DA, con-
sistent with high adrenergic tone depleting NE while DA
increases because of DA conversion to NE being the
rate-limiting step in NE synthesis. On the other hand,
cardiac catecholamines were normal (high NE, low DA) in 5
pts; both NE and DA low in 3 pts; and NE levels preserved
but DA high in 6 pts. Cardiac NE correlated only weakly
with age (r= -.45, p<.05), and examination of multiple
other variables failed to reveal likely causes of the
differences in cardiac NE and DA. We conclude that the
cardiac adrenergic response is not uniform among pts with
severe CHF, and further attempts to delineate the factors
regulating cardiac catecholamine concentratration and
adrenergic function in such pts are needed.
EXPERIMENTAL CANINE MODEL OF HEART FAILURE PRODUCED BY
RAPID VENTRICULAR PACING: CARDIAC EFFECTS
John R. Wilson, M.D., Nancy Ferraro, R.N., Rita A.
Falcone, M.S., Pamela Douglas, M.D., William Hickey, M.D.,
Ali Muhammad, Nathaniel Reichek, M.D.
Hospital of the Univ. of Pennsylvania, Philadelphia, PA
Chronic rapid ventricular pacing reportedly produces a
useful model of low output heart failure in the dog.
However, little information is available regarding cardiac
morphological and functional changes in this model.
Accordingly, we compared hemodynamic, echocardiographic,
and post mortem cardiac findings in 9 control dogs (C) and
in 8 dogs paced continuously at 260 beats/min for 3 weeks
(P). Echo studies in P dogs were performed with pacers
temporarily reprogrammed to 20 beats/min. At 3 weeks, the
paced dogs exhibited reduced cardiac outputs (C: 147±21 vs
P: 112±19 m1/min/kg) and elevated pulmonary wedge (C: 8±3
vs P: 26±5 mmHg) and right atrial pressures (C: 3±2 vs
P: 13±3 mmHg) (all p<.OOl). Over 3 weeks, left ventricu-
lar (LV) echo diastolic dimension increased in paced dogs
(3.6±.6 to 4.3±.6 cm (p<.Ol)) but not in C dogs (3.2±0.4
to 3.4±.5 cm (p=NS)). Pacing also decreased overall %LV
shortening (34±6% to 17±7%) associated with a dispropor-
tionate deterioration of posterior wall thickening (58±16%
to 17±18%) (p<.Ol). At post mortem, paced dogs had larger
LV volumes (C: .8±.3; P: 1.4±.3 m1/kg body weight) and RV
volumes (C: .8±.2 vs P: 1.3±.4 m1/kg) (both p<.OOl). LV
and right ventricular mass were similar in both groups. In
3 additional paced dogs, echo and hemodynamic data were
serially measured for 3 weeks after termination of pacing.
Cardiac hemodynamic and echocardiographic abnormalities
returned to baseline by 1-2 weeks. These data suggest that
rapid ventricular pacing in the dog produces reversible
biventricular dilation and failure with severe regional
dysfunction of the posterior LV wall.
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ANTHRACYCLINE CAl DIOTOXIClTY tx DILATED
CARDIOMYOPATHY: fI..ORPHOMETRIC DISTINCTIONS
Reed A. Rowan. Ph.D., Marilyn A. Masek, B.A., and Margaret
Billingham, M.B., B.S., F.A.C.C., Department of Pathology,
Stanford University School of Medicine, Stanford, CA.
Computer-assisted ultrastructural morphometric methods
were used to measure right ventricular endomyocardial
biopsies from 10 patients with idiopathic dilated
cardiomyopathy (IDCM) and 10 cancer patients with
anthracycline cardiotoxicity (AC), and in control biopsies
from 10 healthy transplant donor hearts. Our purpose was to
establish a standard for representative cases to be used for
diagnostic grading and research. Results are presented in the
following table as a mean ~ SE (* indicates a significant
difference vs controls, p< 0.01 or less).
~ .JQQL ~
myocyte wldtll, ~m 18.8!O.5 29.2:!:.9· 19.2!O.1'
nuclear are.. lIm2 45.2!1.9 88.8!5.S' 54.2:t3.O*
nuclear form factor O.44!O.OI O.28!O.OI' O.46!O.Ol
nucleolar area, pm2 2.21!O.O9 2.55!O.16 2.54!O.IS
nucleoli per nucleus I.03!O.02 1.6!O.O9' 1.3:!:O.OS*
mitochondrial are., lIm2 O.35!O.OI O.32!O.O2 O.33!O.OI
m,oeyttl < 25 ~m width
mitochondrial ere.. 0.28:0.01- O.28!O.O2'
myoeytes > 25 pm width
mitoehondrial area. O.28!O.Ol* 0.27:0.01*.
elteeted m,cw/t..
These results sho , that hypertrophy and bizarre nuclear form
is significantly greater in IDCM than AC, suggesting not only
a different mechanism of development but also a possible
difference in the rate of progression of the two conditions.
DOES REPEAT ENDOMYOCARDIAL BIOPSY AID IN THE DIAGNOSIS
OF ACTIVE MYOCARDITIS? G. William Dec, M. D., JOM T.
Fallon, M.D., Ph.D., Judith M. Scheer, RN, James
Southern, M.D., Ph.D., Igor F. Palacios, M.D.,
F.A.C.C., Massachuaetts General Hospital, Boston, MA.
The diagnosis of myocarditis requires pathologic
confirmation of myocardial necrosis (MN) and cellular
infiltration (CI). Yet, myocarditis is a focal or
multifocal process and sampling error during
endomyocardial biopsy (bx) may occur. We studied the
role of repeat bx in 13 patients (pts) in whom the
clinical suspicion of myocarditis was high but whose
initial right ventricular (RV) bx failed to provide
histologic confirmation. All pts presented with
dilated cardiomyopathy, a left ventricular ejection
fraction < .40, and symptomatic heart failure. Heart
failure was of six months duration or less in 10 pts;
3 pts had at least one previous episode of
biopsy-verified myocarditis and had repeat bx
performed at the time of worsening symptoms to rule
out disease reactivation. All pts underwent repeat RV
bx and 10 pts concurrent left ventricular (LV) bx
between 1-4 weeks of initial RV bx. Repeat bx
demonstrated non-specific histologic findings
including myocyte hypertrophy and interstitial
fibrosis in 11 pts. Myocarditis was diagnosed in 2
pts (15%). MN and CI were detected on RV bx in I pt
and on both RV and LV biopsies in another pt whose
initial RV bx one week before had been negative. In
addition, no ~stologic differences were seen between
concurrent RV and LV biopsies. We conclude that
repeat RV or LV bx can identify an additional number
of pts with myocarditis which was not identified on
initial RV bx.
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Control of Contractile Function
MECHANISM OF POST-EXTRASYSTOLIC POTENTIATION.
Judith K. Gwathmey, V.M.D., Ph.D., Roderick MacKinnon,
M.D., James P. Morgan, M.D., Ph.D. Beth Israel Hospital,
Boston, MA.
We tested the hypothesis that the positive inotropic
effect of post-extrasystolic potentiation (PEP) is dU~
to a¥ increased availability of intracellular Ca2
([Ca2 )i) for activation of the myofilaments by use of
aequorin, a bioluminescent wdicator that emits light
(L) when it combines with Ca 2 • Papillary muscles of < 1
mm diameter were isolated from adult male ferrets, and
perfused in an oxygenated physiologic salt solution at
30·C. Aequorin was loaded chemically; L and isometric
tension (T) were simultaneously record~. In the figure
below, panel (A) shows T, L (i.e., [Ca2 )i) and stimulus
artifact (S) when the muscle was stimurated at 5 sec
intervals. Panel (B) shows T, L, and S when the muscle
was given a pair of stimuli 0.5 sec apart at 5.5 sec
intervals. Following the first stimulus of the pair the
amplitudes of both Land T were significantly increased.
These results demonstrate that PEP and the positive
inotropic effect of paired stimulati~n are associated
with an increased availability of [Ca2 )i for activation
of the myofilaments.
AL.,.._L!J~L.
~~T_A,-1~
1 ",,1_--;:--__--1 j
5 sec
Spcntanecus CCrltractions in Rat cardiac MJacle
Peter P. de Tootle, B.SC., Ha1k E 0 J ter' Keur's, M.D., ftI.D., 8ar'bar'a J M
Mlldel", M.D., !lJcio Ricciar'di, M.D.; The Univel"sity of caJgFy, Alber'ta,
canada
Calcium over-load of car-diac cells leads to sprntaneals contractions (SC)
which may lead to arrhythmias. SC were studied in rat cardiac
trabeculae, SJPel"fused with oxygenated Kl"ebs-Henseleit solution at 21 C
wi th Nomarsky microscopy carbined with analysis of video J"eC(l"(lil"gs and
laser diffr'action techniques. Propagation of SC oocurred at low stinlllus
rates within the limits of one cell as regional waves of sarcarere
shcrtenil"g ;,hich propagated at low speed «50 If!l/s) <r as synchronized
contractile waves ;,hich traveled fr'an intercalated disc to intercalated
disc at a speed of 75 to 125 If!l/s. In each case SC were absent in the
first 400 rrrec following a twitch. After a train of electrically evd<ed
contractions at 2 Ifz, sprntaneals local sarcomere shortening was ob-
served throughout a 250 JJlIl long region close to one end of the
preparatioo, danBged by dissection. The wave of local sarcomere short-
ening prqJagated al~ the W10le trabecula. The velocity of prq:lagatioo
increased fr'an 0 to 10 mn/s in proportion to the ll.IIIber of stilmlli (3-
30) in the train at external calcium ion CCI1C€l1tration of 1.5 nt1. At a
constant I1JIItler' of stinllli, the velocity of prcpagation increased from
0-15 mm/s with increasing extracellular calcium ioo CCI1C€l1tration.
Propagation of SC at low and variable velocity is consistent with the
hypothesis that calcium leakage into danaged cells induces calcium
release fr'an the sarcoplasnic reticulum. This process propagates as a
result of diffusion of calcium into adjacent cells W1ich may trigger
calcium release fr'an their sarcoplasnic reticulum. The observed prqJaga-
tion velocities ceuld be predicted with the aid of a llBthematical nodel
of calcium induced calcium release.
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NORMAL INOTROPIC RESPONSE OF THE HYPERTROPHIED LEFT
VENTRICLE TO SPECIFIC a1 ADRENERGIC STIMULATION IN
CONSCIOUS DOGS. Alan MFujii, MD, Israel Mirsky, PhD,
Juan Serur, MD, Ann Als, MD, Stephen F Vatner, MD.
Harvard Med Sch, NE Reg Primate Res Ctr, Southboro, MA
Reduced inotropic responsiveness to a adrenergic re-
ceptor agonists norepinephrine and isoproterenol,
agents which substantially affect afterload, is com-
monly reported in anesthetized animals with LV hyper-
trophy (H). We studied inotropic responses to prenal-
terol (PRE), a specific a1 adrenergic receptor agon-
ist which has little effect on afterload, in conscious
dogs with severe LVH induced by aortic (A) banding in
puppies. One to 2 yrs later the dogs with LVH [LV/body
weight ratio 7.0z0.4 vs 4.0z0.2 g/kg (p<0.01) in con-
trol dogs] were instrumented with ultrasonic crystals
to measure LV diameter (D) and wall thickness, minia-
ture LV pressure (P) transducers and Acatheters. Base-
line LV systolic/end-diastolic P was 115z2/8z1 mmHg in
controls and 221z12/11z1 in dogs with LVH. In 6 con-
trol dogs PRE (8 meg/kg/min) increased LV dP/dt from
3174z299 to 5210z523 mmHg/sec, dD/dt/D from 1.77z0.06
to 2.7SZ0.22/sec and mean velocity of circumferential
fiber shortening (VCF) from 1.25z0.08 to 1.72z0.11/sec,
while mean AP and mean systolic wall stress did not
change from 96z3 mmHg and 193z17 dynes/cmZ, respec-
tively. In 6 dogs with LVH PRE increased LV dP/dt from
3129Z70 to 5611z348 mmHg/sec, dD/dt/D from 1.69ZQ.21 to
2.60z0.31/sec and VCF from 1.1SZ0.14 to 1.82z0.20/sec,
while mean AP and mean systolic wall stress did not
change from 93z5 mmHg and 220z14 dynes/cmZ, respec-
tively. Thus, in conscious dogs with severe stable
chronic LVH, baseline LV function is normal as is the
inotropic response to a adrenergic receptor stimulation
in the absence of a significant change in afterload.
BOTH PHENYLEPHRINE AND METHOXAMINE AFFECT LEFT
VENTRICULAR CONTRACTILE PERFORMANCE
Marvin W. Kronenberg, M.D., F.A.C.C., David W. Grambow,
Robert W. McCain, Robert J. Boucek. M.D •• Gordon A.
Moreau. M.D •• Kiichi Sagawa. M.D •• Gottlieb C.
Friesinger, M.D •• F.A.C.C., Vanderbilt U•• Nashville. TN.
Pharmacologic vasoconstriction is used to study left
ventricular (LV) systolic pressure-volume relations in
man, but the effects of these agents on the myocardium
itself are understood incompletely. The effects on
contractility of phenylephrine (PE) and methoxamine (MTX)
were studied using dose-response relations. Isovolumic LV
pressure (LVP) was employed to estimate contractility in
isolated blood-perfused rabbit hearts (N-14) (Expt. 1).
Mean arterial pressure (MAP) changes were studied in
intact rabbits (N-10) (Expt._~). 10-4M MTX
%Change vs. Control 10 M PE
CONTRACTILE PROTEIN CONTENT IS INCREASED IN HYPERTROPHY
STIMULATED BY NOREPINEPHRINE BUT NOT BY A PHORBOL ESTER:
AN EXAMPLE OF PATHOLOGICAL HYPERTROPHY IN CULTURED
NEONATAL RAT HEART MUSCLE CELLS
Nea 1 White, M.D., Tanny Tsao, M.S. and Paul Simpson,
M.D.,F.A.C.C. VAMC, CVRI and Univ. Calif., San Francisco
We have previously found that norepinephrine (NE)
stimulates hypertrophy of nondividing neonatal rat heart
muscle cells in serum free cultures and that this
response is mediated by an alpha-1 adrenergic receptor.
A tumor promoter. phorbol 1Z-myristate 13-acetate (TPA)
also stimulates hypertrophy. We asked whether
contractile protein content was increased in these two
types of hypertrophy. Cell cultures were treated for
48-72 hours with NE (2pM), TPA (20-200nM) or TPA + NE
(20-200nM and 2-20pM respectively). Total Protein (TP).
was quantified by the method of Bradford and by a
radioisotopic assay; and myosin heavy chain (MHC), by
densitometry after SDS-PAGE. NE increased TP and MHC
per cell. TPA increased TP but did not change MHC. TPA
+ NE was simi lar to TPA alone.
TP * MHC * MHC/TP *
CONTROL(n=6) IUO TOO 100
NE (n=5) 158.7z11.8 AA 209.7z19.7 AA 133.6z13.6 A
TPA (n=6) 132.9z5.2 AA 107.5$8.3 80.9z5.3 AA
TPA+NE(n=5) 150.3z6.8 AA 117.0$10.6 78.2±6.9 AA
* Values are %of control expressed as mean $ SE
AA p<0.01 vs. control and A p<0.05 vs. control
Conclusion: Our results demonstrate that cells enlarged
by NE have increased contractile protein. whereas cells
enlarged by TPA do not. We suggest that selective
failure of contractile protein accumulation is one
possible mechanism for the genesis of a pathologically
hypertrophied cell.
EFFECTS OF SEX HORMONES ON CARDIAC FUNCTION IN FEMALE
RATS.
Thomas F. Schaible, Ph.D., Alwyn Murphy. Gary Ciambrone
and James Scheuer. Montefiore Medical Center/Albert
Einstein College of Medicine, Bronx, NY
Testosterone profoundly supports cardiac function in the
male rat. To examine the cardiac effects of sex hormones
in adult female rats, hearts were studied from rats
gonadectomized (GX) at 10 wks of age and compared at 20
wks to age-matched sham-operated rats. Sex hormones were
replaced for 10 wks in GX: either 2ug estradiol (E)/day
(GXE); 0.4mg progesterone (P)/day (GXP); combined E and P
(GXEP); or 2mg testosterone (T)/day (GXT). Isolated
working hearts were studied at constant left atrial
pressure, aortic pressure and heart rate. Results were:
(n-8-10, +p(0.05 vs GX, °p(0.05 vs SH)
Sham GX GXE GXP GXEP GXT
BW 280+ 321° 275+ 337° 281+ 347°+
DHW 155 159 154 163 148 190°+
SW 2.26+ 1.96° 2.47+ 1.78° 2.43+ 2.90°+
FS 14.9+ 13.6° 15.3+ 13.1° 15.4+ 17.9°+
VCF 2.35+ 2.11° 2.37+ 2.07° 2.32+ 2.53+
(BW=body weight (g); DEW-dry heart weight (mg); SW=stroke
work (ergs. 105 per DEW); FS=fractional shortening at
midwall (%); VCFzmean velocity of circumferential fiber
shortening (eire/sec».
GX increased body weight and decreased cardiac function
which was corrected by treatment with E, but not P.
Treatment of GX with T increased body and heart weight and
cardiac function when compared with GX or SH. Therefore. E
but not P may regulate cardiac function in female rats,
whereas T has profound effects on both cardiac mass and
function in female rats.
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Cell Studies and Automatic Rhythms
PlATEAU CURRF.N1'S IN CANINE VENrRICUIAR MYOCITES
~. Tsery, Ph.D., R.B. Robinson, Ph.D., and
B.F. Hoffman, M.D.,F.A.C.C. Department of PhaJ:macolC1;lY,
Columbia University, New York, NY 10032
Drugs may exert therapeutic or toxic effects by
affectirY;j the plateau phase (P) of the cardiac action
potential (AP). Plateau currents were studied in rod-
shaped myocytes isolated fran left ventricles of adult
dogs. The cells had a restirY;j potential of -84 mV in
4 11M K and AP characteristics similar to those of intact
tissues. VOltage clll1ll was done with the sirY;jle micro-
electrode nethod. Transient outward current (Ito) was
activated positive to -20 mV and showed voltage-depen-
dent inactivation between -80 and -50 mY. Ito had a
tine to peak (TTP) of 10 msec and decayed with a tine
constant ( T) of 10-20 msec. Slow inward current (Is)
was activated positive to -30 mV and showed voltage-
dependent inactivation between -50 and -20 mY. Is had
TTP of 5-10 msec and decayed with a T of 40-100 msec.
Delayed rectifier current (Ix) was activated positive
to -20 mV and increased with a T of 100-200 msec. The
P configuration and duration showed a CO\illicated de-
pendence on the holding voltage (Vh) precedirY;j the AP:
as Vh changed fran -80 to -60 mV, AP shortened alorY;j
with a decrease in upstroke velocity I fran -60 to -40
mV, AP prolonged alOlYJ with a decrease in notch depth
aOO a positive shift in P voltagel fran -40 to -20 mY,
AP markedly shortened along with a negative shift in P
voltage. 1hese changes could be explained by the
voltage-dependence of ·window· Na current, Ito_ Is_ and
Ix. we conclude that all these four currents contribute
to the plateau phase of canine ventricular action
potentials.
EFFECT OF PROCAINAMIDE ON ANISOTROPIC CONDUCTION-
MECHANISMS Alan Kadish, MD, Joseph F. Spear, PhD, FACC
Joseph H. Levine, MD, E. Neil Moore DVM, PhD, FACC
University of Pennsylvania, Philadelphia, Pa.
We found that procainamide (PCA) decreases conduction
velocity in anisotropic canine ventricular muscle by a
mean of 10% longitudinal (LG) to fiber orientation and
only 5% transverse (TV) to it. Using action potential
parameters and a cable theory model we calculated the LG
and TV specific internal resistance in six preparations.
The ratio of LG to TV conduction velocity decreased from
3.25 to 3.05 after 20 ugm/ml PCA (p<0.05). Internal
resistance LG to fiber orientation was relatively un-
changed (250 vs 267 O-cm) but TV to it decreased by 9%
(3324 to 3039 O-cm). To examine whether differences in
drug binding depending on propagation direction also may
contribute to the preferential depression of LG conduc-
tion, we examined conduction during sudden changes in
pacing direction in 5 preparations perfused with PCA. At
a cycle length of 1000 msec, conduction velocity (normal-
ized to control) was 5% lower LG than TV to fiber orienta-
tion and there was no difference between steady state
conduction velocity in a given direction and that in the
first few beats after a direction change. At cycle
lengths of 600 and 400 msec normalized conduction velocity
LG to fiber orientation was lower in the first few beats
after a change in propagation direction from TV to LG and
decreased further with continued pacing. We conclude: 1)
At a pacing cycle length of 1000 msec, the less marked
depression of TV conduction by PCA is due to a decrease in
internal resistance TV to fiber orientation 2) At shorter
pacing cycle lengths, greater drug binding during LG
pacing contributes to the differential effect of PCA. 3)
The varying activity and binding of PCA depending on cycle
length and fiber orientation may help explain the hetero-
genous response to its clinical use.
DEVELOPMENTAL AND USE-DEPENDENT EFFECTS OF PHENYTOIN ON
NEONATAL AND ADULT PURKINJE FIBERS. Walter Spinelli, Ph.D.
Michael Rosen, M.D.,F.A.C.C., Columbia University, N.Y.
Age-related changes in the actions of antiarrhythmic drugs
have been observed clinically and experimentally. One
drug, phenytoin (P) has been reported particularly effec-
tive in the treatment of postoperative ventricular arrhy-
thmias in children. In this study we: a) tested whether
developmental differences in P action on the transmembrane
action potential (AP) of Tyrode's superfused canine Pur-
kinje fibers might explain the clinical observations; and
b) evaluated the contribution of use-dependent reduction
of V and effects on slow responses to P's antiarrhy-
thmi~~ction. We studied the effects of P in a concentra-
tion range of 1.5-50 ug/ml. P concentrations of 5 and 10
ug/ml (comparable to therapeutic plasma levels) had no
major effects on AP charactfristics or frequency-dependent
effects at either age at [K ] =4 mM. At [K]=6 mM, on de-
creasing the drive cycle leng~h from 1300 to 300 msec, P
reduced V by 25 and 40% at 5 and 10 ug/ml at both ages.
Conductiowa~imeswere significantly prolonged in a dose
and use-dependent manner. The time constant for onset (To)
and recovery (Tr ) from use-dependent block was similar inadults (A) and neonates (N) (p>O.O~). At [P]=5 ug/ml To =
1050±35 (A) and 960±120 msec (N) (X±S.E.); Tr = 319±25 (A)and 263±58 msec (N). The effects of [P]=lO_gg/ml on slow
responses in [K] =22 mM + isoproterenol 10 Mwere signi-
ficant (p<0.05),oalthough modest, at both ages. AP ampli-
tude decreased 6% and V decreased - 19% in A and N;
there was no significanfa~lowing of conduction. This study
indicates that in K -depolarized PF, use-dependent reduc-
tion of the fast Na current is a major determinant of the
antiarrhythmic action of P. In contrast to lidocaine and
quinidine, no age-related changes in P action were found,
underscoring the different developmental effects of indi-
vidual antiarrhythmic drugs.
DEVELOPMENTAL CHANGES IN DELAYED AFTERDEPOLARIZATIONS AND
TRIGGERED ACTIVITY IN CANINE CORONARY SINUS. Nancy Johnso~
M.D., Michael R. Rosen, M.D., F.A.C.C., Columbia Univ.,
New York, NY.
Delayed afterdepolarizations (DAD) and triggered activity
(TA) have been shown to occur in isolated adult canine
coronary sinus (CCS) exposed to catecholamine, and may be
a cause of atrial arrhythmias in vivo. Because there are
developmental changes in cardiac arrhythmias, we studied
the transmembrane potentials and the age-related develop-
ment of DAD and TA in CCS, in the neonatal and adult ca-
nine heart. We used standard microelectrode techniques to
study the action potentials (AP) in the control state at
BCL-lOOO ms of 12 adult and 12 neonatal « 14 days) CCS.
The mean values (±SE) were, respective1y:-MDP -8l±1.3, -80
±1.1 mV; Amplitude l12±3, 105±1.8 mV; V 262±38, l44±26
V/sec; AP duration to 50% repolarizatiowa~APD50) 79±5.6,
54±2.8 msec; AP duration to 90% repolarization (APD90) 199±6.6, 97±5.l msec. Neonatal values for V ,APD 0 and
APD were significantly less than the a~ft (p ~ .02).Sim~2ar measurements were made in 6 adult and 7 neonatal
CCS following 10 min exp~,ure~5to increasing concentra-
tions of epinephrine (10 -10 M). The neonatal concentra-
tion response curve for AP amplitude was shifted signifi-
cantly to the right of that for the adult. All adult CCS
developed DAD (max amplitude 8.9±0.4 mV) and 5 of 6 devel-
oped TA. In contrast, no neonatal CCS develope~7DAD or TA.
Two neonatal CCS were exposed to ouabain, 2xlO M. Both
developed prominant DAD and TA within 10 min. Thus, neo-
natal CCS are capable of generating DAD and TA, but fail
to do so in response to concentrations of epinephrine
having marked effects on the adult. These differences be-
tween neonates and adults may contribute to the different
spectra of arrhythmias seen developmentally.
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IN VIVO RECORDING OF EARLY AFTERDEPOLARIZATIONS
PRECEDING TORSADES de POINTES
William Craelius, Ph.D., Victor Chen, Ph.D., Robert
Zeiler, Ph.D., Nabil El-Sherif, M.D., F.A.C.C., SUNY,
Downstate and VA Medical Centers, Brooklyn, N.Y.
An arrhythmia resembling Torsades de Pointes (TdP) spon-
taneously occurred during bradycardia in dogs given the
inotropic agent anthropleurin-A (APA). Onset of TdP was
preceded by marked QT prolongation. The arrhythmia was
investigated using floating microelectrodes to record
transmembrane potentials from the epicardium of seven in-
tact dogs. Action potentials having magnitudes of 70 to
100 mV were analyzed and data from approximately 100 im-
palements and 55 episodes of arrhythmias are represented.
During normal sinus rhythm (CL350 to 400 ms) APA (4~g/Kg)
prolonged the action potential duration (APD 90) from a
control value of 150 + 40 msec to 220 + 50 msec and
caused a corresponding increase in QT interval. Slowing
of heart rate with vagal stimulation to cycle lengths of
1000 msec caused marked prolongation of QT with APD's
ranging from 400 ms to values greater than the diastolic
interval. Brief depolarizations cf 2 to 8 mV that occur-
red during phase 3 of prolonged action potentials were
common occurrences during bradycardia. These potentials
resembled early after depolarizations (EAD's) and were
frequently seen prior to initiation of arrhythmias.
Ventricular premature beats showing the R-on-T phenomena
were initiated in association with EAD's during phase 3
of action potentials and preceded multiform ventricular
tachycardia that either terminated spontaneously or
degenerated into fibrillation. QT alternans associated
with alternation of EAD and/or action potential duration
were also commonly seen. The in vivo recording of EAD's
in association with TdP provides direct evidence for an
automatic initiation of the arrhythmia.
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Channel and Therapy-Site Specific Control of the
Myocardium
CHARACTERIZATION OF A PARTIALLY PURIFIED NATURALLY
OCCURRING CARDIAC CALCIUM CHANNEL AOONIST.
Mitchell S. Finkel, M.D., John F. Tallman, Ph.D., and
Barry L. Zaret, M.D. F.A.C.C., Yale Univ. School of
Medicine, New Haven, CT
Certain snake venoms may activate the cardiac
voltage-sensitive calcium channel (VSCC). We,
therefore, partially purified Crotalus atrox venom and
characterized its effect on calcium antagonist binding
to rat heart membranes using [3H] nitrendipine (Nit).
Nit binding was saturable from .04 to 2nM with Ki for
nifedipine = nitrendipine «lnM); partial displacement
of 40% by verapamil and 30% potentiation of binding by
diltiazem at 370 • SDS gel electrophoresis of venom
following purification with ion exchange chromatography
revealed proteins of 15,000-60,000 molecular weight.
Venom inhibited Nit binding with an IC50 = 6mg/ml
protein. Scatchard plots revealed inhibition to be
competitive with a decrease in affinity (KD 0.6 vs
1.2nM) and no change in number (Bmax 216 vs 200 fmol/mg
prot.) of binding sites in the absence and presence of
venom respectively. Thus, an extract from Crotalus
atrox venom competitively inhibits binding to the
cardiac high affinity [3M] nitrendipine binding site
in doses similar to those reported to activate the
voltage-sensitive calcium channel in the heart. These
data support a role for this site as an agonist binding
site in the heart. In addition Crotalus atrox venom
prOVides an exciting new tool for purification of
cardiac calcium channels.
ANTIARRHYTHMIC DRUG BINDING TO VOLTAGE-SENSITIVE TOXIN
RECEPTOR ON CARDIAC NA CHANNEL.
Robert S. Sheldon, M.D., Ph.D. and Henry J. Duff, M.D.
University of Calgary, Calgary, Alberta, Canada
Previous studies show that local anaesthetics bind
to a specific site on the nerve Na channel at
physiologically active concentrations, thereby decreas-
ing sodium influx and action potential propagation.
This suggests that Type I antiarrhythmic agents might
be effective by binding to a similar site on the car-
diac Na channel. We tested this concept by measuring
the binding of the Na channel radioligand ['H]
Batrachotoxinin Benzoate (BTXB) to cardiac myocytes.
BTXB binding in this assay is dependent on a second Na
ch~~nel toxin from~ sulcata (ATX). Quiescent,
Ca -tolerant myocytes (80% viable) were isolated by
collagenase digestion of adult rat hearts, and BTXB
binding was measured by filter-binding. Myocytes were
incubated at 37° with BTXB with or without ATX. ATX-
dependent BTXB binding was complete within 45 min. In
l~M ATX the binding was saturable (KD 20nM). ATX-dependent BTXB binding was voltage-dependent, as
demonstrated by inhibition of binding by BaCl. or
elevated KCl in the reaction. The voltage-dependent
BTXB binding had a B of 10 sites/~M' cell surface,
which is similar t&a~lectrophysiologicalestimates of
Na channel density. Type I AA drugs compete with BTXB
binding at pharmacologically relevant concentrations,
with the same rank order of potency clinically and in
vitro (r = 0.84). The stereolsomers of tocalnlde have
a 3-fold different affinity for this site. This indi-
cates that BTXB and Type I AA drugs bind to specific
sites which have characteristics of saturability,
stereospecificity, similar rank order of potency in
vivo and in vitro and voltage-dependence.
oADENOSINE
" CL
ADENOSINE AND ATP SUPPRESS VENTRICULAR ESCAPE
RHYTHMS IN THE CANINE HEART
Amir Pelleg, Ph.D., Hideo Mitamura, M.D., Takao Mitsuoka,
M.D., Eric l. Michelson, M.D., F.A.C.C., leonard S. Dreifus,
M.D., F.A.C.C. The lankenau Medical Research Center,
Philadelphia, PA
In vitro studies suggest a negative chronotropic action of
adenosine on ventricular automaticity. To study the actions of
adenosine and ATP on ventricular escape rhythms in vivo, the
His bundle region was electroablated in 16 closed chest dogs.
All dogs exhibited stable ventricular escape rhythms with mean
cycle length (Cl) = 1210 t 80 msec and QRS = 91 t 5 msec.
Adenosine or ATP (3 ~mol/kg) was given into the right atrium
before (control = C) and after serial iv administration of:
physostigmine (PS; 50 ~ g/kg), atropine (A; 0.2 mg/kg),
propranolol (P; I mg/kg), dipyridamole (0; 250 IJ g/kg), and
aminophylline (AMi 5 mg/kg). As shown in the figure, both
adenosine and ATP markedly increased ventricular escape
rhythm Cl, to 147 t 7% and 157 t 6% of baseline, respectively
(each, p <O.Oil under control conditions. These actions were
only negligibly affected by vagal enhancement (PS), vagal
attenuation (A), and beta adrenergic blockade (P). However, D
which selectively blocks adenosine transport and thereby its
degradation, markedly enhanced the effects of both ATP and
adenosine; while AM, a competitive antagonist of adenosine,
reversed the effects of dipyridamole. Thus, (I) adenosine and
ATP suppress
ventricular escape
~::~TROL >2b1>.. rhythms in vivo,3001 t VI. PROPlWlCl.OL apparently independent
'VI. _.......... of the autonomic
200 nervous system,and (2)
this action of ATP is
100 mediated predominantly
by its degradation to
o L.lcL........p..sL........"..._l.p..._l.o......JL.A,M· adenosine.
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EFFECTS OF VERTEBRATE DIGITALIS-LIKE SUBSTANCES ON THE
CELLULAR ELECTROPHYSIOLOGIC PROPERTIES OF PURKINJE FIBERS.
R. Kieval, B.A., V.P. Butler, M.D., F. Derguini, Ph.D.,
R. Bruening, Ph.D., K. Nakanishi, Ph.D., M.R. Rosen, M.D.,
F.A.C.C., Columbia University, New York.
Substances with digitalis-like immunoreactivity are pro-
duced by several vertebrate species. There also is evi-
dence for the existence of a digitalis-like substance of
human origin. The cellular electrophysiological effects of
these substances on cardiac tissues have not been reported.
Therefore, we studied the effects of bufalin, an unconju-
gated cardiotonic steroid produced by the toad, Bufo
marinus, on the action potential character!~tics~6adult
canine Purkinje fibers (PF). Bufalin (2xlO M) signifi-
cantly reduced maximum diastolic potential (MOP) from -97t
1 to -88t2 mV (XtSE) within 40 minutes of exposure. Italso
reduced the action potential amplitude (Amp) from 132t2 to
121t2 mY; action potential duration (APD) from 316t12 to
262t8 msec; and Vma from 616t35 to 493t17 V/sec (all p <.05). All 6 PF developed delayed afterdepolarizations
(DAD), and 2 developed triggered rhy!?ms. Ouabain demon-
strated lesser potency, in that 2xlO M ouabain was re-
quired to comparably reduce MOP, Amp, APD, and ~max within
30 minutes in 6 PF. All 6 showed DAD, and 2 PF developed
triggered rhythms. In addition, one sample of an extract
of human bile that cross-reacted with anti-digitalis and
anti-bufalin antibodies, also reduced MOP, Amp, APD, and
Vmax ' and produced DAD and triggered activity. In contrastsamples of bile without such cross reactivity had no com-
parable effect on the action potential. These results are
consistent with other evidence that lower vertebrates and
possibly humans produce digitalis-like substances. The
production, and therefore possible overproduction, of a
digitalis-like substance in man and other mammals may
account for the occurrence of some cardiac arrhythmias
which at present are considered idiopathic.
THE EFFECT OF OPIOID PEPTIDES ON THALLIUM TRANSPORT BY
CULTURED MYOCARDIAL CELLS
Bruce J. Friedman, MD, FACC, Joan P. Friedman, AB, Bob
Beihn, MS, Shaker Mousa, PhD, and Glen Van Loon, MD.
University of Kentucky, LeXington, KY
Opioid peptides and opiate receptors are present in
the heart, and have been shown to affect contractility.
However, neither the action nor the mechanism of action
of these peptides on the heart are fully understood.
Therefore, to determine the effect of opioid peptides
on monovalent cation transport, we studied their effect
on thallium-201(Tl) uptake by cultured chick myocardial
cells, a preparation devoid of neural elements. Mono-
layers of synchronously contracting ventricular cells
grown on coverslips were placed in a chamber and perfused
to the asymptote with Tl-labeled media. Radionuclide kin-
etics were then monitored guring washout with unlabeled
media. Leu-enkephalin (10- M), met-enkephalin (10-7M),
a-endorphin (lo-8M), dynorphin A 1-6 (lo-7M) were screened
for an effect on Tl uptake. Each experiment was paired
using, for control, the same coverslips and labeled fol-
lowed by unlabeled perfusion media without peptide. For
each peptide, dual experiments were performed alternating
the sequence of peptide infusion and control. Cellular Tl
uptake was determined by computer using standard formulae.
Leu-enkephalin, met-enkephalin, and a-endorphin had no
significant effect on Tl uptake. Dynorphin A 1-6 (10-7M)
significantly (p<.05) decreased Tl uptake. Varying concen-
trations from 10-8 to 10-5M of dynorphin A 1-6 decreased
Tl uptake in a dose-dependent manner. The maximal decrease
in Tl uptake was 35~. We conclude that dynorphin A 1-6
has direct effects on cultured chick ventricular cells,
decreasing Tl uptake in a dose-dependent fashion. This
effect on monovalent cation transport may play a rule in
the cardiovascular effects of opioid peptides.
HEMODYNAMIC AND CALCIUM ANTAGONIST BINDING
CHARACTERISTICS IN HAMSTER CARDIOMYOPATHY
Mitchell S. Finkel, M.D., Randolph E. Patterson, M.D.
F.A.C.C., Edith H. Speir, B.S., Eric S. Marks, M.D.,
Kenneth Steadman, B.,S., and Harry R. Keiser, M.D.,
NHLBI, NIH, Bethesda, MO.
We compared hemodynamics and (3H) Nitrendipine (N)
binding to cardiac membranes in BI014.6 Cardiomyopathic
Syrian Hamsters (MYO) at 4 and 10 mos. with their FIB.
controls. In ligand competition studies nifedipine =
nitrendipine (Ki =lnM) with 60% maximal displacement
by verapamil and 30% potentiation of binding by
diltiazem at 37 0 in both myopathic and control
hearts. A 50% increase in the number (Bmax) of N
binding sites was seen only in the 4 mo. old MYO vs
controls, with no change in affinity (KD)' (Bmax =
468 + 11 vs 309 + 10 (fmol/mg prot.); (KD = .65 + .12
vs .75 + • l4nM),-MYO vs control while no differences in
Bmax or-KD were seen at 10 mos. (Bmax = 375 ~ 9 vs 362
+ 7 (fmol/mg prot.); (KD = .82 + .18 vs .89 + .17nM),
MYO vs control. Hemodynamic st~dies revealed no
significant differences in CO, CI, SV, HR, mean arterial
pressure, peripheral resistance (PR), body wt., heart
wt. at 4 mos., but a significant decrease in PR (1120 +
360 vs 2080 + 240) increase in body wt. (118 + 2 vs 94-+
2 gms) and heart wt. (97 + 5 vs 78 + 2 gms/IOO gm body-
wt.) in 10 mos. MYO vs control animals. We conclude
that the onset of cardiomyopathy at 4 mos. is associated
with a selective increase in N binding sites; and heart
failure at 10 mos. is associated with a relative
decrease in these sites. Thus, at 4 mos. the increased
number of N binding sites may be compensatory, but this
loss of compensation at 10 mos. results in CHF. These
data support an agonist role for the high affinity N
binding site in heart.
INHIBITION OF SODIUM WITHDRAWAL CONTRACTURES BY
AMILORIDE.
Kathleen Brown, D.V.M. , Augustus Grant, M.D.,Ph.D., and
Harold Strauss, M.D. Duke University Medical Center,
Durham, N.C.
Aailoride blocks both external Na+-stimulated Ca2+ efflux
and Ca2+ influx into Na+ loaded cells, presumably by its
blocking action on the Na-Ca exchanger. To determine if
this mechanism underlies the delay in repolarization
produced by prolonged exposure of canine cardiac Purkinje
fibers to amiloride, we ~asured intracellular Na+
activity (aNai ), contractures (Ctr,mg/..2 ) and membrane
potential as [Nal o was reduced stepwise from 150 to
1.5mM. Removal of K+ alone increased aNai to 13.2tO.6aM;
therefore, l~M strophanthidin was also added to increase
Na+ loading in control fibers and fibers superfused with
.01 to 1mM amiloride for 2 hr. As [Nal o was reduced from
150 -> 30mM, aNa i was linearly related (slope) to aNao .
Results are summarized in table as mean t SD.
control .-J!.LL .1 A _l_A_
peak aNai 19. 8± 2 21.7±2 17.0±0.7 13.5t1
slope .161±.01 .163±.01 .11±0 .068t.01
Ctr 150->30 50.7±17 43.7t 11 20.6t6 29.5±10
max Ctr 53. 4t 24 56.8±12 43. 5± 11 50.5t9
Although delayed repolarization is clearly manifested.
there is no evidence that .01mM amiloride inhibits Na-Ca
exchange. However, Ca2+ entry into Na+-Ioaded cells is
likely inhibited by .1 and 1mM amiloride (notably at 30mM
Ctr). Inhibition of strophanthidin-induced Na+ loading
by 1mM amiloride appeared to increase the contracture,
possibly by interfering with Ca2+ efflux at a lower aNa i .
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CAROTID BAROREFLEX ABNORMALITIES AND END-ORGAN
RESPONSIVENESS IN PATIENTS WITH DIABETES MELLITUS
Eric N. Prystowsky, M.D., F.A.C.C., Mohamed Sheta, M.D.,
David Adams, B.S.E.E., and Frank Vinicor, M.D., Krannert
Institute of Cardiology, Indiana University School of
Medicine, Indianapolis, IN.
We studied 10 normotensive patients (pts) with insulin
dependent diabetes mellitus (OM) to determine characteris-
tics of the carotid baroreflex (CBR) and to test whether
CBR'dysfunction was due in part to end-organ responsive-
ness. Eight age-matched control pts (C) also had CBR
testing. CBR was tested using neck suction pulses (-60
mmHg, .6 sec) introduced at 20-40 msec intervals through-
out the cardiac cycle. Sinus node responsiveness was
determined using 10 mg of iv edrophonium. Intrinsic
heart rate (HR) was obtained with iv atropine (0.03 mg/kg)
and propranolol (0.15mg/kg). OM pts were 45~5 (X ~ SEM)
years old and duration of OM was 17 ~ 3 years. For OM
pts CBR dysfunction varied: 3 had no increase (t) in
sinus intervals (pP) with neck suction; in 7 pts, latency
for onset of PP twas 526 + 42 ms (C= 315 + 40, p=0.003) ,
time to maximum PP twas 1014 + 54 ms (C= 856 + 63, p=
0.08), and maximum PP twas 184 + 46 ms (C= 197 ~ 26, p=
0.8). Maximum PP t for all OM pts correlated (r= .74,
p= .007) with duration of OM but not with age. Edro-
phonium slowed HR in all 10 OM pts by 12 ~ 5 b!m, and HR
slowing did not correlate with maximum PP t during neck
suction. Intrinsic HR was within predicted range for all
pts (87 + 6 b!m). We conclude: 1) carotid baroreflex
in diabetes mellitus pts compared with controls shows
several abnormalities including no response and prolonged
latency; and 2) carotid baroreflex dysfunction is not
related to end-organ unresponsiveness.
SIGNIFICANCE OF PHARMACOLOGIC TOTAL AUTONOMIC BLOCKADE IN
PATIENTS WITH SICK SINUS SYNDROME: ASSESSMENT BY DIRECT
SINUS NODE RECORDINGS.
Iwao Yamaguchi, M.D., Keisuke Kuga, M.D., Takuji Tomizawa,
M.D., Yuichi Noguchi, M.D., Yasuro Sugishita, M.D. and
Iwao Ito, M.D., University of Tsukuba, Ibaraki, Japan
This study was designed to assess effects of pharmacologic
total autonomic blockade (TAB) (atropine 0.04 mg/kg and
propranolol 0.2 mg/kg, i.v.) on sinus node automaticity in
patients with sick sinus syndrome (SSS) by direct sinus
node recordings. The intrinsic heart rate was determined
in 22 SSS patients by TAB. In this way they were classi-
fied into 12 patients with intrinsic sinus node dysfunc-
tion (group I) and 10 patients with disturbed autonomic
regulation of sinus node function (group II). Direct
sinoatrial conduction time for sinus beat (SACTsb) was
lengthened in group I (178±42ms~198±76ms, mean±SD, p<O.OS)
but was shortened in group II (170±63ms~126±3Sms, p<O.OS)
by TAB, which resulted in significant difference in the
SACTsb's of the two groups (p<O.OS). Direct sinus node
recovery time (SNRT) [=indirect SNRT-direct sinoatrial
conduction time for the first postpacing beat (SACTppb)]
was lengthened in group I (1622±47Sms~1906±6S6ms, p<O.Ol)
but was shortened in group II (923±8lms~78S±lSOms, p<O.OS)
by TAB. There was significant difference in direct SNRT
either before or after TAB between group I and group II
(p<O.Ol in either). Regarding sinus node automaticity
after atrial overdrive pacing for SNRT measurement, 10
patients of group II demonstrated both acceleration
(corrected SNRT<SACTppb) and depression (corrected
SNRT>SACTppb): 7 acceleration; 3 depression before TAB,
but all 10 acceleration after TAB. In contrast, all 12
patients of group I demonstrated depression before and
after TAB. This study shows that TAB combined with direct
sinus node recordings may contribute to elucidation of the
electrophysiologic mechanism of SSS.
HEAD-UP TILT TESTING: AN IMPORTANT TOOL IN THE WORK-UP
OF RECURRENT SYNCOPE OF UNKNOWN ETIOLOGY
Freddy M. Abi-Samra, M.D., James O. Maloney, M.D., F.A.C.C
Fetnat M. Fouad, M.D., Lon W. Castle, M.D., F.A.C.C.
Cleveland Clinic Foundation, Cleveland, Ohio
Sixty-four pts with recurrent syncopal attacks (SA) which
were unexplained despite extensive non-invasive investig-
ations (including at least 48 hours of Holter monitoring)
underwent blood pressure (8P) and heart rate (HR) monitor-
ing during standardized 60· head-up tilting (HUT).Syncopal
attacks were precipitated in 27 pts (42%) within 13 ± 7
min of initiation of tilting. Mechanisms underlying the
event were vasovagal in 16 (drop of BP and HR), vasode-
pressor in 5 (drop of BP without drop in HR) and unsus-
pected autonomic dysfunction in 6. Abnormal responses to
HUT (without syncope) were observed in another 15 pts.
Three of the latter had a blunted HT response and were
classified as having chronotropic insufficiency. The
other 12 pts had an exaggerated increase in HR at 60± HUT.
This tachycardic response was later determined to be due
to idiopathic hypovolemia in 4 (125 I-HSA plasma volume
measurement), marked peripheral venous pooling in 4 (orth-
ostatic drop in cardiopulmonary volume), and hyperb~ta
adrenergic state in 4 (abnormal response to graded ISO-
proterenol infusion). Twenty-two patients (34%) had a
normal response to HUT.
Conclusion: 1) HUT is a safe and valuable provocative
tool in the work-up of unexplained recurrent SA. 2)
Abnormalities of autonomic tone are frequently present in
pts with recurrent SA. 3) Coupled with appropriate non-
invasive tests, HUT allowed specific diagnosis of the
syncopal mechanisms in 42% of pts tested and.h~lped
delineate hemodynamic and/or volume abnormalItIes that
may well be contributory to SA in another 23% of pts.
DIVERGENT EFFECTS OF HYPOTHERMIA, QUINIDINE AND
PROCAINAMIDE ON CONDUCTION OF EARLY AND LATE PREMATURE
BEATS IN THE NORMAL CANINE ATRIA
Ross J. Simpson, Jr., H.D., F.A.C.C., James R. Foster,
M.D., F;~C-:C:-: Alatli<."""WOelfel, M.D., Leonard S. Gettes
H.D., F.A.C.C., Division of Cardiology, UniverSity of
North Carolina, Chapel Hill, NC.
Severe hypothermia or a high serum concentration of
either quinidine or procainamide increases refractoriness
and slows conduction. However, in the normal heart, at
moderate concentrations it is not known which effect
predominates, or whether further depression of conduction
of early cycle premature beats occurs. In order to
determine if these interventions have Similar effects on
conduction when a similar lengthening of refractory
period is achieved and, in addition, if conduction of
early premature beats is further depressed, we paced and
recorded the in-situ Bachman Bundle in 25 open chest,
adult, mongrel dogs. Strength-interval curves,
conduction times and the increase in conduction time
during the relative refractory period were measured.
Decreasing core temperature by 4.2±0.4·C or achiev-
ing serum concentrations of qUinidine or procainamide of
4.2±1.4 and 18.5±4.5~g/ml, respectively, produced
similar increases in effective refractory period (46.7±
16.3, 40.6±24.1 and 25.0±12.3 ms) without changing late
diastolic threshold or conduction time in late diastole.
Hypothermia, but not quinidine or procainamide, further
slowed conduction of premature beats during the relative
refractory period (9.7±6.7 vs 0.7±7.1 vs 1.7±1.5 ms).
In the normal canine atria, hypothermia increases
refractoriness and slows conduction of early premature
beats. Quinidine and procainamide prolong refractoriness
without slowing conduction of either late or early cycle
premature atrial beats.
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PRBCORDIAL DPPIIO 0,. SIOIAL lYBUGBD LAD PO!'DTI1LS
CCIIPDID !'O m LI1D8
Edward J, Berbari, Ph,D" Karen J. Friday, M.D., F.A.C.C.,
Warren M. Jackmann, M. D., Patricia Hudgins, R.N., and
Ralph Lazzara, M. D., F. A. C.C. University of Oklahoma
Health Sciences Center and VA Medical Center, Oklahoma
City, OK.
All prior studies of late potentials (LP) recorded via
signal averaging have used either bipolar XIZ leads or a
single precordial lead, thus assuming a total "view" of
the QRS-LP duration. We oompared recordings from a
bipolar IYZ lead system with a set of 24 electrodes
positioned in a grid across the left precordium and
referenced to the back in 8 patients with documented
ventricular tachycardia and LP. All patients had old
inferior infarcts and were undergoing amiodarone therapy.
In 3 patients there was no difference in the longest QRS-
LP duration between the IYZ and mapping leads. In 3
others at least 3 of the mapping leads had a QRS-LP
duration greater than (range 11-14 maec) the IYZ leads
(188 vs 199 maec, 151 vs 165 msec, and 145 vs 157 msec).
The longest QRS-LP duration from the XIZ leads averaged
158.1'30 msec while the longest QRS-LP <turation from tbe
preoordial map averaged 164.1'29 mS80. This was a signifi-
cance difference with p<0.02 using a paired t-test (two
tail). In no case was tbe QRS-LP duration of tbe IYZ
leads longer than all recordings in tbe precordial set.
Tbe leads witb tbe longest durations were between the
borders of the tbird and fifth intercostal space (borizon-
tally) and between V4 and V6 (vertically). CoMluioDI
Late potentials recorded wi tli XIZ leads (or fewer leads)
may inadequately represent tbe total QRS-LP dl1ration.
Since LP may arise from localized regions of the beart tbe
distance of the XIZ leads from tbe source may result in
excessive attenuation of LP.
FOCAL Tc99m PVROPHOSPHATE lPTAKE IN DOGS FCl.LOIlI~ CATl£TER
SHOCK; LOCALIZATION BV EPICARDIAL SCINTI-PROOf MAPPOO.
Dennis Human. M. D.; Louis Vao, M. D; Kym Trask, B. Sc. and
Bodh Jugdutt. M.D. F.A.C.C. University of Albert~
Edmonton. Canada.
To study the feasibility of radionuclide labelling after
catheter shock (CS), we correlated Tc99m pyrophosphate
(PVP) uptake and histologic damage following CS.
Unipolar 25 Joule CS were given once each in the RV and LV
of 5 dogs. Immediately after CS 30mBqIKg of Tc99mPVP was
injected followed by gamma-camera imaging 2 hours later.
After median sternotomy, a specially constructed
epicardial scintillation probe was used to measure
myocardial radioactivity. Ex-vivo images were then
obtained and followed by sectioning of the hearts from base
to apex. Images of the slices applied directly to the
collimator face were obtained and areas of increased uptake
examined histologically.
External imaging showed focal activity in the RV in 2 dogs
and the LV in 4 of 5 dogs. Following sternotomy, external
inspection of the heart showed focal hemorrhage of the LV in
3 dogs and of the RV in 2 dogs. Epicardial probe mapping
showed a focal area of uptake in the RV of 3 dogs and in the
LV of all 5 dogs. Ex-vivo images showed focal areas of
uptake in both the RV and LV in all hearts. These areas of
uptake corresponded directly to the arells predicted by
probe map and necrosis observed histologically.
lie conclude that focal uptake of Tc99mPVP reliably
follows CS and can often be visualized using standard gamma
camera techniques. This focal uptllke of Tc9QmPVP can be
localized using an epicardial scinti-probe and correlates
exactly to the lIrea of necrosis induced by CS. This
technique may prove useful in locating arrhythmogenic foci
in man by combining catheter mapping, low energy CS. and
intraoperative scinti-probemapping.
SIGNIFICANCE OF PERCUTANEOUS INTRACORONARY EPICARDIAL
ELECTROGRAPHY DURING CORONARY ANGIOPLASTY IN MAN.
Bim Sharma, M.D., F.A.C.C., Love Seth, M.D., Joseph K.
Bissett, M.D., F.A.C.C., Joseph R. Dolan, Richard P.
Wyeth, M.A., Joseph A. Franciosa, M.D., F.A.C.C., Univof
Arkansas for Medical Sciences, Little Rock.
This study investigated the significance of percutaneous
intracoronary epicardial electrography (PICEE) during per-
cutaneous transluminal coronary angioplasty (PTCA). Ten
patients (pts) , 6 males and 4 females averaging 56 years
in age (range 38-73), while undergoing PTCA has simulta-
neous recording of unipolar PICEE and standard monitored
ECG. A steerable guide wire was used as a unipolar epi-
cardial electrode for PICEE and was positioned distal to
the stenotic lesion. For right (4 pts) and left circum-
flex (2 pts) coronary artery angioplasty, Leads III, AVF,
V5, & V10, while for left anterior descending (4 pts)
coronary artery angioplasty, I, AVL, V5, & V10 were moni-
tored. Changes in surface ECGs were compared with PICEE
at control, during inflation and after deflation of the
angioplasty balloon. There were no significant changes
in amplitude of the R-wave or QRS duration in standard
ECGs or PICEE during inflation and deflation of the bal-
loon. Most dramatic changes of acute myocardial ischemia
(ST-T changes) during balloon inflation were observed in
PICEE. PICEE showed ST elevation, (range 0.1-2.6 mV) in
3 pts, ST depression (range 0.3-3.4 mV) in 2 pts while
there were no changes in standard ECGs. PICEE also de-
monstrated ischemic T-wave changed during balloon infla-
tion in 4 of 10 pts. Overall, PICEE demonstrated ST-T
changes of ischemia in 6 of 10 pts while standard ECG
showed changes only in 1 pt. In conclusion, this study
indicates that during PTCA, PICEE is more sensitive in
demonstrating acute reversible myocardial ischemia than
standard monitored leads and can be applied routinely.
REVERSE DELTA WAVE FOR PREDICTION OF VENTRICULAR
FIBRILLATION DURING RIGHT CORONARY INJECTIONS
Jonathan C P Crick, DPhil, MRCP
Guy's Hospltal, London, England
In a prospective study 22 episodes of ventricular
fibrlllation (VF) occurred during coronary angiography
over three years. In 20 cases ECG lead I was recorded
initially and Just before the onset of VF. In four cases
VF followed left coronary lnjection of contrast medium
and in 16, injection of the rlght coronary artery or right
aorto-coronary graft. In all but one of these, the
development of a characteristic ECG slgn was observed
before the onset of VF. This conslsts of an S-wave
having a sharp downstroke and a slurred upstroke with a
width of at least 100 mS. The pattern resembles the delta
wave of Wolff-Parkinson-White syndrome, but lnverted and
reversed. In elght cases the reverse delta wave was the
only abnormality preceding VF, in one case there were
also frequent coupled ventrlcular extrasystoles, in three
cases there were sinus pauses and ln three cases the onset
of VF was obscured by artefact. An analysis of 50
unselected coronary angiograms with similar age and sex
distribution and severity of coronary disease showed the
occurrence of the reverse delta wave in only two cases,
in both of which S-waves of at least 40 mS width were
present in the inltial ECG. A lesser version of the
pattern with duration of 40-80 mS was recorded transiently
following RCA lnJectlons ln 31 cases. The reverse delta
wave of at least 100 mS duration, suggestlng delayed
depolarlsatlon of part of the ventricular myocardlum to
the rlght slde, possibly the pUlmonary conus, was thus
a conslstent and specific lndicator of lmpendlng VF
occurring, as the great majority dld, durlng rlght
coronary anglography.
128A ABSTRACTS JACC Vol 7, No 2
February 1986: 128A
ENTRAINMENT OF HUMAN ATRIAL FLUTTER LOCALIZES
THE AREA OF SLOW CONDUCTION IN THE INFERIOR RIGHT
ATRIUM
Brian Olshansky, M.D., Ken Okumura, M.D., Richard W.
Henthorn, M.D., F.A.C.C., Andrew E. Epstein, M.D., F.A.C.C.,
Vance J. Plumb, M.D., F.A.C.C., Albert L. Waldo, M.D.,
F.A.C.C., University of Alabama at Birmingham, Birmingham,
Alabama.
A reentrant tachyarrhythmia usually requires an area of slow
conduction to be perpetuated. We studied 9 patients (pts) with
spontaneous atrial flutter (AF!), mean cycle length (CL) of
2113±30 ms, to determine if slow conduction is a part of the
reentry loop. Multipolar electrode catheters were placed in the
high right atrium (HRA), low lateral right atrium (LRA),
coronary sinus (CS) and His bundle positions. Rapid atrial pacing
(RAP) was used to entrain AFI and thereby, to localize an area
of slow conduction. An activation map was obtained during AFI
from 30 RA sites. During AFI, the activation sequence
proceeded from HRA to LRA to CS to His in all pts. During
RAP from HRA, constant atrial fusion except for the last
captured beat (i.e. entrainment) was demonstrated. Entrainment
of AFI from the HRA at a mean RAP CL of 199±10 ms
demonstrated the same atrial activation sequence to LRA and
CS as during AFI, with conduction times from the stimulus to
LRA and stimulus to CS of 111±1I8 ms (7 pts) and 223±61 ms (9
pts) respectively. In contrast, although RAP (mean CL 207±16
ms) from CS captured all atrial sites, it demonstrated none of
the entrainment criteria (concealed entrainment) and did not
change the ECC flutter wave morphology. This indicates that
CS pacing orthodromically captures the reentry loop distal to the
area of slow conduction, with the wave front proceeding from
His to HRA to LRA (mean stimulus to His, to HRA, and to LRA
intervals were: 58±30 ms 13 pts], 113±16 ms [3 pts] and 236±32
ms [II pts], respectively). These data demonstrate the presence
of an area of slow conduction in the inferior RA and correlate
with the right atrial activation map.
PAroXYSMU. SINUS TACHYCARDIA: :roRmER EXPERIENCE WITH
SUB'roTAL RIGIfl' ATRIAL EXCLUSIClii Su;GFSI'!N3 DIFFUSE
ATRIAL DISEASE.
Arjun D. Sharma, M.D., F.A.C.C., George J. Klein,
M.D., F .A.C.C., Gerard M. Guiraudon, M.D., F .A.C.C. ,
Martin J. Gardner, M.D., F.R.C.P., London and Halifax.
we previously reported that inappropriate paroxysmal
sinus tachycardia may be treated by surgical exclusion
of the sinus node. However, further experience has
roodified our approach. Three wanen presented with
paroxysmal ~ans related to documented sinus
tachycardia with rates up to 180/min at rest. Prior
ineffective therapy included digoxin, beta-blocker,
verapamil, quinidine and amiodarone.
Electro~ysiologic studies were normal except for a
mean intrinsic heart rate of llS/min. Intraoperative
mapping showed atrial activation to originate in the
region of the sinus node. One week postoperatively,
patients (pts) had junctional and low left atrial
rhythns with a mean resting rate of 87.7/min and a
peak exercise rate of 121.7/min. There were no
arrhythmias one week postoperatively. During a mean
followup of 20.3 mnths, 2 pts had paroxysmal atrial
fibrillationl 2 pts had syrrptanatic bradycardias
requir ing permanent pacemaker implantationl 1 pt had
exercise induced ectopic atrial tachycardia at a rate
of 200/min. All pts require ~armacologic therapy.
Evidence for a diffuse abnormality of autanaticity
includes: high intrinsic rate reflecting sinus node
abnormalityI high junctional escape rate; ectopic
atrial tachycardiaI marked bradycardia; and atrial
fibrillation. Thus, inappropriate sinus tachycardia
may be a manifestation of diffuse electrical disease
of the atria, and sinus node exclusion alone is
inadequate therapy.
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RELATIONSHIP BETWEEN LATEST ACTIVATION IN SINUS RHYTHM(SR)
AND ONSET OF VENTRICULAR TACHYCARDIA(VT)
Louise Harris, M.B., F.R.C.P(C), Eugene Downar, M.D., F.R.
C.P(C), Lynda L. Mickleborough, M.D., F.R.C.S(C) and Ian
D. Parson, Ph.D., University of Toronto, Toronto, Canada.
In patients (pts) with ischemic heart disease, latest
activation in SR should represent areas of slowed conduc-
tion in myocardial scarring, necessary for conduction
block and reentrant pathways. If this were associated
with site of onset of VT, mapping during SR could be used
to direct surgical ablation. We thus recorded VT and SR
during map-guided surgery in 8 pts with previous myocar-
dial infarction. Discrete LV aneurysms were present in 6
pts. An automatic mapping system enabled simultaneous
endocardial (ENDO) and epicardial (EPI) recordings from a
total of 220 unipolar electrodes. Using a fixed matrix,
the earliest onset of VT was marked and the last 24 msecs
of activation in SR was delineated. The mean QRS during
SR was prolonged at 149 msecs because of LBBB in 7 pts
while ENDO activation was correspondingly prolonged with
a mean of 124 msecs. No EPI or ENDO electrograms extended
beyond the surface QRS. Of 20 episodes of VT recorded,
the earliest onset of VT occurred on the ENDO in 18 epi-
sodes, and on the EPI in 2. The site of onset of VT was
located either on the border of latest activation in SR or
within a surrounding perimeter no wider than 2 cms, in 85%
of episodes (17 of 20). A further 2 episodes of VT (in 1
pt) had earliest onset on the border of a large LV aneu-
rysm but were remote from the latest detectable activation
in SR. The earliest onset of VT in our pts was thus
closely associated with latest activation in SR and may
represent the exit point of the reentrant pathway. With
improved understanding of reentrant mechanisms in human VT,
our approach to surgical ablation of VT may ultimately be
modified by mapping of latest activation in SR.
THE INCIDENCE AND SIGNIFICANCE OF DELAYED AND
FRACTIONATED RIGHT VENTRICULAR ELECTRICAL
ACTIVITY IN MAN.
J. Anthony Gomes, M.D., F.A.C.C., S. Winters, M.D. and
P. Ban-eca, B.S., Mount Sinai Medical Center, New York.
Abnormal (AB) (i.e delayed and fractionated) LV electrograms
(E's) have been reported in patients (pts) with LV aneurysms
and sustained (sust) ventricular tachycardia (VT). Although
most electrophysiologic studies are performed in the RV, little
is known of the incidence and significance of Ab-RVE's. We
prospectively evaluated RVE's in 50 pts (54 ± 15 yrsl ± S.D.)
during RV catheter (5mm spacing) mapping of 6-10 RV sites.
ZO/50 pts had sust VT, ZO/50 pts had non-sust VT and 10/50
pts had no VT. Results: Two types of Ab-RVE's were seen: Type
I-early potentials (duration (d) = 69 ± 75 ms; peak Voltage (V)
= 114 ± 108 jlv) occurring immediately after the end of the
QRS. Type II-late potentials (d = 168 ± 110 ms; V = 113 ± 65
jlv) occurring Z61 ± 109 ms after the end of the QRS. Ab-RVE's
were seen in 17/50 pts (34%) of which 10/17 pts (59%) had sust
VT; 6/17 pts (35%) had non-sust VT and 1/17 pts (6%) had no
VT. Eleven of seventeen pts had type I, 14 had Type II and 8
had both. Ab-RVE's occurred at the RV apical septum in 65%
and RV basal-septum in 35%. Fractionated Type II E's were
more frequent (90% vs 17%, p<.003) and longer (Z14 ± 99 vs
64 ± 40 ms, p<.OZ) in pts with sust. VT than in non-sust VT.
Fractionated Type II E's occurred in 9/Z0 pts with sust VT, but
in only 1/30 pts without sust VT and had a sensitivity of 45%
a speCIficity of 97% and positive predictive value of 90% in
separating pts with sust VT from those without. Bridging of
RVE's was noted in only 3 pts during VT. Conclusions: (1) Ab-RVE's
are often observed in pts with VT but rarely in pts without VT.
(Z) Fractionated Type II RVE's are seen mostly in pts with sust
VT and reflect desynchronized RV-septal electrical activity.
(3) Fractionated Type II RVE's lack sensitivity but have a high
specificity and positive predictive value for sust VT. (4) Bridging
of RVE's during VT is rare impling remote site of VT origin.
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In this select group of patients studied early and late
post MI, early inducible nonsustained VT was not reprod-
uced late. All the patients with sustained VT induced late
had sustained VT induced early; however, inducible sus-
tained VT persisted in only 50%. Reproducibility of the
electrophysiologic abnormalities identified early after MI
by PVS is therefore highly variable.
REPRODUCIBILITY OF THE RESULTS OF PROGRAMMED VENTRICULAR
STIMULATION EARLY AND LATE AFTER ACUTE MYOCARDIAL
INFARCTION
Janet M. McComb, M.D., Herman K.Gold, M.D., Robert C.
Leinbach, M.D., Jeremy N. Ruskin, M.D., F.A.C.C., Hasan
Garan, M.D., Massachusetts General Hospital, Boston, MA
The significance and long term reproducibility of the
results of programmed ventricular stimulation(PVS) in
patients early after acute myocardial infarction(MI) is
not known. Reproducibility of the response to PVS, using
up to 2 extrastimuli during pacing, and up to 3 during
sinus rhythm, at the RV apex, was investigated in 17 pa-
tients. PVS was performed early, 13+4 days(mean + SD, rang,
8-25 days) after acute MI treated with thrombolytic thera-
py, and late, 10+7 months (range 3-29 months) after MI,
using the same PVS protocol. Ventricular tachycardia (VT)
(cycle length 212+39 ms) was induced early in 13 of 17, and
was treated by cardioversion in 9. VT (cycle length 230 +
49 ms) was induced late in 11 of 17. The results are -
shown below:
No VT
Nonsustained VT
(6-27 beats)
Sustained VT
Early Late
4--(3~ 6
,)<:> 6
10 ~::::g) ) 5
PSEUDO PROLONGATION OF THE HIS VENTRICULAR INTERVAL IN
ANTEROSEPTAL INFARCTION.
Joseph A. Vassallo, MD, Francis E. Marchlinski, MD, FACC,
Dennis M, Cassidy, MD, Alfred E. Buxton, MD, FACC, John
M. Miller, MD, Mark E. Josephson, MD, FACC. University of
Pennsylvania, Philadelphia, PA.
The His-ventricular (HV) interval represents conduction
time from the proximal His-bundle to the ventricular
myocardium. It is traditionally taken as the interval from
the beginning of the His-bundle deflection to the earliest
onset of ventricular activation recorded from surface ECG
leads or local RV electrograms at the atrioventricular
(AV) junction. We have analyzed LV endocardial catheter
mapping data during sinus rhythm in 25 patients (pts) with
anteroseptal infarction (AMI) to determine if pre-systolic
activity was present and hence whether standard measure-
ments using the surface QRS overestimated the HV interval.
The mean HV interval measured in the traditional manner
was 57+9 msec. Presystolic activity was recorded in 22/25
(88%) of pts and was recorded a mean of 15+9 msec prior to
the onset of the surface QRS complex. This-activity was
recorded from the LV septum in 18 pts and from the anter-
ior free wall in 4 pts. When this LV activity was consi-
dered the earliest ventricular activity, the measured HV
interval shortened from 57+9 msec to 42+14 msec (p<.001).
We conclude: 1) Presystolic low amplitude electrical
activity can be recorded from the LV septum or anterior
wall in the majority of pts with AMI. 2) Pseudo prolonga-
tion of the HV interval results when the onset of ventric-
ular activity was measured from AV junction or the surface
QRS in pts with AMI. 3) This data suggests that prolonged
HV interval in pts with AMI may be due to failure to
record low amplitude ventricular activity rather than slow
conduction in the His-purkinje system. This may have
importance in the management of syncope in pts with
bifascicular block and AMI.
EFFECTS OF DIFFERENT PACING PROTOCOLS IN PATIENTS AFTER
ACUTE MYOCARDIAL INFARCTION
David RIchards FRACP, Mark J. Cooper FRACP , OavId L.
Ross FRACP, FACC, John B. Uther FRACP. Westmead
HospItal, Westmead, NSW AustralIa.
We conclude 1. The more aggreSSIve Protocol II produced
not only more slow VT, but also more VF and fast VT,
than Protocol I. 2. RapId VT and VF may be false
POSItIve responses to aggressive stimulation, and their
clinIcal significance remains to be determined.
We have demonstrated that patIents (pts) WIth Inducible
(Protocol I, see below) ventricular tachycardia (VT)
after acute myocardial infarction (AMI) are prone to
sudden death. This prospective study compared the
effects of two separate protocols of programmed
stimulation applied In random order to 81 pts (aged
37-70 years) 7-15 days following AMI. Protocol I
comprised stimulation at the right ventricular apex
(RVA) and outflow tract with 1 and 2 extrastimuli at
twice diastolic current threshold and at 20 mAo Protocol
II comprised 1, 2, 3, 4 & 5 extrastimuli at tWIce
dIastolic threshold at the RVA. End points were
ventrIcular fibrillatIon (VF) and sustained VT.
SIGNIFICANT VARIABILITY IN THE INDUCTION OF VENTRICULAR
TACHYCARDIA.
Carlos E Velasco, MD, Jack Krafchek, MD, Karen J Beckman,
MD, Huang-fa Lin, MD, Sharon A Magro, PA, Christopher RC
Wyndham, MD, fACC.Bay10r College of Medicine, Houston,TX.
E1ectrophysio10gic studies (EPS) to test drug efficacy
for treatment of sustained ventricular tachycardia (VT)
without serial control studies assume a high reproduci-
bility of VT induction and required number of extrastimu-
1i (#ES). To test these assumptions, the results of 2
control studies at the right ventricular apex (EPSI and
EPS2) with in 72 hours, were compa red in 52 consecut ive
patients (pts) with prior infarction and documented spon-
taneous sustained VT (43 pts) or VF (9 pts). Sustained
monomorphic VT (0=30 sees) was induced in 43 pts (83%)
during EPSI and in 44 pts (85%) during EPS2. VT was in-
duced at both EPS in 40 pts and at neither EPS in 5 pts
(concordant result 87%). VT was induced at only one EPS
in 7 pts: 3 at EPSl, 4 at EPS2 (discordant result 13%).
Of the 40 pts ~ith VT inducible at both EPS, the change
in #ES required to induce VT from EPSI to EPS2 was as
follows: 1 ES 2 ES 3 ES 4 ES TOTAL
EPS I ~ --rr- --rr- ~ ;rn--
Same #ES 1 6 5 4 16
Fewer #ES 0 1 6 1 8(20%)
Greater #ES 4 8 4 16(40%)
Variability [0=1 ES] 4/5 9/15 10/15 1/5 24/40(60%)
Major variability [0=2ES (7 pts) or induced ++ non-induced
sustained VT (7 pts)] occurred in 14/52 (27%) pts.
Conclusion: Significant variability exists in inducibil-
ity of sustained VT from day to day. Serial control EPS
are necessary to minimize the chance that intrinsic vari-
ability would mimic a beneficial or detrimental effect
when testing drugs.
23 (28%)
20 (25%)
26 (32%)
12 (15%)
PROTOCOL II
13 (16'';)
7 ( 9%)
10 (12%)
51 (63%)
PROTOCOL
VT CL) 200 ms
VT CL < 200 ms
VF
No VT/VF
INDUCIBLE RHYTHM
130A ABSTRACTS lACC Vol 7. No.2
February 1986 l30A
AaJTE ANTIARRHYTHMIC DRUG EFFICACY IS INDEPEN-
DENTLY RELATED TO LEFT VENTRICULAR FUNCTION.
Ma.u: D.... M~ilU.D.H.... M...D&., Har 01 d R. Kay, M.D.,
F.A.C.C., Scott R. Spielman, M.D., F.A.C.C,
Allan M. Greenspan, M.D., F.A.C.C., Steven P.
Kutalek, M.D., Leonard N. Horowitz, M.D.,
F .A.C.C. Li kof f Card i ovascu lar Ins t i tu t e,
Philadelphia, PA
To evaluate the relation between antiarrhythmic
drug efficacy and LV function we performed 717
electrophysiologic studies (EPS) in 251 patients
(pts) with inducible sustained (>30 sec) ventri-
cular tachyarrhythmias (VTA). A standard EPS
protocol (3 extrastimuli) was used to test:
procainamide and quinidine alone; mexiletine
alone or in combination with procainamide or
quinidine; amiodarone alone or in combination
with procainamide or quinidine; flecainide,
indecainide or other agents. Antiarrhythmic
success was defined as inability to initiate
sustained VTA. The median ejection fraction (EF)
was 30%; thus pts were grouped by radionuclide
EF as ei ther < or L EF of 30%. Success was more
frequent in pts with EF£30% (n=117) than in pts
with EF<30% (n=134) (68% vs 37%, p<.OOl).
Differences between the two groups could not be
explained by differences in drug dose, blood
levels, or type of heart disease (p=NS). We
conclude that: acute response to antiarrhythmic
drugs is related to LV function per se or to
other underlying pathophysiologic mechanisms of
which EF may be a marker.
DO POLYMORPHIC VENTRlaJLAR ARRHYTHMIAS INITIATED IN POST
MI PATIENTS DIFFER FROM THOSE INITIATED IN THE
STRUCTURAL LY NORMAL HEART? WII I Iam G. Stevenson. M.P..
Pedro Brugada, M.D., Bernd Wal decker, M.D., Manfred
Zehender, M.D., Heln J.J. Wellens, M.D, F.A.C.C.
Un Ivers Ity of LJ mburg, Maastr Icht, The Nether lands.
PolymorphIc ventricular arrhythmIas (PYA) InItIated by
programmed stimulatIon may be clInIcally Important or
nonspecifIc. To determine If PYA InItiated In pts wIth
spontaneous sustaIned ventrIcular arrhythmIas (VA) differ
from nonspecIfic PYA, the IncIdence, and characterIstIcs
of > 5 beats of PYA were compared In 32 pts with
structurally normal hearts without spontaneous VA (NH)
and 36 pts with sustained VA late after myocardIal
InfarctIon (MI). Pts receIved 1 to 4 extrastlmul I durIng
sInus rhythm and rIght ventrIcular pacIng at 3 cycle
lengths. ComparIng the same steps In the stImulatIon
protocol there was no difference In the risk of
InItIatIon of a PYA between MI and NH pts (51~ vs 38~
with up to 2 stImulI, p NS). PYA were InitIated by the
same number of stl mu II (2.3 ± 0.5 vs 2.6 ± 0.9, P NS)
wIth the same prematurIty (222 ± 37 vs 215 ± 37 msec, p
NS) In both groups. A mean PYA cycle length> 250 msec
or a coupling Interval of the fIrst PYA beat to the last
stimulus> 320 msec occured In 44~ of PYA In MI pts but
on Iy 1 (6~) pt In the NH group (p < .02>'
Cpnclyslon: Most PYA InItIated In pts with VA after MI
are IndistInguishable In method of InItIation and cycle
length from PVAs Induced In structurally normal hearts
suggestIng that they are nonspecIfIc.
MECHANISM AND ORIGIN OF VENTRICULAR ARRHYTHMIAS FOLLOW-
ING ELECTRICAL CATHETER ABLATION.
Richard N. Hauer, M.D., Etienne O. Robles de Medina, M.D.,
F.A.C.C., Cornelius Borst, M.D., University Hospltal,
utrecht, The Netherlands.
A high incidence of ventricular tachycardias(VT) follow-
ing ventricular electrlcal catheter ablation ln dogs was
shown in prevlous studies. Mechanism and origin of these
VT were studied in 12 beagles treated with slngle R wave
triggered shocks with 30(4 dogs), 80(2 dogs) or 250 J (6
dogs) delivered to the endocardial ventricular wall (5
dogs right ventricular, 7 dogs left ventricular) using a
catheter electrode as the cathode and a back paddle as the
anode. Programmed electrical stimulation (PES) from or
near the ablation site(AS) at tWice dlastolic threshold,
using at least 2 cycle leng~bs and 1, 2 and 3 extrastlmu-
li and burst pacing, was performed prior to the shock and
within 1 hour thereafter. PES was repeated after 1 week
(10 dogs) or 1 month (2 dogs). In each dog many spontane-
ous episodes of monomorphic VT occurred withln the first
hour following the shock. These VT originated from the AS
as determined by recording of early negative deflections
ln the unipolar electrograms derived from the AS during
VT. In addition, QRS morphology(3-6 leads) was identical
to preablation QRS during pacing at the AS. High incl-
dence of VT persisted during the first 3 days after the
shock as shown by extended Holter monitoring and was in-
dependent of delivered energy. However, VT was never in-
ducible with PES. Our results indicate: 1. High incidence
of postablation VT independent of delivered electrical
energy. 2. Early postablation VT orlginates from the AS
and the mechanism is most compatible with abnormal autom-
aticity. 3. No evidence that the ablation lesion creates
appropriate circumstances for early or late reentry with
shocks in the 30-250 J energy range.
HYPOKALEMIA IN PATIENTS WITH VENTRICULAR TACHYCARDIA.
Andrew I. Cohen, M.D., F.A.C.C., Marc H. Wish, M.D.,
Vasilios Papademetriou, M.D., Frederick C. Miller, M.D.,
Ross D. Fletcher, M.D., F.A.C.C. VA and Georgetown
Medical Centers, Washington, D.C.
Pts resuscitated from an episode of sudden cardiac death
(SD) have been found to be hypokalemic at the time of
resusc1tation. Several centers suggest that pts found to
be hypokalemic at the time of SD are at low risk of
recurrence and need no therapy other than correction of
the hypokalemia. The purpose of this study was to evaluate
whether low plasma potassium (pK) may be a result of
ventricular tachycardia (VT) or fibrillalton (VF). In a
group of 9 pts with VT or VF baseline pK and epinephrine
was done prior to electrophysiologic test1ng (EP). Epin-
ephrine and pK were repeated at 2 minutes and 15 minutes
after inductlon of sustained ventricular tachycardia or
fibrillation. EP resulted in 15 episodes of sustained VT
or VF. In 6 eplsodes (group I) pK fell by 0.3mEq or more.
Baseline pK was 4.1±0.4 WhlCh decreased to 3.6±0.3mEq/L at
2 minutes and 3.6±0.4 at 15 minutes followlng VT or VF
(p<0.002). In 9 episodes of VT or VF (group II) pK fell
by 0.2 mEq/L or less. Serum epinephrine rose ln group I
(98.7±103 baseline to 135±36.5 (NS)) and group II (83.6±
42 to 111.0±47(NS)). Duration of VT or VF was 419±689
secs (group I) vs 132±274 (group II (NS)). One pt in
group I was on non-selective B blockers vs 4 in group II.
We conclude that hypokalemia is a frequent result of
sustained ventricular arrhythmlas and that hypokalemia
found at the time of resuscitation should not be thought
of as a cause of the arrhythmia but possible as a result
of It. Hypokalemia may be mediated by a rise in catechol-
amlnes.
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OBSERVATIONS WITH CLOSED-CHEST CATHETER ABLATION OF CANINE
VENTRICULAR ENDOMYOCARDIUM WITH RADIOFREQUENCY ENERGY.
Shoei K. Huang' M.D., F.A.C.C., Keith Wharton, B.S., Anna
R. Graham, M.. , Robert H. Hoyt, M.D., Frank I. Marcus,
M.D., F.A.C.C., University of Arizona, Tucson, Arizona.
Catheter ablation of ventricular arrhythmias using DC
energy has disadvantages. We assessed the efficacy and
safety of closed-chest catheter ablation of vent~icu1ar
endomyocardium using radiofreQuency (RF) energy ln 5 dogs
with microbipo1ar standard RF output (750 KHz). RF energy
was delivered between the tip electrode of a standard 7F
USCI tripo1ar catheter (lOmrn spacing) in the left
ventricle and an external patch electrode on the left
lateral chest wall. RF energy was delivered to 3 LV sites
with different energy settings for the individual sites;
lOW X 10 sec to the septum, 20W X 10 sec to the posterior
wall and 30W X 10 sec to the apex. Twenty-four hour Holter
recordings were obtained, starting immediately after the
procedure. Dogs were sacrificed on the 5th day. Pathology
showed well delineated oblong whitish lesions at the
ablation sites. The mean length of necrosis was 8.2mm,
range 4-l5mm; mean width 4.9mm, range 2-9mm; and mean
depth 4.8mm, range 2-7mm. Microscopic findings consisted
of circumscribed areas of necrosis surrounded by a zone of
fibroblastic and mononuclear proliferation and small
vacuolation. Occasionaly a thin layer of endocardial
thrombus at the ablation site was seen. Creatine
phosphokinase ranged from 8590 to 11090 lUlL with MB
fraction of 3-12%. Ventricular arrhythmias were not
observed during and 24 hrs after ablation. There was no
damage to the electrode catheters. Conclusion: Catheter
ablation of ventricular endomyocardium with RF energy
produced well circumscribed injury and did not induce
ventricular arrhythmias. This technique has potential
utility for catheter ablation of ventricular arrhythmias.
CHARACTERISATION OF CATHETER ABLATION WITH HIGH SPEED
CINEMATOGRAPHY
Eugene Downar, M.D., Louise Harris, M.B., Ian D. Parson,
Ph.D. and Anthony Easty, Ph.D., University of Toronto,
Toronto, Canada.
Although catheter ablation is gaining acceptance as a
treatment for arrhythmias, the physical events associated
with electrical discharge that result in ablation of tissue
remain obscure. To investigate this, we used high-speed
cinematography at 4000 frames/sec to record 300J discharges
in a transparent chamber of normal saline. Discharges
were of a damped sinusoid waveform. The electrodes inclu-
ded a 10 x 8 em steel plate and the distal pole of USCI
electrode catheters. Unipolar cathodal discharges between
catheter and plate produced a blue gaseous sphere (GS)
which reached a maximum size of 25 mm radium in 4 msec and
collapsed with a series of implosions over 6 msec without
visible gaseous residium. During the initial formation
phase of GS, a spark was evident between th~ elect:od~ and
the perimeter of the sphere. Phenolphthaleln dye lndl-
cated a strong alkaline pH around the catheter. No
visible changes occurred at the anodal plate. Changes at
the catheter electrode were indifferent to the position of
the plate electrode. Anodal discharges at the catheter
resulted in similar events except the GS was yellowish and
no alkalinity was observed. Bipolar discharges between
catheters 8 em apart resulted in convergence of the
implosive phases. Unipolar catheter discharges from the
LV apex of sheep hearts resulted in violent movements of
the LV wall by the GS, and perforation by the spark. These
observations suggest catheter ablation may achieve its
effect by a combination of barotrauma, fulguration and
chemical cautery. The configuration of these effects
appears indifferent to the position of the electrode plate.
HAEMATOLOGICAL EFFECTS OF THE ABLATION TECHNIQUE; A
COMPARISON BETWEEN ANODAL AND CATHODAL DELIVERY
E.G.Boyd, Ph.D., P. HoI t, MD, MRCP
Guy's Hospltal, London, England
Ablat10n of atrioventr1cular conduction 1S now w1dely
accepted 1n the management of supraventrlcular arrhythmlas.
Reports of high temperatures, hlgh pressures and gas pro-
ductlon suggest that there may be adverse effects on the
blood the electrode and the cardlovascular system. ThislnVeS~lgatlon, using samples of fresh, heparlnlsed pig's
blood, has measured the haemolytlc damage, the Ilberated
gas volume and composltlon, and electrode erOSlon. The
blood was tested ln a Iltre tank at room temperature. Im-
pulses of 10 Joules to 400 JOUles were appl1ed to new USCI
6F blpolar paclng electrodes uSlng negatlve polarltles.
(Anodal energy dellver1es could not be used above 200J
because the pressures generated destroyed the gas collect-
lon apparatus!. Voltage and current waveforms were re-
corded to assess the simllarlty of the tank to the cllnl-
cal sltuation. The volume of gas Ilberated wlth a catho-
dal electrode was 0.43 ul/J up to 50J and 0.19 ul/J above
100J, It was composed predomlnately of hydrogen and
n1trogen, wlth carbon dloxlde and oxygen. USlng a posit-
lve electrode the gas volume was llnearly related to
energy at 4.25 ul/J up to 200J. In addlt10n the gas also
conta1ned carbon monoxlde. The haemolysis was directly
proport1onal to impulse energy for both cathodal and anod-
al electrodes, being 1.35 ul/J and 4.53 ul/J, respectively.
After 48,000J electrode erOSlon was substantlal and
neutron activatlon analysis showed platinum losses of
2.94mg and 0.84mg. Electron m1croscopy showed very
dlfferent electrode surface patterns for the two types of
energy delivery. The results suggest that lower energies
and cathodal energy dellvery is more appropriate for the
cllnlcal endocardlal ablation procedure.
PATHOLOGICAL AND ELECTROPHYSIOLOGICAL OBSERVATIONS OF
CHRONIC ATRIOVENTRICULAR BLOCK INDUCED BY CLOSED-CHEST
CATHETER ABLATION WITH RADIOFREQUENCY ENERGY.
Shoei K. Huang, M.D., F.A.C.C., Saroja Bharati, M.D.,
F.A.C.C., Maurice Lev, M.D., F.A.C.C., Frank I. Marcus,
M.D., F.A.C.C., University of Arizona, Tucson, Arizona.
DC energy has been used to induce atrioventricular block
(AVB) but this type of energy is not ideally suited for
this purpose. Therefore, we induced chronic AVB by
closed-chest catheter ablation of the AV junction with
radiofrequency (RF) energy in the dog. The animals were
observed for 2 months to determine if the ablation was
permanent to define the chronic pathology and the site of
AV block. Complete AVB was successfully achieved in 4 dogs
with a microbipolar standard RF output (750 KHz) delivered
between the tip electrode of a standard 7F USCI catheter
and an external patch electrode on the left lateral chest
wall. Three dogs had persistent complete AVB, the other
had persistant 2:1 AVB. Permanent pacemakers were
implanted in the 3 animals with complete AVB. His bundle
recordings were performed immediately after ablation and
at 2 months. Results: The site of block was above the His
bundle in all 4 animals. The degree of injury was graded
on a scale of 0-4+. Injury was 4+ at the AV node in all 4
animals; 1-3+ at the approach to the AV node; 0-4+ at the
penetrating bundle and 1+ in only 1 dog at the branching
bundle. The damaged area was well delineated. The AV node
was completely replaced with granulation tissue and
cartilage formation. There was fatty infiltration and
chronic inflammatory cells around the lesions. Neither
perforation, hemorrhage or vacuolation was seen in the
adjacent area. Thrombi were not present. Conclusion: RF
energy can achieve chronic AV block and produce well
circumscribed pathological lesions.
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INDUCTION OF AV NODAL (AVN) DELAYS AND BLOCK BY A THERMAL
CATHETER TECHNIQUE: ACUTE AND CHRONIC STUDIES.
Onkar S. Narula, M.D., F.A.C.C., Birinda K. Boveja, B.S.,
Paul E. de Coriolls, B.A., and Peter P. Tarjan, PhD.,
Univ of Miami, Miami, FlorIda.
In 20 mongrel dogs anaesthetIzed with Nembutal, a speci-
ally designed thermal electrode catheter (7F) was intro-
duced via a femoral vein and positIoned at the His bundle
(BH) and AVN region for intracardiac recordings, localiza-
tion, and delivery of thermal energy. Autonomic blockade
was produced with IV Inderal (5mg) and atropine (lmg).
Thermal energy (9-16 watts) was delivered for 2-6 second
durations to induce graded A-H prolongation in 10, 20
A-H block in 2, and 30 A-H block in 8. Results in dogs
with A-H prolongation are tabulated below:
CONTROL POST PROCEDURE
P-P 380-630, mean 499* 300-700, mean 511*
P-R 110-125, mean 116* 125-190, mean 158*
A-H 55-75, mean 67* 70-140, mean 107*
APCL 190-320, mean 249* 170-410, mean 268*
ERP AVN <140-250, mean 184* <160-370, mean 217*
APCL = Atrial pacing cycle length for 20 A-H block.
* = msec. ERP = Effective refractory period.
In each dog, H-V time (35-40msec), QRS duration (60msec),
and morphology remained unchanged throughout. In dogs
with 30 A-H block, escape BH rhythm (CL=1600-2000msec)
showed H-V time and QRS similar to control. Repeat stud-
ies at 3-7 month intervals documented the persistence of
induced A-H delays, 20 and 30 block without regression.
In conclusion, persistent and graduated AVN delays can be
induced via a catheter technique using thermal energy.
The latter technique is preferable to our previously des-
cribed laser catheter technique, as the instrumentation
is simpler and economical.
EXERCISE CAPACITY AND HEART RHYTHM FOLLOWING TRANSVENOUS
FULGURATION OF ATRIOVENTRICULAR CONDUCTION.
Peter Schofield, MRCP., Robert Bowes, MRCP., David Bennet4
M.D., MRCP. Wythenshawe Hospital, Manchester, England.
24 patients, aged 19-67 years, were studied 4-36 months
after transvenous fulguration of the atrioventricular (AV)
junction in order to assess exercise capacity and spontan-
eous heart rhythm. 15 patients had had atrioventricularre-
entrant tachycardia and 9 patients, 4 with mitral valve
disease and 5 with the brady-tachy syndrome, had had an
uncontrollable ventricular response to atrial fibrillation
or flutter. 1-3 DC shocks of 200-400 joules were delivered
via a His bundle electrode in each case. After fulguration,
17 patients had complete and 5 partial AV block. In 2 pat-
ients sinus rhythm was maintained via an accessory AV
pathway. Though all patients were free of palpitation
after the procedure, 10 developed exertional dyspnoea and
2 patients' pre-existing dyspnoea worsened. 23 patients
underwent exercise testing during ventricular demand pac-
ing at 60 or 70 bpm using the Bruce protocol. Exercise
time was reduced to 45% ± 23% (mean ± SO) of the predicted
value for their age and sex. In 6 patients with complete
AV block, there was an increase in ventricular rate during
exercise. In 3 patients with partial heart block, the
degree of AV block increased on exercise. The 13 patients
with rate responsive pacemakers demonstrated a signifi-
cantly better but still impaired exercise capacity during
physiological pacing (67% ± 24%) as compared with their
performance during fixed rate pacing (41% ± 18%) (p<O.OOl).
We conclude that though the procedure is successful in
controlling tachycardia it may cause a reduction in
exercise capacity. Most patients remain in complete AV
block after the procedure and, in contrast to the prac-
tice as described in early publications, would benefit
from "physiological" pacing though even with this mode
exercise capacity is likely to be abnormal.
COMPARISON OF THE DEFIBRILLATION
THRESHOLD AND THE UPPER LIMIT OF
VENTRICULAR VULNERABILITY
Peng-Sheng Chen, M.D., Nitaro Shibata, M.D., Ellen G. Dixon,
M.S., Michael J. Fine, B.S., and Raymond E. Ideker, M.D.,
Ph.D. Duke University Medical Center, Durham, NC
We have shown that unsuccessful defibrillation shocks > 1 J
applied to the epicardium extinguish all cardiac activations for
64±22 SD ms, yet fail to defibrillate because VF is reinitiated
following the shock. Since VF is sufficiently complex so that
there are always some cells in their repolarizing phase, this
finding raises the hypothesis that unsuccessful shocks:::: 1 J fail
because they reinitiate VF by stimulating portions of myocar-
dium in their vulnerable period. A corollary of this hypothesis
is that the energy of the strongest shock that can induce VF
during the vulnerable period of regular rhythm (the upper limit
of vulnerability) should be correlated with the defibrillation
threshold (DFT) energy. To examine this relationship, we ~tu­
died 14 open chest dogs with epicardial defibrillation electrodes
at the ventricular apex and either the RA or LA. We deter-
mined the upper limit of ventricular vulnerability by giving
shocks of various energy during the vulnerable period of the
repolarization phase of paced rhythm. We also determined the
DFT. In all dogs there was an upper limit to the shock
strength that induced VF during the vulnerable period. This
upper limit of ventricular vulnerability was slightly lower than
the DFT. The correlation coefficient between the two was
highly significant (r=O.92, p<O.OOOl for apex and RA combina-
tion, and 1'=0.89, p<0.OO5 for apex and LA combination).
These results are consistent with the hypothesis that successful
defibrillation with epicardial electrodes requires a shock
strength that reaches or exceeds the upper limit of ventricular
vulnerability and that shocks slightly lower than the DFT fail
because they reinitiate VF by stimulating portions of myoca('-
dium in their vulnerable period.
TRANSMYOCARDIAL ELECTRICAL IMPEDANCE: RELATIONSHIP TO
CANINE DEFIBRILLATION THRESHOLDS.
Rehan 14ahmud, MD, FACC, Jeffrey Milsap, Anita Krebs, RN,
Patrick Tehou, MD, IHehael H. Lehmann, MD, FACe, John
Dongas, MD, Stephen T. Denker, MD, FACC, Masood Akhtar,
MD, FACC, Un,v. of WI Mt. Sinai Med Center, MilwaUkee, WI.
Implant at ion of automat ic Internal def ibri llators (AID,
requires lead placement at sites demonstrating low defIb-
rillation thresholds (OFT). It was hypotheSIzed that if
the transmyocardial impedance (1MZ) was primarily resis-
tive, it may be possible to predict the optimal AID leads
location by determining the sites with low 1MZ; as report-
ed for external carJ loversion. In 10 open chested dogs
(wt > 20 kg), ocm2 AID patches were placed on left
ventricle and right ventricle or atrium simulating
placement during AID Implants. Ventricular fibrillation
was induced using AC current. DFT's were determined using
a damped sine wave discharge of 5 msec duration. Voltage
(V) and current (I) were displayed simultaneously on an
oscilloscope using a 44:1 V attenuator and a low
resistance shunt. TM Z was determined at the peak V and I
waveforms. In 2 control dogs, phase relationship of V and
I was determined by displaying V versus I in an analog
fashion using single ended measurements (LIssajous
figure). Results: 1) In the 2 control dogs using energies
varying from 2-50 Joules (J) the V and I were linearly
related (r= .99) suggesting a primarilY resistive TMZ.
2). In the study group (8 dogs, 24 sites), the mean DFT
was 11 + 6 J (range 3.9 - 13J), and 1MZ was 68 + 13 ohms
(range 45.6 - 94.5 ohms). Coefficent of correlation
between OFT's and 1MZ:r = -.34. Conclusions: Despite the
primarily resistIve character of the 1MZ, there was a
poor correlation between OFT's and 1MZ in the canine
modeL Our data suggest that determination of TMZ may not
have the predictive value that has been reported for
transthoracic impedance dunng external cardioversion.
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SURGICAL INTERRUPTION OF NODOVENTRICULAR VlAHAIM
FIBERS WITH PRESERVATION OF NORMAL A-V CONDUCTION.
John J. Gallagher, MD, FACC, Jay G. Selle, MD, Will C. Sealy,
MD, John M. Fedor, MD, FACC, Robert H. Svenson, MD, FACC,
Samuel H. Zimmern, MD, FACe. Sanger Clinic PA, Charlotte,
North Carolina and James e. Cox, \'lD, FACe, Barnes Hospital,
St. Louis, Missouri.
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Nodoventricular (NV) Mahaim fibers have been shown to be
responsible for some examples of supraventricular tachycardia
(SVT) in man. Because of their intimate relationship to the
atrioventricular (A-V) node, these fibers have been thought to
be unapproachable by ablative techniques because of the risk
of complete A-V block. Successful interruption of an NV fiber
has now been achieved in 3 patients without damage to the
A-V node-His bundle.
Three patients aged 18, 25, and 33 years presented with
recurring SVT. All had preoperative and intraoperative
confirmation of accessory A-V pathways in the right A-V groove
and posterior septal (PS) space in addition to an NV fiber. Two
of the three had coexisting Ebstein's anomaly. The boundaries
of the pyramidal space and the right A-V groove were dissected
thoroughly after identifying the location of the His bundle.
Particular attention was given to dissection of the posterior
limit of the atrial septum, but the septum itself was not entered.
Intraoperative and postoperative studies confirmed division of
all pathways including the NV fiber, with preservation of normal
A-V conduction. Retrograde conduction was absent in all. All
patients have remained free of preexcitation and tachycardia,
with a follow-up of 3 years, 3 years and 3 months respectively.
Despite their proximity to the AV node, NV fibers may be
divided by a septal dissection leaving normal conduction intact,
suggesting a location at the posterior-inferior aspect of the AV
node.
SUIGERY FOR ~..;pARKIN~ SYNDIOm USn«; A cra;m
HEART TEDlNIQJE: FURTHER EXPERIEN::E AND POIml'IAL LIMITA-
TICNS.Gerard M. Qlirau:1on~ M.D., F.A.C.C., GeoIge J.
Klein, M.D., F.A.C.C., Arjun D. Shanna, M.D., F.A.C.C.,
tmiversity Hospital, IonOOn, Qltario, canada.
We have described a closed heart technique for division
of atriCNE!lltri.cular pathways (AP) in the
W:>lff-Parkinson~te (WPW) syndrare. 'rtl.e technique in-
volves dissection and IOObilization of the AV fat pad with
exposure and czyoablation of the AV junction at the site
of the AP.
Ninety three conseaItive WPW patients with LV free wall
AP (66), posteroseptal AP (16) and FN free wall (11)~
operated between JUly 1982 and August 1985. Three patients
had 1IU1ltiple accessory pathways and 8 had associated
cardiac disease. ElectroP'tYsiological testing to detennine
the presence and site of the AP was perfonned before and
after dissection of the fat pad and again after
cl}'Oablation of the AV junction.
All AP but 1~ successfully ablated with no
II'Ortality and no incident of AV bloc:k. Ninety b.'o patients
remtin free of arr~ in the absence of drugs after a
mean follOltMlp of 14 (1-38) II'Onths. '1hree patients
required a se<:X>lld operation within the first week for
recurrence of AP oooduction. In 2 of these patients, AP
conWction persisted after extensive dissection and
exposure of the AV juncticn and cnlydi~ after
cxyoablation. :Aec:urrenoe of AP conduction in the latter
patients suggests the presence of a subendocardi.al pathway
protected fran cryoablation by the wann circulat~ blood
pool.
We conclude that the closed heart technique
is safe and efficacious. A potential limitation may be the
presence of subendocardial AP which may require
alternative approach at the site of the AP.
EFFECT OF INTRAVENOUS METOPROLOL ON INFARCT SIZE
FOLLOWING REPERFUSION: EVALUATION USING CONTRAST
ECHOCARDIOGRAPHY; Charles G. Vasey, M.D., John A.
DeSanto, B.S., William F. Armstrong, M.D., F.A.C.C.;
Indiana University School of Medicine, Krannert Institute
of Cardiology; Indianapolis, Indiana
We studied 38 open chest dogs to assess the effect of
intravenous metoprolol (Met) on the size of reperfused
myocardial infarction. Myocardial contrast echocardio-
graphy (MCE) immediately, 1 and 2 hrs after coronary
artery occlusion (CAO) was used to determine the area at
risk. A 2 hr CAO was followed by 2 hrs of reperfusion.
A pretreated group received Met .5 mg/Kg before CAO and
.25 mg/Kg 1 hr after CAO. Ten dogs received Met 0.75
mg/Kg 1 hr after CAO (delay) and 10 dogs served as
controls. A fourth group received identical pretreatment
with Met but was then atrially paced at the baseline
heart rate (pace). Reperfusion was confirmed with MCE
immediately, 1 and 2 hrs after release of CAO. The
corresponding LV section was stained with nitro-blue
tetrazolium to determine infarct size, which was
expressed as a percent of the risk area.
%Risk MI % MI/Risk %
Pretreat (n = 11) 27.6 5.7 20.7 + 12'~
Delay (n = 10) 29.5 7.8 28.4 ~ 19. <.005
Control (n = 10) 20.3 9.1 45.0 + 20.9 < .05
Pace (n = 7) 29.1 14.6 53.0 + 20.0 NS
While there were no intergroup differences in blood pres-
sure following Met, heart rate slowed in the pretreat and
delay groups in comparison to both the control and pace
groups (p<.05). We conclude that either pretreatment or
delayed treatment with Met, followed by reperfusion, lim-
its infarct size. This effect appears to depend predomi-
nantly on reduction in heart rate and presumably reduced
myocardial oxygen demand follOWing beta blockade.
EVIDENCE OF REVERSE TETHERING OF ISCt-EMIC
MYOCARDIUM BY INOTROPIC Q-1ALLENGE. Andrew J. Buda.
M.D., F.A.C.C., Rainer J. Zotz, M.D., and Kim P. Gallagher,
Ph.D., University of Michigan, Ann Arbor, Michigon
During acute myocardial ischemia, there exists a zone of
myocardiol dysfunction which surrounds the central ischemic
area which has been termed the functional border zone (FBZ).
We hypothesized that nonischemic dysfunctional myocardium
may respond to an inotropic challenge and may affect the
function of the odjacent myocardium by a reverse tethering
effect. To exomine this, we studied 12 open-chest dogs during
acute left circumflex (LCx) occlusion. Simultaneous 2D
echocardiograms and radioactive microspere injections were
used to create circumferential left ventricular (LV) flow-
function maps at the papillary muscle level. Serial studies were
performed ot baseline, IS minutes following left circumflex
occlusion, and following dobutamine (Dob) infusion during LCx
occlusion. Following occlusion, woll thickening decreased from
52±8% (mean ± SEM) to -5±5% (p<.OI) in the central ischemic
zone. The extent of LV dysfunction measured 170+ II 0 while the
subendocordial hypoperfusion zone was 130±90" (p < 0.05)
resulting in 0 FBZ of 42± 11 0 • Following Dob, wall thickening did
not chonge in the central ischemic zone but increased adjacent
to the FBZ (p<O.OI) and in the normal zone (p<0.05) reducing the
extent of the FBZ to 19± 160 (p <0.05). Following Dob, the slope
of the transition of function from nonischemic to central
ischemic zones increased on the free wall border (,71+.11 to
.95±.10, p<0.02) to a greater extent thon on the septal-border
(-.60±.08 to -.73±.06, p=0.07). We conclude: (I) nonischemic
myocardium adjocent to ischemic tissue respands to inotropic
challenge; (2) Dob produces a significant decrease in the size of
the FBZ; (3) reverse tethering can occur following inotropic
intervention; (4) dynamic changes in function following inotropic
intervention are greater in the lateral free wall border thon in
the lateral septal border of the FBZ.
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MECHANICAL SEQUELAE OF SUBACUTE MYOCARDIAL INFARCTION IN
mE CANINE VENTRICLE: IMPLICATIONS FOR INTERVENTIONS
DESIGNED TO SALVAGE MYOCARDIUM
Robert J. Mich MD, Douglas L. Mann MD, Rodney A. Foale MD,
Linda D-;-GillamMD
Massachusetts General Hospital, Boston MA
To assess the functional benefit of ~yocardial salvage, it
is essential to define the natural history of mechanical
dysfunction following myocardial infarction. We hdve
reported t~at the circumferential extent of abnormal wall
motion does not change from 6 to 72 hours. To further
define regional function we examined t~e evolution of
~ypokinesis (HYPO) and dyskinesis (DYS) within the infarct
zone (IZ) and border zone (BZ) in 10 closed-chest dogs at
O. 0.5, 6, 24, 48 and 72 hours following experimental
myo'cardial infarction. Short-axis echocardiograms were
obtained at t~e mid-papillary level. Postmortem
TTC-stained slices corresponding to t~e echo planes were
divided into: IZ = any region showing infarction; and BZ =
300 on either side of IZ. The end-d1astolic to
end-systolic fractional radial change was assessed at 100
intervals: HYPO was defined as a fractional radial change
< 10~ and DYS as a fractional radial change < O~. The
number of 100 radians with HYPO/DYS was expressed as a ~
of the total. Results:
Zone Control O.5hr 6hr 24hr 48hr 72hr
HYPO IT"" O~ 30r 3Dr 3or- 3W- 40-~-
BZ O~ 7% 18~ 10~ 12~ 22~
DYS IZ O~ 45S 52S 40S 42S 49S
BZ OS 5S lOS 7S lOS 5S
Conclusions: 1) Once established at 0.5 hrs there was no
slgnificant change (p>0.05) in the extent of HYPO or DYS
in the Infarct Zone and the Border Zone; 2) therefore
improvements in the extent of HYPO and DYS between 0.5 and
72 hours may prove useful in assessing interventions
designed to salvage myocardium.
NATURAL VARIABILITY OF WALL MOTION ABNORMALITIES
FOLLOWING EXPERIMENTAL MYOCARDIAL INFARCTION: IMPACT ON
THE ASSESSMENT OF INFARCT REDUCTION INTERVENTIONS
Douglas Mann MD, Linda Gillam MD FACC, Rodney Foale MD,
Arthur Weyman MD FACC; Mass General Hospital, Boston MA
If quantitatlve computer-aided echocardiography is to
be instrumental in assessing the functional benefits of
infarct reduction interventions, it is first essential
to establish the 'natural' variability of abnormal (A)
wall motion (WM). The purpose of this study, therefore,
was to define the 95% confldence limits (CONF) for AWM
in a canine infarct (MI) model. Serial short-axis
echocardiograms were obtained in 10 closed-chest dogs
at 0.5,6,24,48 and 72 hours (hrs) post MI, at the level
of the apex, low papillary (PAP),mid PAP, high PAP and
mitral valve (MV). WM was assessed by examining the
radial excursion of 36 evenly spaced endocardial
targets, every 16.7 msec, from end-diastole to
end-systole. We quantified the circumferential extent
(CE) of AWM by 3 methods: the number of radii with <10%
and <20% fractional radial change (FRC) and a method
that correlates radial excursion with 'normal' ray
motion (CORR). The 95% CONF were calculated from the
one-tailed values for the t distribution for the 95th
percentile: 95% CONF = 1.92 X SO of the mean of the
absolute difference in the CE of AWM at 6,24,48,72 hrs
compared with 0.5 hrs. Results were (modal values):
apex low PAP mid PAP high PAP MV
FRC<lO% 40.5 19.7 31.4 15.2 17.6
FRC<20% 10.6 12.1 12.9 9.2 11.9
CaRR 9.2 10.9 11.4 11.9 12.2
In order to demonstrate a significant (p<0.05)
improvement in WM following an intervention, the degree
of improvement must exceed the 95% CONF for AWM; we
conclude, therefore, that this will depend on 1) the
plane analyzed and 2) the method used to analyze AWM.
IS MYOCARDIAL FUNCTION AFFECTED WHEN BLOOD FLOW TO NORMAL
MYOCARDIUM IS INCREASED TO LEVELS ABOVE NORMAL? S. Kaul,
MD, FACC, J.D. Oliner, BA, A.E. Weyman, MD. FACC, N.G.
Pandian MD, L.D. Gillam MD, FACC, J.A. Gascho, MD, FAce.
University of Virginia. Charlottesville, VA and
Massachusetts General Hospital. Boston, MA
Conclusion: Selectively increasing flow to the nor-
mally perfused myocardium increases regional and con-
sequently global function in both nonischemic and ische-
mic left ventricles. This phenomenon may be related to
increased intramyocardial diastolic stretch caused by
increased blood flow into the myocardium. These findings
may have therapeutic implica tions.
There is controversy regarding the effect of in-
creasing blood flow to the normal myocardium in the
intact animal. Accordingly, we studied the effect of
selectively increasing blood flow to the normal myocar-
dium in 12 open chest anesthetized dogs. Selective can-
nulation of the left circumflex artery (LC) was achieved
in 6 normal dogs (Group I) while left main coronary
artery cannulation was achieved in 6 dogs with LC occlu-
sion (Group II). The experiment was conducted in 2
stages: stage 1 - cannulated artery pressure (CAP) = AO
pressure (AoP). stage 2 - CAP>AoP. Myocardial thickening
(MT) in the LC bed in Group I dogs and in the left
anterior descending artery bed in Group II dogs (beds
with normal blood flow) was measured using 2D echo.
Additionally, thermodilution CO was measured in Group I
dogs. The results (means) are as follows:
EVOLUTION OF THE TEMPORAL AND SPATIAL EXTENT OF DYSKINESIS
FOLLOWING EXPERIMENTAL MYOCARDIAL INFARCTION
Kathryn J Ascah MD, Edward F Gibbons MD, Robert D Hogan,
PhD, Thomas D Franklin PhD, Linda D Gillam MD FACC, Arthur
E Weyman MD FACC, Mass. General Hospital, Boston. MA
The effect of infarct maturation on the temporal and
spatial extent of dyskinesis has not been described. We
used cross-sectional echocardiography to study the
myocard1al contraction sequence wit~in the ischemic zones
of 17 dogs, 30 min to 6 wks follOWing acute infarction.
Left ventricular short axis images were digitized from
end-diastole to end-systole and fractional radial change
along 36 evenly spaced rays calculated. The
circumferential extent of dyskinesis (EXTENT) was
determined for each decile of the normal ized contraction
sequence and the decile in which the greatest EXTENT
occured was noted. The decile in which the maximal degree
of dysk1nesis (MAXDD) occured was also noted for each ray.
RESULTS: The greatest EXTENT occurred in the 4th decile
between 30 min and 48 hrs follOWing infarction. The
greatest EXTENT occurred progressively earlier in the
contract ion sequence as the infarct matured, with the
maximal EXTENT occurring in t~e 3rd decile at 1 & 3 wks
post-infarction and in the 1st decile at 6 wks
post-infarction (p=.OO1). Similarly MAXDD occurred most
frequently in the 4th or 5t~ decile during the early
post-infarctional period (30 min to 1 wk), but during the
2nd and 1st deciles respectively. at 3 and 6 wks folloWing
infarction (p=.OOl). End-systolic dyskinesis was present
in 30-50~ of rays up to 1 wk following infarction, but was
no longer observed at 6 wks. CONCLUSION: The maximal
circumferent ial extent and degree of dyskinesis occur
progressively earlier in the systolic contraction sequence
as the infarct matures. Failure to recognize these changes
in the myocardial contraction pattern may result 1n an
underestimation of the degree of myocardial involvement.
Group I
Group II
'0<'05, t
n
(6)
(6)
NS
A CAP(mmHg)
+62'
+56'
A COm
+ 8'
A HR
-2 t
A MT(S)
+18'
+17'
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INTRINSIC CONTRACTILITY OF THE PAPILLARY MUSCLE IN NORMAL
AND ISCHEMIC LEFT VENTRICLE IN VIVO - EXPERIMENTAL ECHO-
CARDIOGRAPHIC STUDIES, Natesa Pandian, M.D., Shan Shen
Wang, M.D., John Funai, M.D. Tufts-New England Medical
Center, Boston, Massachusetts.
Although numerous investigators have used isolated pa-
pillary muscle (PM) to study cardiac muscle physiology,
there are no precise data on the contractile dynamics of
the PM in a normal beating heart. In addition, despite
the implication of ischemic PM dysfunction in the develop-
ment of mitral regurgitation, the effect of ischemia on
the intrinsic contractility of PM has not been quantified
in vivo. To examine the PM dynamics in normal and ischemic
myocardium, we employed two-dimensional echocardiography
with a 5 MHz transducer in 8 dogs and obtained images of
the posteromedial PM in its long-axis (LAX) and short-
axis (SAX), during control and during posterior wall is-
chemia induced by occlusion of circumflex coronary artery.
From end-diastolic and end-systolic echo images we
measured PM area in LAX, PM area and thickness in SAX and
wall thickness (WT) of the subjacent myocardial wall
(SMW) and remote myoca rdi a1 wall (RM\~) in SAX. Resu1 ts:
(x±SE; *p<.Ol): %6 during systole
Control Ischemia
PM area change in LAX 37±5 6±2 *
PM area change in SAX 24±2 -9±3 *
PM thickening in SAX 22±5 -4±2 *
SMW thickening 22±5 4±2 *
RMW thickening 18±4 22±2 NS
Conclusion: The magnitude of intrinsic in vivo PM con-
traction is similar to that of subjacent myocardium in a
normal ventric1 e. Ischemia profoundly impairs the intrin-
sic in vivo contractility of PM in addition to the dys-
function created in the subjacent myocardium.
CHARACTERIZATION OF ACOUSTIC PROPERTIES OF ACUTE INTRACAR-
DIAC THROMBI USING ULTRASOUND.
David D. McPherson, M.D., Boyd M. Knosp, M.S.E.E., Robert
Kieso, M.S., Judy A. Bean, Ph.D., Richard E. Kerber, M.D.,
F.A.C.C., David J. Skorton, M.D., F.A.C.C., Steve M.
Collins, Ph.D., Cardiovascular Center, University of Iowa,
Iowa City, IA.
Echocardiographic differentiation among intracavitary
thrombus, cavity noise, and myocardium may be difficult.
As an initial step toward thrombus characterization, 11
dogs were studied using an in vivo intracardiac thrombus
model: apical coronary arteries were ligated and injec-
tions of 5% Na rescino1eate and 1000 units of thrombin at
the endocardium-blood interface created left ventricular
mural thrombus. Ultrasonic images were obtained in two
views with a digital acquisition system, and a statistical
analysis of echo intensities was performed in regions of
interest in the thrombus, surrounding cavity, and myocar-
dium. Acoustic characterization parameters included mean
gray level, standard deviation (SO) and skewness. RESULTS:
Short-Axis Data (End-Systole, x±SD)
CAVITY AREA - FLOW VELOCITY RELATIONS IN ACUTE MYOCARDIAL
INFARCTION. EXPERIMENTAL ECHOCARDIOGRAPHIC STUDIES.
Shan Shen Wang MD, John Funai MD, Natesa Pandian MD.
Tufts-New Eng1 and Medical Center, Boston, Massachusetts.
To assess the effects of acute myocardial infarction
(AMI) on aortic flow velocity (AoFV) and its relation to
LV cavity area dynamics, we studied 9 heart-rate control-
led dogs in whom AMI was created by left anterior descen-
ding coronary occlusion and infarction verified by TTC
staining. We imaged the LV with 20 echo (2DE) and obtained
AoFV recordings by Doppler echo (DE) in control (C) and
hourly for 6 hours after coronary occlusion. From 2DE we
measured LV cavity size frame-by-frame. From AoFV recor-
dings we measured peak velocity (Vmax), velocity integral
(VI) and acceleration rate (AR). Also, by relating the in-
stantaneous changes in LV cavity size and AoFV, we measu-
red the LV cavity area change required to accomplish peak
velocity (VmaxA6) and total systolic LV cavity area change
(TSA6) and derived two indices: VmaxA6/TSA6 and Vmax/
VmaxA6. Results: (x±SD) (*p<.05 vs C).
C 1 hr 3 hr 6 hr
Vmax(m/s) .97i.2 .~1* .~1* .66±.2*
VI(cm) 13±2 10±2 * 9.2±1 * 10±3 *
AR(m/s/s) 20±6 12±5 * 9.7±3 * 11±6 *
VmaxA6/TSA6 16±6 31±12* 44±11* 31±10*
Vmax/Vmax6 1.0±.2 .58±.2* .39±1 * .48±.2*
Although the changes in AoFV profile were significant in
the group as a whole, Vmax, VI and AR displayed moderate
overlap with C measurements; on the other hand, VmaxA6/
TSA6 and VmaxA6 exhibited no significant overlap with con-
trol values. From these observations we conclude that: 1)
AMI induced LVdysfunction results in adverse changes in
AoFV, 2) Indices derived by relating LV cavity size change
to aortic blood flow reflect pump function better than
conventional indices and 3) pump dysfunction remains ab-
normal in the first 6 hours of AMI.
LEFT VENTRICULAR FLOW PATTERN IN MYOCARDIAL INFARCTION
ASSESSED BY POWER-MODE TWO-DIMENSIONAL COLOR FLOW MAPPING
Kiyoshi Machii, M.D., Hironori Hirai, M.D., Shigeru
Nishi zawa , M.D., Hideo Matsuzaki, M.D., Makoto Suzuki,
M.D., Tetsu Yamguchi, M.D., Kenji Kuwako, M.D., Toho
University, Tokyo, Japan.
Capability of power-mode two-dimensional color flow
mapping for detection of a slow flow was assessed in 30
cases with myocardial infarction and 10 normal controls.
The apparatus we used is either proto-type or
commericially available Toshiba SSH-65A, in which both
the power-mode and the conventional velocity-mode
displays can be obtained. In the power-mode display, the
total power of the backscattered ultrasound with Doppler
effect is imaged in red or blue color according to the
flow diretions. A unicolor display is also obtained by
baseline shift operation. In normal subjects and 10
cases with a mild myocardial infarction, the left
ventricular diastolic inflow directed toward the apex
turned sharply to the opposite direction toward the
outflow. In 12 cases with dilated left ventricle due to
a uniform akinesis or hYPokinesis of the left ventricular
wall, a circular movement of the diastolic flow in the
left ventricle could be visualized, and the lowest
velocity imaged in color was arround 10 em/sec, which was
about one half of that with the velocity-mode display.
In 8 cases with asynergy localized in the apex, flow in
the apex could not be imaged. Our method is useful for
assessing a swirling flow in dilated left ventricles, and
for confirming a small asynergy localized in the apex.
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PULSED DOPPLER-DERIVED MITRAL INFLOW VELOCITY IN ACUTE
MYOCARDIAL INFARCTION: AN EARLY PROGNOSTIC INDICATOR.
Cees A. Visser. M.D •• Harry de Koning, Ben Delemarre,
M.D., Jacques J. Koolen, M.D., and Arend J. Dunning, M.D ••
F.A.C.C., Department of Cardiology, Academic Medical
Center, Amsterdam, The Netherlands.
In order to determine the value of Doppler-derived mitral
inflow characteristics as an early indicator of LV dia-
stolic dysfunction in first, acute myocardial infarction,
60 patients (pts) were studied on admission. Age ranged
from 55 - 71 years. Early peak diastolic velocity to peak
Atrial velocity ratio (E/A) was obtained from an apical
4 chamber view with the sample volume at mitral annular
level. Measurements from 5 cardiac cycles were averaged.
E/A was related to worst Killip class during hospital
stay and mortality. E/A decreased with Killip class: class
I: 1.26±0.43 (n=25), II: 0.72±0.32 (n=21), III: 0.48±0.06
(n=7), IV: 0.42±0.06 (n=7). All 7 class IV pts died. In
contrast,. their admission class had been I (3 pts) or II
(4 pts). E/A of ~0.55 separated the 7 shock pts best.
Sensitivity 100% and specificity 79% (7 false positives).
E/A was poorly related with peak creatine-kinase
(r = -0.65).
Thus: 1. There is a significant trend towards a lower
E/A with a higher Killip class;
2. Assessment of E/A by pulsed Doppler on admission
in pts with acute myocardial infarction helps to
identify those at risk of subsequent death from
cardiogenic shock.
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Hall D, Georgia World Congress Center
Echocardiography/Doppler
VALUE OF PREOPERATIVE M-MODE ECHOCARDIOGRAPHIC INDICES IN
PREDICTING OUTCOME AFTER AORTIC VALVE REPLACEMENT IN
SYMPTOMATIC PATIENTS WITH AORTIC REGURGITATION. K. John
H~ilman, III, M.D.; K.E. Hammermeister, M.D., FAC~1
Burchfiel, Ph.D.; Heidi Krause-Steinrauf, B.S.; Michael
Crawford, M.D., FACC; Gulshan Sethi. M.D.; Participants
in the VA Cooperative Study on Valvular Heart Disease.
The prognostic and functional significance of preopera-
tive echocardiographic measurements was examined in 53
patients with pure aortic regurgitation (AR) undergoing
aortic valve replacement (AVR) and followed prospectively
for a mean of 34.3±15.6 months in the VA Cooperative Study
on Valvular Heart Disease. Thirteen patients died, 4
intraoperatively. Preoperative left ventricular end-
systoliC dimension (LVESD), end-diastolic dimension
(LVEDD), percent fractional shortening (LVFS), and end-
diastolic radius to posterior wall thickness ratio (R/Th)
did not differ significantly between survivors and non-
survivors. The effect of preoperative LVESD and LVFS on
postoperative LVEDD and functional class (FC) was examined
in 25 surviving patients who had technically satisfactory
echocardiograms six or more months after AVR.
LVESD<5.5 LVESD~5.5 LVFS~25% LVFS<25%
(n=14) (n=ll) (n=12) (n=13)
Preop LVEDD 6.7±.6 7.5±.9 6.8±.4 7.3±1.1
Postop LVEDD 5.4±.6 6.1±1.3 5.4±.5 6.0±1.3
Preop FC 2.4±1.0 2.7±.5 2.6±1.0 2.7±.7
Postop FC 1.5±.7 1.4±.6 1.5±.5 1.7±.6
LVEDD and FC improved significantly in all four subgroups
postoperatively. Four year survival was similar in sub-
groups defined by preoperative LVESD or LVFS. We conclude
that commonly used preoperative echocardiographic indices
were not significantly predictive of survival, FC, or
heart size postoperatively. Most patients can expect sig-
nificant improvement in symptoms and decrease in LVEDD
following AVR irrespective of preoperative LVESD or LVFS.
ABNORMAL RESPONSE TO THE VALSALVA MANEUVER IN
PREECLAMPTIC PATIENTS DURING THE THIRD TRIMESTER OF
PREGN,bNCY: EV lDENCE FOR PI.. TERED BAAORECEPTOR FUNCT ION.
.lJl..u.ls 1.. pell'ltal la • .M~.EAC.C, Raymond A. DombroskI,
MD, Brent E. FInley, MD, JackIe MIller, Judy Vlttltoe,
RN, MIchael H. Crawford, MD, FACC, and Robert A.
O'Rourke, MD, FACC. Unlv of Tx Heal th ScI Ctr, San
AntonIo, Tx.
The hemodynam Ic response to the Val sal va maneuver
(VM) has been reported to be normal durIng the thIrd
trImester of pregnancy (preg). However, In patIents
(pts) wrth preeclampsIa (PEC) we noted that durIng a
sustaIned VM for >12 secs at 40mmHg: the systol Ie blood
pressure (SBP) and heart rate (HR) remal ned unchanged
durIng phase (PH) II, whl Ie there was an absence of
reflex bradycardIa durIng PH IV. We postUlated that the
rncreased (t) blood volume of preg. preserved venous
return and caused these abnormal hemodynamIc results.
AccordIngly, we studIed 10 thIrd trImester pts wIth PEC
wIth sImultaneous ECG, SSP (cuff sphygmanananeter), and
2-D echo (apIcal 2 and 4 chamber vIews). LV volumes (V)
were calculated wIth a mrcrosonlc dIgItIzer usIng an
area length formul a for each v lew dur I ng 2 VMls. RV
end-dIastolIc area (EDA) was obtaIned from the 4 chamber
vrew. SBP dId not decrease (+) below control durIng PH
II of VM. HR durIng PH II of VM dId not t sIgnIficantly
(85±7 [SO] to 85±20) and a reflex bradycardIa las absent
In 9 pts. RVEDA +from 14.6B.6 to 11.9B.5cm (p<O.Oll.
Aprcal 2 chamber <76±14 to 62±16ml, p<0.02) and 4
chamber LVEDV's (72±.16 to 53±.18ml, p<O.Oll + slgnlf 1-
cantly durIng PH /I, as dId LV stroke volumes (SV) (43±7
to 35±,9m I, p<0.05; and 40±,7 to 28±.10m I, p<0.005,
respectIvely). We conclude that In pts wrth PEC, SSP Is
maIntaIned durIng PH II of VM despIte a normal + In
RVEDA, LVEDV and LVSV. SInce HR Is unchanged, SBP Is
lIkely maIntaIned due to altered baroreceptor functIon.
DIGITAL ECHOCARDIOGRAPHIC ANALYSIS OF LEFT VE~rRICULAR
FUNCTION AND ITS RESPONSE TO PHOSPHODIESTERASE INHIBITORS
IN SEVERE CONGESTIVE HEART FAILURE
Peter S. Rahko. M.D., James A. Shaver M.D., F.A.C.C.,
Rosemarie Salerni. M.D •• F.A.C.C., Barry F. Uretsky. M.D ••
F.A.C.C., University of Pittsburgh, PA
To evaluate systolic and diastolic function in patients
with NYHA class III-IV heart failure M-mode echocardio-
grams of the LV were recorded and digitized in 46 patients
and canpared to 40 normals. Peak diastolic filling rate
(pDFR), peak and mean systolic ejection rate (pSER, mSER).
peak posterior wall thickening rate (PWTK) and peak pos-
terior wall thinning rate (PWTH) were measured. Results
expressed in cml sec. * = p < 0.005:
pDFR pSER mSER PWTK PWTH
Normals 16.8!4.6 10.5±2.1 4.5±1.0 4.8!l.3 11.4±4.0
Patients 10.6±3.8* 6.2±2.2* 2.5±1.2* 3.9±1.7* 6.7±1.4*
The phosphodiesterase inhibitors enoximone or milrinone
were given to a 10 patient subgroup in which simultaneous
hemodynamic measurements and LV echocardiograms were
performed pre and post acute drug administration. A
borderline decrease in PA wedge pressure (18±7 to 16±7 rom
Hg p = 0.07) and a significant increase in cr (2.0±0.4 to
2. 3±0. 4 L/min/m2 p < 0.00l) ..as noted. Corresponding
digital echocardiographic resu 1ts in cml sec * = p < 0.05:
pDFR pSER mSER PWTK !!i!!!.
PRE 11.9±4.1 7.0±2.3 3.0±1.1 3.6±0.8 6.9±1.8
POST 13.4±5.2 8.4±3.4* 3.6±1.6* 4.9±1.8* 7.2±3.3
Conclusions: Both systolic (pSER. mSER, PWTK) and
diastolic (pDFR, PWTH) indexes of LV function are signifi-
cantly reduced to a relatively equal degree in severe
heart failure. The hemodynamic improvement produced by
phosphodiesterase inhibitors appears to result from im-
provement in indexes of systolic but not diastolic LV
function.
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Emboli in Followup
12% ( I0783)*
2% ( 2/86)
Overall. 29% of LVT patients had emboli either pre-echo or
during followup vs. 7% of controls (p < 0.001). In LVT patients,
emboli during followup occurred a mean of 8.5 months (0.1-51)
after echo and 30.7 months (2-72) after MI; 8 of 10 were in
patients not on anticoagulants. In controls, 4 of 7 emboli were
in patients with atrial fibrillation or flutter. The actuarial
probability of being embolus free at 2 years was 86% in LVT
patients vs 97% in controls (p < 0.02).
We conclude that left ventricular thrombi are associated
with a definite increased embolic risk. The increased risk is not
restricted to the immediate post-MI period, but continues
indefinitely. Whether the long-term embolic risk would be
reduced by chronic anticoagulant therapy at an acceptably low
bleeding rate remains to be determined.
Emboli Pre-Echo
LVT (n=83) 18% (15 783)*
Controls (n=86) 6% ( 5/86)
* p < 0.02 LVT patients vs. controls
INCREASED EMBOLIC RISK IN PATIENTS WITH LEFT
VENTRICULAR THROMBI.
John R. Stratton, M.D., F.A.C.C., Arthur D. Resnick, M.D.,
Chris Hixson, Seattle VA and University of Washington, Seattle,
Washington.
To determine the risk of systemic embolization from left
ventricular thrombi, we followed 83 patients with echo-defined
left ventricular thrombi (LVT) and compared them to a matched
control group (n=86). The LVT and control groups were
comparable with respect to recent « I month) myocardial
infarction (MI) (16% vs 21 %), remote MI (74% vs 70%), anterior
MI (80% vs 67%), cardiomyopathy (10% vs 9%), ejection fraction
(30% vs 32%), echo referral for source of embolus (21 % vs 22%),
and followup duration (21 vs 22 months). Echoes were blindly
read. The prevalence of definite central nervous system or
peripheral emboli before echo and during followup was:
CROSS-SECTIONAL ECHOCARDIOGRAPHIC DIMENSIONS II CHILDREN:
nlE RELIABILIn OF NORMAL VALUES FROM SUBCOSTAL IlU.GES
Robert J. Mich MD, Marco O. Triulzi MD, Linda D. Gillam MD
FACC, MariEttaKing MD, Arthur E. Weyman MD FACC
Massachusetts General Hospital, Boston, MA
The SUbcostal window is frequently used for the cross-
sectional echocardiographic determination of cardiac
chamber size in children. However, proper alignment of the
long axis image of the heart from the SUbcostal window is
more difficult than alignment of the 'equivalent' apical
four chamber image. We hypothesized that this dIfficulty
would increase the spread of the normal values determined
for SUbcostal dimension (DIM) measurements. To test this
hypothesis we 1) measured the supero-inferior (SI).
media-lateral (ML) and area DIM of the left atrium and
left ventriole from the SUbcostal and apical four chamber
images of 196 normal SUbjects, age 6 days to 18 years With
BSA .18 to 2.1-m2 ; 2) determined for each DIM, as an index
of dispersion, the standard deviation (SDR) of the
regression model: DIM = SLOPE • BSA + Y-INT; 3) compared
the SUbcostal and apical four chamber SDR for each DIM.
RESULTS:
APICAL SUBCOSTAL
DIM N SDR N SDR SL
USI 148 -:36 115 ~ p~01
LA ML 146 .40 120 .47 p<.05
LA AREA 146 1.74 115 2.11 p<.05
LV SI 139 .52 108 .69 p<.01
LV 1'1L 137 .46 109 .49 NS
LV AREA 136 2.78 109 3.63 p<.01
CONCLUSION: The significantly greater SDR of most
SUbcostal left heart DIM ind ioates that the spread of
subcostal DIM normal values is wider than for apical four
chamber DIM. In children, therefore, DIM derived from the
subcostal image may be less reliable for identifying
quantitative abnormality.
PREOPERATIVE ASSESSMENT OF SURVIVAL AFTER VENTRICULAR
SEPTAL RUPTURE.
Cees A. Visser, M.D., George K. David, M.D., J.J. Koolen,
M.D., Arend J. Dunning, M.D., F.A.C.C., Department of
Cardiology, Academic Medical Center, Amsterdam,
The Netherlands.
Predictive
Sensit.i!!!Y---,S",pec=ifi.:.;"c",ity:.L.-...;a",cc:::cu",ra.::;cv:.<-_
92% 95% 93%
74% 95% 80%
69% 100% n%
ASD-ES ;;>0 20 mm
RVEoILVED ;7 1.2
ASD-ED.,. 20 mm + RVED/LVED ,:>,1.2
Shunt volume ':>' 40 %
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ESTIMATION OF SHUNT VOLUME IN PATIENTS WITH OSTIUM SECUNDUM
ATRIAL SEPTAL DEFECT BY SUBCOSTAL 2D·ECHOCARDIOGRAPHY
Wolfaang Alchenberll. M.D., ~ Krem.. M.D., Chen Chunguang. M.D., Julia
Polster, M.D., Walter Bleifeld, M.D.,F.A.C.C., Dept. of Cardiology, Uniwnity
Hospital Eppandorf, Hamburg, Wast Germeny
To determine whether shunt volume in patients (pilI with ostium secundum typa
atrial septal defect (ASD III can be predicted by 2D-echocardlography (2[).achol we
studied 75 pII (mean age :n .± 6 yearsl with ASD II who undarw«lt right heart
catheterization. The left·1o·right shunt varied between 19 and 92 %
(mean 51,±, 14 %1; in 50 ptI shunt volume w• .,. 40 %. The endlYstolic dia_
of the etrial leptal defect (ASD-ESI was visualized in 71 of 75 pII by subcostal
2D-echo. Additionally the relation of the enddiastolic right -u:ular 10 left ven·
tricular diameter (RVEoILVED) was determined from the apical fourchamber view.
Because of the only fair correlation be_n ASD-ES and shunt volume (r • 0.74)
and between RVED/LVED and shunt volume (r =0.84), raapectively, it wu not
possible 10 accurately predict the shunt volume. However, with an ASD-ES .,..20 mm
in combination with a RVEoILVED • ratio? 1,2 it wes possibla to differentiate bet-
ween hemodynamically insignificant shunts and shunts ;:740 %. The diagnostic value
of both echocardiographic parameters to predict a shunt volume "'?' 40 % was as
follows:
12.2±2.8
Post. Infarct
LV-WMS RV-WMS
3.6±2.S 6.1±1.6
*n.s.
1. 9±3. 3
n.s.
2.6±1.9lS.1±2.6
Results:
survivors
(n=13)
deaths
(n=18)
* - p<O.Ol
Survivors with post.infarct had a RV-WMS of ~8 and non-
survivors ~9. In ant.infarct survivors had a LV-WMS of
~7, and non-survivors ~12.
Thus, 1) Survival of ventricular septal rupture in ant.
infarct appears to be determined by LV dys-
function, and in post. infarct by RV dysfunction.
2) Two dimensional echocardiography can be of help
to identify preoperatively patients who may
benefit from surgical intervention.
In order to determine preoperatively the survival after
ventricular septal rupture, 31 patients with this infarct
complication were studied by two dimensional echocardio-
graphy. By ECG 17 patients had posterior (post.) and 14
anterior (ant.) infarct. Each of 8 RV and 13 LV segments
was graded on a 6 point scale from -1 (hyperkinesis) to
+4 (aneurysmal). Wall motion score (WMS) of RV and LV was
the sum of the scores for each segment. All patients had
segmental asynergy of both RV and LV.
Ant.Infarct
LV-WMS RV-WMS
6.2±1.0 2.7±2.S
*
These data indicate that an ASD-ES 7' 20 mm in combination with a
RVEoILVED • ratio 7' 1.2 is highly specific for a left-1o-right shunt ?' 40 %;
in this R1bgroup of ptI with ASD II 2D-eeho is able 10 replace right heart catheteri-
zation.
138A ABSTRACTS lACC Vol. 7, No 2
February 1986:138A
20
SYSTOLIC ANTERIOR MOTION OF THE MITRAL VALVE IS TEMPORALLY
RELATED TO PEAK PRESSURE GRADIENT IN HYPERTROPHIC
OBSTRUCTIVE CARDIOMYOPATHY
Robert J. Bryg, MD, Arthur J. Labovitz, MD, FACC, George
A. Williams, MD, FACC, Harold L. Kennedy, MD, FACC, St.
Louis University School of Medicine, St. Louis, MO
The role of systolic anterior motion (SAM) of the
mitral valve (MV) in the development of the pressure
gradient in hypertrophic obstructive cardiomyopathy (HOCM)
remains controversial. Seventeen patients with HOCM, 8
male, 9 female, aged 19-88 (mean 45 years) were studied
with continuous wave Doppler echocardiography and were
compared to 17 normal subjects. SAM and early closure of
the aortic valve were present in 16/17 patients with HOCM,
and were absent in the normal subjects. The time to peak
outflow velocity as a percent of total systolic ejection
time was 63% in HOCM versus 29% in normals (p<O.OOl). In
13/17 patients with HOeM, the time from R wave to closest
approximation of the mitral valve to the septum during SAM
was determined and was 242+66msec; the time from the R
wave to peak velocity in these patients was 242+73msec,
r=0.90. In 3 pts there was prolonged MV contact with the
septum and the velocity peaked early and had a single
spike. In the 10 pts with little or no contact of the MV
with the septum, the Doppler waveform had a notched
appearance and the peak velocity occurred when the MV was
closest to the septum. There was no correlation between
the time to peak velocity and the peak pressure gradient
of the aortic outflow. Therefore, 1) peak outflow tract
velocities occur significantly later in HOeM than in
normal individuals and 2) the demonstration of the
temporal relationship between SAM and peak outflow
velocity in HOCM strongly suggests the importance of SAM
in the development of dynamic outflow tract obstruction.
LEFT VENTRICULAR MUSCLE VOLUME BY DIGITAL SUBTRACTION
ANGIOCARDIOGRAPHY AND 2D-ECHOCARDIOGRAPHY
Wolfgang Radtke, MD, Armin Wessel, MD, Harald Hach, Paul
H. Heintzen, MD, FACC, Department of Pediatric Cardiology
University of Kiel, West Germany
Digital image processing can visualize myocardial dye
perfusion in routine left heart angiocardiography using
EKG and respiration gated background subtraction.
Combination of myocardial and left ventricular image
depicts the myocardial wall. The accuracy of derived
mass and volume measurements was shown in previous exper-
imental work •. Imaging of left ventricular muscle wall is
also achieved by 2D-echocardiography. In this study both
methods were compared in respect of myocardial volume
determination.
In 16 patients (3-78 kg, 5 days - 17 years) muscle volume
was calculated from biplanar digital subtraction "myo-
cardiograms" (multiple slices algorithm) obtained from
standard levocardiograms (0.6-1.0 ml contrast/kg) and
calculated from echocardiographic long and short axis
views (sphere/ellipsoid model) both on the basis of
manually outlined epi- and endocardial contours.
Comparison of both methods showed a good correlation for
end diastole (r=O.951 SEE=27ml) and end systole (r=O.924
SEE=28 ml). Comparison between end diastole and end
systole for each method revealed a close correlation of
r=O.994 (SEE=9 ml) for digital myocardial imaging and
r=0.970 (SEE=17 ml) for 2D-echocardiography.
2D-echocardiography renders reliable volume determination
of left ventricular muscle wall irrespective of heart-
phase.
TRANSESOPHAGEAL TWO DIMENSIONAL ECHOCARDIOGRAPHIC
EVALUATION OF BIVENTRICULAR DYNAMICS DURING POSITIVE END-
EXPIRATORY PRESSURE VENTILATION.
Jacques J. Koolen, M.D., Cees A. Visser, M.D., Eric Wever,
M.D., Nico G. Meyne, M.D., Arend J. Dunning, M.D.,
F.A.C.C., Departments of Cardiology and Cardiac Surgery,
Academic Medical Center, Amsterdam, The Netherlands.
Since CO decrease during positive end-expiratory pressure
is not fully understood RV and LV dynamics were studied
by transesophageal two dimensional echocardiography in 21
stable patients shortly after coronary bypass surgery.
All had normal RV and LV function before and after
surgery. End-diastolic (ED) and end-systolic (ES) area,
and percentage area reduction (PAR) of a RV and LV short-
axis view were obtained during 5 cm H20 stepwise incre-
ments up to 20 cm. Simultaneously, mean AO and RA pres-
sure, and CO were recorded.
mmHg t/mln cm2 %
1°7°5 [ ~"-J~ GAGG 5 1: [ LV.~~[
15[ RV j80~::R
°'-----;o--=--:::--'o-~-_o_--lo ° - 40
° 5 10 15 20 ° cm H20 ° 5 10 15 20 ° cmH 20
Thus, CO decrease by positive end-expiratory pressure is
caused by preload reduction rather than by impaired
biventricular contractility.
ANEURYSMS AND DISSECTIONS OF THE DESCENDING
THORACIC AORTA - IDENTIFICATION BY TRANSESOPHA-
GEAL TWO DIMENSIONAL ECHOCARDIOGRAPHY
Rolf Engberding, M.D., Franz Bender, M.D., Ulf Steffen
Miiller, M.D. and Wolfgang GroBe-Heitmeyer, M.D. Universi-
ty Hospital, Dept. of Cardiology-Angiology, Miinster, FRG.
Aneurysms of the ascending aorta are easily detected by
two dimensional echocardiography (2-DE) using the trans-
thoracic approach (TTH 2-DE). However, TTH 2-DE may
fail to yield diagnostic information about the descending
thoracic aorta. To evaluate the usefulness of transesopha-
geal 2-DE (TEE) in the detection of aneurysms and dissec-
tions of the descending thoracic aorta TTH 2-DE and TEE
were performed on 14 pts (12 males, 2 females, mean age
54.4t18.1 years) with nondissecting aneurysms of the des-
cending aorta (n=5) and with aortic dissections (DeBakey
type I: n=4, type III: n=5).
Echocardiography was performed using a phased array sector
scanner with a 2.25 MHz transducer for TTH 2-DE and with
a 3.5 MHz miniature transducer at the tip of a 9 mm ga-
stroscope for TEE.
In 4 pts with nondissecting aneurysms of the descending
aorta the diagnosis could be established by TTH 2-DE, but
in 1 pt the aneurysm was revealed only by TEE. In 2 pts
with type I dissection the intimal flaps were identified and
localized by TTH 2-DE, whereas 2 cases with type I dissec-
tion and all type III dissections could only be detected by
TEE. Diagnosis was confirmed by angiography or surgery in
all pts. No complication was observed using the transesopha-
geal approach.
Thus, TEE is useful in the detection of aneurysms and
dissections of the descending thoracic aorta.
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'lW) DIMENSIOOAL OCHOCARDICGRAPHY OF THE NON-INFARCl'ID
MYOCARDIUM; PRaX:>SrIC IMPLICATIOOS OF REl3IOOAL
HYPERKINESIS AND RFMJI'E ASYNERGY
Wybren Jaarsma, M.D., J .C.J. Res, M.D., F .W.A.
Verheugt, M.D., and C.A. Visser, M.D., the
Interuniversity cardiology Institute, Amsterdam, '!be
Netherlands.
In order to determine the clinical significance of
regional hyperkinesis (RH) and rennte asynergy (RMA) of
the non-infarcted myocardium, 98 patients were studied
with a first, acute myocardial infarct. All patients
were studied by two dimensional echocardiography within
12 hours after admission, and these findings were
correlated with rrortality and coronary angiography
perfonned 3 weeks later. RH was present in 43/63 (68%)
anterior and in 23/35 (66%) posterior infarcts; RMA in
11/63 (17%) anterior and 6/35 (17%) posterior infarcts.
RH+ RH- RMA
(n = 66) (n = 32) (n = 17)
3-VD 6 (9 %) * 18 (56 %) 12 (71%)
2-VD 21 (32 %) 8 (25 %) 5 (29%)
1-VD 39 (59 %) * 6 (19 %) 0
Mortality 5 ( 7.5%) * 15 (47 %) 9 (53%)
* P <0.001 ; VD = vessel disease
All 20 non-survivors (all anterior infarct) died within
30 days. In 15 of these (75%) RH was absent, and RMA
was present in 9 (45% ) • RH was present in 5
non-survivors of whan 3 had a septal rupture.
We conclude: 1) Regional hyperkinesis is frequently
found in both anterior and posterior infarcts.
2) Regional hyperkinesis is usually present in 1-VD and
absent in 3-VD. 3) In patients with anterior infarct
absence of regional hyperkinesis and/or presence of
renote asynergy is associated with 3-VD and a high early
rrortality.
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Cardiac Surgery
ILOPROST (ZK36374) PERMITS OPEN CARDIAC SURGERY DESPITE
HEPARIN-INDUCED THROMBOCYTOPENIA.
Jeffrey R. Kappa, M.D.; Norig Ellison, M.D.; Carol A.
Fisher, B.A.; and V. Paul Addonizio, M.D., University of
Pennsylvania, Philadelphia, PA.
Heparin-induced thrombocytopenia (HIT) is associated with
hemorrhage, idiopathic thrombosis, and sudden death. For
3 patients with confirmed HIT who required urgent cardiac
surgery, we utilized temporary inhibition of platelet
function with Iloprost (ZK), a new prostacyclin analogue,
to prevent heparin-deperdent platelet activation. In
vitro, ZK prevented both heparin-induced platelet aggre-
gation (82.1% without ZK; 3.3% with ZK) and 3H Serotonin
release (38.7% without ZK; 2.3% with ZK). A continuous
infusion of ZK was begun 1 hr. prior to heparinization,
was continued throughout cardiopulmonary bypass, and was
discontinued 15 min after protamine administration. The
mean platelet count of 130,OOO/ul remained stable and no
spontaneous platelet aggregation was observed following
heparinization. Plasma levels of platelet factor 4 rose
from 26.3 to 843 ng/ml with heparinization and declined
throughout bypass to 52 ng/ml indicating minimal plate-
let release. The mean bleeding time was 10.5 min pre-
operatively and 13.3 min postoperatively. The mean post-
operative chest tube drainage(12 hrs) was 432 + 67 ml
compared to 515 + 86 ml for 21 historical controls under-
going elective coronary artery bypass. Thus, despite con-
firmed heparin-dependent platelet activating factor in the
plasma of these 3 patients, Iloprost prevented heparin-
induced platelet activation during cardiopulmonary bypass
and provided normal platelet function postoperatively as
would be desired for hemostasis.
ABSTRACTS
RECOVERY OF PLATELET FUNCTION AFTER CARDIOPUL'10NARY
BYPASS - FRESH IVHOLE BLOOD IS SUPERIOR TO PLATELET
TRANSFUSION.
Rephael t1ohr, N.D., Daniel Amroch, ~'I.D., Uri
Hartinowitz, H.D., Daniel A. Goor, ~·l.D., Bracha Ramot,
n.D., Depts. of Cardiac Surgery and Hematology, Tel
lIashomer, Israel.
Delayed recovery of platelet (PLT) count and function
is the most common cause of bleeding after
cardiopulmonary bypass (CPB). Recovery of PLT
function was compared in 37 patients (pts) who were
randomized to receive either one unit of fresh whole
blood (FI,B: 15 pts) or 10 PLT units (12 pts). PLT
count, bleeding time, PLT aggregation (agg) (ADP,
collagen, epinephrine) and thromboxane formation were
abnormal after CPB in both gr~ups. The increase in
PLT count after FlJB (34+l7xl0' /1) was identical to
that achieved by 4 units of PLT (31.5+15.4). The
increase was higher after 10 PLT (69.3+32.7). The
correction of bleeding time after QJB ;as identical to
the effect of 8 PLT. However, thromboxane formation
and recovery of PLT agg were better after FlYB compared
to 10 PLT units. (See Table).
Agg (% recovery) Thromboxane
Collagen Epinephrine (ng/ml)
FI,~ 84 + 35 78 + 29 95 + 25
10 PLT units 55 +27 64 +24 46 ±31
p value <0~05 <0~05 <0.05
These results support the clinical observations of
cardiac surgeons claiming the superiority of FI,B in
hemostasis after CPB.
PREOPERATIVE DIPYRIDAMOLE REDUCES POSTOPERATIVE BLEEDING
Kevin H. Teoh MD, George T. Christakis MD, Richard D.
Weisel MD, Mlchael F.X. Glynn ND, PU1-Yuen Wong PhD,
Vlckie A. Mee RT, Joan Ivanov RN, M. Mlndy Madonik BSc,
David Levitt, Paul Reilly PhD, Jack Rosenfeld PhD.
Toronto General Hospital, Toronto, Ontario.
Although antlplatelet agents may be contralndicated
before cardiac surgery, dipyrldamole (DIP) stabilizes
platelet membranes and may reduce postoperative bleeding.
A prospective randomized trlal was conducted in 39
patients (pts) undergoing elective coronary bypass
surgery. DIP was infused (0.24 mg/Kg/hr) preoperatively
(22 hr before surgery), intraoperatively and for 36 hours
postoperatively in 20 patients, and the patients in the
control group (19 pts) did not receive DIP.
Dipyridamole preserved platelets (plat), leukocytes
(WBC) and erythrocytes (ROC) on cardlopulmonary bypass and
postoperatively. Arterial thromboxane B2 (Tx32 per
platelet) levels were lower and 6-keto PG Flo( (6-keto)
levels were higher.
Platelets WBC RBC TxB2/plat
9 9 12 -6
(xlO IL) (xlO IL) (xlO IL) (pmolxlO )
Hours 24 24 48 24
DIP l56± 9lf 9 .6±0. 9" 3.8±0. P 7.2±1.4lf
No DIP 104±10 8.l±0.5 3.4±0.1 l3.4±2.l
MeaniSD If DIP different then no DIP p<O .05
Postoperative blood loss was reduced by 42% (DIP:
0.90±0.38": No DIP: 1.5±1.2 L/pt @48 hr) and blood
transfusion was reduced by 44% (DIP: 1.8±1.4lf ; No DIP:
3.3±2.4 units/pt).
CONCLUSIONS: Dlpyrldamole preserved platelets,
and erythrocytes, reduced platelet thromboxane
and enhanced endothelial prostacyclin
Preoperative dipyridamole reduced postoperative
and blood product utllization.
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BT were similar at 2 hrs. postop (B:13.6 ± .7 mins and
M:13.9 ± .7 mins, P:NS). Mean platelet count for all patients
at 2 and 24 hrs post-op were 124 ± 6K and ll8 ± 7K respectively
with no difference between Band M. Likewise, there were no
differences in blood loss, intraoperative or postoperative thrombo-
xane B2 and beta thrombo-globulin between the two groups. We
conclude that the membrane oxygenator has no advantage over
the bubble oxygenator in its effect on platelet function or on
activation of the complement system during extracorporeal
circulation.
FAILURE OF THE MEMBRANE OXYGENATOR TO PREVENT
COMPLEMENT ACTIVATION AND BLEEDING TIME
PROLONGATION DURlNG CARDIAC SURGERY.
Kenneth G. Warner, M.D., Shukri F. Khuri, M.D., Francis D.
Moore, Jr., M.D., Samar N. Assousa, B.S., Miguel Josa, M.D.,
C. Robert Valeri, M.D., West Roxbury VAMC, Brigham and
Women's Hospital, Naval Blood Research Lab, Harvard and
Boston University Medical School, Boston, Massachusetts.
Activation of the complement system (CS) and bleeding dia-
thesis are important hematologic disorders associated with
extracorporeal circulation (ECC). To compare the effects of
two types of blood gas interfaces upon bleeding time (BT) and
CS, 100 adult patients (PTS) undergoing cardiac surgery were
randomized to either a bubble oxygenator (B, 50 PTS) or a hollow
fiber membrane oxygenator (M, 50 PTS). Plasma levels of the
complement cleavage product C3a were measured in nglml using
radio-immune assay and shown below:
At cannulation
20 Min of ECC
120 Min of ECC
*p<.0005
B
212 ± 38 J *
595 ± 78
1246 ± 177J*
M
251 ± 56 ] *
600 ± 46
1041 ± 135 ] *
P
NS
NS
NS
VALUE OF COLOR DOPPLER ASSESSMENT OF PULMONARY ARTERY
PRESSURE IN CARDIAC TRANSPLANT PATIENTS.
Ming C. Hsiung, M.D., Navin C. Nanda, M.D., F.A.C.C.,
James Kirklin, M.D., F.A.C.C., David McGiffin, M.D.,
David I. Roitman, M.D., F.A.C.C., University of Alabama,
Birmingham, AL
Tricuspid regurgitation (TR) was detected by color
Doppler 53 times in 42 transplant patients (ages 16 to
65, mean 42 years). All studies were performed within
48 hours of right heart catheterization/biopsy.
Pulmonary artery systolic pressure (PAP) was calc~lated
from the Bernoulli equation (4 x TR peak velocity + 10
= PAP mmHg) by directing the continuous wave Doppler
beam through the area of maximum turbulent flow detected
by color Doppler. Color Doppler guided continuous wave
PAP (range 20 - 74 mmHg) and those obtained by
catheterization (21 - 74 mmHg) correlated well (r=0.85).
In 5/7 transplant patients with biopsy proven rejection
(in myocyte necrosis) PAP was higher (34 - 40 mmHG)
during the rejection episodes as compared with absence
of rejection (17 - 22 mmHg) and these increases in PAP
were reliably identified by color Doppler in all. In
the remaining two patients rejection was identified by
the new development of TR which disappeared after
therapy/absence of rejection. In 8 pre-transplant
patients, color Doppler reliably predicted PAP (36 - 74
mmHg, r=0.96). Two patients with high PAP (both 74mmHg)
underwent heterotopic transplant while 6 with lower PAP
(36 - 60mm Hg) had orthotopic transplant. In
conclusion, color Doppler predicts PAP reliably and
noninvasively in pre and post transplant patients. This
has potential value in identification of rejection and
in selecting the type of transplant.
DETERMINANTS OF INTRAMYOCARDIAL ACIDOSIS DURING
CARDIAC SURGERY IN MAN.
Shukri F. Khuri, M.D., Michael D. Butler, B.S., Kenneth G.
Warner, M.D., Miguel Josa, M.D., Peter C. Gherardi, B.S.,
Samar N. Assousa, B.S., Ossama S. Hemadeh, M.D. West
Roxbury VAMC and Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts.
The spectrum and determinants of intramyocardial acidosis
during cardiopulmonary bypass in man are unknown. Intramyo-
cardial pH and temperature were continuously measured in 141
patients undergoing cardiac surgery. Temperature-corrected
myocardial pH during the period of aortic cross-clamping (AC)
ranged from 7.73 to 5.94. The mean integrated pH during this
period (MpH) v'aried from 7.54 to 6.13 with an average of
6.85 ± .02. The patients were divided into two groups
according to whether the MpH was above 6.87 (Group I, n=71,
none to mild acidosis) or below 6.87 (Group II, n=70, moderate to
severe acidosis).
Group I Group II P
Valvular Heart Disease 17% 73% .0001
LV Mass (gms) 244 ± 16 371 ± 27 .0001
Ejection Fraction (%) 59 ± 1.6 55 ± 1.8 NS
LVEDP (mmHg) 15 ± 0.9 20 ± 1.0 .001
pH Prior to AC 7.08 ± .02 6.83 ± .03 .0001
Period of AC (Min.) 55 ± 3.0 89 ± 4.1 .0001
Temperature variations were not significantly different in
both groups. These data indicate that despite current myocardial
protection techniques, intramyocardial acidosis is frequently en-
countered during cardiac surgery, and is determined primarily by
the amount of LV hypertrophy, the magnitude of tissue ischemia
at baseline, and the length of the cross-clamp period. Preopera-
tive LVEDP and not ejection fraction also prognosticated the
degree of intraoperative acidosis.
CAN DOPPLER ECHOCARDIOGRAPHY REPLACE CARDIAC
CATHETERISATION IN THE POSTOPERATIVE HAEMODYNAMIC
ASSESSMENT OF THE ARTERIAL SWITCH PROCEDURE?
John L. Gibbs, MD,Shakeel A. Qureshi, MD., Rosemary
Radley-Smith, FRCP., and Magdi H. Yacoub FRCS., Harefield
Hospital, Middlesex and Heart Unit, Killingbeck, Leeds,
England.
Nineteen children who had undergone the arterial switch
operation for transposition of the great arteries between
the ages of 1 week and 10 years underwent pulsed and
continuous wave Doppler examinations, 1 month - 98 months
following surgery. Mild aortic regurgitation was
detected in 10, but systolic aortic velocities were
normal in all but 1. High flow velocities at pulmonary
valve level, at the pulmonary artery bifurcation or in
the left pulmonary artery were detected in 14 patients.
Doppler sampling of the right pulmonary artery was not
achieved. The site of obstruction to pulmonary flow and
the presence and severity of aortic regurgitation
detected by Doppler correlated well with cardiac
catheterisation performed in 16 patients at a mean
interval of 35 months prior to this stUdy. Peak velocit~s
across the mitral and tricuspid valves were significantly
higher than normal, suggesting that ventricular compliance
in this group of patients may differ from normal. No
pathological atrioventricular valve regurgitation was
seen. Doppler echocardiography prBVides valuable infor-
mation following the arterial switch operation and may
avoid the need for repeat cardiac catheterisation.
However, branch pulmonary artery stenosis may be difficult
to detect with Doppler and occurred in 3 patients follow-
ing the LeCompte manoeuvre.
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All other ECG patterns had variable origins (58 VT), or
occurred <5 times (37 VT). Thus: 1) Prediction of site
of origin from ECG pattern is more accurate with left-BBB
VT than right-BBB VT. 2) Regionalized surgical ablation
can be performed based on VT-ECG criteria in 43% of VT,
but 3) In VT having nonspecific ECG patterns (57% of VT),
mapping is still needed for guided surgical ablation.
USE OF THE 12-LEAD ECG IN PREDICTING VENTRICULAR TACHY-
CARDIA SITE OF ORIGIN: SURGICAL IMPLICATIONS
John M. Miller, MD, Dennis H. Cassidy, MD, Joseph A.
Vassallo, MD, Francis E. Marchlinski, MD, FACC, W. Clark
Hargrove, III, MD, Mdrk E. Josephson, MD, FACC. University
of Pennsylvania, Philadelphia, PA.
ECG's (12-lead) of 166 distinct ventricular tachycardias
(VT) in 106 patients with prior infarcts were related to
endocardial sites of origin (using catheter or operative
mapping) to determine if any ECG patterns were specific
for site of origin. ECG's were analyzed according to bun-
dle branch block (BBB) type, axis (quadrant), precordial
R wave progression (RWP) and infarct location. There were
100 right-BBB VT and 66 left-BBB VT. ECG's in 43 (65%)
left-BBB VT, but only 16 (16%) right-BBB VT, were specific
for site of origin (p<.001). Specific patterns (occurring
>5 times; positive predictive accuracy >65%) were:
ECG (BBB/axis/RWP) Infarct Odoin Accuracy
1)Left BBB/left superior anterior inferoapical 16/17
;-.___!l<LIDYf'__ --- seotum (94%)
2)Left BBB/left axis/ inferior inferobasal 15/18
normal RWP seDtum (83%)
3)Left BBB/inferior/ anterior anteroapical 12/14
any RWP pattern sentum (86%)
4)Right BBB superior/ inferior inferobasal 11/16
reverse RWP free wall (69%)
5)Right BBB/right infer- inferior inferobasal 5/6
ior/reverse RWP free wall (86%)
ProSPECTIVE OON-INVASIVE ASSESSMENT OF BIOPROSTHETIC
DYSFUNCTION: CATHETERIZATION IS IDI' REQUIRED PRIOR 'TO
SUR;ERY.
Joel A. Stran, M.D., Nelson DaBoin, M.D., Ken Carlson,
Ibbert W.M. Frater, M.D., F.A.C.C. Albert Einstein
Cb11ege of Medicine, Bronx, New York.
From september 1984 to July 1985 11 patients (6 mitral
and 5 aortic) were seen with suspected biq>rosthetic dys-
function. All were examined by echo & cbppler cardi-
ography. Six patients had primary degeneration (PG) and
four had infective endocarditis (IE), and 1 had a para-
valvular leak. Of those with PG a tom alsp was seen in
3, calciun in 3, and evidence of aortic insufficiency in
1. Tw:> of the IE patients had definite vegetations and 2
had valve thickeninj. Dq>pler cardiography detected an
increased transvalvular gradient (16-30mnHg) in 4/5 with
mitral dysfunction and an increased gradient (52-81ll1rrHg)
in 4/5 with aortic valve dysfunction. Aortic insuffi--
ciency was seen in 5/5 with aortic valves. Cardiac cathe-
terization was performed in 3 patients with aortic valve
dysfun:::tion and confirmed the non-invasive observations.
One patient with mitral valve dysfunction had a peri-
valvular leak found at catheterization which was not
detected by doppler. Severe pulrronary hypertension was
foond by cbppler in one patient with a calcified stenosed
mitral valve. This was confirmed at surgery. All 11
have had their dysfunctional valves replaced with con-
fimation of the echo-doppler findinjs. we conclude that
quantitative echo-dq>pler cardiography alone can be em-
ployed to diagnose prosthetic valve dysfunction in a
large majority of patients, the dat.a is sufficient for
surgical intervention without resortinj to cardiac
catheterization.
<mrRAST EOl()C},Rl)IOORAPHY: THE NEW OOID~ FOR
INl'RAOPERATIVE EIIAI1lATION OF VALVUlAR REGJRGITATION.
Bruce P. Mi.OOich, M.D., F.A.C.C., Valentin Fuster,
M.D., F .A.C.C., 'Iheresa Guarino, R.N., John Larson,
P.A., Martin E. Goldman, M.D., F.A.C.C., St.
il.Ike's-Roosevelt Hospital center and Mt. Sinai Medical
center, NY, NY.
Because of superior harodynamics and avoidance
of long-term anticoagulation, valve repair is
preferable to valve replacement. However, significant
valvular regurgitation (VR) may persist following
conservative valvular surgery, and if undetected,
precludes a successful result. Present rrethods for the
detection of VR intraq>eratively (OR) by direct
palpation (palp) and pressure tracings are inaccurate.
we have successfully utilized 2-dimensional contrast
echocardiography (2DCE) to detect VR OR. A sterilely
prepared transducer placed directly on the heart
continously images as 5 ml' s of saline is injected
through a needle into the left or right ventricle
generating microbubbles (contrast) which normally exit
antegrade. With VR, systolic reflux of contrast is seen
in the respective atrium, and is graded on a scale of
0-4+, as in ventriculography (cath). 2DCE was carp:lI'ed
to direct OR palpation in 28 patients: 16 with cath
doclInented mitral regurgitation (+MR) 12 without (-MR).
cath 2DCE Palp
+MR 16 16 11
-MR 12 12 17
Carp;lred to cath the sensitivity and specificity for
detection of MR was 100% and 100% by 2DCE and 69% and
100% by palpation. Importantly, besides failing to
detect MR in 5 patients, palp could not quantify
severity of VR. However, 2DCE oould accurately detect
both the presence and severity of OR VR. 2DCE may
becane the "gold standard" for OR evaluation of VR.
IMPROVED SURGICAL OUTCOME IN PATIENTS WITH VENTRICULAR
TACHYCARDIA WITH REPEAT ENDOCARDIAL MAPPING AFTER INITIAL
SUBENDOCARDIAL RESECTION DURING NORMOTHERMIC BYPASS• .Du1lI.
.Eo- Ha1nu. 1m, Bruce B. Lerman MD, John P. DiMarco MD, PhD,
FACC, Irving L. Kron MD, FACC. University of Virginia
Medical Center, Charlottesville, Virginia
The standard surgical approach in patients (pts) with
ischemic heart disease and sustained monomorphic ventric-
ular tachycardia(VT) involves endocardial mapping fol-
lowed by subendocardial resection(SER) during hypothermic
cardioplegia. Failures of the technique are often due to
either imprecise mapping or to the subsequent appearance
of VT of different morphology. To circumvent those limi-
tations we repeated endocardial mapping during normother-
mic partial bypass after an initial SER in 13 consecutive
pts with VT that could be initiated and endocardially
mapped at operation. The group included 11 males and 2 fe-
males with a mean age of 57±.10 yrs(±.SD) and left ventricu-
lar ejection fraction of 31±.14~. After the first map-
directed SER 9/13 pts(69~) had in response to programmed
stimulation monomorphic VT with either a similar (3pts) or
different(6pts) morphology. In these latter 9 pts, 2.8±.1.4
(range 1-5) additional sequences of endocardial mapping
followed by SER were repeated until monomorphic VT could
no longer be initiated in any pt. Mean normothermic bypass
time was 72.±.Z7 min with a total bypass time of 116±.40 min.
There were 2 operative deaths; both occurred in pts who
were in shock before operation. Of 11 operative survivors,
10 had no VT induced at post-operative electrophysiologic
study. These 10 pts and 1 pt on antiarrhythmic therapy
remain free of clinical VT 12.±.8 months after surgery.
Thus, repeat programmed stimUlation, endocardial mapping
and SER after initial resection permits localization and
sequential ablation of residual VT with disparate sites of
origin. This technique is technically feasible, and im-
proves electrophysiologic results of surgery.
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VASODILATOR DRUGS AND LUMINAL SIZE OF BYPASS GRAFTS.
RUdiier Simon, M.D., F.A.C.C., Gunhild Herrmann, M.D.,
Ivomende, M.D., F.A.C.C., Hannover Medical School,
Hannover, West Germany.
It is still unclear whether vasomotor tone can be present
in aortocoronary vein grafts (ACVB) late after operation,
that may be mediated by vasodilator drugs. We studied the
effects of nitroglycerin (NTG), nifedipine (NIF), and di-
pyridamole (DIP) on blood flow and luminal diameter (D) of
35 patent ACVB in 33 patients 6 to 20 months after surgery.
From calibrated biplane cineangiograms D-ACVB was derived
as the average of at least 10 equidistant diameter mea-
surements in each plane. Graft flow (Q) was assessed by
videodensitometry from tape-stored videoangiograms taken
concomitantly with cineangiography. Measurements were per-
formed before and 4 min after 0.8 mg NTG sublingually (sl),
8 min after 10 mg NIF sl, and 1 min after 0.2 mg NTG or
0.5 mg/kg DIP injected directly into the bypass (ib). Mean
values ± SE were (*: p-0.05 vs control values before drug):
NTG sl NTG ib NIF sl DIP ib
n = 12 n = 6 n = 8 n = 9
D-AcVB Control 3.5+0.8 3.5+0.8 3.4+0.5 4.0+0.8
(mm) Drug 3.5+0.8 3.6+0.8 3.4+0.5 4.0+0.8
Q-ACVB Control 57~15* 42~14 * 50±1l -; 49~1 0""*
(ml/min) Drug 50±14..J 49±16..,j 66±13..J 86±24-'
Differences in luminal bypass diameter before and after
drug administration did not exceed ± 6 % in any patient.
Conclusions: Although these potent vasodilator drugs in-
duced slgnlficant changes in bypass blood flow, they did
not alter bypass lumen to any significant extent. Our
data, therefore, do not give any evidence for the presence
of vasomotor tone in venous bypass grafts at later stages
after operation, but support the contention of a fixed
conduit .
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SHOULD AIRLINE PILOTS FLY FOLLOWING CORONARY BYPASS
SURGERY?-A CASS REGISTRY STUDY
Bernard R. Chaitman, MD, FACC, Kathryn B. Davis, PhD,
Harold T. Dodge, MD, FACC, Lloyd D. Fisher, PhD, FACC,
George C. Kaiser, MD, FACC, and CASS hospitals. Saint
Louis University School of Medicine, St. Louis, MO
The risk of sudden incapacitation after coronary
bypass surgery is a major problem in formulating
guidelines for recertification of individuals whose
occupation carries an important risk to public safety.
To address tnis issue, we selected a subset of GASS
registry pts to simulate an airline pilot population and
prospectively determined the 5 year incidence of acute
cardiac events (acute coronary insufficiency, myocardial
infarction, or sudden death) following coronary bypass
surgery. Patients over 60 years, or those with diabetes,
moderate-severe hypertension, congestive heart failure,
perioperative myocardial infarction or significant
noncardiac medical illness were excluded as were pts who
became symptomatic in the year following operation. The
annual incidence of acute cardiac events in the 1207 men
who met these criteria was 1.6 + 0.2% (SEM). Cox
regression analyses of 14 clinical and angiographic
variables selected smoking and mild hypertension as the
only significant predictors of acute cardiac events. The
annual event rate in 838 normotensive patients who either
never smoked, were former smokers, or were current smokers
was 0.4 ! 0.3%, 1.0 ! 0.3%, and 2.2 ! 0.5%. The 5 year
incidence in patients with mild hypertension who never,
were former, or current smokers was 1.4 + 0.7%, 1.8 +
0.7%, and 2.8 + 0.9% respectively. Thus~ the incidence of
acute cardiac events after coronary bypass surgery is
small in subsets of a simulated airline pilot population.
These data are pertinant to the question of pilot
recertification post coronary bypass surgery.
INFUJEOCE OF QIOLESl'EOOL ON IATE GRAFT PATENCY IN 322
PATIEN.rS FOuruED UP '10 14 YEARS AF'l'ER COR:WIRY
BYPASS
Gerald M. Lawrie, M.D., FACe, George C. Morris,Jr.,
M.D. FACe, Steven Thomas, Donald Glaeser, D.Se.
Baylor College of Medicine and The Methodist Hospital
Houston, Texas
In order to determine the influence of total
cholesterol (TC) on late coronary vein graft patency
322 patients (pts) from a series of 1447 pts followed
10-14 years, were analyzed. These 322 pts had
undergone post-operative graft evaluation at a mean
of 65.2 months <1-178 months). Multiple clinical
angiographic and laboratory values were similar for
these pts and the remaining 1125 pts. TC was 249.6+
53.5ng% in unstudied vs 256±.56. 9ng% for studied
pta. (p>0.12) Pts were classified angiographically as
normal <189 pts) or abnormal <133 pts). Abnormal pts
had 1 or more stenotic and/or occluded grafts. TC
was 251+58.8ng% for normal pta and 264+53.8ng%
abnormal pta (p>0.05) A 10 year Kaplan-Meier
analysis was perforrred for 4 groups of pts: TC<200,
~200<245, ~245<280, >280 ng%. There was no
difference in incidence of graft abnormalities among
these 4 groups (p>0.05). Cox, two-way table and
logistic regression analyses of multiple variables
showed no association between TC and graft
abnormality. ()lly the nUllber of grafts perforrred was
predictive of graft failure.
In conclusion, unlike coronary atherosclerosis, TC
at the usual levels encountered in these pta does not
significantly influence the occurrence of graft
occlusion or stenosis over a 10-14 year period.
DETERMINANTS OF DISCHARGE FOLLOWING CORONARY ARTERY BYPASS
GRAFT SURGERY
Harold Lazar MD, Kenneth Wilcox MD, Carolyn McCabe BS,
John McCormick MD, FACC, and Arthur Roberts MD, FACC,
Boston University Medical Center, Boston, MA
Earlier discharge (dIe) following coronary artery bypass
grafting is mandatory in today's cost-containment climate.
The optimal time for discharge following coronary artery
bypass grafting (CABG) remains controversial and varies
among institutions. This study was undertaken to identify
what variables may discriminate between early and late
discharge following CABG. In 177 consecutive patients
undergoing isolated CABG, 3 groups were formed based on
the number of days hospitalized post CABG: Group I~ 8,
Group II 9-11, Group III ~ 12. Variables which discrimi-
nated between early and late discharge were:
Variable Group I Group II
(n=50) (n=79)
Female Gender 5 14
Unstable Angina 4 18*
Heart Failure (CHF) 3 18*
Age>" 65 years 5 22
*p < .05 from Group I +p <.05 from Group I I
Variables which did not discriminate between early and
late discharge included prior MI, hypertension, smoking,
diabetes, crossclamp time, number of bypass grafts, EF
(40%. or PTCA failure. Group I patients had no increase
in return visits or readmissions <60 days post CABG.
These data suggest that certain patients can be safely
discharged~ 8 days after CABG. Female sex, age ~65 years,
unstable angina and CHF are variables which predispose to
longer hospitalizations. These data should prove useful
to surgeons in determining earlier discharge criteria
following CABG surgery.
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DYSRHYTHMIAS ON SHORT TERM HOLTER AS AN INDEPENDENT
PREDICTOR OF MORTALITY IN CONGESTIVE HEART FAILURE. Ross
D. Fletcher. M.D •• F.A.C.C.; Donald Archibald. Josep-h---
Orndorff, R.N.; Jay Cohn. M.D •• F.A.C.C. The Cooperative
Study Group. VA Medlcal Center. Washington, D.C.
To determlne if ventricular dysrhythmia is an lndependent
rlsk factor or merely a marker for left ventricular dys-
functlon we examined out pat lent short-term Holter (STH) at
the time of randomization of 346 pts with CHF into a VA
Cooperative Study deslgned to test efficacy of vasodilator
therapy. Direct reading of tapes on dual channel compacted
prlnt-out averaged 4.5±1.2hrs. mean follow-up was 2.3yrs.
When PVC average increased from <10 to >lO/hr. annual
mortallty rate (AMR) lncreased from 11% to 20% p<.OOl).
Modlfled Lown grade predlcted lncreasing AMR; no PVC 6.3%;
unlfocal 10.8%; multifocal 13.3%; couplets 17.1%; triplets
and runs 24.1% p<.OOI. Whlle presence of coronary artery
dlsease (CAD) or low ejectl0n fraction (EF<median of 28%)
increased AMR. runs on the STH lndependently doubled AMR
ln life table regression p<.OOI. Runs increased AMR in
each subgroup as follows:
No runs
Etlology N
No CAD 124
CAD 125
COMBINED VALVE PROCEDURE AND BYPASS SURGERY IN SEPTUAGEN-
ARIANS AND OCTOGENARIANS - RESULTS IN 120 PATIENTS.
Tsung-Po Tsai, M.D., Jack Matloff, M.D., Aurelio Chaux,
M.D., Robert Kass, M.D., and Myles Lee, M.D. Cedars-Sinai
Medical Center, Los Angeles, California.
Co~ecutive 96 septuagenarians (sept)(male 63, female
33, 74) and 24 octogenarians (oct)(male 9, female IS, 83)
u~derwent.combined valve procedure and bypass surgery
wlth cardlopulmonary bypass using hypothermia (21°C) and
hyperkalemic cardioplegia. Most patients (pts) were in
NYHA Functional Class III (sept 35%, oct 12%) and Class
IV (sept 57%, oct 88%) preoperatively. There were 19
early sept deaths (19.8%) and 9 early oct deaths (37.5%).
Late mortalities were 7 sept (g%) and 1-pct (6.6%) in a
6 month (mo) to 4 year (yr) follow-up (25 mos). Of 84
over 30-day survivors, 78% of sept and 87% of oct pts
improved by one or more NYHA classes postoperatively.
23% sept and 47% oct pts developed major complications
that included bleeding, tamponade, sternal dehiscence
MI, arrhythmia and pump failure. Mortalities were adv~rs~
ly influenced by 1) NYHA Class IV (sept 38% vs oct 43%)
2) Postoperative hemorrhage (sept 16% vs oct 22%), and 3)
Prolonged ischemic aortic cross-clamp time (over 100 min-
utes, sept 30% vs oct 50%).
Total mortalities in Aortic Valve Replacement (AVR) +
Coronary Artery Bypass (CAB) Group, Mitral Valve Replace-
ment (MVR) + CAB Group, Aortic and Mitral Valve Replace-
ment (DVR) + CAB Group, and Mitral Valve (MV) Repair +
CAB. Group were: 21%, 50%, 22%, and 18% respectively. Com-
parlng those groups with isolated valVe replacement in
the same period (44 mos), mortalities in the AVR, MVR and
DVR Groups were 7%, 29% and 33%.
Conclusion: The-risk of combined valve procedure and b~
pass surgery was significantly increased in the elderly
and may warrant a less aggressive procedure, especially
in the mitral position.
Thus, dysrhythmias on STH contribute lndependently to
mortality ln CHF of coronary and noncoronary etlology at
all levels of left ventricular dysfunction.
CRYOABLATION OF RIGHT VENTRICULAR TACHYCARDIA:
IMPLICATIONS IN ISCHEMIC HEART DISEASE.
Jor~e Cheirif, MD, Gerald M Lawrie, MD, FACC, Karen J
Bec man, MD, Jack Krafchek, MD, Sharon A Magro, PAC,
Christopher R C Wyndham, MD, FACC.
Baylor College of Medicine, Houston, TX.
Ventricular tachycardia (VT) with right ventricular (RV)
endocardial breakthrough usually occurs in patients (pts)
without ischemic heart diseasp (rHO). That VT with RV
breakthrough can occur in IHO has not been previously em-
phasized. We encountered 14 out of 46 pts (34 with IHO)
operated upon for VT, in whom earliest endocardial break-
through was in the RV. Pts failed a mean of 3.8 antiar-
rhyth~ic drugs. Of the 14, 10 pts had IHO with prior in-
farctlon, 2 had tetralogy of Fallot, 1 arrhythmogenic RV
dysplasia and 1 cardiomyopathy. Twenty-seven VTs were doc-
umented in the 14 pts; one VT in each pt (all QS or rS in
lead VI) showed earliest activation in the RV: septum in
9, free wall in 4 and crista supraventricularis in 1 pt.
~f 10 pts with IHO, earliest activation was in RV septum
ln 8, free wall in I, crista in 1 pt. RV breakthrough oc-
curred from -145 to +8 (mean -45 ± 38) msec relative to
onset of QRS during VT. Surgery involved RV CR in 13 pts
and RV septal pndocardial excision in 1 pt. Concomitant
procedures included left ventricular (LV) CR in 7 LV en-
docardial .res.ection in 6, LV aneurysmectomy in 6, 'RV out-
flow repalr ln 7, VSO closure in 1 and RV disconnection
~n. 1. pt, without compl ications. Postoperatively VT was
lnltl~ted by programmed stimulation in the 1 pt with IHO
who dld not have RV CR; VT recurred in this pt and one
other with IHO with a VT never seen before. We conclude
th~t i~ approximately 30% of pts with VT and IHO, VT may
a~lse.1n RV endoc~rdium and require RV surgery. Cryoabla-
t10n 1S an effectlve and safe therapy for drug-resistant
tachycardia. .
PREDICTIVE ACCURACIES OF HOLTER MONITORING AND PROGRAMMED
STIMULATION IN PATIENTS TAKING AMIODARONE.
Soo G. Kim. M.D., F.A.C.C., Samuel D. Felder, M.D •• Ilona
Figura. M.D., Lawrence E.Waspe, M.D., F.A.C.C •• John D.
Fisher. M.D., F.A.C.C., Montefiore Hospital, Bronx, N.Y.
Predictive accuracies of Holter Monitoring and programmed
stimulation (PES) were evaluated in 50 patients (pts) on
amiodarone (amio) for recurrent, sustained ventricular
tachycardia (VT). Before amio. all had inducible VT by PES
(1-3 extrastimuli) and frequent ()30/hr) ventricular
premature complexes (VPCs) on Holter. Amio therapy
(86S~271 mg/day for 16~9 days) was effective (negative) by
PES (VT not inducible or (IS beats) in 9 pts and
ineffective (positive) in-41. Amio was effective by Holter
(~8S% reduction of VPCs and abolition of VT. defined as
negative) in 42 and ineffective (positive) in 8. All pts
were discharged on amio and followed for 20+19 months.
Sixteen pts with follow-up less than 1 year~ without
recurrence, were excluded from I-year survival analysis.
One year after discharge, 25 pts had no recurrence
(Holter negative in 23, positive in 2: PES negative in 6,
positive in 19) and 9 had recurrence (Holter negative in
5, positive in 4: PES negative in I, positive in 8). From
I-year survival data, predictive accuracies (PA) and
positive (+) and negative (-) predictive values (PV) were
obtained. (+)PVapositive Holter or PES with recurrence.
PAa(true positive + true negative)/all pts.
Sensitivity Specificity (+)PV (-)PV PA
PES 89% 24% 35"% 8'6% ill
Holter 44% 92% 67% 82% 79%
Conclusion: In pts with recurrent VT and frequent VPCs
before amio. positive PES on amio is non-specific and
positive Holter is insensitive. The negative PV of Holter
and PES are similar but the positive PV of PES is poor.
The PA of Holter appears to be superior to that of PES.
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I/Clinical %Mortality Rela-
Criteria With Without tive
Present N Overall VEA VEA Risk
None 591 4.7 9.1 2.4 3.86
any 1 547 U.S 15.8 8.7 1. 81
any 2 205 19.0 21.1 16.5 1. 28
all 3 31 35.5 41.2 28.6 1.44
3.68
2.53
0.83
0.73
Similar results were obtained when sudden ( hour)
death was considered.
Therefore:
1) Inexpensive easily available clinical criteria can be
used to categorize risk of death in MI survivors over
an 8-fold range.
2) VEA is associated with increased mortality in all risk
categories.
3) Relative risk tends to be higher in the low risk strata.
IS 24 HOURS AMBULATORY ELECTROCARDIOGRAPHY USEFUL IN
PREDICTING MORTALITY OF LOW RISK SURVIVORS OF MYOCARDIAL
INFARCTION (MI)?
John B. Kostis, M.D., F.A.C.C., Robert P. Byington, Ph.D.,
Marvin L. Murphy, M.D., F.A.C.C., Lawrence M. Friedman,
M.D. for the BHAT Study Group
Ventricular ectopic activity (VEA) is associated with
increased mortality in survivors of MI but its relative
prognostic importance in patient subsets with high or low
risk has not been adequately explored. One thousand
three hundred seventy four survivors of acute MI
randomized to the BHAT placebo group were stratified
according to the presence or absence of three easily
obtainable clinical criteria (history of prior MI,
cardiomegaly, ST depression on 12 lead resting ECG).
Presence of VEA ( 10 VPB/h or pairs or VT or multi-
form) was associated with increased risk in all strata
over an average 25 month (12 to 40 months) follow-up.
THE UTILITY OF EARLY HOLTER MONITORING IN PREDICTING CLINICAL EFFICACY
OF AMIODARONE IN VENTRICULAR TACHYCARDIA.
Steven L. Ballas, M.D., Enrico P. Veltn, M.D., Lawrence S.C. Griffith,
M.D., F.A.C.C., Thomas Guarnieri, M.D., F.A.C.C., Philip R. Reid, M.D.,
F.A.C.C. The Johns Hopkins and Sinai Hospitals, Baltimore, Maryland.
To determine the utih ty of Holter monitoring (HM) during the early
phase of therapy with am1odarone in predicting subsequent clinical
events, 96 patients (pts) With symptomatic ventricular tachycardia (VT)
were evaluated. The population characteristics included: 79 males, 17
females~ age 60±l3 years (mean ± standard deviation) i coronary artery
disease in 71 (74\), cardiomyopathy 1n 15(16%), valvular heart disease
in 3(3%), congenital heart disease in 2(2%), primary electrical disease
in 5(5%); eJection fraction 36±15%. Clinical presentations were sudden
death in 38(40%), syncope in 31C32%), presyncope in 27(28%). All pts
had basehne 24 hour HM off all antiarrhythmic drugs> 5 half-lives
revealing nonsustained VTl;!:3 beats). Amiodarone was administered 1200
mg/day for 14 days then 200-400 mg/day maintenance and HM was performed
during the second week of therapy (days 8,9,10). There were 66 pts(69%)
without VT on HM and 30 pts(3l\) With VT noted on second week HM. At
l7±l2 months followup, 35 pts(36%) had clinical arrhythmic events
(sudden death, sustained VT. syncope): 13 of 66 (20%) without VT on HM
and 22 of 30(73%) with VT on HM(p".OOl). The table below depicts the
value of VT on early HM in predicting subsequent clinical efficacy:
Sensitivity 63%
Specificity 87%
POSitive predictive value 73\
Negative predictive value 80%
Predictive accuracy 78%
We conclude that in pts with clinical symptomatic VT wbo manifest
nonsustained VT on baseline HM, early lIM on amiodarone therapy predicts
long-term efficacy.
POOR PREDICTIVE VALUE OF PERSISTENT INDUCTION OF VENTRI-
CULAR TACHYCARDIA BY PROGRAMMED STIMULATION DURING CONVEN-
TIONAL ANTIARRHYTHMIC THERAPY EFFECTIVE BY HOLTER CRITER-
IA. Soo G. Kim, M.D., F.A.C.C., Sam Felder, M.D., Lawrence
E. Waspe, M.D., F.A.C.C., John D. Fisher, M.D., F.A.C.C.
Montefiore Medical Center, Bronx, N.Y.
Wednesday, March 12, 1986
8:30AM-I0:00AM, Room #313/314
Doppler Echocardiographic Assessment of the Right
Heart
While prevention of induction of ventricular tachcardia
(VT) by programmed stimulation (PES) during a therapy is
highly predictive of clinical efficacy, the value of
~ersi~tent induction of VT by PES in predicting clinical
IneffIcacy of a therapy has been questioned in patients
(pts) taking certain agents (propafenone or amiodarone).
The predictive value of persistent induction of VT
during a therapy with conventional agents (procainamide,
quinidine, disopyramide, propranolol and phenytoin)
effective by Holter criteria was studied in 36 pts with
recurrent sustained VT. All had frequent (> 30/hour)
ventricular premature complexes (VPCs) and-inducible VT by
PES (1-3 extrastimuli) at baseline. A therapy was
effective by PES criteria (VT no longer inducible or <
15 beats) in 17 pts (group 1). Remaining 19 pts (group 2)
were dIscharged on a therapy ineffective by PES but
effective by Holter criteria (> 83% reduction of VPCs
and abolition of VT). Duration-of follow-up was 18.0 +
12.3 months. Five pts had recurrences within 12 months (2
in group 1, 3 in group 2: P=NS). Arrhythma-free survival
rates by Kaplan-Meier's method at 6,12,18 and 24 months
were 82%, 82%, 72% and 60% in group 1 and 89%, 77%, 70%
and 70% in group 2 respectively (P=0.343 by Logrank test).
Conclusion: In selected pts with frequent VPCs at base-
line, persistent induction of VT during a therapy with
conventional agents has poor value In predicting clinical
inefficacy and does not preclude good clinical outcome if
the therapy is effective by Holter criteria.
COMPARISON OF THREE DOPPLER METHODS IN THE PREDICTION OF
PULMONARY ARTERY PRESSURE.
Kwan-Leung Chan, H.D., Philip J. Currie, H.B.,B.S.,
James B. Seward, M.D., F.A.C.C., Donald J. Hagler, H.D.,
F.A.C.C., Douglas D. Hair, H.D., F.A.C.C. and A. Jamil
Tajik, M.D., F.A.C.C., Mayo Clinic, Rochester, MN.
The three Doppler methods used in 50 consecutive patients
undergoing cardiac catheterization were: (i) systolic
tricuspid gradient (calculated from Doppler=detected
tricuspid regurgitation) plus clinical jugular venous
pressure or a constant of 14 mm Hg, to yield systolic PA
pressure; (ii) acceleration time from PA flow analysis in
a regression equation to derive mean PA pressure; and
(iii) RV isovolumic relaxation time (RT) (derived from
Doppler-determined pulmonary closure and tricuspid
opening) used in a nomogram to give systolic PA pressure.
In 48 patients (96%), at least 1 of the 3 methods could be
applied. Tricuspid gradient was obtained in 36 patients
(72%). The tricuspid regurgitation velocities ranged from
2.0 to 4.5 mis, with a mean of 2.9. Systolic PA pressure
prediction was superior when 14 mm Hg was used to account
for RA pressure (E = 0.87). In 44 patients (88%) PA flow
contour was obtained; 12 of the 44 did not have Doppler-
detected tricuspid regurgitation. Prediction of mean PA
pressure was unsatisfactory (E = 0.65) but improved when
only patients with heart rates between 60 and 100
beats/min were considered (r = 0.85). Determination of RT
was feasible in only 11 patients (22%), due to high
incidence of arrhythmia. In this subset the prediction
was acceptable (E = 0.83). Thus, noninvasive prediction
of PA pressure by Doppler is feasible in most patients
and, of these 3 methods, the tricuspid gradient method
appears to be the most useful.
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SONOSPIROMETRY: A NON-INVASIVE METHOD FOR ESTIMATING
RIGHT ATRIAL PRESSURE
:!..!r. ~ Simonson, M.D., Robert H. Merz, M.D., Nelson B.
Schiller, M.D., F.A.e.e.
Knowledge of mean right atrial pressure (RAP) is useful
for evaluation of right heart hemodynamic status and for
calculation of pulmonary pressures by Doppler. However,
a non-invasive method for accurate, reliable estimation
of this pressure does not exis t. To es tima te RAP we used
a Bourdin pressure gauge with a 14ga bleed-off port to
measure voluntary inspiratory pressures and supine 2-D
echocardiographic long axis imaging of the inferior vena
cava (IVe) from a subxiphoid window to quantitate the
diameter of the Ive. Thirteen alert and cooperative
patients (8 males) ranging in age from 36 to 79 were
studied on 15 occasions. All patients had pulmonary
artery pressure catheters in place during the study. RAP
was measured from RA tracings immediately following each
study. RAP ranged from 0 to 15mmHg in the patients
studied. Ive diameters were measured at the narrowest
poin t Z to 7 cm from the RA- Ive j unc tion. The Ive
diameter was measured during a series of constant
inspi ra tory pressures at 5cmHZO (4mmHg) incremen ts. The
maximum IVe diameter was determined while the patient
held a full breath. The minimum obtainable Ive diameter
was determined from the minimum measurement during the
study of each patient. The minimum inspiratory pressure
required to collapse the Ive diameter to 75% or more of
the difference between the maximum and minimum Ive
diameter was found to be equal to the RAP (r=O.90). The
method is accurate to +ZmmHg over a RAP range of a least
o to 15 mmHg. The upper limit of RAP de termina tion using
this method remains to be defined. Sonospirometry is a
useful method for non-invasive estimation of RAP.
PULSED OOPPLER HEPATIC VEIN BUXD FLCW IN 'IRIOJSPID
~ITATIOO AW A'IRIAL SEPI'AL DEFECl'
Ali Pabestani. MD, Katsu Takenaka, MD, Walter L Henry,
MD, FAC£. University of California, Irvine, California.
DoWler hepatic vein flow has been shown to be useful
in the diagnosis of tricuspid regurgitatioo ('m). Atrial
septal defect (ASl) and TR both can produce large end-
systolic retrograde v-flow, thus making differentiatioo
difficult. To separate ASl from TR, we studied hepatic
vein flow velocity using pulsed DoWler echocardiography
in 7 normals, 8 patients with TR and 7 with AID. Peak
flow velocities of antegrade (i.e. toward the heart)
systolic and diastolic flow, and retrograde end-systolic
v-flow velocity (i.e. away from the heart and toward the
liver) were measured in C\V'sec. Interval from the ooset
of Q wave of ElCG to the peak of v-flow was measured in
milliseconds (Q-v). Results for both respiratory phases
are (mean + 3):
Diast. Flow v Flow Q-v
STR= Severe TR *p<.OOI
The distance of STCS(tricuspid annulus in pts with TVT)
ranged from 3 to 40mm & was inversely correlated with the
log of PFV (r=-.94, SEE=.lm/s, p<.OOI) or the log of PG
(r=-.94,SEE= .3mmHg, p<.OOI) in 19 pts with laminar flow.
CONCLUSION: Laminar systolic TR flow,low PFV of TR & low
PG in systole, occur in many pts with severe TR. These
features are probably due to a large regurgitant orifice
as evidenced by their association with STCS or TVT.
Therefore, the presence of systol~c laminar TR flow is
strongly suggestive of the presence of severe TR.
SIGNIFICANCE OF LAMINAR SYSTOLIC TRICUSPID REGURGITANT
FLOW IN PATIENTS WITH TRICUSPID REGURGITATION: DOPPLER
AND ECHOCARDIOGRAPHIC STUDY.
Shinichi Minagoe, MD, Charles R McKay, MD,FACC, Shahbudin
H Rahimtoola, MD,FACC, P Anthony N Chandraratna, MD,FACC
LAC-USC Medical Center, Los Angeles, CA.
In order to define the cause & significance of laminar
systolic tricuspid regurgitant flow, pulsed & continuous
wave Doppler (PWD,CWD), two-dimensional and M-mode echo-
cardiography (ZOE, M-mode) were performed in 67 patients
(pts) with tricuspid regurgitation (TR) which included 5
pts with tricuspid valvectomy (TVT). TR flow pattern
(laminar or turbulent), TR severity by detecting the
extension of TR in the right atrium(l+ to 4+) by PWD, the
peak flow velocity of TR (PFV) by CWO and the systolic
pressure gradient (PG) across the tricuspid valve derived
by using modified Bernoulli's equation (6P=4V 2 ;6P=PG,
V=PFV), presence and distance of systolic tricuspid cusp
separation (STCS) by 2DE, & the dimension of the right
ventricle (RVD) by M-mode w~re assessed. Results:
5
o
TRICUSPID REGURGITATION IN NORMAL SUBJECTS: PREVALENCE
AND POSSIBLE MECHANISM.
John J, Lynch. M.D" Kiran B. Sagar, M.D., F.A.C.C.,
L. Samuel Wann, M.D., F.A.C.C., Medical College of
Wisconsin, Milwaukee, Wi.
Doppler echocardiography frequently detects tricuspid
regurgitation (TR) in normal subjects. To determine the
prevalence and possible mechanism of tricuspid
regurgitation in normal SUbjects we performed
two-dimensional and pulsed Doppler echocardiography in
30 normal volunteers. All subjects also underwent
history, physical examination and electrocardiogram.
Diagnosis of tricuspid regurgitation was made if a
turbulent systolic flow was detected in the right atrium
below the tricuspid valve. Measurements of tricuspid
valve annulus diameter at end-diastole (TVD) , right
ventricular diameter at end-diastole (RVD) , right atrium
(RA) length and width at end-systole were made from the
apical four chamber view. These were indexed to body
surface area. Tricuspid regurgitation was present in 16
of 30 subjects (53.3%). SUbjects with tricuspid
regurgitation had greater RA length, RA width, and RVD
than those without. TVD was similar in the two groups.
RA Length RA Width RVD TVD
[Mean + SD]
TR Present 2.42±.42. 2.03±.45. 2.03±.48. 1.77±.45
(16 subjects)
TR Absent 2.02±.42 1.72±.33 1.7 ±.35 1.49±.28
(14 subjects)
• p < .05 + values are cm/m2
We conclude that prevalence of TR in normal SUbjects is
quite high and it may represent a mismatch in RA, right
ventricle and tricuspid valve annulus.
TR flow N PFV PG STR STCS TVT
(m/sec) (mmHg) (4+) (+) (-)
Laminar 21 2.0±.7* 17±11* 14/211 14 2
Turbulent 46 3.1±.7 J 40±18J 4/46 J 0 46
RVD
(mm)
38.2±9.4~
24.7±9.5 J
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INCIDENCE OF VALVULAR DYSFUNCTION IN METASTATIC CARCINOID
SYNDROME: UTILITY OF DOPPLER AND COLOR FLOW MAPPING.
Bijoy K. Khandheria, M.D., A. Jamil Tajik, M.D., F.A.C.C.,
Mark J. Callahan, M.D., John A. Callahan, M.D., F.A.C.C.,
Rick A. Nishimura, M.D., F.A.C.C., Charles G. Moertel,
M.D. and James B. Seward, M.D., F.A.C.C., Mayo Clinic,
Rochester, MN.
The characteristic structural abnormalities of carcinoid
heart disease have been well described by two-dimensional
echocardiography (2DE). Doppler detection of valvular
dysfunction in this entity has not been reported. We
studied 27 pts (20 M, 7 F; mean age 67 yr, range 30-72 yr)
with documented metastatic carcinoid syndrome. 2DE
revealed thick, retracted tricuspid leaflets in 17 (63%);
Doppler examination revealed tricuspid regurgitation (TR)
in 21 (78%) with an average peak jet velocity of 2.5 mls
(range, 1.8-3.0 m/s). Continuous-wave Doppler in 13 pts
revealed tricuspid stenosis in 8 (62%). The average peak
antegrade velocity across the tricuspid valve was 1.3 mls
(range, 1.1-2.0 m/s) and the diastolic half-time ranged
from 70-170 ms. Pulmonary regurgitation (PR) was detected
in all 11 who had optimal Doppler signals; 3/11 (27%) had
evidence of pulmonary stenosis (1.4, 1.8, and 3.0 m/s) and
a thick pulmonary cusp visualized on 2DE. On color flow
imaging performed in 5 recent pts, moderate TR was found
in 4 and mild in 1. A jet configuration consisting of a
central blue zone surrounded by shades of red and yellow--
indicative of color reversal (aliasing)--was seen in 4
(80%); PR was seen in 3 (60%). Conclusion: 1. The
incidence of TR and PR is high in carcinoid heart disease.
2. Associated tricuspid stenosis is present in 61%. 3.
Color flow imaging permits definition of regurgitant jet
configuration and semiquantitation of regurgitation.
Combined 2DE and Doppler examination provides a compre-
hensive assessment of valvular dysfunction in metastatic
carcinoid syndrome.
Wednesday, March 12, 1986
10:30AM-12:00NOON, Room #313/314
New Echocardiographic Technology
"SILENT" ATRIAL SEPTAL DEFECTS FOUND BY CONTRAST ECHO-
CARDIOGRAPHY ARE HIGHLY ASSOCIATED WITH EMBOLIC STROKE
John Harvey MD, Jerome L. Anderson MD, Wyatt F. Voyles
MD, Edwln G. Olson MD, Udho Thadani MD FACC, and Steve
M. Teague MD, Unlverslty of Oklahoma and VA Medlcal
Centers, Oklahoma Clty, Oklahoma
Two-dlmensional echocardlography (2DE) is said
to be of minimal value in the evaluatlon of cardiac
source of cerebral embollzatlon when the cardiac If!ysical
exam, chest radlograph, and ECG are all normal. In
the past year, 16 patients age 50 or younger fulfilled
these criteria, had normal 2DE examinations, and clinical
and radiographlc evidence for cerebral embolization.
DJnng normal resprration, 10 of 16 had positive findings
for rlght-to-left shunts at the atrial level by mlcro-
cavltation contrast 2DE. Lung scans were posltlve
ln 1 of 6, but venography was negative. Flve of the
ten Wlth posltlve contrast 2DE studies underwent cardiac
catheterlzatlon. All five had an atrial defect, normal
right and left heart pressures, and small left-to-
rlght shunts (maximun 1.4 : 1). All had right-to-left
shunts by lndlcator dye curves during a valsalva straln.
Four of the five (ages 18, 29, 41 and 50) unden,ent
surglcal closure of the defect, which ranged from
5 to 15mm ln diameter and was classified as a patent
foramen ovale (3) or a secundum atrial septal defect
(1). The remalning patients received antlcoagulants.
These flndlngs suggest: l)Widely patent foramen ovale
and atrlal septal defects are commonly found in young
patlents with cerebral emboli, making paradoxical
embollzation possibly more common than expected.
2)Contrast 2DE is the only noninvasive technlque that
reliably hnds these defects. 3)Contrast 2DE should
be routlnely performed in young patients wlth stroke.
APPLICATION OF ANNULAR PHASED ARRAY TECHNOLOGY TO
TWO-DIMENSIONAL ECHOCARDIOGRAPHIC IMAGING
Thomas Ryan, M.D., Charles G. Vasey, M.D., William F.
Armstrong, M.D., F.A.C.C., Harvey Feigenbaum, M.D.,
F.A.C.C.; Indiana University School of Medicine, Krannert
Institute of Cardiology; Indianapolis, Indiana
Annular phased array (AA) ultrasonic transducers have
only recently become available for cardiac imaging. These
mechanically oscillating transducers, which consist of
multiple elements aligned in concentric rings, permit
adjustable focusing of the ultrasonic beam and result in
significantly thinner tomographic slices. Although the
advantages of AA transducers, which include improved
lateral resolution, increased signal-to-noise ratio, and
better penetration, are known, the potential role of this
technology in cardiac imaging remains largely unexplored.
We studied 30 adults with both conventional and AA (ATL
Ultramark 8) transducers. The improved penetration of
the AA system permitted the use of higher frequency
transducers (3.5 and 5.0 MHz) than was possible with
conventional systems. This resulted in increased
resolution, better definition of endocardial borders, and
improved recording of fine structures, such as valve
leaflets, chordae tendineae, and coronary arteries. The
AA transducer was particularly helpful in excluding the
presence of intracardiac masses in cases where
conventional systems provided equivocal results. In 3
cases in which the presence of intracardiac thrombus
(2 LV, 1 LA) could not be resolved using a conventional
system, the AA system provided an unequivocal diagnosis.
The AA transducer was useful in excluding the presence of
small valvular vegetations, permitted detection of a
small primum ASD, and allowed diagnosis of a flail mitral
valve, none of which were correctly diagnosed with
conventional transducers. In conclusion, AA technology
is a significant advance in ultrasonic cardiac imaging.
ASSESSMENT OF LEFT VENTRICULAR EJECTION FRACTION
FROM CONTRAST ECHO WASHOUT CURVES: A NEW
METHOD INDEPENDENT OF GEOMETRIC ASSUMPTIONS
Daniele Royaj M D.. Steven E. Nissen, M.D., Oi Ling Kwan,
Anthony N. DeMaria, M.D., FACC; University of Kentucky and VA
Medical Center, Lexington, Kentucky
In previous studies we have demonstrated that the decay phase of time-
intensity curves derived from contrast echocardiography(CON) of the
left ventricle is monexponential. Therefore, this study was performed
to develop a method for calculation of LV ejection fraction by analysis
of the decay phase of such curves. We performed CON by injecting 3
rnl boluses of the saccharide contrast agent SHU454 into the left
ventricle. An independent measurement of ejection fraction was
obtained by area-length analysis of digital subtraction left
ventriculograrns. Data were obtained in 6 closed chest mongrel dogs at
31 different levels of ejection fraction which were created by changes in
preload (volume), afterload (methoxamine) and contractility
(dobutarnine). CON were recorded in the apical4-chamber view, were
digitized off-line, and the mean gray level/pixel in the LV cavity was
measured before, during, and after contrast appearance. The pixel
values from the 2nd to 4th systolic frame of each beat were averaged,
and the resultant intensities plotted against time to yield a rectilinear
decay phase. Multiple linear regression analysis indicated that LV was
related to the slope and peak of the time-intensity curves, as well as to
the mean duration of the cardiac cycle. An index was therefore devised
to account for these variables. Linear regression analysis of this index
and angiographic ejection fraction yielded a correlation of r=O.83,
Thus, these data indicate that analysis of the decay phase of time-
density curves obtained from contrast echocardiography can be utilized
to provide estimates of LV ejection fraction without geometric
assumptions. Values on ejection fraction calculated by contrast echo
correlate well with those of angiography.
lACC Vol 7. No.2
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EFFECT OF REGIONAL ISCHEMIA ON DIASTOLIC LEFT VENTRICULAR
INTRACAVITARY FLOW VORTEX - COLOR DOPPLER AND CONTRAST
ECHOCARDIOGRAPHIC STUDIES.
Natesa Pandian, M.D., John Funai, M.D., Shan Shen Wang,
M.D., Barbara Lowell. Tufts-New England Medical Center,
Boston, Massachusetts.
To assess the effect of regional ischemia and left
ventricular (LV) dysynergy on diastolic LV intracavitary
flow dynamics, we used two-dimensional color Doppler and
saline contrast echocardiographv in 9 doqs in control and
during 20 instances of ischemia created by occlusion of
left anterior descending or circumflex coronary arteries.
From two-dimensional color Doppler images we analyzed the
pattern, direction and distribution of flow jets within
the LV cavity. We measured the width of antegrade dias-
tolic inflow (ADF) and retrograde diastolic vortical flow
(RVF) in controls and during ischemia and calculated ADF/
RVF ratios. From saline contrast echocardiographic images
the diastolic motion of contrast bubbles was analyzed
during washout phase. Results: During all control s, a de-
finite normal flow vortex formation was noted during
diastole with the RVF predomonantly in the anterior
portion of LV. ADF/RVF ratio in control was 5.3±1.4.
During ischemic LV dysfunction however ADF/RVF ratio de-
creased strikingly to 1.4±.25 (p<.Ol). On saline contrast
echocardiography a swirl ing of flow was noted during
ischemia; it was more prominent in the presence of an-
teroapical ischemia or when the ischemic zone was larger.
These findings indicate that regional ischemia alters
the diastol ic 1eft ventricul ar intracavitary flow
dynamics with enhanced tendency for vortex formation and
favoring regional stasis.
DIGITAL ECHOCARDIOGRAPHIC VISUALIZATION OF THE LEFT
CORONARY ARTERIES USING AN ANNULAR PHASED ARRAY SYSTEM
Charles G. Vasey, M.D., Thomas Ryan, M.D., William F.
Armstrong, M.D., F.A.C.C., Harvey Feigenbaum, M.D.,
F.A.C.C.; Indiana University School of Medicine, Krannert
Institute of Cardiology, Indianapolis, Indiana
Annular array (AA) systems for cardiac imaging have
recently been developed. AA utilizes a mechanically
oscillating transducer with circular elements which
electronically focus the beam in both the X and Y axes.
This results in improved lateral resolution « 1 mm in
vitro) and thinner tomographic slices, allowing for the
first time in an adult the direct visualization of a
non-dilated coronary artery (CA) lumen beyond the left
main. We examined the left CA in 34 patients (pts) using
a 5 MHz AA transducer (ATL Ultramark 8). The arteries
were visualized in the short-axis plane and magnified
using a digital zoom. CA images were then captured off-
line (Microsonics analyzer) at 50 msec intervals in an 8
cell digital format that enabled construction of a con-
tinuous loop playback of only the CA. AA allowed visual-
ization of the left main CA in 33 pts, including its bi-
furcation in 29. The lumen of the left anterior descend-
ing was visualized in 29 pts; in 4 a proximal branch was
also seen. The left circumflex was seen in 22 pts, once
including the origin of the first marginal. High inten-
sity echoes corresponding in location to lesions observed
cineangiographically were seen in the left main in 4 pts,
at its bifurcation in 1 pt, in the proximal left anterior
descending in 4 cases, and twice in the circumflex. Ini-
tial experience therefore suggests that the enhanced
resolution resulting from annular array technology,
together with improved digital analysis, is an important
ultrasonic advance that may prove to be of considerable
clinical utility in examining the left coronary arteries.
ECHOCARDIOGRAPHIC CONTRAST PERSISTENCE IS DEPENDENT ON
INJECTATE AND BLOOD TEMPERATURE.
Christopher R. Thompson, M.D., Rosalind P. MacDonald,
B.Sc., John V. Tyberg, M.D., Ph.D., F.A.C.C. and Eldon
R. Smith, M.D., University of Calgary, Calgary, Canada.
Clinical use of echocardiographic contrast (C) to study
myocardial perfusion will depend on production of
microbubbles of known size and persistence (PERSIST).
Previous assessments of bubble size have been made at
room temperature (TEMP). In 7 dogs, we obtained
excellent myocardial C enhancement without significant
hemodynamic alteration following 42 coronary injections
of mechanically and sonically agitated 30% dextrose in
water (D30) but noted marked variation in C PERSIST.
To determine if this variation could reflect
uncontrolled injectate (INJ) TEMP, we evaluated the
TEMP dependence of C PERSIST using echocardiographic
images of rate and pressure-controlled 3 ml injections
of 3 C agents [agitated D30 and D70 and 1: 1 agi tated
Renografin-76/saline (R/S) 1 into a balloon containing
dog blood (BLD). The mean of PERSIST estimates by 2
observers following 6 injections at each of 3 TEMPs
were:
TEMP(OC) PERSISTENCE (sees) ± 1 SD
INJ BLD D30 D70 R/S
21° 21° 112±35 287t61 292t22
21° 37° 524±148t 1001t243t 1063±118t
37° 37° 195t99t 389±127* 461t219t
~ = p<.05. t = p<.005 vs same agent at 21°/21°
In this in vitro model C PERSIST is markedly lon~er at
37° than at 21°. Since larger bubble size may be the
major factor in prolonged C PERSIST, we conclude that:
1) TEMP of INJ is an iwportant, controllable variable
in echocard10graphic myocardial perfusion studies;
2) use of cold INJ for in vivo studies may produce
larger bubbles than previously appreciated.
Wednesday, March 12, 1986
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Ventricular Function
VENTRICULAR VOLUMES, SYSTOLIC AND DIASTOLIC FUNCTION IN
ACUTE MYOCARDIAL INFARCTION: RELATION TO INFARCT SIZE
AND LOCATION
A. Allen Seals, M.D., Sameh Tadros, M.D., Craig M.
Pratt, M. D., F. A. C. C., Robert Roberts, M. D., F.A. C. C.,
Mario S. Verani, M.D., F.A.C.C. Baylor College of
Medicine, Houston, TX.
To date, quantification of LV volumes and diastolic
function in the initial hours of acute infarction has
not been done. Accordi ngly, in 62 patients with acute
myocardial infarction (anterior n = 34, inferior n = 28)
on day 1 of infarction, we performed high-framing rate
radionucl ide angiography and assessed LV end-diastol ic
volume index (EDVI), end-systolic volume index (ESVI),
stroke volume index (SVI), ejection fraction (EF), peak
systolic pressure-volume index (PSP/ESVI) and peak dias-
tolic filling rate (PDFR). Infarct size was calculated
from serial CK-MB curves. Studies were repeated on day
10 post-infarction in 16 patients.
RESULTS (M ± SO): ANTERIOR INFERIOR P
EF(%) 46±15 52±14 ns
EDVI(ml/m2 ) 107±41* 76±21 < .001
ESVI(ml/m2 ) 61±40* 38±21 < .01
SVI(ml/m2 ) 46±15* 38±10 < .05
PSP/ESVI(mmHg/ml) 1.6±1.2 2.1±1.2 ns
PDFR(EDV/s) 2.1±.6 2.1±.8 ns
INFARCT SIZE CK· ·E 35±16* 19±7 < .002
n repeat stu y, an V urt er lncrease p <
.05 vs day 1), although EF, PSP/ESVI, and PDFR were un-
changed. Conclusions: 1) The LV dilates markedly within
hours in patients with anterior infarction, but only
minimally with inferior infarction 2) In contrast, dias-
tolic function was impaired to a similar extent in both,
and 3) Despite extensive myocardial damage, stroke-vol-
ume was maintained by left ventricular dilatation.
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CORONARY ANGIOGRAPKIC AND LEFT VENTRICULAR ABNORMALI-
TIES ASSOCIATED WITK RIGHT VENTRICULAR INFARCTION
Simon Kouz, M.D., Pierre Theroux, M.D., F.A.C.C.,
Sebastien Roux, M.D., David D. Waters, M.D., F.A.C.C.,
Denis Roy, M.D., F.A.C.C. and Georges Dupras, M.D.,
Montreal Heart Institute, Quebec, Canada
Equilibrium gated radionuclide ventriculography was
performed during the acute phase of inferior myocardial
infarction in 128 pts who were catheterized 10±3 days
after admission. All pts without contraindications un-
derwent arteriography. Right ventricular involvement
(RVI) , diagnosed by RV dilatation or RV wall motion ab-
normality was observed in 37 pts (29~). The right coro-
nary artery (RCA) was dominant in 36 of 37 pts with RVI
and in all 16 with RVI and 1 vessel disease. ST depres-
sion in the anterior ECG leads at admission was seen in
21 pts (57~) with RVI vs 43 (47~) without (p=NS).
RVI no RVI £
Peak CPK (lUlL) 2344±301 l689±148 <.02
Q wave MI 32 (86~) 64 (7~) NS
LVEF 53±9 52±10 NS
Posterobasal akinesis 29 (78~) 52 (57~) <.05
Diaphragmatic akinesis 24 (65~) 46 (5l~) NS
1 vessel disease 16 (43~) 22 (24~) <.05
3 vessel disease 6 (16~) 29 (3~) <.05
Proximal RCA ~70~ 28 (76~) 54 (59~) NS
Proximal RCA ~9~ 26 (7~) 40 (44~) <.05
RCA stenosis ~99~ 27 (73~) 44 (48~) <.05
We conclude that radionuclide-detected right ventricu-
lar involvement in inferior myocardial infarction im-
plies total occlusion or severe proximal stenosis of a
dominant right coronary artery usually with postero-
basal akinesis. Higher enzymes reflect associated right
ventricular damage. In patients with right ventricular
involvement who survive to arteriography, 3 vessel dis-
ease is uncommon.
DYSKINESIS, BUT NOT AKINESIS, PREDICTS THE PRESENCE OF
LEFT VENTRICULAR THROMBUS IN ACUTE ANTERIOR MYOCARDIAL IN-
FARCTION, Gervasio A. Lamas, M.D., Douglas E. Vaughan,
M.D., and Marc A. Pfeffer, M.D., Ph.D., FACC. Brigham and
Women's Hospital, Harvard Medical School, Boston, MA.
Left ventricular thrombus (LVT) is an early complication
that occurs in some patients following acute anterior myo-
cardial infarction (AAMI). To determine the factors asso-
ciated with the development of LVT, hemodynamic and angio-
graphic features were assessed in 39 patients undergoing
left ventriculography 14 to 28 days following AAMI. The
extent of the non-contractile segment (A+D) was defined as
the percent of the end-diastolic perimeter that was
akinetic (A) and/or dyskinetic (D). This infarcted segment
(A+D) was partitioned further into regions which were
either solely A or D. Over a wide range of infarct sizes,
A and D were found to vary independently of each other.
As expected in AAMI, LVEDP, EF, systolic and diastolic
volumes, and stroke index were all highly related (P<O.Ol)
to A+D. Angiographic LVT was found in 18/39 (46%) of the
patients. The incidence of LVT increased significantly
(P<O.Ol) as A+D increased.
A+D (%) < 20 21-30 > 31
incidence LVT 2/12 (17%) 3/8 (38%) 13/19 (68%)
Of the components (A,D) of the infarcted segment, only D
was found to correlate (P<O.Ol) with the presence of LVT.
D(%) < 10 10-19.9 > 20
incidence LVT 2/14 (14%) 8/12 (67%) 8/13 (62%)
In patients with AAMI and an extensive infarcted segment
with a large D component, there is a 4 fold increase in
the incidence of LVT compared to patients with a small 0
component. This relationship between the extent of dys-
kinesis and the presence of thrombus is not observed for
comparable degrees of akinesis, suggesting that systolic
bulging is an important component of thrombus formation.
CAN THE DEGREE OF REGIONAL SHAPE DISTORTION ON AN EARLY
TWO-DIMENSIONAL ECHOCARDIOGRAM AFTER MYOCARDIAL INFARCTION
IDENTIFY PATIENTS PRONE TO INFARCT EXPANSION?
Bodh I. Jugdutt, M.B.,F.A.C.C., Univ.of Alberta, Edmonton.
To determine whether the extent of regional shape distort-
ion (SD) on an early two-dimensional echocardiogram (20E)
after myocardial infarction can predict infarct expansion,
serial clinical and 20E data were recorded between 2 and
10 days after acute transmural infarction in 242 consecut-
ive patients (113 anterior, 129 inferior). Regional LV
asynergy (akinesis and/or dyskinesis), regional SD, and
anterior and posterior segment lengths were measured in
endocardial diastolic outlines of papillary or chordal 20E
sections.More than 25% stretching and thinning of asynerg-
ic segments (AS) was found between 2 and 10 day 20E
studies in 50 expanders (acute LV dilatation and failure;
no new ECG or creatine kinase changes). The new SD index,
(Pk or peak of the angular distribution between the dis-
torted asynergic segment and the computed idea~ segment of
a circle), but not the traditional SO index (P /41rA;
P=perimeter, A=area),was markedly different in expanders
than non-expanders at 2 and 10 days.
Expanders(n=50) Non-Expanders(n=192)
p2/4TT' A:2 day 1.09 1.06
Pk(mm):2 day 14.00* 9.70
A% AS length:7 day 53.2* 3.8
L)% AS thickness:7 day -27.8* -6.2
Killip class(maximum) 3.3* 2.4
Deaths (2-10 day) 214(28%)** 15(8%)
* P < 0.05 (ANOVA); ** X = 13.5, P < 0.001
All expanders had Pk>lOmm and AS>15% on the 2DE at 2 days.
Also,10 expanders with >30% increase in Pk (to 21 mm) de-
veloped ventricular septal defects (n=8) or cardiac
rupture (n=2). Thus, the degree of SO on a 2DE at 2 days
can identify expanders and those with higher morbidity.
SILENT VS SYMPTOMATIC ISCHEMIA Oil IWlLI POST-INFARCTIOII
TREADMILL TESTING: AlfGIOGRAPRIC CIWlACTERlZATIOIi AIfD
1 YEAR FOLLOW-OP
Pamela Quyang. M.D',I Edward P, Shapiro, M.D., F.A,C,C' iNisha C. Chandra, M.D.,Sheldon H. Gottlieb, M.D., Pau
H. Chew M.D. and Sidney O. Gottlieb, M.D., The Johns
Hopkins Medical Institutions. Baltimore, Maryland
To determine if post-infarction patients (pts) with
silent (SIL) or symptomatic (SX) ischemia on early exercise
treadmill testing (ETT) differ in angiographic charateristics
or 1 year follow-up, we studied 60 consecutive pts with
positive pre-discharge Naughton ETT (2.1 mm ST shift
or typical angina symptoms) who underwent coronary angio-
graphy 24±.4 days post-HI. Ischemia was silent in 63%
(38/60). Age, sex and use of beta-blockers, calcium
antagonists and nitrates at the time of the ETT did
not differ in the two groups (gps). All 9 pts with diabetes
~ellitus were in the SIL gp (p<.04). ETT did not differ
between gps in total duration (SIL=422±.31 sec, SX=400±46
sec), in workload expressed as HR X BP, in pts unable
to exercise 5 mins (12 SIL, 7 SX), in pts with diffuse
ECG changes (9 SIL, 7 SX) or in pts with ischemic ECG
changes distant from the HI zone (SIL 28, SX 12). Severity
of coronary artery disease (CAD) did not differ between
gps in mean number of coronary arteries with ~70% stenosis
(2. O±.O .2 SIL, 2. 2±.0. 2 SX), or in number of pts with
2J vessel CAD (74% SIL, 73% SX), left main CAD (4 SIL,
1 SX), or total occlusion of the infarct related artery
(66% SIL, 55% SX pts, p=NS). Over 1 year follow-up in
92~ of pts, 4 SIL (11~) and 1 SX (5%) pts had cardiac
death or recurrent MI (NS) and 17 SIL (45%) and 13 SX
(59%) pts underwent revascularization with bypass surgery
or angioplasty (NS). Thus, SIL ischemia occurs frequently
on early post-infarction ETT; the angiographic char-
acteristics and 1 year outcomes of these pts are similar
to pts with SX treadmill ischemia.
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CLINICAL CORRELATIONS AND LONG-TERM PROGNOSIS AFTER UN-
COMPLICATED NON Q-WAVE INFARCTION: A PROSPECTIVE NATURAL
HISTORY STUDY. .Il.QWi.sa..ll1.b.o.gn 1m, Denny D. Watson PhD,
Sharon L. Sayre RN, BSN, Mihai Georghiade MD, FACC, George
A. Beller MD, FACC. Univ. of Virginia, Charlottesville, VA
Despite a smaller infarct size and better LV function,
pts with non Q-wave(NQ) MI appear to have a prognosis com-
parable to QMI. One explanation is that there is more re-
sidual viable tissue in the perfusion zone of the infarct
vessel rendering myocardium more prone to reinfarction.
Accordingly, we prospectively studied 241 consecutive pts
(age~65yrs) with MBCK confirmed acute MI. Predischarge an-
giography(angio), radionuclide ventriculography, exercise
(Ex)TI-201 scintigraphy and 24 hr Holter was performed 10~
3d post-MI. Infarcts were designated NQMI(n=88) or QMI(n=
153) by serial ECGs (d1 ,2,3 and 10). Norris index and angio
jeopardy scores were similar despite less necrosis with
NQMI vs QMI, reflected by lower peak CK(553vs1321,p<.001j 4
hr sampling), higher LVEF(53vs46%,p<.00n, fewer akinetic
or dyskinetic LV segs(1.3vs2.4,p<.001), and fewer persis-
tent Tl-201 defects(O.9vs1.9,p<.OOn. Compared to QMI pts,
NQMI had more patent infarct vessels(25vs53%,p<.OOn and a
shorter time to peak CK(23vs17hrs,p<.OO1). Importantly,
the prevalence and extent of Ex-induced ischemia within
the infarct zone by quantitative TI-201 was greater in
NQMIvsQMI(60vs36%,p<0.001j and O.98vsO.53 segs,p<.OO1).
During 29 mos follow-up, cardiac mortality was 9% in both
groups. However, NQMI pts had a higher reinfarction rate
(17%vs6.5%,p=.02) and greater likelihood of sUbsequent
CABG surgery(33%vs 18%,p=O.017). Thus, in a consecutive se-
ries of uncomplicated HI pts, NQHI is characterized by
equal mortality despite better LV function, a higher re-
current HI and CABG rate at 29 mos, and more evidence for
residual infarct zone ischemia compared to QMI pts. Also,
our data suggest that the pathogenesis of NQHI may involve
spontaneous reperfusion.
Wednesday, March 12, 1986
10:30AM-12:00NOON, Room #264/265/266
Percutaneous Transluminal Angioplasty
EMERGENCY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
IN ACUTE MYOCARDIAL INFARCTION. Donald A. Rothbaum,MD,FACC,
fhomas J. Llnnemeler, MD, FACC, R. Joe Noble, MD, FACC,St.
VI ncent Hospi ta l, Indi anapo lis, IN.
Angioplasty (PTCA) was evaluated as prImary therapy for
acute myocardIal lnfarction(MI) in 75 patients(pts). All
had ECG changes for MI and normal or minimally elevated
cardiac enzymes (less than twice normal) prior to PTCA.
Cardiogenlc shock(CGS) was present in 9 pts, all wIth LAD
occlusion. Followup was 6-24 months.
Subtotal vessel occlusIon (SO) of 90-99% was found In 25
pts (33%), total occlusion (TO) in 50 pts (67%). PTCA was
perfor~ed In less than 3 hours after initIal ECG. The re-
sults are summarized:
Lesion Successful PTCA/Total pts Residual StenosIs
% LAD RCA LCX Total (%) Avg. (Range)
(90-99%) 12/12 9/9 4/4 25/25 (100%) 32% (0-50%)
(100%) 19/23 14/17 9/10 42/50 (84%) 33% (0-70%)
Combined success rate was 89% (67/75 pts). In the TO pts,
unsuccessful PTCA was due to faIlure to cross the lesion in
5 pts and thrombotic reoccluslon In 3 pts.
Total mortality was 6.3% (5/75 pts). All deaths occurred
in pts wIth CGS, 4 died acutely and lduring followup.
Acute vessel reclosure occurred in 2 pts, 1 had successful
re-PTCA, the other had CABG.
Repeat angiography was performed (>3 months post PTCA) in
46 pts. Regional wall motion was improved ~ 20% In 28 pts
(61%); 12/15 SO, 16/31 TO. A widely patent vessel was found
in 31/46 pts (67%). Restenosis e50% occurred in 8 pts(lzt:)
7 had successful PTCA and 1 had CABG. Reoccluslon occurred
in 7 pts (15%) but all occluded vessels had good collateral
fIll and no pts experienced late reinfarction. CABG was per-
formed in a total of 6 pts, 2 acutely il'ld 4 dUring followup.
In summary, emergency PTCA during acute MI was performed
wIth a hIgh initial success rate and a low overall mortal ity
confIned exclusively to pts presenting In cardlogenlc shock.
DIRECT BALLOON ANGIOPLASTY IN ACUTE MYOCARDIAL
INFARCTION: WITHOUT PRIOR USE OF STREPTOKINASE
Barry D. Rutherford, MD FACC, Geoffrey O. Hartzler MD
FACC, David R. McConahay, MD FACC, Warren L. Johnson Jr.
MD FACC. Mid America Heart Institute at S1. Luke's
Hospital, Kansas City, Missouri.
Direct percutaneous transluminal coronary angioplasty
(PTCA) was performed during acute'myocardial infarction
(AMI) in 222 patients (pts). One hundred and seven pts
had anterior AMI, and 115 pts inferior AMI. Q-waves were
present in 78 pts (35%) prior to direct PTCA. Catheteriza-
tion was performed from 1- 24 hours following the onset of
symptoms, mean time from pain onset to patent artery was
4.5 hours (range 1-24 hours). Single vessel coronary
disease was found in 96 pts (43%), double or triple vessel
disease (TVD) in 126 pts (57%). One hundred and thirty-
two pts (60%) had complete occlusion of the infarct vessel,
90 pts (40%) had 75-99% stenoses. Angiographic thrombi
were noted in 57% of pts; 16% had collaterals to the infarct
artery.
Initial successful PTCA was obtained in 203 pts (91%);
total in-hospital mortality was 7%. Twenty-three pts (10%)
reoccluded the infarct artery in the post-PTCA period,
six pts developed early restenosis. Seventeen pts (7%)
went to saphenous vein bypass grafting, 9 pts because of
failed PTCA, 8 pts due to severe TVD.
One hundred and eighty-two pts (82%) were entirely stable
at the time of dismissal. Follow-up studies were obtained
in 123 pts at a mean period of 10 days. One hundred (81%)
of dilated arteries had remained patent, and in these pts
the mean ejection fraction improved from 47% prior to PTCA
to 59% after PTCA.
We conclude that direct PTCA in AMI prOVides: 1) Rapid
total patency of the infarct artery in a majority of pts (91%);
2) Maintained patency of the artery in the early post-PTCA
period; 3) Improved LV function.
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN
CARDIOGENIC SHOCK
Jacob Shani. M.D., Marcos Rivera, Alvin Greengart,
M.D.,F.A.C.C., Gerald Hollander, M.D., F.A.C.C., Paul
Kaplan, Edgar Lichstein, M.D., F.A.C.C., Maimonides
Medical Center, SUNY, Downstate Medical Center,
Brooklyn, N.Y.
Successful coronary angioplasty (A) was performed in 6
of 9 patients (pts) with acute myocardial infarction
(MI) complicated by cardiogenic shock (CS). A was
performed 60-190 minutes (mean 140) after the onset of
symptoms. Three pts required a double vessel A, all had
intra aortic balloon pump inaertion prior to A. The
infarct related artery was the LAD in 7 pts, a dominant
RCA in 1 and a dominant LCX in another. There were 6
males and 1 female with a mean age of 58.7 (range
39-73). Five pts had a previous MI.
Hemodynamics
Pre A Post A 3-6 Months
PCWP mmlHg 17-31 (24.8) 16-26 (21.3) 8-19 (4)
LVEDP mm/Hg 23-40 (31.6) 20-27 (24.7) 16-23 (19.8)
BP mmlHg 60-81 (1) 90-105 (94) 105-130(17)
HR BPM 96-144 (127) 92-110 (03) 68-92 (9)
CI L/min/sq.M 1.2-1.6 (1.4) 1.8-2.1 (1.9) 1.8-2.4(2.2)
EF .27-.4H .36) .3&-.57( .48)
All hemodynamic changes were significant (p < .01).
Three pts died in the catheterization laboratory.
Coronary angiography 3-6 months post A revealed patent
arteries in 5 pts. There was dramatic clinical
improvement immediately after A. At follow-up 5-16
months (mean 9.5) post A, 5 of the 6 survivors are
symptom free and employed. We conclude that A can be
performed successfully in pts with MI and CS.
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PROGNOSIS AFTER ACUTE CORONARY ANGIOPLASTY
ll-ERAPY OF ACUTE MYOCARDIAL INFARCTION. Nathan
Kander. M.D•• William W. O'Neill. M.D., Eric Topol, M.D.,
Joseph A. Walton, Jr., M.D., Patrick D. Bourdillon, M.D., Eric
Bates, M.D., F.A.C.C., Theresa Kryski, R.N., Bertram Pitt,
M.D., F .A.C.C. University of Michigan, Ann Arbor. Michigan.
The prognosis of patients undergoing acute coronary angioplasty
(PTCA) during acute myocardial infarction (AMI) is undefined.
We have performed acute PTCA on 80 consecutive patients,
presenting within 12 hours of symptom onset from December,
1983 to March, 1985. All patients have been followed for at
least 6 months to assess survival, functional class, reinfarction
and clinical restenosis rate.
While the overall 6 month survival was 86%, it was 93% for
patients with successful reperfusion (rep) but only 45% for
unsuccessful rep (p <.00 I). By univariate analysis, significant
differences were present between survivors (S), and non-
survivors (NS) These include age (S=52.9± 10.5 yrs vs.
NS=64.4±10.1, p< .001), anterior location of MI (S=Anterior 70%
vs. NS=Anterior 100%, p < .001), Killip Class (S= 1.64±.71 vs.
NS=3.45±.68, p < .001), symptom duration (S=5.42±2.16 hrs vs.
NS= 7.25±2.0 hrs, p < .05), baseline ejection fraction (EF) (S
52.9±11.6 vs. NS 30.6±11.1 p< .001), and MI size (peak CPK
S=2993±2329 vs. NS=8505±5379, p<.ool) All mortality occurred
during initial admission. Of patients with successful rep, 81%
have NYHA Class 0 or I angina, 8% have had clinical
reinfarction and 8% have clinical restenosis.
We conclude that (I) successful ocute PTCA during AMI may
improve 6 month survival; (2) a low incidence of restenosis or
reinfarction exists; (3) Prognosis is adversely affected by age,
initial extent of jeopardized myocardium, duration of ischemia,
final size of infarction and reperfusion status.
TRANSLUMINAL CORONARY ANGIOPLASTY IN THE ACUTE
INFARCT-RELATED ARTERY. SHORT AND LONG TERM
RESULTS.
Siguemituzo Arie, M.D., Giovanni Bellotti, M. D., Hedy
Checchi, M. D., Lelio Alves, M. D, Jose A. F. Ramires, M. D., and
Fulvio Pileggi, M. D., F. A. C. C. - Heart Institute, UniverSity of
Sao Paulo, Brasil.
Between october 19B1 and april 1984, 56 patients (pts) with
acute myocardial infarction (MI) were successfully submitted to
transluminal coronary angioplasty (TCALin 50 pts TCA was
performed after pharmacological (43 pts) or mechanical (7 pts)
recanalization of the occluded artery and in 6 pts after evidence of severe
obstruction of the infarct-vessel. Angiographic study repeated 1 - 2
weeks later in 48 pts showed a decrease m the degree of obstruction
from 92 ± 6 to 16 ± 10% and an improvement of LVEF from 0.55 ±
0.16 to 0.59 ± 0.17 (p< 0.05). Early coronary re-occlusion occurred
in 3 (5%) pts, 2 (4%) pts died after surgical treatment for severe mitral
regurgitation and 1 died of cerebral hemorrhage due to streptokinase
administration.
Late clinical course (16 - 42, mean 26 months) was avaliable in
50 pts. Re-occlusion of the treated vessel in 5 (10%) pts and severe
re-estenosls in 4 (8%) were observed One pts died suddenly Thirty-
six pts are assymptomatic. Late routine angiography (6-12 months) was
performed ,n 23 of these 36 pts. No significant changes in the degree
of residual obstruction and an additional improvement in the LVEF,
mamly in pts with LVEF 0;; 0.50 (from 0.43 ± 0.05 to 0.60 ± 0.12,
p < 0.02) were observed.
This study confirm that TCA can be performed in selected
patients With acute MI with an acceptable complication rate. In most
patients TCA IS effective both to improve early and late ventricular
function and to determine uneventful clinical course.
EARLY POSTINFARCTION UNSTABLE ANGINA: RESULTS OF CORONARY
ANGIOPLASTY.
Pim de Feyter. MD. Patrick WSerruys MD. Marcel vd Brand,
MD. Paul G Hugenholtz. MD. FACC.
Thoraxcenter. Rotterdam, the Netherlands.
Surgeons are generally reluctant to perform bypass
surgery in the setting of a recent myocardial infarction.
Coronary angioplasty (CA) , as an alternative to bypass
surgery, in pts with early postinfarction unstable angina
(PUA) might be effective to relieve ischemic symptoms and
to prevent re-infarction. PUA was defined as chest pain
at rest. associated with ST-T changes. CA was performed
in all 44 pts with early PUA within 30 days (mean 12!8)
after preceding MI. Thirty seven (84%) were males; the
mean age 59.3 (range 36-73 yrs). Multivessel disease was
present in 39%. Thirty six pts were refractory to
pharmacological treatment consisting of a combination of
intravenous nitroglycerine. beta-blockers and
Ca-antagonists. Eight pts were initially stabilised, but
symptomatic with light exertion. The preceding MI was of
small or moderate size in the majority of the pts. All
pts were followed for at least 6 months.
Results: The initial CA successrate was 89% (39/44 pts).
There was no death related to CA; a MI complicated CA in
9% (4 pts) and urgent bypass surgery was necessary in 7%
(3 pts). At 6 months follow up recurrence of angina
occurred in 26% (10/39 pts). The angiographic restenosis
rate was 33% (11/33 pts); 6 pts refused repeat angio-
graphy) •
This study suggests that in selected pts CA for unstable
angina within 30 days after preceding MI of small or
moderate size can be accomplished with an acceptable
risk, a high initially success rate, and sustained
beneficial effect in the majority of the patients.
Wednesday, March 12, 1986
8:30AM-I0:00AM, Room #260/261
Newer Technologies to Assess Anatomic and
Functional Coronary Artery Disease
INTRAOPERATIVE EVALUATION OF THE EFFECTS OF CORONARY
REVASCULARIZATION BY COLOR FLOW MAPPING 2-D DOPPLER
ECHOCARDIOGRAPHY AND THERMOCARDIOGRAPHY
Shunei Kyo. Hideo Adachi. Shinichi Takamoto, Makoto
Matsumura, Yuji Yokote. Ryozo Omoto. Saitama Medical
School. Saitama. Japan
To evaluate the effects of coronary revascularization
(CR). we examined 11 patients intraoperatively by high
resolution color flow mapping 2-D Doppler
Echocardiography (HR-2DD. 5MHz & 7.5MHz) and real-time
Thermocardiography (TC). In HR-2DD minimum detectable
velocity is 2 em/sec. and in TC an iSChemic myocardium
is displayed as a relative cold area with a thermal
dissolution power of O.l°C. The average bypass flow (BF)
of 21 saphenous vein grafts (SVG) was 74 ±30 ml/min
measured by electro-magnetic flow meter (EMFM), and HR-
2DD could semi-quantitatively visualized BF in 19 SVG
(91%) except two SVG which blood flow was less than 20
ml/min measured by EMFM. Also HR-2DD demonstrated no
stenosis nor turbulent flow pattern at the anastomosis.
TC could visualize BF in all 21 SVG and 6 left internal
mammalian arterial grafts (LIMAG). however. EMFM and HR-
2DD failed to detect BF in 2 LIMAG respectively. In four
patients pre-operative TC demonstrated an ischemic area
in LV anterior wall where a homogeneous myocardial blood
perfusion was confirmed to be restored by postoperative
TC. It was compatible to the pre- and post-operative
thallium scintigram. In conclusion. a combined use of
HR-2DD and TC is useful in immediate intraoperative
confirmation of smooth bypass blood flow through the
anastomosed grafts and evaluation of the restored
myocardial blood perfusion in the critically ischemic
myocardium after CR.
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RAPID IDENTIFICATION OF ISCHEMIC MYOCARDIUM
BEFORE AND AFTER BYPASS SURGERY BY COMBINED USE
OF INTRAOPERATIVE 2-DIMENSIONAL ECHOCARDIO-
GRAPHY AND ATRIAL PACING. Martin E Goldman MD
F ACC, Bruce P Mindich MD FACC, Theresa Guarino RN, Joseph
A Gomes MD FACC, Singhoi Chow MD, Arthur Schwartzbard,
Valentin Fuster MD FACC, Mt. Sinai & St. Lukes Hosp, NY
Angiographic coronary anatomy does not necessarily identify
myocardial regions at greatest ischemic risk in patients with
multi-vessel coronary disease. Once jeopardized myocardium is
defined, ischemic complications during coronary bypass
surgery(CABG) may be reduced by preferential graft sequence
and/or selective cardioplegic infusion. Therefore, we performed
direct on heart 2-D echocardiography (2-DE) in the LV short axis
plane during incremental atrial pacing (AP) (80-120 bpm) pre- &
post CABG in 15 patients (pts) with multivessel disease. 2-DE
images were analyzed blindly for regional wall contractility, &
ejection fraction (EF) at each AP rate. Cardioplegic infusion,
which by 2-DE is similar to a perfusion scan, was also imaged.
Although EF remained constant during AP pre-CABG, 11/15
pts developed new contractility abnormalities (abn) in 18/60
analyzed segments(most commonly in the anteroseptal region).
However, the ischemic region could not be predicted from the
coronary anatomy due to severe multivessel disease. Regions
with cardioplegic perfusion defects by 2-DE correlated with
areas of AP-induced contractility abn. Ouring AP post-CABG,
contractility + in 11/15 pts and 14/18 regions originally abn
during pre-CABG AP, while global EF + in only 3/15 pts.
Therefore, intraoperative 2-DE during AP identifies ischemic
zones that correlate with severe coronary obstructions, but
cannot be predicted solely by angiographic criteria. Abnormal
cardioplegic perfusion of myocardial regions also identified
ischemic zones. Detection of segments at high ischemic risk by
intraoperative 2-DE & AP may guide selective cardioplegia or
CABG sequence; relief of ischemia can be confirmed post-CABG
by improved regional (but not global) wall motion.
MEASUREMENT OF CORONARY BLOOD FLOW AND REGIONAL
MYOCARDIAL PERFUSION USING HYDROGEN DILUTION AND WASHOUT
SUBSELECTIVE CATHETER TECHNIQUES.
Harold Z. Friedman, M.D., Glenn J. Beauman, M.S., Mark J.
McGlllem, B.S., G.B. John Mancini, M.D., F.A.C.C. and
Robert A. Vogel, M.D., F.A.C.C., V.A. Medical Center,
University of Michigan, Ann Arbor, Michigan
The measurement of coronary blood flow and myocardial
perfusion are both clinically difficult and important.
We have developed two new techniques for the assessment
of these parameters. Absolute coronary blood flow (CBF)
is measured using a 2 French platinum electrode-tipped,
i ntracoronary catheter. A 25% hydrogen saturated
reference solution is infused through two side-holes
located 5 em from the catheter tip. Using steady-state
dilutional analysis, CBF is calculated using comparison
of the electrode potentials during 10 s reference
solution infusions (15 ml/min) under coronary occluded
and non-occluded conditions. The second technique
measures regional myocardial perfusion (RMP) using
subselective intracoronary infusion of 10 ml hydrogen
saturated sal i ne over 30 s. Du ri ng steady-state
conditions, RMP is calculated by inert gas washout
analysis of the electrode potential of a platinum-tipped
catheter located in the pulmonary artery. Using an
open-chest canine preparation, validation of these
techniques was accomplished using electromagnetic
flowmeter determined blood flow varied (0-300 ml/min) by
dobutamine, papaverine, atrial pacing, and coronary
Ii gat ion. CBF and RMP were found to carre Iate closely
with absolute (r=0.96) and relative (r=0.94) blood flow,
respectively. These data suggest that CBF and RMP can be
measured accurately using an inexpensive, inert tracer
and subselective coronary catheterization.
CURVATURE ANALYSIS: A NEW, ASSUMPTION-FREE METHOD FOR
QUANTITATION OF REGIONAL VENTRICULAR FUNCTION.
G.B. John Mancini, M.D., F.A.C.C., Scott F. DeBoe, B.S.,
Michael T. LeFree, B.S., Edward Anselmo, B.S., Robert A.
Vogel, M.D., F.A.C.C., VAMC and University of Michigan,
Ann Arbor, MI
Tradit i ona1 assessment of regi ona1 wa 11 mot ion
abnorma1it ies (WMA) entail s assumpt ions regardi ng coor-
dinate, reference and indexing systems and the uniformity
of left ventricular contraction. Detection of shape
characteristics is proposed as an alternative approach to
measurement of ventri cu1ar function that is independent
of these assumptions. Curvature (C), a numerical shape
parameter, is given by the reciprocal of the radius of a
circle that best fits a curve at a given point. Regional
C of 30° RAO left ventriculograms was quantitated with a
commercial image processing unit in 20 normal (N)
patients and 48 with WMA. End-diastolic shape quantita-
t i on showed only small differences between Nand WMA
groups, but end-systo1i c (ES) C showed marked regi ona1
abnormalities in groups with isolated anterior (ANT) or
inferior (INF) hypokinesis or both.
Wall Motion Grou~s
HUMAN EXPERIENCE WITH SYNCHRONIZED CORONARY SINUS
RETROPERFUSION (SCSR): FEASIBILITY AND SAFETY - Joel M.
Gore, MD, Bonnie H. Weiner, MD, Kathy M. Sloan, RN, Joseph
R. Benotti, MD, Okike N. Okike, MD, Thomas J. VanderSalm,
MD, Steven P. Ball, RN, Jeanne Corrao, RN, Joseph S.
Alpert, MD, James E. Dalen, MD, UMass Medical School,
Worcester, MA
Animal studies have demonstrated the value and safety of
SCSR in models of acute unstable ischemic heart disease.
Accordingly, we have initiated a Phase I trial to evaluate
the feasibility and safety of this intervention. To date,
S pts with acute anterior wall ischemia refractory to
maximal medical therapy have been evaluated. SCSR was
initiated at the bedside by inserting 8F catheters (C)
into the femoral artery and coronary sinus for collecting
and delivering oxygenated blood to the myocardium. An
autoinflatable balloon at the CS catheter tip effects
temporary coronary sinus occlusion. This permits
pulsatile retrograde delivery of arterial blood to the
myocardium ECG synchronized with diastole. With
institution of SCSR, ECG changes of anterior ischemia
improved in 3 out of S pts with no hemolysis or fall in
platelet counts. Comparison of preselected parameters
during the 36 hours prior to SCSR and on SCSR revealed:
Pre SCSR On SCSR 2
IV Nitro .786 mg/min/hr .731 mg/min/hr NS
Morphine .74 mg/hr .17 mg/hr p<.02
'Angina Episodes .71 epis/hr .008 epis/hr p<.OS
SL Nitro .23 tab/hr 0 tab/hr p<.OS
SCSR has been maintained for up to 3 days with clinical
benefit and without adverse effects. Direct inspection of
the CS in 4 pts at the time of coronary bypass surgery
revealed no traumatic injury. Conclusion: SCSR is a
feasible and safe intervention capable of alleviating
myocardial ischemia in pts with unstable, ischemic heart
disease.
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ANATOMIC AND FUNCTIONAL ASSESSMENT OF CIRCUMFLEX CORONARY
ARTERY STENOSES USING VIDEODENSITOMETRY.
Mary1 R. Johnson, M.D., F.A.C.C., Steven R. Fleagle, B.S.,
Robert F. Wilson, M.D., Carl W. White, M.D., F.A.C.C.,
Loren F. Hiratzka, M.D., Melvin L. Marcus, M.D., F.A.C.C.,
Steve M. Collins, Ph.D., David J. Skorton, M.D., F.A.C.C.,
University of Iowa, Iowa City, IA
We have shown that videodensitometric analysis (VID) of
left anterior descending (LAD) and right coronary artery
(RCA) stenoses (S) allows accurate and reproducible esti-
mation of S lumen size, as defined by quantitative coro-
nary angiography (QCA), and functional significance, as
defined by intraoperative Doppler reactive hyperemia stu-
dies. Due to the posterior location of the circumflex
(Cx), however, intraoperative studies cannot be performed
on Cx S. We recently validated the use of an intracoronary
Doppler catheter for determining coronary flow reserve in
the catheterization laboratory by measuring the peak-to-
resting velocity ratio (PRVR) following maximal dilation
with intracoronary papaverine. Therefore, in this study
we assessed the ability of VID to assess the anatomy and
physiology of Cx S. Cine frames of Cx S from 8 patients
were digitized. Following background subtraction, inte-
grated optical density (100), an index of lumen area, was
computed. 100 was compared to minimal lumen area defined
by QCA and to PRVR measured using the intracoronary
Doppler catheter. Shown below are results from this study
and from our studies of the VID of LAD and RCA S.
Cx (n-8) LAD (n-I7) RCA (n=I9)
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Technologic Innovations in Coronary Artery Disease
Assessment
VISU1U.lZATI~ OF IN1'EllNAL !WM\RY ARTERY BYP1lSS GRAFl' BY
DIGITAL INTRAVEHlJS JU«;ICGlW'HY. EXPE:RII!K:E wrm 42
CXNSECt1l'IVE PATIENl'S. Gerard M. G1i.raudon, M.D., F.A.C.C. ,
Richard N. Rankin, M.D., william J. Kostuk, M.D.,
F.A.C.C., George Jabloosky, M.D., F.A.C.C., James E.
BrcMn, M.D., Jolm Rowson, M.D., university Ibspital,
london, cntario, canada.
The internal mamnary arteJ:y (IMA) has been established
as the best conduit for CXlr<mary arteJ:y bypass graft
(CABG). Digital intravenous angiograIil (DIVA) was obtained
in 42 consecutive patients (pts) six weeks after surgexy,
to visualize the IMA graft and to establish the value of
the DIVA as a non-invasive test for folloiMlp.
There were 42 left IMA grafts and 2 right IMA grafts.
'lbi.rty two an]iograms were 00t:ained for control. '!be
technical quality of DIVA was excellent (spts), good
(34pts) and poor (spts). The IMA was visualized to the
heart border (6), the lower aortic arch (26), the upper
aortic arch (7), above the aortic arch (3) and not visual-
ized (2). The degree of visualization depended on the
technical quality of the DIVA. Excellent DIVA showed IMA
graft to the heart border (5/6), and good DIVA showed IMA
graft to lower aortic arch (24/34). 5eIIen CABG were
incidentally seen on good and excellent DIVA. Of the 2 IMA
grafts not visualized one was found patent, but of small
caliber on the angiogram.
we concl11de that the IMA graft has an excellent patency
rate (98%) and that DIVA is an excellent test for IMA
graft visualization (100% specificity, 98% sensitivity).
INCIDENCE AND MANAGEMENT OF LIMB ISCHEMIA DURING THE USE
OF CURRENT WIRE-GUIDED INTRA-AORTIC BALLOON PUMPS
James D. Alderman, M.D., Gregory I. I. Gabliani! M.D.,
Cynthia C. Brewer, R.N., M.S., Beverly H. Lorel , M.D.,
F.A.C.C., Richard C. Pasternak, M.D., F.A.C.C., Donald
S. Baim, M.D., F.A.C.C. Harvard-Thorndike Laboratory,
Beth Israel Hospital, Boston, MA.
We followed 78 patients (pts) who had percutaneous,
wire-guided intra-aortic balloon pumps (IABP) between
8/83 and 7/85, including 53 men and 25 women with a mean
age of 63, using clinical exam and ankle-brachial index.
Indications for IABP were unstable angina (58 pts),
cardiogenic shock (17 pts), left main disease (10 pts),
instability during catheterization (3 pts), electively
pre-bypass surgery (5 pts)! other (7 pts). The mean
auration of IABP counterpu sation was 3.4 days.
Post-insertion limb ischemia was noted in 37 pts
(47%) - 24/53 men (45%) and 13/24 women (54%). IABP
removal alone led to resolution of ischemia in 24 pts
(65%), while the remaining 13 pts (35%) required operative
intervention. Only 4 had longterm sequelae (one each:
compartment syndrome, femoral-popliteal bypass, gangrene!
death during embolectomy). Of the 41 pts without clinica
limb ischemia during IABP, only 3 developed a vascular
complication (hematoma), one of whom required surgery. Of
the 12 pts who had previously known peripheral vascular
disease (PVD), 8 (75%) developed ischemia during IABP
versus 29/66 (44%) pts without PVD. Pts with limb ischemia
and PVD were more likely (4/8-50%) to require surgical
intervention than pts with limb ischemia without PVD
(9/29-31%). Moreover, the incidence of longterm seguelae
post-operatively was higher in PVD pts (2/4=50%) than
non-PVD pts (2/9-22%). There was no difference in the
incidence of limb ischemia using 10.5 French(F) IABP
(16/31-52%) versus 12F IABP (18/41=44%). There were 10
in-hospital deaths, but only 1 death was IABP-related
(general anesthesia complication during vascular repair).
Thus, despite advances in IABP technology: l)Limb
ischemia remains a frequent (47%) complication of IABP
therapy, particularly in pts with PVD, 2)While limb
ischemia resolves in most pts when the IABP is removed,
approximately 17% of all pts who undergo IABP will
require vascular surgery, 3)50% of pts with known PVD who
develop ischemia require surgery, 4)IABP complications
only infrequently lead to longterm sequelae or death.
DELINEATION OF MYOCARDIAL ISCHEMIA IN PATIENTS BY
POSITRON EMISSION TOMOGRAPHY WITH H2150
Edward M. Ge1tman, M.D., F.A.C.C., James J. Spadaro, Jr.,
M.D., Keith A.A. Fox, M.B., Ch.B., Ali A. Ehsani, M.D.,
F.A.C.C., and Burton E. Sobel, M.D., F.A.C.C., Washington
University School of Medicine, St. Louis, MO
We have previously quantified myocardial perfusion in
dogs by positron tomography with oxygen-I? 1ab~1~d water
(HZ150) and subtraction of blood pool radl0actlv1ty. To
determine whether ischemia can be delineated in patients,
we performed po~itron emission tomography in 37 patients
(IZ controls and 25 with angiographica11y documented cor-
onary artery disease) after i.v. infusion of 50-150 mCi
of H2150 and inhalation of 50-75 mCi of CI50 (for
calculation of blood pool H2150 radioactivity) at rest
(n = 13) or sequentially at rest and after vasodilator
stress (n = 25) induced with dipyridamole (.56 mg/kg
i.v.). In controls, myocardial perfusion appeared to be
quite homogeneous both at rest and with stress (average
relative to maximal regional perfusion at rest: septum =
.80; anterior wall = .88; lateral wall = .93; posterio-
lateral wall = .90; and with stress: .87, .88, .95, and
.87, respectively). In 75% of patients with pr~or in-
farction marked inhomogeneities of flow were eV1dent at
rest or with stress (relative flow in peri-infarct zones
averaging .39 of that in normal zones at rest and .55
with stress). In patients with coronary stenosis without
infarction, inhomogeneities were seen in 20% at rest and
80% with stress (ischemic zone relative flows = .79 at
rest and .57 with stress). Thus. positron tomography
with H2150 and blood pool ~ubtra~ti?n pe~its noninvasive
delineation of myocardial 1schemla 1n pat1ents.
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EXPERIENCE WITH USE OF THE REPERFUSION CATHETER PRIOR TO
EMERGENCY BYPASS SURGERY. Tomoaki Hinohara, MD, John B.
Simpson, MD, Harry R. Phillips, MD, Eric B. Carlson, MD,
William O'Callaghan, MD, and Richard S. Stack, MD, Duke
University Medical Center, Durham, NC
Refractory coronary artery occlusion during PTCA may
result in myocardial infarction (MI) or death despite
emergency revascularization with coronary artery bypass
surgery (CABG) unless immediate reperfusion can be
established. A recently developed 4.3 FR coronary
infusion catheter with multiple sideholes or "reperfusion
catheter" (RPC) , was utilized to re-establish blood flow
prior to emergency CABG.
In the past seven months, since the introduction of the
RPC, 19 out of 337 PTCA patients (pts) (5.6%) underwent
immediate CABG due to unsuccessful PTCA at our
institution. Insertion of the RPC was attempted in 14
pts (13 pts. with total and one pt with near total
occlusion). Total occlusions following initial PTCA were
associated with chest pain and ST segment elevetion and
were refractory to multiple repeat balloon dilatations and
vasodilators. The RPC was successfully placed across the
coronary artery obstruction in 13 pts (93%). In all pts
with successful RPC placement, angiographically documented
reperfusion was re-established associated with relief of
chest pain. 2 pts had persistent ST segment elevation (I
pt with pre-PTCA MI and 1 pt with intracoronary
thrombosis). There were no deaths. All pts underwent
immediate CABC with the RPC in place and tolerated the
procedure well.
Immediate reperfusion following refractory coronary
occlusion during PTCA may be achieved using the RPC prior
to CABG. This procedure significantly reduces the
morbidity and could potentially reduce the mortality
associated with coronary occlusion during PTCA.
ANGIOSCOPY FOR GUIDANCE OF LASER RECANALIZATION IN MAN.
George S. Abela, M.D., James M. Seeger M.D., Enrico
Barbieri, M.D., Carl J. Pepine, M.D., F.A.C.C., C. Richard
Conti, M.D., F.A.C.C., University of Florida and VAMC,
Gainesville, FL.
Seven patients (ages 52-75) had angioscopy of the peri-
pheral circulation during surgery. All patients had total
occlusion of the superficial femoral artery at angiography
and were undergoing bypass surgery for symptomatic occlu-
sive arterial disease. Three angioscopes were used: a 1.7
mm Optiscope; a 2.8 mm Laser Optiscope (Trimedyne, Inc.)
and a 3.2 mm BF Scope (Olympus Corp.). Visualization in-
side the vessel was done by introducing the scopes through
an arterial cut-down with continuous saline infusion. The
scopes were adapted to a video camera and images displayed
on a monitor. Lasing was done from an Argon laser using a
300 ~m core fiber and a 2 rom metal tip. Energy was varied
using incremental rises, first in power (1-8 watts), then
in exposure (1-10 sec) until recanalization occurred.
Results: Angioscopy showed total atherosclerotic occlu-
sion of 6 superficial femoral arteries and fresh thrombus
in 2 arteries and 1 graft. Using the angioscope, the opti-
cal fiber was positioned at the center of the arterial
occlusion and recanalization done under direct visualiza-
tion. Adequate visualization was acheived by all 3 scopes.
Passing the 1.7 rom scope through the recanalized artery
showed charring along the arterial walls. Intimal flaps
were seen in 2 arteries. Communication with the artery
distal to the occlusion was confirmed by appearance of
blood. The length of recanalized segments was 5 t 1.4 em.
Two of nine vessels perforated at an average of 4.8 cm
from the point of fiber entry into the plaque.
Conclusions: Angioscopy maybe useful in averting perfor-
ation during laser recanalization and could also be used
as a diagnostic device.
DEFINITION OF NEW PATHOPHYSIOLOGIC MECHANISMS AND ALTERED
DECISIONS: AN OUTCOME OF INTRAVASCULAR ANGIOSCOPY
Warren S. Grundfest, M.D., Frank Litvack, M.D., Todd
Sherman,M.D., Myles E. Lee, M.D., Robert Carroll, M.D.,
Aurelio Chaux, M.D., Robert Kass, M.D., Jack Matloff,
M.D., FACC, James S. Forrester, M.D" FACC. Cedars-Sinai
Medical Center, Los Angeles, CA.
Intraoperative angioscopy provides images of the
endothelial surface with <0.2 mm spatial resolution. The
angioscopes have an outer diameter of 1.3-2.8 mm, allow-
ing entry into small peripheral vessels, prosthetic
grafts, and branches of coronary arteries. In 59 opera-
tions (33 coronary, 26 peripheral) there were 131 examin-
ations (86 arteries, 30 new anastomoses, 10 old grafts, 5
argon laser femoral artery angioplasties and 5 in-situ
vein grafts). Aclear viewing field was created by infu-
sion of pressurized saline in peripheral vessels and
crystalloid cardioplegia in arrested hearts.
In 30% of the cases, angioscopy revealed clinically
important but unsuspected anatomic details. Information
that altered surgery included 2 misplaced anastomotic
sutures, 2 partially obstructive intimal flaps requiring
revision, 2 atheroma at planned graft sites which altered
their placement, and 3 reSidual thrombi after allegedly
complete balloon thrombectomy. Critical coronary detail
included detection of 5 angiographically undetected
thrombi in unstable rest angina. In addition, the
spectrum of acute intravascular abnormalities was
substantially greater than that described at routine
postmortem: we found strands of sessile thrombi in
progressive angina, and tiny hemorrhagic ulcers on both
otherwise normal endothelium and on atheromatous plaques
(all undetectable on review of coronary angiograms). We
conclude that angioscopy can alter surgical procedures,
and prOVides unique information about pathophysiologic
mechanisms in coronary syndromes which can be obtained by
no other existing technology.
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Cardiac Studies With Computed Tomography and
Digital Angiography
TEMPORAL FOURIER TRANSFORM OF DIGITAL ANGIOGRAMS FOR LEFT
VENTRICULAR REGIONAL WALL MOTION ANALYSIS
Kazuhiro Katayama, M.D., Thomas F. Widmann, M.D., Brian
Guth, Ph,D., Jong Dae Lee, M.D., Rainald Seitelberger,
M.D., Gerd Heusch, M.D., Mark Miller, B.S.E.E. and Kirk L.
Peterson, M.D., F.A.C.C.
University of California, San Diego, California
To determine whether the first harmonic of a temporal
Fourier transform{TFT), applied pixel-by-pixel on time-
intensity curves, can detect subtle wall motion abnormal-
ities due to ischemia, 6 dogs were instrumented with a LV
micromanometer, circumflex hydraulic cuff occluder, and
sonomicrometers on the inferior (ischemic) and anterior
(non-ischemic) walls. LV images obtained after contrast
injection via pulmonary artery were compared with dimen-
sion signals in control{C) and three progressive levels
of stenosis (StI, StII, StIlI), Normalized, digital func-
tional images (5l2x512 matrix, 256 shades of gray/pixel)
were divided into anterior, apical, and inferior areas to
acquire regional mean phase(PH, degrees) and amplitude
(AMP, intensity units) values. Results (meantSEM):
Non-IschemiC Ischemic
%WTh PH AMP %WTh PH AMP
C 34t6 148t6 143t7 22t2 194t6 l64t7
StI 38t6 l48t6 l53t5* l7t2* 207t6* l58t6
StII 39t7 l46t6 l57t7t 8t2t 2l7t7t l43t8t
StIlI 4lt7 l47tll l67t6t lt2t 233t9t 125t6t
[%WTh: wall thickening{%), *=p<O.05. t~p<O.Oll
There was a progressive increase in PH and decrease in AMP
in ischemic areas as %WTh fell (PH vs. %WTh:r~-0,6l, p<
0.002; AMP vs. %WTh:r~0.77, p<O,OOl). Heart rate and peak
left ventricular pressure showed no significant changes
during stenoses, We conclude that quantitative functional
images, generated from a temporal Fourier transform. are
sensitive for the detection of LV regional wall motion
abnormalities during mild to severe degrees of ischemia.
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QUANTITATION OF AORTIC REGURGITATION BY COMPUTER
ANALYSIS OF DIGITAL SUBTRACTION ANGIOGRAPHY
Paul A Graybum MD, Steven E Nissen MD, Jonathan L Elion MD,
Joyce Evans, and Anthony N DeMaria MD, FACe. University of
Kentucky and VA Medical Center, Lexington, Ky.
Currently existing methods for the quantitation of aortic regurgitation
(AR) are cumbersome and limited in accuracy, particularly in the presence
of mitral regurgitation. Recently, the development ofdigital subtraction
angiography (DSA) has provided a potential method for the quantitative
assessment of AR by analysis of time-density curves from radiographic
contrast in the aorta and left ventricle (LV) following aortography.
Therefore, we developed and validated a method for determining
regurgitant fraction (RF) by DSA in an animal model of AR. Following
thoracotomy, an appropriately sized electromagnetic flow probe (EMF)
was positioned on the ascending aorta to measure forward and regurg-
itant flow. AR was produced by manipulation into the aortic valve orifice
of a custom-designed non-metallic basket catheter capable of inducing
varying degrees of AR. A total of 16 individual regurgitant lesions were
produced in 5 mongrel dogs. For each level of AR, a DSA aortogram
was performed with 6 ml of contrast Isecondfor 3 seconds utilizing ECG
gated pulse-mode X-ray, an R-wave triggered contrast injection, and
mask-mode subtraction of the 512 x 512 pixel image. Logarithmic
transformation was utilized to ensure a linear relationship between
contrast concentration and image intensity. A rectangular region of
interest (175 x 20 pixels) was positioned in the ascending aorta and LV
outflow tract, and integrals of time-intensity curves were generated for
both. Regurgitant fraction was computed as the ratio of LV to aortic
summated intensity. RF by EMF was calculated as the ratio of reverse to
forward flow by planimetry of the EMF flow tracings and varied from
6.9% to 82.6%. The RF by DSA and EMF were compared by linear
regression analysis; the correlation coefficient was r=0.82 for all dogs
and r > 0.94 in individual animals. Thus, these data demonstrate that in
an animal model of AR, DSA may be utilized to obtain time-<lensity
contrast curves of the LV and aorta from which regurgitant fraction may
be calculated. Values of regurgitant fraction obtained by DSA show a
good correlation to those measured by EMF.
MEASUREMENT OF AORTIC REGURGITATION WITH CINE CT
Steven J. Reiter, M.D., John A. Rumberger, Ph.D., M.D.,
Andrew J. Feiring, M.D., William Stanford, M.D., Melvin
L. Marcus, M.D., F.A.C.C., Departments Of Medicine &
Radiology, University of Iowa, Iowa City, Iowa 52242
Current approaches to determining regurgitant volume
provide qualitative or semi-quanitative information at
best. We evaluated the ability of Cine CT (CCT) for
precise quantitative assessment of regurgitant volume
(RgV). CCT enables rapid imaging (17 frames per second)
in cine mode that can be utilized to obtain accurate
determination of nearly simultaneous right ventricular
(RV) and left ventricular (LV) stroke volume (SV)
(Simpson's rule reconstruction of serial short axis
tomograms; end-diastolic minus end-systolic volume of
each ventricle). ~tudies were performed during IV
infusion of a non-ionic contrast agent, Iohexol. A
chronically implanted proximal aortic electromagnetic
flow probe (EMF) was utilized to measure LVSV and RgV.
In 12 studies in the absence of induced aortic
regurgitation the difference between nearly simultaneous
RV and LV SV (range 11-34 ml) waS minimal (mean 1.1 ml;
range 0.1-3.2 ml). In 7 studies during induced aortic
regurgitation (basket catheter through the aortic valve),
the CT RgV (difference between LVSV and RVSV; range
4.0-10.5 ml) correlated closely with the EMF RgV (r=0.85.
slope-l.05, y-intercept- -.08 ml, SEE=l.Z ml).
Calculated regurgitant fraction (RgF) ranged from 13-38%
of total forward SV. The mean difference between
calculated CT RgF and EMF RgF was 3.6±2.6% (range 0 to
7%). Thus, precise quantitative measurements of RgVand
RgF can be obtained with CCT. This technique should be
directly applicable to the quantitative measurement of
valvular regurgitation in patients.
ULTRAFAST COMPUTED TOMOGRAPHY DURING EXERCISE
BICYCLE ERGOMETRY
Eva V. Chomka, M.D., McKindraFletcher, .'d.D., Michael Stein,
M.D., Bruce Brundage, M.D., F.A.C.C., University of Rlinois
College of Medicine, Chicago,Illinois.
Twelve patients(pts) with documentedcoronary artery disease
underwent ultrafast computed tomographic (CT) evaluation
during bicycle ergometry to assess left ventricular (LV)
function. There were 10 males and 2 females, (X) age =52.
Eleven pts were on cardiac medications at the time of
evaluation. Pts were exercised to fatigue or symptomsby a
standard protocol in the semi-supine position, starting at 25
watt-secondsand augmentingworkload every 2 minutes by 25
watt-seconds. Peak workloadaveraged 75 watt-seconds. Pts
received several 25cc injections of contrast medium with a
totaldose X=104cc. Initialstudies were performedat rest and
within 10-15 seconds of exercise termination. Pts were
monitored by EKG throughout the exam. Seventeen scans/sec,
covering 1 cardiac cycle were performedat 4 to 8cm levels of
the L V at rest and immediately after exercise in each pt. Seven
pts had normal ejectionjraction (EF) responses to exercise
increasingfrom 3%-19%, X =10 ± 6.4%. Five pts had abno'!!1al
EF responses to exercise decreasing from 296-13%, X =
8 ± 4.3%. Seven pts had normal end-diastolicdimension (EDD)
respo~es to exercise either not changingor decreasingfrom 0-
16%, X =8.3 ± 5.4%. Five pts had abnormal EDD responses to
exercise increasingfrom 6%-34%, X = 15 ± 14.3%. Nine pts had
normal end-systolic dimensi.Q.n (ESD) responses to exercise
decreasing from 2%-43%, X = 21 ± 15.1%. Three pts had
abnormal ESD responses to exercise increasingfrom 13%-16%,
X = 20 ± 6.5%. Ultrafast CT has the potential for measuring
physiologiccharacteristicsin pts with ischemicheartdisease.
NONINVASIVE EVALUATION OF AORTO-CORONARY BYPASS GRAFTS
USING CINE-CT.
TM Bateman. MD. FACC; JS Whiting, PhD; JS Forrester, MD,
FACC; AL Aronson, MD; SV Schauer, MS; RJ Gray, MD, FACC;
JM Matloff, MD, FACC; OS Berman, MD, FACC; HJC Swan, MD,
PhD, FACC. Cedars-Sinai Medical Center, Los Angeles, CA.
Knowledge of the patency and flow characteristics of
aorto-coronary bypass grafts is often essential for man-
aging post-CABG pts, but is not presently attainable non-
invasively. We evaluated 101 bypass grafts (30 pts; 2 wks
to II yrs post-CABG) using rapid multi-slice cardiac
Cine-CT. Eight gated 8 mm thick cross-sectional tomogra-
phic images from aortic arch to aortic valve were acquir-
ed at 10 consecutive electrocardiographic R waves,
followi~g peripheral IV injection of 30-45 ml of
renografin-76. Scans were acqUired at each level before,
during, and after passage of the contrast bolus. Images
were assessed qualitatively in cine format and semi-
quantitatively by comparison of aortic root and bypass
graft CT density-time curves. Patency for saphenous vein
grafts (SVG) was defined as contrast-enhanced
visualization at both the proximal aortic anastomosis and
at one more caudal level. Of 85 SVG's, 64 were patent by
these criteria; 58 had CT density-time curves that peaked
with the aortic curve, and 8 had curves that peaked later
suggesting reduced flow rate. Of 16 internal mammary
grafts, 13 were patent by Cine-CT. Six pts (18 grafts)
had selective graft angiography within 2 wks of Cine-CT.
Cine-CT established the patency of 12 grafts, while inva-
sive angiography only identified II. Three patent grafts
had CT density-time curves that peaked after the aortic
curve, and these contained 50,60, and 75% stenoses. These
data indicate that Cine-CT can accurately determine the
patency and probable presence of disease in both saphe-
nous vein and internal mammary bypass grafts, and in some
cases may be superior to invasive angiography.
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DETERMINATION OF CHANGES IN CORONARY BYPASS GRAFT FLOW
RATE USING CINE-CT
John A. Rumberger, M.D., Ph.D., Andrew J. Feiring, M.D.,
Loren E. Hiratzka, M.D., Steven J. Reiter, M.D., William
Stanford, M.D., and Melvin L. Marcus, M.D., F.A.C.C.,
University of Iowa and CV Center, Iowa City, Iowa
Assessment of coronary bypass graft (CBG) patency is
highly accurate using computed tomography (CT). However,
measurement of changes in CBG flow rate (necessary to
assess graft function) have not been possible using
conventional CT. We investigated the applicat10n of
cine-CT (Imatron C-I00, 50 msec scan acquisition) to
measurement of relative CBG flow rates in anesthetized
dogs folloWing placement of a left innominate to left
circumflex CBG (lateral saphenous vein). A broad range
of CBG flow rates from maximum vasodilation (4:1 to 5:1
increase in flow over control, intra-CBG adenosine) to
near zero (cuff occluder) were produced in each
experiment. CBG flow velocity was continuously assessed
using a cuff-type Doppler probe directly applied on the
graft. During mechanical ventilation at each flow rate,
twenty transverse tomograms were obtained at a level
where both the ascending aorta and CBG were visualized.
Scans were taken following bolus right atrial injection
of a non-ionic contrast agent (Iohexol/lopamidol, 15 cc
over 2 sec). Simultaneous contrast clearance curves were
constructed and characterized for the ascending aorta and
CBG at each flow rate (n:38). A single, easily definable
parameter, the time between the peak contrast
opacification in the ascending aorta and the CBG, was
found to inversely correlate with changes 1n CBG flow
rates within each dog (r:0.78 to r:0.94, p<.OOI).
Cine-CT way offer a minimally invasive means of
determining CBG function (flow reserve) in addition to
patency in man.
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Ventricular Tachycardia-Mechanisms
ADENOSINE SENSITIVE VENTRICULAR TACHYCARDIA: EVIDENCE
SUGGESTING CYCLIC AMP MEDIATED TRIGGERED ACTIVITY.
~ ~ Lerman, Hn, Luiz Belardinelli, MD, John P.
DiMarco, MD, PhD, FACC. University of Virginia,
Charlottesville, Virginia
Electrophysiologic studies were performed in three
patients without structural heart disease who had exer-
tionally related sustained ventricular tachycardia (VT).
Programmed stimUlation reproducibly initiated and termi-
nated VT in all patients. Ventricular tachycardia was
also initiated with isoproterenol infusion and showed
cycle length-dependent characteristics, 1.e., the cycle
length of induced tachycardia was dependent on the pre-
ceding sinus or drive cycle length. The tachycardia was
terminated by intravenous verapamil and by Val salva and/
or carotid sinus massage. ~-adrenergic receptor blockade
with propranolol prevented induction of VT either during
programmed stimUlation or catecholamine challenge. Adeno-
sine, a nucleoside, whose only electrophysiologic effect
on ventricular myocytes is antagonism of catecholamine-
induced elevation of intracellular cyclic AMP also repro-
ducibly terminated VT within a mean time of 8 seconds,
range 4.5 to 15 seconds (IV dose 75 to 112.5 mg/kg).
Adenosine, verapamil, vagal maneuvers and ~-adrenergic
receptor blockade all decrease the slow inward calcium
current either directly by modulating calcium channels or
indirectly by inhibiting production of cellular cyclic
AMP. These observations along with the characteristic
response of the tachycardia to programmed stimulation and
initiation of VT with catecholamines suggest that the
ventricular tachycardia described in these patients may
be due to cyclic AMP mediated triggered activity.
EXERCISE-INDUCED VENTRICULAR TACHYCARDIA: CATECHOLAMINE-
SENSITIVITY VERSUS CYCLE-LENGTH-DEPENDENCY.
Edmund C. Keung, M.D., Edward C. Huycke, M,D. and Ruey J.
Sung, M.D., F.A.C.C., San Francisco General Hospital,
University of California, San Francisco, CA.
To determine the triggering mechanism of exercise-induced
ventricular tachycardia (VT) , 24 patients (pts) , ages
ranging from 18 to 75 (mean 42.9) years, were studied.
Eight pts manifested sustained and 16 pts non sustained VT
on 2 consecutive treadmill exercise testings (TET). None
of them exhibited electrocardiographic evidence of myo-
cardial ischemia prior to the onset of VT. Electrophysio-
logic studies (EPS) with pharmacologic testings were per-
formed in all pts. Based on the mode of VT initiation,
two groups (Gr) of pts were identified. In Gr I - 15 pts,
VT could not be induced by programmed atrial and ventri-
cular stimulation despite attainment of the ventricular
cycle length at which VT was provoked by TET. The induc-
tion of VT subsequently required intravenous infusion of
isoproterenol (2 - 8 ~g/min) in these 15 pts. Intra-
venous propranolol (P) (0.2 mg/kg) but not verapamil (V)
(0.15 mg/kg bolus followed by 0.005 mg/kg/min drip) pre-
vented the inducibility of VT during intravenous isopro-
terenol infusion in all 15 pts. In Gr II - 9 pts, VT
could be readily induced by atrial and ventricular stimu-
lation while attaining a range of ventricular cycle
lengths at which TET provoked the onset of VT. P could
only slow the rate of VT but V suppressed VT inducibility
in all 9 pts. We conclude that (1) the triggering mecha-
nism of exercise-induced VT can be either primarily of
catecholamine-sensitivity or of cycle-length-dependency
and (2) the triggering mechanism so identified with EPS
predicts responses to antiarrhythmic agents.
EPINEPHRINE INFUSION IN THE CONGENITAL
LONG-QT SYNDROME
El iot Schechter, M.D., F.A.C.C., Jerry
Anderson:-M~D~;-Santosh Prabhu, M.D., Ahmed
Kahn, M.D. and Ralph Lazzara, M.D., F.A.C.C.,
Oklahoma City VA Medical Center and
University of Oklahoma Health Sciences Center,
Oklahoma City, OK
The congeni ta 1 long-QT syndrome (LQTS) is
characterized by abnormalities of the T-U wave
and a susceptability to ventricular
arrhythmias (VA), especially in response to
stress. To evaluate the role of
catecholamines, 8 PTS with LQTS and 6 controls
(C) wi th no cl i ni ca 1 VA underwent i nfusi on of
graded doses of epinephrine (EPI). ECG was
recorded continuously. Serum potassium (K+)
sampled at each stage of the infusion in 3
LQTS and all C. 6/8 LQTS but 0/14 C had VA (P
.0001). Four LQTS had non-sustained
ventricular tachycardia. The 8 LQTS had
larger U-waves than C in the resting state
(0.18 +/- 0.16 mV vs 0.07 +/- 0.03) and with
each dose of EPI (0.2 +/- 0.17,0.29 +/- 0.13,
0.41 +/- 0.25, 0.48 +/- 0.2 vs 0.13 +/- 0.05,
0.2 +/- 0.06, 0.19 +/- 0.03, 0.3 +/- 0.14).
K+ fell from 3.97 +/- 0.47 MEQ/L to 2.65 +/-
0.92 in LQTS and 3.58 +/- 0.4 to 2.35 +/- 0.07
in C, not significantly different.
CONCLUSIONS: (1) LQTS are more sensiti ve to
EPI induced VA. This is coincident with more
prominent U-waves (2) This sensitivity is not
related to differences in K+; (3) The
association of large U-waves and VA's suggest
EPI induced afterdepolarizations as a
mechanism for LQTS.
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NON-UNIFORM RECOVERY OF EXCITABILITY IN THE LEFT VENTRICLE
Joseph A. Vassallo, MD, Dennis M. Cassidy, MD, Francis
E. Marchlinski, MD, FACC, Alfred E. Buxton, MD, FACC, Mark
E. Josephson, MD, FACC, University of Pennsyivania,
Philadelphia, PA.
Dispersion of recovery of excitability in the LV was
determined by catheter mapping and programmed stimulation
in 17 patients (pts): Group 1 (8 pts; no ventricular
tachycardia (VT) and normal QT), Group 2 (3 pts; long QT
syndrome), and Group 3 (6 pts; sustaIned monomorphic VT,
normai QT). Sinus rhythm activation mapping was performed
and locai refractory periods were determined at a mean of
11+3 LV sites per pt. Local refractory period was defined
as-the longest coupling interval of an extrastimulus which
failed to elicit a response foilowing an 8 beat drive from
each LV site. Total recovery time at each LV site was
defined as the local activation time pius local refractory
period. Dispersion was defined as the widest range of
refractory periods and total recovery time per pt. Normal
dispersion of refractoriness and recovery time (Group 1)
were 41+11 msec and 48+14 msec respectively. Group 2 had
greater-dispersion of refractoriness (93+23 msec) and
recovery time (91+25 msec) than Group 1,-p<.005. Disper-
sion of refractorIness was similar in Group 1 and Group 3
(48+20 msec) but recovery times were longer in Group 3
(72+22 msec) than Group 1, p<.05. We conclude:
1) Compared to normals, pts with long QT syndrome have
greater dispersion of total LV recovery time which is
predominantiy due to a wide dispersion of locai refractor-
iness. 2) Pts with VT and normal QT have a greater degree
of dispersion of total recovery time than normai,
however, this is due to dispersion of activation times
rather than refractoriness. Thus, potentially arrhythmo-
genic nonuniform recovery of excitability in the LV may be
due to dispersion of refractoriness or activation times
depending upon the pathophysiologic substrate.
DEMONSTRATION OF THE PRESENCE OF SLOW CONDUCTION
DURING SUSTAINED VENTRICULAR TACHYCARDIA.
Ken Okumura, M.D., Brian Olshansky, M.D., Richard W. Henthorn,
M.D., F.A.C.C., Andrew E. Epstein, M.D., F.A.C.C., Vance J.
Plumb, M.D., F.A.C.C., Albert L. Waldo, M.D., F.A.C.C.
University of Alabama at Birmingham, Birmingham, Alabama.
To test the hypothesis that an area of slow conduction is present
during reentrant ventricular tachycardia (VT), and that the
earliest activation site during VT is within or orthodromically
just distal to the area of slow conduction in the reentry loop, we
studied 10 episodes of VT (mean rate 176±26 bpm) induced in 7
patients (pts) with ischemic heart disease. Rapid ventricular
pacing (RVP) was performed at selected sites during VT,
recording electrograms (EG) at the earliest activation site during
VT (site A) and at a site close to the pacing site (site B). RVP
from the RV apex during RBBB VT and from selected LV sites
during LBBB VT (mean pacing rate 189±32 bpm) demonstrated
constant ventricular fusion beats in the ECG except for the last
captured beat (thus entrained VT) in 9/1 O. During entrainment,
sites A and B were activated at the pacing rate and conduction
time from the last pacing impulse to the last captured EG at site
A (5t-A interval) was 376ib7 msec and spanned the diastolic
interval, while that at site B (5t-B interval) was only 2/i±10 msec.
Also, during entrainment, site A had the same EG morphology as
during VT, while site B had a different EG morphology,
indicating that site A was activated in the same direction during
entrainment as during VT. 8 episodes of VT were entrained at~2
different pacing rates and the 5t-A interval further increased
during higher rate pacing in /i!S while the 5t-B interval remained
unchanged. RVP performed from the same site during sinus
rhythm (mean pacing rate 195±/i0 bpm) showed an 5t-A interval
of 109±/i1 msec (p<0.001 vs the value during entrainment) and an
5t-B interval of 2S±13 msec. These data indicate that an area of
slow conduction not demonstrable during sinus rhythm exists
during VT, and that the earliest activation site during VT is at or
just orthodromically distal to this area of slow conduction.
COMPARISON OF THE RESETTING RESPONSE TO SINGLE AND DOUBLE
EXTRASTIMULI IN VENTRICULAR TACHYCARDIA: IMPLICATIONS FOR
AN EXCITABLE GAP Nicholas J. Stamato, M.D., Mark E.
Rosenthal, M.D., Jesus M. Almendral, M.D., Mark E.
Josephson, M.D., FACC Univ of Penn, Philadelphia, PA
Ventricular tachycardia (VT) may be reset by single
ventricular extrastimuli (SVE). Three types of reset
curves have been described-flat, flat + increasing, or
increasing. The flat curve may result from reset in a
circuit with a fully excitable gap. Since intervening
tissue refractoriness may limit the ability of SVE to
reset VT, we assessed the response to SVE and double
ventricular extrastimuli (DVE) (the coupling interval of
the first set to cause no resetting) in 56 VT. SVE reset
26 (46.4%) VT and DVE reset 43 (76.8%) VT. In 20 VT,
response to SVE and DVE were compared to assess the role
of intervening tissue refractoriness, SVE yielded flat
responses in 10, flat + increasing in 5, and increasing
in 5. DVE yielded flat responses in 7, flat + increasing
in 6, and increasing in 7. The size of the gap (range of
coupling intervals over which resetting occurred) was
55+34 ms with SVE and 92+41 ms with DVE, p<O.OOl. The
length of the gap which was flat was 52+33 ms with SVE
and 84+34 ms with DVE, p<0.002. In those VT reset by DVE
as welT as by SVE both the total reset gap (90+40 ms)
and the flat portion of the reset gap (48+46 ms) was
significantly 10nger than those reset only by DVE (50+37
ms) and (17+26 ms), p<O.Ol and p<0.03 respectively. The
cycle length of VT reset by DVE only (361+51 ms) was no
different from those reset by both DVE and SVE (355+55
ms, p=NS). We conclude: 1) When SVE fail to reset a-VT,
DVE from the same site can reset VT; 2) Intervening tis-
sue refractoriness plays a significant role in determin-
ing the reset response to SVE; 3) The resetting response
to DVE reflects characteristics of the VT circuit; 4) SVE
underestimate the size of the excitable gap.
Wednesday, March 12, 1986
8:30AM-I0:00AM, Room #366/367
Antiarrhythmic Actions of Beta Blocking and Calcium
Blocking Drugs
SUPRAVENTRICULAR TACHYCARDIAS (SVT) TREATED WITH
CONTINUOUS PROPRANOLOL (P) INFUSIONS
Irvin F. Goldenberg, M.D. John W. McBride, M.D.,
F.A.C.C., Harry G. McCoy, Pharm. D., James D. Madison,
M.D., F.A.C.C., Brian C. Campion, M.D., F.A.C.C.
St. Paul Ramsey Medical Center, University of Minnesota,
Minneapolis, Minnesota
Because oral therapy is often contraindicated in hospi-
talized patients (pts), we assessed the efficacy of con-
tinuous propranolol (P) infusions in 9 intensive care
unit pts with supraventricular tachycardia. Four pts
had sinus tachycardia, 4 atrial fibrillation and 1
atrial flutter. The loading dose (LD) used depended
upon the pts clinical response, higher dosages being
used to control the more refractory arrhythmias
(LO~52.2±38.3 ~g!kg, SO). Using a volume of distribu-
tion (Vd) of 3.0 L!kg, the LD given, an elimination rate
constant (Kct) of 0.23 hr-1 and standard pharmacokinetic
formulas, the predicted piasma P concentrations (Cpred)
and the initial maintenance dose (MD) were determined
(Cpred - LO!Vd'Kg; MD = Cpred'Vd'Kd'~)' The initial MD
ranged between 6.1-56.0 ~g/kg/hr (16.1±16.2 ~g!kg/hr).
Subsequent MD (3.9-74.9 ~g/kg/hr) were determined by pt
clinical response. The heart rate (HR) decreased from
146±22 to 98±16 (p(O.OOOl). A significant HR decrease
was noted throughout the infusion. On a MD of 16.1±lO.7
~/kg/hr the P level measured (28±21 ~g/L) did not
differ significantly from the Cpred (22.8±16.8 ~g/L).
The duration of the infusion ranged between 16-288 hr
(92±77 hr). A side effect-transient wheezing occurred
in only 1 pt. This resolved by decreasing the infusion
rate. We conclude that, by using the clinical response
and simple pharmacokinetic formulas, continuous P infu-
sions are safe and effective.
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CLINICAL ELECTROPHYSIOLOGY OF FLESTOLOL, A NEW, POTENT,
ULTRA-SHORT ACTING BETA BLOCKER.
Charles D. Swerdlow, M.D., F.A.C.C. and Jan Peterson,
R.N., Stanford Oniversity, Stanford, CA.
We studied the electrophysiologic effects of
flestolol, a new ultra-short acting beta blocker i in 15patients at 2 infusion rates: a 45 ug/kg bolus p us a 5
ug/kg/min infusion and a 60 ug/kg bolus ~lus a
10ug/kg/min infusion. The table shows intervals 1n msec
after 15 min at each infusion rate (plasma levels 45+11
and 95z23 ng/ml): -CONTROL 5 ug 10 ug p.
Sinus cycle length 724+146 816+145 863+155 .0001
CSNRT 255+144 330+165 338+145 .02
AH 80+16 91+21 96+19 .0001
HV 46+10 46+10 47+10 NS
QRS 105+15 106+16 107+17 NS
QTC 445+39 447+28 448+31 NS
A-ERP600 216+&2 216+49 212+47 NS
AVN-ERP600 281+48 331+67 361+79 .0001
AVN WencRebach 336!62 &14+68 &33!73 .0001
cycle length
V-ERP600 232+22 241+20 244+20 .03
V-ERP400 216+17 225+19 226+18 .02
MAP (torr) 9Fll 93+11 92+13 NS
CSNRT=corrected sinus recovery time; A=atrial; ERP600=
effective refractory period at cycle length 600 msec;
AVN=atrioventricular node; V=ventricular; MAP=mean
arterial pressure; *=linear trend significance.
At 5 meg/kg/min, flestolol 's electrophysiologic
effects were comparable to those reported for 300
meg/kg/min of esmolol, the first ultra-short acting beta
blocker. A significant flestolol concentration-effect
relationship (p<.03) was present for all variables which
had significant-dose-effect relationships. No toxicity
occurred. In the post-infusion period, sinus cycle
length decreased linearlJ with time (r=.99). At 30 min
post-infusion, sinus an AVN Wenckebach cycle lengths
had decreased to control values (716+136 and 342+53
msec) and flestolol plasma level to 4+2 lig/ml. -
Conclusions: Flestolol had typiCal beta blocker
effects on the sinus and AV nodes, increased V
refractoriness, and did not alter A refractoriness or
infranodal conduction. These doses of flestolol were
safe in selected patients, had rapid onset and offset of
action, and did not cause acute rebound.
A OOMPARIS~ OF ESMJLQ NolO VERAPAMIL IN ll-lE TREATMENT OF
ATRIAL FIBRILLATION/FLUTTER.
Eric L. Mlcbelson. MD. FAOC, James K. Porterfield, MO,
Gopa I Das, MO, FAce, Edward V. PI atl a, MO, FAce, Henry S.
SlIW In, MO, FAce, Horace MacVaugh, MO, and Rahmat Legharl,
MO, FAce, for the Multicenter Trial Lankenau Mad Res Ctr,
Ph II adel ph Ia, PA.
The effects of esmolol (E), an ul tra short actl ng beta
blocker and verapamll (V) were compared In controlling
ventrIcular response (VR) In patients with atrial
fibrillation/flutter In a randomized open label study.
Patients wIth either recent onset «48 hours, 1'F15) or 01 d
onset (~48 hours, 1'F6) atrl al flbrlliation/fl utter were
randomized to receIve E (n=l1) or V (n=10). Baseline VR
ranged from 116 to 172 bpm with a mean 146±6 (51 ± SEM),
for the V treated group and from 116 to 184 bpm (mean
14325) for the E treated group. Demographics were similar
for the two groups. E was given by continuous InfusIon In
Incremental doses from 2 to 16 mg/mln for 10 minutes each
following 1000ding doses of 10 or 20 mg boluses. V was
given In 5 or 10 mg I.v. boluses In two titration steps
(If necessary). At the end of the titration, VR was
reduced by 30% In the E group and 31% In the V group.
Response was rapid In both groups. Nine of 11 (82%)
achieved a VR of ~ 100 bpm In the E group, compared with
5/10 (50%) In the V group. Q>nverslons to normal sinus
rhythm (NSR) occurred In 7/11 (65%) of the E group, and
3/10 <30%) of the V group. "bre pts wIth recent onset
atrIal fibrillation/flutter converted to NSR during
titration (within one hour of onset of dosing) with E 6/7
(86%) as compared to V 2/8 (25%), (p <0.05). Side effects
Included asymptomatic and symptomatIc blood pressure
reduct Ion In 3/11 (27%) of the E treated pts and 6/10
(60%) of the V treated pts. E compares favorably with V
In the acute therapy of atrial fibrillation/flutter.
EFFICACY OF ORAL DILTIAZEM TO CONTROL REST AND EXERCISE
VENTRICULAR RESPONSE IN ATRIAL FIBRILLATION.
Jonathan S. Steinberg, MD, Richard J. Katz, MD, FACC,
George B. Bren, MD, Leslie Buff, P. Jacob Varghese, MD,
FACC, Alan G. Wasserman, MD, FACC, and Allan M. Ross, MD,
FACC, George Washington University, Washington, DC
In chronic atrial fibrillation (AF) resting ventricular
response rate (VR) has been controlled using either digi-
talis (DIG), beta blockers, or more recently the calcium
antagonist verapamil (V). During the increased sympa-
thetic tone of exercise, however, VR is minimally affect-
ed with DIG alone but well controlled with addition of V.
We evaluated the effect on exercise VR of DIG plus dil-
tiazem (OIL), another widely used calcium blocker which
unlike V does not increase DIG levels. Nine pts were
studied, all exhibiting VR>lOO/min on 3 min exercise
testing (00 , 3 MPH) while receiving "therapeutic" DIG
(serum level 0.7 - 2.4 ng/ml). After baseline stress
test pts received OIL 240 mg/day for one week and repeat
studies performed. If exercise VR was >135/min (3 pts),
OIL dose was increased to 360 mg/day with retesting one
week later. Results (beats/min):
DIG Alone DIG + OIL p Value
Rest VR 90.6 ± 15.7 72.3 ± 11.9 < .02
3 min Exercise VR 164.0 ± 28.2 119.3 ± 33.5 < .01
By adding OIL 8 of 9 pts (89%) achieved >15% VR reduction
(mean 27 ± 15%) at peak exercise. There-was no change in
DIG levels during OIL therapy (1 .4±0.5~1 .4±0.6 ng/ml,
pNS), and there were no episodes of symptomatic brady-
cardia. One week post OIL withdrawal VR had returned to
baseline values.
Conclusion: The addition of OIL to DIG accomplished
excellent exercise rate control in chronic AF with no
effect on DIG level and no limiting adverse effects.
VERAPAMIL FOR MULnFOCAL ATRIAL TACHYCARDIA.
Brian Anderson, M.D., David Salerno, M.D., Ph.D., FACC,
Patricia Sharkey, R.N., Conrad Iber, M.D. Hennepin County
Medical Center, Minneapolis, MN.
Multifocal atrial tachycardia (MAT) may complicate the
management of seriously ill patients (pts) and is often difficult
to control. We treated 14 consecutive pts in MAT with ver-
apamil (V) to assess its effect. All pts had serious, often pul-
monary, illnesses; electrolytes and arterial gases were accept-
able and none had contraindications to verapamil. Verapamil
was given by slow IV push not exceeding 1 mg/min with con-
stant heart rate (HR) and frequent cuff systolic blood pressure
(SBP) measurement. Infusion was stopped for SBP less than
100, plateau in HR response, or conversion to sinus rhythm
(SR). Oral (p.o.) verapamiJ 80 mg tid was given to 9 pts after
IV trial at the attending stafrs discretion. Four pts received
1 gm of calcium gluconate 5 minutes prior to treatment with
verapamiJ (Group II); 10 pts did not (Group I).
The following results were obtained:
Group I Group II
V dosage (mg) 16.5 18.8
HR before V (bpm) 131 :!: 16 119 :!: 14
HR after V (bpm) 106 :!: 18* 96 :!: 13*
%6 in HR -19 -19
SBP before V (mmHg) 156 + 20 125 + 33
SBP after V (mmHg) 116 ! 25* 112 ! 36**
6 SBP (mmHg) 40 13
*p < .01 vs before Vi **p < .05 vs before V
Seven pts converted to SR, 6 remained in SR at 24 hr, 4
of whom were on p.o. drug.
SBP fell to less than 100 in 2 pts. No other compli-
cations occurred. Arterial gases were unchanged by V (n=7).
Thus, IV verapamiJ is safe and effective therapy for MAT,
reliably lowering HR and often resulting in SR. Calcum ap-
pears to minimize drug-related hypotension without preventing
antiarrhythmic efficacy.
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EFFECT OF CALCIUM CHANNEL BLOCKERS ON HEMODYNAMIC RE-
SPONSES TO DEFIBRILLATION. Pamela Hite BS, Erwin Schroder
MD, Robert Kieso MS, Michelle Hunt BS, Birgit Grimlund,
Ri chard Kerber MD, FACC, U of Iowa, Iowa City, Ia
The hemodynamic response to sequences of ventricular
fibrillation (VF)-defibrillation includes an adrenergic
component, which is important for maintenance of blood
pressure (BP) after successful defibrillation. Since
calcium channel blockers (CCB) have anti adrenergic ef-
fects, we hypothesized that CCB might blunt the adrenergic
response to defibrillation. VF was induced in 25 closed-
chest dogs; each was externally shocked at least 4 times
at 3 energy levels: 25 joules (J), 50J, and 100J to deter-
mine %defibrillation success. Heart rate (HR) and BP
were recorded. Energy sequences were repeated after 45
mins of no intervention (Control (C), n=5), or 45 mins in-
fusion of Diltiazem (D) (.01 mg/kg/min, n=10), or Verap-
amil (V) ~.1 mg/kg bolus + .01 mg/kg/min, n=10). Results
(mean±SE, *=p~.Ol, post drug vs. pre drug):
%Defib Success: C 0 V
Pre--pQSt Pre Post Pre Post
25J 31±19 40±17 28±7 17±6 50±14 15±2*
50J 70±20 70±18 71±9 52±14* 64±11 44±14
100J 84±12 87±13 87±9 82±11 82±9 72±13
Mean BP responses to 100J shocks were as follows (mmHg):
Time 0 Secs 15 Secs 30 Secs 60 Secs 3 Mins
C Pre 120±14 103±13 115±9 114±10 117±9
Post 119±6 106±14 119±11 115±14 113±8
o Pre 103±8 102±9 111±9 113±10 105±5
Post 92±6 64±9 84±9* 87±6* 93±6*
V Pre 106±7 108±9 118±9 113±7 104±6
Post 96±8 78±12* 84±10* 90±10* 92±8*
HR responses were not altered by 0 or V. Conclusions: 0
and Vmodestly reduced %success of shocks, especially at
lower energy levels. BP after defibrillation was lower
with 0 and V, indicating a blunting of the adrenergic re-
sponse to defibrillation by calcium channel blockers.
Wednesday, March 12, 1986
10:30AM-12:00NOON, Room #366/367
Evaluation of Antiarrhythmic Drug Effects and
Toxicity
DRUG ASSOCIATED VENTRICULAR FIBRILLATION: ANALYSIS OF
CLINICAL FEATURES AND QTc PROLONGATION.
Joseph D. Minardo, M.D., James J. Heger, M.D., F.A.C.C.,
Douglas P. Zipes, M.D., F.A.C.C.,William M. Miles, M.D.,
F.A.C.C., and Eric N. Prystowsky, M.D., F.A.C.C. Krannert
Inst. of Cardiology, Indiana Univ. Sch. of Medicine,
Indianapolis, IN.
Reports of clinical features and role of QTc prolongation
in drug associated ventricular fibrillation (DAVF) have
been variable. We analyzed 40 episodes of DAVF in 30 pa-
tients (pts), 17 men, 13 women, mean age 59 yr, initially
treated for sustained ventricular tachycardia (VT) (3 pts),
nonsustained VT (18 pts), PVCs (4 pts), atrial fibrilla-
tion (4 pts) and no arrhythmia (1 pt). DAVF occurred dur-
ing quinidine treatment (Q) in 15, procainamide (PA) in 11,
disopyramide (DP) in 6 and other drugs in 8 episodes. For
Q, PA and DP, median duration of therapy before DAVF was 3
days. Drug serum concentrations in 15 pts were in accepta-
ble ranges and QRS duration was .11+.03 sec. Serum K was
<3.5 meq/L in 12/32 and digitalis was present during 25/40
episodes of DAVF. The QTc intervals that could be measured
after DAVF in 22 pts with Q, PA or DP (Grp I) were compar-
ed with another 31 pts treated for VT with Q, PA or DP who
did not develop DAVF (Grp II).
Control QTc Drug QTc p value
Grp I .45+.04 .49+.06 <.001
Grp II .43+.03 .48+.04 <.001
Drug QTc for Grp I vs Grp II were similar although the in-
crease from control to drug was greater in Grp II (p<.05).
DAVF occurred with >1 drug in 4 of 25 pts treated with Q,
PA or DP after the first episode. Chronic therapy was Q or
PA in 3 pts, investigational drugs in 20 pts and no drug
in 9 pts. During a mean follow-up of 25 months, 1 treated
pt died suddenly. We conclude that DAVF is an early event;
there is a crossover risk of DAVF with Q, PA or DP, and
QTc prolongation is not predictive of DAVF.
DIFFERENT EFFECTS OF ANTIARRHYTHMIC MEDICATION ON
REFRACTORINESS OF ACCESSORY AV PATHWAY AND MYOCARDIAL
TISSUE
Karl-Heinz Kuck, MD, Klaus-Peter Kunze. M.D., Angelika Cottard. M.D.
Michael Schliiter, Ph.D., Dept. of cardiology, University Hospital Eppendorf.
Hamburg, West Germany
To determine the effect of antiarrhythmic drugs (D) on the refractoriness of
accessory AV pathways (AP) and myocardial tiaue (MYI, we measurad the
effective refractory periods (ERPs) of the AP in anterograde (and and retrograde
(red direction, and of RA, LA (via coronary sinus) and RV before and after intra-
venous D administration. Our study population consisted of 42 consecutive patients
(13 women, 29 men; mean age 38 yeers) with an AP. who underwent standard
electrophysiologic investigation. The ERPs of MY were datermined with the ex-
trastimulus method at a paced basic cycle length of 440 ml, the ant ERP of AP
during incremental atrial pacing at the SIte of atrial AP insertion, and the rat ERP of
AP during incremental RV pacing. 14 pta received encainide (1.5 mg/kg). 15 pta
propafenone (2 mg/kg) , and 15 pts sotalol (1.5 mg/kg). D caused significant increases
in ant ERP of AP (250± 46 to 315 ± 105 ml; (p c: .0011. ret ERP of AP (2551.48
to 316 ±.87; p <:..001), RA (2151.20 to 231 ±25; p ..c.01). and RV (2181.28 to
237 ± 26 ml; p <::: .001), but not in LA (245 ±29 to 254 ± 32). Changes ofant ERP
of AP were found to correlate with changes of ret ERP of AP (r = .61). but neither
correlated with changes of ERPs of RA, LA, and RV. The increase in ERP wal
significantly more pronouced in ant and ret AP direction than in any site of MY (p
.05; Friedman test). Thil effect did not differ between encainide, propefenone and
sotalol. ERP increase (defined as ":7 20 ml) in ant and ret ERP of AP was indepen-
dent of D effect on MY.
Conclusions: The effect of D on ant and ret ERP of AP is significantly more pro-
nounced as, and independent from the effect on ERP of MY.
ARE THERE CLINICAL PREDICTORS FOR ARRHYTHMIA
AGGRA VATrON?
William Slater, MD, Philip Podrid, MD, FACC, Steven
Lampert, MD, Bernard Lawn, MD, FACC, Cardiovascular
Laboratories, ijarvard School of Public Health & Dept. of
Med., Brigham & Women's Hospital, Boston, MA
To determine if there are predictors of aggravation of
arrhythmia (AgA) by an antiarrhythmic drug (AAD), we
stUdied 51 patients (PTs) with AgA during therapy with
either Quinidine, type 1A drug (N=16); Mexiletine, type
1B drug (N=13); or Encainide, type 1C drug (N=22). For
each PT with AgA, two controls (N=102) who did not ex-
perience AgA with any AAD were randomly selected. Base-
line evaluation of all PTs included 48 hour ambUlatory
monitoring, treadmill exercise test, and radionuclide
ventriculogram. AgA was defined as: 1) a four-fold
increase in VPB frequency 2) a ten-fold increase in
repetitive forms (couplets or ventricular tachycardia
(VT)) 3) the occurrence of a sustained tachyarrhythmia
not present in control. The clinical variables examined
inclUded age, sex, type of heart disease, presenting
arrhythmia, left ventricular ejection fraction, severity
of ischemia, exercise duration, conduction abnormalities
prior to drug, ECG changes during drug therapy, drug
dose and blood level. The only clinical parameter
associated with AgA was the type of presenting
arrhythmia, i.e. ventricular fibrillation or sustained
VT vs nonsustained VT or VPBs (p<.02).
PTs susceptible to drug-induced AgA cannot be identi-
fied by clinical criteria, electrocardiographic changes
or pharmacokinetics of the AAD. This complication is
however more frequent in those with a history of malig-
nant arrhythmia and AAD must be used cautiously in such
PTs.
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DOES SUPPRESSION OF VENTRICULAR ECTOPIC ACTIVITY CORRELATE
WITH PREVENTION OF INDUCIBLE VENTRICULAR TACHYCARDIA.
John C. Somberg, M.D., Joseph Schwartz, M.D., V1lma
Torres, M.D., Jonathan Wynn, M.D., Deborah Keefe, M.D.,
Dennis Miura, M.D. Albert Einstein College of Med1c1ne,
Bronx, New York.
We evaluated the efficacy of antiarrhythmic agents at
programmed electrical stimulation (PES) 1n 120 drug trials
in 43 patients undergoing PES studies with cardiac arrest
or sustained ventricular tachycardia (VT). Frequency of
ventricular premature depolar1zation (VPD) was assessed by
trending for 15 minutes before and after drug
administration. Initial trending evaluation in 10
patients showed a significant concordance (r=0.98) between
ectopy frequency and grade in 2 consecutive trending drug
free periods. An increase in VPD frequency was defined as
a 10 time or greater increase from baseline if mean
baseline VPD frequency was 1-50 VPDs/hour and a 5 time
increase if baseline VPDs are 51-100 VPDs/hour. A
decrease in VPDs was defined as a 10 time or greater
decrease from baseline if mean VPD frequency were
51-100/hour. The comparative results of PES testing and
VPD trending showed the following:
VPD frequency
PES results increased decreased no change
protected 14 29 11
not protected 10 27 29
There is no correlation between the effects of
antiarrhythmic drug action on VPD frequency and protect10n
against VT induction at PES (chi-square 0.37; p<0.5, ns).
Patients could be protected (no VT provoked) at PES while
having no significant reduction in VPD frequency.
Reduction in VPDs can occur without protection at PES.
These findings suggest that PES testing and VPD frequency
measure different aspects of electrical instabil1ty.
THE EFFICACY OF DIGOXIN IN THE CONVERSION OF ATRIAL FIB-
RILLATION TO NORMAL SINUS RHYTHM.
Anne A. Knowlton, MD, Rodney H. Falk, MB, Ch.B, FACC,
Sheilah Bernard, MD, Jean L. O'Brien, RN, Norman E.
Gotlieb, MD, Nancy J. Battinel1i, RN, Carl S. Apstein, MD,
FACC. Boston City Hospital, Boston, MA.
Although digitalis is the standard therapy for atrial
fibrillation (AF), no randomized study of its efficacy for
conversion to normal sinus rhythm (NSR) has been done.
Therefore, over a 20 month period, we carried out a double
blind, 16 hr protocol comparing a rapidly absorbed oral
digoxin with placebo in new onset AF (~7 days) of various
etiologies (valve disease, n=14, chest disease, n=ll,
"holiday heart", n=lO, other, n=17, idiopathic, n=2 with
some multiple etiologies). Patients (pts) with moderate
or severe CHF, angina, hemodynamic compromise, thyrotoxic-
osis, or pretreated with antiarrhythmic therapy were not
entered into the study. Drug was administered in a dosage
schedule titrated to heart rate, starting with a loading
dose of 0.6mg, with a maximal total dose of 1.2mg. All pts
on digoxin achieved a therapeutic blood level (mean 1.1+0.1
SEM at 4 hrs). Pts wore Holter monitors during the 16 hr
study. The results of 40 pts, 21 randomized to digoxin
(mean age 59.5, 13 male) and 19 randomized to placebo (mean
age 62.5, 10 male) were analyzed. Conversion to NSR
occurred in 11/21 (52%) of pts on digoxin versus 8/19 (42%)
of pts on placebo (NS). Mean time to conversion was 5.7 hrs
in the digoxin group versus 4.0 hrs in the placebo group
(p=NS). Thirty pts had adequate echoes to assess left
atrial size (LA). There was no significant difference in
mean LA size between digoxin (4.2) versus placebo (4.2) nor
between all convertors (4.3) versus nonconvertors (4.2).
We conclude that in our pts digoxin had no significant
effect on conversion of atrial fibrillation to normal sinus
rhythm in the first 16 hrs after presentation.
TREA'fMENT OF FLECAINIDE INDUCED VENTRICULAR TACHYCARDIA
WITH LIDOCAINE.
Sharon R. Maza, M.D., Jonathan Wynn, M.D., Joseph
Schwartz, M.D., Daniel Zanger, B.A., Deborah Keefe, M.D.,
Denn1s Miura, M.D., John C. Somberg, M.D., Department of
Med1cine, Cardiology Division, Albert E1nstein College of
Medic1ne, Bronx, New ·York.
Flecainide acetate (F) is a new class Ic antiarrythmic
agent which prolongs refractoriness and causes significant
depression of the maximal rate of depolarization. When
1ntravenous F has been used for acute drug testing during
programmed electrical stimulation (PES) 1t has
demonstrated both eff1cacy as an antiarrhythmic agent and
potential for arrythmogenicity. We report three cases of
a proarrythm1c response to F which were successfully
treated w1th lidoca1ne (L). All 3 cases received a
2mg/min infuslon of F over 20 minutes in 4 divided doses
with onset of ventr1cular tachycardia (VT) prior to any
PES on F. In Case 1 VT was sustained and associated with
hypotension and apnea whlch necess1tated cardiopulmonary
resuscltat10n. The patlent was unresponsive to pacing
technlques and multiple attempts at def1brillat10n. Case
2 had sustalned VT. Case 3 had lOcessant nonsustained
VT. All 3 cases responded lmmedlately to a bolus of 100
mg of L followed by a 2 mg/mln drlp. In Case I, although
resumption of normal sinus rhythm occurred immed1ately,
nonsustained VT occurred after 10 mlnutes wh1ch was
responsive to an add1tional 50 mg bolus of L and the
institution of the 2 mg/min drip. Lidocaine, because of
its rapid onset and offset kinet1cs and 1tS tendency
towards decreaSing the heterogenicity of refractoriness,
may counteract the effects of F and may thus prove useful
in the treatment of F induced VT.
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COMPARISON OF OUTCOME FIVE YEARS AFTER VALVE REPLACEMENT
WITH A BIOPROSTHESIS VERSUS A MECHANICAL PROSTHESIS.
RESULTS OF A RANDOMIZED TRIAL. Participants in the VA
Cooperative Study on Valvular Heart Disease (Report pre-
pared by K.E. Hammermeister, M.D., FACC, Gulshan Sethi,
M.D., Cecil Burchfiel, Ph.D., Julianne Souchek, Ph.D.,
Charles Oprian, Ph.D., Edward Folland, M.D.,FACC, Shukri
Khuri, M.D., Shahbudin Rahimtoola, M.D., FACC, Thomas
Tosch, Ph.D., and William Henderson, Ph.D.)
One of the major goals of the VA Cooperative Study on
Valvular Heart Disease is to compare survival and inci-
dence of valve related complications (systemic embolism,
endocarditis, valve thrombosis or regurgitation, 'clinic-
ally significant bleeding, and reoperation for any other
reason) in patients undergoing single valve replacement
randomized between a bioprosthesis, the Hancock porcine
valve (H, na 288), and a mechanical prosthesis, the Bjork-
Shiley spherical disc valve (BS, n-287). At an average
followup of 53 months there are no statistically signif-
icant differences in survival for either aortic valve
replacement (AVR) or mitral valve replacement (MVR),
although there is a trend toward improved survival with
the mitral H versus the mitral BS (five year survival
probability = 0.72 versus 0.62). Valve related compli-
cations occurred significantly less frequently in MVR
with H versus MVR with BS (five year complication-free
probabilities of 0.60 and 0.47, respectively; p<.05);
similar trends were observed following AVR favoring H,
but were not statistically significant. The differences
in complication rates are due to increased frequency of
significant bleeding with BS; however, the numbers of
deaths due to bleeding were similar between the two valve
types. We conclude that at intermediate duration of
followup, patients receiving a bioprosthesis and a mechan-
ical prosthesis have similar outcome, except for increased
frequency of non-fatal bleeding in patients receiving BS.
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FIVE-YEAR COMPARISON OF ST. JUDE AND PORCINE MITRAL VALVES
Pamela S. Douglas, M.D., F.A.C.C., John W. Hirshfeld,
Jr., M.D., F.A.C.C., Richard Edie, M.D., Alden Harken,
M.D., F.A.C.C., Larry Stephenson, M.D., F.A.C.C., Kathleen
Gleason, L. Henry Edmunds, M.D., F.A.C.C., University of
Pennsylvania, Philadelphia, PA.
To characterize performance and better guide selection
of mitral valve prostheses, we prospectively examined 106
consecutive patients (pts) undergoing mitral valve re-
placement. pts received either a st. Jude valve (SJV;
n=68) or a porcine valve (PV; n=38) and were similar with
respect to 67 clinical and operative factors, allowing
comparison of valve performance as an independent var-
iable.
Total follow-up was 3312 pt-months (mean 38 months,
range 2-57 months, 93% complete). All SJV and half of PV
were fully anticoagulated; an additional 29% of PV receiv-
ed antiplatelet agents alone. There were no statistical
differences in symptomatic improvement or mortality by
life table analysis. Linearized rates (per pt-year) of
complications and relative risks (RR) for SJV to PV were:
(all NS)
Re-Q:l Infection EilOOli Bleeding Latel:2ath Valve Faillre
SJV 1.8 1.2 1.8 2.9 4.1 0.6 (throrbosis
PV 3.8 1.9 1.0 2.9 3.8 1.0 (degereralion)
RR 0.5 0.6 1.8 1.0 1.1 0.6
Anticoagulation use did not appear to affect rates of
embolization in patients with porcine valves.
Despite differing anticoagulation use, rates of embolic
and bleeding events in PV and SJV were similar. Given
this comparable, low morbidity and mortality, the superior
hemodynamics and durability of the SJV may favor its use
in the mitral position.
THE REPAIR OF MITRAL INCOMPETENCE: A 16-YEAR EXPERIENCE
Mark Sand, M.D., Robert B. Karp, M.D., David Naftel,
Ph.D., Eugene H. Blackstone, M.D., and John W. Kirklin,
M.D., F.A.C.C., Univ of Alabama at Birmingham,
Birmingham.
Between 1967 and 1985 210 patients underwent repair of
mitral incompetence, either isolated or combined with
other cardiac surgical procedures. Those with AV canal
defects were excluded. All patients have been followed.
Mean age was 49 years and the range 2.6 months to 83
years. 180 patients had annular repair, 99 had leaflet
repai r, 7 had tensor apparatus repai r, with 74 patients
having more than one of these. Actuarial survival at 2
weeks, 5 years, 10 years, and 15 years was 95% (70% CL
93%-96%), 75% (CL 71%-78%), 59% (CL 55%-64%), and 36%
(CL 28%-45%). Amonq the subset undergoing isolated
mitral valve repair between 1975 and July 1983, 5-year
survival was 84% (CL 78%-88%), compared wi th 64% (CL
58%-69%) for patients undergoing mitral valve
replacement for mitral incompetence in the same time
period (P = 0.05). 38 of the 210 patients subsequently
underwent mitral valve replacement, with the actuarial
freedom f rom rep 1acement at 2 weeks, and one, 5 and 10
years being 89% (CL 87%-91%), 88% (CL 86%-90%), 82% (CL
79%-85%), and 74% (CL 69%-78%). At the time of last
followup, among the 118 patients surviving without valve
replacement, 63% were in NYHA Class 1,25% in 11,6% in
III, 1% in IV and 6% were undetermined; 83% were free of
thromboembol ism within 10 years of repair. These
results indicate the wisdom of repairing mitral
incompetence whenever possible.
UTILITY OF INTRAOPERATIVE COLOR DOPPLER FLOW IMAGING
AFTER SURGICAL CORRECTION OF VALVULAR REGURGITATION.
Lawrence Czer. MD. FACC; Gerald Maurer, MD, FACC; Michele
DeRobertis, RN; Robert Kass, MD, FACC; Myles Lee, MD,
FACC; Aurelio Chaux, MD, FACC; Jack Matloff, MD, FACC.
Cedars-Sinai Medical Center, Los Angeles, CA.
We evaluated 2-dlmensional color Doppler blood flow
mapping (CFM) for detection and quantitation of valvular
regurgitation before and after surgical correction in 22
pts who underwent valve repair or replacement, and in 12
control pts who had cardiac surgery without valve opera-
tion. CFM was performed intraoperatively (op) before and
after cardiopulmonary bypass by placement of a 3.5 MHz
transducer (Irex 880) directly on the heart; preop and 1-
6 wk postop closed-chest CFM were also done. In 5 aortic,
7 mitral, 3 double St. Jude valve replacements, CFM
demonstrated 3 antegrade flow jets, mild (size dependent)
prosthetic regurgitation, normal bileaflet motion, and
absence of paravalvular leak. Following repair of MR (2
suture annuloplasty, 2 cleft repair) and TR (2 Carpentier
rings, 1 cleft repair), regurgitation decreased from 4+
or 3+ to trace or none in 6/7 by op CFM, confirmed by
late postop CFM. In ischemic MR, adequacy of repair was
assessed before and after vasopressor challenge, without
increase in regurgitation. In 2 additional pts, LV angio
was contraindicated due to LV clot or VTach; decision
was based on op CFM. Severity of valvular regurgitation
(0-4+) by op CFM correlated well (R~.90) with preop cath
and CFM, differing by no more than 1 grade in any pt. No
complications were encountered.
Conclusion: Intraoperative CFM provides safe, accurate,
and rapid assessment of valvular regurgitation and
efficacy of valvular surgery, especially valve repair,
prior to closure of the sternum, without use of contrast
material or radiation. In selected pts valve surgery may
be undertaken without preop angio.
IS MI'ffiAL VALVUlDPIASTY SUPERI~ 'ro MI'ffiAL VALVE
REPIACEMENT R:lR PRESERVATION OF lEFT VENIRIaJIAR
FUNCTION? AN INTRAOPERATIVE 'nIQ-DIMmSIONAL
EX:HOCARDIOORAPHIC SWDY. Martin E. Goldman, MO, :ma::,
Francisoo ~ra, MO, Valentin Fuster, MD, ~, '111eres&
Guarino, RN, Bruce P. Mindich, M.D., F2\.CC, Mt. Sinai--- &
St. 11lke's-Roosevelt Hospitals, NY, NY.
'Ihe ti.lre course and mechanism of LV dysfunction
following mitral valve replac:anent (MVR) has not been
previously determined. In 11 patients (pts)
undergoing surgery for isolated mitral regurgitation,
without ooronary artery disease, we used
intraoperative 2-D echocardiography to evaluate the LV
in the mid-papillary short-axis plane. 6 pts underwent
conventional MVR and 5 pts had mitral valwlq>lasty
(VP). Blinded observers, calculated LV end-diastolic
and end-systolic areas, ejection fractions (EF) and
quadrant regional wall Irotion (WM) before (pre) and
following (post) the MV operation. Intraoperative
hem:Jdynami.cs were similar in all pts. (xcrMP=Crosscl.anp
time in minutes, *;P<0.0001, ;p<0.02)
~ PreEF PostEF fj, EF** XCLMP*
MVR(6) 63+17 .66+.08 .42+.07 -.24+.06 45~10
VP(5) 61+19 .54+.02 .57+.02 .03+:04 27+9
LV EF was maintained by VP rot fell sIgnificantIy post
MVR (P<0.0001). Despite having similar baseline LV
contractility, WM fell in only 1/20 quadrants in VP
pts, rot decreased in 17/24 quadrants in MVR pts,
especially anteroseptally (P<0.01) and posteroseptally
(P<0.03). '!he prolonged XCIMP of MVR may contribute to
LV dysfunction rot should have a diffuse effect. MUle
valwlq>lasty maintains normal LV anataTiy, conventional
MVR alters LV geanetry and may affect regional wall
stress particularly along the septum, leading to LV
dysfunction. Therefore, valwloplasty by preserving LV
geanetry and function is superior to MVR.
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OPERATION FOR HYPERTROPHIC SUBAORTIC STENOSIS IN THE ACED.
Matthew M. Cooper, M.D., Charles L. McIntosh, M.D.,
F.A.C.C, John P. Kupferschmid, M.D., Richard E. Clark,
M.D., F.A.C.C, Surgery Branch, NHLBI, NIH, Bethesda, MD.
To determine if surgical palliation of idiopathic hyper-
trophic subaortic stenosis (IHSS) is worthwhile in the
elderly we examined function, hemodynamic status, and
survival following left ventriculomyotomy and septal
myectomy (Morrow Procedure,LVMM) in 47 patients 65 years
and older (x=68,65-81y,~=35). 79% (n=31) underwent postop
catheterization at an average of 6 months. The average
preop N.Y.H.A. functional class of 3.3±.07* improved at
latest followup to 2.0±.15 (p<.OOI). The peak systolic
left ventricular outflow tract gradient (LVOTC) at rest
decreased from 71±8 to 5±2mmHg (p<.OOI). Mean decreases
in maximal LVOTC with Valsalva, amyl nitrate, and isopro-
terenol were 72% (98±8~27±5mmHg), 71% (110±12~32±7mmHg),
and 61% (114±9~5±8mmHg), respectively (all p<.OOI).
There were no statistically significant differences
between pre- and postop values of CO,CI,~,LA, pulmonary
wedge pressure and vascular resistance, or pulse pressure
response to premature ventricular contraction. 51% (n=24)
had mitral insufficiency preop, 4 (13%) postop
(p<.005,Chi-square). Followup averaged 58 months (1-120
months). 3,5,7 and 9-year actuarial survival was 82±6%
(n=28), 72±8% (n=17), 41± 10% (n=8), and 28±10% (n=3),
respectively. Ventricular septal rupture occurred in 4
patients (8.5%), 3 of whom required coronary bypass, 2 of
whom had septal morphology that would now by revised
operative criteria prompt mitral valve replacement rather
than LVMM, and resulted in 3 early deaths. Acute onset of
a low cardiac output state (n=3) and sepsis (n=2)
contributed to the hospital mortality of 17%. Coronary
artery disease, present in 36% (n=17), did not contribute
to hospital mortality in the absence of septal rupture.
It is concluded that surgical palliation of the elderly
with IHSS can be performed with significant hemodynamic
and functional improvement. Long term survival at
improved functional levels is attainable.
*All values mean ± S.E.M.
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PERFORMANCE OF A FABRICATED TRILEAFLET PORCINE BIO-
PROSTHESIS: 9-YEAR FOLLOWUP OF THE HANCOCK MODIFIED
ORIFICE VALVE
Verdi J. DiSesa, M.D., Elizabeth N. Allred, M.S.,
Richard J. Shemin, M.D., F.A.C.C., John J. Collins,
Jr., M.D., F.A.C.C., Lawrence H. Cohn, M.D., F.A.C.C.
Brigham and Women's Hospital and Harvard Medical
School, Boston, MA
The fabrication of the Hancock MO valve raised
questions about its long-term durability. Since 1976,
262 pts (167M/95F, 16-85, 62 yrs) underwent aortic
valve replacement (AVR) using 103 21 rom, 143 23 rom and
16 25 rom modified orifice (MO) valves. There were 6
operative deaths (2.3%). 234 pts were alive 3-87 (42)
mos postoperatively. Actuarial probability of survival
at 60 mos was 88±3%. 221 survivors are in functional
classes I or II. 29 pts have suffered valve related
complications: thromboembolism in 17 (1.9%/pt yr);
primary valve dysfunction (PVD) in 5 (0.6%/pt yr); and
endocarditis (SBE) in 7 (0.8%/pt yr). 12 pts have
required reoperation (1.3%/pt yr) for PVD (5 pts), SBE
(4 pts), and perivalvar leak (3 pts). At 60 mos
actuarial probability of freedom from TE was 91±3%,
from PVD 95±2%, and from SBE 98±1%. Probability of
freedom from all valve-related complications was 84±3%
and from reoperation 93±2% at 60 mos.
Long-term performance of the Hancock MO valve justifies
its continued use for AVR.
LATE SURVIVAL AFTER ISOLATED AORTIC VALVE REPLACEMENT FOR
236 PATIENTS;INFLUENCE OF VENTRICULAR ARRHYTHMIAS
Bruce W. Lytle, MD, FACC, John Ellis, MD, James D.
Maloney, MD, FACC, Delos M. Cosgrove, MD, FACC, Marlene
Goormastic, MPH, Floyd D. Loop, MD, FACC
The Cleveland Clinic Foundation, Cleveland, Ohio
To assess the influence of perioperative rhythm and
arrhythmias on late survival following aortic valve
replacement (AVR), 236 hospital survivors of AVR with a
porcine heterograft and without significant coronary
artery disease (no obstruction ~501) were reviewed. Pre-
operative and postoperative arrhythmias were sub-grouped
according to the Lown classification. Follow-up at a mean
interval for survivors of 62 mos. (range 28-87 mos.)
documented 29 late deaths (11 non-cardiac,6 sudden) and
survival of 971, 941 and 911 at 1, 2 and 5 postoperative
yrs. For 18 patients with postoperative ventricular
arrhythmias of Lown classification >2, 5-yr. survival was
721 (p=O.0007). Other variables with univariate influence
on survival included age (p=O.02), aortic valve lesion
(p=O.07), atrial fibrillation (p=O.01) and anticoagula-
tion with Coumadin (p=O.08). Multivariate testing,
however, identified only advanced age (p>O.0001) and
valve lesion (survival for mixed lesions >stenotic lesion
(p=O.025) >insufficient lesions (p=O.0017)) as indepen-
dent predictors of decreased survival. Serious
arrhythmias were covariant with valve lesion; only 1
patient with a mixed valve lesion had postoperative Lown
)2 arrhythmias. Exclusion of patients with mixed valve
lesions from the multivariate model showed Lown >2
arrhythmias adversely influenced the survival of patients
with pure stenotic or pure insufficient valve lesions
(p=O.013). Patients without coronary artery disease
undergoing AVR with a bioprosthesis have favorable late
survival and a low incidence of sudden death, although
the presence of serious postoperative ventricular
arrhythmias predicts an increased late risk.
IMPACT OF CORONARY ARTERY DISEASE AND MYOCARDIAL
REVASCULARIZATION ON RESULTS OF AORTIC VALVE REPLACMENT.
lawrence Czer. MD. FACC; Timothy Bateman, MD, FACCj
Richard Gray, MD, FACC; Michele De Robertis, RNj Robert
Kass, MD, FACCj Aurelio Chaux, MD, FACC; Jack Matloff,
MD, FACC. Cedars-Sinai Medical Center, los Angeles, CA.
In order to determine whether coronary artery disease
(CAD) and myocardial revascularization (CABG) influenced
survival following single aortic valve replacement (AVR)
we reviewed our entire experience with AVR between 1969
and 1984. All pts over age 40 had preop coronary angio-
graphy. Of 449 total pts, 40% (180) had no associated
CADj 49% (220) had CAD and CABGj and an additional 11%
(49) had unbypassed CAD. Early (30-day) mortalities were
2.3% (no CAD), 8.1% (CAD + CABGj p<.05), and 4.4% (CAD,
no CABG; p=NS). Use of hypothermic cardioplegia (after
1978; N=220) reduced early mortality in pts requiring
CABG (from 14.3% to 6.0%; p<.05), but had no effect in
pts who had AVR alone (2.3% vs 2.9%). Pts were followed
for up to 15 yrs (mean, 4.1) for a total of 1840 pt-yrs
(2% lostj 98% complete). Actuarial survivals at 7 years
were 80±4% (no CAD), 61±5% (CAD + CABGj p<.05), and
49±11% (CAD, no CABG). Rapid attrition was observed in
the unbypassed CAD group, beginning at 4 years. The major
cause of death (51%) in all groups was cardiac non-
valvular (heart fai1ure, infarction, arrhythmia, or
sudden death).
Conclusions: After AVR, associated CAD has a
significant detrimental affect on late (>4 yrs) survival,
especially if left unbypassedj revascularization improves
late survival. Early mortality has been reduced by the
use of cardioplegia in pts requiring concomitant AVR and
CABG.
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Surgeons undertaking resection of thoracic aortic aneu-
rysms have become a target for malpractice because of the
associated paraplegia (3-16%). Patients who underwent
resection of thoracic and thoraco-abdominal aortic aneu-
rysms over the last 28 years were reviewed. There were
16 patients with associated neurological changes and para-
plegia. The patients ranged in age from 17-75 years. The
diagnoses were: traumatic aortic aneurysm 2, thoracic
arteriosclerotic aortic aneurysm 6, thoraco-abdominal
aortic aneurysm 2, coarctation of aorta 2, and aortic
rupture 4. Discriminate analysis of the factors contri-
buting to paraplegia were analyzed. They were sex, age,
extent of disease, number of intercostal arteries sacri-
ficed, use of shunt, use of cardiopulmonary bypass, and
hypotension. The factors that were most significant were
hypotension and extent of disease. In comparison, in 35
cases of traumatic aortic ruptures, resection with shunts
or partial cardiopulmonary bypass was performed on 25
patients. Ten patients underwent resection without adjunc-
tive support. The incidence of paraplegia was similar for
both groups. Also, fifty aneurysms of various etiologies
were reviewed. Thirteen patients underwent surgery with-
out adjunctive support. Thirty-seven patients utilized
cardiopulmonary bypass and shunts. Again the incidence
of paraplegia was similar in both groups. Currently there
is no monitoring system that would predict the unequivocal
occurrence of paraplegia or other neurological deficit.
Paraplegia and neurological deficits following thoracic
and thoraco-abdominal aortic aneurysm surgery are an in-
herent event of the surgical procedure that should be
accepted as a potential risk and not a cause for litiga-
tion and malpractice.
PARAPLEGIA ASSOCIATED WITH AORTIC RESECTION AND THE LAW.
Safuh Attar, M.D., F.A.C.C. and Javaid Hosnain, M.D.,
University of Maryland School of Medicine, Baltimore, MD
EDP during arrest (mmHg)
LV temperature(oC)
Post ischemic SWI(g-m/kg)*
EDV(ml)Preischemia*vs
Postischemia*
Wall Motion Score
(O=Normal to 36)
LV venting failed to lower LV temperature or improve reg-
ional (wall motion) and global (SWI) function. Distended
hearts had the lowest LV temperature, highest SWI and best
wall motion scores. We conclude that LV venting during
heterogenous cardioplegic arrest does not enhance myocar-
dial protection and may negate the beneficial effects of
moderate (EDP=15mmHg) LV distention.
EFFECTS OF LEFT VENTRICULAR VENTING AND DISTENTION DURING
HETEROGENOUS CARDIOPLEGIC ARREST
Harold Lazar MD, Kenneth Wilcox MD, Thomas Hankins CCP,
Jonathan Plehn MD, and Arthur Roberts MD, FACC, Boston
University Medical Center, Boston, MA
The effects of LV venting and distention on myocardial
protection during heterogenous cardioplegic arrest remain
undefined. This study was undertaken to determine whether
LV venting and distention during arrest alter LV cooling
and the recovery of post ischemic global and regional LV
function. Twenty-one pigs were placed on bypass and sub-
jected to 80 minutes of ischemic arrest with the mid LAD
occluded. Hearts were protected with multidose potassium,
crystalloid gardioplegia supplemented with topical and
systemic (28 C) hypothermia. During arrest, the LV was
vented in 7 pigs; 7 pigs were unvented, and in 7 others,
the EDP(end-diastolic pressure) was maintained at 15mmHg.
We measured stroke work index (SWI), compliance (EDV-EDP
curves), wall motion (2-D echo). LV temperature in the
LAD region, and LV EDP(Millar catheter). Results are:
Mean ± SE, *EDP = 10mmHg, +p <.05 vs vented and nonvented.
Vented Non-Vented Distended
0.8+0.1 3.7+1.715.0+0.5*
14.2+0.7 15.5+1.2 10.1+1.8*
.62+.07 .66+.07 .78+.09
61+10 55+5 42+4
59+9 60+7 45+5- - - +5.5+1.8 4.8±.12 .07±.04
We conclude 1) DMSO can prolong the ischemic tolerance
of the spinal cordi and 2) this agent may be useful as a
pharmacological adjunct to decrease the incidence of
paraplegia in surgery On aneurysms of the thoracic aorta.
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INCREASE IN S WAVE AMPLITUDE - A SENSITIVE MARKER OF ACUTE
MYOCARDIAL ISCHEMIA?
James J. Glazier. M.B•• Sergio Chierchia, M.D.,
Attilio Maseri, M.D., F.A.C.C., Cardiovascular Unit,
Hammersmith Hospital, London, U.K.
The role of changes in QRS amplitude in detecting acute
myocardial ischemia is controversial. The anecdotal obser-
vation of an increase in S wave amplitude associated with
ST segment depression (ST,L) during episodes of both spon-
taneous and exercise induced myocardial ischemia led us to
investigate this phenomenon more comprehensively. In 50
patients (pts) with effort angina,severe coronary artery
disease and a positive exercise test (ET),we assessed the
relation between changes in S and R wave amplitude and ST~
during exercise induced myocardial ischemia.ET was per-
formed using a commercially available computerized system
and the modified Bruce protocol. The lead group with maxi-
mum S wave amplitude in the basal state and diagnostic is-
chemic ST ~ during ET was selected.Measurements of S and R
wave amplitude,heart rate and ST~ were made at 1 min in-
tervals during control, exercise and recovery. With ET all
pts developed ST~(0.19+0.062mV,mean + S.D.,range 0.11 to
0.32 mV).In 49 out of tne 50 pts an increase in S wave
amplitude was observed,whilst R wave amplitude increased
in 25,decreased in 20 and was unchanged in 5.Mean S wave
amplitude increase was 0.26+0.14 mV (range 0.05 to 0.5 mV~
Within individual pts,the mignitude of the increase in S
wave amplitude was proportional to the severity of ST ~
(analysis of covariance: p <. 0.001) but there was no
relation to change in heart rate.
We conclude that an increase in S wave amplitude is almost
invariably observed during diagnostic ST~ in the absence
of consistent R wave changes. Our findings suggest that an
increase in S wave amplitude may be an additional marker
of acute myocardial ischemia and its usefulness in this
regard warrants further investigation.
Group II (n=6)
24.1 + 2.9
Group I (n"8)
23.7 + 2.1
CAN DIMETHYL SULFOXIDE (DMSO) PROLONG THE ISCHEMIC
TOLERANCE OF THE SPINAL CORD?
~ok H. Lim, M.D., Maurice Weiss, B.S, Mark Connolly, M.D' Ian1el Rose, M.D., Israel Jacobowitz, M.D., Josepn
Cunningham Jr., M.D., Maimonides Medical Center, Brooklyn
NY 11219 '
We investieated the use of dimethyl sulfoxide (DMSO) as
a pharmacolog1cal means to prolong the ischemic tolefance
of the spinal cord. Somatosensory evoked potential SEP)
were obta1ned in 14 dogs. Spinal co~d ischemia was
produced ~y.placing aD aortic cro~sclamp (AXC) just distal
to the or1g1D of the left subclav1an artery. Serial SEPs
were d~termined at 1 minute intervals until the SEP became
f!at l1ne, and the AXC was continued for an additional 10
m1n ••. In Group I (controll n=8), no medication was giv~nf9l10w1ng the release of tne AXC. In Group II (DMSO n-6)
41methyl sulfoxide, 1 gm/kg
i
was administered
1ntravenously before the remova of the AXC. The
neurologic!l s~atu~ was assessed postoperatively by using
the Tarlov s cr1ter1a.
Results are summarized:
Aortic crossclamp (min.)
Neurological status
(no. of dogs)
paraplegia/paraperesis 8 0
complete recovery 0 6
Return of postop. SEP No Yes
. ~roup I (control) an~mals had a significantly higher
~nc1dence of parapleg1a tpan Group II (DMSO) animals
(p<O.OOl, Fisher Exact test). In the DMSO treated eroup
the ~EPs returned in the early postoperative period w1thin
60 m1nutes.
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PROLONGED POSTEXERCISE ST SEGMENT DEPRESSION IS AN INDICA-
TOR OF HEKODYNAKICALLY SEVERE AND EXTENSIVE CORONARY ART-
ERY DISEASE (CAD). Steven Reisman, MD; Alan Rozanski, MD;
Jamshid Maddahi, MD, FACC; Daniel Berman, MD, FACC. VA Med
Ctr, Long Beach, & Cedars-Sinai Med Ctr, Los Angeles, CA
To determine the significance of prolonged post (p) exer-
cise (Ex) ST depression (ST~), we studied 81 patients with
>1 mm ST during Bruce protocol treadmill Ex who underwent
Ex Tl-201 scintigraphy and coronary angiography. Three-
view Tl scintigrams were divided into 15 segments (segs).
The extent of myocardium with Tl ischemia was determined
by the number (#) of reversible segs. Forty-six patients
had "normalization" of SIt to <lmm within the first 5 min
pEx (GpI) and 35 patients had prolonged ~lmm ST for ~5
min pEx (GpII). Results:
Ex Dur # Rev Segs ~ Cr V Max Ex SIt
GpI 9.0+3.4 2.1+2.1 2.0+1.1 1~.1 2.0+0.9
GpII 6.9~2.5* 3.5~3.1* 2.5~0.9* 1.7+1.1* 2.7~1.3*
*p<0.05 vs GpI, Dur=duration (min), Rev=reversible, Sig
V=# vessels with >50% stenosis, Cr V=# with >90% stenosis.
Max=maximum. Triple-vessel stenosis (>50%) was more common
in GpII vs GpI (69% vs 41%, p<.OS). Severe exertional
hypotension (drop below resting BP) was also more common
in GpII vs GpI (29% vs 9%, p<.05). Onset of Imm ST~ was
earlier in GpII vs GpI (3.~ 1.9 min vs 6.2~3.3, p=
.0001). Thus, compared to patients with early pEx ST nor-
malization, those with prolonged pEx ST~ manifest more
extensive and severe: 1) anatomic CAD, 2) Tl and Ex ECG
ischemia, and 3) physiologic and hemodynamic abnormali-
ties. These data suggest that assessment of the duration
of postexercise ST depression aids in identifying the
extent and severity of CAD and of exercise-induced
ischemia.
IMPROVED DETECTION OF nUPLE VESSEL DISEASE USING ISCHEMIC AND
HEMODYNAMIC VARIABLES DERIVED FROM ElERCISE TESTING
David Mannering BSc. David BenAe" FRCP. David E. Ward FACC. Keith
DavtiAs MD. Bau&h Valantine MRCP u.d Mart Du.cy MRCP. St
George's Hospital u.d MedicI! School, London. ENGLAND.
There is increasing evidence that patients at high rist after acute
infarction cu. be identified by their response to esercise. We have
undertaken ECG nercise stress testing in 213 patients 18-21 days post
infarction using the Bruce protocol vith BP measured at rest u.d peat
nercise. -CO, (86) had ~IJDJD ST depression &Oms after the Jpoint in I
or more leads vhich vas categorized into upsloping. horizontal or
dovnsloping compleles Of this group. 76 undenvent coronary
u.giography
The rise in systolic BP vas 23 t2.6' for single vessel disease
(SVD)(1l-29]. 17 t •.~' for double vessel disease (DVD) [n.I~) u.d 7
t3,O, fortriplevessel disease (TVD) [32) (p~.OOI). Onset time to 1_
ST segmellt depression vas ~.~ to.• ain for SVD. 3.2 to.• for DVD u.d
2.1 tOJJDin for TVD (p~.OOI). ST segment depression recovery time
after elercise vas •.2 to.lain for SVD. ~.2 to.8ain for DVD u.d 7.9
to ~ ain forTYD (p~.OI). Dovnsloping ST depresssioa vas &SIOciated
with TVD whereas upslopin. ST depression ".. &SIOcia&ed vith SVD
(p<o.OOO The seasitivity u.d specificity of these variables for
detection of TVD is thus:
Onset Recovery 'J. increase Dovnsloping
Time Time inSBP ST depressioa
«3l!liA) (l6mjn) «101)
sensitivity- n' '" 6" ~'J.Specificity· 9O'J. 104'J. M 94"
Conclusioas. Although the preseace or absence of ST selmeat
depression is a poor predictor of the severity of coronary artery
disease, the association of ST morphology. onset time u.d recovery
time together vith the exercise BP response cu. identify severe
coronary vessel disease.
IMPROVED AcaJRACY OF 1REAIX\1ILL EXERCISE TESTING IN
PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY (LVH).
Milton HolleQber~, MD, Julio Tubau, MD, Barry Massie,
MD, FAce, Judith Wisneski, MD, FACC, and Edward Gertz,
MD, FACC, VAMC and UCSF, San Francisco, CA.
Exercise testing in patients (pts) with LVH yields many
false positive responses, caused largely by tall R waves
that exaggerate the degree of exercise-induced ST
depression. To improve test accuracy, 23 pts with LVH
and chest pain were studied with a quantitative
Treadmill Exercise Score (TES) that adjusts the ST
depression for R wave height and for workload. Sixteen
of the pts had coronary artery disease (CAD) by coronary
arteriography and 7 pts had none. In 13 of the 16 LVH
pts who had 3 vessel disease TES averaged 30 units while
it averaged only 3 units in the 7 pts without CAD
(normals without LVIi and CAD fall below 4 units). All
LYH pts without CAD had TES <11 whereas 15/16 pts with
CAD had TES >11 (P<O.OOOI). Thus, TES clearly separated
LYH pts with and without CAD. We studied another 19 pts
with hypertension and mild LVH, but with no symptoms.
All had normal nuclear wall motion and thallium stress
tests (and thus had <1% probability of CAD). All had
normal TES. Thus, when pts from both groups (i.e., with
and without symptoms) were combined, TES was <11 in
25/26 pts with no CAD and >11 in 13/14 pts with 2 or 3
VD, P<.OOOl. By contrast, standard criteria classified
many of the 26 LVH pts without CAD as positive: ST
depression >1 mm in 14, >1.5 mm in 5, and >2 mm in 4.
Thus, even in pts with LVIi (many of whom had ST-T wave
changes on the resting ECG), TES displays good
sensitivity and specificity and allows better separation
of patients with and without CAD than do standard
exe rc ise- ECG c I' ite ria.
ANT ST ~(n=104)
INF ST ~ (n=72)
ANT ST t (n=25)
INF STt(n=5)
*Left dominant circulation ~=
LAD = left anterior descending
artery LCX = left circumflex
EXERCISE ST ELEVATION: A RELIABLE GUIDE TO CORONARY
ANATOMY Daniel B. Mark, M.D., David B. Pryor, M.D.,
Mark A. Hlatky, M.D., F.A.C.c., Kerry L. Lee, Ph.D.,
Frank E. Harrell, Jr., Ph.D., Robert M. Califf, M.D.
Duke University Medical Center, Durham, N.C.
To determine the coronary anatomy associated with
different patterns of exercise ST changes, we studied
432 consecutive patients (pts) with a Bruce treadmill
and I vessel coronary disease ( > 75%) stenosis). Peak
exercise-induced ST deviation > ~IO mV was measured
with a calibrated grid in each-of the 12 standard ECG
leads. Pts with ST elevation in leads showing an old Q
wave myocardial lnfarction as the only exercise change
were excluded. ST changes were classified as elevation
or depression and by lead group involved: anterlor
(ANT), VI-V6, I, AVL; inferior (INF), 2, 3, AVF.
LAD RCA LCX
(n = 229 (n = 137) (n = 66)
47 45% 36 (35%) 21 (20%)
40 (56%) 22 (30%) 10 (14%)
22 (88%) 3 (12%)
4 (80%) 1 (20%)*
depression t= elevation
RCA = right coronary
ANT ST elevation indicated a proximal LAD lesion in
18/25 (72%), a 95% LAD stenosis in 16/25 (64%), and a
proximal 95% LAD stenosis in 12/25 (48%). INF ST
elevation indicated a 95% stenosis of the dominant
artery in 4/5 (80%) of cases.
In summary: 1) exercise ST depression patterns do not
correlate with expected coronary arterial lesions; 2)
exercise ST elevation is a reliable marker of the
vascular territory at risk and often indicates a
proximal and/or severe stenosis.
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TREADMILL ST DEVIATION PREDICTS SURVIVAL
Daniel B Mark, M.D., David B Pryor, M.D. Frank E
Harrell, Ph.D., Kerry L Lee, Ph.D. Mark A Hlatky, M.D.,
F.A.C.C., Robert MCaliff, M.D. Duke University
Medical Center, Durham, N.C. 27710
To investigate whether exercise treadmill (TM) ST
segment deviation adds prognostic information to
clinical and cardiac catheterization (CATH) data, 2722
consecutive medically treated patients (pts) with a
Bruce TM and CATH within 6 weeks were followed for VP
to 10 years (median follow-up 5 years). Surgically
treated pts (n=627) were included only until the date
of operation. All exercise-induced ST deviation> .10
mV was measured with a calibrated grid. ST depression>
.20 mV occurred in 12% of pts. ST elevation> .20 mV
occurred in 2% of pts. -
Survival probabilities (unadjusted Kaplan-Meier
estimates) were:
~ 5 years g years
No ST deviation .99 .95 .93
ST .10 - .15 mV .97 .91 .85
ST > .20 mV .93 .77 .63
Using the Cox regression model, ST deviation added
independent prognostic information after adjusting for
clinical variables (including anginal pain course) and
CATH variables (including coronary anatomy and
ventricular function) (p=.004). A .20 mV or more ST
deviation considered alone was associated with a > 3-fold
increase in the mortality rate relative to a negative
test. After adjustment for clinical and CATH data, the
same TM ST response predicted a > 50% mortality increase.
In summary: 1) marked ST deviatIon identifies a high
risk subgroup of pts; 2) TM ST segment deviation adds
prognostic information to clinical and catheterization
data.
Wednesday, March 12, 1986
10:30AM-12:00NOON, Room #267
Coronary Heart Disease: Prevention
THE OOST OF ADULT CARDIOVASCULAR DISEASE
William R. Harlan, M.D., J. William Thomas, Ph.D., and
Hillary A. Murt, Ph.D.• University of Michigan, Ann Arbor.
Cardiovascular disease has a profound national impact on
the cost of health care and accounted for $50 billion in
health charges in 1980. The distribution of health expen-
ditures reflects the demands for health services and can
help define strategies to improve accessibility and care.
The National Medical Care Utilization and Expenditure Sur-
vey (NMCUES) of 1980 provides the only comprehensive as-
sessment of service utilization and care costs for the
civilian. non-institutionalized U.S. population. These
data were used to determine the health care costs for hy-
pertension and other cardiovascular disease and to compare
these with health care costs for the general population.
Persons reporting cardiovascular diseases accounted for
over 32% of national health care charges. 25% of all ambu-
latory visits, 39% of all hospital days, and reported 30%
of all disability days. There were important differences
among categories of cardiovascular diseases. Hypertension
was associated with only slightly greater costs and func-
tional disability. Per capita costs were only $142 great-
er than health costs for the general population and hyper-
tensives had disability measures that were slightly high-
er. However. other cardiovascular conditions had per cap-
ita medical costs and disability days that were ten times
higher than for hypertension or for the general population.
There were no significant differences by gender, race or
family income in medical costs for cardiovascular disease
suggesting no major impediments to obtaining care. The
tenfold greater costs when cardiovascular disorders com-
plicate hypertension confirm the minimal cost of treatment
and document the cost effectiveness of hypertension treat-
ment.
BLOOD PRESSURE VARIABILITY IN ADOLESCENTS OF
HYPERTENSIVE AND NORMOTENSIVE PARENTS.
Charlotte Ferencz, M.D., F.A.C.C., Joel I.Brenner, M.D.,
F.A.C.C., Patricia C.Dischinger, Ph.D., and P. David
Wilson, Ph.D., Universitv of Maryland School of
Medicine, Baltimore, Maryland.
A population-based epidemiological stUdy investigated
the hypothesis that 24-hour BP recordings can
differentiate children of a hypertensive parents (cases)
from children of normotensive parents (controls).
Adolescents, 13-19 years of age were drawn from a
representative sample of Maryland households in which RP
was measured in the adUlts. Utilizing the AVionics
Pressurometer III 24-hour BP recordings fulfilled rigid
quality standards in 178 children. BP levels were
evaluated for sleep and wake (school hours/non-school
hours) periods. A diary of activities and a
questionnaire prOVided co-variate data. For each child
frequency distributions of the BP measurements were
constructed for each time period and descriptors of the
distributions (mean, median, spread, 90%-ile, skewness)
were used in multiple linear and logistic analyses. The
manual BP at onset could not discriminate between cases
and controls whereas ambulatory BP clearly did, mainly
during waking hours. Although all subjects were
normotensive, systolic and diastolic BP descriptors
showed a significant dependence on case-control status
in interaction with sex and weight. Since manual BP
could not discri~inate between cases and controls, the
24-hour ambUlatory measurements represent an as yet
untapped resource for childhood stUdies.
Supported by NHLBI HL 25870
AN OVERVIEW OF TRIALS OF PHARMACOLOGIC THERAPY OF MILD
HYPERTENSION.
Pat Hebert, Ph.D., James O. Taylor, M.D., Charles H.
Hennekens. M.D., (Channing Laboratory, Department of Medi-
cine, Brigham and Women's Hospital and Beth Israel Hospi-
tal, Harvard Medical School, Boston, MA 02115).
Despite the availability of data from 6 community-based
randomized trials on over 33.000 patients with diastolic
blood pressures from 90 to 119 (of which 4 were < 114) the
value of treatment of mild hypertension with drugs re~ains
debated.
To obtain an overview we pooled the data and found that
those receiving pharmacologic treatment experienced an
overall 13% reduction (RR=0.87) in total mortality which
was statistically significant (95% confidence limits from
0.79 to 0.97). Further. for total cardiovascular (CV)
mortality the pooled RR was 0.8 (0.7, 0.9). As regards
specific CV mortality endpoints, the largest benefit was
seen in fatal stroke (RR=0.6, 0.5 to 0.8) whereas for fatal
MI the reduction was not statistically significant (RR=
0.9, 0.7 to 1.1).
In further analyses restricted to entry DBP's < 109 the
RR for total mortality was 0.87 (0.77 to 0.98). lior fatal
strokes the magnitude and significance of the reduction
was somewhat less (RR=0.7, 0.5 to 1.0) and the fatal MI
effect remained not significant (RR=0.9, 0.7 to 1.1).
This overview (of 6 trials of patients with entry DBP
levels from 90 to 119) indicates a significant benefit of
pharmacologic treatment of mild hypertension on total mor-
tality, total CV mortality as well as fatal and nonfatal
stroke. These benefits were somewhat less but still pre-
sent for those with entry level DBP < 109. The data sug-
gest that previously reported null results of individual
trials may have been due to inadequate power to detect
small to moderate but clinically worthwhile effects of
pharmacologic treatment of mild hypertension.
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CLINICAL AND ECHOCARDIOGRAPHIC RISK FACTORS FOR
SYSTEMIC EMBOLIZATION IN PATIENTS WITH ATRIAL
FIBRILLATION IN THE ABSENCE OF MITRAL STENOSIS
Nicholas A. Ruocco, Jr., M.D., Albert S. Most, M.D., FACC,
Rhode Island Hospital, Brown University, Providenre, Rhode
Island
A significant risk of systemic embolization has been demonstrated
in patients (PTS) with atrial fibrillation (AF) even in the absence
of mitral stenosis (MS). Since anticoagulation to prevent
embolization carries significant morbidity and mortality, we
carried out a risk stratification analysis to determine which PTS
should receive chronic anticoagulation therapy for AF. Clinical
and echocardiographic data, with a spedal emphasis on left atrial
size, were reviewed in 202 PTS with new onset, chronic or
paroxysmal AF who did not have MS. 59 (29%) of the PTS had an
embolic event within 3 months of their echocardiogram and all
were in AF at the time of embolization. Of the clinical
characteristics evaluated (tobacco use, diabetes mellitus, age 65
or older, hypertension, congestive heart failure, myocardial
infarction and coronary artery disease) only hypertension and age
were significant risk factors for embolization (P = 0.001 and 0.01
respectively). Left atrial size, mitral annular calcification,
mitral valve prolapse, normal or abnormal aortic valve and normal
or abnormal left ventricle were the echocardiographic findings
evaluated: Only left ventricular (LV) segmental wall motion
dysflllction was a significant risk factor (P = 0.04). Mean left
atrial size in PTS with an embolic event was 44.5 mm compared
to 43.5 mm in the control group, P=0.43. In summary, PTS with
AF in the absence of MS are at greater risk to embolize if they
are 65 or older, have a history of hypertension or an LV segmental
wall motion abnormality on their echo. Chronic anticoagulation
should be strongly considered in this group. Left atrial size, on
the other hand, is not a significant variable in determining the
risk of an em bolic event.
MORTALITY PREDICTORS IN SURVIVORS OF MYOCARDIAL
INFARCTION. THE BHAT PLACEBO GROUP.
John B. Kostis, M.D., F.A.C.C. Robert P. Byington, Ph.D.,
Sidney Goldstein, M.D., F.A.C.C., Robert Peters M.D.,
Marvin L. Murphy, M.D., F.A.C.C. for the BHAT Study
Group.
During 12 to 40 {mean 25} months of follow-up of 1921
survivors of acute myocardial infarction total mortality
was 9.8% (2.6% in 3 months, 4.2% in 6 months), instantan-
eous mortality was 3.5% and non-sudden atherosclerotic
mortality was 3.9%.
Total mortality was associated at baseline (z>2.5) with
factors reflecting large myocardial damage (heart
failure, relative risk-rr-2.29, prior infarction rr-2.12
cardiomegaly rr-l.97, digitalis rr-2.49, diuretics
rr-l.83, high LDH rr-2.48): myocardial ischemia (ST
depression rr-l.93, angina rr-l.56, prior beta blocker
use rr-2.29): arrhythmias ~10 VPB/hour rr-2.35 on 24 h
ambulatory ECG, use of antiarrhythmics rr-l.53): age 60
rr-2.0: black race rr-l.72: and low level leisure physical
activity rr-l.70.
By multivariate analysis using 20 variables the follow-
ing factors appeared to be independently associated (z>
2.5) with total mortality: ST depression, cardiothoracic
ratio, peak LDH, smoking, prior use of beta blockers,
hematocrit, ~10 VPB/h.
Traditional risk factors were associated with non-sudden
atherosclerotic death (smoking, z-3.12, cholesterol
z-3.09, diabetes, z=2.47) while congestive heart failure
(z-4.26) systolic blood pressure (z-2.67) ST depression
(z-2.64) and prior myocardial infarction (z=2.48) were
aasociated with instantaneous death.
SUDDEN DEATH RISK IN OVERT CORONARY HEART DISEASE: THE
FRAMINGHAM STUDY.
William B. Kannel, M.D., F.A.C.C., Ralph B. D'Agostino,
Ph.D., and L. Adrienne Cupples Ph.D., Boston University
Medical Center, Boston, Massachusetts
Over 30 years of follow-up of persons initially free of
coronary heart disease (CHD) there were 160 sudden deaths
(SD) in men and 73 in women. Of these, 55% in men and
67% in women occurred without intervening overt CHD. The
proportion of coronary attacks in men presenting as SD
increased from 13% at age 45-54 to 20% at age 75-84. In
those with interim CHD, SD incidence was 3-6 fold greater
than in those without intervening CHD whether the clini-
cal manifestation of CHD was angina or myocardial infarc-
tion. Silent or unrecognized myocardial infarctions have
the same SD risk as symptomatic recognized infarctions.
Curiously, the fraction of CHD deaths which were sudden
was lower in those with interim CHD (37%) than in those
without prior CHD (48%). The proportion of CHD deaths
as SD declined with age in men with interim CHD.
Although the relative risks of SD conferred by CHD were
similar in the two sexes, having CHD did not eradicate
the female advantage over men in absolute SD incidence.
Once CHD appeared, only systolic pressure in men and dia-
betes and cigarette smoking in women remained significant
predictors of SD. Cardiac failure and ECG-LVH also pre-
disposed to SD in men with intervening CHD. The propor-
tion of CHD deaths as SD has not declined over 3 decades
despite a national decline in overall CHD mortality.
Wednesday, March 12, 1986
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Ischemia and Electrical Instability
Sarcoplasmic Reticulum Calcium Release and Ischemic
Ventricular Arrhythmias In Rat Heart
U Thandroyen. tlu.. J. McCarthy. B.Sc .. LH Opie. MD.
MRC Heart Research Unit. University Cape Town. South
Africa. *University Texas Health Science Center and
VAMC. Dallas. TX.
We investigated the possible role of release of Ca2+
from sarcoplasmic reticulum (SR) in genesis of
ventricular arrhythmias during 30 mins left main
coronary artery ligation (CAL) in isolated rat hearts.
In control series all 13 hearts developed ventricular
premature beats (VPB number 225±5l). and ventricular
tachycardia (VI duration 123±21secs): 5 hearts
dev~loped ve~tricular fibrillation (VF). R2anodine10- m to 10- m which inhibits rel6,ase of Ca + from SR
prevented all arrhythmias eg RlO- m VPB 5/13. VI
1/14. VF 0/14 (each p<O.Ol vs control). Ryanodine
decreased left v~ntricular dP/dt 8+ ve (mm Hg/sec) at
15 minutes: 10- m. l364±40: 10- 8m UU±108 {ea~h
p<O.Ol vs control 1585±52. R 10- m but not 10- m
impaired LV relaxation. R did not preserve ischemic
tissue ATP. glycogen or reduce tissue lactate or
cyclic AMP. Heart rate ~nd coronary perfusio~ was
unchanged. Caffeine 10- m which decreases Ca + re-
lease from SR (by enhancing release and decreasing
reuptake) prevented VI. 3/10 vs 13/13 and VF 0/10 vs
5/13: each p<O.Ol vs control. Caffeine decreased
ischemic tissue energy stores and increase~ tissue
cyclic AMP. We suggest that release of Ca + from
sarcoplasmic reticulum may play an important role in
ventricular arrhythmogenesis during acute myocardi~l
ischemia. Ryanodine by modifying intracellular Ca +
flux may be prototype for new class of antiarrhythmic
agent.
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DOES INCREASED ADRENERGIC RECEPTOR DENSITY HELP MAINTAIN
SYMPATHETIC ACTIVITY IN THE ISCHEMIC MYOCARDIUM?
Junichi Hayashi, M.D., Ryuichi Matsuo, M.D., Hideharu
Manabe, M.D., Yoshizumi Habuchi, M.D., Akihiko Miyakawa,
M.D., Yoshio Watanabe, M.D., F.A.C.C., Cardiovascular
Institute, Fujita Gakuen Health University, Toyoake,
Aichi, Japan.
To test the hypothesis that an enhanced adrenergic
receptor function maintains sympathetic activity in
acutely ischemic myocardium, we studied the
relationships between the kinetics of beta and alpha-l
receptors and electrophysiologic parameters such as
excitability threshold and conduction time in
ischemic(IZ) and normal zones(NZ) in 12 dogs. Conduction
time was prolonged by l2±20% in IZ 15 minutes after a
left anterior descending coronary artery ligation.
This trend was maintained up to 60 minutes (20±24%),
while conduction time in NZ was not changed.
Excitability threshold was elevated in IZ from
O.ll±O.OlmA to 0.16±0.01mA after 45-60 minutes of
ischemia (p<0.05), but not in NZ. After 60 minutes of
ischemia, left stellate stimulation(SS) normalized the
elevated excitability threshold in IZ (p<0.05) and
slightly reduced the prolonged conduction time in IZ.
With phenol application after 60 minutes of ischemia,
blocking the sympathetic nerves into IZ, excitability
threshold and conduction time in IZ were further
increased. SS and phenol did not change excitability
threshold and conduction time in NZ. Receptor binding
assay showed that the beta receptor number was
significantly higher in IZ than in NZ (368±27 vs 25l±16
xlO-16 M/mg. protein, p<0.05), and so was the alpha-l
receptor number (667±146 vs 465±52, p<0.05). However,
their affinity was not altered. Thus, a homeostatic
mechanism at the receptor site appeared to maintain
sympathetic activity under ischemia.
THE DEPENDENCE OF REENTRY ON THE SITE OF
STIMULATION IN THE ISCHEMIC CANINE VENTRICLE.
William B. Gough, Ph.D.• Mark Restivo. M.S .• Vijayanand
Kowtha, M.S .• Mahshid A. Assadi. M.D .• Nabil El-Sherif.
M.D .• F.A.C.C .• SUNY Downstate and VAMC Brooklyn. N.Y.
It has previously been shown that a premature beat. S ,
from the right ventricular outflow of the canine hear~.
4 days post infarction. produces an arc of functional
conduction block (arc) around which activation slowly
conducts in a figure of 8 pattern and reenters. The
spatial gradient of effective refractoriness (ERP) that
occurs around the border of the IZ comprises the
functional substrate for the arc. Isochrones of ERP
appear as concentric rings which increase from the
border to the core of the IZ. This study determined how
the arc depended on the sight of stimulation (SOS) when
sites circumscribing the IZ were tested. In 9 dogs
showing epicardial reentry. the ERPs (2x diastolic
threshold) were determined at all 62 recording sites.
There were two types of responses observed. At moderate
gradients (20-50 msec/cm) the arc centered opposite the
SOS and rotated as the sas was rotated. However. at
severe ERP gradients (50-110 msec/cm) the arc changed
little when the sas was rotated because the time of
conduction around the IZ was still shorter than the
recovery of excitability of sites forming the arc.
Consequently. the reentrant pattern changed little.
Therefore. 1) The morphology of the arc may vary as a
function of sas. 2) The isochrones of ERP determine the
arc regardless of the fiber orientation between the saS
and the IZ (all fiber orientations between the sas and
IZ were encountered with saS rotation). Thus. the inter-
action of sas and ERP patterns determine the inducibil-
ity of reentry. These principles may apply to the choice
of SOS and inducibility of ventricular reentry in man.
EFFECTS OF PRETREATMENT WITH PROPRANOLOL ON MYOCARDIAL
8-ADRENOCEPTORS DURING ACUTE ISCHEMIA
Joel S. Karliner. M.D., F.A.C.C., Michael
Wanda Woloszyn, Norman Honbo and Julien
M.D. F.A.C.C.. VAMC. CVRI and Dept.
University of California. San Francsico.
Chronic 8-blockade is used to prevent acute ischemia.
but few data exist on the effects of such therapy on
8-receptors either in normal (N) or ischemic (I)
myocardium. We infused propranolol 1.0 mg/kg for 6-8 days
in 4 beagles. 8-blockade was confirmed by a blunted HR
response to isoproterenol. Five dogs served as controls.
Myocardial blood flow was measured by microspheres before
and 1 hr after left anterior descending coronary artery
ligation. The central endocardium of the grossly cynotic
area was selected for blood flow and receptor analysis.
The opposite normal myocardial wall served as an
additional control. In the 8-blocked dogs. blood flow
was reduced from O. 52±0. 20 (SO) to •025±0. 025 ml/min/ gm
wet weight (p <.025). In the opposite normal wall pre-
and post-ligation values were 0.56±0.15 vs 0.64±0.23
ml/min/mg wet weight (p=NS). Values3in control dogs werenot different. 8-receptor density ( H-dihydroalprenolol)
was not increased by 1 hr of I in control dogs when I and
N myocardium were compared (7.22±1.4 vs 6.70±1.1 pmol/mg
DNA). Chronic propranolol treatment also did not affect
S-receptor density in N or I myocardium compared with
control dogs. However. antagonist Kd increased in both Nand I myocardium after 8-blockade compared with control
dogs (23.0±13.3 vs 5.49±2.55 and 17.5±8.9 vs 7.53±3.42
nM. both p<.05). We conclude: 1) contrary to prior
reports acute I does not increase 8-receptor number; 2)
both in N and in severely I myocardium, chronic
S-blockade produces decreased antagonist affinity without
alterations in receptor density.
SUPIISBLIC'l'IYI lCUOI 01' BD-I-28 III llmlll'l'ICrrr lID
COIIlUC'l'IOI D IDIW. lID IIPlIC'I'ID DOG IIIU'l'S
Bon1Wp J. SAMely. Ph.D., F.A.c.e., Eugene Patterson,
Ph.D., LuZhi GUo, M.D., M. Daniel Thompson, Ph.D., and
K. Darrell Berlin, Ph.D. University of Oklahoma Health
Soienoes Center and VAMC, Oklahoma City, OK.
Previously we found a new antiarrhythmic (AA) agent BRB-
1-28 had signifioantly better AA effects than lidooaine
(L). To study the basis of these effects, complete heart
blook was induoed by AV nodal (AVN) damage in 9 anesthe-
tized dogs. The idioventrioular rate (IVR) averaged
42;t6/min. After intravenous L, 3 and 6 mg/kg, IVR was
reduced to 32:t11/min, p=0.04 and 21:t9/min, p=0.009,
respectively. BRB-I-28, 3 and 6 mglkg had no significant
effeot on IVR, 41:t9/min and 41:t6/min. In 10 dogs, 24
hours after left anterior descending ooronary artery
ligation, atrial paoing and His bundle recordings were
used to determine AVN and His-Purkinje conduotion times.
Only L, significantly depressed AVN oonduotion. Wenoke-
baoh cycles (We) ocourred at 321:t14/min during oontrol
paoing and were unohanged after BRB-I-28, 6 mg/kg. After
L, 6 mglkg, we were seen at 274:t21/min. Neither BRB-I-28
nor L signifioantly affected His-Purkinje conduction.
Vagal induoed slowing of the sinus rate unmasked aooeler-
ated IVR, 145:t20/min whioh was slowed by L, 125:t23/min,
p=0.05 but was unaffeoted by BRB-I-28, 138:t19/min, p=0.5.
BRB-I-28 prevented induci ble, reentrant ventricular
taohycardia (RVT) in 3/8 dogs; L in 0/8; and BRB-I-28
slowed RVT by 66/min whereas L slowed VT by only 35/min.
Unlike L which depresses automaticity and conduotion in
normal and infaroted hearts, BRB-I-28 inhibits the
induotion of reentry in infaroted hearts and has no
effeots on normal or abnormal automaticity. Its seleotive
depression of slow conduction only in abnormal tissues
appears to aocount for its AA action.
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EFFECTS OF VENTRICULAR ECTOPY ON MYOCARDIAL INFARCT SIZE
IN DOGS.
Stanley Nattel, M.D'RF.A.C.C., Scott Beau, and GaryMctarragher, B.sc.,cGil' University, Montreal, Canada.
Tachycardia is known to increase the size of an evolving
~ocardial infarction, but the effect of frequent
ventricular ectopic beats on infarct size is unknown. To
evaluate the effects of ventricular extrasystoles on
infarct size, dogs anesthetized with morphine and
chloralose were allocated to a control group (n=15) or to
groups of dogs with ventricular bigeminy produced by
programmed stimulation. A sensing circuit was used to
deliver one extrastimulus after each spontaneous complex
with either a short coupling interval simulating
interpolated PVC's (Group I, n=10) or a long coupling
interval resulting in a compensatory pause (Group 2,
n=10). Ventricular extrastimuli substantially increased
heart rate in group 1 dogs, but did not alter overall
rate in group 2 dogs. All dogs underwent single-stage
left anterior descending coronary artery ligation,
followed by a 6-hour monitoring period. Premature
stimulation was begun at the time of coronary artery
occlusion and continued throughout the observation
period. The ratio of ~ocardial infarct size measured
using vital staining with TTC to the region at risk of
infarction was substantially larger in group 1 dogs (0.58
± .07, p (.01) compared to control dogs (0.24 ± .06) or
to group 2 dogs (0.32 ± .07). We conclude that frequent,
closely-coupled ventricular extrasystoles can increase
th~ size of an evolving acute ~ocardial infarction.
Thl~ may be ~ consideration in evaluating the need for
antlarrhythmlc drug therapy in patients with acute
myocardial infarction.
Wednesday, March 12, 1986
10:30AM-12:00NOON, Room #268
Hypertrophy and Injury
HYPERTROPHIED MYOCARDIUM IS NOT MORE SENSITIVE TO ISCHEMIC
INJURY. Ruth H. Strauss, M.D., Ellen O. Weinberg, W. Mark
Vogel, Ph.D., Carl S. Apstein, M.D., F.A.C.C. Boston Uni-
versity School of Medicine and Boston City Hospital,
Boston, MA
In hypertensive patients, left ventricular hypertrophy
(LVH) is associated with increased mortality. We hypothe-
sized that LVH due to hypertension may increase the
sensitivity of myocardium to ischemia (I). We compared the
effects of 10 min of I at 370 C in isolated isovo1umic
(ba11oon-in-LV) buffer-perfused hearts from 8 wks hyper-
tensive DOC-salt rats with LVH (n=7) to normotensive
control (C) (n=12) rats.
The DOC-salt treatment caused significant hypertension
and LVH. For DOC-salt vs C, systolic (tail cuff) BP was
increased by 75% (l99:!:10 vs 114:!:6nunHg, p<O.OOl), LV weight
by 45% (1390~60 vs 960:!:5Omg, p 0.001), and LV/body weight
by 62% (3.4+0.2 vs 2. 1+0. 1mg/gm; p< 0.001).
During the iso1ated- heart perfusions, the C and LVH
groups received coronary perfusion pressures of 100 and
l40nunHg respectively to approximate in vivo arterial dia-
stolic pressures; myocardial perfusion rates were equal
(20:!:1 vs 22:!:2m1/min/gm for C vs LVH, p=ns) and baseline LV
function was comparable to in vivo values: LV systolic
pressures (at LVEDP=lOnunHg) were 99+5 vs 162+8nunHg for C
and LVH. After 10 min of complete I and 60 min reperfusion,
recovery was 63~4 vs 67:!:1% of baseline developed pressure
and diastolic contracture was 29+6 VB 30+11nunHg for C VB
LVH (p=ns). --
Conclusion: When coronary perfusion pressure is ad-
justed to maintain tissue perfusion rates during pre- and
post-ischemia, hypertrophied myocardium is not more sen-
sitive to ischemic injury.
GREATER INFARCT EXPANSION IN A CHRONIC LEIT VENTRICULAR
HYPERTROPHY MODEL: POSSIBLE MECHANISM OF INCREASED
MORTALITY SEEN IN HYPERTENSIVES WITH ACUTE MYOCARDIAL
INFARCTION. Shel1ee E. Nolan MD, Pamela Dudeck BA,
John A. Mannisi MD, David E. Bush MD, Harlan F. Weisman
MD. Johns Hopkins Medical Institutions, Baltimore, HD
Chronic elevation in afterload which causes left
ventricular hypertrophy (LVH) increases mortality after
myocardial infarction (MI). Infarct expansion, early
thinning and dilatation of the infarct, also increases
mortality. Whether there is a relationship between
chronic afterload stress and infarct expansion is
unknown. To study this, rats had aortic banding or sham
operation, and after 3 weeks had sham thoracotomy or HI
by left coronary ligation. Surviving rats were sacrificed
7 days later and hearts fixed in diastole for analysis.
Mortality was greater in the band/MI group with most
deaths within 24 h. Banded hearts without MI had signifi-
cant LVH by heart weight (p < 0.001). Among survivors,
infarct expansion was seen in MI hearts with and without
bands. However, expansion measured as cavity dilatation
and infarct thinning was greater in the band/MI group:
±S.E. Sham Band MI Band/MI P
n 13 11 26 27
Survival 92% 100% 81% 48% < 0.001
Cav Size (mm3) 40±5 53±5 67±8 87±8 - 0.001
Wall Thick (mm) 2.4±.1 2.7±.2 1. 7±. 2 1. 2±.1 < 0.001
Thus, chronic increases in afterload sufficient to
produce LVH are associated with greater infarct thinning
and dilatation. This increase in expansion might explain
the higher infarct mortality seen in patients with
hypertension and LVH.
REDUCTION OF MORTALITY AND MYOCARDIAL ISCHEMIA REPERFUSION
INJURY WITH FRUCTOSE-l,6-DIPHOSPHATE (FDP).
Angel K. Markov, M.D., F.A.C.C., Jefferson Fletcher, M.D.,
Dennis Strete, M.S., Patrick H. Lehan, M.D., F.A.C.C. and
Harper He11ems, M.D., F.A.C.C., University of Mississippi,
Jackson, MS.
FDP is reported to have substantial therapeutic effect in
myocardial infarction and shock, both in animal models and
man. To verify whether FDP will have similar therapeutic
effect during reperfusion, in 28 anesthetized dogs a major
branch of the LCA was occluded for 2 hours and then the
ischemic myocardium was reperfused. Five minutes prior to
reperfusion 14 dogs received 75 mg/kg IV bolus of FDP
(10%) and then 6 mg/kg/min for a total of 500 mg/kg, and
14 controls received equal amount of glucose in 0.9% NaCl.
The dogs surviving 2 hours post-reperfusion were allowed
to recover and 24 hours later were sacrificed and the
infarct size was determined histochemically. The LVEDP at
2 hours post-reperfusion of the control dogs was 24 + 3 mm
Hg, while in the FDP group it was 13.5 + 2.6 mm Hg (p <
0.005). The CO, arterial pressure and contractility were
higher in the FDP group (p < 0.01; p < 0.05, and p < 0.02
respectively). The myocardial blood flows prior to and
during occlusion were similar between the groups; however,
during reperfusion they were higher in the FDP group
(N.S.). Eight controls died during and after reperfusion
and only one in the FDP group (p < 0.01) despite that both
groups received the same amount of Xy1ocaine. The infarct
size in the FDP group was 17 + 6% of the left ventriclular
mass, while in the dextrose group it was 37 + 8% (p <
0.01). FDP attenuated myocardial reperfusion injury and
reduced significantly mortality in the model described.
The mechanism appears to be related to the positive effect
of FDP on anaerobic glycolysis and its ability to reduce
generation of oxygen free radicals.
I (n=24) 33 ± 15 38 + 16
1/ (N=21) 28 ± II 30 ±12
III (N=17) 25 ± 9* 41 ± 15
* difference SOD vs albumin, p <.01
Therefore, only selective retrograde administration of SOD
significantly reduced IS. This suggests that selective delivery to
the risk region of a high concentration of on agent capable of
reducing IS is critical for successful therapy.
SELECTIVE RETROGRADE ADMINISTRATION OF SUPEROXIDE
DISMUTASE VIA THE CORONARY SINUS IMPROVES INFARCT
SIZE REDUCTION. Emily Diltz, M.D., David Canvasser, DVM,
Nancy Fisco, Thomas Underwaod, Jo'1n Nicklas, M.D. University
of Michigan, Ann Arbor, Michigan.
Infarct size (IS) reduction has been demonstrated in
occlusion/reperfusion animal models with left atrial (LA)
infusions of superoxide dismutase (SOD) begun before ischemia.
To determine if IS could also be reduced by SOD at the time of
reperfusion, 3 experiments were performed randomly comparing
SOD administration with albumin. IS was measured in 69 open
chest <rlesthetized dogs fol/owing 90 min of regional ischemia
produced by occlusion of the proximal LAD and 6 hrs of
reperfusion. Risk moss (RM) and IS were determined after
sacrifice by dual perfusion staining with trypan blue and triphenyl
tetrazolium chloride. Experiment I dogs received SOD (5 mg/kg)
or albumin (10 mg/kg) via the LA over 2 hr beginning 15 min prior
to LAD occlusion. Experiment 1/ dogs received SOD (10 mg/kg) or
albumin (1.0 mg/kg) IV for 5 min beginning I min prior to
reperfusion. Experiment III dogs received SOD (5 mg/kg) or
albumin (10 mg/kg) retrograde via the great cardiac vein for 5
min beginning I min prior to reperfusion. Results (mean ± SD):
IS/RM%
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BENEFICIAL LONG TERM EFFECT OF INTRACORONARY
PERFLUOROCHEMICAL ON INFARCT SIZE AND VENTRICULAR
FUNCTION IN A CANINE REPERFUSION MODEL.
Mervyn B. Forman, M.D., B. Hadley Wilson, M.D.,
David Puett, B.A., Donna Bostick, R.N., Gottlieb C.
Friesinger, M.D., F.A.C.C., Renu Virmani, M.D.
Vanderbilt University, Nashville, Tennessee.
The long term effect of low dose intracoronary (IC)
perfluorochemical (PFC) , Fluosol-DA, on infarct size
reduction, ventricular function and infarct evolution was
studied in 17 anesthetized closed-chest dogs. After 90
minutes of proximal LAD occlusion the animals were reper-
fused with IC streptokinase, ventilated with 100% oxygen
and randomized into two treatment groups (Gp): GpI (n-9)
received oxygenated saline and GpII (n-8) oxygenated PFC
IC at 15 ml/kg. Heart rate, systolic pressure, LV filling
pressure and contrast ventriculograms were obtained at
baseline, occlusion, 3, 24 hours, 1 and 2 weeks post re-
perfusion. 24 hr Holter monitoring was performed 12 days
post reperfusion. Regional LV function was analyzed using
a computerized radial shortening method. Area at risk
(~) was defined in vivo using Monastryl blue and area of
necrosis (~l) with modified trichrome stain. No signifi-
cant differences were noted in hemodynamic parameters.
Results are expressed as mean ± SEM,*p<O.OOl, **p<O.Ol.
~/~ (%) ~/LV (%) ~/LV (%) 6RS+ (%) PVC/hr
GpI 36.4±2.9 l4.4±2.0 33.2±6.6 8.3±2.6 2.9±2.8
GpII *12.8±3.3 *5.l±1.8 34.6±3.5 **25.4±5.3 l8.4±17.7
+ change in radial shortening (RS) 3 brs vs 2 weeks.
There was no significant difference in infarct
morphology at 2 weeks between the two groups. IC PFC
markedly reduces infarct size in the canine reperfusion
model without increasing propensity for ventricular
arrhythmias. IC PFC a1&o resulted in significant
improvement in regional LV function in the ischemic zone.
DOES HYDROGEN PEROXIDE GENERATED BY SUPEROXIDE
DISHUTASE CONTRIBUTE TO REFLOW INJURY?
Giusfj'~e Amb~os~o. M.D., William E. Jacobus, Ph.D.
ando n f.1a erty./. M.D., F.A.C.C., Johns Hopkins
Medical Institutions ~altimore, MD.
Evidence is accumulating that oxygen free radicals,
particularly superoxide anions generated upon reperfu-
sion of ischemic ~ocardium, may play an important role
in the gene,is Qf reflow injury. However, superoxide
dismutase (SOD) catalyzed dismutstion of superoxide
radicals leads to the formation of hydrogen peroxide,
which could potentially cause further myocardial
damage. To determine whether catalase (CAT), an enzyme
capable of scavenging hydrogen seroxide, is benefic1al
when added to treatment with SO or whether endogenous
catalase or glutathione peroxidase activities are
sufficient to metabolize the hydrogen peroxide
generated by SOD, 36 Langendorff perfused r~bbit hearts
were subjected to 30 min of normothermic (37°C) total
global ischemia. At the time of reperfusion l2( heart~
received 60,000 IU of recombinant human SOD h-SOD)
producid by genetic engineering, as a bolus followed by
100 IU ml for 15 min; 12 hearts received h-SOD + 60}OOO
IU of CAT as a bolus followed by 100 IU/ml of Doth
enz~es for 15 min; and 12 hearts received a bolus and
15 min of normal perfusate. All hearts then received
standard perfusate for 30 additional min. Recovery of
left ventricular developed pressure (DP) was measured
by means of an intraventricular balloon. Phos,Phorus
31-NMR spectroscopy allowed continuous mon~tonng of
myocardial ATP and phosphocreatine (PCr) content
Results below are expressed as percent of baseline.
* D P < 0.05 vs Control hearts
Experimental End 0 Ischem1 Eqd of Reflqw
t:~HB ATP % PC % DP!%) Pcr~%~
+ + 68 + 5* 88 + *
h-SOD+CAT 29 "+ 3 7"+ 1 66 "+ 6* 83"+ 6*
Control 34 "+ 2 7"+ 2 48 "+ 4 65"+ 5
Despite equal depletion of-ATP and PCr by the -end of
the ischemic period, recovery of ventricular function
and PCr content was equally improved in h-SOD and
h-SOD+CAT treated hearts compared to Control. Thus,
h-SOD administration resulted 1n significant reduction
in reflow injury. CAT provided no additional benefit,
suggesting e1ther that the hydrogen peroxide generated
by SOD is not harmful or that enaogenous mechanisms are
capable of scavenging the quantities of hydrogen
peroxide generated by the dismutation reaction.
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Valvular Disease
"DOPPLER DISEASE": FOUR VALVE INSUFFICIENCY IS COMMON
THOUGH OFTEN CLINICALLY INSIGNIFICANT. Richard S.
Meltzer. M.D •• F.A.C.C" Laura Abovich, B.S., Mindy
Finkelstein, B.S. Mt. Sinai Medical Center, New York, NY
During a 7 month period in 1984-5, 30 patients were
identified witn regurgitation of all 4 cardiac valves by
Doppler ecnocardiograpny (2029 nad ecnoes, including
1115 Doppler studies during tnis time). Valvular
insufficiency was diagnosed witn the Doppler sample
volume positioned just proximal to the relevant valve;
nolosystolic turbulence was necessary to diagnose mitral
or tricuspid regurgitation, and early and mid-diastolic
turbulence was required for semilunar regurgitation. Of
tne 30 patients witn regurgitation of all 4 valves,
tnere were 7 men and 23 women, aged 43-86 (mean 69)
years. Only 21 of tnem nad nolosystolic murmurs and
only 9 nad early diastolic murmurs of valvular
regurgitation. Left neart failure was clinically
present in 24 and rignt neart failure in 17. In only 4
was valvular regurgitation (2 aortic, 2 mitral) felt to
be the primary problem leading to neart failure. Ecno
measurements (mean t 1 3D): LA: 51 Z 11 mm; LV (end
diastole): 53 t 11 mm; fractional snortening 31 ~ lOS.
It is concluded that insufficiency of all 4 cardiac
valves is common by Doppler ecnocardiograpny, usually in
tne setting of biventricular failure, tnougn as a group
LV dimension and fractional snortening was normal.
Tnere may be a female predominance. Tnougn a mitral or
tricuspid insufficiency murmur is likely to be present,
a semilunar valve insufficient murmur is usually not
detected despite careful auscultation by a
cardiologist. Pnysicians need to be aware of tne
frequency of valvular insufficiency by Doppler
ecnocardiographic tecnniques and to realize that not all
"Doppler disease" is clinical disease.
JACC Vol 7, No 2
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A NBV METHOD IDS CALaJLATUIG VALVE ARKA III MITRAL
STENOSIS, William E, Lawson, M,D"Marcis T,Sodums,M,D"
Claire Proctor, ROMS, Peter F, Cohn, M,D" F,A,C,C,
SUNY Health Sciences Center, Stony Brook, NY,
Use of the Gorlin formula for predicting mitral valve
area (MVA) in mitral stenosis is time consuming, requir-
ing planimetry for estimation of the mean transmitral
gradient, and often limited by the ability to obtain an
accurate cardiac output, The doppler pressure 1/2 time
formula for mitral stenosis is relatively insensitive to
changes in cardiac output and has been shown to provide
an accurate estimation of MVA, Applying this formula to
cath data allows quick and accurate calculation of the
MVA from 4 variables: the initial and end diastolic (D)
wedge (PCW) pressures (Po,P l ), the left ventricular end
diastolic pressure (LVEDP), the diastolic filling period
(DFP-in milliseconds (mS», [ ~ ]
MVA (cm 2): [733] I - !I - LVEDP
DFP P
Since the exponential decline in D transgitral gradient
is altered by atrial systole, in patients in sinus
rhythm the pre "a" values of PCW, LVEDP, and DFP should
be used in the calculation of MVA, A gro~p of II
patients with mitral stenosis(,S7-1,94cm ) had their MVA
calculated using both methods , Both formulas consistently
yielded similar results (correlation coefficient r:,98),
The new method offers the advantage of not requiring
cardiac output to be measured or planimetry of the
valve gradient, In atrial fibrillation the new method
yields a good estimate of the MVA from individual
cycles. Under conditions where D diastasis occurs (such
as mild mitral stenosis and during long cardiac cycles)
the formula simplifies to the easily calculated:
ABNORMAL PLASMA LEVELS OF ATRIAL NATRIURETIC FACTOR
(ANF) IN PATIENTS WITH SYMPTOMATIC MITRAL VALVE PROLAPSE
Andre pasternac
t
M.D., F.A.C.C. Simon Kouz, M.D.,
Jolanta Gutkows a, Ph.D., Robert Petitclerc, M.D.,
Bruno Vellas, M.D., Jacques de Champlain, M.D., Ph.D.,
Marc Cantin, M.D., Ph.D., and Martial G. Bourassa,
M.D., F.A.C.C., Montreal Heart Institute and University
of Montreal, Montreal, Canada,
Volume depletion sensitivity, postural hypotension and
increased adrenergic activity have sug~ested an abnor-
aality in plasma volume control in patients (pts) with
mitral valve prolapse (MVP). To test whether an abnor-
mality in atrial natriuretic factor (ANF) was present,+
we studied 15 pts (12 females, 3 males, mean age 47.1-
3.7 yrs) with MVP (M and 2 0 Echo). Blood pressure,
heart rate and free plasma norepinephrine (NE), epi-
nephrine and dopamine (Peuler and Johnson technique)
were obtained in supine (s) and standing (st) posi-
tions. Plasma ANF was measured by radio-iDlllunoassay,
32 males and 29 females provided ANF control values
(males: 59.6±3.9 (SE) pg/ml; female 79.3±4.4 pg/ml).
Patients were divided into 3 groups: I: low, II: normal
and III: high values of ANF
I II III
, pts 8 3 4
Age (yrs) 48.4±4.6 NS 54.3±12.7 NS 39.0±5.6
M/F 2/6 0/3 1/3
ANF (pg/ml) 39.9±3.2 p<O.OOl 68.l±2.6 p<O.05 l62.0±32.0
NBs (fg/ml) 300±17 NS 318±l08 NS 258±82
NBst ps/ml) 663+51 NS 802+288 NS 557+182
ANF was decreased in 8/15 patients (53.3~) and in-
creased in 4/15 (26.6~). The levels of ANF showed no
relationship to age, blood pressure, heart rate and
catecholamines. NE levels were elevated in all 3 groups
in sand st positions (P<O.Ol with control values), but
epine~hrine and dopamine levels were normal in sand st
positions in all groups.
These data suggest that symptoms in patients with MVP
reflect variable hemodynamic and neuroendocrine re-
sponses to altered adrenergic and plasma volume control.
MVA (cm2): 733
DFPD
(DFPD: DFP to diastasis
in mS)
12 pts had MS without regurgitation and, in these, MVA
calculated after TNG was 0.4 ± 0.1 cm2 larger than
control, Administration of TNG during evaluation of
MS eliminates P vnc which raises PW above LA in some
pts. TNG may add diagnostic accuracy without trans-septal
catheterization. Whether the response to TNG has direct
therapeutic value in MS has yet to be determined,
EFFECT OF NITROGLYCERIN DURING HEMODYNAMIC ESTIMATION
OF VALVE ORIFICE IN PATIENTS WITH MITRAL STENOSIS
Jonathan L, Halperin, M.D.,F.A.C.C., Elizabeth B.
Roth1auf, R.N., Bruce P. Mindich, M.D., F.A.C.C., Kenneth
M. Brooks, M,D., F.A.C.C., and John A. Ambrose, M.D.,
F.A.C.C., Mount Sinai Medical Center, New York, NY.
In mitral stenosis (MS), valve (MV) orifice (MVA)
calculations using pulmonary (P) capillary wedge pressure
(PW) as a substitute for left atrial pressure (LA) may
overestimate the severity of disease. Previous studies
have shown that prosthetic MVA determined from
trans-septal LA pressure exceeds area derived from PW
measurement due to P venoconstriction (vnc), which is
reversed by nitroglycerin (TNG). To assess the effect
of TNG, 0.6 mg sublingual, we studied 20 (pts) with
MV disease during preoperative catheterization using
PW. Data are mean ± SEM; F = flow; G= gradient.
WHY DO INTRAVENOUS DRUG ABUSERS DEVELOP
TRICUSPID VALVE ENDOCARDITIS? Martin E, Goldman MD
FACC, Robert Reichstein MD FACC, Michael Borodkin, Karen
Stavile RN, Stephen Winters MD, Valentin Fuster MD FACC, Mt.
Sinai Medical Center, NY,
Usually, underlying valve pathology predisposes patients (pts)
to endocarditis, Intravenous drug abusers (Addicts) have a much
greater incidence of tricuspid valve (TV) endocarditis than
normal pts, Since TV prolapse is probably the most common
abnorality of the TV, present in up to 52% of pts with mitral
valve prolapse (MVP), we evaluated 28 consecutive addicts with
TV endocarditis to determine if they had a higher incidence of
MVP and therefore possible TV abnormalities. Over a 3 year
period there were 20 males and 8 female addicts aged 32+7
years, all with clinical TV endocarditis and confirmed wITh
positive TV vegetations documented by two-dimensional
echocardiography (2DE), Since the TV was already abnormal due
to endocarditis and could not be analyzed for native
abnormalities, M-mode and 2-dimensional echocardiograms were
read blindly by 2 reviewers for possible MVP or mitral valve
redundancy (3 or more systolic C-D lines). .
Interestingly, 17 of 28 pts (61 %) with TV endocarditis had MVP
and 26 of 28 (93%) had either MVP or redundant mitral valves,
Additionally, the tricuspid vegetation occurred on the atrial side
rather than the ventricular side of the TV in 24/28 (86%) pts
suggesting underlying TV regurgitation. Also, the vegetation
appeared on the anterior leaflet of the TV, the largest of the 3
leaflets, and possibly with the most myxomatous degeneration, in
24/28 pts,
Thus, despite the large number of intravenous drug abusers in
the country, only a small percentage develop tricuspid valve
endocarditis. These patients may have underlying myxomatous
tricuspid valve disease with tricuspid regurgitation as their
predisposing factor to endocarditis.
MVG (mean; mmHg)
MVF (liters/min)
MVA (Gor1in; cm2)
CONTROL
12.6 ± 1.2
4,0 ± 0,3
0,8 ± 0,1
TNG
11.5 ± 1.0
4.1 ± 0,3
1.1 ± 0,2
P
NS
NS
<0.05
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BENEFICIAL EFFECTS OF NITRATE THERAPY ON LEFT VENTRICULAR
HEMODYNAMICS AND FUNCTION IN PATIENTS WITH CHRONIC SEVERE
MITRAL REGURGITATION
Arie Roth, MD, Anil Kumar, MD, Daniel Kulick, MD, Charles
R. McKay, MD, FACC, David Kawanishi, MD, Shahbudin H.
Rahimtoola, MD, FACC, Uri Elkayam, MD, FACC. LAC/USC
Medical Center, Los Angeles, CA
Decrease of LV volume & mitral regurgitant orifice has
been suggested as a potential mechanism of reduction(f)of
mitral regurgitation (MR) • Nitrates exert a predominant
venodilatory effect &may lead to + of venous return & LV
volume. We assessed the hemodynamic effects of intra-
venous nitroglycerin(NTG)titrated to f mean pulmonary ar-
tery wedge pressure(PAW) >30% in 13 patients (pts) with
chronic severe MR. Heart-rate (HR) mean blood pressure
(MBP), right atrial pressure(RA), cardiac index(CI), for-
ward stroke volume index(FSVI) systemic vascular resist-
ance(SVR), LV end diastolic volume(EDV), LV end systolic
volume(ESV), LV ejection fraction(EF), regurgitant frac-
tion(RF) & volume (RV) were evaluated at baseline (C) &
during NTG infusion. * P<0.05 vs C.
HR MBP RA C1 PAW SVR
(beats/min)(mmHg)(mmHg) (L/min/m2 ) (mmHg)(dynes's'cm~)
C 95±20* 92±11* 12±5* 2.0±0.6 23±6* 1986±524*
NTG 89±18 79±12 7±4 2.2±0.5 14±6 1576±557
EDV ESV EF FSVI RF RV
(ml) (ml) (%) (ml) (%) (ml)
C 248±54* 132±61* 48±16* 22±8 67±15 80±34
NTG214±53 97±44 56±16 26±7 64±9 73±32
Summary - NTG resulted in a significant + in LV preload
& afterload leading to + on LV volumes & improvement of
EF. However, there was nO change in RF or RV.
Conclusions: Nitrate therapy exerts beneficial effects
on LV hemodynamics & function in pts with severe MR. 2)
As RV & RF do not change these effects are due to periph-
eral vasodilation effects & not due to improvement of MR.
CLiNICAL-MORPHOLOGIC CORRELATION IN 31 PATIENTS
WITH MITRAL STENOSIS AND PURE TRICUSPID REGURGI-
TATION: ANULAR CiRCUMFERENCE is USEFUL IN PREDICTING
WHICH TRICUSPID VALVES NEED REPLACEMENT OR REPAIR
AT THE TIME OF MITRAL VALVE SURGERY FOR MITRAL
STENOSIS
Bruce F. Waller, M.O.,F.A.C.C., Yousuf Mahomed,
M.D .• F.A.C.C., John W. Brown. M.D.,F.A.C.C .•
John E. Pless.M.D. Indiana University Medical
Center, IndianaPOl is.
Preoperative 'clues to tricuspid valve (TV)
morphology useful in management of pure tricuspid
regurgitation (TR) at the time of mitral valve
stenosis (MS) replacement (MVR) or repair is
lacking. Thus. purely regurgitant TVs from 31
patients (pts) with MS were examined: 17
operatively-excised TVs and 14 necropsy-excised TVs.
Of the 31 TVs, 14 (4St) were morphologically
classified as rheumatic TR and 17 (SSt) as
"functional" TR (normal leaflets and commissures).
TV anular circumference was a useful separator of
the 2 types of TVs: rheumatic valves had normal
anul i (10.5-12.0 em. m=11.4){normal TVs 9.0-12.5 em.
m= 11. 01 wh i Ie the "funct iona I" TR va 1ves had
markedly di lated anul i (12.5-14.5 em, m=13.6),
p<.05. Thu~. measurement of TV anular circumference
is a useful predictor of the morohologic status of
purely regurgitant TV in the presence of MS and may
aid in therapeutic decisions regarding TV
replacement or repair.
FAILURE OF LEFT AIRIAL SIZE TO PREDICT SYSTEMIC EMBOLISM
IN PATIENTS UNDERGOING VALVE REPLACEMENT. ~
~iel, Ph.D., Heidi Krause-Steinrauf, B.S., Karl E.
Hammermeister, M.D., FACC, Michael H. Crawford, M.D.,
FACC, Gulshan K. Sethi, M.D., Participants in VA Coopera-
tive Study on Valvular Heart Disease.
To determine whether left atrial dimension (LAD) meas-
ured by M-mode echocardiography was associated with sys-
temic embolism (SE) following valve replacement (VR), we
compared baseline characteristics and LAD between 39
patients with SE and 487 without SE from the VA Coopera-
tive Study on Valvular Heart Disease. Data were collected
prospectively; average followup after VR was five years.
The average annual incidence rate of SE was 0.5% follOWing
aortic VR (8/338), 2.9% follOWing mitral VR (20/140), and
2.9% following multiple VR (7/48). SE occurred more fre-
quently in patients with nonsinus than sinus rhythm
(12.4% vs. 6.2%, p<.05), and in patients with a prior
history of SE (15.2% vs. 6.7%, p<.05), while mean pulmon-
ary artery pressure was significantly higher in patients
with SE than in those without SE (47 vs. 41 mmHg, p<0.05).
However, mean LAD was not significantly different when
patients with SE were compared to those without SE (4.98
vs. 4.62 em, p>O.lO). LV ejection fraction was slightly
higher in patients with SE than in those without (0.54 vs.
0.49, p=O.lO). Other variables which were not signifi-
cantly associated with SE were functional class, LA en-
largement on chest x-ray or ECG, smoking habits, anti-
coagulant use, systolic shortening fraction, LV end-
diastolic dimension, and CI. We conclude that history of
prior SE, valve(s) replaced, nonsinus rhythm and increased
pulmonary artery pressure, but not left atrial enlargement
by any criteria, identify patients at increased risk for
SE after YR.
RISK OF ANTICOAGULATICN IN PREX:iNANT \01EN WITH ARrIFICIAL
HEI\RI' VALVFS.
IGNACIO lTURBE M.D, CARMEN FCNSOCA,M.D., ALEJANDRO 'lPJA-
RIAS M.D., OSVALOO MU'IOIINIK M.D., ANGEL SANTOS M.D.,
EDUAROO SAIAZAR M.D, F.A.C.C. Instituto Nacioaal de
Cardiologia "Ignacio Chavez" M:xico City, M:xico.
The use of anticoagulants during pregnancy in patients
with artificial heart valves represents a serious thera-
peutic dilemna. In this prospective study \\e followed 64
pregnancies (PR) in 53 patients (P). They \\ere divided in 3
groups according to the tiJre of diagnosis of PR. All \\ere
taking acenocoumarol (AC) at the tiJre of diagnosis. Group
I received 5000U of heparin(H) sc q12h from the 6th to
the 12th of PR (20PR). Group II: The P were switched to
H after the 7th week until the 12th week (l2PR). After
the 12th week the 2 groops received AC. Group III re-
ceived PC. during the whole PR (32PR).
The rate of abortions was 15.6% for the 2 groups that re-
ceived H and 18.7% for the group that received AC during
the whole PR. 49 out of 51 children were examined, 2 out
of 26 fram group III had classical signs of warfarin em-
bryopathy (WE), and 5 nore of group III and 2 of group II
had abnormalities of the facial bones suggestive of WE.
'lID P of group I had valve thrombosis while receiving H
and one died. Both had Bjork-Shiley mitral prostheses.
It is concluded that the risk of WE is high ~f AC is ad-
ministered during the first triJrester of PRo H adminis-
tered sc at a fixed dose has a higher risk of thrombotic
events than PC.. The risk of WE increases if PC. is switbhed
to H after the 7th week carpared to the ones that re-
ceived it before the 7th week. There is a need to eva-
luate the use of higher doses of H to minimize the risk
of thrombosis to the nother.
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PROSTHETIC HEART VALVES AND PREGNANCY: MATERNAL AND
INFANT OUTCOME. John H. McAnulty MD, Nell Blair, Charles
Walance, Kent Ueland MD. Oregon Health Sciences
University, Portland, Oregon and Stanford University,
Palo Alto, CA.
To determine maternal and Infant outcome In pregnancy
In women with prosthetic valves (V) we evaluted 195
patients (age 15-35), 82 wIth tissue (TV) and 113 with
mechanical (MV). Prior to receiving the valve, 54 women
had been sterilized. Of 141 patients capable of
pregnancy, 24 were lost to fol low-up or died with valve
replacement. In the remaining 117 patients, 12 were
eventually sterilized.
35 of 117 women (30%) had 53 pregnencles. Women with TV
off anti-coagulants had 74~ Incidence of live birth,
while those with MV on anti-coagulants had a 27~
Incidence of live birth (p<.D5). Spontaneous abortions
(32~ overal I) and therapeutic abortions (11~ overal I)
were greater In women with MV. Maternal complications
occurred In 47~ overal I and Included emboli (6~),
hemorrhage (13~), congestive heart failure (15~), and
death (2~). Women wIth TV had a greater percentage of
heart failure, while other complications occurred more
often In those wIth MV. In the 25 living offspring, no
obvious congenital abnormalities were detected: 9 were
the result of women on warfarin derivatives.
The Incidence of maternal complication Is high but not
clearly above that In nonpregnant women with prosthetic
valves. The Incidence of spontaneous and therapeutic
abortions Is high, and more common In MV. The live-born
offspring had no major abnormalities.
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COMPARISON OF MODELS TO EVALUATE DIASTOLIC PRESSURE VOL-
UME RELATIONSHIP IN AORTIC VALVE DISEASE
Tomoyuki Murakami, MD, Otto M. Hess, MD, Hans P.
Krayenbuehl, MD. University Hospital, CH-Zurich
Several mathematical models are currently used to evalu-
ate the diastolic pressure (P)-volume (V) relationship.
Three different models [1) simple elastic: P=ale 61V ; 2)
viscoelastic: p=a2e62V+n2dV/dt; 3) simple elastic with
asymptote: p=a3e63V+C3] were tested in 24 pateints with
aortic stenosis (AS) , 20 with aortic insufficiency(AI) and
6 controls(C). P-V relations were obtained from biplane
angios and micromanometry. The constant of chamber stiff-
ness(6j,62,63) was determined from the linear relation
between InP, In (p-n2dV/dt) or In(p-C3) and V using an
iteration procedure and the correlation coefficient(r)
was obtained. Normalization of P-V relation was performed
by defining a reference V as the V at P, p-n2dV/dt or
P-C3=1 mmHg(Vl). with this definition, the constant of
the P-normalized V[(V-Vl)/Vl] relation can be expressed
as -lnaj, -lna2 and -lna3 in each model.
model 1 model 2 model 3
r 6j -lnaj r 62 -lna2 r 63
C .97 .034 .65 .98 .035 .79 .98 .049
AS .93 .024 .09 .95• . 029 .70 .97*§ .063~
AI .91 .023 1.04 .95* .025 2.75 .96* .041"
* P<.05 vs model 1; § P<.05 vs model 2; 0 P<.05
Conclusions: 1) models with an asymptote are required to
evaluate P-V relationship; 2) in the non volume-normalized
model 3, an increased chamber stiffness(63) is observed in
AS as compared to AI; 3) the similar stiffness parameters
(-lna3) obtained in AS and AI by the volume-normalized
model 3 is in keeping with a similar myocardial stiffness
found 1n AS and AI evaluated by the stress-strain rela-
tlonship.
SPONTANEOUS COURSE OF AORTIC VALVE DISEASE.
Juraj Turina, M.D., Otto Hess, M.D., Flav10 Sepulcri,
M.D., Hans P. Krayenbuehl, M.D., Medical Policlinic,
University Hospital, Zurich, Switzerland.
188 patients (pts), age 16 to 72 years (y), with aortic
valve disease of various degree were followed up to 20
y after initial heart catheterization. Evaluated were also
pts which declined surgery or died before recommended ope-
ration. During the follow-up 41 pts died and 85 underwent
valve replacement. Cardiac death and valve surgery were
the end-points for calculation of the event-free survival.
According to hemodynamic data initial aortic valve disease
was severe in 79 pts, moderate in 81 and mild in 28 pts.
Aortic stenosis (AS) was present in 76, aortic regurgita-
tion (AR) in 84 and combined lesion (AS/AR) in 28 pts.
Event-free 5 and 10 y survival was 55% and 25% in AS and
67% and 25% in AR. Event-free 2 and 5 y survival was de-
creased in pts with severe disease (50% and 32% in AS,
86% and 55% in AR, 38% and 38% in AS/AR), severely sympto-
matic (NYHA class III and IV) pts (31% and 22% in AS, 57%
and 29% in AR, 29% and 29% in AS/AR), pts with history
of heart failure (29% and 0% in AS) and syncope (40% and
29% in AS). In severe AS 61% of pts were also severely
symptomatic or had a syncope whereas in severe AR only
17% of pts had the same signs. Event- free 2 y survival
of asymptomatic or oligosymptomatic (NYHA class I and II)
pts was 100% in severe AS and 96% in severe AR. Pts with
mild aortic valve disease had an 100% event-free 5 y sur-
vival. We concluded that 1) severe hemodynamic and sympto-
matic aortic valve disease requires immediate valve surge-
ry, 2) in asymptomatic and oligosymptomatic pts wit~
severe aortic stenosis surgery can be postponed unt11
symptoms increase, 3) in severe aortic regurgitation indi-
cation for surgery should not rely only on symptoms and
4) mild aort1c valve disease does not require observation
within the first 5 y after diagnosis.
THE INFllJENCE OF~ ARTERY DISEASE 00 THE
HEMlDYNAMIC ProFILE OF PATIENrS wrrn ~INA AND llORI'IC
STEN)SIS
Mark Lipton, M.D., James Slater, M.D., Paul Kramer, M.D.,
William SChwartz, M.D., Howard Winer, M.D., F .A.C.C.,
Itzhak Kronzon, M.D., F.A.C.C., Ephraim Glassman, M.D"
F.A.C.C. New York Univeristy Medical Center, New York, NY
'Ib determine whether patients with aortic stenosis (AS)
arxl coronary artery disease (CAD) develop angina with
milder AS than patients without CAD, \\'e reviewed the non-
invasive arxl invasive data fran 77 consecutive adult
patients with angina and significant AS (valve area index
.L 0 . 75 crn/M2 or Feak gradient~ 401lmHg). LV angiography
provided a score of LV dysfunction (higher scores denote
IIOre abnonnality). Patients with significant CAD (';:>'-70%
stenosis) differed fran patients with CAD (neans ± SEM):
AS-ICAD(N=50) AS, no CAD(N=27) f
Age 70±3±1.1 68.4±2.2 NS
Male sex 72.0% 48.1% (0.05
Valve area 0.&l±0.05 0.57±0.04 <0.001
Mean Gradient 48.2±3.7 71.8±6.l <0.001
cardiac index 2.84±0.08 2.70±0.ll NS
LV score 4.8±0.9 1.3±0.9 <:0.02
~en age, sex, and LV function \\'ere rontrolled by IlIllti-
variate analysis, CAD remained a highly significant pre-
dictor of AS severity. '!he degree of CAD was neqatively
correlated with the severity of AS (R=-0.47, p<O.OOl).
EKG and echocardiographic parameters did not differenti-
ate the t\\U groups. '!he additive effects of valvular
and coronary artery stenoses on myocardial 02 suWly-
deman:i ratio result in angina with less severe AS.
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RESPONSE TO SUBMAXlMAL AND MAXIMAL EXERCISE IN AORTIC
INSUFFICIENCY. Richard A. Wilson, MD, Barry H.
Greenberg, MD, FACC, Barry Massie, MD, FACC, J. David
Bristow, MD, FACC, Melvin Cheitlin, MD, FACC, Debra
Loge, CNMT, David Broudy, MD, G. Krishnamurthy, MD,
David Thomas, PhD. Oregon Health Sciences University,
Portland, Oregon.
To evaluate whether changes in cardiac performance
occurred in a stepwise manner during exercise (ex) in
aortic insufficiency (AI) we studied 60 asymptomatic
patients (pts) during graded supine bicycle ex. All had
LV dilatation and preserved resting ejection fraction
(EF).
Measurements of heart rate (HR), systolic blood
pressure (SBP), end-diastolic volume index (EDVI),
end-systolic volume index (ESVI), EF and SBP/ESVI were
obtained serially at rest, at the midpoint of ex (i.e.:
submax) and at peak ex (MAX):
HR SBP EDVI Z ESVI Z EF SBP/ESVI Zkpm/min mmHg cc/m cc/m mmHg/cc/m
Rest 65 140 159 56 .60 2.9
SUBMAX 383 101* 170* 147* 53 .64 4.2*
MAX 673 128+0 200+0 135+0 48+0 .65 6.1+0
p<0.05 *Rest vs SUBMAX, +Rest vs MAX, 0 SUBMAX vs MAX
Patients were divided into three grps: GrpI t >.05 EF,
GrpII <.05 change in ER, and GrpIII i >.05 EF. In all
3 grps-HR, SBP increased and EDVI decreased in a stepwise
progressive manner from rest to submax to max ex. In
GrpI EF increased and in GrpIII EF decreased in a pro-
gressive stepwise fashion. SBP/ESVI increased 4% at sub-
max and 29% at peak in GrpIII: these changes were signif-
icantly less than the 83% and 200% changes seen in GrpI.
We conclude that in this grp of AI pts: 1) stepwise
changes in LV volume and EF occur with supine ex, and
2) these stepwise changes occur regardless of EF
response to ex.
WHAT DOES EXERCISE RADIONUCLIDE ANGIOGRAPHY ADD TO THE
REST STUDY IN THE PREOPERATIVE EVALUATION OF
SEVERE AORTIC REGURGITATION?B' ~ugla. Mi~erf ~'B" John B. Gill. M.D•• Judith H.
urpny. M.D:. do pn. Hutter. Jr •• M.D•• F.A.C.C•• David
J. Kanarek. M.D•• Charles A. Boucher. M.D•• F.A.C.C.
Massachusetts General Hospital. Boston. MA
To determine the additional diagnostic utility of exercise
(ex) radionuclide angiography (RNA) compared to rest RNA
in evaluating severe isolated aortic regurgitation (AR).
53 such patients underwent pulmonary ex gas exchange
analysis and ex first pess RNA. 22 of whom subsequently
underwent valve replacement (AVR). When classified by
rest ejection fraction (EF). 17 had EF ~.50. 19 had
EF=.41-.49 and 17 had EF ~.40. Significant correlations
with a higher rest EF (p~0.05) included: lower rest
end-diastolic volume (342±.9l vs 402±.86 vs 538±.l50ml.
mea~lSD). lower rest end-systolic volume (154±.44 vs
2l7±.48 vs 352±.l15ml). lower ex systolic BP (136~3 vs
l45±30 vs l59±33torr) and higher oxygen uptake at
anaerobic threshold (23±.7 vs l8±.7 vs l6±.5ml/kg/min) and
peak ex (29±.7 vs 25±7 vs 22±.7ml/kg/min). These 3 AR
subgroups did not differ in age or severity of AR measured
by LV/RV stroke counts ratio. The rest EF also predicted
the change in EF from rest to ex (+.05±..06. +.02±..08.
-.04±..06. respectively. p<.Ol). AVR was performed in
1(6%). 7(38%). and 13(76%) of the 3 rest EF groups.
respectively (p<.OOl). Stepwise logistic regression
analysis showed that rest EF was the only clinical.
exercise or radionuclide perameter that correlated with
undergoing AVR (p<O.OOU.
We conclude: first pess rest RNA data alone separates
severe AR pts into functional subgroups. When rest LVEF
is ~.50. EF rises with ex and when rest EF is ~.40. EF
falls with ex. Only in the mid range of EF••41-.49. does
the ex RNA add information to the rest study. because the
ex EF response in this setting is variable.
THE RESTING ELECTROCARDIOGRAM IN AORTIC REGURGITATION
Mary J Roman. MD. Paul Kligfield. MD. FACC. Richard B
Devereux. MD. FACC. Nathaniel Niles. MD. Clare
Hochreiter. MD. Jeffrey S Borer. MD. FACC. Cornell
Medical Center. New York. NY
To test the hypothesis that the "strain" pattern of
repolarization (StR) on the electrocardiogram (ECG) is
associated with structural and functional changes of
potential prognostic value in patients (pts) with aortic
regurgitation (AR). we compared ECG findings with
echocardiographic and radionuclide findings in 95 pts
with pure chronic AR. Both left ventricular (LV) mass and
LV end-systolic stress (ESS) were independently related
to StR by logistic regression analysis. Moreover. in
contrast to 54 pts with normal repolarization (NR). 41
pts with StR had greater LV end-systolic dimension (5.2 ±.
1.2 vs 4.4 ±. 0.7 cm. p<.OOl). greater LV end-diastolic
dimension (7.2 ±. 1.1 vs 6.6 ±. 0.8 cm. p<.002). greater LV
mass (431 ±. 138 vs 303 ±. 89 ~. P<300l). higher LV ESS
(128 ±. 46 vs 95 ± 27 dynes/cm x10. p<.OOl). lower LV
fractional shortening (FS) (28 ± 8 vs 34 ±. 5%. p<.OOl).
lower resting LV ejection fraction (EF) (45 ± 12 vs 51 ±
7%. p<.02). and lower exercise LVEF (39 ±. 11 vs 51 ±. 8%.
p<.OOl). Among the 72 asymptomatic (asx) pts. those with
NR had significantly lower prevalences of FS <25% (1/45
vs 5/27). LV systolic dimension >5.5cm (1/45 vs 8/27).
and exercise LVEF <40% (2/39 vs 10/24. p<.05 for each
comparison). During a 28 month follow-up period. valve
replacement occurred in only 1/37 initially asx pts with
persistently NR but in 10/25 initially asx pts who
exhibited or developed StR (p<.006). We conclude that StR
in AR is associated with markedly increased LV ESS and LV
mass. that asx AR pts with StR have a higher risk of LV
dilatation and dysfunction than asx pts with NR. and that
asx pts with NR have a low likelihood of severe LV
functional and geometric abnormalities.
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Cardiovascular X·Ray/NMRlCT/PET
GLOBAL AND REGIONAL LEFT VENTRICULAR FUNCTION IN ISCHEMIC
HEART DISEASE: ACCURATE EVALUATION BY CINE-CT
TM Bateman. HD. FACC; GT O'Byrne, HD; JS Forrester, HD,
FACC; JS Whiting, PhD; AL Aronson, MD; SV Schauer, MSj OS
Berman, MD, FACC; HJC Swan, MD, PhD, FACC. Cedars-Sinai
Medical Center, Los Angeles, California.
Eight level rapid-acquisition cardiac cine-computed
tomography (Cine-CT) was performed in 23 post-CABG pts
within 2 wks of 3-view radionuc1ide ventriculography
(RNV). Acquisition was ECG-gated (10 images/level, at 58
msec increments from the R wave) following peripheral IV
injection of 30-45 m1 of renografin-76 in the modified
short axis projection. Ejection fraction (LVEF) was
calculated using the summed end-diastolic and end-
systolic tomographic slices. Six myocardial regions
(anterosepta1, antero1at, post-1at, post-basal, inf,
septal) were scored by different, blinded observers for
RNV and Cine-CT images as follows: -1=dyskinesis,
O=akinesis, 1 or 2=mod or mild hypokinesis, 3=norma1.
LVEF by Cine-CT (53±I9%j range 21-76%) did not differ
from that by RNV (50±18%; range 18-73%), and the regres-
sion slope (1.02) and y-intercept (2.2) were not differ-
ent from the line of identity (r-0.92; p=0.22). Eight pts
with transmural HI were correctly identified on Cine-CT
by both akinetic/dyskinetic segments and by systolic myo-
cardial thinning. Of 138 regions for potential evalua-
tion, 25 (18%) could not be scored by RNV vs only 3 (2%)
by Cine-CT. Thirteen of the unscored regions by RNV were
"paradoxic" septae; 7 were normal by Cine-CT and 6 were
hypo or akinetic. Of the remaining 110 segments, there
was agreement (normal vs abnormal) in 103 (94%) of read-
ings. RNV detected 42 abnormal segments, while Cine-CT
detected 47. Wall motion scores differed by >1 in only
18% of concordantly detected abnormal walls. Hence, Cine-
CT accurately evaluates global LV function, may be
superior to RNV for assessing regional function, and
prOVides data about postoperative septal function not
available by RNV.
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QUANTITATION OF LEFT VENTRICULAR MASS AND VOLUMES IN
NORMAL PATIENTS USING CINE COMPUTED TOMOGRAPHY
John A. Rumberger, Ph.D. , M.D., Andrew J. Feiring, M.D.,
Michael R. Rees, M.D., Stephen R. Ell, Ph.D., M.D., and
Melvin L. Marcus, M.D., F.A.C.C., University of Iowa and
CV Center, Iowa City, Iowa
In a majority of patients none of the currently employed
cardiac imaging modalities (contrast ventriculographY,
echocardiography or nuclear angiography) has been shown
to accurately determine left ventricular (LV) mass (M),
cavity volumes (V) and global ejection fraction. Cine
computed tomography (CT) is a minimally invasive
technique which possess high temporal (up to 17
frames/sec) and spatial resolution. This technique can
be applied to evaluate cardiac hypertrophy and dynamics
in a broad spectrum of patients. However, before such
abnormalities can be defined in patients the normal
ranges of LVM and LVV must be established for cine-CT.
To accomplish this, we obtained cine short axis tomograms
from apex to base in 14 normal subjects (ages 21-36
years) during contrast infusion (range 8 to 10 tomograms
per subject). LVM, V, stroke volume (SV) and EF were
calculated from end-diastolic (ED) and end-systolic (ES)
frames using Simpson's reconstruction. Results shown are
mean ± S.D. (* • per body surface area). Mean arterial
pressure and average heart rate were 93±10 mmHg and
72±ll/min.
LVM* LV-EDV* LV-ESV* LV-SV* LV-EF
(gms) (cc) (cc) (cc) (%)
97±14 72±13 23±7 50±9 69±7
LVM at ES and ED were not significantly different. This
study defines the normal range of LVM and LVV in normal,
adults employing cine-CT and demonstrates the feasibility
of obtaining high quality apex to base cardiac short axis
tomograms in patients.
EFFECTS OF HYDRALAZINE AND NITROGLYCERIN ON MYOCARDIAL
pH, PERFUSION, AND FUNCTION DURING ACIDOSIS.
T. Watters, M.D., S. Wu, Ph.D., J. Wikman-Coffelt, Ph.D.,
M. Wendland, Ph.D., T. James, Ph.D., R. Sievers, B.S.,
E. Botvinick, M.D., F.A.C.C., and W. Parmley, M.D.,
F.A.C.C. University of California, San Francisco, Ca.
To determine whether vasodilators would prevent the ob-
served reduction in intracellular pH [pH]i and high energy
phosphates (PCr,ATP) during acidosis, the effects of
hydralazine (10-5 M) and nitroglycerin (2.5 x 10-5 M) on
[pH]i' PCr, and ATP were measured by N.M.R. spectroscopy.
Coronary flow, developed pressure (DevP), and maximum
dP/dT were also measured during 30 minutes of induced
acidosis at high calcium concentration [Ca]o ' 4.0 roM,
and during 15 minutes of re-equilibration in isolated
perfused rat hearts (n=5).
[Ca]o (roM) 4.0 4.0 4.0
Drug - hydralazine nitroglycerin
Results expressed as % of control(except pH· )
[pH]i acid. 6.42:t.13 6.82±.09 6.80±.11
re-eq. died 7.10±.04 7.09:!:.03
PCr acid. 35%±19 98%±11 69%±14
re-ea. died 103%+12 96%+16
ATP acid. 68%±l6 98%±10 76%±11
re-ea. died 103%±12 98%±16
Flow acid. SI%±l7 129%±l9 98%±19
re-eq. died 122%+11 98%+19
DevP acid. 29%±25 9S%±9 73%±15
re-eq. died 110%+11 96%±3
dP/dT acid. 12%±10 95%±13 70%±
re-eq. died 113%±7 100%±3
A decrease in coronary flow causes a decrease in PCr, ATP,
DevP, and dP/dT, which is irreversible after 30 minutes of
acidosis at high [Ca]o' Preserving normal coronary flow
with hydralazine or nitroglycerin prevents biochemical
deterioration, allowing complete recovery.
SERIAL CHANGES IN MYOCARDIAL NMR Tl AND T2 VALUES WITH
AND WITHOUT REPERruSION.
Gerald Wisenberg, M.D., Frank S. Prato, Ph.D., Edwin S.
Carroll, M.D., Katherine L. Turner, M.D., St. Joseph's
Hospital and University of Western Ontario,London,Ontario.
To characterize changes in vivo in ischemic myocardium,
10 dogs were studied by NMR on a 0.15T system a) during
2 hours of coronary occlusion b) :irmediately follCMing
release of the occlusive snare c) 4 days and d) 21 days
after coronary occlusion. Coronary flow and, thus, ade-
quacy of reperfusion was rronitored by rnicrospheres. Ex-
tent of infarction was determined by histological exam-
ination. Results were as follows:
Tl AND T2 VALUES (MsEX:)
Reperfusion (n=7) Non-reperfusion (n=3)
Tl T2 TI T2
445±32* 52±5* 450±50* 50±8*
555±65** 65±8** 455±47* 58±9*
5l2±55* 39±8 49l±6l** 63±8**
450±47* 35±7 425±4l* 54±9*
350±11 40±2 350±11 40±2
EXTENT OF SIGNAL ABNORMALITY (%LV)
Reperfusion(n=7) Non-relirfusion(n=3)
OCclusion l4±8* 19±1
Release 22±11** 20±11
Day 5 l3±6 25±12*
Day 21 11±5 l8±10
Pathology 10±6 l7±9
*p<.05 **p<.Ol vs control or pathology
Thus, 1) Reperfusion produces an abrupt rcarked rise in
early Tl and '1'2 values to a greater degree than non-reper-
fusion. 2) The areas of early abnonnal signal are not
specific for infarction. 3) With reperfusion, on subse-
quent images, nonnalization of T2 oc=s while Tl remains
elevated, while without reperfusion, both Tl and T2
remain elevated.
SERIAL NUCLEAR MAGt£TIC RESONANCE IMAGING IN
ACUTE MYOCARDIAL N"ARCTION N MAN. Lee R.
Dilworth, M.D., Alex M. Aisen, M.D., G.B. John Mancini, M.D.,
F.A.c.c., Kenneth A. Buckwalter, M.D., Andrew J. Buda, M.D.,
F.A.C.C. University of Michigan, Ann Arbor, Michigan.
Gated nuclear magnetic resonance (NMR) imaging has been
shown to distinguish infarcted fram normal myocardium during
initial hospitalization for acute myocardial infarction (MI). To
determine whether the NMR appearance of infarcted
myocardium changes during the early post-MI period, we studied
5 patients (with EKG- and enzyme-documented MI) at 3-5 days
post-MI (acute) and again at 10-14 days post-MI (pre-
discharge). Using a 0.35 Tesla NMR system with a spin-echo
(SE) pulse sequence, first and second SE NMR images were
obtained using transverse acquisition, as well as coronal
acquisition with the patient in the 300 RAO position. Intensities
of infarcted and normal-appearing myocardium were measured
from regions of interest (100 voxels) defined on the acute image
best demonstrating the MI, and from the corresponding pre-
discharge image. With both spin-echo techniques, infarct
intensity was 9reater than normal intensity in both acute and
pre-discharge (p <.05) studies. Similar results were obtained in
camparing T2 relaxation times. Results of % difference of
regional intensity (intensity of infarcted region - intensity of
normal region/intensity of normal region) are summarized below
(meantSEM):
FIRST SE
Acute Pre-discharge
33.3+ 19.8 40.3+ 11.6*
* p:NS, pre-dischar!ivs. acute
We conclude that NMR imaging can differentiate normal from
infarcted myocardium during the early past-MI period.
However, no significant change occurred in the relative
intensity of infarcted and normal myocardium between 4 and 12
days post-MI.
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MYOCARDIAL SIGNAL
RESONANCE IMAGING IN
INFARCTED MYOCARDIAL
CAUlJIATIOO <F lEFT vamuOJLAR vocoe; AND E.nr1'IOO
PRACTIOO FIu. ~c ~ 'lOIDAMS rnIR; A
<XJtllUlERIZID 3-D RtXXIIS'.l'RO'IOO: CCIIPARI!DI wrm vamuaJ-
LOGRAPHY Randall Thanpson, MD, Robert Edelman, MD, Howard
Kantor, MD, PhD, Marcia Leavitt, LOuglas Miller, MD,
Robert Okada, MD, FACC, Thanas Brady, MD, and Robert
DinSTOre, MD. Massachusetts General Hospital, Boston, MA.
Magnetic resonance provides high resolution tomographic
images which have the potential for measurement of LV
vollilieS without problems of geanetric assllllptions inherent
to other methods. 1b determine the accuracy of a new
method of measuring LV vollllle and ejection fraction (EF)
by magnetic resonance (MR) imaging we studied 7 patients
who had undergone biplane left ventriculography (LVG) 24
hours prior. Spin echo MR images were obtained through
the LV short axis. MR vollllle measurement was facilitated
by the use of a technique of short echo delays (TE=15 or
20 msec) which we have recently reported. This made it
possible to obtain 5-8 contiguous tanograhic images fran
aortic valve to LV apex within the same phase of the
cardiac cycle. vlith the use of a canputerized
semi-autanated edge detection system, 3-D reconstructions
of the LV endocardial shell were obtained fran systolic
and diastolic IIR linages. Volunes and ejection fraction
were calculated and compared with LVG measurements.
Results: There was a close correlation between
measurements fran ~!R 3-D LV reconstruction and LVG
calculated values for systolic volune (r=. 91, pC 005) ,
diastolic volune (r=.82, p<.Oll, and ejection fraction
(r=.88, P<.01l.
COnclusioo: Contiguous short axis I'!R tanograms in the
same phase of the cardiac cycle are virtually free of
geanetric assll!lptions and canbined with canputerized 3-D
analysis provide accurate assessment of LV volunes and EF.
EFFECT OF MAlINITOL ON MAGNETIC lESOlilAllCE RELAXATIOlil
PARAMETERS IN CAIlINE MYOCARDIAL INFARCTIOlil:
lELATIOlilSRIP TO TISSUE WATER AIlD MYOCARDIAL BLOOD FLOW
~. Dou&1" "tUek K." Boward L. Kantor. H.D•• Donald L.ohnston. k;.. unlc 1 Roams. H.D•• landall ThOlllpson.
H.D•• ThOlllas J. Brady. M.D•• Hobert D. Okada. M.D••
F.A.C.C••Massachusetts General Hospital. Boston.MA.
To assess the effect of bvperosmotic mannitol on regional
Tl and T2 after myocardial infarction (HI). 7 dogs had a 3
hr left anterior descending coronary artery occlus~on
followed by 1 hr of re~rfusion. Mannitol (12.5~/5Oml)
was infused intravenously at 15.3 ml/min for 15 min before
and after release to obtain a 40 mosmo rise in ,er~
osmolarity. Microsphere 1IIJ0~rdial blood flow (MBF) was
measured at ~ak occlusion(o) and 15 min. of
reperfusion(r}. Excise4 hearts were wrapped in parafilm.
imaged in a maall bore (1.4 T) supe;condu~ting ma~et.
then T.T.C. staine6. SpectrOllleter (20KHz) TI and T2. %
water coptenf(%R20). and MBF were calculated in 100
T.T.C.{-}!MI and normal endocardial segments for
comparlson to 9 untreated control dogs. TI and T2 wer~
lower in normal (TI: 593±l4vs659±Bms; T2: 43±5vs49±J.ms)
and HI sel!!lents C'.l'1: 623±.26vs751±l8ms; T2: 48"±'6vs5~lms)
of msnnitol dogs (p<0.051. TI and T2 did not corre~ate
with %R20. MBFr or MBFo(0.67+.1 ml/min/gm) in normal
segments of msnnitol doss. In HI segments of msnnitol
dogs l MBFo(0.06±..1 ml/mln/gm was l~er and TI. T2 were 5%and 2% greater than normal p<O.OOI. TI and T2 of HI
segments correlated with MBFo (p<O.O I). and rose
exponentially as rt0 approached zero ~n untreated
(Tl:r=.87;T2:r=.81 and mannitol dogs (TI:r=.54;T2r=.50).
The difference in 20 betveen HI and normal segments was
smaller in mannitol dogs (79vs77±3%; p<O.OI). In HI
segments. Tl correlated better toan T2 with %R20 (r=.4Ivs
•30; p<0.05). When the effect of %R29 wa. confrolled for.
TI and T2 correlated leas well with OFo. TI-dependent
inversion recovery and T2 spin-echo images had reduced
contrast between the HI and n0rlll81 zones of mannitol dogs
compared to controls.
We conclude that mannitol. an agent that reduces myocyte
edema. decreases the %R20 and Kl relaxation parameters of
infarcted>normal 1IIf0cariliUID. Occlu.ion myocardial blood
flow and %R20 are lntertiependent determinants of KH
relaxation fimes (TI>T2) ln infarcted se~ents.
Mannitol-induced red~stribution of ~ocardial water
reduces in vitro (TI) and Kl image (Tl and T2) contrast
between infarcted and normal myocardium.
CHARACTERIZATION OF
INTENSITY BY MAGNETIC
PROVEN NORMAL AND
SEGMENTS.
Robert E. Dinsmore M.D., F.A.C.C., Jennifer A. Johns
M.B.BoS., F.R.A.C.P., Tsunehiro Yasuda M.D., Gary L.
Wismer M.D., Donald L. Johnston M.D., Thomas J. Brady
M.D., Robert C. Leinbach M.D., F.A.C.C., Randall
Tnompson M.D., Herman K. Gold M.D., F.A.C.C.
Massachusetts General Hospital, Boston, MA.
Magnetic resonance imaging (M RI) has shown increase in
left; ventricular (LV) myocardial signal after myocardial
infarction (MI), however signal intensity (SI) varies widely
between subjects. To define easily obtained standardized
criteria for identifieation of normal (N MS) or infarcted
myocardial segments (IMS), we studied 19 pts Who
underwent thrombolytic therapy with either tissue
plasminogen activator or streptokinase within 6 hours of
onset of MI. Coronary reperfusi.on was achieved in 12.
Spin echo 30 and 60 msec cardiac MRI at 0.6 Tes1a was
performed 5-13 (mean 9) days and repeat coronary
arteriography and biplane left; ventriculography (LV A), 10
days post-MI. Multiple systolic images criented to the
true LV short axis from aortic valve to apex were
Obtained, alloWing ll"E!Cise con"e1ation of LV segments on
MRI with LV segments on LV A. SI was then measured in
proven NMS and IMS and in adjicent skeletal mW!Cle
(SM). There was no significant difference in SI between
reperftEed and OOl'H'eperfused IMS. The difference
between NMS and IMS in SI units corrected for SM was
high1¥ significant (1.5 + 0.4 vs 2.5 + 0.6, p <0.0001).
Thus, these data ji-ovide easily obtained standardized
criteria for definition of normal and infarcted MS in
recent MI in humans.
CORON~RY ~RTERY GR~FT P~TENCY ~S ~SSESSED BY M~GNETIC
RESON~NCE IM~GING
Hugh GLove, MB BS, MRCP, MRCS; Jeremy PR Jenk1ns,
MBChB, MRCPIUK), DMRD, FRCR; Christopher J Foster,
MBChB, MRCP(UK); Derek J Rowlands, MD, FRCP and Ian
Isherwood, MBChB, DMRD, MRCP, FRCR
Departments of Diagnost1c Rad10logy and Card10logy,
Un1versity of Manchester, Un1ted K1ngdom.
The a1m of th1S study was to assess patency of coronary
artery bypass grafts by Magnet1c Resonance (MR) 1mag1ng
compared w1th Computed Transm1SS10n Tomography (CT) or
coronary graft arteriography.
18 patients were stud1ed pre- and post-operatively on a
Picker Internat10nal superconduct1ng magnet operat1ng at
0.26 Tesla. Images were obta1ned in three orthogonal
planes at end-d1astole and end-systole. Graft patency
was also assessed e1ther ang10graph1cally or by CT. ~
total of 49 grafts were stud1ed. 31 grafts were
cons1dered patent by MR 1mag1ng, 34 by CT and/or
angiography. 18 grafts were not v1sual1sed by MR
imag1ng, 3 of which were detected as patent by the other
method. These grafts were e1ther prox1mally stenosed or
had a poor blood flow veloc1ty pattern. The sens1t1v1ty
of MR imag1ng is 0.93 for the detection of graft
patency .
It 1S concluded that MR 1maging can detect a normally
funct10ning coronary artery bypass graft. It 1S
enVisaged that MR 1mag1ng may prov1de a non-1nvaS1ve
screening technique for assessment of coronary artery
bypass graft patency 1n pat1ents present1ng w1th post-
operat1ve ang1na.
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INDIUM-Ill LABELED MONOCLONAL ANTIFIBRIN SPECIFIC
ANTIBODY FOR DIlTEClION OF CLOT ..
Ki,fihit, )(aU,. ~D.. Ban An Ibaw. Ph.D•• Chuu S. Luu.
M.~ .sUDe1luo Gsuda. M.D•• Gary Mateueda. Ph.D•• Edgar
Haber. M.D•• F.A.C.C•• Keuaeth A. McKusick. M.D•• H.
William Strauss. M.D•• F.A.C.C. Massachusetts General
Hospital. Boston. MA
The monoclonal antifibrin antibody (64CS) binds
s~cifically to human fibrin. and crossreacts with canine
flbrin. Clot imaging w~th In-Ill labeled antifibrin .
antibody was, perf0l'!!'ed ln 6 dOfs., In all dl?gsl_th~OI!Ibl
were formed ln the lsolated Ie t Jugular veln OJ mlxlng
thrombin and bar~um w~t~ blood. Th~bi were ~e!eased 30
minutes later. In addltlon. copper COlIs were lnJected
from the left ju~lar vein in 3 of 6 dogs. Four
hundred-SOO ~Cl Of In-Ill 64CS and 80-100 pCi of I-12S
nonspecific Ig G were injected intravenously one hour
after release of thrombi. Clot u.afing were performed in
the anterio!!-LAO. RAe. !eft latera. right lat~ral.
posterior. L!'U and lPO v:a.ews Zo-24 hours followlng
lntravenous administratio~. The dofs were killed !nd ~he
lungs and hearts were eltC18ed. fol owed bv g_ lm8glng
and X-ra:r confiraati~n of the thrombi. Then the ,!ptake of
radioact:a.ve tracers In tlssue samples were determlned by
scintillation counting. .. "
The weight of the amallest clot that was v~slble ln ln
vivo planar Ulagea was SO.6 mg. The clot 1J!lagea of ~he
excised lungs corresponded to the copp.er)co~l or barlum
clot of x-ray photo~aph. The (%dose7gm tnsue
localization are as follows: l2S
In-Ill 64CS 1-
Sample Nonspecific Ig G
Mean SE Hean SE
PA clot fcopper)coil) 0.181 0.02S 0.019 0.004
PA clot barlum 0.243 0.068 0.012 0.002
RA clot copper coil) 0.102 0.021
infarcted lung 8:81~ 8:88; g:8~ 8:88~!~;:;l lung O.OSI 0.008 0.019 0.016
kidney 0.018 0.004 0.021 0.008
spleen 0.022 0.002 0.018 0.017
skeletal muscle 0.001 0.001 0.002 0.001
heart muscle O.OOS 0.001 0.008 0.002
blood 0.029 0.004 0.034 0.030
These resylts ,uggested that monoclonal antifibrin
antibody l64CS} could specifically detect RA and PA clot.
MYOCARDIAL WASHOUT RATE OF THALLIUM-201: COMPARISON BE-
lVEEN REST. DIPYRIDAMOLE WITH AND WITHOUT AMINOPHYLLINE.
AND EXERCISE S~ATES. George T O'Byrne. MB; Jamshid Madda-
hi, MD. FACC; Kenneth F Van Train, BS; John D Friedman,
MD; Daniel S Berman, MD, FACC. Cedars-Sinai Medical Cen-
ter, Los Angeles. CA
Evaluation of regional percent washout of thallium-201
(Tl-20l) may be a useful adjunct in the detection of hypo-
perfused myocardial regions; however, the relationship be-
tween washout rate and type of Tl-20l procedure being per-
formed has not been previously examined. Thus, we under-
took the present study to compare the percent washout of
myocardial Tl-201 in various states in 88 patients with a
<1% likelihood of CAD. Tl-20l was injected intravenously
at rest in 17, follOWing dipyridamole (dipy) (0.S6 mg/kg)
with hand-grip exercise but without aminophylline (A-) in
10 and with aminophylline (A+) in 12, and following exer-
cise in 49 patients. Ten-minute images were obtained ear-
ly (S-10 minutes) and 4 hours after Tl-201 injection. Fol-
lOWing interpolative background subtraction and 9-point
smoothing, initial distribution and %washout circumferen-
tial profiles were generated. The mean ± standard devia-
tion for regional washout rate of Tl-201 for each proce-
dure was as follows:
Rest ~ Dipy A+ Stress
Mean %wlo -1.7 34.2 42.S 5'3.'7
SD 2S.S 12.2 14.9 9.6
The %washout was progressively higher between rest, dipy
A-. dipy A+, and stress states. The variability of %wash-
out was progressively lower in rest, dipy, and stress
states. We conclude that the normal %washout of myocardi-
al Tl-20l depends on the type of Tl-20l test being perfor-
med. For clinical purposes, specific sets of normal limits
for each type of test are needed for accurate detection of
washout abnormality.
CAN RESTENOOIS AFTER COIOlARY ~IOPlASTY (P'OCA) BE
PREDICl'ED BY EXERCISE FIRST PASS RADICJolUCLIDE
AOOIOCARDICGRAPHY? George Pilcher, M. D., E. Q:>rdon
DePuey, M.D. FACC, Mark A. LibOW, M.D., Gary S. Ibubin,
MS, Ph.D., John S. D::>uglas, M.D. FACC, Spencer B. Kil'YJ,
M.D. FACC, Harvey J. Berger, M.D. FACC, Enory
University SChool of Medicine, Atlanta, GA.
To determine if exercise (ex) first pass
radionuclide al'YJiocardiography (RNA) can predict vessel
status after P'OCA, RNA was perfotm3d within 3 days
after PTCA and compared prospectively to coronary
arYJiography obtained 5.9 + 2.6 months (mean ~ SO) after
P'OCA in 104 patients (pts). Successful sil'YJle vessel
(SV) P'OCA (>20% reduction in diameter stenosis) was
performed in 99 pts with SV disease and 5 pts with
double vessel disease. Mean luninal diameter stenosis
(OS) was reduced fran 71 + 13% to 20 + 10% (P<O.OOl).
At arYJiographic restudy, -39 pts had restenosis (>50%
03) , averagil'YJ 71 + 15% canpared with 26 ± 12%
(p<O.OOl) in the ranainil'YJ 65 pts. Abnormal ex left
ventricular (LV) reserve by RNA was defined as a fall
in LV ejection fraction with ex. All 104 pts were
asymptanatic at time of ex RNA. Abnormal ex RNA
occurred in 32/104 pts, 24 with restenosis and 8 with
continued patency. The value of an aboormal ex RNA in
predictil'YJ restenosis was 75% (24/32 pts). The value
of a normal ex RNA in predictil'YJ continued vessel
patency at restudy was 79% (57/72 pts). '!he
sensitivity and specificity of ex RNA post-P'OCA were
62% and 88% respectively. Evaluation of regional wall
rootion did not improve the utility of ex RNA.
Thus ex RNA obtained prior to discharge post-P'OCA
appears helpful in predictil'YJ restenosis. The time ~f
recurrence is variable, but these data suggest that it
may occur as early as the immediate post-P'OCA period.
LEFT VENTRICULAR FUNCTION IN NORMAL SUBJECTS: SEX AND
AGE RELATED EFFECTS AT REST AND DURING EXERCISE.
Robert O. Bonow, MD, FACe. Stephen L. Bacharach. PhD.
Michael V. Green. MS. Felipe C. Robinson. MD. Edward
Lakatos, PhD. Richard O. Cannon, MD, FACC. Neal R. Cutler.
MD, and Steven M. Larson. MD, NHLBI. Bethesda. Md.
Previous studies of upright exercise demonstrate a sex-
related difference in the LV ejection fraction (EF) res-
ponse to exercise; EF increases with exercise in men. but
is unchanged and may even decrease in women. To assess the
effect of supine exercise on LV function. we perfonaed ra-
dionuclide angiography in 66 normal subjects ace 21-77: 42
men (age 43;t15) and 24 wOllen (age 4l;t17). The increase in
EF with maximal exercise (max liEF) declined linearly as a
function of age (r=.50. p<.OOl). and was less in subjects
older than compared to younger than 45 yrs (7;t4 vs 16;t6S.
p<.Ol). Max liEF also differed between men (l3;t61) and wo-
men (10+61). which was significant when adjusted for age
(p<.Ol)-:- Both men and WOllen decreased end-syatolic volume
similarly at max exercise. but men increased end-diastolic
volume (141 vs 01. p<.005) and hence stroke volume (39S vs
l4S, p<.OOl) to a greater extent than women. However. men
achieved greater max workloads with greater cardiac output
augaentation (lICO) and greater blood pressure (BP). When
compared at workloads of equivalent lICO and BP. men and
women did not differ in either LV volumes or liEF. Although
EF at rest was unrelated to age. resting peak fUling rate
(PFR) decreased (r=.54. p<.OOl) and tiae to PFR increased
(r=.58. p<.OOl) with age in both sexes. Thus. aging does
not affect LV systolic function at rest but significantly
influences LV diastolic function at rest and the LV EF
response to exercise. The greater max liEF achieved b.r men
may reflect the greater workloads attained, differences in
peripheral vascular responses to exercise. or intrinsic
differences in LV function compared to women.
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RESPIRATORY VARIATIONS IN RIGHT VENTRICULAR FUNCTION.
John L. Caplin, M.B., Duncan S. Dymond, M.D., F.A.C.C.,
William D. Flatman, M.Sc., Martin N. Wiseman, M.B. and
Roworth A. J. Spurrell, M.D., F.A.C.C., St. Bartholomew's
Hospital, London, ENGLAND.
Respiratory effort during inspiration (I), expiration (E)
and Valsalva (V) reSUlts in changes in RV preload and
afterload. To investigate the effects of these on RV
ejection fraction (EF), first-pass radionuclide
angiography with gOld-195m (half-life 30.5 sec) was
perfomed in 17 subjects at maximal I and E, and in 8
subjects at rest and during V. RVEF on I was 32z11S
(mean+SD) and fell to 26+10S on E (p<O.Ol). This
represents a fall of 18S-of the I value. 15 sUbjects
showed a fallon E and only 2 a rise. There were no
significant changes in bolus duration, RV transit time,
or the number of RV cycles, all of which might have been
expected to rise during E. V caused a rise in RVEF from
29+7S to 43+10S (p<O.OOl), and all sUbjects showed a
rise. V also prolonged bolus duration from 0.9~.3 sec to
2.7+1.8 sec (p<0.05), increased transit time from 3.3zQ.9
sec-to 5.3+2.3 sec (p<0.05), and increased the number of
cycles from 4.1z1 to 7.8z4 (p<0.05). Qualitative analysis
of time activity curves from the superior vena cava
suggested the development of tricuspid regurgitation. In
conclusion RVEF is higher on I than on E in most
subjects. V causes a rise in in RVEF With development of
tricuspid regurgitation and prolongation of RV transit.
These data suggest 1) the relative influences of venous
return, pUlmonary artery pressure and possible functional
tricuspid regurgitation vary during I, E and V and affect
RVEF and 2) caution in the interpretation of changes in
RV function on exerCise when imaging occurs during
maXimal respiratory effort.
QUANTITATION OF EXTENT, DEPTH AND SEVERITY OF DEFECTS IN
PATIENTS UNDERGOING BXBR.CISE PLANAR THALLIUM-201 SCINTI-
• GRAPHY. Steven Reisman, MD; Jamshid Maddahi, MD, FACC;
Kenneth Van Train, BS; Daniel Berman, MD, FACC. VA Med
Ctr, Long Beach, & Cedars-Sinai Med Ctr, Los Angeles, CA
We studied 133 patients (pts) undergoing exercise planar
Tl-201 (Tl) scintigraphy and coronary arteriography to de-
velop a method for quantitative (Q) analysis of extent (E)
of myocardium with reduced Tl uptake, depth (D) of reduc-
tion of Tl uptake, and Tl defect severity (Sev) which com-
bines E and 0 by integrating the total area below mean
normal. Circumferential profiles for 3 exercise views were
compared to mean profiles from 49 normals to obtain 3 Q
scores (S): QES, QDS, QSevS. Visual (V) Tl analysis used a
4-point S system for 15 segments (segs) in 3 views: VES-#
abnormal segs, VDS-highest 4-point S (0-3) per pt in any
seg, and VSevS-summed S in 15 segs. Q and V S of E, D and
Sev were compared. A close correlation was found between
QES and YES (r-.73) and QSevS and VSevS (r-.79). For iden-
tification of pts with the high-risk pattern of a severe
stress Tl defect (VDS-3), QDS of L36 had 81% sensitivity
and 82% specificity. With increasing extent of CAD a sig-
nificant (p<.05) increase in QSevS and QES was noted:
o Vessel 1 Vessel Multivessel
QSevS 382+226 906+790 1086+814
QES 42+16 58+22 64+20
Pts with exertionsl hypotension- also had higher QSevS
(1558±920 vs 834±715, p<.05) and QES (74±20 vs 57±21, p<
.05) than those without exertional hypotension. Thus, com-
puterized quantitation of extent, depth and severity of
planar Tl defects: 1) is representative of expert visual
analysis, 2) corresponds with exercise-induced hemodynamic
abnormalities, 3) may help identify patients with exten-
sive CAD and jeopardized myocardium, and 4) may prove use-
ful in objectively detecting pts with high-risk scinti-
graphic and/or coronary arteriographic patterns.
A SENSITIVE MEANS TO DIAGNOSE MYOCARDIAL
INFARCTION IN MAN: 1-123 PHENYLPENTADECANOIC ACID
MYOCARDIAL IMAGING. Patrick L. Kennedy, M.D.,
Christopher L. Wolfe, M.D., Padamakar V. Kulkarni, Ph.D.,
Donald E. Jansen, M.D., Christopher L. Hansen, M.D., Gregory
I. Gabliani, M.D., Robert W. Parkey, M.D., F.A.C.C., L.
Maximilian Buja, M.D., F.A.C.C., and James R. Corbett, M.D.,
Univ of Texas Health Sci Ctr, Dallas, TX.
1-123 phenylpentadecanoic acid (IPPA) has shown promise as an
imaging agent in animal models. The goal of this study was to
assess the utility of IPPA myocardial scintigraphy in diagnosing
myocardial infarction (MI) in patients (pts). Nineteen pts with
prior documented MI were evaluated. In these pts, there were 13
Q-wave (7 anterolateral, 6 inferior) and 6 non-Q-wave infarcts.
Two-6 millicuries of IPPA were injected intravenously at rest or
at peak symptom-limited exercise. Planar imaging was
performed beginning at 4 minutes post-injection and continued
for 60 minutes. Quantitative segmental analysis was performed
and results were compared to that of 20 normal volunteers
(NLS). NLS demonstrated relatively homogeneous initial IPPA
activity, varying by 18 ±7% at rest and 13 ±5% following
exercise. In pts studied at rest with IPPA, 14/15 infarct-related
segments demonstrated decreased initial IPPA activity (39 ±15%,
p<O.OOl), and 8/15 demonstrated delayed early IPPA washout
(6.3 ±3.8%, p<O.OOl). In pts studied following exercise, 11/11
infarct-related segments demonstrated decreased initial IPPA
activity (35±15%, p<O.OOl). Two of 11 demonstrated slow, 7/11
normal, and 2/11 enhanced IPPA segmental washout. No corre-
lation was apparent between the presence of a Q-wave infarct
and the rate of IPPA washout. We conclude that: (1) high-
quality myocardial images can be obtained at rest. and foll~wing
exercise with IPPA; (2) NLS demonstrate relatively UnIform
uptake and washout of IPPA; (3) infarcted myocardial segments
are characterized by decreased initial IPPA activity and hetero-
geneity of IPPA washout at rest and following exercise.
LINEAR CORRELATION BETWEEN XENON-133 AND MICROSPHERE
MEASUREMENTS OF MYOCARDIAL BLOOD FLOW OVER A WIDE RANGE
OF FLOWS •
Steven C. Port, M.D., F.A.C.C., Carl W. Christensen,
Ph.D., Raymond P. Grenier, M.S. and Donald H. Schmidt,
M.D. University of Wisconsin, Mount Sinai Med ical
Center, Milwaukee, WI.
It has been suggested that the xenon-133(Xe) washout
method is inadequate for measurement of the elevated
lI\Yocardial blood f 10w(MBF) seen with vasodilators such as
dipy ridamole and adenosine. In this st OOy Xe and
microsphere(MS) measurements of MBF at baseline and after
intracoronary adenosine were cOllq)ared in 17 open-chest
dogs with a cannUlated coronary artery. Xe was injected
into the cannulated vessel and MS were injected into the
left atrium. In addition, a right atrial Xe injection was
performed and waShout of Xe in the lung was recorded in
the same hemodynamic state as the immediately preceding
lI\Yocardial measurement. The lI\Yocardial Xe curves were
corrected ~ a frame ~ frame, pixel ~ pixel subtraction
of the normaliZed lung curve within the lI\Yocardial
territory. Monoexponential analysis of the corrected
curve f rom peak to 50\ peak act i vity gave a linear
correlation of 0.97 (y-0.8lx+13.9, SEE 30.7) with the KS
results over a range of flows from 41-536 ml/lOOgm!min.
When the vascular space factor of the Kety-Schmidt
equation (vascular vo1ume/lI\Yocardial volume) is assumed
to be 0.05 at control and 0.10 during adenosine, then
there is no significant difference (y-0.94x+6 .8, r-O.96,
p-NS) between xenon and microsphere flows.
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ANTIANGINAL EFFECT OF CV-4151, A NEW, POTENT, SELECTIVE
INHIBITOR OF THROMBOXANE SYNTHETASE.
Yoshihiro Kimura, M.D., Kazuhisa Kodama, M.D., Masashi
Naka, M.D., Shinsuke Nanto, M.D., Koichi Taniura, M.D.,
Tsunehiko Kuzuya, M.D., Yasuhiko Hamanaka, M.D., Michihiko
Tada, M.D., F.A.C.C., Cardiovascular Division of Osaka
Police Hospital, Osaka, Japan.
We studied the effect of CV-4151 «E)-7-phenyl-7-(3-
pyridil)-6-heptenoic acid), a new thromboxane synthetase
inhibitor, on the platelet activity and anginal attack of
22 patients with unstable angina. Frequency of angina
(AP), collagen(O.5~g/ml)-induced aggregation of platelet
rich plasma, and immunoreactive thromboxane (TX) B2 ofplasma were measured before and during administration
of CV-4151 (50mgx2/day). During administration platelet
aggregability markedly decreased in 11 cases
(responder), but remained unchanged in 11 cases (non-
responder), whose platelet aggregability before dosing was
lower than that of former cases. During dosing, plasma
TXB2 levels significantly decreased (318~60 to 242~62pg/mlplasma, mean+SEM, p<.05, n=16). Antianginal effect of CV-
4151 (AP/we;k) is shown below (mean~SEM, *p<.05 vs
before);
before 1st week 2nd week 4th week
Responder 8.6+1.3 6.2~1.5 4.7~1.6 3.4+3.4*
Non-responder 6.5+1.8 3.6~1.2 2.7~O.9 2.5±O.8*
Discontinuation of CV-4151 resulted in increasing in AP in
almost all patients. No significant side effect was
observed during administration. These data suggest that
CV-4151 has beneficial effects on unstable angina,
probably due to reduction of platelet aggregabi1ity and
TXA production. Whether the augmentation of localpro~taCYClin production may contribute to this antianginal
effect should further be sought.
A DOUBLE-BLIND TRIAL OF DILTIAZEM IN THE TREATMENT OF
RAYNAUD'S PHENOMENON
Christopher J. White, MD; Lisa A. Abrahams, MD; Patricia
Overton-Keary, MD; Peter J. Singleton Jr., MD; Letterman
Army Medical Center, San Francisco.
Eleven patients with Raynaud's phenomena were entered
into a randomized double-blind crossover study of
diltiazem versus placebo. The study group was composed
of five men and six women. Four were found to have
primary Raynaud's disease and seven were found to have
Raynaud's phenomenon secondary to connective tissue
disease. Digital skin temperature recovery time (STRT)
was measured after immersing the patients hand in ice
water. Baseline measurements were obtained and then
patients were randomized to receive either diltiazem
30mg QID or placebo for two weeks followed by a
crossover phase. The mean STRT during the control phase
was 62 +/- 31 min., after two weeks of diltiazem therapy
STRT was 41 +/- 39 min. (p=.056). After two weeks of
placebo therapy the mean STRT was 50 +/- 33 min
(p=.183). Subjectively, 8 of the 11 patients felt they
were improved on Diltiazem, two of these reported marked
improvement, experiencing no attacks during the two week
treatment period. Diltiazem was universally well
tolerated, with one patient developing transient
diarrhea. We have shown a subjective improvement in
symptomatic patients with a trend toward a significant
objective benefit. We feel that diltiazem, in view of
its lack of side-effects, is an effective alternative
therapy for the treatment of symptomatic Raynaud's
phenomenon.
POTENTIAL ADVERSE EFFECTS OF PENTOXIFYLLINE ON LIMB
HEMODYNAMICS IN PATIENTS WITH INTERMITTENT CLAUDICATION.
Jonathan L. Halperin, M.D., F.A.C.C., Elizabeth B.
Rothlauf, R.N. and Audrey Stern, M.D., Mount Sinai Medical
Center, New York, NY.
Pentoxifylline (Pfx) reportedly improves walking capacity
in patients (pts) with intermittent claudication (IC).
A hemorheologic mechanism is supported by greater
erythrocyte flexibility in vitro and oxygen tension
in skeletal muscle at rest. We studied the limb
hemodynamic (Hd) response to hyperemia following exercise
(Ex) and release of arterial occlusion (AD) by venous
occlusion plethysmography in 8 pts (65±6 year) with
chronic (5.5±2.4 year) IC (l56±52 meters). Measurements
were made before and after two months oral therapy with
Ph, 400 mg t. i .d. and two hours after 800 mg acute
dosing. Table shows chan!les (11;%) in blood flow
(BF; ml/100ml tissue/min), pressure (BP; mmH~) and
resistance (VR; units) as mean±SEM: (Student t-test).
Placebo Pfx P
Rest BF 6.1 ± 0.9 5.2 ± 0.5 NS
Rest BP 93 ± 4 92 ± 5 NS
Rest VR 18.1 ± 3.6 22.9 ± 3.9 NS
Ex BF 16.4 ± 2.5 13.1 ± 2.4 <0.10
Ex VR 8.3 ± 1.4 10.1 ± 1.6 <0.025
AD BF 17.2 ± 2.7 14.1 ± 1.6 <0.10
AD VR 9.9 ± 1.9 12.9 ± 3.0 <0.05
AD II%VR -37 ± 13 -22 ± 16 NS
Long term treatment produced no significant changes
1n IC (141±50 meters; NS) and clinical deterioration
occurred in 3 pts. The rise in hyperemic VR implies
an adverse effect on blood flow properties in the ischemic
1imb. These findings do not support a beneficial effect
upon exercise tolerance, hemodynamics or hyperemic
perfusi on duri ng maintenance therapy wi th pentoxifylline
and suggest a detrimental effect in some patients.
7+
N
3.2+1.3
10+10+10+
PREVENTION OF CORONARY ARTERIAL SPASM WITH A THROMBOXANE
SYNTHETASE INHIBITOR
Fran¥ols A. Thleuleux, M.D., Jean M. Lablanche, M.D.,
Frangois A. Lombard, M.D., Pierre E. Nocon, M.D.,
Michel E. Bertrand, M.D., F.A.C.C. Universlty of Llile.
France
Dazoxlben (D), an lnhibitor of thromboxane synthetase
could be useful in the treatment of patients wlth coro-
nary arterial spasm (CAS). The following protocol was
designed in 10 patients (pts) (mean age: 51 yrs) with
documented CAS. The study conslsted of 4 phases of 2
days. Phase 1 and 3 were a placebo period (PI and P2).
During phase 2 and 4, the patlents were randomly assi-
gned to D (400 mg/day) or nifedipine (N) (60 mg/day).
During each phase, a 24 hour ambulatory monitoring was
recorded and a provocative test with incremental doses
of ergometrine (E) was performed. The criterlon for a
positlve test was an ST segment change> 1 mm.
Phase 1 D Phase 3
15.5+7 6.4+2 11.6+5- -Number ofattacks
Posltive E
test
Ergo. 0.33+0.07 0.26+0.5 0.24+0.03 0.44+0.07*
threshold (mg)
m + SEM * p < 0.05
In-concluslon. the inhibitor of thromboxane synthetase
(D) failed to prevent coronary arterla1 spasm
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These data suggest that atropine unmasks the
deconditioning effect of bedrest in athletic men,
evidenced by a reduction in interbeat interval
spectral power not apparent with placebo. Spectral
analysis offers a new means of quantitating the
effects of bedrest deconditioning and autonomic
perturbations on cardiac dynamics.
ATROPINE UNMASKS BEDREST DECONDITIONING EFFECT IN
HEALTHY MEN: SPECTRAL ANALYSIS OF INTERBEAT INTERVALS
Ary L. Goldberger, M.D., Danielle Goldwater, M.D., and
Valmik Bhargava, Ph.D., Harvard-Thorndike Laboratory,
Beth Israel Hospital, Boston, MA.
Bedrest deconditioning is suspected to reduce cardiac
function. However, quantitation of subtle decreases
in cardiac reserve may be difficult. Normal subjects
show considerable variability in heart rate response,
reflected by a relatively broadband interbeat interval
power spectrum. We hypothesized that the
deconditioning effects of bedrest would induce
narrowing of this spectrum, reflecting a reduction in
the autonomically-modulated variability in heart rate.
Ten aerobically conditioned men (35-50 years)
underwent orthostatic tolerance testing with lower
body negative pressure pre-bedrest and after 10 days
of bedrest, while on placebo and after intravenous
atropine. Spectra were derived by Fourier analysis of
128 interbeat interval data sets from subjects with
sufficient numbers of beats during matched periods of
the protocol. Root-mean-square (RMS) values (X±SD)
for the band encompassing the 2nd to 64th harmonics
were computed.
Condition
Pre-bedrest
Bedrest
Placebo RMS (nE 6)
93±33 ms
paNS [ 84±38 ms
Atropine RMS (n-7)
P{.OI [ 63±24 ms
40±23 ms
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SHOULD NITRATES OR NIFEDIPINE BE PREFERRED AS
FIRST-LINE ANTI-ANGINAL THERAPY IN PATIENTS WITH
LEFT VENTRICULAR DYSFUNCTION? Milton Packer M~
FACC, Wai H.Jng Lee MD, Norma Medina RN; Madeline Yusha
RN. Mount Sinai School of Medicine, New York, NY
Both nifedipine (NIF) and isosorbide dinitrate (ISDN) relieve
angina and ameliorate loading conditions in the normal heart, but
their effects have not !:leen compared in the some patients (pts)
with left ventricular dysfunction (LVD). To do so, 16 pts with
LVD (LV ejection fraction <30%) received NIF (20 mg orally) and
ISDN (40 mg orally) in random order on alternate days. Cardiac
index (CI, l/min/m2), stroke volume index (SVI, ml/beat/m2),
heart rate (HR, bpm), mean arterial (MAP), LV filling (LVFP) &
mean right atrial pressures (RAP, mm Hg), systemic vascular
resistance (SVR, d-s·c) and LV stroke work index (LVSWI,
g_m/m2 ) were measured before (C) and at peak effect of each
drug, where * =r.05 (C vs druqlj t = r<.05 (NIF vs ISDN):
CI S I HR MAp LV P RAp SVR LVSWI
C 1.7 22 83 86 28 15 2033 17
Y\lIF 2.1* 25* 82 62* 26 17 1015* 14
C 1.8 24 83 83 27 15 1857 18
ISDN 2.1 * 28* 80* 72*t 17*t 9*t 1495*t 20*t
Although NIF produced more marked '" in SVR than did ISDN
(-50% vs -19%), this was translated into a greater'" in MAP and
not a greater + in CI or SVI (which + similarly with both drugs).
ISDN produced dramatic '" in LVFP and RAP, whereas NIF did
not, because NIF lacked ISDN's venodilator actions. Hence, LV
performance (LVSWI vs LVFP) was shifted favorably with ISDN
but failed to improve with NIF, despite its more marked effects
on SVR. This likely resulted from NIPs negative inotropic
actions, which limited the + in CI that could occur in response to
a '" in SVR. Such cardiodepression was dramatic in 4 pts, who
deteriorated clinically after NIF; none did so after ISDN.
In conclusion, in pts with left ventricular dysfunction, ISDN
improves LV performance to a greater degree and is better
tolerated hemodynamically and clinically than NIF.
MOLSIDOMINE, A NITRATE-LIKE SUBSTANCE WITH MARKED 001-
ISCHEMIC AND ANTIANGINAL EFFICACY AND NO TOLERANCE
DEVELOPMENT DURING LONG-TERM TREATMENT
Andrea Beyerle, M.D., Gunther Reiniger, M.D.,
Werner Rudolph, M.D., F.A.C.C.,
German Heart Center, Munich, F.R.Germany
There was a decrease in the rate of anginal attacks of
90% and nitrate consumption of 83%. Thus a dosage of 8
mg t.i.d. molsidomine s.r. elicited a marked and long
lasting antiischemic and antianginal effect, which was
documented to be of comparable extent both after acute
administration as well as during long-term treatment.
Molsidomine is a substance with nitrate-like properties,
for which it has not been established whether tolerance
develops similar to that associated with nitrates.
Accordingly to address this question as well as to
assess the extent and duration of action this study with
molsidomine s.r. 8 mg t.i.d. in 10 patients with docu-
mented coronary artery disease and stable reproducible
angina pectoris was carried out. A placebo-controlled,
double-blind, crossover protocol was employed with test-
ing acutely and after 4-week treatment periods with
exercise studies performed before and at 1 and 5 hours
after medication on the 1st and 28th day. As compared
with placebo, the reduction in ST-segment depression
(ST) as well as exercise capacity to onset of 1 mm ST-
segment depression (ST-l), rate of anginal attacks and
daily nitrate consumption was analyzed.
* .. sign.
day 28
1 h. 5 h.
-81%* -34%*
+80%* +23%*
day 1
1 h. 5 h.
-88%* -51%*
+79%* +35%*
ST
ST-l
ESMOLOL FOR HYPERTENSION EARLY AFTER CARDIAC SURGERY.
RJ Gray. MD. FACC; TM Bateman, MD, FACC; lSC Czer, MD,
FACC; CM Conklin, BSN; JM Matloff, MD, FACC. Cedars-Sinai
Medical Center, los Angeles, CA
Systolic hypertension (HTN) early after cardiac surgery
(CS) is common, threatens fresh anastomoses, and increases
cardiac work. Because it is predominantly associated with
elevated catecholamines and preop beta-blocker use; we
evaluated the efficacy of Esmolol (Es), an ultrashort-
acting beta-blocking agent. Twelve pts (18-28 hrs post
CS; CABG 9, AVR 3) received controlled infusions of Es
(142±100 ug/kg/min; SO to 300) and nitroprusside (NTP)
(1.6±1.3 ug/kg/min; 0.5 to 2.75) by randomized sequence.
No complications occurred. Therapeutic response (~15% SBP
reduction) was rapidly achieved in 11/12 Es (mean 22±16
mins) and 12/12 NTP pts (mean 10±10 mins). Hemodynamic
effects were as follows: (*p<.05 Es vs NTP).
Control Es Control NTP
HR* 94+14 82±11 97±14 104±15
SBP 170±12 136±14 173±11 141±15
DBP 69+14 63±14 72±15 50±15
PCW 13+4 15+3 14+4 10+3
CI* 2.9±.4 2.2±.3 3.0±.5 3.2±.5
SVI 31+4 28+4 31+4 31+2
SVR 1506±362 1593+432 1491±391 1060±267
lVSWI 57+8 40+6- 59±10 48+7
O2 SAT* 9B12 9811 98±1 9413
Thus, for HTN early after CS, Es is safe,
effective and rapid. Compared to NTP less un-
wanted decrease in DBP and O2 SAT is seen, butthere is more decrease in HR and cardiac index.
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EFFECTS OF LOW DOSE NICARDIPINE ON SYSTEMIC AND CORO-
NARY HEMODYNAMICS DURING RAPID ATRIAL PACING IN PA-
TIENTS WITH ISCHEMIC HEART DISEASE.
J. Berland. MD; T. Savin, MD; A Cribier, MD; B Letac,
MD FACC; University of ROUEN (FRANCE).
EFFECT OF NISOLDIPINE ON THE ABNORMAL RESPONSE TO COLD
PRESSOR STIMULATION IN PATIENTS WITH SYNDROME X.
Duncan S. Dymond, M.D., F.A.C.C., John L. Caplin, M.B.,
William Flatman, M.Se, seamus Banim, M.B., St.
Bartholomew's Hospital, London, ENGLAND.
'-__.L-_____________________ __
Mean ECG ST depression (lead V5) just after Pacing+NIC
was l±l mm as compared to control Pacing 1.6±1 mm,
p<0.05.
Thus, and in contrast with other calcium antagonists,
NICARDIPINE (2.5 mg IV) during pacing in ischemic heart
patients produced significant improvements in ventricu-
lar function and myocardial metabolism, without lower-
ing myocardial 02 demands. Since CSF and MV02 remained
unchanged, we postulate that NICARDIPINE enhances nu-
tritional flows in ischemic areas.
NICARDIPINE (NIC) , a calcium antagonist, has been re-
ported to feature greater coronary than systemic vaso-
dilator capacity without associated negative inotrop-
ism. To determine if NIC without systemic effects bene-
fit ischemic patients (pts) during stress, we measured
i~O pts with left coronary stenosi~,aortic pressure
(AoP mmHg), cardiac index (CI l/min/m ), maximal dp/dt
(mmHg/sec), coronary sinus thermodilution flow (CSF ml/
min), myocardial lactate extraction (LE%) and oxygen
consumption (MV02 ml/min), during 2 rapid atrial pacing
tests at equivalent maximal heart rate (HR=147±8 beats/
min) during control pacing and after 2.5 mg IV NIC.
Results (mean ±SD, *p<0.05 **p<O.Ol vs control pacing):
12 patients (pts) with Syndrome X, characterised by
typical anginal chest pain, abnormal exercise (ex) ECG's
and ex first pass radionuclide angiograms (FPRA), but
with normal coronaries, were imaged at rest, and after 1
and 2.5 mins of cold pressor stimUlation (CP), before and
after the calcium antagonist nisoldipine (nis). No pt had
clinical or angiographic eVidence of focal coronary
spasm. FPRA were performed using gold-195m (t1/2 30.5
secs). Before nis, mean+SD LVEF fell from 61+9J at rest
to 55+9J at 1 min of CP~ and 56+8J at 2.5 min CP (both
p<o.oT vs rest). 10 pts had an abnormal EF response to CP
(fall in EF of >5J). Nis caused a rise in mean resting
heart rate from-83+12bpm to 92+21bpm, and a fall in
resting systolic pressure, 145;3OmmHg to 136+25mmHg. Both
heart rate and systolic pressure rose signifIcantlY from
rest to both stages of CP before and after nis. Moreover,
the CP induced increases in heart rate and systolic
pressure from resting levels were not attenuated by nis
at either stage. After nis, LVEF was 63+10J at rest,
64+9J at 1min CP and 65+6J at 2.5min CP-(p,ns) and only 3
patients had an abnormal response. LVEF was significantly
higher at each CP stage compared to values before nis
(p<0.001). In conclusion, 1) abnormal response to CP is
common in patients with Syndrome X, 2) this response is
largely blocked by a calcium antagonist, 3) this effect
is not mediated by blocking the heart rate and systolic
pressure responses to CP and may be related to inhibition
of cold induced coronary vasoconstriction.
LE I
7 I
±7
20.7 15*
±6.4 ±12
CSF MV02
173 18.7
±80 ±6.5
3.56** 2143* 204
±.65 ±365 ±86
162
±20
105 174 2.84 1874
±26 ±28 ±.48 ±305
99
±15
Control
Pacing
Pacing
+NIC
INTRAVENOUS NIFEDIPINE VERSUS NITROGLYCERIN IN
PATIENTS WITH ANGINA AT REST
Wolf Rafflenbaul, M.D., F.A.C.C., Claus Bossaller, M.D.,
Paul R. Lichtlen, M.D., F.A.C.C.
Hannover Medical School, Hannover, West Germany
Inappropriate vasoconstriction of coronary arteries - fre-
quently superimposed on pre-existing lesions - may pro-
voke angina at rest responsive to vascular smooth muscle
relaxants. Therefore, in 20 patients with angina pectoris
at rest either Nifedip1ne (15 - 30 mg/24 hrs; n = 10 pa-
tients, group I) or n1troglycerin (30 - 60 mg/24 hrs;
n = 10 patients, group II) was administered intravenously
over a 72 hrs observation period in a CCU. Blood pressure
(RR, via a femoral cannula), heart rate (HR), pulmonary
capillary pressure (PCP), cardiac index (CI, thermodilu-
tion technique) and severity of anignal symptoms were re-
corded on an hourly basis.
Results: In group I patients systolic and diastolic RR
fell lastingly (149 + 10- 134 + 13 mmHg, 95 + 7- 88 +
5 mmHg resp.; p( .05), CI rose from mean 3.0 to 3.6 1/;;;in/
m'; p( .02; HR and PCP remained unaffected. In contrast,
in group II patients only a transient drop in RR, a re-
flectory rise in HR, a lasting fall in PCP (14 + 2 -+
8 ~ 3 mmHg; p( .02) with unchanged CI was observed. Angi-
nal symptoms were alleviated in both groups 15 - 30 min.
after 1nfusion onset and ceased within 2 hours.
We conclude that i.v. Nifedipine acts predominantly
through sustained afterload reduction reversing subjec-
tive and objective signs of acute myocardial ischemia.
This classifies i.v. Nifedipine as an effective alter-
native to i.v. nitroglycerin in patients with ang1na
pectoris at rest.
SUSTAINED RELEASE VERAPAMIL (36Orrg) IN ANGINA PECroRIS -
ElJAWATION OF EFFECI' AFTER ONCE-DlU:LY !\mINISTRATION
Ravinder S. Kohli, M.D., Mohcmned M. Kardash, M.B., Erwin
A. Rodrigues, M.R.C.P.,- Nardev S. Khunni, M.B., Avijit
Lahiri, M.B., Edward B. Raftery, M.D., F.A.C.C.,
Department of Cardiology, Northwick Park Hospital &
Clinical Research Centre, Harrow, Middlesex, ~land.
A new preparation of long-acting verapamil (VSR) was
given in a dose of 360mg onceMlaily to 19 patients with
reproducible angina and its effects evaluated by
treadmill exercise and ambulatory ECG IlOnitoring. The
study was double-blind crossover against placebo for 2
weeks, followed by a 4 week period of open treatment with
VSR. All drugs were given once-daily and 24-hour ECG
IlOnitoring was followed by an exercise test which was
carried out 24 hours after the last dose of medication.
Blood samples were withdrawn for drug level assay prior
to exercise. Exercise time (mean +SEM) increased fran
7.4+0. f) min with placebo to 9.6+0-:-8 min after VSR
(P<O.OOl) and remained at 9.5+0-:-7 min (p<O.OOl) after 4
weeks. The mean time to 1 IlI\l-ST depression also
increased significantly with VSR but there was no
significant change in maximal ST depression. Resting and
peak systolic BP amd double-product decreased
significantly with VSR (P<0.05). Analysis of the 24 hour
tapes revealed a reduction in the heart rate with VSR
particularly between 18 and 24 hours after the last dose.
Blood level assays revealed verapamil and norverapamil
levels (mean+SEM) of l59.8+68ng/ml and 198+63ng/ml
respectively"';"' during the double blind phase and these
levels were unchanged at the end of the open period of
treatment. OUr data suggests that verapamil SR (36Omg)
is an effective antianginal agent for onceMlaily
administration and this m:xle of therapy may improve
patient canpliance.
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16*
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16*
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COMPARATIVE SYSTEMIC AND REGIONAL HEMODYNAMIC EFFECTS OF
CALCIUM CHANNEL BLOCKADE AND ANGIOTENSIN CONVERTING
ENZYME INHIBITION IN HEART FAILURE.
Donna Mancini, M.D., Harry Feld, M.D., Debra Gumbardo,
R.N., Brian Chadwick, R.N., Thierry LeJemtel, M.D.,
Albert Einstein College of Medicine, Bronx, N.Y.
The cardiac and peripheral circulatory response to vaso-
dilators with different physiologic mechanisms may be
dissimilar. A study was conducted in 10 patients with
congestive heart failure in functional class III-IV
(New York Heart Association) after administration of 10-
30 mg oral nitrendipine, a new calcium antagonist agent,
and l2.5-25mg captopril. HR (beats/min), CI (L/min/MZ),
mean system~arterial and pulmonary capillary wedge
pressures (SAP, PCWP, mmHg) , as well as femoral vein
oxygen saturation (FVOz sat, %) at controls (C l , Cz) and
peak effects were as follows:
HR CI SAP
Cl 76 1.8 85
Captopril 73 2.1* 75*
Cz 81 1.9 92
Nitrendipine 80 2.5*+ 83*
*=p<0.05, captopril or nitrendipine
nitrendipine vs captopril.
Thus, nitrendipine elicited a greater increase in CI than
captopril, while both drugs decreased LV filling pressure
similarly. In contrast to captopril, nitrendipine
appeared to increase resting skeletal muscle blood flow.
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LONG-TERM ORAL ADMINISTRATION OF MILRINONE FOR DILATED
CARDIOMYOPATHY.
Ralph Schoeller,M,D.. Thomas Bruggemann, M,S" Hans VOhrlnger,M.D.,
Thorsten Nothel, Christian Opitz, Klaus Schroder, Rolf Schroder, M.D.,
F.A,C.C" Kllnlkum Steglltz, Free University Berlin, Germany
A randomized double-blind cross-over study was performed In 10 pa-
tients with severe Idiopathic dilated cardiomyopathy with 14 week
treat-ment periods of either 4x10mg Mllrlnone (M) or Placebo (P), each
followed by a 3 week washout period, Radlonucllde ventricular studies
(ejection fraction EF, peak ejection rate PER, peak filling rate PFR)
were performed before and 1 h after 10mg M or P, both at rest and
exercise at the beginning and at the end of each 14 week treatment
period, Functional capacity (vital signs, symptom score, maximal exer-
cise capacity, maximal oxygen uptake), systolic time Intervals, and
echocardlographlc Indices of left ventricular size were monitored
throughout each treatment and washout period,
Acute effects: 1 h after 10mg M there was a significant Increase in PER
(1,04,± 0,7 to 1,32,± 0.8 EDV/sec,) and PFR (1.18! 0,8 to 1.66.11,0
EDV/sec.) as compared to 10mg P (1.23.1 0,6 to 1,26 + 0,7 and 1,31
.1 0,7 to 1.40 ±. 0.8, resp.),a trend to an Increased EF (M: 18,7 j; 12 to
21.0 ± 13; P: 21.S i:. 11 to 22.1 .1 14) and during exercise a significant
Increase In EF to 25.3 ± 16 (P: 20,7 ± 14), as 1(571 j; 38 to 556 j; 32)
and PEP/LVET (0.60 ±. 0,13 to 0.58.:!: 0.12) d!ecreased, echocardlo-
graphic fractional shortening increased (13,9 ± 3 to 1S,1 j; 5), There
was no change after 10 mg P.
Long-term effects: Within or between the two 14 week treatment peri-
ods there was no change In the functional capacity parameters. As
compared to the P-perlods there was a trend towards deterioration In
the hemodynamic parameters during M although after 14 weeks there
was stili some effect after 10mg M as compared to 14 weeks baseline.
No major side-effects occurred during M.
Conclusion: In the dosls tested, oral long-term Mllrlnone does not Im-
prove functional capacity and cardiac performance beyond that pro-
vided by standard treatment with digitalis, diuretic drugs and spirono-
lactone In patients with severe Idiopathic dilated cardiomyopathy.
HEMODYNAMIC EFFECTS OF NISOLDIPINE IN ACUTE CARDIAC FAILURE
AFTER MYOCARDIAL INFARCTION.
Wolfgang G. Schmidt M.D., Rainer v. Essen M.D., Frank A. Flachskampf M.D., Eg-
bert Schmitz.
Dept. of Internal Medicine I, RWTH, Aachen, West Garmany.
The effect of an intravenous injection of nisoldipine, a new calcium channel blocker
with predominantly peripheral vasodilating properties, was studied in 10 patients
(pts) with acute cardiac failure (left ventricular enddiastolic pressure > 16 mmHg
or Cardiac index -< 2.4l/min x m2). 2 JIg/kg _re administered in 5 pts, 4 Jlg/kg in
another five. The drug was continuously injected oyer 3 minutes. Heart rate (HR),
aortic pre....re (AOP), Pulmonary artery pre....re (PA), pulmonary wedged pressure
(PC), right atrial pre.... re (RA), cardiac index (CI), total peripheral resistance (TPR),
pulmonary resistance (PAR) and stroke volume index (SVI) were recorded for one
hour after injection. The data are shown in the table:
before immediately after 60'
injectIon thereafter
HR
(min'l) 2 JIg/kg 81.4± 7.2 86.2± 8.8 71.0± 6.6
4 JIg/kg 81.4± 18.5 86.2± 16.6 82.0 ±. 19.6
AOP
(mmHg) 2 JIg/kg 103.2±. 8.5 96.2± 8.3 l00.0± 5.0
4 JIg/kg 75.4± 16.0 62.8± 10.4 78.6± 28.2
CI
Ulmin m2) 2 JIg/kg 2.6± 0.4 3.0±, 0.3 2.5±. 0.5
4 JIg/kg 3.1±. 0.5 3.6±. 0.8 3.a 0.5
TPR (dyn x sec x cm'5)
2J1g/kg 1529±423 1233± 324 1596±481
4 JIg/kg 967±279 680±, 195 991 ±.265
SVI
(ml/m2) 2 JIg/kg 27.1 ± 13.9 36.1 ±. 5.0 32.4 ± 6.7
4 Jlg!kg 39.1 ±. 8.4 42.a 7.6 38.8 ±. 6.6
No side effects could be _n In any pltilnt. In all 10 pts a significant change (p <
0.05) could be noted in HR (+ 5.9 %), AOP (-11.6 %), CI (+ 14.3 %), TPR (- 23.4
%), SVI (+ 7.8 %). RA, PC, PA, PAR did not chlnge significantly. Nisoldipine is a
potent peripheral vasodilator, which significantly increases stroke volume in patients
with cardiac failure.
ENALAPRILAT: A NEW PARENTERAL ANGIOTENSIN-CONVERTING EN-
ZYME INHIBITOR: RAPID CHANGES IN SYSTEMIC AND CORONARY
HEMODYNAMICS AND NEUROHUMORAL PROFILE IN CHRONIC HEART
FAILURE
T. De Marco, M.D., P. Daly, M.D., L, Greenholtz, R.N.,
K. Chatterjee, M.B., F.R.C.P, F.A.C.C., University of
California, San Francisco, Ca.
Systemic and coronary hemodynamic and neurohumoral ef-
fects of a new intravenous angiotensin converting enzyme
(ACE) inhibitor, enalaprilat (E, 1.25 or 5,0 mg IV
bolus), were evaluated in 10 patients (PTS) with chronic
heart failure (ejection fraction 20-40%, 6/10 PTS with
ischemic cardiomyopathy) at baseline (B), at 15 and 30
min. and hourly to 6 hrs. Onset of action occurred
within 15 min., peak hemodynamic effect within 30 min.,
and persisted to 4 hrs. There was a significant reduction
in mean arterial pressure (MAP, mmHg), pulmonary capil-
lary wedge pressure (PCWP, mmHg), systemic vascular re-
sistance, rate-pressure product (RPP, b/min., mmHgxl0 3),
and an increase in cardiac index (CI, 1/min/m2), There
was no change in coronary vascular resistance, coronary
sinus blood flow and average lactate extraction, Three
PTS moved from net lactate production at B to uptake at 2
hrs. Plasma renin activity (PRA, ng/ml/hr) increased and
aldosterone (A, ng/dl) decreased by 30 min.(*p<.05 vs. B)
MAP PCWP Cl RPP PRA A
Baseline 94 -:z.7 2:'4 12.'"3 6:2 21.3
30 min 84* 18* 2.8* 10.9* 25.5,p.06 10.7,p.06
2 hrs. 82* 16* 2.5 10.1* 20.1* 7.2*
4 hrs. 76* 17* 2.6 9.6*
We conclude:l) E is an effective parenteral ACE inhibi-
tor; 2)onset of action is rapid «15 min) and duration
of effect prolonged;3)resting ischemia may be alleviated;
4)the activated renin-angiotensin-aldosterone system re-
sponds rapidly to E.
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IDENTIFICATION OF PATIENTS WITH SEVERE HEART
FAILURE MOST LIKELY TO FAIL LONG-TERM THERAPY
WITH CONVERTING-ENZYME INHIBITORS. Milton Packer MD,
~~C~, Wai I-tJng Lee MD, Norma Medina RN, Madeline YuShak
aul Kessler MD. Mt. Sinai School of Med, New York, NY
Only 60-65% of patients (pts) with severe heart failure (CHF)
improve clinically during long-term converting-enzyme inhibition
(CEO, but previous reports have not been able to distinguish
responders and nonresponders prior to treatment. We correlated
30 pretreatment variables with long-term response in 134 pts
with CHF treated with either captopril (CPT, 75-450 mg/24h,
113 pts) or enalapril (ENL, 20-40 mg/24h, 21 pts) for 1-3 months.
Clinical responders (84 pts) and nonresponders (50 pts) to CEI
were similar with respect to age, sex, CHF etiology & duration,
serum No, cardiac index, LV filling and mean arterial pressures,
systemic & pulmonary vascular resistances, LV ejection fraction,
diuretic dose and plasma renin activity. Responders, however,
had a lower serum creatinine (Cr, 1.5 ± 0.1 vs 2.1 ± 0.2 mg/dl,
p <.05) and a lower mean right atrial pressure (MRAP, 9.9 ± 0.6
vs 14.6 ± 0.9 mm Hg, p<.OI) than did nonresponders. Stepwise
discriminant analysis confirmed that Cr and MRAP were the
primary determinants of long-term clinical response.
To determine their interaction, the proportion of resrnnders to
CEI is tabulated as a function of pretreatment Cr and MAp:
Cr < 1.5 mg!dl Cr> 1.5 mQ!dl
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Pharmacology-Clinical
IV NITROGLYCERIN: INFUSION RATE, PLASMA
CONCENTRATION AND HEMODYNAMIC EFFECTS
David Zimrinl M.D., Nathaniel Reichek, M.D.,
Kathleen Bogin, R.N., Sandra Cameron, Pamela
Douglas, M.D., and Ho-Leung Fung, Ph.D.
University of Pennsylvania, philadelphia, PA
Although intravenous nitroglycerin (IV NTG) is
in wide Clinical use, little is known about the
relationship between infusion rate (IR), plasma
concentration (C) and hemodynamic effects (HR,
BP) over time. We therefore performed acute
titrations to maximal tolerated IR (to BP <100
mmHg) and constant 24 hr infusions of maximal IR
and placebo in 8 subjects with chronic stable
angina. Titration began at 10 meg/min with 10
meg/min increments every 10 min x 6 and 20
meg/min increments every 10 min x6, if needed.
Maximal IR ranged from 10-120 meg/min (m=59
meg/min or .70 + .45 meg/kg/min). IR and C
correlated we11-(r = .79) over 24 hours. Steady
state concentration was achieved within 10
minutes. Most subjects showed strong cor-
relations between IR and BP during titration but
BP-C, HR-C and HR-IR correlations were weaker.
Individual regression lines varied widely. Over
24 hours, IR was constant and C varied little
(m=6.54 ~ 1.12 ng/m1) and remained unchanged
after exercise. HR increase (8 bpm) and
systolic BP reduction (20 mmHg) persisted for 24
hours. We conclude that although hemodynamic
response to a given IV NTG IR and C varies
widely among individuals, the relationship of
IR, C and resting hemodynamic effects of a
maximum tolerated dose of IV NTG is constant
over 24 hours.
TIME-DEPENDING VASOMOTION OF CORONARY ARTERIES FOLLOWING
NIFEDIPINE
Ulrich Nellessen, M.D., Wolf Rafflenbeul, M.D., F.A.C.C.,
Werner G. Daniel, M.D., Hartmut Hecker, M.D., Paul R.
Lichtlen, M.D., F.A.C.C.
Hannover Medical School, Hannover, West Germany
In 15 patients (pts) we correlated 1) the diameter chan-
ges (A-D) of angiographically normal epicardial coronary
artery segmects (CA) (automated contour detection system,
variability (.12 rom), 2) the Nifedipine (Nif) plasma le-
vels (gas chromatography) and 3) the changes of O,-satu-
ration between coronary sinus and aorta (LI.-AVD-O,) before
and 10, 20 and 30 minutes after 20 mg Nif sublingually.
Accord~g to the slope of Nif plasma levels pts were sub-
divided into group A (n ~ 6 pts) and B (n ~ 9 pts). Re-
sults are (mean values ~ SO) :
minutes oost Nifedioine
10 20 30
plasma levels A 21,9~12,5 41,9~21,0 61 ,7~27 ,8
~if (ng/ml) B 14,3~ 3,5 22,6~ 6,7 28,3~1l ,0
p( - .05 .01
A 6,6~ 5,2 10,8~ 4,9 15,2~ 6,4
tl,-D (%)
B -8,1~ 7,6 -7,6~ 9,6 -3,1~11,8
p( .001 .001 .01
With constant heart rate pressure product tl,-D and tl,-AVD-O,
were inversely correlated (r ~ -.90).
Conclusions: Variability of slope and peak plasma levels
after sublingual application of Nif determines the vaso-
dilatory potency of Nif on epicardial and precapillary
CA.
NICARDIPINE - A NEW CALCIUM CHANNEL ANTAGONIST: EFFICACY
IN STABLE EFFORT ANGINA PECTORIS
M. George Thomas, M.D., F.A.C.C., Antonio C. Quiroz, M.D.,
F.A.C.C., Michael B. Given, Ph.D., Gary E. Sander, M.D.,
Ph.D., Thomas D. Giles, M.D., F.A.C.C., Veterans Adminis-
tration MC and Tulane University, New Orleans, LA
Nicardipine (N) - a new dihydropyridine calcium antago-
nist - was studied in chronic stable effort angina pector-
is (AP): 18 patients, randomly assigned to treatment
groups, entered an 8 week trial in which N 10, 20, and 30
mg TID were compared to placebo (PL) in an extended Latin-
Square design with a 5 week double-blind phase. Baseline
reproducibility was assured by repeat testing. There
were no significant differences among group baseline data.
Treadmill exercise time (ET) (Bruce protocol) increased
from 395~18 sec to 451~21 sec after 30 mg N (mean+SEM; 1
hr data; p<0.05). Repeated measures analysis of ;ariance
revealed significant differences among groups over time
after N: resting rate-pressure product at 1 hr and 4 hr
(p<O.OOl); time to onset of AP at 1 hr (p<0.05) and 4 hr
(p<O.Ol); ET at 1 hr (p<0.02) and at 4 hr (p<O.OOl).
There were no significant differences in exercise rate-
pressure products among groups. The inter-group differen-
ces can be attributed to the dosing sequence. A dose-de-
pendent increase in ET was observed, with ET increasing
from 395~18 sec to 398~21 sec (10 mg), 409+16 sec (20 mg),
and 451+21 sec (30 mg) (1 hr data). A similar effect was
seen at-4 hrs. Maximum benefit occurred in the treatment
group which received N in 10 mg increments. Two patients
did not complete the study due to exacerbation of chest
pain and dizziness when assigned directly to 30 mg N TID
from PL. These results indicate that N increases ET and
produces beneficial hemodynamic effects in AP in a dose-
dependent manner. Upward dose titration, beginning with
10 mg TID, produces maximum benefit and fewer adverse
effects.
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Conclusions: Intravenous verapami1 in clinical doses
results in: 1. peripheral vasodilation and LV unloading;
2. a short-lasting reflex-mediated increase in HR; 3. a
progressive fall in dP/dt and a rise in LVEDP, in spite of
sustained unloading, due to a direct myocardial effect;
4. no decline in LV pump function due to LV unloading;
5. a rise in GCF accompanied by trivial changes in MV02.
Thus, the depressant actions of verapami1 on the myo-
cardium are compensated by LV unloading, resulting in pre-
servation of LV pump function.
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Cardiac Pacing
ANTITACHYCARDIA PACING FOR SUPRAVENTRICULAR TACHYCARDIA:
SELECTION OF PATIENTS AND PACING MODES.
Bernd Waldecker, M.D., Pedro Brugada, M.D., Karel den
Dulk, M.D. Manfred Zehender, M.D. and Hein J.J. Wellens,
M.D., F.A.C.C. Dept. of Cardiology, Univ. of Limburg,
Maastricht, The Netherlands.
Antitachycardia pacing (ATP) is increasingly used to
terminate paroxysmal supraventricular tachycardia (SVT).
To identify patients (pts) amenable to ATP we studied
pacing termination of SVT in III pts. Mean age was 41 +
15 years, 62 were male. 76 pts had circusmovement T (CMT)
using an accessory pathway, (mean rate 166 bpm) 35 pts
had A-V nodal T (AVNT) mean rate 167 bpm). Results:
Pacing termination was safe and reproducible in-rD47Tf1
pts (94%) irrespective of pts' SVT, sex and age. Similar
success rate was found for GMT and AVNT of single (43% vs
41%, p n.s.) and double (60% vs 43%, p n.s.) atrial (A)
premature depolarizations (PD). However, in pts with AVNT
ventricular (V) PD were less effective than in CMT: 23%
vs 53%, p<O.OI (I VPD) and 48% vs 79%, p<0.05 (2 VPD).
Atrial (91%) and ventricular (100%) bursts terminated GMT
as well as AVNT. SVT interrupted by 1 APD or 1VPD were
slower than SVT's requiring > 1 APD (157 vs l70/min
p<0.02) or > 1 VPD (156 vs 173/min p<O.OI). Antiarrhyth-
mic drugs did not faCilitate termination by APD's or
VPD's. Induction of atrial fibrillation during pacing
(32/111 pts) or other SVT (6/111 pts) was unpredictable
from pts' age, sex or clinica~ SVT but related to number
and site of PD's. In pts with GMT and dual AV-nodal
pathways pacing induced AVNT in 3/76 pts. Conclusions: 1)
Pts with GMT as well as AVNT are amenable to ATP but
evaluation by pacing is required before implanting an ATP
unit. 2) The efficacy of APD's is SVT rate-related and of
VPD's both rate and type of SVT related. 3) Drugs facili-
tate SVT termination only if they slow SVT-rate.
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DIRECT CARDIAC AND PERIPHERAL ACTIONS OF INTRAVENOUS
VERAPAMIL.
Ivo Amende, M.D., F.A.C.C., RUdiger Simon, M.D., F.A.C.C.,
Paul L1chtlen, M.D., F.A.C.C., Hannover Medical School,
Hannover, West Germany.
The effects of intravenous verapami1 on the LV are still
controversial. To study this problem, we gave verapami1
(0.1 mg/kg bolus followed by 0.005 mg/kg/min) to 10 pa-
tients 4 years after coronary bypass grafting. A tip
manometer was used to measure AO diastolic pressures (DP),
LV systolic (SP) and end-diastolic (EDP) pressures and
peak positive dP/dt. Shortening velocity (V) was de-
termined from filmed LV tantalum markers implanted at
surgery. Great cardiac vein flow (GCF) was measured by
thermodilution and was used to calculate myocardial oxygen
consumption (M~02). Results 1 and 15 min after verapami1
(*p ~0.05 vs control (C); HR = heart rate; TPR = total
peripheral resistance):
C 1'
76 82*
12 12
137 120*
75 68*
1748 1640*
AUTOMATIC DETECTION OF VENTRICUALR FIBRILLATION WITH
CHRONICALLY IMPLANTED PRESSURE SENSORS.
Walter H. Olson, PhD, Tom D. Bennett, PhD, Kenneth P.
Huberty, MS and Kenneth M. Anderson, MS; Pacing Research,
Medtronic, Inc., Minneapolis, Minnesota
We studied the feasibility of using RV pressure changes to
detect ventricular fibrillation (VF) in five chronically
instrumented canines. Permanent pacing leads containing a
pressure sensor 3.0 cm proximal to the tip electrode were
implanted in the RV apex and the dogs were studied 12-34
weeks post implant. The peak-to-peak amplitude of the
pressure (RVP) signal and heart rate were measured before,
during and after multiple episodes (3-8) of electrically
induced VF in each animal under general anesthesia. An
eight beat moving average was used to reduce beat-to-beat
variability. Control values (average of 30 sec prior to
induction of VF) of RVP during ventricular paced and sinus
rhythm were 23.9 + 13.0 mmHg (range 14.0-44.6 mmHg) for
heart rates of 110 + 30 bpm (range 71-149 bpm). During
the first 10 seconds of the 20-30 sec VF episodes, RVP
decreased (P < 0.05) to an average value of 3.7 + 2.1 mmHg
(range 1.0-6.8 mmHg) for heart rates of 445 -! 31 bpm
(range 405-476 bpm). The average percentage decrease in
RVP for each dog was 85%, 81%, 93%, 56%, 93%, (82% mean
decrease). During VF, the small residual RVP values were
associated with atrial activity. The decrease in RVP in
one dog of only 56% during VF was always associated with
monomorphic ventricular flutter at 434 bpm. After
defibrillation, RVP initially (within 5 sec) equaled or
exceeded prefibrillation control values.
CONCLUSION: Since large, significant decreases in right
ventricular pulse pressure occur during VF in dogs,
chronically implanted pressure sensors may be useful for
VF detection in an automatic, implantable defibrillator.
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Thus T 600mg improves Ex tolerance in pts with AP and
CAD, with peak effect 1 hour after administration of a
single oral dose. T BOOmg may produce side-effects.
THE EFFECTS OF TIAPAMIL, A NEW CALCIUM ANTAGONIST, ON
EXERCISE INDUCED ANGINA.
Milton B. Maltz, MB, A. John Camm, MD, FACC.
St. Bartholomew's Hospital, London, England.
A double blind study of the effects of 4 doses of a new
calcium antagonist Tiapamil (T) on exercise (Ex)
performance were studied in 10 patients (pts) with
Coronary disease (CAD) and Ex-induced angina (AP).
Maximal treadmill Ex ECGs were performed pre and post
randomised, oral doses of 200, 400, 600 Or 800 mg T or
placebo (P). Ex duration, work load (mets), time to the
onset of AP and 1 mm ST-depression were similar pre and
post-P, but improved after 60c:mg Or 80c:mg of T. Ex
duration increased from 299+40 secs (mean+SEM) post-P to
399+49 secs post-T 600mg (P<0.05) and 416~49 secs post-T
BOomg (p<0.05). Time to onset of 1mm ST-depression
inCreased from 202+35 secs post-P to 300+48 secs post-T
60c:mg (p<0.05) and-272+51 secs post-T 80Qmg (p<0.05).
B/l0 pts were free of AP post-T >60Omg at similar work
loads to peak Ex post-Po 2/10 pta had dizziness and
blurred vision after T 80Omg. Although T improves Ex
tolerance in pts with CAD and AP, its dUration of action
after a single oral dose is unknown. In another group of
10 pts with AP and CAD, Ex was performed pre and 1, 3, 6
and 9 hours post T 60Omg. Results are shown below.
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Conclusions:l)DOP is more effective in terminating indu-
cible VT when compared to synchronized 00 pacing. 2)DOP
is safe when applied to well tolerated VT episodes with
CL ) 280 msec.
SYNCHRONIZED BURST PACING VS. SELF ADAPTING DECREMENTAL
OVERDRIVE PACING FOR TERMINATION OF VENTRICULAR TACHY-
CARDIA.
George Charos,MD,Charles I.Haffajee,MB,MRCP,FACC,
Robert L.Gold,MD,Barouh V.Berkovits,FACC,Augustin
Castellanos,MD,FACC,Univ.Mass. Medical Center,Worcester
MA.
Our preliminary experience with self adapting auto-
decremental overdrive pacing (DOP) has demonstrated a
high degree of efficacy and relative safety for inter-
ruption of VT with cycle length (CL»280 msec in patients
(pts) undergoing programmed ventricular stimulation(PVS).
In a comparative efficacy/safety study,we have also shown
that this DOP method was superior to anti tachycardia pac-
ing methods currently employed for VT including asyn-
chronous overdrive burst (00) pacing.
In this study we compared in a randomized cross-over
fashion DOP to 7 or more stimuli of synchronized 00 pac-
ing (ODs)(utilizing the Fisher formula to calculate the
burst rate) for induced VT in pts during PVS.The relative
efficacy and safety of these two methods were compared in
8 pts with VT-CL ~ 280msec(CL 280-410msec, Mean 359msec).
EPICARDIAL MAPPING OF THE INITIATION OF
VENTRICULAR FffiRILLATION BY SHOCKS DURING
THE VULNERABLE PERIOD
Nitaro Shibata MD, Peng-Sheng Chen, MD, Ellen G Dixon, MS,
Patnck Wolf, rlS, Ned D. DaDieley, MS, William M Smith, PhD, and
Raymond E. Ideker, MD,PhD. Duke Univ Med. Ctr , Durham, NC
Implantable anti-arrhythmic devices may inadvertently mduce ven-
tricular fibrillation (VF) by shockmg during the vulnerable period
(VP). Little is known about the inductIOn of VF With high energy
shocks. Accordingly, we delivered 5 msec shocks of 01 to 20 J via
electrodes on the LV apex and RA in 7 open-chest dogs At each
energy level, the T-wave was scanned in 10 msec increments while
epicardial recordings were made Simultaneously from 55 electrodes
evenly spaced over both ventricles In no dog did a shock > 5 J
induce VF. Immediately following shocks that induced VF, the site
of earliest recorded epicardial activation occurred more commonly m
the apical half of the ventricles for lower energy shocks and m the
basal half for higher energy shocks Two types of epIcardial activa-
tion patterns were observed followmg these shocks In 57 cases,
activation spread away from the early site m all directions com patl'
ble with a focus of micrcrreentry or triggered actiVity (FOCAL),
while in 45 cases activation appeared to block uDldlrectionally on one
side of the early site compatible with macrcrreentry (UNIDIR)
SHOCK VF EPISODES WITH VF EPISODES
ENERGY EARLIEST ACTIVATION MECHANISM
J AT APEX AT BASE FOCAL UNIDffi
0.01-0.05 14 3 18 1
0.1-0.5 13 42 32 23
1-5 0 40 III 21
Chi Square P<0.OO1 P<0.004
Thus, VF IDitlated by shocks durmg the VP appears to arise by more
than one mechanism. As energy is mcreased, the site of earliest
activation following the shock tends to move progressively away from
the epicardial shocking electrode until an upper energy hmlt is
reached, above whICh VF does not occur.
Results:
Efficacy per pt
Efficacy per VT episode
Acceleration
DOP
878(100%)
17/18(94%)
0/18(0%)
00 synchronized
6/8 (75%)
10/20(50%)
1/20(5%)
PREVENTION OF ACCESSORY PATHWAY MEDIATED TACHYCARDIA
WITH A NEW ANTITACHYCARDIA PACEMAKER.
Peter L. Friedman, M.D'
A
Ph.D., Elliott Antman, M.D.,
and Barouh Berkovlts, Fee. Harvard Medical School,
Brigham and Women's Hospital, Boston, MA.
A-V reentrant tachycardia (AVRT) in patients with an
A-V accessory pathway (AP) is often initiated by an
atrial premature depolarization (APD) that blocks
anterograde in the AP but conducts anterograde through
the A-V node. In such cases, initiation of AVRT re-
quires sufficiently slow conduction of the APD through
the A-V node to allow reentrant atrial depolarization
via retrograde conduction over the AP. P-wave triggered
pacemakers that prevent this necessary prolongation of
the A-V interval after an APD have been proposed as a
means of preventing AVRT, but have been hampered by upper
rate limit algorithms of the devices. In 4 patients
with an AP whose AVRT could be initiated by APD's, pre-
ventive anti tachycardia pacing was tested using a new
DOD pacemaker with modified upper rate limit character-
istics that sensed the APD and then stimulated a ventri-
cular premature depolarization (VPD) with a short A-V
interval. Three patients had Wolff-Parkinson-White
syndrome. One had a concealed AP capable only of retro-
grade conduction. In each patient, the range of APD's
capable of initiating AVRT was determined using program-
med atrial stimulation (PAS). All patients developed
sustained AVRT after appropriately timed APD's. PAS was
then repeated with the antitachycardia pacing device
activated. In all 4 patients, single VPD's initiated
within a short A-V interval after sensed APD's prevented
initiation of AVRT over the entire range of APD's which
previously had initiated AVRT. The mechanism of preven-
tion of AVRT was retrograde block of the VPD in the AP.
No patients developed adverse arrhythmias. This technique
holds promise for prevention of AVRT in some patients.
OCCURRENCE AND SIGNIFICANCE OF ADDITIONAL REENTRANT
TACHYCARDIAS IN PATIENTS WITH AN ANTI-TACHYCARDIA
PACEMAKER.
Karel den Dulk, M.D., Pedro Brugada, M.D., and Hein JJ
Wellens, M.D., F.A.C.C., Dept. of Cardiology, Un. of
Limburg, Maastricht, The Netherlands.
Medical files and electrophysiological studies were re-
viewed retrospectively to determine whether reentrant
tachycardias (T) other than the T for which the anti-
tachycardia pacemaker (ATP) was implanted, interfered
with ATP therapy (21 supra- and 4 ventricular T). At 3
monthly follow-up (mean 21.7 months) T were initiated
and terminated non-invasively. During a total follow-up
of 543 months, 4418 T occurred spontaneously; 4376 were
terminated pranptly by the ATP, 10 in <15 minutes, 22
took >30 minutes, failure to terminate T occurred in 10
pts once. Causes were: Defective ATP activator in 2,
incorrect use in 1, inadequate antiarrhythmic drug
therapy intake in 2, T trigger interval too short after
addition of a drug in 1, failure of the programmed ATP
pacing mode in 2, and in 2 because of a lead problem.
Additional T were seen in 8 pts. In 3, another T (2
atrial, 1 AV-nodal) was identified after ATP implanta-
tion. Rate of T changed markedly with a change in re-
entry circuit due to bundle branch block in 2, WPW
syndrome and dual AV-nodal pathways in 1 and 2: 1 sub-
nodal block during AV-nodal T in 2. Both clinical and
additional T were reproducibly terminated with a single
pacing modality in all pts during follow-up evaluation.
Conclusion: Additional reentrant T occur frequently(8/25
pts), but do not seem to interfere significantly with
the ability to terminate T reproducibly with a single
pacing modality.
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DETECTION OF ECTOPY BY MEASUREMENT OF VENTRICULAR ACTIVA-
TION SEQUENCE USING TWO ELECTRODES
Anthony Mercando, M.D., Mark Gabry, M.D., Peter Klemento-
wicz, M.D., Seymour Furman, M.D., F.A.C.C. Montefiore
Medical Center, Bronx, New York
The use of 2 ventricular sensing electrodes to determine
electrical activation sequence could provide a new method
for differentiation of normal from abnormal rhythms by im-
plantable antitachycardia devices. Simultaneous recordings
from 2 ventricular sites were obtained during dual chamber
pacemaker implantation (5/8 pts), cardioverter-defibrilla-
tor implantation (2/8 pts), or programmed electrical stim-
ulation study (1/8 pts). Recordings were made in normal
sinus rhythm (NSR) (5 beats each in 8/8 pts), during ven-
tricular tachycardia (VT) (38 beats with 7 morphologies in
3 pts) and during premature ventricular contractions (PVCs)
(20 beats with 8 morphologies in 6 pts). Leads were placed
transvenously in the right ventricle in 6 pts, and epicar-
dially on the LV in 2. Intervals between the intrinsic de-
flection of the 2 ventricular electrograms ranged from 0
to 91 ms (mean of 26 ms) during NSR, from 13 to 141 ms
(mean of 66 ms) during VT, and from 10 to 72 ms (mean of
40 ms) during PVC's and were reproducible within each pt
for each type of rhythm. In all pts the differences in se-
quence and timing between the dual electrograms in NSR
beats vs ectopic beats allowed for the differentiation of
normal from abnormal complexes. These differences in each
pt ranged from 23 to 210 ms (mean of 81 ms) during VT and
from 3 to 89 ms (mean of 44 ms) during PVCs. Fourteen of
the 15 ectopic morphologies exhibited > 20 ms difference
in timing compared to their corresponding NSR beats. Com-
bined with the appropriate software, multiple ventricular
leads may be used by anti tachycardia devices to discrimi-
nate between normal and abnormal ventricular activity.
CLINICAL EXPERIENCE WITH A NEW VERSATILE, SOFTWARE BASED,
TACHYCARDIA REVERSION PACEMAKER
Anthony WNathan MD FACC, John E Creamer MS,
D Wyn Davies MB, A John Camm MD FACC.
St Bartholomew's Hospital, London, England.
To overcome many of the limitations of previous
devices, particularly tachycardia recognition and limited
tachycardia responses, a new pacemaker (Intermedics
Intertach) has been developed and implanted in 7
patients. Tachycardia recognition is achieved
automatically using high rate, sudden onset, rate
stability or sustained high rate, alone or in
combination. Termination may be effected using 1-250
stimuli, which may be rate-related. Extrastimuli or
bursts may be scanned with the S1 and S2-Sn intervals
being independently programmed. Scanning may start from
either preset or from rate-related coupling intervals,
and there is also a programmable memory function.
Autodecremental bursts (+ rate-related) are also
available. The number and size of scanning (or
autodecremental) steps can be programmed, as can the
minimum cycle length. Two termination modes, 10 and 20 ,
may be selected. There is telemetry with full
diagnostics, and non-invasive EPS can be performed.
The pacemaker was implanted in 7 patients, aged 23-48,
6 with intra AV nodal and 1 with atrial tachycardia
(cycle lengths 250-500, mean 330 ms). All had frequent
tachycardias (0.5-20, mean 8 per month) and had failed
drug therapy (3-9, mean 6 agents). Only 1 had documented
bradycardia. Right atrial pacing was used in all, With 1
patient using only the bradycardia functions - the others
use 7 or 8 stimuli in rate-related scanning modes for
tachycardia reversion. All 6 experience almost immediate
termination of tachycardia without the need for drug
therapy. Sinus tachycardias have triggered pacing in 3,
but altering the detection criteria has overcome this.
POSTURELY INDUCED ACCELERATION OF SUPRAVENTRICULAR TACHY-
CARDIA AS A CAUSE OF FAILURE OF OVERDRIVE PACE TERMINATION
Lawrence J. Gessman, M.D., Tsu H. Lai, M.D., Melvin C.
White, M.D., F.A.C.C., Deborah Heart & Lung Center, Browns
Mills, NJ
Overdrive burst atrial pacing is a common treatment for
drug refractory supraventricular tachycardia (SVT). The
effective pace termination regimen (PTR) is usually found
via electrophysiology (EPS) testing with the patient su-
pine. The purpose of our study was to compare the efficacy
of pace termination of SVT in supine vs erect position.
SVT was induced by programmed atrial stimulation. The
slowest 10-16 beat burst PTR that could terminate SVT 50
times when supine was retested at least 10 times with the
patient sitting erect. 3 of 4 consecutive SVT patients
tested had acceleration of SVT rate (150 to 170 beats per
minute (bpm), 160 to 210 bpm, and 180 to 220 bpm) when
erect which negated the efficacy of the previously effec-
tive PTR. The PTR in pt 1 was 180 bpm (10 beats) supine,
and 220 bpm (10 beats) erect; pt 2-220 bpm (16 beats)
supine and none found erect; pt 3-220 bpm (10 beats) su-
pine and 250 bpm (10 beats) erect. Pt 1 received an auto-
matic anti tachycardia pacer set at 220 bpm (10 beats) and
has had frequent recurrences of SVT effectively terminated
in both postures. Pt 2 received a manually activated
anti tachycardia pacer. She has had occasional failure to
terminate spontaneous SVT when erect, and has been
instructed to seek supine posture whereupon repeat attempt
at termination have been successful. Pt 3 was treated
with Amiodarone. Posture induced changes of SVT rate are
common, may negate the efficacy of overdrive anti-atrial
tachycardia pacemakers, and should be tested for during
the preimplant EPS study.
AUTOMATIC IMPLANTABLE DEFIBRILLATORS AND PACEMAKERS -
UNIPOLAR VS BIPOLAR. Marc Wish. MD; Andrew Cohen, MD, FACC;
Ross Fletcher, MD, FACC; Fred Miller, MD; Dan McCormick,
DO; Josh Cutler, MD, FACC; Al DelNegro, MD, FACC. VA and
Walter Reed Army Medical Centers, Washington, D.C.
The interaction of b~polar and unipolar pacemakers (PM)
with automatic implantable cardioverter defibrillators
(AICD) was evaluated in 4 pts with dual chamber unipolar
PMs and 1 pt w~th a bipolar single chamber PM.
Amplitudes recorded at implant (in mV, mean and range):
(DVI pacing) A-spike V-spike QRS
AICD large patches 8(4-35) 13(11-15) 9.5(5-14)
AICD epicardial leads 1.9(1-3.2) 14.2(8-21) 18.5(4-10)
Delay from V spike to QRS on AICD leads was variable, mean
80msec (10-150). Inappropriate pacing of unipolar PMs dur-
ing arrhythmia caused no discharge (DC) in 2 pts in DDD or
VVI and delayed DC in 1 in DDD. Appropriate inhibit~on of2
dual chamber PMs in VVI during ventricular tachycardia (VT)
allowed AICD to DC. Spontaneous DC of AICD was noted in 1
pt in DDD mode not having arrhythmia despite need tosatis-
fy both rate and probability density function. Phonographic
recording of AICD audio tone in test mode withs~multaneous
EKG revealed "triple sensing" of A and V spikes and QRS in
pt with long V-spike to QRS delay, particularly after PVC
and pause which increase sensitivity of auto-gain sensing
amplifier. Change to bipolar PMs revealed no problems inVT
for VVI mode. Phono in 1 pt revealed AICD sensing of bi-
polar pacing spikes at less than the normal pacing output;
triple sensing caused DC of the AICD. We conclude that: 1)
Unipolar PMs often prevent appropr~ate DC of AICD because
high amplitude of PM spikes blinds AICD to arrhythmia. 2)
Bipolar PMs cause less inhibition of AICD, but do notelim-
inate the problem. 3) V-spike to QRS delay should be meas-
ured at time of implant and lead positioned to keep delay
less than the AID refractory period (14Omsec) to avoid DC
due to oversens~ng.
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EFFECT OF STIMULUS STRENGTH ON PREVENTIVE STIMULATION OF
RECIPROCATING ATRIOVENTRICULAR TACHYCARDIA
Karl·Heinz Kuc:k. MD. Micheel SChlueter, PH.D., Klaut-Peter Kunze, M.D. ,Walter
Bleifeld, M.D., F.A.C.C., Dept. of Cardiology, University Hospital Eppendorf,
Hamburg, West Germany
Our previous studies heve Ihown thet reciprocating atrioventricular tachycardia
(tech) induced from the atria can be prevented from the same site by a Ihort train
(Tl of extrestimuli delivered right after the tachycardia initiating extrestimulus (SI,
provided that the length of T exceeds the effective refractory period (ERP) of S by
at least 1 stimulus to achieve atrial capture. Amplitude of T stimuli was 2 x diastolic
threshold (dthr). The p_t study was undertaken with 2 objacti_: can prevention
of tech also be achieved by il a subthreshold T deli_ed in the same mannar as de-
scribed above, or iii by a "suparthreshold" T (4 x dthrl delivered completely within
ERP of S, i.e. with stimulation modes not intended to yield atrial depolarisation?
9 pts ( 7 men, 2 women; mean age 38.±. 13 yearsl with tach due to an accessory
AV connection (3 right-sidad, 6 left-sided) were studied. Tach (cycle length 312 ±,40
ms) wes initiated in all pts from high right atrium with a single S, and in 5 from
coronary sinus, with single S in 3 and 2 S in 2, T of 10 stimuli 10 ms apert was de·
livered at the same site as S and prevention was always successful when T exceeded
ERP of S and stimulus strength was 2 x dthr (1.20 - 2.60 V). When stimulus strength
was decreased below dthr in the preventive T, atrial depolarisation no longer occured
in any pt end tach was not prevented. With T delivered completly within ERP of
S and stimulus strength 4 x dthr, tech was also never pre_tad. - Conclusion:
"SuperthrOlhold" stimulation cannot extend ERP of S long enough to prevent tach.
Subthrashold preventive stimulation is not possible from the site of tach initiation.
It remains to be sean if it will be successful when a subthreshold T can be delivered
at the actual anatomic site of the reentry circuit.
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Hypertension
THE EFFECT OF DRUG TREATMENT FOR HYPERTENSION ON
MORTALITY: EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS
Stephen W. MacMahon. Ph.D •• Jeffrey A. Cutler. M,D. and
Curt D. Furberg. M.D •• National Heart. Lung. and Blood
Institute. Bethesda. Maryland.
Much epidemiological evidence indicates that high blood
pressure is an important risk factor for cardiovascular
disease mortality. Most long-term randomized controlled
trials (RCTs) in mild to moderate hypertension report a
substantial reduction in stroke morbidity and mortality
but reports of the effects on total and coronary heart
disease (CHD) mortality are conflicting. Since many stud-
ies have been too small to detect moderate yet important
reductions in mortality. we have pooled results from 10
long-term RCTs in predominantly mild to moderate hyper-
tension with published mortality data. These studies
reported data from a total of 49.500 patients over an
average of 5 years of followup. Mean systolic and dias-
tolic BP in treated patients during followup was 9.3/5.2
mmHg lower than that in control patients. Total mortal-
ity in the treated patients was reduced by 11% (95% CI=
-18% to -3%); mortality from stroke was reduced by 39%
(95% CI= -53% to -21%). Mortality from CHD was 9% lower
in treated subjects but this was not statistically
significant (95% CI= -21% to +4%). The effect of beta-
blockers and diuretics could be compared in two studies
(n=1~.000); in subjects treated with a beta-blocker total
mortality was 7% lower than in subjects treated with a
diuretic but this was not statistically significant (95%
CI- -23% to +11%). The pooled data demonstrate that
antihypertensive drug treatment involving either beta-
blockers or diuretics produces a modest though important
reduction in total mortality. primarily as a consequence
of a reduction in stroke mortality. The data provide
weaker evidence of a reduction in mortality from CHD.
DISPARATE HEMODY~AMIC RESPO~SE TO MENTAL CHALLENGE AFTER
A~TIHYPERTENSIVE THERAPY WITH BETA BLOCKERS AND CALCIUM
ANTAGO~ISTS. Roland E. Schmieder, MD,' Heinz Ruddel.j.
MD,' Hermann Neus, PhD,' Franz H. Messerli, MD, FACC,
August W. von Eiff, MD.' Department of Medicine,
Universi ty of Bonn, Fed. Rep. of Germany, and Ochsner
Clinic and Alton Ochsner Med. Fdn., New Orleans, LA.
The hemodynamic response to mental challenge was
stUdied in 40 male, white outpatients with mild essential
hypertension before and after randomized treatment with
either a beta adrenoreceptor blocker (oxprenolol, 160 mg
q.d.) or a calcium channel entry blocker (nitrendipine,
20 mg q.d.). Cardiovascular reactivity was evaluated
during two different mental arithmetic tasks before and
six months after treatment by measuring systolic and
diastolic blood pressure (Ultrasonic Doppler device),
heart rate (ECG), and stroke volume (impedance
cardiography). Patients of both treatment groups had an
equal decline in blood pressure and the same pressures at
rest. In patients receiving the calcium entry blocker,
mental challenge provoked an increase in stroke volume and
a decrease in total peripheral resistance equivalent to
the reactions without therapy. In contrast, patients on
the beta adrenoreceptor blocker reversed the hemodynamic
response pattern to a distinct decrease in stroke volume
(SV) and an increase in total peripheral resistance (TPR)
(~SV: -13+3~ vs. +25+11~, p<0.05. ,:\,TPR: +11+3~ vs.
-9+5~, p<O:05), In a-ddition; an attenuated heart rate
re;ponse and a higher increa8e in diastolic pressure were
found in the beta blocker group compared to the calcium
entry blocker group (HR: 7 + 1 vs 18 + 2 bpm,
p<O.Ol;~DBP: 16 + 1 vs 11 + 1 mm Hg, p< o.on. -Although
both drugs cause an equal fall in BP, beta adrenoreceptor
blockers evoke an abnormal hemodynamic response to mental
challenge, whereas calcium entry blockers preserve the
physiological reactivity pattern of the untreated status.
DOPPLER EVALUATICN CF LEFT VEN'lRIOJIAR FILLI~ IN MIID
AID SEVERE HYPERTENSIOO.
Julius M. Gardin. MD. FAQ;: Jan I. Drayer, MD; Mary K.
Rohan; Margaret L. Knoll; S. Farrokhtakin, MD; Walter L.
Henry, MD, FACe; Michael A. weber, MD. Long Beach VA
Medical Center and University of California, Irvine, CA.
studies using a variety of techniques have previously
shown abnormalities of left ventricular (LV) mass and LV
filling in patients with hypertension (HTN). However,
the relatiooship of LV filling changes to the severity
of abnormalities in blood pressure (BP) and LV mass is
not well-established. Consequently, LV diastolic filling
was evaluated by pulsed DoWler echocardiography in
11 patients with treated severe H'm (mean BP: 162/104
IIIIiig), 22 with mild HTN (mean BP: 147/96) and 66 normal
subjects (mean BP: 123/78). Dowler recordings of
transmitral flow velocity were made fran apical views.
Because of the ~e-relatiooshipof mitral flow velocity,
Dowler data were coopared after analysis for
differences in patient ages. Mitral early diastolic peak
flow velocity (PFVE) did not differ in the 3 groups
(p>0.05). Although mitral late diastolic PFV (PFVA) did
not differ between mild H'm patients (mean ± &l: 50 ± 14
cnv'sec) and normals (47 ± 11 cnv'sec), PFVA was
significantly higher in the severe HTN patients
(59 ± 14 cnv'sec) than in normals (p<0.03). Furthermore,
early diastolic deceleratioo was significantly less in
the entire HTN group than in normals (p<O. 01). In the
severe H'm patients, mitral PFVA correlated
significantly with LV mass (p<0.05). However, mitral
flow velocity measurements did not correlate with BP.
we cooclude that DoWler can detect abnormalities of
both early and late diastolic LV filling in hyper-
tension. These abnormalities awear to be independent
of the level of BP, but some are related to LV mass.
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MITRAL VALVE PROLAPSE IN HYPERTENSION:
ECHOCARDIOGRAPHIC COMPARISON BETWEEN 133
HYPERTENSIVE AND 230 NORMOTENSIVE CARDIAC
PATIENTS.
Gemelia M. Holgado, M.D., Ravi Prakash, M.D.,
F.A.C.C., Vidya Kaushik, H.D.,F.A.C.C.,
Radha Sarma, M.D., F.A.C.C., and George Marks,
M.D. University of California, Los Angeles.
We evaluated the prevalence of mitral valve
prolapse by two-dimensional echocardiography
in 133 patients with hypertension, 65 males,
68 females, age 19 to 87 years. Mitral valve
prolapse was diagnosed when systolic posterior
or superior arching of the mitral valve
leaflets into the left atrium was present in
the parasternal long-axis and/or apical four-
chamber view. Mitral valve prolapse was seen
in one patient with hypertension, this being
an 83 year old female with kyphoscoliosis.
The 0.75% prevalence in hypertension was
significantly lower than the prevalence of 6.1%
found in 14 of 230 normotensive patients, 124
males 106 females, age 15 to 97 years (P~O.OOl).
Conclusion: Mitral valve prolapse is rare in
hypertension. The low prevalence of mitral
valve prolapse in hypertension maybe due to
papillary muscle hypertrophy. The effective
contraction of the hypertrophied papillary
muscles probably pulls the chordae tendinae and
mitral valve leaflets away from the left
atrium in systole, thus preventing their
eversion and prolapse.
ATENOLOL BUT NOT ACEBUTOLOL REVERSES LEFT VENTRICULAR HY-
PERTROPHY SECONDARY TO ARTERIAL HYPERTENSION
Franco Sau, M.D., Crisotemide Seguro, M.D., Giuseppe Merc~
ro, M.D. and Angelo Cherchi, M.D.
Cattedra di Cardiologia, University of Cagliari, Italy
The effects of antihypertensive therapy on left ventric-
ular (LV) hypertrophy are still poorly defined. 13 hyper-
tensive patients, mean age 40 years, were treated for two
years w1th acebutolol (AC, 200-800 mg/d1e), cardioselec-
tive betablocker (B) w1th 1ntrinsic sympathomimetic act1v-
ity (ISA) , and then, for an other year, with atenolol (AT,
25-100 mg/die), cardioselective B without ISA. They were
serially investigated by recording ECG, blood pressure and
echocardiogram. The results (mean~SE) are as follows:
SBP -PBP HR EDD IVST PWT MASS FS ESS
Control 165 112 69 51 12.5 9.7 154 35 228
4 2 3 1 0.6 0.2 8 1 10
AC ly 140** 97** 62* 51 12.5 9.2 150 39* 18~*
5 1 2 1 0.6 0.2 8 2 11
AC 2yrs 141** 98** 64 52 12.6 9.1 155 38* 18~*
4 1 1 1 0.6 0.2 8 1 9
AT ly 134** 88~~ 55~~ 52 11.5~D 8.2~~ 137~D 40** 181*
5 2 2 1 0.6 0.2 7 1 9
(SBP, DBP= systolic and diastolic pressure, mmHg; HR=heart
rate, b/min; EDD= end-diastolic dimension, mm; IVS2, PWT=septal and posterior wall thickness, mm; mass, glm ; FS=
fractional shortening, %; ESS= systolic stress, dyn.lO~cm2;
* p<0.05, **p<O.Ol vs control; DDp<O.Ol vs AC 2yrs)
AC decreased s1gnif1cantly SBP, DBP, HR and ESS, increased
s1gn1f1cantly FS. AT reduced ulteriorly DBP and HR, decreas
ed s1gn1ficantly also IVST, PWT and LV mass. -
Conclusions: Acebutolol, in spite of its antihypertensive
eff1cacy, d1d not reduce LV mass. Atenolol, on the contrary,
was able to reverse LV hypertrophy, probably for 1tS great
er antihypertensive effect and the absence of ISA. Both
drugs improved LV systo11c funct10n, probably according to
decrease of afterload.
SUPRANORMAL LEFT VENTRICULAR PERFORMANCE WITH SEVERE LEFT
VENTRICULAR HYPERTROPHY IN ESSENTIAL HYPERTENSION.
James Blake, M.D., Edmund Herrold, M.D., Michael Jason,
M.D., Jeffrey Fisher, M.D., Richard Devereux, M.D.,
F.A.C.C., Jeffrey Borer, M.D., F.A.C.C., and John H.
Laragh, M.D., F.A.C.C., Cornell Medical Center, New York.
Left ventricular hypertrophy(LVH) previously has been
associated with decreased LV performance in essential
hypertension(EH). To further examine this relationship we
performed radionuclide cineangiography(RNCA) and
echocardiography in 105 pts with uncomplicated EH; 10/105
(Group A) had supranormal (~70%) resting LV ejection
fraction [EF] (av 76%; range 71-81%), invariably with
normal exercise LVEF[EF ] (always >74%), while 95 pts
(Group B) had normal EFex (45-70%) with 15/95 having
subnormal EF «55%). GF~fl~ A had higher systolic blood
pressure(BP)el179mmHg vs 159, p<.Ol), diastolic BP (109
vs 103, p<.l), and markedly greater LV mass (276gm vs
184, p<.Ol) than Group B; however, because Group A's
marked LVH was concentric, LV dimensions were smaller in
systole (2.4 vs 3.0, p<.05) and diastole (4.4 vs 4.9,
p<.l) with resulting larger relative wall thickness (.68
vs .40, p<.OOl) than Group B. Therefore, calculated end
systol~c wall st~ess(ESS) was normalized in Group A
(43xlO dynes/cm; normal=46~ NS), but 2was markedlyabnormal in Group B (70 x 10 dynes/cm, p<.Ol vs Group
A). Although no relationship existed between LVH and LVEF
in Group A, EF was inversely related to LV mass in
Group B (r=-.56~ p<.OOl). Thus, in EH, progressive LVH
and deterioration in LV performance generally are
associated, but a subset of pts develops marked
concentric LVH in response to abnormal BP, with resulting
supranormal LV performance, presumably because of ESS
normalization in hypertrophied myocardium.
ECHO DETECTION OF PRESSURE-OVERLOAD LEFT VENTRICULAR
HYPERTROPHY: EFFECT OF CRITERIA AND PATIENT POPULATION
Richard B. Deyereux. M.D •• FACC. Paul N. Casale. M.D ••
Isaac W. Hammond. Ph.D•• Michael H. Alderman. M.D ••
Daniel R. Alonso. M.D •• John H. Laragh. M.D •• FACC.
Cornell Medical Center. New York. New York.
To evaluate the performance of M-mode echocardio-
graphy for detection of pressure-overload left ventric-
ular hypertrophy (LVH). we tested the sensitivity of sex
specific upper limits of echo LV measurements from 225
normals in 31 patients (pts) with necropsy-proven
pressure-overload LVH. and determined the prevalence of
LVH detected by each echo criterion in 316 employed pts
with uncomplicated hypertension (HTN). 100 pts with HTN
evaluated in a referral center and 38 hospital pts with
moderate to severe (WHO class 2) HTN. Echo measurements
were LV mass (LVM). LVM index (LVMI). cross-sectional
area (CSA). septal and posterior wall thickness (IVS and
PWT). LV internal dimension (LVID) and relative wall
thickness (RWT). Prevalences of echo LVH were:
Necropsied Patients with Hxpertension
Patients Emploxed Referral Center HQspital
n 31 316 100 38
LVM 24 (77%) 57 (18%) 48 (48%) 27 (71%)
LVMI 26 (84%) 60 (19%) 44 (44%) 33 (87%)
CSA 24 (77%) 58 (18%) 41 (41%) 26 (68%)
IVS 16 (52%) 58 (18%) 35 (35%) 24 (63%)
LVID 9 (29%) 15 (5%) 12 (12%) 8 (21%)
PWT 19 (61%) 52 (16%) 33 (33%) 14 (37%)
RWT 15 (48%) 39 (12%) 28 (28%) 9 (24%)
Thus. 1) echo criteria based on LVM are more sensitive
than other measurements for detection of necropsy-proven
pressure-overload LVH and reveal the highest prevalence
of LVH in clinical HTN populations. and 2) the prevalence
of LVH in HTN is highly dependent on the population
studied.
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ECCENTRIC LEFT VENTRICULAR HYPERTROPHY -- A DETERMINANT
OF INCREASED VENTRICULAR ECTOPY IN OBESITY.
Franz H. Messerli, M.D., Hector O. Ventura, M.D., and
David W. Snyder, M.D., Ochsner Clinic and Alton Ochsner
Medical Foundation, New Orleans, LA.
Obese patients are prone to develop eccentric left ven-
tricular hypertrophy and are at an increased risk of
sudden death (Framingham Study). Cardiac dysrhythmias
were evaluated by Holter monitoring in 22 obese subjects
( >50J overweight) and compared with those in 18 matched
lean subjects «10J overweight). Arterial pressure was
held equal in both groups by study design. Left ventric-
ular dimensions were assessed by M-mode echocardiography.
Results were: (mean + SD)
Obese - Lean ~
Weight (kg) 102+12 62+5.1
MAP 116:-8+11.2 114.1+13.1 n.s.
PWT 1.22+0.26 1.02+0.08 < 0.02
LVDD 5.46+0.61 4.33+0.42 < 0.001
PVCs/24hr 144~79 8.4±20 < 0.01
PACs/24hr 0.78+1.48 0.58+1.24 n.s.
MAP=mean arterial -pressure; PWT=posterior wall thick-
ness; LVDD=left ventricular diastolic diameter; PVCs,
PACs=premature ventricular or atrial contractions.
Ten of 18 obese patients had eccentric left ventricular
.hypertrophy by echocardiographic criteria. Obese
subjects with left ventricular hypertrophy (but not those
with normal heart) had greater (p <. 0.001) prevalence of
PVCs and graded higher (p < 0.01) with regard to Lawn's
classes than lean subjects. We conclude that the occur-
rence of eccentric left ventricular hypertrophy increases
the risk of ventricular ectopy and more serious
arrhythmias in obese patients independent of the level of
arterial pressure.
EARLY CHANGES OF CARDIAC FUNCTION AND METABOLISM IN
SLOWLY PROGRESSING HYPERTENSION OF THE RABBIT.
Heinrich Taegtmeyer, M.D., D.Phil., F.A.C.C. and
Merrill L. Overturf, Ph.D., University of Texas Medical
School at Houston, Tx.
In order to study the early effects of hypertension on
the heart we examined isolated hearts from rabbits with
slowly developing hypertension of up to 5 months
duration after unilateral nephrectomy and renal artery
stenosis (one kidney-one clip). Normotensive animals
kept under identical conditions served as controls.
Mean arterial blood pressure rose from 83 to 111 mmHg
(p<O.OI) in the experimental group, while the ratio of
left ventricular weight/body weight was statistically
not different (0.206~0.060 vs. 0.239~0.093 g dry/ kg,
mean ~ SD, N=6) between groups. Although hypertrophy
had not yet developed, left ventricular peak systolic
pressure of perfused hearts was significantly higher in
hypertensive than in normotensive control hearts
(155~25 vs. 107~23 mmHg, p<0.05, filling pressure =
4mmHg). Furthermore, in hypertensive hearts the peak
systolic pressure did not respond to an increase in
filling pressure. Functional changes were accompanied
by metabolic changes. Rates of glucose utilization were
increased and rates of ketone body utilization were
decreased in hypertensive hearts. Activities of key
enzymes for carbohydrate (hexokinase, lactate
dehydrogenase), fatty acid (3-oxoacid-CoA transferase,
acetoacetyl-CoA synthase) and Krebs cycle metabolism
(citrate synthase, 2-oxoglutarate dehydrogenase) were
not different between groups. We conclude that
functional and metabolic adaptations of the left
ventricle in hypertensive animals antedate the
development of hypertrophy. The mechanism for the
adaptations does not rest in altered enzyme activities.
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Doppler Echocardiographic Assessment of Prosthetic
Valves
MULTIPLE STENOSIS: IN VITRO CORRELATION OF COLOR
DOPPLER/CONTINUOUS WAVE DOPPLER WITH CATHETERIZATION
PRESSURES AND LASER DOPPLER
Ming C. Hsiung, M.D., Sally Moos, Ren Woo, Ph.D., Ajit P.
Yoganathan, Ph.D., Navin C. Nanda, M.D., F.A.C.C.,
University of Alabama, Birmingham, AL
To assess the accuracy of predicting different pressure
gradients in the presence of multiple stenosis of
various types (long tunnel stenosis plus one or two
discrete stenosis placed in series), color Doppler
guided continuous wave Doppler velocitiis and gradients
derived from the Bernoulli equation (4V ) were compared
to hemodynamic direct pressure and laser Doppler
velocities in a mock laboratory type circulatory system.
A plastic disc with variable center holes (50% and 70%
obstruction), 5 prosthetic valves of different sizes,
and 1.4 cm long plastic tunnels (50%, 70%, 80%, 90%
obstruction) were introduced in this system. Heart rate
was set at 70 or 120 beats per minute, cardiac output
varied from 1 to 7 liters per minute, and the tunnel
position was varied from 0 to 4.5 cm downstream and 0 to
1 cm upstream from the valve or disc site. The
pressure was maintained at 100 mmHg. The color Doppler
guided continuous wave peak velocities ranged from 1.25
to 6.5 m/sec; Doppler derived pressure gradients
correlated with direct catheter pressure measurements
with a correlation coefficient (r) of 0.98 for peak
pressures and 0.97 for mean pressures. These findings
were further validated with laser anemometry with
r=0.99. In 25 studies done, the highest velocity
invariably correlated with the most severe stenosis
but was not affected by the coexistent lesser tunnel or
disk velocities. Therefore we confirm that in the
presence of multiple stenosis of varying severities
placed in series at varying distances, the Doppler
velocity always reflects the narrowest orifice size.
OOIDR F'Iai AND cnM:Nl'IONAL OOPPIER UIJl'Rl\SOOND EXAMINA-
TION OF F'Iai BEHIND :m::mm:rIC VALVES: AN IN VITRO DEM-
ONS'IRATION OF CX>NCFAIED F'Iai. - --
RichardJ\damick. M.D., Dennis Sprecher, M.D., David
Adams, arrlJ~ Kisslo, M.D., F.A.C.C., Il.1k.e Univers-
ity, D.lrtlam, North carolina.
conventional p.tlsed wave, continuous wave (0'1) arrl
Doppler (OOP) oolor flow (CF) studies were anlucted in
vitro to assess the limitations in::luoed by the presence
of a prosthetic valve (PV) in the path of an interro-
gatiIq beam. starr-Edwards (silastic arrl stellite p0p-
pets), Bjork-Shiley, arrl st. J\lde's mechanical PV arrl a
Cc1J:llentier-Edwards xenograft were sequentially seated in
closed position on a stage in a water bath at lTD.l1tiple
levels fran the OOP SClUl:'Ce. Behin:l the seatiIq
awaratus, continuous tw:i:lulent flow was created by p.nnp-
iIq a suspension of microballoons throogh rubber tubiIq
in two channels, toward arrl away from the transducer.
Without a PV in place, the tubiIq was readily visualized
arrl OOP flow detect:ed at a peak Velocity of 6 ny's (mean
Velocity 1.5 ny's). No OOP flow could be recorded
throogh the pc:ppets of the Starr- Edwards valves by arrj
OOP technique. '!here was a significant reduction in the
OOP signal (SIG) throogh the central discs of the Bjork-
Shiley arrl st. Jude's valves arrl no reduction in the OOP
SIG throogh the cusps of the xenograft. Selectively, 0'1
OOP demnstrated a marked SIG reduction at all veloci-
ties with elimination of the higher velocity flows for
all disc mechanical PV. '!here was OCIIplete drop-out of
the OOP SIG behin:i the sewin; riIq for all valves stud-
ied. 'Ihese data i.n:licate that all ll¥Jdalities of OOP are
severely arrl variably limited in the detection of flow
behini mechanical PV's due to physical interference with
transmission of the OOP SIG. In clinical examinations,
the potential for concealed abnormal flow nuJSt be reoog-
nized ~er the OOP beam traverses a PV.
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CONTINUOUS WAVE DOPPLER EVALUATION OF NORMALLY
FUNCTIONING NEW PERICARDIAL AORTIC PROSTHETIC VALVES
Jean Philippe Lesbre, M.D., Catherine Chassat, M.D.,
Jacques Lesperance, M.D., Robert Petitclerc, M.D.,
Raoul Bonan, M.D., F.A.C.C., Ihor Dyrda, M.D.,
F.A.C.C., Anare Pasternac, M.D., F.A.C.C., Martial G.
Bourassa, M.D., F.A.C.C., Montreal Heart Institute
No data exist on non invasive determination of maximal
velocity, maximal and mean gradients of new pericardial
aortic prosthetic valves. Therefore, we studied by
continuous-wave-Dop~ler (CD) and 2 dimensional echo 41
patients (pts) wlth aortic bioprothesis (B): 20
Carpentier Edwards (CE), 11 Ionescu (IS), 10 Mitroflow
(MF). The selection criteria were the following:
asymptomat ic pts, valvular replacement <4 years" no
heart failure, no prosthetic dysfunction on clinical
and echo-Doppler ~rounds. Maximal velocity of aortic
flow (V max), maumal (MG) and mean valvular gradients
(mG) derived from the Bernouilli equation were measured
for each type of B.
Size CE IS MF
19 {2. 83±0.14 2 .67±0. 38
21 Vmax 2.75+0.58 2.63±0.18
23 (x±SD m/sec) 2.23±0.43 2.08±0.38 1.85±0.34
25 2.25±0.35 1.5
27 2 1.70±o.14
Size CE IS MF
19 {16.4±1.4 l4.2±5.0
21 mG l7.5±8.2 l4.2±O.7
23 (x±SD 111IIIII15) 11.5 ±4. 8 9.3 ±3. 8 7. 5±3. 3
25 10.6±1.4 6.2
27 9.2±0.7 7.2±1.8
CD-estimated G were very close to published hemodynamic
G. There was no correlation between V max, MG and time
interval since surgery. V max correlated with B size
(r=-0.7l - p<O.Ol) and mG differed according to B
size (B2l mG versus B23 mG: p<0.005 B19+2l mG
versus B23+25 mG: p<0.0005). The only significant
differences between the 3 B-types were found between CE
and MF (p<0.02 for V max, MG, mG).
Thus: 1) during the first 4 years after operation, time
since surgery does not influence V max, MG, mG 2) B
size is the main determinant of these three parameters
3) mG estimated by CD is within the range of reported
hemodynamic mG 4) CD is a reliable non invasive method
of long-term follow-up of pts with B.
VALUE Of DOPPLER ECHOCARDIOGRAPHY IN ASSESSMENT Of
THE FUNCTION Of THE HANCOCK MITRAL VALVE.
ME Fawzy MRCP,FACC; MA Halim MRCP; G Ziady MO,FACC;
E Mercer MO,FACC; and W Andaya RCT, King Faisal Specialis1
Hospital and Research Centre, Riyadh, Saudi Arabia
To determine the value of Doppler echocardiography (DE)
in assessing the function of the Hancock mitral valve, DE
followed within 24 hours by cardiac catheterisation was
performed on 19 patients (12 females, 7 males, average
age 31 years) who had had Hancock mitral valve replace-
ment from 1 to 7 years (mean 4) previously. The mitral
valve gradient was calculated by the modified Bernoulli
equation using maximum velocity; mitral valve orifice
area (MVOA) was calculated by the equation MVOA=220/
pressure half time (P!t). Data from DE and cardiac
catheterisation were compared.
RESULTS: There was strong correlation (r=0.8) between DE
(range 7.2-22 rnrnHg, mean 11.4) and catheterisation deter-
mined gradient (range 4-26 rnrnHg, mean 10.5), and also
between DE (range 1-2 ern', mean 1.44) and catheterisation
calculated MVOA (range 0.7-2.5 ern', mean 1.45, r=0.86);
correlation between p!t and catheterisation calculated
MVOA was good (r=0.86).
DE detected mitral valve regurgitation was confirmed by
LV angiography in 5 patients, in 2 of whom it was very
severe, necessitating surgery. DE detected stenosis
(MVOA ~ 1.1 ern') in 4 patients was confirmed by catheter-
isation and 2 required surgery.
CONCLUSION: DE is reliable for (1) estimating Hancock
mitral valve gradient and MVOA (2) detecting mitral re-
gurgitation and (3) detecting malfunction of the Hancock
valve in both stenosis and regurgitation.
IN VITRO ULTRASOUND FLOW IMAGING THROUGH PROSTHETIC HEART
VALVES.
Gerald L. Gels, M.S., Travis W. Pape, Harold F. Stewart,
PhD. and Stephen W. Smith, PhD, FDA, CDRH, Rockville, MD.
In response to FDA regulatory responsibilities and recent
concern over long term performance of prosthetic heart
valves, we have developed an inexpensive laboratory
instrument for real-time in vitro imaging of the flow
dynamics through prostheses using diagnostic ultrasound
imaging without the need for color-flow Doppler. A linear
sequential array ultrasound imaging system using 3.5, 5.0
or 7.0 MHz transducers was adapted for use in a Dynatek
MY /Tl heart valve visuali:r.ation chamber which includes a
lucite chamber containing a prosthetic input valve and a
positive displacement piston pump (0 to 80 pulses/min)
operating at normal cardiac pressures of 120/80 mm Hg and
a stroke volume of 70 ml. An outflow chamber containing
the prosthetic valve to be evaluated and a downstream
sinus was cast from acoustically transparent Rho-C rubber
(specific gravity of .94 and sound velocity of 1525 m/s).
Using this system, the fluid flow through the outflow
valve was easily visualized in the real-time ultrasound
image using ordinary tap water containing air bubbles as
the contrast medium. Alternatively, we imaged the flow
properties of simulated blood, fabricated using
polystyrene spheres averaging 8 microns in diameter
suspended in degassed, distilled water at concentrations
approximately equal to the normal hematocrit and blood
viscosity. Forward and reverse flow as well as
regurgitation, jets and complex circular eddies in the
spherical sinus were easily seen using both fluids and
the major commercial prosthetic heart valves. The 7.0 MHz
ultrasound images showed the highest spatial resolution
and greatest target sensitivity to both aerated water and
simulated blood at the expense of field of view.
COLOR DOPPLER FLOW IMAGING IN PROSTHETIC VALVES
!lupa M. Shah, M,D., David I. Roitman, M.D., F.A.C.C.,
Navin C. Nanda, M.D., F.A.C.C.
University of Alabama, Birmingham, Alabama
Fifty-four patients (pts) with 70 prosthetic valves
(PRV) were studied by Color Doppler (CD), 30 tissue
valves (VS) in Mitral (M) 19, Aortic (A) 8, Tricuspid
(T) 3 positions (p) and 40 mechanical in M 22, A 16, T 2
P. Thirty-five VS functioned abnormally as defined by
abnormal motion/increased gradient/presence of signifi-
cant regJrgitation. Forward flow patterns were seen as
1 or 2 jets (J). Visualization of J allowed placing of
contil1.lous wave Doppler cursor (DC) in the maximum flow
to obtain peak velocity (PV) and if DC could not be
aligned parallel to flow, one was alerted to underesti-
mating the PV. Of 35 VS with abnormal function, a
narrow jet (less than 50% of orlfice size) was seen in
8, with high PV in all. A PRY showed valvular leak
(VRL) in 8, one with 2 distinct J. M PRY showed VRL in
10 and VRL and paravalvular valvular leak (PVRL) in 1,
some seen as eccentric/thin/multiple J Which could have
easily been missed on conventional Doppler. T PRY showed
VRL and PVRL in 1 and VRL in another. CD also detected
associated lesions in 41 pts (17 with normally
functioning PRY) AR 6, TR 21, MR 4, PR 10. Prosthetic M
inflow and AR could be differentiated by difference in
color in oblique short axis view. Major limitation of
the system was marked reverberation, specially by
mechanical PRY. Thus CD imaging is useful in evaluation
of PRV.
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Myocardial Perfusion by Contrast Echocardiography
FACTORS INFLUENCING THE PHYSICAL CHARACTERISTICS OF
SONICATED MYOCARDIAL ECHO CONTRAST AGENTS
Madeleine Pinaud PP'i'~ Ram E. Rajagopalan, M.B.B.S., J.
kevin Drury, ., •••C, Eliot Corday, M.D., F.A.C.C.,
Cedars-Sinai Medical Center, Los Angeles, CA
Sonicated agents containing microbubbles may permit
quantitation of myocardial perfusion by contrast echo-
cardiography, but these agents must first be standardized
with respect to factors affecting bUbble size distri-
bution, concentration and reproducibility. We thus
sonicated 70' sorbitol (570) at amplitude settings (A) 5
or 6, sonication periods (T) 15 or 30 seconds and
sonicator tip immersion depth -- deep or surface. Samples
of these solutions placed on a hemacytometer were
digitally analyzed using video microscopy, yielding
bubble diameters (D) in microns. Results of microscopic
image analysis for 570 surface sonication ~98 to 870
bubbles) but varying T and A were (mean:!:SEM, p<.001 vs
A=6, +p<0.001 vs 30" ):
Mean Diameter Concentration x104/ml)
A=5 A= T A=5 A=
15" 14.0+0.4 14.1+1.0 15" 599+48*+ 299+45+
30" 14.7~0.4 18.2~1.4 30" 328~75· 152!21
Deep sonication of S70 (at A=5 and T=30") s~ificantlY
lowered the bubble concentration (102+40x10 Iml, p<0.001)
but not the size distribution (13.7+f.3). Samples of S70
(at A=5, T=30 sec) digital!.l analyzed were com/iared to
visual microscopy and to Coulter counter determ nations
rarrca116rated with solid microspheres of known sizes).
The mean number of bubbles measured visually, digitally
and by Coulter counting differed markedly (50, 173, 7430
per sample respectively), and diameter measurements (mean
+SD) were 11.9+7.4, 14.7+7.6, 22.3+10.8, respectively.
~onclusion: SonIcation amplitude, duration and immersion
depth significantly affected microbUbble concentration
;ut not their size distribution. Divergencies of reported
,cho contrast microbubble diameter may be due to both
instrumentation factors and the sample size analyzed.
REACTIVE HYPEREMIA: EVALUATION WITH MYOCARDIAL CONTRAST
ECHOCARDIOGRAPHY; Scott Gage, B.S., Charles G. Vasey,
M.D., James C. Dillon, M.D., F.A.C.C., Harvey Feigenbaum,
M.D., F.A.C.C., William F. Armstrong, M.D., F.A.C.C.;
Krannert Institute of cardiology, Indiana University
School of Medicine, Indianapolis, Indiana
Myocardial contrast echocardiography (MCE) accurately
localizes regions of non-perfused myocardium but little
is known about its characteristics after reperfusion. In
this study we determined left anterior coronary artery
blood flow (CBF) with electromagnetic flow probes in 8
open chest dogs studied at baseline (n~16), during
coronary artery occlusion (CAO) (n~16) and reperfusion
(n=30). Aortic root injections of agitated renografin/
saline were used for MCE. MCE appearance curves were
generated in the involved coronary circulation bed and in
two normally perfused myocardial regions. At baseline
MCE intensity was equivalent in involved and remote
regions; CBF was 23.8 + 5.9 ml/min and fell to 0 ml/min
after CAO. During CAO-definite regions of absent
contrast effect were seen in all dogs. After reperfusion
CBF was 96.6 + 41.1ml/min and MCE demonstrated an
increase in visible brightness in the previously occluded
area. Additionally with reperfusion hyperemia MCE peak
measured intensity and change from baseline were greater
in the involved area than in remote regions (p(.03) or in
the baseline study (p(.005). The ratio of peak image
intensities in the involved and remote areas (all dogs
pooled) correlated with the ratio of hyperemic to basal
flow (r~.64, p(.OOl). Within individual dogs correlation
of CBF and MCE peak ranged from .78 to .92. We conclude
that reperfusion hyperemia can be both visibly identified
and quantified. In individual dogs MCE correlates well
with CBF. MCE may be a valuable means of assessing
reperfusion and of determining the integrity of the
post-occlusion hyperemic response.
Renografln
1
2
Son Icated
o t
1 t
(- p<.OOl vs control)
An Injection of Renografln-76 adequate for anglographlc
Imaging of coronary artery anatomy produced significant
depression In LV contractility (p<.001 vs control); recovery
occurred within 15 sec post Injection. During echo imaging, small
amount of sonicated Renografln-76 opacified the myocardium
without altering LV contractile state. Thus, in humans, sonicated
renografln-76 is a safe echo contrast agent without adverse
effects on LV contractility. The volume of contrast material
Injected rather than the presence of microbubbles appears to be
the major determinant of altered LV hemodynamics.
5 sec
15 sec
EFFECT OF INTRACORQNARY INJECTIONS OF SONICATED
MICROBUBBLES ON LEFT VENTRICULAR CONTRACTILITY IN HUMANS
Roberto Lang, MD, Kenneth M. Borow, MD, Alex Neumann, Jatar
AI-Sadlr, MD, FACC, Steven Feinstein, MD, Unlv of Chicago, IL
Intracoronary Injection of contrast agents used for anglographlc
visualization of coronary arteries produce significant alterations
In LV hemodynamics. However, the effects of echo contrast
agents on LV contractility In humans Is unknown. Seven patients
undergoing elective coronary angiography were studied. 20
targeted m-mode echo and central AO pressures were recorded
during Injection of standard amount of anglographic (I.e. 7-9 cc of
non-sonicated Renografin-76) and echo cardiographic (I.e. 1.5-2.0
cc of sonicated Renografln-76) contrast agents Into the left main
coronary artery. Each patient received both sonicated and non-
sonicated Renografln-76 with the order of Injection randomly
determined. Microbubble size of sonicated Renografin-76 was 10
t 4 Il by light microscopy. LV contractility was assessed under
control conditions as well as 5 seconds and 15 seconds post
intracoronary Injection using the load-Independent relationship
between end-systolic wall stress (oes) and rate corrected velocity
of shortening (Vcfc)' Changes In contractility are shown as /:OVcfc
units from control.
Non-Sonicated Renografln
-11 t 2-
-1 t 1
A NEW METIm FOR REAL TIME ASSESSMENT OF REGICl'lAL
MYOCARDIAL PERFUS ION
Steven B. Feinstein. MD, Roberto Lang, MD, Edward Geiser, MD,
Seth Powsner, MD, Alex Neumann, Kenneth M. Borow, MD, Unlv
of Chicago, Chicago, IL and Unlv of Florida, Galnsville, Fla
There Is no precise method for measuring transmural
distribution of myocardial perfusion In humans. To study the use
of contrast echo as a means of addressing this problem, we
developed a canine model (n=6 dogs) for quantification of regional
myocardial blood flow. Cross sectional 20 echo In conjunction
with Injections of sonicated contrast agent solutions were used.
ECG gated, volume and pressure controlled aortic root Injections
of 5-6 ml of sonicated contrast agents [sorbitol (SORB),
Renografln-76 (RENO), Dextrose-SO (DEXT») resulted In increased
reflectivity of myocardial tissue by ultrasound Imaging. The video
Images of the myocardium were analyzed by an off line computer
equipped with a digitizer and semi-automated edge detection
program. This allowed analysis of up to 64 separate myocardial
segments. Vldeodenslty YS time curves were generated for
comparable regions of Interest of the LV endocardium (ENDO)
and epicardium (EPI) and fit to a monoexponentlal function. The
lower the myocardial transit time (Tl/2) the more rapid the blood
flow (I.e. shorter washout of contrast material). Microbubble sizes
were assessed by light microscopy. T 1/2 Is In seconds (s).
Agent Bubble Size Tl/2(EIII)()) Tl/2(EP1\ ENDO vs EPI
SORB 6 t 2 ~ 2.2t2.2 s 3.5t2.2 s p<0.05
REI'«) 10 t 4 Il 3.3t2.4 s 3.9t2.3 s p<0.05
DEXT 12 t 4 ~ 5.7t2.3 s 8.1t4.4 s p=.20
There was a direct correlation between myocardial transit time
and microbubble size. With all contrast agents endocardial T 1/2
was shorter than epicardial T 1/2. Only the smallest mlcrobubbles
appeared to accurately represent physiologic transit times.
Thus, contrast echo using selected sonicated agents permits
real time repetitive assessment of relative ENDO/EPI blood flow.
This technique may be suitable for assessing the effects of
pharmacologic agents on regional myocardial perfusion.
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New Detection Techniques: Clinical Applications and
Clinical Arrhythmias
CAN ASYMPTOMATIC TELEPHONE ELECTROCARDIOGRAPHIC TRANSMIS-
SIONS SERVE AS A SURVEILLANCE SYSTEM TO DETECT UNSUSPECT·
ED INCREASES IN CO~PLEX VENTRICULAR ARRHYTHMIAS?
Craig Pratt, MD, FACC, Donald Slymen PhD, Ann Wiennan
PAC, Marllyn Francls, RN, LaDean English, LVN, Beth
Thornton, RN, Cindy Stone, RN, James Young, MD FACC and
Robert Roberts, MD, FACC, Baylor College of Medi ci ne,
Houston, TX.
In order to assess the potential of telephone ECG trans-
missions (TECG) to detect asymptomatic increases in
ventricular arrhythmias, we selected 32 patients (pts)
with complex ventricular arrhythmias (10!/,22cf, mean age
48 years) with >40 premature ventricular complexes
(PV~s~/~our. After >1 year. of suc~essful drug therapy,
we lnltlated a one month slngle-bllnd discontinuation of
antiarrhythmi c therapy (placebo pul se). TECGs were
tramsmitted 3 times daily (3 minute rhythm strips);
24-hour ambulatory ECG's were done 3 times weekly to
verify return of high frequency PVCs. A total of 656
TECG stri ps were compared to the simul taneous hour of
AECG .utilizing a model comparable to analysis of
covarlance. A strong linear relationship was found
between PVC frequency on TECG and AECG (p<OOl). TECG
strips with >1 PVC reflected >10 PVC/hour on AECG with a
sensitivity of 82%, specificity of 90% with 0.9% false
positives. In the 21 pts whose arrhythmia frequency
returned from <10 PVC/hour to >40 PVC/hour during the 1
month placebo pulse trial, TECG transmissions reflected
the increase to >40 PVC/hour within 2 days in all
patients (l00% sensitivity). Additionally, 6 pts whose
arrhythmia frequency did not return to >10PVC/hour by
AECG never transmitted a mean of >1 PVC on TECG (despite
an average of 60 TECG's/pt); 100% specificity. Thus,TECG
effectively uncovers potentially dangerous increases in
quantitative arrhythmia frequency, providing daily arrhy-
thmia surveillance.
AUTOMATIC DETECTION OF CARDIAC ARREST RHYTHMS.
Charles M.Jack, M.B., Ernest Hunter, M.B., Terence H.
Pringle, M.B., Trevor Wilson, B.Sc., John Anderson, M.R1il.
and A.A.Jennifer Adgey, M.D., F.A.C.C., Regional Medical
Cardiology Centre, Royal Victoria Hospital, Belfast
BT12 6BA, Northern Ireland.
During the treatment of successive cardiac arrests, the
ECG sensed using disposable pre-gelled defibrillator pads
was continuously analysed every 8-18 sees by a micro-
processor-based system. The system sampled the ECG
digitally and the algorithm looked for absence of an iso-
electric segment, irregular energy density spectrum and
irregular wave shape. The analysis was displayed visuilly
as ventricular fibrillation (VF) or non-VF and
simultaneously the ECG and system's analysis were recorded
on tape. Later,the system's interpretation of the rhythm
was compared with the ECG record. There were 84 cardiac
arrests which occurred in 78 patients(46 male,32 female),
aged 14-85(mean 63 yrs).Twenty-nine of the patients had
had an acute myocardial infarction. The initial rhythm in
5 of the 84 arrests could not be assessed because of
continuous pacing throughout the VF. In the remaining 79
arrests,the initial rhythm was VF in 15 and 14 were
correctly detected by the system (sensitivity=93%) .Of the
non-VF rhythms present initially in the 64 arrests,62 were
correctly detected, 2 incorrectly (polymorphic VT)
(specificity=97%). Of the 223 episodes (eps) of VF (8-18
sees) 165 were correctly determined by the system,ie 74%
sens1t1vity. When the rhythm was non-VF of 5002 eps,4953
were correctly detected,ie, specificity 99%. Of the 58 ~
of VF not detected as VF a change in rhythm to VF occurred
during the 8-18 sees analysis in 24 eps.In 16 eps there
was low voltage VF «0.5mV). The accurate determination of
cardiac arrest rhythms automatically will allow earlier
detection and treatment of cardiac arrest victims
outside hospital.
ACCURATE IDENTIFICATION OF ATRIAL ACTIVATION
DURING SUPRAVENTRICULAR TACHYCARDIA USING SIGNAL
AVERAGED ELECTROCARDIOGRAPHY.
Denms L. Kuchar MB, Raymond P. Kelly MB, Charles W.
Thorburn MB. St. Vincent's Hospital, Sydney, NSW, Austraha.
The mechamsm of supraventricular tachycardia (SVT) can usually
be estabhshed without resorting to Invasive eletrophyslOloglC (EP)
testing, If the morphology and timing of the P wave can be
confidently deduced from surface 12 lead ECG dUring
tachycardia. Unfortunately, thiS IS often diffICult to achieve
espeCially when the tachycardia IS fast and when the P wave hes
within the QRS complex or T wave. USing signal amphficatlOn
and fJltratlon, the high frequency components of the P wave can
be rehably distingUIshed from the low frequency signals that
comprise ventricular repolarlzatlon. We prospectively studied 10
patients (pts) with SVT In whom there was disagreement about the
identification of the P wave during tachycardia and In whom the
mechamsm of SVT was subsequently estabhshed by EP study.
During tachycardia, high fldehty tracings were recorded from 3
orthogonal leads (X, Y, Z) then amphfled (l00 x), signal averaged
for 100-200 beats (to reduce nOise levels to < luV) and filtered
(40-250Hz). The resultant ECG was compared to one taken dUring
sinus rhythm.
Results: Two pts with orthodromIC atrioventricular tachycardia
using an accessory pathway had clearly defined P waves follOWing
the QRS In the ST segment or cOincident with the T wave. Two
patients with atrial tachycardia and 3 with atrial flutter with 2:1
block had discrete atrial signals which allowed a correct diagnOSIs
to be made on the baSIS of established Criteria for P wave rate
and morphology. In 3 pts with AV nodal reentrant tachycardia,
atrial activity was deduced to he partially or wholly within the
QRS complex when It could not be seen elsewhere In the cycle.
Conclusion: The use of signal processing proVides a means of
accurate IdentificatIOn of the P wave dUring tachycardia and
leads to more confident noninvaSive bedSide diagnOSIs of the
mechamsm of SVT.
HEART RATE VARIABILITY PATTERNS IN STABLE AND REJECTING
CARDIAC TRANSPLANT RECIPIENTS.
Kenneth E.F. Sands, Leonard S. Lilly,M.D., F.A.C.C.,
Frederick J. Schoen, M.D., Gilbert H. Mudge, Jr., M.D.,
Richard J. Cohen, M.D., Ph.D. Brigham and Women's
Hospital, and Harvard-MIT Division of Health Sciences
and Technology, Boston, MA.
Power spectrum analysis is a technique used to
characterize beat-to-beat heart rate variability, which
normally reflects ongoing autonomic modulation of
cardiac function. We used power spectrum analysis to
study heart rate variability longitudinally in 8
patients, maintained on cyclosporine A therapy, within
15 months after orthotopic cardiac transplantation, and
in 6 normal subjects. Total heart rate variability in
clinically stable transplant recipients was reduced
98.9% compared to normal subjects (p~O.OOI). In three
transplant recipients, total heart rate variability was
observed to abruptly increase more than 30-fold;
immediately subsequent endomyocardial biopsies in these
patients demonstrated the onset of myocardial rejection.
Heart rate variability during the period of rejection
did not demonstrate the characteristic spectral peaks
seen in normal subjects, but rather a broad-band
pattern.
We conclude: (1) heart rate variability is greatly
reduced in stable transplant recipients; (2) Increased
broad-ba~d heart rate variability may be a significant
non-invasive marker of acute myocardial rejection in
cardiac transplantation patients treated with
cyclosporine.
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Electrocardiographic Manifestations of Ischemia
DIURNAL VARIATION IN OCCURRENCE OF TRANSIENT MYOCARDIAL
ISCHEMIA DOCUMENTED BY COMPACT ANALOG ANALYSIS OF
HOLTER RECORDINGS: DIFFERENCES BETWEEN CHRONIC STABLE
AND PRINZMETAL ANGINA.
Koonlawee Nademanee, M.D., F.A.C.C., Vanida Intarachot,
R.N., Jo Ann Hendrickson, B.S., Martin Josephson, M.D.,
F.A.C.C., Bramah N. Singh, M.D., Ph.D., F.A.C.C.,
Wadsworth VA Hospital, Los Angeles, CA.
Patients(pts) with chronic stable angina (CSA)
experience symptoms on exertion during daytime; those
with Prinzmetal angina(PA) usually spontaneously and
at night. Ambulatory Holter monitoring(AHM) especially
with compact analog(CA) analysis has shown that in
both CSA and PA, most episodes of transient myocardial
ischemia(TMI) are silent. Whether silent TMI has
diurnal variation (DV) is not known. Thus, TMI from
AHM obtained on no therapy in 65 pts with angio-
graphically or ETT-documented coronary artery disease
(CAD) - 56 with CSA and 9 with PA - was analyzed by CA
technique. In PA mean (±SD) number of TMI episodes was
19.5±10(total 176), mean duration of TMI was 3.5±3
min./episode (longest episode 16 min.). In CSA, mean
number was 4.5±2 episodes (total 514), mean duration
11±15 (longest 256) min./episode.
Diurnal pattern of TMI episodes:
6A.M.-Noon Noon-6P.M. 6P.M.-Midnight Midnight-6A.M.
CSA 198 (39%) 217 (42%) 72 (14%) 27 (5%)
PA 35 (20%) 44 (25%) 51 (29%) 46 (26%)
Conclusions: 1) Compared to CSA, TMI episodes in PA
were shorter in duration (p<O.Ol) and more frequent
(p<O.Ol). In CSA, most TMI episodes occur during waking
hours. 3) There is no DV in TMI in pts with PA.
4) These findings are of therapeutic and diagnostic
significance.
MONITORING OF MYOCARDIAL ISCHEMIA BY EPICARDIAL ELECTRO-
GRAMS OURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIO-
PLASTY. Peter L. Friedman, M.D., Ph.D., Andrew Selwyn,
M.D., FACe, James Kirshenbaum, M.D., Thomas L. Shook,
M.D., Peter Ganz, M.D., Harvard Medical School, Brigham
and Women's Hospital, Boston, MA.
Monitoring of myocardial ischemia during percutaneous
transluminal coronary angioplasty (PTCA) is important to
ensure safety during balloon inflation and to detect
possible complications. To aid prompt detection of
ischemia, local unipolar epicardial electrograms (Ep-EG)
were recorded during PTCA in 14 patients from the tips
of teflon-coated PTCA guide wires positioned distal to
stenoses to be dilated. Surface limb and precordial
electrocardiographic leads (ECG) chosen to reflect likely
areas of reversible ischemia during PTCA were recorded
simultaneously. 8 patients had stenoses of the anterior
descending, 5 of the circumflex and 1 of the right cor-
onary artery. 12/14 patients developed marked ST segment
elevation (ST t ) in Ep-EG during balloon inflation that
disappeared after deflation. Of these 12, 10 also had
angina that began and subsided concurrently with EP-EG
STt whereas 2 had reversible Ep-EG STt without angina.
2/14 patients had fixed Ep-EG STt unrelated to balloon
inflation, reflecting prior myocardial infarction and
aneurysm formation in PTCA territory. Reversible ST
changes in the ECG during balloon inflation occurred in
only 6/14 patients, 5 having ST t and 1 ST depression.
These 6 patients all had ST tin Ep-EG that appeared
earlier during inflation and was of much greater magni-
tude than ST changes in ECG. We conclude that myocardial
ischemia during PTCA can be detected easily with Ep-EG
and with greater sensitivity than the surface ECG. Ep-EG
may reveal local ischemia even when angina is absent.
Finally, Ep-EG may clarify the nature of chest pain dur-
ing balloon inflation or during suspected complications.
ABOLITION OF HOLTER-DETECTED SILENT MYOCARDIAL
ISCHEMIA FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY
ANGIOPLASTY.
Martin A. Josephson M.D., F.A.C.C., Howard S. Lewis,
M.D., Koonlawee Nademanee, M.D., F.A.C.C., Vanida
Intarachot, R.N., Kristine Coyle, B.A., Bramah N.
Singh, M.D., Ph.D., F.A.C.C., Wadsworth VA Hospital,
Los Angeles, CA.
Percutaneous trans luminal coronary angioplasty (PTCA)
is effective treatment for exercise-induced ischemia.
The effects of PTCA on silent ischemia(SI) detected by
Holter monitor(HM) are unknown. Forty-six patients
undergoing PTCA had 24 hour HM before and after (n=38)
successful PTCA. Defining a significant stenosis as
>70% diameter reduction, 32 patients had single, 12
double, and 2 triple vessel Coronary artery
disease(CAD). All patients had ischemia on ECG during
either thallium exercise scintigraphy (n=35) or during
angina (n=ll). PTCA markedly reduced or eliminated
exercise-induced ischemia in all patients. SI was
detected in 11 patients (24%) undergoing PTCA.
Nineteen %of single, 33% of double, and 50% of triple
vessel CAD patients had HM SI. There were 3.5 SI
episodes per patient with a mean duration of 8.4
min/episode. Successful PTCA completely abolished SI
in these patients (p2.05). Two patients without SI
pre-PTCA had 1 SI episode following successful PTCA;
one of these patients had 3 vessel CAD and only 1
vessel PTCA.
Conclusions: I)HM SI is infrequent in patients with
or 2 vessel CAD undergoing PTCA. 2) Successful PTCA
abolishes HM SI episodes. In patients with HM SI 3)
HM provides an additional method for assessing
efficacy of PTCA.
CIRCADIAN VARIATION OF TRANSIENT MYOCARDIAL ISCHEMIA.
Michael B. Rocco, M.D., Joan Barry, Stephen Campbell,
M.D., Elizabeth G. Nabel, M.D., George S. Rebecca, M.D.
and Andrew P. Selwyn, M.D., FACC. Brigham and Women's
Hospital, Boston, MA.
Patients with angina may notice increased symptoms in
the mornings. To test the hypothesis that a circadian
variation of myocardial ischemia exists and is not due
to differences in activity or myocardial demand, 33
patients with positive exercise tests and proven
coronary disease underwent 68 days of continuous 24 hour
frequency modulated ST-segment monitoring off medica-
tions to determine the frequency (F) and duration (D) of
ischemic ST-segment depressions (STD) (~lmm at 80 msecs
and ~30 secs duration). Detailed diaries of activity
were kept. The mean waking time was 6:34 AM ± 55 min.
256 episodes of STD occurred in 24 patients (73%) with a
duration of 1 to 253 mins. (median=5.0). The 24 hour
distribution for F and total D was:
12 AM-6 6 AM-12 12 PM-6 6 PM-12
F: 42(16%) 98{38%) 58(23%) 58(23%)
D: 330(14%) 1151(47%) 363(15%) 604(24%)
The distributions of F and D in these 4 time periods
were significantly different (p=0.03 and p=O.OI). 13 of
33 patients had STD throughout both AM and PM waking
activity. There were no significant differences in
physical activity and heart rate at onset of STD or
change in heart rate 1 min prior to onset comparing the
6 hours after waking (peak STD) and 6 hours before bed.
A circadian rhythm of STD exists with peak activity
during the first 6 waking hours. This does not appear to
be due to differences in physical acitivty or simple
measures of myocardial demand and may represent
differences in coronary flow (supply). The medical
therapy of coronary disease may have to consider this
surge of ischemic activity in the morning.
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THE 5IGNIFANCE OF PAINLESS ST SEGMENT DEPRESSION ASSESSED
BY AMBULATORY PULMONARY ARTERY PRESSURE MDNITORING
RIchard D Levy MB BS MRCP(UK), Leonard MShapIro MD MRCP,
ChrIstIne WrIght SRN, Lorna Mockus SRN, Arshed A Quyyuml
MB BS MRCP, Kim MFox MD MRCP
The NatIonal Heart HospItal, London, England.
In order to study the sIgnIfIcance of paInless ST segment
depressIon In patIents WIth coronary artery dIsease (CAD),
we have developed a system for recordIng the ambulatory
pulmonary artery pressure uSIng a transducer tipped
catheter wIth a simultaneous frequency modulated el~ctro­
cardIogram and a minlaturised tape recorder. In 17
patIents WIth CAD studied for 650 hours there were 40
episodes of angina recorded during the day. I~ two
episodes of angina the ECG and PA dIastolIc pressure (PADP)
dId not change. In 9 a sIgnIfIcant Increase In PADP pre-
ceded the onset of ST depression, In 10 the reverse
occurred and in the remaInder the changes were simulta-
neous. Peak ST depressIon and peak PADP occurred simulta-
neously. ST depressIon was more prolonged (2.3mIns) than
the PADP elevation (1.4mIns). The increase In PADP on
exertIon (B6% range 33-237) was greater than at rest (63%
range 23-128). In these patIents 40 epIsodes of daytIme
paInless ST depressIon were also recorded, the haemodynamlc
and 5T segment changes beIng sImIlar to those of the paIn-
ful epIsodes. The Increase In PADP was lower In the paIn-
less (67%) than in the paInful epIsodes (B6%). Two epI-
sodes of PADP rise occurred In the absence of ST changes.
In 13 episodes of nocturnal 5T segment depressIon the
changes were sImilar to those of the daytime epIsodes
other than a ~maller rIse (50%) In PADP. Thus ambulatory
pulmonary artery pressure monitorIng has shown that paIn-
less ST segment depression dIffers from paInful 5T
depressIon only In the magnItude of the haemodynamlc
response.
Wednesday, March 12, 1986
4:00PM-5:00PM, Room #260/261
Clinical Problems Due to Ventricular Malfunction
ECHOCARDIOGRAPHIC INVESTIGATION OF THE HEMODY-
NAMICS OF WEIGHTLESSNESS. Michael W. Bungo.
M.D., F.A.C.C., John B. Charles, Ph.D., Jeanne
Riddle, R.N., JoAnn Roesch. R.N., David A. Wolf,
M.D., and M. Rhea Seddon, M.D., NASA - Johnson
Space Center, Houston. Texas.
Extensive ground-based simulations of space-
flight utilizing bedrest or water immersion have
been performed. Little data, however. has been
acquired on humans during actual spaceflight. A
commercial ADR 4000SLC ultrasound machine was
modified and placed in a Space Shuttle locker
during mission 510. M-mode and 2-D sector images
of the heart were obtained from four crewmembers
daily for the duration of the seven day orbital
flight. These data were compared to resting
supine values acquired preflight and at selected
intervals postflight. Right ventricular dimen-
sion was found to be 35~ decreased throughout
the period of weightlessness and returned to
baseline after flight. Left ventricular volume
index (LVDVI) was 20~ increased on the first day
of flight and 15~ decreased thereafter when com-
pared to prefl ight. Stroke volume tracked LVDVI.
Mean blood pressure and heart rate were both 20~
increased during weightlessness. Increases in
both diastolic and systolic pressure contributed
to the rise of mean pressure. After a 85~ rise
in cardiac Index the first day, values returned
to prefl ight levels for the duration of the mis-
sion, but were again 59~ elevated during the
postflight recovery period. Elevated trends In
cardiovascular work and total peripheral resis-
tance were noted throughout flight. Recovery
from 7 days in space appeared to require a week
of re-exposure to Earth's gravity.
These studies are the fIrst to establish in man that
acute elevatIon of right atrial pressure, produced by
ventricular but not atrial pacing, results in acute
elevation of circulating atrIal natriuretic peptide.
These studies support the hypothesis that atrial pressure
is an important determinant of atrial natriuretIc peptide
release.
ENHANCED LEVELS OF CIRCULATING ATRIAL NATRIURETIC PEPTIDE
DURING VENTRICULAR PACING IN HUMANS
Michael J. Osborn, M.D., F.A.C.C., Stephen C. Hammill, M.D.,
F.A.C.C., John C. Burnett, Jr., M.D., Department of
Medicine, Mayo Medical School, Rochester, MN
Mammalian atrial tissue possess specific atrial
granules which synthesize and release atrial natriuretic
peptide (ANP) which participates in the control of
arterial pressure and renal sodium excretion. The mecha-
nism of release of ANP in man is unclear. The present
study was designed to test the hypothesis that acute
elevation of rIght atrial pressure (RAP) results in acute
release of ANP. Studies were performed in two groups of
patients undergoing diagnostic electrophysiologic investi-
gation. Measurements were obtained of plasma ANP employ-
Ing a radioimmunoassay to alpha-human ANP during atrial
pacing (atrial rate l44±9 bpm) in 6 patients and ventric-
ular pacing (ventricular rate l30±8 bpm) in 5 patients.
ANP pg/ml
Pacing (n=6)
46.0±6.l
35. 1.±4.7
Pacing (n=5)
75.5±11.6
162.4±28.5*
RAP mmHg
Atrial
2.2.±0.5
2. 5.±0.2
Ventricular
0.8±0.5
4.8.±1.l *
*p<.02
Resting
Pacing
Resting
Pacing
ST SEGMENT RESPONSE TO CORONARY OCCLUS ION : DEPENDANCE
ON COLLATERAL FUNCTION
Robert G. Macdonald. M.D , James A. Hill, M.D., F.A.C.C.,
Robert L. Feldman, M.D., F.A.C.C., University of
Florida. Gainesville, FL.
To assess the relationship between ST segment response
to transient coronary occlusion and coronary collateral
function, ECG and coronary and LV hemodynamic responses
were evaluated in 23 patients (pts) undergoing proximal
LAD PTCA. ECG leads I. II, VS; LV, Ao and distal coro-
nary (cor) pressures (p); and great cardiac vein flow
(GCVF, thermodilution) were measured. During a 1 min. LAD
occlusion all pts had angina; 11 had ST elevation (group
I) and 12 had ST depression (group II). Magnitude and di-
rection of ST response were consistent with repeated
occlusions. ST elevation was never preceded by depression
during any LAD occlusion.
Before PTCA, LAD diameter reduction was 68±14% (mean±SD)
in group I vs 83±12% in group II (p<.Ol). Angiographic-
ally visible filling of the LAD via collaterals was pre-
sent in no pts in group I vs S pts in group II (pc.OS).
During LAD occlusion peak LV filling p (19±6 vs 21±8 mmHg,
group I vs group II), heart rate (78±18 vs 77±12 b/min)
and mean AoP (108+20 vs 109+13 mmHg) were similar in both
groups. Group I pts, however, had lower distal cor p
(2S±7 vs 39±14 mmHg, P (.OS) and residual GCVF (3S±9 vs
Sl+21 ml/min, p( .OS) and higher calculated collateral
resistance (2.S+.6 vs 1.6+.7 mmHg/ml/min, p< .OS), com-
pared to group II pts. -
Thus, estimates of myocardial oxygen demand were similar
in both groups. In contrast, in pts with ST depression
pre-PTCA stenoses were more severe; visible collaterals
were more common; and hemodynamic parameters of collateral
function were superior. Collateral function was an impor-
tant determinant of direction of ST response and presum-
ably magnitude of ischemia during coronary occlusion.
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attempts) than upper common paths 6 18 attempts; p<0.03 •
11 of Difference in
~~~ Criterion Cdses Pacing vs T Rates
Upper A-His(A pace»A-His (T) 4 58+46 ms
Wenckebach rate<T rate 2 38+13 beats/min
lower His-A(V pace»His-A (T) 11 26+22 ms
Wenckebach rate<T rate 2 38+37 beats/min
In sum: 1) the AV nodal T circuit is completely intra-
nodal, with nodal tissue between the T circuit and both A
(upper common path) and His (lower common path), 2) using
these criterIa, lower common paths can more frequently be
demonstrated than upper common paths in AV nodal T,
3) properties of such upper and lower common paths in the
AV node may influence the ability to penetrate the T
circuit for initiation, resetting, or termination of T
with rapid pacing or extrastimuli.
Wednesday, March 12, 1986
2:00PM-3:30PM, Room #360/361
Supraventricular Tachycardias
ATRIOVENTRICULAR NODAL TACHYCARDIA-HOW MUCH NODE IS
NECESSARY?
John M. Miller, MD, Mark E. Rosenthal, MD, Joseph A.
Vassallo, MD, Hark E. Josephson, MD, FACC. University of
Pennsylvania, Philadelphia, PA.
Atrio (A)-Ventricular (V) nodal reentrant tachycardia
(T) is presumed to be an intranodal circuit. To determine
if the entire AV node is required for T, we analyzed 21
patients with AV nodal reentrant T by pacing A, then V,
at or near (within 15 beats/minute) T rates. Criteria
suggesting the presence of AV nodal tissue between the T
circuit and A (upper common path) were: during A pacing,
an A-His intervaDA-His in T; or paced AV Wenckebach at a
rate<T rate. Criteria suggesting the presence of AV nodal
tissue between the T circuit and His (lower common path)
were: during V pacing, His-A interval>His-A in T; or paced
VA Wenckebach at a rate<T rate. Criteria were met if paced
Wenckebach rates, A-His or His-A intervals were >10
miiliseconds different from those during T. Criteria for
lower common paths were met more frequently (13/18
( /
ALTERED PLATELET FUNCTION IN PATIENTS WITH SEVERE CONGES-
TIVE HEART FAILURE. Jeanne M. Riddle, Ph.D., Syed M.
Jafri, M.D., Surdara B.K. Raman, M.D., and Sidney Gold-
stein, M.D., F.A.C.C., Henry Ford Hospital, Detroit, MI
We assessed platelet function in 22 patients with severe
congestive heart failure (CHF) and 33 normal subjects of
comparable ages. The platelet count per mm3 was determin-
ed. Platelet surface reactivity (ability of platelets to
spread and aggregate contacting a foreign surface) was
evaluated using a transmission electron microscope.
Aggregometry studies used collagen, adenosine diphosphate,
epinephrine and arachidonic acid as inducers in platelet
rich plasma. Release factors (platelet factor 4 and beta-
thromboglobulin) were evaluated using radioimmunoassay.
The presence of circulating aggregates was also investi-
gated.
The mean number of circulating platelets was 243,700
(196,800, 335,600/mm3). A hyperactive platelet response
C> 27% of spread type platelets and/or> 81 aggregates)
was found in 64% of patients with CHF. Mean % of spread
type platelet and average number of aggregates were 42%
and 67 compared to 14% and 45 found for normal (P<:0.001).
On average aggregation with all of the inducers was normal
(50-55%). The mean PF4 level was 19.3ng/ml (normal 4.5-
11.9ng/ml and B-TG was 124.1ng/ml (normal 25.4-67.1ng/ml).
No circulating aggregates Were detected. Subgroups of
patients with conditions known to alter platelet function
such as gout, diabetes mellitus, coronary artery disease,
CVA and those receiving antiplatelet drugs were analyzed
separately. None of the tests of platelet function were
significantly different in the subgroups compared to CHF
patients without the platelet modifying states. Our stud-
ies indicate that platelet function is abnormal in pat-
ients with CHF. The increased platelet relativity found
might account for the increased incidence of the thrombo-
embolic events in CHF patients.
SUCCESSFUL THROMBOLYSIS DOES NOT PREVENT VENTRICULAR
DILATATION AFTER MYOCARDIAL INFARCTION IN MAN
S.E. Warren, M.D., H.D. Royal, M.D., W. Grossman, M.D.,
J.E. Markis, M.D., and R.G. McKay, M.D., Harvard-Thorndike
Laboratory, Beth Israel Hospital, Boston, Massachusetts.
Left ventricular (LV) dilatation (OIL) after myocardial
infarction (MI) has been reported to occur commonly, but
whether this can be prevented by thrombolysis is uncertain.
We studied this question in 29 patients undergoing throm-
bolytic therapy for acute MI.Streptokinase was used as the
lytic drug in 23 cases and urokinase in 6. The mean time
from chest pain onset to reperfusion was 4.9±1.0 hours.
Radionuclide ventriculography was done within 24 hours of
MI,at 2 weeks,and at 6±4 months, and a geometric technique
was used to derive LV end~diastolic volume (EDV). Patients
were identified as showing dilatation if they had ~20% in-
crease in LVEDV from base1i ne at either 2 weeks or 6months
post-MI.Thrombolysis outcomes,occlusion sites,and presence
or absence of dilatation are listed for left anterior
descending (LAD) and right (RCA) coronary arteries.
Thrombolysis successful, Thrombolysis unsuccessful,
n = 16 n = 13
Occlusion site Occlusion site
LAD RCA LAD RCA Graft occlusions
LV OIL 6 3 3 2 1
No LV OIL 3 4 3 4
Incidence of LV DIL,thrombolysis successful: 9/16} =NS
Incidence of LV DIL,thrombolysis unsuccessful:6/l3 p
LV dilatation after LAD occlusion: 9/15;after RCA:5/13
Overall incidence of LV dilatation after Ml: 15/29
Conclusions: 1. Thrombolysis relatively late(4.9±1.D hours)
in the course of MI did not influence development of LV
dilatation; 2. LV dilatation following MI was a frequent
event, occurring in about half of patients, and was more
common after LAD occlusion than after RCA occlusion.
PREVENTION OF REENTRY BY PRE-EXCITATION OF AV JUNCTIONAL
REENTRANT CIRCUITS: EFFICACY AND ELECTROPHYSIOLOGIC
MECHANISMS.
Rehan Mahmud, MD, FACC, Mohammed Jazayeri, MD, Patrick
Tchou, MD, Stephen T. Denker, MD, FACC, Masood Akhtar,
MD, FACC, Univ. of WI Mt. Sinai Med Center, Milwaukee, WI.
The concept of prevention of reentry (Re) by "pre-
excit1ng" areas of conduction delay and/or unidirectional
block (,.e., the AV node (AVN) and/or accessory pathway
(AP), was tested in" patients (pts) with clinical AV
nodal Re (N=3) or W-P-W syndrome and orthodromic
tachycardia (N=3). The zone of Re was defined i:¥ atrial
(A) drive (ArAl) followed by premature stimUli (A2) at
progress1vely shorter Ar-A2 interval (control method).
Then the AI-AI drive was replaced i:¥ ventriculo-atrial
(V-A) sequential drive in order to "pre-excite" (or
depolarize earlier) the AVN and/or AP, prior to delivery
of A2' The degree of pre-excitation was increased by
programming longer V-A intervals (0-100 msec).
Results: V-A sequential pacing decreased the
tachycardia (SVT) zone, longer VA intervals produced
greater decrease in zone of Re and in 5/6 pts abolished
SVT altogether. The prevention of Re i:¥ A2 was related
to a) decrease in conduction time in "slow" pathway,
l.e., failure to achieve "critical" AVN delay (from 274 +
49 to 190 .:t 47 msec: P < .02). b) a shift in site of block
1n retrograde pathway, as Re failed to occur despite
achievement of crit ical AVN delay at short Ar-A2
interval and c) a decrease in antegrade effective
refractory period of AP.
Conclusions: 1l Slmultaneous "pre-eXcitation" of areas
of conduction delay and unidirectional block produce
functional changes in Re circuits which are effective in
preventing Re 2) Our data indicates that the concept of
prevent10n of Re i:¥ pre-excitation may be applicable to
both small and large clinical Re circuits.
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ENTRAINMENT OF CIRCUS MOVEMENT TACHYCARDIA BY VENTRICULAR
PACING:SIGNIFICANCE OF SUPRA AND INFRA-HIS BUNDLE
COLLISION
Liaqat Zaman,M.D.,Agust1n Castellanos, M.D.,
F.A.C.C.,Richard G. Trohman, M.D.,Richard M. Luceri,
M.D.,Alberto Interian,Jr.,M.D.,and Robert J. Myerburg,
M.D.,F.A.C.C., University of Miami,Miami, Fl.
Entrainment of circus movement tachycardia (CMT) by ven-
tricular pacing(VP) is usually difficult to demonstrate
due to the lack of an apparent retrograde His bundle
electrogram(H') during VP.We studied 7 patients w1th
atrioventricular accessory pathways and analyzed 18 ep1-
sodes of induced CMT with clearly apparent H' during
attempted entrainment by VP.Conventional criteria for
entrainment were achieved in all CMTs, Le., capture of
all elements of CMT at VP cycle length and resumption of
CMT on cessation of VP. To determine the supra or infra-
His(H) level of collision of successive VP impulses,H'-H'
during VP was compared with the cycle between H' from the
last VP impulse and H of the first CMT beat (H'-H).H'-
H'=H'-H in 9 CMTs (3l7:!;62 ms)-group A. In contrast, the
remaining 9 CMTs showed H'-H> H'-H'(3l0:!;34 vs23l:!;27,11
H=79:!;25 ms)-group B. Mean CMT cycle length in group
A=339:!;53 and in group B=273±25 ms. Mean VP cycle length
in group A was 3l5±58 ms (92±3% of CMT cycle length) and
23l±27(84±3% of CMT) in group B. The first VP impulse was
delivered as late as possible 1n the CMT cycle ;74-97(89±
7)% of CMT cycle length in group A, and 8l-93(87:!;3)% in
group B. In conclusion:l)H'-H prolongation relative to
H'-H' in group B CMTs reflects supra-H (AV nodal) col-
lision of successive VP impulses during entrainment;2)in-
fra-H col11sion in group A occurred due to longer VP
cycle length;and 3) the later may be a more accurate
method to demonstrate entrainment, because the former may
result in CMT termination and reinitiation during VP.
MECHANISTIC DISTINCTION BETWEEN LONG R-P' REENTRANT
TACHYCARDIAS: DIFFERENTIAL EFFECTS OF ADENOSINE AND
VERAPAMIL.~~~ HQ, Mark Greenberg, MD, Luiz
Belardinelli, MD, T. Duncan Sellers, MD, FACC, John P.
DiMarco, MD, PhD, FACe. University of Virginia,
Charlottesville, Virginia
Long R-P' supraventricular reentrant tachycardias
(SVT) often demonstrate decremental conduction properties
in the retrograde limb of a circui t. The anatomic sub-
strate of the retrograde limb can be Quite variable since
it may be comprised of the AV node or represent extra-
nodal tissue with AV nodal-like properties. Differential
electrophysiologic effects between nodal tissue and ex-
tranodal accessory pathways with decremental conduction
properties have not been previously reported. To eluci-
date the physiologic substrate of this tissue, electro-
physiologic effects of adenosine and verapamil were ex-
amined in 5 patients (pts) with fast-slow AV nodal re-
entry (F-S), and 2 pts with accessory pathways having
decremental conduction properties. Verapamil (10 mg), an
agent which decreases Ca++ conductance in the AV node,
terminated all episodes of F-S tachycardia in the retro-
grade limb but had no effect on the 2 pts with decre-
mental accessory pathways. Adenosine (3.8 j: 0.5 mg), a
nucleoside which enhances K+ conductance and hyperpol-
arizes supraventricular tissue, terminated SVT in the
retrograde limb in all pts.
Therefore retrograde accessory pathways with decre-
mental conduction properties may be distinguished from AV
nodal tissue by their differential responses to verapamil
and adenosine. This suggests that r conductance rather
than the inward calcium current is a major determinant of
the conduction properties of decremental retrograde
accessory pathways in the basal state.
INCIDENCE AND DIAGNOSTIC VALUE OF QRS ALTERNANCE DURING
WIDE QRS TACHYCARDIA. Mohammad Shenasa, M.D., Ph.D.,
Reg1nald Nadeau, ~.D., F.A.C.C., Rene Card1nal, Ph.D.,
Mohammad A. Sadr-Ame11, M.D., Pierre Page, M.D.,
F.A.C.C. Sacre-Coeur Hosp1tal, Universite de Montreal,
Canada.
QRS alternance during narrow QRS tachycard1a 1S
reported to be specific for the part1cipation of
accessory pathway (AP) in the retrograde d1rect10n. We
examined occurrence of QRS alternance during sustained
monomorphic wide QRS tachycardia of either right (R) or
left (L) bundle branch block (BBB) configuration in 148
patients (pts) in whom the site of or1gin of tachycardia
was determined during electrophysiologic studies. 79 pts
had ventricular tachycardia (VT) and 69 pts had wide QRS
supraventr1cular tachycardia (SVT) as follows: 33 with
intra A-V nodal tachycard1a and 36 pts had SVT due to
participation of AP in the retrograde direction. Of the
latter pts, 9 had right-sided AP and 27 had left-sided
AP. QRS alternance occurred in 13 (16%) of pts with VT
independent of QRS conf1guration (RBBB vs LBBB) and QRS
duration. QRS alternance did not occur in any of pts
with intra A-V nodal tachycardia of either RBBB or LBBB
morphology. QRS alternance observed in 6 (8.6%) pts with
SVT due to AP 1n the following manner. In those with
left-sided AP, QRS alternance never occurred dur1ng
SVT-LBBB but occurred during SVT-RBBB (5 cases). In pts
with right-sided AP, QRS alternance occurred only in 1
pt during SVT-LBBB. Conclusions: QRS alternance occurs
during wide QRS tachycardia either due to VT or SVT.
Therefore, it is not helpful in differentiating VT from
SVT. In pts with APs, QRS alternance may be seen only in
counterlateral SVT-BBB to the AP s1te.
ATRIAL MAPPING OF HUMAN ATRIAL FLUTTER
DEMONSTRATES REENTRY IN THE RIGHT ATRIUM
Brian Olshansky, M.O., Ken Okumura, M.O., Richard W.
Henthorn, M.D., F.A.C.C., Andrew E. Epstein, M.D., F.A.C.C.,
Vance J. Plumb, M.D., F.A.C.C., Albert L. Waldo, M.D., F.A.C.C.,
University of Alabama at Birmingham, Birmingham, Alabama
Reentry in the right atrium has been demonstrated during atrial
flutter (AFI) induced in dogs with sterile pericarditis. Here we
demonstrate a similar finding in 8 patients with spontaneous AFI,
If with coronary artery disease, and If with other conditions. All
underwent electrode catheter mapping of the right atrium during
AFI, mean cycle length 21f5±28 ms. Bipolar atrial electrograms
were recorded from the right atrial catheter utilizing a grid of
30 equaHy spaced sites, with catheter position confirmed by 3
independent observers. A reference electrode catheter was
placed in the coronary sinus (7 patients) or in the His bundle
position (j patient). The sequence of right atrial activation was
determined during stable AFl off antiarrhythmic medications. In
aH patients with AFI, the mapping sites from the free waH of the
right atrium were activated in a cranio-caudal direction and the
septal sites were activated in a caudo-cranial direction. In 4
patients, atrial electrograms were recorded throughout the
entire AFI cycle. An area of slow conduction was always present
in the inferior right atrial free wall. In the other If patients,
atrial electrograms were not recorded during 40til% of the AFl
cycle, due to a missing interval in the inferior right atrial free
wall. Double and fractionated atrial electrograms were always
recorded in the posterior-inferior portion of the free waH of the
right atrium during AFI, but were either normal or of low
amplititude during sinus rhythm. These data demonstrate: I) the
similarity between AFI in the dog model and in humans; 2) that a
reentry loop can be identified during AFl in the right atrium;
3) that during AFI, abnormal atrial electrograms and an area of
slow conduction exist in the inferior right atrium.
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Ventricular Arrhythmias-Electrophysiologic
Testing II
PROGRAMMED ELECTRICAL STIMULATION IN HYPERTROPHIC CARDIO-
MYOPATHY - SPECIFICITY AND SENSITIVITY OF DIFFERNT STIMULATION
PROTOCOLS
Klaus-Peter Kunze, M. D. Karl·Heinz Kud<, MD., Manfred Geiger, M.D., Walter
Bleifeld, MD., FA,C.C., Dept. of Cardiology, University Hospital Eppendorf,
Hamburg, West Germany
The value of programmed electrical stimulation (PES) in identifying patients with
hypertrophic cardiomyopathy (HC) at risk for syncope (S) or sudden death ( SD)
is under inwstigation. To determine the sensitivitY (SE), specificitY (SP), and pro·
gnostic value (PV) of two different stimulation protocols (STIM) consisting of 2
and 3 ventricular extrastimuli (VES), respectively, we analysed the data obtained
during PES of 26 consecutive pis with HS (13 men, 13 women, mean age 45 years).
Four pts hed a history of S, 2 had had cardiac arrest (CA) due to ventricular fi·
brillation NF). STIM included atrial as well as RV and LV stimulation. Endpoint
of STIM was induction of sustainad (sus) ventricular tachycardia (VT) or VF. Pts
were defined as pts at risk, if sus VT or VF could be initiated during PES. During
the follow-up period of 32 ± 5 months pts with S or CA were treated with oral
amiodarone ( 400 mg/day) independently from the results of PES according only to
dinical data. All other pis received either calcium antagonists or beta blockers. RV
and LV stimulation with maximally 2 YES resulted in VF in 3/26 pts. Two of these
3 pts had a history of S or CA. Using 3 YES at the same sites of stimulation VF was
initiated in another 7 of the remaining 23 pts, of whom none had a history of S or
CA. Sus VT was never induced. During dinical follow·up no pt suffered from S or
CA. Thus only pis with a previous history of S or CA were considered to be pts at
risk. Based upon these data, SE, SP, and PV of each STIM for the recognition of pts
at risk for S or CA were: STIM using 2 YES: SE 20 %, SP 95 %, PV 66 %, STIM using
3 YES: SE 0 %, SP 66 %, PV 0 %. - Condusion: PES using STIM with 3 YES should
not be performed in pts with HC because of its lack of sensitivitY and specificity. A
STiM using 2 YES needs further evaluation.
RESULTS OF A STANDARDIZED VENTRICULAR STIMULATION
PROTOCOL IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY.
Annette Geibe1,M.D., Pedro Brugada,M.D., Manfred
Zehender,M.D., Ivo Kersschot,M.D., Hein J.J. Wellens,
M.D.,F.A.C.C. Dept. of Cardiology, Univ. of Limburg,
Maastricht, The Netherlands.
Hypertrophic cardiomyopathy (HCM) is frequently asso-
ciated with the occurrence of spontaneous complex ventri-
cular arrhythmias (VA)or sudden death. The relevance of
VA induced during programmed electrical stimulation (PES)
in these patients (pts) remains uncertain. 18 pts with
HCM were studied with a standardized stimulation pro-
tocol. Three pts had been resuscitated from documented
(D) ventricular fibrillation (VF-group), 2 pts had a
history of syncope (Syn) and 2 pts had D sustained mo-
nomorphic ventricular tachycardia (DSMVT-group), 11 pts
had no D VA (No-VA-group). PES consisted of 1-2 extra-
stimuli (EX)(part-l) and 3 EX (part-2) during sinus
rhythm (SR) and pacing at 100, 120 and 140/min from the
RV-apex; part-2 also included pacing with increasing
rates (IR) in the atrium and the RV-apex. Part-2 was used
in 11 pts when part-l failed to induce a SMVT or VF.
Results: In 12/18 pts (67%) repetitive ventricular re-
sponses and in 10/18 pts (56%) a sustained VA was in-
duced. Part-l induced a SMVT only in 2 pts with DSMVT and
VF in no pt. Part-2 induced SMVT in 1 pt without DSMVT,
and a polymorphic VA requiring DC-shock in 7/11 pts (64%)
(3/3 pts with VF, 2/3 pts with No-VA, 1/2 pts with Syn,
1/2 pts with SMVT). 1/3 VA induced during part-l and 8/8
VA induced during part-2 required DC-shock for termina-
tion. Conclusions: 1) In pts with HCM, 1-2 EX can easily
identify pts with D SMVT, with a low risk for DC-shock,
2) 3 EX and IR frequently induce non-specific polymorphic
VA requiring DC-shock for termination, 3) pts with HCM
without D SMVT are rarely inducible by PES to a SMVT.
PROGNOSIS IN SunDEll DEATH SURVIVORS WITHOUT INDUCIBLE
VElfTRICULAR ARRBITHHIAS. Q~y~q_~~!~~rl_t~, Beth Kelly
RH, Hasan Garan, ND, Jeremy Ruskin, [lD, FACC.
tlassachusetts General Hospital, Boston tlA,
Thirty-two patients ~lho survived out-of-hospital
cardiac arrest not associated with acute myocardial
infarction had no inducible ventricular arrhythmias
(IVA) during subsequent programmed ventriCUlar stimUla-
tion, Of 21 patients with obstructive coronary artery
disease (CAD), 12 had 3 vessel disease and 9 had remote
myocardial infarction. The remaining patients had
valvular disease (3), dilated cardiomyopathy (2), mitral
valve prolapse (1), or no structural heart disease (5).
The mean left ventriCUlar ejection fraction was .48 :I:
.19, and was similar in those with and I<ithout CAD.
Six patients had reCUrreliG cartiiac arrest (RCA)
uurinL follo\lu., ['dlGWb frOi'l 3-88 mo: 3 with CAD, 2 with
valvular disease, and 1 With no structural disease.
Ejection fraction was> 50% in 3 l'atients with RCA, Of
11 patients treated w~th antiarrhythmic agents, 2/9
treated for spontaneous high grade ventricular ectopy
and 0/2 treated for atrial arrhythmias had RCA. In CAD
patients, 0/4 treated with revascularization and 1/10
treated with beta adrenergic blockade had RCA. Two
patients died from heart failure and 2 of noncardiac
causes. Actuarial incidences were:
1 year 3 years 5 years
RCA 13% 11% 25%
All cardiac deatbs 13% 21% 2g'f,
All deatbs 16% 28% 35%
Conclusion: Sudden death survivors without IVA during
electrophysiologic testing, including those with normal
ventriCUlar function, remain at moderate risk for RCA.
The potential protective effect of beta blockade/
coronary revascularisation requires furthur study,
RISK OF ARRHYTHMIA RECURRENCE IN VENTRICULAR
TACHYARRHYTHMIA PATIENTS WITHOUT INDUCED SUSTAINED
ARRHYTHMIAS.
Charles D. Swerdlow, M.D., LA,C'Cd Roger A. Freedman,
M.D.; Jan Peterson, R.N.; Debra lay, R.N.; Stanford
University, Stanford, CA.
We studled 59 patients (pts) with sustained (>30 sec)
ventricular tachycardia (VT, 27 pts) or ventricular
fibrillation (VF, 32 pts) in whom programmed
stimulation induced < 15 repetitive ventricular
complexes. In all pts,-programmed stimulation included
3 extrastimuli from 2 ventricular sites at 2 cycle
leneths and burst pacing. pts were treated with
ant~arrhythmic drugs (33 pts), surgery (6 pts) or
devices (4 pts); 16 pts had no therapy. During foliowup
of 2.2+1.5 yrs, 13 pts had an arrhythmia recurrence:
sudden-aeath in 7, aborted VF in 4, and sustained VT in
2. At 1, 2, and 3 years, the actuarial incidence of
arrhythmia recurrence was 15+5%, 17+5%, and 23+6% and
that of sudden death was 6+4:\, 15+6%-; and 21+8%.- Prior
myocardial infarction (MIT was ~he only lndependent
predictor of arrhythmia recurrence (p<.02) and sudden
death (r=.05): At 2 yr, 36+12% of 18 pts with MI and
8+4% 0 41 pts without fiad arrhythmia recurrence;
2~+12% with MI and 3+3% without had sudden death. None
or-the 9 pts with > 70% coronary stenosis but no MI had
arrh~thmia recurrEince after anti ischemic therapy.
Posslble arrhythmia-precipi tating conditions were
present during all arrhythm~as in f4 pts (antiarrhythmic
drugs, K+<3.0, ischemia, or perioperative state), but
did not predict freedom from arrhythmia recurrence
(p=.52) or sudden death (p=.81). A~e, sex, LV ejection
fraction, use of LV programmed stlmulation~ clinical
arrhythmla type (V, or VF), use 01 chronic
antiarrhythmic therapy, or number of induced ventricular
complexes did not correlate with arrh)'thmia recurrence
or sudden death. Conclusions: In th~s group of pts,
prior MI predicted arrhythmia recurrence and sudden
death. The risk of arrhythmia recurrence was low in
coronary pts without MI who received antiischemic
therapy. The risk did not correlate significantly with
possible arrhythmia-precipitating conditions or the
duration of induced non sustained VT up to 15 complexes.
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Non-rejection (n=8)
Tl T2
500±l9* 62±4*
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Evaluation of the Heart by NMR
I-DNI'roRING OF CIIRDIAC ALlCGRAF'l' R£JECl'ION WITH MAGNETIC
RESONANCE IMAGING.
Gerald Wisenberg, M.D., Peter Pflugfelder, M.D., William
J. Kostuk, M.D., F.A.C.C., St. Joseph's and University
Hospitals, University of Western Ontario, London, Ontario.
To determine the reliability of magnetic resonance
imaging in the diagnosis of cardiac allograft rejection,
12 patients were imaged 10-14 days, 25-30 days, and 45-60
days following surgery on a 0.15T resistive system. Endo-
myocardial biopsies were ootained within 24 hrs of imaging
in all cases. Rejection was defined as the presence of
both a cellular infiltrate and myocytolysis.
Results were as follows:
Rejection (n=4)
Tl T2
Early imaging 490±17* 6l±4*
(10-14 days)
Late imaging 500±18* 62±5* 350±13 35±4
(25-60 days)
Control 350±12 35±4 350±12 35±4
*p<.05 vs control
Thus, magnetic resonance imaging does not appear
capable of separating early rejection accurately fran the
tissue changes that occur following graft harvesting and
inplantation, but has premise for subsequent II'Onitoring
of patients beginning 3-4 weeks after surgery.
DISSOCIATIOI BBTWKEI B-1 lIIR Tl AID VATER CHARGES WITH
MYOCARDIAL ISCHllMIC IBSULT
R.C. Canby. M.E.E., R.C. Reeves, M.D., F.A.C.C.,
W.T. Evanochko, Ph.D., and C.M. Pohost, M.D., LA.C.C.
University of Alabama at Birmingham.
Contrast produced by differences in regional proton
relaxation times provides the potential to assess the
extent of myocardial infarction (MI) using NMR imaging.
Previous studies have shown that TI is prolonged in acute
MI, and these prolongations have been wholly attributed to
increases in tissue water content. No study has focused
on total ischemia, where regional myocardial blood flow
(RMBF) is zero, and t is sue wa t er content shou Id not
increase, although the insult is severe. The left
anterior descending coronary artery and collaterals to a
region of the left ventricle were ligated in 8 dogs for
four hours, and bulk Tl values of myocardial biopsy
samples were measured at 20 MHz. TI values (.70~.03s) with
severe flow reduction (SR, RMBFg% of preocclusion flow)
were not significantly different from TI values (.69~.02)
with no flow reduction (NR, RMBF>50%), while the wet
weight to dry weight ratios (WID) of SR (4.75~.28) were
larger than NR (4.44~.17, p<.OI). TI values (.78~.05s)
with moderate flow reduction (MR, 2%<RMBF~50%) were
significantly higher than NR (p<.OOOll and SR (p<.OOOll;
the WID of MR (4.93!..29) were also greater than NR
(p<.OOOl), but were not greater than SR. The data suggest
that contrary to previous beliefs the behavior of Tl
changes in MI is not solely determined by tissue water
content. Furthermore, clinical imaging of Tl relaxation
times nwy provide a means for characterizing the severity
of ischemic insults; we anticipate that Tl-weighted images
of severe myocardial infarction might demonstrate a
doughnut pattern with an area of increased TI in the
peripheral zone and no increase in the central zone.
At lower concentrations contrast was better with Gd-P
than with Gd-DTPA. These results suggest that Gd-P
localizes more specifically to regions of infarction than
Gd-DTPA. Agents such as Gd-P may be usefu1 in the
detection of infarction by magnetic resonance imaging.
A NEW PARAMAGNETIC CONTRAST AGENT FOR MAGNETIC RESONANCE
IMAGING OF EXPERIMENTAL MYOCARDIAL INFARCTION.
Ronald M. Peshock. M.D •• Padmakar V. Kulkarni. Ph.D ••
Saul Schaeffer. M.D •• Jose Katz. M.D. Ph.D., Roxann
Rokey. M.D •• Craig Malloy. M.D •• Robert W. Parkey, M.D ••
F.A.C.C., and James T. Willerson. M.D •• F.A.C.C••
University of Texas Health Science Center at Dallas.
Da1las, TX.
A paramagnetic contrast agent which enhanced contrast be-
tween infarcted and normal myocardium with high speci-
ficity could improve the sensitivity and specificity of
magnetic resonance imaging in the detection of myocardial
infarction. The phosphonate complex is known to localize
in regions of infarction. Hence, a Gadolinium phosphonate
complex (Gd-P) was prepared and compared to a non-speci-
fic paramagnetic contrast agent Gadolinium diethylene
triamine pentaacetic acid (Gd-DTPA) in a model of infarc-
tion. In 24 dogs the left anterior descending coronary
artery was occluded for 2 hours. released. and each dog
was given 0.34, 0.034 or 0.0034 mM/kg Gd-DTPA or Gd-P
intravenously. Following one hour of reperfusion the
hearts were excised and imaged. In relatively Tl weighted
spin echo images (SE 500/28) the ratio of infarcted to
normal myocardial signal intensity was as shown below:
ESTIMATION OF SIZE AND LOCALIZATION OF
MYOCARDIAL INFARCTION BY MAGNETIC RESONANCE
IMAGING.
Jennifer A. Jotms M.B.B.s, F.R.A.C.P., Tsunehiro Yasuda
M.D., Herman K. Gold M.D., F.A.C.C., Robert C. Leinbach
M.D., F.A.C.C., Donald L. Johnston M.D., Thomas J. Brady
M.D., Robert E. Dinsmore M.D., F.A.C.C.
Massachusetts General Hospital, Boston, MA.
Magnetic resonance imaging (M RI) has shown regional
increase in myocardial signal intensity falloWing acute
myocardial infarction (MI). The aim of this study was to
determine the ability of MRI to accurately estimate the
size and location of MI. We studied 19 patients with MI,
14 of whom received thrombolytic therapy with either
tissue plasminogen activator or streptokinase, within 6
hours of onset of MI. All patients underwent repeat
coronary arteriography and left ventriculography (LV A) 10
days post.-MI. Multi-elice spin echo MRI at TE=30/60
msec, fallowed by single-slice imaging at TE=60 msec at
0.6 Tes1a was performed 5-20 days (mean 9) post.-MI.
Image planes oriented to the true short axis of the left
ventricle were used and multiple gated systolic images from
aortic valve to apex were obtained, allowing p-'ecise
comparison of left ventricular segment location on MRI
with LV A. The length of infarcted myocardium on MRI
was measured by multiplying the number of contiguous
image slices showing increased signal intensity by 1.5cm
(i.e. slice thickness). This was then compared with the
location and length of akinesis (cm) on LV A.
Infarct location on MRI agreed with angiographic
location in all cases. There was good cOl'T'e1ation of MRI
infarct length with angiographic akinesis (M RI length =
0.85 LV A akinesis + 0.6, r:0.85, p < 0.001), indicating that
MRI has potential for accurate estimation of infarct size
and localization in humans.
Gd-DTPA
Gd-P
0.34 mM/kg
L39±0.1l
L38±0.12
p=NS
0.034 mM/kg 0.0034 mM/kg
1.21±0.OB 1.08±0.04
1.50±0.09 1.29±0.10
p<0.005 p<O.Ol
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PROTON MAGNETIC RESONANCE FOR THE DETECTION OF VIABLE
MYOCARDIUM WITHIN A REPERFUSED ISCHEMIC RISK AREAf' DpuaA'ft Miller. f·D•• Boward L. Kantor. M.D•• B. Thomas
retz. • •• Donna utrario. B.S•• Arno Villringer M.D••
Thomas J. Brady. M.D•• Robert D. Okada. M.D •• F.A.C.C••
Massachusetts General Hospital. Boston. MA.
To determine whether proton magnetic resonance (MR) can
detect viable myocardlum in reperfused infarctions (MI). 7
dogs had 3 hrs of left anterior descending coronary
Qcclusion followed by 1 hr of reperfusion. Mannitol
l12.5gm/5Oml) was infused at 15.3 ml/min for 15 min before
and after release to promote myocatdial salvage.
Microsphere myocardial blood flow 1MBF) was measured at
control(c). ~ak occlusion(o) and 15 min of
reperfusion(r). Biopsies were obtained before sacrifice
from the normal. central and border ischemic zones for
electron microscQpy (EM). After MR imaging in a
small-bore (1.4T) superconducting magnet. exc~sed hearts
were stained with T.T.C. Spectrometer (20MHz) Tl and T2.
% water contentl%H20) and MBF were calculated for 34
normal. 57 central and 27 border endocardial segments for
corr~lationwith EM and T.T.C. Segments with the lowest
MBFol7% of MBFc = 0.06+.07 ml/min/gm) had the highest Tl
(623±3Om,) and T2 (48~6ms) and were predominantly (>90%)
T.T.~.(-). In these MI s~gments. Tl and T2 correlated
with MBFo (r=.52; p<O,OOl!1 and rose exponenti,lly as MBFo
9Pproached zero.' TI \593±J4ms) and T2 l43~ms) were lower
lp<O.OOl) and unrelated to MBFo in normal segments.
Segments bordering the MI were moderately ischemic (46% of
MBFc=0.33+.07 ml/min/~) fnd >90% T.T.C.l+). MBFo. Tl
(607~OmsJ and T2 (46±5ms) in bor4er segments differed
from MI and normal varues (p<0.05). T2 correlated
linearly with MBFo in these segments (r=.4l; p<0.05).
%B20 content did not differ between normal. bOrder and
infarcted segments l77!3. vs 78~ vs 7~%). All segments
show,d mannitol effect (i.e. decreased Tl. T2. and
%H20) compared to 9 untreated hearts (p<0.05). EM of MI
segments confirmed the ultrastrpctural changes of
irreversible injury (grade 3-4+). while border zone
changes were less marked and reversible (grade 0-1+).
Tl-dependent inversion recovery and T2 spln-echo images
had smaller abnormal it ie, than control dOgs in the
distribution of T.T.C.(-) segments.
We conclude that although significant differences in blood
flow. Tl and T2 can be measured in vitro. viable ischemic
myocardium does not produce sufficient intrinsic MR
contrast to be imaged at 1.4T.
DYNAMIC S'lUDIES OF CARDIAC ICI'IOO AND FLCM Willi A FAST
MULTIPHASE MRI TECHNIQUE.
Ir. Pieter van Dijk, Ir. Peter van der Meulen, Roderic
1. Pettigrew, Ph.D., M.D., Rainer Bli.itrn, M.D., wayne
Dannels, B.S., and Joost Ibornbos, Ph.D., Philips
Medical Systems, Best, 'lhe Netherlands.
'lhe low signal intensity of fast flowing blood in
conventional spin echo (SE) imaging makes the
assessment of cardiovascular flow abnormalities
difficult. In addition, the dynamic studies which can
be obtained using variable slice order SE techniques
have limited temporal resolution, since these are
typically based on images of a slice obtained at 5-6
phases of the cardiac cycle. we report our experience
with a new fast imaging sequence which uses gradient
echos, canbined with short echo times and small angle
excitation pulses, to produce positive contrast for
flowing blood. In addition, with ECG gating, images of
a single slice at typically 16 phases of the cardiac
cycle can be obtained in only 4 minutes. Cine display
of these images provides high temporal resolution
studies in which the dynamics of blood flow, and to a
lesser extent the heart wall motion, can be evaluated.
Initial clinical assessment suggest particular utility
of this technique in the differentiation of slow
flowing blood fran thranbus, identification and
assessment of false hrnen flow in aortic dissection,
and the evaluation of pulroonary hypertension and flow
patterns in congenital heart disease. This technique
also holds promise for fast flow quantification and MRI
angiography.
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Exercise Testing and Myocardial Infarction
THE ST/HR SLOPE IDENTIFIES THREE-VESSEL CORONARY DISEASE
AFTER REMOTE BUT NOT AFTER RECENT MYOCARDIAL INFARCTION
Olivier 4meiBen MD. Paul Kligfield MD. FACC. Peter M Okin
MD. David H Miller MD. FACC. Jeffrey S Borer MD. FACC.
Cornell Medical Center. New York. NY
The rate-related change in exercise ST segment
depression (ST/HR slope) has been shown to accurately
identify 3-vessel (3v) coronary disease (CAD) in patients
(pts) with stable angina (SA). but the method is
inaccurate after recent «3 weeks) Q-wave myocardial
infarction (MI). Although some pts with SA have had prior
MI. the possible effect of remote (>8 weeks) Q-wave MI on
ST/HR slope accuracy in pts with chest pain has not been
examined. To quantify and compare the ability of an ST/HR
slope >6 pV/beat/min to identify 3v CAD in pts with
recent and remote MI. we evaluated 107 pts studied by the
Bruce protocol in whom ST/HR slope analysis was limited
to leads aVF. V5. and V6. The 58 pts with SA. including
17 with remote Q-wave MI. were similar to the 49 pts with
recent MI with respect to age and peak exercise heart
rate. In pts with SA and no prior Q-wave MI. an ST/HR
slope >6 had a sensitivity (sens) of 92% (11/12).
specificity (spec) of 97% (28/29). and positive
predictive value (ppv) of 92% (11/12) for 3v CAD. In SA
pts with remote MI sens was 83% (5/6). spec 91% (10/11).
and ppv 83% (516). After recent MI. spec was preserved at
95% (39/41). but sens was only 37% (3/8) (p<0.025
compared with sensitivity in SA patients) and ppv 60%
(3/5). These findings suggest that discordant reports of
the accuracy of the ST/HR slope in pts with CAD may be
partly explained by varying admixture of recent MI and SA
pts in study populations. We conclude that the markedly
reduced sens and ppv after recent Q-wave MI are important
limitations of the ST/HR slope. but that the method is
highly accurate for the identification of 3v CAD in pts
with SA. either with or without remote Q-wave MI.
EXERCISE AND RECOVERY SYSTOLIC BLOOD PRESSURES
AND PROGNOSIS IN ISCHEMIC HEART DISEASE.
Charles N. Leach, MD, FACC and Elizabeth R.
Sunderman, New Britain General Hospital, New
Britain, CT and Univ. of CT, Farmington CT.
Abnormal systolic blood pressure (SBP) responses
to exercise reflect ischemic heart disease
(IHD). Few studies have examined the prognostic
value of SBP abnormalities, especially those
during the recovery phase. We studied 239
consecutive patients for 5 years after a
standard-protocol treadmill. By clinical
criteria, 42 were normal (group I), 84 had
probable IHO (group II), and 113 had definite
IHD (group Ill). 21 MI's and 8 IHD deaths
occurred during followup: none in group I; 4
MI's and 2 deaths in group II, and the remainder
in group III. Exercise SBP abnormalities (EAb)
were defined as (A) SBP increase < 8mm Hg in any
stage; (B) SBP decrease ~ 11mm Hg in any stage;
( C) SBP dec rea s e ~ 20 mm Hgin the 1a S t ex e r cis e
minute. Recovery SBP abnormalities (RAb) were:
(D) any recovery SBP~10 mm Hg above peak exer-
cise SBP and (E) any recovery SBP ~11 mm Hg
above the preceding SBP. There was no signifi-
cant difference in frequency of each EAb among
groups I II & Ill, while RAb (O&E) differences
were highly significant (p~O.005 for each).Of
all EAb and RAb, only (A) was significantly
associated with subsequent MI (p-e:O.025). 7 of 8
deaths had EAb or RAb. We conclude that SBP res-
ponse to exercise is a means for identifying pts
with IHD and is a predictor of MI. RAb are more
sensitive and specific for rHD than are EAb,
whlle EAb have slightly greater prognostic valu~
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CORONARY ARTERY DOMINANCE AND MYOCARDIAL MASS REDUCTION AS
DETERMINANTS OF TREADMILL STRESS TEST NEGATIVITY IN
CORONARY ARTERY DISEASE
Frank J. Forlinl, Jr., M.D., F.A.C.C., Rock Island
FranCIscan MedIcal Center, Rock Island, IllInOIS
A false negatIve response durIng maXImal treadmIll stress
testIng (TST) has been a perSIstent clInIcal problem In
evaluatIon of coronary artery dIsease (CAD). ThIS study e~
arnlnes the underlyIng anatomIC causes for thIS negatIve
electrophyslologlcal response. One hundred fIfty false
negative TST responders (Grp A) and 150 arterlographlcally
matched pOSItIve TST responders (Grp B) are compared. All
patIents (pts) presented WIth angIna pectoriS and 94% ex-
perIenced angina durIng TST. NO pt had a myocardIal lnf~r~
tlon Within 8 weeks of the TST. LV aneurysm and congestive
heart faIlure pts were excluded. All pts had anglographlc
eVIdence of ~ 50% trans lumInal narrOWing of one or more
coronary arterIes. Coronary system domInance/balance and %
wall length motIon abnormalitIes were determIned. In GrpA
pts, all SIngle vessel CAD leSions occurred In a non-do-
mInant vessel (57) or a domInant vessel With an Infarcted
LV wall >40% of ItS linear length. POSItIve pre-InfarctIon
TST's were present In 85% of the latter group. Two and 3
vessel CAD pts had multIple non-domInant vesselobstructiffi
(62) while 27 were assocIated WIth InfarctIon of a domi-
nant coronary artery. All members of the Infarcted group
prevIously had pOSitIve TST's. The remaInIng 4 pts had
multi-vessel balanced obstructIons. Grp B pts had obstruc-
tion of a domInant SIngle vessel (42); domInant SIngle
plus addItIOnal vessel (s) (79); balanced domInance (3) or
1 or 2 vessel non-domInant obstructIon WIth a dImInutive
3rd vessel (6). Infarct SIze assocIated WIth a domInant
vessel was always <40% of lInear wall length. In conclu-
sIon, TST negatIve responders have non-domInant vessel ob-
structIon or sIgnifIcant InfarctIon reductIon of active
myocardIum 10 a previously dominant perfUSIon vessel zone.
SYMPTOM-LIMITED THALLIUM-201 EXERCISE TESTING AT 3 MONTHS
AFTER MYOCARDIAL INFARCTION: A COMPARISON WITH SUBMAXIMAL
PREDISCHARGE TESTING. William ~ Hll42n HQ, George A.
Beller MD, FACC, Denny D. Watson PhD, Sharon L. Sayre RN,
BSN, Donald L. Kaiser PhD, Thomas W. Nygaard MD, FACC,
Robert S. Gibson MD. Univ. of VA, Charlottesville, VA
We prospectivelY studied 241 consecutive pts with MBCK-
confirmed acute MI with predischarge angiography and sub-
maximal exercise Tl-201 scintigraphy (Tl-GXT). Of these,
180 pts returned for symptom-limi ted Tl-GXT 3 mos after
MI. Age was 51±9 yrs; LVEF 50±11%; 33% had non-Q wave MI
and 52% had multivessel disease by angiography. At the 3-
mo Tl-GXT (Bruce protocol), peak HR t by a mean of 15±22
bpm, peak SBP t by a mean of 15±26 mmHg, and workload t by
a mean of 3.3±2.8 METs compared to predischarge Tl-GTX
(Naughton protocol). Despite this increase in exercise
performance, 94% of pts had ei ther no change (66%) or a
decrease (28%) in the number of vascular supply regions
considered to be hypo perfused. In only 6% of pts was an
additional abnormal region detected. Also, 75% of pts had
either no change (48%) or a decrease (27%) in the number
of scan segments with Tl redistribution (Rd) despite a
higher workload and double product. Infarct zone per-
sistent Tl defects remained constant <39%) or decreased
(24%) in number in 63% of pts. Of 148 pts without angina
on predischarge Tl-GXT, 22 (15%) developed angina during
the 3-mo Tl-GXT. Of 128 pts with no predischarge ST~, 34
(27%) had ST~ on the 3-mo test. Finally, of 77 pts with no
predischarge Tl-Rd, 21(27%) showed Rd at 3 mos.
ThUS, in comparison to submaximal predischarge Tl-GXT,
3-mo symptom-limited testing is associated with little en-
hancement in the detection of hypoperfused myocardium
despite a greater workload. In some pts, Rd actually
decreased, possibly due to an interim increase in collat-
eral flow; yet 21 of our 180 pts did develop new Rd at the
higher 3-mo workload.
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New Issues in Cardiac Pacing
COMPARATIVE SURVIVAL FOLLOWING PERMANENT VENTRICULAR AND
DUAL CHAMBER PACING FOR HIGH DEGREE AV BLOCK IN PATIENTS
WITH AND WITHOUT PRE-EXISTENT CONGESTIVE HEART FAILURE.
Martin A. Alpert, M.D., F.A.C.C., Jack J. Curtis, M.D.,
F.A.C.C., John F. Sanfe1ippo, M.D., Greg C. Flaker, M.D.,
F.A.C.C., Univ of Missouri School of Medicine, Columbia,
Missouri
To determine whether survival following permanent ventri-
cular pacing differs from survival following permanent
dual chamber pacing in patients with chronic high degree
atrioventricular (AV) block (Mobitz type II or trifasci-
cular block) we followed 132 patients (Group 1) who recei-
ved a VVI pacemaker and 48 patients (Group 2) who received
a DVI or DOD pacemaker for 1-5 years. There was no signi-
ficant difference in the mean age, sex, or the incidence
of coronary artery disease, hypertension, valvular heart
disease, or other chronic co-existent diseases between
Groups 1 and 2. Overall, predicted cumulative survival
rates at 1, 3 and 5 years were 89%, 76% and 63% respec-
tively in Group 1 and 95%, 82% and 72% respectively in
Group 2 (no significant difference). Predicted cumulative
survival rates at 1, 3 and 5 years for patients with pre-
existent congestive heart failure (CHF) were 85%, 66% and
47% respectively in Group 1 (n=53) and 94%, 74% and 69%
respectively in Group 2 (n=20, p < 0.05). There was no
significant difference in predicted cumulative survival
rates between Groups 1 and 2 for patients without pre-
existent CHF. The results suggest that permanent dual
chamber pacing enhances survival to a greater extent than
permanent ventricular pacing in patients with high degree
AV block and pre-existent CHF.
PACEMAKER PROBLEMS AND ASSESSMENT OF MEDICARE GUIDELINES
Lawrence E. Vallario, M.D. ,Robert B. Leman,M.D.,FACC, Paul
C. Gillette,M.D., FACC, Med. Univ. of S.C., Charleston
The time of occurrence of cardiac pacemaker problems post
implantation was identified to assess the adequacy of pub-
lished federal gUidelines for clinic (C) and transtele-
phonic (TT) followup for single and dual chamber devices.
189 total pacemaker patients (Pts) were followed between
July, 1982 and August, 1985. Retrospective examination of
these Pts charts was performed to identify pacemaker pro-
blems: nonsense, noncapture, battery failure, myoinhibi-
tion, muscle stimulation, inadequate safety threshold mar-
gin. 32 Pts (17%) were identified as having pacemaker pro-
blems. A total of 43 problems were identified which 30
(70%) were corrected by reprogramming and 13 (30%) were
corrected surgically (5 Pts due to battery failure). 67%
of the problems were found on or during C visit and 33%
during TT transmission.
%of Problems Identified For:
Time Period Single Chamber Dual Chamber
To Problem 0-.5 18% 35%
(Yrs) .5-1 14% 30%
1-4 41% 30%
> 4 27% 5%
Problems in dual devices occurred more frequently during
the first year (65%) vs single devices (32%). During years
1-4 when few problems are expected, 41% of the single
chamber problems and 30% of the dual chamber problems oc-
curred. This is a period of time that Medicare guidelines
allow for 1 C visit per year for single and 2 visits per
year for dual devices. these data suggest: Many pacemaker
problems will be missed with TT alone. The majority of
problems involving dual devices occurred in the first year,
For both dual and single devices an unexpected significant
percentage of problems occurred in 1-4 years. Medicare
guidelines for year 1-4 may be inadequate for followup.
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PACEMAKER DYSFUNCTION OCCURS COMMONLY IN ASYMPTOMATIC PA-
TIENTS.
Peter T. Klementowicz, M.D. and Seymour Furman, M.D., F.A.
C.C., Montefiore Medical Center, Bronx, New York
Transtelephonic monitoring and pacemaker clinic checks are
accepted methods of pacemaker evaluation. With the increa-
sing complexity of pacemakers, these techniques often do
not detect abnormalities of sensing and pacing. We have
found that ambulatory monitoring(AM) is a useful adjunct
to routine pacer checks and frequently reveals pacemaker
malfunction, when it is not otherwise suspected. We evalu-
ated 97 AM in pts with DDD pacemakers and S3 AM in pts
with VVI pacemakers. These asymptomatic pts were evaluated
in the early post-op period, 2.4 + 1.8 d post-op for
those with DDD and 2.1 + 1.7 d for those with VVI, and af-
ter the 1 mo post-op pacer check, 34.4 + 7.6 d for DDD
and 37.3 + l2.S d for VVI. The number of pts with atrial
and ventricular sensing abnormalities(SA), non-capture(NC)
and myopotential interference(MPI) recorded by AM, are:
ATRIAL VENTRICULAR
PACER TIME #PTS SA-----NC SA NC MPI
DDD Early 69 32 1 2 2 6
DDD Late 28 7 3 1 7
VVI Early 36 7 1
VVI Late 17 7 1
Conclusions: The incidence of transient pacer malfunction
detected by AM is high. Atrial sensing abnormalities oc-
cur in 46% of pts in the early post-op period a2d decrea-
se to 2S% in the late post-op period (p<C. ODS, 1- ). Atrial
and ventricular non-capture are rare. Inappropriate ven-
tricular sensing occurs more commonly in VVI pacer~, in
both the early and late post-op periods (p <.OS,ll ). Myo-
potential interference occurs in 8.7% of DDD pts in the
early post-op period and increases to 2S% in the late post-
op period.
CAN PACEMAKER IMPLANTATION BE DONE AS AN OUTPATIENT
PROCEDURE?
David L. Hayes, M.D., F.A.C.C., Ronald E. Vlietstra,
M.D., F.A.C.C., Jane Trusty, R.N., Peter Downing, M.D.,
Nicholas Cavarocchi, M.D., Mayo Clinic, Rochester, MN.
To determine the feasibility of outpatient pacemaker
implantation or of an abbreviated hospital stay following
pacemaker implant, we analyzed the hospital course of 100
consecutive patients undergoing pacemaker implant at Mayo
Clinic. The patient population included 62 males and 38
females with an average age of 66 years. Single chamber
devices were implanted in Sl patients and dual chamber
devices in 49 patients. Average acute thresholds were:
atrial 0.96 V, 2.2 mA, 2.9 mV P wave; ventriculsr O.S V,
1.0 mA, 9.S mV R wave. All patients were followed at
least 72 hours in the hospital. Pneumothorax requiring
chest tube placement occurred in 2 patients. Ventricular
lead dislodgement occurred in 2 patients, 1 pacemaker
dependent and 1 not. Atrial lead repositioning was
required in 1 patient. Cardiac tamponade occurred in
and required echo-directed pericardial tap. Repro-
gramming of atrial sensitivity was necessary in S pa-
tients to correct atrial undersensing; ventricular over-
sensing was corrected with reprogramming in 1 patient;
and extension of the atrial refractory period to prevent
pacemaker-mediated tachycardia was needed in 3 patients.
The 6 complications requiring an invasive procedure were
all clinically evident within 24 hours post-implant.
While the need for reprogramming was recognized at up to
24 hours there were no further new events occurring in
the 24 to 72 hour period. Based on this data we do not
advocate pacemaker implantation as an outpatient proce-
dure but recognize that patients could be discharged from
the hospital 24 to 49 hours following the procedure with
low likelihood of further new events.
ELECrRJDE MATURATICN IN WI PACEMAKERS AS CONl'roLIED BY
INl'RACARDIAC ELEX:'l.'ROGRAM.
Ulrich J.Winter,M.D., Dieter W.Behrenbeck,M.D., Martin
Hoeher,M.D., Johannes Missler, Ursula Dick, Thanas Brill,
Vinzenz Hanbach,M.D., Hans H.Hilger,M.D., Medical Clinic
III, cardiology, University of Cologne, FRG
The electrode maturation process was controlled in 16
patients (6female, 10 male, aged 60.6+ 18.5 ys) whose
syrrq:>tara.tic brcrlyarrhytbmias were treated with the Medtro-
nic Speetrax SlIT 8423 (WI) aM. a traumatic (Biotronik DY,
n=10l or a ncn-traumatic (Vitatron Helifix, n=6) ventricu-
lar lead. The telerretry of the intracardiac electrogram
(ICEG) was perfortred at the 1st, 2nd, 5th, 10th, 30th,
60th and 154th+ 31 day after implantation (a.i.), taking
into account the same conditions (posture, respiration,
filters) that rrodify the lCEG. In all ICEG's but one there
was a rrean sr-elevation (STE) in the acute phase ranging
fran 0.45 to 5.50 mY. ~ main groups with different STE
behaviour were found: one group (n=5, all DY-eleetrodes)
displayed a high sr-arcplittrle (4.81 +0. 49mV) that de-
creased to half of its value (2.38+ 1.26 mY) within the
first 60 minutes a. i.. The other gi=oup of acute lCEG's
showed a much less prcnounced ST-elevation (1.73+ 0.84mV)
that diminished not l:efore the end of the first iionth a. i.
to it's half. The recovery of the initially reduced R-wave
arrplitude developed. as fast as the STE was pronounced:
small R-waves with high arcplittrle STE regenerated within
the first day a.i., small R-waves associated with low STE
needed a month to reach an acceptable value. The effects
of posture aM. respiration on the arrplitudes of the lCEG
decreased as the electrode got fixed by a fibrotic sheet.
There was no statistical significant difference l:etween
the lCEG' s of traumatic aM. ncn-traumatic electrodes.
Although being a tirre-consuming method the telerretry of
the lCEG enables a reliable control of the maturation
process of traumatic or non-traumatic leads.
SHOULD THE AUTOMATIC IMPLANTABLE DEFIBRILLATOR PACE?
Peter D. Chapman, M,D" Sharon E. Duquette, R.N., Jule
N. Wetherbee, M.D., Paul J. Troup, M.D., F.A.C.C.,
Medical College of Wisconsin, Milwaukee, Wi.
To assess the need for pacing in patients (pts) with
implanted defibrillators (IDs), we examined the length
of post-shock pauses (PSPs) during intraoperative
defibrillation threshold (DFT) testing in 17 pts
undergoing 1D generator placement with (9 pts) or
without (8 pts) concomitant lead placement. Pts with
pacemakers and those requiring additional cardiac
surgery or cardiopulmonary bypass were excluded. Two
epicardial patch electrodes were employed for
defibrillation in all pts. DFT testing was performed
with truncated exponential pulses from an external
cardioverter defibrillator. Twenty joules (J) was tested
initially, and if successful in terminating ventricular
fibrillation, testing continued with energy output
decrements of 5 J until DFT was defined. The ID
generator was then tested. The PSP was measured as the
time from termination of the arrhythmia to the first
non-ventricular tachycardia/fibrillation complex. The
mean pause during the generator trials (25 to 30 J
discharges) was 918.2 msec (range 400 to 1,780). There
was no significant difference between the generator
alone versus generator plus lead implant groups (963.8 ±
411.4 versus 877.8 ± 350.8; mean ± S.D.) and no
significant difference between the mean length of the
PSP at 10, 15, or 20 J during DFT testing (1,061.7 ±
594.4, 934.3 ± 386.0, and 1,004.3 ± 534.3 respectively).
We conclude: 1) over the range of energies tested, the
PSP is not related to shock energy, 2) prolonged PSPs do
not occur follOWing ID discharges through two
ventricular patch electrodes, and 3) "back-up"
post-shock pacing appears unnecessary.
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Devices for Arrhythmia Therapy: The Implantable
Defibrillator
MORBIDITY, MORTALITY AND DEVICE fAILURE ASSOCIATED
WITH THE INTERNAL AUTOMATIC CARDIOVERTER/DEfIBRILLATOR
francis E. Marchlinski, MD, fACC, Belinda flores, MSN,
University of Pennsylvania, Philadelphia, PA
The automatic internal cardioverter defibrillator (AICD)
has been reported to improve survival with low risk.
The AICD generator and leads were implanted in 26 patients
(pts) with refractory ventricular tachycardia/fibrillation
(VT/VF), and a patch lead was placed at cardiac surgery in
seven other pts. During 11+6 mos, the AICD discharged
in nine pts (35%) for documented (7 pts) or suspected (2
pts) sustained VT/VF. No sudden deaths occurred. There
were 31 complications 1n 17 pts. The patch lead or AICD
1mplant may have contributed to early postoperative death
with coronary artery erOS10n beneath patch in one pt and
refractory heart failure 1n a second pt. Other major com-
plications 1ncluded subclavian vein thrombosis, postoper-
at1ve stroke after conversion of atrial fibr11lation by
AICD, and thoracotomy site infection in one pt each. The
AICD discharged when pt was asymptomatic with rhythm un-
known 1n 4 pts, sinus in 3 pts, nonsustained VT in 2 pts,
and atrial flbnllation in one pt. Other complications in-
cluded lead migrat10n (3 pts), atelectasis/pneumonia (4
pts), symptomatic pleural effusion (3 pts), seroma at AICD
site (3 pts), pneumothorax (2 pts), and subcutaneous hema-
toma (one pt). In addition to complications, 4 pts had
early generator failure, 3 pts had VT with rates too slow
to trigger the AICD during chronic amiodarone therapy, and
3 pts (2 on amiodarone) had Vf which could not be termi-
nated by AICD during postoperative testing despite suc-
cessful interoperative testing. One other pt had delayed
sensing of Vf due to interference from unipolar RV pacing.
Thus, although the AICD can be life saving, significant
morbid1ty and potential mortality may accompany its use.
Potential complications and drug/pacing interactions w1th
the AICD should be considered at time of pt selection.
COMPLICATIONS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER-
DEFIBRILLATOR.
Edward V. P1atia, MD, FACC, Lawrence S.C. Griffith, MD,
FACC, Philip R. Reid, MD, FACC, Thomas Guarnieri,MD, FACC,
Levi Watkins, Jr., MD, Morton M. Mower, MD, FACC, M.
Mirowski, MD, FACC, The Johns Hopkins Medical Institutions
and Sinai Hospital, Baltimore, MD; and Washington Hospital
Center, Washington, DC.
We reviewed the complications encountered in 116 patients
(pts) with the automatic implantable cardioverter-defib-
ri11ator (AICD). Our population consisted of 86 men and
30 women, mean age 55 yr (range 19-76 yr), with sustained
VT or VF in whom we implanted the 2nd generation AICD.
Over the period of study, 146 pulse generators were im-
planted in 116 pts. Fo110wup averaged 15 mo, (range 4-48
mol, during which time there were 21 deaths, of which 3
were sudden. 109/116 pts had an active AICD at hospital
discharge and 25 complications, none lethal, occurred in
23 pts. Post-operative infection of the pulse generator
pocket occurred in 7 pts, all of whom had the generator
(or a pulse generator simulator box) implanted. In 2 of
these pts infection tracked to the heart via AICD lead,
prompting extirpation and replacement of both pulse gen-
erator and leads. SVC lead displacement occurred in 4 of
the first 31 implants, but has not occurred following
adoption of improved lead fixation at the venous entry
site. Six pts experienced inappropriate AICD discharge
during supraventricular tachycardias when the ventricular
rate was above 150 bpm. Beta-blockers were required to
prevent recurrences. Other complications: subclavian
vein thrombosis (2), pneumothorax (I), lead fracture (1)
and need for psychologic support (2). In conclusion, non-
fatal AICD complications are relatively common. Particu-
.ar attention should be paid to minimize wound infections,
1ea~ migration, and unwanted AICD discharges during supra-
ventricular tachycardias.
CAUSES OF DEATH IN PATIENTS WITH THE INTERNAL
DEFIBRILLATOR: ANALYSIS OF 188 PATIENTS AT 60
MONTHS FOLLOWUP.
Igor Singer, M.B"B S., Philip R. Reid, MD., F.A,C,C., Lawrence
S.c. Griffith, M,D., FAe.C., Morton M. Mower, M.D., FAe.e.,
Enrico P. Veltri, MD., M Mirowski, MD., F.A.C,C., Edward
V. Platia, MD., F,A.C.C., Thomas Guarnieri, MD.,F.A.C.C., Eva
Magiros, MD., Sara Schmitt, B.S., Juan Juanteguy, M.D., Levi
Watkins, M.D. The Johns Hopkins and Sinai Hospitals, Baltimore,
Maryland
Between Feb, 1980 and Jul,1985, 188 patients were evaluated for
the automatic internal cardioverter defibrillator (AICD). There
were two groups: LEADS ONLY (N=32) patients who received only
the lead system with (88%)/without additional cardiovascular
(CY) surgery in anticipation of a pulse generator. AICD patients
(N=156) who received the leads !!liI. pulse generator with (14%)/
without additional CY surgery, The groups were not different with
respect to the type of heart disease (80% coronary disease;20%2
cardiomyopathy), sex, or ejection fraction (33 vs 31%).
In LEADS ONLY patients 17 deaths occurred (53%) over 39 days
(mean): 8/32 (25%) from arrhythmias; 4/32 (13%) from heart failure
with/without acute infarction; 5/32 (16%) from post-operative
complications, In-hospital death from ventricular tachycardia/fib-
rillation (YT/YF) occurred in 6/32 (19%).
In AICD patients 35 deaths (22%) occurred over 367 (mean)days:
17/156 (II %) from arrhythmias; 13/156 (8%) from heart failure
with/without infarction; 5/156 (3%) from post-operative complica·
tions, In-hospital death due to VT/YF occurred in 2/156 (I %).
These results demonstrate:!) The LEADS ONLY group has higher
mortality than the AICD group over shorter followup (39 vs 365
days),;2) LEADS ONLY patients died more frequently from arrhyth-
mias (p=.04); 3) in·hospital death due to YT/VF is significantly
greater in the LEADS ONLY patients (19% vs 1%,p<.007); and 4)
suggest that the AICD significantly reduces sudden death in
patients at high risk of YT/YF.
IAQl - PATImr AND BATIERY I1HlEVI'1Y AN> SIIXI< IELIWFl
Han D. Gabry, M.D., Richard BrodDan, M.D., Debra Johnston, R.N.,~
mary Frame, R.N., Jdln D. Fishel', M.D., F.A.C.c., SeynnIr F\JnIIIn, M.D.,
F.A.C.C. MJntefiore Medical Center, Bronx, New York
Ber-t 5/82-6/15/85, 20 pts (14 M ani 6 F1Vl!rage age 57.8) 38-76) rot
of appI'l:lldm1te1y 250 who were evalll8ted by PF.S fOl' Sll8tained ventricular
taehycaI'dia ani/or fibrillation (vr/VF) unlel'lelt initial fDplantation
of an Jmplantable cardiovertel' defibrillatol' (IAQl). Eigllteen had cot'on-
ary artery disease (CAD), 2 non--ischemic card:lanyopathy (1 with mitral
valve prolapse - MVP) ani 1 CAD ani rheulBtic heart disease. The avg
ejection fractioo (EF) was 28% (~%) ani all MIIIined with vr/VF after
IIlJ1tiple d~ trlals iocl~ 3 with eaIocardial resectioo. ere (1/20)
58 yr old F with MVP ani an initial EF of 64% died 5 1006 postfDplant of
a oonarrllytl1Dic cardiac event aftel' MV replacement ani intIllOpel'8tive AV
node ablatioo. She had received 47 sOOcks fOl' vr/VF ani recurrent atrial
fibrillatioo. (AF).AltOOugh 55% (11/20) never had a spclltareous shock for
vr/VF ani all are alive, 45% (9/20) experienced 1 or 1IDl'e, the 1st event
~ within 5 lIDS in 7 of 9. If the 1st shock prevented death, the
ClIIIl1ative SUl'Vival rate at 30 lIDS lOl1d have been 54% rathel' than 95%.
E1.ENeI (11/20) pts experienced spclltareous sOOcks: 9 (9/11) appropriate,
2 (2/ll) inappropriate, but at least 4/9 reeeived both appropriate ani
inappropriate sOOcks (sims tachycardia, AF ani/or pac8IIIker l'e1ated).
Fourteen have been exp1anted: ~ttery depletion (Ill); 1~ output fail-
ure; 2-infectioo ani Hack of sensing ani insufficient output; HIE!D8ing
prob1enB. The lUIiler of sIn:ks given does not inf1J.Jeln! IAalloqJeYity
unless extensively used. The 9 depleted units lasted 171006 (1l-22).
The shortest (111006) disclm'ged 3OX, the l.cqest (22 1006) 18K, the
othen 12X or less. The 4 (4/9) units that never gave spontaneous sOOcks
averaged 17.51006 (1)-19) while the 5 (5/9) that did, averaged 171006
(11-22). Elimination of the glass corrosion battery failure unIe in Jan
1984 has not prevented early ach:I.ewment of the Elective Rep1.acaDi!nt In-
dicator (l'1U) (approx. 90% III & 3.3 lIDS IIIXIitoring thlle). 83% (5/6) with
gl'eatel' than 6 lIDS follOlMJll thlle have J:elIChed this ElU within 8 lIDS
(5-81006). The validity of the ElU ia uncertain as none have failed ani
3 IaIBin active 10-11 1006 latel'.
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Congenital Heart Surgery
DOES THE SUBCLAVIAN FLAP OPERATION DECREASE THE
NEED FOR REOPERATION FOLLOWING COARCTATION
REPAIR IN INFANCY?
R.H. Beekman, MD, FACC, A.P. Rocchini, MD, D. Behrendt,
MD, FACC, E.L. Bove, MD, FACC, A. Rosenthal, MD, FACC.
C.S. Mott Children's Hospital, Ann Arbor, MI.
To assess the influence of surgical technique on the need for
reoperation (reop) after coarctation (coa) repair in infancy,
data were compared for 55 consecutive survivors of left
subclavian angioplasty (LSA) (1977-85) and 44 consecutive
survivors of end-to-end repair (END) (1960-1977). Mean age
at operation for LSA was 1.5!.0.3 months (!.SEM; range 0.1-12)
and for END was 2.7+0.4 months (range 0.1-11) (p<.05). There
was equal distributionof complex anatomy and arch hypoplasia
between groups. Follow-up was 2.6!.0.3 yr for LSA and 8.0!.0.8
yr for END (p<.Ol). Indication for reop was resting coa gradient
>40mmHg and upper extremity hypertension. Reop was
performed during the first 3 postop years in 5 LSA and 3 END
pts, and by the 7th postop year in a total of 5 LSA and 8
END pts. The 3 and 7 year reop rate (per 100 pt-years) and
individual reop risk (%; incidence density method) for each
surgery are given below. NS = not significant.
LSA END
REOP 3 YR 7 YR 3 YR 7 YR
P VALUE
3 YR 7 YR----
FONTAN PROCEDURE FOR CHILDREN LESS THAN FIVE YEARS OF AGE
W. James Parks, M.D.: Kenneth J. Dooley, M.D.,FAAP; Willis
Williams, M.D.; Pediatric Cardiology, Emory University
School of Medicine
Sixteen (16) patients underwent Fontan procedure for
treatment of tricuspid atresia complex (12), single ven-
tricle, left atrioventricular valve atresia (I), pulmonary
atresia (2), and hypoplastic left ventricle with ventricu-
lar septal defect (1) between October, 1981 and July,
1985. All patients underwent a pallative procedure before
Fontan. Fifteen (15) patients survived surgery and eleven
(11) were alive at discharge (69% survival). All patients
over two years of age (8/8) survived (100%). Three of
eight patients, under 2 years of age survived (37.5%).
Pulmonary artery pressure (PAP) was measured directly or
via pulmonary vein wedge in 14 patients and was used to
calculate pulmonary resistance (PR). Left ventricular end
diastolic pressure (LVed) was less than 12 mmHg for the
group with a mean of 7.6 mmHg.
PAP (range) PR (range) LVed (range)
<2yrs (6) 16.2(6-27) 1.70(0.5-2.5) 7.5(4-11)
)2yrs (8) 12.3(9-15) 1.54(0.8-3) 7.75(3-12)
Deaths (3) 20.3(14-27) 2.23(2.1-2.3) 8.6(7-11)
Pulmonary artery cross sectional area/indexed, cardiac
output, pulmonary to systemic flow ratio, pulmonary artery
to aortic ratio, aortic cross clamp time, pump time, and
arrest time were all evaluated. No single factor other
than age influenced the outcome. Although numbers are
small a pulmonary vascular resistance of greater than two
units may influence the outcome.
RATE 4.1
RISK 12
3.1
20
2.4
07
3.1
20
NS
NS
NS
NS
Compared to END, the relative risk for reop after LSA was
1.7 at 3 yr (95% CI: 0.8, 3.5) and 1.0 at 7 yr (95% CI: 0.99,
1.01). The risk of requiring reop during the first 7 postop
years was 20% regardless of the type of initial surgery. Thus,
LSA does not decrease the need for reop following coa repair
in infancy.
REGIONAL AND GLOBAL LEFT VENTRICULAR FUNCTION IN
ANOMALOUS ORIGIN OF LEFT CORONARY ARTERY FROM
THE PULMONARY TRUNK. Azaria J.J.T. Rein, MD, Steven D.
Colan, MD, Ira Parness, MD, Stephen P. Sanders, MD, Department
of Cardiology, The Children's Hospital, Boston, MA.
Five infants (2-8.5 months old) had serial 2D echo evaluation
before and 6-36 months after intrapulmonary artery baffle repair
of anomalous left coronary artery (ALCA) and were compared
with 17 infants (10 normal and 7 with idiopathic dilated
cardiomyopathy) matched for age. Quantitative analysis of
regional wall motion (center of mass model), end-(\iastolic volume
(EDV), EF, LV mass, and the mass to volume ratio (MVR) were
calculated using a computerized review center.
HF HDV Mass MVR
_%_ ml/m2 ml/m2
Normal 66.5+5.9 60+15 64+13 1.03+0.11
Cardiomyopathy 23.0+13 28f+144 182+124 0.63+0.11
ALCA-Preop 22.2+11.6 268+97 141+55 0.70~0.14
ALCA-Postop 59.0+8.1 85+14 90+15 1.06+0.14
Severe hypokinesis of all LV segments was noted in the
patients with ALCA without significant regional variation in wall
motion, a pattern indistinguishable from that seen in the
cardiomyopathy group. The EDV and mass were markedly
enlarged and the EF depressed in the patients with ALCA, as in
those with cardiomyopathy. After repair of ALCA, the EF rose
to near normal while the EDV and mass decreased. The MVR,
which had been low pre-operatively, became normal after
surgery.
We conclude that: 1) infants with ALCA generally exhibit
global LV hypokinesis indistinguishable from cardiomyopathy
rather than specific segmental abnormalities, 2) as in
cardiomyopathy, preoperative LV dysfunction in ALCA is
associated with inadequate hypertrophy leading to an abnormally
low MVR, 3) following successful surgery of this type for ALCA,
there is a rapid reduction in LV volume along with regression of
hypertrophy with dramatic recovery of systolic function.
VENTRICULAR FUNCTION IN PATIENTS WITH OBSTRUCTED RIGHT
VENTRICULAR-PULMONARY ARTERY CONDUITS. Imre Palik, MD,
Thomas P. Graham, MD, FAAC, Judith Burger, RN.
Vanderbilt University, Nashville, TN 37232.
Children with right ventricular (RV) to pulmonary ar-
tery (PA) conduits frequently have progressive RV pressure
overload. The effect of the increased RV pressure on ven-
tricular function and the optimal timing for reoperation
in order to prevent irreversible ventricular dysfunction
are unclear. Accordingly RV and left ventricular (LV)
end-diastolic volumes (EDV) and ejection fractions (EF)
were assessed using biplane cine angiography and radio-
nuclide angiography (RNA) in 18 patients studied an aver-
age of 5.2 yr after valved conduit repair for RV-PA dis-
continuity. There were 7 repairs done in infancy (group
I) and 11 done between 2-9 yr of age (group II). Values
below are x ± S.D.
GROUP RVP RVEF LVEF RVEDV RV-PAP RVEDP
-1- 92+21 0.60+0.10 0.68+0.08 116+34% 64+24-s+2
II 128±S3 0.43±0.11* 0.56±0.10* 11~29% 84±66 13±7
*p<O.OS vs. Group I. P = pressure in mmHg
There was an inverse relationship between RVEF and age
at repair. r=0.714, p<0.005. In addition, the RNA RVEF
response to exercise was abnormal in 7/7 and the LVEF ab-
normal in 7/8 with all but one of these patients operated
upon after 2 yr of age. Abnormal pump function is preva-
lent in patients with obstructed RV-PA conduits whose ini-
tial repair is performed after infancy whereas patients
with repair during infancy show normal function despite
similar RV pressure overload. The progressive decrease
in RVEF with age indicates the inadequacy of hypertrophy
and other compensatory mechanisms to normalize RV pump
function in older children with obstructed conduits.
Further prospective data are needed to discern risk factors
for permanent RV dysfunction in this clinical setting.
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CRYOABLATIVE TECHNIQUES IN THE TREATMENT OF CARDIAC
TACHYARRHYTHMIAS
David A. Ott, M.D., F.A.C.C., Arthur Garson, M.D., F.A.C.C.
Denton A. Cooley, M.D., F.A.C.C., Richard T. Smith, M.D.
and Jeffrey Moak, M.D. Texas Heart Institute, Houston, TX
Forty-four patients underwent electrophysiologic
mapping and definitive surgical treatment for potentially
lethal and refractory cardiac tachyarrhythmias using cryo-
ablative (cryo) techniques. Included were 16 patients with
supraventricular tachycardia due to accessory pathways
(Kent bundle) in the anterior or posterior paraseptal lo-
cation. Cryo was successful in abolishing tachycardia in
93.7% (11/12). Seventeen of 18 patients with atrial ec-
topic tachycardia were treated by cryo alone or in combin-
ation with excision of the atrial appendage with success
in 13 (76.5%). Five of these were left atrial foci cured
by cryo alone. Thirteen right atrial foci were treated by
excision of the appendage only (1), excision of the appen-
dage and local cryo (8), and cryo alone (4). Five right
sided lesions required cardiopulmonary bypass and 2 of
these underwent partial atrial disconnection after ex-
cisional and cryo techniques failed to control the tachy-
cardia. Multiple ectopic atrial foci were common (8) and
successful cryo was accomplished in 100% of patients with
a single atrial ectopic focus (9), but in only 50% of
these with multiple foci. Seven of 13 infants with crit-
ical ventricular tachycardia were treated by cryo at the
site of the ectopic focus either alone or in combination
with excision of the area (5). Elimination of tachycardia
was accomplished in all 7 patients. One patient with ven-
tricular tachycardia after repair of tetralogy of Fallot
underwent successful cryo of an ectopic focus on the crista
supraventricularis. We conclude that cryo techniques are
effective and safe in selected cases of tachycardia and
may be used alone or in combination with other methods to
effect a high rate of cure.
LONG-TERM FOLLOW-UP AFTER SURGICAL CORRECTION OF
WOLFF-PARKINSON-WHITE SYNDROME IN 45 PATIENTS
Tim A. Fischell, M.D.; Edward B. Stinson, M. D., FACC;
GeraIdwe C. Deroy, R.N.; Charles D. Swerdlow, M.D.,
FACG; Stanford University Medical Center, Stanford, CA.
Surgical correction of Wolff-Parkinson-White syn-
drome (WPW) was performed in 45 consecutive patients
(pts) , age 2-59 yrs. Preoperatively, 40 pts . had
reciprocating tachycardia refractor)' ~o 2. ~~1.8 antiar-
rhythmic drugs, and 13 had atrial fibrillation (shortest
RR interval = 212+51 ms). Intraoperative mapping iden-
tified 48 accessory pathways: 33 left free wall, 8
posteroseptal, 5 nght free wall, and 2 ante!"osep,tal.
The princi9al operative p!"ocedure was ~ndo~ardial inCi-
sion in 43 pts, endo,?ardial. cryoabla.tion ~n 1 pt, and
epicardial cryoablation without dissection of the
atrioventricular fat pad in 1 pt. Adjunctive procedures
were coronary bypass grafting in 2 pts aryd mitr~l valve
rep,lacement in 2 pts. Thre.e pts ~ad penoper~tive com-
plications: 1 pt had a periopera~ive stroke with sUb~e­
quent resolution of the neurologiC deflci t; 2 fts with
posteroseptal accessory pathways had asymptoma ic com-
plete heart block which resolved wi thin 2 wks. No pt
had atrial fibrillation postoperatively. At postoper~­
tive electrophysiologic study, the pt who unde!"went ep,i-
cardial cryoablation had inducible reciprocating
tachycardia; no other pt had accessory pathway conduc-
tion. Two pts with normal postoperative elec-
trophysiologic studies had intermittent delta waves on
p,ostoperative ECGs, similar to preoperat~ve delta waves
in 1 pt and different in the other. During a mean fol-
10W-UD of 2.1 yrs (range 1 mo ~ 5.9 yrs), 1 pt with Eb-
stein's anomaly had supraventricular tachycardia of un-
certain mechanism, 1 ~t had late recurrence o.f dlClta
waves without arrhythmias i and 3 pts had palpi tati(,lOS
due to extrasystoles. A 1. 12 pts whose arrhythmias
limited employment preoperatively have returned to work.
By actuarial analysis at 1, 2, and 3 yrs, 98~, 94~, and
94~ of pts were free of arrhythmias; all are alive •.
Conclusions: Surgical correction ,?f WPW prov~des
excellent long-term arrhythmia control with low morbidi-
t:(. Pts whose arrhythmias limited employmeryt preopera-
tively return to work. Del~a waves may pers~st or r~cur
wi thout return of arrhythmias. Postoperative palpi ta-
tions may not correlate with tachyarrhythmias.
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Studies of Myocardial Metaholism by PET and NMR
RELATION BETWEEN BLOOD FLOW AND GLUCOSE METABOLISM IN
HYPOPERFUSED VENTRICULAR SEGMENTS IN CHRONIC ISCHEMIC
HEART DISEASE. R.C. Brunken, M.D., F.A.C.C., M.
Schwaiger, M.D., J.H. Tillisch, M.D., R.C. Marshall,
M.D., M. Phelps, Ph.D., and H.R. Schelbert, M.D.,
F.A.C.C., UCLA School of Medicine, Los Angeles,
California.
Residual glucose metabolism distinguishes hypoperfused,
ischemic tissue from regions of infarction. To assess
the relation between flow reduction and metabolic activ-
ity, PET with tracers of flow (N-13 ammonia, NH3) and
glucose metabolism (F-18 deoxyglucose, FDG) was per-
formed in 13 patients with chronic ischemic heart dis-
ease. Septal, anterior, lateral, apical and inferior
segments were analyzed. Tracer concentrations were
normalized to peak activity over the entire heart and
calculated for each of the 12, 30° sectors in the cir-
cumferential profile of each cross-sectional plane.
Ratios derived from normals were used to correct rela-
tive tissue concentrations for partial volume effect.
Using previously published criteria, 34 segments with
depressed NH3 activity were identified. In 20 segments
with concurrently reduced FOG activity (PET infarct),
mean relative NH3 activity was 44. HIO.8%, while in 14
segments with preserved FOG activity (PET ischemia),
mean NH3 activity was 61.2:1:20.0% (p(O.OI). Although the
decrease in FOG activity paralleled that of NH3 in PET
infarction (44.0:1:9.1%, FDG/ NH3=0.99), FDG uptake was
augmented relative to flow in segments of PET ischemia
(83.8 :I: 10.7%, FDG/NH3=1.37). Thus, moderately severe
reductions in perfusion are associated with residual
metabolic activity and accelerated glucose utilization
relative to blood flow. More severe reductions in flow
are associated with concordant decreases in glucose
utilization, suggesting irreversible tissue necrosis.
RELATIVE REDUCTION OF EXOGENOUS GLUCOSE UTILIZATION IN
THE SEPTUM OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY.
Maleah Grover-McKay, M.D. F.A.C.C., Markus Schwaiger,
M.D., Janine Krivokapich, M.D., F.A.C.C, Michael E.
Phelps, Ph.D., Heinrich R. Schelbert, M.D., F.A.C.C.,
UCLA School of Medicine, Los Angeles, California.
We examined regional myocardial glucose utilization with
F-18 deoxyglucose (FDG) and positron emission tomography
(PET) in 10 patients (pts) with hypertrophic cardiomy-
opathy (HCM). Six pts were studied at rest (R), 3 pts
during maximal exercise (EX), and 1 pt at both R and EX
(11 studies). On visual analysis, FOG uptake in the
septum (S) was markedly reduced relative to the lateral
wall (LW) in 6 studies and only mildly reduced in 5
studies. Echocardiographic (echo) wall thickness was
used to correct underestimation of regional FDG uptake
by PET (partial volume effect). The S/LW ratio for wall
thickness averaged 1.9 :I: 0.3; i.e., S was 90% thicker
than LW. In contrast, corrected FDG concentrations were
reduced in S relative to LW. This decrease was less in
pts with visually mild (37.0:1: 6.2%) than in pts with
visually marked FOG reduction (54.8 :I: 9.8%; p(.OI).
Marked septal FOG reduction was always present during EX
(4/4), but only in 2/6 at R, and was present during EX
but not R in the pt with both R and EX. Echo HCM
severity, on a scale of 10 (based on thickness of S,
extent of S hypertrophy, and extension of hypertrophy to
the anterolateral wall), was similar between pts wi th
mildly and markedly reduced septal FOG (7.5 :I: 1.3 vs 5.6
:I: 2.2). We conclude that in HCM pts exogenous glucose
utilization is relatively reduced in the hypertrophied
septum compared to the lateral wall. The underlying
pathophysiology remains uncertain and warrants further
investigation.
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INFLUENCE OF WORK ON MYOCARDIAL pH DURING ACIDOSIS.
S. Wu, Ph.D., T. Watters, M.D. J. Wikman-Coffelt, Ph.D.,
M. Wendland, Ph.D., T. James, Ph.D., E. Botvinick, M.D.,
F.A.C.C., and W. Parmley, M.D., F.A.C.C. University of
California, San Francisco, Ca.
Return to control was observed in all preparations except
that related to "high workload." Intracellular pH, ven-
tricular function and flow, as well as high energy
phosphates, were severely depressed only in the "high
workload" model. Induced either by calcium or loading,
work was the major determinant of biochemical deteriora-
tion and ventricular dysfunction was secondary.
We sought to aSSess the effects of acidosis on ventricu-
lar function and the biochemical milieu during varying
calcium concentrations [Cal o and working conditions. To
this end, we measured intracellular pH [pH]i and high
energy phosphates (ATP,PCr) by nuclear magnetic resonance
spectroscopy. Coronary flow, developed pressure (Dev P),
and maximum dP/dt were also measured during 30 min. of
induced acidosis and 15 min. re-equilibriation each at
varying [Cal o and (DevP) in isolated perfused rat hearts.
[cal o (DIM)
Workload
Dev P (IlDIIHg)
[Phli
ATP
PCr
DevP
dP/dt
Flow
(n=5)
0.8
41+7
Results
6.82+.06
1.03+.09
0.94+.13
0.77+.16
0.86+.26
0.95+.10
2.0
112+12
Expressed
6.90+.03
1.08+.21
0.76+.13
0.77+.04
0.78+.18
0.96+.09
4.0 4.0
High Low
208+55 32+3
as %of Control -
6.42+.13 6.90+.03
0.68+.16 1.00+.07
0.35+.19 0.86+.08
0.29+.25 0.55+.15
0.21+.10 0.65+.18
0.51+.17 0.90~.12
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Cardiomyopathy: Prognosis, Arrhythmia
UNEXPECTED POOR SURVIVAL WITH DILATED CARDIOMYOPATHY
WHEN TRANSPLANTATION DENIED DUE TO LIMITED SYMPTOMS
.L...~ Steyenson•.J!IJl.., Michael B. Fowler, M.D., John
S. Schroeder, M.D., F.A.C.C., Rex N. MacAlpln, M.D.,
F.A.C.C., Kathleen A. Dracup, R.N., Victoria Fond. UCLA
and Stanford Medical Centers, Los Angeles and Stanford,
CalifornIa.
When referred for transplantation, patients with
dilated cardiomyopathy (CM) may have limited symptoms
despIte abnormal hemodynamics. To study the natural
history of this patient group, outcomes were obtained and
compared to clinical and hemodynamic data for 26
consecutIvely referred patients with non-Ischemic dilated
CM who were rejected for transplantation due to lack of
severe symptoms.
Actuarial survival fol lowing evaluation was 42% at 1
yr., and 24% at 2 yrs. When patients dying within 1 yr.
were compared to 1 yr. survivors, there were no
sIgnifIcant differences In clinical class (2.5 vs 2.5),
ejection fract~on (16~ vs 17%), stroke volume Index
(27 vs 29 cclm ), pUlmonary wedge pressure (22 vs
17 mmHg), right atrial pressure (6 vs 4 mmHg), or
systolic blood pressure <102 vs 96 mmHg).
9/11 first yr. deaths were sudden. Documented history
of ventricular arrhythmias (non-sustained or sustained
ventricular tachycardia, ventricular fibrillation, or
sudden death) was present at Initial evaluation In 8/9
patients who died suddenly, 0/2 patients who died from
hemodynamic failure, and 1/10 patients who survived the
first yr.
Patients with dilated CM rejected as "too well" for
transplantation have an unexpectedly high mortality.
Hemodynamics do not Identify risk of early death, which
Is usually sudden. For patients referred with mildly
symptomatic CM, ventricular arrhythmias may be an
IndIcation for early transplantation.
DDIO.STRATIO. OF CARDIAC ALLOGIlAFT IlLJBCnOB I. RATS USIBG
I. vno P-31 -.a SPBCTROSCOPY
Robert C. Canby. M.E.E .. William T. Evanochko, Ph.D.,
Leslie V. Barrett, B.S., Robert E. Foster, B.S., Russell
C. Reeves, M.D., F.A.C.C., and Gerald M. Pohost, M.D.,
F.A.C.C., University of Alabama at Birmingham.
Monitoring of human cardiac allograft rejection currently
requires endomyocard ia I biopsy. A non inva s ive technique
to assess the rejection of transplanted organs would
greatly simplify the medical management of the transplant
patient. In vivo P-3l NMR spectroscopy has been
successful in monitoring phosphorous metabolites in
both man and animal models. We have applied this
technique to noninvasively assess cardiac allograft
rejection in a rat model. Brown Norway rat hearts were
placed subcutaneously into the anterior region of the neck
of Lewis recipients. Control isografts employed Lewis
donors and recipients. Transplanted hearts were monitored
using surface coil P-31 NMR spectroscopy (4.7 Tesla) daily
for eight days. Phosphocreat ine to inorganic phosphate
ratios (PCr/Pi) were serially determined throughout the
course of rejection. To allow recovery from surgical
compromise day 2 was used as baseline PCr/Pi. Overall,
seria 1 P-31 spectra of isografts showed either no
significant change (p>.05) or an increase in PCr/Pi
(p< .02), whereas allografts demonstrated a continual
decrease in PCr/Pi. In the allograft group the decrease
in PCr/Pi was not statistically significant at day 3
(p=.25), but was significant by day 4 (p<.04) and at
later days (p<.005). A comparison between isograft and
allograft PCr/Pi showed no significant difference until
day 4 (p< .01). The difference became greater at
subsequent time intervals (p<.003). These data suggest
that in vivo P-3l NMR spectroscopy may offer a noninvasive
method to monitor cardiac allograft rejection.
SPONTANEOUS VARIABILITY OF VENTRICULAR ARRHYTHMIA IN
HYPERTROPHIC CARDICl1YOPATHY
John P. Mulrow, MD, Michael JR Healy, MA, William J.
McKenna, MD. Royal Postgraduate Medical School, London.
Asymptomatic ventricular arrhythmias are canmon in
hypertrophic cardiomyopathy (HCM) and are associated with
sudden death. To assess the variability of premature
ventricular ccxnplexes (PVC) and the duration of ECG
monitorirJIZ necessary to exclude VT, 16 pts with tr;M who
had VT on the firs t 48 hours of ECG moni to ri~ were
studied. They had 48 - 168 hours of ECGmonitoriTl!'
(median 72) off cardiac medication within a one year
period. Daily PVC rates were 2 - 17693 (median 172); 108
episodes of VT (0 - 10, mean 1.5 per day) were recorded.
Logarithmic transformation am analysis of variance were
applied to PVC counts of 10 pts with PVC's duri~ > 18
hours of each 24 hour period. The root mean square
difference in PVC frequencies between correspoming 8 hour
and 24 hour periods was 48% and 38%. A sine curve fi ttal
to these PVC counts revealed a circadian rhythm with a
peak between 23:30 and 02:30 hours in 5 pts and between
12:40 and 17:40 hours in 5 pts. A 73% raluction in mean
PVC frequency on corresponding 8 hour or a 61% raluction
in consecutive 24 hour periods was necessary to attribute
an effect to intervention with 95% confidence. The
likelihood of excludirJIZ VT on K days of ECG monitoring was
detenninal. The prooobility of failing to detect VT was
48% for 24 hours of ECG monitoring, 23% for 48 hours am
11% for 72 hours. We conclUde: In pts wi th tr;M and VT
(1) there is substantial biologic variability for PVC
frequency. (2) A circadian rhythm indicates similar hours
of monitorirJIZ for PVC freauency should be canparal to
assess an intervention effect. (3) 48 - 72 hour ECG can be
used to assess drug therapy for VT while 5-6 days of
monitorirJIZ is required to exclude VT in all pts with ICM.
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PROGNOSTIC SIGNIFICANCE OF MYOFILAMENT LOSS IN PATIENTS
WITH IDIOPATHIC CARDIOMYOPATHY DETERMINED BY ELECTRON
MICROSCOPY. Elizabeth H. Hammond, M.D., Jeffrey L.
Anderson, M.D., F.A.C.C., Ronald L. Menlove, Ph.D.,
University of Utah, LOS Hospital, Salt Lake City, Utah
Light microscopic (LM) analysis of endomyocardial biopsy
samples in idiopathic dilated cardiomyopathy (IDC) has
usually been nonspecific, both diagnostically and prog-
nostically. However, electron microscopy (EM) has been
inadequately explored. We evaluated biopsies from 63
consecutive patients (pts) with clinical features of IDC
by EM and LM. LM findings were nonspecific in 49, and
showed cardiac inflammation in 14. Ten EM indices, po-
tentially useful as predictors of disease severity, were
assessed, including myofilament loss. Myofilament loss
was graded by EM from 0 (none) to 3+ (extensive). EM
findings were correlated with pt survival during a subse-
quent followup interval of 1-48 mo (mean 18.3 mo).
Survival was found to signifiicantly correlate with myo-
filament loss on EM, as shown below (X2=9.3, p<'026).
Myofilament Loss Pt Alive Pt Dead % Mortality
o 20 1 5%
1+ 24 4 14%
2+ 17 9 35%
3+ 2 2 50%
Mortality in pts with 2-3+ myofilament loss was 37% vs 10%
in those with grade 0-1+ loss (p=.05). The sensitivity of
the mortality determination was 0.69, specificity 0.69,
positive predictive value 0.33, and negative predictive
value 0.9. Similar mortality trends were found in sub-
groups of pts both with and without cardiac inflammation,
but were significant only for the latter (larger) sub-
group. In conclusion myofilament loss, graded semiquanti-
tatively by EM, appears to be a significant and clinical-
ly valuable predictor of mortality risk in pts with IDC.
ARRHYTflIoIIA IN CHILDREN AND ADOLESCENTS WITH IlYPERTRJPHIC
CARDICMYOPftTllY: INCIlENCE AND RELATION TO PROGNOSIS.
William J. McKenna, MD, John Deanfield, MB, Rodney
Franldin, MB, Shirley Krikler, Shwghan Dickie, OCR.
Hammersmith Hospital, R.P.M.S., London, U.K.
The annual mortality frOlll sudden death is approximately 5
per cent in children and adolescents wi th hypertrophic
cardiomyopa thy (HCM). Clinical, ECG am hemodynamic
characterisation does not identify those who are at
particular risk. To detel1lline the incidence am relation
of arrhythmia to prognosis we have performed prospective
48 hour ECG monitoring in 36 coreecut ive pa tients wi th
HCM: 3 were infants «1 year), 17 were 1-14 am 16 were 15
to 21 years of age. On the initial 48 hour ECG monitori~
all were in sinus rhythm, none had ventricular tachycardia
(VT), one had more than 250 ventricular extrasystoles per
day, 3 had episodes of sUp"aventricular tachycardia am
another had reentry atrioventricular tachycardia
associated with overt preexci tation. The pa tients were
followed 1-6, median 2 years frOlll the initial 48 hour ECG.
In 12 patients, 23 additional 48 hour FCG's were
performed: two had VT, one developed atrial fibrillation
but no other new arrhythmias were detected. Twenty eight
received beta blockers, 2 had verapamil and the child with
the Wolff-Parkinson-White syndrane had amiodarone. Pour
patients died suddenly, another was resuscitated fran out
of hospital ventricular fibrillation and the only child to
undergo myectomy died post-operatively. None of the
patients who died had arrhythmias during 1-7, median 3
days of ECG monitoring. In contras t to ad ults, arrhythmias
are uncanJllOn in children am adolescents with HeM and are
not a marker of those at particular risk 'of sudden death.
This suggests that in children with HeM the initiatirg
event of sudden dea th is more likel y to be an acut e
hemodynamic alteration than an arrhythmia.
MALIGNANT VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH
IDIOPATHIC CARDIOMYOPATHY
Michael A. Ruder, M.D., Michael Eldar, M.D., Joseph A.
Abbott, M.D~C~John J. Seger, M.D., Melvin M.
Scheinman, M.D., LA.C.C., University of California, San
Francisco, CA.
We evaluated 22 patients (pts) with idiopathic
cardiomyopathy (ICM) and sustained ventricular
tachycardia (vr) (14) or ventricular fibrillation (VF)
(8). Mean age was 56 + 14 years, mean ejection fraction
was 29 + 7 and 36% we;E; in NYHA functional class III or
IV. Programmed ventricular stimulation (PVS) was
performed in 18 of the 22 and replica ted the clinical
arrhythmia in 17 (94%). These pts underwent serial drug
tes ting with conven tiona 1 and experimen ta 1 drugs; those
with persistently inducible arrhythmias were treated
with amiodarone (A). In 4 pts, empiric drug trials were
used because of the almost incessant nature of the
tachycardia. Chronic therapy consisted of A alone (18),
A and mexiletine (1), quinidine (1), bepridil (1) and
lorcainide (1). Over a mean follow-up interval of 17.3
+ 8.0 months, 77% are well, 1 died of CHF, 1 died
suddenly (A) and 1 had recurrent vr (1orcainide). Two
pts discontinued A and died suddenly. Conclusions: 1)
In pts with malignant ventricular arrhythmias and ICM,
PVS is extremely sensitive in replicating the clinical
arrhythmia. 2) Conventional antiarrhythmic therapy is
seldom effective in preventing VT inducibility. 3) A
appears to be highly effective in prevention of VT
recu rrence or sudden dea tho
PROGRAMMED VENTRICULAR STIMULATION IN PATIENTS
WITH DILATED CARDIOMYOPATHY WITHOUT SYMPTOMATIC
ARRHYTHMIAS.
Sunil Dos, M.D., Fred Maady, M.D., F.A.C.C., Laenzo DiCarlo,
M.D., Jeffrey Boerman, M.D., Ryszard Krol, M.D., Michael
DeBuitleir, M.D., Barry Crevey, M.D. University of Michigan,
Ann Arbor, Michigan.
A high incidence of sudden death (SD) in patients with dilated
cardiomyopathy (DCM) coupled with our inability to predict its
occurrence, prompted this prospective study using programmed
ventricular stimulation (PVS). Twenty-two pts, 14 males, 8
females, mean age 40.7 yrs, fulfilling strict criteria for the
diagnosis of DCM without symptomatic arrhythmias underwent
PVS with 1-3 extrastimuli at 2 right ventricular sites, 24-hour
Holter monitor (N=20), rest radionuclide left ventriculography
(RNLVEF, N=22) hemodynamic measurements (N=21), and
myocardial biopsy (N= 16). In 7 pts (Gr I) sustained (4) or non-
sustained (3) ventricular tachycardia was induced. In 15 pts (Gr
II) VT was not induced. No significant differences were noted
between Gr I and Gr II pts in the following parameters: Age: 40.7
vs 40.8; NYHA class: 3 vs 2.9; highest Lown arrhythmia class: 3.3
vs 3.1; RNLVEF: 27.6 vs 22.5; pulmonary capillary wedge
pressure: 14.4 vs 21.2 mm Hgj cardiac index: 2.5 vs 2.4
l/mm/mL.. The degree of histologic fibrosis in the myocardial
biopsy specimens in each group appeared similar. There were 3
SDs over a mean follow up of 8.6 (range 1-19) months, I in Gr I
and 2 in Gr II; I additional death in Gr II was due to congestive
heart failure. Thus, there is no correlation between inducible VT
and other parameters including functional class, arrhythmia class,
hemodynamic, degree of myocardial fibrosis, and incidence of SD
during follow up in pts with DeM. The lack of inducible VT in
these pts without symptomatic arrhythmias does not preclude SD
during follow up.
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Pericardium: Physiology and Pathophysiology
REGIONAL VARIATION IN PERICARDIAL CONTACT PRESSURE.
Brian Hoit, M.D., Wilbur Lew, M.D., F.A.C.C. and Martin
LeWinter, M.D., F.A.C.C., VAMC and Univ of California San
Diego, San Diego, CA.
Based on studies performed with open ended catheters, it
has been assumed that pericardial pressure is uniform over
the surface of the heart. Recently, however, it has been
shown that flat balloons more accurately reflect the peri-
cardial "contact" pressure (PCP) between parietal and
visceral pericardium. Accordingly, we used flat balloons
in eight open chest dogs to determine if there are region-
al variations in PCP. PCP was measured simultaneously at
two non-dependent sites (lateral RV and LV) while cardiac
volume was varied by dextran infusions. Ventricular end-
diastolic PCP (EDPCP) and mean PCP (PCP) at selected mean
left atrial pressures (LAPs) were as follows (mmHg):
LAP EDPCP-LV EDPCP-RV PCP-LV PCP-RV
6±I(SD) -0.4±1.1 -0.8±I.S -O.6±1.4 -1.4±2.0
13±1 4.0±2.0 1.6±1.9 2.S±2.7 O.S±2.S
20±1 9.1±2.4 * 4.3±2.3 6.2±3.S * 1.S±2.4
* LV>RV pressure at p<.OS
These variations in PCP remained after severing the peri-
cardial diaphragmatic attachments or turning the dog such
that one or the other balloon was dependent. To further
delineate the regional distribution of PCP, we positioned
a single balloon sequentially at multiple ventricular
sites. PCP was highest over the posterior and lateral LV,
declined over the anterior LV and septum, and remained low
over the anterior, lateral and posterior RV. We conclude
that in the dog, PCP varies over the surface of the ven-
tricles as cardiac volume increases, being highest over
the lateral and posterior LV. These results suggest that
the influence of the pericardium on ventricular filling is
non-uniform and more complex than previously appreciated.
DOPPLER ECHOCARDIOGRAPHY IN CONSTRICTIVE PERICARDITIS AND
CORRELATION WITH COMPUTED TOMOGRAPHY AND PATHOLOGY.
Natesa Pandian, M.D., Jamil Kirdar, M.D., Jeffrey Isner,
M.D., FACC, Julius Gardin, M.D., FACC, Kevin McInerney,
Marjory Caldeira, David Fulton, M.D., FACC, Liv Hatle,
M.D., FACC. Tufts-New England Medical Center, Boston, MA.
To assess the utility of Doppler echocardiography (DE)
in constrictive pericarditis (CP) we used DE in 8 pts
with clinical and hemodynamic evidence of CP, proven later
by surgery. Morphologic measurements of the excised peri-
cardium were made in all pts. In 6/8 pts, pericardial
thickness was measured by computed tomography (CT) pre-
operatively. From DE mitral flow recordings we obtained
early peak filling velocity (E), late peak fill ing velo-
city (A), E/A ratio, duration of early fill ing and % dia-
stol ic fill ing (%DF) from normal ized diastol ic fill ing
curves. In addition we measured the maximal %6 in velocity
during respiration (Resp %6V). These were compared to data
from 8 normals. Results: (x±SD)
Normals CP p
E m/sec ~ 0.8bI.26 <~05
Am/sec 0.44±.07 0.28±.08 <.05
E/A ratio 1.36±.14 3.0±1.3 <.01
E duration millisec 274±38 183±27 <.01
%DF at 40% diastole 53±4 69±4 <.01
%DF at 50% diastole 58±3 77±6 <.001
%DF at 60% diastole 62±5 85±4 <.001
Resp %6V 16±4 99±67 <.01
DE findings consistent with increased early filling were
present in each pt. CT showed thickened pericardium in all
6 pts who had CT (range 3-7mm). CT measurements were iden-
tical with morphologic measurements. We conclude that DE
can reliably detect the characteristic filling abnormali-
ties in CPo With accurate CT measurement of pericardial
thickness, the combination of DE and CT can provide defi-
nitive non-invasive diagnosis of constrictive pericarditi~
CORONARY ARTERY BLOOD FLOW DURING CARDIAC TAMPONADE IN
THE CONSCIOUS DOG MEETS MYOCARDIAL REQUIREMENTS.
Gregory A. Bernath. M.D., Terrence L. Cogswell, M.D.,
Lawrence E. Boerboom, Ph.D., Donna Peterson, B.S.,
Dennis Janzer, M.S.B.E., H. Sidney Klopfenstein, M.D.,
Ph.D., Medical College of Wisconsin and Zablocki VA
Medical Center, Milwaukee, Wi.
Coronary artery blood flow (CABQ) and left ventricular
external work decrease dramatically during cardiac
tamponade (CT) in conscious and anesthetized dogs. Since
the hemodynamics of CT in anesthetized and recuperating
animals differ from that normally seen, we used
conscious dogs who had completely recovered from surgery
to test the hypothesis that the decline in CABQ during
progressive CT is a result of decreased myocardial
requirements. Seven dogs were used to measure arterial
and coronary venous 02 content, lactate and pyruvate
levels, as well as cardiac output (electromagnetic
flowmeter) and regional myocardial blood flow
(radionuclide - labeled microspheres) during CT induced
by intrapericardial saline infusion.
LV-MV02 LV-CABQ LV Lactatel
(m! Qa/gm/min) (m!/min/gm) endo/epi Pyruyate
Baseline: 1.26±O.1_ 1.26±O.13 1._1±O.09 7.56±0.9
Decamp: 0.7_±p.111 0.53±P.061 1.37±P.09 7.78±1._
Baseline = empty pericardium; Decomp = decline in
mean blood pressure to 70S of baseline level. Means
± S.E.M.; • = P < .05 versus baseline.
The decline in cardiac work during CT is associated with
a decrease in LV-MV02 and despite a reduction in
LV-CABQ, no change in LV endo/epi or coronary venous
lactate/pyruvate ratios. This suggests that the decline
in CABQ seen in conscious dogs during CT is appropriate
to the needs of the myocardium and is not responsible
for the changes observed in cardiac work.
COMPARATIVE EFFECTS OF PERICARDIECTOMY ON LEFT AND RIGHT
VENTRICULAR DIASTOLIC PRESSURE-LENGTH RELATIONS.
Deodato Assanelli, M.D., Wilbur Lew, M.D., F.A.C.C.,
Martin LeWinter, M.D., F.A.C.C. VAMC and Univ of
California San Diego, San Diego, CA.
The pericardium is known to restrain filling in the LV in
the dog, but less is known about its effects on RV fill-
ing. Accordingly, we used sonomicrometers to measure seg-
mental lengths (SL) in the RV inflow (IT) and outflow
tracts (OT) and the LV free wall in six open-chest dogs.
End-diastolic pressure (EDP) was varied with dextran in-
fusions and vena caval occlusions before and after peri-
cardiectomy. RV and LV filling were characterized by lin-
ear fits of In EDP-SL data and determining the slope and
the SL at EDP 1 mmHg. After pericardiectomy, the slope of
the In EDP-SL relationship did not change in the LV, but
decreased in the RV IT (.94±.64[sd] vs .48±.29 mm/mmHg,
p<.02) and RV OT (.93±.48 vS •. 67±.4± mm/mmHg, p NS).
After pericardiectomy, the SL at EDP 1 mmHg increased by
lOt6% (p<.OS) in the LV. but did not change in the RV IT
or OT. In an additional dog, the RV and LV septal-lateral
chord dimensions were measured with similar results, i.e.
after pericardiectomy, the slope of the In EDP-chord di-
mension did not change in the LV but decreased markedly in
the RV. The In EDP-SL data was also used to calculate the
"effective" pericardial pressure over the RV and LV.
Although the "effective" pericardial pressure did not dif-
fer between the RV and LV, the pericardium accounted for
a significantly larger proportion of RVEDP than LVEDP at
EDP above 2-3 mmHg. We conclude that the pericardium has
qualitatively different effects on the RV and LV end-dias-
tolic pressure-length relations and that the pericardium
accounts for a larger proportion of the RV than LV end-
diastolic pressure at all but low cardiac volumes.
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Myocardial Infarction-Experimental: Reperfusion
m!mARY RESERVE AFFEr:TS MYOCARDIAL BIroD F'LCM DISTRI-
oorrrn AFl'ER REPERFUSIrn.
Makoto Akaishi, M.D., William S. Weintraub, M.D.,
~C.~ M:-SChneider, M.D., F.A.C.C., Lloyd W.
Klein, M.D., F.A.C.C., Jai B. Agarwal! M.D., F.A.C.C.,
Richard H. Helfant, M.D., F.A.C.C., Mid-Atlantic Heart
& Vase Institute, Presbyterian-U of PA Med Ctr, Phi-
ladelphia, PA.
To determine the significance of underlyinq coronary
steoosis on lII}'OCardial blood flow (MBF) after total
coronary occlusion (TCD), MBF was measured 30 sec and
30 minutes after reperfusion (Rep) following 15
minutes TCD in OOgs with carotid to left anterior des-
cending coronary arterial cannulation. Group 1 (G-l)
cx:xnprised 6 OOgs with critical coronary stenosis (<D»
with no resting dysfunction, 00 deficit of resting
flow but minimal reactive hyperemia (RH) (35+7%, re-
duced fran 183+59%); group 2 (G-2) cx:xnprisea 5 OOgs
with patent coronary artery (RH=133+31%). MBF(ratio to
oormal zone) before, during TCD -and after Rep (*
p<0.02 vs G-l) :
Pre-TCD TCD 30"_Rep 30'-Rep
Errlo-MBF G-l .94+.09 .05+.01 .50+.08 .43+.22
G-2 1.13+.48 .06+.07 2.07+.86* .94+'24*
EPi-MBF G-l .95+.26 .26+.17 1.7s:l-. 70 •8.fF. 21
G-2 1.05+.22 .27+.18 3.78+T.48* .90+.13
In G-2, post-ischemic hyperemic frow was obServed in
both subendocardium and subepicardium iJrrnediately
after Rep, returning to normal 30 min after Rep. In
G-l subendocardial underperfusion lasted for 30
minutes after Rep. Regional segment shortening
recovered to 54+16% of control at 30 min-Rep in G-2
and 33+27% in G-1:. There was no difference in hem:>-
dynamics between the two groups. Cooclusions: Under-
Ivinq coronary stenosis lim~ting coronary reserve,
without deficit in resting flow and function, induces
prolonged subendocardial underperfusion after Rep.
Patients with underlying stenosis are disposed to
longer ischemia after Rep.
CHRONIC MODIFICATIONS OF DIETARY SODIUM ALTER VENTRICULAR
DILATATION IN RATS WITH MYOCARDIAL INFARCTION. Peter J.
Gaudron, M.D., Janice M. Pfeffer, Ph.D., and Marc A.
Pfeffer, M.D •• Ph.D., F.A.C.C. Brigham and Women's
Hospital, Harvard Medical School, Boston, MA.
Ventricular size is an integral component of ventricular
function and a major prognostic factor for survival in
patients with heart failure. We have observed progressive
ventricular enlargement in rats with moderate and large
experimental myocardial infarctions (MI) even after the
h1stologic resolution of the MI. To determine whether
modifications in dietary sodium intake could alter ven-
tricular enlargement post-MI, sham operated (C) and in-
farcted (20 to 40% of LV circumference) rats were placed
on either a low (L, 0.04%), regular (R, 0.5%), or high
(H, 3.6%) Na diet two weeks post-MI and followed for a
period of 8 additional weeks. Rats were anesthetized with
ether for assessment of hemodynamics and subsequent
passive LV pressure-volume relations. In C rats, Na diets
did not alter hemodynamics or LV size. In contrast, even
though hemodynamics were not altered by diet in MI rats,
LV size (volume index at 5 and 20 mmHg distending
pressure) increased 1n relation to d1etary sodium intake.
n MAP CI LVEDP Vol * Vol *
(mmHg) (ml/kg) (mmHg) (ml/k~) (ml/~B)
L 14 112+4 226+15 9+1 1.23+0.08t 1.89+0.13
R 13 109+5 239+13 7+1 1.44+0.12 2.14+0.15
H 16 105+4 228+12 8+1 1.60+0.10 2.39+0.12
(*variable altered by diet, ANOVA p<0.05-;- t p<0.05 versus
H) •
Thus, this study demonstrates that the process of ventri-
icular d1latation (remodeling) post-MI can be modified by
dietary manipulation. The attenuation of ventricular
dilatation may be a key factor 1n preventin9 late-onset
heart failure post-MI.
PROSTACYCLINE-INDUCED PROTECTION OF ISCHEMIC MYOCARDIUM
IN RABBITS WITH CORONARY ARTERY OCCLUSION-REPERFUSION.
M. Chiariello M.D., F.A.C.C., P. Oolino M.D., M. Cappel-
li-Bigazzi M.D., M. Salvatore M.D., S. Quattrin M.D., P.
Perrone-Filardi M.D. Dept. of Internal Medicine, 2nd
School of Medicine, University of Naples, Italy.
To assess whether prostacycline (P) is able to partially
prevent myocardial damage after coronary artery occlu-
sion (CAO) followed by reperfusion (R), 19 rabbits un-
derwent CAO for 1 hr and reperfusion for 5 hrs. One mi-
nute after CAO, 2X105 99Tc-labeled albumin microspheres
were injected into the left atrium for later assessment
of the hypoperfused zone, (HZ), Le., the area at risk
of infarcting. Fifteen min after CAO, the animals were
randomly assigned to a control (n=9) and a treated group
(n= 10, T) receiving an infusion of a stable analogue of
P, ZK36374, 1.2 meg/kg/min for 6 hrs. Blood samples were
drawn ilnmediately before and 5 hrs after starting the
treatment to measure platelet function. Arterial pressu-
re and ECO (lead aW) were continuosly monitored • At
the end of the experiment, infarct size (IS) was calcu-
lated by planimetry on left ventricular slices stained
by triphenyltetrazolium chloride. HZ was assessed plani-
metrically by autoradiography of the same slices. CAO +
R produced similar HZs in both groups, being 30+3% and
32+4% of left ventricle in C and T, respectively. How-
ever, IS, i.e., the percentage of HZ that actually evol-
ved to necrosis, was dramatically smaller in T than C,
47+4% vs. 98+9% respectively (p .00n. This represents
a 55% salvage of jeopardized tissue. ZK36374 provoked a
complete inhibition of platelet function, as demonstra-
ted by an absolute unresponsiveness of platelets to ag-
gregating agents in vitro but did not change hemodyna-
mics. Thus, ZK36374 protects ischemic myocardium from
reperfusion damage: this beneficial action may be media-
ted by the effect of the drug on platelet function.
PROMPT DETECTION OF MYOCARDIAL REPERFUSION BY ANALYSIS
OF CREATINE KINASE ISOFORMS IN PLASMA
Stephen R. Devr1es, M.D., Burton E. Sobel, M.D.,
F.A.C.C., and Dana R. Abendschein, Ph.D., WaSh1ngtOn
University School of Medicine, St. Louis, Missouri
Myocardium undergoing infarction liberates the tissue
1soform of CK MM isoenzyme (MMA)' To determine whether
sudden washout of MMA reflected by altered plasma CK
isoform profiles is a more sensitive criterion for
early noninvasive detection of reperfusion than conven-
tional enzyme assay, coronary occlusion was induced in
11 conscious dogs, released 2 hr later in 6 dogs, with
reflow verified with a previously implanted Doppler
flow probe. Isoforms were analyzed in serial plasma
samples with a non-denaturing, quantitative, chromato-
focusing procedure developed and validated preiously.
With reperfusion, the percentage of total CK activity
attributable to MMA (MMA%) peaked at 54 ± 6% (SO)
within 30 min (2.5 hr after occlusion). In the absence
of reperfusion, peak MMA% occurred much later (4.8 ±
1.3 hr after occlusion). The rate of increase of plasma
MMA% was ten-fold greater within 30 min after reperfu-
sion (1.28 ± .45% min-I) than in its absence (.12 ±
.03% min-I) (p < .002) an augmentation not depen-
ent on absolute CK actlvity in plasma or infarct size
measured histochemically 24 hr after occlusion (r =
,03). Comparable rates of increase of MMA% occurred in
6 other dogs subjected to reperfusion either 1 hr (n =
3) or 3 hr (n = 3) after coronary occlusion (1.44 ±
.42% min-1 and 1.15 ± .29% min-I). Because reperfusion
elicits rapid rates of increase of MMA% in plasma,
analysis of MMA% in only two blood samples obtained
within 30 min permits prompt, definitive, and nonin-
vasive detection of reperfusion.
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MeLhaniLa1 Thrombolysis in ALute Canine Coronary
Thrombosis. D. Dennis Hansen, David Auth, Rudy VraLko,
James L. RitLhie. Seattle VA Hospital and University of
Washington, Seattle, WA.
Coronary thrombosis preLipitates most aLute myoLardia1
infarLtions. We studied a new thrombeLtomy Latheter
system with a rotating guidewire Lapab1e of lysing aLute
arterial thrombus. The TC Lonsists of an .008 or .006"
diameter wire with a steerab1e .025" diameter platinum
tip. Rotation of the wire (6000 rpm) within the
thrombus entwines fibrin tightly about the shaft,
allowing its withdrawal. Cellular elements are released
into the LirLu1ation and the L10t is effeLtive1y
lysed. In vitro, the rotating Te was passed through
human thrombus in a test tube. EaLh pass removed 22±8
mg of material (n=37), mostly fibrin. Thrombi were
1iquified when 10% of their weight was removed. One
gram of L10t Lou1d be 1iquified with 5.5±.07 (n=4)
passes with the deviLe. PartiL1e sizing of the
1iquified thrombus showed only single red Le11s and
L1umps of red Le11s under 10 miLrons in diameter. In
vivo, aLute Loronary thrombi were produLed in 10 open
Lhest dogs by Lrush arterial injury and injeLtion of
thrombi n. The TC was then passed through the L1ot Wl th
an 8 frenLh angiop1asty introduLer. Initial flow was
restored ina11 Lases with one pass. An average of
2.2±1.4 passes were performed. Fibrin was removed in 7
of the 10 arteri es. Flow was graded by the TIM I sLori ng
system (O=no flow, 3=n1 flow). TIMI grade 3 flow was
aLhieved in 9 of 10 arteries and the residual diameter
stenosis was estimated to be 22±22%. Residual thrombus
was histo10giLa11y present in 80%. One early per-
foration oLLurred.
We Lon1Lude that a new rotational TC Lan easily restore
flow in aLute1y thrombosed Lanine Loronary arteries.
LATE MYOCARDIAL RBPEUUSIOR CAR 11K IIKUFICIAL WIm-
OUT IIiFAll.Cl IlEDUClIOIi. Prasad S. Gadde, M.D., Rita
D.Swinford, B.S., Andrew T. Smyth, B.S., Bennett J.
Shatkin, M.D., Teresa A. Smith, Peter F. Cohn, M.D.,
F.A.C.C., Edward J. Brown, Jr., M.D., F.A.C.C., SUNY
Health Sciences Center, Stony Brook, N.Y.
It is generally believed that to be beneficial,
reperfusion must be performed early enough post in-
farction to salvage ischemic tissue. However, a re-
cent clinical trial demonstrated improved survival
in patients undergoing coronary reperfusion despite
no reduction in infarct size (IS). This improvement
could be explained on the basis of less myocardial
expansion. To investigate this hypothesis, acute dogs
were randomized to 6~ hrs. of left anterior descend-
ing coronary occlusion(C) or 5~ hrs. of occlusion
and 1 hr. reperfusion(R). Pairs of ultrasonic crys-
tals were placed circumferentially in the midmyocar-
dium of the infarct and normal zones. Area at risk
was determined by an injection of thioflavin-S prior
to sacrifice. IS was determined by triphenyltetrazo-
lium chloride incubation and was expressed as a % of
the area at risk. Infarct end diastolic crystal sepa-
ration (EDS) in R (n~4) and C dogs (n=4) is shown and
expressed..~s.a %c~~~ge__~:o~.(reOCClusion EDS, (mean±SEM):2~j~-:~rl\ll~ ',<0.0515 1 **p<O.OOl~ 10 .. (as compared to
.." 05 , I ~1t!r~bR I 15 min. EDS)
1 2' 4 5 6 7 TIME(hrs)
Infarct size was similar in R (90+9%) and C
animals (97+1%). Thus, reperfusion results in a de-
crease in myocardial expansion even when there is no
salvage of myocardial tissue.
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Laser Technology
ESTIMATION OF ARTERIAL WALL THICKNESS AND DETECTION OF
ATHEROSCLEROSIS BY LASER INDUCED ARGON FLUORESCENCE.
Michele Sartori M.D., Philip D. Henry, M.D., F.A.C.C.,
Robert Roberts ~ F.A.C.C. Baylor College of Med-
icine, Houston, TX. Robert P. Chin B.S., Michael J.
Berry P.h.D. Rice University, Houston, TX.
Vascular wall perforation represents t.he main compli-
cation of laser angioplasty, and the detennination of
wall thickness is critically important for the safe
ablation of atherosclerotic lesions. To assess whether
the interaction of laser with arterial tissue provides
information about arterial wall structure including
changes in wall thickness, we determined the argon
fl uorescence spectra of 16 nonna 1 (N) and 17 athero-
scl eroti c segments (A) from human aortas and coronary
arteries. The arterial walls were excited at low power
(100 microwatts) with an argon ion laser at a wave-
length of 45gnm. Three emission peaks (p) were identi-
fied at 530, 550 and 600 nm. The ratio (R) of the peak
at 530nm to the peak at 550nm differed significantly
between N and A, values averagi ng l. 55±0. 27 (SO) and
l.09±0.17 (p<O.OOI). Excluding lesions with a low
R-va1ue «0.9) due to dense calcification there was a
significant negative correlation between R and intimal
thickness measured by light microscopy of frozen
tissue (r=-.747,p<0.001). Thus, in addition to its
ablative properties at high energy, low energy argon
laser may be used to characterize arterial structure.
The recording of argon laser excitation fluorescence
spectra provides infonnation about 1) the thickness of
the normal and atherosclerotic arterial wall, and 2)
the presence or absence of atherosclerotic lesions.
EXCIMER LASERS FOR ANGIOPLASTY: COMPARISON OF KrF AND
XeCl AND MECHANISM OF TISSUE ABLATION
Martin B. Leon, MD, FACC, David J. Underhill, MD, Paul D.
smith. PhD, James R. McDonald, PhD, Stephen E. Epstein,
MD, FACC, Richard E. Clark, MD, FACC, Robert F. Bonner,
PhD, NHLBI, Bethesda, Md.
Although Excimer lasers (Ex) have been shown to produce
efficient tissue ablation without surrounding thermal in-
jury, the mechanisms of ablation and effects of different
wavelengths are poorly understood. Therefore, human cada-
ver coronary arter~es (n=8, target sites=114) were exposed
to KrF(248nm) and XeCl(308nm) in air at varying pulse en-
ergy densities (ED) and power densities (PD). For both
Ex, infrared thermography and ocular micrometry demons-
trate that increasing ED above the ablative threshold pro-
duces linear changes in surface temperature and crater
depth suggesting that tissue cutting is dependent upon li-
near absorption of ultraViolet light by protein and nu-
cleic acids. Eccentric craters with lateral clefts creat-
ed by shock waves from non-lin~ar plasma formation were
observed at higher PD (1 GW/cm ) which is near the dam-
age threshold of commercial fibers. Important differences
were found among Ex; ED, PD, and peak surface temperature
elevations at the ablative2threshold w~re all significant-ly lower with KrF (2 mJ/mm , .O~ OW/em , and 6 C) than
With XeCl (18 mJ/mm , .11 GW/cm , and 12oC). Corres-
pondi~y, ablation efficiency
3
was greater with KrF
(.9mm /J) than with XeCl (.4mm /J). We conclude (1) Ex
ut~lize the strong linear ultraViolet absorption of tissue
for specific and predictable ablative effects, (2) super-
ficial ablation can be achieved with Ex at PD below the
damage threshold of quartz fibers, and (3) KrF is more
efficacious than XeCl due to stronger protein absorption
at 248nm. These stUdies help to clarify the design para-
meters necessary for precise intra-arterial microsurgery.
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CQN'IR)WO ABIATIOO OF ATHEROOCLEROTIC PIAQUE:
EXPERIMmI'AL AND THIDRETICAL LQ3IMETRY
R:lbert M. COthren, M. S., carter Kittrell, Fh.o., R:lbert
L. Willett, M.o., Qjward G. Malk, Ph.o., Corinne
Bott-Silverman, M.o., John R. Kramer, M.o., F.A.C.C.,
Michael S. Feld, Ph. 0., MIT Spectroscopy Laboratory,
Cambridge, MA
Understandirg the laser ablation process is crucial for
establishirg conditions for efficient renoval of
atherosclerotic plaque with minbnal damage to adjacent
tissue. A simple theory of theITDal tissue renoval has
been developed which predicts the steady-state ablation
velocity (v) and tissue tenperature profile as
functions of the thermal tissue properties, penetration
depth (0) of laser light into tissue, and the laser
power (P) and beCIII diameter (d). Both thetmal
diffusion and optical scatterirg are included. Results
were canpared 'with accurate dosimetry studies taken in
f iberous plaque cadaver artery usirg blulHJreen argon
ion laser light. For example, for P=3-l and d=1/4, 1/2,
3/4 and lnm, we find experimentally that V=2.8, 2.7,
1.4 and 0.87 mrv'sec, respectively. Usirg our measured
value of 0"0.38nm and asslJllirg (thermal properties of
water), these results are in good agreement with
theory. The theory can thus be used to predict
ablation velocities at new laser wavelergths and direct
the user to the correct photon dose.
EXCIMER LASER ANGIOPLASTY: OUANTITATIVE
COMPARISON OF ArF.l. KrF & XeF ENERGY ON
NORMAL AND ATHEKOMATOUS TISSUE.
Tim Bowker ¥BpFrank Cross MB. Philip Rumsby PhD,
MaTcOTiif"UljW rhO. Philip Poole-Wilson MD. KIm Fox MD
Stephen Bown MD and Anthony Rickards FACe. •
The National Heart Hospital. London. England.
The risk of vessel perforation in laser angioplasty may be
reduced by the use of pulsed U.v. excimer lasers, whicli destroy
tissue by photo-ablation (a non-thermal mechanIsm of molecular
disruption), without causmg surrounding thermal damage to the
residual non-vaporised arterial wall immediately subjacent to
the laser crater.
To find which u.v. wavelength would be appropriate for the
photo-ablation of atheroma, we quantified the effect of
different energy densities of an excimer laser run at three
different wavelengths - 193nm (ArF), 249nm (KrF) and 351nm
(XeF), on samples of normal ana of atheromatous human post-
mortem aortic wall in which, craters were produced by
delivering a train of 250 20ns pulses of the directly focussed
beam at a repetition rate of 2.5 Hz. The range of energy
densities usea per crater were as follows - 56, SO; 101, 167,
23S, 277, 350 and 555 J/sq.cm at both 193 and 2'19 nm, and 101,
167 277 and 555 J/sq.cm at 351nm. Five craters were made in
both normal and atheromatous samples at each wavelength and at
each power density. A careful record was kept of the energy
parameters used to produce each crater, the depths of which
were then measured to the nearest 10 urn.
At all three wavelengths crater depth was proportional to energy
density, a plateau being reached at 160 J/sq.cm with 351nm, 350
J/SQ,;cm with 249nm ana 270 J/sq.cm with 193nm. The gradient of
the dose-response' relationship was least steep at 351nm
(0.125 um ~enetration per J/sq.cm of energy delivered), steep.cr
at 193nm 0.62 um per J/sq.cm) and steepest at 249nm at which
wavelengt • each energy density consistently Eave greater
penetratIOn into atheromatous tissue than it did into normal
~1.I3um per J(sg.cm & 0.71um per J/sQ.cm respectively). Such an
atheroma-selective effect was not seen at 193 or 351 nm. Indced,
with 249nm. at an ener~ density of 230 J/sq.cm, the gradient
steepened further to 3.09um per JIsq.cm and I.90um per JIsq.cm
for atheromatous and normal tissue respectively. Thus of the
three wavelengths, 249nm (KrF) appears appropriate for laser
angioplasty. and is the pulsed exclmer laser wavelength for whieh
a fjbre-optic intra-coronary delivery system should oe developed.
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Coronary Artery Disease-Clinical
COMBINED INTRACORONARY PROSTAGLANDIN El AND STREPTOKINASE
INFUSION IN ACUTE MYOCARDIAL INFARCTION.
Bim Sharma, M.D., F.A.C.C., Richard P. Wyeth, M.A., Gary
E. Lane, M.D., Horacio J. Gimenez, M.D., Steve W.
Hutchins, M.D., Joseph A. Franciosa, M.D., F.A.C.C., Univ
of Arkansas for Medical Sciences, Little Rock.
Fourteen patients (pts; 13 males, mean 51 + 14 yr) with
acute myocardial infarction (MI) were studied within 5.0
+ 2.2 hr of the onset of chest pain. Ten pts (Gr A) re-
ceived intracoronary (IC) prostaglandin El (PGE1) followed
by IC streptokinase (SK) while four pts who failed to re-
canalize with IC SK were subsequently infused with IC
PGEl (Gr B). In both groups IC SK was infused at a rate
of 4,000 to 10,000 IU/min till thrombolysis occured or a
total of 400,000 IU of SK. Infusion of PGEl began at a
rate of 5 ng/kg/min and was increased by 5 ng/kg/min at
10 min intervals to a Maximum of 20 ng/kg/min or until
angiographic evidence of reperfusion. Prior to therapy
all infarct related vessels were occluded. In both groups
coronary angiography was repeated at 10 min intervals. In
Gr A reperfusion was achieved in all 10 pts while in Gr B
reperfusion occured in 2 of 4 IC SK failures. The total
IC SK dose required for reperfusion was 118,000 ~ 84,000
IU (range 0 to 250,000 IU) in Gr A while in Gr B both pts
were recanalized with 20 ng/kg/min PGEl after failing to
open with 400,000 IU of IC SK. There were no bleeding
complications associated with this combined therapy, but
one pt developed transient hypotension. This preliminary
study indicates such combined therapy, IC PGEl with SK, is
both safe and efficacious. The 100% recanalization rate
when IC PGEl is followed by IC SK is greater than that
reported with SK alone. Intracoronary PGEl merits further
evaluation in acute MI.
SIOOFICANCE <F R)8l' IRH:TION AtG:NA IN PA'l'I1H'S WI'1H
SIllSLE VESS~ DISEASE.
rpyis Gleckcl. M.D., She1Yl WUlkan, M.D., Jerane H.
!fOSs, M.D., F.A.C.C., M:lnty M. eodenheiDer, M,D.,
F.A.C.C. lDPJ Island Jewish Medical center, New Hyde
Park, m.
While the prognosis of patients (pts) with aJ'X,Jina and
single vessel disease (SVD) is cpod, the pr0910sis of
pts unc1etgOing coronaq an;,iognphy for post infaxct
angina (PIA) and found to haw SVD is unclear. All of
40 consecutive pts with SVD (> 70% stenosLs)
catheterized for PIA within 3 IIOS of an MI tere followed
up after a mean of 39 ItOS (rarge 26-51 ItOs). Eight pts
(20%) had sul:8equent ItOrbid events including: 3 d!aths,
1 from heart failure, right coronaq arteq (ICA) lesion
and 2 suddenly, 1 left ~terior descending (lAD) and 1
0; 1 successfully resuscitatEiJ sudcl!n death 0 and 4
nonfatal myocardial infarctJons (MI) (2 lAD, 1 left
circl.1llflex (IQt). 1 0). Of the 4 pta with rECurrent
MI, 3 _re in the same vascular distribution. 1r1other 4
pts had bypass (1 died) and 1 pt had successful P'JX:A.
Of the 32 pta with no ItOrbid events, 12 had lAD, 13 had
ICA and 7 had u:x lesions. IBft ventricular contr«:tion
t.U sewtrely hypokinetic or akinetic in the autserved
zone in 6/8 pta ('75') with ItOrbid events and in 23/32
pts (72\) with no ewnts. 'l'bJs: 1) Angina within 3 DOS
of infarction is associatEiJ with a high ItOrbid event
rate. (2) Neither the coronary \lII!Ssel involved nor the
severity of dyBfunct.ion in the sul:BetVed zone pr8Ucted
out:cal1e. 3) 'lbe beniCJ1 pt'O<JIosis associated with SVD
does not apply to this group and ItOre aggressive ther~
may be warnnte:1.
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IMPAIRED ENDOTHELIAL-DEPENDENT CORONARY DILATION IN
PATIENTS WITH CORONARY ARTERY DISEASE
Paul L. Ludmer, M.D., Andrew P. Selwyn, M.D., FACC,
Richard R. Wayne, Gilbert H. Mudge, M.D., R.Wayne
Alexander, M.D.,FACC, and Peter Ganz, M.D., Brigham &
Women's Hospital and Harvard Medical School, Boston, MA
Endothelial dysfunction underlies atherogenesis. Many
vasodilators including acetylcholine (ACH) relax smooth
muscle indirectly by stimulating the release by endo-
thelium of relaxing factor(s). We tested the hypothesis
that endothelial-dependent vasodilator function is also
impaired in patients with coronary disease. We infuse~9
gr~§ed c~~cent~gtions of ACH (final concentrations 10 ,
10 ,10 ,10 M) and for comparison, nitroglycerin
(TNG), a dilator without endothelial dependence, subse-
lectively in the left anterior descending artery (LAD)
of 7 pts with LAD stenosis and 2 normals. The responses
were evaluated by quantitative coronary angiography with
non-ionic contrast. In multiple segments of 2 normal
coronary arteries, ACH caused a dose-dependent dilation
from 1.62±0.48 mm (control) to 2.20± 0.70 mm (maximal
ACH dose) (p < 0.01). In contrast, all 7 pts with LAD
stenoses showed a dose-dependent constriction to ACH
with temporary complete vessel occlusion in 4. A dose-
dependent constriction to ACH occurred in the presten-
otic coronary segment (1.86±0.25 to 1.06±0.63 mm maximal
response, p < 0.01) and the stenotic coronary segments
(1.01±0.12 to 0.52±0.48 mm, p < 0.01). Subselective LAD
infusion of TNG (50 meg) produced dilation (p < 0.01) in
both normal and stenotic coronary arteries. Thus the
paradoxical constriction by ACH of the atherosclerotic
coronary artery together with the normal response to the
direct smooth muscle dilator TNG implies the loss of
normal endothelial vasodilator function in CAD. This
impairment of endothelium-dependent relaxation may
contribute to inappropriate coronary vasoconstriction.
EMPLOYMENT IN MEN WITH CORONARY DISEASE: EFFECTS OF
DISEASE, PSYCHOLOGIC AND DEMOGRAPHIC FACTORS.
Mark A. Hlatky, M.D., F.A.C.C., Thomas Haney, M.S. P.H.,
John C. Barefoot, Ph.D., David B. Pryor, M.D., Redford B.
Williams, M.D. Duke University Medical Center, Durham,
North Carolina.
To study the relative importance of extent of disease,
psychologic and demographics upon employment in patients
with coronary disease, we examined 818 men below 60 years
of age. Employment status at the time of cardiac
catheterization was related to clinical factors,
psychological test results (Minnesota Multiphasic
Personality Inventory, Zung Depression and Anxiety Scales,
Type A interviews, Jenkin's Activity Survey) and
demographics. StepWise logistic multiple regression
analyses were used to assess the relative importance of
these factors.
Many single factors differed between the 234 (29%) men
who were not working compared with the 584 (61%) who were.
Non-working men had greater extent of disease (more
coronary disease, lower ejection fractions, higher indices
of angina, previous myocardial infarction and co-existing
vascular disease). Non-working men were also more
depressed and anx ious, and had lower ego strength and
hi gher hypochondri as is, but were no different in Type A
behavior. Non-working men were also less educated but no
different in age, or number of dependents.
By multivariable analysis, the most significant
(p<O.Ol) independent predictors of non-working status
were, in order, low education level, history of myocardial
infarction, high levels of depression and high levels of
hypochondri as is. We conclude that psycho1ogi c and soc ia1
factors are strongly related to work status in patients
with coronary disease, and may be more important than
medical factors.
CORONARY ATHEROSCLEROSIS AND PLATELET ACTIVATION IN
ISCHEMIC HEART DISEASE: A NON-QUANTITATIVE LINK.
Raffaele De Caterina, M.D., Paolo Gazzetti, Annamaria
Mazzone, M.D., Mario Marzilli, M.D., and Antonio L'Abbat~
M.D., F.A.C.C., CNR Institute of Clinical Physiology,
Pisa, Italy.
We evaluated the relationship between indexes of in vivo
platelet activation (plasma 8-thromboglobulin (BTG) and
platelet factor 4 (PF4)) in 42 patients (pts) with
Ischemic Heart Disease and 40 controls. pts had one-week
continuous ECG monitoring in absence of therapy, by which
they were diVided into 3 groups: A: active disease (>1
episode/day of spontaneous ischemia, n=9); B: rare
spontaneous ischemia «1 episode/day, n=17); C: inactive
d~sease (n=16). pts underwent 2 baseline blood samplings,
coronary angiography, and 3 samplings while on effective
oral nitrates and calcium antagonists. Compared to
controls, group A pts had higher BTG and PF4 values
(49. 7±9.6 vs. 25.9±6.3 and 8.6±3.1 vs. 4.4±1. 7, ng/ml,
mean±SD, P<.OOI and .05, respectively). Group C pts had
normal values (22.9±8.1 and 4.6±2.8). Group B pts had
intermediate values (29.0±11.2 and 6.0±3.8). The extent of
coronary atherosclerosis (ATS) was similar in group A and
C, however group C pts had a greater prevalence of severe
()90%) stenotic segments (12% vs. 6%). BTG and PF4 in
group A became normal during therapy (29.3±11.1 and
5.5±3.2). We conclude that (I) the activity of the disease
and not the extent or hemodynamic severity of ATS is
pos~tively correlated with platelet activation; (2)
effective medical treatment normalizes platelet function.
CIRCADIAN VARIATION OF SUDDEN CARDIAC DEATH
Paul L. Ludmer. MD, Gail Z. Alymer, James E. Muller, MD,
FACC, Harvard Medical School, Boston, MA
A circadian rhythm (CR) in frequency of onset of
non-fatal myocardial infarction (MI) has recently been
demonstrated with a peak onset from 0600 to 1200 hours,
a period when platelet aggregability (PA) is aho
increased. Sudden cardiac death (SCD) may be caused by
PA which could have led to MI had the patient survived.
We performed a retrospective review of the time of
SCD. Data were compiled from death certificates of a
random sample (n-1063) of the 8223 individuals presumed
to have died from ''MI'' (ICDA Code 1410) in Massachusetts
in 1983. SCD was defined as death occurring without
prodromata or <1 hour after onset of sY18Ptoms. The
percent of deaths during quarters of the day are:
TIME: 0-6 6-12 12-18 18-24 hours
Deaths from
"presumed MI" 22% 30%* 26% 22%
(n = 1063)
Total SCD 22% 31%* 27% 21%
(n - 632)
In hospital SCD 19% 31%* 26% 24%
(n - 245)
Out of hospital SCD 24% 31%* 27% 19%
(n = 387)
* = p < 0.001 vs. mean of other three 6-hour periods
It is unlikely that the CR is an artifact produced
by delayed recognition of SCD during sleep since it was
observed in individuals in whom <1 hour elapsed from
symptom onset to death. Thus, there appears to be a
marked circadian variation in frequency of SCD which
parallels that of MI and PA. If prospective study
confims the existence of this CR, the pathogenesis of
SCD and its relation to MI would be better understood,
and new approaches to prevention could be designed.
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PlASMA CONCENTRATION OF IMl'UNOREACTIVE ATRIAl NATRIURETlC F~CTOR (IR-ANF)
IN PATIENTS WITH CORONARY ARTERY OISEASE
STloon KOllz. M.D., Martl.:!l G. 8ourassa, "".D., F.A.C.C., Jean LaUrli?f, M.Sc.,
Jolanta Gutkowska. Ph.D., Jacques Genest, M.D., Paul R. Davld, M.D •• F.A.C.C.,
Ihor Oyrda. M.D .• F.A.C.C. ,nd M,rc Cannn. M.D .• Ph.D .• Montre,l Heart
Instltute and C11n1ca1 Resparch Institute of Montreal, Montreal t QIJebec. Canada.
To lnvestlgate whether plasma concentrati()ns of U~·Ar'F are lncreased 1"
pat1ents W1 tl'l coronary artery dlsease, dQrtlC bloed samples were obtalned
1n 110 consecutlve patients undergolnq d1agnostic coronary angiol;raphy. IR-
ANF was measured by a spec'f1c radio-lmmunoassay for human plasma (S1ochem.
Blophys. Res. COl1ll .• 1985; 12B: 1350-1357) and expressed as picograms (pg)
per m,l1i1,ter (mll. !R-ANF plasma concentratlons were Slgn,ficantly h'9her
1" 98 patients with coronary artery 01sease ~70~ reductlOn 1n lumen dia-
meter of COI·onary vessels) than 1" 12 subJects wlth atypical chest pal",
normal coronary anatomy and nonnal left ventdcular (lV) functlon (l31±55 vs
102!37 pg/m1. p(O.Ol). In p,t1ents with coronary ,rtery dlSeasE. 5 of 18
basel1ne cJin1ca1 and angl0gl"aph1c variables were associated wlth lncreased
plasma concentratlons of IR·ANF:
No. of IR-ANF p v.lue
pat'ents (pg/ml)
Hypertentlon - No 64 11'lZ481
Yes 34 142'=56-> 0.0329
lVEDPa14 mmHg 53 109"'35)
>14 I1IIH9 45 148~60J 0.0001
EF ~0.50 Bl 119!44 (
<:'0.50 17 164J:l0":' 0.0012
No. dlSeased V150t-l 31 99<31;
2+3 67 154<55)" 0.0001
~o. diseased V~70%-1 51 112"44).
2.3 47 144~55~ 0.0022
EF=eJection fractlon, lVEOP=lV eM diasto11c pressure; 't=vessels; 't-I'I',P::,"
i" S.D.
The stepw1se lOglStlC regrt?sslon a",,~yslS ido:ntlfied multlVessel dlsease
~50% or ~:70: and abnonnal lVEOP as predictors of 1ncreased Dlasl'la IR-ANF"
concentratl0ns (~1l5 pg/ml). W~ coneluce that plasma IR-ANF concentrations
are frequently incl"easesd 1" patlents with coronary artery d'sease anc
~ha:, 1M add1tlon to left ventrl':I.. 1ar d)sfl.nc'tll)n, thl? seventy a"d extent
of coronary disease contnDutes tl) thlS elevat~on.
CIGARETTE SMOKING-INDUCED RELEASE OF e-THROMBOGLOBULIN
FROM PLATELETS IS NOT INHIBITED BY DIPYRIDAMOLE AND
ASPIRIN
James W. Davis, M.D., Charles R. Hartman, M.D., Loretta
Shelton, B.S., and Helen A. Ruttinger, B.S., VAMC,
Kansas City, MO and Univ of Kansas, Kansas City, KS.
Platelet activation seems a likely mediator of the asso-
ciation of cigarette smoking with coronary artery disease
(CAD) morbidity and mortality. The purpose of this study
was to learn whether cigarette smoking caused release of
e-thromboglobulin from platelets of men with CAD and
whether dipyridamole and aspirin prevented release. This
random-order, double-blind crossover study compared the
effects of placebo, dipyridamole, and dipyridamole plus
aspirin on smoking-induced release of e-thromboglobulin.
Each of 12 male habitual smokers with (CAD) took dipyri-
damole 75 mg and aspirin 324 mg, dipyridamole 75 mg and
placebo for aspirin, or a placebo for each drug t.i.d.
for 1 week before each of 3 20-min periods (2 weeks apart)
of smoking 2 Winston King Size cigarettes after 12 hr of
abstinence. During each period there was an increase
(p = 0.02 or less) in the mean plasma concentration of e-
thromboglobulin (determined by radioimmunoassay) of 11 to
23% and nicotine (determined by gas chromatography). Di-
pyridamole alone and in combination with aspirin had no
significant effect on the mean presmoking value of or the
mean smoking-induced change in either variable. After
smoking, correlation coefficients between concentrations
of nicotine and e-thromboglobulin after taking both pla-
cebos, dipyridamole and placebo for aspirin, and dipyri-
damole and aspirin were 0.85 (p < 0.001), 0.60 (p < 0.05)
and 0.96 (p < 0.001) respectively. We conclude that smok-
ing consistently increased the mean plasma concentration
of a platelet-specific a-granule protein and that this
release was not inhibited by dipyridamole and aspirin.
EFFECTS OF SEVERE MYOCARDIAL ISCHEMIA DURING CORONARY
OCCLUSION ON SYNTHESIS OF THROMBOXANE A
2
IN HUMAN CORONARY
CIRCULATION
Shinsuke Nanto, MD. Kazuhisa Kodama. MD. Yoshihiro Kimura.
MD, Masashi Naka, MD, Koichi Tanlura, MD, Tsunehiko
Kuzuya, MD. Michihiko Tada. MD. FACC. Cardlovascular
Division of Osaka Police Hospital. Osaka. Japan
To examine whether the increase in plasma thromboxane
B (TXB) is primary or secondary slgnificance inp~tients2with lshemic heart disease, plasma level of TXB2
in great cardiac vein (GCV) were determ~ned before and
immediately after occlusion of anterior descending
coronary artery with balloon catheter in ten patients who
underwent percutaneous coronary angioplasty. Blood samples
were obtained simultaneously from the artery and the GCV
for determination of lactate and TXB
2
concentration. using
enzymatic method and radioimmunoassay respectively. Efflux
of TX~ was calculated as the product of concentration of
arterio-GCV TXB difference and GCV flow measured by
continuous thefmodilution technique on the seccond
occlusion. One minute occlusion of proximal portlon of
anterior descending coronary artery induced ST-T segment
elevation in chest leads of ECG and marked decrease 1n
lactate extraction ratio(LER). Wh1Ch reveal severe
ischemia in the anterior myocardium. However, plasma TXB
2
level in GCV and TXB
2
efflux did not change as follows.
before after
TXB 2 in GCV (pg/ml plasma) 263 ~ 67 253 ~ 73
TXB 2 efflux (ng/min plasma) 6.7 + 2.6 6.1 + 2.4
LER (%) 23 ~ 19 -10 ~ 9 *
( mean ± SD. *P(O.Ol vs before. LER = ((arterial lactate -
GCV lactate)/arterial lactate) x 100 )
We conclude that TXB
2
is not the secondary substance WhlCh
was induced by myocardial ischemia. but may be primarily
derived from the altered platelet function in patients
with 1schemic heart disease.
A LARGE PEDIGREE WITH MIXED ADVERSE LIPOPROTEIN LEVELS
AND A PREDISPOSITION TO CARDIOVASCULAR DISEASE: BOGALUSA
HEART STUDY.
Peter A. Rosenbaum, Ph.D., Sathanur R. Srinivasan, Ph.D.,
Charles L. Shear, Dr.P.H., Christopher I. Amos, M.S.,
Robert C. Elston, Ph.D., and Gerald S. Berenson, M.D.,
F.A.C.C. National Research and Oemonstratlon Center --
Arteriosclerosis, LSU Medical Center, New Orleans, LA.
Two hundred (121 females, 79 males) living pedigree mem-
bers of a large kindred (N=420) were examined for cardio-
vascular disease (CVD) risk factors and their correlates.
Mixed adverse changes of lipoproteins (LP) were found
consisting of elevated LDL-C and VLDL-C, and low HDL-C
in both sexes, resulting in extremely high LDL-CjHDL-C
ratios. CVD risk factor abnormalities were reported in
nearly 45% of those examined. While over 10% of this
total kindred had a history of myocardial infarction (MI),
only about 3% of screened pedigree members had previous
history of MI. Within this pedigree, 34% of members were
first degree relatives of MI victims. Also, women ap-
peared to be less susceptible to the atherogenic pheno-
type of elevated LDL-C and decreased HDL-C than men, as
evidenced by the absence of LDL-C abnormalities among
men (but not women) living into or past the fifth decade
of life. In addition, increasing levels of LP risk were
found as the degree of genetic relationship increased to
a pedigree member with MI. These data indicate that the
phenotypic effect of elevated LDL-C, VLDL-C and decreased
HDL-C yields persons especially susceptible to CVD (e.g.,
heart, cerebral, kidney. diabetes). Genetic analysis
suggests the possibility of a major gene segregating in
this pedigree to produce this LP phenotype and that it
may be common within families where CVD is aggregating.
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PATIENTS WIll1 SYNffilM: X: EFfECTS CF CCRONAAY DILATCRS ON EXERCISE
CAPACITY AND MYOCAADIAL OXYGEN SUPPLY,
Raffaele Bugiardini, M.D., lbnatella Ferrim, M.D., Marcello Galvani,
M.D., Daniela Tollereto, M.D., JIIldrea Pozzati, M.D., Paolo Puddu, M.D.,
Sergio Lenzi, M.D., Clinica ~ica II, University of Bologna, Italy.
Patients (pts) with effort related angina, angiographically nomal
coronary arteries am no evidence either of epicardial artery spasm or
l1!fOCardial hypertrophy, i.e. pts with syndrare X,have been suggested to
be affected by an inappropriate constriction of coronary resistive
vessels during stress andlor tachycardia. Thus coronary dilation could
result in increased oxygen supply am exercise duration. Jlccordingly 'iI2
assessed the effects of isosorbide dinitrate (ID), verapanil (V) and
iloprost(I),a stable prostacyclin analog,on exercise capacity,coronary
blood fl(J,oJ (CSF) am resistance (CR) in 15 pts with the above set of
findings and exercise stress testing limited by chest pain. Supine
bicycle ergareter testing(25 W increrents every 2 min)was performed
before(control)am during vasodilation lIilich was obtained in 5 pts with
V(lO mg i.v.),in 5 with IDOO mg s.l.)and in the remaining with I (6
nglkg per min for the entire test). Interventions'il2re randanized ir 1
single blind fashion. Coo1Jared to control, V significantly ( p< .001
paired-t-test) prolonged exercise duration (x;tSD: 51O;t74 vs 364:t67 see)
am time to onset of 0.1 mV ST ~ (393±50 vs 237±36 sec). Its
ministration resulted also in increased (p<.OO5) CSF (137±3l vs 95t28
ml/min) and decreased (p<.005) CR (0.86±O.15 vs 1.20±0.24 Il1THg/ml per
min) at peak exercise. Conversely no significant changes in exercise
capacity and coronary harodynffilics 'il2re found following both ID and I.
Thus VilTllroves exercise capacity in patients with syndrare X. Benefits
may be due to increased l1!fOCardial perfUS1on. The lack of efficacy of
other po.o.erful coronary dilators suggests a disregulation of calcium
uptake as the most likely mechan1sm for inappropriate constriction.
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Coronary Artery Disease-Clinical
POST-INFARCTION ANGINA: A HIGH RISK PRESENTATION OF
UNSTA~LE ANGINA
Jose C. Martin, M.D., Robert M. Califf, M.D., Frank E.
Harrell, Ph.D., Daniel B. Mark, M.D., Mark A. Hlatky,
M.D., F.A.C.C., Kerry L. Lee, Ph.D., David B. Pryor, M.D.,
Duke University Medical Center, Durham, N.C.
The prognostic significance of the clinical presentation
was investigated in 559 consecutive patients (pts) under-
going cardiac catheterization during Cardiac Care Unit
admission for unstable angina (UA). Fourteen pts had new
onset «6 weeks) effort angina, 91 had new onset «6
weeks) rest angina, 249 had crescendo angina (acceleration
of chronic angina), and 205 had UA within 6 weeks of a
documented myocardial infarction (post-MI). Baseline
clinical characteristics, results of cardiac catheteriza-
tion, and follow-up were recorded prospectively. Rela-
tionships between baseline characteristics and infarction-
free survival from the time of Cardiac Care Unit admission
were examined using the Cox regression model.
Left main or 3 vessel coronary disease was found 1n 21%
of new onset effort patients, 26% of new onset rest
patients, 38% of crescendo patients and 52% of post-MI
patients (p<.OOI). Median LV ejection fraction was 57%,
63%, 60%, and 49% (p<O.OOI), respectively. Infarction-free
survival probabilities are given below:
1 month 6 months 12 months
New onset effort ~ .73 .73
New onset rest .92 .87 .83
Crescendo .91 .91 .89
Post-MI .81.78 .69
Infarction-free survival was different for post-MI pts
compared to the other groups (p<.OOI). No other sign1fi-
cant differences in infarction-free surv1val were found
among groups. Post-MI UA is associated with more severe
anatomic disease, worse LV function and worse prognosis
than other forms of UA.
PERCUTANEOUS LASER THERMAL ANGIOPLASTY - CLINICAL
EXPERIENCE IN PERIPHERAL ARTERY OCCLUSIONS.
David C. Cumberland, F.R.C.R., Timothy Sanborn, M.D.,
David I. Tayler, M.R.C.P., Thomas J. Ryan, M.D., F.A.C.C.,
Northern General Hospital, Sheffield, England, and
University Hospital, Boston, MA.
Percutaneous angioplasty is only applicable in a limited
number of complete arterial occlusions. To investigate
the role of laser-assisted angioplasty, a metal-tipped
laser fibre (laser probe) was used to traverse complete
arterial occlusions, of length 2 cm to 12 c~in 12
patients having percutaneous femoral angioplasty, with a
mean symptom duration of 22 (range 4-48) months. After
initial probing of the proximal limit of the occlusion
by a guide wire, 3 lesions were classified as potentially
"easy" and 6 probably "difficult" to cross by
conventional means. Previous sustained attempts to cross
3 occlusions (6, 9 and 12 em long) had failed; these
were Classified as "impossible". The probe was applied
using 10 watts Argon laser power for 4 to 20 seconds.
There was one technical failure, probably due to a false
channel produced by the initial guide wire, without
sequelae. All 3 "impossible" occlusions were
successfully traversed. In all 11 successes a
sufficient channel (mean lumen diameter (HLD) 1.27 !
0.326 mm (SD» was produced for subsequent passage of a
balloon catheter for definitive dilatation (HLD 2.89!
0.98 mm (SD». Thus the laser probe can traverse
complete arterial occlusions not amenable to
conventional angioplasty techniques, and produces an
adequate initial channel prior to balloon dilatation.
This has implications for widening the role of
percutaneous angioplasty.
BALLOON ANGIOPLASTY FOR TOTAL CORONARY OCCLUSION NOT
ASSOCIATED WITH EVOLVING MYOCARDIAL INFARCTION
David R. Holmes Jr., M.D., F.A.C.C., Ronald E. Vlietstra,
M.D., F.A.C.C., Guy S. Reeder, M.D., F.A.C.C., John F.
Bresnahan, M.D., F.A.C.C., Jeffrey M. Piehler, M.D., Mayo
Clinic, Rochester, MN.
The role of percutaneous trans luminal coronary
angioplasty (PTCA) in patients (pts) with total coronary
arterial occlusions requires continued evaluation.
Through August 1985, PTCA was attempted in 74 pts with
total coronary occlusion not associated with evolving
acute myocardial infarction (AMI). There were 55 males
and 19 females (mean age 58 years). Twenty-five pts had
a history of AMI within 1 month prior to PTCA. The
occluded vessel was the left anterior descending (LAD) in
41, the right coronary artery (RCA) in 24, and the cir-
cumflex (LCX) in 9. The mean duration of occlusion esti-
mated from the time between a prior angiogram with a high
grade but subtotal stenosis or from the time of onset of
acute symptoms to the time of PTCA was 8.0 weeks. PTCA
was successful in 49 pts (66%). PTCA was successful in
66% LAD, 67% RCA, and 67% LCX occlusions. The duration
of occlusion had a significant impact: of 26 pts with
occlusion estimated to be <1 week, PTCA was successful in
22 (85%); of pts with occl~sions 1 week to <12 weeks,
PTCA was successful in 65%. In the 8 pts wIth occlusions
>12 weeks, PTCA was successful in 2 (25%). During
follow-up, a subset of 26 pts with successful PTCA under-
went angiography; 10 (38%) had restenosis. In 9110, the
artery was patent with a significant stenosis, but not
complete reocclusion. In conclusion, PTCA is effective
for treatment of recent coronary occlusion without asso-
ciated AMI. When the occlusion is <1 week old, PTCA is
successful in 80%. Restenosis rates in this population
appear to be higher than in pts without total occlusion.
212A ABSTRACTS lACC Vol 7. No 2
February 1986.212A
DOES AORTOCORONARY VEIN BYPASS SURGERY RESTORE NORMAL
CORONARY FLOW RESERVE? Robert F. Wilson, MD, Carl W.
White, MD, FACC. CV Center, U of Iowa, Iowa City, IA.
Previous studies employing digital subtraction angiography
or Xenon 133 measurements of coronary flow reserve (CFR)
have suggested that vein bypass surgery (VBS) does not re-
store normal CFR. These studies, however, were hampered
by methodo10gic limitations in measuring CFR, and by
failure to assess abnormalities in the myocardium perfused
by the graft which are known to limit coronary vasodilator
capacity [e.g. hypertrophy (LVH) or infarction (MI)]. To
further investigate this question, we determined CFR using
an extensively validated selective Doppler catheter (DC)
in 11 pts. with 20 vein bypass grafts (VBG) leading to
nonstenotic distal coronary vessels (10 LAD, 5 Cx, 5 RCA).
Twelve VBG perfused normal myocardium (N MYO) and 8 per-
fused abnormal myocardium (ABN MYO; 3 LVH, 5 prior MI).
The DC was positioned in the mid portion of the graft and
CFR measured as the peak/resting velocity ratio following
selective graft injection of a dose of papaverine pre-
viously shown to cause maximal coronary vasodilation.
These results were compared to DC measurements of CFR
obtained in 13 patients with normal coronary arteries and
normal myocardium (N coronary - N MYO) (5 RCA, 4 Cx, 4
LAD) .
Results (mean±SEM): n CFR range
N Coronary (N MYO) 13 5.1±0.6 3.7-8.3
VBG (N MYO) 12 5.2±0.4** 3.7-7.6
VBG (ABN MYO) 8 2.4±0.2* 1.8-3.2
* p<O.Ol vs. NCoronary (N MYO) or VBG (N MYO)
** p=NS vs. NCoronary (N MYO)
Hence, if the myocardium perfused by the graft is abnormal,
then CFR is usually diminished. If the graft perfuses a
nonstenotic coronary vessel and normal myocardium, how-
ever, the VBS does restore normal CFR.
LASER TREATMENT OF ATHEROSCLEROSIS IN THE MONKEY: REENDO-
THELIALIZATION WITHOUT THROMBOSIS EFFECTED BY FIBEROPTIC
METAL CAP.
Jerold H. Theis, DVM, Garrett Lee, M.D., Ming C. Chan,
M.D., Richard M. Ikeda, M.D., Marshall H. Lee, M.D., John
L. Rink, Eugene P. Steffey, DVM, William P. Thomas, B.S.,
and Dean T. Mason, M.D., F.A.C.C., University of Cali-
fornia, Davis, California.
To study the acute and chronic effects of laser application
to atherosclerotic plaques, four 15-year-01d monkeys
(Macaca Mu1ata), 5.4 to 9.3 kg, fed an atherogenic diet for
7-8 years were used. Following persantine 50 mg bid for
72 hours, anesthesia was performed with Ketamine 5 mg/kg 1M
and Isof1urance. Angiography showed moderate to extensive
mural plaques in abdominal aorta and iliac arteries. Via
a 3.7 mm diameter fiberoptic scope, a metal cautery cap-
tipped laser fiber was guided to plaque sites for laser
application of energies from 1.5 to 9 joules. No effect
was seen at 1.5 to 2 joules applied perpendicularly, but
3 to 6 joules applied tangentially produced superficial
burn. Six joules applied perpendicularly produced burn
into vasavasorum and 9 joules applied tangentially produced
burn into tunica media. Three months post-treatment with
9 joules, the lased area had healed without thinning of the
vessel wall. Thromboses of the vessel at site of laser
treatment did not occur. These experiments show angle of
application of cautery cap influences depth of burn; re-
endothe1ia1ized scar post-laser treatment does not result
in aneurysm formation provided burn depth is controlled.
INTRAVENOUS DIPYRIDAMOLE IN DETECTING CORONARY STENOSIS.
ASSESSMENT BY TWO-DIMENSIONAL ECHOCARDIOGRAPHY AND RA-
DIONUCLIDE ANGIOGRAPHY.
Ciro Indolfi M.D., Gabriella Giustino M.D.,Federico Pi-
scione M.D., Sandro Betocchi M.D., Marco Salvatore M.D.,
Paolo Golino M.D., Massimo Chiariello M.D.,F.A.C.C. De-
partment of Internal Medicine, 2nd School of Medicine,
University of Naples, Italy.
Dipyridamole-induced vasodilation may contribute in i-
dentifying patients with coronary artery stenosis (CAD).
Thus, in 22 patients with documented coronary artery
stenosis by selective coronary arteriography without
myocardial infarction (age 55+8), and 21 age matched
controls without CAD, two-dimensional echoes were obtai-
ned under basal conditions and after dipyridamole (0.75
mg/kg i.v.). Percent ejection fraction (EF) and wall mo-
tion score index (WMSI) were calculated. In the same
sUbjects, radionuclide angiography was also performed in
different day before and after dipyridamole. In con-
troIs, EF measured by two-dimensional echocardiography,
rose after dipyridamole from 58+8 to 76+8 (p « .on, whe-
reas in CAD patients it decrease frciii 51+ 11 to 42+ 10
(p < .05). Similary WMSI in CAD patients decrease from
0.8 and basal conditions, to 0.6 after dipyridamole
(p <.01). EF measued by radionuclide angiography increa-
sed with dipyridamole from 54+15 to 42+12 (p < .01) in
CAD patients. A close correlation was found between EF
changes measured with two-dimensional echocardiography
and radionuclide angiography (r=0.86, p< .on. Thus, in
CAD patients dipyridamole reduces EF and WMSI probably
by inducing coronary steal; these changes are detectable
both by two-dimensional echocardiography and radionucli-
de angiography.
CORONARY FLOW RESERVE LATE AFTER PTCA - DO THE EARLY
ALTERATIONS PERSIST? Robert F. Wilson, MD, Philip E.
Aylward, MD, Wayne N. Leimbach, MD, Charlotte L. Ta1man,RN
Carl W. White, MD, FACC. CV CTR., U of lA, Iowa City, IA.
We have recently shown that quantitative measurements of
coronary artery stenosis (CAS) [percent area stenosis
(%AS) and minimum lumenal cross-sectional area (mCSA)
measured using Brown/Dodge quantitative coronary angio-
graphy (QCA)] correlate highly with measurements of coro-
nary flow reserve (CFR) obtained using a 3 Fr. coronary
Doppler catheter (CDC) and maximally vasodi1ating doses of
intracoronary papaverine (P). We have also shown that
immediately following successful PTCA, coronary flow re-
serve remains depressed in some patients and that neither
quantitative measurements of lumenal stenosis nor the
trans1esiona1 pressure gradient correlates with CFR. To
determine if this dissociation beteween lesion severity
and coronary flow reserve persists, we studied 17 patients
5.4±.6 months following PTCA. Angiograms of the dilated
vessel were obtained in orthogonal projections and ana-
lyzed using QCA. A CDC was placed proximal to the lesion
and CFR measured using P. CFR by this technique in normal
vessels is >3.7 peak/resting velocity (mean±SEM, 5.1±0.6).
In patients with <70 %AS immediately after PTCA, 8/16 had
low CFR «3.5). In contrast, all patients studied late
after PTCA or without PTCA had normal CFR if %AS was <70
(p<O.Ol). CAS-No PTCA PTCA-ear1y PTCA-1ate
Correlation (r value) (n=24) (n=19) (n=17)
%AS vs. CFR 0.82 0.11 0.83
mCSA vs CFR 0.70 0.10 0.72
Hence, in contrast to lesions studied immediately after
PTCA, lumen stenosis measured precisely with QCA corre-
lates highly with coronary flow reserve both before and
late following PTCA. These results suggest that the dis-
sociation between lesion stenosis and CFR measured im-
mediately after PTCA does not persist.
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ImlIBITIOO OF 5.Lcr-lABELLED PIATEl.ET ACaMJIATIOO
AFl'ER BALI.<:nl AOOIOPlASlY IN RABBITS: <noIPARISCN OF
HEPARIN, ASPIRIN, AND 03S 13080, A SELEX:TIVE 'lliRCMOOXANE
SYNl'HEl'ASE ImuBITOR.
Tinothy A. sanborn, M.D., Lynanne M. Ball~li.' B.S.,
David P. Faxoo, M.D., F.A.C.C., O1nstlan C.
Haudenschild, M.D., C. R:lbert Valeri, M.D., 'lbaDas J.
Ryan, M.D., F.A.C.C., Bostal University Medical center,
Bostal, Massachusetts.
Despite pretreatment with antiplatelet and anticoagulant
agents, platelet aCCUDlllatim (pL'r-A) may be respa1Sible
for the restenoeis ~ich ClCIIplicates ballom angiqllasty
(Mo) • By inhibitirJ3 thranboxane A2 but oot
prostacyclin proouctim a selective thranbo~
synthetase inhibitor, 03S 13080, may be lIDre effectlve
in inhibitirJ3 PLT-A after Mo. Therefore, 5lcr-platelet
accUllll1atim was quantitated 30 minutes after successful
BF\ in a total of 70 significant ra1:X>it iliac stenoses
pretreated with the folloorJ3 regimens:Gr~ n PLT x L06/em (x + SO)
*p < 0.02 vs. omtrol
Thus, 03S 13080 significantly reduced PLT-A while
heparin and aspirin treatment did oot. The variability
in neointimal dissectim ooted m histologic examinatim
a<:lCOIIDtEd for the high standard deviatim ootEd in each
group.
In this experimental DDiel, a selective thranboxane
synthetase inhibitor is lIDre effective than heparin. or
aspirin in inhibitirJ3 PLT-A after Mo. Further Studles
to evaluate the effectiveness of thranboxane synthetase
inhibitors m restenoeis are warrantEd.
THALLIUM-201 SINGLE PHOTON EMISSION TOMOGRAPHY USING
ORAL DIPYRIDAMOLE IN THE ASSESSMENT OF CORONARY STENOSIS
IN PATIENTS UNDERGOING CORONAPY ANGIOPLASTY.
Avanindra Jain, M.D., John J. Mahmarian, M.D., Albert E.
Ralzner. M.D., F.A.C.C., John M. Lewis, M.D., F.A.C.C.,
Robert Roberts, M.D., F.A.C.C., Mario S. Verani, M.D.,
F.A.C.C. The Methodist Hospital, Baylor College of
Medicine, Houston, TX.
Objective assessment of the significance of coronary ar-
tery stenosis in patients being evaluated for coronary
angioplasty (PTeA) by traditional stress testin~ is ham-
pered by inadequate exercise performance and/or use of
cardiac medications. We evaluated oral dipyridamole
(30Omg) combined with thallium (Tl)-201 single photon e-
mission computerized tomography (SPECT) in 16 patients
pre- and 3 days post-PTCA. Cardiac medications were not
discontinued. Three mCi of Tl-201 were injected at on-
set of angina and ischemic ECG changes (4 patients) or 1
hour after dipyridamole (12 patients). Transaxial tomo-
graphic imag~s were obtained over an arc of 1800 and re-
oriented in the short axis. horizontal long axis and sa-
gittal axis. Planar images were obtained using standard
techniques. Ischemia was present in th~ areas supplied
by the stenosed vessel in 14 patients by tomography and
in only 8 patients by planar imaging. PTCA reduced the
mean cross-sectional area stenosis from 90% to 35%. All
patients but 2 had negative tomographic scans after suc-
cessful PTCA. SPECT in conjunction with oral dipyrida-
mole demonstrated hemodynamically significant coronary
stenosis in larger percentage of patients then planar
images (89% vs 50%). Thus. dipyridamole Tl-?Ol tomogra-
phy provides a safe and sensitive means of evaluating
the hemodynami'c significance of coronary stenosis and in
PTCA patients it affords early objective documentation
of the adequacy of dilatation without requiring exercise
or withdrawal of medications.
Rotating MeLhaniLal Angioplasty in AtherosLlerotiL IliaL
Arteries in Rabbits. D. Dennis Hansen. David Auth, Rudy
VraLko, James L. RitLhie. Seattle VA Hospital and
University of Washington, Seattle, WA.
PerLutaneous transluminal Loronary angioplasty is
unsuLLessful in 10% of Lases and restenosis OLLurs in up
to 30%. We are studying a new, rotating, ablation tip
athereLtomy deviLe (AD) Lapable of opening narrowed
atherosLlerotiL arteries. The AD Lonsists of a .042
inLh diameter, rapidly rotating ablative tip with a .005
inLh radiopaque Lentral guidewire. The guidewire Lan be
steered independently aLross a narrowed or obstruLted
arterial segment. It then serves as a rail over whiLh
the rotating, miLro disseLting tip of the AO Lan be
safely advanLed. We fed 18 rabbits a 2% Lholesterol
diet for 10 weeks. After the first 14 days of the diet,
we disrupted the intima of the right il iaL artery by
repetitive passes with an inflated Fogarty Latheter.
Cholesterol levels at this time ranged from 1600 to 3600
mg%. After the final 8 weeks of the diet, Lontrast
angi ography was performed. Si x rabbits had developed
angiographiL stenosis, four had greater than 80%
narrowing. and 2 had Lomplete oLLlusion. The guidewire
was first passed and was followed by the rotating
disseLtion head. In all Lases, angiograms demonstrated
a new lumen equal to the size of the rotating deviLe.
One perforation was seen in an oLLl uded artery.
Histology of the exLised arteries demonstrated severe
atherosLlerosis.
We LonLlude that a rotating, miLro disseLtion Latheter
Lan open narrowed or bloLked atherosLlerotiL arteries in
rabbits. This approaLh provides a direLt and easily
performed alternative to laser ablation.
TAIID£n BAlLOON CATHETER FOR COROllARY AIIIIOPLASTY.
Bernlwd Meier. M.D., Leo Finel, M.D., e1l1SllPPI Sterfenino, M.D., Wilhelm
Rutishuer, M.D., FAC.C., CardlolOlW Center, UniY8l"Sity Hospital, aeneve,
SWIt2llrlend.
The t8ndIlm balloon ClIlheter Is II trlpllllumen steerllble catheter for COl"OnlIrY
engiap1llsty with 2 3llI)ntaly Innlllllb1e balloons mauntlld lit the tip. The
dillllltt8r or the distill balloon Is smllll.. then the dillllMlter or the praxlmlll one.
IndiCllllons lIIld results or 26 lXIIlSIlCutlve plltlents (pts)t~ with II t8ndIlm
balloon clItheter lII'8 reviewed.
The balloon dillllleters or 24 tandem clItheters _ were 2.0/3.0 mm. The
remlllning 2 clIthetars !led dillllleters or 2.5/3.4 mm. The length or lIlI:tl balloon
is 20 mm. AdIqulIte distill pr8Ure 11I...-..n8llta were obtellBl in 711 or the
CBS. In 10 pts the t8ndIlm balloon WIll cIDIlIn beclIUge or 2 or more stenoses
In different Sl9lIents or the SlIIIlll OOI'OIWY III"tery. AngIopIesty WIll successful
for 1I11I.ions In 5 pta lIld for lit 1elIst the strlIteQIc lesions in 5 pis. In I pt or
the letter IrOUP. the t8ndIlm balloon ClIth8ter !led to ba rep1lllllld IlV II single
balloon ClIth8tlIr to aua:lIlld. In 7 pts the t8ndIlm balloon WIll cIelIn to dilllte
stenoses In 2 different COI'OIIlII'y III"terl. or di8plll"llte ClIlibllrs. Angiop1esty
WIll SlmlSSful for both YeS8lIls In 3 lIIld for 1 VlIS8lII In 4 pta. In 6 pta the
t8ndIlm balloon WIll cIelIn for II VfIfY t1~ stenosis lIld In 3 pts for II totel
oa:lusion in the hope thllt the rigidity or the triple lumen shlIft would fs:i1itllte
the pessing or the obstruction lIld II predl1etlItion with the lIIIlIIIl balloon would
IIllow for _ PIB8lIlJlt or the IlIf"98 balloon. In 1111 6 tllIlt stenoses the procedure
WIll SlmlSSfu1. In I pt, hoWeYer. whlll"e the t8ndIlm balloon ClIlheter !led been
uaed lifter en ullSUCCllllSfulllttampt with a low profile slngla balloon ClIlhetar ,
myocardial inflll"Ctlon oa:ured within 24 hours lifter engIop1esty suggesting
lDIte VlIS8lI1 oa:lusion. Of the 3 totel oa:lusions only I a1Uld be pesslld lIIld
8UCOlIlI8fuily dilllt8d. In 1of the 2 fllilures 81Y81'1I1 other balloon ClIlhetllrs were
IIlso tried to no mil.
The tandem balloon clItheter provldlls II henctt' tool for aJIIlPIIlK OOI'OIWY
lIIlgiopll8ty. It offers aJIIlperllble .. in menipullltion lIld pressure
trllllSlllltSlon lIld mil'( SlIYe time. oost, lIld rdlltlon lIlCposure IlV avoiding
ClIth8tlIr IIKchlIngIls.
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Coronary Artery Disease-Clinical
* P<.05 vs R; § P<.05 vs C
Dur1ng EX, MVOP increased from 17 to 39 mmHg(P<.05) in CA~
Of 26 nIR, RPFR increased in 25(96%) regions and Ae in-
creased in 24(92%) regions during Ex. Of 54 IR, RPFR also
increased in 23(43%) regions and Ae increased in 17(31%)
reg10ns during Ex. Reflecting regional filling dynamics,
GPFR increased in 21(95%) CAD pts during EX, although EF
decreased 1n all pts. During Ex, GPFR increases in CAD as
in C, due to an increased driving P(tMVOP). Thus, GPFR is
not a sensitive index for detecting pts with CAD.
IS DIASTOLIC PEAK FILLING RATE DURING EXERCISE A SENSITIVE
INDEX TO DETECT PATIENTS WITH CORONARY ARTERY DISEASE?
Tomoyuki Murakami, MD, Otto M. Hess, MD, John D. Carroll,
MD, Hans P. Krayenbuehl, MD. University Hospital, Zurich,
Switzerland
Radionuclide stUdies have shown that diastolic peak fill-
ing rate (PFR) during exercise(Ex) is more sensitive than
ejection fraction(EF) to detect patients (pts) with CAD.
To evaluate this concept, we used biplane angios and
micromanometry and assessed global and regional diastolic
filling dynamics at rest(R) and during supine bicycle Ex
in 22 pts with CAD and Ex-induced asynergy, and in 10 con-
trols(C). Time-volume curves from biplane angios and time
-area curves for 6 regions of the RAO angio were con-
structed. Normal limits of regional EF(REF) were deter-
mined from C. Of 132 regions in CAD 26 were normokinetic
at R and during Ex, with an increase in REF during Ex(non-
ischemic regions:nIR) and 54 were normokinetic at R but
hypokinetic during Ex(ischemic regions:IR). Global EF(%),
global PFR(GPFR;ml/s), regional PFR (RPFR; cm2/s) , the early
diastolic area increase from mitral valve opening(MVO) to
the lowest pressure(P) (Ae;cm2), and P at MVO(MVOP;mmHg)
were determined.
IV
108
21%t
96%*
79%**
68%*
UNlERlJITLrzATICN OF CLINICAL r.v.TA LEADS 10 <NERlJl'ILIZATICN OF
TEXlNJI.(X;Y•
Richard M. Stei!Eart, M.D., Sylvia Wassertheil-SIDJller, Ph.D.,
Join \Exler, Ph.D., M.D., Nancy &Jdner, M.P .H., Jonathan Tobin, M.A.,
Joseph Wachspress, M.D., Uoyd tense, M.D. Albert Einstein College of
/otrlic:lre, Bronx, NoY.
At our hospitals, clinicians use nuclear exercise tests to evaluate
virtually all pts with suspected or proven coronary disease (CAD). Since
the proper selection of noninvasive tests is critically depen:lent on the
pts likelibJod for CAD, which in turn is deperrlent on the history for
~ina "'" prospectively asked all physicians (IDs) wOO referred out-pts
for mclear exercise tests about their pts~ history. Ie also asked
if they tlrJught their pts bOO CAD & whether they "",re trest~ for CAD.
Their pts "",re then interviewed by project cardiologists wOO obta:lred
the history for~ usi!E Coronary Artery Surgery Stu:!y gu!del:lres.
This history was used with pt age & gender to create categories of CAD
likelihood: GP I, CAD likelihood <ll%;GP II, CAD likelihood >10% <91%;
GP III, CAD likelihood >90%. Pts with prior MI, N=66, or CAD at
~iography, No42, are GP IV. M) d:iagooses & plans for GPS I-IV are
shol.n.
M) RF.SIWSE GP
I II III
N 58 156 56
IEFINI1E Al'{;INA 2% 15%t 18%t
CAD I'RESrnl' 45% 53% 45%
ANl'It\N:;INAL RX 50% 67% 69%
PIAN Al'{;I<GW'HY 33% 37% 41%
* p<.D01, ** p<.05 vs CPS I-III. t = p<.025 vs GP I.
M) rarely tlrJught that their pts bOO definite~ (especially GP I
pts), but still d:I.agrosed CAD & treated as if CAD was present. FUrther,
both M) cililgnosis of CAD and RX ""'re :lnleperrlent of the pretest likeli-
hood for CAD, differiIE only for pts with proven disease. Thus M)
decision making is mt explained by the history they elicit for ~,
mr by disease likelihood based on a standardized history, gender & age.
It appears that clinical data are m:lerutilized, leatlng to the
OIIerutilization of therapy & testi!E procedures.
26/23*
1.2/0.8*
IR(n=54)
RPFR(R!Ex) 23/37*
Ae 1.2/1.8*
nIR(n=26)C CAD
EF(R/EX) 63/67* 62/50*§
GPFR 565/928* 631/891*
CORONARY VASOMOTOR RESPONSE TO ISOMETRIC EXERCISE IN
PATIENTS WITH AND WITHOUT SIGNIFICANT CORONARY ARTERY
STENOSES. Rodney L. Henry, ~ID, John T. Miller, MD, Morton
J. Kern, MD, FACC and Robert A. O'Rourke, MD, FACC.
University of Texas Health Science Center and VA Hospital
San Antonio, TX.
A recent study reported constriction of epicardial
stenoses in response to isometric handgrip (HG) exercise
with an estimated 243% increase(t) in angiographic sten-
otic flow resistance (R). To examine the effect of this
response on directly measured coronary R, we studied 19
patients (pts) by measuring total coronary sinus flow(CSF)
and great vein flow (GVF) at control (C), during HG,
during intracoronary nitroglycerin (ICNTG), and during HG
+ ICNTG. 9 pts had no significant left anterior descending
(LAD) stenosis (gr 1) and 10 pts had >70% LAD stenosis (gr
2). C-CSF averaged 104±5 ml/min, C-GVF 66±4, C-MAP 98±3
mmHg and C-HR 62±2 with no difference between groups. Peak
responses vs C are as follows: *p<.05 vs C,± = lSE
Intervention %6CSF %6GVF %6CSR %6GVR %6MAP %6HR
HG Gr 1 +14±13 +19±7 +10±14 +6±7 +15±2* +IO±2*
Gr 2 +13±7 +17±8 +11±7 +6±6 +20±3* +11±2*
NTG Gr 1 +74±13* +72±1* -43±3* -42±4* -2±2 +2±1
Gr 2 +53±8* +35±5* -35±4* -28±2* -5±2 +l±l
HG+ Gr 1 +59±16* +72±7* -24±7* -33±4* +12±2* +11±2*
NTG Gr 2 +76±11* +60±11* -32±5* -25±6* +16±3* +11±2*
Both groups had a small t in CSF, GVF, CSR, and GVR, and a
significant t in mean arterial pressure (MAP) and HR with
HG. HG did not change the CSF or CSR response to ICNTG in
either group. The GVF and GVR response to ICNTG was un-
changed by HG for gr 1. Gr 2 had a greater t in GVF with
ICNTG+HG compared to C due to t MAP with HG and no change
in the GVR response. We conclude: 1. HG causes an insig-
nificant t in measured CSR and GVR; with no greater t in
GVR in pts with LAD stenoses. 2. HG does not blunt the
hyperemic response to ICNTG in pts with or without CAD.
VARIABILTIY <F llINL'lS IJI{IR; RH'AT EXEH:lS!: 'n'Sl'IIG IN STAII.E mmr
AlCINA R!X:'ItJUS: A am ID m;: PII9XE <F JMWUC CIJIH\RY SI»IEI;S.
FiliWO Crea, M), Alberto l\t3rgcrlato, MJ, Juan C Kaski, MJ, lW.s
Rodriguez-Plaza, MJ, sergio Chiercllla, MJ, Grahan J Davies, MRCP,
Attilio Maseri, MD, FPaC. RFM3, ItJrmersmth Ibspital, Larln, UK.
Patienta (pta) with stable effort angma (FA) often report a
lustory of vanable effort tolerance. TIns stllqy was mmed at assessmg
IAhether qynanic oorcnary stencses(lXS) can acc<U1t for a vanable
exernse capacity. 3) pta Wlth FA and corenary heart disease (CAD) were
studied. In 10 of these pta (Grc::4J A) the possib1lity of develq:>mg lXS
was indicated by a pooitive result of ergroav:me testmg (>0.1 mV ST
depressim EI1d angma) not preceded by obvlaJS increases of heart
rate-blood pressure prod1ct (RPP). In 4 pta of this grrup v.ro underwent
ergmovine testmg also durmg angiograp-ly, ergmovine caused an
increase of the severity of corenary stencses follCMed by dlagnstic
ischanic ECG changes and angina. The rereJrung 10 pta (Grc::4J B) v.ro had
sJ1l1llar syrrptars and severity of CAD but a negative result of
ergonovine testing (neither ST shifta nor ang:ma) were U3ed as cmtrol
grrup. All pta underwent 2 lIpn!?J'1t syrrptcm-liJTuted treadnill exercl6e
testa in the rronu.ng m different days during l2-lead ECG and blood
pressure (cuff) I101itonng; the interval between the 2 testa never
exceded 2 weeks. In eoch pt grrup for eoch exercl6e paraneter,
vanabillty was calculated as mean + lSD of the absolute differences
between the values during the 2~ testa. Var1abillty of heart
rate and RPP at 0.1 mV ST clepressim and variability of RPP at mset
of angina were slgplf1cantly Iugj1er in Grcql A than in Grcql B (12 + 4
vs 4 + 4 tpn p< 0.001, 3,3f() + l,!U) vs 93) + 900 tpnxrmtlg p < 0.005
and 3-;88J + 2,400 vs 1,43::> +1,a:xJ tpnxrmtlg - P < O.04,respectlvely).
Variablllty-of time to 0.1 mV-ST depressim, mset of angma and peak
exercise was 1ugj1er ill Grcql A than ill Grcql B, but this difference dld
not achieve statistical sigj1if1cance. Thus, the var1ability of resulta
durmg repeat exercise testing, 1S 1ugj1er in th:lSe pta with stable
effort angma v.ro develq:> OCS in respmse to ergrooville testmg. In
these pta OCS sean to rrodllate the respmse to exercise and ca.l1d
acCCU1t for a lustory of var1able effort tolerance.
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AFTER DIPYRIDAMOLE
REDUCED CORONARY
DYSFUNCTION
OF REGIONALLY
MYOCARDIAL
AN INDEX
A1m of th1s study w~s to test the hypothes1s whether the
mech~n1c~1 beh~v10ur of the LV ~fter d1pyr1d~mole (DIP)
reflects better the phYS1olog1c~1 consequences of the
coron~ry stenoS1S r~ther th~n its ~ng1ogr~ph1c sever1ty,
In 19 p~t1ents w1th severe (80-99%) proximal 1solated
stenos1s of Left Anter10r Descend1ng Artery (LAO) ~nd 1n
10 controls, reg10n~1 coronary reserve was ev~luated
me~sur1ng coronary S1nUS blood flow (CF) ~fter DIP
infuS10n (0,56 mg/Kg 1n 4 m1nutes) by posit10ning 1nto
the gre~t c~rd1~c ve1n the distal therm1stor of a 3
therm1stor thermod1lutlon catheter, reg10nal
contract111ty was evaluated by means of cont1nuous 2-D
echo mon1tor1ng, Accord1ng to the result of the echo
mon1tor1ng, fOllow1ng DIP the 19 pat1ents were d1v1ded
In ~ groups IA) w1th tr~nslent reg10nal asynergy 1n the
LAD tel'l'1tory (anteroseptal wall and/or ape:'), Ie.)
w1thout reg10nal asynergy, No one of the controls (group
II) showed reg10nal asynergy. No s1gn1f1cant d1fference
was present 1n the ang10graph1c severity - evaluated by
quant1tat1ve analys1s and expressed as % lumen reduct10n
- of the LAD stenos1s between groups IA and IB (89 ,9!
6,3% vs 88.1 ! 7,0%), The 1n,:rease of ar,tenor CF 1n
group IB (136 ± 45%, me~n + SO) w~s s1m11~r to group II
1166 ± 68%, P = ns), but 1t was sign1f1cantly lower 1n
group IA (46 ± ~9%, p ( 0.01 vs group IB and II), In
conclus10n, the mechan1cal behav10ur of the LV after DIP
reflects better the phys1010g1c~1 consequences of the
stenoS1S than 1ts ~ng10graph1c sever1ty.
TRANSIENT
INFUSION
RESERVE.
EugeniO Plc~no MD, Ign~zlo Simonetti MD, Michele M~sinl
MD, F~bIO L~tt~nzl MD, M~rlO M~rzlill MD, Aless~ndro
Dist~nte MD, Anton10 L'Abb~te MD FACC, C.N,R., Cl1n1c~1
Phys1010gy Inst1tute, Un1vers1ty of P1S~, ITALY,
LOW-DOSE ORAL DIPYRIDAMOLE PRODUCES CORONARY BLOOD FLOW
REDISTRIBUTION ON THALLIUM-201 MYOCARDIAL IMAGING IN
PATIENTS WITH CORONARY ARTERY DISEASE. A.T.Jakubowski MD~
V.F.Huckell MD, FACC, J.A.Cooper RN, D.M~Lyster-PhD;---­
T.K.Maybee MD, P.D.Fry MD, I.J.Szasz MD, M.A.Stewart RTNM
University of British Columbia and Vancouver General
Hospital, Vancouver, B.C. Canada.
It has been found that IV (O.56mg/kg) and a large oral
dose (300mg) of Dipyridamole (D) produce myocardial per-
fusion abnormalities on Thallium-201 myocardial imaging
in patients (pts) with myocardial ischemia. To see if low
-dose (IOOmg) oral D also induced redistribution of coro-
nary blood flow on Dipyridamole/Thallium (D/T) myocardial
imaging we studied 8 pts (6 males, 2 females, mean age
63 years) who previously had transient defects (TD) +/-
persistent defects (PD) on IV D/T myocardial imaging.
Each pt received 100mg of pulverized tablets in 30ml of
sugar-free solution. Vital signs and EKG were monitored
by a cardiologist. 45 minutes later, 2 mCi of TI-201
were given IV and serial Thallium imaging began within
5 minutes. Myocardial regional perfusion was assessed by
2 independent observers using original analog images with
segmental profile analysis.
8 pts had TD on initial IV D/T myocardial imaging. In 5/8
pts (63%) TD was also present after oral 100mg D. In 3 pts
who had TD and PD on initial IV D/T imaging only a PD
could be demonstrated after oral lOOmg D. One pt with
angiographically documented severe triple-vessel coronary
artery disease developed chest pain and ischemic EKG
changes after the oral dose. No other side effects were
seen. We conclude that low dose (IOOmg) oral Dipyridamole
can produce myocardial blood flow redistribution in isch-
emic areas. This effect may be of clinical significance
in patients with coronary artery disease who are on oral
Dipyridamole for its anti-platelet effects.
6EF/ex dur(%/min)
6EF/ 6 HR(%/bpm)
THE EXTENT AND RATE OF RAPID CHANGES IN LEFT VENTRICULAR
FUNCTION ON EXERCISE AS A PREDICTOR OF CORONARY ANATOMY.
John L. Caplin, M.B., Duncan S. Dymond, M.D., F.A.C.C.,
James C. O'Keefe, M.B., William D. Flatman, M.SC. and
Roworth A.J. Spurrell, M.D., F.A.C.C., St. Bartholomew's
Hospital, London, ENGLAND.
Gold-195m (t1/2=30.S sec) allows rapid sequential first-
pass studies of LV function. Serial imaging was performed
in 25 patients (pts), 7 With normal coronaries (nls), 11
With 1/2 vessel disease (VD), and 7 with 3VD, at rest,
and at 3 mins, 6 mins, peak, immediately post and 2 mins
post exercise (ex). Nls increased their ejection fraction
(EF) throughout ex and at 2 mins post-ex EF, 68+6%, was
above rest, 60+6% (p<O.OS). In 1/2VD pts EF fell during
ex. with a maximum fall at peak, 58+10% vs 47+10%
(p<O.OS), but at 2 mins post-ex EF rebounded above rest
value. In 3VD pts EF again fell during ex with a maximum
fall at peak, S7~11% vs 3S~8% (p<0.001), but no rebound
occured. Rates of change in EF related to ex duration and
change in heart rate showed significant differences
between the groups, but there was considerable overlap:
nls 1/2VD 3VD
.6+1.0 -2.1+1.8* -4.8+2.9*
.01~.07 -.19~.16* -.41~.29*
(*=p<0.01-vs nls) - -
In conclusion the extent and rate of change in LV
function derived from rapid, sequential first-pass
studies 1) can differentiate pts with severe coronary
artery disease, 2) suggests that there is an overlap in
extent of myocardium at risk between pts with and without
3VD, and 3) suggests that an algorithm incorporating ex
duration and change in heart rate into the interpretation
of EF change may improve the stratification of pts in
terms of myocardium at risk.
THE ERGOMETRINE TEST : A PROVOCATIVE TEST FOR CORONARY
ARTERY SPASM OR ESOPHAGEAL MOTILITY DISORDERS
Guy Vaksrnann, M.D., Jean Manouvrler, M.D., Christian
Caron, M.D., Jean-Marc Laurent, M.D., Gerard Ducloux,
M.D., Hopltal Cardlologique, C.H.U., Lille, France.
Ergometrine (ergo) can evoke coronary spasm in pa-
tients with varlant angina. The cause of ergo induced
chest pain (CP) In the absence of coronary spasm 15
not clear. To determlne whether ergo produced esopha-
geal dysfunction and CP, we evaluated 28 patients by
esophageal manometry (EM). SlX had CP in response to
ergo durlng cardiac catheterizatlon (group I) and 22
dld not (group II). Results of cardiac catheterlza-
tlons were normal ln all patlents. EM was performed
before and after ergo (0,4 mg LV.). Results : ergo
provocatlon during EM caused slgnifiant deterioration
in esophageal motllity assoclated wlth famlliar paln
In 5/6 group I patients. The motlilty disorders were
characterlzed by the presence of repetitive contrac-
tlons of exceedlngly hlgh amplitude and long duratlon
in the distal esophagus. There were no ECG changes du-
rlng any eplsodes of CP. No patlent from group II ex-
perlenced CP after ergo and only 2/22 developed long
duration contractions. Baseline manometry failed to
predlct a posltlve response to ergo. Concluslon : in
patlents with normal coronary angiogram, ergo induced
CP without assoclated coronary artery spasm suggests
that esophageal motility disorders originate CPo
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crnREIATIOO CF MINIMUM LUMEN DIAMETER WITH LEFl'
VEN'IRIaJLAR FUl'Cl'ICNAL IMPAIRHEm' IlURIN3 M.RIAL PACIl-li
Jonathan Tobia. W. FllCC. David Sato, MD, warren D.
Johnston, MD, Tim Reese, Orhan Nalcioglu, PhD, Walter L.
Henry, MD, FAa:.
The quantitative analysis of corooary artery disease
using percent stenosis is a relative standard that is
dependent upon the width of the "noIllla1" segment.
Absolute lumen dianeter is a less subjective measurement
but is usually tedious to obtain. The PJrpose of this
sttrly was to relate measurements of lesicn severity to
segmental wall moticn abnoIllla1ities induced during atrial
pacing. en line digital aoquisiticn of corooary
angiograms were performed in 18 patients to permit rapid
access of conp.iter algoritiJns for quantitative analysis.
IJJw dOse (lSml) ccntrast digital left ventriculograms
were obtained at rest and peak pacing. Percent stenosis
and absolute minim.un lumen diameter were calculated by
edge detectioo methods. These measurements were coopared
to the functicnal inpairment in global ejecticn fracticn
(EF) and segmental percent radial shortening indJced
during atrial pacing sttrlies. The mean percent stenosis
was 63 ±. 16% and the mean minim.un lumen dicrneter was 1.3
±. 0.6 RIll. The mean EF at rest was 62 ±. 16% and at peak
pacing was 54 ±. 22%. The mean percent radial shortening
was 57 ±. 24% at rest and at peak pacing was 49 ±. 31%. The
absolute stenotic lumen dianeter correlated most closely
with the change in segmental wall moticn (r=0.84)
coopared to the change in global EF (r=O.64). Percent
stenosis was also correlated with EF (r-0.62) and wall
moticn (r-0.68). A proximal corenary diameter of <1.4R1l1
tended to identify patients with marked segmental wall
moticn defects induced by atrial pacing. 'lbus, absolute
minim.un lumen dianeter corresponds more closely with
functiooal assessments of corenary lesicns than do
calculaticns of percent stenosis.
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ENCHANCED REGIONAL LEFT VENTRICULAR FUNCTION AFTER
DISTANT CORONARY BYPASS VIA IMPROVED COLLATERAL FLOW
Vasken Dilsizian. MD. Robert O. Bonow. MD. FACC. CYnthia
M. Tracy. MD. Richard O. Cannon. MD. FACC. Charles L.
McIntosh. MD. FACC. Michael Jones. MD. Dino F. Vitale. MD.
Stephen L. Bacharach. PhD and Michael V. Green. MS.
NHLBI. Bethesda. Md.
To determine whether coronary artery bypass (CABG) can.
through collaterals. improve function in left ventricular
(LV) regions not revascularized (because of non-bypassable
arteries or occluded grafts). we studied 21 pts with mul-
tivessel coronary artery disease (CAD) by radionuclide an-
giography and coronary arteriography before and 6 mos af-
ter CABG. All had proximal stenosis of the left circum-
flex artery (LCX) or a major obtuse marginal branch. pts
were exercised after all cardiac medicines were withdrawn.
LV regional function was assessed by dividing the LV re-
gion of interest into 20 sectors; the 8 sectors corres-
ponding to the posterolateral free wall were used to as-
sess function in the LCX distribution. For the total
group. CABG significantly increased both the global LV
ejection fraction (EF) during exercise (40±13 to 51±141.
p<.OOl) and the magnitUde of change in EF from rest to ex-
ercise (-8+10 to +2+61. p<.OOl). Such improvement was ob-
served in 8/10 pts with all stenoses bypassed. but also to
an equivalent degree in 9/11 pts in whom the LCX was not
bypassed. In 10 of these 11 pts. exercise induced wall
motion abnormalities improved and regional EF during exer-
cise increased (from 49+15 to 65+161. p<.OOl) in the lat-
eral wall that was not revascularized. Improved collater-
al perfusion to this region was demonstrated angiographic-
ally in 8/10 pts. Hence. many pts with a non-bypassable
coronary artery may still benefit from CABG. if the jeo-
pardized myocardium is perfused by collateral vessels sup-
plied by a stenosed artery amenable to bypass surgery.
LAD LESION MORPHOLOGY AS A PREDICTOR OF ANTERIOR
INFARCTION IN CASS
Stephen G. Ellis, M.D •• Kevin Cain, Ph.D., Lloyd Fisher, Ph.D ••
'vIartial G. Bourassa, M.D., F.A.C.C., Edwin L. Alderman, M.D ••
F.A.C.C. Stanford University. Stanford, California and CASS
Investigators.
Trials assessing the benefits of coronary revascularization
have assumed that risk of MI is determined primarily by the
degree of coronary stenosis (96CS). We examined the extent to
which 21 aspects of LAD stenosis morphology contributed to the
risk of anterior MI (AMI) in CASSo AMI occurred within 3 years
after baseline angio in 5% of ~,59S medically treated patients
(pts) with ~3096 LAD stenosis. liS of the AMI pts had good
quality angios which were compared against angios from I~l
non-AMI pts, matched on the basis of 96CS in the LAD and
presence of disease in other vessels. Morphology was assessed in
557 LAD lesions by an experienced angiographer unaware of
clinical outcome. Predictive strength was expressed for each
parameter as the odds ratio (R) for AMI.
Univariate analysis revealed luminal irregularity; i.e., edge
roughness {R=~.5; p=.OOIl, stenosis length {R=I.7; p<.OIl, lesion
assymmetry (R=I.9; p=.06) and jeopardized collaterals (R=2.7;
p=.OS) to be risk factors for AMI. Parameters such as vessel
angulation at lesion site, lesion involving a bifurcation. acuity of
proximal lesion edge, tandem lesions and distal stenoses were
not predictive. Multivariate analysis which included clinical and
LAD lesion morphology variables as well as 96CS ranked lesion
roughness, 96CS, smoking and male sex in that order to be
predictive of AMI.
The fact that luminal irregularity increases the risk of AMI
from a given stenosis by four-fold may relate to lesion potential
for thrombogenesis. This was suggested by the fact that the
statistical power of roughness declined with the interval from
baseline angio. We conclude that morphology should be
considered in future angie-based clinical trials and may be an
important factor in making decisions about revascularization.
SURVIVAL ANALYSIS OF MEDICAL AND PROMPT SURGICAL THERAPY
IN PATIENTS WITH TRIPLE VESSEL CORONARY ARTERY DISEASE
AND SEVERE ANGINA PECTORIS: A CASS REGISTRY STUDY.
William O. Myers. M.D., F.A.C.C., Bernard J. Gersh, M.D.,
F.A.C.C., Lloyd D. Fisher. Ph.D., F.A.C.C., Michael B.
Mock, M.D., F.A.C.C., David R. Holmes, M.D., F.A.C.C.,
Hartzell V. Schaff, M.D., F.A.C.C., M. McConney, Ph.D.,
Thomas J. Ryan, M.D., F.A.C.C., George C. Kaiser, M.D.,
F.A.C.C., Robert L. Frye, M.D., F.A.C.C. and CASS
Investigators, Marshfield, Clinic, Marshfield, WI.
Results of coronary artery bypass surgery were eval-
uated in 2600 non-randomized patients with 3 vessel dis-
ease (3VD) in angina class III-IV, 679 treated medically
and 1921 treated surgically within the time from entry in
which 95\ of those who received surgery at each CASS site
did so, about 90 days. Six-year survival was 55\ with
medical and 83\ with surgical therapy (p' .0001). With
normal LV wall motion (CASS score 5) and with 0 Or 1
proximal vessels stenosed (PROXVES) significantly longer
survival with surgery in 3VD was not found. With 2 and 3
PROXVES there was survival benefit for surgery with normal
LV. With increasing LV dysfunction (score 6-9, 10-15 and
16-30), and 1 to 3 PROXVES, benefit increased.
Cox analysis identified variables predicting surviv-
al; surgery had an independent effect for survival. Ana-
lysis by propensity score (PROSCOR) identified variables
which influenced therapy received. Divided into quintiles
of the PROSCOR. groups with equal l~kelihood of surgery
(1:10 to 1:1) were compared. Survival benefit was found
in all quint~les of PROSCOR. Relative survival benefit
of surgery increased with decreasing propensity for oper-
ation. Conclusion: relative survival benefit of surgery
in 3VD and severe angina increases with increasing ana-
tomical severity (above 1 PROXVES in normal LV) and de-
creasing likelihood of operation.
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AORTO-CORONARY BYPASS SURGERY IN PATIENTS WITH A
SEVERELY COMPROMISED LEFT VENTRICLE.
Harold Carlson, MD, Virendra Mathur, MD, FACC, Lucelli
Cuasay, MPH, Albert Gray, PhD, Robert Hall, MD, FACC,
Denton Cooley, MD, FACC, Efrain Garcia, MD, FACC, Ali
Massumi, MD, FACC, Carlos DeCastro, MD, FACC, Neil Strick-
man, MD, FACC; Texas Heart Institute, Clayton Research
Foundation, St. Luke's Episcopal Hospital, Houston, Texas.
Consecutive patients (pts) (284) on one cardiology
section whose ejection fraction (EF) was 35% or less by
radionuclide angiography underwent aorto-coronary bypass
(ACB) alone (179) and/or LV aneurysm repair (LVA) (105)
between 1977-1983. Class III-IV angina was present in 76
and 65% and major LV failure in 40 and 56% of pts in these
two groups respectively. Mean ischemic and pump time were
31 and 58 min in ACB and 38 and 62 min in LVA, with
average number of grafts, 3.6 and 2.2, respectively.
Early and late prognosis was studied. Postoperative
interventions: intraortic balloon, pressors, resuscita-
tion, were required in 4, 14 & 6% of ACB and 10, 25 & 11%
of LVA pts. Perioperative myocardial infarction occurred
in 10.6% (30/284). Cerebral complications occurred in
0.6% (1/179) of ACB and 5.7% (6/105) of LVA pts. Early
death occurred in 3.4% (6/179) of ACB and 8.6% (9/105) of
LVA pts.
Follow-up (1-95, av 30 months), was available on 253
(89%) pts. No limiting symptoms were present in 189 (85%)
survivors. Ejection fraction improved 6-10% points in 22%
(59/269) and more than 10% points in 29% (78/269) pts.
Return to work was reported in 61% (135/222) of survivors.
Late death occurred in 31 pts. Actuarial survival (5 yr.)
was 72%, 89% and 80% amongst pts. with preop EF less than
20% (135), 20-35% (149) and total group (284).
We conclude that patients with major LV dysfunction
have acceptable early mortality. The longterm symptom
relief and survival is excellent.
INFLUENCE OF OPERATIVE THERAPY ON LONG-TERM
PROGNOSIS IN PATIENTS WITH THREE-VESSEL
CORONARY ARTERY DISEASE
LH Muhlbaier PhD, JS Re.nkin MD, FACC, RM Califf
MD, DB Pryor MD, KL Lee PhD, FE Harrell PhD,
DC Sabiston Jr MD, FACC
Duke University Medical Center, Durham, N. C.
Controversy persists regarding timing of surgical
therapy in symptomatic patients with angina and three-
vessel coronary artery disease (3VD). Of 2125 3VD
patients diagnosed at catheterization since 1969 by 75%
stenosis criteria (left main and emergency surgery
patients excluded), 1060 received medical therapy and
1065 underwent surgery. 937 patients having early
surgery (ES), i. e. within 60 days of catheterization,
were compared to the remaining 1188 medical and late
surgery (M+LS) patients to examine factors influencing
outcome. There were 141 total cardiovascular deaths
in ES and 382 in M+LS. Baseline differences included
mean ejection fraction, .53 in ES vs .46 in M+LS
(p <. 01), and progressive or pre-infarctional angina 68%
VB 49% (p <.01) . After adjusting for these and other
baseline variables as well as the bias due to ES waiting
time with the Cox proportional hazards model, ES
showed improved survival compared to M+LS (p <.01).
The adjusted 5 year survival was 90% after ES and 76%
with M+LS. The relative treatment benefit was the
same for all levels of medical risk, with the absolute
magnitude of improvement in survival being greater in
the higher risk patients. Thus, ES improves survival
in symptomatic patients with 3VD. The clinical impor-
tance of ES is related to the underlying medical prog-
nosis and is greatest in patients at increased medical
risk, such as those with worse symptoms or reduced
ejection fraction.
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SUBENDOCARDIAL SPARING IN MYOCARDIAL INFARCTS OF PATIENTS
WITH AND WITHOUT VENTRICULAR TACHYCARDIA.
David R. Bolick, BS, Donald B. Hackel, MD, Keith A.
Reimer, MD, PhD, and Raymond E. Ideker, MD, PhD. Duke
University Medical Center, Durham, NC.
The ability of endocardial resection to halt ventricular
tachycardia (VT) indicates the possible importance
of subendocardial sparing (SES) of myofibers for the
maintenance of VT. To see how SES differs in patients
with and without VT, the hearts were examined from
22 deceased patients with sustained VT and 21 patients
without VT who had an old or organizing myocardial
infarct (MI). Circumferential histologic sections
were made from a cross section of the LV that included
a representative region of the MI. SES was defined
as all viable myofibers between the LV cavity and a
solid MI scar. The dimensions of SES were measured.
The amount of patchy SES fibrosis was estimated, and
hydropic change (myocytolysis) was jUdged using a
semi-quantitative scale of 0 to 4+. The mean
circumferential extent of SES around the LV cross section
was greater in the VT than the non VT group (161 vs.
76mm, P<0.0005), however, mean SES thickness throu9h
the LV wall was not different (0.71 vs. 0.76mm, p=0.64).
The mean degree of hydropic change was significantly
greater for the VT than the non VT group (1.4 vs. 0.3,
p< 0.001), but the mean fibrosis was not (14% vs 13%,
p=0.46). Thus, patients with VT have more SES.
Interestingly, the SES in the VT group does not have
more patchy fibrosis, even though patchy fibrosis is
thought to lead to fractionated activation and VT.
However, the VT group does have more hydropi c change
suggesting increased chronic ischemia in the VT group.
CAN ION CHANNELS BE ANTIGENS TO IMMUNOGLOBULIN G (IgG) IN
MYOCARDIAL INFARCTS? M. Rappaport, H. Hammerman, M.D.,
H. Meiri, Ph.D., The Rappaport Institute and School of
Medicine, Technion, Haifa, Israel.
Radioimmunoassay showed a high level of free IgG in pa-
tient sera within the first 24 hours following first (3.4
11.9 mg/ml) (X1SD) and recurrent (3.4±1.1 mg/ml) myocar-
dial infarction (MI). IgG level after MI remained high at
4 and 8-10 days. Sera of subjects without cardiovascular
disease contained 20±2.3 ug/ml only. Four ion channel spe-
cific monoclonal antibodies (mAb) were then used to inves-
tigate the possibility that their antigens also might in-
duce an elevation of IgG in patient sera. Our mAb's were:
1) 72-14 that deprfsses ~ in canine Purkinje fibers by
modulating fast Na channWixconductance, 2) 61-44 that
binds to Na channel molecule without physiological activi-
ty, 3) 72-38 that competitively blocks the binding of
tityus y toxin to the activation gate of fast Na ~¥annel
and 4)+79-17 that modifies both Na channel and Ca depen-
dent K channel. A 50±9% reduction (p<O.OOI) of 72-14
binding and a 50±23% reduction (p<O.OI) of 61-44 binding
were found in presence of sera of patients 24 hours after
first MI. After recurrent MI the binding of 72-14 and 61-
44 was further depressed (94±7, p<O.OOI, and 57±9, p<0.002
respectively). Suppression of binding persisted when the
same patient sera employed at 4 and 8-10 days after first
and second MI's. The binding of 72-38 and 79-17 was modi-
fied insignificantly. Sera of subjects without cardiovas-
cular disease modified binding of each mAb by no more than
7-12%. The correlation between sera level of free IgG and
their ability to modify mAb binding to their channel anti-
gen was improved from first to recurrent MI. We conclude
that some ion channel determinants may be modified prior
to first but more significantly prior to recurrent MI and
may induce IgG production in patients.
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HEMODYNAMICALLY IMPORTPNT RIGHT VENTRIOJLAA MYOCARDIAL
INFARCTION: ACUTE AND 1 YEAR MORTAL lTV AND
IDENTIFICATION OF HIGH RISK PATIENTS.
.L..Qul.s.J... Dell'ltalla. Mll...E...8.CC, NIcholas J. Lembo, MD,
Mark R. StarlIng, MD, FACC, Betty Heyl. MIchael H.
Crawford, MD, FACe, and Robert A. O'Rourke, MD, FACC.
The Unlv. of Tx Health ScI Ctr, San AntonIo, Texas.
No stUdy has systematIcally evaluated consecutIve
patIents (pts) with hemodynamIcally Important RV myocar-
dIal InfarctIon (Mil In a prospectIve fashion to deter-
mIne acute and one year (yr) mortality as well as what
factors IdentIfy a hIgh risk subgroup of RVMI pts. We
evaluated clinical, hemodynamic and EGG varIables In 27
consecutive pts who met the RVMI criterIa of both a RA
pressure (P) ~1 OmmHg and a RA:pu I monary artery wedge P
~0.8. Three pts died wIthIn the first 72 hours. Group 1,
and 24 surv Ived hospl tal Izatl on, Group 2. There were
no clInical variables that separated Groups 1 & 2. All
Group 1 pts had a stroke volume Index (SVI) <20ml/m2, LV
stroke work Index (SWI) 5.20g o m/m2, and summed ST
depressIon V1-V4 >10mm, whl Ie no Group 2 pts demon-
strated eIther of these hemodynamic and ECG fIndings.
Two Group 1 pts at autopsy had extensIve RVMI and LVMI
Involving LV postero-Iateral and anterIor walls; while
the remaining Group 1 pt had cardiomegaly and pulmonary
edema on chest x-ray. Group 2 pts had mean radl onucll de
anglographlc (RNA) RV ejectIon fraction (EF) 0.29±'0.07
with evidence of akinesis or dysklnesls on wall motion
analysis and a mean LVEF of 0.56±.O.11. At 1 yr follow-up
only 1 pt died due to anterior MI. We conclude that RVMI
which Is confIrmed by both hemodynamic monItorIng and
RNA has a low acute and 1 yr mortalIty when extensive
LVMI I s not present. AI ~o, the combl natIon of SV I
<20m 11m2• LVSW 1<20 go mlm , and summed ST depression
V1-V4 >10mm portends a poor prognosis In acute RVMI due
to extensIve concomItant LVMI.
RECURRENT CHEST PAIN IN PATIENTS WITH PRIOR MYOCARDIAL
INFARCTION: HIGH FREQUENCY OF RESIDUAL JEOPARDIZED
VIABLE MYOCARDIUM IN AREA OF PREVIOUS INFARCTION.
Kenneth A. Brown, MD, FACC, Frans J.Th. Wackers, MD,
FACC, John Clements, MD. University of VT, Burlington,
VT.
We examined the location of myocardium at risk in
patients with prior myocardial infarction (MI) who pre-
sent with chest pain. A series of 61 consecutive
patients with a prior (1 mo-8 yr) Q-wave MI who had
stress Tl-20 1 imaging and cardiac catheterization were
examined. Regional Tl-201 defects and the presence of
Tl-201 redistribution, a marker of ischemic viable
myocardium, were compared to corresponding myocardial
segments with MI based on analysis of EKG Q-waves.
In 59 (98%) patients, Tl-201 perfusion defects were
present in the area of prior MI. Tl-201 redistribution
was present in 1 or more of these segments in 33 (54%)
patients. Among 32 patients with mu1tivessel disease,
Tl-201 defects outs1de the MI were present in 16,
inclUding 13 with redistribution. A total of 38
patients had redistribution: in 25 (67%) this was
limited to the area of MI; in only 5 (13%) was redistri-
bution limited to outside the MI. The influence of
clinical, exercise, and coronary variables on the pre-
sence o~ Tl-201 redistribution within the area of prior
MI was examined using mUltiple logistic repression.
Significant positive correlates of infarct redistribu-
tion were: 1) the presence of good collateralization of
the distal coronary artery supplying the MI (p<O.05),
and 2) the time since the prior MI (p<O.05).
In conclusion, there is a high frequency of residual
jeopardized viable myocardium within the area of MI
among patients with ~rior MI and recurrent chest pain.
The presence of th1s persistent myocardium at risk
appears to be related to: 1) collateralization of
vessels supplying the area of MI, and 2) the duration of
time since the MI.
Compared to QMI pts, those with NQMI had a
smal1er lSI and a higher EF on entry, yet had more
recurrent MIs and a similar 4 year cardiac mortality.
When pts were divided into ant (316 pts) and inf 009
pts) MI locations, however, pts with ant "viI had a
higher II yr mortality than pts with inf MI (28% vs 111%.
P < 0.0001l regardless of QMI or NQMI type, or lSI.
We conclude that although ~ of MI (QMI vs NQMIl
and infarct size influence prognosis, location of MI
(ant vs int) is arnore important determinan-t.---
p
12.8 20.9 < 0.0001
50.9 115.8 < 0.0004
23.2 30.6 0.06
17 10 < 0.01
17 20 NS
(N =)
Infarct Size Index (I5I~
(CK-MB lSI, g'eq/m )
E.jection Fraction
on admission (EF,%)
In-hospital CHF (%)
Recurrent MI (II yr,%)
Cardiac neath (II yr, %)
PROGNOSTIC SIGNIFICJ\NCE OF TYPE AND
LOCATION OF MYOCARDIAL INFARCTION.
Peter H. Stone MD, FACC, Daniel S. Raabe MD, FJ\CC,
Allan S. Jaffe MO, FACC, Nancy Gustafson, Zoltan G. Turi
MO, FACC, James E. Multer VlO, F.I\CC, John O.
Rutherford MD, FACC, Eugene Braunwald, MD, FACC for
the MILlS Group. Harvard \1edical School, Boston, MA
The prognostic significance of non Q-wave (NQ) vs Q-
wave (Q) myocardial infarctions (MI), and of anterior (ant)
vs inferior (jnt) MIs was evaluated in 625 patients (pts) with
a first MI. Those with NQMI (190 pts) had more diabetes
(20.5% vs 13.6%, P < 0.03), and were more likely to be
female (38% vs 23%, P < O.OJ) than those with QMI (1135
pts). All other risk factors were similar.
\lQ\H QMI
(j 90) (1135)
1 12 .52+.03
2 16 .51+.02
3 14 .51+.02
4 3 .44±.03
p (ANOVA) NS
CONCLUSIONS: Estimation of the extent of acute inf
ischemia/MI by ECG within six hours of chest pain is
highly inaccurate and therefore not helpful in theraputic
decision making.
Numerous studies supporting electrocardiographic (ECG)
estimates of inferior (inf) infarction (MI) extent have
been reported. However, a multivariate discriminant
instrument for estimating acute inf MI size at this insti-
tution rejected precordial ST segment shifts as a pre-
dictive variable. Therefore, a new ECG score employing QR
data and ST segment shifts in lead I, II, III and aVf com-
bined with depth and distribution (lead number) of pre-
cordial ST depression was employed to analyze the first
(emergency room) ECG of 45 consecutive inf MI patients
preceding contrast ventriculography within six hours of
chest pain onset. A score of "1" reflected the most exten-
sive QRST changes in the greatest number of leads, and "4",
the least. These scores were related to the extent of acute
ischemia/MI per ejection fraction (EF) as follows (mean +
SEM): -
score n EF
THE ELECTROCARDIOGRAPHIC ESTIMATION OF VENTRICULAR
IMPAIRMENT (INFARCTION SIZE?) IN ACUTE INFERIOR MYOCARDIAL
INFARCTION
Gerald C. Timmis, M.D., F.A.C.C., Renato G. Ramos, M.D.,
Douglas C. Westveer, M.D., F.A.C.C., James Stewart, M.D.,
F.A.C.C., Seymour Gordon, M.D., F.A.C.C., William Beaumont
Hospital, Royal Oak and Oakland University, Rochester,
Michigan.
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PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN THE
MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION
George Pilcher, M.D., Pierre Abi-Mansour, M.D., Henry
Liberman, M.D., Douglas Morris, M.D., Andreas Gruentzig,
M.D., F.A.C.C. Emory University School of Medicine,
Atlanta, Georgia.
From 11/81 to 5/85 50 patients (38 male, 12 female)
had percutaneous transluminal coronary angioplasty
(PTCA) performed in the setting of acute myocardial in-
farction (AMI). Mean age was 54+11 years. Infarct-re-
lated vessel was the LAD in 27 (54%), RCA in 20 (40%),
and circumflex in 3 (6%). 38 pts (76%) had initial
total occlusion (TO). Pl'CA alone was used successfully
as the primary approach in pts with subtotal occlusion
(12 pts) and those with TO and angiographic evidence of
an antegrade channel (6 pts). There were no acute com-
plications in this subgroup. Intra-coronary thromboly-
tic therapy (TT) was attempted in 32 pts with TO and
thrombosis. Of these, reper fusion wi th TT alone was
achieved in 23 pts (72%). PTCA was then successful in
relieving the stenosis in 20/23 pts (87%) with success-
ful TT and in 6/9 pts (66%) with unsuccessful TT. PTCA
failure occurred in 6 pts due to inability to cross in
1 and thrombus resistant to numerous inflations in 5.
Four of these proceeded to emergency surgery (CABG).
Five others had CABG within 24 hrs because of diffuse
disease in 3 and acute closure syndrome in 2. There
were two in-hospital cardiac deaths (septal rupture on
day 8 after PTCA; sudden death on day 9).
Conclusion: PTCA may be ideal for patients wi th AMI
without coronary thrombus. In pts with coronary throm-
bosis, the combined use of PTCA and TT may be asso-
ciated with relative low riSk of acute coronary reclo-
sure.
CORONARY ANGIOPLASTY IN THE TREATMENT OF CARDIOGENIC
SHOCK: THE THERAPY OF CHOICE. Richard R. Heuser, M.D.,
F.A.C.C., Gerry L. Maddoux, M.D., F.A.C.C., Jerome E.
Goss, M.D., F.A.C.C., Barry W. Ramo, M.D., F.A.C.C.,
Gilbert L. Raff, M.D., F.A.C.C., Neal Shadoff, M.D.,
Presbyterian Heart Institute, Albuquerque, New Mexico.
Cardiogenic shock (CS) due to pump failure is nearly 100%
fatal. Fibrinolytic therapy works slowly and often results
in only partial reperfusion resulting in inadequate left
ventricular recovery. We used coronary angioplasty (CA)
as initial therapy in 74 patients with acute myocardial
infarction (MI). Ten patients presented to the Cardio-
vascular Lab with CS. CS was defined as clinical evidence
of systemic hypoperfusion as well as systolic blood pres-
sure <80 mm/Hg and pulmonary capillary wedge pressure) 30
mm/Hg. Eight patients had left anterior descending total
occlusion, 1 patient had a right coronary artery occlusion
and 1 patient had a circumflex graft total occlusion with
all native coronary arteries as well as a right coronary
artery bypass graft chronically occluded. Successful
dilation was achieved in 60% of patients with CS. One
patient who underwent successful CA died of pump failure
one week after CA. All other CS patients after success-
ful dilation were free of angina pectoris and congestive
heart failure with only 1 requiring diuretic therapy on
follow-up from 3-17 months (mean 8.6 months). Three of
the patients who had unsuccessful dilation of the occlu-
ded vessel died of pump failure in the Cardiovascular Lab.
The other patient continues to have symptoms of congestive
heart failure and angina pectoris. This compares with a
success rate of 91% in the MI group without CS who under-
went acute CA. Two of the successfully dilated CS
patients developed restenosis, one undergoing repeat CA,
the other coronary bypass. Acute CA can be effective in
some patients with CS.
POSITIVE INTRAVENOUS TECHNETIUM-ll9m PYROPHOSPHATE
SCINTIGRAPHY - AN EARLY NON·INVASIVE MARKER OF MYOCARDIAL
REPERFUSION
Joachim Schofer, M.D., Rolf Spielmann. M.D.·, Annette ae_n, M.D.,·Ricerdo
Montz, MD.·, Welter Bleifeld, M.D., FAC.C., Dedsf G. Mathey, M.D.·, Dept. of
Cardiology and ·Nuclear Medicine, University Hospital Eppenclorf, Hamburg, Wert
Germany
Recently we found that tllchnetium-98m pyrophosphllt8 ITc-PYPI eecumul_ in
necrotic myocardium immedietelyafter i_nary thrombolysis end intreeorona·
ry injection into the re-opened coronary ertery. To determine, whether acute
Tc.pyP accumulation is 11IIo -. after intrevenoUl (Ivl epplication in Patients (ptsl
with acute myocenllel myocenllel infln:tlon (AMII undergoiRll thrombolysis, 17 ph
with AMI (IYmptollll """ 3 hounl __ studied. 10 mCI Tc-PYP __ injected iv
30-60 minut81 after thrombolYlil, foMowed by coronary Ind laft _rieuler ILVI
angio.,aphy. After inv-nery injection of 0.3 • 0.5 me; thallium ITL·2011into
both coronary Irteries, ple_ duel iIotopa ..intignphy Ind, in 7/17 pts additional
emmilion computed tomography IECTI were parfonMd. Regional Ind g10bel ejec-
tion fraction were determined from acute Ind follow-up LV angiogrellll. According
to the petency of the infarct Irtery Ind the size of the TJ-dsfect pts were devided in-
to 3 groups.
TC·PYP regional EF % global EF %
Infarcted TI-201 aceumu- follow- follow-
Group artery defect l&tian acute up acute up
large missive 7.0 6.2 49.8 44.6
A 1"..61 open 7"30 % of cardiac ±10.4 ± 18.3 111.9 ± 13.7
silhouette
.!"J!IIJ4Lf~ _ 43.9' 54.0' 67.4·· 67.0'
81n=71 open nona (3) !'IO!I!tive %21.0 ± 17.9 :tl0.1 ± 9.0
9.3 11.3 53.3 47.7
c In=41 occluded large negative ±3.2 :t 4.9 :t 2.5 ± 2.5
"p ~ 0.01, up <:. 0.02 ( B VI A and C). These findings Mre confirmed by ECT In 7/17 pts.
Conclusionl: 11 Ealty intravenoul Tc-PYP scintigraphy il I reliable non·invasive
method to detect myocardial reperfulion after thrombolylis in the pr8MIlC8 of myo·
cardial necrosil. 21 Me_ive ealty Tc.pyP accumulation Ifter thrombolysil predicts
compromised LV function at follow-up.
THE USE OF INTRAVENOUS ANISOYL PLASMINOGEN STREPTOKINASE
ACTIVATOR COMPLEX (BRL 26921) IN ACUTE MYOCARDIAL
INFARCTION.
Shahid Ikram MRCP, Clifford A Bucknall MRCP, Susan J Lewis
MRCP, Richard Vincent MD FRCP, Douglas A Chamberlain MD
FRCP, Royal Sussex County Hospital, Brighton, Sussex. UK.
We have used a new fibrin-dependent thrombolytic agent,
Anisoyl plasminogen streptokinase activator complex
(APSAC), to study the role of intravenous thrombolytic
therapy for suspected acute myocardial infarction, in
a community hospital. APSAC shares with TPA the dual
advantage of high local concentration and relatively
low systemic actiVity, but in add~tion it has prolonged
action sustained over several hours after a single
intravenous bolus. 149 patients with onset of major
symptoms within 4 hr were randomised to receive either
30 mg APSAC (76, group A) or conventional treatment
alone (73, group B). All had typical symptoms with
ECG changes including ST segment elevation. Evolution
to completed infarction occurred subsequently in
significantly fewer patients treated with APSAC than
in the control group (79% v 92%, p<.05). Discharge
R wave scores of 49 in group A and 37 in group B
indicated better preservation of myocardial depolari-
sation after APSAC (p <.05). Peak CK-MB enzyme levels
tended to be earlier and higher in group A (p = .081.
Fewer patients had recurrent ischaemic pain in group A
than group B (47% v 63% p =.061. Total 7-day hospital
mortali ty was 3 in the APSAC group and 6 in the control
group. No definite serious complications were observed
but one patient in the APSAC group had a shower of
emboli to the lower trunk and limbs. Thus Anisoyl
plasminogen streptokinase activator complex is relatively
safe, simple to administer by intravenous route and
shows promise for reducing myocardial damage after
thrombotic occlusion.
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MYOCARDIAL CONTRACTILE RESERVE AFTER THROMBOLYSIS.
Lowell F. Sa tler MD FACC, Kenneth M. Kent MD PhD
FACC, Lay M. Fox MD FACC, William J. Rogers MD FACC,
Randolph S. Pallas MD, Albert A. Del Negro MD FACC,
David L. Pearle MD FACC, Charles E. Rackley MD FACC,
Georgetown University, Washington, D.C.
The early assessment of myocardial salvage after
thrombolysis is difficult due to the prolonged
recovery of the stunned myocardium. In order to
unmask "stunning", we sought to compare left
ventricular inotropic contractile reserve of patients
after successful versus unsuccessful thrombolysis.
Radionuclide ventriculograms were obtained in 80
consecutive patients 2 weeks after myocardial
infarction, at rest and during intravenous
isoproterenol infusion. Resting and isoproterenol
stressed left ventricular ejection fractions (EF)
were compared in the patent and closed infarct-
related vessel groups. Data are recorded as mean ±
standard error.
Vessel Number Resting EF Isoproterenol EF
Patent ~ 0.49 ± 0.02 0.62 ± 0.02
Closed 27 0.48 ± 0.02 0.54 ± 0.02
Although there was no difference in the resting EF
between the 2 groups, isoproterenol increased the EF
in the patent infarct-related vessel group ( 0.13 +
0.01) significantly more than in the closed
infarct-related vessel group ( 0.06 ± 0.01) (p <
0.0001). Thus, 1) there was a significantly greater
increase in the left ventricular ejection fraction in
response to isoproterenol in patients with a patent
infarct vessel as compared to a closed infarct
vessel; and 2) the restoration of blood flow in acute
myocardial infarction results in improved inotropic
contractile reserve, suggesting myocardial salvage.
SYMPTOMATIC AND ASYMPTOMATIC CORONARY REOCCLUSION AFTER
SUCCESSFUL REPERFUSION IN RELATION TO THE INITIAL TIME OF
TRANSMURAL MYOCARDIAL ISCHEMIA.
Rolf DO.. M.D.. Rainer v. Essen M.D., Rainer Uebis M.D., Wolfgang G. Schmidt
M.D., Heinz Lambertz M.D., Sven Effert M.D.
Dept. of Internel Medicine I, RWTH, Aechen, West Germany.
One main limitation of reperfusion therapy in ecute myocerdiel inferction (AMI} is
the time interval between onset of angina and stert of treetment. To contribute to
the definition of this intervel, symptoms in patients (pts) suffering either symptoma-
tic or asymptom.tic coronery reocclusion were analysed.
In 57 ceses (48 (j and 9 ~ ) pts with previously successful intrecoronary thrombo-
lysis started up to 8 hours after AMI, reocclusion was documented in the follow·up
8IIgiogrem. Pts with initially subtotal occlusion of the inferet releted v_I and
evidence of coll.terels at first or repeat angiography were excluded. All pts were
followed up for clinical, electrocardiogrephical (ST t > 0.1 mV in inferior end >
0.2 mV in anterior leeds), enzymatic (CPK t )and .;;;iocerdiogrephical signs ( t;
EF % ~ ) of reinferction. Reocclusion happened at.n everega of 16 days (0 - 270)
after the ecute intervention
ConclUSions: If reoccluslon occurs, less then 50 % of pts With an 'nltlal t,me of
ischemia exceeding 4 hours, but almost every pt successfully reperfused within 2
hours, suffers from symptomatic reinfarction. After .n initial time of ischemia
longer than 6 hours, however, reocclusion usually does not cause symptoms of re-
infarction. This may emphasize, that thrombolytic therapy in pts without evidence
of collaterals is unlikely to salvage significant amounts of ischemic myocerdium,
when reperfusion is echieved later than 4 hours after onset of symptoms.
Results: Age/ Initiel Reocclusion
yrs. time of Chest· ECG CPK t 6EF% ~
Group occl./min pein STt
A (n ~ 10) 58±, 15 0·120 10/10 10/10 8/10 8/10
B (n ~25) 56±. 10 120·240 18/25 17/25 14/25 12/25
\; (n ~ 17) 56±'10 240·360 9/17 8/17 6/17 5/17
Dln= 5) 55±, 10 360·480 1/ 5 0/5 0/5 0/5
Iln ~ 57) 56±, 10 0·480 38/57 35/57 28/57 24/57...
STREPTOKINASE AND NITRATES INCREASE THE FREQUENCY OF
CORONARY REPERFUSION IN ACUTE MYOCARDIAL INFARCTION.
David Hackett, MB, Graham Davies, MB, Sergio Chierchia,
MD, Attilio Maseri, MD,FACC. Royal Postgraduate Medical
School, London, United Kingdom.
The relative roles of thrombosis and coronary vaso-
constriction in the pathogenesis of acute myocardial
infarction remain poorly understood. We performed
coronary arteriography in 22 patients (pts) within 4
hours of the onset of continuous chest pain associated
with ST elevation. In all pts the ischemia related
vessel was occluded and failed to reopen with intra-
coronary {IC} isosorbide dinitrate (ISDN; 2mg).
Thrombolysis with IC streptokinase (SOOOiu/min)
reestablished patency in 16 pts (in 5 within 2 hours
from the onset of symptoms with no subsequent develop-
ment of Q waves). During streptokinase infusion in these
16 pts, reocclusion occurred in 6 pts (group A), and in
6 other pts (group B) partial patency was associated
with poor distal filling and run-off of contrast medium.
Followi~IC ISDN the reoccluded vessel was reopened
in 4 pts of group A and patency with normal filling and
run-off of contrast medium was achieved in all 6 pts
of group B.
Despite thrombolysis intermittent arterial reocclusion
may be seen during the acute evolution of myocardial
infarction. Interaction between intraluminal thrombosis
and coronary vasoconstriction appears to perpetuate the
coronary occlusion. Combined IC thrombolytic and nitrate
therapy increases the frequency of coronary recanal-
isation in acute myocardial infarction.
LONG-TERM SURVIVAL FOLLOWING STREPTOKINASE
THERAPY IN ACUTE MYOCARDIAL INFARCTIO.~.
Jennifer A Johns M.B.B.s., F.R.A.C.P., Robert C Leinbach
M.D., F.A.C.C., Tsunehiro Yasuda M.D., Cary W Akins ['1.D.
F.A.C.C., Herman K Gold M.D., F.A.C.C.
Massachusetts General. Hospital, Boston, MA.
One hundred patients (pts) aged 23-79 years (mean 52)
underwent coronary and left ventricular angiography within
6 hours of onset of acute myocarili.al infarction (MI).
Seventy pts received intrncoronary and 30 intravenous
streptokinase (,3K). Refto'lI was achieved in 64 pts (oll %),
with persistent occlusion or reocclusion occurnng in 36
(36 %). Seven pts (7 %) died in hospital, of whom 5 had
persistent occlusion or reocclusion. Of the 8~ survivors, 21
(23;) underwent coronary artery bypass surgery (CABG) and
22 (24 %) coronary angioplasty (P rCA) prior to hospital
discnarge. Tnere was no Slgnificant difference between
mean left ventricular akinetic segment (AK) length on
admission (12.4 + 8cm) and at repeat angiography 10 days
post-MI (11.1 + "'8c,n). Hospital survivors were follolled for
35 + 19 months (range 1.5-70). There were only 2 late
deaths, both non-caroi.ac. Of the remaining 91 survivors, 5
nad recurrent 1'1 I, 3 in the region of previous MI. Four
pts underwent CABG 3-15 months post-i'1I for recurrent
angina.
In summary, there is an excellent long-term survival in
this group of pts, despite lack of objective evidence of
myocardial salva",e. This survival may reflect the high
incidence of post-I"!I intervention with CABG and PTCA.
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ISIS COLLABORATIVE GROUP: RANDOMIZED TRIAL OF EARLY
rv ATENOLOL IN MYOCARDIAL INFARCTION, SUBSIDIARY
ANALYSES
ISIS Collaborative Group, Radcliffe Infirmary, Oxford,
England (Chairman p.Sleight, D.M., F.R.C.P.,
Co-ordinator R.Collins, M.B. B.S., M.Sc.)
16048 patients, admitted to 250 hospitals with
suspected myocardial infarction (MI) were randomized to
receive either immediate rv atenolol followed by oral
atenolol for 7 days or routine coronary care treatment.
There was no apparent reduction in the probability of a
2x enzyme elevation or in cardiac arrest, a moderate
but non-significant reduction in non-fatal reinfarction
and an increase in non-fatal heart block; 1-2% extra
required inotropes (but survived).
Prognosis and apparent mortality reduction was similar
for patients entering 0-4, 5-8, 9+ hours after onset
(mean = 5 hrs). No clear interaction of proportional
risk reduction with initial age, HR, SBP, ECG findings
or history of MI or diabetes was found.
To check for early hazards of beta-blockade (days 0-1)
or Withdrawal effects (after trial treatment stopped
on day 7), early mortality was split (0-1, 2-3, 4-5,
6-7, 8-9 days): no effect whatever was apparent except
in days 0-1, where all the apparent benefit was
concentrated (170/8002 control deaths, 118/8048
atenolol) •
P·value
<.0001
<.007
HRG (764 pts)
13% (104)
5.3% (41)
LRG (332 pts)
0.3% (1)
1. 8% (6)
IN-HOSPITAL COURSE OF PATIENTS ADMITTED WITH A MYOCARDIAL
INFARCTION: IDENTIFICATION OF A LOW-RISK GROUP FOR DEVE-
LOPING LIFE-THREATENING ARRHYTHMIAS. Joe Anderson, M.D.,
Mihai Gheorghiade, M.D., F.A.C.C., Bernard Velardo, M.D.,
Loni Schultz, M.S., Alan Friedman, David Goldberg, M.D.,
Howard Rosman, M.D., F.A.C.C., and Sidney Goldstein, M.D.,
F.A.C.C., Division of Cardiovascular Medicine, Henry Ford
Hospital, Detroit, Michigan.
One thousand and ninety-six patients (pts) admitted to the
CCU with a definite myocardial infarction were evaluated
and followed prospectively throughout their hospitaliza-
tion. Of these, 764 pts were considered to be in a high
risk group (HRG) based upon the following characteristics
obtained at the time of admission: pulmonary rales, 53
gallop, heart failure by chest x-ray, blood pressure <100
mmHg, cardiogenic shock, complex ventricular arrhythmias
and high degree AV block. The remaining 332 pts were
considered to be at low risk. The mean age for the low
risk group (LRG) was 62.3 years and for the HRG was 62.8
years (NS).
CCU deaths
Post CCU deaths
Invasive
monitoring 3% (10) 20% (158) <.0002
Defibrillation 0% 10% (77) <.0002
Cardioversion 0% 6% (47) <.0002
Pacemaker Rx 1.8% (6) 14% (114) <.002
In the low risk group no pt had to be readmitted to the
CCU because of a life-threatening arrhythmia. We conclude
that a LRG of pts can be defined based upon admission
clinical criteria. They have a low likelihood of life-
threatening arrhythmias during hospitalization and could
be admitted to an intermediate care unit reducing admis-
sions to the ceu by 30% without compromising patient care.
BETA-BLOCKER POOLING PROJECT ; SUBGROUP FINDINGS IN
POST-MYOCARDIAL INFARCTION PATIENTS.
BETA-BLOCKER POOLING PROJECT GROUP. Presented by
Alain LEIZOROVICZ, M.D., Unite de Pharmacologie
Clinique, Lyon, France.
The objectives of beta-blockp.r pooling project (BBPP)
was to collect data from large long-term late entry
(24 hours or more) clinical trials of beta-blockers (B)
in post-infarction (MI) patients (PTS) in order to
conduct subgroup analyses for which the individual
trials had inadequate power. 1 year all cause mortality
data from 9 trials involving more than 13,700 PTS were
obtained. Overall, mortality was 25 % lower in the B
group compared to the placebo controls. However, sta-
tistical tests suggested some heterogeneity between
the trials, which tested 7 different B. There was no
evidence that treatment outcome was related to sex,
baseline level of heart rate (range 50-90) or blood
pressure or the time at which treatment was initiated
(usually 5 to 14 days). In contrast, SUbgroups with
high placebo group mortality (history of previous MI,
angina, mechanical or electrical complications or
digitalis usage) benefited clearly from treatment with
homogeneous outcomes from the pooled trials whereas in
the complementary SUbgroups results were not homoge-
neous.
In conclusion, BBPP indicates that high risk MI PTS
without contra-indications are the prime candidates
for B therapy.
INFARCT SIZE AND CONDUCTION SYSTEM INVOLVEMENT IN
ACUTE ANTERIOR AND POSTERIOR INFARCTS WITH
COMPLETE HEART BLOCK
Maria-Dorine. C. Sevilla, M.D., Donald B. Hackel, M.D., Eileen
M. Mikat, Ph.D., Keith A. Reimer, M.D., Ph.D., Raymond E.
Ideker, M.D., Ph.D., Zoltan G. Turi, M.D., MILlS Group, Duke
University Medical Center, Durham, North Carolina
This study determined the differences between myocardial
infarct (MI) size, degree of conduction fiber necrosis and/or
hydropic degeneration, and clinical presentation and outcome in
patients with acute anterior (AMI) and acute posterior infarcts
(PMI) with and without complete heart block (CHB) who came to
autopsy. The hearts from 46 patients were grouped into: I-AMI
with CHB (8), n-AMI without CHB (13), In-PMI with CHB (19),
and IV-PMI without CHB (6). In each heart, areas of MI were
identified on histologic sections and infarct size was measured
(% of LV) using a digitizer and computer. Necrosis and hydropic
degeneration in the conduction system were graded from 0 to +4.
Clinical diagnosis and location of acute MI were determined by
ECG and serum enzyme levels. CHB was considered present if
seen on anyone ECG tracing post MI. The infarct size of I
(42.8%±8.5) was significantly larger than m (24.1 %±10.4)
(p<.OOI). Conduction fiber necrosis occurred in the common
bundle and bundle branches in I and in the approaches to the
atrioventricular node (AVN), AVN itself, common bundle and
posterior left bundle in IU. Although only focal necrosis of 2+ in
I and 2 to 3+ in mwas noted, hydropic degeneration ranged from
2 to 3+ in I and IU, and the adjacent myocardium showed 4+
necrosis in both groups. No conduction tissue necrosis was seen
in n and IV. The onset of CPB post MI occurred with a mean of
2 days in I and 6 days in III where it was often transient. Thus,
AMrs with CHB are larger; CHB occurs sooner and is more
persistent and necrosis involves the more anterior portions of the
conduction system. In the smaller PMfs with CHB, CHB occurs
later, may be transient and necrosis involves the more posterior
portions of the conduction system.
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DIFFERENTIAL INCIDENCE OF WALL MOTION ABNORMALITIES AND
RESIDUAL MYOCARDIAL JEOPARDY IN NON-Q-WAVE INFARCTIONS.
Joe K. Bissett, M.D., F.A.C.C., John Matts, M.D., Henry
Buchwald, M.D., and the POSCH Study Group, Univ of Arkan-
sas for Medical Sciences, Little Rock and Univ of Minne-
sota Medical School, Minneapolis.
The purpose of this study was to compare the incidence of
residual myocardial jeopardy in patients with non-Q and
Q-wave infarctions. Abnormal wall motion and coronary ana-
tomy were determined in 486 patients with stable symptoms
for at least 6 months following a single anterior (A=40)
or inferior (1=35) non-Q-wave infarction and compared with
411 similar patients after a Q-wave infarction. Abnormal
wall motion was measured from a ventriculogram in the
right anterior oblique position in 4 anterior-apical and
2 inferior segments. Results include abnormal wall motion
expressed as % segments without retained wall motion in
infarcted area (%AWM), number of patients with/without
retained wall motion (normal hypokinetic) distal to coro-
nary lesions >50% but <100% (jeopardized myocardium=JEPM),
global ejection fraction (GEF), and collaterals.
ANT NON Q INF NON Q ANT Q INF Q
N 40 35 ----rss ~
%AWM Segments .03+.10* .20+.35 .33+.32 .42+.43
JEPM Patients 20/20** 9/26 28/130 47/206
GEF 65+12* 63+9* 52+14 57+11
Collaterals 20/20 19/16 81/77 171/82*
*p<.Ol vs all other groups; **p<.05 vs inferior non-Q and
p<.Ol vs all other groups. Conclusions: patients with an-
terior non-Q infarctions have 1) a significantly decreas-
ed incidence of severe wall motion abnormalities, 2)
increased incidence of jeopardized myocardium, 3) ECG
patterns predict the incidence of abnormal wall motion in
non-Q infarctions.
IMPROVEMENT OF MYOCARDIAL METABOLISM IN PERI-
INFARCT ZONES INDUCED BY NIFEDIPINE IN PATIENTS WITH
INFARCTION.
Edward M. Geltman, M.D., F.A.C.C, Burton
E. Sobel, M.D., F.A.C.C., and Allan S. Jaffe,
M.D.,F.A.C.C. Washington University School of
Medicine, St. Louis, MO.
To determine whether nifedipine can improve myo-
cardial metabolism in jeopardized zones undergoing
infarction, we performed a double-blind, randomized,
placebo-controlled trial in which regional myocardial
metabolism was assessed by positron emission tomography
with intravenous carbon-II (llC) labeled palmitate,
ventricular function by radioventriculography (RVG),
and infarct size by serial MB CK analysis. Immediately
after initial tomographic and RVG studies performed at
admission, nifedipine (20 mg) or placebo was given q 4
hr for 48 hr as tolerated and tapered over the next 7
days. Tomography and RVG studies were repeated on day
10. Infarct size and initial ejection fraction were
indistinguishable between groups. The estimated extent
of impaired llC-palmitate accumulation declined from
58 ± 8 (SD) g-eq to 49 ± 7 in treated patients (p <
•05) but did not change at all in controls (44 ± 9
initially and 44 ± 12 after 10 days). Ejection
fraction decreased by an average of 16% of baseline in
controls but remained constant (51 ± 6 and 50 ± 5%) in
treated patients. Thus, despite the lack of gross
reduction of infarct size, nifedipine initiated early
after the onset of infarction exerts salutary effects
on regional myocardial metabolism in the peri-infarct
zone compatible with decreased afterload, reduced
coronary spasm, direct myocardial protection, or
combinations of the three.
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AUTONOMIC NEUROPATHY CAUSES IMPAIRMENT OF THE HEMODYNAMIC
RESPONSES TO EXERCISE IN DIABETICS WITHOUT ISCHEMIC HEART
DISEASE.
Joel K. ~ahn, M.D., Benjamin Zola, M.D., Jack Juni, M.D.,
Aaron I. Vinik, M.D., University of Michigan, Ann Arbor.
Abnormal hemodynamic responses to exercise have been
observed in diabetics. We hypothesized that autonomic
neuropathy (AN) contributed significantly to these alter-
ations. We studied 32 long-term (>10 years) insulin-
dependent diabetics without clinical evidence of cardiac
disease by graded treadmill exercise testing. Two of the
32 had occult ischemic heart disease by stress and re-
perfusion thallium scintigraphy and were excluded from
subsequent analysis. Of the remaining 30 subjects, 17
had AN by a battery of cardiovascular reflex testing. We
compared the responses to exercise of the 17 subjects
with to the 13 subjects without AN. At rest the pressure
rate product (PRP) was higher in those with AN (114.0±5.7
vs. 95.9±5.3,p<.05). With maximal exercise the increase
in heart rate (44.6±4.8 vs. 79.0±5.4 beats/minute,p<.OOl),
systolic blood pressure (36.8±5.9 vs. 55.0±5.8 mmHg,p=.02)
and the PRP (98.0±7.3 vs. l82.0±8.2,p<.001) were all
lower among those with AN despite similar total treadmill
times (63l±47 vs. 587±40 seconds,p>.lO). At each stage
of exercise the increase in heart rate and systolic blood
pressure was lower (p<.05) among the diabetics with AN.
The severity of AN correlated inversely with the maximal
increase in heart rate (r=-.68,p<.001) and PRP (r=-.58,
p<.005). Age, duration of diabetes mellitus and the
presence and severity of microvascular complications did
not correlate with any of the hemodynamic parameters.
Thus, AN is a cause of the profound impairment of the
hemodynamic responses to exercise in diabetics without
ischemic heart disease.
DOES EXERCISE CAUSE PROLONGED REDUCTION OF ALPHA-ADRENERGIC
RESPONSIVENESS OR ALTER POST-EXERCISE BAROREFLEX FUNCTION?
Michael Maddens, M.D., Robert Levine, B.A., Josef Gurian,
B.S., David Mendelowitz, B.S., Thomas Lincoln, B.A., and
Jeanne Y. Wei, M.D., F.A.C.C., Beth Israel Hospital,
Harvard Medical School, Boston, Massachusetts.
To test the hypothesis that exercise (EX) may alter the ar-
terial response to ~adrenergic stimulation, we studied 12
adult (5-9mo) male rats with chronic indwelling venous and
arterial catheters. In 6 rats the mean arterial pressure
response (aMAP) to bolus (16 ug/lO s) IV phenylephrine (PE)
was measured before EX. After a 30 min EX (rodent tread-
mill, 0.9km/hr, 00 elevation) the AMAP was measured in re-
sponse to serial boluses of PE at 15, 30, 45, and 60 min
post-EX, and was compared to pre-EXaMAP in paired samples.
15 min 30 min 45 min 60 min
post/pre-EX aMAP 66% * 51% **~~
In six other rats, studies were performed using variable
doses of PE to obtain 4 sequential 10 mm Hg rises in MAP.
The PE dose needed to reach target aMAP's was determined
pre-EX. Then, sequential infusions were performed at 15,
30, 45, 60, and 75 min post-EX. The dose (ug) of PE needed
to reach target aMAP's was determined at each time post-EX,
and using paired samples, was compared to the pre-EX dose .
aMAP 15 min 30 min 45 min 60 min 75 min
10mmHg~~~ +4**~
20 mm Hg +11 * +7 * +4 * +4 * +4 *
30 mm Hg +12 * +9*** +4 * +4 * +5 *
40 mm Hg >+17** >+15** +5 +5 +4
Finally, when MAP was plotted against RR interval (RR~ the
~~P to the major inflection point was smaller at 15 min
(p<.OI) and 30 min (p<.025).
Thus, exercise diminishes responsiveness to~·adren­
ergic stimulation for >75 min, and improves baroreflex
function. These findings suggest that exercise may give
prolonged protection against arterial pressure elevation.
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A NEW STRESS TESTING TECHNIQUE, NONINVASIVE
TMNSTHORACIC PACING TACHYCARDIA: COMPARISON TO
EXERCISE STRESS TESTING. MD Feldman, EV Gervino, JM
Aroesty, FACC, HD Royal, JA Parker, KJ Silverman, FACC,
RC Pasternak, FACC, WGrossman, FACC,
PM Zoll, FACC, R McKay. Harvard Thorndike Laboratory,
Beth Israel Hospital, Boston, MA
Improvements in noninvasive (NI) external ventri-
cular pacing (PAC) have led to a technique with
reliable electrical capture and minimal patient
discomfort. We applied this technique in combination
with thallium-20I scintigraphy (TI) to 9 patients (pts)
referred for coronary angiography. TI after NI PAC was
compared with TI after an exercise treadmill test
(ETT). Pts were NI paced to greater than 85% of age
predicted maximum heart rate, and underwent maximal
exercise to a respiratory exchange ratio> 1. O. The
paced and exercised groups3achieved similar rate
pressure product (RPP X 10 ) at onset (15.1 t 2 versus
15.3 t 2) and termination (12.5 ~ 2 versus 11.9 t 1) of
angina, and similar maximal RPP (19.5 t 1 versus 21.6 t
3), respectively. NI PAC produced reversible TI
defects in all 8 patients with coronary artery disease
(CAD) and no defect in the patient with normal
coronaries. ETT produced reversible TI defects in only
4, normal TI in 3 despite CAD, and a fixed TI defect in
1 with CAD. We conclude that NI PAC with TI may be
comparable to ETT in detecting CAD. This new modality
warrants further study for pts unable to undergo the
exercise required for standard ETT.
CARDIOVASCULAR COMPLICATIONS OF OUTPATIENT CARDIAC
REHABILITATION PROGRAMS
Steven P. Van Camp, M.D., F.A.C.C., Richard A. Peterson,
Ph.D., San Diego State University, San Diego, California
To determine the incidence of major cardiovascular
complications which occurred within the conduct of out-
patient cardiac rehabilitation programs from January,
1980, through December, 1984, we surveyed a random sample
of America's cardiac rehabilitation programs. Programs
were identified from American Heart Association, Califor-
nia Society for Cardiac Rehabilitation, YHCARDIAC Therapy,
and Cardiac Treatment Center directories. A random sample
of 150 operational outpatient programs received a ques-
tionnaire and a follow-up phone call. Programs were cate-
gorized by the degree of EGG monitoring during exercise
sessions as continuous, intermittent or graduated. Gradu-
ated programs monitored new patients continuously for
at least three exercise sessions before progressing to
intermittent monitoring. Data was obtained from 115 pro-
grams. Seven programs responding had continuous and inter-
mittent programs resulting in data from 122 programs.
Complications during60r related to exercise sessions:
(incidence per 10 patient-hours in parentheses)
Program Patient- Cardiac Myocardial
Type --!L Hours Arrests Infarctions Fatalities
Continuous 74 719,436 9 (12.5) 4 (5.6) °
Intermittent37 811,096 7 (8.6) 2 (2.5) 3 (3.7)
Graduated .!! 180,545 2 (11.1) 4 (22.2) 1 (5.5)
Total 122 1,711,077 18 (10.5) 10 (5.8) 4 (2.3)
Conclusions: Within the survey period there was a low
incidence of major cardiovascular complications during
or related to prescribed supervised exercise in cardiac
rehabilitation programs. The incidence was similar regard-
less of the type of program.
EXERCISE INDUCED SUSTAINED VENTRICULAR TACHYCARDIA IN
YOUNG HEALTHY ADULTS: CLINICAL, ELECTROPHYSIOLOGIC
FINDINGS, AND TREATMENT
James R. Higgins, M.D., F.A.C.C., Wilford Hall USAF
Medical Center, Lack1and Air Force Base, Texas
Exercise induced ventricular tachycardia (EIVT) has been
reported to adversely effect prognosis. Clinically sus-
tained monomorphic VT is reproducible utilizing standsrd
electrophysiologic stimulation (EPS) techniques in a
majority of patients. We wish to report on 12 patients
(pts), average age· 23.6 yrs (20-26 yrs) who demon-
strated reproducible sustained EIVT (cycle length 285-
350 msec) on exercise testing (ET). No pt had chest
pain or ST segment changes during ET, but 6 developed
symptomatic hypotension. In ten of the 12 pts under-
going cardiac catheterization, normal coronary anatomy
before/after ergonovine was found. Left ventricular
function was normal in all pts. In all 12 pts, EPS
studies were negative (3 right ventricular sites/2 cycle
lengths/ 3 extrastimuli) until isoproterenol (I) was
administered. During I administration to 4mg/min, all
12 pts developed VT Without electrical stimulation.
Treatment with B-blocking agents for a mean of 22 months
(10-32) has prevented EIVT and I induced VT in all pts.
In conclusion, in 12 young adults with sustained EIVT:
(I) there was no associated cardiac disease; (2) ET or I
infusion reproduced VT in all pts while standard EPS was
negative; (3) treatment with B-blocking agents prevents
EIVT in follow-up.
+13.0 <.001
+ 9.0 <.001
+4.0
+2.3
CHANGE IN V02MAX(ML/KG/MIN) AFTER 12 WEEKS OF TRAINING:
Group N Baseline 12 Weeks Difference %Diff. P
Exercisers V02max V02max
Male 28 31.8 35.8
Female 28 25.8 28.1
Controls
Male 26 32.8 32.6 -0.2 - 0.2 NS
Female 25 26.6 25.9 -0.7 - 2.5 NS
The mean increase in V02max was 44% higher in men than in
women (p<.05). Adherence to training defined by a combina-
tion of frequency, intensity, duration of sessions and
number of weeks in program exceeded 90% in men and women.
CONCLUSIONS: Self-monitored home-based moderate intensity
exercise training is as effective as supervised group
training in increasing V02max in sedentary healthy indivi-
duals.
SELF-MONITORED HOME-BASED MODERATE INTENSITY EXERCISE IN
MEN AND WOMEN: EFFECTS ON FUNCTIONAL CAPACITY
Martin Juneau, MD, Flay Rogers, BA, Victoria deSantos, PA,
Martin Yee, BA, Anthony Evans, PhD, Andrea Bohn, BA,
William L. Haskell, PhD, FACC, Craig B. Taylor, MD, Robert
F. DeBusk, MD, FACC, Stanford Medical Center, Stanford, CA
Moderate intensity exercise performed in supervised groups
significantly increases maximum oxygen uptake(V02max).This
study was designed to evaluate the effectiveness of a self-
monitored home-based exercise program in increasing vOZmax
in 60 men aged 49±6 and 60 women aged 47±5. These healthy
sedentary subjects were randomized to a control(C) or exer-
cise(E) group which trained at 65-72% of pre-training peak
heart rate for a duration that resulted in a caloric experr
diture of approximately 300kcal/aession(mean 5l±8min)5x/wk.
A heart rate(HR) monitor was used to regulate training in-
tensity. A solid-state microprocessor recorded HR and phy-
sical activity for 3 consecutive days. Daily logs were used
to record frequency, intensity and duration of training.
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Group I: SeDsitiv!ty=76'. Specificity=86'. Positive
predictive ~-50':. Negative predictive~ =
76*. Group II: SeD8itivity =lOOl. Specificity = B6'.
Positive predictive accuracy =SM. Negative predictive
accuracr =lOOl.
CoDclusiClll8: 1) LP recorded by SAV are predictive of
exercise-related VA. 2) Thia asaociation ia stronger iD
pts with VA duriug the exercise phase.
VIlft'RlCULAR DIPOLARIZATIOIf LATH POTBN'l'IALS RKCORDID BY
SIGNAL-AVDAGIllG PRlDICT RIIIlCISB-RKLATKD VBlf1'RlCULAR
ARRIIYTIIIIAS •
BD Bai~ M.D.; .1_ C_ron. M.D'i Th_ f. Deeriug.~tiDO G. Criscitiell0. M.JJ .... f.A.C.C. i Linda
UI'Y; Beverly Cobb; N. A. Mark utes. III. M.D.•
f.A.C.C. Tufts-N. R. Neil. Ceater. Boston. NA.
To iDvestigate the relatioilship of veDtricular
depolarization late poteatials to the devel~t of
exercise-related veatricular ~ias (VA~.
ai....l-averaged vectorcanl~~SAV)were_perforEd ~D
54 petieats (pta) before . iately a1'ter exercise
strea teatiug (Bnace protocol). Pts iDCluded 33 _lea
lIIICl21 f_lea aged 55+12 yrlI (_ + S.D.); iDcludiug 23
pta with i~ic be8rt disease. -No pt had cliDical
ventricular tacbycardia (VT) or was takiug autiarrhythaic
druo for VA. SAY were recorded _iug bip()lar X1 _ Y. zleaiJa with b!lJlC!peas filters of 25. 50-300 Hz. J.t" were
defiDed by the C:albiuati~ of QRS duration >130 -ec aud
terwiual .-plitude (TA) 40 _ec t;ior to QRS offset) <35
J!V at 25 Hz hie plI8S Ii ter (llPf aDd QRS duratioD >115_ec aud TA ~25)JV at 50 liz at rest or duriDg
exerci.. Exercise-related VA were defiDed as au iDcre-e
or _rgeace of frequeat or .utifocal veatricular
p~ture beats. couplets or VT duriug exercise or
recovery Phase CCJ!IIP8i'ed with baseline. 1lhytJ. was
.uuitored lor at least 3 .iDutea prior to exercise.
during exercise aDd iD the recovery (>base «6 .iD.).
Ilesults for pts with VA duriug exerc~se aud recovery
(G~ I) aDd with VA duriug exercise (Group II) are as
toll-.:
Twenty six patients with coronary artery disease
and an abnormal diastolic blood pressure response
to treadmill exercise (elevation '715 mmHg) were exer-
cised before and after coronary bypass surgery. In
addition 17 of these patients underwent graft restudy
at a mean time of 15 ± 1.5 months post surgery. Follow-
ing surgery the mean ejection fraction improved from
55% ± 3.4 to 68% ± 3.1 (p < o.oon. Eleven patients
had a negative preoperative stress test by ST segment
but had a s'ignificantly lower ejection fraction pre
operation than those with abnormal ST segments (49%
± 2.8 v 64% ± 4.8 p <o.oon. Patients were exercised
at 2 weeks and 3, 6 and 12 months after surgery.
With the improvement in ejection fraction the diastolic
blood pressure response to exercise reverted to normal.
However, an abnormal diastolic blood pressure response
recurred in 4 patients, 3 of whom also developed
ST segment depression on exercise. Graft occlusion
and a reduced ejection fraction was demonstrated at
angiography in all four. The graft patency rate in
the 17 patients studied was 83% at 15 months.
Conclusion: A reduction in ejection fraction is
probably respons1ble for the abnormal diastolic blood
pressure response which occurs earlier than ST segment
depression during exercise testing. The mechanism
is probably reflex vasoconstriction secondary to a
fall1ng card1ac output. When coronary bypass surgery
improves the eject10n fraction normalization of the
diastol1c blood pressure response follows.
EFFECTS OF CORONARY REVASCULARIZATION ON EJECTION
FRACTION AND ABNORMALLY DOCUMENTED DIASTOLIC BLOOD
PRESSURE RESPONSE TO EXERCISE TESTING
Fawaz Akhras MD, John Keates, FRCS,
Graham Jackson, FRCP. King's College Hospital, London, UK
IJ'
AbSeDt---u--
36
Group II
(50 pts)
IJ'
Present--,r-
6
G~ I
(54 pta)
IJ' LP
Preseat Abseat
----g-- ~
6 36
VA Preseat
VA Ab8eDt
*p<.05 vs control. FC-Forearm circumference(cm)
These results demonstrate that unilateral, prolonged,
peripheral immobilization reduces localized maximal
vasodilator capacity. Thus, the peripheral circulation
participates in the detraining process associated with
immobilization.
THE EFFECTS OF PROLONGED UNILATERAL FOREARM IMMOBILIZATIO~
ON MAXIMAL PERIPHERAL BLOOD FLOW.
Lawrence I. Sinoway, M.D., John R. Minotti, M.D., Carl
Sirio, M.D., Timothy I. Musch, Ph.D., William Matthews,
and Robert Zelis, M.D., F.A.C.C., Cardiology, PA State
University, Hershey, PA
FBFBasal
RHBF
R
C
FC
We studied the effects of prolonged forearm casting on
maximal peripheral blood flow in an effort to determine
whether peripheral immobilization leads to reduced local
vasodilator capacity. The subjects (n=4) were studied
within hours of removal of forearm casts applied for
fractured forearms or wrist bones. The forearms were
immobilized for at least 30 days prior to study. Forearm
blood flow (FBF) (ml/min.lOOml) was measured in both arms
of each subject using a strain-gauge plethysmograph
(venous occlusion technique). In addition to basal FBF,
the blood flow response after release of 5 minutes of
arterial occlusion, the peak reactive hyperemic blood
flow response (RHBF), was measured as an index of vasodi-
lator capacity. Minimal resistance (R) and maximal
conductance (C) were derived from the RHBF and mean BP.
Casted Arm Control Arm
3.0 + .5 1.8 + .4
29.6* + 2.4 37.7 + 4.4
3.5* + 8.4 2.8 + .4
.29* ± .05 .39 ± .03
25.8 + .9 27.0 + 1.1- -
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CATHETERIZATION DOES NOT ADD TO CLINICAL AND TREADMILL
DATA FOR PREDICTING PROGNOSIS IN LOW-RISK PATIENTS
Daniel B. Mark, M.D., David B. Pryor, M.D., Kerry L. Lee,
Ph.D., Mark A. Hlatky, M.D., F.A.C.C., Frank E. Harrell,
Jr., Ph.D., Robert M. Califf, M.D., Duke University
Medical Center, Durham, N.C. 27710
To identify patients undergoing treadmill testing (TM)
in whom results of cardiac catheterization (eATH) do not
alter predicted prognosis, we studied 2,722 consecutive
patients (pts) who had a Bruce TM and CATH within 6 weeks.
Pts were followed for up to 10 years (median follow-up 5
years). Surgically treated pts (n=627) were censored at
the date of operation. All exercise-induced ST deviation
> .10 mV was measured using a calibrated grid. Five
clinical and 2 TM variables were independent prognostic
factors in these pts: summary measures of myocardial
damage, angina severity and extra-cardiac vascular
disease, sex, age, amount of exercise ST deviation, and
exercise duration. In the overall population, additional
prognostic data at CATH was obtained from the ejection
fraction, amount of left main and proximal left anterior
descending stenosis and number of stenosed ( ~ 75%)
coronary arteries. CATH data changed Cox model predicted
5 year survival by ~ .01 in 1013 pts (37%). In this
latter group, a low-risk subset could be defined on
clinical grounds: no CHF; no resting Qwaves; stable pain
course; exercise ST deviation < .20 mV; and exercise
duration> 6 minutes. In this subset of 844 pts (31%),
there were 6 left main pts «1%), 58 3 vessel disease pts
(7%) and 9 pts with an ejection fraction ~ 40 (1%). The
majority of pts had < 1 vessel disease and normal LV
function. -
In conclusion, it is possible to identify a low-risk
group of pts using clinical and exercise data in whom very
little added prognostic information is obtained from
catheterization.
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Normals +3.1±3.0% -10:lS.9"/o
TP +19 9t2 9%' t4 7±3.5"/oO
5..1±..aQ..
TP exhibited only a slight change in HR during X1 compared to a 34%
increase in N(p<.001). Cardiac index (CI) rose comparably in both groups
during X1 a~hough by different means:
ASlrpke Index (mVm21 AEnd systorlC index (mVnJ2l.
Rest to X1 Rest to X1
means given ±SEM; X1 • exercise stage 1; 'p<.001 vs N. 2P<.01 vs N.
An increase in the stroke index (SVI), mediated mainly by an increase in
the end diastolic index (EDI) accounted for the rise of CI in TP. The brisk
decrease in the end systolic index (ESI) seen in normals was not observed
in TP and remained essentially unchanged until post exercise. In contrast,
SV and EDV remained unchanged in N, the rise in CI resulting from an
increase in HR. In TP the SV plateaued after the innial rise during X1 and
because peak HR was lower in TP peak CI was less than in N.
These data support the concept that in TP, the rise in cardiac output
during early exercise occurs by augmented preload. Systolic performance
as judged by ESI response to exercise may be diminished by cardiac
denervation and peak exercise CI may be less due to limned preload
reserve and blunted chronotropic response.
POST EXERCISE VITAL CAPACITY: A USEFUL SUPPLEMENT TO
EXERCISE ELECTROCARDIOGRAPHY FOR THE RECOGNITION OF
FUNCTIONALLY SEVERE CORONARY ARTERY DISEASE
Helmut W. Lange, MD, Hugo E. Saner, MD, Anthony M. Cook,
MD, Fredarick L. Gobel, MD, FACC, Claus A. Pierach, MD,
University of Minnesota, Abbott-Northwestern Hospital,
Minneapolis, Mil
To assess whether post exercise spirometry could improve
the recognition of coronary artery disease (CAD) with
significant exercise-induced left ventricular dysfunc-
tion (EXLVDF, defined as a fall in ejection fraction of
at least 5~), we measured the forced vital capacity
(FVC) before and immediately after supine bicycle exer-
cise in q7 subjects (5 normal volunteers [NV] and q2
patients (PTs) undergoing exercise electrocardiography
(EXECG), exercise radionuclide ventriculography (EXRNV)
and coronary angiography for suspected CAD).
The mean change in FVC (+1SD) from rest to exercise was
+1+2~ in NV, 0+7~ in 10 PTs without CAD, +1+6~ in 13 PTs
with CAD but without EXLVDF. In contrast, the mean FVC
fell by 5+9~ (p<O.02) in 19 PTs with CAD and EXLVDF.
The use of a )2~ fall in FVC with exercise as a crite-
rion for the recognition of CAD with EXLVDF had a sen-
sitivity of 63~, specificity of 7Q, and predictive
accuracy (PA) of 69~, which compared favorably with the
PA of EXECG-eriteria ()1mm ST-segment depression or a
maximum workload <50 Watt), whose PA were 6Q~ and 71S,
respectively. The highest PA (76S) was achieved by a
combination of both EXECG-eriteria and the post exercise
FVC.
We conclude that changes in FVC with exercise can be
used as a supplement to the EXECG for the identification
of PTs with CAD and significant EXLVDF by RNV.
Peak
7.6±.4
4,3+ 2
Normals 13.0±.8 67±3 90±3 132:lS 3.3±2 4.6±.2
TP 113+ 9 86+3' 89±3 116+52 36+ 2
CARDIAC DYNAMICS DURING SUPINE EXERCISE FOLLOWING HEART
TRANSPLANTATION: ASSESSMENT BY RADIONUCLIDE
ANGIOGRAPHY
peter W Pllugfelder MD. Paul D. Purves, F. Neil McKenzie MD, William J.
Kostuk MD, FACC, Universny Hospnal, London. Ontario. Canada.
The mechanisms by which the denervated heart responds to supine
exercise were examined in 20 cardiac transplant (TP) recipients 1 to 25 mo
(mean 11.6 mo)following surgery. Results were compared to 15 normal
subjects (N). Left ventricular volumes were determined by equilibrium
gated radionuclide angiography at rest and during graded (25 w
increments), symptom limned supine bicycle exercise. Responses to
exercise are shown below:
Ex Dur Heart Rate cardiac Index (Vrrimn2)
"Dol Res! X1 Pea< Best X1
MECHANISM OF CARDIAC OUTPUT INCREASE DURING DYNAMIC
EXERCISE IN CARDIAC TRANSPLANT PATIENTS
1 2 . 1 1S. Yus~f ' , J. A,~enhead , S'ITheodoropou10s , N.
Dha11a , J. Wittes , M. Yacoub. Harefie1d Hospital,
Middlesex, England and NHLBI, Bethesda
Conclusions: During volume loading and mild EX, increase
in EDV and SV with little change in ESV or HR is the
chief mechanism increasing CO. During more severe EX,
further increases in CO are mediated by increased HR.
Throughout, there is little change in EF. These
responses differ from those reported in normal
individuals and suggests that the denervated heart is
more dependent on a Frank-Starling mechanism.
DIASTOLIC DYNAMICS DURING EXERCISE
Luigi Meloni,M.D,Pierpaolo Giua Marassi,M.D.,Giovanni
Cioglia,M.D.,Angelo Cherchi,M.D.,Institute of Cardiology,
University of Cagliari,Italy.
To assess left ventricular (LV) diastolic dynamics during
exercise, simultaneous recordings of echo-phono-electro_
cardiogram were performed at rest and during sitting bi_
cycle exercise (10 watts/min) in 10 normal subjects, male,
aged 26~3.4 years (mean~SD). Isovolumic relaxation time
(IRT. from the aortic closure sound to the mitral valve
opening), LV filling time (LVFT, from the onset of mitral
valve opening to the mitral valve leaflet coaptation), LV
end-diastolic, end-systolic dimension (ESD) and shorten_
ing fraction (SF) were measured. At rest IRT increased
from supine (54.6~IO.8 msec) to sitting bicycle position
(70.7~7.2 msec, p<O.OOI). During exercise IRT shortened
progressively and significantly (I8.8~5.6, at peak exer_
cise, HR 175 beats/min, p<O.OOI). LVFT decreased from su_
pine (575~IOI msec) to sitting bicycle position (438~I03
msec, p<O.OOI) and during exercise showed a further de_
crease (I47~IO msec, at peak exercise, HR 175 beats/min,
p<O.OOI). When compared with the indexes of systolic func
tion, IRT was directly related to LV ESD (r=0.62, p<O.OOI)
and inversely related to LV SF (r=-O.60, p<O.OOI). Thus,
the progressive decrease of IRT during exercise appears
to be related to the concomitant increase of LV systolic
shortening, according to the positive influence of cardiac
contractility on the rate of myocardial relaxation.
45W
100'*
151±6**
91±7*
129±8**
43±4
87±7**
.70±.03
9.1±.7**
15W
97±2
141±5*
86±4
127±9**
44±4
83±7**
.68±.02
7.9±.6**
HR
SBP
DBP
EDV
ESV
SV
EF
CO
Mechanisms by which cardiac output (CO) increases during
dynamic exercise (EX) was assessed in 17 cardiac
transplant (CT) patients at rest, during volume loading
(leg elevation), and exercise on a bicycle ergometer at
15 and 45 watts. Heart rate (HR), systolic and diastolic
blood pressure (SBP-DBP), end-diastolic volume (EDV), end
systolic volume (ESV), stroke volume (SV) ejection
fraction (EF) and CO were measured by radionuc1eide
angiography. Data are expressed as mean ± 1 SEM.
(*p<O.05 **p(O.OI)
Rest Leg Raising
~ 95±2
126±3 132~4
82±3 84±3
106±7 116±8*
39±3 42±3
67±5 75±6*
.66±.02 .67±.02
6.5±.4 7.05±.5*
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*P<0.002 and **<0.03 WTA versus TA; AEF - Exercise EF -
Rest EF; t.RPP = Peak RPP - RPP at onset of angina.
In contrast to TA patients, WTA patients exercise
further after onset of angina, increase their EF with
exercise and have persistent ExWMA associated with com-
plete resolution of their chest pain.
CONCLUSIONS: In patients with WTA: 1) Wall motion abnor-
malities persist despite relief of angina symptoms. 2)
Increased peak exercise ejection fraction suggests less
compromise of global left ventricular function. 3) The
increased presence of nonjeopardized col laterals may
playa role in limiting the area of myocardium at risk.
PERSISTENT ABNORMALITIES IN SEGMENTAL MYOCARDIAL CONTRAC-
TILITY IN "WALK THROUGH ANGINA", Stephen A. Stowers, M.D.,
F.A.C.C., Donald A. Conetta, M.D., F.A.C.C .• Theodore A.
Bass, M.D., F.A.C.C., Alan B. Miller, M.D., F.A.C.C.,
University of Florida, College of Medicine, University
Hospital, Jacksonville, FL
To understand adaptation to exercise in patients with
"walk through angina" (WTA) we studied 19 patients with
angiographic proven coronary artery disease. Six pat-
ients with WTA and 13 control patients with typical
angina (TA). We measured 2 view radionuclide angio-
graphy exercise wall motion abnormalities (ExWMA) , ejec-
tion fraction (EF) changes, exercise heart rate, blood
pressure and angina severity. (l 7 10, mild ~ severe).
Rate pressure product (RPP) was calculated at onset of
angina and at peak exercise.
Results (as mean ± S.E.M.):
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COMPARATIVE EFFECTS OF B-BLOCKADE, CALCIUM ANTAGONISM,AND
THEIR COMBINATION ON MAXIMAL EXERCISE PERFORMANCE IN PHY=
SICALLY ACTIVE MEN.
Neil F. Gordon, M.B.B.Ch., Johan P. van Rensburg, M.Sc.,
and Dirk P. Myburgh, M.B.Ch.B., F.A.C.C., Institute for
Aviation Medicine, Pretoria, South Africa.
When selecting an antihypertensive drug for physically ac=
tive patients it is essential to consider its effect on
effort tolerance. The purpose of this study was to compare
the effect of B-blockade, calcium antagonism, and their
combination on maximal performance in physically active
men, and to establish the ventilatory responses to graded
treadmill testing that accompany dual B-blockade and cal=
cium antagonism. Clinically used doses of propranolol
(PROP), atenolol (ATEN), nifedipine (NIFED), PROP+NIFED,
and ATEN+NIFED were administered with placebo for 4d each
to 12 healthy, physically active, young men. Maximal per=
formance was reduced to a greater degree (p<O.OS) with
PROP (8.8%,p<0.001) and PROP+NIFED (ll.l%,p<O.OOl) than
with ATEN (3.2%,0.05<p<0.1), NIFED (2.1%,p<0.OS), or ATEN+
NIFED (3.9%,p<0.01). Maximal performance and chronotropic
and ventilatory responses to maximal work were equivalent
with a B-blocker and its combination with NIFED. At sub=
maximal exercise, B-blockade reduced the heart rate and
O. consumption; NIFED accentuated the heart rate but did
not alter ventilation; all drugs modified the relative
O. consumption corresponding to 85% of the maximal heart
rate; and physiologic responses during dual B-blockade
and calcium antagonism were similar to those with B-bloc=
kade alone. This study concludes that ATEN, NIFED, and
ATEN+NIFED, in contrast to PROP and PROP+NIFED, induce
only minor impairments in the maximal performance of
physically active men. Furthermore, chronotropic and
ventilatory responses to exercise testing during dual B-
blockade and calcium antagonism can be predicted from
that during B-blockade.
~pp(lO-3)*
TA 2.1±0.8
WTA 8.9±3.6
~F(%)*
-4. 2±1. 5
+5.1±2.1
ExWMA
11/13
6/6
Nonjeopardized
Co11aterals**
3/13
5/6
RAPID CHANGES IN BETA ADRENERGIC RECEPTOR NUMBERS AFTER
EXERCISE IN SEDENTARY AND TRAINED SUBJECTS.
Margaret R. Eisinger, M.D., Richard S. Engelmeier, M.D.,
Patrick J. Scanlon, M.D., F.A.C.C., Loyola University
Medical Center, Maywood, Illinois.
Although various conditions are known to alter beta adren-
ergic receptor numbers (BAR), the rate of change of human
BAR is unknown. Since chronic submaxirnal exercise train-
ing regulates lymphocyte BAR, we evaluated acute changes
occurring in lymphocyte BAR after maximal treadmill exer-
cise in 9 healthy subjects. Five sedentary individuals
(S) were otherwise similar to 4 actively exercising sub-
jects (EX) in age (30±2.3 vs 30±2.5), sex (3 vs 4 male),
occupation and absence of medication. All subjects exer-
cised to exhaustion by the Bruce protocol, and had lympho-
cyte BAR measured immediately before and after exercise.
Lymphocytes were separated from 25cc of blood across a
Ficoll-Hypaque density gradient at 70-80% efficiency. BAR
was measured by incubating membrane preparations with 7
dilutions of 1125 cyanopindolol in the presence or absence
of luM(-) propranolol in a total assay volume of 450ul.
BAR was standardized to Lowry-Peterson protein at rest
(RBAR fm/mg) and exercise (ExBAR fm/mg) and to lymphocyte
number at rest (RBAR fm/lym) and exercise (ExBAR fm/lym)
and expressed as mean ± SD:
~ RBARfm/mg EXBAR fm/mg RBARfm/lym EXBARfm/lym
S *[73±Z4]****256±22 ] ** *[146lb4l***353l~721J*
Ex 46±30 ***142±30 1302±24 ***2646±705
*p=NS, **p<.005, ***P<.OOl I I
Maximal exercise was significantly better in trained (18.6
±lmin) vs sedentary (14.5±3min) subjects (p<.05). KD did
not change after exercise, and specific binding was 86±9%.
Conclusions: 1) BAR increase 2-3 times above control after
exercise and this increase is independent of exercise in-
duced lymphocytosis. 2) BAR increase is less in Ex than in
S subjects, even though the former exercise longer.
PREOPERATIVE SUPINE EXERCISE RADIONUCLIDE ANGIOGRAM
PREDICTS PERIOPERATIVE CARDIOVASCULAR EVENTS IN
VASCULAR SURGERY.
S.L. Kopecky, M.D., R.~ Gibbons, M.D. FACC, L.H. Hollier,
M.D. FACC, Mayo Clinic, Mayo Foundation, Rochester, MN.
To predict perioperative cardiovascular (CV) events
in high risk patients (pts) undergoing peripheral vascu-
lar surgery (VS), we studied 114 consecutive pts with
known or suspected coronary artery disease who underwent
a supine exercise radionuclide angiogram (RNA) prior to
surgery. Pts with prior CABG were not included. Four
pts were excluded due to inadequate RNA imaging. The
exercise began at a low workload and increased until one
of the following: marked ST segment depression (> 2
mm), moderate angina, arrhythmia, or severe fatigue.
There were 8 perioperative events (7%) in the 110 pts
-4 deaths and 4 myocardial infarctions (MI). The CV event
group did not differ from the non event group with re-
gards to age, sex, incidence of prior MI, anginal class,
rest ejection fraction, change in ejection fraction or
appearance of new regional wall motion abnormalities at
peak exercise. However, all 8 events occurred in pts un-
able to exercise OVer 400 kilogram-meters/minute (Kg M/M)
workload.
Workload Total
(k M/M) Pts. Deaths MI Events
~ 400 63 4 4 8 p=.Ol for
total
> 400 47 0 0 0 events
CONCLUSION: Peak workload, but not indices of left
ventricular function, during supine exercise RNA pre-
dicts a subgroup of patients with a high risk of
perioperative CV events during VS.
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CARDIAC OUTPUT DURING UPRIGHT EXERCISE IN
CHILDREN WITH AORTIC STENOSIS
Stephen Cyran, M.D., Frederick W. James, M.D., F.A.C.C.,
Wayne Mays, M. Katherine Mackzum, Samuel Kaplan, M.D.,
F.A.C.C., Children's Hospital Medical Center, Cinti., Ohio
Few completely non-invasive and independent methods for the
determination of cardiac output during exercise have been
reported in children. We studied 14 consecutive patients, mean
age I2± 5 yrs, with isolated valvar or discrete subvalvar aortic
stenosis during upright cycle ergometry. Patients rebreathed a
mixture of C2H2, He, N2 and 02 at rest and peak exercise; CO
was determined from a time concentration curve derived from
analysis of exhaled gases. l\1l studies were preoperative, and a
cardiac catheterization was performed within 3-6 months.
Oxygen consumption, heart rate (HR), and diastolic and systolic
pressure were measured independently. CI, systemic vascular
resistance index (SVRI) and stroke volume index (SVI) were
derived. Patients were assigned to one of two groups on the basis
of their resting aortic valve gradient. Results (*p<O.Ol)
CO CI 2 SVRI SVI 2 HR
Total (Lfmin) (L/mm/M ) (+) (cc/M )
Rest 5.3± 1.7 * 4.2± 1.1* 1176±654* 50± 16 75± 13 *
Exercise 12.3±4.5 9.5± I.~ 2582±359 57±8 180±25
Grad.<30mmHg +(dynes sec/cm /M )
Rest 5.5±1.6*4.8±1.0* 11I7±566,. 57±13 75±14*
Exercise 12.2±5.4 9.9±2.0 643±436 60±10 178±32
Grad.~30mmHg
Rest 5.0± 1.8* 3.7± 1.0* 1235+773* 42+16 75+13 *
Exercise 12.4±3.9 9.0± 1.1 522±285 59± 15 182± 18
At rest, patients with a gradient <30 mmHg tended to have a
greater CI and SVI (p<o.on than those with a gradient ~30
mmHg. These differences were abolished at peak exercise
suggesting that patients with more severe aortic stenosis were
able to augment their stroke volume during exercise. CI during
exercise negatively correlated with SVRI (coef.-0.60,p<0.03)
indicating that a decrease in SVR may be the causative factor.
The magnitude of peak Dv during Asys did not reflect
changes in LV volume, nor relate either to peak Dv
during RF or LV mass, which was 220±38 g. in AVS and
245±29 g. in CM. Peak Dv in Asys and the ratio of peak
Dv(Asys)/peakDv(RF) in the total pt population both
correlated with the ratio LV mass/volume (r=.80, slope=
.76; and r=.80, slope=.69), p<.Ol. We conclude that MV
Dv correlates with LV architecture and not with absolute
LV mass or with changes in LV volume.
LEFT VENTRICULAR DIASTOLIC FILLING DYNAMICS IN ACUTE MYO-
CARDIAL INFARCTION: IMMEDIATE EFFECTS OF ISCHEMIA, TIME
COURSE IN FIRST 6 HOURS AND RELATION TO INFARCT SIZE.
Maxine Rosoff, M.D., FACC, John Funai, M.D., Shan Shen
\~ang, M.D., Natesa Pandian, M.D. Tufts-New England
Medical Center, Boston, Massachusetts.
To assess the effects of acute myocardial infarction on
LV diasto1 ic fill ing we employed Dopp1 er echocardiography
(DE) and analyzed mitral flow velocity in 8 heart rate
contro11 ed dogs (atrial pacing), which underwent total
left anterior descending coronary occlusion (CO). Mitral
flow velocity (MFV) data were obtained in control (C), 5
minutes after CO and hourly for 6 hours. Pathologic in-
farct extent was delineated by TTC staining and size de-
termined as %LV infarcted. From MFV, early filling velo-
city (E) and late filling velocity (A) were measured and
E/A ratio calculated. Results: (i±SE): E/A ratio in C was
1.6±0.2. Following CO, E/A ratio was: 5 min: 0.51±0.l, 1
hr: 0.74±0.2; 2 hrs: 0.75±0.3; 3 hrs: 0.74±0.3; 4 hrs:
0.45±0.2; 5 hrs: 0.47±0.2; and 6 hrs: 0.26±0.2 (All p<.05
compared to C). These changes were coupled with a sus-
tained elevation in LV end-diastolic pressure from 10±1 to
16±2 mm Hg. Individually, E/A ratio fell to less than 0.8
in 7/8 dogs at 5 min of CO regard1 ess of eventual infarct
size. Infarct size ranged from 17 to 64%LV with a mean of
38±5%. In 4 dogs with infarct size >28%LV, E was totally
abolished with LV filling occurring only during A during
the 6 hour follow-up. Even though the E/A ratio fell
significantly in the remaining dogs, there was no clear
relationship between infarct size and the magnitude of
change in E/A ratio. We conclude that 1) ischemia acutely
impairs LV early diastolic filling irrespective of even-
tual infarct size, 2) fill ing dysfunction once estab1 ished
early remains abnormal for 6 hours and 3) there appears to
be some but imprecise relation between the extent of
fill ing dysfunction and infarct size.
ASSESSMENT OF DIASTOUC LEFf VENTRICULAR FUNCI10N
BY DOPPLER: COMPARISON WInI CATIIETERIZAnON
MEASUREMENTS
Njksa Drinkovjc M 0, Thomas Wisenbaugh, M.D., Oi Ling Kwan,
Jonathan Elion, M.D., Mikel Smith, M.D., Anthony N. DeMaria, M.D"
FACC; University of Kentucky, Lexington, Kentucky
Although measurements ofLV ftlling velocity may be readily obtained
from Doppler recordings, few data are available comparing Doppler with
catheterization assessment of LV diastolic function. Therefore, we
performed continuous wave Doppler examination of transmitral flow
velocity in 20 patients without aortic regurgitation who underwent car-
diac catheterization. At catheterization, high fidelity pressure measure-
ments from micrornanometer tip catheters were obtained simultaneously
with cineangiographic LV volumes to construct pressure-volume plots
during diastole. Doppler examination was performed in the 4 chamber
apical view with the sample volume positioned through the center of the
mitral orifice. Doppler measurements included: maximal velocity during
early diastolic filling(E) and atrial contraction(A); integrated velocity ofE
and A diastolic ftlling waves; the ratio ofE to A for both maximal and
integrated velocities; and the time to peak early diastolic velocity (TPE).
Catheterization assessment ofdiastolic function, included maximal
negative dp/dt (an index ofLV relaxation), as well as the slope of the log
pressure(p)/volume(V) relationship(K) and dV/ VdP, (indices of LV
passive elastance). The ratio ofearly and atrial filling velocities
demonstrated a correlation with indices of passive elastance, with opti-
mal correlation coefficients: r=.60 for rnaxirnaI FJA vs dVN dP and
r =.68 for integratedEl.A. TPE correlated best with an index ofLV dia-
stolic relaxation: r=.81 for TPE vs negative dp/dt. Thus, these data indi-
cate that Doppler velocity recordings may be of value in assessing LV
diastolic function. Individual Doppler measurements appear to correlate
best with specific diastolic properties. The optimal correlation exists
between time to peak early diastolic velocity by Doppler and LV
relaxation represented by maximal negative dpldt.
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DOPPLER EVALUATION OF LEFT VENTRICULAR DIASTOLIC FILLING
BEFORE AND AFTER CORONARY ANGIOPLASTY Barry E. Wind, MD,
A. Rebecca Snider,MD,FACC, Andrew J. Buda,MD,FACC, William
W. O'Neill,MD, Eric J. Topol,MD, Univ of MI, Ann Arbor,MI
To determine if diastolic function is altered post-PTCA
in patients with ischemic heart disease(IHO) and normal
systolic function, 17 lHO patients and 19 normals had
pulsed Doppler(Dop) exams of the LV inflow. IHO patients
were examined 1 day before and 1 day after PTCA. Pre-PTCA,
IHO patients had typical angina, >70% stenosis in 1 or 2
coronary arteries with >40 mm translesional gradient, and
LV ejection fraction >50%. Post-PTCA, IHD patients had no
recurrent angina, no residual ischemia by thallium ETT,
and <40% stenosis with residual gradients < 15 mm. Dap
peak-velocities at rapid filling(E vel) and atrial con-
traction(A vel) and the ratio E/A were measured. The fol-
lowing Dop areas and their % of the total area(TA) were
determined: 1st 33% of diastole(.33 area), and triangles
under the A vel(A area) and E vel(E area). Pre-PTCA, IHD
patients differed from controls(p<.Ol) in E vel(pre=.s7±
.10,NL=.68±.12 m/s), A vel(pre=.s8±.13,NL=.3s±.08m/s), EIA
ratio(pre=1.03±.28,NL=2.03±.s8), and Dop areas(table).
Post-PTCA, E vel(.ss±.10 m/s), A vel(.s7±.12m/s), E/A
ratio(1.0±.27) and Dop areas did not differ from pre-PTCA.
E area E <irea A area A area .33 area .33 area E area
---rA ---rA -T-A- ~
NL .093±-019 .63±-06 .024'.006 .17±-05 .087'.02 . 59±-05 4.1'1.6
PRE .079'.016 .56;.07 .050>.015.36;'11 .065'.02 .46±-11 1.7;.53
POST .072'.012 .54±-09 .047>.016.35±.11 .063±.02 .46±.09 1.7;.46
conclusion: In patients with IHO and preserved systolic
function, diastolic filling abnormalities are detectable
by Dop echo. These diastolic abnormalities are unimproved
24 hours after PTCA despite angiographic, pressure grad-
ient, thallium ETT, and clinical evidence for successful
abolition of ischemia. Chronic myocardial ischemia there-
fore alters diastolic compliance in a manner which is not
immediately reversible following relief of ischemia.
ANALYSIS OF LEFT VENTRICULAR WALL MOTION BY PULSED DOPPLER
ECHOCARDIOGRAPHY - APPLICATION TO ASSESSMENT OF MYOCARDIAL
FUNCTION, Karl Isaaz, MD, Jean L, Cloez, MD, Gerard Ethe-
venot, MD, Nicolas Danchin, MD, Beatrice Perrot, MD, Clau-
de Pernot, MD, FACC, Department of Cardiology, UNIV of
Nancy, France,
The purpose of this study was to examine the value of pul-
sed Doppler Echocardiography (PDE) in assessment of left
ventricular posterior wall (LVPW) motion. We studied 21
normal adult patients (pts) and 11 pts with impaired sys-
tolic LV function (angiographic systolic ejection fraction
< 0,50), Two-dimensional images of the LV was obtained
by placing the transducer in a standard short axis orien-
tation and the Doppler sample volume was placed at the
level of the LVPW endocardium just inferior to the mitral
valve sulcus. The angle between Doppler sampling direction
and direction of the mitral inflow was about 90° so that
no Doppler shift frequency could be produced by the axial
blood flow. The high-pass filter was set to 100 hertz so
that the doppler shift frequencies of low frequency pro-
duced by the moving heart wall could be recorded. Slight
adjustments in transducer angulation and sample volume
position were required to maximize the audio and graphic
quality of Doppler signal. The doppler waveforms was mor-
phologically similar to the rate of change of the LVPW
thickness obtained by a digitized echocardiogram, and per-
mitted direct measurement of maximal LVPW velocities du-
ring systole and diastole. In normal pts, the maximalLVPW
velocity ranged from 7.1 to 11.scm/s (mean 8.7+1.1) in
systole, and ranged from 13.2 tp 24.3 cmls (mean 19.5 +
2.9) in diastole. By contrast, the average values for the
11 pts with impaired systolic LV function was depressed
to s.7:::0.9cm/s in systole (p <0.01). We conclude that PDE
may be used for analysis of instantaneous LVPW velocities,
providing a new method for assessment of LV function.
Thursday, March 13, 1986
8:30AM-IO:OOAM, Room #264/265/266
Intra-operative Doppler Echocardiography
In patients (pts) undergoing mitral valve surgery, a
method for the intraoperative evaluation of mitral valve
function just prior to and immediately following
cardiopulmonary bypass would be clinically useful. We
assessed the value of intraoperative transesophageal
Doppler echocardiography in six pts undergoing mitral
valve valvuloplasty (MVplasty) or replacement (MVR). Two
pts had rheumatic mitral stenosis (MS), two pts had
mitral regurgitation (MR) due to mitral valve prolapse
(MVP) and two pts had bioprosthetic malfunction. In pts
with MS the presence and severity of MR was assessed
intraoperatively by Doppler to guide the surgical
decision between commissurotomy versus valve replacement.
In the two pts with MVP-MR, posterior MVplasty with Duran
ring implant was performed. In these, the adequacy of
repair was assessed intraoperatively by the absence of
demonstrable MR as the pta were weaned from
cardiopulmonary bypass. The decision to defer valve
replacement was based partially on these studies.
Similarly, in the four pts undergoing MVR, normal
prosthetic function (no significant MS or MR) was shown
intraoperatively. Follow-up precordial Doppler
echocardiography on all six pts showed no MR in three
pts and slight MR in three others. In conclusion, this
technique appears to have value in the intraoperative
assessment of the results of mitral valve surgery. The
sensitivity of transesophageal Doppler echocardiography
1n the detection of MR is comparable to that of the
precordial techniquL The limitation on transducer
positioning intrinsic to the transesophageal approach may
present difficulty in the detection of small
eccentrically-directed mitral regurgitant jets.
INTRAOPERATIVE ASSESSMENT OF MITRAL VALVE REGURGITATION
BY TRANS ESOPHAGEAL DOPPLER ECHOCARDIOGRAPHY
Bruce Shively, M.D., Michael Cahalan, M.D., David
"!eiimeI M.D., Nelson Schiller, M.D., F.A.C.C.
A CSA
1.8 ± 1.3*
0.3 ± 0.2
PPH
N
ABNORMAL PATTERNS OF LEFT VENTRICULAR FILLING IN
PATIBNTS WITH PRIMARY PULMONARY HYPERTBNSION,
ASSESSED BY DOPPLER BCHOCARDIOGRAPHY.
Eric K. Louie, M.D., F.A.C.C., Stuart Rich, M.D., F.A.C.C.,
Bruce Brundage, M.D., F.A.C.C., Universityof Illinois Hospital,
Chicago,lllinois.
Patients (pts) with primarypulmonaryhypertension(PPH) are
thought to have intrinsically normal LV function. 2D-echo,
however, shows that the ventricular septum is abnormally
displaced towards the LV in systoleand early diastole in these
pts raising the possibilitythat LV fillingmightbe alteredby RV
compressionof the LV. To studythis hypothesis,9 pts with PPH
(mean PI. pressure = 61 ± 20mmHg, pulmonary vascular
resistance:: 18 ± 8 Wood Units) and normal pulmonarycapillary
wedge pressure= 6 ± 4mmHg were compared with 9 normal pts
(N). LV isovolumic relaxationti;ne (IVR) obtainedfrom M-mode
echo; ratio of late to early peak LV inflow velocity (A/E)
measured by pulsed Doppler; and fractional increase in LV
cavity cross-sectionalarea measured before and after atrial
systole (A CSA) derived from 2D-echo short axis views at the
papillarymuscle level were analyzed:
IVR (msec) A/E
108 ± 31** 1.7 ± 0.5**
49 ± 7 0.6 ± 0.2
**p< .001, *p <.01 for PPH vs. N
In PPH IVR is prolonged and the inversion of the A/E ratio
suggests that early inflow velocity is impeded while late inflow
velocity is augmented. Correspondinglythe increasedtlCSA
indicates that atrial systole contributesa larger than normal
proportionto LV filling. In conclusionin PPH LV filling is
characterizedby increased late inflow followingatrial systole
to compensate for Impaired early diastolic filling; the latter
abnormalityresultingfrom compressionof the L V by the RV in
early diastole. These {iruIingssuggest that the LV in PPH moy
be particularlysensitive to alterations in preload and this may
have importantimplications for vasodilatortherapy.
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DOPPLER ECHOCARDIOGRAPHIC MEASUREMENT OF CARDIAC OUTPUT
USING AN IMPLANTABLE AORTIC TRANSDUCER.
~Ililam J. Stewart. M.D., F.A.C.C" ~Ililam A. Schiavone,
D.O., F.A.C.C., Ernesto E. Salcedo, M.D., F.A.C.C., Paul
Rom, Altagracia M. Chavez, M.D., Delos M. Cosgrove, M.D.,
F.A.C.C.
Cardiac output In post-operative cardiac surgery pts has
traditionally been measured uSing thermoollutlon techniques
(TDCO). In other settings, Doppler echocardlography has
been used to calculate cardiac output (DCO) uSing the
product of the cross-sectional area (CSA) of tne aorta, tne
mean velocity (V) derived from the Doppler signal, and the
heart rate. ~e studied 11 patients with a miniature Doppler
probe Implanted In the ascending aortic adventitia. CSA was
derived from direct caliper measurement of aortic diameter.
Postoperatively, V was measured by 0 In order to calculate
cardiac output continuously. Simultaneous TDCO and DCO
were compared at baseline, after volume loading, during
Dopamine infusion, and during atrial pacing. The Doppler
transducer was removed within 24 hours with no complica-
tions. Results: In 7 of the 11 pts, DCO correlated
significantly with TDCO (r values ranged from .57 to .92).
Of 4 pts In whom DCO did not correlate significantly with
TDCO, 2 had aortic prostheses and In one, a obvIous change
In the V signal Indicated a shift In transducer position.
In 4 pts, a CSA setting other than that measured by
calipers was needed to make the volumetric flow Similar to
the TDCO measurement. Reproducibility of DCO (r = .98) was
superior to TDCO (r = .91). ConclUSions; 1) DCO measure-
ment uSing an Implantable probe IS a safe and promising
technique which needs further refinement; 2) DCO measures
relative changes In flow adequately; however, accurate
measurement of absolute volumetric flow IS limited by
inaccuracies In CSA measurement 3) DCO gives reproducible
minute-to-mlnute flow data, without the repeated InJections
or nursing attention required for TDCO.
INTRAOPERATIVE DOPPLER MEASUREMENT OF MITRAL REGURGITANT
FL(J.l VELOCITY COMPARISON ~ITH THE SYSTOLIC LEFT
VENTRICULAR TO LEFT ATRIAL PRESSURE GRADIENT.
~illiam J. Stewart. M.D., F.A.C.C" ~Ililam A. Schiavone,
D.O., F.A.C.C., Ernesto E. Salcedo, M.D., F.A.C.C., Andrew
Benko, B.S.E.T. Carl C. Gill, M.D., F.A.C.C., Bruce W.
Lytle, M.D., F.A.C.C., Delos M. Cosgrove, M.D., F.A.C.C.
The Cleveland Clinic Foundation, Cleveland, Ohio.
PrevIous studies of Doppler (D) echocardlography In tri-
cuspid regurgItatIon and in pts With stenosIS of the aor-
tiC, mitral, pulmoniC, and tricuspid valves, show that the
o estimation of gradient (G-DOP) correlates well With In-
vaslvely measured pressure gradient (G). To evaluate If
G-DOP also correlates With the systoliC left ventricular
to left atrial pressure gradient (G) In mitral regurgita-
tion (MR) , we measured MR velOCity (V) Intraoperatively In
13 patients uSing sterile 0 transducers placed directly on
the heart. G was measured Simultaneously uSing direct
puncture of the LV and LA and solid state hub transducers.
G-20P was calculated uSing the Bernoulli equation (G-DOP =
4V ).
Results: In 10 pts G-DOP varied from 41 to 159 (mean 84.4)
mm Hg, while G varied from 54 to 163 (mean 84.2) mm Hg;
the mean difference between G and G-DOP was only 10.6 ~
9.7 (range 0 to 31) mm Hg. The shape of the V envelope
reflects the algebraic difference between LA and LV
pressure. In 3 pts With flail mitral valves, 0 Signals
did not show a clean envelope despite the advantages of
intraoperative access.
ConclUSions: The BernOUlli equation appears to govern the
relationship between V and G In MR, Similar to the phYSICS
present In valvular stenosIs. ThiS allows a better under-
standing of the V patterns seen In MR. However, D recor-
dings of V In MR are not presently accurate enough to
derive LV filling pressures nonlnvaslvely.
ANALYSIS OF FLOW VELOCITY PROFILE AT THE AORTIC ROOT
MEASURED WITH ULTRASONIC PULSED DOPPLER TECHNIQUE.
Megumi Mathison, M.D., Hiroshi Matsumoto, M.D., Ph.D.,
Ken-ichi Asano, M.D., Ph.D., Univ of Tokyo, Tokyo, JAPAN.
Although it has been believed that the flow velocity
profile at the aortic root is uniform like a trapezoid,
our recent study about aortic valve calcification
suggested that somewhat jet-like flow velocity distri-
bution might exist at the aortic root. To analyze the
distribution of flow velocity at the aortic root, special
apparatus using ultrasonic pulsed doppler, connected to
the computer and the display, with the direct probe on
the aortic wall was designed. The flow velocity profiles
were described by the three-dimentional graph. Six
patients were examined when they underwent the open heart
surgeries, none of 6 subjects were related to the aortic
valve diseases; three with ASD, two with coronary artery
disease, one with mitral valve disease. Jet-like flow
patterns were always found and it was also shown that
the jet was not in the center, but obliquely toward the
right. In conclusion, in this study we have demonstrated
the jet f~rmation at the aortic valve.
•\
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THE COLOR CODED MULTIGATE M-MODE DOPPLER DISPLAY IN A
REAL-TIME FLOW MAPPING SYSTEM: DOES IT PROVIDE ADDITIONAL
INFORMATION? Richard E. Swensson,M.D.,F.A.C.C., David J.
Sahn, M.D.,F.A.C.C., Lilliam M. Valdes-Cruz, M.D.,
F.A.C.C •• Kyung J. Chung, M.D., F.A.C.C., Frederick S.
Sherman, M.D., Univ of Calif, San Diego, CA.
We examined the information content of the color coded
multigate Doppler M-Mode or MQ display obtained along
with 20 flow mapping and single-gate spectral Doppler in
14 patients(PTS) with ventricular septal defects(VSD), 7
PTS with patent ductus arteriosus(PDA), and 4 open chest
dogs with a variable sized AD to PA "PDA-like" shunt. In
the VSD PTS at heart rates >IOO/min, the IS frame/sec
rate of the 20 flow map made it difficult to appreciate
in real-time, bidirectional shunting, present at cathet-
erization in 5. Single-gated spectral Doppler demonst-
rated the bidirectional shunt in only 4 PTS, even when
sampling under 20 flow imaging guidance. The MQ display
by showing flow direction proximal and distal to the
position of the single gate gave additional information
as to the timing of formation of both left-to-right and
right-to-left shunt jets and their penetration across the
septum. In the 7 PDA PTS and in the animal model of var-
iable PDA, we found that the 2D flow map localized the
ductal shunting stream but that the MQ display showed
more accurately the phasic timing of its penetration into
the PA towards the pulmonary valve. In small PDA shunts
the MQ mode showed that especially in systole, the ductal
shunt was sequestered in the distal PA by forward flow
and was directed into the left PA so that it did not pen-
etrate the main PA or appear on the main PA sampled spec-
tral Doppler. The real-time flow map, single-gate spec-
tral and MQ modes of Doppler display each have a unique
information content. The MQ display has the advantage of
a fast multigate sampling rate to aid delineation of
cardiac physiology, especially in shunt lesions.
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Pacing+N
129±14
94±1l**
10±4**
1B±3**
8±3
3.2±.5**
HOW SENSITIVE IS STRESS DOPPLER ECHOCARDIOGRAPHY IN THE
DETECTION OF TRANSIENT ISCHEMIA IN CORONARY STENOSIS?
Morgan Werner MD, John Funai MD, Shan Shen Wang MD,
Natesa Pandian MD. Tufts-New Engl. Med. Ctr., Boston, MA.
Our aim was to assess the effects of transient stress-
induced ischemia on aortic flow velocity (AFV) in the
setting of coronary stenosis. To do this we studied 5 dogs
in which experimental one or two vessel coronary stenoses
were created using a cal ibrated occluder. Atrial pacing
stress was employed and 20 instances of ischemia were pro-
duced. Presence of ischemia was verified by the develop-
ment of LV wall dysynergy detected by 20 echo. Using Dop-
pler echocardiography (DE) we recorded the AFV in the dogs
with coronary stenosis during resting state without ische-
mia and again immediately after development of stress in-
duced ischemia. From the aortic flow profile we measured
peak velocity (PV) and acceleration rate (AR). A wall
motion score was computed incorporating both the spatial
extent and the magnitude of LV dysynergy. A wall motion
score less than 70 indicated mild dysynergy; 70-I20=mode-
rate LV dy~ynergy and greater than 120=severe dysynergy.
Results: (x±SD). PV was 0.8±.18 m/s in restin~ coronary
stenosis and 0.79±.16 during stress ischemia (p=NS). PV
increased during 8 ischemic episodes, showed no change
during 2 and fell during 12 episodes. AR was 13.04±4 m/s 2
during resting coronary stenosis and 11.2±4 m/sec2 during
stress ischemia (p<.Ol). AR fell during all but 3 of the
20 instances of ischemia. AR always fell whenever the wall
motion score exceeded 70. We conclude that: 1) measurement
of aortic peak velocity is not sensitive in detectin~
transient myocardial ischemia, 2) a decrease in aortlC
flow velocity acceleration rate is a sensitive indicator
of transient ischemia in coronary stenosis only when there
is significant LV dysynergy. These findings indicate a
need for caution in the use of stress Doppler echocardio-
graphy.
Thursday, March 13, 1986
lO:30AM-12:00NOON, Room #264/265/266
Anti-Ischemic Drug Therapy
ISOSORBIDE 5 MONONITRATE AS MONOTHERAPY IN PATIENTS
WITH CHRONIC STABLE ANGINA
Fawaz Akhras, MD, Graham Jackson, FRCP. Cardiac
Department, King's College Hospital, London, England UK
Isosorbide-5-mononitrate (ISMN) is not subject
to first pass metabolism. To evaluate its efficacy
as monotherapy in patients with chronic stable angina
14 patients with coronary artery disease were studied.
All were limited by angina on a treadmill exercise
test. After a 2-week placebo period ISMN was admin-
istered in a single blind fashion titrating the dosage
at 2 week intervals. The increments were 20 mg once
daily, 20 mg twice daily, 40 mg once daily and 40
mg twice daily. Patients were assessed subjectively
by anginal attack rate and glyceryl trinitrate (GTN)
consumption and objectively by treadmill exercise
testing at 12 hours post dosage. ISMN increased the
exercise ability significantly from 319 ± 21 (SE)
sees on placebo to 394 ± 26 (p <0.001) on 20 mg once
daily to 434 ± 27 (p < o. 001) on 20 mg twice daily
to 445 ± 26 (p < 0.001) on 40 mg once daily and to
465 ± 27 (p <: 0.001) on 40 mg twice daiy, increases
of 24, 36, 39 and 46J respectively. However, a signi-
ficant reduction in ST segment depression occurred
only wlth the twice daily regimes. This objective
improvement was associated with a significant decrease
in anginal attacks from 21.4 ± 5.7 on placebo to 11.3
± 4.5 (p < 0.001) on 20 mg twice daily, to 10.9 ± 4.6
(p<O.OO1) on 40 mg once daily and 7.1 ± 3.0 (p<O.OO1)
on 40 mg twice daily, a reduction of 48J 50J and
67J respectively. GTN consumption decreased similarly.
ISMN is an effective antianginal agent with no signs
of early tolerance. Whilst no significant difference
emerged between 20 and 40 mg twice daily individual
variations occurred, indicating a need for dosage
flexibili ty.
NlCARDIPINE INCREASES MYOCARDIAL CONTRACTILITY AND
REDUCES PACING INDUCED ISCHEMIA.
Martin A. Josephson, M.D., F.A.C.C., Kristine Coyle,
B.A., Barbars Behnke, R.N., Bramah N. Singh, M.D.,
Ph.D., F.A.C.C., Wadsworth VA Medical Center, Los
Angeles, CA.
The hemodynamic and anti-ischemic effects of nicardi-
pine(N), a new dihydro~yridine calcium antagonist, are
poorly defined. Therefore, 17 patients with coronary
artery disease(CAD) undergoing catheterization were
given N 2mg bolus followed by a 6 mg infusion over 30
min. producing a mean serum N of 147 ± 30 ng/ml.
Standard hemodynamic variables, radionuclide left
ventricular ejection fraction(LVEF), and
thermodilution coronary sinus flow(CSF) were measured
at rest and during pacing-induced ischemia before and
after N. Results:Means ±SD:
Control vs N Pacing vs
HR(beats/min) 71±13 79±14** 129±14
AO(mmH~ 107±14 85±9 ** 124±lB
PCW(mm) 9±4 B±3 15±5
PAlmmHg , 15±3 16±4 21±4
RA DlDHg B±3 B±2 9±3
CI L/min/M2) 2.2±.3 2.8±.4** 2.6±.5
LV e/dt 1509±376 1660±465 (n-B)
CSF(ml/min) 105±5B 154±8B** 18B±117 169±67
MV02 (ml/min) 10±5 9±5 21±13 14±6*LVEr(%) 57±9 6B±7** 4B±12 63±10**
(*p<0.05 **P<O.Ol Comparison between control
and N, and between Pacing and Pacing+N).
N reduced systemic and coronary resistance before
(39%; 46%) and after (39%; 14%) pacing. N also
decreased pacing-induced angina and improved %
myocardial lactate extraction during pacing from -15.7
to -4.7. Conclusions: 1) N is a coronary and
systemic vasodilator which causes increases in CI,
CSF, and LVEF. 2) N lessens the ischemia-induced fall
in LVEF and the increase in PCW. 3) The absence of a
negative inotropic effect and the hemodynamic profile
of N are favorable for treatment of patients with
coronary arterI disease and suggest N may be useful in
CAD patients w th impaired LVEF.
BENEFICIAL CLINICAL AND HEMODYNAMIC EFFECTS OF LABETALOL
IN ISCHEMIC HEART DISEASE
Xavier E. Prida. M.D., Robert L. Feldman, M.D., F.A.C.C.,
James A. Hill, M.D., F.A.C.C., Carl J. Pepine, M.D.,
F.A.C.C., University of Florida, Gainesville, Fl.
Coronary and systemic hemodynamic effects of Labetalol
(L), a nonselective beta adrenergic blocker with the
ancillary property of alpha I-adrenergic blockade were
investigated at rest and during supine bicycle exercise
in 12 normotensive patients (pts). -
Before L, exercise evoked angina in all pts. After L
(IV, 0.5 mg/kg) at the same Ex work load which evoked
angina before L, angina occurred in only 4 pts. No
adverse effects occurred after L.
At rest, L reduced mean AoP, (100+12,mean+SD to 92+9
mmHg, p<.05), as cardiac output, CO-(7.1+1.2 to 7.9+1.8
L/min,p<.05) increased and CSF, (133+45 to 137+35 ml/min,
paNS) was preserved without an increase in HR (70+11 to
68+8 b/min, paNS). During exercise CO (11.3+2.6 to
10~1+2.4 L/min, paNS) and CSF (225+62 to 180+62 ml/min,
paNS) were only slightly lower after L than during
control exercise while mean AoP (118+14 to 104+9 mmHg,
p<.05) and HR (100+13 to 88+7 b/min,p<.05) were reduced.
The relationship between CO-and LVEDP improved at rest
after L and improvement was maintained during exercise.
LVdp/dt max. however, decreased slightly at rest (1602+282
to 1476+250 mmHg/sec) and during peak exercise (2288+775
to 1803+569 mmHg/sec) after L (both p<.05). -
Thus,-L has a unique hemodynamic profile among drugs
which produce beta blockade. L combines vasodilator and
beta blocker actions resulting in beneficial hemodynamic
effects in normotensive pts with CAD.
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IMPACT OF SUBLINGUAL NITROGLYCERIN ON THE CORONARY
COLLATERAL CIRCULATION IN MAN.
John W. Danforth, M.D., Thomas A. Ports, M.D., F.A.C.C.,
Elias H. Botvinick, M.D., F.A.C.C., Michael Dae, M.D.,
J. William O'Connell, M.A., William W. Parmley, M.D.,
F.A.C.C., University of California, San Francisco.
Nitroglycerin (NTG) has been shown to enhance coronary
collateral blood flow within regions of myocardial ischemia
in animal experiments. To determine the impact of NTG on
myocardial collateral circulation in man, during transient
ischemia, selective intracoronary inj ection of radio-labeled
MAA particles (15-40u) was performed in 11 pts during
angioplasty balloon dilatation and occlusion of the contra-
lateral diseased coronary artery before & after the admin-
istration of sl NTG. A log transform color enhanced com-
puter comparison of the scintigraphic images obtained
before (A) & after (B) NTG was used to detect the effect
of NTG on collateral distribution. Relative to the native
coronary distribution, NTG resulted in a modest increase
in the region of anticipated collaterals (11±12% in LAO 45,
6±7% in ANT) in 9 of 11 pts. In 2 pts, NTG resulted in a
reduction in collateral distribution. Although the mean BP
fell in all pts p NTG (p=.Ol), the mean BP of these 2 pts
(72±5 mm Hg) was lower than the mean BP of the other 9 pts
(84±9 mm Hg) p NTG. Relative to the distribution of the
collaterals, (determined in 4 pts by comparing (A) to the
distribution of MAA injected p PTCA) , NTG resulted in a
substantial increase in collateral distribution (range:
10-210% in LAO 45°,29-85% in ANT). These data suggest
that sl NTG enhances the distribution of coronary collat-
eral blood flow in man during transient ischemia provided
that the mean BP is maintained. That NTG enhanced collat-
eral distribution despite a consistent reduction in mean
BP suggests that NTG effects vasodilatation of coronary
microeollaterals.
THE EFFECT OF INTRACORONARY NITROGLYCERIN ON MYOCARDIAL
BLOOD FLOW TO CORONARY COLLATERAL-DEPENDENT REGIONS.
John T. Miller, MD, Rodney L. Henry, MD, Morton J. Kern,
MD, FACC, Robert A. O'Rourke, MD, FACC. University of
Texas Health Science Center, San Antonio, TX.
Intracoronary (IC) nitroglycerin (NTG) augments myo-
cardial blood flow (MBF) to regions perfused by normal as
well as partially occluded coronary arteries (CA). The
effect of IC NTG on collateral MBF to areas of infarcted
myocardium is less well known. Such patients(pts) often
undergo procedures during which IC NTG is administered.
Therefore, to determine the effects of IC NTG on MBF to
collateral dependent regions, we measured heart rate(HR),
mean arterial pressure (MAP), great cardiac vein blood
flow (GVF) by continuous thermodilution technique during a
200 mcg bolus of IC NTG. Great vein resistance (GVR)=MAP f
GVF. Group (Gp) I pts had normal CA. Gp II pts had >70%
narrowing of the left anterior descending (LAD) CA. Gp
III pts had total occlusion of the LAD, anterior wall
dysynergy and the LAD was supplied by angiographic col-
lateral CA. There was no significant change in HR or MAP
during IC NTG. Peak (pk) GVF, change (8) in GVF and
percent (%) 8 as mean ± SD during IC NTG were:
GpI(n=6) GpII(n=9) GpIII(n-7)
pk GVF(ml/min) 140±60 86±27* 76±40*
8GVF 65±41 28±15* 14±15:*
%8GVF 84±38 50±31 19±18 **
*p<.05 **p<.Ol GpI vs.GpII or III +p<.05 GpII va.GpIII
The 8GVR & %8GVR paralleled pk GVF. Conclusion: The MBF
response to IC NTG is preserved but significantly attenu-
ated in infarcted regions supplied by collateral CAl
however, because IC NTG significantly increased MBF from
control in all Gps, IC NTG may relieve ischemia during
invasive procedures likely to alter MBF to collaterally-
dependent regions.
BEPRIDIL VERSUS NIFEDIPINE FOR TREATMENT OF CHRONIC
STABLE ANGINA.
Richard J. Katz~ M.D., F.A.C.C., Udho Thadani, M.D.,
F.A.C.C., and t e Bepridil-Nifedipine Multicenter Study
Group, George Washington University, Washington, DC.
Bepridil (B), a new once-a-day calcium blocker, has been
shown to be an effective antianginal drug. We compared
B to nifedipine (N) in 97 pts with chronic stable angina
(>5 anginal attacks/week) and abnormal treadmill exercise
test (TET) (>1 mm ST depression with chest pain). Proto-
col was parallel design consisting of a 2 week single-
blind placebo phase and a 7 week double-blind dose ti-
tration phase to maximum tolerated dose. Dose range for
B was 200-400 mg/day (270±55mg) and for N 30-120 mg/day
(53±2lmg). Patients were evaluated with TET and diaries
in each phase. Baseline treadmill and clinical findings
were similar in both groups. Results are expressed as
change (8) from placebo to drug for each parameter
(total treadmill time =TT; time to angina =TA; time to
1 mm ST depression =TST; angina frequency/week =A/wk;
nitro usage = NTG/wk).
aTT(min) aTA(min) aTST(min) aA/wk aNTG/wk
B 1. 2±1. 7 2.l±2.3 1.4±2.1 -7.9±8.1 -4.1±14.3
N 0.4±1.8 1.3±1.8 0.2±2.6 -3.9±6.8 -2.9± 6.5
p(BvsN) .05 .07 .03 .02 NS
Additionally, resting heart rate decreased on B (72.9±~
65.2±/min) and increased on N (70.8±~73.0±/min), p<.OOl.
QTc increased on B (.41~.44±/msec) and was unchanged on
N (.40±~.41±/msec), p<.03. Adverse reactions requiring
drug discontinuation were noted in 4/49 (8%) pts on B
versus 12/48 (25%) on N (p<.05). Conclusions: Comparing
B to N, B provides better anginal relief and somewhat
enhanced treadmill performance with fewer side effect
related to drop outs.
Thursday, March 13, 1986
8:30AM-I0:00AM, Room #260/261
Exercise Testing
SIGNIFICANCE OF EXERCISE-INDUCED T WAVE NORMALIZATION IN
THE ECG DURING TREADMILL TESTING
Jairo Marin MD, Ming K. Heng MD FACC, Roger Sevrin MD,
Vasant N. Udhoji MD FACC, Sepulveda VA Medical Center and
UCLA School of Medicine, Los Angeles, CA.
Normalization of previously inverted T waves is often not-
ed during exercise treadmill testing (ETT) but has been
of uncertain significance. To study this, we reviewed
578 thallium-ETT and found T wave normalization during or
immediately after exercise in 35 men (ages 37-77 yr, mean
59). ETT was done using the Bruce protocol with 2.2 mCi
of thallium-201 (T-201) injected 1 minute before the end
of exercise. Computarized T-201 images were obtained in
standard projections immediately after exercise and 4
hours later. ECG and T-201 imaging were analyzed with re-
gard to changes in the anterior-septal (AS) and inferior-
posterior (IP) cardiac segments. 34 of 35 patients had
positive T-201 imaging consistent with previous infarction
or exercise-induced ischemia. 97% (64/66) of segments
with T wave normalization were associated with positive
T-201 imaging. 95% (21/22) of segments with T wave nor-
malization in IP leads, and 97% (43/44) of segments with
T wave normalization in AS leads, had positive T-201 imag-
ing. Of 21 segments with IP T wave normalization, 71%
(15/21) had positive T-201 imaging in IP sites. Of 44
segments with AS T wave normalization, 73% (32/44) had
positive T-201 imaging in AS sites. For segments with
previous infarction, the site correlation was 80% (28/35)
for AS segments, and 70% for IP segments. For segments
showing exercise ischemia, the site correlation was 75%
(9/12) for AS segments, and 70% (7/10) for IP segments.
Conclusion: T wave normalization during ETT indicates
presence of coronary artery disease in over 95% of in-
stances. It localizes the affected site in about 70% of
cardiac segments, suggesting that it represents mainly a
primary, rather than reciprocal, ECG change.
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We conclude that HR adjustment of XEKG improves
accuracy compared to CA, but not to T, and is inferior to
T when both are compared to CA.
HEART RATE ADJUSTED ST SEGMENTS VERSUS THALLIUM SCINTIG-
RAPHY IN THE DIAGNOSIS OF CORONARY ARTERY DISEASE
Robert Detrano, M.D., and Ernesto E. Salcedo, M.D.,
F.A.C.C. Cleveland Clinic Foundation, Cleveland, OH.
Heart rate adjustment of stress induced ST depressions
has shown good correlat ion with the resul ts of coronary
angiography (CA), but there have been no comparisons of
heart rate (HR) adjustment with thallium scintigraphy
(T). We submitted 303 consecutive subjects (206 men,
mean age S4 years) without prior myocardial inf~rction
referred for CA to exercise EKG (XEKG) and T. Fifty-five
percent had at least 1 >SO% CA obstruction. Unadjusted
and adjusted ST segment depressions (mm/beats/min) and T
defects were compared with the results of CA (>50%
obstruction);
Cut point
Spec i f ici t.y
Sensitivity
Accuracy
Comparing
defect)'
Cut point
Specificity
Sensitivity
Accuracy
ST depression HR adjusted ST T
1 mm O.OlS
73%----p<0.OS----79% 79%
6S%------NS------66%---p<0.OS---73%
70%----p<0.OS----73%-----NS-----76%
XEKG with the results of T (any perfusion
ST depression HR adjusted ST
1 mm 0.013
67% 67%
S9%------NS-------6l%
63%------NS-------64%
DETERMINANTS OF THE HEMODYNAMIC EFFECTS OF ISOLATED
PROXIMAL CORONARY STENOTIC LESIONS ON REGIONAL
MYOCARDIAL PERFUSION DURING EXERCISE
Allen B. Nichols, MD, FACC, Thomas A. Schwann, BA,
Jennifer Han, BA, Peter Esser, PhD, and David K.
Blood, MD, FACC. Columbia University, New York, NY
This study tested the hypothesis that absolute
dimensions of coronary stenotic lesions are more
important determinants of their hemodynamic effect on
regional myocardial perfusion during exercise than
percent relative stenosis. The 22 patients studied had
isolated proximal lesions of the left anterior
descending artery (LAD) without prior myocardial
infarction. Regional myocardial perfusion was assessed
from quantitative thallium-20l scans obtained in the
left anterior oblique projection after symptom-limited
tre2dmill exercise. The minimal cross-sectional area
(mm ), diameter (mm), and percent area reduction of LAD
stenoses was measured by computer-assisted cinevideo-
densitometric analysis of projected coronary
arteriograms digitized in a 5l2x5l2 pixel matrix with
256 grey levels. TI-201 uptake in the LAD distribu-
tion, expressed as a ratio of Tl-20l in the circumflex
(CX) distribution, correlated poorly (r--O.66) with
relative percent stenosis. However, LAD/CX ratios
correlated well with absolute lesion area (r-O.83) and
with lesion diameter (r-O.84). Thus, execise-induced
TI-20l perfusion defects correlate best with absolute
dimensions of coronary stenotic lesions. Relative
coronary stenosis, expressed as a percentage, is a less
precise predictor of the hemodynamic effects of a
stenotic lesion, which is consistent with principles of
fluid mechanics.
ARM ~ISE 'lHALLIUM 'IESl'INi: A RELIABLE ME:lBJD FOR
~IW COR:NARY DISEASE.
Gary J. ZtM.D., I:Olald A. weiner, M.D., F.A.C.C.,
James A. er, M.D., F.A.C.C., Cindy Mangene, B.S.,
John LaGambina, A.S., Charles McCarthy, A.S., am
Thcmas J. Ryan, M.D., F.A.C.C., Boston University
Medical Center, Boston, Massachusetts.
P<O.1
ThUS, scintigraphy allowed an eightfold improvement in
prognostic risk stratification in the 525 high probab-
ility patients (p<O.OOOI) and a threefold improvement in
the 556 intermediate probability patients (p-0.05).
Stratification in the low probability subset was not
improved (p-0.7). We conclude that testing is capable of
providing important prognostic information even when this
information is redundant relative to diagnosis.
PROGNOSTIC STRATIFICATION BY THALLIUM SCINTIGRAPHY:
WHO NEEDS IT?
Todd S. Kotler. M.D., Brad H. Pollock, MPH, Jeffery W.
Work, M.D., George A. Diamond, M.D., FACC. Cedars-Sinai
Medical Center, Los Angeles, CA.
Does thallium scintigraphy improve the prognostic as-
sessment of patients already stratified according to dis-
ease probability? Disease probability (P) was calculated
by Bayesian analysis of age, sex, symptoms, exercise dur-
ation and ST segment response in 1370 patients without
prior infarction. Patients were then grouped into low
(P<O.I), intermediate (O.I<P<O.9) and high (P>O.9)
disease probability groups. Thal1ium scintigrams were
interpreted as negative, equivocal or positive. There
were 35 coronary events (cardiac death or nonfatal
infarction) in the year following testing. This overall
event rate of 2.6%, however, ranged from a low of 0.6% in
the 159 patients with low probability and a negative
scintigram to 8.8% in the 227 patients with high
probability and a positive scintigram:
THALLIUM
Predictive Value
Positive ,tive
94% %
88% 24%
Sensitivity
83%*
54%
~ifiCity
8%
67%
*p<O.Ol
we conclude that thallium scintigr~y durin:J arm E:l'
is: 1) IlDre sensitive am specific, am has a better
predictive value for the diagnosis of CAD than the &Xi
response alone; am 2) is a practical alternative test
for evaluatiD;J CAD in patients with lower extremity
impairment.
Thalhl.Ull
EXn
Patients with lower extremity impairment are often
unable to perform standard exercise tests (E:l'). To
assess the diagIXlStic accuracy of thallil.Ull scintigraphy
duriD;J upright arm ergaoetry E:l', we studied 50 patients
(age 56 + 10 years) prior to cardiac catheterization for
eValuatioo of coronary artery disease (CAD).
Significant'CAD (~70% StenoslS) was present in 41
patients (82%). Exercise was begun at 10 watts am
continued at 10 watt increments every 2 mnutes. The
test was terminated for lOOderate aD;Jina in 5 (10%),
marked ST depression (>3 IIDII) in 1 (2%), am fatigue in
44 patients (88%). All thallil.Ull images were of
diagIXlStic quality am read indeperxlantly accordin:J to a
qualitative scoring system by 2 observers blinded to
clinical am aD;Jiographic data. Electrocardiograms
(&Xi) were blindly analyzed for 21 IIDII ST depression.
Results were as follows:
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0.001
0.001
0.003
EXERCISE TESTING AND THALLIUM SCINTIGRAPHY FOR THE DIAGNO-
SIS OF CORONARY DISEASE: AN OPTIMAL COST-EFFECTIVE STRATEGY
Jean-Marie R.Detry ,MD, FACC, Annie R. Robert ,MS, Raymond J .Lu-
waert,MD, Roland J.Vanbutsele,BS, Christian R.Brohet,MD,Jac-
ques A.Melin ,MD, St-Luc University Hospital, Brussels, Belgium
We have shown that the diagnostic value of maximal (max) exer-
cise (ex) was greatly enhanced by a multivariate and compart-
mental analysis (MEX) (Eur. H. J. ,6,277 ,1985). Since thallium ex
scintigraphy is also used for diagnosis of CAD, we have compa-
red these 2 methods in 277 men without myocardial infarction
who all underwent bicycle MEX and TL; coronary arteriography
(CA) was the diagnostic standard. The ex ECGwas averaged by
computer; 5 ex variables were selected by multivariate analysis
of the data collected at peak ex (heart rate,ST level,angina at
max ex, max workload and ST segment slope); the results of this
analysis were entered in a compartmental and bayesian model. TL
data was visually analyzed (normal(nl) or abnormal (anI) ).
From history, the pre-test likelihood(L) of CAD was calcula-
ted from the available tables; the post-test (POST) L was calcu-
lated from Bayes formula after 4 diagnostic strategies: (l)MEX
only; (2)TL only; (3)MEX and TL in all patients(pts) and (4)MEX
in all pts and TL only in pts with a diagnostic uncertainty_af-
ter MEX(l0%<POST<90%). The average information content (I)
was calculated after each strategy as well as the accuracy of
the classification of the pts: correct=POST>90% with anI CA or
<10% with nl CA, incorrect=POST<10% with anI CA or >90% with nl
CA, uncertain in other situations.
The I and the classifications are given in the table:
STRATEGY I correct uncertain incorrect Me Nemar
(1) 39% 76% 18% 5%
(2) 36% 68% 30% 2%
(3) 57% 81% 15% 4%
(4) 83% 10% 6%
Thus, the diagnostic value of MEX is slightly superior to
that one of TL since it provided a greater 1. The best classi-
fication of the pts was provided by strategy (4). This strategy
using sequential testing is cost-effective since it allowed
to avoid TL in 81% of the pts without loss of accuracy. The in-
correctly classified pts after strategy (4) included only 5
CAD pts who had all a single vessel disease.
ALTERED RENIN-ANGIOTENSIN-ALDOSTERONE ACTIVATION DURING
EXERCISE INDUCED BY CHRONIC ACE INHIBITION IN HEART
FAILURE
Philip C. Kirlin, M.D., F.A.C.C., Carolyn Koestner, R.N.,
Park W. Willis, III, M.D., F.A.C.C., Cardiology Section,
Michigan State University, East Lansing.
Heart failure (CHF) often activates the renin-angioten-
sin-aldosterone system (RAAS) , resulting in increased
plasma renin activity (PRA) and increased plasma aldo-
sterone (aldo) levels. Exercise (E) in CHF and angio-
tensin converting enzyme inhibition (ACEI) further ele-
vate PRA. In order to assess the effects of chronic
ACEI on RAAS activation during E in CHF, NYHA Functional
Class 2-3(n=8) or 4(n=1) patients receiving digitalis
and diuretics performed maximum treadmill E before and
after 8-12 wk lisinopril (10-15 mg/d) or captopril (25-
50 mg tid). Before ACEI, E caused elevated PRA (rest to
E, 5.5±1.7 to 7.4±2 ng/ml/h, p<.04, ±SEM). However,
plasma aldo did not change with E (376±96 to 381±94 pg/ml
p >.9). As expected, chronic ACEI elevated PRA at rest
(to 18±1.3 ng/ml/h) and decreased plasma aldo at rest (to
160±21 pg/ml). At the same level of E as before ACEI,
PRA rose even higher during chronic ACEI (to 20.4±1.3,
p<.Ol). However, with chronic ACEI plasma aldo also rose
during E (to 190±28, p< .04). These data indicate:
1. Converting enzyme blockade is sustained during chronic
(8-12 wk) ACEI in CHF (elevated PRA and decreased plasma
aldol. 2. E induced PRA elevations in CHF are augmented
by chronic ACEI. 3. Increased plasma aldo levels do not
rise during E in CHF before ACEI. 4. E raises lowered
plasma aldo levels during chronic ACEI. The latter re-
sult suggests that chronic ACEI induces greater respon-
siveness by the adrenal cortex to the limited angiotensin
II released during the physiologic stress of E in CHF.
Thursday, March 13, 1986
10:30AM-12:00NOON, Room #260/261
Cardiac Function and Exercise
STRATIFICATION OF SUBMAXlMAL AND MAXIMAL EXERCISE RESPONSE
ACCORDING TO FUNCTIONAL CLASS IN PATIENTS WITH CONGESTIVE
HEART FAILURE.
Donna Mancini, M.D., Lawrence Davis, M.D., John Wexler,
M.D., Brian Chadwick, R.N., Debbie Gumbardo, R.N., Edmund
H. Sonnenblick, M.D., F.A.C.C., Thierry LeJemtel, M.D.,
Albert Einstein College of Medicine, Bronx, N.Y.
Submaximal (sm) and maximal (max) exercise (Ex) was com-
pared in 21 patients (pts) with congestive heart failure.
LV ejection fraction was <20% in all pts. Maximum oxygen
uptake (MV02, ml/kg/min), HR (beats/min), skeletal muscle
blood flow (MBF, ml/min) using xenon 133 , and femoral vein
oxygen saturation (FV02. ml/lOOml), lactate and ph (FVph)
were measured throughout treadmill Ex at max (100% MV02)
and sm (50-70% MV02) workloads, and were as follows:
Class IV Class III Class II Class I
n=5 n=6 n=5 n=5 HR BP RA PAW CI SVI SVR PVR SWI
C 98 94 10 27 2.2 23 1895 242 21
IEX1 104+ 101++ 14++ 31++ 2.0+ 19++ 2190+ 277 19
IEX2 103 97 9** 22** 2.3** 22* 1892* 235 24*
+=P<0.05 ++=P<O.Ol VS C *P<0.05 **=P<O.Ol VS IEX1
SUMMARY: TNTG results in a significant hemodynamic
improvement during lEX with a fall in right and left
ventricular preload and afterload and a marked
improvement in cardiac output and SWI.
CONCLUSIONS: Direct vasodilatory effect of TNTG
counteracts lEX mediated hemodynamic deterioration in pts
with CHF and leads to a significant improvement in right
ventricular and LV function.
HEMODYNAMIC EFFECT OF NITRATE THERAPY DURING ISOMETRIC
EXERCISE IN PATIENTS WITH CHRONIC HEART FAILURE
Arie Roth, M.D., Lee Freidenberger, R.N., Terence Baruch,
M.D., Shahbudin H. Rahimtoola, M.D., F.A.C.C., Uri
Elkayam, M.D., F.A.C.C. LAC-USC Medical Center,~s
Angeles, CA.
Isometric exercise (lEX) can lead to hemodynamic
deterioration in patients (pts) with severe heart failure
(CHF) due to increase in LV preload and afterload.
Nitrate therapy has been proven beneficial both at rest
and during dynamic exercise in pts with CHF. However,
its hemodynamic effects during lEX has not been
established. We evaluated the acute effect of 120mg
transdermal nitroglycerin (TNTG) on hemodynamic changes
mediated by lEX in 18 pts with severe CHF. Heart rate
(HR) , mean blood pressure (BP), right atrial (RA) and
pulmonary artery wedge (PAW) pressures, cardiac index
(CI), stroke volume index (SVI), systemic vascular
resistance (SVR), pulmonary vascular resistance (PVR) and
stroke work index (SWI) were measured at rest (C) and
during lEX prior to (IEX1) and follOWing TNTG (IEX2).
max
22.5
27
7.27
144
7.6
sm
13.7
29
7.39
100
max
17.7
29
7.27
143
2.1
Sm
10.9
33
7.39
109
max
13.8
28.5
7.30
135
1.1
sm
8.6
32
7.35
118
max
9.8
28
7.23
140
sm
V02 8.4
FV02 31
FVph 7.26
HR 135
~ MBF 0.86Sm
During max Ex, a linear rise in FV lactate over time waS
documented in all pts. With Sm Ex, pts in Class I-III
displayed an early rise with subsequent plateau in lac-
tate concentration for the remainder of Ex. However, pts
with Class IV had a continual increase in lactate concen-
tration over time even at the lowest sm workloads. Thus,
1) pts with Class I have preserved Ex performance due to
their ability to vasodilate; 2) sm Ex is sufficient to
elicit max MBF in pts with Class III-IV; 3) the continual
rise in lactate production in pts with Class IV invali-
dates the concept of anerobic threshold and sm Ex levels
in this group.
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REGIONAL DISTRIBUTION OF CARDIAC OUTPUT AT REST AND
DURING EXERCISE: EFFECT OF NIFEDIPINE
Andrew Thomson MB, Ben Freedman PhD, Peter Fletcher PhD,
David Kelly MB FACC, Phillip Harris D Phil FACC.
Hallstrom Institute of Cardiology, Sydney, Australia
The purpose of the study was to determine the effects of
nifedipine on muscle blood flow during exercise in
patients with coronary artery disease. Femoral vein flow
(FVF) and cardiac output (CO) were measured by
thermodilution in 6 patients before (Control) and after
20mg sublingual nifedipine (NIF). Haemodynamic
measurements were made at rest and during bicycle
exercise (50 watts). All patients were on chronic
metoprolol therapy (100-200mg/day).
REST EXERCISE
Control---- NIF Control NIF
V02 leg ~ 35±12 53±32 330±29 333±49
V02 total ~ 252±7l 237±34 7l5±14l 867±6l
FVF(l!min) 0.4±0.1 0.8±0.6 2.8±0.4 2.6±0.4
CO(l/min) 4.5±0.9t 5.4±0.7 7.8±1.2* 10.6±2.l
%CO to legs l6±6 20±15 69±14§ 52±5
SVR 20.2±3.2§ l3.0±2.8 l2.7±1.6§ 7.7±1.6
mean±s.d. *p<0.05 §p<O.Ol tp=0.02 ~=mls/min
Leg and total body oxygen consumption were not different
on NIF. Although NIF caused a significant reduction in
systemic vascular resistance (SVR) and an increase in
CO, there was no change in leg blood flow. Thus the
proportion of cardiac output going to the legs during
exercise decreased. We conclude that nifedipine
increases rest and exercise cardiac output but does not
increase oxygen delivery to peripheral exercising
muscle due to a redistribution of cardiac output.
LARGE INCREASE IN PRELOAD ALTERS CARDIAC OUTPUT REGULATION
DURING DYNAMIC EXERCISE
Jeffrey L. Christie, MD, Lois M. Sheldahl, PhD, Felix E.
Tristani, MD, FAcc, L. Samuel Wann, MD, FACC, Michael
Ptacin, MD, Scot Levandoski, BA, John H. Kalbfleisch, PhD.
VAMC and Medical College of Wisconsin, Milwaukee, WI
The effect of large increases in preload on cardiac output
regulation during exercise remains unclear. Head-out water
immersion (WI), which produces a marked increase in central
blood volume at rest and an associated rise in central ven-
ous pressure, was used to investigate the effects of an
increase in preload on cardiac performance during exercise.
Five healthy men aged 21-30 years were evaluated with a
Swan-Ganz catheter while exercising upright on cycle er-
gometers on land (L) and with WI (32°C) at workloads ~or­
responding to 40 and 80% maximal oxygen consumption (V02
max). Five hours rest separated the two tests and the order
of testing was alternated. Mean (±SEM) RA pressure (RAP),
CO, stroke vulume (SV), and heart rate (HR) were:
(*;p<0.05 WI vs L)
Rest 40% V02Max. 80% V02Max.
L WI [ WI [ WI
RAP,mmHg 1±1 13±2* 3±2 14±3 4±1 11±3*
HR,bpm 70±4 66±4 110±4 107±2 161±6 153~*
SV,ml/min 74±17 122±22* 125±26 145±24* 129±30 150±34*
CO,l/min 5.1±1 7.9±1* 13.5±3 15.4±23* 20.5±5 24.4±5*
Core temperature on L and WI did not differ. The results
indicate that at rest and at each stage of exercise, WI
was associated with an increase in RAP (i.e., preload),
SV and CO compared to L. These changes were all of greater
magnitude than results from previous studies comparing up-
right and supine exercise suggesting that preload reserve
is not maximally utilized during supine or upright exer-
cise on land.
'mE RELATION BETWEEN PEAK FILLING RATE AND EXERCISE
TOLERANCE IN PATIENTS WI'm LEFT VENlRICllLAR DYSFUNCTIoo.
Jae~onlk ~eo. -Hi.-' 1\bdulmassih S. Iskandr;ian. M.D.,
F.A.~ .,. aml aKkl, M.D., F.A.C.C., Cardlovascular
Institute, FbiladelIilia, PA
Previous studies show no correlation between systolic
left ventricular (LV) performance assessed as the
ejection fraction (EF) and exercise (EX) tolerance.
This study examined the relation between LV diastolic
performance and EX tolerance in 63 patients (pts) with
LV dysfunction (EF < 50%) due to known or suspected
coronary artery disease. The 51 men and 12 women, aged
54 ± 8 years (mean ± SO) underwent upright EX testing on
a bicycle ergometer starting at a workload of 200
kpm/min and increased by 100 kpm every 2 minutes.
Radionuclide ventriculograms were obtained at rest (R)
and peak EX. The EX end-points were angina (n:5) ,
dyspnea,(n:16) and fatigue (n:42). The pts were divided
into: group 1 (n:28) had normal EX tolerance (9.5 ± 2.4
min), group 2 (n:18) had mild EX intolerance (5.8 ± 0.5
min) and group 3 (n:17) had severe EX intolerance (3.7 ±
0.9 min). The 3 groups did not differ in age, EX end-
points, EF (R & EX). EX heart ra~e (HR) , EX end-
diastolic volume index (EDVI, ml/m ), and LV peak
filling rate (PFR, EDV/sec) at rest. The EX PFR was
however significantly higher in group 1 (p = 0.03).
Group REF EX EF EX HR EX EDIT! R-PFR EX PFR
1 40±8 43±13 13l±26 115+37 1.8±O.7 3.711.8
2 33+9 38+10 120+28 122±35 2.0±l.0 2.9±2.2
3 38±8 3lijll 11@2 125+34 1,6±O.5 2.23:1.1
Stepwise mUltivanate discriminate-analysls-of imporI"ant
variables, identified the EX PFR as the only predictor
of EX tolerance (F = 6.0).
'!bus, variation in EX PFR may explain the variability of
EX tolerance in pts with LV dysfunction; pts with
preserved EX capacity have higher EX PFR than those with
EX intolerance.
Thursday, March 13, 1986
8:30AM-I0:00AM, Room #360/361
Mapping and Surgery for Cardiac Arrhythmias
MAPPING OF ENDOCARDIAL(ENDO) ACTIVATION DURING VENTRICULAR
TACHYCARDIA(VT) - A "CLOSED-HEART" PROCEDURE
Eugene Downar, M.D.,F.R.C.P(C), Lynda L. Mickleborough, M.
D.,F.R.C.S(C), Louise Harris, M.B.,F.R.C.P(C) and Ian D.
Parson, Ph.D., University of Toronto, Toronto, Canada.
Traditional ENDO mapping requires introduction of an ex-
ploring electrode through a ventriculotomy so that local
timing data may be acquired sequentially from a conceptual
grid. This is tedious and requires sustained runs of VT.
Ventriculotomy, by disrupting the activation sequence and
reducing wall tension, may make initiation of VT difficult
or impossible. Furthermore, it may be associated with an
increased morbidity and mortality if the incision is
through friable ischemic or normal tissue, in contrast to
scar. To overcome this, we developed an array of 110 sil-
ver bead electrodes stitched on a mesh over a latex bal-
loon for ENDO recordings. At surgery, the array is passed
via a left atriotomy into the intact LV and the balloon
inflated with saline until stable electrograms are ob-
tained. The balloon pressure is monitored to prevent LV
ejection. All electrograms are recorded and displayed on-
line by a previously described video-multiplex system.
Induction of VT was rapid « 4 min) and successful in 8/8
patients (pts), as opposed to 3/8 pts post-ventriculotomy.
Of 16 episodes VT, ENDO mapping revealed incomplete circu-
lar activity in 12. Continuous circular activity (2) and
figure of 8 patterns (2) were bridged by discrete low
amplitude electrograms. Cautery applied to the electrode
at earliest site of activation of VT, marked the site for
subsequent surgical ablation. There were no complications
related to the balloon. No VT could be induced in 5/5 pts
at time of discharge. We conclude that ENDO mapping may
be performed as a "closed-heart" procedure. Future
electrical ablation via the ENDO electrode may obviate the
need for ventriculotomy in pts without aneurysms.
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SCINTIGRAPHY PROVIDES A THOROUGH EVALUATION OF
"ELECTRICAL" AND MECHANICAL EVENTS DURING VENTRICULAR
TACHYCARDIA
E. Botvinick, M.D., F.A.C.C., N. Schechtmann, M.D.,
M. Dae, M.D., J. Abbott, M.D., F.A.C.C., J. Davis, M.D.,
J. Iskikian, M.D., F.A.C.C., W. O'Connell, M.D., D.
Faulkner, N.M.T, University of California, San Francisco,
Ca.
In order to assess scintigraphic accuracy for the loca-
lization of the focus and evaluation of functional
changes during ventricular tachycardia (VT), we studied
25 patients (PTS) during VT by radioangiography. Each
had electrophysiologic study demonstrating 28 foci, 18
successfully mapped. The phase image (PI) during VT
localized 6 RV, 10 septal and 12 LV foci which corre-
sponded to the same or adjacent EPS sites in 14 and
matched ECG findings in 10 others, including 2 PTS with
multiple foci. Accurate PI were acquired with as little
as 40 sec of data, despite poor LV function, and often
influenced EPS. When compared to rest radioangiography
in 19 PTS, hemodynamic deterioration during VT in 8 PTS
related to a higher mean VT rate (159) and a greater
relative fall in end-diastolic volume (.74), stroke
volume (.31) and cardiac output (.62) compared to these
values in 11 PTS tolerant to VT during scintigraphic
study (127, .94, .64, 1.25, respectively, all p<0.05).
Hemodynamic deterioration was also related to greater
dysynchrony in wall motion and a lower ejection fraction
during VT (.28 vs •• 13, p <0.05).
Radioangiography with PI analysis can accurately loca-
lize the focus, characterize functional changes and
complement EPS in VT evaluation. It provides insight
into the cause of hemodynamic intolerance during VT.
IDENl'IFICATIOO OF INITIAL SITE AND~ OF
vmI'RIaJIAR a:Nl'RACl'IOO BY FUJRIER PHASE ANALYSIS
OF 'lW) DIMENSICIU\L EXXJCARDIOORAMS.
James A. lbthendler, M.D., F.A.C.C., Edgar C. SChick,
M.D., F .A.C.C., Mary Jane Birnungham, B.A., Thc:llIas J.
Ryan, M.D., F.A.C.C. Bostoo University Medical Center,
Boston, Massachusetts.
A noninvasive means to identify the initial site and
quantitate the sequence of cootractioo of the left
ventricle (LV) fran a siD;j'le cardiac cycle could be used
to investigate both disorders causiD;j' dyssynChrony of
cootraetioo and the locus of ectopic LV activatioo. we
applie:i Foorier IiJase analysis (FPA) to digitize:i two
dimensiooal echocardiograms (200) in 16 patients, 8 with
right ventricular endocardial pacemakers and 8 oormals,
to determine the awlicability of FPA. The mean heart
rate was similar between the two groups (73+12 vs. 71+7,
oormal vs. pace:l, P--NS). Phase maps were-generate:i-by
determiniD;j' the P'Jase aD;j'le for each piXel within a
regioo in proximity to the endocardial surface of the LV
duriD;j' a siD;j'le cardiac cycle. Maps fran pace:l
patients, all correctly distiD;j'Uished fran the oormals
by blinde:i reading, displaye:i: 1) earliest IiJase aD;j'les
in the apical-septal regioo of the LV with progressioo
to the basal and posterior walls coosistent with the
site of artificial pacing; 2) a larger dispersioo in
IiJase aD;j'les caopare:i to oormals (124' +45° vs 54' +11',
P< .01) coosistent with IIOre dysynchrooyof mechanIcal
cootraetioo as a result of the abnormal electrical
activaticn pathway.
We ooncllrle: 1) FPA of 200 accurately identifies and
quantifies the ooset and sequence of LV cootractioo, and
2) this technique provides a useful non-invasive tool
for study of abrlormal LV activatioo fran single cardiac
cycles.
ECHOCARDIOGRAPHIC LOCALIZATION OF THE SITE OF ACTIVATION
IN VENTRICULAR TACHYCARDIA AND VENTRICULAR PRE-
EXCITATION.
Denise Janosik, M.D., Robert Redd, M.D., Denise
Windhorst, Arthur Labovitz, M.D., F.A.C.C.,George
Williams, M.D., F.A.C.C., St. Louis Univ, St. Louis, MO
Noninvasive localization of the site of ventricular
activation (SVA) in patients (pts) with ventriCUlar
tachycardia (VT) or Wolff-Parkinson-White syndrome (WPW)
may be a useful adjunct to invasive mapping. Two-dimen-
sional echocardiograms (2DE) were performed during hemo-
dynamically stable VT (5 pts; 1 pt with 2 VT morpholo-
gies) or during sinus rhythm in pts with WPW (7 pts). The
SVA of VT was identified at electrophysiologic study
(EPS) in all pts. The SVA in pts with WPW was localized
by delta wave polarity on 12-lead electrocardiogram (EOG)
in 7 pts and confirmed by EPS in 5 pts. Short axis and
apical 4 chamber views of the left ventricle were
analyzed by computer assisted segmental wall motion
analysis and the SVA was determined by an observer
blinded to the results of ECG and EPS localization. In 6
episodes of VT, 2DE identified the SVA as upper septum in
2, inferior septum in 2, posterior wall in 1 and lateral
wall in 1 and correlated with EPS mapping in 5/6 cases. A
posterior basal site was incorrectly identified by 2DE as
lateral wall. In WPW pts, the SVA determined by 2DE was
anterior in 3, left anterior paraseptal in 2, left
posterior paraseptal in 1 and right anterior in 1 and
correlated with EPS and ECG localization of SVA in 5/7
pts. A right paraseptal tract was incorrectly identified
by 2DE as left paraseptal and a left posterior tract as
anterolateral in a pt with an inferior posterior infarct.
Thus, computer assisted segmental wall motion analysis of
2DE accurately identified the SVA in the majority of
cases and this noninvasive method may be a useful adjunct
in localizing the origin of dysrhythmias.
LONG-TERM SURVIVAL AFTER LEFT CERVICG-THORACIC
SYMPATIlECTOMY IN HIGH RISK LONG QT SYNDROME PATIENTS
WITII REFRACTORY VENTRICULAR ARRHYTHMIAS.
Emanuela Locati, MD, Peter J. Schwartz, MD FACC,
Arthur J. Moss, MD FACC, Richard S. Crampton, MD FACC.
Univ• of Milano, Italy; Univ. of Rochester, NY, and
Univ. of Charlottesville, VA, USA.
In 1969, on the basis of clinical and experimental
observations, left cervico-thoracic sympathectomy
(LCTSX) was introduced for the therapy of patients (pts)
with long QT syndrome (LQTS) refractory to conventional
therapy. During the past 16 years, 56 LQTS pts
worldwide have had LCTSX. Detailed information is
available on 51 pts: 82% are females, 6% had congenital
deafness, 45% had family history of LQTS; mean age at
LCTSX was 22 yrs (range 1 to 58 yrs). Before LCTSX
surgery, all pts were symptomatic and 60% had prior
cardiac arrest; 77% failed to respond to beta blockers
(BB). The exact extent of surgery was not known in all
pts: 39 pts (76%) had adequate denervation (ablation of
the lower-midportion of 7th cervical ganglion to 3rd-4th
thoracic ganglia), 5 pts required a second, more
extensive sympathectomy due to inadequate initial LeTSX
surgery. Follow-up was available in 49/51 pts: the mean
follow-up was 4.8 yr/pt (range 0.5 to 16 yrs). Following
LCTSX, 80% of the pts continued BB therapy alone or
combined with other drugs and 12 pts (20%) had pacemaker
implantation for better control of symptoms. Using life-
table analysis, survival at I, 3 and 7 yrs after LCTSX
was 94%, 91% and 86%, respectively. In conclusion, in
high risk LQTS pts with malignant ventricular
arrhythmias refractory to conventional medical
treatment, LCTSX is associated with very favorable long-
term survival.
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FEASmILITY OF CRYOllBIATICN OF THE POSTERIOR PAPILlARY
KEeLE IN THE 000. Gerard M. GJiraudon, M.D., F.A.C.C.,
Douglas L. Jones, PhD., George J. Klein, M.D., F.A.C.C.,
William J. KDstuk, M.D., F.A.C.C., George Jablonsky, M.D.,
F.A.C.C., Douglas G. M::Le11an, M.A., James L. M.
MacDonald, C.C.P., university lbspital, london, Q:ltario.
The posterior papillary muscle (PIM) may be part of the
arrhyt:hlIDgenic zene in patients undergoing surgery for
ventricular tachycardia and this may necessitate its
resection for cure of the arrhythmia. Cryoablation of the
PlM or its ventricular attaclment is feasible but the
henDdynami.c cx:nsequences and the effects on mitral valve
(W) function are Wlknown. we studied the heroodynami.c
effects of extensive cryoablation of the PIM in dogs
(_ighing 25-3Okg) who had their PlM and the ventricular
attadmmt cryoablated under cold cardioplegic ~diac
arrest. A circular cryoprobe (diameter 1.5cm, -60 C for 2
minutes was applied both to the endocardium and epicardium
to achieve this. Hem:ldynami.c neasurem:mts and LV
aIXJiography 1.<Iere 00tained prior to cryosurgery and 4 1.<IeE!ks
postoperatively after which the hearts 1.<Iere excised for
pathological examination. CIyosurgery of the PIM resulted
in no chanJe in arterial pressure (116-Sl vs 11S-S4mn Hg) ,
left ventricular dP/c'!£ (1S40 vs 1740), mean pu1m::lnary
capillary wed:]e pressure (S vs 7.!imI Hg) and cardiac
ouq:ut (2.71 vs 2.l6L per min). Left ventricular
aIXJiograms 1.<Iere unchanJed with no evidence of mitral
insufficiency preoperatively or postoperatively.
Pathological examination s~ harogeneous dense fibrosis
of the PPM and its ventricular attaclment _11 delineated
fran noonalll1lScle. 'lhere was no bulging or thinning of
the LV wall and no necrosis outside the cryoablated area.
we conclude that cryoablation of the PlM and its
attaclment does not inpair lIN function in the dog. It may
be an alternative to resection and lIN replacem:mt in
patients with arrhythmias originating in this area.
Thursday, March 13, 1986
10:30AM-12:00NOON, Room #360/361
Arrhythmias-Electrical and Laser
Ablation Techniques
EFFECTIVENESS OF ELECTRICAL CATHETER ABLATION FOR VENTRIC-
ULAR TACHYCARDIA: FOLLOW-UP WITHOUT ANTI-ARRHYTHMIC DRUGS.
Richard N. Hauer, M.D., Etienne O. Robles de Medina, M.D.,
F.A.C.C., Paul J. Kuijer, M.D., Pieter W. Westerhof, M.D.,
University Hospital, Utrecht, The Netherlands.
Electr~cal catheter ablation(ECA) for chron~c recurrent
ventricular tachycardia(VT) was performed in 5 pts ( 2
chronic ischemic, 1 congenital and 2 with primary electri-
cal heart disease), using rigid criteria to define the ar-
rhythmogenic site(AS). These criter~a were:l) During VT
reproducible recording of the earliest obtained local dia-
stolic activation (DA) .2) A fixed relationship of DA to
the subsequent QRS complex of VT during spontaneous or
pacing induced change of the RR interval. All pts proved
refractory or intolerant to at least 3 anti-arrhythmic
drug trials. The number of VT episodes during 3 months
preceding ECA was: 2 in 2 pts, 6 in 1 pt and more than
20 in 2 pts. Endocardial catheter mapping was performed
using s~multaneous bipolar and unipolar recordings. The
AS was localized in the left ventricle ~n 3 pts and in
the right ventricle in 2 pts. The interval between DA
and the onset of QRS at the AS was 5, 10, 60, 90 and
130 ms. A single R wave synchronized 250 J cathodal shock
was delivered at the AS using an external chest paddle as
the anode. One pt had symptomatic sustained VT ep~sodes
during the first 3 days after the shock, otherwise no com-
plications occurred. All pts were discharged off anti-
arrhythmic drugs and followed for a mean 3.5 + 2.5 months.
There was no recurrence of VT in 4 pts. In 1 pt VT epi-
sodes with identical morphology recurred. Our results in-
dicate:l. ECA without additional drug treatment is prom-
ising in pts w~th VT. 2. Efficacy with less energy than
preViously reported may be due to rigid criteria for AS
localization. 3. ECA itself can provoke VT in the first
days after the shock.
VENTRICULAR ARRHYTHMIAS DURING ENDOCARDIAL CATHETER
FULGURATION OF VENTRICULAR TACHYCARDIAS.
J.L.Tonet, MD, M.Baraka, MD, G.Fontaine, MD, FACC,
S.Abdelali, MD. R.Frank, MD, L.Menezes Falcao, MD,
C.Funck-Brentano, MD, Y.Grosgogeat, MD, FACC.
Hopital Jean Rostand, Paris-Ivry, France.
31 consecutive patients (pts) (mean age 48 yrs, 26 men)
with chronic refractory ventricular tachycardias (VT)
underwent endocardial catheter fulguration (F). 13 had
prior myocardial infarction, 11 arrhythmogenic ventricu-
lar dysplasia, 4 idiopathic dilated cardiomyopathy, 1
operated congenital anomaly, and 2 had normal hearts.
Cardiomegaly was present in 20 pts. None were receiving
digitalis or class I antiarrhythmic drugs at the time of
F, 17 pts (55%) were on amiodarone. 167 shocks (82 in the
LV) of 160 to 320J (mean 210J, 3J/kg) were delivered
between the distal pole (anode) of a selected catheter
and a posterior external chest plate, 129 during VT, 38
in sinus rythm (SR). Mean peak of creatine kinase reached
306 + 354, MB fraction 40 + 30 UI/l.
25-shocks (15%) caused 13 ventricular fibrillation (FV)
and 12 VT (14 shocks in the LV, 13 properly synchroni-
zed); 23 were done during VT and 2 in SR (. 05<p< .10).
There is no relation between : sites of shock in the
ventricles, type of heart disease, amount of energy
delivered, peak of creatine kinase, weight of pts, and
these arrhythmias. Surprisingly, timing of shock with
respect to QRS surface did not affect the frequency of VF
or VT.
We conclude: 1) Endocardial shocks of 210J had a pro-
pensity to initiate ventricular arrhythmias. 2) Properly
synchronized endocardial shocks delivered during VT or SR
may produce VF or VT. 3) Endocardial shocks of 210J has
minor defibrillatory properties. 4) Because VF and VT
during F are usually not transient, anterior patch
electrode for immediate cardioversion is mandatory.
PATHOLOGICAL AND CLINICAL OBSERVATIONS AFTER
CATHETER FULGURATION IN MAN
Richard W. Henthorn, M.D., F.A.e.c., Mark D. Cohen, M.D.,
Peter G. Anderson, D.V.M., Andrew E. Epstein, M.D.,
F.A.C.C.,Vance J. Plumb, M.D., F.A.C.C., Arian Olshansky,
M.D., Albert L. Waldo, M.D., F.A.C.C. University of Alabama at
Birmingham, Birmingham, Alabama
We performed catheter fulguration (FLG) guided ~y catheter
mapping in 8 patients (pts) with sustained monomorphic ventricu-
lar tachycardia. In 518 pts, cardiac tissue was available for
study: 3 from surgical resections (6, 6, and 13 days post-FLG) and
2 from autopsy material (6 and 190 days post-FLG). These 5 pts
with coronary artery disease (CAD) status post myocardial
infarction and a mean ejection fraction (EF) of .17±'06 underwent
FLG with delivery of 200 or 300 joules (J) (533f821 J/pt) between
the distal electrode of a 6 French catheter and a back paddle, or
100J across the septum using the distal electrodes of 2
catheters. The 5 pts developed CPK rise of 204±65 lUlL and
CPKMB of 31±17 lulL. Only 1/5 pts had an identifiable
pathologic lesion, which was 4 mm in depth and 14 mm at its
widest point composed of coagulated myocytes and thrombotic
material adherent to the endocardial surface. FLG lesions were
not discernible in the other 4 pts whose FLG sites were
composed of mineralized scar or adherent thrombotic material.
Three of the 8 pts undergoing FLG 033±58J) had pre and post-
FLG 2-D echocardiography (2-D). One of the 3 pts had primary
electrical disease (EF=.56) and a post-FLG (400J) CPK rise of
809 lUlL, MB of 210 lUlL. The post-FLG 2-D showed a new
dyskinetic area at the FLG site. The other 2 pts had CAD with a
mean EF of .18 and a post-FLG OOOJ) mean CPK rise of 226
lUlL, mean MB rise of 44 lUlL. These 2 pts had no discernible 2-
D change. Conclusions: J) Demonstrable pathological andlor 2-D
changes were evident only in pts who underwent FLG at sites of
apparently normal myocardium; 2) There was significant
variability of FLG tissue destruction dependent on whether
normal or scarred myocardium was fulgurated.
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INTERCATHETER ENERGY DELIVERY FOR ABLATION OF VENTRICULAR
MYOCARDIUM Alan H. Kadish, MD, Joseph F. Spear, PhD,
FACC, Charles Prood, MA, Joseph H. Levine, M.D. and E.
Neil Moore, DVM, PhD, FACC University of Pennsylvania,
Philadelphia, Pa.
We delivered 12 50 joule shocks through endocardial
catheters in 12 anesthetized dogs. In 6, a back paddle
was used as the anode (AN). In six intercatheter ablations
(ICA) a second nearby epicardial or coronary sinus cathe-
ter served as the AN. We measured current and voltage
with a custom made electronic device and calculated
impedance, power, and total energy. Mean Results:
Anode V IRE Sz
Back Paddle 1499 9 176 46 14
Catheter 1165 34* 15* 59 17**
* p<0.05; **=.07; V=peak voltage (volts) 1 I=peak current
(amps); R=Impedance at peak I; E= total energy (joules);
Sz=lesion size. During ICA, peak currents were high and
delivered energy was higher than set energy, presumably
because standard defibrillators do not provide accurate
energy delivery at low impedance. When an epicardial
catheter was used as the AN, epicardial and endocardial
necrosis were similar. In 3 shocks the epicardial catheter
was placed at a point distant from the endocardial cathe-
ter. Distinct lesions were produced at both AN and
cathodal site. Damage was asymmetric extending 2 times
further in the area between electrodes than away from the
opposite pole. We conclude: 1) Varying AN position can
determine the direction of tissue injury during ICA.2)
Equal damage occurs around both the AN and cathode pre-
sumably because of similar high current density. 3)
Although the ability to direct tissue inJury is a poten-
tial advantage of ICA, damage to both AN and cathodal
areas, high peak currents, greater tissue damage and a
trend towards higher than set energy delivery must be
taken into account in any potential clinical use.
SUCCESSFUL INTRAOPERATIVE Nd:Y AG LASER ABLATION OF
VENTRICULAR TACHYCARDIA. Robert H. Svenson, MD, FACC,
John J. Gallagher, MD, FACC, Jay G. Selle, MD, win C. Sealy,
MD, Samuel H. Zimmern, MD, FACC, John M. Fedor, MD, FACC,
Marie-Claire Marroum, MD, G.P. Tatsis, BS, K.T. Seifert, MS,
Francis Robicsek, MD, FACC. Sanger Clinic P.A., Heineman
Research Center, and Carolina's Heart Institute, Charlotte, N.C.
We recently utilized intraoperative Nd:Y AG laser photocoagula-
tion to treat 5 patients (pts) with drug resistant ventricular
tachycardia (VT). All pts underwent preoperative electrophysi-
ologic studies (EPS), intraoperative mapping, intraoperative EPS
postlasing and EPS on the 7-9th postoperative day. All pts had
coronary disease but only pts 1-4 had a previous myocardial in-
farction. Following informed consent intraoperative mapping was
performed to locate the origin of the VT. pts 1-4 had sites of
VT origin >6 em apart. Lasing was performed in sinus rhythm or
YT. A continuous wave Nd:Y AG laser coupled to a 600.AI. gas
cooled fiber delivered radiation at 30 and/or 50 watts with a
spot size of~0.5 em. Operative data is summarized below.
Pt No. YT YT Lased Joules EF
- Morph Site area (cm 2) per cm2 ~ ~
1 2 AS,IS 18 1003 .29 .31
2 2 A, S 24 772 .18 .20
3 2 L, S 31 967 .26 .29
4 4 BS,S,A 42 1629 .24 .28
5 1 IS 24 966 .18 .27
(A=anterior freewall, AS=anterior septal margin, BS=basilar sep-
tum, L=lateral freewall, IS=inferior septal margin, S=septum, EF=
ejection fraction). Following lasing delayed potentials were
abolished and VT could not be induced intraoperatively or 7-9
days postop. Pts 1-3 had no inducible YT 6-8 wks postop. pts
4 and 5 have been followed less than 6 wks. Nd:Y AG laser photo-
coagulation is a promising new technique for the surgical therapy
of refractory YT. It can be performed safely without adverse ef-
fects on ventricUlar or valvular function.
Thursday, March 13, 1986
8:30AM-I0:00AM, Room #366/367
Considerations in Angioplasty and Laser Ablation
MULTIPLE VESSEL ANGIOPLASTY: DEFINITION, CLASSIFICATION
AND RESULTS. Richard K. Myler, M.D., FACC, Giles Cote,
M.D., Eric J. Topol, M.D., Simon H. Stertzer, M.D., FACC,
Jodi Fishman-Rosen, R.N., M.S., Mary C. Murphy, R.N.,
M.S. San Francisco Heart Institute, Daly City, CA
Coronary angioplasty (PTCA) was performed in two or more
major vessels in 313 consecutive patients (P) with 690
vessels (V) treated. In this cohort, the age range was
32-78 yrs. (m = 57), 81% were males; 82% had two vessel,
16% three vessel, and 2% four vessel angioplasty. Success
was achieved in 95% of P and 89% of V. Ten patients
(3.2%) required emergency coronary bypass surgery (CABG),
with 6 sustaining myocardial infarction. There was 1
death (0.3%). Patients were divided into 2 groups: Group
A - single lesions in two or more vessels (162 F, 351 V);
Group B - complex lesions in at least one of the vessels
treated (151 P, 339 V). Chi-square analyses of success
and complications indicated a trend towards a higher
incidence of MI and recurrence (p = .16) in Group B vs.
Group A. However, no statistically significant
difference was noted in the success rate or incidence of
emergency CABG. Ninety-six percent of Group A patients
had the entire angioplasty performed at one time,
Whereas in Group B - 88% (p = .09) did; the other 12%
had the angioplasty staged over 2 days. Repeat PTCA of
patients with recurrence showed 94% success, but a 6%
emergency CABG. Thus, multiple vessel angioplasty in
carefully selected patients can be performed as safely
and effectively as with single vessel disease. The vast
majority can have all vessels treated at one time,
though staging the procedure might be advisable in
selected complex (Group B) patients. Repeat PTCA in
multivessel patients with recurrence, although as
effective, may not be as safe as redo PTCA in single
vessel angioplasty patients.
10
APA (mv)
52
DVIDT (Volts/sec)
2 5 10Distance
( nrn)
HE 21+11 52!.9 69+9: 1!.2
(n=5) - :
L 70+17 81!.5 78+6: 58!.31 87!.18 91!.11! 64!.37 93!.8 92!.14
(n=6) - - : I
p <,001 .0001 ns: .01 .00001 ns : .01 .0001 ns
CONCLUSION: Action potential abnormalities and the border
zone of depressed tissue were more extensive following HEA
vs. LA at energy levels that yield comparable area of
central necrosis. The more focal electrophysiologic
effects of LA may explain its less frequent association
with arrhythmias and regional wall motion abnormality.
LASER ABLATIOK LEADS to MORE FOCAL ELECTROPHYSIOLOGIC
EFFECTS COMPARED TO CATHETER DELIYERED, HIGH EKERGY
ABLATIOK. John h Merillat, M.D.. Joseph H. Levine, M.D.,
Harlan F. Weisman, M.D., Michael D. Stern, M.D., Joseph F.
Spear, Ph.D., F.A.C.C., E. Neil Moore, D.V.M., Ph.D.,
F.A.C.C., Alan A. Kadish, M.D., James Fonger, M.D., Raul
Guzman, B.S., Thomas Guarnieri, M.D., F.A.C.C., The Johns
Hopkins University, Baltimore, MD
Laser ablation (L) in animals is associated with fewer
arrhythmias and less regional wall motion abnormality when
compared to catheter delivered high energy (HE), possibly
due to the more focal injury produced by L. We examined
this question by comparing the electrophysiologic effects
associated with a small matched 1-1.5 mm region of visible
necrosis produced with either argon L <3.5 Watts over 4
seconds via 200 micron quartz fiber) or HEA (10-20 Joules
via a cathode 1 mm in diameter) in 11 normal canine
epicardial preparations. Comparisons were made of action
potential amplitude (APA), DVIDT, and resting potential
(RMP) at varying distances from the center of the necrotic
zone. RESULTS (llI+sd):
RMP (mv)
2 5 10
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CORONARY ANGIOPLASTY (PTCA) FOR TOTAL CORONARY
OCCLUSION: SUCCESS RATE AND FOLLOW-UP
Raoul Bonan, M.D., F.A.C.C., Simon Kouz, M.D., Jacques
Crepeau, M.D., Jacques Lesperance, M.D., and Pierre
TherouK, M.D., F.A.C.C., Montreal Heart Institute,
Montreal, Canada.
From June 1984 to June 1985, PTCA was attempted in our
Institution in 478 coronary artery segments in 393 pts.
In 32 of these pts, a previously documented stenosis
(S) had progressed to complete coronary occlusion with-
out myocardial infarction (MI). The primary success
rate in these 32 pts was 65" compared to 87" for all
PTCAs (p<.05) and similar whether the left anterior
descending (6/9), the circumfleK (719) or the right
coronary artery (8/13) was dilated. The residual (S)
averaged 32 .lU13 .1" and the trans-occlusion gradient
was reduced from 49±12 to 13±9 mmHg (p<.OOl). The time
elapsed between initial documentation of (S) and PTCA
was shorter when it was successful (3.4±4 vs
7.3±7mo., p<.05). The success rate was 8~ when this
time interval was less than 3 mo. and 5~ when it was
more (p<.05). The severity of the initial (S) did not
influence results. Complications associated with the
procedure were a non-sustained ventricular tachycardia
in 1 pt, and a prolonged chest pain without MI in one.
After a mean follow-up of 6±2 mo., 13 of the 21 di-
lated pts were symptom-free, 6 had improved angina and
2 did not. A treadmill &Kercise test induced ischemia
in only 3 pts. Control angiography in 11 pts showed re-
stenosis ;;:7~ in 3, two had successful redilatation;
in the 8 others the (S) was 36.2±2~ vs 24.4±16"
just after PTCA (NS).
Thus PTCA in total coronary obstruction has a high suc-
cess rate particularly when attempted early after the
obstruction; the procedure appears safe and associated
with good long-term results.
PULSE DURATIOj~ IS THE MAJOR DETER:-lINANT OF THERHAL DAHAGE
DURI1~ PULSED LASER TISSUE ABLATION.
Lawrence Ie Deckelbaym, M,D" Josepn K. Lam, A.S.,
Soni Clubb, B.S., and Henry S. Cabin, M.D., F.A.C.C.
West Haven VAMC and Yale University, New Haven, CT.
Successful cardlovascular applications of lasers may
require focal ablation of tissue without thern~l dama&e
to adjacent tissue. This has been aChieved during pUlsed
laser ablation using low repetition rate, hi6h pulse
energy, and short pulse duration. Because the resultant
hlgh peak power (pulse energy/pulse duration) impedes
fiberoptic coupling, we evaluated whether prolonging the
pulse duration to decrease peak power would alter laser
tissue ablation. The peak power of a Nd:YAG laser
(wavelength 1064 nm, repetition rate 10 Hz) was altered
by prolonging the Q-switched (Q) pulse duration of .01 ~s
to 200).ls using non-Q switcheu (;I) pulsing. Sixty 3-mn
thick myocardial slices were irradiated in air using
pulse energles of 200 mJ in Nand Q modes. All parameters
of laser irradiation were identical except for pulse
duratlon. As a result, peak energy was 1.0 kilowatt in N
mode and 20 megawatts in Q f1Xlde. The energy required to
bore a hole in the myocardial slices was markedly in-
creased in the N versus Q mode (813 ± 62 (M ± SEM)
versus 16 ± 2 Joules). Tissue temperature ,neasured oy a
thermocouple 1 eRli from the hole rose to 62 .± 3°C in N
mode compared to only 25 ± l'C in Q mode. Gross, light
and scanning electron microscoplC examination all re-
vealed evidence of thermal boundary damage with N but not
with Q !lXlde.
Conclusion: Short pulse duration is crucial to eliminate
thermal dal,Jage during pUlsed laser tissue ablation. In-
creasinb pulse duration to decrease peaK power decreases
the efficiency of tissue vaporization and increases heat
diffusion and thermal injury to adjacent tissue.
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY OF
PROTECTED AND UNPROTECTED LEFT MAIN CORONARY STENOSIS
Gary GerShOn" M.D., F.R.C.P.(C), Pierre Abi-Mansour,
M.O:, James 91entz, M.D., Giry 1t>ubin, M.B., Ph.D.,
Nancy Braman, R.N., Beverly Mellen, B.A., Andreas
Gruentzig, M.D., F.A.C.C. &nory University School of
Medicine, Atlanta, GA
Initial experience with percutaneous transluminal coro-
nary angioplasty (PTCA) of left main (LM) stenoses sug-
gested an increased risk of early and late canplica-
tions due to the extent of jeopardized myocardium. We
analyzed the results in 17 patients (pts) undergoing 20
dilatation procedures of IM stenosis between July 1981
and August 1985. Ten dilatations were performed in 9
pts without prior coronary artery bypass graft surgery
(CABG), "unprotected", either as palliative procedures
when CABG was contraindicated or early in the PTCA ex-
perience. Ten dilatations were performed in 8 pts with
prior CABG either for progression of native disease or
partial graft failure. In this group, part of the IM
distribution thus remained "protected". There were 13
males, 4 females, with a mean age of 54 years. Mean
duration of anginal symptoms was 21+30 (mean+SD) months.
The primary success rate was 18/20-(90'). Rean percent
diameter stenosis pre- and post-PTeA was 70+14 and 32+
16 respectively. The mean post-PTCA transstenotic gra~
dient was 12+7mHg. There were no in-hospital deaths.
Of the 10 runprotected" procedures, 2 pts required
emergency CABG and 1 of these had a myocardial infarc-
tion. No acute major complications occurred in the
"protected" group. Of the 18 successfully dilated
stenoses, 9 underwent restudy ang iography 7+3 months
after PTCA. Five of these 9 (56') demonstrateOrresteno-
sis. Conclusions: 1) PTeA of IM stenosis can be per-
formed sAfely in the setting of "protected" myocardium.
2) Because of the risk of complications and restenosis
"unprotected" LM should remain a relative contraindica-
tion to PTCA.
ABSCLtlrr. CROSS SECTION\L ARFA ()JM1I'!TATION OF CORQNl.RY
SI'FN'lRTS usn~ A NEW ONE VIEW VIIEOIENsrrolF.I'RIC 11E'llJOD.
Jo~ Wiesel, /:l.D., AndrEW M. (:rulll~ald, I-I.D., F,A.C.C.,
Bruce Robin, fobnty M. Bodenheirrer, M.D., F.A.C.C. wng
Island Jewish /<ledical center, New Hyde park, New York.
Al:5olute cross sectional area (<:SA) of a stenosis best
reflects harodynamic severity. Edge deta::tion (ED)
algorithnB alone require t~ ortho9>nal views for
argiographic quantitation of irrEgular lesions. While
videodensitooetry (Va3) requi res only one view, it
provides only relative but not absolute data on CSA.
'ltlerefore, we evalLated a coobined approach using ED to
determine the CSA of a normal segment and vn; to determine·
the perrent narrowing of an adjarent stenosis, '!he
absolute CSA of the stenosis is ca] culata:l frOll' these two
results. We valicBted this new conbined rrethod (ED-VOO)
by ronparing it to the starmrd two view ED rretiX>d in 8
anesthetized closed dlest dogs. Ten plastic cylind:!rs
with pra::isely measura:l circular and irrEgular ]L1llens were
inserted into the coronary arteries and digital angiogrcum
recorded. A first derivative ED rrethod with an OIl!rator
int.eractive Vffi program was used. With the di.arreter of
the argiographic catheter as the measurenent stcrtdard, ED
was used to corrpute the ('; rcular CSA of a normal arterial
Se::Jrnent. '!he GSA of the stenoses were crnputErl based on
the VOO ratio of the normal and stenotic segrrents for eadl
view independently. '!he two viE.'\V ED method used two
orthogmal views to calcuJate the CSP.. '!he mean and
staldard deviation of the absolute differences between the
true CSA of the cylinders and the ED,1Vr6 rrethod was
.45±.53 and the two view ED metood was .91±.42 sq mm. 'nle
correJation for the ED,1Vr6 method (r='.87) was slightly
higher than the two view metood (r='. 75). 'nle nEW one view
ED/VDS rrethod is as cccurate as the two vi ew ED rrethod to
quantitate CSA of stenoses.
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SAFETY OF BETA BLOCKERS WITH CORONARY ANGIOPLASTY.
Mitchell W. Krucoff MD, Lowell F. Satler MD FACC,
Kenneth M. Kent MD PhD FACC, Carolyn J. Ewels BS,
Susan W. Ahmed PhD, Ross D. Fletcher HD FACC, Charles
E. Rackley MD FACC, Georgetown University,
Washington, D.C.
Calcium blockers with vasodilator properties are
presumed to be superior to beta blockers after
angioplasty. To compare the incidence of ischemic
episodes after angioplasty wi th beta blockers to the
incidence with calcium blockers, 3 channel continuous
ST segment recording was performed in 40 consecutive
patients undergoing single vessel angioplasty.
Recordings were performed over 198 hours following
angioplasty in 12 patients treated with beta blockers
and compared to data base recordings of 503 hours in
28 patients treated with calcium blockers. ST
changes on Holter were documented by recording during
balloon occlusion of the coronary during angioplasty.
Maximum ST elevation relative to baseline
during angioplasty was 2.5 % 1.3mm in the beta
blocker group and 2.6 % 1.9mm in the calcium blocker
group (NS). Recording then continued for a mean of 18
hours after angioplasty. Mean heart rate was 58 % 7
in the beta blocker group versus 74 % 7 in the
calcium blocker group (p < .05). There was 1
post-angioplasty infarct in each group (NS). With
calcium blockers, there were 12 episodes recorded in
6 patients totaling 8.6 hours. There were no episodes
of ischemia in the beta-blocked group (NS). Thus:
1) angioplasty induces equivalent ischemia in
patients on beta blockers or calcium channel
blockers; and 2) beta blockade is not associated with
an increased incidence of episodes of ischemia after
angioplas ty •
Thursday, March 13, 1986
10:30AM-12:00NOON, Room #366/367
Electrocardiographic Evaluation of Ischemia and the
Effects of Interventional Therapy
VALIDATION OF A DEVICE FOR AMBULATORY MONITORING AND
ON-LINE ANALYSIS OF ISCHEMIA IN PATIENTS WITH ANGINA.
Joan Barry, B.A., Elizabeth E. Nabel, M.D., Michael B.
Rocco, M.D., Stephen Campbell, M.D. and Andrew P.
Selwyn, M.D., FACC. Brigham & Women's Hospital,
Boston, MA.
Patients with angina and coronary artery disease have
frequent episodes of asymptomatic myocardial ischemia
demonstrated with frequency modulated (FM) holter
recordings. In order to assess the clinical use of on-
line analysis of ischemic ST depression (STD), long term
monitoring, and an audible beep that can interact with
patients, we evaluated a programmable micro-
processor EKG monitor (Q-Med) for detection and
measurement of ischemic STD episodes. For validation,
22 patients with chest pain underwent diagnostic
exercise tests. Q-Med detected 9 of 9 episodes of
significant STD with comparable measurement of degree
and duration with the standard Marquette EKG and 12 of
13 negative results (1 false positive). In 4 of the 5
patients developing symptoms, an audible beep preceded
the onset of chest pain correctly (no false positives).
Additionally, 5 ambulant patients with angina and
coronary disease underwent simultaneous FM holter and
Q-Med recordings for STD. Q-Med detected 5 of 5
episodes of ischemic STD correctly with no false
positives registered in 111 hours of simultaneous
recordings. This preliminary analysis suggests that
Q-Med appears to be accurate in the detection and
quantification of STD. The device is capable of long
term monitoring and a beep preceding ischemic chest pain
may permit patient interaction prior to the development
of symptoms.
REGIONAL MYOCARDIAL BLOOD FLOW CORRELATES OF ISCHEMIC S-T
SEGMENT DEPRESSION.
David M. Mirvis, M.D., K. B. Ramanathan, M.D.,
Jack L. Wilson, PhD, University of Tennessee, Memphis, TN
Tschycardia produces subendocardial ischemia and S-T seg-
ment abnormalities after coronary obstruction. To deter-
mine if a quantitative relation exists between the onset
of S-T shifts and transmural blood flow, 19 dogs were
studied. Coronary obstruction was produced by ameroid con-
striction of the left circumflex artery in 14 dogs, and
tachycardia was generated by incremental atrial pacing at
90 to 210 beats/min. S-T shifts were studied by body sur-
face isopotential maps using an 84-electrode torso grid,
and blood flow was quantitated by serial radiolabelled
microsphere injections. Isopotential maps at each paced
rate, 40 msec into S-T segment, were classified as normal
or ischemic based upon spatial patterns of voltages. Pac-
ing after 3 weeks of ameroid constriction reduced endo/epi
flow ratios in 11 dogs from 1.16 + 0.22 at rest to 0.41 +
0.18 at 210 beats/min. Abnormal S7T depression with isch7
emic map patterns developed at 184.0 + 16.5 beats/min.
Endo/epi ratios at rates with ischemi; S-T pattern (0.45 +
0.15) were lower than at those with normal S-T maps (1.05-
+ 0.19, p<O.Ol). Heart rate, perfusion bed size (determin-
;d by dye infusion), and endo/epi ratios were entered into
a logistic regression model to determine which were pre-
dictors of an ischemic S-T pattern. Only the endo/epi flow
ratio was a significant predictor of S-T patterns; a 951.
probability of an ischemic pattern corresponded to a endo/
epi ratio of < 0.58, while a 951. probability of a normal
S-T pattern o;curred with a flow ratio of > 0.76 (p<O.Ol).
Using this model, 95.51. of cases were corr;ctly classi-
fied. Neither heart rate nor perfusion bed size were
predictors. Thus, onset of S-T changes of ischemia corres-
ponds to a predictable degree of flow redistribution.
TRANSIENT ISCHEMIA IN CORONARY DISEASE IS ASSOCIATED
WITH MENTAL AROUSAL DURING DAILY LIFE
George S. Rebecca, M.D., Richard R. Wayne,B.S., Stephen
Campbell, M.B., Michael Rocco, M.D., Elizabeth Nabel,
M.D., Joan Barry, Andrew P. Selwyn, M.D., FACC. Brigham
&Women's Hospital, Harvard Medical School, Boston, MA.
Patients with angina and coronary disease have frequent
asymptomatic episodes of ischemic ST depression (STD)
during daily life. We tested the hypothesis that the
majority of events are associated with routine activities
demanding mental arousal. Twenty-one patients with
chronic stable angina (CSA), positive exercise tests and
proven coronary disease underwent 891 hours of frequency
modulated holter monitoring to measure episodes of STD
( .;" 1 mm, .;,,80 msec, and lasting 230 seconds duration)
and demonstrated 233 episodes of transient ischemia with
87% being asymptomatic. A structured diary of mental
(usual events, stress) and physical state (rest, usual,
exercise) were used to specify activities and on review
showed that 19% of episodes occurred while asleep, 18%
occurred at physical rest, 52% during minimal physical
activity, with 11% during exercise. In contrast 6% of
episodes occurred during mental stress but 75% occurred
in association with tasks demanding routine mental work
(conversation, office work, reading, watching TV). STD
was most often related to mental arousal even when the
number of episodes was normal~zed for time spent at
each activity. (Chi Square X p <.001). Thus,
episodes of transient ischemia were most commonly
associated with activities demanding mental arousal and
not physical exertion. This new characteristic describes
the most frequent trigger associated with myocardial
ischemia during daily life and may have therapeutic
implications as behavior and levels of stress can be
modified.
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PAJ1US) JMX:AII)!AL :J:lIHXIA IN <lRJ«C srAIlIE ARmfA.. ITS JmATI(ft 10
mlI:ISE 'KUIW«E AM> <nIHlRY ARJmmnWfl'{
Francesco Ranee loll, sergio Olierchia loll, Attllio Maseri loll, FNX.
Cardiovascular Unt, RIM3, fIam1ers'nith H:spital, Lcndcn, UK.
Al1:tx::4?)1 the occurrence of painless IT\Yocardial lschani.a is well
reec>@1lzed, its incaden::e in an unselected pq:JUlatim of patients (pts)
W1th chrcnic stable angina (CSA) , and its relatim to exercise
tolerance and seventy of cormary artery disease (CAD) are not kn<::1.I41.
we studled 84 cmsecutive pts with CSA, pcsitive exercise test (ET) and
cbcunented CAD. All underwent ootulatory EO} nmitonng for 48 h::Iurs,
off rredicatim ;;part fran nitroglycerin. R~ were perfonned
using JiM !blter boxes, within 2 weeks of cormary arterie>grapl'w and ET.
In the period of nmitoring, 49 pts (58%, Gro.p 1) had episodes of
diagnostlC Sf BegITleI1t depressim and 35 (42%, Gro.p 2) did not. Of the
Gro.p 1 pts 6, 18 and 75lb had 1,2 and 3 vessel disease respectively,
wist, in Gro.p 2, percentages for the sane severity SLtJgro..ps were
11,31 and '57. Overall, exercise capacity was lower 1rl Gro.p 1 and 57%
of these pts had an exercise tJ.rre~6 mins (Bruce rrodified protocol).
Ibwever, a large degree of overlap was OOserved and 10 pts (28%) of
GraJp 2 had a sJJ11ilar exercise tolerance.
In the 49 pts of GraJp 1 we recorded 3)4 episodes of sr segnent
depressim of IIoIuch mly 59 (19%) were associated with a1gina; 25 pts
had both episodes with and witha.lt chest pain wist 24 mly had
asyrrptaratic isc:haTua. The presen:e or 00sence of a1gina was not
related to the severity of CAD and exerclSe tolerance. Therefore: (1)
in a large percentage of pts with CSA ootulatory EO} lIO"titoring
detects frequent eplsodes of l1\YOC8!'Chal ischsnia wch are mly
partially related to the severity of CAD and inpairment of cormary
flcm reserve. (2) the rrajority of these episodes are painless and sane
pts (25%) can be totally asyrrptaratic in spite of cbcunented ischemia.
(3) the occurrence of asyrrptaratic ischanla is not predicted by the
severity of CAD nor by the degree of inpairment of exercise tolerance.
TRE VALUE OF THE ADMISSION ELECTROCARDIOGRAM TO PREDICT
EFFECT OF THROMBOLYSIS ON INFARCT SIZE.
Frits Bar, M.D., Frank Vemeer, M.D., X Hanno Krauss,
M.D., Jan Res, M.D., Maarten Simoons, M.D., F.A.C.C.,
Christoffel de Zwaan, M.D., Arnoud vd Laarse, PhD, Rein
JJ Wellens, M.D., F.A.C.C. The Netherlands Interuniver-
sity Cardiology Institute.
Predictive value of the ECG on admission was studied in
488/533 patients (pts) from a randomized trial of
thrombolysis versus conventional therapy. All baseline
data were similar in both groups. Presence or absence of
Q's and sum of ST elevation (I) (mm) were correlated
with infarct size, estimated from cumulative myocardial
a1fa RBDR enzyme release.
Results: Overall, thrombolysis pts had significant lower
infarct size (410U=30%) compared to control. Infarct
size limitation was greatest in pts with Q's or high STI
(> 12 mm) in anterior (Ant) infarct (reduction of 820U=
47% and 750U=39% respectively) and high STI (> 6 mm) in
inferior (Int) infarct (reduction of 460U=36%). Nor in
Ant or Inf infarct was infarct size influenced by
streptokinase when the ECG showed the combination of low
ST I and absence of Q's. The delay between onset of
symptoms was an independent predictor of infarct size.
In Ant and Inf infarct, control and thrombolysis pts had
equal infarct size in presence of no Q + delay> 120'
and low STI + delay> 120'. The other pts showed lower
infarct size after thrombolysis.
Conclusions: 1. Number of Q's and degree of STI predict
success of thrombolysis. 2. Thrombolysis does not reduce
infarct size when the ECG on admission shows: no Q + low
STI, independent of the delay between infarct and admis-
sion. 3. Infarct size also does not change when the
combination: absence of Q's + delay> 120' or low STt +
delay> 120' is present. Those pts should not be treated
with streptokinase.
THE HIGH PREVALENCE OF VENTRICULAR ARRHYTHMIAS IN THE
24 HOURS FOLLOWING REPERFUSION DOES NOT INDICATE A HIGH
RISK FOR SUBSEQUENT SEVERE ARRHYTHMIAS.
Bojan Cercek MD, Allan S. Lew, MD, Pierre Laramee, MD,
P.K.Shah, MD, FACC, William Ganz, MD, CSc, FACC, and
Thomas Peter, MD, FACC. Cedars-Sinai Medical Center,
Los Angeles.
In 28 consecutive patients (Pts) with acute myocardial
infarction who underwent early successful thrombolysis
with intravenous streptokinase, a continuous 24-hr ECG
was recorded immeadiately postreperfusion and on pre-
discharge day (8±2).
During the 24 hr following reperfusion, all 28 Pts had
isolated premature ventricular complexes (PVC) (median
- 17 beats/hr, range: 1-176), 27 Pts (96%) had couplets
(median - 1 couplet/hr, range: <1-24) and 25 Pts (89%)
had runs of ~ ectopic beats (median - 67/24 hr, range
l-829).The number of beats in the longest run in any
given Pt ranged from 4 - 7892 (median - 23) at a rate
of l39±49 beats/min. PVCs were recorded throughout 24
hr in all patients. During the last 3 hr of recording
significant arrhythmias tended to disappear with coup-
lets being present in 6 Pts (21%) and runs in 5 Pts
(18%) only.
Predischarge, 26 Pts (93%) had isolated PVCs (median -
<1 beat /hr, range 1 39),only 3 Pts (11%) had <1
couplet/hr and 2 Pts (7%) had 1 short run of 3 and 6
ectopic beats respectively. There was no instance of
ventricular fibrillation in either recording.
Conclusion' 1) Ventricular arrhythmias occur in most
patients during the first 24 hr following early reper-
fusion. Couplets and runs of ventricular ectopic beats
tend to cluster during the first hours after reperfu-
sion and in most patients disappear over 24 hr. 2) At
the time of discharge none of these patients developed
severe ventricular arrhythmia.
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Cardiac Resuscitation
TWENTY FOUR HOUR SURVIVAL IN A CANINE MODEL
COMPARING THREE METHODS OF MANUAL
CARDIOPULMONARY RESUSCITATION.
Karl B. Kern. M.D., Alice B. Carter, Lee
Showen, M.S., William D. Voorhees, Ph.D.,
Charles F. Babbs, M.D., Ph.D., Willis A.
Tacker, M.D., Ph.D., Gordon A. Ewy, M.D.,
F.A.C.C., University of Arizona, Tucson,
Arizona.
Two new methods of cardiopulmonary
resuscitation (CPR), both suitable for basic
life-support, have been reported to produce
better hemodynamics than conventional CPR.
However, whether either of these new methods
will improve survival after cardiac arrest is
unknown. Twenty-four hour survival and
neurologic outcome were compared among 3 forms
of manual CPR: standard at 60 compressions per
min, high impulse compression (HIC) at l20/min,
and interposed abdominal compression (lAC) at
60/min. Thirty mongrel dogs (20 to 32 kg) were
equally divided among the 3 CPR methods.
Following 3 minutes of ventriCUlar fibrillation
without intervention, CPR was performed for 17
minutes. No medications were given during the
CPR period. Defibrillation was attempted at 20
minutes. Five standard CPR, 3 HIC CPR, and 2
lAC CPR animals survived 24-hours. There was
no difference i~ 24 hour survival among t~e 3
types of CPR (x =2.37, d.f.=2, p>O.l). N1ne
of the 10 survivors had totally normal
neurologic function. properly performed
standard CPR appears as effective for survival
and neurologic outcome as these two new
modified versions of basic life-support.
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SELF-ADHESIVE MONITOR/DEFIBRILLATION PADS:PREHOSPITAL USE
Kenneth R. Stults B.S.,PA-C, Donald D. Brown, M.D., and
Richard E. Kerber, M.D., Univ of Iowa Hosps, Iowa City IA
The purpose of this study was to determine the relative
efficacy of self-adhesive, dual function monitor/defib-
rillation pads vs. standard chest monitoring leads and
defibrillation paddles in the management of prehospital
cardiac arrest. Monitoring and defibrillation parameters,
including incidence of loose-lead artifact which impaired
rhythm interpretation, elapsed time from paramedic arriv-
al to first shock, first shock conversion to organized
rhythms, and overall termination of ventricular fibril-
lation (VF), were compared longitudinally in an urban
paramedic system. For 14 months paramedics monitored
through standard 3-lead chest electrodes (lead 2) and
defibrillated with standard hand-held paddles. During the
subsequent 12 months, self-adhesive monitor/defibril-
lation pads (R2 Corp., Skokie, Ill.) were employed for
both functions. The pads performed significantly better
with respect to a number of key parameters:
Standard Leads/ Self-Adhes. P
Paddles Pads value
Time from Arrival
to First Shock (min.) 2.54+1.39 1.67+.87 <.001
First Shock Conversion
to Organized Rhythm 18/67(27%) 17/34(50%) < .05
Termination of VF:
Per Patients 49/67(73%) 30/34(88%) NS
Per Shocks 79/209(38%) 52/96(54%) <.025
In addition, 19 of 73 patients (26%) monitored with
standard leads received at least one shock when severe
loose-lead artifact was misinterpreted as VF, while this
happened with only 2 of 46 patients (4%, p<.Ol) when pads
were used. Self-adhesive monitor/defibrillation pads are
superior to standard chest leads and hand-held paddles in
the management of prehospital cardiac arrest.
HYPOKALEMIA AFTER RESUSCITATION FROM VENTRICULAR
FIBRILLATlON.
David M. Salerno, Ph.D., M.D., FACC, Joseph Elsperger,
CCPT, Peter Helseth, Vinaya Chepuri, Darryl Erlien, MS.
Hennepin County Medical Center and Univ. of MN.
Minneapolis, MN.
Hypokalemia has been reported in up to 1/3 of patients
(pts) after resuscitation from out-of-hospital ventricular fibril-
lation (VF), being implicated as a predisposing condition. To
test whether hypokalemia can occur secondary to VF and re-
suscitation, we induced VF in anesthetized dogs. After a
period of VF, the dogs underwent ventilation and chest
massage and finally electrical cardioversion. Arterial gases and
serum potassium (K), sodium (Na), calcium (Ca), magnesium
(Mg), phosphorus (P), and glucose (G) were obtained before and
7, 15, 30, 45, 60, 90, 120, and 180 min after VF.
Twenty dogs were resuscitated: 7 needed epinephrine (E)
during resuscitation and 13 did not (no E). Five other dogs
were anesthetized and instrumented but VF was not induced
(control). The following K values (mmole/L) were obtained:
n Baseline 30 45 90 180
Control (5) 3.7 3.5 3.4 3.4 3.6
All VF (20 3.7 3.3 3.2* 3.3 3.5
VF (no E) (13) 3.7 3.3 3.2* 3.3 3.5
VF (E) (7) 3.8 3.5 3.3 3.3
*p<.005 by ANOVA from baseline
Changes in K were independent of pH. Serum G rose after
VF (p<.OOl) but not in control dogs. Ca and Mg decreased
after VF in both control and VF dogs. No changes in Na or P
were observed.
Thus, after VF, K decreased independently of pH or exo-
genous E. These data suggest that the hypokalemia seen after
VF In humans may develop following the event rather than
exist as a predisposing condition as previously suggested.
TWO FORMS OF "NEW" CPR: POSSIBLE ROLE OF A
COMBINED THORACIC AND VASCULAR PUMP.
Karl B. Kern, M.D., Alice Carter, Lee Showen,
M.S., William D. Voorhees, Ph.D., Charles F.
Babbs, M.D., Ph.D., Willis A. Tacker, M.D.,
Ph.D., Gordon A. Ewy, M.D., F.A.C.C.,
University of Arizona, Tucson, AZ.
simultaneous compression and ventilation (SCV)
cardiopulmonary resuscitation (CPR) and vest
CPR, were compared for survival and neurologic
outcome. Twenty large (23 ± 0.7 kg) mongrel
dogs were anesthetized with morphine and
halothane. Ventricular fibrillation was
electrically induced and one of the "new" CPR
types begun after a 3 minute downtime.
Simultaneous compression and ventilation CPR
was performed with chest compressions at 40
times/min and simultaneous ventilations at 90
mm Hg. Vest CPR was performed using cyclic
inflations at 50/min of both a pneumatic chest
bladder (200 mm Hg) and an abdominal bladder
(100 mm Hg), and with simultaneous ventilations
(15 ml/kg). CardiopUlmonary resuscitation was
performed for 17 minutes before defibrillation
was attempted. Simultaneous compression and
ventilation (SCV) produced significantly more
coronary perfusion pressure at 2 and 7 min of
CPR (p<0.05), but not at 12 or 17 min. Five of
10 SCV animals survived 24 ho~rs versus only 1
of 10 vest animals (p<0.05, x = 3.81 df= 1).
Neurologic deficits were significantly less
following SCV (54±16%) versus vest (9l±9%;
p <0.05). The differences between these two
forms of "new" CPR may be due to a combination
of a thoracic and a vascular pump affecting
blood flow in SCV CPR.
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AUTOMATED IMPEDANCE-BASED ENERGY ADJUSTMENT FOR TRANS-
THORACIC DEFIBRILLATION AND CARDIOVERSION IN PATIENTS WITH
HIGH TRANSTHORACIC IMPEDANCE: CONTINUED CLINICAL EXPERI-
ENCE. Richard Kerber MD, FACC, James Martins MD, Michael
Kienzle MD. Brian Olshansky MD. Francis Charbonnier PhD.
U of Iowa. Iowa Ci ty. Ia
We have previously shown that transthoracic impedance is
a major determinant of ability to defibrillate when using
low energy; low energy shocks. although safer. may be in-
effective if transthoracic impedance is high. We have
developed a method which identifies high transthoracic
impedance (>70n) in advance of any shock and automatically
compensates for the high impedance by doubling the oper-
ator-selected energy. Studies in animals and preliminary
human experience. previously reported. were favorable. We
have now used this automated approach in 29 high impedance
(>70n) patients. In these high impedance patients the
energy-adjusting defibrillator automatically increased
operator-selected 100J shocks to 200J. The results of
such energy-adjusted shocks were compared to the results
of shocks given to an additional 30 high impedance patients
using a standard defibrillator set at 100J. Some patients
received several shocks. Results:
Rhythm Defibrillator Shocks: Succ/Total
At Fib Standard 8/24]**
Automatic energy t 14/18
V Tach Standard 11/19]*
Automatic energy t 19/19
Standard 8/17
Automatic energy t 4/4
*=p<.05. **=p<.Ol by Chi-square test
Conclusion: Automated impedance-based energy adjustment
improves the success of low-energy shocks for defibrilla-
tion and cardioversion by automatically increasing shock
energy to compensate for high transthoracic impedance.
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AUTOMATIC IMPLANTABLE DEFIBRILLATORS: TWO SEQUENTIAL
PULSES ARE AS EFFECTIVE AS THREE.
Jerry ~. ~, Ph.~; Joe D. Bourland, Ph.D; Gregory
M. Ayers, B.S.; Willis A. Tacker, M.D., Ph.D; Michael J.
Kallok, Ph.D; and Leslie A. Geddes, Ph.D., F.A.C.C.
Biomedical Engineering Center, Purdue University, West
Lafayette, IN
Use of 2 sequential shocks reduces the energy required
for internal defibrillation by 60 to 80% in animals and
man when 3 or 4 electrodes are used to create 2 separate
current pathways in the heart. Whether use of 3 pulses
will further reduce energy is not known, and is the sub-
ject of this study. In each of 6 mongrel dogs (mean
body weight 29.3 kg), ventricular defibrillation
threshold energy was determined for 2 pulses and for 3
pulses delivered via epicardial electrodes. For 2
pulses, the sequence of current flowing through the
heart was from 1) right to left and 2) anterior to pos-
terior. For 3 pulses, the current sequence was: 1)
apical-anterior to basal-posterior; 2) left to right;
and 3) apical-posterior to basal-anterior. Total capa-
citance and duration of current flow were the same for 2
and 3 pulses. Pulse separation was 0.2 msec.
Truncated-exponential waveforms with total durations of
1,2,5 and 10 msec and tilts of 50, 65, or 80% were
tested. Mean energy for 3-pulse defibrillation was not
less than for 2-pulse (p-0.01). For example, using
pulses with total duration of 5 msec and tilts of 50%,
the mean energy for 2-pulse defibrillation was 3.9± 1.0
joules (mean ± sd) and for 3-pulse was 4.8 ± 1.6 joules.
Of 36 threshold pairs, energy for 3-pulses was greater
in 24, the same in 8, and less in 4. For the electrode
configuration tested, we conclude that defibrillation
with 3 pulses does not reduce the energy requirement
when compared to defibrillation with 2 pulses.
P
<.025
<'025
<.025
Group 2
1187±536
l57±158
14951:928
ALTERATIONS IN ADENYLATE CYCLASE ACTIVITY AND
aI-RECEPTORS IN PATIENTS WITH VENTRICULAR TACHYCARDIA
Joel S. Karliner, M.D., F.A.C.C., Melvin Scheinman, M.D.,
F.A.C.C., Lawrence DiCarlo, M.D., Jesse Davis, M.D.,
Wan~a Wolozyn and Norman Honbo. VAMC, CVRI and Dept of
Med1cine, Univ. of California, San Francsico, California.
We measured adenylate cyclase (AC) activity and a -
receptor properties in right ventricular septal bibpsies
from 8 patients (pts) undergoing electrophysiologic study
for ventricular tachycardia (VT). None were on
m~dication. Four pts with exercise-induced VT and 1 pt
wHh septal VT, all with normal LV function, comprised
group 1; 2 pts with a cardiomyopathy and 1 pt with
myocarditis comprised group 2. AC activity (-basal) is
expressed as pmol/mg protein/30min.
Group 1
5568±1739
3029±906
4672±1263
1) NaF 10mM
2) GppNHpp O.lmM
3) GppNHp O. lmM
+isoproterenol luM
4) Isoproterenol luM 4891:285 401:35 <.025
5) [3]-[2] 16431:529 13371:781 <.025
In 3 pts with normal12~V function, the K for the
aI-selective antagonist I-IBE-2254 was 379f95 pM and
tfie maximum number of binding sites (Bmax) was 1741:58
fmol/mg protein. In 1 pt with cardiomyopathy and 1 with
myocarditis, values were 627 and 1200 pM and 670 and 644
fmol/mg protein, respectively. We conclude: 1) human
myocardium contains high affinity low-capacity sites for
al-re~eptors; 2) human AC, unlike rat but like the dog,
is m1nimally responsive to luM (-)-isoproterenol, but
increases markedly in the presence of 100uM GppNHp; and
3) abnormalities in AC activity and in a -receptors
relate to the presence of underlying myocardIal disease
rather than to VT per se.
AVERAGING OF
INTRACARDIAC
PATIENTS WITH
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Electrical Therapy and Detection of
Arrhythmogenic States
MULTIPLE VS SINGLE PULSES TO AVOID VOLTAGE BREAKDOWN AND
SHOCK-WAVE GENERATION WITH CATHETER MEDIATED ELECTRICAL
PULSES. Gust H Bardy,MD,FACC, Fernando coltorti,MD,
Michael Rackson,BSEE, Karl Hanson,BSEE, H Leon Greene,
MD,FACC, Tom D Ivey,MD. Univ WA, Seattle, WA.
Electrical ablation of cardiac tissue can result in
high pressure shock-waves. This phenomenon is signaled
by breakdown in the voltage waveform as impedance rises
during bubble formation at the electrOde surface.
We used a high voltage, variable waveform modulator
with a wide dynamic range to stUdy whether multiple
constant current, rectangular pulses (MP) with a shorter
pulse width (PW) could deliver more energy before
voltage breakdown than a single pulse (SP) at the same
current but with a longer PW. All pulses were cathodal
and delivered to a 6Fr 16mm2 surface area CU electrode
in bovine blood. For sp's, PW was determined by the
maximum possible pulse duration before voltage breakdown
occurred. With MP'S, the PW of indiVidual component
pulses was half of the SP PW at the corresponding
current. MP duty factor was 10\. The number of pulses
used for a MP burst was the maximum delivered before
voltage breakdown occurred. The relation between SP and
MP delivered energy before voltage breakdown follows:
current(Amps) 6 8 10 12 14 l§
SP:PW(ps) 320 180 140 96 72 62
SP:Energy(J) 0.9 0.9 1.1 1.1 1.1 1.2
MP:PW(ps) 160 90 70 48 36 31
MP:Energy(J) 2.4 3.0 2.8 2.5 2.4 5.2
MP:. of Pulses 5 6 5 4 4 9
Conclusion: For any given current Sp's are less
efficient in delivering energy than MP's with shorter
PW's. MP's at very short PW's (3~s) yield the most
energy before voltage breakdown. Eventually, however,
even with MP's, voltage breakdown and shock-wave
generation occur.
A COMPARATIVE ANALYSIS OF SIGNAL
THE SURFACE QRS COMPLEX AND
ELECTRODE CATHETER RECORDING IN
VENTRICULAR TACHYCARDIA.
J.A. Gomes, M.D., F.A.C.C., R. Mehra, Ph.D, P. BalTeca, B.S.,
S. Winters, M.D., The Mount Sinai Medical Center., New York,
N.Y. and Medtronics Inc; Minneapolis
Signal averaging (SA) of the surface QRS complex has been
used to detect late potentials in patients (pts) with ventricular
tachycardia (VT). However, these potentials may be more
enhanced when recorded from a RV electrode due to its proximity
to the source of delayed conduction. Thus, we performed a
prospective study in 9 pts (59 ± 13 yrs) with sustained VT. All
pts had SA of surface QRS (method [Me] 1) and SA of an
intracardiac electrogram utilizing an unipolar RV apical
electrogram (Me TIl during electrophysiologic studies. SA by
the Z (Me's) was performed within < Z4 hours of each other
utilizing a band pass filter frequency of Z5 to Z50 Hz. The
duration of the high frequency total QRS (HFTD), low amplitude
signals (LAS) of <40jlv and the RMS-voltage of the terminal
40 msec (V40) were determined for the Z Me's. Results: There
was a significant correlation between HFTD (r=.98,p<.OOl);
LAS (r=.87,p<.005) and V40 (r=.89,p<.00I) between the Z Me's.
The SA-parameters obtained by the Z Me's are shown below.
Method HFTD(ms) LAS(ms) V40(Jlv) Noise
I l39±Z5 37±Z5 52±56 1.1±.6
II l48±Z6 3I±Z8 36±30 1.3±.7
There was no significant difference between the Z Me's. HFTD
was >IZO ms in 56% (Me 1) vs 89% (Me Ill; LAS was> 3Z ms
in 33% (Me 1) vs 22% (Me II) and V40 was <25 jlV in 44% (Me
I) vs 33% (Me II). In one pt Me II (HFTD=I70 vs 105ms, LAS
= 75 vs 33ms and V40 = 14 vs 40jlv) provided more information
relative to Me I. In conclusion: (1) SA of intracardiac eIectrograms
correlates well with SA of surface QRS; (Z) SA of intracardiac
electrograms may provide additional information on SA
parameters relative to surface QRS in some pts.
lACC Vol. 7, No.2
February 1986 243A
ABSTRACTS 243A
SELECTIVE PERCUTANEOUS CATHETER ABLATION Of THE RIGHT BUNDLE BRANCH
IN PATIENTS WITH SUSTAINEO BUNDLE BRANCH REENTRANT TACHYCARDIA
J YelJ1g Lai Wah, I'IB ChB, K Friday, MD, FACC, E Olson, MD, FACC, A Khan,
MO, S Prabhu, MD and W Jackman, MO, University of Oklahoma and VA Medical
Center, Oklahoma Cit y, OK
BlJ1dle branch reentry (BBR) has beer I'roposed as an uncommon mechanism
for sustained ventricular tachycardia (VT). Creating right bundle branch
(RB) block should eliminate the tachycardia and validate the mechanism.
In 3 patients (pts) with intraventricular conduction delay (QRS = 180,
120 and 130 msec) and sustained VT exhibiting LBBB pattern, programmed
ventricular stimulation (PVS) induced sustained VT similar in rate and
morphology to the clinical VT. Induction of VT by PVS was reproducible
and dependent upon critical V-H delay (~ 180, 220 and 210 msec). BBR
was confirmed as each VT complex was preceded by retrograde H ane ante-
grade RB potentials and H-V and RB-V rerrained fixed despite changes
in VT cycle length. Right ventricular extrastimuli during VT advanced
the timing of subsequent QRS complexes only if the timing of the preced-
ing Hand RB potentials "ere advanced first, and terminated VT cnly
by producing V-H block. The RB potential was recorded from an 8-electrode
catheter with 3 mm spacing (center-to-center). In 2 pts, the RB poten-
tial was traced during VT until it merged with earliest ventricular
activation near the apex. To selectively ablate the RB, the distal pair
of electrodes was positioned over the proximal RB (10, 10 and 18 mm
distal to the His bundle electrode) with H-RB = 10, 20 and 2S msec and
RB-V = SO, 30 and SO msec, respectively. One (2 pts) or two (1 pt)
shocks of 300 joules were delivered between the coupled 2 distal catheter
electrodes (cathode) and lateral/posterior chest paddle (anode). New
RBBB was still present on ECG ~ S days post-shock in all 3 pts. The
first 2 pts were restudiea cit 1 week. The RS potential was absent and
BBR complexes could not be induced duI ing PV= c'espite achiev ing V-H
intervals as long as 230 and 260 msec, respectively. We conclude: 1)
selective RB ablation is feasible and safe, and 2) interruption of VT
by proximal RB ablation confirms BBR mechanism.
COMPARISON OF RESETTING AND TERMINATION OF VENTRICULAR
TACHYCARDIA WITH PROGRAMMED EXTRASTIMULI.
Jesus M. Almendral, MD, Mark E. Rosenthal, MD, Nicholas
J. Stamato, MD, John M. Mi ller, MD, Lawrence H. Frame,
MD, FACC, Mark E. Josephson, MD, FACC, University of
Pennsylvania, Philadelphia, PA.
Both resetting and termination of ventricular tachycardia
(VT) require that the paced impulse reaches the VT origin
at a critical time. Single ventricular extrastimuli
(SVE) were delivered during B1 distinct VT from the RV -
apex. Double ventricular extrastimuli (DVE) (with the
coupling interval of the first set to cause no resetting)
were delivered in 34 VT. In total, 60 VT were reset and
21 terminated. Resetting was more frequent than
termination with both SVE (56% vs. 9%; p<.OOl) and DVE
(100% vs 41%; p<.OOl). Resetting preceded termination in
19 of 21 VT, thus termination occurred in only 2 VT
without prior reset. The ability to reset or terminate
VT was not related to VT morphology, axis, or site of
origin determined by LV mapping. Compared to VT requiring
DVE for resetting, VT reset with SVE demonstrated left
bundle branch block QRS more frequently than right bundle
branch block (53% vs 25%, p<.03), a shorter activation
time to the RV apex during VT (62±48 ms vs 98±60 ms,
p<.03), and a longer VT cycle length (382±60 vs 338±49
ms; p<.02). A similar comparison for VT termination,
demonstrated that only a longer VT cycle length (399±59
vs 346±39; p<.03) significantly distinguished VT termi-
nated by an SVE from VT requiring DVE for termination. We
conclude: 1) Both resetting and termination of VT by SVE,
as compared to DVE, are faciliated by a longer VT cycle
length and, in the case of resetting alone, a shorter
activation time to the pacing site during VT; 2) The
abi 1ity to reset VT is a marker for the abi 1ity to
terminate VT with programmed extrastimuli and may select
patients in whom pacing therapy may be considered.
DEMONS'ffiATION OF CATHETER ABLATIVE TECHNIQUE FOR CON'ffiOL
OF VENTRICULAR TACHYCARDIA DUE TO MACRO REENTRY WITHIN
THE HIS-PURKINJE SYSTEM.
Stephen T. Denker, M.D., F.A.C.C., Rehan Mahmud, H.D.,
F.A.C.C., Patrick Tchou, H.D., Mohammad Jazayeri, H.D.,
Issam AI-Bitar, H.D., Masood Akhtar, M.D., F.A.C.C.,
Univ. of WI Mt. Sinai Med. Center, Milwaukee, WI.
Symptomatic ventricular tachycardia (VT) due to
reent ry wit hin the His-Purkinje sy stem (Re-HPS) has been
reported to occur in 6\ of patients with sustained
monomorphic VT. This form of VT is also reportedly
d iff icult to cont rol with antiarrhythmic drugs. However,
in contrast to other forms of VT, Re-HPS has a well
defined circuit with accessible landmarks including the
bund Ie branches (BBs). While cat heter ablat i ve technique
may therefore be useful for Re-HPS it has never been
preViously demonst rated. This was attempted in a pat ient
with VT and syncope found to have sustained Re-HPS. 200 J
was delivered through the distal electrode of a
quadripolar electrode catheter (with proximal electrode
pair recording HB) to a posterior chest paddle. EKG
recorded new RBBB but intact AV conduct ion. Re-HPS was no
longer inducible immediately and 3 days post ablation.
Syncope or VT has not recurred during one year follow up.
We conclude that: 1) Selective RB ablation using
elect rode catheter technique is possible and is a
potential therapy for VT due to sustained Re-HPS. 2) In
such cases RB ablation is preferable to HB ablation
because complete heart block is not required for
treatment. 3) Moreover, since the reentrant circuit may
not include the more proximal HB, HB ablation, in
contrast to RB ablation, may not prevent Re-HPS.
Thursday, March 13, 1986
8:30AM-I0:00AM, Room #157
Dynamics of Left Ventricular Diastolic Filling
LOAD-DEPENDENT RELAXATION IN THE INTACT LEFT VENTRICLE.
William H Gaasch HD FACC, Yoram Ariel PhD, Thomas A
McMahon PhD. Tufts University-Boston V.A. Medical Center
and Harvard University-Division of Applied Sciences,
Boston and Cambridge, Ma.
In isolated heart muscle preparations an abrupt increase
in load during the latter half of contraction (at a time
when there is little if any potential to develop addition-
al force) causes a premature and more rapid relaxation;
this load-dependent relaxation (LDR) characterizes relax-
ation in myocardium with normal aarcoplasmic reticulum.
The purpose of this study was to evaluate the presence of
this phenomenon in the intact left ventricle (LV). Using
a microcomputer controlled servo-pump attached to the LV
apex (5 anesthetized dogs), we studied the effects of 6 ml
volume increments (quick stretch or volume steps) on LV
pressure transients (micromanometer). Each step (given at
30 msec intervals throughout systole) waa carried out in a
single beat with 20 control beats between step beats. In
ejecting beats (n-23) an early systolic step near aortic
valve opening caused an increased duration of contraction-
relaxation (average 10 maec); however, a late step near
aortic valve closure caused an early onset of relaxation
and shorter duration (average 23 maec). In "isovolumic
beats" (single-beat aortic occlusion plus step, n-47),
results were similar; steps after the first 1/3 of systole
caused early relaxation with maximum effect at peak
pressure: duration fell by 13% (average 28 msec) and peak
(-)dP/dt increased by 75% (average 1710 to 2975 mmHg/sec).
The observed premature and rapid relaxation with late
systolic volume steps confirms a form of LDR in the intact
LV. Hemodynamic steps (i.e. reflected pressure waves and
other late systolic events) and/or alterations in the
mechanisms underlying LDR (i.e. abnormal sarcoplasmic
reticulum) may be responsible for changes in relaxation in
normal and diseased hearts.
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VARIABLE RELATIONSHIPS OF MITRAL VALVE MOTION AND FLOW
Pamela S. Douglas, M.D., F.A.C.C., Barbara A. Berko, M.D.,
Alfred Ioli, Nathaniel Reichek, M.D., U of Penn, Phila. PA
To examine the relationship between transmitral flow and
diastolic mitral valve (MY) motion, we compared MV echo-
grams with pulsed Doppler recordings of LV inflow in 44
subjects. There were 17 normals (NL), 15 hypertensives
(HBP, all normal LV function) and 12 cardiomyopathies (CM,
EF 20+6%). Echograms were analyzed for maximal early and
late diastolic leaflet separations, their ratio and early
anterior leaflet opening and closing slopes. Flow profiles
were analyzed for peak early and late velocities, their
ratio and early flow acceleration and deceleration. Volume
flow was estimated as leaflet separation times velocity.
Corresponding MV leaflet separations and peak velocities
were poorly correlated. Early flow decceleration and MV
E-F slope were weakly related (r=.49), while flowacceler-
ation and rate of leaflet opening were not. In CM, E and A
point MY leaflet separations (E-E, A-A) and early flow
velocity (E) were reduced. In HBP, E-E was reduced and
late flow velocity (A) was increased (p<.01). Early
volume flows were decreased in CM and HBP, and late flow
was increased in HBP (p<.05). The ratios of early to late
velocities (EfA) and volumes were smaller in HBP (p<.05),
although the ratios of MY leaflet separations were similar
in all subjects. (*p<.01vNL,HBPj**p<.05vNL,CMjtp<.05vNL)
E-E A-A E-EfA-A E A EfA
NL 3.18 2.31 1.41 61.8 40.1 1.61
HBP 2.83t 2.34 1.28 52.2 52.5** 1.04t
CM 2.19* 1.76* 1.24 48.4t 41.8 1.38
Despite qualitative similarities, MY motion and flow are
poorly related and are affected differently in CM, with
reduced leaflet excursion throughout diastole, and in HBP,
with increased peak velocity and volume of atrial filling.
Alterations of volume flow may be due to changes in MY
orifice size, flow velocity or both.
TORSIONAL DEFORMATION OF THE HUMAN LEFT VEI'\
TRICLE: ALTERATIONS DURING CARDIAC ALLOGRAFT
REJECTION.
David E. Hansen, M.D., George T. Daughters, M.A., Edwin L.
Alderman, M.D., F.A.C.C., John C. Baldwin, M.D., Philip E.
Oyer, M.D., Neil B. Ingels, Ph.D., Edward B. Stinson, M.D., D.
Craig Miller, M.D., F.A.C.C., Stanford University, Stanford, CA.
To Investigate LV systolic torsion and diastolic recoil in man,
serial measurements were made in 7 heart transplant recipients
over a span of 8 weeks following surgery and related to the
presence or absence of biopsy-proven rejection. Measurements
are based on 12 tantalum markers implanted in the basal,
equatorial, and apical portions of the anterior, inferior, and
lateral walls. The torsional deformation characteristics rela-
tive to an internal reference system were calculated by com-
puter-aided analysis of the 3-dimensional marker motion on
biplane cinefluoroscopic recordings. Comparisons of measure-
ments before, during, and following recovery from 9 rejection
episodes enabled assessment of the effects of an acute rever-
sible myopathy on LV torsion and recoil. Compared to pre-
rejection values, the amplitude of torsion in the maximally
deforming segment (TO max) decreased during acute rejection
with myocyte necrosis from 20.1+5.6 to 17.1+5.50 (p<O.OO1).
Peak systolic torsion and diastolic-recoil rateswere unchanged
at 178+92 vs. 147+56 (NS) and 209+93 vs. 191+73 deg/sec (NS)
respectively. The segmental hierarchy of the amplitude of
torsion was consistently maintained during rejection. Over a
wide range of values in 49 studies, no correlation between
TO max and stroke volume, peak coiling rate and velocity of
fiber shortening, and peak recoil rate and maximum LV filling
velocity were demonstrated. We conclude that during acute
rejection: 1) The amplitude of LV torsion decreases without
altering LV coiling or recoil ratesj 2) The regional hierarchy of
torsional deformation is preservedj and 3) LV systolic torsion
and diastolic recoil may be functionally dissociated from seg-
mental shortening and filling of the LV cavity.
PARTIALLY VERSUS FULLY CONSTRAINED MODELS OF THE
DIASTOLIC LEFT VENTRICLE
Chester M. Bolt\\Qod, Jr., M.D., Pravin M. Shah, M.D.,
F.A.C.C. Wadsworth VA/UCLA, Los Angeles, CA.
A real istic model of the diastolic LV should account
for extramural as well as intracavitary forces. The pres-
sure outside the LV septum is RVDP (diastolic pressure).
The pressure exerted by the pericardium on the LV free
wall (PP) is controversial, but presumably satisfies O~
PP~ RVDP. Assuming that the septum carries 1/3 of the
total LV external surface, we therefore estimated the av-
erage transmural LVDPtm as (LVDP - 1/3 RVDP) (partially
constrained, PC, ie. PP=O), or as (LVDP - RVDP) (fully
constrained, FC, ie. PP=RVDP). In 6 coronary pts without
Q waves frame-by-frame angiographic LV vol ume (V) was re-
lated to micromanometer LVDPtm after nitroglycerin (NTG)
and subsequent volume challenge (VC). Curve shifts were
assessed by regression in a dummy variable S (0 for NTG,
1 for VC). Unstressed volume Vo was obtained byextrapol-
ating to zero LVDPtm, and compared to end-systOlic Yes.
Results: From NTG to VC RVEDP rose 8+2 to 19+11 mm Hg
(p<0.05), LVEDP 12+2 to 32+6 mm Hg (p<O~OOl), and LV
pressure decay ~~ 37+7 to 40+6 ms (p=0.053). PC S coef-
ficient was 6.5+3.3 mm while-FC was 2.4+2.1 mm Hg (p<
0.05). PC Vo was -37+51 ml while FC was 68+20 ml (p<
0.01), and FC VO was always>Ves of 34+10 mT (p<O.Ol).
Conclusions: The PC model predicts a Vo which is non-
physiologically small or even negative. The FC model al-
ways satisfies Vo> Ves, which may be physiologic if elas-
tic recoil occurs during early diastole. Diastolic pres-
sure-volume curve shifts induced by volume manipulations
were much smaller in the Fe than PC model, but not wholly
eliminated. Thus, the relation PP ; RVDP suggested in
recent literature may be accurate, but other factors be-
sides constraint may contribute to residual pressure-
volume curve shifts.
ASSESSMENT OF DIASTOLIC PRESSURE-VOLUME RELATION IN THE
INTACT LEFT VENTRICLE BY PULSED-DOPPLER ECHOCARDIOGRAPHY.
Robert D. Aronoff, M.D., William A. Zoghbi, M.D., Roxann
Rokey, M.D., Roberto Bolli, M.D., Miguel A. Quinones,
M.D., F,A.C.C., Baylor College of Medicine, Houston, TX
Assessment of LV diastolic pressure (P)-volume (V) has
previously required angiography and this has limited the
capacity for serial observations and beat by beat
analysis. We have shown that mitral annulus (MA) flow,
derived as the product of flow velocity by Doppler and
the annulus area repres~nts a measure of LV filling rate.
Accordingly, Doppl er MA flow curves were integrated and
combined with end-diastolic volumes by 2-dimensional echo
in 30 patients to derive diastolic volume curves which
qualitatively resembled those obtained by angiography. In
5 patients, simultaneous recordings of MA flow velocity
and LVP (micromanometers) were used to construct diasto-
lic P-V curves which were of high resolution in all pa-
tients. Viscoelastic properties were readily appreciable
as deviations from an ideal ized exponential curve. The
modulus of chamber stiffness (K) was determined as the
slope of dP/dV vs P during the curvilinear segment of the
P-V curve. This method was applied in 5 open-chest dogs
to examine diastolic P-V relations during acute ischemia
induced by <10 min coronary occlusions (n=10). A readily
appreciable-shift upward and to the left was seen in the
P-V curves with ischemia. Flattening of the curves during
diastole and prominent viscoelastic effect resulted in
non-l inear dP/dV-P relations (n=5). In cycles with a
linear dP/dV-P relation (n=5), a significant increase in
K was observed from control (.37 ± ,22 ml- 1 ) to ischemia
(.85 ± .54; p<.05). Thus, combined use of Doppler-MA flow
velocity and LVP provides a new method of assessment of
diastolic pressure- volume relations on a beat by beat
basis which is highly suitable for acute and serial
observations.
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ASYNCHRONY IN REGIONAL FILLING DYNAMICS AS A CONSEQUENCE
OF UNCOORDINATED SEGMENTAL CONTRACTION DURING
TRANSLUMINAL CORONARY OCCLUSION.
Federico Piscione, MO, Patrick W. Serruys, MO.
Thoraxcenter, Rotterdam, the Netherlands.
The effects of brief periods of a major coronary artery
occlusion on the global (GPFR) and regional (RPFR) peak
filling rates were studied in 14 patients during angio-
plasty. None had had a previous myocardial infarction.
High-fidelity left ventricular pressure and volume
(angiography) measurements were obtained before,20 and
SO seconds after the onset of transluminal coronary
occlusion (TCO) and shortly after the last TCO. Segmental
wall motion was analyzed frame by frame along 20 hemi-
axes. GPFR decreased significantly both after 20 (-2S%;
p < .OS) and SO seconds (-24%;p< .OS). The term 2:~ t 1 was
defined as the sum of the absolute values of the time
differences between the occurrence of GPFR and the peak
velocity of segmental outward displacement, which re-
flects the RPFR, in 20 segments. This parameter increased
significantly during both periods of TCO (by 64%; p<.OOS
and by S4%; p <.OOS respectively) thus indicating an asyn-
chrony in the occurrence of RPFR. Simultaneously the sum
of time intervals between the aortic valve closure (end-
systole) and the occurrence of peak segmental shortening,
2: ~ t 2, measured in the 20 segments, increased to a similarextent, thus demonstrating an asynchrony in segmental
contraction. We found a significant, negative correlation
between GPFR and both2:~t1 and 2:~t2 (r =-.68; p<.OOOl and
r=-.73; p<OOOl respectively). In addition a significant
correlation existing between 2:~t1 and 2:~t2 (r=.66;p<
.0001) indicates that the asynchrony in RPFR reflects an
asynchronous segmental contraction. and thus, a decrease
in GPFR occurring early during acute ischemia, actually
demonstrates an altered myocardial contraction.
Thursday, March 13, 1986
10:30AM-12:00NOON, Room #157
Experimental Hypertension
BETA ADRENERGIC RECEPTORS AFTER HYPERTROPHY AND ITS
REVERSAL IN THE RENAL HYPERTENSIVE RAT
Jadwiga Szlachcic, M.D., Julio F. Tubau, M.D., Barry
Massie, M.D., F.A.C.C., Wanda Woloszyn, Norman Honbo and
Joel S. Karliner, M.D., F.A.C.C. Cardiology Section, VAMC
and UCSF San Francisco, California.
There is evidence that a-adrenergic receptor changes
accompany the development of hypertrophy due to pressure
overload, but few data exist regarding a-receptor
properties after reversal of long-standing hypertrophy.
Thus, we used the 1 clip-2 kidney Goldblstt model to
produce LV hypertrophy. Treatment with a-methyldopa
(MO), 400 mg/kg/day, diltiazem (DL), 6Omg/kg/day or
placebo (PL) was was started after 12 weeks of
hypertension and continued for 3 months. Sham operated
(SH) animals were used as controls. Saturation
radioligand binding isotherms USe performed in cardiac
particulate preparations using I-iodcyanopindolol.
BP LV weight Kd Bmax
(mmHg) (gm) ~ (fmol/mg DNA)
SH (n=4) 119:!:l9 1. 02! .108 162!47 S8S!46
** ** **PL (n=3) 176:!:lS 1.S0!26 93:!:20 924:!:l4
134!12*/11I ** S41!78#1IMO (n=4) 1. 12!.20 116:!:l0
DL (n=4) 14S:!:lz'l# 1.27!.14*11 147!31 649!7SII11
* p<.OS, **p<.Ol vs SH, IIp<.OS, IIlIp<.Ol vs PL
We conclude 1) a-receptor density is increased after 6
months of sustained hypertension; 2) virtually complete
reversal of hypertrophy by the centrally acting
sympatholytic agent a-methyldopa or partial reversal by
the calcium entry blocker diltiazem are both accompanied
by a return of a-receptor numbers to control levels.
DECREASED ENDOTHELIUM-DEPENDENT RELAXATIONS TO
ACETYLCHOLINE IN THE AORTA OF HYPERTENSIVE DAHL RATS.
Thomas F. Luscher, M.D., Leopoldo Rai] , M.D. and Paul M.
Vanhoutte, M.D., Department of Phys101ogy, Mayo Clinic,
Rochester, M1nnesota.
The endothelium may play an important role in the local
control of vascular smooth muscle. In hypertension the
endothelium changes morphologically and functionally.
Endothelium-dependent relaxations to acetylcholine (ACh)
are decreased in spontaneously hypertensive rats. In the
present study endothelium-dependent relaxations were
investigated in a different model of hypertension. Salt-
sens1tive and salt-resistant Dahl rats were given 8% NaCl
for 8 weeks. At the end of this period systolic blood
pressure averaged 183 + 7 mrnHg in salt-sensitive (n=6)
and 125 + 3 mmHg in salt-resistant animals (n=4; P< 0.05).
Rings with or without endothelium, of thoracic aorta,
from both stra1ns were suspended in organ chambers for
isometric tension recording. In both groups ACh (10-9-
10-4M) caused relaxations 1n rings with but not in those
without endothelium. However, relaxations were signifi-
cantly depressed in salt-sensitive as compared to salt-
resistant rats (ICSO: 5.6 x 10-7M and 4.2 x 10-8M: P <
0.05). In the latter, the maximal relaxations occurred
at lower concentrations (10-6M) and were more pronounced
(100%) than in salt-sensitive rats (1.5 x 10-SM; 78 ~ 9%).
Relaxations to sodium nitroprusside did not differ in
aortas of the two strains. Thus, the decreased endothe-
lium-dependent relaxations to ACh in hypertensive Dahl
rats may be due to decreased release of and/or sensitivity
of the smooth muscle to endothelium-derived relaxing
factor(s) rather than structural changes occurring in
hypertension. (Supported in part by NIH grant HL 31183.)
DISSOCIATION OF ADRENERGIC RECEPTOR DENSITY FROM
RESPONSES TO ADRENERGIC AGENTS IN A BABOON MODEL OF
HYPERTENSION
Marilyn L.Hurwitz, M.Sc. and Clive Rosendorff, M.D.,
Ph.D. F.A.C.C., MRC/University Circulation Research
Unit and Departments of Physiology and Medicine,
University of the Witwatersrand Medical School,
Johannesburg, South Africa.
There have been some reports of increased vascular res-
pons1veness to aj-adrenoceptor agonists and reduced myo-
cardial sensitivity to a-adrenoceptor agonists in human
and experimental hypertension. To study the mechanism
of these effects we measured aj and a adrenoceptor (R)
number (Bmax) by radioligand binding assay, and the hemo-
dynarn~c responses to phenylephrine (PE, aI-agonist), pra-
zosin (PRAZ, aj-antagonist), isoproterenol (ISO, a-ago-
n1st) and propranolol (PROP, a-antagonist) in the 2-
kidney Grollman model of hypertension in the baboon (HT,
n=8) vs sham-operated controls (C, n=8). In HT vascular
smooth muscle aj-R Bmax was increased (S62!1 vS 134!1
fmol/mg protein, P<O.OS) and myocardial a-R Bmax was
decreased (44±S vS 119±3 fmol/mg protein, P<O.OOS). Dose-
response curves of PE (10-8_10-2M) vs mean arterial blood
pressure showed no difference between HT (EDSO=S.OxlO-4M)
and C (EDSO=S.8xIO-4M). Pretreatment with PRAZ failed
to show up any difference between HT and C (EDSO=2.8xlO-3
M and 3.3xlO-3M). On the other hand, ISO (10-8_10-3M) vs
heart rate was s1gnificantly shifted to the right in HT
(EDSO=2.3xlO-6M) compared to C (EDSO=7.SxlO-7M) consist-
ent with the lower myocardial a-R Bmax; but this diff-
erence disappeared after PROP (EDSO=7.3xlO-6M vs 6.SxIO-6
M). We conclude that, in this animal model of hyperten-
sion, there is a d1ssociation of adrenergic receptor
density from adrenergic drug responsiveness.
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B-ADRENOCEPTOR DENSITY ON ADIPOSE TISSUE-AN INDICATOR
FOR CARDIAC B-ADRENOCEPTOR DENSITY IN SPONTANEOUSLY
HYPERTENSIVE RATS.
Fumitaka Ohsuzu,M.D., Shuichi Katsushika,M.D.,Nobuhiro
Sakata,Noboru Aosaki,M.D.,Shigeki Yanagida,M.D.,
Kiyoshi Hosono,M.D.,F.A.C.C.,Haruo Nakamura,M.D.
National Defense Medical College, Tokorozawa,Saitama,JAPAN
A reduction in B-adrenergic receptor density has been
reported in hypertensive myocardium. To determine the
correlation among a-adrenergic receptor density in
peripheral lymphocytes, fat and ventricular myocardium, we
simultaneously sampled lymphocytes, fat and myocardium
from 7 spontaneously hypertensive rats(SHR)(70-100 days old
). Receptor density was assessed by [1-125] cyanopindolol
(ICYP) binding normalized to mg protein, and it correlated
highly in fat and myocardium (r=O.92). However, the
correlation between lymphocytes and myocardium was very
poor(r=O.28). ICYP Kd was not significantly different
among 3 groups( 171 pM in lymphocytes, 133pM in fat and
234 pM in myocardium). Competitive binding for propranolol
and a-I selective blocker, metopro101 was also examined
in these tissues. Antagonist inhibition curve showed
Similar pattern in fat and myocardium, but it was different
in lymphocytes. These results suggest that adipose tissue
could serve as an indicator for~adrenoceptor density of
cardiac tissue in SHR. However, lymphocyte had binding
characteristics of B-2 subclass and it might not be
available as an indicator for cardiac a-adrenoceptor
density in hypertension.
MYOCARDIAL BIOCHEMICAL, CONTRACTILE AND ELECTRICAL
PERFORMANCE FOLLOWING IMPOSITION OF HYPERTENSION IN YOUNG
AND OLD RATS.
~oheph ~ Cagasso, PH.D., Ashwani Malhotra, PH.D., James
c euer, M•• , F.A~and Edmund H. Sonnenb1ick, M.D.,
F.A.C.C., Albert Einstein College of Medicine, New York.
To study the effects of hypertension on the biochemical,
contractile and electrical performance of aged myocardium
male rats at 2-, 7-, 12-, and 17-mo of age were made
hypertensive by left renal artery constriction. Ten weeks
after the onset of hypertension left ventricular
papillary muscles were isolated from these four age
groups at 5-, 10-, 15-, and 20-mo of age. Mechanical
performance and transmembrane electrical events were
recorded simultaneously. Contractile protein enzyme
activity was determined in the same hearts. Control
groups revealed a decrease in mechanical, electrical and
biochemical performance as a function of age.
Hypertensive groups revealed myocardial hypertrophy
resulting from the pressure overload which was
approximately 50% in the 5-, and 15-mo-o1d animals and
approximately 10% in the 20-mo-o1d animals. Adaptation to
the stress of hypertension was observed in each age group
and was revealed as prolongation of mechanical and
electrical timing parameters and depression of the load-
velocity relation and contractile protein enzyme
actiVity. The biochemical, electrical and mechanical
response of 2-mo-o1d animals to the stress of
hypertension was significantly greater than that
exhibited by the 17-mo-old animals. These biochemical
and electrophysiological alterations may help to explain
the contractile modification seen with the combination of
aging and hypertension. The inabi1 ity to compensate to
the stress of hypertension may play an important role in
heart failure in the aged, hypertensive population.
t SW vs SED, p<0.02.
Exercise increased functional coronary CSA in normoten-
sive rats only. This beneficial effect did not occur in
hypertension, probably because of the functional or
structural changes in the coronary vessels of RHR.
EFFECTS OF EXERCISE ON THE CORONARY CIRCULATION OF
CONSCIOUS HYPERTENSIVE RATS.
Pierre A. Wicker, M.D. and Robert C. Tarazi, M.D.,
F.A.C.C., Cleveland Clinic Foundation, Cleveland, Ohio.
Exercise is known to promote myocardial vascularity. We
therefore, studied whether it could prevent coronary
abnormalities of hypertensive left ventricular (LV)
hypertrophy. Female Sprague-Dawley lC-2K Goldblatt
hypertensive rats (RHR) and their appropriate controls
(Sham-SH), were either made to swim (RHR-SW, SH-SW) or
kept sedentary (RHR-SED, SH-SE D) for 9 weeks. Minimal
coronary resistance after carbochrome (total LVCR/LV
mmHg/m1/min), an index of functional cross sectional area
(CSA) of coronary resistance vessels, was determined in
conscious rats by microspheres. Results (m ± SO) (n=12 in
all groups):
111±9 111±18 179±30 186±10
2.3±0.2 2.7±0.3t 3.6±0.5 4.1±0.6t
10±3.3 7.3±1.4t 9.4±1.4 9.9±2.8
Thursday, March 13, 1986
8:30AM-I0:00AM, Room #267
Epidemiology: Risk Factors
LINOLEIC ACID AND CORONARY HEART DISEASE (CHD).
David A. Wood, M.Se •• M.R.C.P •• Susan M. Butler, Ph.D.,
Rudolph A. Riemersma. Ph.D., Cecilia C. A. Maclntyre.M.Sc.,
Robert A. Elton, Ph.D. and Professor M. F. Oliver, M.D.,
F.R.C.P.
Cardiovascular Research Unit, University of Edinburgh,
Edinburgh, Scotland, U.K.
The relationship between the essential fatty acid linoleic
aeid (LA) measured in adipose tissue and the risk of CHD
has been investigated in a case control study. R8 cases
of acute myocardial infarction (AMI) in men «(55 years)
with no history of CHD were studied. 107 new cases of
angina pectoris (AP) with no reported history of CHD,
were identified by the WHO chest pain questionnaire in a
postal survey of a random sample of 6000 men (35-55 years)
and studied with 393 asymptomatic healthy controls drawn
from the same random sample.
The relative risks of CHD by quintiles of adipose tissue
LA distribution in the controls are given In the table
(<p(O. 05) •
L.A.
7.1% 8.1% 9.3% 10.6% 13.1%(M",dians %)
AMI 3.3- 3.2- 2.7- 0.75 1.0
AP 3.2- 2.6- 2.4- 1.5 1.11
RHR-SED RHR-SWSH-SWSH-SEDGROUP
MAP (mmHg)
LVW/BW (mg/g)
LVCR/LV
There is a strong correlation between dietary LA and
adipose LA (r-0.58) and thlS study provides evidence of an
inverse relationship between LA and the risk of CRn for
individuals.
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MaxEPA®pre
post
QTc{ms)
MARINE LIPID CONCENTRATE REDUCES CORONARY RISK
FACTORS: DOUBLE BLIND COMPARISON WITH OLIVE OIL.
Michael H. Davidson, M.D., Philip R. Liebson, M.D.,F.A.C.C.,
John D. Bagdade M.D., Joseph V. Messer, M.D.,F.A.C.C., and
James A. Schoenberger, M.D. F.A.C.C. Rush-Medical College,
Chicago, IL.
Dietary omega-3 polyunsaturated fatty acids eicosapentaenoic
acid (EPA) and docosahexanoic acid have been shown to lower
plasma lipids and reduce blood pressure. This study eX¥1ined
the efficacy of a marine lipid concentrate (MaxEPAQ!) ) in
lowering plasma lipids and blood pressure in a double blind
randomized study in patients with documented coronary artery
disease. Thirty patients with elevated cholesterol levels were
randomized in~ two groups, each receiving 20 capsules of
either MaxEP~or olive oil. The total daily dose of EPA was
3.6 grams. Baseline total cholesterol (TC), HDL-cholesterol
(HDL), triglyce~ides (TG) and resting systolic (SBP) and dias-
tolic (DBP) blood pressure measurements were repeated after
30 days of treatment. The results were as follows:
TC HDL TG SBP DBP
326 47.2 237 137 87
285 4'M 142 128 80
p<.025 (NS) p<.005 p<.005 p~OI
Olive oil pre 291 45.8 270 146.4 88.1
post 283 45.4 254 147.2 84.3
(NS) (NS) (NS) (NS) (NS)
The TC/HDL ratio fell 17% in the MaxEP~roup(p<.005) and
only 4% (NS) in the olive oil group. Compliance as determined
by capsule counting was excellent and neither group reported
significant adverse reactions. In conclusion, marine lipid
concentrate dietary supplementation is an effective means of
utilizing omega-3 fatty acids to lower plasma lipids, especially
triglyceride rich lipoproteins and lowers blood pressure in
motivated patients with coronary artery disease.
APOLIPOPROTEINS A-I AND B IN CHILDREN ARE BETTER PRE-
DICTORS OF PATERNAL MYOCARDIAL INFARCTION THAN ARE
LIPOPROTEIN CHOLESTEROLS.
David S. Freedman, Ph.D., Sathanur R. Srinivasan, Ph.D.,
Charles L. Shear, Dr.P.H., Larry S. Webber, Ph.D., and
Gerald S. Berenson, M.D., F.A.C.C. National Research
and Demonstration Center--Arteriosclerosis, Louisiana
State University Medical Center, New Orleans, LA.
Clinical studies indicate the protein components of
lipoproteins are good predictors of coronary artery
disease. Associations of childhood levels of apo-
lipoproteins A-I and B (apo A-I, apo B) to reported
histories of early (before age 50) paternal myocardial
infarction (MI) were therefore assessed in a community-
wide, biracial examination of 5- to 17-year-olds. Off-
spring whose father reported MI (n=141, 5.7%) had lower
levels of both apo A-I (136.6 vs 140.B mg/dl, p=0.02)
and the ratio of low density lipoprotein cholesterol
(LDL-C) to apo B (1.09 vs 1.11 mg/dl, p=O.OOl), along
with higher levels of apo B/apo A-I (0.65 vs 0.61 mgt
dl, p=O.Ol) than did children without paternal MIs.
Associations were evident in both whites and blacks,
and in boys and girls independently of age, obesity,
smoking, alcohol intake and oral contraceptive use.
Fathers of children at high risk (high apo B/apo A-I,
low LDL-C/apo B) were 3.5 times more likely to have
had an MI than were fathers of low-risk children. In
contrast, offspring with paternal MIs did not have
significantly different levels of total cholesterol,
or high density lipoprotein cholesterol than did chil-
dren without paternal MIs. Apolipoproteins appear to
be better predictors of future MI than are levels of
total cholesterol and lipoprotein cholesterol fractions.
Optimal assessment of cardiovascular disease risk should
therefore include apo A-I and apo B measurements.
HIGH SERUM CHOLESTERCL AND ATHEROSCLEROSIS 00 NOT
CONTRIBUTE TO INCREASED ARTERIAL STIFFENING WITH AGE.
Michael F. O'Rourke, MD, FACC, Alberto P. Avolio, PhD,
Kathy Clyde, Leon Simons, MD, Kenneth Ho and Donald
Bains. St. Vincent's Hospital, Sydney, Australia.
Accelerated arterial stiffening with age is often
attributed to atherosclerosis. To test this concept,
aortic pulse wave velocity (PWV), an accepted index of
arterial stiffness, was measured non-invasively in two
population groups with different levels of serum
cholesterol and different prevalence of arthero-
sclerosis:- 53 subjects (aged 6-71 years) with hetero-
zygous familial hypercholesterolemia (FH) and 53 Seventh
Day Adventist subjects (aged 18-76 years) who followed a
strict vegetarian diet (VD). Each group was compared
with a group of 53 control subjects matched for age and
mean arterial pressure (Cl and C2 respectively).
Regression equations were obtained for PWV (Y, em/sec)
and age (X, years). Results were as follows:
Serum Cholesterol(mmol/L) PWV
FH 8.32 SE 0.30 (P(O.OOl) Y=7.6X+460;r=0.67;P(0.OOl
Cl 5.64 SE 0.19 Y=8.4X+535;r=0.39;P(0.05
VD 4.90 SE 0.22 (P(0.005) Yz lO.8X+387;r=O.59;P(0.01
C2 5.68 SE 0.13 Y=7.8X+614;r=O.30;P(0.05
Aortic PWV increased with age in a similar fashion in
the FH and VD subjects and there was no significant
difference compared to controls. Ser~ cholesterol,
however, was markedly different (P(O.OOOl). These
findings complement previous studies on Australian and
Chinese subjects which showed that arterial stiffening
with age is related to arterial pressure and salt intake
but not to levels of serum cholesterol nor to prevalence
of atherosclerosis.
SOTALOL FOR THE TREATMENT OF PATIENTS WITH DOCUMENTED
VENTRICULAR FIBRILLATION: ELECTROPHYSIOLOGICAL AND
ANTIARRHYTHMIC PROPERTIES
Johannes Brachmann, M.D., Jochen Senges, M.D., Ioannis
Rizos, M.D., Claus Schmitt, M.D., Isaac Aidonidis, M.D.,
Wolfgang Kubler, M.D., F.A.C.C., Department of Cardiology,
University of Heidelberg, West Germany.
Twenty-three resuscitated patients (P) with clinically
documented ventricular fibrillation (VF) and inducible
malignant ventricular tachyarrhythmias were selected for
investigation of the acute effects of sotalol (SOT) using
programmed right ventricular stimulation; sotalol (1.5 mg/
kg iv) resulted in plasma concentration of 2.3±0.44 ~g/ml.
The following parameters were determined: I) inducible
ventricular tachyarrhythmias: VF and sustained ventricular
tachycardia (S-VT); non-sustained ventricular tachycardia
(NS-VT); 2) electrophysiological parameters: V-ERP, ven-
tricular effective refractory period; QRS, QRS duration;
QTc, corrected QT interval.
Results: SOT vs. control (CON), ·p(0.05
VF S-VT NS-VT All V-ERP{ms) QRS (ms)
CON 5P 12P 6P 23P 244±12 106±13
SOT 3P 3P 4P lOp· 283±14· 108±16
Eight P receiving long-term oral sotalol treatment (340-
480 mg/d) had no symptomatic recurrence for 11±6 months.
Conclusion: In approximately half of the resuscitated P
with documented VF,inducibility and clinical occurrence
of malignant ventricular tachyarrhythmias are suppressed
by sotalol; the electrophysiological effects can be
explained by its class III antiarrhythmic properties.
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PREDICTION OF EJECTION FRACTION USING ROUTINE CHEST X-RAY
AND ECG: A PRACTICAL NON-INVASIVE METHOD BASED ON THE
CONCEPT OF VOLUME/MASS RELATIONSHIP.
Miodra~ Ostojic, MD, James B. Young, MD, FACC, Srecko
RedelJ OV1C, MD, Wllliam H.Spencer III, MD, FACC, William
L. Winters, MD, FACC, Craig M. Pratt, MD, FACC, Miquel A.
Quinones,MD,FACC, Milosav Milosevic,MD, Univ of Belgrade,
YU, and Baylor College of Medicine, Houston, TX.
An accurate, rapid, inexpensive, non-invasive method of
determining LV ejection fraction(EF) is necessary to
evaluate LV function in epidemiologic studies and indi-
viduals. Applying the concept of LV mass (ECG l:RV 3-S)
interrelating with LV volume (chest[C] X-ray[XR] heart
volume) an equation and nomogram was created that cor-
related angiographic EF in 59 patients with ischemia (EF
range 13-79%, mean=50±17) using 3 independent variables:
1) CXR heart volume (cc/kg)=(heart length) (heart width)
(lateral diameter)(.4); 2) Sum of ECG R waves=l:R(V3-VS);
and 3) Inferior wall motion abnormality CODE 0, or 1 if
a:Q in AV{, or b:l:R<27 and HV>ll, or c:HV>17 and l:R<75.
Multiple inear rearession formula is:
EF=20.2 + 548.2 HV 1.3 + 2.3~ - 15.6 (CODE) with a
correlation, R=.86, SEE=8.86 anJ p<.OOl. This concept was
then tested with 23 coronary artery disease (CAD), 15
dilated myopathy (OM), and 16 aortic valve disease (AVO)
patients. The mean±SD predicted EF is compared to the
measured EF with r=correlation coefficient, ti=mean of
l:EFpred-EFmeas; SEE=standard estimate error:
EFpred EFmeas EF range r P SEE ti
CAD 36±13 36±16 11-65 .91 .001 6.7 -.13
OM 29±5 24±10 11-48 .75 .05 7.1 -4.7
AVO 49±15 52±19 25-80 .89 .001 9.5 3.1
This method utilizes 2 simple tests routinely performed
and separates patients with EF<50% vs >50% (sensitivity
94%, specificity 89%). Lack of pxpense stresses applica-
bility as a screening tool for occult dysfunction.
Thursday, March 13, 1986
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Systolic Function
INFLUENCE OF HEART RATE ON THE LEFT VENTRICULAR END-
SYSTOLIC PRESSURE-VOLUME RELATION IN CONSCIOUS OOGS.
Gregory L. Freeman, M.D.,F.A.C.C., William C. Little,
M.D.,F.A.C.C., Robert A. O'Rourke, M.D.,FA.C.C., UTHSC
and Audie Murphy V.A. Hospital, san Antonio, TX, 78284.
Prior studies on the influence of increased heart rate
(HR) on left ventricular (LV) performance have had
conflicting results. Accordingly, we studied the
effects of atrial pacing on the end-systolic (ES)
pressure (P) volume (V) relation (R) a relatively load-
insensitive index of LV performance, in 6 chronically
instrumented, conscious dogs. LVP was measured by a
micromanorneter catheter and LW was determined from
three ultrasonic orthogonal dimensions. Pressure was
varied by caval occlusions at control (C) HR and 100,
120, 140, 160, 180, and 200 beats/min (BPM). The ESPVR
s linear in every case (r=.96+.03, SD). Ema¥, the~~ope of the ESPVR, was directly and monotonlcally
related to HR in every dog increasing to 221+69% of C
at peak pacing rate (180 or 200 BPM, p<.005). -Vo ' the
volume axis intercept of the ESPVR was also directly
related to HR in every dog arrl showed a similar increase
with pacing (255+135%, p<.Ol). This shift reduces
stroke V from any end diastolic V, attenuating the
benefits of enhanced contractility. we conclu:le that in
conscious, autonomically intact dogs, increased HR has a
dual effect on LV function.
While contractility is
increased, the ESPVR is
shifted to the right, such
that overall LV performance
is relatively unchanged.
mD-SHORTENING W<mi-TENSION REIATION IN CAT PAPILLARY MUSCIE:
n1lPEmlENCE ON LOADING HISTORY IN AFTERLOADED CONTRACTIONS
Thierry C. Gillebert, M.D., Stanislas U. Sys, Victor A. Claes
and Dirk L. Brutsaert, M.D., F.A.C.C.
University of Antwerp, Antwerp, Belgium.
l!nI-shortening length-tension (LT) values of afterloaded
isotonic contractions yield a curvilinear relation. To compare
contractions with different systolic history and equal
end-shortening tension, load clamps of various magnitude were
imposed at various times during shortening of afterloaded
isotonic contractions with physiologically sequenced relaxation.
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Unloading clamps, lIDposed on contrachons nth a higher
afterload (contraction 2) resulted in a decreased extent of
shortening, compared to the control contraction (contraction 1),
hence in a shift to the right of the LT relation; later
unloading clamps increased this shift. Loading clamps, imposed
early on contractions with 101l'er afterload (contraction 3)
resulted in an increased extent of shortening, hence in a shift
to the left of the LT relation; with later loading clamps, the
control tension was not reached.
These data indicate that end-shortening LT relations depend on
the history of the contractile events during systole, resulting
in a family of LT curves instead of a single LT curve. They
suggest that abnonnal systolic loading profiles may influence LV
pressure-volume relations.
DISSOCIATION BETWEEN REGIONAL MYOCARDIAL FUNCTION AND
SUBENDOCARDIAL ST SEGMENT ELEVATION DURING EXERCISE-
INDUCED ISCHEMIA WITHOUT AND WITH BETA BLOCKADE.
Maleah Grover-McKay, M.D. FACC, Masunori Matsuzaki,
M.D., W. Scott Kemper M.S.E.E., John Ross, Jr, M.D.,
F.A.C.C., UCSD School of Medicine, La Jolla, California.
We examined the onset and resolution of ischemic changes
using an electrical and a functional measure of myocar-
dial ischemia. ST elevation on subendocardial electro-
grams and percent change in posterior wall thickness by
sonomicrometry (%AWT) were measured in 9 conscious dogs
with critical circumflex coronary artery stenosis (amer-
oid constrictor). The dogs performed control treadmill
exercise (C) and a second identical exercise on the same
day after atenolol, 1 mg/kg p.o. (A).
Rest EX:1min 2min End p EX:1min smin 30 min
C ST(mm) 1.8 3.6 4.9* s.8t 4.1t 1.8 1.6
C %AWT 27.9 s.4t 4.st s.ot 16.2t 20.9* 21.9
A ST(mm) 1.5 2.3 3.6* 4.3t 3.3t 1.6 1.5
A %AWT 26.2 8.3t 8.7t 9.1t 19.7 24.5 24.1
EX=exercise;p EX=post exercise;*p<.Os;tp<.Ol;mean values
During both C and A, %AWT became abnormal prior to ST
elevation. Following C, ST elevation returned to rest-
ing values prior to %AWT, but following A, %&IT returned
to resting values prior to ST elevation. Transmural
myocardial blood flow (MBF) in the ischemic region,
normalized to the control region, decreased from
1.0 ± 0.1 at rest to 0.4 ± 0.2 during C (p<.Ol) and was
significantly higher during A than C (0.7 ± 0.2;
p<.Ol). We conclude that reduced MBF leads to rapid
deterioration in %AWT which resolves slowly, and to
slower onset of ST elevation which resolves quickly.
After a-blockade the relative improvement in MBF to the
ischemic region leads to more rapid improvement in %00
but no change in the time of ST elevation resolution.
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DEPRESSED SYSTOLIC MYOCARDIAL RESERVE
IN DILATED CARDIOMYOPATHY
James D. Alderman, M.D., Raymond G. McKay, M.D.,
James J. Ferguson, M.D.! Julian M. Aroesty, M.D.,
F.A.C.C., Henry D. Roya , M.D., William Grossman, M.D.,
F.A.C.C. Harvard-Thorndike Laboratory,
Beth Israel Hospital, Boston, MA.
Increases in heart rate (HR) result in enhanced
systolic function due to a Treppe contractility effect,
but quantification of this effect is not well-documented.
Accordingly, 13 patients (pts) were examined during
cardiac catheterization using 3 or more increasing atrial
~acing rates with simultaneous measurement of high
fidelity left ventricular (LV) micromanometer pressure
and radionuclide ventriculography (RVG). Pressure-volume
diagrams were constructed for each pacing level using LV
pressure tracings and RVG volume curves. Group A included
5 cardiomyopathy (CMP) pts with normal coronary arteries
(mean LV eiection fraction = 0.14). Group B included 8
pts with mild or no coronary artery disease (mean LV
ejection fraction = 0.70).
All pts showed a variable leftward and downward shift
of their pressure-volume diagrams. Changes in systolic
function from baseline HR to HR+50 are shown below.
(EF=LV Ejection Fraction, ESPVR=LV End-Systolic Pressure-
Volume Ratio, LVEDV=LV End-Diastolic Volume, LVEDP=LV
End-Diastolic Pressure).
EF dP/dt ESPVR
0.14+0.11 +4%(876+916) -14%(0.81+0.70)
0.70+0.66 +18(1259+1760) +20%(6.90+8.30)
Relative LVEDV(%) LVEDP(mmHg)
+14%(100+114) -31%(26+18)
-38%(100+62) -50%(12+6)
Conclusion: Patients with dilated cardiomyopathy and
depressed resting LV ejection fraction fail to exhibit
increased contractility with tachycardia, suggesting loss
of inotropic reserve.
IMPOUAfI:E IF THE ANTIRHR Aft) POSlIRIIR MITRAL CIOIDAE ON
GllXlAl. LEFT VENTRICUlAR SYSTOLIC FlJI(;TION
David E. Hansen, M.D., Peter D. Cah1ll, M.D. W1ll1am M.
DeCampIT,~PhJJ:: Donald C. Harrison, M.D., F.A.C.C.,
Cynthia Handen, B.A., Geraldine Derby, B.A., R. Scott
Mitchell, M.D., D. Craig Miller, M.D., F.A.C.C. Stanford
University, Stanford, CALIFORNIA
To determine the mechanical consequences of severing the
anterior and posterior mitral leaflet chordae, 14 fentanyl-
anestheti zed dogs were studi ed duri ng cardi opu1monary bypass.
The slope of the LV peak isovolumic pressure-volume relation
(Emax) was measured with a micromanomete~ in.side a LV
intracavitary balloon to assess global LV funct10n 1ndependent
of load. Balloon herniation was prevented by a disk
reversibly secured to the mitral annulus. Compared to
basel i ne determi nat ions wi th the chordae intact, Emax
decreased by 25% in 7 dogs (Group I) from 1l.22!.3.23 (!.SD) to
8.44+3.29 mmHg/ml (p=0.02) after the chordal connections of
the anterior leaflet were severed. Emax decreased similarly,
from 13.13+4.27 to 9.80+3.13 mmHg/ml (p=0.02), in 7 dogs
(Group II) in which the -posterior leaflet connections were
severed first. Severing the chordae of the remaining mitral
leaflet caused additional decreases in Emax of 22% for Group I
(p=0.10) and 33% for Group II (p=0.OO2). Since Emax decreased
without discernible myocardial injury, these results challenge
the concept that the slope of the peak isovo1umi c pressure-
volume relation is solely dependent upon the contractile state
of the ventricular myocardium. We conclude that both mitral
chordae significantly (but unequally) influence global LV
systolic function, which suggests that. excision of the mi~ral
apparatus at the time of MVR is detr~mental to LV .functlOn.
Chordae sparing surgery may be a, ratlOnal alternatlVe based
upon better understanding of the complex m:chanical
interaction between the mitral valve and LV myocard1um.
NORMALIZATION OF CARDIAC DYSFUNCTION INDUCED BY DIABETES
BY REDUCTION OF THE CONCENTRATION OF EXOGENOUS FATTY ACID
Larry E. Fields, M.D. and Steven R. 8ergmann, M.D., Ph.D.
Washington University, St. Louis, MO . ..
We previously demonstrated that 1n add1t1on to hyper-
glycermia in vivo, alloxan-diabetic rabbits (n = 24)
exhibit higher plasma free fatty acid (FA) levels than
controls (n = 18) (333 ± 70 vs 116 ± 22 j.lM, mean.± S.E:,
p < .05) and that hearts isolated !rom the d1abe~1c
animals exhibit depressed LV functlon. To determ1ne
whether the LV dysfunction associated with diabetes
reflects increased susceptibility to deleterious effects
of high concentrations of exogenous FA, we characterized
hearts isolated from 10 normal and 6 diabetic rabbits
perfused at constant flow a~ 37'C wi.th erythrocyte-
enriched modified Krebs-Henselelt med1a w1th a low concen-
tration of palmitate (.06 mM bound to 0.4 InM al bumi n) and
hearts isolated from 22 normal and 24 diabetic animals
perfused with high FA (0.4 mM with equimolar.albumin). LV
systolic pressure, dP/dt, and pressure-t1me lndex at a
fixed EDP and HR were decreased by > 40% in hearts from
diabetics perfused with high FA (p < .01 vs. controls). ~n
contrast, LV performance did not differ from that 1n
controls when hearts from diabetic rabbits were perfused
with low FA. Perfusion of diabetic hearts with low FA was
associated with lower tissue FA (149 ± 18 nmol/g) and
triacylglycerol (TAG) (3.8 ± 0.5 j.lmol/g) compared to di a-
betlc hearts perfused with high FA (FA: 495 ± 70 nmol/g;
TAG: 15.6 ± 3.1 j.lmol/g; p < .05 for each). Hyperlip~m~a
in vivo as well as LV performance and myocardlal IlP1d
content were normalized as well by insulin given over 10
days (n = 7). Thus, impaired LV perfor~ance in hearts
from diabetic animals appears to reflect lncreased sus-
ceptibllltj t,) the deleterious eff~cts?f exogen.ou.s FA,
suggesting that reduction of hyperllpemla may m1tlgate
cardiac dysfunction in d1abetics.
Thursday, March 13, 1986
8:30AM-I0:00AM, Room #268
Modulation of Arrhythmias with Adrenergic and
Calcium Blocking Agents
DOES VERAPAMIL INCREASE OR DECREASE VAGAL
EFFECT ON ATRIOVENTRICULAR NODAL CONDUCTION?
Todor Mazga1ev, Ph.D., Takao Mitsuoka, M.D., Amir Pelleg,
Ph.D., Leonard S. Dreifus, M.D., F .A.C.C., Eric L. Michelson,
M.D., F.A.C.C., The Lankenau Med Res Ctr, Philadelphia, PA
Possible direct vago1ytic effects of verapamil (V) on the sinus
and atrioventricular (AV) nodes were recently reported. To
evaluate the interaction of V and vagus (VG) the effect of
postganglionic vagal stimulation (PGV~) on AV nod~l
conduction was studied in 16 isola!fd atrJ~-AV nodal rabbit
preparations before and after V 00 to 10 M) at a constant
drive cycle length (400-500 msec). Microelectrode recordings
showed that PGVS produced hyperpolarization and subsequent
decrease of dv/dt and amplitude of slow-channel-dependent
action potentials in the N region of the node. V also decreased
dv/dt and amplitude of these action potentials, but did not
produce hyperpolarization or change of the take-off potential.
In combination, V and PGVS consistently accentuated the
depression of AV nodal conduction (p ~ 0.00. For exampl~,
maximal increase in conducti~n time With PGVS was 3~ In
control, 40% after V (5 x 10- M) and 61% after V 00 M).
Also, AV nodal block was observed with PGVS plus V while
neither intervention alone resulted in AV block. The direct
effect of V on PGVS-induced maximum hyperpolarization was
not significant, although the vagal-induced rebound,
responsible for increased diastolic depolarization after PGVS,
was accentuated by V. Moreover, action potentials showed
greater depression of dv/dt when PGVS was introduced after V,
even though the cells fired from similar take-off potentials.
Thus, the combined effect of V and PGVS on AV nodal
conduction was additive and could be explained by increased
sensitivity of V-depressed slow channel currents in response to
vagal-induced hyperpolarization, resulting in conduction delay
and block. The enhanced negative dromotropic action of vagal
stimulation on the AV node after verapamil argues against
direC1 vagolytic properties of this drug.
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EFFECTS OF d- AND I-SOTAlOl ON ATRIAL ELECTROPHYS-
IOLOGY AND ATRIAL FLUTTER INDUCED IN CONSCIOUS
DOGS WITH STERILE PERICARDITIS.
Ken Okumura, M.D., Augusto Scalabrini, M.D., Albert L. Waldo,
M.D., F.A.C.C., University of Alabama at Birmingham, Birming-
ham, Alabama.
Agents which prolong the atrial effective refractory period
(ERP) have been shown to slow or interrupt atrial flutter. We
studied the effects of d-sotalol (d-S), said mainly to prolong
ERP, and I-sotalol O-S), said mainly to be a Il-blocker, on stable,
reentrant atrial flutter (AFJ) induced in conscious dogs with
sterile pericarditis. d-S and I-S (2 mg/kg) were given intra-
venously during AFI in 7 and 8 dogs, respectively. Their effects
on the flutter cycle length (AFI-Cl) and ventricular rate (VR)
during AFI and also on the sinus cycle length (SCl), atrial
excitability threshold, atrial ERP and intraatrial conduction time
(CT) were noted. Atrial excitability threshold, ERP and CT were
measured during atrial pacing at 150 bpm. 3 pairs of wire
electrodes placed at selected atrial sites were used for pacing
and recording and for AFI induction. Results: Neither drug
affected atrial excitability threshold or CT.
VERAPAMIL, DTI.TIAZEM AND NIFEDIPINE: DIFFERENl' EE'F'El:TS rn
'!HE RABBIT SINUS NODE
Ral@ Haberl, M.D., Frank Miigdfessel, M.D., Gerhard Stein-
beck, M.D.
Medical Hospital I, University of Munich, Fffi
In humans, the direct effects of verapamil (V), diltia-
zan (D) and nifedipine (N) on sinus ncxl.e function are
concealed-by reflex mechanisms. We studied the direct
action of V, D and N (1 to 30 x 10-7 M) on the isolated
rabbit sinus ncxl.e (n=46) by nultiple intracellular record-
:i.n;Js. '!he increase of cycle length (CL) after drug appli-
cation differed substantially: N caused severe bradycardia
already in low doses induc:i.n;J sinus arrest with 24 x 10-7 M
at rrost. '!he bradycardic effect of V was carparable to N
at m:::>lar concentrations farr times higher. Increase of CL
under D was rooderate with sinus arrest in only 2/16 cases.
Corrected sinus node recovery time increased with V and
D, but was unaffected with N.
Each drug decreased effective atrial refractory period by
abalt 10% (p<0.01).
'!he transnenbrane potential of daninant fibers revealed
different mecj1anisms of the bradycardic action: V caused
a shift of the take-off potential and increase of action
potential duration, phase 4 remained unchanged. D slowed
diastolic depolarization, but did not alter action po-
tential duration. N slowed phase 4 and repolarization.
All drugs (10-6 M) decreased the total transmenbrane po-
tential by 16 mV ± 15. Pacerraker shifts in caudal direc-
tion occurred with V and N, not with D.
Q.lr results reveal differences of extent and cellular
mechanism of the negative chronotropic actions of V, D
and N on the isolated sinus node.
Control d-S Control
SCl(ms) 454±21 536±26* 453!48
ERP(ms} 133!13 156±15* 133!14
AFI-Cl(ms} 132!:16 150±16* 124±12
VR(bpm} 212!:30 176±41** 206±40
I-S
633!112**
I 63±25*
143!19+
158±32+
EVIDENCE FOR MODULATED RECEPTOR EFFECTS OF CALCIUM
ANTAGONISTS IN VIVO.
Stanley Nattel, M.D., F.A.C.C., Mario Talajic, M.D., and
Scott Beau, McGill University, Montreal, Canada
The modulated receptor hypothesis suggests that calcium
antagonists should produce interval-dependent calcium
channel blockade. To evaluate this possibility in vivo,
loading and maintenance infusions of diltiazem (nr-ana-
verapamil (V) were used to study drug effects at 4 stable
concentrations in anesthetized autonomically blocked
dogs. Programmed stimulation was applied to evaluate the
interval dependence of AV conduction time (AVCT) prior to
and after drug infusion. AVCT of early premature beats
increased under control conditions with a time constant
(t) of 79!:20 msec (M!:SD). 0 and V did not alter the
interval dependence of AVCT slowing for very early
premature beats, but resulted in two additional time -
dependent phases of conduction slowing with t averaging
2.S±.S and 11.3±3.1 sec for 0, and 2.4!:1.4 and 30.1!:11.9
:sec for V. While AVCT and AV node ERP (AVERP) were
constant over a wide range of heart rates under control
conditions, increases in AVCT and AVERP resulting from 0
and V were greatly enhanced by increases in heart rate
over the physiologic range, and substantially reduced
with pauses or bradycardia. We conclude that the effects
of 0 and V in vivo are consistent with predictions from
the modulated receptor hypothesis and previous in vitro
work. These results have potentially important
implications for understanding the effects of calcium
blocking drugs on supraventricular tachyarrhythmias.
DELETERIOUS EFFECTS OF BRETYLIUM ON HEMODYNAMIC
RECOVERY FROM VENTRICULAR FIBRILLATION.
David E. Euler, Ph.D., Therese W. Zeman, M.D., Michael
E. Wallock, B.S., and Patrick J. Scanlon, M.D., F.A.C.C.,
Loyola University Medical Center, Maywood, Illinois
To study the effects of bretylium (B) on the restoration
of circulatory function after resuscitation from ventri-
cular fibrillation (VF) , closed-chest anesthetized dogs
were fibrillated by applying 60 Hz current to the right
ventricle via a transvenous catheter. After one minute
of VF, defibrillation was achieved by a single 150 watt-
second DC shock. After one control episode of VF, 16
dogs received an intravenous bolus of B (10 mg/kg). A
second episode of VF was studied in eight dogs three
minutes after B and in eight dogs four hours after B.
Prior to B mean arterial blood pressure spontaneously
recovered to exceed 200 mg Hg by two minutes after
defibrillation in all 16 dogs. However, after B, 13/16
dogs were in electromechanical dissociation two minutes
after defibrillation (p ~ 0.001). Despite external
chest compression, epinephrine and sodium bicarbonate, a
stable blood pressure could not be restored in 6/16 dogs.
The duration of exposure to B (three min. vs. four hours)
did not significantly influence the degree or rate of
hemodynamic recovery following defibrillation. In eight
dogs treated with saline instead of B, there was spon-
taneous recovery of normal hemodynamic function within
two minutes after defibrillation in all dogs. Also, a
B analogue lacking sympathetic influences, clofilium
(2 mg/kg), did not alter the pattern of hemodynamic re-
covery after one minute of fibrillation in 5/5 dogs.
The results suggest that the effects of B on the sym-
pathetic nervous system may profoundly influence the
outcome of cardiac resuscitation from VF.
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MBCHAIISM or PRIlEITIOI or SUDDD DEATH BY IADOLOL:
DIFPIUIITIlL .&eTIOIS~ ftIOODS JID AJI1UIn'IIfIA
SUBSTlIA'l'I
Eugene PattersQn. Ph.D., Benjamin J. Scherlag, Ph.D.,
F.A.C.C., and Ralph Lazzara, M.D., F.A.C.C. University
Qf OklahQma Health Sciences Center and VA Medical Center,
OklahQma City, OK.
HQlter mQnitQring and prQvQcative ventricular pacing
(PVP) were used tQ evaluate cQntrQl and nadQIQl treat-
ment grQups, 6-24 hr after left anteriQr descending
CQrQnary artery ligatiQn (CAL) in the dQg. The cQntrQl
grQup (N=20) develQped ventricular cQuplets and triplets
(>270 bpm), 6-24 hr after CAL. Seven dQgs develQped
spQntaneQus sustained mQnQmQrphic ventricular tachycar-
dia (SHYT) (421~12 bpm) at 13%2 hr. The SHYT was present
fQr 38~8 sec befQre ventricular fibrillatiQn develQped.
VP (345~11 bpm) prQduced SHYT (378~12 bpm) in 9 Qf 13
survi ving animals at 24 hr. NadQIQI (1 mg/kg, N=19),
administered 6 hr after CAL, prevented spQntaneous SHYT in
the 6-24 hr periQd (OJ; p=0.005) and increased survival at
24 hr (95Ji p=0.0047). NadQIQI failed tQ prevent SHYT
(88Ji 365~12 bpm) prQduced by PVP (356~12 bpm) at 24 hr
and failed to alter infarct mass (27~12 vs 29~2 gm). BQth
the PVP rate tQ induce SHYT and the SHYT rate were nQt
different in cQntrQI and drug treatment grQups. The drug,
hQwever, IQwered bQth the rate (241~8 vs 328~8 bpm,
p=O.OOOl) and the incidence (8~6 bs 198~61/hr, p=0.004) Qf
rapid ventricular triplets in the 6-24 hr periQd. The
data suggest that nadQIQI prevents spontaneQus SHYT by
selectively suppressing the arrhythmia trigger (rapid
ventricular triplets) withQut altering the underlying
withQut altering the underlying substrate capable Qf
sustained myQcardial reentry.
Thursday, March 13, 1986
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Coronary Vasomotion-Flow and Function
ROLE OF CORONARY ENDOTHELIUM IN CONSTRICTION AND RELAX-
ATION.
Richard J. Bing, M.D. and May them Saeed, Ph.D., Huntington
Medical Research Institutes, Huntington Memorial Hospital,
Pasadena, Calfornia
The protective action of the endothelium in isolated aor-
tic rings against vasoconstriction has been demonstrated
by Furchgott. Using rabbit hearts in supported working
heart preparations perfused with FC-43, a perfluorocarbon.
we demonstrated the presence of this protective factor
(EDRF. endothelial derived relaxing factor) in intact cor-
onary arteries. Cardiac function, coronary flow and myo-
cardial oxygen consumption and changes in internal dia-
meter of epicardial coronary arteries were measured. The
latter was accomplished by means of color arteriography
(injection of patent blue dye in the left atrium followed
by gated photography). Diameter of coronary arteries was
determined on projected slide. We demonstrated the pres-
ence of EDRF in intact coronary arteries with preserved
endothelium. Activated platelets and acetylcholine failed
to constrict these vessels. Since EDRF activates cGMP, we
measured the vasodilatory effect of a substituted cyclo-
phosphate. In aortic rings. 8-Br-cGMP (10- 5 M) caused
more relaxation in endothelial deprived preparation. In
den~~ed art~~ies, dose response curves with 8-Br-cGMP
(10 to 10 M) shifted to the left. In intact coronary
arteries (perfusion model). 8-Br-cGMP (10-' M) blocked
coronary vasoconstriction induced by 0.1 units of Pitres-
sin (decrease in coronary flow 50%. decline in internal
diameter of coronary artery with Pitressin from 0.38 !
0.02 mm to 0.23 ± 0.03 mm; after 8-Br-cGMP: from 0.40 ±
0.02 to 0.36 ± 0.02). It is concluded 1) that EDRF is
protective in intact coronary arteries and 2) 8-Br-cGMP
prevents coronary artery constriction, particularly in
arteries deprived of endothelium.
POST-SYNAPTIC ALPHA2-ADRENERGIC RECEPTORS MEDIATE CORONARY
VASOCONSTRICTION DURING SYMPATHETIC NERVE STIMULATION.
Xue-Zheng Dai. M.D •• D.G. Chen, M.D., Robert J. Bache,
M.D., F.A.C.C.
University of Minnesota, Minneapolis, Minnesota.
This study examined the relative importance of post-syn-
aptic al and a2 activity in mediating cQronary vaSQcon-
strictiQn during sympathetic neural stimulation. The left
circumflex cQrQnary artery was cannulated and blQQd per-
fused with a pump at a CQnstant flQW rate in 8 Qpen chest
vagQtomized dogs; S-adrenergic blQckade was prQduced with
propranolol, I mg/kg, i.v. CQrQnary vasomQtor activity was
assessed from changes in cQrQnary perfusion pressure in
response to electrical stimulatiQn of the decentralized in-
feriQr cardiac nerve (NS) and intracQrQnary nQrepinephrine
(NE) (0.03 \lg/kg bQlus dQsages) during baseline cQnditiQns,
after al-blQckade with prazosin, 300 \lg/kg 1.v. (PRAZ) , and
after the addition of a2-adrenergic blQckade with idozQxan,
5 \lg/kg/min intracQronary (100). CQrQnary perfusiQn pres-
sure (mmHg) during cQntrQl cQnditiQns (CON) and the re-
spQnse tQ NS AND NE are listed belQw.
CORONARY PERFUSION PRESSURE (mm Hg)
CON~11 CON NE 11
Baseline 73±7 94± 9t 2l±3 7l±4 92±5t 21±1
PRAZ 67±9 90±13t 22±4 57±8* 78±8t 21±2
IDO 54±9* 54±10* l±l* 58±9* 58±9* O±l*
*P<0.05 vs. Baseline. tP<0.05 vs. CON
The increased corQnary perfusion pressure was nQt signifi-
cantly altered by PRAZ but was markedly decreased after
IDO. These data indicate that corQnary vasocQnstrictiQn
in respQnse to cardiac NS and exQgenQus NE is mediated
principally by post-synaptic a2-adrenergic mechanisms.
NEUROPEPTIDE Y CORONARY VASOCONSTRICTION IS INDEPENDENT
ON ADRENERGIC AND MUSCARINIC RECEPTORS.
Jose M. Brum, M.D., Ronald Dotaon, B.S., Lair G.
Ribeiro, M.D., Alfred A. Bove, M.D., Ph.D., F.A.C.C.,
Geetha Ghai, Ph.D., MaYQ Clinic/Ciba Geigy, RQchester, MN/
Summit, NJ.
Neuropeptide Y (NPY) is a neurQtransmitter pQlypeptide
found in adrenergic nerves in the epicardial cQronary
arteries, whose actiQn is vasoconstriction. In the pre-
sent experiment the interaction of NPY with adrenergic
and muscarinic receptors was studied in isolated rabbit
coronary arteries. The arteries were perfused in a 20 ml
chamber by a constant flow perfusion system with Qxyge-
nat:d KrebsHenseleit solution at 37°C. Changes in per-
fUSion pressure reflected changes in vessel resistance.
NPY effects were compared with control perfusion pressure
and with the increase in pressure produced by prostaglan-
din (PG) F2a 10-5 M. NPY dose-response curves varying
from 10-12M to 10-8 M were obtained in the presence of
phentolamine (10-5 M), propranolol (10-5 M), and atro-
pine (10-6M). Increase in perfusion pressure by PGF2a
(35+8.9 mmHg) was larger than the response to NPY up to
10-~ M (9.2!4.6 mmHg). However, NPY at 10-8 M (44.6+16.2
mmHg) produced signficant coronary constriction that-did
not differ from the constrictQr effect Qf PGF2a 10-5 M.
Adrenergic alpha and beta and cholinergic muscarinic
blockade did nQt significantly inhibit the vasQcQnstric-
tQr res~onse to NPY. ,The presence Qf NPY in the cQrQnary
autQnOmiC nerves and itS CQrQnary constrictor actiQn
independent Qf adrenergic and cholinergic receptors
suggests an important role in coronary vasoregulatory
mechanisms. This mediator might be a contributing factor
in the pathophysiology of the coronary artery spasm.
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CALCI'lWIN GENE RElATED PEPI'IDE IS A POI'ENT (»OCNAR¥
ARI'ERY DILATOR.
Jean McEwan, Sergio Chierchia MD, Graham Davies MD, John
Stevenson, Morris Bram MD, Attilio Maseri MD FACe, lain
McIntyre MD. Departments of Cardiovascular Medicine,
Clinical Pharmacology and Biochemistry, Royal Post-
graduate Medical School, lAndon, U.K.
The localizatioo of neuropeptides in the cardiovascular
system has suggested a physiological role of peptidergic
nerves in cardiovascular regulatioo. Calcitooin Gene
Related Peptide (03RP) is produced by post-
transcriptiooal nmificatioo of the calcitooin gene mRNA.
It circulates in man and has been identified in' the rat
heart particularly in the coronary arteries, and ar:pears
to be a potent systemic vasodilator in man. \-1e studied
the effect on corooary artery diameter of infusioo of
saline as control folla.red by 03RP in incremental doses
into the left coronary artery. Six patients were examined
during routine angiography. Four patients had atypical
chest pain and normal coronary arteries and 2 had variant
angina with coronary spasm superi.nlJOsed on non-critical
lesioos. The maximum dose of 200 ng/min for 5 minutes was
1/20th of the maximum systemic dose reported and caused
no systemic effect other than mild facial flushing.
COronary arteriography was repeated after each infusion
period and epicardial vessel diameter measured manually
and using a CMS carpJter system. No effect of saline was
found but a dose dependent increase in arterial diameter
occurred during 03RP infusion. The maximum increase in
proximal circumflex, and in proximal, mid and distal left
anterior descending artery diameter was 35%, 20%, 21% and
83%, respectively with a 32% increase at the site of the
two atheranatous lesions. Intracorooary injectioo of 1.5
ug 03RP relieved erganetrine-induced pain, sr elevatioo
and corooary spasm in 2 patients, though prior infusion
had not prevented the spasm.
The demonstration of dilatation of coronary arteries as
well as vascular localization suggests that 03RP could
have a role in the control of coronary SllOOth muscle
tone. -'
EPICARDIAL CORONARY ENDOTHELIAL DAMAGE PRODUCED BY
CHRONIC SPASM IN DOGS.
Alfred A. Bove, M.D., Ph.D., FACC, Jose M. Brum, M.D,
Qian Sufan, M.D. Mayo Clinic, Rochester, MN.
We have recently observed increased sensitivity to
serotonin vasoconstriction in endothelial damaged epi-
cardial coronary artery segments in vivo. In vitro stu-
dies have demonstrated that acute vasoconstriction can
produce areas of endothelial injury in large conducting
arteries. In this study, we examined the effects of
focal, chronic left anterior descending epicardial coro-
nary constriction in 6 dogs gi~n a 2 week perivascular
ergonovine (ergo) infusion (120 bg/hr) with a surgically
implanted perivascular catheter connected to an
implanted osmotic minipump. Focal constriction with
ergo, by quantitative coronary angiography, averaged
19.2% cross sectional reduction in 5 treated dogs. In 3
saline controls, area increased 12.3% (p<.Ol) following
angiographic study, the heart was removed, the arteries
flushed with saline, and perfusion fixed with 1.5% glu-
teraldehyde at 100 mm Hg for 4 hours. The arteries were
dissected, mounted and prepared for scanning electron-
microscopy. In all ergo constricted segments the
endothelium demonstrated disruption, and overlapping in
a shingle-like arrangement not found in untreated
arteries or in saline treated controls. These in vivo
data confirm in vitro studies demonstrating that focal
coronary spasm causes endothelial damage. Spasm induced
endothelial damage may be an initiating event in intra-
coronary thromhus formation, and in the production of
fixed coronary narrowing.
REGIONAL ALPHA 2 BLOCKADE IMPROVES FUNCTION
AND FLOW IN THE ISCHEMIC DOG MYOCARDIUM DURING
EXERCISE.
Rainald Seitelberger,M.D., Brian D.Guth,PhD, Gerd
Heusch,M.D., Kazuhiro Katayama,M.D., Jong-Dae Lee,M.D.
and John Ross,Jr.,M.D.,FACC, UC San Diego, La Jolla,
California.
Sympathetic vasoconstriction mediated by postsynaptic alpha
receptors could aggravate myocardial ischemia during exercise.
To investigate this question, we carried out experiments in
conscious dogs instrumented with an intracoronary (IC)
catheter and a hydraulic occluder on the circumflex coronary
artery. Systolic wall thickening (%WTH, sonomicrometry) and
regional myocardial blood flow (MBF, radiolabeled
microspheres) were assessed. After beta-blockade
(propranolol, 0.8mg!kg iv.), treadmill exercise (5mph, 5%
elevation) initially increased posterior wall (PW) %WTH, but
while running continued acute coronary stenosis then
decreased PW-%WTH from 21.0 + 1.8 (S.D.) to 5.1 + 1.6. With
steady state running MBF was-measured and the selective
alpha 2 blocker idazoxan was given IC (80llg!kg). PW-%WTH
promptly improved from 5.1 :t 1.6 to 10.8:t 2.8 (n=5, p<0.028)
without changing anterior wall %WTH, heart rate or arterial
pressure. In every experiment the PW subendocardial MBF
improved (0.17:t 0.05 vs 0.45:t 0.30mJ/min!g, n=5), and the PW
endo!epi ratio increased markedly (0.22 :t 0.09 vs 0.60 :t 0.41,
n=5). In the same model, the selective alpha I blocker
prazosin (20\lg!kg) diminished PW function and MBF and
reduced arterial pressure. We conclude that in the presence of
beta blockade, significant post junctional alpha 2 coronary
vasoconstriction is induced by exercise even with severe
ischemia. Regional alpha 2 blockade can markedly reduce
ischemia by attenuating sympathetic vasoconstriction. This
response may carry clinical implications for patients on beta
blockers and open a new approach to therapy.
